<SEC-DOCUMENT>0001178913-24-000730.txt : 20240227
<SEC-HEADER>0001178913-24-000730.hdr.sgml : 20240227
<ACCEPTANCE-DATETIME>20240227091546
ACCESSION NUMBER:		0001178913-24-000730
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		107
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240227
DATE AS OF CHANGE:		20240227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ReWalk Robotics Ltd.
		CENTRAL INDEX KEY:			0001607962
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36612
		FILM NUMBER:		24682564

	BUSINESS ADDRESS:	
		STREET 1:		3 HATNUFA ST.
		STREET 2:		FLOOR 6
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			2069203
		BUSINESS PHONE:		97249590123

	MAIL ADDRESS:	
		STREET 1:		3 HATNUFA ST.
		STREET 2:		FLOOR 6
		CITY:			YOKNEAM ILIT
		STATE:			L3
		ZIP:			2069203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Argo Medical Technologies Ltd.
		DATE OF NAME CHANGE:	20140513
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>zk2431037.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:lfwd="http://www.rewalk.com/20231231" xmlns:ecd="http://xbrl.sec.gov/ecd/2023"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>ReWalk Robotics Ltd. - 1607962 - 2024</title></head><body style="font-size:10pt;font-family:Times New Roman;"><div style="font-size: 10pt;"><div style="font-size: 10pt;"><div style="font-size: 10pt;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20230101to20231231" id="FFact_0000000001043">0001607962</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20230101to20231231" id="FFact_0000000001044">FY</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20230101to20231231" id="FFact_0000000001045">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="C_20230101to20231231" id="Fdei_EntityTaxIdentificationNumber20230221042354850">00-0000000</ix:nonNumeric><ix:nonFraction name="lfwd:FinancialExpensesAndIncomeNet" contextRef="C_20220101to20221231" id="Fxbrl_20230213140028626" unitRef="USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember" id="FFact_0000000001035" unitRef="pure" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember" id="Fxbrl_20230213145458513" unitRef="pure" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember" id="Fxbrl_20230213145510899" unitRef="pure" xsi:nil="true"></ix:nonFraction><ix:footnote id="FN20230213122658952" xml:lang="en-US">Less than 10%</ix:footnote>
<ix:nonFraction name="lfwd:FinancialExpensesIncomeNet" contextRef="C_20220101to20221231" id="Fxbrl_20230213115503054" unitRef="USD" xsi:nil="true"></ix:nonFraction><ix:footnote id="FN20230214190043507" xml:lang="en-US">Represents an amount lower than $1.</ix:footnote>
<ix:footnote id="FN20240226172242835" xml:lang="en-US">See Note 9a.</ix:footnote>
<ix:footnote id="FN20240226172623659" xml:lang="en-US">See Note 9f.</ix:footnote>
<ix:footnote id="FN20230213183214461" xml:lang="en-US">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.&#160;</ix:footnote>
<ix:footnote id="FN20230214191805234" xml:lang="en-US">Represents warrants for ordinary shares issuable upon an exercise price of $7.500 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited (&#8220;Kreos&#8221;) in connection with a loan made by Kreos to the Company and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2022.</ix:footnote>
<ix:footnote id="FN20230214191754407" xml:lang="en-US">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</ix:footnote>
<ix:footnote id="FN20230214191736834" xml:lang="en-US">Represents common warrants that were issued as part of the Company&#8217;s follow-on public offering in November 2018.</ix:footnote>
<ix:footnote id="FN20230214191719804" xml:lang="en-US">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on public offering in November 2018.</ix:footnote>
<ix:footnote id="FN20230214191708673" xml:lang="en-US">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on public offering in February 2019.</ix:footnote>
<ix:footnote id="FN20230214191658539" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019. </ix:footnote>
<ix:footnote id="FN20230214191649202" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</ix:footnote>
<ix:footnote id="FN20230214191637851" xml:lang="en-US">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019, and June 6, 2019, respectively. </ix:footnote>
<ix:footnote id="FN20230214191626730" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants. </ix:footnote>
<ix:footnote id="FN20230214191613929" xml:lang="en-US">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</ix:footnote>
<ix:footnote id="FN20230214191559676" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants. </ix:footnote>
<ix:footnote id="FN20230221050033557" xml:lang="en-US">	 Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020. As of December 31, 2022, 3,740,100 warrants were exercised for total consideration of $4,675,125. During the twelve months that ended December 31, 2022, no warrants were exercised.</ix:footnote>
<ix:footnote id="FN20230221050050277" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering. As of December 31, 2022, 230,160 warrants were exercised for total consideration of $359,625. During the twelve months that ended December 31, 2022, no warrants were exercised.</ix:footnote>
<ix:footnote id="FN20230221050124457" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020. As of December 31, 2022, 2,020,441 warrants were exercised for total consideration of $3,555,976. During the twelve months that ended December 31, 2022, no warrants were exercised.</ix:footnote>
<ix:footnote id="FN20230214191510956" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</ix:footnote>
<ix:footnote id="FN20230221050209309" xml:lang="en-US">	 Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020. As of December 31, 2022, 3,598,072 warrants were exercised for total consideration of $4,821,416. During the twelve months that ended December 31, 2022, no warrants were exercised.</ix:footnote>
<ix:footnote id="FN20230221050221334" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement. As of December 31, 2022, 225,981 warrants were exercised for total consideration of $405,003. During the twelve months that ended December 31, 2022, no warrants were exercised.</ix:footnote>
<ix:footnote id="FN20240224222832702" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in September 2021.</ix:footnote>
<ix:footnote id="FN20240224223024526" xml:lang="en-US">	 Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s September 2021 registered direct offering.</ix:footnote>
<ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" id="FFact_0000000000446" unitRef="pure" xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" id="FFact_0000000000448" unitRef="pure" xsi:nil="true"></ix:nonFraction><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="C_20231231_srtProductOrServiceAxis_lfwdSCIProductsMember" id="Fxbrl_20230214112251731">P5Y</ix:nonNumeric><ix:footnote id="FN20240224211802328" xml:lang="en-US">Balance presented net of unrecognized revenue that was not yet collected.</ix:footnote>
<ix:footnote id="FN20240224211739424" xml:lang="en-US">$401 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="lfwd-20231231.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20230101to20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-08-08</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-08</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipWarrantyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipWarrantyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipRentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipRentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipDistributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipDistributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230801to20230808"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-08</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_srtAsiaPacificMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_srtAsiaPacificMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_srtAsiaPacificMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_countryIL"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_countryUS"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtStatementGeographicalAxis_countryDE"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtStatementGeographicalAxis_countryDE"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtStatementGeographicalAxis_lfwdRestOfWorldMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfwd:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_lfwdRestOfWorldMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfwd:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtStatementGeographicalAxis_lfwdRestOfWorldMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfwd:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:BacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:BacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230930_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:RegisteredDirectMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20240227"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2024-02-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210202to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-02-02</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-02-19</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-02-19</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210901to20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-09-01</xbrli:startDate>
        <xbrli:endDate>2021-09-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210901to20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-09-01</xbrli:startDate>
        <xbrli:endDate>2021-09-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-09-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfwd:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfwd:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfwd:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeThreeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150101to20151231_deiLegalEntityAxis_lfwdKreosCapitalVMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:KreosCapitalVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20161228_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lfwd:KreosCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2016-12-28</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20151231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lfwd:KreosCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220602_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-02</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210201to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-02-01</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210201to20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-02-01</xbrli:startDate>
        <xbrli:endDate>2021-02-19</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInDecember2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInDecember2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInJuly2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInJuly2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020TwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020TwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:December2020PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:December2020PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220721_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-07-21</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221222_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-22</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdBestOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:BestOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231201to20231212_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfwd:TwoZeroTwoThreeReorganizationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2023-12-12</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfwd:TwoZeroTwoThreeReorganizationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtProductOrServiceAxis_lfwdReStoreProductMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ReStoreProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtProductOrServiceAxis_lfwdSCIProductsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:SCIProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtProductOrServiceAxis_usgaapProductMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtProductOrServiceAxis_usgaapProductMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtProductOrServiceAxis_usgaapProductMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_lfwdRevenueObligationAxis_lfwdRentalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:RevenueObligationAxis">lfwd:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_lfwdRevenueObligationAxis_lfwdRentalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:RevenueObligationAxis">lfwd:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_lfwdRevenueObligationAxis_lfwdRentalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lfwd:RevenueObligationAxis">lfwd:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ServiceAndWarrantyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ServiceAndWarrantyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ServiceAndWarrantyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230930"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230811_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-08-11</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230812to20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-08-12</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:RewalkRoboticsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:RewalkRoboticsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:RewalkRoboticsGmbhMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapStateAndLocalJurisdictionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20231231_deiLegalEntityAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapForeignCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-01-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001607962</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-01-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:unit id="NIS_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="segment"><xbrli:measure>lfwd:segment</xbrli:measure></xbrli:unit>
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="FFact_0000000001035" toRefs="FN20230213122658952"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213145458513" toRefs="FN20230213122658952"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213145510899" toRefs="FN20230213122658952"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213115913875" toRefs="FN20230214190043507"></ix:relationship><ix:relationship fromRefs="FFact_0000000000327" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="FFact_0000000000327" toRefs="FN20240226172623659"></ix:relationship><ix:relationship fromRefs="FFact_0000000000328" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="FFact_0000000000328" toRefs="FN20240226172623659"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213124756646" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213124808685" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213133255195" toRefs="FN20240226172623659"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213133255195" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213231152958" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213231158622" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213231209903" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213231215958" toRefs="FN20240226172242835"></ix:relationship><ix:relationship fromRefs="FFact_0000000000717" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000719" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000723" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000725" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000735" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000737" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000741" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000743" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000745" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000747" toRefs="FN20230213183214461"></ix:relationship><ix:relationship fromRefs="FFact_0000000000766" toRefs="FN20230214191805234"></ix:relationship><ix:relationship fromRefs="FFact_0000000000767" toRefs="FN20230214191805234"></ix:relationship><ix:relationship fromRefs="FFact_0000000000768" toRefs="FN20230214191805234"></ix:relationship><ix:relationship fromRefs="FFact_0000000000769" toRefs="FN20230214191754407"></ix:relationship><ix:relationship fromRefs="FFact_0000000000770" toRefs="FN20230214191754407"></ix:relationship><ix:relationship fromRefs="FFact_0000000000771" toRefs="FN20230214191754407"></ix:relationship><ix:relationship fromRefs="FFact_0000000000772" toRefs="FN20230214191736834"></ix:relationship><ix:relationship fromRefs="FFact_0000000000773" toRefs="FN20230214191736834"></ix:relationship><ix:relationship fromRefs="FFact_0000000000774" toRefs="FN20230214191736834"></ix:relationship><ix:relationship fromRefs="FFact_0000000000775" toRefs="FN20230214191736834"></ix:relationship><ix:relationship fromRefs="FFact_0000000000776" toRefs="FN20230214191719804"></ix:relationship><ix:relationship fromRefs="FFact_0000000000777" toRefs="FN20230214191719804"></ix:relationship><ix:relationship fromRefs="FFact_0000000000778" toRefs="FN20230214191719804"></ix:relationship><ix:relationship fromRefs="FFact_0000000000779" toRefs="FN20230214191719804"></ix:relationship><ix:relationship fromRefs="FFact_0000000000780" toRefs="FN20230214191708673"></ix:relationship><ix:relationship fromRefs="FFact_0000000000781" toRefs="FN20230214191708673"></ix:relationship><ix:relationship fromRefs="FFact_0000000000782" toRefs="FN20230214191708673"></ix:relationship><ix:relationship fromRefs="FFact_0000000000783" toRefs="FN20230214191708673"></ix:relationship><ix:relationship fromRefs="FFact_0000000000784" toRefs="FN20230214191658539"></ix:relationship><ix:relationship fromRefs="FFact_0000000000785" toRefs="FN20230214191658539"></ix:relationship><ix:relationship fromRefs="FFact_0000000000786" toRefs="FN20230214191658539"></ix:relationship><ix:relationship fromRefs="FFact_0000000000787" toRefs="FN20230214191658539"></ix:relationship><ix:relationship fromRefs="FFact_0000000000788" toRefs="FN20230214191649202"></ix:relationship><ix:relationship fromRefs="FFact_0000000000789" toRefs="FN20230214191649202"></ix:relationship><ix:relationship fromRefs="FFact_0000000000790" toRefs="FN20230214191649202"></ix:relationship><ix:relationship fromRefs="FFact_0000000000791" toRefs="FN20230214191649202"></ix:relationship><ix:relationship fromRefs="FFact_0000000000792" toRefs="FN20230214191637851"></ix:relationship><ix:relationship fromRefs="FFact_0000000000793" toRefs="FN20230214191637851"></ix:relationship><ix:relationship fromRefs="FFact_0000000000794" toRefs="FN20230214191637851"></ix:relationship><ix:relationship fromRefs="FFact_0000000000795" toRefs="FN20230214191637851"></ix:relationship><ix:relationship fromRefs="FFact_0000000000796" toRefs="FN20230214191626730"></ix:relationship><ix:relationship fromRefs="FFact_0000000000797" toRefs="FN20230214191626730"></ix:relationship><ix:relationship fromRefs="FFact_0000000000798" toRefs="FN20230214191626730"></ix:relationship><ix:relationship fromRefs="FFact_0000000000799" toRefs="FN20230214191626730"></ix:relationship><ix:relationship fromRefs="FFact_0000000000800" toRefs="FN20230214191613929"></ix:relationship><ix:relationship fromRefs="FFact_0000000000801" toRefs="FN20230214191613929"></ix:relationship><ix:relationship fromRefs="FFact_0000000000802" toRefs="FN20230214191613929"></ix:relationship><ix:relationship fromRefs="FFact_0000000000803" toRefs="FN20230214191613929"></ix:relationship><ix:relationship fromRefs="FFact_0000000000804" toRefs="FN20230214191559676"></ix:relationship><ix:relationship fromRefs="FFact_0000000000805" toRefs="FN20230214191559676"></ix:relationship><ix:relationship fromRefs="FFact_0000000000806" toRefs="FN20230214191559676"></ix:relationship><ix:relationship fromRefs="FFact_0000000000807" toRefs="FN20230214191559676"></ix:relationship><ix:relationship fromRefs="FFact_0000000000808" toRefs="FN20230221050033557"></ix:relationship><ix:relationship fromRefs="FFact_0000000000809" toRefs="FN20230221050033557"></ix:relationship><ix:relationship fromRefs="FFact_0000000000810" toRefs="FN20230221050033557"></ix:relationship><ix:relationship fromRefs="FFact_0000000000811" toRefs="FN20230221050033557"></ix:relationship><ix:relationship fromRefs="FFact_0000000000812" toRefs="FN20230221050050277"></ix:relationship><ix:relationship fromRefs="FFact_0000000000813" toRefs="FN20230221050050277"></ix:relationship><ix:relationship fromRefs="FFact_0000000000814" toRefs="FN20230221050050277"></ix:relationship><ix:relationship fromRefs="FFact_0000000000815" toRefs="FN20230221050050277"></ix:relationship><ix:relationship fromRefs="FFact_0000000000816" toRefs="FN20230221050124457"></ix:relationship><ix:relationship fromRefs="FFact_0000000000817" toRefs="FN20230221050124457"></ix:relationship><ix:relationship fromRefs="FFact_0000000000818" toRefs="FN20230221050124457"></ix:relationship><ix:relationship fromRefs="FFact_0000000000819" toRefs="FN20230221050124457"></ix:relationship><ix:relationship fromRefs="FFact_0000000000820" toRefs="FN20230214191510956"></ix:relationship><ix:relationship fromRefs="FFact_0000000000821" toRefs="FN20230214191510956"></ix:relationship><ix:relationship fromRefs="FFact_0000000000822" toRefs="FN20230214191510956"></ix:relationship><ix:relationship fromRefs="FFact_0000000000823" toRefs="FN20230214191510956"></ix:relationship><ix:relationship fromRefs="FFact_0000000000824" toRefs="FN20230221050209309"></ix:relationship><ix:relationship fromRefs="FFact_0000000000825" toRefs="FN20230221050209309"></ix:relationship><ix:relationship fromRefs="FFact_0000000000826" toRefs="FN20230221050209309"></ix:relationship><ix:relationship fromRefs="FFact_0000000000827" toRefs="FN20230221050209309"></ix:relationship><ix:relationship fromRefs="FFact_0000000000828" toRefs="FN20230221050221334"></ix:relationship><ix:relationship fromRefs="FFact_0000000000829" toRefs="FN20230221050221334"></ix:relationship><ix:relationship fromRefs="FFact_0000000000830" toRefs="FN20230221050221334"></ix:relationship><ix:relationship fromRefs="FFact_0000000000831" toRefs="FN20230221050221334"></ix:relationship><ix:relationship fromRefs="FFact_0000000000832" toRefs="FN20240224222832702"></ix:relationship><ix:relationship fromRefs="FFact_0000000000833" toRefs="FN20240224222832702"></ix:relationship><ix:relationship fromRefs="FFact_0000000000834" toRefs="FN20240224222832702"></ix:relationship><ix:relationship fromRefs="FFact_0000000000835" toRefs="FN20240224222832702"></ix:relationship><ix:relationship fromRefs="FFact_0000000000836" toRefs="FN20240224223024526"></ix:relationship><ix:relationship fromRefs="FFact_0000000000837" toRefs="FN20240224223024526"></ix:relationship><ix:relationship fromRefs="FFact_0000000000838" toRefs="FN20240224223024526"></ix:relationship><ix:relationship fromRefs="FFact_0000000000839" toRefs="FN20240224223024526"></ix:relationship><ix:relationship fromRefs="FFact_0000000000416" toRefs="FN20240224211802328"></ix:relationship><ix:relationship fromRefs="FFact_0000000000417" toRefs="FN20240224211802328"></ix:relationship><ix:relationship fromRefs="FFact_0000000000418" toRefs="FN20240224211739424"></ix:relationship><ix:relationship fromRefs="FFact_0000000000418" toRefs="FN20240224211802328"></ix:relationship><ix:relationship fromRefs="FFact_0000000000419" toRefs="FN20240224211739424"></ix:relationship><ix:relationship fromRefs="FFact_0000000000419" toRefs="FN20240224211802328"></ix:relationship><ix:relationship fromRefs="FFact_0000000000446" toRefs="FN20230213122658952"></ix:relationship><ix:relationship fromRefs="FFact_0000000000448" toRefs="FN20230213122658952"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213122445435" toRefs="FN20230213122658952"></ix:relationship><ix:relationship fromRefs="Fxbrl_20230213122457908" toRefs="FN20230213122658952"></ix:relationship></ix:resources></ix:header></div><div><div style="">
  <div>
    <div>
      <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center"/>
      <div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold">&#160;</div>
        <div>
          <div>
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:14pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">UNITED STATES</span><br/>&#160;<span style="color:rgb(0, 0, 0)">SECURITIES AND EXCHANGE COMMISSION</span></span></span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Washington, D.C. 20549</span></span></div>
              <div style="line-height:1.25">
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-size:14pt;font-weight:bold"><span style="font-size:14pt"><span><span style="font-family:Times New Roman,Times,serif">FORM <ix:nonNumeric id="Fxbrl_20230501112549533" name="dei:DocumentType" contextRef="C_20230101to20231231">10-K</ix:nonNumeric></span></span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20230501112555996" name="dei:DocumentAnnualReport" contextRef="C_20230101to20231231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span>&#160;<span style="font-weight:bold">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the fiscal year ended&#160;<ix:nonNumeric id="Fxbrl_20231216103530967" name="dei:DocumentPeriodEndDate" contextRef="C_20230101to20231231" format="ixt:date-monthname-day-year-en"><ix:nonNumeric id="Fxbrl_20231216111836216" name="dei:CurrentFiscalYearEndDate" contextRef="C_20230101to20231231" format="ixt:date-monthname-day-en">December 31</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20231216111856641" name="dei:DocumentFiscalYearFocus" contextRef="C_20230101to20231231">2023</ix:nonNumeric></ix:nonNumeric></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">or</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20230501112602301" name="dei:DocumentTransitionReport" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span>&#160;<span style="font-weight:bold">TRANSITION REPORT PURSUANT OR SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the transition period from ______ to ______</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commission File Number: <ix:nonNumeric id="Fxbrl_20230501112759821" name="dei:EntityFileNumber" contextRef="C_20230101to20231231">001-36612</ix:nonNumeric></span></span>
                <p style="margin:0pt">&#160;</p>
              </div>
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><img alt="image00001.jpg" src="image00001.jpg" style="width:256px;height:126px"/></span></span></div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:16pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold;color:rgb(0, 0, 0)"><ix:nonNumeric id="Fxbrl_20230501112814956" name="dei:EntityRegistrantName" contextRef="C_20230101to20231231">ReWalk Robotics Ltd.</ix:nonNumeric></span></span></span></span><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Exact name of registrant as specified in charter)</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49.02%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501112819931" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20230101to20231231" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></span></div>
                    </td>
                    <td style="width:2.04%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:48.95%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Not applicable</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.02%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(State or other jurisdiction of</span></span></div>
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">incorporation or organization)</span></span></div>
                    </td>
                    <td style="width:2.04%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:48.95%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(I.R.S. employer</span></span></div>
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">identification no.)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.02%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:2.04%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:48.95%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.02%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501112826511" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20231231">3 Hatnufa Street</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230501112834811" name="dei:EntityAddressAddressLine2" contextRef="C_20230101to20231231">Floor 6</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230501112839187" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20231231">Yokneam Illit</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230501112850769" name="dei:EntityAddressCountry" contextRef="C_20230101to20231231" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></div>
                    </td>
                    <td style="width:2.04%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:48.95%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501112859220" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20231231">2069203</ix:nonNumeric></span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49.02%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Address of principal executive offices)</span></span></div>
                    </td>
                    <td style="width:2.04%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:48.95%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Zip Code)</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric id="Fxbrl_20230501112906186" name="dei:CityAreaCode" contextRef="C_20230101to20231231">972</ix:nonNumeric>.<ix:nonNumeric id="Fxbrl_20230501112915301" name="dei:LocalPhoneNumber" contextRef="C_20230101to20231231">4.959.0123</ix:nonNumeric></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities registered pursuant to Section 12(b) of the Act:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:32.17%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Title of Each Class</span></span></div>
                    </td>
                    <td style="width:1.84%;vertical-align:bottom">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:31.94%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading Symbol(s)</span></span></div>
                    </td>
                    <td style="width:1.84%;vertical-align:bottom">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:32.2%;vertical-align:bottom;border-bottom:#000000 2px solid">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name of Each Exchange on Which Registered</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:32.17%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240226144236291" name="dei:Security12bTitle" contextRef="C_20230101to20231231">Ordinary Shares, par value NIS 0.25 per share</ix:nonNumeric></span></span></p>
                      </div>
                    </td>
                    <td style="width:1.84%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:31.94%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501112929217" name="dei:TradingSymbol" contextRef="C_20230101to20231231">LFWD</ix:nonNumeric></span></span></div>
                    </td>
                    <td style="width:1.84%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:32.2%;vertical-align:top">
                      <div style="text-align:center;line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501112936746" name="dei:SecurityExchangeName" contextRef="C_20230101to20231231" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities Registered Pursuant to Section 12(g) of the Act: None</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;</span>&#8194;<ix:nonNumeric id="Fxbrl_20230501113149840" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_20230101to20231231">No</ix:nonNumeric>&#160;<span>&#9746;</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;</span>&#8194;<ix:nonNumeric id="Fxbrl_20230501113158305" name="dei:EntityVoluntaryFilers" contextRef="C_20230101to20231231">No</ix:nonNumeric>&#160;<span>&#9746;</span></span></span></div>
              <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
                <div style="page-break-after:always">
                  <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
                </div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501113204770" name="dei:EntityCurrentReportingStatus" contextRef="C_20230101to20231231">Yes</ix:nonNumeric>&#8194;<span>&#9746;</span>&#8194;No&#8194;<span>&#9744;</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501113210527" name="dei:EntityInteractiveDataCurrent" contextRef="C_20230101to20231231">Yes</ix:nonNumeric>&#160;<span>&#9746;</span>&#8194;No&#8194;<span>&#9744;</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></span></div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:46.63%;vertical-align:top">&#160;</td>
                    <td style="width:1.82%;vertical-align:top">&#160;</td>
                    <td style="width:46.82%;vertical-align:top">&#160;</td>
                    <td style="width:4.73%;vertical-align:top">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:46.63%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Large accelerated filer <span>&#9744;</span></span></span></div>
                    </td>
                    <td style="width:1.82%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:46.82%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accelerated filer&#8194;<span>&#9744;</span></span></span></div>
                    </td>
                    <td style="width:4.73%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:46.63%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230501113218185" name="dei:EntityFilerCategory" contextRef="C_20230101to20231231" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric><span>&#9746;</span></span></span></div>
                    </td>
                    <td style="width:1.82%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:46.82%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Smaller reporting company <ix:nonNumeric id="Fxbrl_20230501113230475" name="dei:EntitySmallBusiness" contextRef="C_20230101to20231231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></span></div>
                    </td>
                    <td style="width:4.73%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:46.63%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:1.82%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                    <td style="width:46.82%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Emerging growth company <ix:nonNumeric id="Fxbrl_20230501113248536" name="dei:EntityEmergingGrowthCompany" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
                    </td>
                    <td style="width:4.73%;vertical-align:top">
                      <div style="line-height:1.25;color:#000000;font-family:'Times New Roman', serif">&#160;</div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span>&#9744;</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 USC. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span><ix:nonNumeric id="Fxbrl_20230501113300995" name="dei:IcfrAuditorAttestationFlag" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <span><ix:nonNumeric id="Fxbrl_20231216101033126" name="dei:DocumentFinStmtErrorCorrectionFlag" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <span>&#9744;</span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#8194;<span>&#9744;</span>&#8194;No&#8194;<span><ix:nonNumeric id="Fxbrl_20230501113316846" name="dei:EntityShellCompany" contextRef="C_20230101to20231231" format="ixt:fixed-false">&#9746;</ix:nonNumeric></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The aggregate market value of the Ordinary Shares held by non-affiliates of the Registrant based upon the closing price of the Ordinary Shares as reported by The Nasdaq Capital Market on June 30, 2023 (the last business day of the Registrant&#8217;s most recently completed second fiscal quarter) was $<ix:nonFraction id="Fxbrl_20230501113328597" name="dei:EntityPublicFloat" contextRef="C_20230630" unitRef="USD" scale="0" decimals="0" format="ixt:num-dot-decimal">35,050,478</ix:nonFraction>.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of February 27, 2024, the Registrant had outstanding <ix:nonFraction id="Fxbrl_20230501113339229" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20240227" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">59,480,132</ix:nonFraction> Ordinary Shares, par value NIS 0.25 per share.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">DOCUMENTS INCORPORATED BY REFERENCE</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Portions of our proxy statement for our 2024 Annual Meeting of Shareholders, which is to be filed within 120 days after the end of our 2023 fiscal year, are incorporated by reference into Part III of this annual report on Form 10-K.</span></span></div>
            </div>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000"/>
          </div>
        </div>
        <div>&#160;</div>
      </div>
    </div>
  </div>
</div><div style="">
  <!-- Field: Include-Text; File: pf\body.htm; Date: 2024%2D02%2D27T15:36:29; Size: 0x000BBC60; Options: XMLPreprocess -->
<div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold">REWALK ROBOTICS LTD.<br/> FORM 10-K FOR THE YEAR ENDED DECEMBER&#160;31,
2023<br/> TABLE OF CONTENTS</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"> <br/> </div>

<table cellspacing="0" cellpadding="2" border="0" id="z59deb5f7bf5d4795bc56752e72cdb921" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Page<br/> No</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">PART I</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">&#160;</td>
    <td style="width: 86%; vertical-align: top">&#160;</td>
    <td style="width: 5.94%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTI">ITEM 1.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTI">BUSINESS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">1</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1A.RISKFACTORS">ITEM&#160;1A.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1A.RISKFACTORS">RISK FACTORS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">24</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1B.UNRESOLVEDSTAFFCOM">ITEM 1B.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1B.UNRESOLVEDSTAFFCOM">UNRESOLVED STAFF COMMENTS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">55</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1B.UNRESOLVEDSTAFFCOM">ITEM 1C.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM1B.UNRESOLVEDSTAFFCOM">CYBERSECURITY</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom; text-align: center">&#160;55</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2.PROPERTIES">ITEM 2.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2.PROPERTIES">PROPERTIES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">56</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">&#160;</td>
    <td style="width: 86%; vertical-align: top">&#160;</td>
    <td style="width: 5.94%; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2.PROPERTIES">ITEM 3.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2.PROPERTIES">LEGAL PROCEEDINGS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">56</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2.PROPERTIES">ITEM 4.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM2.PROPERTIES">MINE SAFETY DISCLOSURES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">56</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">PART II</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTII">ITEM&#160;5.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTII">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES
        OF EQUITY SECURITIES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">57</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM6.RESERVED">ITEM 6.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM6.RESERVED">SELECTED FINANCIAL DATA</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">58</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM6.RESERVED">ITEM&#160;7.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM6.RESERVED">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">58</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM7A.QUANTITATIVEANDQUA">ITEM&#160;7A.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM7A.QUANTITATIVEANDQUA">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></div>
        </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">71</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8.FINANCIALSTATEMENTS">ITEM 8.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8.FINANCIALSTATEMENTS">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">71</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8.FINANCIALSTATEMENTS">ITEM 9.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8.FINANCIALSTATEMENTS">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
        DISCLOSURE</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">71</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8.FINANCIALSTATEMENTS">ITEM 9A.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM8.FINANCIALSTATEMENTS">CONTROLS AND PROCEDURES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">71</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM9B.OTHERINFORMATION">ITEM 9B.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM9B.OTHERINFORMATION">OTHER INFORMATION</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">72</div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM9C"><span style="font-weight: normal">ITEM 9C.</span></a></div> </td>
    <td rowspan="1" style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM9C"><span style="font-weight: normal">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
        INSPECTIONS</span></a></div> </td>
    <td rowspan="1" style="width: 5.94%; vertical-align: bottom; text-align: center">72<br/> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">PART III</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIII">ITEM 10.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIII">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">73</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">ITEM 11.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">EXECUTIVE COMPENSATION</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom; text-align: center">&#160;74</td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">ITEM 12.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
        RELATED STOCKHOLDER MATTERS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom; text-align: center">74<br/> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">ITEM 13.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></div>
        </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">74</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">ITEM 14.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#ITEM11.EXECUTIVECOMPENSAT">PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">74</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">PART IV</div> </td> </tr>
  <tr>
    <td colspan="3" style="vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIV">ITEM 15.</a></div> </td>
    <td style="width: 86%; vertical-align: top">
        <div style="line-height: 1.25"><a href="#PARTIV">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">75</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#ITEM16.FORM10-KSUMMARY">ITEM 16.</a></div> </td>
    <td style="width: 86%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="#ITEM16.FORM10-KSUMMARY">FORM 10-K SUMMARY</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom; text-align: center">77</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#SIGNATURES">SIGNATURES</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom; text-align: center">78</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#POWEROFATTORNEY">POWER OF ATTORNEY</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom; text-align: center">79</td> </tr>
  <tr>
    <td colspan="2" style="vertical-align: top">
        <div style="line-height: 1.25"><a href="#a_001">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</a></div> </td>
    <td style="width: 5.94%; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25">F -1</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25; text-align: center">i<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Definitions and Introduction</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our legal name is ReWalk Robotics Ltd. As of January 29, 2024,
we began doing business as &#8220;Lifeward&#8221;. We are a company limited by shares organized under the laws of the State of Israel
and were founded in 2001. In September 2014, we listed our shares on The Nasdaq Global Market, and in May 2017, we transferred our listing
to The Nasdaq Capital Market. We have irrevocably appointed Lifeward, Inc. (formerly ReWalk Robotics, Inc.) as our agent to receive service
of process in any action against us in any United States federal or state court. The address of Lifeward, Inc. is 200 Donald Lynch Blvd.,
Marlborough, Massachusetts 01752. As used herein, and unless the context clearly indicates otherwise, the terms &#8220;ReWalk&#8221;,
&#8220;Lifeward&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or &#8220;ours&#8221; refer to
ReWalk Robotics Ltd. DBA Lifeward and its subsidiaries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">Special Note Regarding Forward-Looking Statements</span>&#160;<span style="font-weight: bold">and
Risk Factors Summary</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">This annual report on Form 10-K (&#8220;annual report&#8221;) contains
forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, Section
21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995, that are based on our management&#8217;s beliefs and assumptions and on information currently available
to our management. Forward-looking statements include information concerning our possible or assumed future results of operations, business
strategies, financing plans, competitive position, industry environment, potential growth opportunities, potential market opportunities
and the effects of competition. Forward-looking statements may include projections regarding our future performance and, in some cases,
can be identified by words such as &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;seek,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221;
&#8220;project,&#8221; &#8220;future,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or similar expressions that
convey uncertainty of future events or outcomes and the negatives of those terms. These statements may be found in the sections of this
annual report titled &#8220;Part I. Item 1. Business,&#8221; &#8220;Part I. Item 1A. Risk Factors,&#8221; &#8220;Part II. Item 7. Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this annual report. The statements are
based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us.
These statements are only predictions based upon our current expectations and projections about future events. There are important factors
that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of
activity, performance or achievements expressed or implied by the statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">These factors include those listed in &#8220;Part I. Item 1A. Risk
Factors,&#8221; including those factors summarized below.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf1ed1c1db6ca403ea059140372ae2713" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our expectations regarding future growth, including our ability to increase sales in our existing geographic markets and expand to
        new markets;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="ze8bd31c99787493b89548d308154cbec" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to maintain and grow our reputation and the market acceptance of our products;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z476510d819ce4a0db1caa81b3fab76b3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to achieve reimbursement from third-party payors or advance Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;)
        coverage for our products;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zfdd00059ad1c4aedae125fb4536e1132" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to regain and maintain compliance with the continued requirements of The Nasdaq Capital Market and the risk that our
        ordinary shares will be delisted if we fail to regain and maintain compliance with such requirements;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z6e621f088f7d48fd8fe460faa0b918ef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to successfully integrate the operations of AlterG, Inc. into our organization, and realize the anticipated benefits
        therefrom;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z69afddc055604c6499d44c727eb7d916" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to have sufficient funds to meet certain future capital requirements, which could impair our efforts to develop and commercialize
        existing and new products;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z334c427520274c2a8f0922cc1c096b0c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to leverage our sales, marketing and training infrastructure;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z97a0a7f6f980453bace805f67a5632bf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to grow our business through acquisitions of businesses, products or technologies, and the failure to manage acquisitions,
        or the failure to integrate them with our existing business;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zafd1a6046c8640d3acc07866d95b836f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our expectations as to our clinical research program and clinical results;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z329aa308d4344045b5e4db0e14579ff1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to obtain certain components of our products from third-party suppliers and our continued access to our product manufacturers;</div>
        </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z26d6c08cd0664e3db95dee73d55e70d0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to improve our products and develop new products;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zb1e162b40228470e956428a9ef79bb83" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our compliance with medical device reporting regulations to report adverse events involving our products, which could result in voluntary
        corrective actions or enforcement actions such as mandatory recalls, and the potential impact of such adverse events on our ability to
        market and sell our products;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z4723918089234191bbf290f72780d5dd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to gain and maintain regulatory approvals and to comply with any post-marketing requests;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zeb1dcb05f8b44cdab175683b4f369143" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the risk of a cybersecurity attack or incident relating to our information technology systems significantly disrupting our business
        operations;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z9e551b60c05c4f598b7370c0039cbf73" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to maintain adequate protection of our intellectual property and to avoid violation of the intellectual property rights
        of others;</div> </td> </tr>
  </table>

<div style="text-align: center"> <br/> ii<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" id="z3140ad2b6c5b425eb016a546c4e31066" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the impact of substantial sales of our shares by certain shareholders on the market price of our ordinary shares;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z8df0a65348614c9ab2de9ba56875210c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our ability to use effectively the proceeds of our offerings of securities;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zad4493feeb04477ba436a981bc2bcad1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the impact of the market price of our ordinary shares on the determination of whether we are a passive foreign investment company;</div>
        </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zb3b4d614343845f19c139d5f6e50355b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>market and other conditions, including the extent to which inflation or global instability may disrupt our business operations or
        our financial condition or the financial condition of our customers and suppliers, including the outbreak of war between Israel and Hamas
        and the ongoing tension between China and Taiwan; and</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z0ec8f44f993d462ebfada0160c9fdf8f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>other factors discussed in &#8220;Part I. Item 1A. Risk Factors.&#8221;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">You should not rely upon forward-looking statements as predictions
of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee
that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be
achieved or will occur.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">You should not put undue reliance on any forward-looking statements.
Any forward-looking statement in this annual report speaks only as of the date hereof. Except as required by law, we undertake no obligation
to update publicly any forward-looking statements for any reason after the date of this annual report, to conform these statements to
actual results or to changes in our expectations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Where You Can Find Other Information</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our principal executive offices are located at 3 Hatnufa Street,
Floor 6, Yokneam Illit 2069203, Israel, and our telephone number is +972 (4) 959-0123. Our website is golifeward.com<span style="font-style: italic">.&#160;</span>Information
contained, or that can be accessed through, our website does not constitute a part of this annual report and is not incorporated by reference
herein. We have included our website address in this annual report solely for informational purposes. Information that we furnish or file
with the Securities and Exchange Commission (the &#8220;SEC&#8221;), including annual reports on Form 10-K, quarterly reports on Form
10-Q, current reports on Form 8-K and any amendments to, or exhibits included in, these reports are available for download, free of charge,
on our website as soon as reasonably practicable after such materials are filed or furnished with the SEC. The SEC also maintains a website
at www.SEC.gov that contains reports, proxy and information statements, and other information regarding&#160;issuers&#160;that file electronically
with the SEC.&#160;Our SEC filings, including exhibits filed or furnished&#160;therewith,&#160;are&#160;also&#160;available&#160;on&#160;this&#160;website.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div style="text-align: center; line-height: 1.25; font-family: Times New Roman,Times,serif">iii<br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>
<!--PROfilePageNumberReset%Num%1%%%-->

<div class="BRPFPageFooter">

<div style="line-height: 1.25"><br/> </div> </div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTI"><!--Anchor--></span>PART I</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 1. BUSINESS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are a medical device company that designs, develops, and commercializes
life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health
benefits in clinical settings as well as in the home and community.&#160; Our initial product offerings were the ReWalk Personal and ReWalk
Rehabilitation Exoskeleton devices for individuals with spinal cord injury (&#8220;SCI Products&#8221;).&#160; These devices are robotic
exoskeletons that are designed for individuals with paraplegia that use our patented tilt-sensor technology and an onboard computer and
motion sensors to drive motorized legs that power movement.&#160; These SCI Products allow individuals with spinal cord injury (&#8220;SCI&#8221;)
the ability to stand and walk again during everyday activities at home or in the community. In March 2023, we received clearance of our
premarket notification (&#8220;510(k)&#8221;) from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) for the ReWalk Personal Exoskeleton
with stair and curb functionality, which adds usage on stairs and curbs to the indication for use for the device in the United States
(U.S.). The clearance permits U.S. customers to participate in more walking activities in real-world environments in their daily lives
where stairs or curbs may have previously limited them when using the exoskeleton for its intended, FDA-indicated uses. This feature has
been available in Europe since initial CE Clearance, and real-world data from a cohort of 47 European users throughout a period of over
seven years consisting of over 18,000 stair steps was collected to demonstrate the safety and efficacy of this feature and support the
FDA submission.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have sought to expand our product offerings beyond the SCI Products
through internal development and distribution agreements and acquisitions.&#160; We have developed our ReStore Exo-Suit device, which
we began commercializing in June 2019. The ReStore is a powered, lightweight soft exo-suit intended for use during the rehabilitation
of individuals with lower limb disabilities due to stroke. During the second quarter of 2020, we finalized and moved to implement two
separate agreements to distribute additional product lines in the United States. We are the exclusive distributor of the MYOLYN MyoCycle
FES Pro cycles to U.S. rehabilitation clinics and for the MyoCycle Home cycles available to US veterans through the Veterans Health Administration
(&#8220;VHA&#8221;) hospitals. In the second quarter of 2020, we also became the exclusive distributor of the MediTouch Tutor movement
biofeedback systems in the United States; however, due to unsatisfactory sales performance of the MediTouch product lines, we terminated
this agreement as of January 31, 2023. We refer to the MediTouch and MyoCycle devices as our &#8220;Distributed Products.&#8221;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">

<div style="line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">On August 11, 2023, we made our first acquisition to supplement
our internal growth when we acquired AlterG, Inc. (&#8220;AlterG&#8221;), a leading provider of Anti-Gravity systems for use in physical
and neurological rehabilitation. Our AlterG Anti-Gravity systems use patented, National Aeronautics and Space Administration (&#8220;NASA&#8221;)
derived differential air pressure (&#8220;DAP&#8221;) technology to reduce the effects of gravity and allow patients to rehabilitate with
finely calibrated support and reduced pain. AlterG Anti-Gravity systems are utilized in over 4,000 facilities globally in more than 40
countries. We will continue to evaluate other products for distribution or acquisition that can broaden our product offerings further
to help individuals with neurological injury and disability.</div> </div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are in the research stage of ReBoot, a personal soft exo-suit
for home and community use by individuals post-stroke, and we are currently evaluating the reimbursement landscape and the potential clinical
impact of this device. This product would be a complementary product to ReStore as it provides active assistance to the ankle during plantar
flexion and dorsiflexion for gait and mobility improvement in the home environment, and it received Breakthrough Device Designation from
the FDA in November 2021.&#160; Further investment in the development path of the ReBoot was paused in 2023 pending determination regarding
the clinical and commercial opportunity of this device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our principal markets are primarily in the United States and Europe
with some lesser sales in Asia, the Middle East and South America. We sell our products primarily directly in the United States, through
a combination of direct sales and distributors (depending on the product line) in Germany, Canada, and Australia, and primarily through
distributors in other markets. In markets where we sell direct to consumers, we have established relationships with clinics and rehabilitation
centers, professional and college sports teams, and individuals and organizations in the SCI community, and in markets where we do not
sell direct to consumers, our distributors maintain these relationships. We have primary offices in Marlborough, Massachusetts, Fremont,
California, Berlin, Germany and Yokneam, Israel, from where we operate our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have in the past generated and expect to generate in the future
revenue from a combination of clinics and rehabilitation centers, commercial distributors, third-party payors (including private and government
payors), professional and college sports teams, and self-pay individuals. While a broad uniform policy of coverage and reimbursement by
third-party commercial payors currently does not exist in the United States for exoskeleton technologies such as the ReWalk Personal Exoskeleton,
we are pursuing various paths of reimbursement and support fundraising efforts by institutions and clinics, such as the VHA policy that
was issued in December 2015 for the evaluation, training, and procurement of ReWalk Personal Exoskeleton systems for all qualifying veterans
living with SCI across the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">We have also pursued updates with the CMS to clarify the Medicare
coverage category (i.e., benefit category) applicable for personal exoskeletons. In 2022, the National Spinal Cord Injury Statistical
Center (&#8220;NSCISC&#8221;) reported that CMS is the primary payor for approximately 57% of the SCI population which are at least five
years post their injury date, with Medicare representing a majority of this percentage. In July 2020, following a successful submission
and hearing process, a code was issued for ReWalk Personal Exoskeleton, which may be used for purposes of claim submission to Medicare,
Medicaid, and other payors.&#160;</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">1</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On November 1, 2023, CMS released the Calendar Year 2024 Home Health
Prospective Payment System Final Rule, CMS-1780-F (&#8220;Final Rule&#8221;), which was adopted through the notice and comment rulemaking
process. The Final Rule includes a policy confirming that personal exoskeletons are included in the Medicare brace benefit category, as
of January 1, 2024. Medicare personal exoskeleton claims with dates of service on or after January 1, 2024 that are billed using HCPCS
code K1007 are assigned to the brace benefit category. CMS reimburses items classified under the brace benefit category using a lump sum
payment methodology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On November 29, 2023, CMS included the &#8220;ReWalk Personal Prosthetic
Exoskeleton System&#8221; in the HCPCS public meeting&#160;where it solicited feedback on a preliminary payment determination of $94,617
for HCPCS code K1007. The preliminary payment determination was made by CMS by applying a &#8220;gap filling&#8221; process, which was
used in light of CMS determining that the code describing the technology has no fee schedule pricing history and that lower extremity
exoskeletons incorporate &#8220;revolutionary features&#8221; that cannot be described by or considered comparable to any other existing
code or combination of codes. As part of gap-filling, CMS utilizes verifiable supplier or commercial pricing information and adjusts this
pricing information according to a deflation and update factor methodology. In applying this formula to the K1007 code describing the
ReWalk Personal Exoskeleton, CMS says that it relied on information about average prices from 2020 market transactions for which CMS had
data.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">CMS solicited information on updated verifiable market transactions
from ReWalk, as well as any other makers of similar bilateral, lower limb exoskeletons, to &#8220;ensure that the Medicare payment amount
for this code accurately reflects the full market of devices that would be classified in this code.&#8221; We participated in the HCPCS
meeting process on November 29, 2023 to provide additional information to help ensure that the final payment determination accurately
reflects current pricing information related to the market of lower-limb exoskeleton devices, including the current ReWalk Personal Exoskeleton.
A final Medicare payment determination is expected from CMS in first quarter of 2024 with an April 1, 2024, effective date.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In Germany, we continue to make progress toward achieving coverage
from the various government, private and worker&#8217;s compensation payors for our SCI products. In September 2017, each of German insurer
BARMER GEK (&#8220;BARMER&#8221;) and national social accident insurance provider Deutsche Gesetzliche Unfallversicherung (&#8220;DGUV&#8221;),
indicated that they will provide coverage to users who meet certain inclusion and exclusion criteria. In February 2018, the head office
of German Statutory Health Insurance (&#8220;SHI&#8221;) Spitzenverband (&#8220;GKV&#8221;) confirmed their decision to list the ReWalk
Personal Exoskeleton system in the German Medical Device Directory. This decision means that ReWalk is listed among all medical devices
for compensation, which SHI providers can procure for any approved beneficiary on a case-by-case basis. During the year 2020 and 2021,
we announced several new agreements with German SHIs, including TK and DAK Gesundheit, as well as the first German Private Health Insurer
(&#8220;PHI&#8221;), which outline the process of obtaining our devices for eligible insured patients. We are also currently working with
several additional SHIs on securing a formal operating contract that will establish the process of obtaining a ReWalk Personal Exoskeleton
for their beneficiaries within their system. Additionally, to date, several private insurers in the United States and Europe are providing&#160;reimbursement
for ReWalk in certain cases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ReWalk Personal Exoskeleton and ReWalk Rehabilitation Exoskeleton</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Development of our SCI Products took over a decade and was spurred
by the experiences of our founder, Dr. Amit Goffer, who became a quadriplegic due to an accident. Current ReWalk designs are intended
for people with paraplegia, an SCI resulting in complete or incomplete paralysis of the legs, who have the use of their upper bodies and
arms. We currently offer two products in this category: the ReWalk Personal Exoskeleton and the ReWalk Rehabilitation Exoskeleton. The
ReWalk Rehabilitation Exoskeleton is substantially similar to the ReWalk Personal Exoskeleton system except that it is sold with multiple
sizes of our adjustable parts to allow different users the ability to train within a clinic.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The ReWalk Personal Exoskeleton is a novel product that seeks to
fundamentally change the health and life experiences of users. Designed for daily use, the device is battery-powered and consists of a
wearable exoskeleton with integrated motors at the joints, an array of sensors and a computer-based control system to power knee and hip
movement. The user controls the device movement using a combination of user inputs on the wrist-worn controller, as well as through subtle
weight shifts of the upper body. Because the exoskeleton supports its own weight and facilitates the user&#8217;s gait, users do not expend
unnecessary energy while walking. The ReWalk Personal Exoskeleton also allows users to sit, stand and climb and descend stairs and curbs.
In March 2023, the FDA cleared the ReWalk Personal Exoskeleton for use on stairs and curbs, allowing users to participate in walking activities
in more real-world environments in their daily lives and experience more opportunities to enjoy the health benefits of walking.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">2</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z29a06a6d44ec46bbb414003fe76519e9" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td rowspan="2" style="width: 68.65%; vertical-align: top">
        <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#9679;&#160;&#160;&#160; <span style="font-style: italic">ReWalk
        Personal Exoskeleton</span>: intended for everyday use at home, at work or in the community with a trained companion. We began marketing
        ReWalk Personal Exoskeleton in Europe with CE mark clearance at the end of 2012. We received FDA clearance to market the ReWalk Personal
        Exoskeleton in the United States in June 2014. ReWalk Personal Exoskeleton units are all manufactured according to the same mechanical
        specifications. Each unit is then permanently sized to fit the individual user and the software is configured for the user&#8217;s specifications
        by the rehabilitation center, clinic, or distributor. We are currently offering our 6<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>&#160;generation
        device (6.0) with current research and development for our 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup>
        generation device (7.0).<br/> <br/> </div>
        <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; line-height: 1.25">&#9679;&#160;&#160;&#160; <span style="font-style: italic">ReWalk
        Rehabilitation Exoskeleton</span>: the current offering for clinics who wish to implement exoskeleton training is composed of our Rewalk
        Personal Exoskeleton unit along with multiple sizing of different parts, enabling multiple patient use. The ReWalk Rehabilitation Exoskeleton
        provides a valuable means of exercise, training, and therapy. Use of the ReWalk Rehabilitation Exoskeleton in the clinic also enables
        individuals to evaluate their capacity for using the ReWalk Personal Exoskeleton in the future.</div> </td>
    <td style="width: 5.57%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div> </td>
    <td style="width: 25.78%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">ReWalk Personal Exoskeleton</div> </td> </tr>
  <tr>
    <td style="width: 5.57%; vertical-align: bottom">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 25.78%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25"><img src="image00003.jpg" alt="" style="width: 154px; height: 332px"/></div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, we have received regulatory approval to sell the
ReWalk Personal Exoskeleton device in other countries. In the future we intend to seek approval from the applicable regulatory agencies
in other jurisdictions where we may seek to market ReWalk Personal Exoskeleton. For more information about the safety of using our SCI
products see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to our Business and our Industry&#8212; Defects in our products
or the software that drives them could adversely affect the results of our operations.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Overview of Spinal Cord Injury</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-style: italic">Spinal Cord Injury</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The spine is the central core of the human skeleton and provides
structural support, alignment, and flexibility to the body. The spinal cord, housed inside the bones of the spinal column, is a complex
bundle of nerves serving as the main pathway for information connecting the brain, and nervous system. Spinal cord injury is a serious
medical condition that occurs as a result of physical damage to the nerves of the spinal cord, resulting in a loss of function, such as
mobility or feeling. In most people who have spinal cord injury, the spinal cord is intact. Spinal cord injury is not the same as back
injury, which may result from pinched nerves or ruptured disks. Even when a person sustains a break in a vertebra or vertebrae, there
may not be any spinal cord injury if the spinal cord itself is not affected. There are two types of spinal cord injury &#8211; complete
and incomplete. In a complete injury, a person loses all ability to feel and voluntarily move below the level of the injury. In an incomplete
injury, there is some functioning below the level of the injury.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Upon medical examination, a patient is assigned a level of injury
depending on the location of the spinal cord injury. Cervical level injuries cause paralysis or weakness in both arms and legs and is
referred to as quadriplegia. Sometimes this type of injury is accompanied by loss of physical sensation, respiratory issues, bowel, bladder,
and sexual dysfunction. Thoracic level injuries can cause paralysis or weakness of the legs (paraplegia) along with loss of physical sensation,
bowel, bladder, and sexual dysfunction. In most cases, arms and hands are not affected. Lumbar level injuries result in paralysis or weakness
of the legs (paraplegia). Loss of physical sensation, bowel, bladder, and sexual dysfunction can occur. The shoulder, arm, and hand functions
are usually unaffected. Sacral level injuries primarily cause loss of bowel and bladder function as well as sexual dysfunction.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">3</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Clinical Evidence</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Published clinical studies indicate the ReWalk Personal Exoskeleton&#8217;s
ability to deliver a functional walking speed. In addition, certain potential secondary health benefits have been reported by healthcare
practitioners and ReWalk users, including study participants. Although these benefits have not been established as conclusive clinical
data in randomized controlled trials, these reported secondary health benefits include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z91cec8c99447426b95cd9bf4fc145ee1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>reduced pain;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd57f0f132b7c4d019d11a7ae9af18dcd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>improved bowel and urinary tract function;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9dd8219190fc40a5b1908451c4f86be0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>reduced spasticity;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfc02dc59408c49e89a57ab76ddd028aa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>increases in joint range of motion for the hip and ankle joints;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0c2ada3279614b3db70f6cdef0b75838" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>improved sleep and reduced fatigue;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9c994510c5734c18be2cb699c85f4cca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>increase in oxygen uptake and heart rate as a result of walking as opposed to sitting and standing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8e348e4e62ca444eb29b01ad0d436491" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>ability to ambulate at a speed greater than 0.4 meters per second, which is considered to be conducive to outdoor related community
        ambulation; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0a0908bb4243402fb1566cd2eaf9b586" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>reduced hospitalizations.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that using our SCI Products may have the ability to
reduce the lifetime healthcare costs of individuals with spinal cord injuries, which we believe will make our SCI Products economically
attractive for individuals and third-party payors. While we believe that using our SCI Products could potentially offer significant advantages
over competing technologies and therapies, disadvantages include the time it takes for a user to put on the device, the slower pace of
the device compared to a wheelchair, the training required by the user and companion to use the device, the weight of the device when
carried, which makes it more burdensome for a companion to transport than a wheelchair, and the requirement that users be accompanied
by a trained companion.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Market Opportunity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Current and near-term market opportunities include providing a
solution for persons with SCI that can be used in the clinic and/or home settings. For persons with SCI, reduced physical activity and
the predominance of seated activities can lead to severe physical and psychological deterioration, resulting in bad health, poor quality
of life, low self-esteem, and high medical expenses. In addition, the secondary medical consequences of paralysis can include difficulty
with bowel and urinary tract function, osteoporosis, loss of lean mass, gain in fat mass, insulin resistance, diabetes, and heart disease.
The cost of treating these conditions is substantial. The NSCISC estimates that complications related to paraplegia cost approximately
$500,000 in the first-year post-injury, excluding indirect costs such as loss in wages, fringe benefits, and productivity, and significant
additional amounts over the course of an individual&#8217;s lifetime. Further, secondary complications related to spinal cord injury can
reduce life expectancies for SCI patients. The young average age at time of injury and significant remaining life expectancy, the likelihood
of living at home, and the lifetime cost of treatment highlight the need for an out-of-hospital solution with demonstrated health and
social benefits.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The NSCISC estimates according to its 2023 SCI Data Sheet that
there are 302,000 people in the United States living with SCI, with an annual incidence of approximately 18,000 new cases per year.&#160;
According to the VHA data there are approximately 42,000 of such patients who are veterans and are eligible for medical care and other
benefits from the VHA, out of which the VHA states that 27,000 veterans are receiving SCI treatment annually. With 25 VHA spinal cord
injury centers designated SCI/D Hub locations, the VHA has the largest single network of spinal cord injury care in the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The University of Alabama-Birmingham Department of Physical Medicine
and Rehabilitation operates the NSCISC, which maintains the world&#8217;s largest database on spinal cord injury research. Since 2015,
motor vehicle crashes have been the leading cause of reported spinal cord injury cases (38%), followed by falls (32%), acts of violence
(15%)&#160;and sports injuries (8%). Approximately 79% of spinal cord injuries occur among the male population. According to NSCISC data,
upon hospital discharge, 87% of persons with spinal cord injuries are sent to private, non-institutional residence (in most cases, their
homes prior to injury).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Based on information from the 2022 annual report published by the
NSCISC, 40% of the total U.S. population of SCI patients suffered injuries between levels T4 and L5. Four published ReWalk trials for
SCI patients had an aggregate screening acceptance rate of 50% considering all current FDA limitations, resulting in an estimated 20%
of the total population of SCI patients can be considered as candidates for current ReWalk Personal Exoskeleton or ReWalk Rehabilitation
Exoskeleton according to the device instructions for use. For important qualifying information about this determination, see &#8220;Part
I, Item 1A. Risk Factors&#8212;Risks Related to our Business and our Industry&#8212;The market for medical exoskeletons, including soft
exo-suit devices, remains relatively new and unproven, and important assumptions about the potential market for our current and future
products may be inaccurate.&#8221;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">4</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Third-Party Reimbursements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-style: italic">United States</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the U.S., individuals typically obtain a ReWalk Personal Exoskeleton
for home use through third-party medical coverage. For an individual who suffered an SCI through a work-related incident, workers&#8217;
compensation insurance can be a source of funding to purchase the device.&#160; Similarly, for U.S. veterans, an individual may be covered
by the VHA for the purchase of the device regardless of whether the SCI occurred during active military service.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;In December 2014, the VHA issued a national policy or standard
operating procedure (&#8220;SOP&#8221;) for the evaluation, training, and procurement of ReWalk Personal Exoskeleton systems for all qualifying
veterans across the United States and U.S. Territories.&#160; The VHA SOP is the first national coverage policy in the United States for
qualifying individuals who are living with spinal cord injury. In June 2018, the VHA updated the SOP, in part, to expand training options
for individuals who could not complete the mandatory training due to excessive distance/drive times from a VHA-designated site. As of
December 31, 2023, we had placed 42 units as part of the VHA policy. The VHA accounted for 12% of our total revenue for the year ended
December 31, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We continue to work with the VHA to both accelerate the pace of
implementation of the current VHA policy nationally, and to again expand opportunities for veterans to gain access to assessments, training,
and devices in facilities outside VHA&#8217;s traditional spinal cord injury &#8220;hub and spoke&#8221; infrastructure.&#160; Community-based,
non-VHA clinics are also being leveraged to allow veterans to be trained closer to their homes, while still being reimbursed by the VHA
as part of the VHA&#8217;s Community Care Network program.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Successful commercialization depends in significant part on adequate
coverage and reimbursement from third party payors, which may include government payors (such as Medicare and Medicaid programs in the
United States), managed care organizations, and private health insurers.&#160; In general, each third-party payor decides which devices
will be covered and reimbursed, establishes reimbursement and co-pay levels and sets conditions for coverage and reimbursement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">While no broad uniform policy of coverage and reimbursement for
electronic exoskeleton medical technology exists among commercial insurance payors in the United States, reimbursement may be evaluated
by the payor on a case-by-case basis. To date, payments for the ReWalk Personal Exoskeleton have been made primarily through case-by-case
determinations by third-party payors, including commercial insurers in the United States, by self-payors and donations and, to a lesser
extent, through the use of funds from insurance and/or accident settlements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December&#160;31, 2023, we had 21 cases pending in the United
States for private insurance and CMS coverage decisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">According to the NSCISC 2022 annual report, approximately 57% of
the spinal cord injury population received primary coverage from Medicare and Medicaid within five years after their injury date, with
Medicare representing the larger primary payor.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In order to be covered and reimbursed by Medicare, the ReWalk Personal
Exoskeleton&#160;must, among other things, be classified into an applicable Medicare benefit category.&#160; In addition, appropriate
codes describing the technology must also be established to facilitate billing and claims processing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In December 2019, we submitted the first application for a unique
code to describe the ReWalk Personal Exoseleton and, in July 2020, a unique code was issued for ReWalk Personal Exoskeleton.&#160; On
November 1, 2023, CMS released the Final Rule, which was adopted through the notice and comment rulemaking process. The Final Rule includes
a policy confirming that personal exoskeletons are included in the Medicare brace benefit category Medicare personal exoskeleton claims
with dates of service on or after January 1, 2024 that are billed using HCPCS code K1007 will be assigned to the brace benefit category.
CMS reimburses items classified under the brace benefit category using a lump sum payment methodology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On November 29, 2023, CMS included the &#8220;ReWalk Personal Prosthetic
Exoskeleton System&#8221; in the HCPCS public meeting, where the agency had proposed a preliminary payment determination of $94,617 for
HCPCS code K1007. The preliminary payment determination was made by CMS by applying a &#8220;gap filling&#8221; process, which was used
in light of CMS determining that the code describing the technology has no fee schedule pricing history and that lower extremity exoskeletons
incorporate &#8220;revolutionary features&#8221; that cannot be described by or considered comparable to any other existing code or combination
of codes. As part of gap-filling, CMS stated that it relied on information about average prices from 2020 market transactions for which
CMS had data. In the agenda describing the preliminary payment determination, CMS noted that it would welcome information on updated verifiable
market transactions. We participated in the HCPCS meeting process to provide additional information to help ensure that the final payment
determination accurately reflects current pricing information related to the market of lower-limb exoskeleton devices, including the current
ReWalk Personal Exoskeleton. A final Medicare payment determination is expected from CMS in first quarter of 2024 with an April 1, 2024,
effective date.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">5</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For more information about coverage and reimbursement risk factors,
see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks Related to our Business and our Industry.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As part of our plan for growth, we intend to continue working with
both national and regional commercial insurance companies, health care practitioners, physicians, researchers, and the SCI community to
support efforts to demonstrate the benefits of our SCI Products. In addition, we plan to pursue potential coverage policies with third
party payors based on supportive data and appeal rulings that have deemed exoskeleton devices a &#8220;medically necessary&#8221; under
the standard of care for individuals with SCI. Our efforts in the future will be focused on continued education of third-party payors
through data application, supporting clinical trials to demonstrate the clinical benefits of using the SCI Products, working with advocacy
groups, ongoing communication as well continuing to seek greater clarity regarding Medicare coverage and reimbursement standards applicable
to the ReWalk Personal Exoskeleton.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25; font-style: italic">Europe</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Reimbursement for ReWalk in Europe varies by country and historically
certain third-party payors have provided reimbursement for our products in certain cases in Germany and Italy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We initially focused our European efforts in Germany where we continue
to make progress toward achieving ReWalk coverage from the various government, private, and workers&#8217; compensation payors. Specifically:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4ad6e53e070e41ffadf163f4a5881cff" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In September 2017, the German insurer BARMER confirmed it will provide ReWalk systems to all qualifying beneficiaries. BARMER provides
        coverage for nearly nine million people in Germany, as a member of the SHI network and one of the most significant national insurers in
        the country. Exoskeletons are provided to users that meet certain inclusion criteria and assessment by the German Health Insurance Medical
        Service (Medizinischer Dienst der Krankenversicherungen) before and after training. We remain in discussion with BARMER regarding a contract
        based on their 2017 decision.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd5db00d5e3b440e483fecb0695accf3a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In September 2017 Germany&#8217;s national social accident insurance provider, DGUV, indicated that the DGUV&#8217;s member payors,
        including the health insurance association&#160;<span style="font-style: italic">Berufsgenossenschaft&#160;</span>(also known as BG) and
        state insurers, will approve the supply of exoskeleton systems for qualifying beneficiaries on a case-by-case basis. DGUV is comprised
        of 36 different insurers, which provide coverage for more than 80 million individuals in Germany. Per the agreement, eligible individuals
        go to BG clinics for evaluation as a part of the procurement.&#160; In May 2020 the DGUV agreed to a binding offer to the evaluation,
        training, and supply of the ReWalk Personal Exoskeleton to qualified individuals.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf35d5f47ff6e44cba083e7495c318c02" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In February 2018, the GKV-Spitzenverband (Central Federal Association of (the) Statutory Health Insurance Funds) confirmed its decision
        to list the ReWalk Personal Exoskeleton system in the German MDD, a comprehensive list of all medical devices which are principally and
        regularly reimbursed by German SHI and PHI providers. The ReWalk Personal was added to the official German list of medical aids, code
        number 23.29.01.2001, in June 2018. This decision means that ReWalk Personal Exoskeleton is listed among all medical devices for compensation,
        which SHI providers can procure for any approved beneficiary on a case-by-case basis.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9c598314245c49eea71d3108e1030a4c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>During the year 2020 we announced several new agreements with SHIs such as TK and DAK-Gesundheit and others as well as the first
        PHI that chose to enter into an agreement with us that outline the process to obtaining a device for eligible insured patients.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9c8d3c6b2eb847f7b5609f66838e268b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In March 2021 we entered into a contract with BKK Mobile Oil health insurance to supply ReWalk&#8217;s Personal Exoskeleton to eligible
        persons in Germany.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc38a6534e37d4f8b9a3c063f2b003ec8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In June 2020, BARMER appealed the decision of the State Social Court, which ordered the supply of the SHI&#8217;s insured SCI person
        with ReWalk. The State Social Court ruled and deemed ReWalk as the medical aid which will directly compensate the plaintiff&#8217;s disability.
        BARMER initially appealed this ruling with the Federal Social Court (<span style="font-style: italic">Bundessozialgericht</span>), but
        later, in November 2022, withdrew its pending case and accepted the prior ruling from the state court that exoskeletons are considered
        as a direct disability compensation.&#160; This outcome means that an eligible insured person with spinal cord injury (SCI) in Germany
        has a legal basis for the supply of an exoskeleton as an orthopedic aid for direct disability compensation. Patients in Germany who are
        covered under these contracts and policies must be medically evaluated for their eligibility to use the ReWalk Personal Exoskeleton device.
        If medically qualified, the patient, along with his or her physician, must apply for coverage of the device. If a patient is found eligible
        and medically fit to use our ReWalk Personal Exoskeleton device, we first enter into a rental agreement which allows the patient the necessary
        period to train on how to use the device which usually takes between 3 to 6 months and then after approval from the insurer the patient
        receives a personal device to use at home or in the community. We are currently working with several additional SHIs and PHIs on securing
        a formal operating contract that will establish the process of obtaining a ReWalk Personal Exoskeleton for their beneficiaries within
        their system.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">6</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December&#160;31, 2023, there were 49 insurance cases pending
in Germany. We believe that our recent coverage decisions and the existing claims will eventually lead other German insurers to provide
coverage on a broader scale, but this is not guaranteed.&#160;&#160; For more information, see &#8220;Part I, Item 1A. Risk Factors&#8212;Risks
Related to our Business and our Industry&#8212; We may fail to secure or maintain adequate insurance coverage or reimbursement for our
products by third-party payors which risk may be heightened if insurers find the products to be investigational or experimental or if
new government regulations change existing reimbursement policies. Additionally, such coverage or reimbursement, even if maintained, may
not produce revenue that is high enough to allow us to sell our products profitably.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We continue to support clinical research and academic publications,
which we believe will further support the case for coverage.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have distribution agreements in several European countries where
we also had success with reimbursement by private insurers and worker&#8217;s compensation. One of the examples was achieved in March
2018, when the Italian Ministry of Labor and Social Policy&#8217;s statutory insurance corporation put in place a coverage policy that
will provide exoskeleton systems for all qualifying beneficiaries. This policy, the first of its kind in Italy, provides individuals with
spinal cord injury access to obtain their own ReWalk Personal Exoskeleton device so that they can stand and walk again. Since the initiation
of coverage, we have supplied 10 units through our Italian distributor to individuals covered by this policy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.3pt; line-height: 1.25; font-style: italic">Other Funding Sources</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to being funded by third-party payors, including private
insurance plans, government programs such as the VHA, and workers&#8217; compensation plans, ReWalk Personal Exoskeleton is also funded
by self-payors. This includes individuals who purchase ReWalk with funds from legal settlements with insurance companies or third parties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">AlterG Anti-Gravity System</div>

<div style="line-height: 1.25"><img src="image1.jpg" alt="" style="width: 345px; height: 309px"/></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The DAP technology that underpins our AlterG Anti-Gravity systems
was originally developed by researchers at the NASA Moffet Field Research Center to help astronauts maintain their muscle strength and
bone density during extended periods in space outside of the effects of earth&#8217;s gravity.&#160; The DAP technology was used to create
a pressurized bubble that could exert pressure on an astronaut while exercising to simulate the impact of gravity.&#160; While the technology
ultimately was never implemented by NASA, it also had promise for use on earth.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The DAP technology was modified by the founders of AlterG, Inc.
for the opposite purpose of using the buoyancy of a pressurized air chamber to uniformly reduce gravitational load and body weight.&#160;
With subsequent product development, the initial AlterG Anti-Gravity system design was supplemented with other complementary features.&#160;
Our current models utilize a precise air calibration system which modulates the air pressure supporting the user 100 times a second to
ensure precise and consistent weight displacement that allows for modification of the pressurized support in one-percent increments of
each user&#8217;s weight.&#160; Additionally, the AlterG systems can be fitted with cameras for live video monitoring and pressure sensors
that track the user&#8217;s gait pattern.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Our proprietary Stride Smart software can provide real-time data and analytics so that
the user can watch and self-correct gate abnormalities.&#160; Clinicians also can simultaneously read and respond to five gait assessment
key performance indicators (&#8220;KPIs&#8221;).&#160; The five KPIs include:</div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8df1a730056f4b3eb4da8b205dc40ccf" style="font: 10pt Times New Roman, Times, serif; margin-top: 12pt; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt">&#160;</td>
    <td style="width: 27pt; vertical-align: top; text-align: right">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman">&#9679;</span></div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">weight-bearing symmetry;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zae90feb96b9342f4afa7ef6cd84a59a0" style="font: 10pt Times New Roman, Times, serif; margin-top: 12pt; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt">&#160;</td>
    <td style="width: 27pt; vertical-align: top; text-align: right">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman">&#9679;</span></div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">step length symmetry;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3f3ba8fc502145c3a5de441fe4491414" style="font: 10pt Times New Roman, Times, serif; margin-top: 12pt; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt">&#160;</td>
    <td style="width: 27pt; vertical-align: top; text-align: right">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman">&#9679;</span></div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">stance time symmetry;</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="za8947a02721049f489433b1807060047" style="font: 10pt Times New Roman, Times, serif; margin-top: 12pt; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt">&#160;</td>
    <td style="width: 27pt; vertical-align: top; text-align: right">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman">&#9679;</span></div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">cadence (stepping frequency); and</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z9d3278eb25134d27bf40c6c1be9d7d6f" style="font: 10pt Times New Roman, Times, serif; margin-top: 12pt; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt">&#160;</td>
    <td style="width: 27pt; vertical-align: top; text-align: right">
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman">&#9679;</span></div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">pain level.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">&#160;&#160;The Stride Smart software provides clinicians with clear, objective data
with which to assess, adjust, and modify a patient&#8217;s rehabilitation progress. Since Stride Smart collects and presents patient gait
data automatically, clinicians can focus their efforts rehabbing the patient and selecting the data most useful to their&#160;gait analysis&#160;and
correction recommendations.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Based on usage patterns and feedback of clinicians, we believe
that the AlterG Anti-Gravity system provides a versatile tool for the rehabilitation of lower extremity injuries and conditions.&#160;
By treating a broad range of conditions and facilitating faster recovery times, the AlterG Anti-Gravity system enables rehabilitation
clinics the opportunity to gain more referrals, increase the throughput of the facility, and improve the productivity of the staff.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">7</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We offer a range of AlterG Anti-Gravity systems depending on the
needs and budget of each customer as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z73b7db9a374145a3a5f3db6b3e66fe21" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>FIT &#8211; This is the entry-level and most affordable model of anti-gravity system.&#160; In addition to the standard DAP technology,
        the FIT also includes live video monitoring.&#160; The treadmill is equipped to run at up to 12 miles per hour (&#8220;mph&#8221;) in
        forward and 3 mph in reverse with a maximum incline of 15 degrees;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd5df9f1d5cad4579a2a0108c5693d158" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>VIA &#8211; The mid-range model has the features of the FIT, plus the inclusion of the Stride Smart analytics and the AlterG Assistant;
        and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z02fb130e53254761b91eb7978dde5645" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>PRO &#8211; The PRO is our top-of-the-line model for sports medicine applications with utilization by professional and collegiate
        athletes.&#160; The PRO includes all the features of the VIA, plus several additional features that add durability and accommodate elite
        user performance.&#160; The treadmill is a high-performance slat belt design equipped to run at up to 18 m.p.h in forward and 10 m.p.h
        in reverse.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">In addition to sales of the AlterG Anti-Gravity systems, we also provide consumables
and services that support the utilization of the installed base.&#160;&#160; For example, the AlterG systems require the users to wear
proprietary shorts that zip the user into the air chamber to create the seal to retain the air that pressurizes the chamber.&#160; With
frequent use, these shorts need to be periodically replaced.&#160; Additionally, we maintain a network of approximately 40 contract service
engineers who perform the installation, maintenance, and repair work.&#160; As the 12-month assurance warranties expire, we market extended
service contracts which can provide a recurring revenue base that can grow with the size of the installed base.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The potential market for AlterG Anti-Gravity systems is large and
fragmented with several types of facilities that treat patients with conditions who could benefit from rehabilitation using partial weight
displacement.&#160; According to the MedPAC 2021 Report, there are approximately 1,150 inpatient rehabilitation facilities in the U.S.&#160;
These facilities treat patients with a range of conditions including stroke, lower extremity fractures, joint replacements, neurological
conditions and brain injury, cardiac conditions, and other types of orthopaedic conditions.&#160; Depending on the specific details of
each case, many of these patients are candidates for therapy using partial weight displacement.&#160; Globally, we estimate that there
are approximately 3,500 inpatient rehabilitation facilities that are comparable in budget and quality of care to those in the U.S.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The largest potential market for the AlterG Anti-Gravity are outpatient
clinics, some of which are in national and regional affiliations and most of which are independent facilities.&#160; According to the
IBIS World website (which tracks the number of physical therapy rehabilitation centers), there are approximately 44,000 outpatient clinics
in the U.S.&#160; These facilities treat patients with less severe conditions than inpatient facilities with a greater mix of patients
skewed towards lower extremity fractures, joint replacements, and other types of orthopedic conditions.&#160; Globally, we estimate that
there are over 100,000 outpatient clinics based on scaling of population and standard of living that there are over 100,000 outpatient
clinics. One other major segment of the market for AlterG systems consists of professional and elite level sports teams, including major
university and college sports programs.&#160; These teams use the AlterG Anti-Gravity system to assist their players in maintaining higher
levels of fitness and accelerating the recovery time from sports-related injuries.&#160; Based on our internal estimates of the market,
we believe that there are approximately 1,400 sports programs in the U.S. who are potential AlterG customers.&#160; Globally, we estimate
this figure to be greater than 4,000 teams.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">8</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z3c20e25b817242d4b2d48d5298e0ca31" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 68.22%; vertical-align: top">
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="line-height: 1.25; font-weight: bold">ReStore Exo-Suit</div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In June 2017 we unveiled our lightweight exo-suit ReStore system
        designed initially for rehabilitation of stroke patients. The patented soft exo-suit technology was originally developed at&#160;Harvard
        University&#8217;s&#160;Wyss&#160;Institute for Biologically Inspired Engineering (&#8220;Harvard&#8221;), where it also underwent initial
        clinical testing that demonstrated potential to improve walking for stroke survivors. ReWalk and Harvard&#160;entered into a multi-year
        research collaboration agreement in 2016 which provides ReWalk license to intellectual property relating to lightweight exo-suit system
        technologies for lower limb disabilities and provides access to future innovations that emerge from this collaboration and may be relevant
        to additional stroke products or other therapies. The development and regulatory clearance process for ReStore took us approximately three
        years.&#160; We received FDA clearance&#160;for ReStore in June 2019 and CE clearance in May 2019. Following the regulatory clearances,
        we began to commercialize the ReStore product. For more information on the collaboration with Harvard, see &#8220;Research and Development-Research
        and Development Collaborations.&#8221;</div> </td>
    <td style="width: 0.92%; vertical-align: top">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td style="width: 30.86%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">&#160;<img src="image2.jpg" alt="" style="width: 152px; height: 206px"/></div>
        <div style="line-height: 1.25"><span style="line-height: 1.25">&#160;</span></div>
        <div style="text-align: center; line-height: 1.25; font-style: italic">ReStore Exo-Suit</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The ReStore product consists of a soft, fabric-based design that
connects to a lightweight waist pack and mechanical cables that help lift the patient&#8217;s affected leg in synchronized timing with
their natural walking pattern. The lightweight structure wraps around the waist and supports an actuator with a motor, computer, and cable,
along with sensors attached to a stable point on the user&#8217;s calf and footplate in the user&#8217;s shoe. This design provides targeted
mechanical assistance to the patient&#8217;s ankle during forward propulsion (plantarflexion) and ground clearance (dorsiflexion), two
key phases of the gait cycle. The ReStore system is designed to provide advantages to stroke rehabilitation clinics and therapists as
compared to other traditional therapies and devices by enabling the therapist to specifically target and train for improved propulsion
symmetry, which is a key contributor to improved walking speed and efficiency for patients recovering from stroke.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Published clinical trials using the soft exo-suit design on stroke
patients have shown varying levels of improvements, with the main ones being improved walking speed, improved propulsion symmetry, reductions
in compensatory behaviors including paretic hip hiking and circumduction as well as reduction in metabolic burden associated with post
stroke walking. There are additional studies on-going with the ReStore device that examine the improvement in walking speed following
training with the soft exo-suit as well as comparing the results of traditional training with soft exo-suit training.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">9</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">The main market for ReStore is rehabilitation clinics with a
stroke therapy program or clinics that would like to broaden their stroke presence. This product is marketed and sold directly to rehabilitation
clinics for use during the treatment of their patients which is generally reimbursed by commercial and government payors. During the second
half of 2019 we expanded our sales and marketing presence in the United States to accelerate product penetration after receiving FDA and
CE clearance. These efforts were adversely impacted by the COVID-19 pandemic, as clinics and hospitals shifted resources and attention
during the pandemic. During 2023, new research has been published on the clinical efficacy using ReStore in stroke rehabilitation and
we see this technology as a building block for future portfolio development. Geographically, the ReStore system is commercially available
through our direct sales teams in the United States and Germany.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Stroke incidence rate in the United States is approximately 800,000
incidences per year and the survival rate is approximately 80%. Of this stroke population, 80% are left with some type of lower limb disability.
This patient population seeks treatment in one of the approximately 1,600 primary and comprehensive inpatient, outpatient, and rehabilitation
clinics providing therapy to stroke patients. With the clinical evidence we have to date on ReStore, its unique design and its cost-effectiveness
compared to other products, we believe the ReStore soft exosuit has an opportunity to be adopted by clinics for use in therapy of their
stroke patients.&#160; However, we also recognize that the process to achieve that might be long and will likely only occur once national
or regional healthcare providers include the device within their stroke therapy programs. We also believe that to accelerate adoption,
further clinical evidence is required as well as continued education on the new ReStore design and its unique advantages compared to current
therapies and products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, and December 31, 2022, we had placed 42
and 33 ReStore units, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ReBoot Product</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are also in the research stage of ReBoot, a soft exoskeleton
for stroke home and community use, and are currently evaluating the reimbursement landscape and the potential clinical impact of this
device. This product would be a complementary product to ReStore, and it received Breakthrough Device Designation from the FDA in November
2021.&#160; The ReBoot is a lightweight, battery-powered exo-suit intended to assist ambulatory functions in individuals with reduced
ankle function related to neurological injuries, such as stroke.&#160; The ReBoot is a customizable personalized device intended for home
and community use with an estimated market of approximately 400,000 annual stroke patients who require walking assistance after being
discharged home.&#160; Further investment in the development path of the ReBoot was paused in 2023 pending further determination about
the clinical and commercial opportunity of this device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Sales and Marketing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">With added resources from the AlterG acquisition, we have created
a U.S. commercial team that we believe has the capacity and capabilities to support a broad range of physical and neurological rehabilitation
products for use in facilities, the home and the community.&#160; As part of this integration, we have rebranded our company under the
name Lifeward, to emphasize our commitment to pioneering a portfolio of innovative technologies to empower the pursuit of life&#8217;s
ambitions in the face of physical limitation or disability. For the sake of clarity, we will continue to use the ReWalk name to designate
our line of Exoskeleton products and the AlterG name to describe our line of anti-gravity systems.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the U.S., our commercial efforts are direct sales focused generally
on rehabilitation centers, hospitals, rehabilitation clinics, and similar facilities that treat patients who could benefit from offerings
within our portfolio of products.&#160; We market our facility-based products, such as the AlterG and the MyoCycle Pro to these institutions
for their use in providing care to their patients.&#160; We also market our home-based products, such as the ReWalk Personal Exoskeleton
or MyoCycle Home, to physicians and physical therapists for referrals to individuals who could benefit from these devices as part of a
home-based activity regimen that elevates the health and wellness of these individuals.&#160; Additionally, some sales of the ReWalk Personal
Exoskeleton or MyoCycle Home are also generated from referrals through the spinal cord injury community and direct inquiries from potential
users through our different marketing efforts. Beyond healthcare facilities, we also market our AlterG systems to professional and college
sports teams who use the systems to help their athletes recover from lower extremity sports injuries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Outside the U.S., our distribution varies depending on the product
and the geographic market.&#160; We market our ReWalk Personal Exoskeleton product directly in Germany and primarily through third-party
distributors, who maintain the customer relationships, in our other markets. We market our AlterG systems directly in Canada and Australia,
and in other territories utilize a network of over 40 third-party distributors who generally have exclusivity in their respective geographic
territories.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, we had placed 131 ReWalk Rehabilitation
Exoskeleton units in use at rehabilitation centers and 598 ReWalk Personal Exoskeleton units in a home or community use, compared to 128
ReWalk Rehabilitation Exoskeleton units and 572 ReWalk Personal Exoskeleton units as of December&#160;31, 2022.&#160; We estimate the
installed base of AlterG systems is over 6,000 installed units worldwide as of December&#160;31, 2023.&#160; With the anticipated finalization
of the Medicare payment rates for exoskeletons which will be effective April 1, 2024, we intend to aggressively target the eligible Medicare
customer base for growth while also continuing to focus on expanding commercial and other reimbursement coverage.&#160;Additionally, with
our increased direct sales resources and distributor network, we also expect to greater penetrate the base of facilities which could utilize
AlterG systems for rehabilitation of their patients.<br/> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">10</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Competition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The market in which we operate is characterized by active competition
and rapid technological change, and we expect competition to increase. Competition arises from providers of other mobility systems and
prosthetic devices used in the clinic and/or home settings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are aware of several other companies developing competing technology
and devices, and some of these competitors may have greater resources, greater name recognition, broader product lines, or larger customer
bases than we do.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our principal competitors in the medical exoskeleton market consist
of Ekso Bionics (NASDAQ: EKSO), Rex Bionics Pty, Cyberdyne (Tokyo Stock Exchange: 7779), FREE Bionics, DIH (formerly known as Hocoma),
Wandercraft, and Bioness (acquired by Bioventus (NASDAQ: BVS). The competitors&#8217; products may also compete with the ReStore soft
exo-suit, as well as manual forms of gait training which do not involve robotic assistive devices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that our ReWalk Personal Exoskeleton possesses key competitive
advantages over these companies&#8217; products, such as our tilt-sensor technology that provides a self-initiated walking experience,
six degrees of freedom which enable a more natural gait, faster functional walking speed, the ability to support its own weight, and broad
user specifications. In addition, ReWalk Personal Exoskeleton is the only medical exoskeleton with FDA and CE clearance for use on stairs
and curbs, which greatly improves the ability to use the device in everyday real-world environments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that our ReStore soft exo-suit device has several competitive
advantages over the products of our competitors, including a design that facilitates a natural, functional walking pattern through flexible
materials, sensors, and powered plantarflexion as well as dorsiflexion, making it the only solution of its type of which we are aware
of that supports such movements, achieving that with a lower cost and weight than rigid exoskeletal devices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, we compete with alternative devices and alternative
therapies, including treadmill-based gait therapies, such as those offered by Hocoma, Tyromotion, Boost, Aretech, BTL, and Reha Technology.
Other medical device or robotics companies, academic and research institutions, or others may develop new technologies or therapies that
provide a superior walking experience, are more effective in treating the secondary medical conditions that we target or are less expensive
than our current or future products. Our technologies and products could be rendered obsolete by such developments.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We may also compete with other treatments and technologies that
address the secondary medical conditions that ReWalk seeks to mitigate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Community Engagement and Education</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We devote significant resources to engagement with and education
of the spinal cord injury community with respect to the benefits of our SCI Products, as well as for our ReStore device. We actively seek
opportunities to partner with hospitals, rehabilitation centers and key opinion leaders to engage in research and development and clinical
activities. We also seek to educate and gain support from organizations such as patient advocacy groups and clinician societies with the
goal of promoting adoption of exoskeleton technology from patient, clinician, and payor communities. We believe that our success has been
and will continue to be driven in part by our reputation and acceptance within the spinal cord injury community.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">To date, multiple advocacy groups have issued public endorsements
of the ReWalk Personal Exoskeleton, including leading United States-based national organizations such as the United Spinal Association
and the Dana and Christopher Reeves Foundation, as well as others. In addition, the National Institute for Health and Care excellence
in the United Kingdom (also known as &#8220;NICE&#8221;), has issued a public announcement regarding the ReStore device.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">11</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Services and Customer Support</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our centers of operations in Marlborough, Massachusetts, Fremont,
California, and Berlin, Germany coordinate all customer support and product service functions for North America and Europe, respectively,
through dedicated technical service personnel who provide product services and customer support through training to healthcare providers
and support to product users.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Research and Development</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are committed to investing in a robust research and development
program to support our current product line and to potentially develop our pipeline of new and complementary products, and we believe
that ongoing research and development efforts are essential to our success. Our research and development team consists of both in-house
and external staff, including engineers, machinists, researchers and marketing, quality, manufacturing, regulatory and clinical personnel,
which we employ as efficiently as possible meet our current and future needs, and who work closely together to design, enhance, and validate
our technologies. This research and development team conceptualizes technologies and then builds and tests prototypes before refining
and/or redesigning, as necessary. Our regulatory and clinical personnel work in parallel with engineers and researchers, allowing us to
anticipate and resolve potential issues at early stages in the development cycle. Our level of research and development investment depends
on our available resources, business plans, and future needs. For more information, see &#8220;Part I, Item 1A. Risk Factors &#8212; Risks
Related to Our Business and Our Industry &#8212; Our future growth and operating results will depend on our ability to develop, receive
regulatory clearance for, and commercialize new products and penetrate new product and geographic markets.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are working on product design improvements and expanded labeling
for the ReWalk Personal Exoskeleton product which we plan to launch following obtaining regulatory clearance and approvals. In the longer
term we are conducting research for our next generation exoskeleton with design improvements and advanced robotic technologies as part
of the Human Robot Interaction Consortium research program. New medical indications impacting the ability to walk that we may pursue include
multiple sclerosis, cerebral palsy, Parkinson&#8217;s disease, and elderly assistance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are also developing new generations of anti-gravity systems
utilizing our DAP technology.&#160; We plan to introduce a new model of the AlterG system in mid-2024 that reduces the cost of manufacturing
which in turn will allow us to make it more affordable for independent rehabilitation clinics, thereby expanding the potential market
opportunity.&#160; Additionally, we are evaluating other applications for DAP technology to create entirely new rehabilitation systems
for our facility-based customers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We conduct our research and development efforts mainly at our facility
in Yokneam, Israel. We believe that the close interaction among our research and development and manufacturing groups allows for timely
and effective realization of our new product concepts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our research and development efforts have been financed, in part,
through funding from the Israel Innovation Authority (formerly known as Office of the Chief Scientist in the Israel Ministry of Economy)
(the &#8220;IIA&#8221;). From our inception through December&#160;31, 2023, we received funding totaling $2.6 million from the IIA. For
more information regarding our research and development financing arrangements, see &#8220;Part II. Item 7. Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8221; and &#8220;&#8212;Grants and
Other Funding.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Research and Development Collaborations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">On April 1, 2022, we entered a research and development cooperation agreement with several
companies and universities in the Human Robot Interaction (&#8220;HRI&#8221;) Consortium, part of the IIA&#8217;s MAGNET incentive program.
This incentive program provides grants for R&amp;D collaboration as part of a consortium comprised of private businesses and leading academic
centers. The goals of the HRI consortium are to &#8220;develop advanced technologies aimed at providing robots with social capabilities,
enabling them to carry out various tasks and effective interactions with different users in diverse operational environments.&#8221;&#160;
The total program has a budget of NIS 57 million, which includes funding for research and development grants to help drive technological
innovation. The Consortium is a 3-year program which has allocated NIS 1.745 million to fund ReWalk-specific projects over the first 18-month
period of the program. As of December 31, 2023, the Company spent total funds in the amount of NIS 1.571 million which has allocated for
the first 18-month period. In November 2023, we entered the second 18-month period of the program, the Consortium has allocated NIS 1.336
million to fund ReWalk-specific projects over the second 18-month period. As a member of the HRI Consortium, we collaborate with several
universities to develop advanced technologies aimed at improving the human-exoskeleton interaction.&#160; This research collaboration
with top researchers in the fields of robotics, behavioral sciences and human-computer interaction will seek to make the use of exoskeletons
easier and more natural to promote wider adoption of the technology.</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">12</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On May 16, 2016, we&#160;entered into the Research Collaboration
Agreement (&#8220;Collaboration Agreement&#8221;) and the Exclusive License Agreement (&#8220;Harvard License Agreement&#8221;) with Harvard.
Under the Collaboration Agreement, we and Harvard agreed to collaborate on research regarding the development of lightweight soft suit
exoskeleton system technologies for lower limb disabilities, which are intended to treat stroke, multiple sclerosis, mobility limitations
for the elderly and other medical applications. Under the Collaboration Agreement, we paid Harvard quarterly installment payments to help
fund the research. Subject to the terms of the Collaboration Agreement, we and Harvard were required to report our respective research
results and findings to each other on a regular basis. The Collaboration Agreement governed ownership of the research results and inventions
generated in performance of the research collaboration and provided us the option to negotiate with Harvard for a license to certain new
inventions of Harvard conceived in performance of the collaboration. The Collaboration Agreement concluded on March 31, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Under the Harvard License Agreement, we have been granted an exclusive,
worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#8220;soft suit&#8221; exoskeleton system
technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license to
certain inventions conceived under our joint research collaboration. Harvard retains the right to practice the patents for research, educational
and scholarly purposes. We are required to use commercially reasonable efforts to develop products under the Harvard License Agreement
in accordance with an agreed-upon development plan and to introduce and market such products commercially. In addition to an upfront fee
and royalties on net sales, we are obligated to pay Harvard certain milestone payments upon the achievement of certain product development
and commercialization milestones. We have also agreed to reimburse Harvard for expenses incurred in connection with the filing, prosecution,
and maintenance of the licensed patents.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Harvard License Agreement will continue in full force and effect
until the expiration of the last-to-expire valid claim of the licensed patents, or it is terminated in accordance with its terms. We may
terminate the License Agreement for any reason upon 60 days&#8217; prior written notice, while Harvard may terminate the License Agreement
if we do not maintain requisite insurance or become insolvent. The Harvard License Agreement may also be terminated by Harvard or us due
to the other party&#8217;s material uncured breach.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Harvard License Agreement contains, as applicable, customary
representations and warranties and customary enforcement, indemnification, and insurance provisions. For further discussion of the Collaboration
Agreement and Harvard License Agreement, see Note 10 to our consolidated financial statements for the fiscal year ended December 31, 2023
included elsewhere in this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Protection of our intellectual property is important to our business.
We seek to protect our intellectual property through a combination of patents, trademarks, confidentiality, and assignment agreements
with our employees and certain of our contractors and confidentiality agreements with certain of our consultants, scientific advisors
and other vendors and contractors. In addition, we rely on trade secrets law to protect our proprietary software and product candidates/products
in development.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to our portfolio of issued patents and pending patent
applications, we license certain patented and patented pending technology from a third party as described above under the &#8220;Research
and Development&#8221; section.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, we have 11 issued patents in the United
States and 19 issued patents outside of the United States, as well as 13 pending patent applications for our technology in the United
States, China, and Europe.&#160; For our patents associated with DAP and other AlterG technology, we have 25 issued patents in the United
States and 21 patents issued outside the United States, as well as 10 pending patent applications for anti-gravity associated technology
in the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the United States and Europe, we have apparatus patent claims
covering aspects of both our exoskeleton and our anti-gravity products and similar devices or systems, which focus on protecting our products
in terms of structural characteristics and functionality.&#160; Moreover, we also have method patent claims covering certain methods of
operation and control of our exoskeleton and anti-gravity products, which provide additional protection for our technology. We do not
currently license any of the technology contained in our currently commercialized ReWalk and AlterG products, other than with respect
to technology that is generally publicly available, but we may do so in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Patents filed both in the United States and Europe (as well as
other countries) generally have a term of 20 years from their earliest effective filing date, although they can be slightly longer depending
upon a local jurisdiction&#8217;s rules and laws. For example, the oldest of our issued patents relating to our tilt-sensor technology
was filed in May 2001 in the United States and would typically expire in May 2021. However, this patent actually expired in April of 2023
due to patent term adjustment (PTA) of 689 days for delays in examination by the United States Patent and Trademark Office.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">13</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently hold a registered trademark in the United States,
Europe, Israel, and the United Kingdom, for the mark &#8220;ReWalk.&#8221; We currently hold a registered trademark in United States,
Europe and the United Kingdom for the mark &#8220;ReStore&#8221;.&#160; We currently hold a registered trademark in the United States,
Europe, Israel, and the United Kingdom for the mark &#8220;Alter G.&#8221;&#160; We have also recently sought trademark registration of
&#8220;Lifeward&#8221; in the United States, Europe, and Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;We cannot be sure that our intellectual property will provide
us with a competitive advantage especially as some of our older patents begin to expire, or that we will not infringe on the intellectual
property rights of others. In addition, we cannot be sure that any patents will be granted in a timely manner or at all with respect to
any of our patent pending applications. For a more comprehensive discussion of the risks related to our intellectual property, see &#8220;Part
I, Item 1A. Risk Factors&#8212;Risks Related to Our Intellectual Property.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Government Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">U.S. Regulation</span>&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our medical products and manufacturing operations are regulated
by the FDA and other federal and state agencies. Our products are regulated as medical devices in the United States under the Federal
Food, Drug, and Cosmetic Act, or the FFDCA, as implemented and enforced by the FDA. The FDA regulates the development, testing, manufacturing,
labeling, storage, installation, servicing, advertising, promotion, marketing, distribution, import, export, and market surveillance of
our medical devices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Premarket Regulatory Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Unless an exemption applies, each medical device commercially distributed
in the United States requires either FDA clearance of a 510(k) premarket notification, approval of a premarket approval application (PMA),
or issuance of a de novo classification order. Under the FFDCA, medical devices are classified into one of three classes&#8212;Class I,
Class II or Class III&#8212;depending on the degree of risk associated with each medical device and the extent of control needed to provide
reasonable assurance of safety and effectiveness. Classification of a device is important because the class to which a device is assigned
determines, among other things, the necessity and type of FDA review required prior to marketing the device. Class I devices are those
for which reasonable assurance of safety and effectiveness can be assured by adherence to general controls that include compliance with
the applicable portions of the FDA&#8217;s Quality System Regulation, or QSR, facility registration and product listing, reporting of
adverse medical events, and appropriate, truthful and non-misleading labeling, advertising, and promotional materials. Class I also includes
devices for which there is insufficient information to determine that general controls are sufficient to provide reasonable assurance
of the safety and effectiveness of the device or to establish special controls to provide such assurance, but that are not life-supporting
or life-sustaining or for a use which is of substantial importance in preventing impairment of human health, and that do not present a
potential unreasonable risk of illness of injury.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Class II devices are those for which general controls alone are
insufficient to provide reasonable assurance of safety and effectiveness and there is sufficient information to establish &#8220;special
controls.&#8221; These special controls can include performance standards, post-market surveillance, and patient registries. While most
Class&#160;I devices are exempt from the 510(k) premarket notification requirement, most Class&#160;II devices require a 510(k) premarket
notification to be marketed in the U.S. As a result, manufacturers of most Class II devices are required to submit to the FDA premarket
notifications under Section&#160;510(k) of the FFDCA in order to market or commercially distribute those devices. To obtain 510(k) clearance,
manufacturers must demonstrate that the proposed device is &#8220;substantially equivalent&#8221; to a predicate device already on the
market. A predicate device is a legally marketed device that is not subject to premarket approval, or PMA, meaning, (i) a device that
was legally marketed prior to May&#160;28, 1976 (pre-amendments device) and for which a PMA is not required, (ii) a device that has been
reclassified from Class III to Class II or I, or (iii) a device that was found substantially equivalent through the 510(k) process. If
the FDA agrees that the device is substantially equivalent to a predicate device currently on the market, it will grant 510(k) clearance
to commercially market the device. If the device is not &#8220;substantially equivalent&#8221; to a previously cleared device, the device
is automatically a Class III device. The device sponsor must then fulfill more rigorous premarket approval requirements or can request
a risk-based classification determination for the device in accordance with the &#8220;de novo&#8221; classification process, which is
a route to market for medical devices that are low to moderate risk but are not substantially equivalent to a predicate device.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">14</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Devices that are intended to be life sustaining or life supporting,
devices that are implantable, devices that present a potential unreasonable risk of harm or are of substantial importance in preventing
impairment of health, and devices that are not substantially equivalent to a predicate device are placed in Class III and generally require
approval of a PMA, unless the device is a pre-amendment device not yet subject to a regulation requiring premarket approval. The PMA process
is more demanding than the 510(k) premarket notification process. In a PMA, the manufacturer must demonstrate that the device is safe
and effective, and the PMA must be supported by extensive data, including data from preclinical studies and clinical trials. The PMA must
also contain a full description of the device and its components, a full description of the methods, facilities and controls used for
manufacturing, and proposed labeling. Following receipt of a PMA, the FDA determines whether the application is sufficiently complete
to permit a substantive review. If the FDA accepts the application for review, it has 180&#160;days under the FFDCA to complete its review
of a PMA, although in practice, the FDA&#8217;s review often takes significantly longer, and can take one year or even longer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Clinical trials are almost always required to support PMAs and
are sometimes required to support 510(k) submissions. All clinical investigations of devices to determine safety and effectiveness must
be conducted in accordance with the FDA&#8217;s investigational device exemption, or IDE, regulations that govern investigational device
labeling, prohibit promotion of the investigational device, and specify recordkeeping, reporting and monitoring responsibilities of study
sponsors and study investigators. If the device presents a &#8220;significant risk,&#8221; as defined by the FDA, the agency requires
the device sponsor to submit an IDE application to the FDA, which must become effective prior to commencing human clinical trials. The
IDE will automatically become effective 30 days after receipt by the FDA, unless the FDA denies the application or notifies the company
that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE that require modification
of the study, the FDA may permit a clinical trial to proceed under a conditional approval. In addition, the study must be approved by,
and conducted under the oversight of, an Institutional Review Board, or IRB, for each clinical site. If the device presents a non-significant
risk to the patient, a sponsor may begin the clinical trial after obtaining approval for the trial by one or more IRBs without separate
approval from the FDA, but must still comply with abbreviated IDE requirements, such as monitoring the investigation, ensuring that the
investigators obtain informed consent, and labeling and record-keeping requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In June 2014, the FDA granted our request for &#8220;de novo&#8221;
classification, and classified ReWalk as a Class II powered exoskeleton device subject to special controls. The ReWalk is intended to
enable individuals with spinal cord injuries to perform ambulatory functions under supervision of a specially trained companion, and inside
rehabilitation institutions. The special controls established in the de novo classification order for all powered exoskeleton devices
include the following: clinical testing to demonstrate safe and effective use considering the level of supervision necessary and the use
environment; non-clinical safety and performance testing, including durability testing to demonstrate that the device performs as intended
under anticipated conditions of use; a training program; and labeling related to device use and user training. The special controls of
this de novo order also apply to competing powered exoskeleton products seeking FDA clearance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In June 2019, the FDA issued a 510(k) clearance for ReStore, which
means that the device can be marketed in the U.S. ReStore is intended to be used to assist ambulatory functions in rehabilitation institutions
under the supervision of a trained therapist for people with hemiplegia or hemiparesis due to stroke. ReStore complies with special controls
for powered exoskeletons as described above. In order for us to market ReStore and ReWalk, we must comply with both these special controls
as well as general controls, including controls related to quality, facility registration, reporting of adverse events and labeling. Failure
to comply with the general and special controls could lead to removal of ReStore or ReWalk from the market, which would have a material
adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In June 2022, we submitted a 510(k) premarket notification for
ReWalk Personal Exoskeleton seeking to enable the stairs functionality and add uses on stairs and curbs to the indication for use for
the device in the US. In March 2023, the FDA issued the 510(k) clearance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For more information, see &#8220;Part I, Item 1A. Risk Factors-Risks
Related to Government Regulation-We are subject to extensive governmental regulations relating to the manufacturing, labeling and marketing
of our products, and a failure to comply with such regulations could lead to withdrawal or recall of our products from the market.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Expedited Development and Review Programs</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">FDA&#8217;s Breakthrough Devices Program is a voluntary program
offered to manufacturers of certain medical devices and device-led combination products that may provide for more effective treatment
or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. The goal of the program is to provide patients and
health care providers with more timely access to qualifying devices by expediting their development, assessment and review, while preserving
the statutory standards for marketing authorization.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">15</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The program is available to medical devices that meet certain eligibility
criteria, including that the device provides more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases
or conditions, and that the device meets one of the following criteria: (i) the device represents a breakthrough technology, (ii) no approved
or cleared alternatives exist, (iii) the device offers significant advantages over existing approved or cleared alternatives, or (iv)
the availability of the device is in the best interest of patients. Breakthrough Device designation provides certain benefits to device
developers, including more interactive and timely communications with FDA staff, use of post market data collection, when scientifically
appropriate, to facilitate expedited and efficient development and review of the device, opportunities for efficient and flexible clinical
study design, and prioritized review of premarket submissions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Post-Market Regulatory Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">After a device is cleared for marketing, numerous regulatory requirements
apply. These include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd1a25b9f15eb467fb6f3142edd9cd307" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>establishment registration and device listing;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z77ecc52755cb42cc8065598af4f60506" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>development of a quality assurance system, including establishing and implementing procedures to design and manufacture devices;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z13df8b84bf3945418f3fb429772cf569" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>labeling regulations that prohibit the promotion of products for unapproved or &#8220;off-label&#8221; uses and impose other restrictions
        on labeling;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zeb81aa08781b4872aa0ccb9c4884779d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>FDA&#8217;s Unique Device Identification requirements that call for a unique device identifier (UDI) on device labels and packages
        and submission of data to the FDA&#8217;s Global Unique Device Identification Database (GUDID);</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z491cc1ccb8214a1584766b6d1a316fc0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>medical device reporting regulations that require manufacturers to report to the FDA if a device may have caused or contributed to
        a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur;
        and corrections and removal reporting regulations that require manufacturers report to the FDA field corrections and product recalls or
        removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FFDCA that may present a risk to
        health; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z8cb5068a010346fc892f4ad9645c52ec" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>post-market surveillance.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our manufacturing processes are required to comply with the applicable
portions of the FDA&#8217;s Quality System Regulation (&#8220;QSR&#8221;) that covers the methods and the facilities and controls for
the design, manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation,
and servicing of finished devices intended for human use. In February 2024, the FDA issued the Quality Management System Regulation (&#8220;QMSR&#8221;)
Final Rule to amend the QSR, incorporating by reference the international standard for medical device quality management systems set by
the International Organization for Standardization (ISO), ISO 13485:2016. The rule will become effective on February 2, 2026. Until then,
manufacturers are required to comply with the QSR. We actively maintain compliance with the FDA&#8217;s QSR, and the European Union&#8217;s
Quality Management Systems requirements, ISO&#160;13485:2016.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a manufacturer, we are subject to periodic scheduled or unscheduled
inspections by the FDA. If the FDA believes we or any of our contract manufacturers are not in compliance with the quality system requirements,
or other post-market requirements, it has significant enforcement authority. Specifically, if the FDA determines that we failed to comply
with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, which may result in any of the following
sanctions:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7eb5a6b8a82a4a4a87a8764782cf2229" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zec841a910cd74faaa9a3bdc58327d2a7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>customer notifications or repair, replacement, or refunds;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z873b8ea123cf47dd8a81b54bf2d4ff6c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>recalls, withdrawals, or administrative detention or seizure of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7d3afb0e8cb847198af94df2feafbe2d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>operating restrictions or partial suspension or total shutdown of production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z502bd9b13bc0490e9ae00b9514460499" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusing or delaying requests for approval of pre-market approval applications relating to new products or modified products;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zed1d5ff7ad4046de9e205c954b92adde" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>withdrawing PMA approval or reclassifying our devices;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1ba2cd3280b44cb7b2761dd0df929028" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusal to grant export approvals for our products; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z616d1f8d4502480ab495ae8402675959" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>pursuing criminal prosecution.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Any such action by the FDA would have a material adverse effect
on our business. In addition, these regulatory controls, as well as any changes in FDA policies, can affect the time and cost associated
with the development, introduction, and continued availability of new products. Where possible, we anticipate these factors in our product
development processes.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">16</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Regulation Outside of the U.S.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to the United States regulations, we are subject to
a variety of foreign regulations governing clinical trials and commercial sales and distribution of our products. In the E.U., medical
devices are regulated by the European Union Medical Devices Regulation (EU) 2017/745 or MDR, which became applicable on 26 May 2021 and
replaced the EU Medical Devices Directive 93/42/EEC, or MDD. The MDR and its associated guidance documents and harmonized standards, govern,
among other things, device design and development, preclinical and clinical or performance testing, premarket conformity assessment, registration
and listing, manufacturing, labeling, storage, claims, sales and distribution, export and import and post-market surveillance, vigilance,
and market surveillance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Before a device can be placed on the market in the E.U., compliance
with the MDR requirements must be demonstrated in order to affix the CE Mark to the product. The method of assessing conformity varies
depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment
by a &#8220;Notified Body.&#8221; This third-party assessment may consist of an audit of the manufacturer&#8217;s quality system or specific
testing of the manufacturer&#8217;s product. The Notified Body issues a CE Certificate of Conformity to confirm successful completion
of a conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the essential
requirements provided in the MDR. Under transitional provisions provided in the MDR, medical devices that had valid CE Certificates of
Conformity issued under the MDD prior to May 26, 2021 and that remained valid (and not withdrawn) on March 20, 2023, can continue to be
placed on the EEA market until the end of December 2027 or 2028 (depending on the class of device), provided the&#160;device&#8217;s manufacturer
complies with&#160; certain requirements, including that there are no significant changes in the design and intended purpose of the applicable
device. After the expiry of any applicable transitional period, only devices that have been CE marked on the basis of the MDR may be placed
on the market in the EEA. We comply with the E.U. requirements and have received ta Notified Body Certificate of Conformity under the
MDD for all of our ReWalk systems including the ReStore device which are distributed in the E.U. This allows us to continue to apply the
CE mark to our products and place them on the market throughout the E.U. during the transition period or until we have completed an appropriate
conformity assessment procedure under the MDR.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Following the U.K.&#8217;s exit from the E.U. (known as &#8220;Brexit&#8221;),
the MDR does not apply in the United Kingdom (except for Northern Ireland, which under the Northern Ireland Protocol is bound by certain
E.U. laws).&#160; The medical device legislative framework in the United Kingdom is set out in the Medical Devices Regulations 2002, as
amended.&#160; These regulations are based on the previous medical device directives of the E.U. but have been amended so that they function
properly now the United Kingdom is no longer part of the E.U.&#160; The Medical Devices Regulations 2002 have introduced several changes
including (but not limited to) replacing the CE mark with a UKCA marking (although E.U. CE marks will be recognized potentially up until
June 2030), requiring manufacturers outside of the United Kingdom to appoint a &#8220;UK Responsible Person&#8221; if they place devices
on the Great Britain market and more wide-ranging device registration requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Sales in other jurisdictions are subject to the foreign government
regulations of the relevant jurisdiction, and in most cases, we must obtain approval by the appropriate regulatory authorities before
we can commence clinical trials or marketing activities in those countries. The approval process varies from country to country, and the
time may be longer or shorter than that required to obtain a marketing authorization in the United States or the CE mark in the E.U. The
requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from country to country.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The policies of the FDA and foreign regulatory authorities may
change, and additional government regulations may be enacted that could prevent or delay regulatory approval of our products and could
also increase the cost of regulatory compliance. We cannot predict the likelihood, nature, or extent of adverse governmental regulation
that might arise from future legislative or administrative action, either in the United States or abroad.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">U.S. Anti-Kickback, False Claims and Other Healthcare Fraud and
Abuse Laws</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the United States, there are federal and state anti-kickback
laws that prohibit the payment or receipt of kickbacks, bribes or other remuneration intended to induce the purchase or recommendation
of healthcare products and services. Violations of these laws can lead to civil and criminal penalties, including exclusion from participation
in federal healthcare programs. These laws apply to manufacturers of products, such as us, with respect to our financial relationship
with hospitals, physicians and other potential purchasers or acquirers of our products. The U.S. government has published regulations
that identify &#8220;safe harbors&#8221; or exemptions for certain practices from enforcement actions under the federal anti-kickback
statute, and we will seek to comply with the safe harbors where possible. To qualify for a safe harbor, the activity must fit squarely
within the safe harbor. Arrangements that do not meet a safe harbor are not necessarily illegal but must be evaluated on a case-by-case
basis. A person or entity may be found to violate the anti-kickback statute even absent actual knowledge of this statute or specific intent
to violate it. In addition, the government may assert that a claim that includes items or services resulting from a violation of the federal
anti-kickback statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act (&#8220;FCA&#8221;).</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">17</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The civil FCA prohibits, among other things, any person or entity
from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to, or approval by, the federal government,
knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal
government, or avoiding, decreasing, or concealing an obligation to pay money to the federal government. A claim includes &#8220;any request
or demand&#8221; for money or property presented to the U.S. government. The civil FCA has been used to assert liability on the basis
of kickbacks and other improper referrals, improper use of Medicare provider or supplier numbers when detailing a provider of services,
improper promotion of off-label uses not covered by a device&#8217;s clearance or approval, and allegations as to misrepresentations with
respect to products, contract requirements, and services rendered. In addition, private payors have been filing follow-on lawsuits alleging
fraudulent misrepresentation, although establishing liability and damages in these cases is more difficult than under the FCA. Intent
to deceive is not required to establish liability under the civil FCA. Civil FCA actions may be brought by the government or may be brought
by private individuals on behalf of the government, called &#8220;qui tam&#8221; actions. If the government decides to intervene in a
qui tam action and prevails in the lawsuit, the individual will share in the proceeds from any fines or settlement funds. If the government
declines to intervene, the individual may pursue the case alone. The civil FCA provides for treble damages and a civil penalty for each
false claim, such as an invoice or pharmacy claim for reimbursement, which can aggregate into millions of dollars. For these reasons,
FCA lawsuits against biopharmaceutical and device companies have increased significantly in volume and breadth, leading to several substantial
civil and criminal settlements, as much as $3.0&#160;billion, regarding certain sales practices and promoting off label uses. Civil FCA
liability may further be imposed for known Medicare or Medicaid overpayments that are not refunded within 60&#160;days of discovering
the overpayment, even if the overpayment was not caused by a false or fraudulent act. In addition, conviction or civil judgment for violating
the FCA may result in exclusion from federal health care programs, and suspension and debarment from government contracts, and refusal
of orders under existing government contracts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The government may further prosecute conduct constituting a false
claim under the criminal FCA. The criminal FCA prohibits the making or presenting of a claim to the government knowing such claim to be
false, fictitious, or fraudulent and, unlike the civil FCA, requires proof of intent to submit a false claim.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The civil monetary penalties statute is another statute under which
medical device companies may potentially be subject to enforcement. Among other things, the civil monetary penalties statue imposes fines
against any person who offers to provide remuneration to any individual eligible for benefits under Medicare or Medicaid that the offerer
knows or should know is likely to influence the individual to order or receive from a particular provider or supplier of any item or service
reimbursable under those programs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The federal Health Insurance Portability and Accountability Act
of 1996 (&#8220;HIPAA&#8221;) also created federal criminal statutes that prohibit, among other actions, knowingly and willfully executing,
or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any
of the money or property owned by, or under the custody or control of, a healthcare benefit program, regardless of whether the payor is
public or private, in connection with the delivery or payment for health care benefits, knowingly and willfully embezzling or stealing
from a health care benefit program, willfully obstructing a criminal investigation of a health care offense and knowingly and willfully
falsifying, concealing, or covering up by any trick or device a material fact or making any materially false statements in connection
with the delivery of, or payment for, healthcare benefits, items, or services relating to healthcare matters. Additionally, the Patient
Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or collectively the
&#8220;ACA&#8221;, amended the intent requirement of certain of these criminal statutes under HIPAA so that a person or entity no longer
needs to have actual knowledge of the statute, or the specific intent to violate it, to have committed a violation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Physician Payments Sunshine Act (&#8220;Sunshine Act&#8221;)
requires annual reporting, by applicable device and drug manufacturers, of covered products, payments, and other transfers of value to
certain health care providers, and ownership and investment interests held by physicians and their immediate family members.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">18</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further, we may be subject to data privacy and security regulation
by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology
for Economic and Clinical Health Act (&#8220;HITECH&#8221;) and its respective implementing regulations imposes certain requirements on
covered entities relating to the privacy, security, and transmission of certain individually identifiable health information, known as
protected health information. Among other things, HITECH, through its implementing regulations, makes HIPAA&#8217;s security standards
and certain privacy standards directly applicable to business associates, defined as a person or organization, other than a member of
a covered entity&#8217;s workforce, that creates, receives, maintains, or transmits protected health information on behalf of a covered
entity for a function or activity regulated by HIPAA. HITECH also strengthened the civil and criminal penalties that may be imposed against
covered entities, business associates, and individuals, and gave state attorneys general new authority to file civil actions for damages
or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal
civil actions. In addition, other federal and state laws may govern the privacy and security of health and other information in certain
circumstances, many of which differ from each other in significant ways and may not be pre-empted by HIPAA, thus complicating compliance
efforts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Many states have also adopted laws similar to each of the above
federal laws, which may be broader in scope and apply to items or services reimbursed by any third-party payor, including commercial insurers.&#160;
Certain states also require implementation of commercial compliance programs and compliance with the medical device industry&#8217;s voluntary
compliance guidelines and the applicable compliance guidance promulgated by the federal government, or otherwise restrict payments or
the provision of other items of value that may be made to healthcare providers and other potential referral sources; impose restrictions
on marketing practices; or require companies to track and report information related to payments, and other items of value to physicians
and other healthcare providers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If our operations are found to be in violation of any of the laws
or regulations described above or any other applicable laws, we may be subject to penalties or other enforcement actions, including criminal
and significant civil monetary penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government healthcare
programs, corporate integrity agreements, suspension and debarment from government contracts, and refusal of orders under existing government
contracts, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which
could adversely affect our ability to operate our business and our results of operations. Enforcement actions can be brought by federal
or state governments, or as &#8220;qui tam&#8221; actions brought by individual whistleblowers in the name of the government under the
civil FCA if the violations are alleged to have caused the government to pay a false or fraudulent claim.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">To the extent that any of our products are sold in a foreign country,
we may be subject to similar foreign laws and regulations, which may include, for instance, applicable post-marketing requirements, including
safety surveillance, anti-fraud and abuse laws, and implementation of corporate compliance programs and reporting of payments or transfers
of value to healthcare professionals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Coverage and Reimbursement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The commercial success of our product candidates and our ability
to commercialize any approved product candidates successfully will depend in part on the extent to which governmental payor programs at
the federal and state levels, including Medicare and Medicaid, private health insurers, and other third-party payors provide coverage
for and establish adequate reimbursement levels for our products. Government authorities, private health insurers, and other organizations
generally decide which products and services they will pay for and establish reimbursement levels for healthcare. Medicare is a federally
funded program managed by CMS through local fiscal intermediaries and carriers that administer coverage and reimbursement for certain
healthcare items and services furnished to the elderly and disabled. Medicaid is an insurance program for certain categories of patients
whose income and assets fall below state defined levels and who are otherwise uninsured that is both federally and state funded and managed
by each state. In the United States, private health insurers and other third-party payors often provide reimbursement for products and
services based on the level at which the government provides reimbursement through the Medicare or Medicaid programs for such products
and services.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the United States, the European Union, and other potentially
significant markets for our products, government authorities and third-party payors are increasingly attempting to limit or regulate the
price of medical products and services, particularly for new and innovative products and therapies, which often has resulted in average
selling prices lower than they would otherwise be. In the United States, it is also common for certain government and private health plans
to use coverage determinations to leverage rebates from labelers to reduce the plans&#8217; net costs. These restrictions and limitations
influence the purchase of healthcare services and products and lower the realization on manufacturers&#8217; sales of products.&#160;
Third-party payors are developing increasingly sophisticated methods of controlling healthcare costs. Third-party payors may limit coverage
to specific therapeutic products on an approved list, or formulary, which might not include all of the FDA-approved products for a particular
indication or might impose high co-payment amounts to influence patient choice. Third-party payors also control costs by requiring prior
authorization or imposing other restrictions. Third-party payors are increasingly challenging the price and examining the medical necessity
and cost-effectiveness of medical products and services, in addition to their safety and efficacy.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">19</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Federal programs also impose price controls through mandatory ceiling
prices on purchases by federal agencies and federally funded hospitals and clinics. These restrictions and limitations influence the purchase
of healthcare services and products. Legislative proposals to reform healthcare or reduce costs under government programs may result in
lower reimbursement for our products or exclusion of our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Private payors often rely on the lead of the governmental payors
in rendering coverage and reimbursement determinations. Therefore, achieving favorable CMS coverage and reimbursement is usually a significant
gating issue for successful introduction of a new product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further, the increased emphasis on managed healthcare in the United
States and on country and regional pricing and reimbursement controls in the European Union will put additional pressure on product pricing,
reimbursement, and utilization, which may adversely affect our future product sales and results of operations. These pressures can arise
from rules and practices of managed care groups, competition from other products, judicial decisions and governmental laws and regulations
related to Medicare, Medicaid, and healthcare reform, and pricing in general. Patients who are prescribed treatments for their conditions
and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare
costs. Sales of our product candidates will therefore depend substantially, both domestically and abroad, on the extent to which the costs
of our products will be paid by health maintenance, managed care, and similar healthcare management organizations, or reimbursed by government
health administration authorities, such as Medicare and Medicaid, private health insurers, and other third-party payors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Moreover, a payor&#8217;s decision to provide coverage for a product
does not imply that an adequate reimbursement rate will be approved or that significant price concessions will not be required to avoid
restrictive conditions. High health plan co-payment requirements may result in patients seeking alternative therapies. Adequate third-party
reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment.
Legislative proposals to reform healthcare or reduce costs under government insurance programs may result in lower reimbursement for our
products or exclusion of our products from coverage. The cost containment measures that healthcare payors and providers are instituting
and any healthcare reform could significantly reduce our revenue from the sale of any approved product candidates.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Healthcare Reform Measures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The United States and many foreign jurisdictions have enacted or
proposed legislative and regulatory changes affecting the healthcare system. The United States government, state legislatures and foreign
governments also have shown significant interest in implementing cost-containment programs to limit the growth of government-paid healthcare
costs, including price controls, restrictions on reimbursement and requirements for substitution of generic products for branded prescription
drugs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The ACA substantially changed the way healthcare is financed by
both governmental and private insurers, and significantly impacts the pharmaceutical industry. The ACA is intended to broaden access to
health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against healthcare fraud and abuse, add new
transparency requirements for healthcare and health insurance industries, impose new taxes and fees on pharmaceutical and medical device
manufacturers, and impose additional health policy reforms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The ACA has been subject to challenges in the courts.&#160; On
December 14, 2018, a Texas U.S. District Court Judge ruled that the ACA is unconstitutional in its entirety because the &#8220;individual
mandate&#8221; was repealed by Congress.&#160; On December 18, 2019, the Fifth Circuit U.S. Court of Appeals held that the individual
mandate is unconstitutional, but did not invalidate the entire law, and remanded the case to the Texas District Court to reconsider its
earlier invalidation of the entire ACA.&#160; An appeal was taken to the U.S. Supreme Court, which ruled on June 17, 2021, that the plaintiffs
lacked standing to challenge the law as they had not alleged personal injury traceable to the allegedly unlawful conduct.&#160; As a result,
the Supreme Court did not rule on the constitutionality of the ACA or any of its provisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Other legislative changes have been proposed and adopted since
passage of the ACA. The Budget Control Act of 2011, among other things, created the Joint Select Committee on Deficit Reduction to recommend
proposals in spending reductions to Congress. The Joint Select Committee did not achieve its targeted deficit reduction of an amount greater
than $1.2 trillion for the fiscal years 2012 through 2021, triggering the legislation&#8217;s automatic reductions to several government
programs. These reductions included aggregate reductions to Medicare payments to healthcare providers of up to 2.0% per fiscal year.&#160;
The Bipartisan Budget Act of 2018 retained the federal budget &#8220;sequestration&#8221; Medicare payment reductions of 2% and extended
it through 2027 unless congressional action is taken.&#160; On January 2, 2013, the American Taxpayer Relief Act was signed into law,
which, among other things, reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment
centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">20</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further legislative and regulatory changes under the ACA remain
possible, although President Biden indicated that he intends to use executive orders to undo changes to the ACA made by the Trump administration
and would advocate for legislation to build on the ACA.&#160; It is unknown what form any such changes or any law would take, and how
or whether it may affect our business in the future. We expect that changes or additions to the ACA or the Medicare and Medicaid programs,
and changes stemming from other healthcare reform measures, especially with regard to healthcare access, financing or other legislation
in individual states, could have a material adverse effect on the healthcare industry.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">At the state level, legislatures may also increasingly pass legislation
and implement regulations designed to control product pricing, including price or patient reimbursement constraints, discounts, restrictions
on certain product access and marketing cost disclosure and transparency measures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect that additional federal, state, and foreign healthcare
reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare
products and services, which could result in limited coverage and reimbursement and reduced demand for our products, or additional pricing
pressures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">Environmental Matters</span>&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are subject to various environmental, health and safety laws
and regulations, including those governing air emissions, water and wastewater discharges, noise emissions, the use, transport, management
and disposal of chemicals and hazardous materials, the import, export and registration of chemicals, and the cleanup of contaminated sites.
Based on information currently available to us, we do not expect environmental costs and contingencies to have a material adverse effect
on us. The operation of our business and facilities, however, entails risks in these areas. Significant expenditures could be required
in the future to comply with environmental or health and safety laws, regulations, or requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">In Israel, where our contract manufacturer produces all of our
ReWalk and ReStore products, businesses storing or using certain hazardous materials (including materials necessary for our manufacturing
process) are required, pursuant to the Israeli Dangerous Substances Law, 5753-1993, to obtain a toxin permit from the Ministry of Environmental
Protection.&#160; In the U.S., where we manufacture our AlterG products in our Fremont, California facility, we do not utilize chemicals
which require a toxic materials license.&#160; We have a hazardous waste disposal license with the County of Alameda and dispose of our
expired and empty containers through a process in accordance with the license.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the European marketplace, electrical and electronic equipment
is required to comply with the Directive on Waste Electrical and Electronic Equipment, which aims to prevent waste by encouraging reuse
and recycling, and the Directive on Restriction of Use of Certain Hazardous Substances, which restricts the use of ten hazardous substances
in electrical and electronic products. Our products and certain components of such products &#8220;put on the market&#8221; in the E.U.
(whether or not manufactured in the E.U.) are subject to these directives. Additionally, we are required to comply with certain laws,
regulations, and directives, including the Toxic Substances Control Act in the United States and REACH in the E.U., governing chemicals.
These and similar laws and regulations require the testing, reporting and registration of certain chemicals we use and ship. We believe
we comply in all material respects with applicable environmental laws and regulations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Manufacturing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our ReWalk exoskeletons, ReStore exo-suits, and AlterG Anti-Gravity
systems include off-the-shelf and custom-made components produced to our specifications by various third parties, for technical and cost-effectiveness.
We have contracted with Sanmina Corporation (&#8220;Sanmina&#8221;), a well-established contract manufacturer with expertise in the medical
device industry, for the manufacture of our SCI Products and ReStore at its facility in Ma&#8217;alot, Israel. We manufacture the AlterG
product ourselves at our facility in Fremont, California. Each product line is manufactured pursuant to the same applicable set of specifications.
We place our manufacturing orders with Sanmina and other suppliers pursuant to purchase orders or by providing forecasts for future requirements.
We may terminate our relationship with Sanmina or our other suppliers at any time upon written notice. Either we or Sanmina may terminate
the relationship in the event of a material breach, subject to a 30-day cure period. Our agreement with Sanmina contains a limitation
on liability that applies equally to us and Sanmina.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that this contract manufacturing relationship with Sanmina
allows us to operate our business efficiently by focusing our internal efforts on the development and commercialization of our technology
and our products and provides us with substantial scale-up capacity. We regularly test quality on-site at Sanmina&#8217;s facility and
we obtain full quality inspection reports. We maintain a non-disclosure agreement with Sanmina.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">21</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We develop certain of the software components internally and license
other software components that are generally available for commercial use as open-source software.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We manufacture products based upon internal sales forecasts. We
deliver products to customers and distributors based upon purchase orders received, and our goal is to fulfill each customer&#8217;s order
for products in regular production within two weeks of receipt of the order.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Suppliers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We have contracted with Sanmina for the sourcing of all components and raw materials
necessary for the manufacture of our ReWalk and ReStore products, although there are instances that we purchase raw materials ourselves.
In addition, we directly source all components and raw materials necessary for the manufacture of our AlterG products.&#160; Components
of our products and raw materials come from suppliers in the United States, Europe, China, Taiwan, and Israel, and we depend on certain
of these components and raw materials, including certain electronic parts, for the manufacture of our products. To date, we have not experienced
significant volatility in the prices of these components and raw materials. However, during the COVID-19 pandemic several specific parts,
mainly electronic parts, experienced temporary price increases which have returned to more normal levels. Such prices are subject to a
number of factors, including purchase volumes, general economic conditions, currency exchange rates, industry cycles, production levels,
and scarcity of supply.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe that our in-house manufacturing, Sanmina&#8217;s facilities,
our contracted manufacturing arrangement, and our supply arrangements are sufficient to support our potential capacity needs for the foreseeable
future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Human Capital</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Employees</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December&#160;31, 2023, we had 108 employees (including full-time
and hourly employees), of whom 74 were located in the United States, 20 were located in Israel and 14 were located in Europe. The majority
of our employees are, and have been, engaged in sales and marketing activities. We do not employ a significant number of temporary or
part time employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are subject to labor laws and regulations within our locations
mainly in the U.S., Germany, and Israel. These laws and regulations principally concern matters such as pensions, paid annual vacation,
paid sick days, length of the workday and work week, minimum wages, overtime pay, insurance for work-related accidents, severance pay
and other conditions of employment. Our employees are not represented by a labor union. We consider our relationship with our employees
to be good. To date, we have not experienced any work stoppages.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Compensation and Benefits</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We provide our employees with competitive salaries and bonuses,
opportunities for equity ownership, and a robust employment package that promotes well-being across all aspects of our employees&#8217;
lives, including health care, retirement planning, and paid time off. We also invest in the ongoing development of our employees through
our internal training programs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Diversity and Inclusion</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We value the diversity of our employees and take pride in our commitment
to diversity and inclusion across all levels of our organizational structure. We encourage a diversity of views and strive to create an
equal opportunity workplace, including working with managers to develop strategies for building diverse teams and promoting the advancement
of employees from diverse backgrounds.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Financial Information about Geographic Areas and Significant Customer
Information</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following table sets forth the geographical breakdown of our
revenue for each of the years ended December&#160;31, 2023, and 2022 (in thousands):</div>

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zf2a6c4f3e2d14db1b0b5eb5190103633" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">
        <div style="line-height: 1.25">&#160;</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Revenue based on customer&#8217;s location:</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="margin-left: 8.65pt; line-height: 1.25">United States</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">7,636</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">2,303</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 8.65pt; line-height: 1.25">Europe</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,044</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,057</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="margin-left: 8.65pt; line-height: 1.25">Asia-Pacific</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">387</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">115</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 8.65pt; line-height: 1.25">Rest of the world</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">787</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">36</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="margin-left: 8.65pt; line-height: 1.25">Total revenue</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">13,854</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,511</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">22</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additional discussion of financial information by reportable segment
and geographic area and sales in excess of 10% of total revenue to certain of our customers is contained in Note 13 to our consolidated
financial statements set forth in &#8220;Part II. Item 8. Financial Statements and Supplementary Data&#8221; of this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">2023 Recent Developments&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z937967937d7c4c84807ba79aa00914dc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In March 2023, the ReWalk Personal Exoskeleton technology received clearance from the FDA for use on stairs and curbs in the United
        States, making it the only personal exoskeleton to receive FDA clearance for this indication. The clearance follows the FDA&#8217;s designation
        of the device as a "Breakthrough Device" in recognition of its unprecedented ability to provide ambulatory access to environments containing
        stairs and curbs for paralyzed individuals with SCI.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za01fb9bf093c4638b0d929a4a4bb745b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In August 2023, we completed the acquisition&#160;of AlterG, which adds significant scale to our revenue base, extensive sales and
        service capabilities to our commercial team, and innovative systems that utilize DAP technology to our portfolio of rehabilitation solutions
        that facilitate mobility and wellness in rehabilitation and daily life.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="zfab03c2252d940708dbb4267f402f0fb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In November 2023, CMS released the Final Rule, which explicitly includes exoskeletons within a Medicare brace benefit category. The
        rule went into effect on January 1, 2024.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<table cellspacing="0" cellpadding="0" id="z58f6edeb5df3419f9c66ca359f69a1c1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In November 2023, CMS included the ReWalk Personal Exoskeleton system in the agenda for the November 29, 2023 HCPCS public meeting.&#160;
        The agency also proposed a preliminary payment determination of $94,617 for HCPCS code K1007 based on a &#8220;gap filling&#8221; process
        applied to 2020 market data. At the meeting, CMS solicited additional information for updated market transactions for use in developing
        a final payment determination. We participated in the HCPCS meeting process to provide additional information to help ensure that the
        final payment determination accurately reflects current pricing information related to the market of lower-limb exoskeleton devices, including
        the current ReWalk Personal Exoskeleton. A final Medicare payment determination is expected from CMS in first quarter of 2024 with an
        April 1, 2024, effective date.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z99c0466b84d142fcb4e367fbc360ffa6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>In December 2023, our first claim with Medicare for&#160;reimbursement for a ReWalk Personal Exoskeleton was paid;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z33b0b644a9914900b056f8102e2e487c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Record annual revenue for 2023 was $13.9 million, compared to $5.5 million in 2022, an increase of 151%.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z44154d46d47041c18e9931901b7dab73" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Our cash position remained strong with $28.1 million as of December 31, 2023, with no debt.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br/> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">23</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM1A.RISKFACTORS"><!--Anchor--></span>ITEM 1A. RISK FACTORS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Our business faces significant risks. You should
carefully consider all of the information set forth in this annual report and in our other filings with the SEC, including the following
risk factors which we face and which are faced by our industry. Our business, financial condition and results of operations could be materially
and adversely affected by any of these risks. In that event, the trading price of our ordinary shares would likely decline and you might
lose all or part of your investment. This report also contains forward-looking statements that involve risks and uncertainties. Our results
could materially differ from those anticipated in these forward-looking statements, as a result of certain factors including the risks
described below and elsewhere in this report and our other SEC filings. See also &#8220;Special Note Regarding Forward-Looking Statements
and Risk Factors Summary&#8221; on page (ii).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Our Business and Our Industry</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may fail to realize the benefits expected from our acquisition
of AlterG, which could adversely affect the price of our ordinary shares.</div> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As discussed above in &#8220;Part I. Item 1. Business - Overview&#8221;,
on August 11, 2023, we completed the acquisition of AlterG which became an indirect and wholly-owned subsidiary of the Company.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The anticipated benefits from our acquisition of AlterG are based
on projections and assumptions about the combined businesses of ReWalk and AlterG, which may not materialize as expected or which may
prove to be inaccurate. The value of our ordinary shares could be adversely affected if we are unable to realize the anticipated benefits
from the acquisition on a timely basis or at all. Achieving the benefits of the acquisition will depend, in part, on our ability to integrate
the business, operations and products of AlterG successfully and efficiently with our business. The process of integrating the operations
of ReWalk and AlterG could encounter unexpected costs and delays, which include: the loss of key personnel; the loss of key customers;
the loss of key suppliers; inability to properly identify, acquire or obtained required regulatory approvals; and unanticipated issues
in integrating sales, marketing and administrative functions. In addition, the acquired AlterG business, products and technologies may
not achieve anticipated revenues and income growth.</div>

<div style="text-align: justify; text-indent: 42.55pt; line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Further, the integration of AlterG may involve a number of additional
risks, including diversion of management&#8217;s attention away from the rest of the business, which could adversely affect our results
of operations. In addition, our failure to identify or accurately assess the magnitude of certain liabilities we assumed in the acquisition
could result in unexpected litigation or regulatory exposure, unfavorable accounting charges, unexpected increases in taxes due, a loss
of anticipated tax benefits or other adverse effects on our business, operating results or financial condition. If we do not realize the
expected benefits or synergies of the acquisition, such as revenue gains or cost reductions, there could be a material adverse effect
on our business, results of operations, and financial condition.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Global, regional, and local economic weakness
and uncertainty could adversely affect our demand for our products and services and our business and financial performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our business and financial performance depends on worldwide economic
conditions and the demand for our products and services in the markets in which we compete. Ongoing economic weakness, including an economic
slowdown or recession, uncertainty in markets throughout the world and other adverse economic conditions, including inflation, changes
in monetary policy and increased interest rates, have resulted, and may result in the future, in decreased demand for our products and
services and increased expenses and difficulty in managing inventory levels and accurately forecasting revenue, gross margin, cash flows
and expenses. Ongoing U.S. federal government spending limits may continue to reduce demand for our products and services from organizations
that receive funding from the U.S. government and could negatively affect macroeconomic conditions in the United States, which could further
reduce demand for our products and services.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Prolonged or more severe economic weakness and uncertainty could
also cause our expenses to vary materially from our expectations. Any financial turmoil affecting the banking system and financial markets
or any significant financial services institution failures could negatively impact our treasury operations, as the financial condition
of such parties may deteriorate rapidly and without notice. Poor financial performance of asset markets and the adverse effects of fluctuating
currency exchange rates could lead to higher pension and post-retirement benefit expenses. Interest and other expenses could vary materially
from expectations depending on changes in interest rates, borrowing costs, currency exchange rates, costs of hedging activities and the
fair value of derivative instruments. Economic downturns also may lead to future restructuring actions and associated expenses.&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">24</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may not have sufficient funds to meet certain
future operating needs or capital requirements, which could impair our efforts to develop and commercialize existing and new products,
and as a result, we may in the future consider one or more capital-raising transactions, including future equity or debt financings, strategic
transactions, or borrowings which may also further dilute our shareholders or place us under restrictive covenants limiting our ability
to operate freely.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We intend to finance our business by close management of our operating
expenses until we reach profitable operation using existing cash on hand, issuances of equity and/or debt securities, and other future
public or private issuances of securities, cash exercised of outstanding warrants, or through a combination of the foregoing, though we
may also consider additional capital raising alternatives, such as entering into a credit facility, if the foregoing alternatives are
not available to us or unavailable on reasonable terms. Although we had a cash and cash equivalents of $28.1 million as of December 31,
2023, which we believe will be sufficient to fund our planned operations through at least the next twelve months from the date of this
annual report, if we are incorrect in our assumptions, we may need to raise additional capital sooner than expected or on less favorable
terms than what might otherwise be available. Raising additional capital through one or more of these alternatives may further dilute
our shareholders or place us under restrictive covenants limiting our ability to operate freely.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Raising additional capital in the public markets could also entail
certain downsides. Although we are currently eligible to use our&#160;Form S-3, we are limited to selling no more than one-third of our
unaffiliated market capitalization, or public float, on Form S-3 in a 12-month period unless our public float rises above $75 million.
For more information on our inability to use Form S-3, see &#8220;Part II. Item 2, Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Equity Raises&#8221; below. Additionally, due to these
limitations on our use of Form S-3, we may be required to seek other methods for access to capital, such as a registration statement on
Form S-1.&#160; The preparation of a registration statement on Form S-1 is, and has in the past, been more time-consuming and costly than
using Form S-3. We may also conduct fundraising transactions in the form of private placements, potentially with registration rights or
priced at a discount to the market value of our ordinary shares, which could require shareholder approval under the rules of The Nasdaq
Stock Market LLC (&#8220;Nasdaq&#8221;), or other equity raise transactions such as equity lines of credit. In addition to entailing increased
capital costs, any such transactions have historically resulted in and could result in substantial dilution of our shareholders&#8217;
interests and may also transfer control to a new investor or diminish the value of an investment in our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We may also need to pursue strategic transactions, such as joint
ventures, in-licensing transactions, or the sale of our business, or all, or substantially all, of our assets if our financial stability
is uncertain, and we are unable to raise additional capital effectively. These strategic transactions have in the past and could in the
future require significant management attention, disrupt our business, adversely affect our financial results, be unsuccessful or fail
to achieve the desired results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Overall, if we cannot raise the required funds, or cannot raise
them on terms acceptable to us or investors, we may be forced to curtail substantially our current operations or cease operations altogether.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; margin-right: 6.35pt; line-height: 1.25; font-style: italic; font-weight: bold">We face economic and
political risks associated with doing business in Taiwan, particularly due to the geopolitical tension between Taiwan and China, and in
Russia that could negatively affect our business and hence the value of your investment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">&#160;Currently, we rely on third party suppliers in Taiwan
for a portion of the components we use in our AlterG products. Accordingly, our business, financial condition and results of operations
and the market price of our securities may be affected by changes in governmental policies, taxation, growth rate, inflation rate or interest
rates and by social instability and diplomatic and social developments in or affecting Taiwan. In particular, the unique political status
of Taiwan and its internal political movement cause sustained tension between China and Taiwan. Past developments related to the interactions
between China and Taiwan, especially in relation to trade activities such as bans on exports of goods from time to time, have on occasions
depressed the transactions and business operations of certain Taiwanese companies and overall economic environment. We cannot predict
whether there will be escalation of the tensions between China and Taiwan, which would lead to new bans or tariffs on exports or even
conflict. Any conflict which threatens the military, political or economic stability in Taiwan could have a material adverse effect on
our current or future business and financial conditions and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">In addition, we also sell our AlterG products in Russia. The
current invasion of Ukraine by Russia has escalated tensions among the United States, the North Atlantic Treaty Organization (&#8220;NATO&#8221;)
and Russia. The United States and other NATO member states, as well as non-member states, have announced new sanctions against Russia
and certain Russian banks, enterprises and individuals. AlterG prior to the acquisition and Lifeward subsequent to the acquisition has
remained in compliance with these sanctions by obtaining export licenses for each shipment to our distributor that serves Russia. These
and any future additional sanctions and any resulting conflict between Russia, the United States and NATO countries could have an adverse
impact on our current operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">25</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">Further, such invasion, ongoing military conflict, resulting
sanctions and related countermeasures by NATO states, the United States and other countries are likely to lead to market disruptions,
including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions for equipment,
which could have an adverse impact on our operations and financial performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We do not satisfy all requirements for continued
listing on The Nasdaq Capital Market. We can provide no assurance that we will be able to comply with the continued listing requirements
over time or that our ordinary shares will continue to be listed on The Nasdaq Capital Market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As previously disclosed, on October 10, 2022, we received a notification
letter (the &#8220;Bid Price Letter&#8221;) from Nasdaq that we failed to evidence a minimum closing bid price of $1.00 per share for
the prior 30-consecutive business day period in contravention of Nasdaq Listing Rule 5550(a) (&#8220;Rule 5550(a)&#8221;).&#160; We were
provided an initial period of 180 days to regain compliance with Rule 5550(a).&#160; On April 11, 2023, we received a second notification
letter from Nasdaq indicating that we had been provided with an additional period of 180 calendar days, or until October 9, 2023, to regain
compliance with Rule 5550(a). The bid price of our ordinary shares did not close at $1.00 per share or more for a minimum of 10 consecutive
business days by October 5, 2023, and on October 6, 2023 we were notified by Nasdaq that, based upon our non-compliance with Rule 5550(a),
as of October 5, 2023, our securities were subject to delisting unless we timely requested a hearing before the Nasdaq Hearings Panel
(the &#8220;Panel&#8221;). We participated in an expedited review with the Panel, which first granted us an extension until January 31,
2024, to regain compliance with Rule 5550(a), including by implementing a reverse share split should such action be necessary to regain
compliance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We thereafter requested a further extension, through March 30,
2024, to allow for additional time for the finalization and implementation of the home health rule administrative proposal by CMS that
explicitly includes exoskeletons within a Medicare benefit category. Our updated compliance plan continues to include the possible implementation
of a reverse share split should such action be deemed necessary to maintain our listing on Nasdaq. On December 8, 2023, we were notified
that the Panel had granted us the requested extension through March 30, 2024, to regain compliance with Rule 5550(a)(2). To do so, we
must evidence a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days by March 30, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we are not successful in regaining compliance with Rule 5550(a)(2)
during the extension period, our ordinary shares will be removed from trading on The Nasdaq Capital Market. Any delisting determination
could seriously decrease or eliminate the value of an investment in our ordinary shares and other securities linked to our ordinary shares.
While an alternative listing on an over-the-counter exchange could maintain some degree of a market in our ordinary shares, we could face
substantial material adverse consequences, including, but not limited to, the following: limited availability for market quotations for
our ordinary shares; reduced liquidity with respect to our ordinary shares; a determination that our ordinary shares are &#8220;penny
stock&#8221; under SEC rules, subjecting brokers trading our ordinary shares to more stringent rules on disclosure and the class of investors
to which the broker may sell the ordinary shares; limited news and analyst coverage, in part due to the &#8220;penny stock&#8221; rules;
decreased ability to issue additional securities or obtain additional financing in the future; and potential breaches under or terminations
of our agreements with current or prospective large shareholders, strategic investors and banks. The perception among investors that we
are at heightened risk of delisting could also negatively affect the market price of our securities and trading volume of our ordinary
shares. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with the listing requirements
would allow our ordinary shares to become listed again, stabilize the market price or improve the liquidity of our ordinary shares, prevent
our ordinary shares from dropping below the Nasdaq minimum bid price requirement, or prevent future non-compliance with Nasdaq&#8217;s
listing requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our future growth and operating results will
depend on our ability to develop, receive regulatory clearance for and commercialize new products and penetrate new product and geographic
markets.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are currently engaged in research and development efforts to
address the needs of patients with mobility impairments besides paraplegia, such as stroke, and, in the future, we may engage in efforts
to address these needs in patients with other conditions such as multiple sclerosis, cerebral palsy, Parkinson&#8217;s disease and elderly
assistance. In 2019, we commercialized our first product for stroke patients, the ReStore Exo-Suit. For more information, see &#8220;Part,
Item 1. Business&#8212;ReStore Products&#8221; above. While our Collaboration Agreement with Harvard for the design, research and develop
lightweight exoskeleton system technologies for lower limb disabilities intended to treat stroke, multiple sclerosis, mobility limitations
for the elderly and other medical applications successfully concluded on March 31, 2022, Harvard has licensed to us certain of its intellectual
property relating to lightweight exoskeleton system technologies for lower limb disabilities. We are obligated to use commercially reasonable
efforts to develop products under the license in accordance with an agreed-upon development plan and to introduce and market such products
commercially.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">26</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect that a portion of our revenue will be derived, in the
next few years, from the ReStore soft exo-suit product,&#160;other new products utilizing DAP,&#160;and, in later years, if we choose
to advance the current designs, from other potential new products, such as ReBoot, a home use device for stroke patients, or new products
aimed at addressing other medical indications which affect the ability to walk, including multiple sclerosis, cerebral palsy, Parkinson&#8217;s
disease and elderly assistance. As such, our future results will depend on our ability to successfully develop and commercialize such
new products and to penetrate our targeted markets with our existing ReStore product in larger scale than we have done to date. We cannot
ensure that we will be able to introduce new products, products currently under development or products contemplated for future development
for additional indications in a timely manner, or at all, as it depends on our available resources to fund such projects, as well as our
ability to conduct clinical trials and testing. While we received governmental clearance to market our ReStore product on the anticipated
timetable in 2019, obtaining clearance for any other products we may develop could be an extensive, costly, and time-consuming process,
which could delay any planned commercialization timelines. For more information on the clearance processes for our products, see &#8220;Part
I, Item 1. Business&#8212;Government Regulation&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Harvard may terminate its License Agreement with us if we fail
to maintain the requisite insurance or become insolvent. Any such termination of this aspect of the collaboration with Harvard could impair
our research and development efforts into lightweight soft suit exoskeleton system technologies for lower limb disabilities such as the
ReBoot device which is intended to be used at home by people who suffered a stroke. In addition, we may not be able to clinically demonstrate
the medical benefits of our products for new indications. We have limited clinical data demonstrating the benefits of our products and
we might not be able to support the economic benefits our products have for our potential customers. We may also be unable to gain necessary
regulatory clearances or approvals to enable us to market new products for additional indications or the regulatory process may be more
costly and time-consuming than expected, which could adversely impact us given our cash position and ongoing capital requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Even if we are successful in the design and development of new
products, our growth and results of operations will depend on our ability to penetrate new markets and gain acceptance and reimbursement
coverage in non-SCI markets such as the stroke rehabilitation market, and, in the longer term, the home use device market for stroke-caused
lower limb disability, multiple sclerosis, elderly assistance and cerebral palsy patients. We may not be able to gain such market acceptance
and coverage for these indications in a timely manner, or at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">While our new products currently under development will share some
aspects of the core technology platform of our current products, their design features and components may differ from our current products.
Accordingly, these products will also be subject to the risks described in the risk factor immediately below entitled &#8220;We rely on
sales of our ReWalk Personal Exoskeletons, ReStore Exo-Suits, and AlterG Anti-Gravity systems and related service contracts and extended
warranties for our revenue. We may not be able to achieve or maintain market acceptance of our ReWalk, ReStore, or AlterG Anti-Gravity
products, or to generate sufficient revenue from these current and future products to sustain our operations.&#8221; To the extent we
are unable to successfully develop and commercialize products beyond our existing commercial product portfolio, we will not meet our operating
and financial objectives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We rely on sales of our ReWalk Personal Exoskeletons,
ReStore Exo-Suits, and AlterG Anti-Gravity systems and related service contracts and extended warranties for our revenue. We may not be
able to achieve or maintain market acceptance of our ReWalk, ReStore, or AlterG Anti-Gravity products or to generate sufficient revenue
from these current and future products to sustain our operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently rely, and expect in the future to rely, on sales of
our ReWalk Personal Exoskeleton, ReStore Exo-Suit, and AlterG Anti-Gravity systems, and related service contracts and extended warranties
for our revenue. We began marketing the ReStore lightweight soft exo-suit in 2019 in the United States and the E.U. (following the receipt
of FDA and CE mark clearance) to support mobility for individuals suffering from other lower limb disabilities. Several factors could
negatively affect our ability to achieve and maintain market acceptance of our ReWalk, AlterG, or ReStore systems, which could in turn
materially impair our business, financial condition, and operating results, as follows:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc8cfba78c5504fb084b62c92c2e61c9f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div><span style="font-style: italic">ReWalk</span>. We have sold a limited number of ReWalk systems, and market acceptance and adoption
        depend on educating people with limited upright mobility and health care providers as to the distinct features, ease-of-use, positive
        lifestyle impact, and other benefits of ReWalk compared to alternative technologies. ReWalk may not be perceived to have sufficient potential
        benefits compared with these alternatives. Users may also choose other alternatives due to disadvantages of ReWalk, including the time
        it takes for a user to put on the device, the slower pace of ReWalk compared to a wheelchair, the weight of ReWalk when carried, which
        makes it more burdensome for a companion to transport than a wheelchair, the required training, and the requirement that users be accompanied
        by a trained companion. Also, we believe that healthcare providers tend to be slow to change their medical treatment practices because
        of perceived liability risks arising from the use of new products and the uncertainty of third-party reimbursement. Accordingly, healthcare
        providers may not recommend ReWalk until there is sufficient support for the device to convince them to alter the treatment methods they
        typically recommend, such as expanded reimbursement coverage by payors, and/or recommendations by prominent healthcare providers or other
        key opinion leaders in the spinal cord injury community that ReWalk is effective in providing identifiable immediate and long-term health
        benefits.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">27</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; margin-left: 36pt; line-height: 1.25">In the United States, many private third-party payors use coverage
decisions and payment amounts determined by CMS as guidelines in setting their coverage and reimbursement policies. In July 2020, CMS
issued a Healthcare Common Procedure Coding System Level II Code for ReWalk Personal Exoskeleton. These codes are used to identify medical
products and supplies and to facilitate insurance claim submissions and processing for these items. On November 1, 2023, CMS issued Calendar
Year 2024 Home Health Prospective Payment System Rule CMS-1780, which explicitly included exoskeletons within a Medicare brace benefit
category. The rule went into effect on January 1, 2024. However, even with a positive coverage and reimbursement response from CMS regarding
a product of ours, future action by CMS or other government agencies may diminish possible payments to clinicians, outpatient centers
and/or hospitals that provide training to the patients so that they can operate the ReWalk Personal Exoskeletons satisfactorily before
they take them home, which would discourage access to training sites to prospective users of ReWalk Personal Exoskeletons.&#160; Additionally,
any decision by CMS regarding reimbursement could influence other payors, including private insurers. If CMS declines to provide for reimbursements
of our products, or if its reimbursement price is lower than that of other payors, our products may not be reimbursed at a cost-effective
level or at all. Those private third-party payors that do not follow the Medicare guidelines may adopt different coverage and reimbursement
policies for purchase of our products or their use in a hospital or rehabilitative setting. In addition, we expect that the purchase of
ReWalk Rehabilitation Exoskeleton systems and the ReStore system, as it is currently being sold for use in rehabilitative settings, will
require the approval of senior management at hospitals or rehabilitation facilities, inclusion in the hospitals&#8217; or rehabilitation
facilities&#8217; budget process for capital expenditures, and in the case of ReWalk Personal Exoskeleton, fundraising, and financial
planning or assistance.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="ze938651a582240dfaf94202c0fc9ae9c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div><span style="font-style: italic">ReStore</span>. The ReStore system is designed to provide advantages to stroke rehabilitation clinics
        and therapists as compared to other traditional therapies and devices by minimizing setup time, improving patients&#8217; clinical results
        during therapy, supplying real-time analytics to optimize session productivity, and generating ongoing data reports to assist with tracking
        patient progress Since the ReStore device is currently only indicated for use in the rehabilitative clinical setting, its market reception
        will depend heavily on our ability to demonstrate to clinics and therapists the systemic and economic benefits of using the ReStore device,
        its clinical advantage when compared to other devices or manual therapy, the functionality of the device for a significant portion of
        the patients that they treat and the overall advantages that the device provides to their patients compared to other technologies. Because
        the ReStore system is only indicated for use in a clinical setting and we received FDA approval and CE clearance in 2019, close in time
        to the start of the COVID-19 pandemic, the overall sales of the system have been lower than originally anticipated, as many healthcare
        providers and rehabilitation centers have shifted focus from the clinical setting to at-home therapies and are generally less open for
        introduction of new technologies such as the ReStore</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1f3b0aec2a9d492cae845ebf9fd9a0b5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">.</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>AlterG. The AlterG Anti-Gravity system has broad clinical utility for treating a wide variety of lower extremity conditions where
        partial displacement of a patient&#8217;s weight can enable exercise which facilitates healing and recovery of improved function.&#160;
        The potential of the AlterG Anti-Gravity systems to achieve greater penetration of the addressable market of rehabilitation hospitals,
        clinics, and sports medicine practices will depend upon the continued expansion of conditions for which clinicians utilize the AlterG
        and the ability for greater numbers of these facilities to afford the initial capital outlay for these devices. We are developing and
        hope to introduce in 2024 a new, lower-cost AlterG system, which we believe will make it more affordable for smaller, independent rehabilitation
        clinics. However, there can be no assurance that the introduction of this product can expand the size of the addressable market or will
        not reduce the sales of the existing, higher-priced models.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a general matter, achieving and maintaining market acceptance
of our current or future products could be negatively impacted by many other factors, including, but not limited to the following: contribution
to death or serious injury or malfunction, results of clinical studies relating to our or similar products; claims that our products,
or any of their components, infringe on patent or other intellectual property rights of third parties; our ability to support financially
and leverage our sales, marketing and training infrastructure, as well as our level of research and development efforts; our ability to
enhance and broaden our research and development efforts and product offerings in response to the evolving demands of people with paraplegia
and lower limb disability and healthcare providers; our estimates regarding our current or future addressable market; perceived risks
associated with the use of our products or similar products or technologies; the introduction of new competitive products or greater acceptance
of competitive products; adverse regulatory or legal actions relating to our products or similar products or technologies; and problems
arising from the outsourcing of our manufacturing capabilities, or our existing manufacturing and supply relationships. Any or all of
these factors could materially and negatively impact our business, financial condition and operating results.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">28</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The market for medical exoskeletons, including
soft suit devices, remains relatively new and unproven, and important assumptions about the potential market for our current and future
products may be inaccurate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The market for medical exoskeletons, including lightweight exo-suit
devices, remains relatively new and unproven. Accordingly, it is difficult to predict the future size and rate of growth of the market.
We cannot be certain whether the market will continue to develop or if medical exoskeletons will achieve and sustain a level of market
acceptance and demand sufficient for us to continue to generate revenue and achieve profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">We obtained FDA clearance for our ReWalk Personal Exoskeleton device in June 2014.
This clearance permits us to market the device for use by individuals with spinal cord injury at levels T7 to L5 and for use by individuals
in rehabilitation institutions with spinal cord injury at levels T4 to T6. We obtained FDA clearance for our ReStore system in June 2019.
This clearance permits us to market the device to be used to assist ambulatory functions in rehabilitation institutions under supervision
of a trained therapist for people with hemiplegia or hemiparesis due to stroke who can ambulate at least 1.5 meters (5 feet) with no more
than minimal to moderate levels of assistance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Future products for those with paraplegia or other mobility impairments
or spinal cord injuries may have the same or other restrictions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our business strategy is based, in part, on our estimates of the
number of individuals with physical limitations and disability and considers the occurrence of spinal cord injuries, strokes, lower-extremity
orthopedic injury or surgery, neurological disease, and obesity in our target markets, and the percentage of those groups that would be
able to use our current and future products. Limited sources exist to obtain reliable market data with respect to the number of mobility-impaired
individuals and the incurrence of spinal cord injuries and strokes in our target markets. In addition, there are no third-party reports
or studies regarding what percentage of those with limited mobility and/or spinal cord injuries would be able to use exoskeletons, in
general, or our current or planned future products, in particular. Our assumptions may be inaccurate and may change.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The NSCISC estimates according to its 2023 SCI Data Sheet that
there are 302,000 people in the United States living with SCI, with an annual incidence of approximately 18,000 new cases per year. Based
on information from the 2022 annual report published by the NSCISC, 40% of the total U.S. population of SCI patients suffered injuries
between levels T4 and L5.&#160; Four published ReWalk trials with respect to such eligible SCI patients had an aggregate screening acceptance
rate of 50% considering all current FDA limitations, resulting in an estimated 20% of the total population of SCI patients being qualified
candidates for current ReWalk products under its medical labeling criteria. There may be other permanent or short-term factors that affect
the market size such as the ability to participate in the training program, the ability to use the device in the user&#8217;s current
home environment as well as available companion support. With regards to our ReStore product for stroke rehabilitation, as the indication
of use is currently in rehabilitation clinics our target market is based on the number of current and future clinics who treat stroke
patients. Although there are thousands of inpatient, outpatient and rehabilitation clinics providing therapy in the U.S. for example,
we currently see that only a limited portion of the clinics have decided to include ReStore in their stroke rehab program. For more information
on our expectations regarding these plans, see &#8220;&#8212;Our future growth and operating results will depend on our ability to develop,
receive regulatory clearance for and commercialize new products and penetrate new product and geographic markets&#8221; below. For more
information regarding the potential market for future products, including our lightweight soft suit exoskeleton, see &#8220;Part I, Item
1. Business&#8212;ReWalk Personal and ReWalk Rehabilitation Products&#8212;Market Opportunity&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We cannot assure you that our estimate regarding our current products
is accurate or that our estimate regarding future products will remain the same. FDA or CE mark clearance for such products, if received
at all, may contain different limitations from the ones the FDA or EU has placed on the devices we currently market for paraplegia. If
our estimates of our current or future addressable market are incorrect, our business may not develop as we expect, and the price of our
securities may suffer.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">29</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may fail to secure or maintain adequate
insurance coverage or reimbursement for our products by third-party payors, which risk may be heightened if insurers find the products
to be investigational or experimental or if new government regulations change existing reimbursement policies. Additionally, such coverage
or reimbursement, even if maintained, may not produce revenue that are high enough to allow us to sell our products profitably.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect that in the future a significant source of payment for
ReWalk systems will be private insurance plans and managed care programs, government programs such as the VHA, CMS, workers&#8217; compensation
plans, and other third-party payors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In December 2015, the VHA issued a national reimbursement policy
for the ReWalk system, which entails the evaluation, training and procurement of ReWalk Personal Exoskeleton systems for all qualifying
veterans across the United States. Additionally, in September 2017, German insurer Barmer signed a confirmation and letter of agreement
regarding the provision of ReWalk systems for all qualifying beneficiaries and the German national social accident insurance provider
DGUV indicated that its member payors will approve the supply of exoskeleton systems for qualifying beneficiaries on a case-by-case basis.
However, no broad uniform policy of coverage and reimbursement for electronic exoskeleton medical technology exists among third-party
payors in the United States, although reimbursement may be achieved on a case-by-case basis. To date, payments for our products, which
are largely for our ReWalk systems, have been made primarily through case-by-case determinations by third-party payors (including several
private insurers in the United States), by self-payors and, to a lesser extent, through the use of funds from insurance and/or accident
settlements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Generally, private insurance companies in the United States do
not cover or provide reimbursement for any medical exoskeleton products for personal use, including ReWalk Personal Exoskeleton, and may
ultimately provide no coverage at all. Additionally, there is limited clinical data related to the ReWalk and ReStore systems, and third-party
payors may consider use of them to be experimental and therefore refuse to cover any or all of them. Additionally, the majority of independent
medical review decisions to date made following the denial of ReWalk coverage have determined that ReWalk is experimental and/or investigational,
citing a lack of clinical data.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As described above, in the United States, many private third-party
payors use coverage decisions and payment amounts determined by CMS as guidelines in setting their coverage and reimbursement policies.
On November 1, 2023, CMS issued Calendar Year 2024 Home Health Prospective Payment System Rule CMS-1780, which explicitly included exoskeletons
within a Medicare brace benefit category, effective January 1, 2024. CMS also solicited comment on a preliminary payment determination
for the ReWalk Personal Exoskeleton as part of the November 29, 2023 HCPCS meeting process, and we participated to provide updated pricing
information to inform CMS&#8217;s final payment determination. A final Medicare payment determination is expected from CMS in first quarter
of 2024 with an April 1, 2024, effective date.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">However, even with a positive coverage and reimbursement response
from CMS regarding a product of ours, future action by CMS or other government agencies may diminish possible payments to physicians,
outpatient centers and/or hospitals that purchase our products for use by their patients and possible payments to individuals who purchase
the ReWalk Personal Exoskeleton for their own use. Additionally, a decision by CMS to provide reimbursement could influence other payors,
including private insurers. If CMS declines to provide for reimbursements of our products or if its reimbursement price is lower than
that of other payors, our products may not be reimbursed at a cost-effective level or at all. Those private third-party payors that do
not follow the Medicare guidelines may adopt different coverage and reimbursement policies for purchase of our products or their use in
a hospital or rehabilitative setting. In addition, we expect that the purchase of ReWalk Rehabilitation Exoskeleton systems and the ReStore
system, as it is currently being sold for use in rehabilitative settings, will require the approval of senior management at hospitals
or rehabilitation facilities, inclusion in the hospitals&#8217; or rehabilitation facilities&#8217; budget process for capital expenditures,
and in the case of ReWalk Personal Exoskeleton, fundraising, and financial planning or assistance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Third-party payors are developing increasingly sophisticated methods
of controlling healthcare costs. These cost control methods include prospective payment systems, capitated rates, benefit redesigns and
an exploration of other cost-effective methods of delivering healthcare. These cost control methods potentially limit the amount that
healthcare providers may be willing to pay for electronic exoskeleton medical technology if they provide coverage at all. We may be unable
to sell our products on a profitable basis if third-party payors deny coverage or provide insufficient levels of reimbursement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Future legislation could result in modifications to the existing
public and private health care insurance systems that would have a material adverse effect on the reimbursement policies discussed above.
If enacted and implemented, any measures to restrict health care spending could result in decreased revenue from our products and decrease
potential returns from our research and development initiatives.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">30</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Defects in our products or the software that
drives them could adversely affect the results of our operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The design, manufacture and marketing of our products involve certain
inherent risks. Manufacturing or design defects, unanticipated use of ReWalk, ReStore, or AlterG, or inadequate disclosure of risks relating
to the use of our products can lead to injury or other adverse events. In addition, because the manufacturing of some of our products
is outsourced to Sanmina, the original equipment manufacturer of such products, we may not be aware of manufacturing defects that could
occur. Such adverse events could lead to recalls or safety alerts relating to those products (either voluntary or required by the FDA
or similar governmental authorities in other countries), and could result, in certain cases, in the removal of our products from the market.
A recall could result in significant costs. To the extent any manufacturing defect occurs, our agreement with Sanmina contains a limitation
on Sanmina&#8217;s liability, and therefore we could be required to incur the majority of related costs. Product defects or recalls could
also result in our inability to profitably grow our business due to parts shortages, increased field service demand, and inventory shortages,
and the resulting negative publicity, customer dissatisfaction, damage to our reputation or, in some circumstances, delays in new product
clearances or approvals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">When an exoskeleton is used by a paralyzed individual to walk,
the individual relies completely on the exoskeleton to hold him or her upright. Between 2013 and 2021, we submitted medical device reports
(&#8220;MDRs&#8221;) to the FDA (and equivalent authorities outside of the United States) relating to reports of falls and fractures of
individuals using the ReWalk Personal Exoskeleton system.&#160; We conducted a voluntary correction related to certain use instructions
in the device&#8217;s labeling, which the FDA classified as a Class II recall.&#160; The recall was closed in November 2019, and the FDA
cleared our 510(k) containing revised instructions for use in May 2020.&#160; Since that time, we have submitted no further MDRs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, our products incorporate sophisticated computer software
and hardware. Complex software frequently contains errors, especially when first introduced. Our software may experience errors or performance
problems in the future. If any part of our product&#8217;s hardware or software were to fail, the user could experience death or serious
injury. For example, in 2021 ReWalk submitted medical device reports to the FDA and medical device vigilance reports to the European regulatory
authorities and initiated a correction in response to two complaints regarding battery thermal runaway events. The correction that includes
clarification of previous instructions and additional information on battery operation and storage is closed in Europe and in the United
States. ReWalk has separately initiated a design project to improve power management and battery operation during charge and discharge,
and this project remains in process. Additionally, users may not use or maintain our products in accordance with safety, storage, and
training protocols, which could enhance the risk of death or injury. Any such occurrence could cause delay in market acceptance of our
products, damage to our reputation, the need for additional regulatory filings, product recalls, increased service and warranty costs,
product liability claims, and loss of revenue relating to hardware or software defects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The medical device industry has historically been subject to extensive
litigation over product liability claims. We have been and anticipate that as part of our ordinary course of business we may be subject
to product liability claims alleging defects in the design, manufacture, or labeling of any of our products which has resulted in an injury
or death. A product liability claim, regardless of its merit or eventual outcome, could result in significant legal defense costs and
high punitive damage payments. Although we maintain product liability insurance, the coverage is subject to deductibles and limitations,
and may not be adequate to cover future claims. Additionally, we may be unable to maintain our existing product liability insurance in
the future at satisfactory rates or adequate amounts.&#160;Any alleged defect that has resulted in an adverse event involving our products
could result in future voluntary corrective actions, such as recalls or customer letters, or in an FDA enforcement action, such as a mandatory
recall, notification to healthcare professionals and users, warning letter, seizure, injunction or import alert. In addition, failure
to report such adverse events to appropriate government authorities on a timely basis, or at all, could result in enforcement action against
us. Any action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, will require financial resources and distract
management, and may harm our reputation and financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to leverage our sales, marketing,
and training infrastructure we may fail to increase our sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A key element of our long-term business strategy is the continued
leveraging of our sales, marketing, training, and reimbursement infrastructure, through the training, retention, and motivation of skilled
sales and marketing representatives and reimbursement personnel with industry experience and knowledge. Our ability to derive revenue
from sales of our products depends largely on our ability to market the products and obtain reimbursements for them. In order to continue
growing our business efficiently, we must therefore coordinate the development of our sales, marketing, training and reimbursement infrastructure
with the timing of regulatory approvals, decisions regarding reimbursements, limited resources consideration and other factors in various
geographies. Managing and maintaining our sales and marketing infrastructure is expensive and time consuming, and an inability to leverage
such an organization effectively, or in coordination with regulatory or other developments, could inhibit potential sales and the penetration
and adoption of our products into both existing and new markets. However, certain decisions we make regarding staffing in these areas
in our efforts to maintain an adequate spending level could have unintended negative effects on our revenue, such as by weakening our
sales infrastructure, impairing our reimbursement efforts and/or harming the quality of our customer service.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">31</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, we expect to face significant challenges as we manage
and continue to improve our sales and marketing infrastructure and work to retain the individuals who make up those networks. Newly hired
sales representatives require training and take time to achieve full productivity. If we fail to train new hires adequately, or if we
experience high turnover in our sales force in the future, we cannot be certain that new hires will become as productive as may be necessary
to maintain or increase our sales. Likewise, following our acquisition of AlterG in August 2023 and in connection with integrating AlterG
with ReWalk, each set of sales representatives had to learn how to sell new products and services. In addition, if we are not able to
retain existing and recruit new trainers to our clinical staff, we may not be able to successfully train customers on the use of ReWalk,
ReStore, or AlterG systems which could inhibit new sales and harm our reputation. If we are unable to expand our sales, marketing, and
training capabilities, we may not be able to effectively commercialize our products, or enhance the strength of our brand, which could
have a material adverse effect on our operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The potential health benefits of our ReWalk products have not been
substantiated by long-term clinical data, which could limit sales of such products.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Although published research and users of our ReWalk products have
reported the potential secondary health benefits of our ReWalk products such as a reduction in pain and spasticity, improved bowel and
urinary tract functions and emotional and psychosocial benefits, among others, currently there is no large scale, randomized clinical
trial establishing the secondary health benefits of ReWalk products due to the relatively small size of the applicable user population.
There is also a lack of randomized clinical data for such health benefits of the ReStore-specifically its long-term benefits following
the usage of the product within the clinic as the trials conducted to date using this product are limited.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a result, potential customers and healthcare providers may be
slower to adopt or recommend ReWalk products or ReStore and third-party payors may not be willing to provide coverage or reimbursement
for our products. In addition, future studies or clinical experience may indicate that treatment with our current or future products is
not superior to treatment with alternative products or therapies. Such results could slow the adoption of our products and significantly
reduce our sales.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We depend on a single third-party supplier
to manufacture some of our products, and we rely on a limited number of third-party suppliers for certain components of our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have contracted with Sanmina, a well-established contract manufacturer
with expertise in the medical device industry, for the manufacture of all our ReWalk and ReStore systems and the sourcing of all of our
components and raw materials for those products. We may terminate our relationship with Sanmina at any time upon written notice. In addition,
either we or Sanmina may terminate the relationship in the event of a material breach, subject to a 30-day cure period. For our business
strategy to be successful, Sanmina must be able to manufacture our products in sufficient quantities, in compliance with regulatory requirements
and quality control standards, in accordance with agreed upon specifications, at acceptable costs and quality levels, and on a timely
basis. Increases in our product sales, whether forecasted or unanticipated, could strain the ability of Sanmina to manufacture an increasingly
large supply of our current or future products in a manner that meets these various requirements. In addition, although we are not restricted
from engaging an alternative manufacturer, and potentially have the capabilities to manufacture our products in-house, the process of
moving our manufacturing activities would be time consuming and costly, and may limit our ability to meet our sales commitments, which
could harm our reputation and could have a material adverse effect on our business.&#160;Moreover, the failure of Sanmina to comply with
applicable regulatory requirements could expose us to regulatory action including warning letters, product recalls, termination of distribution,
product seizures or civil penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We also rely on third-party suppliers, many of which contract directly
with Sanmina, to supply certain components of our products, and in some cases, we purchase these components ourselves. In our factory
in Fremont, California, where we manufacture our AlterG products, we also rely on third-party suppliers for key components of our products.&#160;
Neither Lifeward nor Sanmina has long-term supply agreements with most of the suppliers and, in many cases, make purchases on a purchase
order basis and our ability to secure adequate quantities of such products may be limited. Suppliers may encounter problems that limit
their ability to manufacture components for our products, including financial difficulties or damage to their manufacturing equipment
or facilities. If Lifeward or Sanmina fails to obtain sufficient quantities of high-quality components to meet demand on a timely basis,
we could lose customer orders, our reputation may be harmed, and our business could suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Our results of operations and liquidity could be adversely impacted by supply chain
disruptions and operational challenges faced by our manufacturer or suppliers. Sanmina generally uses a small number of suppliers for
ReWalk and ReStore. Our manufacturing operations for AlterG also utilize a limited number of suppliers, some of which are the sole suppliers
to us of such supplies.&#160; Depending on a limited number of suppliers exposes us to risks, including limited control over pricing,
availability, quality, and delivery schedules. Such risks were heightened in light of the interruptions in supply chains and distribution
networks related to the COVID-19 pandemic. For example, as a result of the COVID-19 pandemic, several components, mainly electronic parts,
experienced price increases. If any one or more of our suppliers ceases to provide sufficient quantities of components in a timely manner
or on acceptable terms, we or Sanmina would have to seek alternative sources of supply or accept price increase as we saw during the pandemic.
It may be difficult to engage additional or replacement suppliers in a timely manner. Failure of these suppliers to deliver products at
the level our business requires would limit our ability to meet our sales commitments, which could harm our reputation and could have
a material adverse effect on our business. We or Sanmina also may have difficulty obtaining similar components from other acceptable suppliers,
which could require Sanmina or us to cease using the components, seek alternative components or technologies and we could be forced to
modify our products to incorporate alternative components or technologies, which could result in a requirement to seek additional regulatory
clearances or approvals. Any disruption of this nature or increased expenses could harm our commercialization efforts and adversely affect
our operating results.</div> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">32</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 42.55pt; line-height: 1.25">Sanmina&#8217;s manufacturing and assembly of our ReWalk and
Restore products pursuant to our specifications is conducted at a single facility in Ma&#8217;alot, Israel. Accordingly, we are highly
dependent on the uninterrupted and efficient operation of this facility. If operations at this facility were to be disrupted as a result
of acts of war or terrorism, equipment failures, earthquakes and other natural disasters, fires, accidents, work stoppages, power outages,
or other reasons such as a local shutdown as we experienced during the COVID-19 pandemic, our business, financial condition and results
of operations could be materially adversely affected. In particular, this facility is located in the north of Israel within range of rockets
that have from time to time been fired into the country during armed conflicts with Hezbollah and other armed groups in Lebanon, Syria
or other countries in the region. For more information, see the risk factor below entitled &#8220;Risks Related to Our Incorporation and
Location in Israel<span style="font-weight: bold"> - </span>Conditions in Israel, including Israel&#8217;s war against Hamas and other
terrorist organizations in the Gaza Strip and a potential escalation of the conflict on Israel&#8217;s northern border, may materially
and adversely affect our business and results of operations.&#8221; Although our manufacturing and assembly operations could be transferred
elsewhere, either in-house or to an alternative Sanmina facility, the process of relocating these operations would cause delays in production.
Lost sales or increased costs that we may experience during the disruption, or a forced relocation, of operations may not be recoverable
under our insurance policies, and longer-term business disruptions could result in a loss of customers. If this were to occur, our business,
financial condition and operations could be materially negatively impacted. Additionally, our reliance on Sanmina as a contract manufacturer
or any other contract manufacturer makes us vulnerable to possible capacity constraints and reduced control over component availability,
delivery schedules, manufacturing yields and costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We operate in a competitive industry that is
subject to rapid technological change, and we expect competition to increase.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There are several other companies developing technology and devices
that compete with our products. Our principal competitors in the medical exoskeleton market consist of Ekso Bionics, Rex Bionics, Cyberdyne,
FREE Bionics, Wandercraft, and others. These companies have products currently available for institutional use and in some cases personal
use. We expect some of such products to become available for personal use in the next few years, especially as we continue to expand coverage
by different payors and geographies. In addition, we compete with alternative devices and alternative therapies, including treadmill-based
gait therapies, such as those offered by DIH (formerly known as Hocoma), Boost, Aretech, BTL, Reha Technology, and Bioness, which is a
unit of Bioventus. Our competitor base may change or expand as we continue to develop and commercialize our soft suit exoskeleton product
in the future. These or other medical device or robotics companies, academic and research institutions, or others, may develop new technologies
or therapies that provide a superior walking and usage experience, are more effective in treating the secondary medical conditions that
we target or are less expensive than ReWalk, ReStore, AlterG, or future products. Our technologies and products could be rendered obsolete
by such developments. We may also compete with other treatments and technologies that address the secondary medical conditions that our
products seek to mitigate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our competitors may respond more quickly to new or emerging technologies,
undertake more extensive marketing campaigns, have greater financial, marketing, and other resources than we do or may be more successful
in attracting potential customers, employees, and strategic partners. In addition, potential customers, such as hospitals and rehabilitation
centers, could have long-standing or contractual relationships with competitors or other medical device companies. Potential customers
may be reluctant to adopt ReWalk, ReStore, or AlterG, particularly if it competes with or has the potential to compete with or diminish
the need/utilization of products or treatments supported through these existing relationships. If we are not able to compete effectively,
our business and results of operations will be negatively impacted.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">33</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, because we operate in a new market, the actions of
our competitors could adversely affect our business. Adverse events such as product defects or legal claims with respect to competing
or similar products could cause reputational harm to the exoskeleton market on the whole. Further, adverse regulatory findings or reimbursement-related
decisions with respect to other exoskeleton products could negatively impact the entire market and, accordingly, our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We utilize independent distributors for the
ReWalk and ReStore products who are free to market other products that compete with ours.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">While we expect that the percentage of our sales generated from independent distributors
will decrease over time as we continue to focus our resources on achieving reimbursement within our direct markets in the United States
and Europe, we believe that independent distributors of the ReWalk or ReStore products will continue to be an important distribution channel
for us in the future. None of our independent distributors has been required to sell our products exclusively. Our agreements with these
distributors generally have one-year initial terms and automatic renewals for an additional year. If any of our key independent distributors
of the ReWalk or ReStore products were to cease to distribute our products, our sales could be adversely affected. In such a situation,
we may need to seek alternative independent distributors or increase our reliance on our other independent distributors or our direct
sales representatives, which may not prevent our sales from being adversely affected. Additionally, to the extent that we enter into additional
arrangements with independent distributors to perform sales, marketing, or distribution services, the terms of the arrangements could
cause our product margins to be lower than if we directly marketed and sold our products.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may receive a significant number of warranty
claims or our ReWalk, ReStore, or AlterG systems may require significant amounts of service after sale.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Sales of ReWalk generally include a five-year warranty for parts
and services, other than for normal wear and tear. Some of our active devices were delivered prior to 2019 with a two-year warranty so
we provide these&#160;customers with the option to purchase an extended warranty for up to an additional three years. Our ReStore product
offering includes a two-year warranty for parts and services. The AlterG Anti-Gravity systems are sold with a one-year factory warranty
covering parts and services.&#160; If product returns or warranty claims are significant or exceed our expectations, we could incur unanticipated
expenditures for parts and services, which could have a material adverse effect on our operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may not be able to enhance our exoskeleton product offerings
through our research and development efforts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In order to increase our sales and our market share in the exoskeleton
market, we are working to enhance and broaden our research and development efforts and product offerings in response to the evolving demands
of people with paraplegia, paralysis, other medical conditions and healthcare providers, as well as competitive technologies. We are also
currently involved in ongoing research and development efforts directed to the needs of patients with other mobility impairments, such
as stroke, and began commercializing our ReStore product for stroke patients in 2019. Depending on our future resources and business focus,
we plan to address these needs in patients with other conditions or devices for stroke patients to be used at home, improving our current
products, or developing products to address additional medical conditions such as multiple sclerosis, Parkinson&#8217;s disease or cerebral
palsy and support elderly assistance. We may decide to invest our business development resources in partnerships, licensing agreements,
business acquisition&#160;and other ways that will provide us new product offerings without significant research and development activities.
We may not be successful in developing, obtaining regulatory approval for, or marketing our currently proposed products, or our approved
products for additional indications, products proposed to be created in the future or products that will be available for us through business
acquisitions. In addition, notwithstanding our market research efforts, our future products may not be accepted by consumers, their caregivers,
healthcare providers or third-party payors who reimburse consumers for our products. The success of any proposed product offerings will
depend on numerous factors, including our ability to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf9316f039626486bbd640b27f5df75e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>identify the product features that people with paraplegia or paralysis, their caregivers, and healthcare providers are seeking in
        a medical device that restores upright mobility and successfully incorporate those features into our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3a7139175cf14614adc1d3a64b929050" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>identify the product features that people with stroke, multiple sclerosis or other similar indications require while the products
        are used at home as well as what items are valuable to the clinics that provide them rehabilitation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za79fafb9a96243fd94716d025da78703" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>develop and introduce proposed products in sufficient quantities and in a timely manner;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2de3e045dc23408eb0b601b6fba29e03" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third-parties;</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">34</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z6efa434ba19149e9a01eb51ac6ef3d6d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>demonstrate the safety, efficacy, and health benefits of proposed products; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z770d0bef9f7f4358ada69702bd446ee8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 18pt"><br/> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>obtain the necessary regulatory clearances and approvals for proposed products.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we fail to generate demand by developing products that incorporate
features desired by consumers, their caregivers or healthcare providers, or if we do not obtain regulatory clearance or approval for proposed
products in time to meet market demand, we may fail to generate sales sufficient to achieve or maintain profitability. We have in the
past experienced, and we may in the future experience, delays in various phases of product development, including during research and
development, manufacturing, limited release testing, marketing, and customer education efforts. Such delays could cause customers to delay
or forgo purchases of our products, or to purchase our competitors&#8217; products. Even if we are able to successfully develop proposed
products when anticipated, these products may not produce sales in excess of the costs of development, and they may be quickly rendered
obsolete by changing consumer preferences or the introduction by our competitors of products embodying new technologies or features.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may enter into collaborations, in-licensing
arrangements, joint ventures, strategic alliances, business acquisitions or partnerships with third parties that may not result in the
development of commercially viable products or the generation of significant future revenue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the ordinary course of our business, we may enter into collaborations,
in-licensing arrangements, joint ventures, strategic alliances, business acquisitions, partnerships or other arrangements to develop our
products and to pursue new geographic or product markets. Proposing, negotiating, and implementing collaborations, in-licensing arrangements,
joint ventures, strategic alliances, or partnerships may be a lengthy and complex process. Other companies, including those with substantially
greater financial, marketing, sales, technology or other business resources, may compete with us for these opportunities or arrangements.
We may not identify, secure, or complete any such transactions or arrangements in a timely manner, on a cost-effective basis, on acceptable
terms or at all. We have limited institutional knowledge and experience with respect to these business development activities, and we
may also not realize the anticipated benefits of any such transaction or arrangement. In particular, these collaborations may not result
in the development of products that achieve commercial success or result in significant revenue and could be terminated prior to developing
any products. For example, we have entered into agreements with MediTouch and MYOLYN for the distribution of their products in the U.S.
After several years of commercial collaboration, we determined that the agreement with MediTouch would not yield commercially acceptable
results for us and we terminated the agreement as of January 31, 2023. Similarly, the distribution arrangement with MYOLYN or other new
future arrangements may not be as productive or successful as we hope.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On&#160;May 16, 2016, we entered into the Collaboration Agreement
and License Agreement with Harvard. Pursuant to the Collaboration Agreement, we have agreed to collaborate with Harvard for the research,
design, development, and commercialization of lightweight exoskeleton system technologies for lower limb disabilities, aimed to treat
stroke, multiple sclerosis, mobility limitations for the elderly and other medical applications. The Collaboration Agreement concluded
on March 31, 2022.&#160; The License Agreement will continue in full force and effect until the expiration of the last-to-expire valid
claim of the licensed patents. For more information on the collaboration with Harvard, see &#8220;Part I. Item 1. Business - Research
and Development - Research and Development Collaborations&#8221;.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, as we pursue these arrangements and choose to pursue
other collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships in the future, we may not be in
a position to exercise sole decision-making authority regarding the transaction or arrangement. This could create the potential risk of
creating impasses on decisions, and our collaborators may have economic or business interests or goals that are, or that may become, inconsistent
with our business interests or goals. It is possible that conflicts may arise with our collaborators. Our collaborators or any future
collaborators may act in their self-interest, which may be adverse to our best interest, and they may breach their obligations to us.
Disputes between us and our collaborators or any future collaborators may result in litigation or arbitration which would increase our
expenses and divert the attention of our management. Further, these transactions and arrangements are contractual in nature and may be
terminated or dissolved under the terms of the applicable agreements. Our collaborators or any future collaborators may allege that we
have breached our agreement with them, and accordingly seek to terminate such agreement, which could adversely affect our competitive
business position and harm our business prospects.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">35</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may seek to grow our business through acquisitions
of businesses, products or technologies, and the failure to manage acquisitions, or the failure to integrate them with our existing business,
could have a material adverse effect on our business, financial condition, and operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">From time to time, we may consider opportunities to acquire or
license other products or technologies that may enhance our product platform or technology, expand the breadth of our markets or customer
base, or advance our business strategies. For example, as discussed above in &#8220;Part I. Item 1. Business - Overview&#8221;, on August
11, 2023, we completed the acquisition of AlterG, and AlterG became an indirect and wholly-owned subsidiary of the Company. Potential
acquisitions involve numerous risks, including:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2afce2c3dcb74e759f067ac8e3072bd4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>problems assimilating the acquired products or technologies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb72f7bf91ff74fb5944c71b49d5ea5ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>issues maintaining uniform standards, procedures, controls and policies;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zff9d40a311a2438ca5e39a4f5de90194" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>problems integrating employees from an acquired organization into our company and integrating each company&#8217;s accounting, management
        information, human resources and other administrative systems;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdc3937b2c3b347cc8ca0418cc798bf4b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>unanticipated costs associated with acquisitions;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za9d394050e034e7fa97166836d89b11a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>diversion of management&#8217;s attention from our existing business operations;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z40686363e0d548d9846bafc1fb1d723d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>potential incurrence of debt, contingent liabilities or amortization expenses, or write-offs of goodwill;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z26a1bfc79ab444d0819b618287e71e54" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>risks associated with entering new markets in which we have limited or no experience; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6cb935100045436d987a27f3445601ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>increased legal and accounting costs relating to the acquisitions or compliance with regulatory matters.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have no current commitments with respect to any acquisition
or licensing. We do not know if we will be able to identify such acquisitions or licensing we deem suitable, whether we will be able to
successfully complete any such transactions on favorable terms, or at all, or whether we will be able to successfully integrate any acquired
products or technologies. Our potential inability to integrate any acquired products or technologies effectively may adversely affect
our business, operating results, and financial condition. For more information, see the risk factor above entitled &#8220;Risks Related
to Our Business and Our Industry &#8211; We may fail to realize the benefits expected from our acquisition of AlterG, which could adversely
affect the price of our ordinary shares.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Risks Related to Government Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Although the FDA granted Breakthrough Device
Designation status to our ReBoot device, this designation does not guarantee regulatory clearance, or a speedier clearance timeline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In November 2021, the FDA granted Breakthrough Device Designation
status to ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.&#160; In May 2021, the FDA granted Breakthrough
Device Designation status to the ReWalk with stair functionality.&#160; For more information regarding the Breakthrough Device, see &#8220;Part
I, Item 1. Business-Government Regulation&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">However, achieving Breakthrough Device Designation status does
not guarantee regulatory clearance or approval or a speedier clearance or approval timeline.&#160; We have not yet submitted a premarket
submission to the FDA or any foreign regulatory agency for clearance or other marketing authorization of ReBoot.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">U.S. healthcare reform measures and other potential
legislative initiatives could adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Recent political changes in the United States could result in significant
changes in, and uncertainty with respect to, legislation, regulation, global trade, and government policy that could substantially impact
our business and the medical device industry generally. Certain proposals, if enacted into law, could impose limitations on the prices
we will be able to charge for our ReWalk system or any products we may develop and offer in the future, or the amounts of reimbursement
available for such products from governmental agencies or third-party payors. Additionally, any reduction in reimbursement from Medicare
or other government-funded federal programs, including the VHA, or state healthcare programs could lead to a similar reduction in payments
from private commercial payors. The FDA&#8217;s policies may also change, and additional government regulations may be issued that could
prevent, limit, or delay regulatory approval of our future products, or impose more stringent product labeling and post-marketing testing
and other requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect that changes or additions to the ACA or the Medicare
and Medicaid programs, changes allowing the federal government to directly negotiate drug prices and changes stemming from other healthcare
reform measures, especially with regard to healthcare access, financing or other legislation in individual states, could have a material
adverse effect on the healthcare industry.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">36</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Other legislative changes have been proposed and adopted since
passage of the ACA. The Budget Control Act of 2011, among other things, created the Joint Select Committee on Deficit Reduction to recommend
proposals in spending reductions to Congress. The Joint Select Committee did not achieve its targeted deficit reduction of an amount greater
than $1.2 trillion for the fiscal years 2012 through 2021, triggering the legislation&#8217;s automatic reductions to several government
programs. These reductions included aggregate reductions to Medicare payments to healthcare providers of up to 2% per fiscal year. This
2% reduction was temporarily suspended during the pandemic, but has since been reinstated and, unless Congress and/or the Administration
take additional action, will begin to increase gradually starting in April 2030, reaching 4% in April 2031, until sequestration ends in
October 2031. On January 2, 2013, the American Taxpayer Relief Act was signed into law, which, among other things, reduced Medicare payments
to several types of providers, including hospitals, imaging centers, and cancer treatment centers, and increased the statute of limitations
period for the government to recover overpayments to providers from three to five years. The 2022 Inflation Reduction Act, among other
things, directs CMS to engage in price-capped negotiation for certain drugs and biologics that CMS reimburses under Medicare Part B and
Part D, penalizes drug manufacturers that increase prices of Medicare Part B and Part D drugs at a rate greater than the rate of inflation,
and redesigns the Part D drug benefit, effective in 2025.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The implementation of cost containment measures or other healthcare
reforms may thus prevent us from being able to generate revenue, attain profitability or further commercialize our existing or future
products. We are currently unable to predict what additional legislation or regulation, if any, relating to the health care industry may
be enacted in the future or what effect recently enacted federal legislation or any such additional legislation or regulation would have
on our business. The pendency or approval of such proposals or reforms could result in a decrease in our stock price or limit our ability
to raise capital or to enter into collaboration agreements for the further development and commercialization of our programs and products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our devices are subject to the FDA&#8217;s
regulations pertaining to marketing and promotional communications, among others. Failure to comply with such regulations may give rise
to a number of potential FDA enforcement actions, any of which could have a material adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our sales and marketing efforts, as well as promotions, are subject
to various laws and regulations. Medical device promotions must be consistent with and not contrary to labeling and the indication for
use, be truthful and not false or misleading, and be adequately substantiated. In addition to the requirements applicable to 510(k)-cleared
products, we may also be subject to enforcement action in connection with any promotion of an investigational new device. A sponsor or
investigator, or any person acting on behalf of a sponsor or investigator, may not represent in a promotional context that an investigational
new device is safe or effective for the purposes for which it is under investigation or otherwise promote the device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our marketing and promotional materials are subject to FDA scrutiny
to ensure that the device is being marketed in compliance with these requirements. If the FDA investigates our marketing and promotional
materials and finds that any of our current or future commercial products were being marketed for unapproved or uncleared uses or in a
false or misleading manner, we could be subject to FDA enforcement and/or false advertising consumer lawsuits, each of which could have
a material adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to extensive governmental regulations
relating to the manufacturing, labeling, and marketing of our products, and a failure to comply with such regulations could lead to withdrawal
or recall of our products from the market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our medical products and manufacturing operations are subject to
regulation by the FDA, the European Union, and other governmental authorities both inside and outside of the United States. These agencies
enforce laws and regulations that govern the development, testing, manufacturing, labeling, storage, installation, servicing, advertising,
promoting, marketing, distribution, import, export and market surveillance of our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our products are regulated as medical devices in the United States
under the FFDCA as implemented and enforced by the FDA. Under the FFDCA, medical devices are classified into one of three classes (Class
I, Class II or Class III) depending on the degree of risk associated with the medical device, what is known about the type of device,
and the extent of control needed to provide reasonable assurance of safety and effectiveness. Classification of a device is important
because the class to which a device is assigned determines, among other things, the necessity and type of FDA review required prior to
marketing the device. For more information, see &#8220;Part I, Item 1. Business-Government Regulation&#8221; above.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">37</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In June 2014, the FDA granted our request for &#8220;de novo&#8221;
classification, which provides a route to market for medical devices that are low to moderate risk, but are not substantially equivalent
to a predicate device, and classified ReWalk as Class II powered exoskeleton device subject to certain special controls. In March 2023
the FDA granted 510(k) clearance for the ReWalk Personal Exoskeleton with stair and curb functionality, which adds usage on stairs and
curbs to the indication for use for the device in the U.S. The ReWalk is intended to enable individuals with spinal cord injuries to perform
ambulatory functions under supervision of a specially trained companion, and inside rehabilitation institutions. The special controls
established in the de novo order for all powered exoskeletons include the following: clinical testing to demonstrate safe and effective
use considering the level of supervision necessary and the use environment; non-clinical safety and performance testing, including durability
testing to demonstrate that the device performs as intended under anticipated conditions of use; a training program; and labeling related
to device use and user training. In order for us to market ReWalk, we must comply with both general controls, including controls related
to quality, facility registration, reporting of adverse events and labeling, and the special controls established for the device. Failure
to comply with these requirements could lead to an FDA enforcement action, which would have a material adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In June 2019, the FDA issued a 510(k) clearance for our ReStore
device. ReStore is intended to be used to assist ambulatory functions in rehabilitation institutions under the supervision of a trained
therapist for people with hemiplegia or hemiparesis due to stroke who have a specified amount of ambulatory function. In order for us
to market ReStore and ReWalk, we must comply with both general controls, including controls related to quality, facility registration,
reporting of adverse events and labeling, and the special controls established for powered exoskeleton devices as described above. Failure
to comply with these requirements could lead to an FDA enforcement action, which would have a material adverse effect on our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the E.U. we are subject to regulations and standards regulating
the design, manufacture, clinical trials, labeling and adverse event (i.e., vigilance) reporting for medical devices. The Medical Devices
Regulation (EU) 2017/745 (MDR) became fully applicable on May 26, 2021, repealing and replacing the pre-existing E.U. Medical Devices
Directive 93/42/EEC. Devices that comply with the requirements of the MDR, subject to certain transitional provisions that allow continued
compliance of certain products to the Directive, are entitled to bear the CE mark, indicating that the device conforms to the essential
requirements of the MDR and, accordingly, can be commercially distributed throughout the European Economic Area (i.e., the E.U. Member
States plus Norway, Iceland, and Lichtenstein). We comply with the E.U. requirements and have received the CE mark for all of our ReWalk
systems including the ReStore device which are distributed in the E.U. As compared with the Directive, the MDR includes additional premarket
and post-market requirements, as well as potential product reclassifications and more stringent commercialization requirements that could
adversely affect our CE mark. Failure to comply with these new requirements could lead to substantial penalties, including fines, revocation
or suspension of CE mark and criminal sanctions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Following the introduction of a product, the governmental agencies
will periodically inspect our manufacturing processes and quality controls, and we are under a continuing obligation to ensure that all
applicable regulatory requirements continue to be met. The process of complying with the applicable good manufacturing practices, adverse
event reporting and other requirements can be costly and time consuming, and could delay or prevent the production, manufacturing, or
sale of our devices. In addition, if we fail to comply with applicable regulatory requirements, it could result in fines, closure of manufacturing
sites, seizures or recalls of products and damage to our reputation, as well as enforcement actions against us. For example, the FDA could
request that we recall our ReWalk Personal Exoskeleton or ReStore device in case of product defects or require us to conduct post-market
surveillance studies. If we fail to recall the device and/or conduct requested post-market surveillance studies to FDA&#8217;s satisfaction,
we could be subject to FDA enforcement action.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, governmental agencies may impose new requirements
regarding registration or labeling that may require us to modify or re-register our products or otherwise impact our ability to market
our products in those countries, such as the May 2021 Medical Device Regulation changes in the European Union. The process of complying
with these governmental regulations can be costly and time consuming, and could delay or prevent the production, manufacturing, or sale
of our products.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">38</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we or our third-party manufacturers fail
to comply with the FDA&#8217;s Quality System Regulation, or QSR, our manufacturing operations could be interrupted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We and our manufacturer Sanmina are required to comply with the
FDA&#8217;s QSR which covers the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging,
sterilization, storage, and shipping of our products. We, Sanmina, and our suppliers are also subject to the regulations of foreign jurisdictions
regarding the manufacturing process if we or our distributors market our products abroad. We continue to monitor our quality management
to maintain our overall level of compliance. Our facilities are subject to periodic and unannounced inspection by U.S. and foreign regulatory
agencies to audit compliance with the QSR and comparable foreign regulations. If our facilities or those of Sanmina or our suppliers are
found to be in violation of applicable laws and regulations, or if we, Sanmina, or our suppliers fail to take satisfactory corrective
action in response to an adverse inspection, the regulatory authority could take enforcement action, including any of the following sanctions:&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9aea2c748b6446d59468b04405d977c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z99dd49fee07745528364f0c3d98db907" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>customer notifications or repair, replacement, or refunds;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4ea02702768a4f3aa9c0561143b88f5c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>operating restrictions or partial suspension or total shutdown of production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1769af706f8c458897c9a9909f8f9407" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>recalls, withdrawals, or administrative detention or seizure of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za20d8d96674f4afabe461d3e32eaa9c6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>denials or delays of approvals for pre-market approval applications relating to new products or modified products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9ff43e76eaa0432ba66ff61d7ae253ba" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>withdrawals of a PMA approvals;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf804c60c2df94e84bf076739335db9c5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusal to provide Certificates for Foreign Government;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4a3fc3347f9c4099952fb39c15ea80f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>refusal to grant export approval for our products; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z932b69aff0c448b8a67957517cbed223" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>pursuit of criminal prosecution.&#160;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Any of these sanctions could impair our ability to produce our
products in a cost-effective and timely manner in order to meet our customers&#8217; demands and could have a material adverse effect
on our reputation, business, results of operations, and financial condition. We may also be required to bear other costs or take other
actions that may have a negative impact on our future sales and our ability to generate profits.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to various laws and regulations,
including &#8220;fraud and abuse&#8221; laws and anti-bribery laws, which, if violated, could subject us to substantial penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Medical device companies such as ours have faced lawsuits and investigations
pertaining to alleged violations of numerous statutes and regulations, including anti-corruption laws and health care &#8220;fraud and
abuse&#8221; laws, such as the federal False Claims Act, the federal Anti-Kickback Statute, and the U.S. Foreign Corrupt Practices Act,
or the FCPA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">U.S. federal and state laws, including the federal Sunshine Act,
and the implementation of Open Payments regulations under the Sunshine Act, require medical device companies to disclose certain payments
or other transfers of value made to certain healthcare providers or funds spent on marketing and promotion of medical device products.
Further, some state laws require medical device companies to report information related to payments to physicians and other health care
providers or marketing expenditures. They also impose additional administrative and compliance burdens on us. In particular, these laws
influence, among other things, how we structure our sales offerings and other interactions with health care providers, including discount
practices, customer support, education and training programs and physician consulting and other service arrangements, including those
with marketers and sales agents. We may face significant costs in attempting to comply with these laws and regulations. If we are found
to be in violation of any of these requirements or any actions or investigations are instituted against us, those actions could be costly
to defend and could have a significant impact on our business, including the imposition of significant criminal and civil fines and penalties,
exclusion from federal healthcare programs or other sanctions, and damage to our reputation or business.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The FCPA applies to companies, including ours, with a class of
securities registered under the Exchange Act. The FCPA and other anti-bribery laws to which various aspects of our operations may be subject
generally prohibit companies and their employees, agents, and other intermediaries from authorizing, promising, offering, providing, or
making, directly or indirectly, improper payments or anything else of value to government officials for the purpose of obtaining or retaining
business. The FCPA also requires covered companies such as ours to make and keep books and records that accurately and fairly reflect
the transactions of the corporation and to devise and maintain an adequate system of internal accounting controls.&#160; In various jurisdictions,
our operations require that we and third parties acting on our behalf routinely interact with government officials, including medical
personnel who may be considered government officials for purposes of these laws because they are employees of state-owned or controlled
facilities. Other anti-bribery laws to which various aspects of our operations may be subject, including the United Kingdom Bribery Act,
also prohibit improper payments to private parties and prohibit receipt of improper payments. Our policies prohibit our employees from
making or receiving corrupt payments, including, among other things, to require compliance by third parties engaged to act on our behalf.
Our policies mandate compliance with these anti-bribery laws; however, recent years have seen an increase in the global enforcement of
anti-corruption laws and our international operations could increase the risk of such violations. As a result, the existence and implementation
of a robust anti-corruption program cannot eliminate all risk that unauthorized improper acts have been or will be committed by our employees
or agents. Violations of these anti-corruption laws, or allegations of such violations, could result in civil or criminal sanctions or
other adverse consequences, including disruption of our business and harming our financial condition, results of operations, cash flows
and reputation.&#160;&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">39</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we are found to have violated laws protecting
the confidentiality of patient health information, we could be subject to civil or criminal penalties, which could increase our liabilities
and harm our reputation or our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There are a number of federal, state and foreign laws protecting
the confidentiality of certain patient health information, including patient records, and restricting the use and disclosure of that protected
information. In particular, the U.S. Department of Health and Human Services, or HHS, promulgated patient privacy rules under HIPAA. These
privacy rules protect medical records and other personal health information by limiting their use and disclosure, giving individuals the
right to access, amend and seek accounting of their own health information and limiting most use and disclosures of health information
to the minimum amount reasonably necessary to accomplish the intended purpose. Additionally, the E.U. General Data Protection Regulation
(the &#8220;GDPR&#8221;), imposes more stringent data protection requirements and provides for penalties for noncompliance. Thus, with
respect to our operations in Europe, the GDPR may increase our responsibility and liability in relation to personal data that we process
and we may be required to put in place additional mechanisms ensuring compliance with the GDPR. This may be onerous and adversely affect
our business, financial condition, results of operations and prospects. Additionally, if we or any of our service providers are found
to be in violation of the promulgated patient privacy rules under HIPAA or the GDPR, we could be subject to civil or criminal penalties,
which could be substantial and could increase our liabilities, harm our reputation and have a material adverse effect on our business,
financial condition and operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, a number of U.S. states have enacted data privacy
and security laws and regulations that govern the collection, use, disclosure, transfer, storage, disposal, and protection of sensitive
personal information, such as social security numbers, financial information and other personal information. For example, several U.S.
territories and all 50 states now have data breach laws that require timely notification to individual victims, and at times regulators,
if a company has experienced the unauthorized access or acquisition of sensitive personal data. Other state laws include the California
Consumer Privacy Act (&#8220;CCPA&#8221;) which, among other things, contains new obligations for businesses that collect personal information
about California residents and affords those individuals new rights relating to their personal information that may affect our ability
to use personal information or share it with our business partners. Meanwhile, other states have enacted or are considering enacting privacy
laws like the CCPA.&#160; Furthermore, it is anticipated that the California Privacy Rights Act of 2020, effective January 1, 2023, expands
the CCPA&#8217;s requirements, including applying to personal information of business representatives and employees and establishing a
new regulatory agency to implement and enforce the law.&#160; We will continue to monitor and assess the impact of state law developments,
which may impose substantial penalties for violations, impose significant costs for investigations and compliance, allow private class-action
litigation and carry significant potential liability for our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The interpretation and enforcement of the laws and regulations
described above are uncertain and subject to change and may require substantial costs to monitor and implement compliance with any additional
requirements. Failure to comply with U.S. or international data protection laws and regulations could result in government enforcement
actions (which could include substantial civil and/or criminal penalties), private litigation, and/or adverse publicity and could negatively
affect our operating results and business.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Compliance with various regulations, including
those related to our status as a U.S. public company and the manufacturing, labeling, and marketing of our products, may result in heightened
general and administrative expenses and costs, divert management&#8217;s attention from revenue-generating activities and pose challenges
for our management team, which has limited time, personnel and finances to devote to regulatory compliance.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As a U.S. public company, we are subject to various regulatory
and reporting requirements, including those imposed by the SEC, the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, the Dodd-Frank
Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, the listing requirements of The Nasdaq Capital Market and
other applicable securities rules and regulations. Additionally, our medical products and manufacturing operations are regulated by the
FDA, the European Union and other governmental authorities both inside and outside of the United States. Compliance with the rules and
regulations applicable to us as a publicly traded company in the United States and medical device manufacturer has greatly increased,
and may continue to increase, our legal, general and administrative and financial compliance costs and has made, and may continue to make,
some activities more difficult, time-consuming or costly. Additionally, these regulatory requirements have diverted, and may continue
to divert, management&#8217;s attention from revenue-generating activities and may increase demands on management&#8217;s already-limited
resources.&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">40</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our management team consists of few employees, as the majority
of our employees are engaged in sales and marketing and research and development activities. For more information, see &#8220;Part I,
Item 1. Business&#8212;Employees&#8221; above. In light of such constraints on its time, personnel and finances, our management may not
be able to implement programs and policies in an effective and timely manner to respond adequately to the heightened legal, regulatory
and reporting requirements applicable to us. In the past, for example, we have not always been able to respond on a timely basis to requests
from regulators, although we have not to date experienced any long-term material adverse consequences as a result. Similar deficiencies,
weaknesses, or lack of compliance with public company, medical device and other regulations could harm our reputation in the capital markets
or for quality and safety, negatively affect our ability to maintain our public company status and to develop, commercialize or continue
selling our products on a timely and effective basis, and cause us to incur sanctions, including fines, injunctions, and penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, complying with public disclosure rules makes our business
more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If such
claims are successful, our business and operating results could be harmed, and even if the claims do not result in litigation or are resolved
in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm
our business and operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are also subject to the requirement of Section 1502 of the Dodd-Frank
Act and SEC rules related thereto to conduct due diligence and disclose and report on whether certain minerals and metals, known as &#8220;conflict
minerals,&#8221; are contained in our products and whether they originate from the Democratic Republic of Congo and certain adjoining
countries.&#160; Each year our management team devotes significant time to conduct the required due diligence, and we may face reputational
challenges if we determine that certain of our products contain minerals not determined to be conflict free or if we are unable to sufficiently
verify the origins of all conflict minerals used in our products through the procedures we implement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Intellectual Property and Information Technology</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We depend on computer and telecommunications
systems we do not own or control and failures in our systems or a cybersecurity attack or incident relating to our IT systems or technology
could significantly disrupt our business operations or result in sensitive customer information being compromised which would negatively
materially affect our reputation and/or results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have entered into agreements with third parties for hardware,
software, telecommunications, and other information technology services in connection with the operation of our business. It is possible
we or a third party that we rely on could incur interruptions from a loss of communications, hardware or software failures, a cybersecurity
attack or an incident relating to our IT systems or technology, ransomware, phishing attacks, computer viruses or malware. We believe
that we have positive relations with our vendors and maintain adequate anti-virus and malware software and controls; however, any interruptions
to our arrangements with third parties, to our computing and communications infrastructure, or to our information systems or any of those
operated by a third party that we rely on could significantly disrupt our business operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the current environment, there are numerous and evolving risks
to cybersecurity and privacy, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, employee malfeasance
and human or technological error. High-profile cybersecurity incidents at other companies and in government agencies have increased in
recent years, and security industry experts and government officials have warned about the risks of hackers and cyberattacks targeting
businesses such as ours. Computer hackers and others routinely attempt to breach the security of technology products, services, and systems,
and to fraudulently induce employees, customers, or others to disclosure information or unwittingly provide access to systems or data.
A cyberattack of our systems or networks that impairs our information technology systems could disrupt our business operations and result
in loss of service to customers, including technical support for our ReWalk devices. While we have certain cybersecurity safeguards in
place designed to protect and preserve the integrity of our information technology systems, we have experienced and expect to continue
to experience actual or attempted cyberattacks of our IT systems or networks. However, none of these actual or attempted cyberattacks
has had a material effect on our operations, business strategy, or financial condition.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">41</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, we have access to sensitive customer information
in the ordinary course of business. If a significant cybersecurity incident occurred, our reputation may be adversely affected, customer
confidence may be diminished, or we may be subject to legal claims, any of which may contribute to the loss of customers and have a material
adverse effect on us. For more information, see &#8220;&#8212;Risks Related to Government Regulation&#8221; above.&#160; If we are found
to have violated laws protecting the confidentiality of patient health information, we could be subject to civil or criminal penalties,
which could increase our liabilities and harm our reputation or our business.&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our success depends in part on our ability
to obtain and maintain protection for the intellectual property relating to or incorporated into our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our success depends in part on our ability to obtain and maintain
protection for the intellectual property relating to or incorporated into our products. We seek to protect our intellectual property through
a combination of patents, trademarks, confidentiality, and assignment agreements with our employees and certain of our contractors, and
confidentiality agreements with certain of our consultants, scientific advisors, and other vendors and contractors. In addition, we rely
on trade secret law to protect our proprietary software and product candidates/products in development. For more information, see &#8220;Part
I, Item 1. Business&#8212;Intellectual Property&#8221; above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our patent position with respect to our exoskeleton and anti-gravity
systems can be highly uncertain and involves many new and evolving complex legal, factual, and technical issues. Patent laws and interpretations
of those laws are subject to change and any such changes may diminish the value of our patents or narrow the scope of our right to exclude
others. In addition, we may fail to apply for or be unable to obtain patents necessary to protect our technology or products from competition
or fail to enforce our patents due to lack of information about the exact use of technology or processes by third parties. Also, we cannot
be sure that any patents will be granted in a timely manner or at all with respect to any of our patent pending applications or that any
patents that are granted will be adequate to exclude others for any significant period of time or at all. Given the foregoing and in order
to continue reducing operational expenses in the future, we may invest fewer resources in filing and prosecuting new patents and on maintaining
and enforcing various patents, especially in regions where we currently do not focus our market growth strategy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Litigation to establish or challenge the validity of patents, or
to defend against or assert against others infringement, unauthorized use, enforceability, or invalidity, can be lengthy and expensive
and may result in our patents being invalidated or interpreted narrowly and restricting our ability to be granted new patents related
to our pending patent applications. Even if we prevail, litigation may be time consuming, force us to incur significant costs, and could
divert management&#8217;s attention from managing our business while any damages or other remedies awarded to us may not be valuable.
In addition, U.S. patents and patent applications may be subject to interference proceedings, and U.S. patents may be subject to re-examination
and review proceedings in the U.S. Patent and Trademark Office. Foreign patents may also be subject to opposition or comparable proceedings
in the corresponding foreign patent offices. Any of these proceedings may be expensive and could result in the loss of a patent or denial
of a patent application, or the loss or reduction in the scope of one or more of the claims of a patent or patent application.&#160;&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, we seek to protect our trade secrets, know-how, and
confidential information that is not patentable by entering into confidentiality and assignment agreements with our employees and certain
of our contractors and confidentiality agreements with certain of our consultants, scientific advisors, and other vendors and contractors.
However, we may fail to enter into the necessary agreements, and even if entered into, these agreements may be breached or otherwise fail
to prevent disclosure, third-party infringement, or misappropriation of our proprietary information, may be limited as to their term and
may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information. Enforcing a claim that a
third party illegally obtained or is using our trade secrets without authorization may be expensive and time consuming, and the outcome
is unpredictable. Some of our employees or consultants may own certain technology which they license to us for a set term. If these technologies
are material to our business after the term of the license, our inability to use them could adversely affect our business and profitability.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We also have taken precautions to initiate reasonable safeguards
to protect our information technology systems. However, these measures may not be adequate to safeguard our proprietary information, which
could lead to the loss or impairment thereof or to expensive litigation to defend our rights against competitors who may be better funded
and have superior resources. In addition, unauthorized parties may attempt to copy or reverse engineer certain aspects of our products
that we consider proprietary, or our proprietary information may otherwise become known or may be independently developed by our competitors
or other third parties. If other parties are able to use our proprietary technology or information, our ability to compete in the market
could be harmed. Further, unauthorized use of our intellectual property may have occurred, or may occur in the future, without our knowledge.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we are unable to obtain or maintain adequate protection for
intellectual property, or if any protection is reduced or eliminated, competitors may be able to use our technologies, resulting in harm
to our competitive position.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">42</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our patents and proprietary technology and
processes may not provide us with a competitive advantage.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Robotics, exoskeletons, and anti-gravity system technologies have
been developing rapidly in recent years. We are aware of several other companies developing competing exoskeleton devices for individuals
with limited mobility and we expect the level of competition and the pace of development in our industry to increase.&#160; Likewise,
we are aware of several companies with commercial anti-gravity or treadmill-based gait therapy systems. For more information, see &#8220;Part
I, Item 1. Business&#8212;Competition&#8221; above. While we believe our tilt-sensor technology provides a more natural and superior method
of exoskeleton activation, which creates a better user experience, as well as that our licensed technology used in our ReStore device
is unique and provides better results when compared to other products, a variety of other activation and control methods exist for exoskeletons,
several of which are being developed by our competitors, or may be developed in the future. Additionally, while our DAP technology provides
what we believe is a superior method for partial weight displacement with strong market acceptance, there may be competitors developing
innovative alternative gait therapies that could be introduced in the future. As a result, our patent portfolio and proprietary technology
and processes may not provide us with a significant advantage over our competitors, and competitors may be able to design and sell alternative
products that are equal to or superior to our products without infringing on our patents. In addition, as our current patents begin to
expire, we may lose a competitive advantage over our competitors as we will no longer be able to keep our competitors from practicing
the technology covered by the claim of the expired patents. We may also be unable to adequately develop new technologies and obtain future
patent protection to preserve a competitive advantage. If we are unable to maintain a competitive advantage, our business and results
of operations may be materially adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Even in instances where others are found to infringe on our patents,
many countries have laws under which a patent owner may be compelled to grant licenses for the use of the patented technology to other
parties. In addition, many countries limit the enforceability of patents against other parties, including government agencies or government
contractors. In these countries, a patent owner may have limited remedies, which could diminish the value of a patent in those countries.
Further, the laws of some countries do not protect intellectual property rights to the same extent as the laws of the United States, particularly
in the field of medical products, and effective enforcement in those countries may not be available. The ability of others to market comparable
products could adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are not able to protect our intellectual
property rights in all countries.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Filing, prosecuting, maintaining, and defending patents on each
of our products in all countries throughout the world would be prohibitively expensive, and thus our intellectual property rights outside
the United States and Europe are limited. In addition, the laws of some foreign countries, especially developing countries, such as China,
do not protect intellectual property rights to the same extent as federal and state laws in the United States. Also, it may not be possible
to effectively enforce intellectual property rights in some countries at all or to the same extent as in the United States and other countries.
Consequently, we are unable to prevent third parties from using our inventions in all countries, or from selling or importing products
made using our inventions in the jurisdictions in which we do not have (or are unable to effectively enforce) patent protection. Competitors
may use our technologies in jurisdictions where we have not obtained patent protection to develop, market or otherwise commercialize their
own products, and we may be unable to prevent those competitors from importing those infringing products into territories where we have
patent protection, but enforcement may not be as strong as in the United States. These products may compete with our products and our
patents and other intellectual property rights may not be effective or sufficient to prevent them from competing in those jurisdictions.
Moreover, strategic partners, competitors, or others in the chain of commerce may raise legal challenges against our intellectual property
rights or may infringe upon our intellectual property rights, including through means that may be difficult to prevent or detect.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Many companies have encountered significant problems in protecting
and defending intellectual property rights in foreign jurisdictions. Proceedings to enforce our patent rights in the United States or
foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could
put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke
third parties to assert patent infringement or other claims against us. We may not prevail in any lawsuits that we initiate, and the damages
or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights
in the United States and around the world may be inadequate to obtain a significant commercial advantage from the intellectual property
that we develop or license from third parties.<span style="font-weight: bold; font-style: italic">&#160;</span></div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">43</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"> <br/> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to patent infringement claims,
which could result in substantial costs and liability and prevent us from commercializing our current and future products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The medical device industry is characterized by competing intellectual
property and a substantial amount of litigation over patent rights. Our competitors in both the United States and abroad, many of which
have substantially greater resources and have made substantial investments in competing technologies, have been issued patents and filed
patent applications with respect to their products and processes and may apply for other patents in the future. The large number of patents,
the rapid rate of new patent issuances, and the complexities of the technology involved increase the risk of patent litigation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Determining whether a product infringes a patent involves complex
legal and factual issues and the outcome of patent litigation is often uncertain. Even though we have conducted research of issued patents,
no assurance can be given that patents containing claims covering our products, technology or methods do not exist, have not been filed
or could not be filed or issued. In addition, because patent applications can take years to issue and because publication schedules for
pending applications vary by jurisdiction, there may be applications now pending of which we are unaware, and which may result in issued
patents that our current or future products infringe. Also, because the claims of published patent applications can change between publication
and patent grant, published applications that initially do not appear to be problematic may issue with claims that potentially cover our
products, technology, or methods.&#160;&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Infringement actions and other intellectual property claims brought
against us, whether with or without merit, may cause us to incur substantial costs and could place a significant strain on our financial
resources, divert the attention of management, and harm our reputation. We cannot be certain that we will successfully defend against
any allegations of infringement. If we are found to infringe another party&#8217;s patents, we could be required to pay damages. We could
also be prevented from selling our infringing products, unless we can obtain a license to use the technology covered by such patents or
can redesign our products so that they do not infringe. A license may be available on commercially reasonable terms or none at all, and
we may not be able to redesign our products to avoid infringement. Further, any modification to our products could require us to conduct
clinical trials and revise our filings with the FDA and other regulatory bodies, which would be time consuming and expensive. In these
circumstances, we may not be able to sell our products at competitive prices or at all, and our business and operating results could be
harmed.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We rely on trademark protection to distinguish
our products from the products of our competitors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We rely on trademark protection to distinguish our products from
the products of our competitors. We have registered the trademark &#8220;ReWalk&#8221; in Israel and in the United States. The trademark
&#8220;ReStore&#8221; is registered in Europe, the United States and the United Kingdom. The trademark &#8220;Alter G&#8221; is registered
in the United States, Europe, Israel, and the United Kingdom.&#160; We have also recently sought trademark registration of &#8220;Lifeward&#8221;
in the United States, Europe, and Israel.&#160; In jurisdictions where we have not registered our trademark and are using it, and as permitted
by applicable local law, we rely on common law trademark protection. Third parties may oppose our trademark applications, or otherwise
challenge our use of the trademarks, and may be able to use our trademarks in jurisdictions where they are not registered or otherwise
protected by law. If our trademarks are successfully challenged or if a third party is using confusingly similar or identical trademarks
in particular jurisdictions before we do, we could be forced to rebrand our products, which could result in loss of brand recognition,
and could require us to devote additional resources to marketing new brands. If others are able to use our trademarks, our ability to
distinguish our products may be impaired, which could adversely affect our business. Further, we cannot assure you that competitors will
not infringe upon our trademarks, or that we will have adequate resources to enforce our trademarks.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We may be subject to damages resulting from
claims that our employees or we have wrongfully used or disclosed alleged trade secrets of their former employers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Many of our employees were previously employed at other medical
device companies, including our competitors or potential competitors, and we may hire employees in the future that are so employed. We
could in the future be subject to claims that these employees, or we, have inadvertently or otherwise used or disclosed trade secrets
or other proprietary information of their former employers. If we fail in defending against such claims, a court could order us to pay
substantial damages and prohibit us from using technologies or features that are found to incorporate or be derived from the trade secrets
or other proprietary information of the former employers. If any of these technologies or features that are important to our products,
this could prevent us from selling those products and could have a material adverse effect on our business. Even if we are successful
in defending against these claims, such litigation could result in substantial costs and divert the attention of management.<span style="font-weight: bold; font-style: italic">&#160;</span></div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-weight: bold; font-style: italic"> <br/> </span></div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">44</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Ownership of Our Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Sales of a substantial number of ordinary shares
by us or our large shareholders, certain of whom may have registration rights, or dilutive exercises of a substantial number of warrants
by our warrant-holders could adversely affect the value of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Sales by us or our shareholders of a substantial number of ordinary
shares in the public market, or the perception that these sales might occur, could cause the value of our ordinary shares to decline or
could impair our ability to raise capital through a future sale of our equity securities. Additionally, dilutive exercises of a substantial
number of warrants by our warrant-holders, or the perception that such exercises may occur, could put downward price on the market price
of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of February 27, 2024, 19,135,096 ordinary shares were issuable
pursuant to the exercise of warrants, with exercise prices ranging from $1.25 to $9.375 per warrant, issued in private and registered
offerings of ordinary shares and warrants in April 2019, June 2019, February 2020, July 2020, December 2020, February 2021 and September
2021. We have registered with the SEC all of these warrants and/or the resale of the shares issuable upon their exercise. There were also
6,679 ordinary shares issuable pursuant to the exercise of warrants granted to Kreos Capital V (Expert Fund) Limited (&#8220;Kreos&#8221;),
in connection with the loan agreement we signed with Kreos on December 30, 2015 (the &#8220;Loan Agreement&#8221;) in January and December
2016, with an exercise price that is&#160; set to $7.50 per warrant. For more information, &#8220;Part I, Item 2.&#160; Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources&#8212;Equity Raises&#8221;,
below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">All shares sold pursuant to an offering covered by a registration
statement would be freely transferable. With respect to the outstanding warrants, there may be certain restrictions on the holders to
sell the underlying ordinary shares to the extent they are restricted securities, held by &#8220;affiliates&#8221; or would exceed certain
ownership thresholds. Certain of our largest shareholders, may also have limitations under Rule 144 under the Securities Act on the resale
of certain ordinary shares they hold unless they are registered for resale under the Securities Act. Despite these limitations and the
liquidity that we may gain from cash exercises of outstanding warrants, if we, our existing shareholders, or their affiliates sell a substantial
number of the above-mentioned ordinary shares in the public market, the market price of our ordinary shares could decrease significantly.
Shareholders may also incur substantial dilution if holders of our warrants exercise their warrants to purchase ordinary shares, which
could lower the market price of our ordinary shares. Any such decrease could impair the value of your investment in us.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Future grants of ordinary shares under our
equity incentive plans to our employees, non-employee directors and consultants, or sales by these individuals in the public market, could
result in substantial dilution, thus decreasing the value of your investment in our ordinary shares, and certain grants may also require
shareholder approval. In addition, stockholders will experience dilution upon the exercise of outstanding warrants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have historically used, and continue to use, our ordinary shares
as a means of both rewarding our employees, non-employee directors, and consultants and aligning their interests with those of our shareholders.
As of December 31, 2023, 4,824,530 ordinary shares remained available for issuance to our and our affiliates&#8217; respective employees,
non-employee directors, and consultants under our equity incentive plans, including 3,805,585 ordinary shares subject to outstanding awards
(consisting of outstanding options to purchase 33,171 ordinary shares and 3,772,414 ordinary shares underlying unvested RSUs, and we may
seek to increase the number of shares available under our equity incentive plans in the future. For more information, see Note 9b to our
consolidated financial statements for the year ended December 31, 2023, below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, to the extent registered on a Form S-8, ordinary
shares granted or issued under our equity incentive plans will, subject to vesting provisions, lock-up restrictions, and Rule 144 volume
limitations applicable to our &#8220;affiliates,&#8221; be available for sale in the open market immediately upon registration. Further,
as of December 31, 2023, there were 19,187,375 ordinary shares underlying issued and outstanding warrants, which if exercised for ordinary
shares, could decrease the net tangible book value of our ordinary shares and cause dilution to our existing shareholders. Sales of a
substantial number of the above-mentioned ordinary shares in the public market could result in a significant decrease in the market price
of our ordinary shares and have a material adverse effect on an investment in our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we do not meet the expectations of equity
research analysts, if any, if the sole remaining equity analyst following our business does not continue to publish research or reports
about our business, or if the analyst issues unfavorable commentary or downgrade our ordinary shares, the price of our ordinary shares
could decline. Additionally, we may fail to meet publicly announced financial guidance or other expectations about our business, which
would cause our ordinary shares to decline in value.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">There is currently one equity analyst publishing research reports
about our business, and we are currently seeking to attract additional coverage. If our results of operations are below the estimates
or expectations of our sole analyst or consensus assuming we have some analysts and investors, our share price could decline. Moreover,
the price of our ordinary shares could decline if one or more securities analysts downgrade our ordinary shares or if analysts issue other
unfavourable commentary or stop publishing research or reports about us or our business (as has occurred over time, with a decrease in
the number of analysts following us from five in 2014 to one in 2022). Given that there is only one analyst that currently covers our
business, we face an increased risk that such analyst&#8217;s evaluation of our business, if less than positive, will cause a larger decline
in our stock price than would otherwise be the case if we had multiple analysts covering our business.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">45</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">From time to time, we have also faced difficulty accurately projecting
our earnings and have missed certain of our publicly announced guidance. If our financial results for a particular period do not meet
our guidance or if we reduce our guidance for future periods, the market price of our ordinary shares may decline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are a &#8220;smaller reporting company&#8221;
and the reduced reporting requirements applicable to such companies may make our ordinary shares less attractive to investors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are a &#8220;smaller reporting company&#8221; as defined in
Item 10(f)(1) of Regulation S-K, which allows us to take advantage of certain scaled disclosure requirements available specifically to
smaller reporting companies. For example, we may continue to use reduced compensation disclosure obligations, and, provided we are also
a &#8220;non-accelerated filer,&#8221; we will not be obligated to follow the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act. We will remain a smaller reporting company until the last day of the fiscal year in which we have at least $100 million in revenue
and at least $700 million in aggregate market value of ordinary shares held by non-affiliated persons and entities (known as &#8220;public
float&#8221;), or, alternatively, if our revenue exceed $100 million, until the last day of the fiscal year in which our public float
was at least $250.0 million (in each case, with respect to public float, as measured as of the last business day of the second quarter
of such fiscal year).&#160; For the year ended December 31, 2023, we recorded revenue of approximately $13.9 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We cannot predict or otherwise determine if investors will find
our securities less attractive as a result of our reliance on exemptions as a smaller reporting company and/or &#8220;non-accelerated
filer.&#8221; If some investors find our securities less attractive as a result, there may be a less active trading market for our ordinary
shares and the price of our ordinary shares may be more volatile.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to ongoing costs and risks associated
with determining whether our existing internal controls over financial reporting systems are compliant with Section 404 of the Sarbanes-Oxley
Act, and if we fail to achieve and maintain adequate internal controls it could have a material adverse effect on our stated results of
operations and harm our reputation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are required to comply with the internal control, evaluation,
and certification requirements of Section 404 of the Sarbanes-Oxley Act and the Public Company Accounting Oversight Board, which requires
us to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. Once
we no longer qualify as a &#8220;smaller reporting company&#8221; and &#8220;non-accelerated filer,&#8221; our independent registered
public accounting firm will need to attest to the effectiveness of our internal control over financial reporting under Section 404. When
our independent registered public accounting firm is required to undertake an assessment of our internal control over financial reporting,
the cost of our compliance with Section 404 will correspondingly increase. Our compliance with applicable provisions of Section 404 will
require that we incur substantial accounting expense and expend significant management time on compliance-related issues as we implement
additional corporate governance practices and comply with reporting requirements. Moreover, if we are not able to comply with the requirements
of Section 404 applicable to us in a timely manner, or if we or our independent registered public accounting firm identifies deficiencies
in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline
and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial
and management resources.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The process of determining whether our existing internal controls
over financial reporting systems are compliant with Section 404 and whether there are any material weaknesses or significant deficiencies
in our existing internal controls requires the investment of substantial time and resources, including by our Chief Financial Officer
and other members of our senior management. This determination and any remedial actions required could divert internal resources and take
a significant amount of time and effort to complete and could result in us incurring additional costs that we did not anticipate, including
the hiring of outside consultants. We could experience higher than anticipated operating expenses and higher independent auditor fees
during and after the implementation of these changes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Irrespective of compliance with Section 404, any failure of our
internal controls could have a material adverse effect on our stated results of operations and harm our reputation. If we are unable to
implement any of the required changes to our internal control over financial reporting effectively or efficiently or are required to do
so earlier than anticipated, it could adversely affect our operations, financial reporting and/or results of operations and could result
in an adverse opinion on internal controls from our management and our independent auditors. Further, if our internal control over financial
reporting is not effective, the reliability of our financial statements may be questioned, and our share price may suffer.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">46</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">

<div style="line-height: 1.25"><span style="font-weight: bold; font-style: italic">U.S. holders of our ordinary shares may suffer adverse
U.S. tax consequences if we are characterized as a passive foreign investment company, or a PFIC</span>,<span style="font-weight: bold; font-style: italic">
under Section 1297(a) of the Code.</span></div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Generally, if for any taxable year 75% or more of our gross income
is passive income, or at least 50% of the average quarterly value of our assets (which may be determined in part by the market value of
our ordinary shares, which is subject to change) are held for the production of, or produce passive income, we would be characterized
as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes. Passive income for this purpose generally includes,
among other things, certain dividends, interest, royalties, rents, and gains from commodities and securities transactions and from the
sale or exchange of property that gives rise to passive income. Passive income also includes amounts derived by reason of the temporary
investment of funds, including those raised in an offering. In determining whether a non-U.S. corporation is a PFIC, a proportionate share
of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into
account.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The determination of whether we are a PFIC will depend on the nature
and composition of our income and the nature, composition, and value of our assets from time to time. The 50% passive asset test described
above is generally based on the fair market value of each asset, with the value of goodwill and going concern value determined in large
part by reference to the market value of our ordinary shares, which may be volatile. If we are characterized as a &#8220;controlled foreign
corporation,&#8221; or a &#8220;CFC&#8221;, under Section 957(a) of the Code and not considered publicly traded throughout the relevant
taxable year, however, the passive asset test may be applied based on the adjusted tax bases of our assets instead of the fair market
value of each asset (as described above). However, if we are treated as publicly traded for at least 20 trading days during the relevant
taxable year, our assets would generally be required to be measured at their fair market value, even if we are a CFC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Based on our gross income and assets, the market price of our ordinary
shares, and the nature of our business, we believe that we were not a PFIC for the taxable year ended December&#160;31, 2023. However,
this determination is subject to uncertainty. In addition, there is a significant risk that we may be a PFIC for future taxable years,
unless the market price of our ordinary shares increases, or we reduce the amount of cash and other passive assets we hold relative to
the amount of non-passive assets we hold. Accordingly, no assurances can be made regarding our PFIC status in one or more subsequent years,
and our U.S. counsel expresses no opinion with respect to our PFIC status in the taxable year ended December 31, 2023, or the current
year 2024, and also expresses no opinion with respect to our predictions or past determinations regarding our PFIC status in the past
or in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">If we are characterized as a PFIC, U.S. holders of our ordinary
shares may suffer adverse tax consequences, including having gains realized on the sale of our ordinary shares treated as ordinary income,
rather than capital gain, the loss of the preferential tax rate applicable to dividends received on our ordinary shares by individuals
who are U.S. holders and having interest charges apply to distributions by us and to the proceeds of sales of our ordinary shares. In
addition, special information reporting may be required. Certain elections exist that may alleviate some of the adverse consequences of
PFIC status and would result in an alternative treatment (such as mark-to-market treatment or being able to make a qualified electing
fund election). However, we do not intend to provide the information necessary for U.S. Holders to make qualified electing fund elections
if we are classified as a PFIC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Additionally, if we are characterized as a PFIC, for any taxable
year during which a U.S. holder holds ordinary shares, we generally will continue to be treated as a PFIC with respect to such U.S. holder
for all succeeding years during which such U.S. holder holds ordinary shares unless we cease to be a PFIC and such U.S. holder makes a
&#8220;deemed sale&#8221; election with respect to such ordinary shares. If such election is made, such U.S. holder will be deemed to
have sold such ordinary shares held by such U.S. holder at their fair market value on the last day of the last taxable year in which we
qualified as a PFIC, and any gain from such deemed sale would be treated as described above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Each U.S. holder of our ordinary shares is strongly urged to consult
his, her or its tax advisor regarding the application of these rules and the availability of any potential elections.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">47</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The price of our ordinary shares may be volatile,
and you may lose all or part of your investment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our ordinary shares were first publicly offered in our initial
public offering in September 2014, at a price of $300.00 The market price of our ordinary shares has been in the past, and could continue
to be, highly volatile and may fluctuate substantially as a result of many factors. Moreover, while there is no established public trading
market for the warrants offered in our follow-on public offerings, and we do not expect one to develop, our ordinary shares will be issuable
pursuant to exercise of these warrants. Because the warrants are exercisable into our ordinary shares, volatility, or a reduction in the
market price of our ordinary shares could have an adverse effect on the trading price of the warrants. Factors which may cause fluctuations
in the price of our ordinary shares include, but are not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zedc5a549965549e58f181139eab097d1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>actual or anticipated fluctuations in our growth rate or results of operations or those of our competitors;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5596670bb2824ad981805ba6dc37aa69" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>customer acceptance of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z15e14602d20d41d396388b9cad4a4b3e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>announcements by us or our competitors of new products or services, commercial relationships, acquisitions, or expansion plans;</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z683009e5238a40c3ae3c3b6f53fca601" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>announcements by us or our competitors of other material developments;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3f06e37925f04060924d7ac8a17cd3e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>our involvement in litigation;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9333790c6793416f970562bb89776fec" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in government regulation applicable to us and our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z185c5a3cd2e845249d2eb18db1eda1f9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>sales, or the anticipation of sales, of our ordinary shares, warrants and debt securities by us, or sales of our ordinary shares
        by our insiders or other shareholders, including upon expiration of contractual lock-up agreements;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z184cae1c1e584721b30a8b7d05703ba9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>developments with respect to intellectual property rights;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0391f39ccdf34241ad749a0f00d61533" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>competition from existing or new technologies and products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z107095d5fce341fd92f903e0ead2def9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in key personnel;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z00a4bf084b9e4118b6fa00447bef00ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>the trading volume of our ordinary shares;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za3aa62cf267c443898b259298ccb65f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in the estimation of the future size and growth rate of our markets;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z219987a0cbe64bb9be0164da834d09dd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>changes in our quarterly or annual forecasts with respect to operating results and financial conditions;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7f3903cf03b34ce79f155daaa9d6d2ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>general economic and market conditions and;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z998b8ce0ca854e5c9e18e14979e2873d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>announcements regarding business acquisitions.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, the stock markets have experienced extreme price and
volume fluctuations. Broad market and industry factors may materially harm the market price of our ordinary shares, regardless of our
operating performance. Technical factors in the public trading market for our ordinary shares may produce price movements that may or
may not comport with macro, industry or Company-specific&#160;fundamentals, including, without limitation, the sentiment of retail investors
(including as may be expressed on financial trading and other social media sites), the amount and status of short interest in our securities,
access to margin debt, trading in options and other derivatives on our ordinary shares and any related hedging or other technical trading
factors.&#160;In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action
litigation has often been instituted against that company, as was the case for ReWalk in a securities class action dismissed in full in
November 2020. If we become involved in any similar litigation, we could incur substantial costs and our management&#8217;s attention
and resources could be diverted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Incorporation and Location in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Conditions in Israel, including Israel&#8217;s
war against Hamas and other terrorist organizations in the Gaza Strip and a potential escalation of the conflict on Israel&#8217;s northern
border, may materially and adversely affect our business and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
In early October 2023, Hamas terrorists based in the Gaza Strip attacked cities and villages inside Israel, murdering approximately 1,400
Israelis, wounding thousands, and abducting more than 200. The attack was accompanied by numerous rocket attacks on central and southern
Israel. These rocket attacks continue through the date of this annual report. Israel called up substantial numbers of reservists and responded
with extensive aerial attacks and a broad ground attack on terrorist targets in Gaza.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Following the attack by Hamas on Israel&#8217;s southern border, Hezbollah in Lebanon has also launched missile, rocket, and shooting
attacks against Israeli military sites, troops, and civilian areas in northern Israel. In response to these attacks, the Israeli army
has carried out a number of targeted strikes on Hezbollah in southern Lebanon and targets in Syria. It is possible that other terrorist
organizations, including those located in the West Bank, as well as other countries hostile to Israel, such as Iran, will join the hostilities.
Terrorist groups have also attacked U.S. military targets in the Middle East. These clashes have recently intensified and may escalate
into a greater regional conflict.</div>

<div style="text-align: justify; text-indent: 30.5pt; margin-right: 6.3pt; margin-left: 5.5pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">48</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Although we continue to monitor the situation closely, to date our operations in Israel &#8211; consisting primarily of the operations,
quality, and R&amp;D functions of the legacy ReWalk business and some finance functions &#8211; have continued without material interruption.
In 2023, sales to customers in Israel accounted for less than 2% of our total revenues, and as of the date of this filing, approximately
80% of our employees are located outside of Israel. With the acquisition of AlterG in August 2023 and the anticipated shift in our sources
of revenue in connection therewith, our Israel operations have become a less significant portion of our consolidated ReWalk operations.
Our Israeli facilities are based in northern Israel, in an area that to date has seen minor disruptions from rocket attacks. Although
to date none of our Israeli employees have been mobilized for emergency military service, we cannot predict whether there will be further
mobilization of reservists and any further mobilization could further impact our employees, including employees who serve in critical
roles in our company, which could adversely affect our ability to operate and our results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
Sanmina, a well-established contract manufacturer with expertise in the medical device industry, manufactures all of our legacy ReWalk
products at its facility in northern Israel. There has been no disruption to date to Sanmina&#8217;s business. If this facility were to
be damaged or destroyed, or if Sanmina were otherwise unable to operate this facility, this could affect the supply of our legacy ReWalk
products, and our business and our operating results would be negatively affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">&#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;
This is a rapidly changing situation, and we cannot predict how events will develop over the coming weeks and months. There can be no
assurance that a significant expansion or worsening of the war will not have a material adverse effect on our ongoing development efforts,
our business and our operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our technology development and quality headquarters
and the manufacturing facility for our products are located in Israel and, therefore, our results may be adversely affected by economic
restrictions imposed on, and political and military instability in, Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Our technology development and quality headquarters, which houses substantially all
of our research and development and our core research and development team, including engineers, machinists, and quality and regulatory
personnel, as well as the facility of our contract manufacturer, Sanmina, are located in Israel. Many of our employees, directors and
officers are residents of Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly
affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel
and its Arab neighbors, Hamas, Hezbollah (an Islamist militia and political group in Lebanon) and other armed groups. Any hostilities
involving Israel or the interruption or curtailment of trade within Israel or between Israel and its trading partners could materially
and adversely affect our business, financial condition and results of operations and could make it more difficult for us to raise capital.
In particular, an interruption of operations at the Tel Aviv airport related to the conflict in the Gaza Strip or otherwise could prevent
or delay shipments of our components or products. Although we maintain inventory in the United States and Germany, an extended interruption
could materially and adversely affect our business, financial condition, and results of operations.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Recent political uprisings, social unrest, and violence in various countries in the
Middle East and North Africa, including Israel&#8217;s neighbors Lebanon, Egypt, and Syria, are affecting the political stability of those
countries. This instability may lead to deterioration of the political relationships that exist between Israel and these countries and
has raised concerns regarding security in the region and the potential for armed conflict. Our commercial insurance covers some, but not
all, losses that may occur as a result of an event associated with the security situation in the Middle East. Any losses or damages incurred
by us could have a material adverse effect on our business. In addition, Iran has threatened to attack Israel and is widely believed to
be developing nuclear weapons. Iran is also believed to have a strong influence among parties hostile to Israel in areas that neighbor
Israel, such as the Syrian government, Hamas in Gaza and Hezbollah in Lebanon. Any armed conflicts, terrorist activities or political
instability in the region could materially and adversely affect our business, financial condition, and results of operations.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our operations and the operations of our contract
manufacturer, Sanmina, may be disrupted as a result of the obligation of Israeli citizens to perform military service.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Many Israeli citizens are obligated to perform one month, and in
some cases more, of annual military reserve duty until they reach the age of 45 (or older, for reservists with certain occupations) and,
in the event of a military conflict, may be called to active duty. In response to terrorist activity, there have been periods of significant
call-ups of military reservists. Some of our executive officers and employees, as well as those of Sanmina, the manufacturer of all of
our products, are required to perform annual military reserve duty in Israel and may be called to active duty at any time under emergency
circumstances. As described in the risk factor above entitled &#8220;Conditions in Israel, including Israel&#8217;s war against Hamas
and other terrorist organizations in the Gaza Strip and a potential escalation of the conflict on Israel&#8217;s northern border, may
materially and adversely affect our business and results of operations,&#8221; in response to the attack by Hamas on Israel in October
2023 Israel has called up substantial numbers of reservists. Although to date these call-ups have not had a material impact on our operations
or on Sanmina&#8217;s ability to manufacture our products, we cannot predict whether there will be further mobilization of reservists
and our operations and the operations of Sanmina could be disrupted by such call-ups.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">49</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our sales may be adversely affected by boycotts
of Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Several countries, principally in the Middle East, restrict doing
business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli
companies whether as a result of hostilities in the region or otherwise. In addition, there have been increased efforts by activists to
cause companies and consumers to boycott Israeli goods based on Israeli government policies. Such actions, particularly if they become
more widespread, may adversely impact our ability to sell our products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">The tax benefits that are available to us require
us to continue to meet various conditions and may be terminated or reduced in the future, which could increase our costs and taxes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Some of our operations in Israel, referred to as &#8220;Beneficiary
Enterprises,&#8221; carry certain tax benefits under the Israeli Law for the Encouragement of Capital Investments, 5719-1959, or the Investment
Law. Substantially all of our future income before taxes can be attributed to these programs. If we do not meet the requirements for maintaining
these benefits or if our assumptions regarding the key elements affecting our tax rates are rejected by the tax authorities, they may
be reduced or cancelled, and the relevant operations would be subject to Israeli corporate tax at the standard rate. In addition to being
subject to the standard corporate tax rate, we could be required to refund any tax benefits that we may receive in the future, plus interest
and penalties thereon. Even if we continue to meet the relevant requirements, the tax benefits that our current &#8220;Beneficiary Enterprises&#8221;
receive may not be continued in the future at their current levels or at all. If these tax benefits were reduced or eliminated, the amount
of taxes that we pay would likely increase, as all of our Israeli operations would consequently be subject to corporate tax at the standard
rate, which could adversely affect our results of operations. Additionally, if we increase our activities outside of Israel, for example,
by way of acquisitions, our increased activities may not be eligible for inclusion in Israeli tax benefit programs. For a discussion of
our current tax obligations, see &#8220;Part II. Item 7, Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We have received Israeli government grants
for certain of our research and development activities and we may receive additional grants in the future. The terms of those grants restrict
our ability to manufacture products or transfer technologies outside of Israel, and we may be required to pay penalties in such cases
or upon the sale of our company.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">From our inception through December 31, 2023, we received a total
of $2.6 million from the IIA. We may in the future apply to receive additional grants from the IIA to support our research and development
activities. With respect to some grants that were royalty-bearing grants, we are committed to paying royalties at a rate of 3.0% on sales
proceeds up to the total amount of grants received, linked to the dollar, and bearing interest at an annual rate of LIBOR applicable to
dollar deposits. Even after payment in full of these amounts, we will still be required to comply with the requirements of the Israeli
Encouragement of Industrial Research, Development and Technological Innovation Law, 1984, or the R&amp;D Law, and related regulations,
with respect to those past grants. When a company develops know-how, technology or products using IIA grants, the terms of these grants
and the R&amp;D Law restrict the transfer outside of Israel of such know-how, and of the manufacturing or manufacturing rights of such
products, technologies, or know-how, without the prior approval of the IIA. Therefore, if aspects of our technologies are deemed to have
been developed with IIA funding, the discretionary approval of an IIA committee would be required for any transfer to third parties outside
of Israel of know-how or manufacturing or manufacturing rights related to those aspects of such technologies. Furthermore, the IIA may
impose certain conditions on any arrangement under which it permits us to transfer technology or development out of Israel or may not
grant such approvals at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Furthermore, the consideration available to our shareholders in
a future transaction involving the transfer outside of Israel of technology or know-how developed with IIA funding (such as a merger or
similar transaction) may be reduced by any amounts that we are required to pay to the IIA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition to the above, any non-Israeli citizen, resident or
entity that, among other things, (i) becomes a holder of 5% or more of our share capital or voting rights, (ii) is entitled to appoint
one or more of our directors or our chief executive officer or (iii) serves as one of our directors or as our chief executive officer
(including holders of 25% or more of the voting power, equity or the right to nominate directors in such direct holder, if applicable)
is required to notify the IIA and undertake to comply with the rules and regulations applicable to the grant programs of the IIA, including
the restrictions on transfer described above. Such notification will be required in connection with the investment being made by an investor
which may discourage or limit investments from foreign investors in our company.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">50</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may become subject to claims for remuneration or royalties for
assigned service invention rights by our employees, which could result in litigation and adversely affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A significant portion of our intellectual property has been developed
by our employees in the course of their employment for us. Under the Israeli Patent Law, 5727-1967 (the &#8220;Patent Law&#8221;) and
recent decisions by the Israeli Supreme Court and the Israeli Compensation and Royalties Committee, a body constituted under the Patent
Law, employees may be entitled to remuneration for intellectual property that they develop for us unless they explicitly waive any such
rights. Although we enter into agreements with our employees pursuant to which they agree that any inventions created in the scope of
their employment or engagement are owned exclusively by us, we may face claims demanding remuneration. As a consequence of such claims,
we could be required to pay additional remuneration or royalties to our current and former employees, or be forced to litigate such claims,
which could negatively affect our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Provisions of Israeli law and our Articles
of Association may delay, prevent, or otherwise impede a merger with, or an acquisition of, us, even when the terms of such a transaction
are favorable to us and our shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Israeli corporate law regulates mergers, requires tender offers
for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors, officers or significant
shareholders and regulates other matters that may be relevant to such types of transactions. For example, a tender offer for all of a
company&#8217;s issued and outstanding shares can only be completed if the acquirer receives positive responses from the holders of at
least 95% of the issued share capital. Completion of the tender offer also requires approval of a majority of the offerees that do not
have a personal interest in the tender offer, unless at least 98% of the company&#8217;s outstanding shares are tendered. Furthermore,
the shareholders, including those who indicated their acceptance of the tender offer (unless the acquirer stipulated in its tender offer
that a shareholder that accepts the offer may not seek appraisal rights), may, at any time within six months following the completion
of the tender offer, petition an Israeli court to alter the consideration for the acquisition. Israeli law also requires a &#8220;special
tender offer&#8221; in certain cases where a shareholder crosses the 25% or 45% holding threshold, and it imposes procedural and special
voting requirements for the approval of a merger in certain cases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our Articles of Association provide that our directors (other than
external directors, a requirement of Israeli corporate law from which we have opted out in accordance with an exemption for which we are
currently eligible) are elected on a staggered basis, such that a potential acquirer cannot readily replace our entire board of directors
at a single annual general shareholder meeting. This could prevent a potential acquirer from receiving board approval for an acquisition
proposal that our board of directors opposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Furthermore, Israeli tax considerations may make potential transactions
unappealing to us or to our shareholders whose country of residence does not have a tax treaty with Israel exempting such shareholders
from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to the same extent as U.S. tax law. With respect
to mergers involving an exchange of shares, Israeli tax law allows for tax deferral in certain circumstances but makes the deferral contingent
on the fulfillment of a number of conditions, including, in some cases, a holding period of two years from the date of the transaction
during which sales and dispositions of shares of the participating companies are subject to certain restrictions. Moreover, with respect
to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if no
disposition of the shares has occurred. These and other similar provisions could delay, prevent or impede an acquisition of us or our
merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">It may be difficult to enforce a judgment of
a U.S. court against us, our officers, and directors, to assert U.S. securities laws claims in Israel or to serve process on our officers
and directors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are incorporated in Israel. Although the majority of our directors
and executive officers reside within the United States and most of the assets of these persons are also likely located within the United
States, some of our directors and executive officers reside and may have the majority of their assets outside the United States. Additionally,
most of our assets are located outside of the United States. Therefore, a judgment obtained against us, or those of our directors and
executive officers residing outside of the United States, including a judgment based on the civil liability provisions of the U.S. federal
securities laws, may not be collectible in the United States and may not be enforced by an Israeli court. It also may be difficult for
you to effect service of process in the United States on those directors and executive officers residing outside of the United States
or to assert U.S. securities law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an
alleged violation of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring such a claim. In addition,
even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S.
law is found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses, which can be a time-consuming
and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel that
addresses the matters described above. As a result of the difficulty associated with enforcing a judgment against us in Israel, you may
be able to collect only limited, or may be unable to collect any, damages awarded by either a U.S. or foreign court.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">51</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In April 2021, we amended our articles of association such that,
unless we consent in writing to the selection of an alternative forum, (i) the federal courts of the United States will be the exclusive
forum for the resolution of any claim arising under the Securities Act, and (ii) the Tel-Aviv District Court will be the exclusive forum
for (a) a derivative action or derivative proceeding that is filed in the name of the Company; (b) any action grounded in a breach of
fiduciary duty of a director, officeholder or other employee towards us or our shareholders; or (c) any action the cause of which results
from any provision of the Companies Law or the Israel Securities Law, 5728-1968. We have retained the ability to consent to an alternative
forum in circumstances if we determine shareholder interests are best served by permitting a particular dispute to proceed in a forum
other than the federal district courts or State of Israel, as applicable. However, there is uncertainty as to whether a court would enforce
these provisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Your rights and responsibilities as a shareholder
will be governed by Israeli law, which differs in some material respects from the rights and responsibilities of shareholders of U.S.
companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The rights and responsibilities of the holders of our ordinary
shares are governed by our Articles of Association and by Israeli law. These rights and responsibilities differ in some material respects
from the rights and responsibilities of shareholders in U.S.-based corporations. In particular, a shareholder of an Israeli company has
a duty to act in good faith and in a customary manner in exercising its rights and performing its obligations towards the company and
other shareholders, and to refrain from abusing its power in the company, including, among other things, in voting at a general meeting
of shareholders on matters such as amendments to a company&#8217;s articles of association, increases in a company&#8217;s authorized
share capital, mergers and acquisitions and related party transactions requiring shareholder approval. In addition, a shareholder who
is aware that it possesses the power to determine the outcome of a shareholder vote or to appoint or prevent the appointment of a director
or executive officer in the company has a duty of fairness toward the company. There is limited case law available to assist us in understanding
the nature of this duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations
and liabilities on holders of our ordinary shares that are not typically imposed on shareholders of U.S. corporations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our business could be negatively affected as
a result of actions of activist shareholders, and such activism could impact the trading value of our securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In recent years, certain Israeli issuers listed on United States
exchanges have been faced with governance-related demands from activist shareholders, unsolicited tender offers and proxy contests. Given
our relatively low market cap and cash balance we might be an attractive target for such activists, in connection with our 2022 Annual
General Meeting of Shareholders, Creative Value Capital Limited Partnership (&#8220;CVC&#8221;), which claimed to hold approximately three
percent of our outstanding shares, nominated two candidates for election to our board of directors and submitted two additional proposals
(including amendments to our Articles of Association) for approval at our 2022 Annual General Meeting of Shareholders held on July 27,
2022. Although none of CVC&#8217;s proposals were approved at the meeting, addressing and responding to such proposals was significantly
costly and time-consuming, and diverted the attention of our management and employees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Responding to these types of actions by activist shareholders could
be costly and time-consuming, disrupting our operations and diverting the attention of management and our employees. Such activities could
interfere with our ability to execute our strategic plan. In addition, a proxy contest for the election of directors at our annual meeting
would require us to incur significant legal fees and proxy solicitation expenses and require significant time and attention by management
and our board of directors. The perceived uncertainties as to our future direction also could affect the market price and volatility of
our securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">General Risks</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Exchange rate fluctuations between the U.S.
dollar, the euro and the NIS may negatively affect our earnings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The U.S. dollar is our functional and reporting currency. However,
we pay a significant portion of our expenses in NIS and in euro, and we expect this to continue. As a result, we are exposed to exchange
rate risks that may materially and adversely affect our financial results. Accordingly, any appreciation of the NIS or euro relative to
the U.S. dollar would adversely impact our net loss or net income, if any. For example, if the NIS appreciates against the U.S. dollar
or if the value of the NIS declines against the U.S. dollar at a time when the rate of inflation in the cost of Israeli goods and services
exceeds the rate of decline in the relative value of the NIS, then the U.S. dollar cost of our operations in Israel would increase and
our results of operations could be materially and adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">52</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our operations also could be adversely affected if we are unable
to effectively hedge against currency fluctuations in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">We cannot predict any future trends in the rate of inflation in Israel or the rate of
devaluation (if any) of the NIS against the U.S. dollar. For example, while the NIS devalued against the U.S. dollar at a rate of approximately
3.1% and 4% during the fiscal year 2023 and 2022, respectively, during the fiscal year 2021 the NIS appreciated against the U.S. dollar
at a rate of approximately 3%, respectively. The Israeli annual rate of inflation amounted to 2.96%, 5.3%, and 1.5% for the years ended
December 31, 2023, 2022 and 2021, respectively.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have in the past engaged in limited hedging activities, and
we may enter into other hedging arrangements with financial institutions from time to time. Any hedging strategies that we may implement
in the future to mitigate currency risks, such as forward contracts, options and foreign exchange swaps related to transaction exposures
may not eliminate our exposure to foreign exchange fluctuations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We are subject to certain regulatory regimes
that may affect the way that we conduct business internationally, and our failure to comply with applicable laws and regulations could
materially adversely affect our reputation and result in penalties and increased costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are subject to a complex system of laws and regulations related
to international trade, including economic sanctions and export control laws and regulations.&#160;We also depend on our distributors
and agents for compliance and adherence to local laws and regulations in the markets in which they operate. Significant political or regulatory
developments in the jurisdictions in which we sell our products, such as those stemming from the presidential administration in the United
States or the U.K.&#8217;s exit from the E.U., are difficult to predict and may have a material adverse effect on us.&#160;For example,
in the United States, the Trump administration-imposed tariffs on imports from China, Mexico, Canada, and other countries, and expressed
support for greater restrictions on free trade and increase tariffs on goods imported into the United States. Changes in U.S. political,
regulatory, and economic conditions or in its policies governing international trade and foreign manufacturing and investment in the United
States could adversely affect our sales in the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are also subject to the FCPA and may be subject to similar worldwide
anti-bribery&#160;laws that generally prohibit companies and their intermediaries from making improper payments to government officials
for the purpose of obtaining or retaining business.&#160; Despite our compliance and training programs, we cannot be certain that our
procedures will be sufficient to ensure consistent compliance with all applicable international trade and anti-corruption laws, or that
our employees or channel partners will strictly follow all policies and requirements to which we subject them.&#160;Any alleged or actual
violations of these laws may subject us to government scrutiny, investigation, debarment, and civil and criminal penalties, which may
have an adverse effect on our results of operations, financial condition and reputation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Our business may be materially affected by
changes to fiscal and tax policies. Potentially negative or unexpected tax consequences of these policies, or the uncertainty surrounding
their potential effects, could adversely affect our results of operations and share price.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The rules dealing with U.S. federal, state and local income taxation
are constantly under review by persons involved in the legislative process and by the Internal Revenue Service (the &#8220;IRS&#8221;)
and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders
of our ordinary shares. In recent years, many such changes have been made, and changes are likely to continue to occur in the future.
It cannot be predicted whether, when, in what form or with what effective dates tax laws, regulations and rulings may be enacted, promulgated
or issued, which could result in an increase in our or our shareholders&#8217; tax liability or require changes in the manner in which
we operate in order to minimize or mitigate any adverse effects of changes in tax law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In addition, foreign governments may enact tax laws in response
to the changes in the rules dealing with U.S. federal, state and local income taxation or otherwise that could result in further changes
to global taxation and materially affect our financial position and results of operations. The uncertainty surrounding the effect of the
reforms on our financial results and business could also weaken confidence among investors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Certain U.S. holders of our ordinary shares
may suffer adverse U.S. tax consequences if we are characterized as a controlled foreign corporation, or a CFC, under Section 957 of the
Code.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Each &#8220;Ten Percent Shareholder&#8221; (as defined below) in
a non-U.S. corporation that is classified as a &#8220;controlled foreign corporation,&#8221; or a CFC, for U.S. federal income tax purposes
generally is required to include in income for U.S. federal tax purposes such Ten Percent Shareholder&#8217;s pro rata share of the CFC&#8217;s
&#8220;Subpart F income,&#8221; global intangible low-taxed income, and investment of earnings in U.S. property, even if the CFC has made
no distributions to its shareholders. Subpart F income generally includes dividends, interest, rents and royalties, gains from the sale
of securities and income from certain transactions with related parties.&#160; In addition, a Ten Percent Shareholder that realizes gain
from the sale or exchange of shares in a CFC may be required to classify a portion of such gain as dividend income rather than capital
gain. A non-U.S. corporation generally will be classified as a CFC for U.S. federal income tax purposes if Ten Percent Shareholders own,
directly or indirectly, more than 50% of either the total combined voting power of all classes of stock of such corporation entitled to
vote or of the total value of the stock of such corporation. A &#8220;Ten Percent Shareholder&#8221; is a United States person (as defined
by the Code), who owns or is considered to own 10% or more of (1) the total combined voting power of all classes of stock entitled to
vote or (2) the value of all classes of stock of such corporation. The determination of CFC status is complex and includes attribution
rules, the application of which is not entirely certain.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">53</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During our 2023 taxable year, we believe that we had one shareholder
that was a Ten Percent Shareholder for U.S. federal income tax purposes. However, our CFC status for the taxable year ending on December
31, 2023, and our current taxable year is unknown, and we may be a CFC for the taxable year ending on December 31, 2023, our current taxable
year or a following year. In addition, recent changes to the attribution rules relation to the determination of CFC status may make it
difficult to determine our CFC status for any taxable year or the CFC status of any of our subsidiaries. U.S. holders should consult their
own tax advisors with respect to the potential adverse U.S. tax consequences of becoming a Ten Percent Shareholder in a CFC. If we are
classified as both a CFC and a passive foreign investment company, or PFIC, we generally will not be treated as a PFIC with respect to
those U.S. holders that meet the definition of a Ten Percent Shareholder during the period in which we are a CFC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If there are significant disruptions in our
information technology systems, our business, financial condition, and operating results could be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The efficient operation of our business depends on our information
technology systems. We rely on our information technology systems to effectively manage sales and marketing data, accounting and financial
functions, inventory management, product development tasks, research and development data, customer service and technical support functions.
Our information technology systems are vulnerable to damage or interruption from earthquakes, fires, floods and other natural disasters,
terrorist attacks, attacks by computer viruses or hackers, power losses, and computer system or data network failures. In addition, our
data management application is hosted by a third-party service provider whose security and information technology systems are subject
to similar risks, and our products&#8217; systems contain software which could be subject to computer virus or hacker attacks or other
failures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The failure of our or our service providers&#8217; information
technology systems or our products&#8217; software to perform as we anticipate or our failure to effectively implement new information
technology systems could disrupt our entire operation or adversely affect our software products and could result in decreased sales, increased
overhead costs, and product shortages, all of which could have a material adverse effect on our reputation, business, financial condition,
and operating results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we fail to properly manage our anticipated
growth, our business could suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our growth and product expansion has placed, and we expect that
it will continue to place, a significant strain on our management team and on our financial resources. Failure to manage our growth effectively
could cause us to misallocate management or financial resources, and result in losses or weaknesses in our infrastructure, which could
materially adversely affect our business. Additionally, our anticipated growth will increase the demands placed on our suppliers, resulting
in an increased need for us to manage our suppliers and monitor for quality assurance. Any failure by us to manage our growth effectively
could have an adverse effect on our ability to achieve our business objectives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold; font-style: italic">We are highly dependent on the
knowledge and skills of our senior management</span>, <span style="font-weight: bold; font-style: italic">and if we are not successful
in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our ability to compete in the highly competitive medical devices
industry depends upon our ability to attract and retain highly qualified managerial, scientific, sales and medical personnel. We are highly
dependent on our senior management team and have benefited substantially from the leadership and performance of our senior management.
For example, we depend on our Chief Executive Officer&#8217;s experience successfully scaling an early-stage medical device company, as
well as the experience of other members of management. The loss of the services of any of our executive officers and other key employees,
and our inability to find suitable replacements could result in delays in product development and harm our business. Competition for senior
management in our industry is intense and we cannot guarantee that we will be able to retain our personnel. Additionally, we do not carry
key man insurance on any of our current executive officers. The loss of the services of certain members of our senior management could
prevent or delay the implementation and completion of our strategic objectives or divert management&#8217;s attention to seeking qualified
replacements.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">54</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Shutdowns of the U.S. federal government could
materially impair our business and financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Development of our product candidates and/or regulatory approval
may be delayed for reasons beyond our control. For example, in 2018 and 2019 the U.S. government shut down several times and certain regulatory
agencies, such as the FDA and the SEC, had to furlough critical FDA, SEC, and other government employees and stop critical activities.
If a prolonged government shutdown or budget sequestration occurs, it could significantly impact the ability of the FDA to timely review
and process our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public
company, future government shutdowns could impact our ability to access the public markets, such as through the declaration of effectiveness
of registration statements and obtain necessary capital in order to properly capitalize and continue our operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold"><span id="ITEM1B.UNRESOLVEDSTAFFCOM"><!--Anchor--></span>ITEM 1B.
UNRESOLVED STAFF COMMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 1C. CYBERSECURITY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Cybersecurity Risk Management and Strategy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Company relies on information systems and the data stored on
them to conduct its operations. We have adopted and maintain a cybersecurity risk management program in accordance with our risk profile
and business that is informed by and incorporates elements of industry standards.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our cybersecurity risk management program incorporates multiple
components, including, but not limited to, ongoing monitoring of critical risks from cybersecurity threats using automated tools. Additionally,
we have implemented an employee education and training program, which we provide on an annual basis, that is designed to raise awareness
of cybersecurity threats. To support our cybersecurity risk management program, we leverage managed service providers and other third-party
information technology and cybersecurity providers and consultants, including to perform regular system scans and threat intelligence
analysis. Additionally, we require certain third-party providers and consultants to adhere to contractual requirements relating to privacy
and cybersecurity standards.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have not identified any cybersecurity incidents or threats that
have materially affected us or are reasonably likely to materially affect us, including our business strategy, results of operations,
or financial condition. However, like other companies in our industry, we and our third-party vendors have from time to time experienced
threats and security incidents that could affect our information or systems. For more information, please see the section entitled &#8220;Risk
Factors&#8221; in this Annual Report on Form 10-K.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Governance</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our audit committee, which reports directly to the board of directors,
is responsible for overseeing our cybersecurity risk management program. The audit committee receives periodic updates on cybersecurity
risks, mitigation strategies, and, in the event of a cybersecurity incident, incident response strategies from our Chief Financial Officer
(&#8220;CFO&#8221;). The audit committee updates the full board of directors on matters relating to cybersecurity risk management and
critical cybersecurity risks as appropriate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our Chief Technology Officer (&#8220;CTO&#8221;), who reports directly
to our Vice President of Finance and, ultimately, our Chief Financial Officer, is responsible for the day-to-day management of our cybersecurity
risk management program. The individual currently serving in this position is a third-party consultant who maintains 20 years of experience
advising similarly situated companies on information technology and cybersecurity risk management.&#160; Our CTO provides regular cybersecurity
updates to our Vice President of Finance and Chief Financial Officer on matters relating to our cybersecurity program and cybersecurity
risk management.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">55</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold"><span id="ITEM2.PROPERTIES"><!--Anchor--></span>ITEM 2. PROPERTIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Our corporate headquarters are located in Yokneam, Israel, our U.S. headquarters are
located in Marlborough, Massachusetts, with additional offices in Fremont, California, and Queens, New York, and our European headquarters
are located in Berlin, Germany.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">All of our facilities are leased, and we do not own any real property.
The table below sets forth details of the square footage of our current leased properties, all of which are utilized. We have no material
tangible fixed assets apart from the properties described below.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z0db3f921ff4446dcab405e659aab3ec7" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Square<br/> feet (approximate)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Fremont, California</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">40,320</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 88%">
        <div style="line-height: 1.25">Marlborough, Massachusetts</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">11,850</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 88%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Yokneam, Israel</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">11,500</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 88%">
        <div style="line-height: 1.25">Queens, New York</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,105</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Berlin, Germany</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">950</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 88%; padding-bottom: 4px">
        <div style="line-height: 1.25">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">65,725</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We believe our facilities are adequate and suitable for our current
needs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 3. LEGAL PROCEEDINGS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Occasionally we are involved in various claims, lawsuits, regulatory
examinations, investigations and other legal matters arising, for the most part, in the ordinary course of business. The outcome of litigation
and other legal matters is inherently uncertain. In making a determination regarding accruals, using available information, we evaluate
the likelihood of an unfavorable outcome in legal or regulatory proceedings to which we are a party and records a loss contingency when
it is probable a liability has been incurred and the amount of the loss can be reasonably estimated.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Where we determine an unfavorable outcome is not probable or reasonably
estimable, we do not accrue for any potential litigation loss. These subjective determinations are based on the status of such legal or
regulatory proceedings, the merits of our defenses and consultation with legal counsel. Actual outcomes of these legal and regulatory
proceedings may materially differ from our current estimates. It is possible that resolution of one or more of the legal matters currently
pending or threatened could result in losses material to our consolidated results of operations, liquidity, or financial condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For information regarding legal proceedings, see Note 7 &#8220;Commitments
and Contingent Liabilities&#8221; in the notes to our audited consolidated financial statements included in this annual report, which
discussion we incorporate by reference into this Item.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">ITEM 4. MINE SAFETY DISCLOSURES</span>.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">56</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTII"><!--Anchor--></span>PART II</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Market Information</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Our ordinary shares began trading publicly on The Nasdaq Global Market on September
12, 2014 under the symbol &#8220;RWLK&#8221; and were transferred for listing on The Nasdaq Capital Market effective May 25, 2017. In
January 2024, the symbol for our ordinary shares was changed to &#8220;LFWD&#8221;. As of February 23, 2024, we had approximately 278,478
shareholders of record.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Dividend Policy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have never declared or paid any cash dividends on our ordinary
shares. We do not anticipate paying any cash dividends in the foreseeable future. We currently intend to retain future earnings, if any,
to finance operations and expand our business. Any future determination relating to our dividend policy will be made at the discretion
of our board of directors and will depend on a number of factors, including future earnings, capital requirements, financial condition
and future prospects and other factors our board of directors may deem relevant. The distribution of dividends may also be limited by
Israeli law, which permits the distribution of dividends only out of retained earnings or otherwise upon the permission of an Israeli
court.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Israeli Taxes Applicable to U.S. Holders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A non-Israeli resident who derives capital gains from the sale
of shares in an Israeli resident company that were purchased after the company was listed for trading on a stock exchange outside of Israel
will be exempt from Israeli tax so long as (amongst other things) the shares were not held through a permanent establishment that the
non-resident maintains in Israel. A partial exemption may be available for non-Israeli resident shareholders who acquired their shares
prior to the issuer&#8217;s initial public offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">However, non-Israeli corporations will not be entitled to the foregoing
exemption if Israeli residents (i) have a controlling interest of more than 25% in such non-Israeli corporation or (ii) are the beneficiaries
of, or are entitled to, 25% or more of the revenue or profits of such non-Israeli corporation, whether directly or indirectly. Such exemption
is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be a business income. Additionally,
under the United States-Israel Tax Treaty, or the treaty, the sale, exchange or other disposition of shares by a shareholder who (i) is
a U.S. resident (for purposes of the treaty), (ii) holds the shares as a capital asset, and (iii) is entitled to claim the benefits afforded
to such person by the treaty, is generally exempt from Israeli capital gains tax. Such exemption will not apply if: (i)&#160;the capital
gain arising from the sale, exchange or other disposition can be attributed to a permanent establishment in Israel; (ii)&#160;the shareholder
holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period preceding
the disposition, subject to certain conditions; or (iii)&#160;such U.S. resident is an individual and was present in Israel for 183 days
or more during the relevant taxable year. In such case, the sale, exchange, or disposition of our ordinary shares should be subject to
Israeli tax, to the extent applicable; however, under the treaty, the taxpayer would be permitted to claim a credit for such taxes against
the U.S. federal income tax imposed with respect to such sale, exchange, or disposition, subject to the limitations under U.S. law applicable
to foreign tax credits.&#160; The treaty does not relate to U.S. state or local taxes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In some instances where our shareholders may be liable for Israeli
tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source.
If the above exemptions from capital gains tax are not available, individuals will be subject to a 25% tax rate on real capital gains
derived from the sale of shares as long as the individual is not a substantial shareholder of the corporation issuing the shares (in which
case the individual will be subject to a 30% tax rate), and corporations will be subject to a 23% corporate tax rate. A substantial shareholder
is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with such person on a
permanent basis, holds, directly or indirectly, at least 10% of any of the means of control of the corporation, including the right to
vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of
the aforesaid rights how to act, regardless of the source of such right. The determination of whether the individual is a substantial
shareholder will be made on the date on which the securities are sold. In addition, the individual will be deemed to be a substantial
shareholder if at any time during the 12 months preceding the date of the sale he or she was a substantial shareholder.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">57</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Dividends paid on publicly traded shares, like our ordinary shares,
to non-Israeli residents are generally subject to Israeli income tax at the rate of 25%, or 30% if the recipient of the dividend was a
substantial shareholder at the time of distribution or at any time during the prior 12-month period. Such dividends are generally subject
to Israeli withholding tax at a rate of 25%&#160;if the shares are registered with a nominee company (whether the recipient is a substantial
shareholder or not), unless a different rate is provided under an applicable tax treaty, provided that a certificate from the Israeli
Tax Authority allowing for a reduced withholding tax rate is obtained in advance. Under the United States-Israel Tax Treaty, the maximum
rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a U.S. resident (for purposes of
the treaty) is 25%. The treaty provides for reduced tax rates on dividends if (a) the shareholder is a U.S. corporation holding at least
10% of our issued voting power during the part of the tax year that precedes the date of payment of the dividend and held such minimal
percentage during the whole of its prior tax year, and (b) not more than 25% of the Israeli company&#8217;s gross income consists of interest
or dividends, other than dividends or interest received from subsidiary corporations or corporations 50% or more of the outstanding voting
shares of which is owned by the Israeli company. The reduced treaty rate, if applicable, is 15% in the case of dividends paid from income
derived from a Beneficiary or Preferred Enterprise (which is entitled to corporate tax benefits) or 12.5% otherwise. We cannot assure
you that in the event we declare a dividend we will designate the income out of which the dividend is paid in a manner that will reduce
shareholders&#8217; tax liability. If the dividend is attributable partly to income derived from a Beneficiary or Preferred Enterprise
and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of
income. U.S. residents who are subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for U.S. federal
income tax purposes in the amount of the taxes withheld.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Individuals who are subject to tax in Israel are also subject to
an additional tax at the rate of 3% on annual income exceeding a certain threshold (NIS 721,560 for 2024, linked to the annual change
in the Israeli Consumer Price Index), including, but not limited to, income derived from dividends, interest, and capital gains.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Recent Sales of Unregistered Equity Securities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold"><span id="ITEM6.RESERVED"><!--Anchor--></span>ITEM 6.&#160;&#160;
[RESERVED]</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">The following discussion and analysis should
be read in conjunction with our audited consolidated financial statements and the related notes included elsewhere in this annual report.
This discussion contains forward-looking statements that are based on our management&#8217;s current expectations, estimates and projections
for our business, which are subject to a number of risks and uncertainties. Our actual results may differ materially from those anticipated
in these forward-looking statements as a result of many factors, including those set forth under &#8220;Special Note Regarding Forward-Looking
Statements and &#8220;Part I. Item 1A. Risk Factors.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are a medical device company that designs, develops, and commercializes
life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health
benefits in clinical settings as well as in the home and community.&#160; Our initial product offerings were the ReWalk Personal and ReWalk
Rehabilitation Exoskeleton devices for individuals with spinal cord injury (&#8220;SCI Products&#8221;).&#160; These devices are robotic
exoskeletons that are designed for individuals with paraplegia that use our patented tilt-sensor technology and an onboard computer and
motion sensors to drive motorized legs that power movement.&#160; These SCI Products allow individuals with spinal cord injury (&#8220;SCI&#8221;)
the ability to stand and walk again during everyday activities at home or in the community. In March 2023, we received clearance of our
premarket notification (&#8220;510(k)&#8221;) from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) for the ReWalk Personal Exoskeleton
with stair and curb functionality, which adds usage on stairs and curbs to the indication for use for the device in the United States
(U.S.). The clearance permits U.S. customers to participate in more walking activities in real-world environments in their daily lives
where stairs or curbs may have previously limited them when using the exoskeleton for its intended, FDA-indicated uses. This feature has
been available in Europe since initial CE Clearance, and real-world data from a cohort of 47 European users throughout a period of over
seven years consisting of over 18,000 stair steps was collected to demonstrate the safety and efficacy of this feature and support the
FDA submission.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">58</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have sought to expand our product offerings beyond the SCI Products
through internal development and distribution agreements and acquisitions.&#160; We have developed our ReStore Exo-Suit device, which
we began commercializing in June 2019. The ReStore is a powered, lightweight soft exo-suit intended for use during the rehabilitation
of individuals with lower limb disabilities due to stroke. During the second quarter of 2020, we finalized and moved to implement two
separate agreements to distribute additional product lines in the United States. We are the exclusive distributor of the MYOLYN MyoCycle
FES Pro cycles to U.S. rehabilitation clinics and for the MyoCycle Home cycles available to US veterans through the Veterans Health Administration
(&#8220;VHA&#8221;) hospitals. In the second quarter of 2020, we also became the exclusive distributor of the MediTouch Tutor movement
biofeedback systems in the United States; however, due to unsatisfactory sales performance of the MediTouch product lines, we terminated
this agreement as of January 31, 2023. We refer to the MediTouch and MyoCycle devices as our &#8220;Distributed Products.&#8221;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><br/> </div>

<div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25">

<div style="line-height: 1.25">

<div style="text-indent: 35.45pt; line-height: 1.25">On August 11, 2023, we made our first acquisition to supplement our internal growth
when we acquired AlterG, Inc. (&#8220;AlterG&#8221;), a leading provider of Anti-Gravity systems for use in physical and neurological
rehabilitation. Our AlterG Anti-Gravity systems use patented, National Aeronautics and Space Administration (&#8220;NASA&#8221;) derived
differential air pressure (&#8220;DAP&#8221;) technology to reduce the effects of gravity and allow patients to rehabilitate with finely
calibrated support and reduced pain. AlterG Anti-Gravity systems are utilized in over 4,000 facilities globally in more than 40 countries.
We will continue to evaluate other products for distribution or acquisition that can broaden our product offerings further to help individuals
with neurological injury and disability.</div> </div> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We are in the research stage of ReBoot, a personal soft exo-suit
for home and community use by individuals post-stroke, and we are currently evaluating the reimbursement landscape and the potential clinical
impact of this device. This product would be a complementary product to ReStore as it provides active assistance to the ankle during plantar
flexion and dorsiflexion for gait and mobility improvement in the home environment, and it received Breakthrough Device Designation from
the FDA in November 2021.&#160; Further investment in the development path of the ReBoot was paused in 2023 pending determination regarding
the clinical and commercial opportunity of this device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our principal markets are primarily in the United States and Europe
with some lesser sales in Asia, the Middle East and South America. We sell our products primarily directly in the United States, through
a combination of direct sales and distributors (depending on the product line) in Germany, Canada, and Australia, and primarily through
distributors in other markets. In markets where we sell direct to consumers, we have established relationships with clinics and rehabilitation
centers, professional and college sports teams, and individuals and organizations in the SCI community, and in markets where we do not
sell direct to consumers, our distributors maintain these relationships. We have primary offices in Marlborough, Massachusetts, Fremont,
California, Berlin, Germany and Yokneam, Israel, from where we operate our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have in the past generated and expect to generate in the future
revenue from a combination of clinics and rehabilitation centers, commercial distributors, third-party payors (including private and government
payors), professional and college sports teams, and self-pay individuals. While a broad uniform policy of coverage and reimbursement by
third-party commercial payors currently does not exist in the United States for exoskeleton technologies such as the ReWalk Personal Exoskeleton,
we are pursuing various paths of reimbursement and support fundraising efforts by institutions and clinics, such as the VHA policy that
was issued in December 2015 for the evaluation, training, and procurement of ReWalk Personal Exoskeleton systems for all qualifying veterans
living with SCI across the United States.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have also pursued updates with the Centers for Medicare &amp;
Medicaid Services (&#8220;CMS&#8221;) to clarify the Medicare coverage category (i.e., benefit category) applicable for personal exoskeletons.
In 2022, the National Spinal Cord Injury Statistical Center (&#8220;NSCISC&#8221;) reported that CMS is the primary payor for approximately
57% of the SCI population which are at least five years post their injury date, with Medicare representing a majority of this percentage.
In July 2020, following a successful submission and hearing process, a code was issued for ReWalk Personal Exoskeleton, which may be used
for purposes of claim submission to Medicare, Medicaid, and other payors.&#160;</div>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On November 1, 2023, CMS released the Calendar Year 2024 Home Health
Prospective Payment System Final Rule, CMS-1780-F (&#8220;Final Rule&#8221;), which was adopted through the notice and comment rulemaking
process. The Final Rule includes a policy confirming that personal exoskeletons are included in the Medicare brace benefit category, as
of January 1, 2024. Medicare personal exoskeleton claims with dates of service on or after January 1, 2024 that are billed using HCPCS
code K1007 are assigned to the brace benefit category. CMS reimburses items classified under the brace benefit category using a lump sum
payment methodology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On November 29, 2023, CMS included the &#8220;ReWalk Personal Prosthetic
Exoskeleton System&#8221; in the HCPCS public meeting&#160;where it solicited feedback on a preliminary payment determination of $94,617
for HCPCS code K1007. The preliminary payment determination was made by CMS by applying a &#8220;gap filling&#8221; process, which was
used in light of CMS determining that the code describing the technology has no fee schedule pricing history and that lower extremity
exoskeletons incorporate &#8220;revolutionary features&#8221; that cannot be described by or considered comparable to any other existing
code or combination of codes. As part of gap-filling, CMS utilizes verifiable supplier or commercial pricing information and adjusts this
pricing information according to a deflation and update factor methodology. In applying this formula to the K1007 code describing the
ReWalk Personal Exoskeleton, CMS says that it relied on information about average prices from 2020 market transactions for which CMS had
data.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">59</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">CMS solicited information on updated verifiable market transactions
from ReWalk, as well as any other makers of similar bilateral, lower limb exoskeletons, to &#8220;ensure that the Medicare payment amount
for this code accurately reflects the full market of devices that would be classified in this code.&#8221; We participated in the HCPCS
meeting process on November 29, 2023 to provide additional information to help ensure that the final payment determination accurately
reflects current pricing information related to the market of lower-limb exoskeleton devices, including the current ReWalk Personal Exoskeleton.
A final Medicare payment determination is expected from CMS in first quarter of 2024 with an April 1, 2024, effective date.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In Germany, we continue to make progress toward achieving coverage
from the various government, private and worker&#8217;s compensation payors for our SCI products. In September 2017, each of German insurer
BARMER GEK (&#8220;BARMER&#8221;) and national social accident insurance provider Deutsche Gesetzliche Unfallversicherung (&#8220;DGUV&#8221;),
indicated that they will provide coverage to users who meet certain inclusion and exclusion criteria. In February 2018, the head office
of German Statutory Health Insurance (&#8220;SHI&#8221;) Spitzenverband (&#8220;GKV&#8221;) confirmed their decision to list the ReWalk
Personal Exoskeleton system in the German Medical Device Directory. This decision means that ReWalk is listed among all medical devices
for compensation, which SHI providers can procure for any approved beneficiary on a case-by-case basis. During the year 2020 and 2021,
we announced several new agreements with German SHIs, including TK and DAK Gesundheit, as well as the first German Private Health Insurer
(&#8220;PHI&#8221;), which outline the process of obtaining our devices for eligible insured patients. We are also currently working with
several additional SHIs on securing a formal operating contract that will establish the process of obtaining a ReWalk Personal Exoskeleton
for their beneficiaries within their system. Additionally, to date, several private insurers in the United States and Europe are providing&#160;reimbursement
for ReWalk in certain cases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Components of Our Statements of Operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Revenue</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We currently rely, and in the future will rely, on sales and rentals
of our ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices, sales and rentals of our AlterG Anti-Gravity systems and related
consumables and services, and sales of our ReStore exo-suit device, additional Distributed Products such as the MyoCycle, and related
extended service contracts for the SCI Products. Our revenue is generated from a combination of third-party payors, including private
and government employers, institutions, and self-payors. Payments for our products by third party payors have been made primarily through
case-by-case determinations. Third-party payors include, without limitation, private insurance plans, workers&#8217; compensation programs,
managed care organizations, and government programs including the VHA and Medicare. We expect that third-party payors will be an increasingly
important source of revenue in the future as we increase the volume of sales of ReWalk Personal systems to Medicare-eligible beneficiaries
following establishment of a benefit category and anticipated pricing.&#160; In December 2015, the VHA issued a national policy for the
evaluation, training, and procurement of ReWalk Personal Exoskeleton systems for all qualifying veterans across the United States. The
VHA policy is the first national coverage policy in the United States for qualifying individuals who have suffered spinal cord injury.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-align: left; line-height: 1.25">&#160;ReWalk Personal and ReWalk Rehabilitation Exoskeleton systems are generally covered
by a five-year warranty from the date of purchase, which is included in the purchase price. The warranty covers all elements of the systems,
including the batteries, other than normal wear and tear. Our ReStore device is sold with a two-year warranty. The AlterG Anti-Gravity
systems are sold with a one-year factory warranty covering parts and services in the U.S. and a two-year factory warranty covering parts
only in the rest of the world. Warranties for our Distributed Products range between three years to ten years depending on the specific
product and part and are the responsibility of the manufacturers.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Cost of Revenue and Gross
Profit</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For ReWalk and ReStore, cost of revenue consists primarily of complete
systems purchased from our outsourced manufacturer, Sanmina.&#160; For these products, cost of revenue also includes internal costs such
as salaries and related personnel costs including non-cash share-based compensation, functions that support manufacturing and inventory
management, training and inspection, service activities, freight costs, and reserves for warranty and inventory condition. The cost of
revenue also includes royalties and expenses related to royalty-bearing research and development grants.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">60</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For our AlterG systems, which we manufacture ourselves at our facility
in Fremont, California, cost of revenue consists primarily of raw materials, direct labor, indirect labor, and other factory overhead
costs such as rent and utilities.&#160; In addition, cost of revenue also includes field service costs, shipping expenses and reserves
for warranty and inventory condition.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For Distributed Products such as the MyoCycle cost of revenue consists
primarily of complete systems purchased from MYOLYN. In addition, the cost of revenue also includes field service costs and shipping expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our gross profit and gross margin (defined as gross profit as a
percentage of revenue) are influenced by a number of factors, including the volume and price of our products sold, fluctuations in the
mix of products sold, and variability in our cost of revenue. We expect gross profit and gross margin will expand in the future as we
increase our revenue volumes and realize operating efficiencies associated with greater scale which will reduce the cost of revenue as
a percentage of revenue.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Operating Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Research and Development Expenses, Net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Research and development expenses, net consist primarily of salaries
and related personnel costs including share-based compensation, supplies, materials, and consulting expenses associated with to product
design and development, clinical studies, regulatory submissions, patent costs, sponsored research and other related activities. We expense
all research and development expenses as they are incurred.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Research and development expenses are presented net of the amount
of any grants we receive for research and development in the period in which we receive the grant. We previously received grants and other
funding from the IIA. Certain of those grants require us to pay royalties on sales of certain systems, which are recorded as cost of revenue.
We may receive additional funding from these entities or others in the future. See &#8220;Grants and Other Funding&#8221; below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Sales and Marketing Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our sales and marketing expenses consist primarily of salaries
and related personnel costs including share-based compensation for sales, sales support, marketing, and reimbursement related activities,
travel, marketing, advertisement, tradeshows and conferences, lobbying, and public relations activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">General and Administrative Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our general and administrative expenses consist primarily of salaries
and related personnel costs including share-based compensation for our administrative, finance, and general management personnel, professional
services, and insurance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Financial Expenses (Income), Net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Financial income and expenses consist of bank commissions, foreign
exchange gains and losses, interest earned on investments in short term deposits and royalty income.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Interest income consists of interest earned on our cash and cash
equivalent balances. Interest expense consists of interest accrued on, and certain other costs with respect to any indebtedness. Foreign
currency exchange changes reflect gains or losses related to transactions denominated in currencies other than the U.S. dollar.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Taxes on Income</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December&#160;31, 2023, we had not yet generated taxable
income in Israel. As of that date, our net operating loss carryforwards for Israeli tax purposes amounted to approximately $242.6 million.
After we utilize our net operating loss carryforwards, we are eligible for certain tax benefits in Israel under the Law for the Encouragement
of Capital Investments, 1959. Our benefit period currently ends ten years after the year in which we first have taxable income in Israel
provided that the benefit period will not extend beyond 2024. AlterG had federal net operating loss carry forwards totalling $31.4 million
and state net operating loss carry forwards of $47.2 million, set to expire in 2025 and 2028, respectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our taxable income generated outside of Israel will be subject
to the regular corporate tax rate in the applicable jurisdictions. As a result, our effective tax rate will be a function of the relative
proportion of our taxable income that is generated in those locations compared to our overall net income.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">61</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Grants and Other Funding</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Israel Innovation Authority
(formerly known as the Office of the Chief Scientist)</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">From our inception through December 31, 2023, we have received
a total of $2.6 million in funding from the IIA, $1.6 million of which are royalty-bearing grants, $400 thousand were received in consideration
for an investment in our preferred shares while&#160;$570 thousand was received without future obligation. Of the royalty-bearing grants
received, we have paid royalties to the IIA in the total amount of $110 thousand. The agreements with IIA require us to pay royalties
at a rate of 3% on sales of certain systems and related services up to the total amount of funding received for the development of these
systems, linked to the dollar, and bearing interest at an annual rate of LIBOR applicable to dollar deposits. If we transfer IIA-supported
technology or know-how outside of Israel, we will be liable for additional payments to IIA depending upon the value of the transferred
technology or know-how, the amount of IIA support, the time of completion of the IIA-supported research project and other factors. As
of December&#160;31, 2023, the aggregate contingent liability to the IIA was $1.6 million. For more information, see &#8220;Part I, Item
1A. Risk Factors-We have received Israeli government grants for certain of our research and development activities and we may receive
additional grants in the future. The terms of those grants restrict our ability to manufacture products or transfer technologies outside
of Israel and we may be required to pay penalties in such cases or upon the sale of our company.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Results of Operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Year Ended December&#160;31, 2023 Compared
to Year Ended December&#160;31, 2022</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Revenue</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our revenue for 2023 and 2022 were as follows (dollars in thousands,
except unit amounts):</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z09246a65c1ce437dbf8a2698835cfe21" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Revenue</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">13,854</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">5,511</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Revenues consist of SCI Products, AlterG Anti-Gravity systems,
ReStore and Distributed Products.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">62</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Revenue was $13.9 million, an increase of $8.3 million, or 51%,
during 2023 as compared to 2022. Of this increase, $7.7 million was attributable to the AlterG business, which was acquired on August
11, 2023.&#160; The remaining increase of $0.7 million was a result of a higher revenues from ReWalk Personal Exoskeletons and MyoCycles.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the future, we expect our growth to be driven by sales of our
ReWalk Personal device through expansion of coverage and reimbursement by commercial and government third-party payors, and our AlterG
Anti-Gravity systems,&#160;as well as sales of Distributed Products, and the ReStore device to rehabilitation clinics and personal users.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Gross Profit</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Our gross profit for 2023 and 2022 were as follows (in thousands):&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z31c210b760df42439d91623cd1a5bef8" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Gross profit</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,453</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,905</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Gross profit was $4.5 million, or 32% of revenue, for 2023, as compared to a gross profit
of $1.9 million, or 35% of revenue for 2022. The AlterG business contributed $2.1 million of gross profit for 2023. Gross profit for 2023
also included the impact of $1.5 million for the amortization of intangible assets and purchase accounting inventory adjustments from
the acquisition of AlterG.&#160; Excluding the impact of these factors resulting from the acquisition of AlterG, gross profit was $2.4
million, or 38% of revenue for 2023, as compared to $1.9 million, or 35% of revenue for 2022. This increase was a result of a higher average
selling price in 2023 due to new features in our ReWalk Personal Exoskeleton and MyoCycles.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect gross profit and gross margin will increase in the future
as we increase our revenue volumes and realize operating efficiencies associated with greater scale which will reduce the cost of revenue
as a percentage of revenue. Improvements may be partially offset by the lower margins we currently expect from ReStore as well as due
to an increase in material costs.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Research and Development
Expense, Net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Our research and development expense, net for 2023 and 2022 was as follows (in thousands):&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z587a2aa1428c464ea57ba3ee7099bfd4" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Research and development expense, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,148</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,031</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Research and development expense was $4.1 million in 2023, an increase
of $0.1 million, or 3%, during 2023 as compared to 2022. The AlterG business contributed $0.8 million of research and development spending
for 2023.&#160; Excluding the impact of the acquisition of AlterG, research and development declined by $0.7 million, or 17% for the year
ended December 31, 2023. The decrease is attributable to the conclusion of the stairs capability project and the gradual reduction of
spend on the ReWalk 7 development project as it approached conclusion.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<div style="text-align: justify; text-indent: 35.9pt; line-height: 1.25">We intend to focus the rest of our research and development expenses
mainly on our current product support, as well as to advance the FDA submission for clearance of the ReWalk 7 next-generation exoskeleton
model. We have ongoing product development activity with our AlterG Anti-Gravity systems, including a program to develop a new entry level
model of AlterG Anti-Gravity system aimed to improve the affordability to price-conscious customers.</div>

<div style="text-align: justify; text-indent: 35.9pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">63</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Sales and Marketing Expense</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Our sales and marketing expense for 2023 and 2022 was as follows (in thousands):&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z0e9e40744bf94ea48590fdca5534499a" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Sales and marketing expense</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">13,922</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9,842</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Sales and marketing expense was $13.9 million in 2023, an increase
of $4.1 million, or 41%, during 2023 as compared to 2022. The AlterG business contributed $2.0 million of sales and marketing expenses
for 2023. Sales and marketing expenses for 2023 also included $0.6 million of amortization of intangible assets from the acquisition of
AlterG. Excluding the impact of these factors resulting from the acquisition of AlterG, sales and marketing expenses increased $1.5 million,
or 15%, for 2023.&#160;The remaining increase was primarily driven by higher consulting expenses related to the CMS reimbursement process
and market access initiatives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">In the near term our sales and marketing expense are expected to
be driven by our efforts to expand the reimbursement coverage of our ReWalk Personal Exoskeleton device, to integrate and unify the combined
sales and marketing resources of the ReWalk and AlterG organizations, and to support our current commercial product activities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">General and Administrative
Expense</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Our general and administrative expense for 2023 and 2022 was as follows (in thousands):&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd196b43965c44764b637f08dcb4ab199" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">General and administrative</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">9,995</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">7,134</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">General and administrative expense was $10.0 million, an increase
of $2.9 million, or 40%, during 2023 as compared to 2022. The AlterG business contributed $1.1 million of general and administrative expenses
for 2023. General and administrative expenses also included $2.5 million of M&amp;A-related expenses, and $0.1 million of amortization
of intangible assets from the acquisition of AlterG offset partially by $0.3 remeasurement of earn out liability. Excluding the impact
of these factors resulting from the acquisition of AlterG, general and administrative expenses decreased $0.6 million, or 7%, for 2023.&#160;
The decrease was mainly driven by lower professional services expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Financial income, net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Our financial income, net for 2023 and 2022 was as follows (in thousands):&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z8504de0dd3b447c8809663eca5967001" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Financial income, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,467</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Financial income, net, reflects an increase in financial income
of $1.5 million during 2023 as compared to 2022. The increase&#160;in financial income was primarily due to a change in cash management
practices to move cash balances to accounts that pay a higher interest rate and yield greater interest income, as well as exchange rate
fluctuations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">*) Represents an amount lower than $1.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Income Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25">Our income tax for 2023 and 2022 was as follows (in thousands):&#160;</div>

<div style="margin-left: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z1233c4ebc2c6471584355acb30208cf7" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Taxes on income (benefit)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(12</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">467</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Income tax decreased by $0.5 million during 2023 as compared to 2022, mainly due to
the utilization of net operation losses forward arising from the acquisition of AlterG.</div>

<div style="text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">64</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Year Ended December 31, 2022 Compared to Year Ended December 31,
2021</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 21pt; line-height: 1.25">A discussion of changes in our results of operations in 2022 compared
to 2021 has been omitted from this annual report on Form 10-K but may be found in &#8220;Part I. Item 7. Management's Discussion and Analysis
of Financial Condition and Results of Operations&#8221; of our Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC
on February 23, 2023, which is available free of charge on the SEC's website at www.sec.gov and at golifeward.com, and is incorporated
by reference herein.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Critical Accounting Policies</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our consolidated financial statements are prepared in accordance
with United States generally accepted accounting principles. The preparation of our financial statements requires us to make estimates,
judgments and assumptions that can affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base our estimates,
judgments and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. Materially
different results can occur as circumstances change and additional information becomes known. Besides the estimates identified above that
are considered critical, we make many other accounting estimates in preparing our financial statements and related disclosures. See Note&#160;2
to our consolidated financial statements presented elsewhere in this annual report for a description of the significant accounting policies
that we used to prepare our consolidated financial statements. The critical accounting policies that were impacted by the estimates, judgments
and assumptions used in the preparation of our consolidated financial statements are discussed below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Revenue Recognition</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our revenue is recognized in accordance with ASC Topic 606 when
obligations under the terms of a contract with our customer are satisfied; generally, this occurs with the transfer of control of our
products or services. Revenue is measured as the amount of consideration to which we expect to be entitled in exchange for transferring
products or providing services. To achieve this core principle, we apply the following five steps:</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">1. identify the contract with a customer;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">2. identify the performance obligations in the contract;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">3. determine the transaction price;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">4. allocate the transaction price to performance obligations in
the contract; and</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">5. recognize revenue when or as we satisfy a performance obligation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Provisions are made at the time of revenue recognition for any
applicable warranty cost expected to be incurred. The timing for revenue recognition among the various products and customers is dependent
upon satisfaction of such criteria and generally varies from either shipment or delivery to the customer depending on the specific shipping
terms of a given transaction, as stipulated in the agreement with each customer. Other than pricing terms which may differ due to the
different volumes of purchases between distributors and end-users, there are no material differences in the terms and arrangements involving
direct and indirect customers. Our products sold through agreements with distributors are non-exchangeable, non-refundable, non-returnable
and without any rights of price protection or stock rotation. Accordingly, we consider all the distributors as end-users. We generally
do not grant a right of return for our products except in rare circumstances, and in those cases we record reductions to revenue for expected
future product returns based on our historical experience and estimates.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">65</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">For the majority of sales of ReWalk Rehabilitation Exoskeleton systems, we include insignificant&#160;training
and consider the elements in the arrangement to be a single performance obligation. Therefore, the Company recognizes revenue for the
system only when control is transferred after delivery and when the training has been completed, in accordance with the agreement terms
with the customer, once all other revenue recognition criteria have been met. For sales of ReWalk Personal Exoskeleton systems to end
users, and for sales of ReWalk Personal Exoskeleton or ReWalk Rehabilitation Exoskeleton systems to third party distributors, we do not
provide training to the end user as this training is completed by the rehabilitation centers or by the distributor that have previously
completed the ReWalk Training program.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Warranties are classified as either assurance type or service type
warranty. A warranty is considered an assurance type warranty if it provides the consumer with assurance that the product will function
as intended for a limited period of time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">SCI Products include a five-year warranty. The first two years
are considered as an assurance type warranty and the additional period is considered an extended service arrangement, which is a service
type warranty. A service type warranty is either sold with a unit or separately for a unit for which the warranty has expired. A service
type warranty is accounted as a separate performance obligation and revenue is recognized ratably over the life of the warranty.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">The ReStore device is sold with a two-year warranty which is considered as assurance
type warranty.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Distributed Products are sold with an assurance type warranty
ranging from between three years to ten years, depending on the specific part.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">The AlterG Anti-Gravity systems are sold with a one-year assurance type warranty for
parts and labor in the US and with a two-year assurance type warranty for parts for distributors.&#160; We also sell extended warranties
for AlterG Anti-Gravity systems for the periods after the expiration of the original warranty.&#160; These are accounted for as separate
performance obligations from the AlterG Anti-Gravity system.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">We rent our AlterG Anti-Gravity systems&#160;to customers for a fixed monthly fee over
the rental term, which typically ranges from 2 to 3 years. Rental revenues accounted for under ASC Topic 842 and are recorded as earned
on a monthly basis. We also offer for the SCI Products a rent-to-purchase model in which we recognize revenue ratably according to the
agreed rental monthly fee for a limited period prior to selling its products. For units placed, we transfer control and recognize a sale
when title has passed to our customer and rental revenue ratably according to the agreed rental monthly fee. Each unit placed is considered
an independent, unbundled performance obligation.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Income Taxes</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As part of the process of preparing our consolidated financial
statements, we are required to estimate our taxes in each of the jurisdictions in which we operate. We account for income taxes in accordance
with ASC Topic 740, &#8220;Income Taxes,&#8221; or ASC Topic 740. ASC Topic 740 prescribes the use of an asset and liability method whereby
deferred tax asset and liability account balances are determined based on the difference between book value and the tax bases of assets
and liabilities and carryforward tax losses. Deferred taxes are measured using the enacted tax rates and laws that are expected to be
in effect when the differences are expected to reverse. We exercise judgment and provide a valuation allowance, if necessary, to reduce
deferred tax assets to their estimated realizable value if it is more likely than not that some portion or all of the deferred tax asset
will not be realized. We have established a full valuation allowance with respect to our deferred tax assets.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">ASU 2015-17, &#8220;Balance Sheet Classification of Deferred Taxes&#8221;
provides presentation requirements to classify deferred tax assets and liabilities, along with any related valuation allowance, are classified
as non-current on the balance sheet. We account for uncertain tax positions in accordance with ASC&#160;740 and recognize the tax benefit
from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing
authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position
should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Accordingly,
we report a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in a tax return.
We recognize interest and penalties, if any, related to unrecognized tax benefits in tax expense.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">66</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Recently Issued and Adopted Accounting Pronouncements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A discussion of recent accounting pronouncements is included in
Note&#160;2w,&#160;New Accounting Pronouncements,&#160;to our consolidated financial statements included elsewhere in this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Liquidity and Capital Resources</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Sources of Liquidity and Outlook</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Since inception, we have funded our operations primarily through
the sale of our equity securities and convertible notes to investors in private placements, the sale of our equity securities in public
offerings, cash exercises of outstanding warrants and the incurrence of bank debt.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">For the full year ended December 31, 2023, we incurred a consolidated
net loss of $22.1 million and had an accumulated deficit in the total amount of $235.9 million. Our cash and cash equivalents on December
31, 2023, totalled $28.1 million. Our negative operating cash flow for the full year ended December 31, 2023, was $20.7 million. We have
sufficient funds to support our operation for more than 12 months following the approval of our consolidated financial statements for
the fiscal year ended December 31, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We expect to incur future net losses and our transition to profitability
is dependent upon, among other things, the successful development and commercialization of our products and product candidates, the establishment
of contracts for the distribution of new product lines, or the acquisition of additional product lines, any of which, or in combination,
would contribute to the achievement of a level of revenue adequate to support our cost structure.&#160;&#160;Until we achieve profitability
or generate positive cash flows, we will continue to need to raise additional cash from time to time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We intend to fund future operations through cash on hand, additional
private and/or public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing.
In addition, we may seek additional capital through arrangements with strategic partners or from other sources and we will continue to
address our cost structure. Notwithstanding, there can be no assurance that we will be able to raise additional funds or achieve or sustain
profitability or positive cash flows from operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our anticipated primary uses of cash are funding (i) sales, marketing,
and promotion activities related to market development&#160;for our ReWalk Personal Exoskeleton device and AlterG Anti-Gravity system,
broadening third-party payor and CMS coverage for our ReWalk Personal Exoskeleton device and commercializing our new product lines added
through distribution agreements; (ii) development of future generation designs for our ReWalk device, new AlterG products utilizing DAP
technology, and our lightweight exo-suit technology for potential home personal health utilization for multiple indications; (iii) routine
product updates; (iv) potential acquisitions of businesses, such as our recent acquisition of AlterG, and (v) general corporate purposes,
including working capital needs.&#160;&#160;Our future cash requirements will depend on many factors, including our rate of revenue growth,
the expansion of our sales and marketing activities, the timing and extent of our spending on research and development efforts, the attractiveness
of potential acquisition candidates and international expansion. If our current estimates of revenue, expenses or capital or liquidity
requirements change or are inaccurate, we may seek to sell additional equity or debt securities, arrange for additional bank debt financing,
or refinance our indebtedness. There can be no assurance that we will be able to raise such funds on acceptable terms.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Equity Raises</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Use of Form S-3</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Beginning with the filing of our Form 10-K on February 17, 2017,
we were subject to limitations under the applicable rules of Form S-3, which constrained our ability to secure capital with respect to
public offerings pursuant to our effective Form S-3. These rules limit the size of primary securities offerings conducted by issuers with
a public float of less than $75 million to no more than one-third of their public float in any 12-month period. At the time of filing
this annual report, we were subject to these limitations because our public float did not reach at least $75 million in the 60 days preceding
the filing of this annual report. We will continue to be subject to these limitations for the remainder of the 2024 fiscal year and until
the earlier of such time as our public float reaches at least $75 million or when we file our next annual report for the year ended December
31, 2024, at which time we will be required to re-test our status under these rules. If our public float is below $75 million as of the
filing of our next annual report on Form 10-K, or at the time we file a new Form S-3, we will continue to be subject to these limitations,
until the date that our public float again reaches $75 million. These limitations do not apply to secondary offerings for the resale of
our ordinary shares or other securities by selling shareholders or to the issuance of ordinary shares upon conversion by holders of convertible
securities, such as warrants. We have registered up to $100 million of ordinary shares warrants and/or debt securities and certain other
outstanding securities with registration rights on our registration statement on Form S-3, which was declared effective by the SEC in
May 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">67</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Equity Offerings</span>&#160;<span style="font-style: italic">and
Warrant Exercises</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On February 19, 2021, the Company entered into a purchase agreement
with certain institutional and other accredited investors for the issuance and sale of 10,921,502 ordinary shares, par value NIS 0.25
per share at $3.6625 per ordinary share and warrants to purchase up to an aggregate of 5,460,751 ordinary shares with an exercise price
of $3.60 per share, exercisable from February 19, 2021, until August 26, 2026. Additionally, the Company issued warrants to purchase up
to 655,290 ordinary shares, with an exercise price of $4.578125 per share, exercisable from February 19, 2021, until August 26, 2026,
to certain representatives of H.C. Wainwright as compensation for its role as the placement agent in our February 2021 private placement
offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">On September 27, 2021, we signed a purchase agreement with certain
institutional investors for the issuance and sale of 15,403,014 ordinary shares, pre-funded warrants to purchase up to an aggregate of
610,504 ordinary shares and ordinary warrants to purchase up to an aggregate of 8,006,759 ordinary shares at an exercise price of $2.00
per share. The pre-funded warrants have an exercise price of $0.001 per ordinary share and are immediately exercisable and can be exercised
at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary share was sold at an offering
price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus
the exercise price of the pre-funded warrant). The offering of the ordinary shares, the pre-funded warrants and the ordinary shares that
are issuable from time to time upon exercise of the pre-funded warrants was made pursuant to our shelf registration statement on Form
S-3 initially filed with the SEC on May 9, 2019, and declared effective by the SEC on May 23, 2019, and the ordinary warrants were issued
in a concurrent private placement. The ordinary warrants are exercisable at any time and from time to time, in whole or in part, following
the date of issuance and ending five and one-half years from the date of issuance. All of the pre-funded warrants were exercised in full
on September 27, 2021, and the offering closed on September 29, 2021. Additionally, we issued warrants to purchase up to 960,811 ordinary
shares, with an exercise price of $2.5438 per share, exercisable from September 27, 2021, until September 27, 2026, to certain representatives
of H.C. Wainwright as compensation for its role as the placement agent in our September 2021 private placement offering.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of December 31, 2023, warrants to purchase a total of 9,814,754
ordinary shares with exercise prices ranging from $1.25 to $1.79 were exercised, for total gross proceeds of approximately $13.8 million.
During the twelve months that ended December 31, 2023, no warrants were exercised.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic">Share Repurchase Program</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">On June 2, 2022, our board of directors approved a share repurchase program to repurchase
up to $8.0 million of our ordinary shares . On July 21, 2022, we received approval from an Israeli court for the share repurchase program.
The program was scheduled to expire on the earlier of January 20, 2023, or reaching $8.0 million of repurchases. On December 22, 2022,
our board of directors approved an extension of the repurchase program, with such extension to be in the aggregate amount of up to $5.8
million. The extension was approved by an Israeli court on February 9, 2023, and it expired on August 9, 2023.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">As of December 31, 2023, pursuant to the share repurchase program, we had repurchased
a total of 4,022,607 of our outstanding ordinary shares at a total cost of $3.5 million.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold">Cash Flows</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic; font-weight: bold"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="zd3d6b32b92a6472da57c331841cfc94b" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Years Ended December 31,</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2023</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2022</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Net cash used in operating activities</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(20,667</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(17,891</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(11,469</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Net cash used in investing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(18,149</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(25</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(47</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Net cash (used in) provided by financing activities&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(992</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(2,500</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">79,512</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Effect of Exchange rate changes on Cash, Cash Equivalents and
        Restricted Cash</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">45</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(79</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Net cash flow</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(39,763</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(20,495</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">67,996</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">68</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Year Ended December 31, 2023 to Year Ended December 31, 2022</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Net Cash Used in Operating Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Net cash used in operating activities was $20.7 million in 2023,
an increase of $2.8 million as compared to 2022 mainly due to higher consulting and professional services fees primarily associated with
the acquisition of AlterG and the CMS reimbursement process, as well as increased inventory purchases.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Net Cash Used in Investing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">

<div style="text-indent: 36pt; line-height: 1.25">Net cash used in investing activities increased to $18.1 million in 2023 as compared
to $0.03 million in 2022, primarily due to the acquisition of AlterG.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic">Net Cash Used in Financing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Net cash used in financing activities was $0.9 million in 2023,
a decrease of $1.5 million, as compared to 2022. The decrease was due to the repurchase of our ordinary shares under our share repurchase
program, which expired on August 9, 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Year Ended December 31, 2022 Compared to Year
Ended December 31, 2021</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">A discussion of changes in our cash flows in 2022 compared to 2021
has been omitted from this annual report on Form 10-K but may be found in &#8220;Part I. Item 7. Management's Discussion and Analysis
of Financial Condition and Results of Operations&#8221; of our Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC
on February 23, 2023, which is available free of charge on the SECs website at www.sec.gov and at golifeward.com, and is incorporated
by reference herein.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">69</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Obligations and Commercial Commitments</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">Set forth below is a summary of our contractual obligations as of December&#160;31,
2023:</div>

<div style="text-indent: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z895e2e80013b460f8174090dbd354736" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25"><span style="font-weight: bold">Payments due by period (in dollars, in thousands</span>)</div>
        </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Contractual obligations</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Less than<br/> 1 year</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">1-3 years</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: bottom">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Purchase obligations (1)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,551</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,551</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Collaboration Agreement and License Agreement obligations (2)</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">34</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">&#8212;</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Operating lease obligations (3)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,050</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,364</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">686</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25">Earnout liability (4)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,292</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">576</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">2,716</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -8.65pt; margin-left: 8.65pt; line-height: 1.25; font-weight: bold">Total</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">13,927</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">10,525</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,402</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z242fd252f87e4124995360f551820cd9" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>We depend on one contract manufacturer, Sanmina Corporation, for both the SCI products and the ReStore Products. We place our manufacturing
        orders with Sanmina pursuant to purchase orders or by providing forecasts for future requirements. The AlterG Anti-Gravity systems are
        produced in Fremont, California by us. Purchase orders are executed with suppliers based on our sales forecast.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div> </div>

<table cellspacing="0" cellpadding="0" id="z795cbb22d49f4a4884546dd535766540" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Under the Collaboration Agreement, we were required to pay in quarterly installments the funding of our joint research collaboration
        with Harvard, subject to a minimum funding commitment under applicable circumstances. Our License Agreement with Harvard consists of patent
        reimbursement expenses payments and a license upfront fee payment. There are also several milestone payments contingent upon the achievement
        of certain product development and commercialization milestones and royalty payments on net sales from certain patents licensed to Harvard.
        All product development milestones contemplated by the License Agreement have been met as of December 31, 2023; however, there are still
        outstanding commercialization milestones under the License Agreement that depend on us reaching certain sales amounts, some or all of
        which may not occur. Our Collaboration Agreement with Harvard was concluded on March 31, 2022.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za7fd496a60a34ff68d8293602100233a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Our operating leases consist of leases for our facilities in the United States, Israel and Germany and motor vehicles in Israel.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z027b6fcd982445bbbe6dcfc2c3623a3f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Earnout payments based on AlterG&#8217;s revenue growth during the two consecutive trailing twelve-month periods following closing
        of the acquisition.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We calculated the payments due under our operating lease obligation
for our Israeli office that are to be paid in NIS at a rate of exchange of NIS 3.627:$1.00, of which were the applicable exchange rate
as of December&#160;31, 2023.</div>

<div style="line-height: 1.25">&#160;

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Off-Balance Sheet Arrangements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We had no off-balance sheet arrangements or guarantees of third-party
obligations during the periods presented.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Trend Information</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">For information on significant known trends, please see &#8220;Part I-Item 1. &#8220;Business
&#8211; Overview&#8221; in this annual report.</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">70</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div> <br/> <br/>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM7A.QUANTITATIVEANDQUA"><!--Anchor--></span>ITEM 7A. QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Currency Exchange Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our results of operations and cash flows are affected by fluctuations
in foreign currency exchange rates.&#160;Since 2015, most of our expenses were denominated in U.S. dollars and the remaining expenses
were denominated in NIS and euro, until 2018 most of our revenue was denominated in U.S. dollars and the remainder of our revenue was
denominated in euro and British pound whereas in the last four years our euro revenue is higher than our U.S dollar revenue. Accordingly,
changes in the value of the NIS and Euro relative to the U.S. dollar in each of the years 2023, 2022, and 2021 impacted amounts recorded
on our consolidated statements of operations for these periods. We expect that the denominations of our revenue and expenses in 2024 will
be consistent with what we experienced in 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following table presents information about the devaluation
in the exchange rates of the NIS and euro against the U.S. dollar in 2023, 2022 and 2021:</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="za9ef21ab8d4742079c11db6b4b389681" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Change in Average Exchange Rate</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25; font-weight: bold">Period</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">NIS against the<br/> U.S. Dollar (%)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Euro against the<br/> U.S. Dollar (%)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2023</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(9.00</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2.67</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="line-height: 1.25">2022</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3.70</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">10.84</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2021</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(6.38</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3.46</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The figures above represent the change in the average exchange
rate in the given period compared to the average exchange rate in the immediately preceding period. Negative figures represent the devaluation
of the U.S. dollar compared to the NIS or the euro. A 10% increase or decrease in the value of the NIS against the U.S. dollar would have
decreased or increased our net loss by approximately $513 thousand in 2023. A 10% increase or decrease in the value of the euro against
the U.S. dollar would have decreased or increased our net loss by approximately $14 thousand in 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Other Market Risks</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">We do not believe that we have material exposure to interest rate risks or to inflationary
risks.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span id="ITEM8.FINANCIALSTATEMENTS"><!--Anchor--></span><span style="font-weight: bold">ITEM 8.</span>&#160;
<span style="font-weight: bold">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The information required hereunder is set forth under Report of
Independent Registered Public Accounting Firm, Consolidated Balance Sheets, Consolidated Statements of Operations, Statements of Changes
in Shareholders&#8217; Equity, Consolidated Statements of Cash Flows and Notes to Consolidated Financial Statements included in the Consolidated
Financial Statements that are a part of this annual report. Other financial information is included in the Consolidated Financial Statements
that are a part of this annual report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 9.&#160; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 9A. CONTROLS AND PROCEDURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Disclosure Controls and Procedures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We maintain disclosure controls and procedures that are designed
to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within
the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial
disclosure.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">As of the end of the period covered by this annual report, we carried
out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief
Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e)
and Rule 15d-15(e) of the Exchange Act). Based upon, and as of the date of, this evaluation, the Chief Executive Officer and the Chief
Financial Officer concluded that our disclosure controls and procedures were effective such that the information required to be disclosed
by us in our SEC reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and
is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to
allow timely decisions regarding required disclosure.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">71</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Management&#8217;s Report on Internal Control over Financial Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our management is responsible for establishing and maintaining
adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control
over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with U.S. GAAP.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Our internal control over financial reporting includes those policies
and procedures that:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z887bb3b30b554e4f8e044f9c9b42b5b0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions
        of our assets;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z28911ff32e234a478daa977db1e3600b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
        with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors;
        and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdf4f1fda41424b6d8376a0aacd8792fc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br/> </td>
    <td style="width: 36pt; vertical-align: top">&#9679;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets
        that could have a material effect on our financial statements.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Management has assessed the effectiveness of our internal control
over financial reporting as of December&#160;31, 2023. In making its assessment, management used the criteria described in Internal Control
&#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">We have excluded from the scope of our assessment of internal control
over financial reporting the operations and related assets of AlterG, which we acquired on August 11, 2023. Based on management&#8217;s
assessment, management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2023 to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements
for external reporting purposes in accordance with U.S. GAAP.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">This annual report does not include an attestation report of our
independent registered public accounting firm regarding internal controls over financial reporting because we are exempt from this requirement
as a smaller reporting company and non-accelerated filer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Changes in Internal Control over Financial Reporting</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">During the fourth quarter of the fiscal year ended December&#160;31,
2023, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange
Act) that materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span id="ITEM9B.OTHERINFORMATION"><!--Anchor--></span><span style="font-weight: bold">ITEM 9B.</span>
&#160; <span style="font-weight: bold">OTHER INFORMATION</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold"><span id="ITEM9C"><!--Anchor--></span>ITEM 9C.</span> &#160; <span style="font-weight: bold">DISCLOSURE
REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">72</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTIII"><!--Anchor--></span>PART III</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Information About Our Executive Officers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The following table sets forth the name, age and position of each
of our executive officers as of February 27, 2024:</div>

<table cellspacing="0" cellpadding="0" id="z818de47751c147eb9e22df5b39e574b3" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 49%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 49%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Name</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 5%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Age</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 40%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">Position</div> </td> </tr>
  <tr>
    <td style="width: 49%; vertical-align: top">
        <div style="line-height: 1.25">Larry Jasinski</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">66</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Chief Executive Officer and Director</div> </td> </tr>
  <tr>
    <td style="width: 49%; vertical-align: top">
        <div style="line-height: 1.25">Michael Lawless</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">56</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Chief Financial Officer</div> </td> </tr>
  <tr>
    <td style="width: 49%; vertical-align: top">
        <div style="line-height: 1.25">Charles Remsberg</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">62</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Chief Sales Officer</div> </td> </tr>
  <tr>
    <td style="width: 49%; vertical-align: top">
        <div style="line-height: 1.25">Jeannine Lynch</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">59</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Vice President of Market Access</div> </td> </tr>
  <tr>
    <td style="width: 49%; vertical-align: top">
        <div style="line-height: 1.25">Almog Adar</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">40</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Vice President of Finance</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Larry Jasinski </span>has served
as our Chief Executive Officer and as a member of our board since February 2012. From 2005 until 2012, Mr.&#160;Jasinski served as the
President and Chief Executive Officer of Soteira, Inc., a&#160;company engaged in development and commercialization of products used to
treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr.&#160;Jasinski
was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease,
which was acquired by Alphatec in 2005. From 1985 until 2001, Mr.&#160;Jasinski served in multiple sales, research and development, and
general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines
since 2015 and of LeMaitre Vascular, Inc. since 2003. Mr.&#160;Jasinski holds a B.Sc. in marketing from Providence College and an MBA
from the University of Bridgeport.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Michael Lawless </span>has served
as our Chief Financial Officer since September 2022. Prior to Lifeward, Mr. Lawless served as a CFO consultant for Danforth Advisors,
LLC, a provider of financial consulting services to the life sciences industry. From 2015 to 2020, Mr. Lawless held several financial
leadership positions including Division CFO at Azenta, Inc. (formerly Brooks Automation, Inc.), a worldwide provider of management solutions
for biological samples. Previously, Mr. Lawless also held financial leadership roles for AECOM Technology, Inc., PerkinElmer, Inc., Momenta
Pharmaceuticals, Inc. and CTI Molecular Imaging, Inc.&#160; Mr. Lawless has a Bachelor of Arts degree in Economics from Swarthmore College,
a Master of Business Administration degree from the Tuck School of Business at Dartmouth College and is a Certified Public Accountant.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Charles Remsberg </span>has served
as our Chief Sales Officer since August 2023.&#160; Prior to Lifeward, Mr. Remsberg served as CEO of AlterG from March 2017 until the
acquisition of AlterG in August 2023.&#160; An industry veteran of over 30 years, Charles has been responsible for bringing innovative
rehabilitation technology to physical therapy, neuro-rehabilitation, sports medicine, and wellness customers.&#160; Prior to serving at
AlterG, Mr. Remsberg served in both executive and commercial leadership roles for Tibion (for which he served as the CEO from December
2009 to April 2013, when it was acquired by AlterG), Hocoma (for which he served as the U.S. CEO and Global Head of Sales from September
2003 to November 2009), and Biodex Medical Systems (for which he served as the Head of Worldwide Sales from January 1997 to October 2002).&#160;
He holds an AS in Business Administration from Suffolk County Community College.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Jeannine Lynch </span>has served as our Vice President
of Market Access and Strategy since August 2021. Prior to Lifeward, Ms. Lynch served as Senior Director of Patient Access Services at
BioMarin Pharmaceuticals from April 2009 to September 2021. In addition to her work with BioMarin, Ms. Lynch has worked for industry leaders
such as Genentech and Pfizer/Agouron. She has held leadership roles in commercial management, product launches and built customized patient
services to address several different rare and ultrarare medical conditions. Ms. Lynch also sits on the Board of Directors for MVP, a
non-profit organization to help young people of color prepare, perform, progress, and prosper in their education, leadership and early
professional careers. Ms. Lynch is a graduate of the University of California Berkeley and holds a Master of Public Health from the University
of Michigan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"><span style="font-style: italic">Almog Adar </span>has served as
our Vice President of Finance since December 2022. From 2020 to 2022, Mr. Adar served as our Director of Finance and Corporate Financial
Controller. Prior to Lifeward, Mr. Adar served as Controller of Infinya Recycling Ltd. (previously Amnir Recycling) from January 2018
until December 2019. From January 2016 until December 2017, Mr. Adar served as Assistant Controller of Delta Galil Industries. Mr. Adar
has a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed
by the Israeli Ministry of Justice.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">73</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The remaining information required by this Item will be included
in, and is incorporated herein by reference from, our definitive proxy statement for our 2024 Annual Meeting of Shareholders to be filed
with the SEC pursuant to Regulation 14A within 120 days after the end of our fiscal year ended December&#160;31, 2023 (the &#8220;Proxy
Statement&#8221;).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold"><span id="ITEM11.EXECUTIVECOMPENSAT"><!--Anchor--></span>ITEM 11.
EXECUTIVE COMPENSATION</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The information required by this Item 11 will be included in, and
is incorporated herein by reference from, our Proxy Statement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The information required by this Item 12 will be included in and
is incorporated herein by reference from, our Proxy Statement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The information required by this Item 13 will be included in and
is incorporated herein by reference, from our Proxy Statement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">The information required by this Item 14 will be included in and is incorporated herein
by reference, from our Proxy Statement.&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">74</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>
<!--PROfilePageNumberReset%Num%75%%%-->

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="PARTIV"><!--Anchor--></span>PART IV</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">ITEM 15.&#160;&#160; EXHIBITS, FINANCIAL STATEMENT SCHEDULES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">(a)(1) Financial Statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">The Consolidated Financial Statements filed as part of this annual
report are identified in the Index to Consolidated Financial Statements on page F-1 hereto.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">(a)(2) Financial Statement Schedules.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">&#160;Financial Statement Schedules have been omitted because the
information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25">(a)(3) Exhibits.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">See accompanying Exhibit Index included after the signature page
of this report for a list of the exhibits filed or furnished with or incorporated by reference in this report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">EXHIBIT INDEX</div>

<div style="line-height: 1.25; font-weight: bold"> <br/> </div>

<div style="line-height: 1.25; font-weight: bold">

<div style="line-height: 1.25">

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002776/0001178913-23-002776-index.htm">2.1</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002776/0001178913-23-002776-index.htm">Agreement
        and Plan of Merger, dated as of August 8, 2023, by and among ReWalk Robotics, Inc., Atlas Merger Sub, Inc., AlterG Inc. and Shareholder
        Representative Services LLC (incorporated by reference to Exhibit 2.1 of the Company&#8217;s Current Report on Form 8-K filed with the
        SEC on August 9, 2023). +</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321001827/exhibit_3-1.htm">3.1</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321001827/exhibit_3-1.htm">Fourth Amended
        and Restated Articles of Association of the Company (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on
        Form 8-K filed with the SEC on May 21, 2021).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex41.htm">4.1</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex41.htm">Specimen
        share certificate (incorporated by reference to Exhibit 4.1 to the Company&#8217;s registration statement on Form F-1/A (File No. 333-197344),
        filed with the SEC on August 20, 2014).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891322000800/exhibit_4-2.htm">4.2</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891322000800/exhibit_4-2.htm">Description
        of the registrant&#8217;s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference
        to Exhibit 4.2 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 24, 2022).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891316003859/exhibit_10-2.htm">4.3</a></div>
        </td>
    <td style="width: 92%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891316003859/exhibit_10-2.htm">Warrant,
        dated December 30, 2015, between the Company and Kreos Capital V (Expert Fund) Limited (incorporated by reference to Exhibit 10.2 to the
        Company&#8217;s Current Report on Form 8-K filed with the SEC on January 4, 2016).</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018016422/f8k111618ex4-1_rewalkrob.htm">4.4</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018016422/f8k111618ex4-1_rewalkrob.htm">First
        Amendment to Warrant to Purchase Shares between the Company and Kreos Capital V (Expert Fund) Limited, dated November 20, 2018 (incorporated
        by reference to Exhibit 4.1 to the Company&#8217;s current report on Form 8-K filed with the SEC on November 21, 2018).</a></div> </td>
        </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019003063/f8k0219ex4-1_rewalkrobo.htm">4.5</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019003063/f8k0219ex4-1_rewalkrobo.htm">Form
        of placement agent warrant from February 2019 &#8220;best efforts&#8221; public offering (incorporated by reference to Exhibit 4.1 of
        the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 25, 2019).</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-1_rewalk.htm">4.6</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: bottom">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-1_rewalk.htm">Form
        of purchaser warrant from April 2019 registered direct offering and concurrent private placement of warrants (incorporated by reference
        to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 5, 2019).</a></div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-2_rewalk.htm">4.7</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019005819/f8k040319bex4-2_rewalk.htm">Form
        of placement agent warrant from April 2019 registered direct offering and concurrent private placement of warrants (incorporated by reference
        to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 5, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-1_rewalkrobo.htm">4.8</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-1_rewalkrobo.htm">Form
        of private placement warrant from June 2019 private placement of warrants (incorporated by reference to Exhibit 4.1 of the Company&#8217;s
        Current Report on Form 8-K filed with the SEC on June 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-2_rewalkrobo.htm">4.9</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex4-2_rewalkrobo.htm">Form
        of placement agent warrant from June 2019 private placement of warrants (incorporated by reference to Exhibit 4.2 of the Company&#8217;s
        Current Report on Form 8-K filed with the SEC on June 11, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-1_rewalkrobo.htm">4.10</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-1_rewalkrobo.htm">Form
        of purchaser warrant from June 2019 registered direct offering and concurrent private placement of warrants (incorporated by reference
        to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2019).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-2_rewalkrobo.htm">4.11</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010548/f8k061019bex4-2_rewalkrobo.htm">Form
        of placement agent warrant from June 2019 registered direct offering and concurrent private placement of warrants (incorporated by reference
        to Exhibit 4.2 of the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 12, 2019).</a></div> </td> </tr>
  </table>

<div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-1_rewalk.htm">4.12</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-1_rewalk.htm">Form
        of common warrant from February 2020 best efforts offering (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report
        on Form 8-K filed with the SEC on February 10, 2020).</a></div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-3_rewalk.htm">4.13</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390020003105/f8k0220ex4-3_rewalk.htm">Form
        of placement agent warrant from February 2020 best efforts offering (incorporated by reference to Exhibit 4.3 of the Company&#8217;s Current
        Report on Form 8-K filed with the SEC on February 10, 2020).</a></div> </td> </tr>
  </table>

<div><br/> </div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-family: Times New Roman,Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal">75</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top"><br/> </td>
    <td style="width: 92%; vertical-align: top"><br/> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-1.htm">4.14</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-1.htm">Form of purchaser
        warrant from July 2020 registered direct offering (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form
        8-K filed on July 6, 2020).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-2.htm">4.15</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320001968/exhibit_4-2.htm">Form of placement
        agent agreement from July 2020 registered direct offering (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report
        on Form 8-K filed on July 6, 2020).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-1.htm">4.16</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-1.htm">Form of purchaser
        warrant from December 2020 private placement (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K
        filed with the SEC on December 8, 2020).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-2.htm">4.17</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891320003336/exhibit_4-2.htm">Form of placement
        agent warrant from December 2020 private placement (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on
        Form 8-K filed with the SEC on December 8, 2020).</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000792/exhibit_4-1.htm">4.18</a><br/>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000792/exhibit_4-1.htm">Form of purchaser warrant from February
        2021 private placement (incorporated by reference to Exhibit&#160;&#160; of&#160; &#160; the Company&#8217;s Current Report on Form 8-K
        filed with the SEC on February 25, 2021).</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000792/exhibit_4-2.htm">4.19</a></td>
    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000792/exhibit_4-2.htm">Form of placement agent warrant from
        February 2021 private placement (incorporated by reference to Exhibit of the Company&#8217;s Current Report on Form 8-K filed with the
        SEC on February 25, 2021).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003062/exhibit_4-1.htm">4.20</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003062/exhibit_4-1.htm">Form of ordinary
        warrant from September 2021 private placement (incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form
        8-K filed with the SEC on September 29, 2021).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003062/exhibit_4-2.htm">4.21</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003062/exhibit_4-2.htm">Form of placement
        agent warrant from September 2021 private placement (incorporated by reference to Exhibit 4.2 of the Company&#8217;s Current Report on
        Form 8-K filed with the SEC on September 29, 2021).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003062/exhibit_4-3.htm">4.22</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003062/exhibit_4-3.htm">Form of pre-funded
        warrant from September 2021 private placement (incorporated by reference to Exhibit 4.3 of the Company&#8217;s Current Report on Form
        8-K filed with the SEC on September 29, 2021).</a></div> </td> </tr>
  </table> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000678/exhibit_10-1.htm">10.1</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000678/exhibit_10-1.htm">Letter of Agreement, dated July 11,
        2013, between the Company and Sanmina Corporation (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Annual Report on Form
        10-K filed with the SEC on February 18, 2021).*</a></div> </div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000678/exhibit_10-8.htm">10.2</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321000678/exhibit_10-8.htm">License Agreement, dated May 16, 2016,
        between the Company and the President and Fellows of Harvard College (incorporated by reference to Exhibit 10.8 to the Company&#8217;s
        Annual Report on Form 10-K filed with the SEC on February 18, 2021).*</a></div> </div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex1011.htm">10.3</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000119312514315654/d724635dex1011.htm">Form of
        indemnification agreement between the Company and each of its directors and executive officers (incorporated by reference to Exhibit 10.11
        to the Company&#8217;s registration statement on Form F-1/A (File No. 333-197344), filed with the SEC on August 20, 2014).**</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420417056327/tv478568_ex99-1.htm">10.4</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000114420417056327/tv478568_ex99-1.htm">2014 Incentive
        Compensation Plan, as amended (incorporated by reference to Exhibit 99.1 to the Company&#8217;s registration statement on Form S-8 (File
        No. 333-239258), filed with the SEC on June 18, 2020).**</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1016.htm">10.5</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1016.htm">Executive
        Employment Agreement, dated as of January 17, 2011, between the Company and Larry Jasinski (incorporated by reference to Exhibit 10.16
        to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6, 2016).**</a></div> </td>
        </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1018.htm">10.6</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1018.htm">2014
        Incentive Compensation Plan Form of Option Award Agreement for employees and executives (incorporated by reference to Exhibit 10.18 to
        the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6, 2016).**</a></div> </td>
        </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1019.htm">10.7</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1019.htm">2014
        Incentive Compensation Plan Form of Restricted Share Unit Award Agreement for non-Israeli employees, and executives (incorporated by reference
        to Exhibit 10.19 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May 6, 2016).**</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20i_rewalkrobot.htm">10.8</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20i_rewalkrobot.htm">2014
        Incentive Compensation Plan Form of Restricted Share Unit Award Agreement for Israeli non-employee directors, employees and executives
        (incorporated by reference to Exhibit 10.20.1 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with
        the SEC on October 15, 2018).**</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20ii_rewalkrobot.htm">10.9</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-20ii_rewalkrobot.htm">2014
        Incentive Compensation Plan Form of Restricted Share Unit Award Agreement between the Company and Jeffrey Dykan, as director (incorporated
        by reference to Exhibit 10.20.2 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with the SEC on
        October 15, 2018).**</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1020.htm">10.10</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796216000007/rwlk10-k12312015exhibit1020.htm">2014
        Incentive Compensation Plan Prior Form of Restricted Share Unit Award Agreement for non-Israeli non-employee directors (incorporated by
        reference to Exhibit 10.20 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 29, 2016, as amended on May
        6, 2016).**</a></div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-22_rewalkrobot.htm">10.11</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018ex10-22_rewalkrobot.htm">2014
        Incentive Compensation Plan New Form of Restricted Share Unit Award Agreement for non-Israeli non-employee directors (incorporated by
        reference to Exhibit 10.22 to the Company&#8217;s registration statement on Form S-1 (File No. 333-227852), filed with the SEC on October
        15, 2018).**</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1021.htm">10.12</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1021.htm">2014
        Incentive Compensation Plan Prior Form of Option Award Agreement for Israeli non-employee directors (incorporated by reference to Exhibit
        10.21 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 17, 2017, as amended on April 27, 2017).**</a></div>
        </td> </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-family: Times New Roman,Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal">76</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1022.htm">10.13</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000160796217000006/rwlk10-k12312016exhibit1022.htm">2014
        Incentive Compensation Plan Prior Form of Option Award Agreement for non-Israeli non-employee directors (incorporated by reference to
        Exhibit 10.22 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 17, 2017, as amended on April 27, 2017).**</a></div>
        </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018008531/f8k062918ex10-2_rewalkrobot.htm">10.14</a></td>
    <td rowspan="1" style="width: 92%; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390018008531/f8k062918ex10-2_rewalkrobot.htm">Amendment No. 1 to the
        Exclusive License Agreement and Amendment No. 2 to the Research Collaboration Agreement, dated April 1, 2018, between the Company and
        the President and Fellows of Harvard College (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form
        8-K filed with the SEC on June 29, 2018).*</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex10-1_rewalkrobo.htm">10.15</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000121390019010476/f8k060519ex10-1_rewalkrobo.htm">Form
        of warrant exercise agreement from June 2019 private placement of warrants (incorporated by reference to Exhibit 10.1 of the Company&#8217;s
        Current Report on Form 8-K filed with the SEC on June 11, 2019).</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003473/exhibit_10-3.htm">10.16</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891321003473/exhibit_10-3.htm">Employment
        Agreement, dated July 9, 2021, by and between the Company and Jeannine Lynch (incorporated by reference to Exhibit 10.3&#160; to the Company&#8217;s
        Quarterly Report on Form 10-Q filed with the SEC on November 10, 2021**.</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891322001956/exhibit_10-1.htm">10.17</a></td>
    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891322001956/exhibit_10-1.htm">Employment Agreement dated December
        10, 2019, by and between the Company and Almog Adar (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report
        on Form 10-Q filed with the SEC on May 13, 2022).*&#160; **</a></div> </td> </tr>
  </table>

<div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002828/exhibit_10-1.htm">10.18</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002828/exhibit_10-1.htm">Amendment
        No. 1 to Employment Agreement, dated May 4, 2023, by and between the Company and Almog Adar (incorporated by reference to Exhibit 10.1
        to the Company&#8217;s Quarterly report on Form 10-Q filed with the SEC on August 11, 2023).**</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891322003847/exhibit_10-1.htm">10.19</a></div>
        </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891322003847/exhibit_10-1.htm">Employment
        Agreement, dated September 2, 2022, by and between the Company and Michael A. Lawless (incorporated by reference to Exhibit 10.1 to the
        Company&#8217;s Quarterly report on Form 10-Q filed with the SEC on November 7, 2022).*&#160; **</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002786/zk2330095.htm">10.20</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002786/zk2330095.htm">Consulting
        Agreement, dated as of January 1, 2023), by and between the Company and Richner Consultants LLC (incorporated by reference to Appendix
        A to the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed with the SEC on August 9, 2023).**</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002786/zk2330095.htm">10.21</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002786/zk2330095.htm">ReWalk
        Robotics Ltd. Compensation Policy for Executive Officers and Non-Executive Directors (incorporated by reference to Appendix B to the Company&#8217;s
        Definitive Proxy Statement on Schedule 14A filed with the SEC on August 9, 2023).**</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323003671/exhibit_10-1.htm">10.22</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323003671/exhibit_10-1.htm">Employment
        Agreement, dated as of August 11, 2023, by and between the Company and Charles Remsberg (incorporated by reference to Exhibit 10.1 to
        the Company&#8217;s Quarterly report on Form 10-Q filed with the SEC on November 14, 2023).**</a></div> </td> </tr>
  <tr>
    <td rowspan="1" style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323003671/exhibit_10-2.htm">10.23</a></div>
        </td>
    <td rowspan="1" style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323003671/exhibit_10-2.htm">Form
        of Restricted Share Unit Award (Inducement Award) for non-Israeli employees and executives (incorporated by reference to Exhibit 10.2
        to the Company&#8217;s Quarterly report on Form 10-Q filed with the SEC on November 14, 2023).**</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="exhibit_21-1.htm">21.1</a></div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_21-1.htm">List of subsidiaries of the Company.***</a></div> </td>
        </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="exhibit_23-1.htm">23.1</a></div> </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_23-1.htm">Consent of Kost Forer Gabbay &amp; Kasierer, a member of
        Ernst &amp; Young Global Limited.</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="exhibit_31-1.htm">31.1</a></div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_31-1.htm">Certification of Principal Executive Officer pursuant to
        Section 302 of the Sarbanes-Oxley Act 2002.</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="exhibit_31-2.htm">31.2</a></div> </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_31-2.htm">Certification of Principal Financial Officer pursuant to
        Section 302 of the Sarbanes-Oxley Act 2002.</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="exhibit_32-1.htm">32.1</a></div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_32-1.htm">Certification of Principal Executive Officer and Principal
        Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.***</a></div>
        </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="exhibit_32-2.htm">32.2</a></div> </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25"><a href="exhibit_32-2.htm">Certification of Principal Financial Officer pursuant to
        18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.***</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002786/zk2330095.htm">97.1</a></div>
        </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1607962/000117891323002786/zk2330095.htm">Compensation
        Recovery Policy (incorporated by reference to Annex A to the ReWalk Robotics Ltd. Compensation Policy for Executive Officers and Non-Executive
        Directors filed herewith as Exhibit 10.21).</a></div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">101.INS</div> </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">XBRL Instance Document.</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25">101.SCH</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">XBRL Taxonomy Extension Schema Document.</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">101.PRE</div> </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: justify; line-height: 1.25">XBRL Taxonomy Presentation Linkbase Document.</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25">101.CAL</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">XBRL Taxonomy Calculation Linkbase Document.</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">101.LAB</div> </td>
    <td style="width: 92%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">XBRL Taxonomy Label Linkbase Document.</div> </td> </tr>
  <tr>
    <td style="width: 8%; vertical-align: top">
        <div style="line-height: 1.25">101.DEF</div> </td>
    <td style="width: 92%; vertical-align: top">
        <div style="line-height: 1.25">XBRL Taxonomy Extension Definition Linkbase Document.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">+</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Certain identified information in the exhibit has been omitted because it is the type of information that (i) the Company customarily
        and actually treats as private and confidential, and (ii) is not material.</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">**</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Management contract or compensatory plan, contract or arrangement.</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt; vertical-align: top">***</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Furnished herewith.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div> </div> </div> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM16.FORM10-KSUMMARY"><!--Anchor--></span>ITEM 16. FORM 10-K SUMMARY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">77</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="SIGNATURES"><!--Anchor--></span>SIGNATURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>

<table cellspacing="0" cellpadding="0" id="z7661f6595f8743088b76f6cd7e580921" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">&#160;</td>
    <td style="width: 45%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">&#160;</td>
    <td colspan="2" style="width: 50%; vertical-align: top">
        <div style="line-height: 1.25; font-weight: bold">ReWalk Robotics Ltd.</div> </td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">&#160;</td>
    <td style="width: 45%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">
        <div style="line-height: 1.25">By:</div> </td>
    <td style="border-bottom: #000000 2px solid; width: 45%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Larry Jasinski</div> </td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">&#160;</td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">Name: Larry Jasinski</div> </td> </tr>
  <tr>
    <td style="width: 50%; vertical-align: top">&#160;</td>
    <td style="width: 5%; vertical-align: top">&#160;</td>
    <td style="width: 45%; vertical-align: top">
        <div style="line-height: 1.25">Title: Chief Executive Officer</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25">Date: February 27, 2024</div>

<div style="line-height: 1.25"> <br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">78</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; line-height: 1.25; font-weight: bold"><span id="POWEROFATTORNEY"><!--Anchor--></span>POWER OF ATTORNEY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">KNOW ALL PERSONS BY THESE PRESENT: That the undersigned officers
and directors of ReWalk Robotics Ltd. do hereby constitute and appoint Larry Jasinski and Mike Lawless the lawful attorney and agent with
power and authority to do any and all acts and things and to execute any and all instruments which said attorney and agent determines
may be necessary or advisable or required to enable ReWalk Robotics Ltd. to comply with the Securities and Exchange Act of 1934, as amended,
and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this report. Without limiting
the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned
officers and directors in the capacities indicated below to this report or amendments or supplements thereto, and each of the undersigned
hereby ratifies and confirms all that said attorneys and agents, or either of them, shall do or cause to be done by virtue hereof. This
Power of Attorney may be signed in several counterparts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25">Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</div>

<div style="text-align: justify; text-indent: 36pt; line-height: 1.25"> <br/> </div>

<table cellspacing="0" cellpadding="0" id="z49e3a609a4f34a54b82c74155a59f102" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Signature</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 40%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Title</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Date</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Larry Jasinski</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Director and Chief Executive Officer</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Larry Jasinski</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">(Principal Executive Officer)</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Mike Lawless</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Chief Financial Officer</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Mike Lawless</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">(Principal Financial Officer)</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Almog Adar</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Vice President of Finance</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Almog Adar</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">(Principal Accounting Officer)</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Jeff Dykan</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Chairman of the Board</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Jeff Dykan</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Dr. John William Poduska</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Dr. John William Poduska</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Randel Richner</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Randel Richner</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Joseph Turk</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Joseph Turk</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 27%; vertical-align: top">
        <div style="line-height: 1.25">/s/ Hadar Levy</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">
        <div style="line-height: 1.25">Director</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">
        <div style="text-align: center; line-height: 1.25">February 27, 2024</div> </td> </tr>
  <tr>
    <td style="width: 27%; vertical-align: top">
        <div style="line-height: 1.25">Hadar Levy</div> </td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 40%; vertical-align: top">&#160;</td>
    <td style="width: 3%; vertical-align: top">&#160;</td>
    <td style="width: 27%; vertical-align: top">&#160;</td> </tr>
  </table>

<div><br/> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-family: Times New Roman,Times,serif; font-weight: normal; font-style: normal">79</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000"/></div>
</div>

<div> <br/> </div> <br/> </div>
<!-- Field: /Include-Text -->
<div style="margin-top:0pt;margin-bottom:0pt">
    <div style="margin-top:0pt;margin-bottom:0pt">
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">PART IV</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">REWALK ROBOTICS LTD</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">CONSOLIDATED FINANCIAL STATEMENTS</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">U.S. DOLLARS IN THOUSANDS</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div><a id="a_001"></a>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">INDEX</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div>
        <table border="0" cellpadding="2" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:11.18%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Page</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a href="#REPORTOFINDEPENDENTREGIST_integixAnchor" style="margin-top:0pt;margin-bottom:0pt">Report of Registered Public Accounting Firm</a></span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">F -2</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">(PCAOB ID <ix:nonNumeric id="FFact_0000000000032" name="dei:AuditorFirmId" contextRef="C_20230101to20231231">1281</ix:nonNumeric>)</span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">&#160;</td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a href="#BALANCESHEETS_integixAnchor" style="margin-top:0pt;margin-bottom:0pt">Consolidated Balance Sheets</a></span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">F -4</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a href="#STATEMENTSOFOPERATIONS_integixAnchor" style="margin-top:0pt;margin-bottom:0pt">Consolidated Statements of Operations</a></span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">F -6</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a href="#EQUITY_integixAnchor" style="margin-top:0pt;margin-bottom:0pt">Statements of Changes in Shareholders&#8217; Equity</a></span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">F -7</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a href="#FCASHFLOWS_integixAnchor" style="margin-top:0pt;margin-bottom:0pt">Consolidated Statements of Cash Flows</a></span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">F -8</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:88.82%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a href="#Note_integixAnchor" style="margin-top:0pt;margin-bottom:0pt">Notes to Consolidated Financial Statements</a></span></span></div>
              </td>
              <td style="width:11.18%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">F -10</span></span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
        <div style="break-after:page;margin-top:15pt;margin-bottom:0pt">
          <hr style="border-width:0px;clear:both;margin:0pt 0px;width:100%;height:2px;color:rgb(0, 0, 0);background-color:rgb(0, 0, 0)"/>
        </div>
      </div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="margin-top:15pt">
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:15.91%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><img alt="image0.jpg" src="image0.jpg" style="height:50px;width:56px;margin-top:0pt;margin-bottom:0pt"/></div>
              </td>
              <td style="width:62.2%;margin-top:0pt;margin-bottom:0pt;vertical-align:bottom">
                <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Kost Forer Gabbay &amp; Kasierer</span></span></div>
                <div style="line-height:1.25;font-weight:normal;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Menachem Begin 144,</span></span></div>
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Tel-Aviv 6492102, Israel</span></span></div>
              </td>
              <td style="width:21.9%;vertical-align:middle;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Tel: +972-3-6232525</span></span></div>
                <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Fax: +972-2-5622555</span></span></div>
                <div style="text-align:right;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">ey.com</span></span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span id="REPORTOFINDEPENDENTREGIST_integixAnchor" style="margin-top:0pt;margin-bottom:0pt"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">To the Shareholders and the Board of Directors of</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">REWALK ROBOTICS LTD.</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Opinion on the Financial Statements</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">We have audited the accompanying consolidated balance sheets of Rewalk Robotics Ltd. and subsidiaries (the Company) as of December 31, 2023 and 2022, the related consolidated statements of operations, changes is shareholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Basis for Opinion</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Critical Audit Matters</span></span></div>
      <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></span></div>
      <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt">
          <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;2</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
        </div>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt">
        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Revenue recognition</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Description of the Matter</span></span></div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">As described in Note 2 to the consolidated financial statements, the Company generates revenues from sales of its medical devices. Revenue is recognized when obligations under the terms of a contract with the Company's customers are satisfied. Revenue is measured as the amount of consideration to which the Company expects to be entitled in exchange for transferring products or providing services. In addition, the Company provides a service type warranty which is accounted for as a separate performance obligation. Revenue is recognized ratably over the life of the warranty. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis. The Company does not sell the service type warranty of its SCI products on a standalone basis.</span></span></div>
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></div>
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Auditing the Company&#8217;s evaluation of the allocation of the transaction price to the distinct performance obligations was challenging due to the effort and assumptions required to evaluate the standalone selling price of the SCI products service type warranty. The assumptions used in determining the standalone selling price of the service type warranty included costs allocation, inflation rates and expected margins.</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">&#160;</td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">How We Addressed the</span></span></div>
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Matter in Our Audit</span></span></div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">To test the management&#8217;s determination of standalone selling prices of the SCI products service type warranty, our audit procedures included, among others, evaluating the methodology applied and testing the calculations as well as the completeness and accuracy of the underlying data including the costs allocation, inflation rates and expected margins used by the Company in its estimates. We also evaluated the Company&#8217;s disclosures included in notes to the consolidated financial statements.</span></span></div>
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></div>
                <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Business Combinations &#8211; Valuation</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Description of the Matter</span></span></div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">&#160;</td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">As discussed in Notes 2 and 5 to the consolidated financial statements, the Company completed an acquisition of AlterG Inc. during 2023 for consideration of $22.1 million. The Company accounted for this acquisition as a business combination. The acquisition resulted in the recognition of intangible assets amounting to $14.1 million, which consisted of technology, customer relationship, trademark assets and backlog of $6.1 million, $6.9 million, $0.8 million and $0.3 million respectively.</span></span></div>
                <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></div>
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Auditing the Company&#8217;s estimation of the fair value of the acquired intangible assets was complex due to the estimation and uncertainty in the Company&#8217;s determination of the fair value of acquired identifiable intangible assets. The estimation uncertainty for the acquired intangible assets was primarily due to the underlying assumptions about the future performance of the acquired business, which were utilized in determining the fair value of the acquired intangible assets. The significant assumptions used by management included discount rates and certain assumptions that form the basis of the forecasted results, including revenue growth rates. These significant assumptions were forward-looking and could be affected by future economic and market conditions.</span></span></div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              </td>
            </tr>
            <tr style="margin-top:0pt;margin-bottom:0pt">
              <td style="width:33.58%;vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">How We Addressed the</span></span></div>
                <div style="line-height:1.25;font-style:italic;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Matter in Our Audit</span></span></div>
              </td>
              <td style="width:66.42%;vertical-align:bottom;margin-top:0pt;margin-bottom:0pt">
                <div style="text-align:justify;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">To test the estimated fair value of the acquired intangible assets, our audit procedures included, among others, assessing the fair value methodology used by the Company and testing the significant assumptions and the underlying data used by the Company in its analyses. We also performed sensitivity analyses over the significant assumptions used to evaluate the change in the fair value resulting from changes in the assumptions. Additionally, we tested the completeness and accuracy of the underlying data used in the valuation. We involved our valuation specialists to assist us in our evaluation of the Company&#8217;s valuation model, related assumptions and output of the valuation model.</span></span></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="Fxbrl_20240226173350336" name="dei:AuditorName" contextRef="C_20230101to20231231">KOST FORER GABBAY &amp;</ix:nonNumeric> KASIERER</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">A Member of EY Global</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">We have served as the Company&#8217;s auditor since 2014.</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_0000000000034" name="dei:AuditorLocation" contextRef="C_20230101to20231231">Tel-Aviv, Israel</ix:nonNumeric></span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">February 27, 2024</span></span></div>
      <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
        <p style="margin:0pt">&#160;</p>
        <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;3</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REWALK ROBOTICS LTD. AND SUBSIDIARIES</span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED BALANCE SHEETS<span id="BALANCESHEETS_integixAnchor"></span></span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CURRENT ASSETS:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000035" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,083</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000036" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67,896</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivable, net of credit losses of $<ix:nonFraction id="Fxbrl_20240223111331182" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">328</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20240223111353081" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction>, respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000037" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,120</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000038" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,036</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000039" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,366</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000040" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">649</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000041" name="us-gaap:InventoryNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,653</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000042" name="us-gaap:InventoryNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,929</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000043" name="us-gaap:AssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,222</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000044" name="us-gaap:AssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,510</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LONG-TERM ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash and other long-term assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000045" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">784</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000046" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">694</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease right-of-use assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000047" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,861</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000048" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">836</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000049" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,262</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000050" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111434241" name="lfwd:IntangibleAssetsNonCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,525</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111441762" name="lfwd:IntangibleAssetsNonCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111454400" name="us-gaap:Goodwill" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,538</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111513656" name="us-gaap:Goodwill" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total long-term assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000051" name="us-gaap:AssetsNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,970</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000052" name="us-gaap:AssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,726</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000053" name="us-gaap:Assets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,192</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000054" name="us-gaap:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,236</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
    <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
      <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;4</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </div>
    </div>
    <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">REWALK ROBOTICS LTD. AND SUBSIDIARIES</span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED BALANCE SHEETS</span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands (except share and per share data)</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CURRENT LIABILITIES:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade payables</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000057" name="us-gaap:AccountsPayableCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,069</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000058" name="us-gaap:AccountsPayableCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,950</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000059" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,034</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000060" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,282</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenue</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000061" name="us-gaap:DeferredRevenueCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,504</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000062" name="us-gaap:DeferredRevenueCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of operating leases liability</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000055" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,296</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000056" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">564</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout liability</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111531511" name="lfwd:EarnoutLiabilityCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">576</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111550304" name="lfwd:EarnoutLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000063" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000064" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">685</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000065" name="us-gaap:LiabilitiesCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,795</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000066" name="us-gaap:LiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,782</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LONG-TERM LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout liability</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111601459" name="lfwd:LongTermEarnoutLiability" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,716</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111618216" name="lfwd:LongTermEarnoutLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000067" name="us-gaap:DeferredRevenueNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,506</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000068" name="us-gaap:DeferredRevenueNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">890</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current operating leases liability</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000069" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">607</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000070" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000071" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000072" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total long-term liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000073" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,887</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000074" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,289</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000075" name="us-gaap:Liabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,682</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000076" name="us-gaap:Liabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,071</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COMMITMENTS AND CONTINGENT LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"><ix:nonFraction id="Fxbrl_20240223105824526" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20231231" unitRef="USD" xsi:nil="true"></ix:nonFraction></td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"><ix:nonFraction id="Fxbrl_20240223105831205" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20221231" unitRef="USD" xsi:nil="true"></ix:nonFraction></td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholders&#8217; equity:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share capital</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:17.3pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary share of NIS <ix:nonFraction id="Fxbrl_20230213172319680" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20221231" unitRef="NIS_per_Share" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000078" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20231231" unitRef="NIS_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.25</ix:nonFraction></ix:nonFraction> par value-Authorized: <ix:nonFraction id="Fxbrl_20230214053645228" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_0000000000079" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">120,000,000 </ix:nonFraction></ix:nonFraction>shares at December 31, 2023 and December 31, 2022; Issued: <ix:nonFraction id="Fxbrl_20230213112949242" name="us-gaap:CommonStockSharesIssued" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">64,132,706</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20230213112956319" name="us-gaap:CommonStockSharesIssued" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">63,023,506</ix:nonFraction> shares at December 31, 2023 and December 31, 2022, respectively; Outstanding: <ix:nonFraction id="Fxbrl_20230214055452653" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">60,110,099</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20230213113027734" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">60,090,298</ix:nonFraction> shares as of December 31, 2023 and December 31, 2022 respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000085" name="us-gaap:CommonStockValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,487</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000086" name="us-gaap:CommonStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,489</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional paid-in capital</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000087" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281,109</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000088" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">279,857</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury Shares at cost, <ix:nonFraction id="Fxbrl_20230214105901072" name="us-gaap:TreasuryStockCommonShares" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,022,607</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20240223105714719" name="us-gaap:TreasuryStockCommonShares" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,933,208</ix:nonFraction> ordinary shares at December 31, 2023 and December 31, 2022, respectively</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213111754081" name="us-gaap:TreasuryStockCommonValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,203</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213111801774" name="us-gaap:TreasuryStockCommonValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,431</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000089" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">235,883</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000090" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">213,750</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total shareholders&#8217; equity</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000091" name="us-gaap:StockholdersEquity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,510</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000092" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,165</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities and shareholders&#8217; equity</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000093" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,192</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000094" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,236</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    <div style="line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;5</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REWALK ROBOTICS LTD. AND SUBSIDIARIES</span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF OPERATIONS<span id="STATEMENTSOFOPERATIONS_integixAnchor"></span></span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands (except share and per share data)</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000095" name="us-gaap:Revenues" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,854</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000096" name="us-gaap:Revenues" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,511</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000097" name="us-gaap:Revenues" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,966</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000098" name="us-gaap:CostOfRevenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,401</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000099" name="us-gaap:CostOfRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,606</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000100" name="us-gaap:CostOfRevenue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,063</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross profit</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000101" name="us-gaap:GrossProfit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,453</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000102" name="us-gaap:GrossProfit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,905</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000103" name="us-gaap:GrossProfit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,903</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating expenses:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000104" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,148</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000105" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,031</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000106" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,939</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales and marketing</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000107" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,922</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000108" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,842</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000109" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,993</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000110" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,995</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000111" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,134</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000112" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,626</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating expenses</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000113" name="us-gaap:OperatingExpenses" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,065</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000114" name="us-gaap:OperatingExpenses" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,007</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000115" name="us-gaap:OperatingExpenses" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,558</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000116" name="us-gaap:OperatingIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">23,612</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000117" name="us-gaap:OperatingIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,102</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000118" name="us-gaap:OperatingIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,655</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial income, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213115913875" name="lfwd:FinancialExpensesIncomeNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,467</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213115503054">*</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000121" name="lfwd:FinancialExpensesIncomeNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before income taxes</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223105404398" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,145</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000123" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,102</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000124" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,642</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income (benefit)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000125" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000126" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">467</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000127" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000128" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,133</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000129" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,569</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000130" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,736</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per ordinary share, basic and diluted</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240225004900065" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20230101to20231231" unitRef="NIS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240225004814776" name="us-gaap:EarningsPerShareBasic" contextRef="C_20230101to20231231" unitRef="NIS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.37</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240225004929118" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20221231" unitRef="NIS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240225004830611" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20221231" unitRef="NIS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.31</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240225004938878" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20211231" unitRef="NIS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240225004840147" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20211231" unitRef="NIS_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.27</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average number of shares used in computing net loss per ordinary share, basic and diluted</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240225004700425" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240225004604120" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">59,719,064</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240225004710111" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240225004635413" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">62,378,797</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240225004722287" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240225004640323" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">47,935,652</ix:nonFraction></ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)&#160; &#160; &#160; &#160; &#160; Represents an amount lower than $1.</span></span></div>
    <div style="line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;6</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REWALK ROBOTICS LTD. AND SUBSIDIARIES</span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY<span id="EQUITY_integixAnchor"></span></span></span></div>
    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands (except share data)</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary Share</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional</span></span></div>
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">paid-in</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">shareholders&#8217;</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
            <div style="line-height:1.25">&#160;</div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amount</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">capital</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">equity</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000172" name="us-gaap:SharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">25,332,225</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000173" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,827</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000174" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201,392</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045239675" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000175" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">181,445</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000176" name="us-gaap:StockholdersEquity" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,774</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation to employees and non-employees</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050536515" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000177" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">833</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045253195" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045737411" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000178" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">833</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000179" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">398,164</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000180" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000181" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045308210" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045808051" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050245787" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares in a &#8220;Best Efforts&#8221; offering, net of issuance expenses in the amount of $<ix:nonFraction id="FFact_0000000000183" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdBestOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,679</ix:nonFraction> (1)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000184" name="lfwd:StockIssuedDuringPeriodSharesOrdinaryShares1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,921,502</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000185" name="lfwd:StockIssuedDuringPeriodValueOrdinaryShares1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">832</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000186" name="lfwd:StockIssuedDuringPeriodValueOrdinaryShares1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,489</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045317130" name="lfwd:StockIssuedDuringPeriodValueOrdinaryShares1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045815626" name="lfwd:StockIssuedDuringPeriodValueOrdinaryShares1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000188" name="lfwd:StockIssuedDuringPeriodValueOrdinaryShares1" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,321</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of pre-funded warrants and warrants (1)(2)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000189" name="lfwd:ExerciseOfPreFundedWarrantsAndWarrantsShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,425,258</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000190" name="lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">772</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000191" name="lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,288</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045324826" name="lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045824098" name="lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000193" name="lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,060</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $<ix:nonFraction id="FFact_0000000000194" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,215</ix:nonFraction> (1)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000195" name="lfwd:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">15,403,014</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000196" name="lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,199</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000197" name="lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,932</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045336466" name="lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045840938" name="lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000199" name="lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,131</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050511427" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050505475" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045359925" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000206" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,736</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000207" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,736</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000209" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,480,163</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000210" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,661</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045413642" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">278,903</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000211" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">194,181</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000212" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,383</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation to employees and non-employees</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050446027" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000213" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">993</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045421561" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045934986" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000214" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">993</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000215" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">543,343</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000216" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000217" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">39</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045431322" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045952457" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050231003" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares at cost</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223111257860_xbrl_20230213144339403" name="us-gaap:TreasuryStockSharesAcquired" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal" sign="-">2,933,208</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223111257860_xbrl_20230213144442451" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">211</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111257860_xbrl_20230214050313843" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223111257860_xbrl_20230213144626406" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,431</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223111257860_xbrl_20230214050051930" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223111257860_xbrl_20230213150705871" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,642</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;padding-bottom:2px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050406195" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050421835" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045511674" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000236" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,569</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000237" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,569</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223110903813" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">60,090,298</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000239" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,489</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000240" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">279,857</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230214045521729" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,431</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000241" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">213,750</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000242" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,165</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation to employees and non-employees</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050343571" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213143856752" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,328</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045531002" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050031882" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213143813750_Fact_0000000000178" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,328</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213144043463_Fact_0000000000179" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,109,200</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213144043463_Fact_0000000000180" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144043463_Fact_0000000000181" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">76</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214045547258" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050042386" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050217259" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares at cost</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144339403" name="us-gaap:TreasuryStockSharesAcquired" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal" sign="-">1,089,399</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144442451" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">78</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050313843" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144626406" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">772</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214050051930" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213150705871" name="lfwd:Sharesissuedduringperiodvaluetreasurystock" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">850</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230221161452108" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230221161500959" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230221161507919" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144102938_Fact_0000000000236" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,133</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144102938_Fact_0000000000237" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,133</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:28%;padding-bottom:4px;vertical-align:bottom">
            <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2023</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213144150665_Fact_0000000000238" name="us-gaap:SharesOutstanding" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">60,110,099</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213144150665_Fact_0000000000239" name="us-gaap:StockholdersEquity" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,487</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213144150665_Fact_0000000000240" name="us-gaap:StockholdersEquity" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281,109</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213150722524" name="us-gaap:StockholdersEquity" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,203</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213144150665_Fact_0000000000241" name="us-gaap:StockholdersEquity" contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">235,883</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213144150665_Fact_0000000000242" name="us-gaap:StockholdersEquity" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,510</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) </span></span><span style="padding-left:20pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See Note 9a.</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2) </span></span><span style="padding-left:20pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See Note 9f.</span></span></div>
    <div style="line-height:1.25">&#160;</div>
    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these consolidated financial statements.</span></span></div>
    <div style="line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;7</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <div style="line-height:1.25;font-weight:bold">REWALK ROBOTICS LTD. AND SUBSIDIARIES</div>
  <div style="line-height:1.25;font-weight:bold">CONSOLIDATED STATEMENTS OF CASH FLOWS<span id="FCASHFLOWS_integixAnchor"></span></div>
  <div style="line-height:1.25;font-weight:bold">U.S. dollars in thousands</div>
  <div style="line-height:1.25">&#160;</div>
  <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

      <tr>
        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
          <div style="line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">Year ended December 31,</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
          <div style="line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">2023</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">2022</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash flows used in operating activities:</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Net loss</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000243" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,133</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">)</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000244" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,569</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000245" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,736</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Adjustments to reconcile net loss to net cash used in operating activities:</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Depreciation</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000246" name="us-gaap:Depreciation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000247" name="us-gaap:Depreciation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">202</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000248" name="us-gaap:Depreciation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">266</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Amortization of intangible assets</p>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><ix:nonFraction id="Fxbrl_20240227143628290" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,608</ix:nonFraction></p>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><ix:nonFraction id="Fxbrl_20240227143636963" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)"><ix:nonFraction id="Fxbrl_20240227143654356" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Share-based compensation</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000249" name="us-gaap:ShareBasedCompensation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,328</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000250" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">993</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000251" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">833</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Deferred taxes</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000252" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000253" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">316</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000254" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">29</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Remeasurement of earnout liability</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20240223123422747_Fact_0000000000252" name="lfwd:EarnOutRemeasured" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">315</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123422747_Fact_0000000000253" name="lfwd:EarnOutRemeasured" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123422747_Fact_0000000000254" name="lfwd:EarnOutRemeasured" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Interest income</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20240223123424851_Fact_0000000000252" name="us-gaap:InterestIncomeExpenseNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123424851_Fact_0000000000253" name="us-gaap:InterestIncomeExpenseNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123424851_Fact_0000000000254" name="us-gaap:InterestIncomeExpenseNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Exchange rate fluctuations</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20240223123426651_Fact_0000000000252" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">45</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123426651_Fact_0000000000253" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123426651_Fact_0000000000254" name="us-gaap:ForeignCurrencyTransactionLossBeforeTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Changes in assets and liabilities:</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Trade receivables, net</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213132603222" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;padding-bottom:0px;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000259" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">408</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000260" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">99</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Prepaid expenses, operating lease right-of-use assets and other assets</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000261" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">531</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000262" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">94</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000263" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">592</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Inventories</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213132623934" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">277</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000265" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000266" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">432</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Trade payables</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000267" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,037</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000268" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">566</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213151537465" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">884</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Employees and payroll accruals</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000270" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000271" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000272" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">275</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Deferred revenues</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213132658787" name="us-gaap:IncreaseDecreaseInDeferredLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">269</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;padding-bottom:1pt;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000274" name="us-gaap:IncreaseDecreaseInDeferredLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">34</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000275" name="us-gaap:IncreaseDecreaseInDeferredLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Operating lease liabilities and other liabilities</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000276" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">973</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213151613737" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">153</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000278" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">391</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Net cash used in operating activities</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000279" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,667</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000280" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,891</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000281" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,469</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash flows used in investing activities:</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Acquisition of a business, net of cash acquired</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20240223123430355_Fact_0000000000252" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,068</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123430355_Fact_0000000000253" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123430355_Fact_0000000000254" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Purchase of property and equipment</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000282" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000283" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000284" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Net cash used in investing activities</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000285" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18,149</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000286" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">25</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000287" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">47</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">)</div>
        </td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash flows from financing activities:</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount of $<ix:nonFraction id="FFact_0000000000318" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,679</ix:nonFraction> (1)</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213231158622" name="lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213124756646" name="lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213231152958" name="lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,321</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $<ix:nonFraction id="FFact_0000000000322" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,215</ix:nonFraction> (1)</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213231215958" name="lfwd:ProceedsFromIssuanceOfRegistrationCostTwo" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213124808685" name="lfwd:ProceedsFromIssuanceOfRegistrationCostTwo" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213231209903" name="lfwd:ProceedsFromIssuanceOfRegistrationCostTwo" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,131</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Exercise of pre-funded warrants and warrants (1)(2)</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213133255195" name="lfwd:ExerciseOfPreFundedWarrants" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000327" name="lfwd:ExerciseOfPreFundedWarrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000328" name="lfwd:ExerciseOfPreFundedWarrants" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,060</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Purchase of treasury shares</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213132126265" name="lfwd:PaymentsForPurchaseOfTreasuryStock" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">992</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213153846345" name="lfwd:PaymentsForPurchaseOfTreasuryStock" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,500</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213153904715" name="lfwd:PaymentsForPurchaseOfTreasuryStock" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Net cash (used in) provided by financing activities</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213152442041" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">992</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000330" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,500</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000331" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,512</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213133113041" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213154813996" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">79</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213154824814" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Increase (decrease) in cash, cash equivalents, and restricted cash</div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="Fxbrl_20230213152756011" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">39,763</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">(<ix:nonFraction id="FFact_0000000000333" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,495</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">)</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000334" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67,996</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(255, 255, 255)">
        <td style="width:64%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash, cash equivalents, and restricted cash at beginning of period</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000335" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,555</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000336" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,050</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">&#160;</td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(255, 255, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230221200509741" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,054</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255)">&#160;</td>
      </tr>
      <tr style="background-color:rgb(204, 238, 255)">
        <td style="width:64%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash, cash equivalents, and restricted cash at end of period</div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123504369" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,792</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000339" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,555</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
        <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom;background-color:rgb(204, 238, 255)">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000340" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,050</ix:nonFraction></div>
        </td>
        <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)">&#160;</td>
      </tr>

  </table>
  <div style="line-height:1.25">&#160;</div>
  <div style="line-height:1.25">
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) &#160; &#160; &#160; &#160; &#160;See Note 9a.</span></span></p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2) &#160; &#160; &#160; &#160; &#160;See Note 9f.</span></span></p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
  </div>
  <div style="line-height:1.25">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="line-height:1.25">
    <p style="margin:0pt">&#160;</p>
    <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;8</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  </div>
  <div style="line-height:1.25;font-weight:bold">REWALK ROBOTICS LTD. AND SUBSIDIARIES</div>
  <div style="line-height:1.25;font-weight:bold">CONSOLIDATED STATEMENTS OF CASH FLOWS</div>
  <div style="line-height:1.25;font-weight:bold">U.S. dollars in thousands</div>
  <div style="line-height:1.25">&#160;</div>
  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

      <tr>
        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
          <div style="line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">Year ended December 31,</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
          <div style="line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">2023</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">2022</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
          <div style="text-align:center;line-height:1.25;font-weight:bold">2021</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;vertical-align:bottom">
          <div style="line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25;font-weight:bold">Supplemental disclosures of non-cash flow information</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Classification of other current assets to property and equipment, net</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000344" name="lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000345" name="lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213231847568" name="lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Classification of inventory to property and equipment</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000350" name="lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">481</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000351" name="lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000352" name="lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Amounts related to shares re-purchase not yet paid</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123437986_Fact_0000000000252" name="lfwd:PaymentToRepurchaseOfShares" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123437986_Fact_0000000000253" name="lfwd:PaymentToRepurchaseOfShares" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">142</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123437986_Fact_0000000000254" name="lfwd:PaymentToRepurchaseOfShares" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">ROU assets obtained from new lease liabilities</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123440530_Fact_0000000000252" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">513</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123440530_Fact_0000000000253" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20240223123440530_Fact_0000000000254" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25;font-weight:bold">Supplemental disclosures of cash flow information:</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash paid for income taxes</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000371" name="us-gaap:IncomeTaxesPaid" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000372" name="us-gaap:IncomeTaxesPaid" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">113</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000373" name="us-gaap:IncomeTaxesPaid" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash received from interest</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213160047968" name="lfwd:InterestReceived" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,341</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000375" name="lfwd:InterestReceived" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="FFact_0000000000376" name="lfwd:InterestReceived" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25;font-weight:bold">Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flows</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Cash and cash equivalents</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213133556489" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,083</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213133605897" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67,896</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134422132" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88,337</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Restricted cash included in other long-term assets</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134447328" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">709</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134505203" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">659</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134516052" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">713</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>
      <tr>
        <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
          <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">Total Cash, cash equivalents, and restricted cash</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134525739" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,792</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134555684" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,555</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25">$</div>
        </td>
        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
          <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230213134626502" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89,050</ix:nonFraction></div>
        </td>
        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
      </tr>

  </table>
  <div style="line-height:1.25">&#160;</div>
  <div style="line-height:1.25">
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) &#160; &#160; &#160; &#160; &#160;See Note 9a.</span></span></p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2) &#160; &#160; &#160; &#160; &#160;See Note 9f.</span></span></p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
  </div>
  <div style="line-height:1.25">The accompanying notes are an integral part of these consolidated financial statements.</div>
  <div style="line-height:1.25">
    <p style="margin:0pt">&#160;</p>
    <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;9</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  </div>
</div><div style="">
  <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>REWALK ROBOTICS LTD. AND SUBSIDIARIES</strong></span></span><br/><span id="Note_integixAnchor"><span><span><strong>Notes to Consolidated Financial Statements</strong></span></span></span><br/><span><span><strong>U.S. dollars in thousands</strong></span></span></span></span></p>
  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  <ix:nonNumeric id="FFact_0000000000377" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:72pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 1:-</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>GENERAL</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>ReWalk Robotics Ltd. (&#8220;RRL&#8221;, and together with its subsidiaries, the &#8220;Company&#8221;) was incorporated under the laws of the State of Israel on June 20, 2001 and commenced operations on the same date.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>RRL has three wholly-owned (directly and indirectly) subsidiaries: (i) ReWalk Robotics, Inc. (&#8220;RRI&#8221;) incorporated under the laws of Delaware on February 15, 2012, (ii) ReWalk Robotics GMBH (&#8220;RRG&#8221;) incorporated under the laws of Germany on January 14, 2013, and (iii) AlterG, Inc. (&#8220;AlterG&#8221;) incorporated in Delaware on October 21, 2004 under the name of Gravus, Inc. On June 30, 2005, the Company re-incorporated in Delaware and changed its name to AlterG, Inc. in September 2005.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company is a medical device company that is designing, developing, and commercializing innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions. The Company&#8217;s initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury (collectively, the &#8220;SCI Products&#8221;). These devices are robotic exoskeletons that are designed for individuals with paraplegia that use the Company&#8217;s patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. These SCI Products allow individuals with spinal cord injury the ability to stand and walk again during everyday activities at home or in the community.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has sought to expand the product offerings beyond the SCI Products through internal development and distribution agreements. The Company has developed its ReStore Exo-Suit device, which it began commercializing in June 2019. The ReStore is a powered, lightweight soft exo-suit intended for use during the rehabilitation of individuals with lower limb disability due to stroke. During the second quarter of 2020, the Company signed two separate agreements to distribute additional product lines in the United States. The Company is the exclusive distributor of the MYOLYN MyoCycle FES Pro cycles to United States (&#8220;U.S.&#8221;) rehabilitation clinics and for the MyoCycle Home cycles available to US veterans through VA hospitals. In the second quarter of 2020, the Company also became the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States; however, due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023. We refer to the MediTouch and MyoCycle devices as the Company&#8217;s &#8220;Distributed Products.&#8221;</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On August 11, 2023, pursuant to an Agreement and Plan of Merger among RRI, AlterG, Atlas Merger Sub, Inc., a wholly owned subsidiary of RRI (&#8220;Merger Sub&#8221;), and Shareholder Representative Services LLC, dated August 11, 2023, RRI acquired AlterG and AlterG became a wholly owned subsidiary of the Company.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For accounting purposes, RRI was considered the acquirer and AlterG was considered the acquiree. The acquisition was accounted for using the acquisition method of accounting. See Note 5 for additional information.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company made its first acquisition to supplement its internal growth when it acquired AlterG, a leading provider of AlterG Anti-Gravity systems for use in physical and neurological rehabilitation. &#160;The Company paid a cash purchase price of $19.0 million at closing and additional cash earnouts may be paid based upon a percentage of AlterG&#8217;s year-over-year revenue growth over the two years following the closing. The AlterG Anti-Gravity systems use patented, NASA-derived Differential Air Pressure (&#8220;DAP&#8221;) technology to reduce the effects of gravity and allow people to rehabilitate with finely calibrated support and reduced pain. &#160;The Company will continue to evaluate other products for distribution or acquisition that can broaden its product offerings further to help individuals with physical and neurological injury and disability.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company markets and sells its products directly to institutions and individuals and through third-party distributors. The Company sells its products directly primarily in the United States, through a combination of direct sales and distributors (depending on the product line) in Germany, Canada, and Australia, and primarily through distributors in other markets. In its direct markets, the Company has established relationships with clinics and rehabilitation centers, professional and college sports teams, and individuals and organizations in the spinal cord injury community, and in its indirect markets, the Company&#8217;s distributors maintain these relationships. RRI and AlterG market and sell products mainly in the United States. RRG markets and sells the Company&#8217;s products mainly in Germany and Europe.</span></span></span></span></div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25">
              <div><ix:exclude>
                <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;10</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </ix:exclude></div>
            </div>
            <div style="text-align:justify;line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>d.</span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company depends on one contract manufacturer to manufacture the ReWalk and the ReStore products in its portfolio, Sanmina. Reliance on this vendor makes the Company vulnerable to possible capacity constraints and reduces control over component availability, delivery schedules, manufacturing yields and costs.</span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">
              <div style="text-align:justify;line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>For the full year ended December 31, 2023 the Company incurred a consolidated net loss of $<ix:nonFraction id="Fxbrl_20230213110552606" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">22.1</ix:nonFraction> million and has an accumulated deficit in the total amount of $<ix:nonFraction id="Fxbrl_20230213110606448" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">235.9</ix:nonFraction> million. The Company&#8217;s negative operating cash flow for the full year ended December 31, 2023 was $<ix:nonFraction id="Fxbrl_20230213110610952" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal" sign="-">20.7</ix:nonFraction> million. Our cash and cash equivalent on December 31, 2023 totalled $<ix:nonFraction id="Fxbrl_20230213110614536" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">28.1</ix:nonFraction> million. The Company has sufficient funds to support its operation for more than 12 months following the approval of its consolidated financial statements for the fiscal year ended December 31, 2023.</span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company expects to incur future net losses and the transition to profitability is dependent upon, among other things, the successful development and commercialization of the Company&#8217;s products and product candidates, the establishment of contracts for the distribution of new product lines, or the acquisition of additional product lines, any of which, or in combination, would contribute to the achievement of a level of revenue adequate to support the cost structure. Until the Company achieves profitability or generates positive cash flows, it will continue to need to raise additional cash. The Company intends to fund future operations through existing cash on hand, additional private and/or public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, the Company may seek additional capital through arrangements with strategic partners or from other sources and will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.</span></span></span></span></span></span></div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240224171306811" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:72pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2:-</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SIGNIFICANT ACCOUNTING POLICIES</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;), applied on a consistent basis, as follows:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000378" name="us-gaap:UseOfEstimates" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt;vertical-align:top">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of Estimates</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions. The Company&#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company&#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards, contingent liabilities, provision for warranty, allowance for credit losses and sales return reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000379" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial Statements in U.S. Dollars:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The functional currency is the currency that best reflects the economic environment in which the Company and its subsidiaries operate and conduct their transactions. Most of the Company&#8217;s revenues and costs are incurred in U.S. dollar. In addition, the Company&#8217;s financing activities are incurred in U.S. dollars. The Company&#8217;s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#8217;s and its subsidiary's functional and reporting currency.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with ASC 830 &#8220;Foreign Currency Matters.&#8221; All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the consolidated statements of operations as financing income or expenses as appropriate.</span></span></div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p>
        <div><ix:exclude>
          <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;11</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
        </ix:exclude></div>
        <ix:nonNumeric id="FFact_0000000000380" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of Consolidation:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances have been eliminated upon consolidation.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000381" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash Equivalents:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000385" name="us-gaap:InventoryPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories are stated at the lower of cost or net realizable value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company periodically evaluates the quantities on hand relative to historical, current, and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its net realized value.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost is determined as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products - based on raw materials and manufacturing costs on an average basis.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials - The weighted average cost method.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value. If actual demand for the Company&#8217;s products deteriorates, or market conditions are less favourable than those projected, additional inventory reserves may be required.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20230213124352469" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and Equipment:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <ix:nonNumeric id="Fxbrl_20230214132735237" name="us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000390" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" format="ixt-sec:duryear">20</ix:nonNumeric>-<ix:nonNumeric id="FFact_0000000000391" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" format="ixt-sec:duryear">33</ix:nonNumeric> (mainly 33)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20231216125503382" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" format="ixt-sec:duryear">6</ix:nonNumeric> - <ix:nonNumeric id="FFact_0000000000393" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" format="ixt-sec:duryear">10</ix:nonNumeric> (mainly 10)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000394" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember" format="ixt-sec:duryear">15</ix:nonNumeric></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240224235531218" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember" format="ixt-sec:duryear">20</ix:nonNumeric>-<ix:nonNumeric id="FFact_0000000000395" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember" format="ixt-sec:duryear">50</ix:nonNumeric></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20240225015948429" name="lfwd:PropertyPlantAndEquipmentUsefulLifeDescription" contextRef="C_20230101to20231231">Over the shorter of the lease term </ix:nonNumeric></span></span></div>
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>or estimated useful life</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240224171937266" name="us-gaap:BusinessCombinationsPolicy" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Business Combinations</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for business combinations in accordance with ASC 805, &#8220;Business Combinations&#8221; (&#8220;ASC 805&#8221;). For business combinations accounted for under the acquisition method, ASC 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. The Company determines the recognition of intangible assets based on the following criteria: (i) the intangible asset arises from contractual or other rights; or (ii) the intangible asset is separable or divisible from the acquired entity and capable of being sold, transferred, licensed, returned or exchanged.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The excess of the fair value of the purchase price over the fair values of the identifiable assets and liabilities is recorded as goodwill. Determining the fair value of the identifiable assets and liabilities requires management to use significant judgment and estimates including the forecasted revenue and revenues growth rates, discount rates, customer contract renewal rates and customer attrition rates. The process of estimating the fair values requires significant estimates, especially with respect to intangible assets. Management&#8217;s determination of fair value of assets acquired and liabilities assumed at the acquisition date is based on the best information available in the circumstances and incorporates management&#8217;s own assumptions and involves a significant degree of judgment.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition related costs include legal fees, consulting and success fees, and other non-recurring integration related costs. Acquisition-related costs are expensed as incurred.</span></span></div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p>
        <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;12</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <ix:nonNumeric id="Fxbrl_20240224172000970" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill and Other Intangibles</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has no indefinite-lived intangible assets other than goodwill. Acquired identifiable finite-lived intangible assets include identifiable acquired technology, customer relationships, trademarks and backlog and are amortized on a straight-line basis over the estimated useful lives of the assets. The Company routinely reviews the remaining estimated useful lives of finite-lived intangible assets.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill is not amortized and is tested for impairment at least annually.</span></span></div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates as one reporting unit and the fair value of the reporting unit is estimated using quoted market prices of the Company&#8217;s stock in active markets. The Company tests goodwill for impairment annually in the fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When testing goodwill for impairment, the Company may first perform a qualitative assessment. If the Company determines it is not more likely than not the reporting unit&#8217;s fair value is less than its carrying value, then no further analysis is necessary. If the Company determines that it is more likely than not that the fair value of its reporting unit is less than its carrying amount, then the quantitative impairment test will be performed. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Under the quantitative impairment test, if the carrying amount of the Company&#8217;s reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, no impairments of goodwill have been recognized.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000402" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of Long-Lived Assets</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s long-lived assets, including right-of-use (&#8220;ROU&#8221;) assets and identifiable intangible assets that are subject to amortization, are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2023, 2022 and 2021, no impairment losses have been recorded.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000403" name="lfwd:RestrictedCashAndOtherLongTermAssets" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash and Other long-term assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20230213114516865" name="lfwd:TreasurySharesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company repurchased its ordinary shares and holds them as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction of shareholders' equity.</span></span></div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p>
        <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;13</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <div>
          <ix:nonNumeric id="Fxbrl_20240226182957243" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue Recognition:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to clinics and rehabilitation centres, professional and college sports teams, private individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), and distributors.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in accordance with ASC 606, &#8220;Revenue Recognition&#8221; when, or as, control of the promised good or service is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company applies the following five steps:</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the contract with a customer</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generally considers a purchase order or a signed quote to be a contract with a customer. In evaluating the contract with a customer, the Company analyzes the customer&#8217;s intent and ability to pay the amount of promised consideration (credit risk) and considers the probability of collecting substantially all of the consideration.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the performance obligations in the contract</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At a contract&#8217;s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determine the transaction price</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not offer extended payment terms beyond one year to customers.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocate the transaction price to performance obligations in the contract</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognize revenue when or as the Company satisfies a performance obligation</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control either transfers over time or at a point in time, which affects when revenue is recorded.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has elected to apply the practical expedient for financing component for transactions in which the difference between the payment date and the revenue recognition timing is up to 12 months.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disaggregation of Revenue (in thousands):</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:36pt">
                <ix:nonNumeric id="Fxbrl_20230214132800531" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175447534_Fact_0000000000410" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtProductOrServiceAxis_usgaapProductMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,681</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175447534_Fact_0000000000411" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtProductOrServiceAxis_usgaapProductMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,175</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175447534_Fact_0000000000412" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtProductOrServiceAxis_usgaapProductMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,916</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175449358_Fact_0000000000410" name="us-gaap:Revenues" contextRef="C_20230101to20231231_lfwdRevenueObligationAxis_lfwdRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,033</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175449358_Fact_0000000000411" name="us-gaap:Revenues" contextRef="C_20220101to20221231_lfwdRevenueObligationAxis_lfwdRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">859</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175449358_Fact_0000000000412" name="us-gaap:Revenues" contextRef="C_20210101to20211231_lfwdRevenueObligationAxis_lfwdRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">533</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranty</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175454398_Fact_0000000000410" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,140</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175454398_Fact_0000000000411" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">477</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224175454398_Fact_0000000000412" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">517</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000410" name="us-gaap:Revenues" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,854</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000411" name="us-gaap:Revenues" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,511</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000412" name="us-gaap:Revenues" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,966</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </ix:nonNumeric>
              </div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product revenue</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from Products is comprised of sale of Anti-Gravity products, sale of systems products to rehabilitation facilities and sale of ReWalk Personal Exoskeleton systems to end users. Revenues generated from the sale of Products are recognized at a point in time, once the customer has obtained the legal title to the items purchased.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For systems sold to rehabilitation facilities, the Company includes insignificant training and considers the elements in the arrangement to be a single performance obligation. Therefore, the Company recognizes revenue for the system only when control is transferred after delivery and when the training has been completed, in accordance with the agreements terms with the customer.</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                  <div><ix:exclude>
                    <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;14</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                  </ix:exclude></div>
                </div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For sales of ReWalk Personal Exoskeleton systems to end users, and for sales of ReWalk Personal or ReWalk Rehabilitation Exoskeleton systems to third party distributors, the Company does not provide training to the end user as this training is completed by the rehabilitation center or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generally does not grant a right of return for its products. In rare circumstances when the Company provides a right of return for its products. the Company records reductions to revenue for expected future product returns based on the Company&#8217;s historical experience and estimates.</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023, the Company offered six products: (1) ReWalk Personal Exoskeletons, (2) ReWalk Rehabilitation Exoskeleton, (3) ReStore, (4) AlterG Anti-Gravity systems, (5) MyoCycle and (6) MediTouch. Due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental revenue</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental revenue for the AlterG Anti-Gravity systems is accounted for under ASC Topic 842, Leases. The Company rents its products to customers for a fixed monthly fee over the rental term, which typically ranges from 2 to 3 years. Rental revenues are recorded as earned on a monthly basis. See Note 2x for additional information.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the SCI Products, the Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee for a limited period prior to selling its products.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranties</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company services its products after expiration of the initial warranty. Service revenue, consisting of time and materials to perform the repairs, is recorded as services are rendered.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determining the transaction price requires of level judgment, which is discussed by revenue category in further detail below.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranties are classified as either an assurance type or a service type warranty. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended for a limited period of time. An assurance type warranty is not accounted for as a separate performance obligation under the revenue model.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SCI Products include a <span style="-sec-ix-hidden:Fxbrl_20230214112251731"> five -year warranty</span>. The first <ix:nonNumeric id="Fxbrl_20230213113636337" name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="C_20231231_srtProductOrServiceAxis_lfwdReStoreProductMember" format="ixt-sec:durwordsen"> two years</ix:nonNumeric> are considered as an assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. A service type warranty is either sold with a unit or separately for a unit for which the warranty has expired. A service type warranty is accounted as a separate performance obligation and revenue is recognized ratably over the life of the warranty.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The ReStore device is sold with a two-year warranty which is considered as assurance type warranty.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Distributed Products are sold with assurance type warranty ranging between three years to ten years, depending on the specific product and part.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">or AlterG Anti-Gravity Products, the Company offers customers extended warranty contracts that extend or enhance the technical support, parts, and labor coverage offered as part of the base warranty included with the Anti-Gravity system products. Extended warranty revenue is recognized ratably over the extended warranty coverage period. The Company offers a one-year assurance type warranty to customers in the U.S. and two years assurance type warranty for spare parts only to its international distributors. For these products, the Company determines standalone selling price based on the price at which the performance obligation is sold separately.</span>
                <p style="margin:0pt">&#160;</p>
              </div>
              <div style="line-height:1.25">
                <div><ix:exclude>
                  <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;15</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                </ix:exclude></div>
              </div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract balances (in thousands):</span></span></div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20230214132841000" name="lfwd:ScheduleOfContractBalancesTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <div style="margin-left:36pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivable, net of credit losses (1)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000416" name="us-gaap:AccountsReceivableNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,120</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000417" name="us-gaap:AccountsReceivableNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,036</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues (1) (2)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000418" name="us-gaap:DeferredRevenue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,010</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000419" name="us-gaap:DeferredRevenue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,191</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance presented net of unrecognized revenue that was not yet collected.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="Fxbrl_20230213113701196" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">435</ix:nonFraction> thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenue which represent a contract liability, include unearned amounts related to service type warranty obligations as well as other advances and payments which the Company received from customers prior to satisfying the performance obligation, for which revenue has not yet been recognized. The Company's unearned performance obligations as of December 31, 2023 and <ix:nonNumeric id="Fxbrl_20240225002529864" name="lfwd:RevenueRecognitionRecognized" contextRef="C_20230101to20231231">the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.</ix:nonNumeric></span></span></div>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20230214154625382" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounting for Share-Based Compensation:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for share-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#8220;OPM&#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s consolidated statements of operations.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company account for forfeitures as they occur.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility is calculated based on actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options, or based on certain peer companies that the Company considered to be comparable, in case there is no sufficient trading volume to rely on market volatility. The expected option term is determined based on the simplified method, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of Restricted Stock Units (&#8220;RSUs&#8221;) granted is determined based on the price of the Company&#8217;s ordinary shares on the date of grant.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for options granted to consultants and other service providers under ASC 718. The fair value of these options was estimated using a Black-Scholes-Merton option-pricing model.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25;margin-left:18pt">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000436" name="lfwd:ClassOfWarrantOrRightPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants to Acquire Ordinary Shares:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the twelve -month ended December 31, 2021, the Company issued warrants to acquire up to <ix:nonFraction id="Fxbrl_20240225001203400" name="us-gaap:WarrantsAndRightsOutstanding" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,083,611</ix:nonFraction> ordinary shares. There were no issued warrants during the twelve months ended December 31, 2023 and 2022. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815 "Derivatives and Hedging" and determined that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 9f for additional information.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000437" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and Development Costs:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the Company received for research and development in the period in which the grant was received.</span></span></div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p>
        <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;16</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <ix:nonNumeric id="FFact_0000000000439" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">p.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income Taxes</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its taxes on income. As of December 31, 2023, and 2022, the Company did not identify any significant uncertain tax positions.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000445" name="us-gaap:StandardProductWarrantyPolicy" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty provision:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For assurance-type warranty, the Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <ix:nonNumeric id="Fxbrl_20230214132919102" name="lfwd:ScheduleOfWarrantyProvisionTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US Dollars</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000440" name="lfwd:WarrantyProvisionBalance" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG acquisition &#8211; see note 5</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181155550_xbrl_20231114052336091" name="lfwd:BusinessCombinationRecognizedWarrantProvision" contextRef="C_20230101to20230930" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">535</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000441" name="lfwd:AmountOfWarrantProvision" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Usage</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000442" name="lfwd:AmountOfWarrantProvisionUsage" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">479</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000443" name="lfwd:WarrantyProvisionBalance" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">348</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000471" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">r.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of Credit Risks:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution. The bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration exists with respect to these deposits.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The below table reflects the concentration of credit risk for the Company&#8217;s current customers as of December 31, 2023, to which substantial sales were made.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230214132947301" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" contextRef="C_20230101to20231231" escape="true">
              <div>
                <div style="margin-left:36pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000446">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213122412367" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">27</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000448">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213122431177" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer C</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000450" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" unitRef="pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213122445435" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer D</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000452" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" unitRef="pure" scale="-2" decimals="2" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213122457908" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></div>
                      </td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">
              <div><ix:exclude>
                <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;17</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </ix:exclude></div>
            </div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance for credit losses is based on the Company's assessments of factors that may affect a customer's ability to pay. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current customer's aging balance, the nature and size of the customer, the financial condition of the customer, and the amount of any receivables in dispute. The Company does not have any off-balance sheet credit exposure related to its customers. As of December 31, 2023, and 2022 trade receivables are presented net of $<ix:nonFraction id="Fxbrl_20230213123241844" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">328</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230213123248078" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction> thousand allowance for credit losses, respectively.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000476" name="us-gaap:PostemploymentBenefitPlansPolicy" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">s.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued Severance Pay:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. All of the employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#8220;section 14&#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of <ix:nonFraction id="FFact_0000000000472" name="lfwd:SeverancePayMonthlyDepositByEmployeesPercentage" contextRef="C_20230101to20231231" unitRef="pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.33</ix:nonFraction>% of their monthly salary, made in their name with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Company&#8217;s expenses related to severance pay amounted to $<ix:nonFraction id="Fxbrl_20230213123343796" name="us-gaap:PostemploymentBenefitsPeriodExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114</ix:nonFraction> thousand , $<ix:nonFraction id="Fxbrl_20230213123352196" name="us-gaap:PostemploymentBenefitsPeriodExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">113</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230213123357469" name="us-gaap:PostemploymentBenefitsPeriodExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">104</ix:nonFraction> thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000477" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Measurements:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company uses a three -tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The three -tiers are defined as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 1. </span>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 2. </span>Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 3. </span>Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such instruments.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables present information about the Company&#8217;s financial assets and liabilities that are measured in fair value on a recurring basis as of December 31, 2023 and December 31, 2022 (in thousands):</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20231114040807672" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" contextRef="C_20230101to20231231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements as of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Hierarchy</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial assets:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208242_xbrl_20231114040301156" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20230930_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,550</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208242_xbrl_20231114040321655" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury bills included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208246_xbrl_20231114040337583" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20230930_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,525</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208246_xbrl_20231114040352540" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Assets Measured at Fair Value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208251_xbrl_20231114163536004" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20230930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,075</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208251_xbrl_20231114163644690" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial Liabilities:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208254_xbrl_20231114040456623_xbrl_20231114040301156" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_20230930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,292</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208254_xbrl_20231114040456623_xbrl_20231114040321655" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities measured at fair value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208257_xbrl_20231114040551803_xbrl_20231114040456623_xbrl_20231114040301156" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,292</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181208257_xbrl_20231114040551803_xbrl_20231114040456623_xbrl_20231114040321655" name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">
              <div><ix:exclude>
                <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;18</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </ix:exclude></div>
            </div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies cash equivalents within Level 1, because the Company uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair values.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The earnout was valued using a Monte Carlo simulation analysis, which is considered to be a Level 3 fair value measurement.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the earnout liability activity as of December 31, 2023 (in thousands):</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <ix:nonNumeric id="Fxbrl_20231114043103809" name="lfwd:ScheduleOfWarrantsLiabilityActivityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:85.4%;vertical-align:top">&#160;</td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial Measurement (August 11, 2023)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181228922_xbrl_20231114042729572" name="lfwd:WarrantsLiabilityActivity" contextRef="C_20230811_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,607</ix:nonFraction></span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in fair value</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224181228923_xbrl_20231114042843938" name="lfwd:ChangeInFairValueOfWarrantsLiabilityActivity" contextRef="C_20230812to20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">315</ix:nonFraction>)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December 31, 2023</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224181234367_xbrl_20231114042759943" name="lfwd:WarrantsLiabilityActivity" contextRef="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,292</ix:nonFraction></span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </ix:nonNumeric>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="FFact_0000000000491" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="text-align:justify;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">u.<span style="padding-left:7pt">&#160;</span>Basic and Diluted Net Loss Per Share:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted loss per share is computed based on the weighted average number of ordinary shares outstanding during the period, plus dilutive potential shares considered outstanding during the period.</span></span></div>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000492" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.<span style="padding-left:8pt">&#160;</span>Contingent liabilities</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for its contingent liabilities in accordance with ASC 450, &#8220;Contingencies.&#8221; A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="FFact_0000000000499" name="lfwd:GovernmentGrantsPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.<span style="padding-left:8pt">&#160;</span>Government grants</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalty and non-royalty-bearing grants from the Israeli Innovation Authority (the &#8220;IIA&#8221;) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a reduction from research and development expenses (see Note 8c).</span></span></div>
          </div>
        </ix:nonNumeric>
        <p style="margin:0pt">&#160;</p>
        <div style="line-height:1.25">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;19</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <ix:nonNumeric id="FFact_0000000000500" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x.<span style="padding-left:8pt">&#160;</span>Leases</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating lease liabilities and their corresponding right-of-use assets are recorded at commencement date based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items, such as initial direct costs paid or incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </span></span></div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lessor accounting - Operating leases</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A portion of the AlterG rental revenues for the AlterG Anti-Gravity systems are made through lease arrangements.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG products are available for lease agreements ranging from <ix:nonNumeric id="Fxbrl_20240225003637472" name="lfwd:LeaseAgreementsTerm" contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember" format="ixt-sec:duryear">12</ix:nonNumeric> to <ix:nonNumeric id="Fxbrl_20240225003648971" name="lfwd:LeaseAgreementsTerm" contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember" format="ixt-sec:duryear">42</ix:nonNumeric> months. If the customer terminates the contract during the lease period, they are required to pay a cancellation fee. The lease period may be extended by an additional period as specified in the contract.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In determining the leases classification as a sales type or operating lease, the Company assesses, among other criteria: (i) the lease term to determine if it is for the major part of the economic life of the underlying equipment; and (ii) the present value of the lease payments to determine if they are equal to or greater than substantially all of the fair market value of the equipment at the inception of the lease AlterG Anti-Gravity systems. When these criteria are not met, the lease accounted for as operating leases and revenues are recognized over the term of the lease.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under these arrangements, when the Company acts as the lessor for its product line, the Company accounted for the lease arrangements as operating leases in accordance with ASC 842, &#8220;Lease&#8221; (&#8220;ASC 842&#8221;).</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total rental revenue for the AlterG Anti-Gravity Products has amounted to $<ix:nonFraction id="Fxbrl_20240225000541381" name="lfwd:RentalRevenueForAntiGravityProducts" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">249</ix:nonFraction> thousand from the time of acquisition through December 31, 2023.</span></span></div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20230214154904726" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">y. <span style="padding-left:20pt">&#160;</span>New Accounting Pronouncements</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recently Implemented Accounting Pronouncements</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td rowspan="1" style="width:13.57%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                      <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.&#160; &#160; &#160; &#160; &#160; &#160;Financial Instruments</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The Company adopted ASU 2016-13 as of January 1, 2023. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recent Accounting Pronouncements Not Yet Adopted</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:10%;vertical-align:top">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:6%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></div>
                  </td>
                  <td style="width:84%;vertical-align:top">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, &#8220;Income Taxes - Improvements to Income Tax Disclosures&#8221; requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impact of the adoption of this standard.</span></span></div>
                    <div style="text-align:justify;line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:10%;vertical-align:top">&#160;</td>
                  <td style="width:6%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii.</span></span></div>
                  </td>
                  <td style="width:84%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In&#160;November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, &#8220;Segment Reporting&#8221; on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </ix:nonNumeric>
      </div>
    </ix:nonNumeric>
    <p style="margin:0pt">&#160;</p>
    <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;20</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20230220102403022" name="lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div>
              <div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 3:-</span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of prepaid expenses and other current assets are as follows (in thousands):</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:36pt">
                  <ix:nonNumeric id="Fxbrl_20240223112912519" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000503" name="lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000504" name="lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000505" name="us-gaap:PrepaidExpenseCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,227</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000506" name="us-gaap:PrepaidExpenseCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">242</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to vendors</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000507" name="us-gaap:Supplies" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">139</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000508" name="us-gaap:Supplies" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">174</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000509" name="us-gaap:OtherAssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">747</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000510" name="us-gaap:OtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">152</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000511" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,366</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000512" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">649</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </ix:nonNumeric>
                </div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </div>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000000522" name="us-gaap:InventoryDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 4:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">INVENTORIES</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of inventories are as follows (in thousands):</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223113120447" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000515" name="us-gaap:InventoryFinishedGoods" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,157</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000516" name="us-gaap:InventoryFinishedGoods" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,421</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000517" name="us-gaap:InventoryRawMaterials" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,496</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000518" name="us-gaap:InventoryRawMaterials" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">508</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000519" name="us-gaap:InventoryNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,653</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000520" name="us-gaap:InventoryNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,929</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the twelve months ended December 31, 2023, 2022, and 2021, the Company recognized, at cost of revenues, reserves for excess and obsolete in the amount of $<ix:nonFraction id="Fxbrl_20230221162309076" name="us-gaap:InventoryWriteDown" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">398 </ix:nonFraction>thousand, $<ix:nonFraction id="Fxbrl_20230221162316072" name="us-gaap:InventoryWriteDown" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">502</ix:nonFraction> thousand, and $<ix:nonFraction id="Fxbrl_20230221162319494" name="us-gaap:InventoryWriteDown" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction> thousand, respectively.</span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;21</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20240224182510607" name="us-gaap:BusinessCombinationDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>NOTE 5:-</span></span><span style="padding-left:20pt">&#160;</span><span><span>BUSINESS COMBINATION</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>On August 11, 2023, pursuant to an Agreement and Plan of Merger among RRI, AlterG, Merger Sub, and Shareholder Representative Services LLC, RRI, August 8, 2023, the Company acquired AlterG and AlterG became a wholly owned subsidiary of the Company. AlterG develops, manufactures, and markets Anti-Gravity systems for use in physical and neurological rehabilitation and athletic training, both in the United States and internationally. The aggregate purchase price was a total of $<ix:nonFraction id="Fxbrl_20240226144531129" name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.0</ix:nonFraction> million in cash, subject to working capital and other customary purchase price adjustments. Additional cash earnouts may be paid based upon a percentage of AlterG&#8217;s year-over-year future revenue growth over the next two years subject to working capital and other customary purchase price adjustments.</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The total consideration transferred is as follows (in thousands):</span></span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240224182601790" name="us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224182938993" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,493</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Earnout payments</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224182949929" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,607</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Total consideration</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224182954721" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,100</ix:nonFraction></span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:-42.55pt;margin-left:81.8pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Earnout payments</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184906775" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription" contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember">The Company will pay an amount of cash equal to 65% of the amount, if any, by which </ix:nonNumeric><span>AlterG revenue attributable to the first 12 months period exceeds revenue target ("first earnout payment"), and an amount in cash equal to 65% of the amount, if any, by which AlterG revenue attributable to the following 12 months period exceeds the revenue from the first 12 month period ("second earnout payment").</span> At the date of acquisition, management estimated fair value of the earnout payment based on the actual up to date performance of the acquired entity and the probability of the earn out payment occurrence to be at approximately $<ix:nonFraction id="Fxbrl_20240224184726640" name="lfwd:EarnOutPaymentOfBusinessCombination" contextRef="C_20230801to20230808" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.6</ix:nonFraction> million. The Earn-out was accounted for as a liability and will be remeasured at each reporting period through the consolidated statement of operations.</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:0.05pt;margin-right:9.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company has accounted for the AlterG acquisition as a business combination. The Company has preliminarily allocated the purchase price of approximately $<ix:nonFraction id="Fxbrl_20240224184749536" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.1</ix:nonFraction> million fair values, and the excess of the purchase price over the aggregate fair values is recorded as goodwill.</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The following table summarizes the preliminary fair value of assets acquired and liabilities assumed as of the acquisition date (in thousands):</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240224182628575" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash and cash equivalent</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183401530" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">478</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Restricted cash</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183520314" name="lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accounts receivable</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183549200" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,773</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Inventory</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183553870" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,330</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Prepaid expenses and other current assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183558886" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">470</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Right of use asset</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183604087" name="lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,151</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Property and equipment, net</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183611030" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">827</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other non-current assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183615694" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Goodwill</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183624054" name="us-gaap:Goodwill" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,538</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Intangible assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183632919" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,133</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accounts payable</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224183638183" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,082</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accrued compensation</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224183642568" name="lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">766</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other accrued liabilities</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224183647143" name="lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,059</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred revenue</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224183651750" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,088</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Warranty Obligations</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224183656215" name="lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">535</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Leases Liability</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224183701927" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,151</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Total purchase consideration</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183709142" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,100</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <div><ix:exclude>
        <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;22</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </ix:exclude></div>
      <div>
        <div style="margin-left:36.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The following table presents the details of the intangible assets acquired at the date of AlterG acquisition (in thousands):</span></span></span></span></span></span></div>
      </div>
      <ix:nonNumeric id="Fxbrl_20240224182743126" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" contextRef="C_20230101to20231231" escape="true">
        <div>
          <div>&#160;</div>
          <div style="margin-left:36pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Estimated</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Estimated Useful Life</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair Value</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(Years)</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trademark</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224183951623" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">795</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184112372" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Technology</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184211659_xbrl_20240224183951623" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,161</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184211659_xbrl_20240224184112372" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember" format="ixt-sec:duryear">4</ix:nonNumeric></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Warranty</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184214674_xbrl_20240224183951623" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184214674_xbrl_20240224184112372" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember" format="ixt-sec:duryear">2</ix:nonNumeric></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Rental</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184216962_xbrl_20240224183951623" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,102</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184216962_xbrl_20240224184112372" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember" format="ixt-sec:duryear">4</ix:nonNumeric></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Distribution</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184218882_xbrl_20240224183951623" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,578</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184218882_xbrl_20240224184112372" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Backlog</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184220747_xbrl_20240224183951623" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonNumeric id="Fxbrl_20240224184220747_xbrl_20240224184112372" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember" format="ixt-sec:duryear">1</ix:nonNumeric></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </ix:nonNumeric>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.25pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Under the preliminary purchase price allocation, the Company allocates the purchase price to tangible and identified intangible assets acquired and liabilities assumed based on the preliminary estimates of their fair values. The fair values for the intangible assets acquired were primarily based on significant inputs that are not observable in the market and thus represent a Level 3 measurement in the fair value hierarchy. Customer relationships, distributor relationships, backlog, trademark and developed technology were valued using the income approach, based on estimated projections of expected cash flows to be generated by the assets, discounted to the present value at discount rates commensurate with perceived risk. The discounted cash flow analyses factor in assumptions on revenue and expense growth rates including estimates of customer growth and attrition rates, distributor growth and attrition rates, technology obsolescence, and relief from royalty projections. Additionally, these discounted cash flow analyses factor in expected amounts of working capital, fixed assets, assembled workforce and cost of capital for each intangible asset. Such estimates are subject to change during the measurement period which is not expected to exceed one year. Any adjustments to the preliminary purchase price allocation identified during the measurement period will be recognized in the period in which the adjustments are determined.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:38pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company incurred acquisition-related costs of $<ix:nonFraction id="Fxbrl_20240224184933783" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.5</ix:nonFraction> million included in General and administrative costs.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The table below presents the pro forma revenue and earnings of the combined business as if the acquisition had occurred as of January 1, 2022 (in thousands):</span></span></span></span></span></span></div>
      <div style="text-align:justify;margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
      <div style="margin-left:36pt">
        <ix:nonNumeric id="Fxbrl_20240224182826627" name="us-gaap:BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Twelve Months Ended</span></span></span></span></span></span></div>
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>December 31,</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:middle;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Revenues</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184418399" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,923</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><ix:nonFraction id="Fxbrl_20240224184425935" name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,307</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net loss</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224184435045" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">21,761</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(<ix:nonFraction id="Fxbrl_20240224184446635" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28,369</ix:nonFraction></span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </ix:nonNumeric>
      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.4pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The total revenues and net loss of AlterG, included in the consolidated income statement, since the acquisition date through December 31, 2023, amounted to <ix:nonFraction id="Fxbrl_20240224185017577" name="us-gaap:Revenues" contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,658</ix:nonFraction> thousand and <ix:nonFraction id="Fxbrl_20240224185042803" name="us-gaap:Revenues" contextRef="C_20230101to20231231_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">249</ix:nonFraction> thousand, respectively.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The pro forma financial information for all periods presented above has been calculated after adjusting the results of AlterG to reflect the business combinations accounting effects resulting from these acquisitions.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>These proforma results reflect additional depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant, and equipment and intangible asset occurred at the beginning of the period, along with consequential tax effects. The unaudited pro forma results have been prepared for comparative purposes only and are not necessarily indicative of what would have occurred had the business combinations been completed on January 1, 2022, nor it is necessarily indicative of future results of operations of the combined company. Furthermore, the unaudited pro forma financial information does not reflect the impact of any synergies resulting from the acquisition.</span></span></span></span></span></span></div>
    </div>
  </ix:nonNumeric>
  <div style="clear:both;margin-top:17pt;margin-bottom:0pt">
    <div>
      <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;23</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20240224175948099" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">NOTE 6:-</span></span></span><span style="padding-left:20pt">&#160;</span><span><span><span style="font-weight:bold">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:0.05pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has $<ix:nonFraction id="Fxbrl_20240224175327663" name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="C_20230101to20230930_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">7.5</ix:nonFraction> million of goodwill related to its purchase of AlterG in the third quarter of fiscal year 2023, which has an indefinite life, and is not deductible for tax purposes.</span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="margin-left:38pt;line-height:1.25;font-family:Times New Roman, Times, serif;margin-bottom:0pt;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">As of December 31, 2023, the components of, and changes in, the carrying amount of intangible assets, net, were as follows (in thousands):</span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="margin-left:36pt">
        <ix:nonNumeric id="Fxbrl_20240224180124162" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:14pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost</span></span></span></span></div>
                </td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2023 Accumulated</span></span></span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortization</span></span></span></span></div>
                </td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:6pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible Assets, Net</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trademark</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314110_xbrl_20231110042331576_23" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">795</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314110_xbrl_20231110042331576_27" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">104</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314110_xbrl_20231110101228212" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Technology</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314113_xbrl_20231110042331576_33" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,161</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314113_xbrl_20231110042331576_37" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">604</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314113_xbrl_20231110101206388" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,557</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Warranty</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314117_xbrl_20231110042331576_43" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">201</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314117_xbrl_20231110042331576_47" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314117_xbrl_20231110042331576_411" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Rental</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314120_xbrl_20231110042331576_53" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,102</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314120_xbrl_20231110042331576_57" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314120_xbrl_20231110042331576_511" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,896</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Distribution</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314124_xbrl_20231110042331576_63" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,578</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314124_xbrl_20231110042331576_67" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">358</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314124_xbrl_20231110042331576_611" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,220</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Backlog</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314128_xbrl_20231110042331576_73" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314128_xbrl_20231110042331576_77" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314128_xbrl_20231110042331576_711" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Amortized Intangible Assets</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314131_xbrl_20231110042331576_83" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,133</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20240224175314131_xbrl_20231110042331576_87" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,608</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175314131_xbrl_20231110042331576_811" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,525</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        </ix:nonNumeric>
        <p style="margin:0pt;font-size:10pt">&#160;</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The estimated amortization expense is shown below (in thousands):</span></span></span></p>
        <p style="margin:0pt">&#160;</p>
        <ix:nonNumeric id="Fxbrl_20240224180213353" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2024</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175320961_xbrl_20231110042304382_23" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,347</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2025</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175320962_xbrl_20231110042304382_33" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,307</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2026</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175320964_xbrl_20231110042304382_43" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,143</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2027</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175320965_xbrl_20231110042304382_53" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,172</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2028</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175320967_xbrl_20231110042304382_63" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">556</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20240224175320969_xbrl_20231110042304382_73" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,525</ix:nonFraction></span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        </ix:nonNumeric>
      </div>
    </div>
  </ix:nonNumeric>
  <div style="margin-top:0pt;margin-bottom:0pt">&#160;</div>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000000543" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 7:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">PROPERTY AND EQUIPMENT, NET</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of property and equipment, net are as follows (in thousands):</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <ix:nonNumeric id="Fxbrl_20240223115425936" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000523" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,690</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000524" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">743</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000525" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">468</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000526" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">308</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000527" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">621</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000528" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">621</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000529" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,166</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000530" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,816</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000531" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">658</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000532" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">333</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000533" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,603</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000534" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,821</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000535" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,341</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000536" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,625</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000537" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,262</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000538" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses amounted to $<ix:nonFraction id="FFact_0000000000540" name="us-gaap:Depreciation" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">239</ix:nonFraction> thousand, $<ix:nonFraction id="FFact_0000000000541" name="us-gaap:Depreciation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">202</ix:nonFraction> thousand, and $<ix:nonFraction id="FFact_0000000000542" name="us-gaap:Depreciation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">266</ix:nonFraction> thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  <div>
    <div style="width:100%;clear:both">
      <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;24</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000000592" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 8:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">COMMITMENTS AND CONTINGENT LIABILITIES</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase commitment:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has contractual obligations to purchase goods from its contract manufacturer as well as raw materials from different vendors. Purchase obligations do not include contracts that may be cancelled without penalty. As of December 31, 2023, non-cancellable outstanding obligations amounted to approximately $<ix:nonFraction id="Fxbrl_20230213125818493" name="us-gaap:PurchaseObligation" contextRef="C_20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.6</ix:nonFraction> million.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease commitment:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates from leased facilities in Israel, the United States and Germany. <ix:nonNumeric id="FFact_0000000000563" name="us-gaap:LesseeOperatingLeaseDescription" contextRef="C_20230101to20231231">These leases expire between 2024 and 2025.</ix:nonNumeric> A portion of the Company&#8217;s facilities leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2024 and 2026 A subset of the Company&#8217;s cars leases is considered variable. The variable lease payments for such cars leases are based on actual mileage incurred at the stated contractual rate. RRL and RRG have an option to be released from these agreements, which may result in penalties in a maximum amount of approximately $30 thousand as of December 31, 2023.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the Company&#8217;s consolidated balance sheets as of December 31, 2023 are as follows (in thousands): </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223120636180" name="lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000566" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,363</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000567" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">674</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213125847323" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease payments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000568" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,050</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: imputed interest</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000569" name="lfwd:ImputedInterest" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">147</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Present value of future lease payments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000570" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,903</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: current maturities of operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000571" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,296</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000572" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">607</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-average remaining lease term (in years) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000573" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_20231231" format="ixt-sec:duryear">1.92</ix:nonNumeric></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-average discount rate</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000574" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="C_20231231" unitRef="pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.21</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease expenses for the years ended December 31, 2023, 2022 and 2021 were $<ix:nonFraction id="Fxbrl_20230213125937048" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">976</ix:nonFraction> thousand, $<ix:nonFraction id="Fxbrl_20230213125942584" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">739</ix:nonFraction> thousand, and $<ix:nonFraction id="Fxbrl_20230213125949313" name="us-gaap:OperatingLeaseLeaseIncomeLeasePayments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">730</ix:nonFraction> thousand, respectively.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s research and development efforts are financed, in part, through funding from the Israel Innovation Authority (&#8220;IIA&#8221;). Since the Company&#8217;s inception through December 31, 2023, the Company received funding from the IIA in the total amount of $<ix:nonFraction id="Fxbrl_20230214005355014" name="us-gaap:ProceedsFromRoyaltiesReceived" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction> million. Out of the $<ix:nonFraction id="Fxbrl_20230213131612634" name="us-gaap:ProceedsFromRoyaltiesReceived" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction> million in funding from the IIA, a total amount of $<ix:nonFraction id="Fxbrl_20230213131623874" name="lfwd:ResearchAndDevelopmentRoyaltyBearingGrants" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction> million were royalty-bearing grants, $<ix:nonFraction id="Fxbrl_20230213131725050" name="lfwd:ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">400</ix:nonFraction> thousand was received in consideration of <ix:nonFraction id="Fxbrl_20230213131738827" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" contextRef="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">209</ix:nonFraction> convertible preferred A shares, which converted after the Company&#8217;s initial public offering in September 2014 into <ix:nonNumeric id="Fxbrl_20230213131752876" name="us-gaap:ConversionOfStockDescription" contextRef="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">ordinary shares in a conversion ratio of 1 to 1</ix:nonNumeric>, while $<span id="xbrl_20240224212733893">570</span> thousand was received without future obligation. The Company is obligated to pay royalties to the IIA, amounting to <ix:nonFraction id="Fxbrl_20230213131801581" name="lfwd:RoyaltyFeesPercentage" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction>% of the sales of the products and other related revenues generated from such projects, up to <ix:nonFraction id="Fxbrl_20230213131809862" name="lfwd:PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the grants received. The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company paid royalties to the IIA in the total amount of $<ix:nonFraction id="Fxbrl_20230213131932927" name="us-gaap:RoyaltyExpense" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">110</ix:nonFraction> thousand.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties expenses in cost of revenue were $<ix:nonFraction id="Fxbrl_20230213131823871" name="us-gaap:RoyaltyExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction> thousand, $<ix:nonFraction id="Fxbrl_20230213131830824" name="us-gaap:RoyaltyExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction> thousand and $<ix:nonFraction id="Fxbrl_20230213131836112" name="us-gaap:RoyaltyExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction> thousand, for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the contingent liability to the IIA amounted to $<ix:nonFraction id="Fxbrl_20230213131846121" name="lfwd:ContingentLiabilityRelatedToGrantsReceived" contextRef="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction> million. The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the IIA. Such approval is not required for the sale or export of any products resulting from such research or development. The IIA, under special circumstances, may approve the transfer of IIA-funded know-how outside Israel.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">dditionally, the License Agreement requires the Company to pay College (&#8220;Harvard&#8221;) royalties on net sales, see Note 10 below for more information about the Collaboration Agreement (as defined below) and the License Agreement (as defined below).</span>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div><ix:exclude>
          <div style="text-align:justify;line-height:1.25">
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;25</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </div>
        </ix:exclude></div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liens</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As part of the Company&#8217;s restricted cash and other long-term assets, as of December 31, 2023, an amount of $<ix:nonFraction id="Fxbrl_20230213132046214" name="us-gaap:OtherLongTermDebt" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">709</ix:nonFraction> thousand has been pledged as security in respect of a guarantee granted to a third party. Such deposit cannot be pledged to others or withdrawn without the consent of such third party.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal Claims:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Occasionally, the Company is involved in various claims such as product liability claims, lawsuits, regulatory examinations, investigations, and other legal matters arising, for the most part, in the ordinary course of business. While the outcome of any pending or threatened litigation and other legal matters is inherently uncertain, the Company does not believe the outcome of any of the matters will have a material adverse effect on the Company&#8217;s consolidated results of operation, liquidity or financial condition.</span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000000866" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 9:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">SHAREHOLDERS&#8217; EQUITY</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity raise:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Follow-on offerings</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 19, 2021, the Company entered into a purchase agreement with certain institutional and other accredited investors for the issuance and sale of <ix:nonFraction id="FFact_0000000000654" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20210202to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,921,502</ix:nonFraction> ordinary shares, par value NIS <ix:nonFraction id="FFact_0000000000655" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="NIS_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.25</ix:nonFraction> per share at $<ix:nonFraction id="FFact_0000000000656" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">3.6625</ix:nonFraction> per ordinary share and warrants to purchase up to an aggregate of <ix:nonFraction id="FFact_0000000000657" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,460,751</ix:nonFraction> ordinary shares with an exercise price of $<ix:nonFraction id="FFact_0000000000658" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">3.6</ix:nonFraction> per share, <ix:nonNumeric id="Fxbrl_20230213231801285" name="lfwd:WarrantsExercisableDescrition" contextRef="C_20210201to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">exercisable from February 19, 2021, until August 26, 2026</ix:nonNumeric>. Additionally, the Company issued warrants to purchase up to <ix:nonFraction id="FFact_0000000000659" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">655,290</ix:nonFraction> ordinary shares, with an exercise price of $<ix:nonFraction id="FFact_0000000000660" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">4.578125</ix:nonFraction> per share, <ix:nonNumeric id="Fxbrl_20230213231849967" name="lfwd:WarrantsExercisableDescrition" contextRef="C_20210201to20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">exercisable from February 19, 2021, until August 26, 2026</ix:nonNumeric>, to the Company February 2021 private placement offering.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 27, 2021, the Company signed a purchase agreement with certain institutional investors for the issuance and sale of <ix:nonFraction id="FFact_0000000000661" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20210901to20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">15,403,014</ix:nonFraction> ordinary shares, par value NIS <ix:nonFraction id="FFact_0000000000662" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="NIS_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.25</ix:nonFraction> per share, pre-funded warrants to purchase up to an aggregate of <ix:nonFraction id="FFact_0000000000663" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20210901to20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">610,504</ix:nonFraction> ordinary shares and ordinary warrants to purchase up to an aggregate of <ix:nonFraction id="FFact_0000000000664" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,006,759</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction id="FFact_0000000000665" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">2.00</ix:nonFraction> per share. <ix:nonNumeric id="FFact_0000000000666" name="lfwd:DescriptionOfUnderwritingAgreement" contextRef="C_20210901to20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember">The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant).</ix:nonNumeric> The ordinary warrants are exercisable at any time and from time to time, in whole or in part, following the date of issuance and ending five and one-half years from the date of issuance. All of the pre-funded warrants were exercised in full on September 27, 2021, and the offering closed on September 29, 2021. Additionally, the Company issued warrants to purchase up to <ix:nonFraction id="FFact_0000000000667" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">960,811</ix:nonFraction> ordinary shares, with an exercise price of $<ix:nonFraction id="FFact_0000000000668" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">2.5438</ix:nonFraction> per share, exercisable from September 27, 2021, until September 27, 2026, to the Company September 2021 registered direct offering.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, a total of <ix:nonFraction id="Fxbrl_20230213230048560" name="lfwd:NumberOfWarrantsOutstandingTotal" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">9,814,754</ix:nonFraction> outstanding warrants with exercise prices ranging from $<ix:nonFraction id="Fxbrl_20230213175822808" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_srtRangeAxis_srtMinimumMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.25</ix:nonFraction> to $<ix:nonFraction id="Fxbrl_20230213175829064" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_srtRangeAxis_srtMaximumMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.79</ix:nonFraction> were exercised, for total gross proceeds of approximately $<ix:nonFraction id="Fxbrl_20230213175852234" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20230101to20231231" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.8</ix:nonFraction> million. During the twelve months that ended December 31, 2023 no warrants were exercised.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share option plans:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 30, 2012, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2012 Equity Incentive Plan.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 19, 2014, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2014 Incentive Compensation Plan or the &#8220;Plan&#8221;. The Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, RSUs, cash-based awards, other stock-based awards and dividend equivalents to the Company&#8217;s and its affiliates&#8217; respective employees, non-employee directors and consultants.</span></span></div>
        <div style="text-align:justify;line-height:1.25">
          <p style="margin:0pt">&#160;</p>
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;26</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Starting in 2014, the Company grants to directors and employees also RSU under this Plan. An RSU award is an agreement to issue shares of the company&#8217;s ordinary shares at the time the award is vested.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company had reserved <ix:nonFraction id="Fxbrl_20230213180434110" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,018,945</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20230213180439271" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,934,679</ix:nonFraction> shares of ordinary shares, respectively, available for issuance to employees, directors, officers, and non-employees of the Company.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options generally vest over four years, with certain options granted to non-employee directors vesting over one year.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Any option or RSUs that are forfeited or cancelled before expiration becomes available for future grants under the Plan.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A summary of employee and non-employee shares options activity during the fiscal year ended 2023 is as follows: </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223133930542" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">exercise</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life (years)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Aggregate</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">intrinsic</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">value (in</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000674" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">43,994</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000675" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20221231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">41.27</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000676" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20220101to20221231" format="ixt-sec:duryear">4.39</ix:nonNumeric></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214162103893" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214162208421" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214162141286" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214162222550" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:52%;padding-bottom:4px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000682" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,823</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000683" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">52.78</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000684" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">33,171</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000685" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">37.51</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000686" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231" format="ixt-sec:duryear">4.39</ix:nonNumeric></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000688" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">33,171</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000689" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">37.51</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000690" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_20230101to20231231" format="ixt-sec:duryear">4.39</ix:nonNumeric></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There were no options granted during the fiscal year ended December 31, 2023, 2022 and 2021. The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders, which hold options with positive intrinsic value, exercised their options on the last date of the exercise period. During the years ended December 31, 2023, 2022 and 2021, no options were exercised.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A summary of employee and non-employee RSUs activity during the fiscal year ended 2023 is as follows: </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223134242480" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">shares</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">underlying</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">grant date</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">fair value</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unvested RSUs at the beginning of the year </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000693" name="lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" contextRef="C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,755,057</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214162434759" name="lfwd:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" contextRef="C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.16</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000695" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,258,370</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230214162447647" name="lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.66</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000697" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,109,200</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000698" name="lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.14</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:76%;padding-bottom:4px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited </span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000699" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">131,813</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000700" name="lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.13</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unvested RSUs at the end of the year </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000701" name="lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" contextRef="C_20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,772,414</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000702" name="lfwd:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" contextRef="C_20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.87</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The weighted average grant date fair values of RSUs granted during the fiscal year ended December 31, 2023, 2022 and 2021, were $<ix:nonFraction id="Fxbrl_20230213182329782" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.66</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230213182403626" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.00</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230213182357641" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD_per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.69</ix:nonFraction>, respectively.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total fair value of shares vested during the year ended December 31, 2023, 2022 and 2021 were $<ix:nonFraction id="Fxbrl_20230213182417788" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,268</ix:nonFraction> thousand, $<ix:nonFraction id="Fxbrl_20230213182423124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">860</ix:nonFraction> thousand, and $<ix:nonFraction id="Fxbrl_20230213182431629" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">802</ix:nonFraction> thousand, respectively. As of December 31, 2023, there were $<ix:nonFraction id="Fxbrl_20230213182444566" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction> million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2014 Plan. This cost is expected to be recognized over a period of approximately <ix:nonNumeric id="Fxbrl_20230213182450823" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">2.9</ix:nonNumeric> years.</span></span></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div><ix:exclude>
          <div style="text-align:justify;line-height:1.25">
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;27</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </div>
        </ix:exclude></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The number of options and RSUs outstanding as of December 31, 2023 is set forth below, with options separated by range of exercise price:</span></span></div>
        <div style="text-align:justify;line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223134338946" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="width:42%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise price</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options and</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">as of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(years) (1)</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">as of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(years) (1)</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs only </span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000713" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,772,414</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="FFact_0000000000715" name="lfwd:InvestmentOptionsExercisePrices" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">5.37</ix:nonFraction>&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000716" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">12,425</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000717" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember" format="ixt-sec:duryear">5.24</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000718" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">12,425</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000719" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember" format="ixt-sec:duryear">5.24</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="FFact_0000000000720" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">20.42</ix:nonFraction>- $<ix:nonFraction id="FFact_0000000000721" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">33.75</ix:nonFraction>&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000722" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">12,943</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000723" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember" format="ixt-sec:duryear">4.35</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000724" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">12,943</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000725" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember" format="ixt-sec:duryear">4.35</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="FFact_0000000000726" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeThreeMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">50</ix:nonFraction>-$<ix:nonFraction id="FFact_0000000000727" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeThreeMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">52.5</ix:nonFraction>&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000734" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">6,230</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000735" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember" format="ixt-sec:duryear">3.46</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000736" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">6,230</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000737" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember" format="ixt-sec:duryear">3.46</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$<ix:nonFraction id="FFact_0000000000732" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">182.5</ix:nonFraction>-$<ix:nonFraction id="FFact_0000000000733" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">524.25</ix:nonFraction>&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000740" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,573</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000741" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember" format="ixt-sec:duryear">1.65</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000742" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,573</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000743" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember" format="ixt-sec:duryear">1.65</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000744" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,805,585</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000745" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">4.39</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000746" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">33,171</ix:nonFraction></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000747" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">4.39</ix:nonNumeric></span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="vertical-align:top;width:34pt">&#160;</td>
              <td style="vertical-align:top;width:20pt">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) </span></span></div>
              </td>
              <td style="vertical-align:top;width:auto">
                <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term. </span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">c.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Equity compensation issued to consultants:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company granted <ix:nonFraction id="Fxbrl_20230213183439405" name="lfwd:WarrantsToPurchaseOrdinaryShares" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">32,895</ix:nonFraction> RSUs during the fiscal year ended December 31, 2023, to non-employee consultants. As of December 31, 2023, there are 21,929 outstanding RSUs held by non-employee consultants.</span></span></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">d.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share-based compensation expense for employees and non-employees:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-indent:18pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognized share-based compensation expense in the consolidated statements of operations as follows (in thousands): </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223134403289" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000750" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000751" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000752" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development, net </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000753" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">157</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000754" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000755" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales and marketing </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000756" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">381</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000757" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">250</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000758" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000759" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">781</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000760" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">633</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000761" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">597</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000762" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,328</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000763" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">993</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000764" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">833</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">e.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Treasury shares:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On June 2, 2022, the Company&#8217;s Board of Directors approved a share repurchase program to repurchase up to $<ix:nonFraction id="Fxbrl_20230213222918352" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="C_20220602_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction> million of its Ordinary Shares, par value NIS <ix:nonFraction id="Fxbrl_20230213222931458" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_20220602_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember" unitRef="NIS_per_Share" decimals="INF" format="ixt:num-dot-decimal">0.25</ix:nonFraction> per share. On July 21, 2022, the Company received approval from an Israeli court for the share repurchase program. The program was scheduled to expire on the earlier of January 20, 2023, or reaching $<ix:nonFraction id="Fxbrl_20230222055803517" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="C_20220721_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction> million of repurchases. On December 22, 2022, the Company&#8217;s Board of Directors approved an extension of the repurchase program, with such extension to be in the aggregate amount of up to $<ix:nonFraction id="Fxbrl_20230222055944621" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="C_20221222_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.8</ix:nonFraction> million. The extension was approved by an Israeli court on February 9, 2023, and it expired on August 9, 2023.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, pursuant to the Company&#8217;s share repurchase program, the Company had repurchased a total of <ix:nonFraction id="Fxbrl_20230213223518090" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" contextRef="C_20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,022,607</ix:nonFraction> of its outstanding ordinary shares at a total cost of $<ix:nonFraction id="Fxbrl_20230213223526081" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20230101to20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million.</span></span>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div style="text-align:justify;line-height:1.25">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;28</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">f.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Warrants to purchase ordinary shares:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes information about warrants outstanding and exercisable as of December 31, 2023:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240223134439177" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" contextRef="C_20230101to20231231" escape="true">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;width:42%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance date</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">per warrant</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">exercisable</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">term</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(number)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(number)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;padding-bottom:2px;width:10%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2015 (1) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000766" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,771</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000767" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">7.500</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000768" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,771</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See footnote (1)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 28, 2016 (2) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000769" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,908</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000770" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">7.500</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000771" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,908</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See footnote (1)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 25, 2019 (5) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000772" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">45,600</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000773" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">7.187</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000774" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">45,600</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000775" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" format="ixt:date-monthname-day-year-en">February 21, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 5, 2019 (6) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000776" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">408,457</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000777" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">5.140</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000778" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">408,457</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000779" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" format="ixt:date-monthname-day-year-en">October 7, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 5, 2019 (7) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000780" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">49,015</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000781" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">6.503</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000782" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">49,015</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000783" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" format="ixt:date-monthname-day-year-en">April 3, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2019, and June 6, 2019 (8) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000784" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,464,665</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000785" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">7.500</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000786" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,464,665</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000787" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" format="ixt:date-monthname-day-year-en">June 5, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2019 (9) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000788" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">87,880</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000789" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">9.375</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000790" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">87,880</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000791" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" format="ixt:date-monthname-day-year-en">June 5, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 12, 2019 (10) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000792" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">416,667</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000793" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">6.000</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000794" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">416,667</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000795" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" format="ixt:date-monthname-day-year-en">December 12, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 10, 2019 (11) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000796" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000797" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">7.500</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000798" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000799" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" format="ixt:date-monthname-day-year-en">June 10, 2024</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2020 (12) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000800" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">28,400</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000801" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.250</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000802" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">28,400</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000803" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" format="ixt:date-monthname-day-year-en">February 10, 2025</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2020 (13) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000804" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">105,840</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000805" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.563</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000806" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">105,840</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000807" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" format="ixt:date-monthname-day-year-en">February 10, 2025</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 6, 2020 (14) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000808" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">448,698</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000809" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.760</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000810" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">448,698</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000811" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" format="ixt:date-monthname-day-year-en">January 2, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 6, 2020 (15) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000812" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">296,297</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000813" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">2.278</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000814" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">296,297</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000815" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" format="ixt:date-monthname-day-year-en">January 2, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 8, 2020 (16) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000816" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">586,760</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000817" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.340</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000818" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">586,760</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000819" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" format="ixt:date-monthname-day-year-en">June 8, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 8, 2020 (17) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000820" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">108,806</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000821" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">1.792</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000822" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">108,806</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000823" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" format="ixt:date-monthname-day-year-en">June 8, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 26, 2021 (18) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000824" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,460,751</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000825" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">3.600</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000826" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,460,751</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000827" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" format="ixt:date-monthname-day-year-en">August 26, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 26, 2021 (19) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000828" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">655,290</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000829" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">4.578</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000830" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">655,290</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000831" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" format="ixt:date-monthname-day-year-en">August 26, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 29, 2021 (20) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000832" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,006,759</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000833" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">2.000</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000834" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,006,759</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000835" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" format="ixt:date-monthname-day-year-en">March 29, 2027</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 29, 2021 (21) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000836" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">960,811</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000837" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">2.544</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000838" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">960,811</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_0000000000839" name="lfwd:WarrantsExpitationDate" contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" format="ixt:date-monthname-day-year-en">September 27, 2026</ix:nonNumeric></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000848" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,187,375</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000849" name="lfwd:ClassOfWarrantOrRightExercisable" contextRef="C_20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,187,375</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>

            </table>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants for ordinary shares issuable upon an exercise price of $<ix:nonFraction id="Fxbrl_20230213221744619" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20151231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal">7.500</ix:nonFraction> per share, which were granted on <ix:nonNumeric id="FFact_0000000000850" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" contextRef="C_20150101to20151231_deiLegalEntityAxis_lfwdKreosCapitalVMember" format="ixt:date-monthname-day-year-en">December 31, 2015</ix:nonNumeric> to Kreos Capital V (Expert) Fund Limited (&#8220;Kreos&#8221;) in connection with a loan made by Kreos to the Company and are <ix:nonNumeric id="Fxbrl_20230214153827207" name="lfwd:WarrantsExercisableDescrition" contextRef="C_20150101to20151231_deiLegalEntityAxis_lfwdKreosCapitalVMember">currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.</ix:nonNumeric></span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents common warrants that were issued as part of the $<ix:nonFraction id="FFact_0000000000854" name="us-gaap:DebtInstrumentCollateralAmount" contextRef="C_20161228_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.0</ix:nonFraction> million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents common warrants that were issued as part of the Company&#8217;s follow-on public offering in November 2018.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on public offering in November 2018.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on public offering in February 2019.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;29</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019, and June 6, 2019, respectively.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020. As of December 31, 2023, <ix:nonFraction id="Fxbrl_20230221045623403" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,740,100</ix:nonFraction> warrants were exercised for total consideration of $<ix:nonFraction id="Fxbrl_20230221045640309" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,675,125</ix:nonFraction>. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering. As of December 31, 2023, <ix:nonFraction id="Fxbrl_20230221045607023" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">230,160</ix:nonFraction> warrants were exercised for total consideration of $<ix:nonFraction id="Fxbrl_20230221045614684" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359,625</ix:nonFraction>. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in July 2020. As of December 31, 2023, <ix:nonFraction id="Fxbrl_20230221045547348" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,020,441</ix:nonFraction> warrants were exercised for total consideration of $<ix:nonFraction id="Fxbrl_20230221045554109" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,555,976</ix:nonFraction>. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(16)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s private placement offering of ordinary shares in December 2020. As of December 31, 2023, <ix:nonFraction id="Fxbrl_20230221045526364" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,598,072</ix:nonFraction> warrants were exercised for total consideration of $<ix:nonFraction id="Fxbrl_20230221045533780" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,821,416</ix:nonFraction>. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement. As of December 31, 2023, <ix:nonFraction id="Fxbrl_20230221045700629" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">225,981</ix:nonFraction> warrants were exercised for total consideration of $<ix:nonFraction id="Fxbrl_20230221045709176" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">405,003</ix:nonFraction>. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s private placement offering of ordinary shares in February 2021.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2021 private placement.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in September 2021.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s September 2021 registered direct offering.</span></span></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000000870" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>NOTE 10:-</strong></span></span></td>
              <td style="vertical-align:top;width:auto">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</strong></span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 16, 2016, the Company entered into a Collaboration Agreement (as amended, the &#8220;Collaboration Agreement&#8221;) and an Exclusive License Agreement (as amended, the &#8220;License Agreement&#8221;) with Harvard. The Collaboration Agreement concluded on March 31, 2022.</span></span></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the License Agreement, Harvard has granted the Company an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#8220;soft suit&#8221; exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the joint research collaboration.</span></span>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div style="text-align:justify;line-height:1.25">
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;30</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
        </div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The License Agreement required the Company to pay Harvard an upfront fee, reimbursements for expenses that Harvard incurred in connection with the licensed patents, royalties on net sales and several milestone payments contingent upon the achievement of certain product development and commercialization milestones. The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid claim of the licensed patents.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company achieved three of the milestones which represent all development milestones under the License Agreement. The Company continues to evaluate the likelihood that the other milestones will be achieved on a quarterly basis.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has recorded expenses in the amount of $<ix:nonFraction id="Fxbrl_20230213132350179" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction> thousand, $<ix:nonFraction id="Fxbrl_20230213132355930" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction> thousand, and $<ix:nonFraction id="Fxbrl_20230213132403571" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">293</ix:nonFraction> thousand as research and development expenses related to the License Agreement and to the Collaboration Agreement for the years ended December 31, 2023, 2022 and 2021, respectively. No withholding tax was deducted from the Company&#8217;s payments to Harvard in respect of the Collaboration Agreement and the License Agreement since this is not taxable income in Israel in accordance with Section 170 of the Israel Income Tax Ordinance 1961-5721.</span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="Fxbrl_20240224183848740" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 11:-</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME TAXES</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate tax rates in Israel:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Presented hereunder are the tax rates relevant to the Company in the years 2021-2023:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli statutory corporate tax rate and real capital gains were <ix:nonFraction id="Fxbrl_20230213145314219" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230213144711350" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230213144701076" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20200101to20201231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></ix:nonFraction></ix:nonFraction>% in the years 2021-2023.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.<span style="padding-left:8.5pt">&#160;</span>Income (loss) before taxes on income is comprised as follows (in thousands):</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240223144044842" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Domestic</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000878" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,638</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000879" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,110</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000880" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,780</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000881" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,507</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000882" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000883" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000884" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,145</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000885" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,102</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000886" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,642</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income (benefit) are comprised as follows (in thousands):</span></span></div>
          <div style="text-indent:18pt;line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240223144314043" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <div style="margin-left:36pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000888" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000889" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000890" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000891" name="lfwd:DeferredIncomeTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000892" name="lfwd:DeferredIncomeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">316</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000893" name="lfwd:DeferredIncomeTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000894" name="lfwd:TaxesOnIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000895" name="lfwd:TaxesOnIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">467</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000896" name="lfwd:TaxesOnIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:36pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Domestic</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213154420766_Fact_0000000000900" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213154420766_Fact_0000000000901" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213154420766_Fact_0000000000902" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000900" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000901" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">467</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000902" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:4px;vertical-align:baseline">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000903" name="lfwd:TaxesIncome" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000904" name="lfwd:TaxesIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">467</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000905" name="lfwd:TaxesIncome" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <p style="margin:0pt">&#160;</p>
          <div><ix:exclude>
            <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;31</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          </ix:exclude></div>
          <div style="text-indent:18pt;line-height:1.25;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income taxes (in thousands):</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company&#8217;s deferred tax assets as of December 31, 2023 and 2022 are derived from temporary differences.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. Based on the Company&#8217;s history of losses, the Company established a full valuation allowance for RRL.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Undistributed earnings of certain subsidiaries as of December 31, 2023 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a result, the Company has not provided for any deferred income taxes.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240223144332603" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carry forward tax losses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000907" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,090</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000908" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,833</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development carry forward expenses-temporary differences</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000909" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,311</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000910" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">844</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrual and reserves</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000911" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">849</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000912" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">392</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230221105010103_Fact_0000000000911" name="lfwd:DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">394</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230221105010103_Fact_0000000000912" name="lfwd:DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">456</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit tax carry forwards</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223155141498_Fact_0000000000907" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,714</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223155141498_Fact_0000000000908" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000913" name="lfwd:DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">480</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000914" name="lfwd:DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000915" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,838</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000916" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,739</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use asset</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000917" name="lfwd:DeferredTaxLiabilitiesRightOfUseAsset" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">470</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000918" name="lfwd:DeferredTaxLiabilitiesRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible Assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223155146219_Fact_0000000000907" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,015</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223155146219_Fact_0000000000908" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223155148314_Fact_0000000000907" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">144</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223155148314_Fact_0000000000908" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000919" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,209</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000920" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,525</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:76%;padding-bottom:2px;vertical-align:baseline">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000921" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,209</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000922" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,525</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000923" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000924" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The net changes in the total valuation allowance for each of the years ended December 31, 2023, 2022 and 2021, are comprised as follows (in thousands):</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20240223144348387" name="us-gaap:SummaryOfValuationAllowanceTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000926" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,525</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000927" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,098</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000928" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,941</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes due to exchange rate differences</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000929" name="lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000930" name="lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,418</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000931" name="lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,488</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment previous year loss</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240226140612653" name="lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">)</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213155451007" name="lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000934" name="lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224230420217_xbrl_20230213155446375" name="lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,269</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224230420217_xbrl_20230213155451007" name="lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240224230420217_Fact_0000000000934" name="lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000935" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,410</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000936" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,831</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000937" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,669</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000938" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,209</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000939" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,525</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000940" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,098</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
        </div>
      </div>
      <p style="margin:0pt">&#160;</p>
      <div><ix:exclude>
        <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;32</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </ix:exclude></div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of the theoretical tax expenses:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit) as reported in the consolidated statements of operations is as follows (in thousands):</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <ix:nonNumeric id="Fxbrl_20240223144408211" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_20230101to20231231" escape="true">
        <div style="margin-left:36pt">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before taxes, as reported in the consolidated statements of operations</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000942" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,145</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000943" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,102</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000944" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,642</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000945" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20230101to20231231" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000946" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">23.0</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000947" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">23.0</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000948" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,093</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000949" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,393</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000950" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,908</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax at rate other than the Israeli statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213160009177_Fact_0000000000951" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213160009177_Fact_0000000000952" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213160009177_Fact_0000000000953" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses including equity-based compensation expenses and other&#8201;</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000954" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000955" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">262</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000956" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating losses and other temporary differences for which valuation allowance was provided</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000957" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,410</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000958" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,375</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000959" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,669</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Permanent differences</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000960" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">342</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000961" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">775</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000962" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">784</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment in respect of prior years</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240223155439943_Fact_0000000000960" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223155439943_Fact_0000000000961" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223155439943_Fact_0000000000962" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213160019546_Fact_0000000000963" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213160019546_Fact_0000000000964" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213160019546_Fact_0000000000965" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Actual tax expense (benefit)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000966" name="us-gaap:OtherTaxExpenseBenefit" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000967" name="us-gaap:OtherTaxExpenseBenefit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">467</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">&#160;</td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000968" name="us-gaap:OtherTaxExpenseBenefit" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        </div>
      </ix:nonNumeric>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span><span style="padding-left:9.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign tax rates:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxable income of RRI and AlterG was subject to tax at the rate of <ix:nonFraction id="Fxbrl_20231216140603322" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20231216140556608" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230213144755943" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction></ix:nonFraction></ix:nonFraction>% in 2023, 2022 and 2021.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxable income of RRG was subject to tax at the rate of <ix:nonFraction id="Fxbrl_20231216140621676" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20231216140615011" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230213144800051" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">30</ix:nonFraction></ix:nonFraction></ix:nonFraction>% in 2023, 2022, and 2021.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the &#8220;Investment Law&#8221;):</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Conditions for entitlement to the benefits:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Investment Law, in 2012 the Company elected &#8220;Beneficiary Enterprise&#8221; status which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular rate.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income derived from Beneficiary Enterprise from productive activity will be exempt from tax for <ix:nonNumeric id="FFact_0000000000977" name="lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" contextRef="C_20230101to20231231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> from the year in which the Company first has taxable income, providing that <ix:nonNumeric id="FFact_0000000000978" name="lfwd:BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" contextRef="C_20230101to20231231" format="ixt-sec:duryear">12</ix:nonNumeric> years have not passed from the beginning of the year of election. In the event of a dividend distribution from income that is exempt from company tax, as aforementioned, the Company will be required to pay tax of <ix:nonFraction id="FFact_0000000000979" name="lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction>%-<ix:nonFraction id="FFact_0000000000980" name="lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction>% on that income.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Beneficiary Enterprise&#8217;s income. Tax-exempt income generated under the Company&#8217;s &#8220;Beneficiary Enterprise&#8221; program will be subject to taxes upon dividend distribution or complete liquidation.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The entitlement to the above benefits is conditional upon the Company&#8217;s fulfilling the conditions stipulated by the Law and regulations published thereunder.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assessments:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RRL, RRI and RRG has had final tax assessments up to and including the 2017 tax year.</span></span></div>
      <p style="margin:0pt">&#160;</p>
      <div><ix:exclude>
        <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;33</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </ix:exclude></div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG files income tax returns in the United States and in various U.S. states. &#160;AlterG returns for the years ended December 31, 2020 and later are generally subject to federal tax examination, while the AlterG returns for the years ended December 31, 2019 and later are generally subject to state tax examination. &#160;However, the AlterG net operating losses and tax credits generally remain subject to tax examination and adjustment until they are utilized on a future tax return and the statute of limitations closes for that year. &#160;Thus, the AlterG tax attributes generally remain open to federal and state tax examination and adjustment.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span><span style="padding-left:9.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net operating carry-forward losses for tax purposes:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, RRL has carry-forward losses amounting to approximately $<ix:nonFraction id="Fxbrl_20230213160514050" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">242.6</ix:nonFraction> million, which can be carried forward for an indefinite period.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, AlterG had approximately $<ix:nonFraction id="Fxbrl_20240226141105239" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">31.4</ix:nonFraction> million of federal net operating loss (&#8220;NOL&#8221;) carry forwards, and $<ix:nonFraction id="Fxbrl_20240226141123559" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapStateAndLocalJurisdictionMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">47.2</ix:nonFraction> million of state NOL carry forwards, which will begin to expire in <ix:nonNumeric id="Fxbrl_20240226141138302" name="lfwd:NetOperatingCarryForwardLossesExpirationTerm" contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdAltergIncMember">2025 and 2028</ix:nonNumeric>, respectively. &#160;The federal net operating losses from years beginning after January 1, 2018, of approximately $<ix:nonFraction id="Fxbrl_20240226141153085" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapForeignCountryMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">14.7</ix:nonFraction> million may be carried forward indefinitely and losses prior to January 1, 2018 of approximately $<ix:nonFraction id="Fxbrl_20240226141205791" name="lfwd:OperatingLossCarryforwardsPriorPeriod" contextRef="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember" unitRef="USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.7</ix:nonFraction> million expire beginning in 2028 under prior law.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Internal Revenue Code Section 382 places a limitation ("Section 382 Limitation") on the amount of taxable income which can be offset by NOL carry forwards after a change in control (generally greater than 50% change in the value of the stock owned by 5% shareholders during the testing period) of a loss corporation. California has similar rules. On August 11, 2023, AlterG was involved in an equity transaction that constitutes a Section 382 change in ownership. The change in ownership limits the ability to utilize net operating loss carry forwards in future years. The 382-limitation impact on NOLs has been included in the current period provision. The Company may have had earlier Section 382 changes in ownership. This will be assessed upon realization of tax attributes.</span></span></div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
  <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;34</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000001000" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span>NOTE 12:-</span></span></td>
          <td style="vertical-align:top;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt"><span>FINANCIAL (EXPENSES) INCOME, NET</span></span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of financial (expenses) income, net were as follows (in thousands):</span></span></div>
        <ix:nonNumeric id="Fxbrl_20240223122326676" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transactions and other</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000987" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">133</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000988" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000989" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest Income</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223123158362" name="us-gaap:InterestIncomeOther" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,354</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223123212166" name="us-gaap:InterestIncomeOther" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223123222290" name="us-gaap:InterestIncomeOther" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank commissions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000993" name="lfwd:BankCommissions" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000994" name="lfwd:BankCommissions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_0000000000995" name="lfwd:BankCommissions" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000996" name="lfwd:FinancialExpensesAndIncomeNet" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,467</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213140028626">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000000998" name="lfwd:FinancialExpensesAndIncomeNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">*) </span>Represent an amount lower than $1.</span></span></div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin:0pt">&#160;</p>
</div><div style="">
  <ix:nonNumeric id="FFact_0000000001040" name="us-gaap:SegmentReportingDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
    <div>
      <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

          <tr>
            <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13:-</span></span></td>
            <td style="vertical-align:top;width:auto">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</span></span></div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company manages its business on a basis of <ix:nonFraction id="Fxbrl_20240223125143289" name="us-gaap:NumberOfReportableSegments" contextRef="C_20230101to20231231" unitRef="segment" decimals="INF" format="ixt-sec:numwordsen">one </ix:nonFraction>reportable segment.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues from external customers on the basis of the Company's geographical areas are as follows (in thousands):</span></span></div>
        <ix:nonNumeric id="Fxbrl_20240223125203861" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue based on customer&#8217;s location:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001005" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,636</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001006" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,303</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001007" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,519</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001008" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,044</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001009" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,057</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001010" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,381</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia-Pacific</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001011" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_srtAsiaPacificMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">387</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001012" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_srtAsiaPacificMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">115</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001013" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_srtAsiaPacificMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest of the world</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223125344982" name="us-gaap:Revenues" contextRef="C_20230101to20231231_srtStatementGeographicalAxis_lfwdRestOfWorldMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">787</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223125735347" name="us-gaap:Revenues" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_lfwdRestOfWorldMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20240223125750616" name="us-gaap:Revenues" contextRef="C_20210101to20211231_srtStatementGeographicalAxis_lfwdRestOfWorldMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001020" name="us-gaap:Revenues" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,854</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001021" name="us-gaap:Revenues" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,511</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001022" name="us-gaap:Revenues" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,966</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
        <ix:nonNumeric id="Fxbrl_20240223125219492" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" contextRef="C_20230101to20231231" escape="true">
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets by geographic region:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001024" name="us-gaap:NoncurrentAssets" contextRef="C_20231231_srtStatementGeographicalAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">529</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001025" name="us-gaap:NoncurrentAssets" contextRef="C_20221231_srtStatementGeographicalAxis_countryIL" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">757</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001026" name="us-gaap:NoncurrentAssets" contextRef="C_20231231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,404</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001027" name="us-gaap:NoncurrentAssets" contextRef="C_20221231_srtStatementGeographicalAxis_countryUS" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001028" name="us-gaap:NoncurrentAssets" contextRef="C_20231231_srtStatementGeographicalAxis_countryDE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">190</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001029" name="us-gaap:NoncurrentAssets" contextRef="C_20221231_srtStatementGeographicalAxis_countryDE" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001030" name="us-gaap:NoncurrentAssets" contextRef="C_20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,123</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001031" name="us-gaap:NoncurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,032</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*)</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets are comprised of property and equipment, net, and operating lease right-of-use assets.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </ix:nonNumeric>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Major customers data as a percentage of total revenue:</span></span></div>
      </div>
    </div>
    <ix:nonNumeric id="Fxbrl_20240223125235177" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001033" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.2</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_0000000001034" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">14.2</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000001035">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213145458513">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213145510899">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213145523610" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">11.0</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border:0px;width:100%">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                  <td style="width:auto">
                    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></p>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
  <div style="width:100%;margin-top:0pt"><p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-bottom:3pt;margin-top:10pt">F&#8201;-&#8201;35</p></div><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;page-break-after:always;margin-bottom:10pt"/><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240224191043321" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 14:-</span><span style="padding-left:20pt">&#160;</span><span style="font-weight:bold">BASIC AND DILUTED NET LOSS PER SHARE</span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">
          <ix:nonNumeric id="Fxbrl_20240224191102857" name="lfwd:BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" contextRef="C_20230101to20231231" escape="true">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224192413364_Fact_0000000000128" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,133</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224192413364_Fact_0000000000129" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,569</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224192413364_Fact_0000000000130" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,736</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to ordinary shares</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224192423512_Fact_0000000000128" name="us-gaap:NetIncomeLoss" contextRef="C_20230101to20231231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,133</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224192423512_Fact_0000000000129" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,569</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20240224192423512_Fact_0000000000130" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,736</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares used in computing net loss per ordinary shares, basic and diluted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213105231681" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240224192433025_Fact_0000000000134" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">59,719,064</ix:nonFraction></ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213105240146" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240224192433025_Fact_0000000000135" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">62,378,797</ix:nonFraction></ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230213105249498" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20240224192433025_Fact_0000000000136" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">47,935,652</ix:nonFraction></ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per ordinary share, basic and diluted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213105205583" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20230101to20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240224192413366_Fact_0000000000131" name="us-gaap:EarningsPerShareBasic" contextRef="C_20230101to20231231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">0.37</ix:nonFraction></ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213105214455" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20221231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240224192413366_Fact_0000000000132" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20221231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">0.31</ix:nonFraction></ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230213105224480" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20211231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20240224192413366_Fact_0000000000133" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20211231" unitRef="USD_per_Share" decimals="INF" format="ixt:num-dot-decimal" sign="-">0.27</ix:nonFraction></ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </ix:nonNumeric>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and warrants outstanding would have been anti-dilutive.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the twelve months ended December 31, 2023, the total number of ordinary shares related to the outstanding warrants and share option plans aggregated to <ix:nonFraction id="Fxbrl_20240224193823449" name="lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" contextRef="C_20230101to20231231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,220,546</ix:nonFraction>, was excluded from the calculations of diluted loss per ordinary share since it would have an anti-dilutive effect.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the twelve months ended December 31, 2022, the total number of ordinary shares related to the outstanding warrants and share option plans aggregated to <ix:nonFraction id="Fxbrl_20240224193844593" name="lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,464,888</ix:nonFraction>, was excluded from the calculations of diluted loss per ordinary share since it would have an anti-dilutive effect.</span></span></div>
      </div>
    </ix:nonNumeric>
    <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
  </div>
</div><div style="">
  <div>
    <ix:nonNumeric id="Fxbrl_20240226134602269" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" contextRef="C_20230101to20231231" escape="true">
      <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 15:-</span></span></span><span style="padding-left:20pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">RESTRUCTURING ACTIVITIES</span></span></span>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 12, 2023, the Board of Directors of the Company approved a re-organization plan (the &#8220;2023 Reorganization Plan&#8221;) that included, among other things, downsizing approximately <ix:nonFraction id="Fxbrl_20240224171054032" name="lfwd:WorkforcePercentage" contextRef="C_20231201to20231212_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember" unitRef="pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction>% of the Company&#8217;s workforce and adapting the Company's organizational structure, roles, and responsibilities accordingly.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">During the year ended December 31, 2023, in connection with the 2023 Reorganization Plan, the Company recorded expenses of $<ix:nonFraction id="Fxbrl_20240224171136760" name="lfwd:AmountOfEmployeeTerminationBenefitsAndLegalExpenses" contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">670</ix:nonFraction> thousand, for one time employee termination benefits and legal expenses. $<ix:nonFraction id="Fxbrl_20240224171156688" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">175</ix:nonFraction> thousand attributable to research and development, net, $<ix:nonFraction id="Fxbrl_20240224171235576" name="us-gaap:MarketingAndAdvertisingExpense" contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70</ix:nonFraction> thousand to sales and marketing and $<ix:nonFraction id="Fxbrl_20240224171248551" name="us-gaap:SellingAndMarketingExpense" contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">425</ix:nonFraction> thousand to General and administrative expenses.</span>&#160;<span style="color:rgb(0, 0, 0)">However, none of these amounts were paid in 2023. The Company does not expect to incur additional costs related to the 2023 Reorganization Plan.</span></span></span></div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  <p style="margin-top:10pt;margin-bottom:0pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt">F - 36</span></p>
  <hr style="border:none;border-bottom:4px solid #000000;border-top:1px solid #000000;height:10px;width:100%;color:#000000;text-align:center;text-align:center"/>
  <div>&#160;</div>
</div></div></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>exhibit_21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 21.1</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">List of Subsidiaries of ReWalk Robotics Ltd.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td nowrap="nowrap" style="width: 50.99%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-weight: bold;">Name of Subsidiary</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">&#160;</td>
          <td nowrap="nowrap" style="width: 48%; vertical-align: bottom; border-bottom: 2px solid #000000;">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-weight: bold;">Place of Incorporation</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 50.99%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;">Lifeward, Inc.</div>
          </td>
          <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="line-height: 1.25;">Delaware, United States</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50.99%; vertical-align: top;">
            <div style="line-height: 1.25;">Lifeward CA, Inc.</div>
          </td>
          <td style="width: 1%; vertical-align: bottom;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Delaware, United States</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50.99%; vertical-align: top; background-color: #CCEEFF;">
            <div style="line-height: 1.25;">Lifeward GmbH</div>
          </td>
          <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
          <td style="width: 48%; vertical-align: bottom; background-color: #CCEEFF;">
            <div style="line-height: 1.25;">Germany</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
          </u></div>
        <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 23.1</u></div>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zb189aa06eb8648be8fd7a5793b4f16ae" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18.29%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;"><img width="70" height="74" src="image00002.jpg"></div>
          </td>
          <td style="width: 33.44%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Kost&#160;Forer&#160;Gabbay&#160;&amp;&#160;Kasierer</div>
            <div style="line-height: 1.25;">Menachem Begin 144,</div>
            <div style="line-height: 1.25;">Tel-Aviv 6492102, Israel</div>
          </td>
          <td style="width: 48.28%; vertical-align: bottom;">
            <div style="text-align: right; line-height: 1.25;">Tel: +972-3-6232525</div>
            <div style="text-align: right; line-height: 1.25;">Fax: +972-2-5622555</div>
            <div style="text-align: right; line-height: 1.25;">ey.com</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">We consent to the incorporation by reference in the following Registration Statements:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z3863569efcf746d9a845e6b10d608edc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 18pt; line-height: 1.25;">(1)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Registration Statements (Form S-3 No. 333-231305, 333-260382 and 333-263984) of ReWalk Robotics Ltd.,</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="za8d5ff1b436c4fa58f417a5a80c4c9db" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 18pt; line-height: 1.25;">(2)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Registration Statements (Form S-1 No. 333-235931, 333-239733, 333-251454 and 333-254147) of ReWalk Robotics Ltd., and</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z29670aed797d41bcb9895445e65da060" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; margin-left: 18pt; line-height: 1.25;">(3)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Registration Statements (Form S-8 No. 333-199688, 333-221357, 333-230485, 333-239258 and 333-267284) pertaining to the ReWalk
                Robotics Ltd. 2006 Stock Option Plan, ReWalk Robotics Ltd. 2012 Equity Incentive Plan and ReWalk Robotics Ltd. 2014 Incentive Compensation Plan;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">of our report dated February 27, 2024, with respect to the consolidated financial statements of ReWalk Robotics Ltd. included in this
      Annual Report (Form 10-K) of ReWalk Robotics Ltd. for the year ended December 31, 2023.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zd7c376373bcd4b44a90a991c9261ecc0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 67%; vertical-align: top;">
            <div style="line-height: 1.25;">/s/ KOST FORER GABBAY &amp; KASIERER</div>
          </td>
          <td style="width: 33%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 67%; vertical-align: top;">
            <div style="line-height: 1.25;">A Member of EY Global</div>
          </td>
          <td style="width: 33%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 67%; vertical-align: top;">
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="line-height: 1.25;">February 27, 2024</div>
          </td>
          <td style="width: 33%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;">Tel-Aviv</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT&#160;31.1</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXCHANGE ACT RULE&#160;13A-14(A)/15D-14(A)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;302</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">I, Larry Jasinski, certify that:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">1.&#160;I have reviewed this annual report on Form&#160;10-K of ReWalk Robotics Ltd. (the &#8220;registrant&#8221;);</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
      necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
      material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
      procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
      designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
      prepared;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting
      to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report
      our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;&#160;and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred
      during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial
      reporting; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
      financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over
      financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information;&#160;and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in
      the registrant&#8217;s internal control over financial reporting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zbe00586c916f4c3289c250e437d543eb" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">(Principal Executive Officer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;Date: February 27, 2024</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
      </u></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT&#160;31.2</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXCHANGE ACT RULE&#160;13A-14(A)/15D-14(A)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;302</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">I, Mike Lawless, certify that:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">1.&#160;I have reviewed this annual report on Form&#160;10-K of ReWalk Robotics Ltd. (the &#8220;registrant&#8221;);</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">2.&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
      necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">3.&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
      material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">4.&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
      procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
      designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
      prepared;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting
      to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report
      our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred
      during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial
      reporting; and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">5.&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
      financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over
      financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information;&#160;and</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25;">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in
      the registrant&#8217;s internal control over financial reporting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7eafa758b79a4c128e35cec2a4843933" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;">/s/ Mike Lawless</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Mike Lawless</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Chief Financial Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">(Principal Financial Officer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Date: February 27, 2024</div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="text-align: right; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: right; line-height: 1.25;">&#160;<font style="font-weight: bold;"><u>EXHIBIT&#160;32.1</u></font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">18&#160;U.S.C. SECTION&#160;1350</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;906</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Annual Report of ReWalk Robotics Ltd. (the &#8220;Company&#8221;) on Form&#160;10-K for the period ended December&#160;31, 2023, as
      filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Larry Jasinski, do hereby certify, pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my
      knowledge:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z029fa08fcce344bab6517be4d413eb28" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
                and</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z6e5b29cdad334cd4bb2db018b77ebc13" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of
                operations of the Company.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zfa680d384bfb4025b1a4176157a8db21" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;">/s/ Larry Jasinski</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Larry Jasinski</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Chief Executive Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">(Principal Executive Officer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Date: February 27, 2024</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company
      and furnished to the Securities and Exchange Commission or its staff upon request.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 23.12.1.5186
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>EXHIBIT&#160;32.2</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">18&#160;U.S.C. SECTION&#160;1350</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO SECTION&#160;906</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Annual Report of ReWalk Robotics Ltd. (the &#8220;Company&#8221;) on Form&#160;10-K for the period ended December&#160;31, 2023, as
      filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Mike Lawless, do hereby certify, pursuant to 18&#160;U.S.C. Section&#160;1350, as
      adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="ze3229972586b49968fff67ddcccd17f0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
                and</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z09587d1eb3a949318aba432c2643c267" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; text-align: right;">
              <div style="text-align: left; line-height: 1.25;">&#8226;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of
                operations of the Company.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zc83e1a44639b4fd4b2944f3c4a6bc8d8" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; line-height: 1.25;">/s/ Mike Lawless&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Mike Lawless&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Chief Financial Officer</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">(Principal Financial Officer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Date: February 27, 2024</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company
      and furnished to the Securities and Exchange Commission or its staff upon request.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"></div>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>lfwd-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:lfwd="http://www.rewalk.com/20231231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" targetNamespace="http://www.rewalk.com/20231231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
  <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.rewalk.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
        <link:definition>0005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical" id="StatementsOfChangesInShareholdersEquityParenthetical">
        <link:definition>0006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" id="ConsolidatedStatementsOfCashFlowsParenthetical">
        <link:definition>0008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/General" id="General">
        <link:definition>0009 - Disclosure - GENERAL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets" id="PrepaidExpensesAndOtherCurrentAssets">
        <link:definition>0011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/Inventories" id="Inventories">
        <link:definition>0012 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERG" id="ACQUISITIONOFALTERG">
        <link:definition>0013 - Disclosure - BUSINESS COMBINATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET" id="GOODWILLANDOTHERINTANGIBLEASSETSNET">
        <link:definition>0014 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>0015 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilities" id="CommitmentsAndContingentLiabilities">
        <link:definition>0016 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquity" id="ShareholdersEquity">
        <link:definition>0017 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement" id="ResearchCollaborationAgreementAndLicenseAgreement">
        <link:definition>0018 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>0019 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNet" id="FinancialExpensesIncomeNet">
        <link:definition>0020 - Disclosure - FINANCIAL EXPENSES (INCOME), NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData" id="GeographicInformationAndMajorCustomerAndProductData">
        <link:definition>0021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE" id="BASICANDDILUTEDNETLOSSPERSHARE">
        <link:definition>0022 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES" id="RESTRUCTRINGACTIVITIES">
        <link:definition>0023 - Disclosure - RESTRUCTURING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <link:definition>0025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" id="PrepaidExpensesAndOtherCurrentAssetsTables">
        <link:definition>0026 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/InventoriesTables" id="InventoriesTables">
        <link:definition>0027 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGTables" id="ACQUISITIONOFALTERGTables">
        <link:definition>0028 - Disclosure - BUSINESS COMBINATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables" id="GOODWILLANDOTHERINTANGIBLEASSETSNETTables">
        <link:definition>0029 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <link:definition>0030 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables" id="CommitmentsAndContingentLiabilitiesTables">
        <link:definition>0031 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityTables" id="ShareholdersEquityTables">
        <link:definition>0032 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>0033 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNetTables" id="FinancialExpensesIncomeNetTables">
        <link:definition>0034 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables" id="GeographicInformationAndMajorCustomerAndProductDataTables">
        <link:definition>0035 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables" id="BASICANDDILUTEDNETLOSSPERSHARETables">
        <link:definition>0036 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeneralDetails" id="GeneralDetails">
        <link:definition>0037 - Disclosure - GENERAL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails" id="SignificantAccountingPoliciesDetails">
        <link:definition>0038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/TestrereDetails" id="TestrereDetails">
        <link:definition>0039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/TestrereDetails1" id="TestrereDetails1">
        <link:definition>0040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6" id="SIGNIFICANTACCOUNTINGPOLICIESDetails6">
        <link:definition>0041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2" id="SignificantAccountingPoliciesDetails2">
        <link:definition>0042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4" id="SIGNIFICANTACCOUNTINGPOLICIESDetails4">
        <link:definition>0043 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5" id="SIGNIFICANTACCOUNTINGPOLICIESDetails5">
        <link:definition>0044 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual" id="SignificantAccountingPoliciesDetailsTextual">
        <link:definition>0045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" id="PrepaidExpensesAndOtherCurrentAssetsDetails">
        <link:definition>0046 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/InventoriesDetails" id="InventoriesDetails">
        <link:definition>0047 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/INVENTORIESNarrativeDetails" id="INVENTORIESNarrativeDetails">
        <link:definition>0048 - Disclosure - INVENTORIES (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails" id="ACQUISITIONOFALTERGDetails">
        <link:definition>0049 - Disclosure - BUSINESS COMBINATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1" id="ACQUISITIONOFALTERGDetails1">
        <link:definition>0050 - Disclosure - BUSINESS COMBINATION (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2" id="ACQUISITIONOFALTERGDetails2">
        <link:definition>0051 - Disclosure - BUSINESS COMBINATION (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3" id="ACQUISITIONOFALTERGDetails3">
        <link:definition>0052 - Disclosure - BUSINESS COMBINATION (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails" id="ACQUISITIONOFALTERGNarrativeDetails">
        <link:definition>0053 - Disclosure - BUSINESS COMBINATION  (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails" id="GOODWILLANDOTHERINTANGIBLEASSETSNETDetails">
        <link:definition>0054 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1" id="GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1">
        <link:definition>0055 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails" id="GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails">
        <link:definition>0056 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET  (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
        <link:definition>0057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual" id="PropertyAndEquipmentNetDetailsTextual">
        <link:definition>0058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails" id="CommitmentsAndContingentLiabilitiesDetails">
        <link:definition>0059 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual" id="CommitmentsAndContingentLiabilitiesDetailsTextual">
        <link:definition>0060 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails" id="ShareholdersEquityDetails">
        <link:definition>0061 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails1" id="ShareholdersEquityDetails1">
        <link:definition>0062 - Disclosure - SHAREHOLDERS' EQUITY (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails2" id="ShareholdersEquityDetails2">
        <link:definition>0063 - Disclosure - SHAREHOLDERS' EQUITY (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails3" id="ShareholdersEquityDetails3">
        <link:definition>0064 - Disclosure - SHAREHOLDERS' EQUITY (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails4" id="ShareholdersEquityDetails4">
        <link:definition>0065 - Disclosure - SHAREHOLDERS' EQUITY (Details 4)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ShareholdersEquityDetailsTextual" id="ShareholdersEquityDetailsTextual">
        <link:definition>0066 - Disclosure - SHAREHOLDERS' EQUITY (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails" id="ResearchCollaborationAgreementAndLicenseAgreementDetails">
        <link:definition>0067 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <link:definition>0068 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesDetails1" id="IncomeTaxesDetails1">
        <link:definition>0069 - Disclosure - INCOME TAXES (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesDetails2" id="IncomeTaxesDetails2">
        <link:definition>0070 - Disclosure - INCOME TAXES (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesDetails3" id="IncomeTaxesDetails3">
        <link:definition>0071 - Disclosure - INCOME TAXES (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesDetails4" id="IncomeTaxesDetails4">
        <link:definition>0072 - Disclosure - INCOME TAXES (Details 4)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/IncomeTaxesDetailsTextual" id="IncomeTaxesDetailsTextual">
        <link:definition>0073 - Disclosure - INCOME TAXES (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails" id="FinancialExpensesIncomeNetDetails">
        <link:definition>0074 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails" id="GeographicInformationAndMajorCustomerAndProductDataDetails">
        <link:definition>0075 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1" id="GeographicInformationAndMajorCustomerAndProductDataDetails1">
        <link:definition>0076 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2" id="GeographicInformationAndMajorCustomerAndProductDataDetails2">
        <link:definition>0077 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" id="GeographicInformationAndMajorCustomerAndProductDataDetailsTextual">
        <link:definition>0078 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails" id="BASICANDDILUTEDNETLOSSPERSHAREDetails">
        <link:definition>0079 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails" id="BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails">
        <link:definition>0080 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE  (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails" id="RESTRUCTRINGACTIVITIESNarrativeDetails">
        <link:definition>0081 - Disclosure - RESTRUCTURING ACTIVITIES  (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="lfwd-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="lfwd-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="lfwd-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="lfwd-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AcquisitionDeferredTaxAssetAdjustmentsAmount" id="lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AdditionallyWarrantsIssuedMember" id="lfwd_AdditionallyWarrantsIssuedMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AggregateNumberOfOrdinaryShares" id="lfwd_AggregateNumberOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AgreementAxis" id="lfwd_AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="AgreementDomain" id="lfwd_AgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AllowanceForSalesReturns" id="lfwd_AllowanceForSalesReturns" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AltergIncMember" id="lfwd_AltergIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfAdditionalCashEarnouts" id="lfwd_AmountOfAdditionalCashEarnouts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmountOfEmployeeTerminationBenefitsAndLegalExpenses" id="lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfWarrantProvision" id="lfwd_AmountOfWarrantProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfWarrantProvisionUsage" id="lfwd_AmountOfWarrantProvisionUsage" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BacklogMember" id="lfwd_BacklogMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankCommissions" id="lfwd_BankCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" id="lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" id="lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" id="lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" id="lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BestOfferingMember" id="lfwd_BestOfferingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" id="lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" id="lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" id="lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" id="lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" id="lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BusinessCombinationRecognizedWarrantProvision" id="lfwd_BusinessCombinationRecognizedWarrantProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" id="lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashlessExerciseOfPreFundedWarrants" id="lfwd_CashlessExerciseOfPreFundedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CertainInstitutionalPurchasersMember" id="lfwd_CertainInstitutionalPurchasersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangeInFairValueOfWarrantsLiabilityActivity" id="lfwd_ChangeInFairValueOfWarrantsLiabilityActivity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassificationOfInventoryToOtherCurrentAssets" id="lfwd_ClassificationOfInventoryToOtherCurrentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClassificationOfInventoryToPropertyAndEquipmentNet" id="lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClassificationOfInventoryToPropertyAndEquipmentNetOne" id="lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" id="lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ClassOfWarrantOrRightExercisable" id="lfwd_ClassOfWarrantOrRightExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassOfWarrantOrRightPolicyTextBlock" id="lfwd_ClassOfWarrantOrRightPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommitmentsAndContingenciesLiabilitiesAbstract" id="lfwd_CommitmentsAndContingenciesLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" id="lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" id="lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonUnitsAndPreFundedUnits1Member" id="lfwd_CommonUnitsAndPreFundedUnits1Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonUnitsAndPreFundedUnitsMember" id="lfwd_CommonUnitsAndPreFundedUnitsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonUnitsMember" id="lfwd_CommonUnitsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContingentLiabilityRelatedToGrantsReceived" id="lfwd_ContingentLiabilityRelatedToGrantsReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards" id="lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CustomerAMember" id="lfwd_CustomerAMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerBMember" id="lfwd_CustomerBMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerCMember" id="lfwd_CustomerCMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerDMember" id="lfwd_CustomerDMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerEMember" id="lfwd_CustomerEMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerFMember" id="lfwd_CustomerFMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerGMember" id="lfwd_CustomerGMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerHMember" id="lfwd_CustomerHMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerIMember" id="lfwd_CustomerIMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerJMember" id="lfwd_CustomerJMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerRelationshipDistributionMember" id="lfwd_CustomerRelationshipDistributionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerRelationshipRentalMember" id="lfwd_CustomerRelationshipRentalMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CustomerRelationshipWarrantyMember" id="lfwd_CustomerRelationshipWarrantyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended" id="lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="December2020PrivatePlacementMember" id="lfwd_December2020PrivatePlacementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DeferredIncomeTax" id="lfwd_DeferredIncomeTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" id="lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" id="lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxExpenseEffectOfChangeInTaxRate" id="lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DeferredTaxLiabilitiesRightOfUseAsset" id="lfwd_DeferredTaxLiabilitiesRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" id="lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfUnderwritingAgreement" id="lfwd_DescriptionOfUnderwritingAgreement" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" id="lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock" id="lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EarnoutLiabilityCurrent" id="lfwd_EarnoutLiabilityCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EarnoutMember" id="lfwd_EarnoutMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EarnOutPaymentOfBusinessCombination" id="lfwd_EarnOutPaymentOfBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EarnOutRemeasured" id="lfwd_EarnOutRemeasured" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="EmployeesAndNonEmployeesMember" id="lfwd_EmployeesAndNonEmployeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeeStockOptionAndRestrictedStockUnitsRsuMember" id="lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EquityExchangeProgramMember" id="lfwd_EquityExchangeProgramMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExerciseOfPreFundedWarrants" id="lfwd_ExerciseOfPreFundedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExerciseOfPreFundedWarrantsAndWarrantsShares" id="lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExerciseOfPreFundedWarrantsAndWarrantsValue" id="lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ExercisePriceOrdinaryShares" id="lfwd_ExercisePriceOrdinaryShares" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeFiveMember" id="lfwd_ExercisePriceRangeFiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeFourMember" id="lfwd_ExercisePriceRangeFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeMember" id="lfwd_ExercisePriceRangeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeOneMember" id="lfwd_ExercisePriceRangeOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeThreeMember" id="lfwd_ExercisePriceRangeThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceRangeTwoMember" id="lfwd_ExercisePriceRangeTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueWarrantsLiabilityActivityLineItems" id="lfwd_FairValueWarrantsLiabilityActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueWarrantsLiabilityActivityTable" id="lfwd_FairValueWarrantsLiabilityActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="FeesAndOtherRelatedExpenses" id="lfwd_FeesAndOtherRelatedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FieldServiceUnitsMember" id="lfwd_FieldServiceUnitsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinancialExpensesAndIncomeNet" id="lfwd_FinancialExpensesAndIncomeNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FinancialExpensesIncomeNet" id="lfwd_FinancialExpensesIncomeNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FirstAmendmentMember" id="lfwd_FirstAmendmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FixedCommissionAmount" id="lfwd_FixedCommissionAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FixedCommissionRate" id="lfwd_FixedCommissionRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralAbstract" id="lfwd_GeneralAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeographicInformationAndMajorCustomerAndProductDataAbstract" id="lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentGrantsPolicyTextBlock" id="lfwd_GovernmentGrantsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GuarantorObligationsCollateralPledged" id="lfwd_GuarantorObligationsCollateralPledged" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ImputedInterest" id="lfwd_ImputedInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IncomeTaxesAbstract" id="lfwd_IncomeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" id="lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InitialRecognitionOfOperatingLeaseLiabilities" id="lfwd_InitialRecognitionOfOperatingLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InitialRecognitionOfOperatingLeaseRightOfUseAssets" id="lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IntangibleAssetsNonCurrent" id="lfwd_IntangibleAssetsNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="InterestReceived" id="lfwd_InterestReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="InvestmentOptionsExercisePrices" id="lfwd_InvestmentOptionsExercisePrices" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraeliMember" id="lfwd_IsraeliMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraelInnovationAuthorityMember" id="lfwd_IsraelInnovationAuthorityMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" id="lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount" id="lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="KreosCapitalMember" id="lfwd_KreosCapitalMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KreosCapitalVMember" id="lfwd_KreosCapitalVMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseAgreementsTerm" id="lfwd_LeaseAgreementsTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicenseAgreementAndCollaborationAgreementMember" id="lfwd_LicenseAgreementAndCollaborationAgreementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" id="lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension" id="lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="LongTermEarnoutLiability" id="lfwd_LongTermEarnoutLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MachineryAndLaboratoryEquipmentMember" id="lfwd_MachineryAndLaboratoryEquipmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" id="lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetOperatingCarryForwardLossesExpirationTerm" id="lfwd_NetOperatingCarryForwardLossesExpirationTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetOperatingCarryForwardLossesTerms" id="lfwd_NetOperatingCarryForwardLossesTerms" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" id="lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" id="lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsOutstandingTotal" id="lfwd_NumberOfWarrantsOutstandingTotal" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfferingOfOrdinarySharesInDecember2020Member" id="lfwd_OfferingOfOrdinarySharesInDecember2020Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfferingOfOrdinarySharesInFebruary2020Member" id="lfwd_OfferingOfOrdinarySharesInFebruary2020Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfferingOfOrdinarySharesInFebruary2020TwoMember" id="lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfferingOfOrdinarySharesInJuly2020Member" id="lfwd_OfferingOfOrdinarySharesInJuly2020Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" id="lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="OperatingLossCarryforwardsPriorPeriod" id="lfwd_OperatingLossCarryforwardsPriorPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PaycheckProtectionProgramLoanMember" id="lfwd_PaycheckProtectionProgramLoanMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsForPurchaseOfTreasuryStock" id="lfwd_PaymentsForPurchaseOfTreasuryStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="PaymentToRepurchaseOfShares" id="lfwd_PaymentToRepurchaseOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" id="lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedMember" id="lfwd_PreFundedMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedUnitsMember" id="lfwd_PreFundedUnitsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaidExpenseAndOtherAssetsDisclosureTextBlock" id="lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaidExpensesToGovernmentInstitutionsCurrent" id="lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfRegistrationCost" id="lfwd_ProceedsFromIssuanceOfRegistrationCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfRegistrationCostTwo" id="lfwd_ProceedsFromIssuanceOfRegistrationCostTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromOfferingCost" id="lfwd_ProceedsFromOfferingCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromStockOne" id="lfwd_ProceedsFromStockOne" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromStockTwo" id="lfwd_ProceedsFromStockTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PropertyAndEquipmentNetTextualAbstract" id="lfwd_PropertyAndEquipmentNetTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PropertyPlantAndEquipmentUsefulLifeDescription" id="lfwd_PropertyPlantAndEquipmentUsefulLifeDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" id="lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PurchaseAgreementWithCertainInstitutionalInvestorsMember" id="lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" id="lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RegisteredDirectMember" id="lfwd_RegisteredDirectMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RegisteredDirectOfferingMember" id="lfwd_RegisteredDirectOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" id="lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RelatedPartiesTransactionsAndBalancesPolicyTextBlock" id="lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RelatedPartyTransactionOwnershipPercentage" id="lfwd_RelatedPartyTransactionOwnershipPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RentalMember" id="lfwd_RentalMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RentalRevenueForAntiGravityProducts" id="lfwd_RentalRevenueForAntiGravityProducts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReorganizationExpenses" id="lfwd_ReorganizationExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" id="lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentRoyaltyBearingGrants" id="lfwd_ResearchAndDevelopmentRoyaltyBearingGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" id="lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestOfWorldMember" id="lfwd_RestOfWorldMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReStoreProductMember" id="lfwd_ReStoreProductMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestrictedCashAndOtherLongTermAssets" id="lfwd_RestrictedCashAndOtherLongTermAssets" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestrictedCashIncludedInOtherNonCurrentAssets" id="lfwd_RestrictedCashIncludedInOtherNonCurrentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RestructringActivitiesAxis" id="lfwd_RestructringActivitiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="RestructringActivitiesLineItems" id="lfwd_RestructringActivitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestructuringActivitiesDomain" id="lfwd_RestructuringActivitiesDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestructuringAndRelatedActivitiesTable" id="lfwd_RestructuringAndRelatedActivitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="RevenueObligationAxis" id="lfwd_RevenueObligationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="RevenueObligationDomain" id="lfwd_RevenueObligationDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RevenueRecognitionRecognized" id="lfwd_RevenueRecognitionRecognized" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RewalkRoboticsGmbhMember" id="lfwd_RewalkRoboticsGmbhMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReWalkRoboticsIncMember" id="lfwd_ReWalkRoboticsIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltyBearingGrantsExpenses" id="lfwd_RoyaltyBearingGrantsExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RoyaltyFeesPercentage" id="lfwd_RoyaltyFeesPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RrlAndRrgMember" id="lfwd_RrlAndRrgMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfContractBalancesTableTextBlock" id="lfwd_ScheduleOfContractBalancesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfIncomeTaxLineItems" id="lfwd_ScheduleOfIncomeTaxLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfIncomeTaxTable" id="lfwd_ScheduleOfIncomeTaxTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" id="lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" id="lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfWarrantsLiabilityActivityTableTextBlock" id="lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfWarrantyProvisionTableTextBlock" id="lfwd_ScheduleOfWarrantyProvisionTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SCIProductsMember" id="lfwd_SCIProductsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecondAmendmentMember" id="lfwd_SecondAmendmentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SecuritiesPurchaseAgreementsMember" id="lfwd_SecuritiesPurchaseAgreementsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SellingAndMarketingExpenseNet" id="lfwd_SellingAndMarketingExpenseNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ServiceAndWarrantyMember" id="lfwd_ServiceAndWarrantyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeverancePayMonthlyDepositByEmployeesPercentage" id="lfwd_SeverancePayMonthlyDepositByEmployeesPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" id="lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" id="lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" id="lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" id="lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" id="lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" id="lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" id="lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareholdersEquityTextualAbstract" id="lfwd_ShareholdersEquityTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareRepurchaseProgramMember" id="lfwd_ShareRepurchaseProgramMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Sharesissuedduringperiodvaluetreasurystock" id="lfwd_Sharesissuedduringperiodvaluetreasurystock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SignificantAccountingPoliciesTextualAbstract" id="lfwd_SignificantAccountingPoliciesTextualAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SiliconValleyBankMember" id="lfwd_SiliconValleyBankMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SparePartsAndWarrantiesMember" id="lfwd_SparePartsAndWarrantiesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StateNetOperatingLossCarryForwards" id="lfwd_StateNetOperatingLossCarryForwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="StockIssuedDuringPeriodShareOrdinaryShares" id="lfwd_StockIssuedDuringPeriodShareOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" id="lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" id="lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" id="lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesOrdinaryShares" id="lfwd_StockIssuedDuringPeriodSharesOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesOrdinaryShares1" id="lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesPrivatePlacement" id="lfwd_StockIssuedDuringPeriodSharesPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" id="lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" id="lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" id="lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueNewIssuesGross" id="lfwd_StockIssuedDuringPeriodValueNewIssuesGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueOrdinaryShares" id="lfwd_StockIssuedDuringPeriodValueOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueOrdinaryShares1" id="lfwd_StockIssuedDuringPeriodValueOrdinaryShares1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValuePrivatePlacement" id="lfwd_StockIssuedDuringPeriodValuePrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SupplementalCashFlowCashAndCashEquivalents" id="lfwd_SupplementalCashFlowCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SupplementalDisclosuresOfCashFlowInformation" id="lfwd_SupplementalDisclosuresOfCashFlowInformation" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TaxesIncome" id="lfwd_TaxesIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TaxesOnIncome" id="lfwd_TaxesOnIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="TreasurySharesPolicyTextBlock" id="lfwd_TreasurySharesPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoZeroTwoThreeReorganizationPlanMember" id="lfwd_TwoZeroTwoThreeReorganizationPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TypeOfCurrencyAxis" id="lfwd_TypeOfCurrencyAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="TypeofCurrencyDomain" id="lfwd_TypeofCurrencyDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnitsPlacedMember" id="lfwd_UnitsPlacedMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" id="lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" id="lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="WarrantExerciseAgreementMember" id="lfwd_WarrantExerciseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantExerciseMember" id="lfwd_WarrantExerciseMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExercisableDescrition" id="lfwd_WarrantsExercisableDescrition" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExpitationDate" id="lfwd_WarrantsExpitationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsLiabilityActivity" id="lfwd_WarrantsLiabilityActivity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinaryShares" id="lfwd_WarrantsToPurchaseOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember" id="lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantyProvisionBalance" id="lfwd_WarrantyProvisionBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WorkforcePercentage" id="lfwd_WorkforcePercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="YaskawaElectricCorporationMember" id="lfwd_YaskawaElectricCorporationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>lfwd-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.rewalk.com/role/ConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedStatementsOfOperations" roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#InventoriesDetails" roleURI="http://www.rewalk.com/role/InventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#CommitmentsAndContingentLiabilitiesDetails" roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails1" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails2" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails4" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails4"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#FinancialExpensesIncomeNetDetails" roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails1" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IntangibleAssetsNonCurrent" xlink:label="loc_lfwd_IntangibleAssetsNonCurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutLiabilityCurrent" xlink:label="loc_lfwd_EarnoutLiabilityCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermEarnoutLiability" xlink:label="loc_lfwd_LongTermEarnoutLiability_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaap_TreasuryStockCommonValue_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_30"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_InventoryNet_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_lfwd_IntangibleAssetsNonCurrent_9" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_Goodwill_10" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_Liabilities_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13" xlink:to="loc_us-gaap_LiabilitiesCurrent_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_AccountsPayableCurrent_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_DeferredRevenueCurrent_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_lfwd_EarnoutLiabilityCurrent_17" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_13" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_18" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_13" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_20" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_20" xlink:to="loc_lfwd_LongTermEarnoutLiability_20" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_20" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_21" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_20" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_22" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_20" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_23" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_CommitmentsAndContingencies_26" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_12" xlink:to="loc_us-gaap_StockholdersEquity_27" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_27" xlink:to="loc_us-gaap_CommonStockValue_27" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_27" xlink:to="loc_us-gaap_AdditionalPaidInCapital_28" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_27" xlink:to="loc_us-gaap_TreasuryStockCommonValue_29" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_27" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_30" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_us-gaap_OperatingIncomeLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1" xlink:to="loc_us-gaap_GrossProfit_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1" xlink:to="loc_us-gaap_Revenues_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1" xlink:to="loc_us-gaap_CostOfRevenue_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1" xlink:to="loc_us-gaap_OperatingExpenses_4" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_5" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:to="loc_lfwd_FinancialExpensesIncomeNet_9" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_11" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutRemeasured" xlink:label="loc_lfwd_EarnOutRemeasured_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrants_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentsForPurchaseOfTreasuryStock" xlink:label="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCostTwo" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_28"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_lfwd_EarnOutRemeasured_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_NetIncomeLoss_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ShareBasedCompensation_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_6" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_Depreciation_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9" order="80" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_10" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_11" order="100" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_12" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_13" order="120" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_14" order="130" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_15" order="140" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_17" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_18" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_20" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_20" xlink:to="loc_lfwd_ExerciseOfPreFundedWarrants_20" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_20" xlink:to="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_21" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_20" xlink:to="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_22" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_20" xlink:to="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_23" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_27" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_28" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies" xlink:label="loc_us-gaap_Supplies_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_Supplies_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_OtherAssetsCurrent_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/InventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0" xlink:to="loc_us-gaap_InventoryFinishedGoods_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0" xlink:to="loc_us-gaap_InventoryRawMaterials_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails1">
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesOnIncome" xlink:label="loc_lfwd_TaxesOnIncome_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredIncomeTax" xlink:label="loc_lfwd_DeferredIncomeTax_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesIncome" xlink:label="loc_lfwd_TaxesIncome_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_TaxesOnIncome_0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_TaxesOnIncome_0" xlink:to="loc_lfwd_DeferredIncomeTax_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_TaxesIncome_3" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_TaxesIncome_3" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_5" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_12"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xlink:to="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xlink:to="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_9" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1" xlink:to="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_10" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_12" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_7" order="60" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails">
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BankCommissions" xlink:label="loc_lfwd_BankCommissions_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_0" xlink:to="loc_lfwd_BankCommissions_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_0" xlink:to="loc_us-gaap_InterestExpenseDebt_3" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_0" xlink:to="loc_us-gaap_InterestIncomeOther_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_16"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_3" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_4" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_10" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_11" order="100" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_12" order="110" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_13" order="120" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_14" order="130" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_Goodwill_15" order="140" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_16" order="150" use="optional" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>lfwd-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#StatementsOfChangesInShareholdersEquity" roleURI="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" roleURI="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesDetailsTextual" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#CommitmentsAndContingentLiabilitiesDetailsTextual" roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails1" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails2" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails3" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails3"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails4" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails4"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetailsTextual" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ResearchCollaborationAgreementAndLicenseAgreementDetails" roleURI="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetailsTextual" roleURI="http://www.rewalk.com/role/IncomeTaxesDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails1" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails2" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#RESTRUCTRINGACTIVITIESNarrativeDetails" roleURI="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETDetails" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesDetails2" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails4" roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails5" roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails2" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGNarrativeDetails" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesDetails" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#TestrereDetails" roleURI="http://www.rewalk.com/role/TestrereDetails"/>
  <roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockPreferredMember" xlink:label="loc_us-gaap_TreasuryStockPreferredMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards" xlink:label="loc_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_23"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_27"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_28"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_Sharesissuedduringperiodvaluetreasurystock" xlink:label="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_TreasuryStockPreferredMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_17" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_18" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_19" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_20" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_21" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_22" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_23" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_24" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_25" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_26" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_27" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_28" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_29" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_30" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_31" order="230" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BestOfferingMember" xlink:label="loc_lfwd_BestOfferingMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingMember" xlink:label="loc_lfwd_RegisteredDirectOfferingMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseMember" xlink:label="loc_lfwd_WarrantExerciseMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_lfwd_BestOfferingMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_lfwd_RegisteredDirectOfferingMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_us-gaap_PrivatePlacementMember_4" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_lfwd_WarrantExerciseMember_5" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectMember" xlink:label="loc_lfwd_RegisteredDirectMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BestOfferingMember" xlink:label="loc_lfwd_BestOfferingMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseMember" xlink:label="loc_lfwd_WarrantExerciseMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_us-gaap_PrivatePlacementMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_lfwd_RegisteredDirectMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_lfwd_BestOfferingMember_4" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2" xlink:to="loc_lfwd_WarrantExerciseMember_5" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeesAndNonEmployeesMember" xlink:label="loc_lfwd_EmployeesAndNonEmployeesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_YaskawaElectricCorporationMember" xlink:label="loc_lfwd_YaskawaElectricCorporationMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReStoreProductMember" xlink:label="loc_lfwd_ReStoreProductMember_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SCIProductsMember" xlink:label="loc_lfwd_SCIProductsMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_32"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RelatedPartyTransactionOwnershipPercentage" xlink:label="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_33"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AllowanceForSalesReturns" xlink:label="loc_lfwd_AllowanceForSalesReturns_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueRecognitionRecognized" xlink:label="loc_lfwd_RevenueRecognitionRecognized_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_37"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" xlink:label="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_38"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaap_PostemploymentBenefitsPeriodExpense_40"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyBearingGrantsExpenses" xlink:label="loc_lfwd_RoyaltyBearingGrantsExpenses_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_42"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_43"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalRevenueForAntiGravityProducts" xlink:label="loc_lfwd_RentalRevenueForAntiGravityProducts_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_45"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LeaseAgreementsTerm" xlink:label="loc_lfwd_LeaseAgreementsTerm_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_47"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1" xlink:to="loc_lfwd_EmployeesAndNonEmployeesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_MajorCustomersAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_5" xlink:to="loc_srt_NameOfMajorCustomerDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5" xlink:to="loc_lfwd_YaskawaElectricCorporationMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_5" xlink:to="loc_srt_NameOfMajorCustomerDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9" xlink:to="loc_us-gaap_AccountsReceivableMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_13" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_13" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_13" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_17" xlink:to="loc_us-gaap_TypeOfAdoptionMember_Default" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_17" xlink:to="loc_us-gaap_TypeOfAdoptionMember_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_ProductOrServiceAxis_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_20" xlink:to="loc_srt_ProductsAndServicesDomain_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_20" xlink:to="loc_lfwd_ReStoreProductMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_20" xlink:to="loc_lfwd_SCIProductsMember_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_20" xlink:to="loc_srt_ProductsAndServicesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_RangeAxis_25" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_25" xlink:to="loc_srt_RangeMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_25" xlink:to="loc_srt_MinimumMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_25" xlink:to="loc_srt_MaximumMember_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_25" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_InventoryWriteDown_31" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_32" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_33" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_AllowanceForSalesReturns_34" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_35" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_RevenueRecognitionRecognized_36" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_37" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_38" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_39" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_PostemploymentBenefitsPeriodExpense_40" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_RoyaltyBearingGrantsExpenses_41" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_RoyaltyExpense_42" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_43" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_RentalRevenueForAntiGravityProducts_44" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_45" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_lfwd_LeaseAgreementsTerm_46" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_31" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_47" order="160" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_lfwd_MachineryAndLaboratoryEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FieldServiceUnitsMember" xlink:label="loc_lfwd_FieldServiceUnitsMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4" order="30" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_ComputerEquipmentMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_lfwd_MachineryAndLaboratoryEquipmentMember_6" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_lfwd_FieldServiceUnitsMember_7" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_8" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraelInnovationAuthorityMember" xlink:label="loc_lfwd_IsraelInnovationAuthorityMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RrlAndRrgMember" xlink:label="loc_lfwd_RrlAndRrgMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommitmentsAndContingenciesLiabilitiesAbstract" xlink:label="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRoyaltiesReceived" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRoyalties" xlink:label="loc_us-gaap_PaymentsForRoyalties_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyFeesPercentage" xlink:label="loc_lfwd_RoyaltyFeesPercentage_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaap_ConversionOfStockDescription_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_27"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_29"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GuarantorObligationsCollateralPledged" xlink:label="loc_lfwd_GuarantorObligationsCollateralPledged_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaap_LesseeOperatingLeaseDescription_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_33"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_us-gaap_OtherCommitmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_IsraelInnovationAuthorityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_RrlAndRrgMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_RangeAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6" xlink:to="loc_srt_RangeMember_Default" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6" xlink:to="loc_srt_RangeMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9" xlink:to="loc_us-gaap_ClassOfStockDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_13" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13" xlink:to="loc_us-gaap_IPOMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_13" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_0" xlink:to="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_PurchaseObligation_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_PaymentsForRoyalties_22" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_23" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_24" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_RoyaltyFeesPercentage_25" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_ConversionOfStockDescription_26" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_27" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_28" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_RoyaltyExpense_29" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_lfwd_GuarantorObligationsCollateralPledged_30" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_LesseeOperatingLeaseDescription_31" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_OtherLongTermDebt_32" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_18" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_33" order="150" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_1" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_6" xlink:to="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_6" xlink:to="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_6" xlink:to="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_6" xlink:to="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11" order="20" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11" xlink:to="loc_us-gaap_AwardTypeAxis_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_11" xlink:to="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeMember" xlink:label="loc_lfwd_ExercisePriceRangeMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeOneMember" xlink:label="loc_lfwd_ExercisePriceRangeOneMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeTwoMember" xlink:label="loc_lfwd_ExercisePriceRangeTwoMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeThreeMember" xlink:label="loc_lfwd_ExercisePriceRangeThreeMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFourMember" xlink:label="loc_lfwd_ExercisePriceRangeFourMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFiveMember" xlink:label="loc_lfwd_ExercisePriceRangeFiveMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InvestmentOptionsExercisePrices" xlink:label="loc_lfwd_InvestmentOptionsExercisePrices_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" xlink:to="loc_lfwd_ExercisePriceRangeMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" xlink:to="loc_lfwd_ExercisePriceRangeOneMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" xlink:to="loc_lfwd_ExercisePriceRangeTwoMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" xlink:to="loc_lfwd_ExercisePriceRangeThreeMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" xlink:to="loc_lfwd_ExercisePriceRangeFourMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5" xlink:to="loc_lfwd_ExercisePriceRangeFiveMember_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_lfwd_InvestmentOptionsExercisePrices_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_20" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_21" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_22" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails3">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_CostOfSalesMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_4" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_14"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_27"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightExercisable" xlink:label="loc_lfwd_ClassOfWarrantOrRightExercisable_28"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExpitationDate" xlink:label="loc_lfwd_WarrantsExpitationDate_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_20" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_21" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_27" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_lfwd_ClassOfWarrantOrRightExercisable_28" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0" xlink:to="loc_lfwd_WarrantsExpitationDate_29" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareRepurchaseProgramMember" xlink:label="loc_lfwd_ShareRepurchaseProgramMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalMember" xlink:label="loc_lfwd_KreosCapitalMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementAxis" xlink:label="loc_lfwd_AgreementAxis_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementDomain" xlink:label="loc_lfwd_AgreementDomain_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SecuritiesPurchaseAgreementsMember" xlink:label="loc_lfwd_SecuritiesPurchaseAgreementsMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EquityExchangeProgramMember" xlink:label="loc_lfwd_EquityExchangeProgramMember_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CertainInstitutionalPurchasersMember" xlink:label="loc_lfwd_CertainInstitutionalPurchasersMember_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementDomain" xlink:label="loc_lfwd_AgreementDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInJuly2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInDecember2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_December2020PrivatePlacementMember" xlink:label="loc_lfwd_December2020PrivatePlacementMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnitsMember" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsMember" xlink:label="loc_lfwd_CommonUnitsMember_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PreFundedUnitsMember" xlink:label="loc_lfwd_PreFundedUnitsMember_27"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_28"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_29"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_30"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_40"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalVMember" xlink:label="loc_lfwd_KreosCapitalVMember_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeOfCurrencyAxis" xlink:label="loc_lfwd_TypeOfCurrencyAxis_44"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeofCurrencyDomain" xlink:label="loc_lfwd_TypeofCurrencyDomain_44"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraeliMember" xlink:label="loc_lfwd_IsraeliMember_44"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeofCurrencyDomain" xlink:label="loc_lfwd_TypeofCurrencyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_48"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AdditionallyWarrantsIssuedMember" xlink:label="loc_lfwd_AdditionallyWarrantsIssuedMember_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareholdersEquityTextualAbstract" xlink:label="loc_lfwd_ShareholdersEquityTextualAbstract_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_58"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_59"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_64"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_66"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionRate" xlink:label="loc_lfwd_FixedCommissionRate_67"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionAmount" xlink:label="loc_lfwd_FixedCommissionAmount_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_73"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_74"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_75"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AggregateNumberOfOrdinaryShares" xlink:label="loc_lfwd_AggregateNumberOfOrdinaryShares_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_77"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_78"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_79"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_81"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExercisableDescrition" xlink:label="loc_lfwd_WarrantsExercisableDescrition_82"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaap_DebtInstrumentCollateralAmount_83"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaap_ProceedsFromStockPlans_84"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_85"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_FeesAndOtherRelatedExpenses_86"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_87"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:label="loc_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_88"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfUnderwritingAgreement" xlink:label="loc_lfwd_DescriptionOfUnderwritingAgreement_89"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_90"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_91"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_92"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceOrdinaryShares" xlink:label="loc_lfwd_ExercisePriceOrdinaryShares_93"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_94"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinaryShares_95"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_96"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfWarrantsOutstandingTotal" xlink:label="loc_lfwd_NumberOfWarrantsOutstandingTotal_97"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_98"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_1" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1" xlink:to="loc_lfwd_ShareRepurchaseProgramMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_1" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_5" xlink:to="loc_lfwd_KreosCapitalMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_lfwd_AgreementAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lfwd_AgreementAxis_9" xlink:to="loc_lfwd_AgreementDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_AgreementDomain_9" xlink:to="loc_lfwd_SecuritiesPurchaseAgreementsMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_AgreementDomain_9" xlink:to="loc_lfwd_EquityExchangeProgramMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_AgreementDomain_9" xlink:to="loc_lfwd_CertainInstitutionalPurchasersMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lfwd_AgreementAxis_9" xlink:to="loc_lfwd_AgreementDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_19" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_15" xlink:to="loc_lfwd_December2020PrivatePlacementMember_20" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_24" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_us-gaap_PrivatePlacementMember_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_CommonUnitsMember_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_PreFundedUnitsMember_27" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_28" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_29" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_30" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_24" xlink:to="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_31" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_24" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_35" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_35" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_35" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_35" xlink:to="loc_us-gaap_EmployeeStockOptionMember_36" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_35" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_dei_LegalEntityAxis_40" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_40" xlink:to="loc_dei_EntityDomain_40" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_40" xlink:to="loc_lfwd_KreosCapitalVMember_40" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_40" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_lfwd_TypeOfCurrencyAxis_44" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lfwd_TypeOfCurrencyAxis_44" xlink:to="loc_lfwd_TypeofCurrencyDomain_44" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_TypeofCurrencyDomain_44" xlink:to="loc_lfwd_IsraeliMember_44" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lfwd_TypeOfCurrencyAxis_44" xlink:to="loc_lfwd_TypeofCurrencyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_48" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48" xlink:to="loc_us-gaap_ClassOfStockDomain_48" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_48" xlink:to="loc_lfwd_AdditionallyWarrantsIssuedMember_48" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_48" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_srt_RangeAxis_52" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_52" xlink:to="loc_srt_RangeMember_52" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_52" xlink:to="loc_srt_MinimumMember_52" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_52" xlink:to="loc_srt_MaximumMember_53" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_52" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_0" xlink:to="loc_lfwd_ShareholdersEquityTextualAbstract_58" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_58" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_59" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_60" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_62" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_63" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_64" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_65" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_66" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_FixedCommissionRate_67" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_FixedCommissionAmount_68" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_69" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_70" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_71" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_72" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_73" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_74" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_75" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_AggregateNumberOfOrdinaryShares_76" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_77" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_78" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_79" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_81" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_WarrantsExercisableDescrition_82" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_DebtInstrumentCollateralAmount_83" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ProceedsFromStockPlans_84" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_85" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_FeesAndOtherRelatedExpenses_86" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_87" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_88" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_DescriptionOfUnderwritingAgreement_89" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_90" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_91" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_92" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_ExercisePriceOrdinaryShares_93" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_94" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinaryShares_95" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_96" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_lfwd_NumberOfWarrantsOutstandingTotal_97" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_58" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_98" order="400" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:label="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementAxis" xlink:label="loc_lfwd_AgreementAxis_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementDomain" xlink:label="loc_lfwd_AgreementDomain_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LicenseAgreementAndCollaborationAgreementMember" xlink:label="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementDomain" xlink:label="loc_lfwd_AgreementDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0" xlink:to="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_3" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_3" xlink:to="loc_lfwd_AgreementAxis_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lfwd_AgreementAxis_3" xlink:to="loc_lfwd_AgreementDomain_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_AgreementDomain_3" xlink:to="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lfwd_AgreementAxis_3" xlink:to="loc_lfwd_AgreementDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetailsTextual">
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxLineItems" xlink:label="loc_lfwd_ScheduleOfIncomeTaxLineItems_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxTable" xlink:label="loc_lfwd_ScheduleOfIncomeTaxTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReWalkRoboticsIncMember" xlink:label="loc_lfwd_ReWalkRoboticsIncMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RewalkRoboticsGmbhMember" xlink:label="loc_lfwd_RewalkRoboticsGmbhMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxesAbstract" xlink:label="loc_lfwd_IncomeTaxesAbstract_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate" xlink:label="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesTerms" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesTerms_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_27"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLossCarryforwardsPriorPeriod" xlink:label="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_28"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesExpirationTerm" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_29"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lfwd_ScheduleOfIncomeTaxLineItems_0" xlink:to="loc_lfwd_ScheduleOfIncomeTaxTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_ReWalkRoboticsIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_RewalkRoboticsGmbhMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_AltergIncMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" xlink:to="loc_us-gaap_ForeignCountryMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_7" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_srt_RangeAxis_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MinimumMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MaximumMember_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_ScheduleOfIncomeTaxLineItems_0" xlink:to="loc_lfwd_IncomeTaxesAbstract_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_22" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_23" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_us-gaap_OperatingLossCarryforwards_24" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_25" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_NetOperatingCarryForwardLossesTerms_26" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_27" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_28" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_IncomeTaxesAbstract_19" xlink:to="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_29" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember" xlink:label="loc_srt_AsiaPacificMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember" xlink:label="loc_srt_LatinAmericaMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AfricaMember" xlink:label="loc_srt_AfricaMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestOfWorldMember" xlink:label="loc_lfwd_RestOfWorldMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_EuropeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_AsiaPacificMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_LatinAmericaMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_AfricaMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_lfwd_RestOfWorldMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_0" xlink:to="loc_us-gaap_Revenues_12" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_country_DE_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xlink:to="loc_us-gaap_NoncurrentAssets_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_2" xlink:to="loc_srt_StatementGeographicalAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2" xlink:to="loc_srt_SegmentGeographicalDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2" xlink:to="loc_country_IL_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2" xlink:to="loc_country_US_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2" xlink:to="loc_country_DE_4" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerBMember" xlink:label="loc_lfwd_CustomerBMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerCMember" xlink:label="loc_lfwd_CustomerCMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" xlink:to="loc_us-gaap_SalesRevenueNetMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_srt_MajorCustomersAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_5" xlink:to="loc_srt_NameOfMajorCustomerDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5" xlink:to="loc_lfwd_CustomerAMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5" xlink:to="loc_lfwd_CustomerBMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5" xlink:to="loc_lfwd_CustomerCMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_5" xlink:to="loc_srt_NameOfMajorCustomerDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_11" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_11" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_11" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_16" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructringActivitiesLineItems" xlink:label="loc_lfwd_RestructringActivitiesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructuringAndRelatedActivitiesTable" xlink:label="loc_lfwd_RestructuringAndRelatedActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TwoZeroTwoThreeReorganizationPlanMember" xlink:label="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WorkforcePercentage" xlink:label="loc_lfwd_WorkforcePercentage_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses" xlink:label="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lfwd_RestructringActivitiesLineItems_0" xlink:to="loc_lfwd_RestructuringAndRelatedActivitiesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lfwd_RestructuringAndRelatedActivitiesTable_1" xlink:to="loc_us-gaap_PlanNameAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1" xlink:to="loc_us-gaap_PlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1" xlink:to="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1" xlink:to="loc_us-gaap_PlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_RestructringActivitiesLineItems_0" xlink:to="loc_lfwd_WorkforcePercentage_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_RestructringActivitiesLineItems_0" xlink:to="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_RestructringActivitiesLineItems_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_RestructringActivitiesLineItems_0" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_RestructringActivitiesLineItems_0" xlink:to="loc_us-gaap_SellingAndMarketingExpense_10" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BacklogMember" xlink:label="loc_lfwd_BacklogMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TrademarksMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipWarrantyMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipRentalMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_BacklogMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_13" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_lfwd_AltergIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_0" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerBMember" xlink:label="loc_lfwd_CustomerBMember_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerCMember" xlink:label="loc_lfwd_CustomerCMember_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerDMember" xlink:label="loc_lfwd_CustomerDMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" xlink:to="loc_us-gaap_AccountsReceivableMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_5" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_MajorCustomersAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_9" xlink:to="loc_srt_NameOfMajorCustomerDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9" xlink:to="loc_lfwd_CustomerAMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9" xlink:to="loc_lfwd_CustomerBMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9" xlink:to="loc_lfwd_CustomerCMember_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9" xlink:to="loc_lfwd_CustomerDMember_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_9" xlink:to="loc_srt_NameOfMajorCustomerDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_17" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_21"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_11" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_11" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_15" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_15" xlink:to="loc_lfwd_EarnoutMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_15" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_21" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5">
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityLineItems" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityTable" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_Default"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ChangeInFairValueOfWarrantsLiabilityActivity" xlink:label="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_0" xlink:to="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1" xlink:to="loc_lfwd_EarnoutMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_0" xlink:to="loc_lfwd_WarrantsLiabilityActivity_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_0" xlink:to="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_7" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_lfwd_AltergIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipDistributionMember" xlink:label="loc_lfwd_CustomerRelationshipDistributionMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TrademarksMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipWarrantyMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipRentalMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipDistributionMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_12" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfAdditionalCashEarnouts" xlink:label="loc_lfwd_AmountOfAdditionalCashEarnouts_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutPaymentOfBusinessCombination" xlink:label="loc_lfwd_EarnOutPaymentOfBusinessCombination_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_12"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_lfwd_AltergIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_lfwd_AmountOfAdditionalCashEarnouts_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_lfwd_EarnOutPaymentOfBusinessCombination_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_0" xlink:to="loc_us-gaap_Revenues_12" order="70" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_lfwd_MachineryAndLaboratoryEquipmentMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FieldServiceUnitsMember" xlink:label="loc_lfwd_FieldServiceUnitsMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PropertyPlantAndEquipmentUsefulLifeDescription" xlink:label="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_ComputerEquipmentMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_lfwd_MachineryAndLaboratoryEquipmentMember_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6" xlink:to="loc_lfwd_FieldServiceUnitsMember_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_16" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/TestrereDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationAxis" xlink:label="loc_lfwd_RevenueObligationAxis_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationDomain" xlink:label="loc_lfwd_RevenueObligationDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalMember" xlink:label="loc_lfwd_RentalMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationDomain" xlink:label="loc_lfwd_RevenueObligationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ServiceAndWarrantyMember" xlink:label="loc_lfwd_ServiceAndWarrantyMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_lfwd_RevenueObligationAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lfwd_RevenueObligationAxis_1" xlink:to="loc_lfwd_RevenueObligationDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lfwd_RevenueObligationDomain_1" xlink:to="loc_lfwd_RentalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lfwd_RevenueObligationAxis_1" xlink:to="loc_lfwd_RevenueObligationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_ProductOrServiceAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5" xlink:to="loc_srt_ProductsAndServicesDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5" xlink:to="loc_us-gaap_ProductMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5" xlink:to="loc_lfwd_ServiceAndWarrantyMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5" xlink:to="loc_srt_ProductsAndServicesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_Revenues_11" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:label="loc_us-gaap_UsefulLifeDescriptionOfTermDomain_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UsefulLifeTermOfLeaseMember" xlink:label="loc_us-gaap_UsefulLifeTermOfLeaseMember_0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UsefulLifeDescriptionOfTermDomain_0" xlink:to="loc_us-gaap_UsefulLifeTermOfLeaseMember_0" order="1" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>lfwd-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_country_DE_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_44"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_45"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_46"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_47"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AdditionallyWarrantsIssuedMember" xlink:label="loc_lfwd_AdditionallyWarrantsIssuedMember_48"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AdditionallyWarrantsIssuedMember" xlink:label="loc_lfwd_AdditionallyWarrantsIssuedMember_49"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AggregateNumberOfOrdinaryShares" xlink:label="loc_lfwd_AggregateNumberOfOrdinaryShares_50"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AggregateNumberOfOrdinaryShares" xlink:label="loc_lfwd_AggregateNumberOfOrdinaryShares_51"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementAxis" xlink:label="loc_lfwd_AgreementAxis_52"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementAxis" xlink:label="loc_lfwd_AgreementAxis_53"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AllowanceForSalesReturns" xlink:label="loc_lfwd_AllowanceForSalesReturns_54"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AllowanceForSalesReturns" xlink:label="loc_lfwd_AllowanceForSalesReturns_55"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AllowanceForSalesReturns" xlink:label="loc_lfwd_AllowanceForSalesReturns_56"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_57"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_58"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfAdditionalCashEarnouts" xlink:label="loc_lfwd_AmountOfAdditionalCashEarnouts_59"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfAdditionalCashEarnouts" xlink:label="loc_lfwd_AmountOfAdditionalCashEarnouts_60"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfAdditionalCashEarnouts" xlink:label="loc_lfwd_AmountOfAdditionalCashEarnouts_61"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses" xlink:label="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_62"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses" xlink:label="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_63"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses" xlink:label="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_64"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvision" xlink:label="loc_lfwd_AmountOfWarrantProvision_65"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvision" xlink:label="loc_lfwd_AmountOfWarrantProvision_66"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvision" xlink:label="loc_lfwd_AmountOfWarrantProvision_67"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvisionUsage" xlink:label="loc_lfwd_AmountOfWarrantProvisionUsage_68"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvisionUsage" xlink:label="loc_lfwd_AmountOfWarrantProvisionUsage_69"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvisionUsage" xlink:label="loc_lfwd_AmountOfWarrantProvisionUsage_70"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BacklogMember" xlink:label="loc_lfwd_BacklogMember_71"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BacklogMember" xlink:label="loc_lfwd_BacklogMember_72"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BacklogMember" xlink:label="loc_lfwd_BacklogMember_73"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BankCommissions" xlink:label="loc_lfwd_BankCommissions_74"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BankCommissions" xlink:label="loc_lfwd_BankCommissions_75"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BankCommissions" xlink:label="loc_lfwd_BankCommissions_76"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" xlink:label="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_77"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" xlink:label="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_78"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" xlink:label="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_79"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_80"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_81"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_82"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_83"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_84"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_85"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_86"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_87"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_88"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BestOfferingMember" xlink:label="loc_lfwd_BestOfferingMember_89"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BestOfferingMember" xlink:label="loc_lfwd_BestOfferingMember_90"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_91"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_92"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_93"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_94"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_95"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_96"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_97"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_98"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_99"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_100"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_101"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_102"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_103"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_104"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_105"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_106"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_107"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_108"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedWarrantProvision" xlink:label="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_109"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedWarrantProvision" xlink:label="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_110"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedWarrantProvision" xlink:label="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_111"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:label="loc_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_112"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:label="loc_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_113"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent" xlink:label="loc_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_114"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CashlessExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_CashlessExerciseOfPreFundedWarrants_115"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CashlessExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_CashlessExerciseOfPreFundedWarrants_116"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CertainInstitutionalPurchasersMember" xlink:label="loc_lfwd_CertainInstitutionalPurchasersMember_117"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CertainInstitutionalPurchasersMember" xlink:label="loc_lfwd_CertainInstitutionalPurchasersMember_118"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ChangeInFairValueOfWarrantsLiabilityActivity" xlink:label="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_119"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ChangeInFairValueOfWarrantsLiabilityActivity" xlink:label="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_120"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ChangeInFairValueOfWarrantsLiabilityActivity" xlink:label="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_121"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToOtherCurrentAssets" xlink:label="loc_lfwd_ClassificationOfInventoryToOtherCurrentAssets_122"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToOtherCurrentAssets" xlink:label="loc_lfwd_ClassificationOfInventoryToOtherCurrentAssets_123"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_124"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_125"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_126"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_127"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_128"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_129"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_130"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_131"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightExercisable" xlink:label="loc_lfwd_ClassOfWarrantOrRightExercisable_132"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightExercisable" xlink:label="loc_lfwd_ClassOfWarrantOrRightExercisable_133"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightExercisable" xlink:label="loc_lfwd_ClassOfWarrantOrRightExercisable_134"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightPolicyTextBlock" xlink:label="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_135"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightPolicyTextBlock" xlink:label="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_136"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightPolicyTextBlock" xlink:label="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_137"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommitmentsAndContingenciesLiabilitiesAbstract" xlink:label="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_138"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_139"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_140"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_141"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_142"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_143"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_144"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_145"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_146"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_147"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnitsMember" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_148"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnitsMember" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_149"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsMember" xlink:label="loc_lfwd_CommonUnitsMember_150"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsMember" xlink:label="loc_lfwd_CommonUnitsMember_151"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_152"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_153"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_154"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards" xlink:label="loc_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_155"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_156"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_157"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_158"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_159"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerBMember" xlink:label="loc_lfwd_CustomerBMember_160"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerBMember" xlink:label="loc_lfwd_CustomerBMember_161"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerCMember" xlink:label="loc_lfwd_CustomerCMember_162"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerCMember" xlink:label="loc_lfwd_CustomerCMember_163"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerDMember" xlink:label="loc_lfwd_CustomerDMember_164"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerDMember" xlink:label="loc_lfwd_CustomerDMember_165"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerEMember" xlink:label="loc_lfwd_CustomerEMember_166"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerEMember" xlink:label="loc_lfwd_CustomerEMember_167"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerFMember" xlink:label="loc_lfwd_CustomerFMember_168"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerFMember" xlink:label="loc_lfwd_CustomerFMember_169"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerGMember" xlink:label="loc_lfwd_CustomerGMember_170"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerGMember" xlink:label="loc_lfwd_CustomerGMember_171"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerHMember" xlink:label="loc_lfwd_CustomerHMember_172"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerHMember" xlink:label="loc_lfwd_CustomerHMember_173"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerIMember" xlink:label="loc_lfwd_CustomerIMember_174"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerIMember" xlink:label="loc_lfwd_CustomerIMember_175"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerJMember" xlink:label="loc_lfwd_CustomerJMember_176"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerJMember" xlink:label="loc_lfwd_CustomerJMember_177"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipDistributionMember" xlink:label="loc_lfwd_CustomerRelationshipDistributionMember_178"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipDistributionMember" xlink:label="loc_lfwd_CustomerRelationshipDistributionMember_179"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_180"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_181"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_182"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_183"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_184"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_185"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended" xlink:label="loc_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_186"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended" xlink:label="loc_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_187"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended" xlink:label="loc_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_188"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_December2020PrivatePlacementMember" xlink:label="loc_lfwd_December2020PrivatePlacementMember_189"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_December2020PrivatePlacementMember" xlink:label="loc_lfwd_December2020PrivatePlacementMember_190"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredIncomeTax" xlink:label="loc_lfwd_DeferredIncomeTax_191"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredIncomeTax" xlink:label="loc_lfwd_DeferredIncomeTax_192"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredIncomeTax" xlink:label="loc_lfwd_DeferredIncomeTax_193"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_194"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_195"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_196"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_197"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_198"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_199"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate" xlink:label="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_200"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate" xlink:label="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_201"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_202"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_203"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_204"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_205"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_206"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfUnderwritingAgreement" xlink:label="loc_lfwd_DescriptionOfUnderwritingAgreement_207"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfUnderwritingAgreement" xlink:label="loc_lfwd_DescriptionOfUnderwritingAgreement_208"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_209"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_210"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock" xlink:label="loc_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_211"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock" xlink:label="loc_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_212"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock" xlink:label="loc_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_213"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutLiabilityCurrent" xlink:label="loc_lfwd_EarnoutLiabilityCurrent_214"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutLiabilityCurrent" xlink:label="loc_lfwd_EarnoutLiabilityCurrent_215"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutLiabilityCurrent" xlink:label="loc_lfwd_EarnoutLiabilityCurrent_216"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_217"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_218"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_219"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutPaymentOfBusinessCombination" xlink:label="loc_lfwd_EarnOutPaymentOfBusinessCombination_220"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutPaymentOfBusinessCombination" xlink:label="loc_lfwd_EarnOutPaymentOfBusinessCombination_221"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutPaymentOfBusinessCombination" xlink:label="loc_lfwd_EarnOutPaymentOfBusinessCombination_222"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutRemeasured" xlink:label="loc_lfwd_EarnOutRemeasured_223"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutRemeasured" xlink:label="loc_lfwd_EarnOutRemeasured_224"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutRemeasured" xlink:label="loc_lfwd_EarnOutRemeasured_225"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeesAndNonEmployeesMember" xlink:label="loc_lfwd_EmployeesAndNonEmployeesMember_226"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeesAndNonEmployeesMember" xlink:label="loc_lfwd_EmployeesAndNonEmployeesMember_227"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_228"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_229"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EquityExchangeProgramMember" xlink:label="loc_lfwd_EquityExchangeProgramMember_230"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EquityExchangeProgramMember" xlink:label="loc_lfwd_EquityExchangeProgramMember_231"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrants_232"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrants_233"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrants_234"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrants_235"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_236"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_237"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_238"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_239"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_240"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceOrdinaryShares" xlink:label="loc_lfwd_ExercisePriceOrdinaryShares_241"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceOrdinaryShares" xlink:label="loc_lfwd_ExercisePriceOrdinaryShares_242"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFiveMember" xlink:label="loc_lfwd_ExercisePriceRangeFiveMember_243"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFiveMember" xlink:label="loc_lfwd_ExercisePriceRangeFiveMember_244"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFiveMember" xlink:label="loc_lfwd_ExercisePriceRangeFiveMember_245"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFourMember" xlink:label="loc_lfwd_ExercisePriceRangeFourMember_246"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFourMember" xlink:label="loc_lfwd_ExercisePriceRangeFourMember_247"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFourMember" xlink:label="loc_lfwd_ExercisePriceRangeFourMember_248"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeMember" xlink:label="loc_lfwd_ExercisePriceRangeMember_249"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeMember" xlink:label="loc_lfwd_ExercisePriceRangeMember_250"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeMember" xlink:label="loc_lfwd_ExercisePriceRangeMember_251"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeOneMember" xlink:label="loc_lfwd_ExercisePriceRangeOneMember_252"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeOneMember" xlink:label="loc_lfwd_ExercisePriceRangeOneMember_253"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeOneMember" xlink:label="loc_lfwd_ExercisePriceRangeOneMember_254"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeThreeMember" xlink:label="loc_lfwd_ExercisePriceRangeThreeMember_255"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeThreeMember" xlink:label="loc_lfwd_ExercisePriceRangeThreeMember_256"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeThreeMember" xlink:label="loc_lfwd_ExercisePriceRangeThreeMember_257"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeTwoMember" xlink:label="loc_lfwd_ExercisePriceRangeTwoMember_258"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeTwoMember" xlink:label="loc_lfwd_ExercisePriceRangeTwoMember_259"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeTwoMember" xlink:label="loc_lfwd_ExercisePriceRangeTwoMember_260"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityLineItems" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_261"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityLineItems" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_262"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityTable" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityTable_263"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityTable" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityTable_264"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_FeesAndOtherRelatedExpenses_265"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_FeesAndOtherRelatedExpenses_266"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FieldServiceUnitsMember" xlink:label="loc_lfwd_FieldServiceUnitsMember_267"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FieldServiceUnitsMember" xlink:label="loc_lfwd_FieldServiceUnitsMember_268"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_269"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_270"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_271"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_272"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_273"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_274"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_275"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_276"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_277"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_278"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_279"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_280"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FirstAmendmentMember" xlink:label="loc_lfwd_FirstAmendmentMember_281"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FirstAmendmentMember" xlink:label="loc_lfwd_FirstAmendmentMember_282"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionAmount" xlink:label="loc_lfwd_FixedCommissionAmount_283"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionAmount" xlink:label="loc_lfwd_FixedCommissionAmount_284"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionRate" xlink:label="loc_lfwd_FixedCommissionRate_285"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionRate" xlink:label="loc_lfwd_FixedCommissionRate_286"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GeneralAbstract" xlink:label="loc_lfwd_GeneralAbstract_287"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract" xlink:label="loc_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_288"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GovernmentGrantsPolicyTextBlock" xlink:label="loc_lfwd_GovernmentGrantsPolicyTextBlock_289"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GovernmentGrantsPolicyTextBlock" xlink:label="loc_lfwd_GovernmentGrantsPolicyTextBlock_290"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GovernmentGrantsPolicyTextBlock" xlink:label="loc_lfwd_GovernmentGrantsPolicyTextBlock_291"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GuarantorObligationsCollateralPledged" xlink:label="loc_lfwd_GuarantorObligationsCollateralPledged_292"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GuarantorObligationsCollateralPledged" xlink:label="loc_lfwd_GuarantorObligationsCollateralPledged_293"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GuarantorObligationsCollateralPledged" xlink:label="loc_lfwd_GuarantorObligationsCollateralPledged_294"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ImputedInterest" xlink:label="loc_lfwd_ImputedInterest_295"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ImputedInterest" xlink:label="loc_lfwd_ImputedInterest_296"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ImputedInterest" xlink:label="loc_lfwd_ImputedInterest_297"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ImputedInterest" xlink:label="loc_lfwd_ImputedInterest_298"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxesAbstract" xlink:label="loc_lfwd_IncomeTaxesAbstract_299"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" xlink:label="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_300"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" xlink:label="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_301"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" xlink:label="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_302"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InitialRecognitionOfOperatingLeaseLiabilities" xlink:label="loc_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_303"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InitialRecognitionOfOperatingLeaseLiabilities" xlink:label="loc_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_304"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets" xlink:label="loc_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_305"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets" xlink:label="loc_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_306"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IntangibleAssetsNonCurrent" xlink:label="loc_lfwd_IntangibleAssetsNonCurrent_307"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IntangibleAssetsNonCurrent" xlink:label="loc_lfwd_IntangibleAssetsNonCurrent_308"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IntangibleAssetsNonCurrent" xlink:label="loc_lfwd_IntangibleAssetsNonCurrent_309"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InterestReceived" xlink:label="loc_lfwd_InterestReceived_310"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InterestReceived" xlink:label="loc_lfwd_InterestReceived_311"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InterestReceived" xlink:label="loc_lfwd_InterestReceived_312"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InvestmentOptionsExercisePrices" xlink:label="loc_lfwd_InvestmentOptionsExercisePrices_313"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InvestmentOptionsExercisePrices" xlink:label="loc_lfwd_InvestmentOptionsExercisePrices_314"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InvestmentOptionsExercisePrices" xlink:label="loc_lfwd_InvestmentOptionsExercisePrices_315"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraeliMember" xlink:label="loc_lfwd_IsraeliMember_316"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraeliMember" xlink:label="loc_lfwd_IsraeliMember_317"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraelInnovationAuthorityMember" xlink:label="loc_lfwd_IsraelInnovationAuthorityMember_318"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraelInnovationAuthorityMember" xlink:label="loc_lfwd_IsraelInnovationAuthorityMember_319"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraelInnovationAuthorityMember" xlink:label="loc_lfwd_IsraelInnovationAuthorityMember_320"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_321"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_322"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_323"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_324"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_325"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_326"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalMember" xlink:label="loc_lfwd_KreosCapitalMember_327"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalMember" xlink:label="loc_lfwd_KreosCapitalMember_328"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalVMember" xlink:label="loc_lfwd_KreosCapitalVMember_329"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalVMember" xlink:label="loc_lfwd_KreosCapitalVMember_330"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LeaseAgreementsTerm" xlink:label="loc_lfwd_LeaseAgreementsTerm_331"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LeaseAgreementsTerm" xlink:label="loc_lfwd_LeaseAgreementsTerm_332"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LeaseAgreementsTerm" xlink:label="loc_lfwd_LeaseAgreementsTerm_333"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LicenseAgreementAndCollaborationAgreementMember" xlink:label="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_334"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LicenseAgreementAndCollaborationAgreementMember" xlink:label="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_335"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:label="loc_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_336"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual" xlink:label="loc_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_337"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension" xlink:label="loc_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_338"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension" xlink:label="loc_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_339"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension" xlink:label="loc_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_340"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermEarnoutLiability" xlink:label="loc_lfwd_LongTermEarnoutLiability_341"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermEarnoutLiability" xlink:label="loc_lfwd_LongTermEarnoutLiability_342"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermEarnoutLiability" xlink:label="loc_lfwd_LongTermEarnoutLiability_343"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_lfwd_MachineryAndLaboratoryEquipmentMember_344"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_lfwd_MachineryAndLaboratoryEquipmentMember_345"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_346"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_347"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesExpirationTerm" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_348"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesExpirationTerm" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_349"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesExpirationTerm" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_350"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesTerms" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesTerms_351"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesTerms" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesTerms_352"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_353"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_354"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_355"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" xlink:label="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_356"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" xlink:label="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_357"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" xlink:label="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_358"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfWarrantsOutstandingTotal" xlink:label="loc_lfwd_NumberOfWarrantsOutstandingTotal_359"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfWarrantsOutstandingTotal" xlink:label="loc_lfwd_NumberOfWarrantsOutstandingTotal_360"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfWarrantsOutstandingTotal" xlink:label="loc_lfwd_NumberOfWarrantsOutstandingTotal_361"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInDecember2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_362"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInDecember2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_363"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_364"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_365"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_366"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_367"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInJuly2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_368"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInJuly2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_369"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_370"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_371"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLossCarryforwardsPriorPeriod" xlink:label="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_372"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLossCarryforwardsPriorPeriod" xlink:label="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_373"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLossCarryforwardsPriorPeriod" xlink:label="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_374"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaycheckProtectionProgramLoanMember" xlink:label="loc_lfwd_PaycheckProtectionProgramLoanMember_375"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaycheckProtectionProgramLoanMember" xlink:label="loc_lfwd_PaycheckProtectionProgramLoanMember_376"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentsForPurchaseOfTreasuryStock" xlink:label="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_377"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentsForPurchaseOfTreasuryStock" xlink:label="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_378"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentsForPurchaseOfTreasuryStock" xlink:label="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_379"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentToRepurchaseOfShares" xlink:label="loc_lfwd_PaymentToRepurchaseOfShares_380"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentToRepurchaseOfShares" xlink:label="loc_lfwd_PaymentToRepurchaseOfShares_381"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentToRepurchaseOfShares" xlink:label="loc_lfwd_PaymentToRepurchaseOfShares_382"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_383"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_384"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PreFundedMember" xlink:label="loc_lfwd_PreFundedMember_385"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PreFundedMember" xlink:label="loc_lfwd_PreFundedMember_386"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PreFundedUnitsMember" xlink:label="loc_lfwd_PreFundedUnitsMember_387"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PreFundedUnitsMember" xlink:label="loc_lfwd_PreFundedUnitsMember_388"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:label="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_389"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:label="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_390"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:label="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_391"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_392"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_393"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCost" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCost_394"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCost" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCost_395"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCostTwo" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_396"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCostTwo" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_397"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCostTwo" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_398"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromOfferingCost" xlink:label="loc_lfwd_ProceedsFromOfferingCost_399"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromOfferingCost" xlink:label="loc_lfwd_ProceedsFromOfferingCost_400"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromStockOne" xlink:label="loc_lfwd_ProceedsFromStockOne_401"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromStockOne" xlink:label="loc_lfwd_ProceedsFromStockOne_402"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromStockOne" xlink:label="loc_lfwd_ProceedsFromStockOne_403"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromStockTwo" xlink:label="loc_lfwd_ProceedsFromStockTwo_404"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromStockTwo" xlink:label="loc_lfwd_ProceedsFromStockTwo_405"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PropertyAndEquipmentNetTextualAbstract" xlink:label="loc_lfwd_PropertyAndEquipmentNetTextualAbstract_406"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PropertyPlantAndEquipmentUsefulLifeDescription" xlink:label="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_407"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PropertyPlantAndEquipmentUsefulLifeDescription" xlink:label="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_408"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_409"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_410"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_411"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_412"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_413"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_414"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_415"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectMember" xlink:label="loc_lfwd_RegisteredDirectMember_416"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectMember" xlink:label="loc_lfwd_RegisteredDirectMember_417"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingMember" xlink:label="loc_lfwd_RegisteredDirectOfferingMember_418"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingMember" xlink:label="loc_lfwd_RegisteredDirectOfferingMember_419"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingMember" xlink:label="loc_lfwd_RegisteredDirectOfferingMember_420"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:label="loc_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_421"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:label="loc_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_422"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid" xlink:label="loc_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_423"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:label="loc_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_424"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock" xlink:label="loc_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_425"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RelatedPartyTransactionOwnershipPercentage" xlink:label="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_426"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RelatedPartyTransactionOwnershipPercentage" xlink:label="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_427"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalMember" xlink:label="loc_lfwd_RentalMember_428"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalMember" xlink:label="loc_lfwd_RentalMember_429"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalRevenueForAntiGravityProducts" xlink:label="loc_lfwd_RentalRevenueForAntiGravityProducts_430"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalRevenueForAntiGravityProducts" xlink:label="loc_lfwd_RentalRevenueForAntiGravityProducts_431"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalRevenueForAntiGravityProducts" xlink:label="loc_lfwd_RentalRevenueForAntiGravityProducts_432"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReorganizationExpenses" xlink:label="loc_lfwd_ReorganizationExpenses_433"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReorganizationExpenses" xlink:label="loc_lfwd_ReorganizationExpenses_434"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_435"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_436"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_437"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_438"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:label="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_439"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestOfWorldMember" xlink:label="loc_lfwd_RestOfWorldMember_440"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestOfWorldMember" xlink:label="loc_lfwd_RestOfWorldMember_441"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReStoreProductMember" xlink:label="loc_lfwd_ReStoreProductMember_442"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReStoreProductMember" xlink:label="loc_lfwd_ReStoreProductMember_443"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestrictedCashAndOtherLongTermAssets" xlink:label="loc_lfwd_RestrictedCashAndOtherLongTermAssets_444"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestrictedCashAndOtherLongTermAssets" xlink:label="loc_lfwd_RestrictedCashAndOtherLongTermAssets_445"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestrictedCashAndOtherLongTermAssets" xlink:label="loc_lfwd_RestrictedCashAndOtherLongTermAssets_446"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestrictedCashIncludedInOtherNonCurrentAssets" xlink:label="loc_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_447"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestrictedCashIncludedInOtherNonCurrentAssets" xlink:label="loc_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_448"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructringActivitiesAxis" xlink:label="loc_lfwd_RestructringActivitiesAxis_449"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructringActivitiesAxis" xlink:label="loc_lfwd_RestructringActivitiesAxis_450"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructringActivitiesLineItems" xlink:label="loc_lfwd_RestructringActivitiesLineItems_451"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructringActivitiesLineItems" xlink:label="loc_lfwd_RestructringActivitiesLineItems_452"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructuringActivitiesDomain" xlink:label="loc_lfwd_RestructuringActivitiesDomain_453"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructuringActivitiesDomain" xlink:label="loc_lfwd_RestructuringActivitiesDomain_454"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructuringAndRelatedActivitiesTable" xlink:label="loc_lfwd_RestructuringAndRelatedActivitiesTable_455"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructuringAndRelatedActivitiesTable" xlink:label="loc_lfwd_RestructuringAndRelatedActivitiesTable_456"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationAxis" xlink:label="loc_lfwd_RevenueObligationAxis_457"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationAxis" xlink:label="loc_lfwd_RevenueObligationAxis_458"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationDomain" xlink:label="loc_lfwd_RevenueObligationDomain_459"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueRecognitionRecognized" xlink:label="loc_lfwd_RevenueRecognitionRecognized_460"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueRecognitionRecognized" xlink:label="loc_lfwd_RevenueRecognitionRecognized_461"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RewalkRoboticsGmbhMember" xlink:label="loc_lfwd_RewalkRoboticsGmbhMember_462"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RewalkRoboticsGmbhMember" xlink:label="loc_lfwd_RewalkRoboticsGmbhMember_463"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReWalkRoboticsIncMember" xlink:label="loc_lfwd_ReWalkRoboticsIncMember_464"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReWalkRoboticsIncMember" xlink:label="loc_lfwd_ReWalkRoboticsIncMember_465"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyBearingGrantsExpenses" xlink:label="loc_lfwd_RoyaltyBearingGrantsExpenses_466"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyBearingGrantsExpenses" xlink:label="loc_lfwd_RoyaltyBearingGrantsExpenses_467"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyFeesPercentage" xlink:label="loc_lfwd_RoyaltyFeesPercentage_468"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyFeesPercentage" xlink:label="loc_lfwd_RoyaltyFeesPercentage_469"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RrlAndRrgMember" xlink:label="loc_lfwd_RrlAndRrgMember_470"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RrlAndRrgMember" xlink:label="loc_lfwd_RrlAndRrgMember_471"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfContractBalancesTableTextBlock" xlink:label="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_472"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfContractBalancesTableTextBlock" xlink:label="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_473"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfContractBalancesTableTextBlock" xlink:label="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_474"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxLineItems" xlink:label="loc_lfwd_ScheduleOfIncomeTaxLineItems_475"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxLineItems" xlink:label="loc_lfwd_ScheduleOfIncomeTaxLineItems_476"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxTable" xlink:label="loc_lfwd_ScheduleOfIncomeTaxTable_477"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxTable" xlink:label="loc_lfwd_ScheduleOfIncomeTaxTable_478"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" xlink:label="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_479"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" xlink:label="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_480"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" xlink:label="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_481"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:label="loc_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_482"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock" xlink:label="loc_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_483"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_484"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_485"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_486"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantyProvisionTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_487"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantyProvisionTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_488"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantyProvisionTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_489"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SCIProductsMember" xlink:label="loc_lfwd_SCIProductsMember_490"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SCIProductsMember" xlink:label="loc_lfwd_SCIProductsMember_491"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SecondAmendmentMember" xlink:label="loc_lfwd_SecondAmendmentMember_492"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SecondAmendmentMember" xlink:label="loc_lfwd_SecondAmendmentMember_493"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SecuritiesPurchaseAgreementsMember" xlink:label="loc_lfwd_SecuritiesPurchaseAgreementsMember_494"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SecuritiesPurchaseAgreementsMember" xlink:label="loc_lfwd_SecuritiesPurchaseAgreementsMember_495"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SellingAndMarketingExpenseNet" xlink:label="loc_lfwd_SellingAndMarketingExpenseNet_496"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SellingAndMarketingExpenseNet" xlink:label="loc_lfwd_SellingAndMarketingExpenseNet_497"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ServiceAndWarrantyMember" xlink:label="loc_lfwd_ServiceAndWarrantyMember_498"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ServiceAndWarrantyMember" xlink:label="loc_lfwd_ServiceAndWarrantyMember_499"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_500"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_501"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_502"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_503"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_504"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_505"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_506"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_507"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_508"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_509"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_510"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_511"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_512"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_513"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_514"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_515"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_516"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_517"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_518"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareholdersEquityTextualAbstract" xlink:label="loc_lfwd_ShareholdersEquityTextualAbstract_519"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareRepurchaseProgramMember" xlink:label="loc_lfwd_ShareRepurchaseProgramMember_520"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareRepurchaseProgramMember" xlink:label="loc_lfwd_ShareRepurchaseProgramMember_521"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_Sharesissuedduringperiodvaluetreasurystock" xlink:label="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_522"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_Sharesissuedduringperiodvaluetreasurystock" xlink:label="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_523"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_Sharesissuedduringperiodvaluetreasurystock" xlink:label="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_524"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_525"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SiliconValleyBankMember" xlink:label="loc_lfwd_SiliconValleyBankMember_526"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SiliconValleyBankMember" xlink:label="loc_lfwd_SiliconValleyBankMember_527"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SparePartsAndWarrantiesMember" xlink:label="loc_lfwd_SparePartsAndWarrantiesMember_528"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SparePartsAndWarrantiesMember" xlink:label="loc_lfwd_SparePartsAndWarrantiesMember_529"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StateNetOperatingLossCarryForwards" xlink:label="loc_lfwd_StateNetOperatingLossCarryForwards_530"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StateNetOperatingLossCarryForwards" xlink:label="loc_lfwd_StateNetOperatingLossCarryForwards_531"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StateNetOperatingLossCarryForwards" xlink:label="loc_lfwd_StateNetOperatingLossCarryForwards_532"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_533"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_534"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_535"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_536"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_537"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_538"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_539"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_540"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_541"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_542"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_543"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_544"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_545"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_546"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_547"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_548"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_549"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_550"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_551"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_552"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_553"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_554"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_555"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_556"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_557"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_558"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_559"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_560"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_561"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_562"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_563"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_564"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SupplementalCashFlowCashAndCashEquivalents" xlink:label="loc_lfwd_SupplementalCashFlowCashAndCashEquivalents_565"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SupplementalCashFlowCashAndCashEquivalents" xlink:label="loc_lfwd_SupplementalCashFlowCashAndCashEquivalents_566"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SupplementalCashFlowCashAndCashEquivalents" xlink:label="loc_lfwd_SupplementalCashFlowCashAndCashEquivalents_567"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SupplementalDisclosuresOfCashFlowInformation" xlink:label="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_568"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SupplementalDisclosuresOfCashFlowInformation" xlink:label="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_569"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesIncome" xlink:label="loc_lfwd_TaxesIncome_570"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesIncome" xlink:label="loc_lfwd_TaxesIncome_571"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesIncome" xlink:label="loc_lfwd_TaxesIncome_572"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesOnIncome" xlink:label="loc_lfwd_TaxesOnIncome_573"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesOnIncome" xlink:label="loc_lfwd_TaxesOnIncome_574"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesOnIncome" xlink:label="loc_lfwd_TaxesOnIncome_575"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TreasurySharesPolicyTextBlock" xlink:label="loc_lfwd_TreasurySharesPolicyTextBlock_576"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TreasurySharesPolicyTextBlock" xlink:label="loc_lfwd_TreasurySharesPolicyTextBlock_577"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TreasurySharesPolicyTextBlock" xlink:label="loc_lfwd_TreasurySharesPolicyTextBlock_578"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TwoZeroTwoThreeReorganizationPlanMember" xlink:label="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_579"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TwoZeroTwoThreeReorganizationPlanMember" xlink:label="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_580"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TwoZeroTwoThreeReorganizationPlanMember" xlink:label="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_581"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeOfCurrencyAxis" xlink:label="loc_lfwd_TypeOfCurrencyAxis_582"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeOfCurrencyAxis" xlink:label="loc_lfwd_TypeOfCurrencyAxis_583"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_UnitsPlacedMember" xlink:label="loc_lfwd_UnitsPlacedMember_584"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_UnitsPlacedMember" xlink:label="loc_lfwd_UnitsPlacedMember_585"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_586"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_587"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_588"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" xlink:label="loc_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_589"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" xlink:label="loc_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_590"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseAgreementMember" xlink:label="loc_lfwd_WarrantExerciseAgreementMember_591"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseAgreementMember" xlink:label="loc_lfwd_WarrantExerciseAgreementMember_592"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseMember" xlink:label="loc_lfwd_WarrantExerciseMember_593"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseMember" xlink:label="loc_lfwd_WarrantExerciseMember_594"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExercisableDescrition" xlink:label="loc_lfwd_WarrantsExercisableDescrition_595"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExercisableDescrition" xlink:label="loc_lfwd_WarrantsExercisableDescrition_596"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExpitationDate" xlink:label="loc_lfwd_WarrantsExpitationDate_597"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExpitationDate" xlink:label="loc_lfwd_WarrantsExpitationDate_598"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_599"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_600"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_601"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_602"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_603"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinaryShares_604"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinaryShares_605"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_606"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_607"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_608"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_609"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_610"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_611"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_612"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_613"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_614"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_615"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_616"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_617"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_618"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_619"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_620"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_621"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_622"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_623"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_624"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_625"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_626"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_627"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_628"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_629"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_630"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_631"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_632"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_633"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_634"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_635"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_636"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_637"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_638"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_639"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_640"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_641"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_642"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_643"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_644"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_645"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_646"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_647"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_648"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_649"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantyProvisionBalance" xlink:label="loc_lfwd_WarrantyProvisionBalance_650"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantyProvisionBalance" xlink:label="loc_lfwd_WarrantyProvisionBalance_651"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantyProvisionBalance" xlink:label="loc_lfwd_WarrantyProvisionBalance_652"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantyProvisionBalance" xlink:label="loc_lfwd_WarrantyProvisionBalance_653"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WorkforcePercentage" xlink:label="loc_lfwd_WorkforcePercentage_654"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WorkforcePercentage" xlink:label="loc_lfwd_WorkforcePercentage_655"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WorkforcePercentage" xlink:label="loc_lfwd_WorkforcePercentage_656"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_YaskawaElectricCorporationMember" xlink:label="loc_lfwd_YaskawaElectricCorporationMember_657"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_YaskawaElectricCorporationMember" xlink:label="loc_lfwd_YaskawaElectricCorporationMember_658"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AfricaMember" xlink:label="loc_srt_AfricaMember_659"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember" xlink:label="loc_srt_AsiaPacificMember_660"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_661"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember" xlink:label="loc_srt_LatinAmericaMember_662"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_663"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_664"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_665"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_666"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_667"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_668"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_669"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_670"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_671"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_672"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_673"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_674"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_675"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_676"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_677"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_678"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_679"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_680"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_681"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_682"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_683"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_684"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_685"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_686"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_687"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_688"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_689"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_690"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_691"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_692"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_693"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_694"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_695"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_696"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_697"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_698"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_699"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_700"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_701"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_702"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_703"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_704"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_705"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_706"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_707"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_708"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_709"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_710"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_711"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_712"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_714"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_715"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_716"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_717"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_718"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_719"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_720"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_721"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_722"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_723"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_724"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_725"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_726"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_727"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_728"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_729"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_730"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_731"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_732"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_733"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_734"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_735"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_736"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_737"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_738"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_739"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_740"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_741"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_742"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_743"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_744"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_745"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_746"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_747"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_748"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_749"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_750"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_751"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_752"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_753"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_754"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_755"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_756"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_757"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_758"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_759"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_760"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_761"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_762"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_763"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_764"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_765"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_766"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_767"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_768"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_769"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_770"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_771"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_772"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_773"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_774"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_775"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_776"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_777"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_778"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_779"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_780"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_781"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_782"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_783"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_784"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_785"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_786"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_787"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_788"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_789"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_790"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_791"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_792"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_793"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_794"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_795"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_796"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_797"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_798"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_799"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_800"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_801"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_802"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_803"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_804"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_805"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_806"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_807"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_808"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_809"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_810"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_811"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_812"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_813"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaap_ConversionOfStockDescription_814"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_815"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_816"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_817"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_818"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_819"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_820"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_821"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_822"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_823"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_824"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_825"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_826"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_827"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaap_DebtInstrumentCollateralAmount_828"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_829"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_830"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_831"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_832"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_833"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_834"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_835"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_836"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_837"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_838"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_839"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_840"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_841"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_842"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_843"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_844"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_845"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_846"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_847"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_848"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_849"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_850"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_851"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_852"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_853"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_854"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_855"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_856"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_857"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_858"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_859"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_860"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_861"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_862"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_863"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_864"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_865"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_866"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_867"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_868"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_869"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_870"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_871"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_872"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_873"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_874"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_875"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_876"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_877"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_878"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_879"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_880"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_881"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_882"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_883"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_884"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_885"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_886"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_887"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_888"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_889"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_890"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_891"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_892"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_893"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_894"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_895"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_896"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_897"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_898"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_899"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_900"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_901"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_902"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_903"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_904"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_905"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_906"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_907"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_908"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_909"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_910"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_911"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_912"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_913"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_914"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_915"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_916"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_917"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_918"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_919"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_920"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_921"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_922"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_923"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_924"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_925"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_926"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_927"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_928"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_929"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_930"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_931"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_932"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_933"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_934"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_935"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_936"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_937"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_938"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_939"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_940"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_941"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_942"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_943"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_944"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_945"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_946"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_947"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_948"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_949"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_950"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_951"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_952"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_953"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_954"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_955"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_956"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_957"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_958"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_959"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_960"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_961"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_962"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_963"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_964"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_965"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_966"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_967"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_968"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_969"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_970"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_971"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_972"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_973"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_974"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_975"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_976"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_977"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_978"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_979"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_980"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_981"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_982"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_983"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_984"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_985"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_986"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_987"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_988"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_989"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_990"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_991"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_992"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_993"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_994"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_995"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_996"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_997"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_998"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_999"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_1000"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_1001"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_1002"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1003"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_1004"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_1005"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_1006"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_1007"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_1008"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_1009"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_1010"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_1011"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_1012"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_1013"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_1014"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1015"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_1016"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaap_LesseeOperatingLeaseDescription_1017"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1018"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1019"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1020"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1021"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1022"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1023"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1024"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1025"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1026"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1027"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_1028"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_1029"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1030"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1031"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1032"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1033"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1034"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1035"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1036"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1037"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1038"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_1039"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_1040"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_1041"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_1042"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1043"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_1044"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_1045"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1046"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1047"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_1048"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1049"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1050"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1051"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1052"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1053"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1054"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1055"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1056"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1057"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1058"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1059"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1060"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1061"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1062"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1063"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1064"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_1065"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_1066"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_1067"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_1068"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1069"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1070"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1071"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_1072"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1073"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1074"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1075"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1076"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1077"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1078"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1079"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1080"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1081"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1082"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_1083"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_1084"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_1085"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1086"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1087"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_1088"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1089"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1090"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_1091"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_1092"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1093"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1094"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1095"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_1096"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_1097"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1098"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1099"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_1100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_1101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_1102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_1103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_1104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRoyalties" xlink:label="loc_us-gaap_PaymentsForRoyalties_1107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_1119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaap_PostemploymentBenefitsPeriodExpense_1120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_1126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRoyaltiesReceived" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_1131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaap_ProceedsFromStockPlans_1132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_1134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_1149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaap_RepaymentsOfDebt_1151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_1152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_1170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_1171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_1175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_1183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_1184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_1210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_1216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_1219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:label="loc_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_1222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_1223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_1225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_1226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_1227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_1240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_1241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_1267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_1273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_1275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrual" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_1284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_1285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPayments_1286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_1287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_1288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_1289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_1291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_1307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_1309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1323"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1324"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1325"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1326"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1327"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1328"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1329"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1331"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_1332"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1333"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1334"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies" xlink:label="loc_us-gaap_Supplies_1335"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1336"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_1337"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1338"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1339"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_1340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_1341"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1342"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaap_TreasuryStockCommonValue_1344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaap_TreasuryStockCommonValue_1345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaap_TreasuryStockCommonValue_1346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockPreferredMember" xlink:label="loc_us-gaap_TreasuryStockPreferredMember_1347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockPreferredMember" xlink:label="loc_us-gaap_TreasuryStockPreferredMember_1348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebt" xlink:label="loc_us-gaap_UnsecuredDebt_1351"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1352"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_1353"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_1354"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1355"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1356"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1357"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1358"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1359"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1360"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1361"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1362"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1363"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1364"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1365"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_DE_0" xml:lang="en-US">Germany [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_IL_0" xml:lang="en-US">Israel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_US_0" xml:lang="en-US">United States [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentDescription_0" xml:lang="en-US">Amendment Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm Id</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag_0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityPublicFloat_0" xml:lang="en-US">Entity Public Float</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness_0" xml:lang="en-US">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber_0" xml:lang="en-US">Entity Tax Identification Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">Entity Voluntary Filers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-Known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_0" xml:lang="en-US">Acquisition, Deferred Tax Asset, Adjustments, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_1" xml:lang="en-US">Represents the acquisition, deferred tax asset, adjustments, amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_2" xml:lang="en-US">Acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AdditionallyWarrantsIssuedMember_0" xml:lang="en-US">Additionally Warrants Issued [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AdditionallyWarrantsIssuedMember_1" xml:lang="en-US">Additionally Warrants Issued [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AggregateNumberOfOrdinaryShares_0" xml:lang="en-US">Aggregate number of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AggregateNumberOfOrdinaryShares_1" xml:lang="en-US">Aggregate number of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AgreementAxis_0" xml:lang="en-US">Agreement Axis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AgreementAxis_1" xml:lang="en-US">Agreement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AllowanceForSalesReturns_0" xml:lang="en-US">Allowance for Sales Returns</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AllowanceForSalesReturns_1" xml:lang="en-US">Allowance For Sales Returns</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_AllowanceForSalesReturns_2" xml:lang="en-US">Net of sales return reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AltergIncMember_0" xml:lang="en-US">Information about AlterG Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AltergIncMember_1" xml:lang="en-US">Alterg Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AmountOfAdditionalCashEarnouts_0" xml:lang="en-US">Amount Of Additional Cash Earnouts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AmountOfAdditionalCashEarnouts_1" xml:lang="en-US">Information about amount of additional cash earnouts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_AmountOfAdditionalCashEarnouts_2" xml:lang="en-US">Amount of additional cash earnouts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_0" xml:lang="en-US">Amount Of Employee Termination Benefits And Legal Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_1" xml:lang="en-US">Represents the amount of employee termination benefits and legal expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_2" xml:lang="en-US">Amount of employee termination benefits and legal expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AmountOfWarrantProvision_0" xml:lang="en-US">Amount Of Warrant Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AmountOfWarrantProvision_1" xml:lang="en-US">It represents amount of warrant provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_AmountOfWarrantProvision_2" xml:lang="en-US">Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_AmountOfWarrantProvisionUsage_0" xml:lang="en-US">Amount Of Warrant Provision Usage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_AmountOfWarrantProvisionUsage_1" xml:lang="en-US">It represents amount of warrant provision usage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_AmountOfWarrantProvisionUsage_2" xml:lang="en-US">Usage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BacklogMember_0" xml:lang="en-US">Backlog [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_BacklogMember_1" xml:lang="en-US">Backlog</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BacklogMember_2" xml:lang="en-US">Information about Backlog.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BankCommissions_0" xml:lang="en-US">Amount of bank commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BankCommissions_1" xml:lang="en-US">Bank commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_BankCommissions_2" xml:lang="en-US">Bank commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_0" xml:lang="en-US">Basic And Diluted Net Loss Per Ordinary Share [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_1" xml:lang="en-US">Tabular disclosure of basic and diluted net loss per ordinary share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_2" xml:lang="en-US">Schedule of basic and diluted net loss per ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_0" xml:lang="en-US">Beneficiary Enterprise from Productive Activity, Maximum Time from Period of Election for Tax Exemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_1" xml:lang="en-US">Beneficiary Enterprise From Productive Activity Maximum Time From Period Of Election For Tax Exemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_2" xml:lang="en-US">Beneficiary enterprise from productive activity, maximum time from period of election for tax exemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_0" xml:lang="en-US">Beneficiary Enterprise from Productive Activity, Tax Exemption Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_1" xml:lang="en-US">Beneficiary Enterprise From Productive Activity Tax Exemption Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_2" xml:lang="en-US">Beneficiary enterprise from productive activity, tax exemption period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_0" xml:lang="en-US">Beneficiary Enterprise from Productive Activity, Tax Rate on Dividend Distributions from Tax Exempt Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_1" xml:lang="en-US">Beneficiary Enterprise From Productive Activity Tax Rate On Dividend Distributions From Tax Exempt Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_2" xml:lang="en-US">Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BestOfferingMember_0" xml:lang="en-US">Best Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BestOfferingMember_1" xml:lang="en-US">Best Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_0" xml:lang="en-US">The amount of accrued compensation recognized as of the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_1" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_2" xml:lang="en-US">Accrued compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_3" xml:lang="en-US">Accrued compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_0" xml:lang="en-US">The amount of other accrued liabilities recognized as of the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_1" xml:lang="en-US">Other accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_2" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Other Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_3" xml:lang="en-US">Other accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_0" xml:lang="en-US">The amount of restricted cash recognized as of the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_1" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_2" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_1" xml:lang="en-US">The amount of Right of use asset recognized as of the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_2" xml:lang="en-US">Right of use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Warranty Obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_1" xml:lang="en-US">Warranty Obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_2" xml:lang="en-US">The amount of warranty obligations recognized as of the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_3" xml:lang="en-US">Warranty Obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_BusinessCombinationRecognizedWarrantProvision_0" xml:lang="en-US">Business Combination Recognized Warrant Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_BusinessCombinationRecognizedWarrantProvision_1" xml:lang="en-US">It represents business combination recognized warrant provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_BusinessCombinationRecognizedWarrantProvision_2" xml:lang="en-US">AlterG acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_0" xml:lang="en-US">Amount of total cash, cash equivalents, and restricted cash for the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_1" xml:lang="en-US">Cash And Cash Equivalents Restricted Cash And Restricted Cash Equivalent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_2" xml:lang="en-US">Total Cash, cash equivalents, and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CashlessExerciseOfPreFundedWarrants_0" xml:lang="en-US">Cashless exercise of pre-funded warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CashlessExerciseOfPreFundedWarrants_1" xml:lang="en-US">Cashless Exercise Of Pre Funded Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CertainInstitutionalPurchasersMember_0" xml:lang="en-US">Certain institutional purchasers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CertainInstitutionalPurchasersMember_1" xml:lang="en-US">Certain institutional purchasers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_0" xml:lang="en-US">Change In Fair Value Of Warrants Liability Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_1" xml:lang="en-US">It represents change in fair value of warrants liability activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_2" xml:lang="en-US">Change in fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ClassificationOfInventoryToOtherCurrentAssets_0" xml:lang="en-US">Classification of inventory to other current assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ClassificationOfInventoryToOtherCurrentAssets_1" xml:lang="en-US">Classification of inventory to other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_0" xml:lang="en-US">Classification of Inventory to Property and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_1" xml:lang="en-US">Classification Of Inventory To Property And Equipment Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_2" xml:lang="en-US">Classification of inventory to property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_0" xml:lang="en-US">Classification of inventory to property and equipment, net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_1" xml:lang="en-US">Classification Of Inventory To Property And Equipment Net One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_2" xml:lang="en-US">Classification of inventory to property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_0" xml:lang="en-US">Classification of other net current assets to property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_1" xml:lang="en-US">Classification of other current assets to property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ClassOfWarrantOrRightExercisable_0" xml:lang="en-US">Class of Warrant or Right, Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ClassOfWarrantOrRightExercisable_1" xml:lang="en-US">Class Of Warrant Or Right Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ClassOfWarrantOrRightExercisable_2" xml:lang="en-US">Warrants outstanding and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ClassOfWarrantOrRightPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for warrants or rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ClassOfWarrantOrRightPolicyTextBlock_1" xml:lang="en-US">Class Of Warrant Or Right [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ClassOfWarrantOrRightPolicyTextBlock_2" xml:lang="en-US">Warrants to Acquire Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_0" xml:lang="en-US">Commitments And Contingencies Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_0" xml:lang="en-US">Common Stock, Aggregate Offering Price Authorized Under Equity Distribution Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_1" xml:lang="en-US">Common Stock Aggregate Offering Price Authorized Under Equity Distribution Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_2" xml:lang="en-US">Aggregate offering price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_0" xml:lang="en-US">Stock issuance costs under equity distribution agreement as a percent of gross proceeds.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_1" xml:lang="en-US">Common Stock Issuance Costs Under Equity Distribution Agreement As Percent Of Gross Proceeds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_2" xml:lang="en-US">Stock issuance costs under equity distribution agreement as a percent of gross proceeds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CommonUnitsAndPreFundedUnits1Member_0" xml:lang="en-US">Common units and pre-funded units one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CommonUnitsAndPreFundedUnits1Member_1" xml:lang="en-US">Common Units And Pre Funded Units 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_CommonUnitsAndPreFundedUnits1Member_2" xml:lang="en-US">Common units and pre-funded units one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CommonUnitsAndPreFundedUnitsMember_0" xml:lang="en-US">Common units and pre-funded units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CommonUnitsAndPreFundedUnitsMember_1" xml:lang="en-US">Common units and pre-funded units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CommonUnitsMember_0" xml:lang="en-US">Common units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CommonUnitsMember_1" xml:lang="en-US">Common units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ContingentLiabilityRelatedToGrantsReceived_0" xml:lang="en-US">Represents the contingent liability related to grant received as of the balance sheet date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ContingentLiabilityRelatedToGrantsReceived_1" xml:lang="en-US">Contingent Liability Related To Grants Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ContingentLiabilityRelatedToGrantsReceived_2" xml:lang="en-US">Contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_0" xml:lang="en-US">Cumulative Effect To Accrued Deficit From Adoption Of New Standards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerAMember_0" xml:lang="en-US">Customer A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerAMember_1" xml:lang="en-US">Customer A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_CustomerAMember_2" xml:lang="en-US">Customer A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_CustomerAMember_3" xml:lang="en-US">Customer A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerBMember_0" xml:lang="en-US">Customer B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerBMember_1" xml:lang="en-US">Customer B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerCMember_0" xml:lang="en-US">Customer C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerCMember_1" xml:lang="en-US">Customer C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerDMember_0" xml:lang="en-US">Customer D [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerDMember_1" xml:lang="en-US">Customer D [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerEMember_0" xml:lang="en-US">Customer E [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerEMember_1" xml:lang="en-US">Customer E [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerFMember_0" xml:lang="en-US">Customer F [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerFMember_1" xml:lang="en-US">Customer F [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerGMember_0" xml:lang="en-US">Customer G [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerGMember_1" xml:lang="en-US">Customer G [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerHMember_0" xml:lang="en-US">Customer H [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerHMember_1" xml:lang="en-US">Customer H [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerIMember_0" xml:lang="en-US">This member stands for Customer I.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerIMember_1" xml:lang="en-US">Customer I [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerJMember_0" xml:lang="en-US">This member stands for Customer J.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerJMember_1" xml:lang="en-US">Customer J [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerRelationshipDistributionMember_0" xml:lang="en-US">The member stands for Customer relationship - Distribution.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerRelationshipDistributionMember_1" xml:lang="en-US">Customer Relationship - Distribution [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_CustomerRelationshipRentalMember_0" xml:lang="en-US">Customer relationship - Rental</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerRelationshipRentalMember_1" xml:lang="en-US">Customer Relationship Rental [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerRelationshipRentalMember_2" xml:lang="en-US">Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_CustomerRelationshipWarrantyMember_0" xml:lang="en-US">Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_CustomerRelationshipWarrantyMember_1" xml:lang="en-US">Customer relationship - Warranty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_CustomerRelationshipWarrantyMember_2" xml:lang="en-US">Customer Relationship Warranty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_0" xml:lang="en-US">Debt Instrument, Proceeds from Issuance of Common Stock Required for Repayment Period to be Extended</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_1" xml:lang="en-US">Debt Instrument Proceeds From Issuance Of Common Stock Required For Repayment Period To Be Extended</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_2" xml:lang="en-US">Required proceeds from issuance of common stock required for repayment period to be extended</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_December2020PrivatePlacementMember_0" xml:lang="en-US">December 2020 private placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_December2020PrivatePlacementMember_1" xml:lang="en-US">December 2020 private placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DeferredIncomeTax_0" xml:lang="en-US">Deferred Income Tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_DeferredIncomeTax_1" xml:lang="en-US">Deferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DeferredIncomeTax_2" xml:lang="en-US">Deferred Income Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_0" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_1" xml:lang="en-US">Deferred Tax Assets Tax Deferred Expense Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_0" xml:lang="en-US">Represents the amount of deferred tax assets tax deferred expense share based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_1" xml:lang="en-US">Deferred Tax Assets Tax Deferred Expense Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_2" xml:lang="en-US">Share based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_0" xml:lang="en-US">Represents the amount of deferred tax expense effect of change in tax rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_1" xml:lang="en-US">Deferred Tax Expense Effect Of Change In Tax Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_0" xml:lang="en-US">Amount of deferred tax liability attributable to taxable temporary differences from right-of-use asset.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_1" xml:lang="en-US">Right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_2" xml:lang="en-US">Deferred Tax Liabilities Right Of Use Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_0" xml:lang="en-US">Description of income tax law for encouragement of capital investments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_1" xml:lang="en-US">Description of income tax law for encouragement of capital investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DescriptionOfUnderwritingAgreement_0" xml:lang="en-US">Description of underwriting agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DescriptionOfUnderwritingAgreement_1" xml:lang="en-US">Description of underwriting agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_0" xml:lang="en-US">Description of wainwright or its designees warrants to purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_1" xml:lang="en-US">Description of wainwright or its designees warrants to purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_0" xml:lang="en-US">Disclosure of Term Loans and Warrants to Purchase Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_1" xml:lang="en-US">Disclosure Of Term Loans And Warrants To Purchase Ordinary Shares [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_2" xml:lang="en-US">LOAN AGREEMENT WITH KREOS AND RELATED WARRANT TO PURCHASE ORDINARY SHARES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EarnoutLiabilityCurrent_0" xml:lang="en-US">Earnout Liability Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EarnoutLiabilityCurrent_1" xml:lang="en-US">Represent the amount of Earnout liability current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_EarnoutLiabilityCurrent_2" xml:lang="en-US">Earnout liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EarnoutMember_0" xml:lang="en-US">Earnout [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EarnoutMember_1" xml:lang="en-US">This member stands for Earnout.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_EarnoutMember_2" xml:lang="en-US">Earnout [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EarnOutPaymentOfBusinessCombination_0" xml:lang="en-US">The amount of earn out payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EarnOutPaymentOfBusinessCombination_1" xml:lang="en-US">Earn Out Payment Of Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_EarnOutPaymentOfBusinessCombination_2" xml:lang="en-US">Earnout payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EarnOutRemeasured_0" xml:lang="en-US">Earn Out Remeasured</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EarnOutRemeasured_1" xml:lang="en-US">Information about earnout remeasured.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_EarnOutRemeasured_2" xml:lang="en-US">Remeasurement of earnout liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EmployeesAndNonEmployeesMember_0" xml:lang="en-US">Employees and non- employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EmployeesAndNonEmployeesMember_1" xml:lang="en-US">Employees and non- employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_0" xml:lang="en-US">Represents details pertaining to employee share option and RSU.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_1" xml:lang="en-US">Employee Stock Option And Restricted Stock Units Rsu [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_EquityExchangeProgramMember_0" xml:lang="en-US">Equity Exchange Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_EquityExchangeProgramMember_1" xml:lang="en-US">Equity Exchange Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrants_0" xml:lang="en-US">Exercise of pre-funded warrants and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrants_1" xml:lang="en-US">Exercise Of Pre Funded Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrants_2" xml:lang="en-US">Exercise of pre-funded warrants and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrants_3" xml:lang="en-US">Exercise of pre-funded warrants and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_0" xml:lang="en-US">Number of shares exercise of pre-funded warrants and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_1" xml:lang="en-US">Exercise of pre-funded warrants and warrants, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_0" xml:lang="en-US">Value of exercise of pre-funded warrants and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_1" xml:lang="en-US">Exercise Of Pre Funded Warrants And Warrants Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_2" xml:lang="en-US">Exercise of pre-funded warrants and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceOrdinaryShares_0" xml:lang="en-US">Exercise price ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceOrdinaryShares_1" xml:lang="en-US">Exercise Price Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceRangeFiveMember_0" xml:lang="en-US">Represents information by five range of option prices pertaining to options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceRangeFiveMember_1" xml:lang="en-US">Exercise Price Range Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExercisePriceRangeFiveMember_2" xml:lang="en-US">$182.5-$524.25 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceRangeFourMember_0" xml:lang="en-US">Represents information by four range of option prices pertaining to options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceRangeFourMember_1" xml:lang="en-US">Exercise Price Range Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExercisePriceRangeFourMember_2" xml:lang="en-US">$50-$52.5 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceRangeMember_0" xml:lang="en-US">Exercise Price Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceRangeMember_1" xml:lang="en-US">Exercise Price Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExercisePriceRangeMember_2" xml:lang="en-US">RSUs only [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceRangeOneMember_0" xml:lang="en-US">Represents information by one range of option prices pertaining to options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceRangeOneMember_1" xml:lang="en-US">Exercise Price Range One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExercisePriceRangeOneMember_2" xml:lang="en-US">5.37 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceRangeThreeMember_0" xml:lang="en-US">Represents information by three range of option prices pertaining to options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceRangeThreeMember_1" xml:lang="en-US">Exercise Price Range Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_ExercisePriceRangeThreeMember_2" xml:lang="en-US">$37.14-$38.75 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ExercisePriceRangeTwoMember_0" xml:lang="en-US">Represents information by two range of option prices pertaining to options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ExercisePriceRangeTwoMember_1" xml:lang="en-US">Exercise Price Range Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ExercisePriceRangeTwoMember_2" xml:lang="en-US">$20.42- $33.75 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FairValueWarrantsLiabilityActivityLineItems_0" xml:lang="en-US">Fair Value Warrants Liability Activity [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FairValueWarrantsLiabilityActivityLineItems_1" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FairValueWarrantsLiabilityActivityTable_0" xml:lang="en-US">Fair Value Warrants Liability Activity [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FairValueWarrantsLiabilityActivityTable_1" xml:lang="en-US">Disclosure of information about fair value warrants liability activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FeesAndOtherRelatedExpenses_0" xml:lang="en-US">The amount of fees and other related expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FeesAndOtherRelatedExpenses_1" xml:lang="en-US">Fees and other related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FieldServiceUnitsMember_0" xml:lang="en-US">Field service units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FieldServiceUnitsMember_1" xml:lang="en-US">Field service units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FinancialExpensesAndIncomeNet_0" xml:lang="en-US">Financial Expenses And Income Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FinancialExpensesAndIncomeNet_1" xml:lang="en-US">Represents the Financial Expenses And Income Net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_lfwd_FinancialExpensesAndIncomeNet_2" xml:lang="en-US">Financial (expenses) income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_FinancialExpensesAndIncomeNet_3" xml:lang="en-US">Financial expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_FinancialExpensesAndIncomeNet_4" xml:lang="en-US">Financial income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_lfwd_FinancialExpensesAndIncomeNet_5" xml:lang="en-US">Financial (expenses) income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FinancialExpensesIncomeNet_0" xml:lang="en-US">Represents the aggregate amount of financial expense or income from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FinancialExpensesIncomeNet_1" xml:lang="en-US">Financial expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_lfwd_FinancialExpensesIncomeNet_2" xml:lang="en-US">Financial (expenses) income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_FinancialExpensesIncomeNet_3" xml:lang="en-US">Financial expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_FinancialExpensesIncomeNet_4" xml:lang="en-US">Financial income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_lfwd_FinancialExpensesIncomeNet_5" xml:lang="en-US">Financial (expenses) income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FirstAmendmentMember_0" xml:lang="en-US">First Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FirstAmendmentMember_1" xml:lang="en-US">First Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FixedCommissionAmount_0" xml:lang="en-US">Fixed commission amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FixedCommissionAmount_1" xml:lang="en-US">Fixed commission amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_FixedCommissionRate_0" xml:lang="en-US">Fixed commission rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_FixedCommissionRate_1" xml:lang="en-US">Fixed commission rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_GeneralAbstract_0" xml:lang="en-US">General [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_0" xml:lang="en-US">Geographic Information And Major Customer And Product Data [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_GovernmentGrantsPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for government grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_GovernmentGrantsPolicyTextBlock_1" xml:lang="en-US">Government Grants [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_GovernmentGrantsPolicyTextBlock_2" xml:lang="en-US">Government grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_GuarantorObligationsCollateralPledged_0" xml:lang="en-US">Guarantor obligations as collateral pledged.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_GuarantorObligationsCollateralPledged_1" xml:lang="en-US">Guarantor Obligations Collateral Pledged</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_GuarantorObligationsCollateralPledged_2" xml:lang="en-US">Amount pledged as security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ImputedInterest_0" xml:lang="en-US">Less: imputed interest.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_ImputedInterest_1" xml:lang="en-US">Less: imputed interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ImputedInterest_2" xml:lang="en-US">Imputed Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ImputedInterest_3" xml:lang="en-US">Less: imputed interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IncomeTaxesAbstract_0" xml:lang="en-US">Income Taxes [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_0" xml:lang="en-US">Percentage of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_1" xml:lang="en-US">Income Tax Examination Likelihood Of Unfavorable Settlement 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_2" xml:lang="en-US">Maximum percentage of likely to be realized upon ultimate settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_0" xml:lang="en-US">Initial recognition of operating lease liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_1" xml:lang="en-US">Initial recognition of operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_0" xml:lang="en-US">Initial recognition of operating lease right-of-use assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_1" xml:lang="en-US">Initial Recognition Of Operating Lease Right Of Use Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IntangibleAssetsNonCurrent_0" xml:lang="en-US">Intangible Assets Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_IntangibleAssetsNonCurrent_1" xml:lang="en-US">Represent the amount of Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_IntangibleAssetsNonCurrent_2" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_InterestReceived_0" xml:lang="en-US">Interest Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_InterestReceived_1" xml:lang="en-US">Represent the amount Cash received from interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_InterestReceived_2" xml:lang="en-US">Cash received from interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_InvestmentOptionsExercisePrices_0" xml:lang="en-US">Exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_InvestmentOptionsExercisePrices_1" xml:lang="en-US">Investment Options Exercise Prices</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_InvestmentOptionsExercisePrices_2" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_IsraeliMember_0" xml:lang="en-US">Israeli Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IsraeliMember_1" xml:lang="en-US">Israeli [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_IsraelInnovationAuthorityMember_0" xml:lang="en-US">Israeli Innovation Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IsraelInnovationAuthorityMember_1" xml:lang="en-US">Israel Innovation Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_IsraelInnovationAuthorityMember_2" xml:lang="en-US">IIA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_0" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_1" xml:lang="en-US">Issuance Of Ordinary Shares In Private Placement Net Of Issuance Expenses Paid In Amount Of 3582</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_2" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount of $3,679</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_3" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount of $3,679</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_0" xml:lang="en-US">Issuance of ordinary shares in a &#8220;warrant exercise&#8221; agreement, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_1" xml:lang="en-US">Issuance Of Ordinary Shares In Warrant Exercise Agreement Net Of Issuance Expenses In Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_KreosCapitalMember_0" xml:lang="en-US">Kreos Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_KreosCapitalMember_1" xml:lang="en-US">Kreos Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_KreosCapitalVMember_0" xml:lang="en-US">Kreos Capital V [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_KreosCapitalVMember_1" xml:lang="en-US">Kreos Capital V [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_LeaseAgreementsTerm_0" xml:lang="en-US">Lease Agreements Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_LeaseAgreementsTerm_1" xml:lang="en-US">Represents the amount of lease agreements term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_LeaseAgreementsTerm_2" xml:lang="en-US">Leases agreement term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_LicenseAgreementAndCollaborationAgreementMember_0" xml:lang="en-US">License Agreement and to the Collaboration Agreement member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_LicenseAgreementAndCollaborationAgreementMember_1" xml:lang="en-US">License Agreement and Collaboration Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_0" xml:lang="en-US">Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_1" xml:lang="en-US">Loan Agreement with Kreos and Related Warrant to Purchase Ordinary Shares (Textual)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_0" xml:lang="en-US">Long-term Debt, Maturities, Portion of Principal Subject to Repayment Extension</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_1" xml:lang="en-US">Long Term Debt Maturities Portion Of Principal Subject To Repayment Extension</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_2" xml:lang="en-US">Portion of principal subject to repayment extension</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_LongTermEarnoutLiability_0" xml:lang="en-US">Long Term Earnout Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_LongTermEarnoutLiability_1" xml:lang="en-US">Represent the amount of Earnout Liability non current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_LongTermEarnoutLiability_2" xml:lang="en-US">Earnout liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_MachineryAndLaboratoryEquipmentMember_0" xml:lang="en-US">Machinery and laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_MachineryAndLaboratoryEquipmentMember_1" xml:lang="en-US">Machinery and laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_0" xml:lang="en-US">The net aggregate proceeds of the first tranche closing after deducting fees and other related expenses in the amount of approximately.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_1" xml:lang="en-US">Net aggregate proceeds of after deducting fees and other related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_NetOperatingCarryForwardLossesExpirationTerm_0" xml:lang="en-US">Net Operating Carry Forward Losses Expiration Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_NetOperatingCarryForwardLossesExpirationTerm_1" xml:lang="en-US">Net operating carry forward losses expiration term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_NetOperatingCarryForwardLossesExpirationTerm_2" xml:lang="en-US">Net operating carry forward losses expiration term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_NetOperatingCarryForwardLossesTerms_0" xml:lang="en-US">Net operating carry-forward losses, terms.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_NetOperatingCarryForwardLossesTerms_1" xml:lang="en-US">Net operating carry-forward losses, terms</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_0" xml:lang="en-US">Addition of lease assets and liabilities related to operating leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_1" xml:lang="en-US">New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoptions Quantification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_2" xml:lang="en-US">Addition of lease assets and liabilities related to operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_0" xml:lang="en-US">Number Of Shares Excluded From Diluted Loss Per Share Anti Dilutive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_1" xml:lang="en-US">Represents the shares excluded from diluted loss per share anti dilutive.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_2" xml:lang="en-US">Shares Excluded from Diluted Loss per Share - Anti-Dilutive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_NumberOfWarrantsOutstandingTotal_0" xml:lang="en-US">Total number of warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_NumberOfWarrantsOutstandingTotal_1" xml:lang="en-US">Number Of Warrants Outstanding Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_NumberOfWarrantsOutstandingTotal_2" xml:lang="en-US">Total number of warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInDecember2020Member_0" xml:lang="en-US">Offering of ordinary shares in December 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInDecember2020Member_1" xml:lang="en-US">Offering of ordinary shares in December 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_0" xml:lang="en-US">Offering of ordinary shares in February 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_1" xml:lang="en-US">Offering of ordinary shares in February 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_0" xml:lang="en-US">Offering of ordinary shares in February 2020 Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_1" xml:lang="en-US">Offering of ordinary shares in February 2020 Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInJuly2020Member_0" xml:lang="en-US">Offering of ordinary shares in July 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_OfferingOfOrdinarySharesInJuly2020Member_1" xml:lang="en-US">Offering of ordinary shares in July 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_0" xml:lang="en-US">Represents the maximum amount of penalties payable on early release of lease agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_1" xml:lang="en-US">Operating Leases Maximum Penalties Payable On Early Release Of Agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_OperatingLossCarryforwardsPriorPeriod_0" xml:lang="en-US">Operating Loss Carryforwards Prior Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_OperatingLossCarryforwardsPriorPeriod_1" xml:lang="en-US">Represents the amount of operating loss carryforwards prior period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_OperatingLossCarryforwardsPriorPeriod_2" xml:lang="en-US">Operating loss carry forwards prior period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PaycheckProtectionProgramLoanMember_0" xml:lang="en-US">Paycheck Protection Program Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PaycheckProtectionProgramLoanMember_1" xml:lang="en-US">Paycheck Protection Program Loan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PaymentsForPurchaseOfTreasuryStock_0" xml:lang="en-US">The amount represents for Payments For Purchase Of Treasury Stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_PaymentsForPurchaseOfTreasuryStock_1" xml:lang="en-US">Purchase of treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PaymentsForPurchaseOfTreasuryStock_2" xml:lang="en-US">Payments For Purchase Of Treasury Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PaymentToRepurchaseOfShares_0" xml:lang="en-US">Payment To Repurchase Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PaymentToRepurchaseOfShares_1" xml:lang="en-US">Represent amount of cash out flow of shares repurchased not yet paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_PaymentToRepurchaseOfShares_2" xml:lang="en-US">Amounts related to shares re-purchase not yet paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_0" xml:lang="en-US">Represents the percentage of grant received considered to determine royalty fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_1" xml:lang="en-US">Percentage Of Grant Received Considered To Determine Royalty Fees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PreFundedMember_0" xml:lang="en-US">Pre Funded [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PreFundedMember_1" xml:lang="en-US">Pre-Funded [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PreFundedUnitsMember_0" xml:lang="en-US">Pre-funded units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PreFundedUnitsMember_1" xml:lang="en-US">Pre-funded units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_0" xml:lang="en-US">The entire disclosure for prepaid expenses and other current assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_1" xml:lang="en-US">Prepaid Expense And Other Assets Disclosure Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_2" xml:lang="en-US">PREPAID EXPENSES AND OTHER CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_0" xml:lang="en-US">Amount of asset related to consideration paid in advance to government institutions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_1" xml:lang="en-US">Prepaid Expenses To Government Institutions Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ProceedsFromIssuanceOfRegistrationCost_0" xml:lang="en-US">Issuance of ordinary shares of registered direct, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ProceedsFromIssuanceOfRegistrationCost_1" xml:lang="en-US">Proceeds From Issuance Of Registration Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_0" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_1" xml:lang="en-US">Proceeds From Issuance Of Registration Cost Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_2" xml:lang="en-US">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $3,215</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ProceedsFromOfferingCost_0" xml:lang="en-US">Issuance of ordinary shares in a offering, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ProceedsFromOfferingCost_1" xml:lang="en-US">Proceeds From Offering Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ProceedsFromStockOne_0" xml:lang="en-US">Proceeds from issuance of stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ProceedsFromStockOne_1" xml:lang="en-US">Proceeds From Stock One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ProceedsFromStockOne_2" xml:lang="en-US">Issuance of ordinary shares in a "best effort" offering, net of issuance expenses in the amount of $686</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ProceedsFromStockTwo_0" xml:lang="en-US">Proceeds from issuance of stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ProceedsFromStockTwo_1" xml:lang="en-US">Proceeds From Stock Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PropertyAndEquipmentNetTextualAbstract_0" xml:lang="en-US">Property And Equipment Net Textual Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_0" xml:lang="en-US">Property Plant And Equipment Useful Life Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_1" xml:lang="en-US">Property plant and equipment useful life description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_0" xml:lang="en-US">Purchase agreement with certain institutional and accredited investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_1" xml:lang="en-US">Purchase Agreement With Certain Institutional Accerdited Investors Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_0" xml:lang="en-US">Purchase agreement with certain institutional investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_1" xml:lang="en-US">Purchase agreement with certain institutional investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_0" xml:lang="en-US">Purchase agreement with certain institutional investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_1" xml:lang="en-US">Purchase Agreement With Certain Institutional Investors One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_2" xml:lang="en-US">Purchase agreement with certain institutional investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RegisteredDirectMember_0" xml:lang="en-US">Registered Direct.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RegisteredDirectMember_1" xml:lang="en-US">Registered Direct [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RegisteredDirectOfferingMember_0" xml:lang="en-US">Registered Direct [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RegisteredDirectOfferingMember_1" xml:lang="en-US">Registered Direct Offering Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_RegisteredDirectOfferingMember_2" xml:lang="en-US">Registered Direct [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_0" xml:lang="en-US">"Registered direct" offerings issuance cost incurred not yet paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_1" xml:lang="en-US">Expenses related to offerings not yet paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_2" xml:lang="en-US">Registered Direct Offerings Issuance Cost Incurred Not Yet Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for related parties transactions and balances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_1" xml:lang="en-US">Related Parties Transactions And Balances Policy Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RelatedPartyTransactionOwnershipPercentage_0" xml:lang="en-US">Related party transaction, ownership percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RelatedPartyTransactionOwnershipPercentage_1" xml:lang="en-US">Related Party Transaction Ownership Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RentalMember_0" xml:lang="en-US">Rental [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RentalMember_1" xml:lang="en-US">The member stands for rental.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RentalRevenueForAntiGravityProducts_0" xml:lang="en-US">Rental Revenue For Anti Gravity Products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RentalRevenueForAntiGravityProducts_1" xml:lang="en-US">Represents the amount of rental revenue for anti-gravity products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_RentalRevenueForAntiGravityProducts_2" xml:lang="en-US">Rental revenue for anti-gravity products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ReorganizationExpenses_0" xml:lang="en-US">Reorganization Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ReorganizationExpenses_1" xml:lang="en-US">Represents the amount of reorganization expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_0" xml:lang="en-US">Represents the portion of aggregate amount received in consideration of convertible preferred shares by the entity to fund research and development activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_1" xml:lang="en-US">Research And Development Amount Received In Consideration Of Convertible Preferred Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_0" xml:lang="en-US">Represents the portion of aggregate amount received as royalty bearing grants by the entity to fund research and development activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_1" xml:lang="en-US">Research And Development Royalty Bearing Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_0" xml:lang="en-US">Research Collaboration Agreement And License Agreement Textual Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestOfWorldMember_0" xml:lang="en-US">Rest Of World [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestOfWorldMember_1" xml:lang="en-US">Rest of the world member.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ReStoreProductMember_0" xml:lang="en-US">ReStore product [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ReStoreProductMember_1" xml:lang="en-US">Re Store Product [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestrictedCashAndOtherLongTermAssets_0" xml:lang="en-US">Disclosure of accounting policy for other long term assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestrictedCashAndOtherLongTermAssets_1" xml:lang="en-US">Restricted Cash And Other Long Term Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_RestrictedCashAndOtherLongTermAssets_2" xml:lang="en-US">Restricted Cash and Other Long-Term Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_0" xml:lang="en-US">Amount of restricted cash included in other long term assets for the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_1" xml:lang="en-US">Restricted Cash Included In Other Non Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestructringActivitiesAxis_0" xml:lang="en-US">Restructring Activities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestructringActivitiesAxis_1" xml:lang="en-US">Information by restructuring activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestructringActivitiesLineItems_0" xml:lang="en-US">Restructring Activities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestructringActivitiesLineItems_1" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestructuringActivitiesDomain_0" xml:lang="en-US">Restructuring Activities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestructuringActivitiesDomain_1" xml:lang="en-US">Represents the domain information related restructuring activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RestructuringAndRelatedActivitiesTable_0" xml:lang="en-US">Restructuring And Related Activities [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RestructuringAndRelatedActivitiesTable_1" xml:lang="en-US">Disclosure of information about Restructuring activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RevenueObligationAxis_0" xml:lang="en-US">Revenue Obligation [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RevenueObligationAxis_1" xml:lang="en-US">Revenue Obligation [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RevenueObligationDomain_0" xml:lang="en-US">Revenue Obligation [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RevenueRecognitionRecognized_0" xml:lang="en-US">Revenue Recognition Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RevenueRecognitionRecognized_1" xml:lang="en-US">Revenue Recognition Recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RewalkRoboticsGmbhMember_0" xml:lang="en-US">ReWalk Robotics GMBH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RewalkRoboticsGmbhMember_1" xml:lang="en-US">Rewalk Robotics Gmbh [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ReWalkRoboticsIncMember_0" xml:lang="en-US">Represents information pertaining to the ReWalk Robotics Inc., a wholly-owned subsidiary of the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ReWalkRoboticsIncMember_1" xml:lang="en-US">Re Walk Robotics Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RoyaltyBearingGrantsExpenses_0" xml:lang="en-US">Represents the expenses related to royalty bearing grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RoyaltyBearingGrantsExpenses_1" xml:lang="en-US">Royalty-bearing grants expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RoyaltyFeesPercentage_0" xml:lang="en-US">Represents the percentage of royalty fees.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RoyaltyFeesPercentage_1" xml:lang="en-US">Royalty Fees Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_RrlAndRrgMember_0" xml:lang="en-US">RRL and RRG [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_RrlAndRrgMember_1" xml:lang="en-US">RRL and RRG [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfContractBalancesTableTextBlock_0" xml:lang="en-US">The tabular disclosure of of Contract balances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfContractBalancesTableTextBlock_1" xml:lang="en-US">Schedule Of Contract Balances [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ScheduleOfContractBalancesTableTextBlock_2" xml:lang="en-US">Schedule of contract balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfIncomeTaxLineItems_0" xml:lang="en-US">Schedule of Income Tax Line Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfIncomeTaxLineItems_1" xml:lang="en-US">Schedule Of Income Tax Line Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfIncomeTaxTable_0" xml:lang="en-US">Disclosure of information about income tax.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfIncomeTaxTable_1" xml:lang="en-US">Schedule of Income Tax [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_0" xml:lang="en-US">Tabular disclosure of the Minimum Royalty Payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_1" xml:lang="en-US">Schedule Of Minimum Royalty Payments Table Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_2" xml:lang="en-US">Schedule of minimum royalty payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_0" xml:lang="en-US">Tabular disclosure of trade receivables and short and long term deferred revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_1" xml:lang="en-US">Schedule Of Trade Receivables And Deferred Revenues Table Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_0" xml:lang="en-US">Schedule Of Warrants Liability Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_1" xml:lang="en-US">Tabular disclosure of schedule of warrants liability activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_2" xml:lang="en-US">Schedule of warrants liability activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_0" xml:lang="en-US">Schedule Of Warranty Provision [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_1" xml:lang="en-US">Schedule of warranty provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_2" xml:lang="en-US">Tabular disclosure of warranty provision.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SCIProductsMember_0" xml:lang="en-US">SCI Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SCIProductsMember_1" xml:lang="en-US">SCI Products [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SecondAmendmentMember_0" xml:lang="en-US">Second Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SecondAmendmentMember_1" xml:lang="en-US">Second Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SecuritiesPurchaseAgreementsMember_0" xml:lang="en-US">Securities Purchase Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SecuritiesPurchaseAgreementsMember_1" xml:lang="en-US">Securities Purchase Agreements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SellingAndMarketingExpenseNet_0" xml:lang="en-US">Selling And Marketing Expense Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SellingAndMarketingExpenseNet_1" xml:lang="en-US">Represents the selling and marketing expense net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ServiceAndWarrantyMember_0" xml:lang="en-US">Service And Warranty [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ServiceAndWarrantyMember_1" xml:lang="en-US">The member stands for Service and warranty.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_0" xml:lang="en-US">Represents the percentage of monthly deposit required by employees as per the severance pay law.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_1" xml:lang="en-US">Severance Pay Monthly Deposit By Employees Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_0" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Outstanding Roll Forward Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_0" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Exercise Price Roll Forward Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options and Equity Instruments Other than Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_1" xml:lang="en-US">Unvested RSUs at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_2" xml:lang="en-US">Unvested RSUs at the Beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_3" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Outstanding Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options forfeited.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Forfeited In Period Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Granted In Period Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options vested.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Vested In Period Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_0" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Options Plans, Exercise Price Range, Outstanding Options and Equity Instruments Other than Options, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_1" xml:lang="en-US">Unvested RSUs at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_2" xml:lang="en-US">Unvested RSUs at the Beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_3" xml:lang="en-US">Sharebased Compensation Shares Authorized Under Stock Options Plans Exercise Price Range Outstanding Options And Equity Instruments Other Than Options Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareholdersEquityTextualAbstract_0" xml:lang="en-US">Shareholders Equity Textual Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ShareRepurchaseProgramMember_0" xml:lang="en-US">Share repurchase program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ShareRepurchaseProgramMember_1" xml:lang="en-US">Share Repurchase Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_Sharesissuedduringperiodvaluetreasurystock_0" xml:lang="en-US">The amount represent shares issued during period value treasury stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_Sharesissuedduringperiodvaluetreasurystock_1" xml:lang="en-US">Sharesissuedduringperiodvaluetreasurystock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_Sharesissuedduringperiodvaluetreasurystock_2" xml:lang="en-US">Treasury shares at cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SignificantAccountingPoliciesTextualAbstract_0" xml:lang="en-US">Significant Accounting Policies Textual Abstract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SiliconValleyBankMember_0" xml:lang="en-US">Silicon Valley Bank [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SiliconValleyBankMember_1" xml:lang="en-US">Silicon Valley Bank [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SparePartsAndWarrantiesMember_0" xml:lang="en-US">Spare parts and warranties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SparePartsAndWarrantiesMember_1" xml:lang="en-US">Spare parts and warranties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StateNetOperatingLossCarryForwards_0" xml:lang="en-US">State Net Operating Loss Carry Forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StateNetOperatingLossCarryForwards_1" xml:lang="en-US">Represents the amount of state net operating loss carry forwards.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_StateNetOperatingLossCarryForwards_2" xml:lang="en-US">State net operating loss carry forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_0" xml:lang="en-US">Issuance of ordinary shares, shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_1" xml:lang="en-US">Stock Issued During Period Share Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_0" xml:lang="en-US">Number of shares issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_1" xml:lang="en-US">Stock Issued During Period Shares Issuance Of Ordinary Shares In Net Of Warrant Exercise Issuance Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_0" xml:lang="en-US">Number of shares issuance of ordinary shares in a "Registered Direct" offerings , net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_1" xml:lang="en-US">Stock Issued During Period Shares Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_0" xml:lang="en-US">Number of further shares issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_1" xml:lang="en-US">Stock Issued During Period Shares Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_2" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_0" xml:lang="en-US">Number of shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_1" xml:lang="en-US">Stock Issued During Period Shares Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_0" xml:lang="en-US">Number of further shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_1" xml:lang="en-US">Stock Issued During Period Shares Ordinary Shares1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_2" xml:lang="en-US">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_0" xml:lang="en-US">Number of new stock issued during the period under private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_1" xml:lang="en-US">Stock Issued During Period Shares Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_0" xml:lang="en-US">Value of issuance of ordinary shares in a "Warrant exercise" agreement, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_1" xml:lang="en-US">Stock Issued During Period Value Issuance Of Ordinary Shares In Net Of Warrant Exercise Issuance Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_0" xml:lang="en-US">Value of issuance of ordinary shares in a "Registered Direct" offerings , net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_1" xml:lang="en-US">Stock Issued During Period Value Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_0" xml:lang="en-US">Value of further issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_1" xml:lang="en-US">Stock Issued During Period Value Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_2" xml:lang="en-US">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_0" xml:lang="en-US">Stock Issued During Period, Value, New Issues, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_1" xml:lang="en-US">Stock Issued During Period Value New Issues Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_0" xml:lang="en-US">Value of issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_1" xml:lang="en-US">Stock Issued During Period Value Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_0" xml:lang="en-US">Value of further issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_1" xml:lang="en-US">Stock Issued During Period Value Ordinary Shares1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_2" xml:lang="en-US">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_0" xml:lang="en-US">Equity impact of the value of new stock issued during the period under private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_1" xml:lang="en-US">Stock Issued During Period Value Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SupplementalCashFlowCashAndCashEquivalents_0" xml:lang="en-US">Amount of cash and cash equivalents for the preiod.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_SupplementalCashFlowCashAndCashEquivalents_1" xml:lang="en-US">Supplemental Cash Flow Cash And Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_SupplementalCashFlowCashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_SupplementalDisclosuresOfCashFlowInformation_0" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_SupplementalDisclosuresOfCashFlowInformation_1" xml:lang="en-US">Supplemental disclosures of cash flow information:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_TaxesIncome_0" xml:lang="en-US">Taxes on income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_TaxesIncome_1" xml:lang="en-US">Taxes Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_lfwd_TaxesIncome_2" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_TaxesOnIncome_0" xml:lang="en-US">Taxes on income.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_TaxesOnIncome_1" xml:lang="en-US">Taxes On Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_lfwd_TaxesOnIncome_2" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_TreasurySharesPolicyTextBlock_0" xml:lang="en-US">Represents the accounting policy for treasury shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_TreasurySharesPolicyTextBlock_1" xml:lang="en-US">Treasury Shares [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_lfwd_TreasurySharesPolicyTextBlock_2" xml:lang="en-US">Treasury shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_TwoZeroTwoThreeReorganizationPlanMember_0" xml:lang="en-US">Two Zero Two Three Reorganization Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_TwoZeroTwoThreeReorganizationPlanMember_1" xml:lang="en-US">2023 Reorganization Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_TwoZeroTwoThreeReorganizationPlanMember_2" xml:lang="en-US">2023 Reorganization Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_TypeOfCurrencyAxis_0" xml:lang="en-US">Type of Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_TypeOfCurrencyAxis_1" xml:lang="en-US">Type Of Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_UnitsPlacedMember_0" xml:lang="en-US">Units Placed [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_UnitsPlacedMember_1" xml:lang="en-US">Units placed [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_0" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Adjustments, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_1" xml:lang="en-US">Adjustment previous year loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_2" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Adjustments, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_0" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Changes Due Exchange Rate Differences, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_1" xml:lang="en-US">Valuationallowancedeferred Tax Asset Changes Due To Exchange Rate Differences Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantExerciseAgreementMember_0" xml:lang="en-US">Warrant exercise agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantExerciseAgreementMember_1" xml:lang="en-US">Warrant Exercise Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantExerciseMember_0" xml:lang="en-US">Warrant Exercise.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantExerciseMember_1" xml:lang="en-US">Warrant Exercise [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsExercisableDescrition_0" xml:lang="en-US">Warrants exercisable, description.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsExercisableDescrition_1" xml:lang="en-US">Warrants Exercisable Descrition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsExpitationDate_0" xml:lang="en-US">Warrants Expitation Date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsExpitationDate_1" xml:lang="en-US">Warrants Expitation Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsLiabilityActivity_0" xml:lang="en-US">It represents warrants liability activity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_WarrantsLiabilityActivity_1" xml:lang="en-US">Warrants liability activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsLiabilityActivity_2" xml:lang="en-US">Warrants Liability Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_lfwd_WarrantsLiabilityActivity_3" xml:lang="en-US">Initial Measurement (August 11, 2023)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_lfwd_WarrantsLiabilityActivity_4" xml:lang="en-US">Balance September 30, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinaryShares_0" xml:lang="en-US">Warrants to purchase ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinaryShares_1" xml:lang="en-US">Warrants to purchase ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_0" xml:lang="en-US">Warrants To Purchase Ordinary Shares[Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_0" xml:lang="en-US">April 5, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On April Five Two Thousand Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_0" xml:lang="en-US">April 5, 2019 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On April Five Two Thousand Nineteen One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_0" xml:lang="en-US">December 8, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On December Eight Two Thousand Twenty Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_0" xml:lang="en-US">December 8, 2020 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On December Eight Two Thousand Twenty One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_0" xml:lang="en-US">Warrants to Purchase Ordinary Shares Issued on December Two Thousand Fifteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On December Two Thousand Fifteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_0" xml:lang="en-US">Warrants to Purchase Ordinary Shares Issued on December Two Thousand Sixteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On December Two Thousand Sixteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_0" xml:lang="en-US">February 10, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On February Ten Two Thousand Twenty Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_0" xml:lang="en-US">February 10, 2020 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On February Ten Two Thousand Twenty One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_0" xml:lang="en-US">February 25, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On February Twenty Five Two Thousand Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_0" xml:lang="en-US">February 26, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On February Twenty Six Two Thousand Twenty One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_0" xml:lang="en-US">February 26, 2021 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On February Twenty Six Two Thousand Twenty One One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_0" xml:lang="en-US">July 6, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On July Six Two Thousand Twenty Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_0" xml:lang="en-US">July 6, 2020 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On July Six Two Thousand Twenty One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_0" xml:lang="en-US">June 5, 2019 and June 6, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On June Five And Six Two Thousand Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_0" xml:lang="en-US">June 5, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On June Five Two Thousand Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_0" xml:lang="en-US">June 10, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On June Ten Two Thousand Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_0" xml:lang="en-US">June 12, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On June Tweleve Two Thousand Nineteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_0" xml:lang="en-US">November 20, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On November Twenty Two Thousand Eighteen Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_0" xml:lang="en-US">November 20, 2018 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On November Twenty Two Thousand Eighteen One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_0" xml:lang="en-US">September 29, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On September Twenty Nine Two Thousand Twenty One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_0" xml:lang="en-US">September 29, 2021 One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_1" xml:lang="en-US">Warrants To Purchase Ordinary Shares Issued On September Twenty Nine Two Thousand Twenty One One Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WarrantyProvisionBalance_0" xml:lang="en-US">Warranty Provision Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WarrantyProvisionBalance_1" xml:lang="en-US">Represents the amount of Warranty provision balance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_lfwd_WarrantyProvisionBalance_2" xml:lang="en-US">Balance at December 31, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_lfwd_WarrantyProvisionBalance_3" xml:lang="en-US">Balance at September 30, 2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_WorkforcePercentage_0" xml:lang="en-US">Workforce Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_WorkforcePercentage_1" xml:lang="en-US">Represents the percentage of workforce.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_lfwd_WorkforcePercentage_2" xml:lang="en-US">Workforce Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_lfwd_YaskawaElectricCorporationMember_0" xml:lang="en-US">YEC [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_lfwd_YaskawaElectricCorporationMember_1" xml:lang="en-US">Yaskawa Electric Corporation Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_AfricaMember_0" xml:lang="en-US">Africa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_AsiaPacificMember_0" xml:lang="en-US">Asia Pacific [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EuropeMember_0" xml:lang="en-US">Europe [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_LatinAmericaMember_0" xml:lang="en-US">Latin America [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MajorCustomersAxis_0" xml:lang="en-US">Customer [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductOrServiceAxis_0" xml:lang="en-US">Product and Service [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductsAndServicesDomain_0" xml:lang="en-US">Product and Service [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_RangeAxis_1" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember_0" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis_0" xml:lang="en-US">Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis_0" xml:lang="en-US">Scenario [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xml:lang="en-US">Title of Individual [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_0" xml:lang="en-US">Sale of stock price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent_0" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableMember_0" xml:lang="en-US">Trade Receivables [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNet_0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNet_1" xml:lang="en-US">Trade receivable, net&#160;of credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableNet_2" xml:lang="en-US">Trade receivable, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_0" xml:lang="en-US">Trade receivable, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_1" xml:lang="en-US">Trade receivable, net of credit losses of $328 and $26, respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0" xml:lang="en-US">Accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital_0" xml:lang="en-US">Additional paid-in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional paid-in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0" xml:lang="en-US">Accounting Standards Update [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0" xml:lang="en-US">Share-based compensation to employees and non-employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0" xml:lang="en-US">Issuance expenses, amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_0" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_1" xml:lang="en-US">Non-cash share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1" xml:lang="en-US">Allowance for credit losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_0" xml:lang="en-US">Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_1" xml:lang="en-US">Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_2" xml:lang="en-US">Amortization of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_3" xml:lang="en-US">Amortization of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_0" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_1" xml:lang="en-US">Schedule of total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_0" xml:lang="en-US">Assets, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_1" xml:lang="en-US">Financial Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">Total long-term assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">LONG-TERM ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis_0" xml:lang="en-US">Award Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_0" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_0" xml:lang="en-US">Business Acquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0" xml:lang="en-US">Business Acquisition, Transaction Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1" xml:lang="en-US">Amount of additional cash earnouts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2" xml:lang="en-US">Earnout payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_0" xml:lang="en-US">Business Acquisition [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_0" xml:lang="en-US">Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_1" xml:lang="en-US">Schedule of pro forma revenue and earnings</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_0" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_1" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0" xml:lang="en-US">Business Combination, Acquisition Related Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1" xml:lang="en-US">Acquisition-related costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0" xml:lang="en-US">Business Combination, Consideration Transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1" xml:lang="en-US">Total consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_2" xml:lang="en-US">Purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_0" xml:lang="en-US">Business Combination Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1" xml:lang="en-US">BUSINESS COMBINATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_0" xml:lang="en-US">Leases Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_1" xml:lang="en-US">Leases Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_2" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" xml:lang="en-US">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2" xml:lang="en-US">Cash and cash equivalent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_1" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0" xml:lang="en-US">Accounts receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0" xml:lang="en-US">Accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2" xml:lang="en-US">Accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_1" xml:lang="en-US">Deferred revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2" xml:lang="en-US">Deferred revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1" xml:lang="en-US">Intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1" xml:lang="en-US">Inventory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0" xml:lang="en-US">Other non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1" xml:lang="en-US">Total purchase consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_0" xml:lang="en-US">Business Combinations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationsPolicy_0" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationsPolicy_1" xml:lang="en-US">Business Combinations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_0" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_1" xml:lang="en-US">Description of Earnout payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0" xml:lang="en-US">Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xml:lang="en-US">Total Cash, cash equivalents, and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1" xml:lang="en-US">(Decrease) increase in cash, cash equivalents, and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">Increase (decrease) in cash, cash equivalents, and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_0" xml:lang="en-US">Warrants grant date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis_0" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0" xml:lang="en-US">Warrant exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xml:lang="en-US">Exercise price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xml:lang="en-US">Exercise price per warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems_0" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_0" xml:lang="en-US">Warrant to purchase one ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0" xml:lang="en-US">Warrants to acquire common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2" xml:lang="en-US">Number of warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3" xml:lang="en-US">Warrants to purchase common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding_0" xml:lang="en-US">Warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable_0" xml:lang="en-US">Class of Warrant or Right [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0" xml:lang="en-US">Contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0" xml:lang="en-US">Shares reserved for future issuance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember_1" xml:lang="en-US">Ordinary Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_1" xml:lang="en-US">Ordinary shares, par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_2" xml:lang="en-US">Per share value of stock repurchase authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Ordinary shares, authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Ordinary shares, issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Ordinary shares, outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Common Stock Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary share of NIS 0.25 par value-Authorized: 120,000,000 shares at September 30, 2022 and December 31, 2021; Issued: 62,901,945 and 62,480,163 shares as of September 30, 2022 and December 31, 2021 respectively; Outstanding: 62,717,316 and 62,480,163 shares as of September 30, 2022 and December 31, 2021 respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockValue_2" xml:lang="en-US">Ordinary share of NIS 0.25 par value-Authorized: 120,000,000 shares at December 31, 2023 and December 31, 2022; Issued: 64,132,706 and 63,023,506 shares at December 31, 2023 and December 31, 2022, respectively; Outstanding: 60,110,099 and 60,090,298 shares as of December 31, 2023 and December 31, 2022 respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComputerEquipmentMember_0" xml:lang="en-US">Computer equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain_0" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis_0" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_0" xml:lang="en-US">Concentrations of Credit Risks</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskLineItems_0" xml:lang="en-US">Concentration Risk [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_0" xml:lang="en-US">Concentration of credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1_1" xml:lang="en-US">Concentration risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTable_0" xml:lang="en-US">Concentration Risk [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_0" xml:lang="en-US">Principles of Consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockDescription_0" xml:lang="en-US">Description of conversion ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember_0" xml:lang="en-US">Convertible preferred A shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_0" xml:lang="en-US">Convertible preferred shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfRevenue_0" xml:lang="en-US">Cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CostOfRevenue_1" xml:lang="en-US">Cost of revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfSalesMember_0" xml:lang="en-US">Cost of revenue [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditConcentrationRiskMember_0" xml:lang="en-US">Credit Concentration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0" xml:lang="en-US">Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember_0" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CustomerRelationshipsMember_0" xml:lang="en-US">Customer Relationships [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CustomerRelationshipsMember_1" xml:lang="en-US">Customer relationship - Distribution</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureAbstract_0" xml:lang="en-US">Debt Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_0" xml:lang="en-US">PAYCHECK PROTECTION PROGRAM LOAN</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentAxis_0" xml:lang="en-US">Debt Instrument [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentCollateralAmount_0" xml:lang="en-US">Drawdown amount under loan agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_0" xml:lang="en-US">Face amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0" xml:lang="en-US">Annual interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" xml:lang="en-US">Interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentLineItems_0" xml:lang="en-US">Debt Instrument [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTable_0" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTerm_0" xml:lang="en-US">Loan term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtInstrumentTerm_1" xml:lang="en-US">Initial period of loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_0" xml:lang="en-US">Schedule of prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0" xml:lang="en-US">Deferred taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenue_0" xml:lang="en-US">Deferred revenues and advance payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredRevenue_1" xml:lang="en-US">Deferred revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredRevenue_2" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenueCurrent_0" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredRevenueCurrent_1" xml:lang="en-US">Deferred revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent_0" xml:lang="en-US">Deferred Revenue, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent_1" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_0" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_1" xml:lang="en-US">Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_1" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract_0" xml:lang="en-US">Deferred tax assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_0" xml:lang="en-US">Research and development carry forward expenses-temporary differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_1" xml:lang="en-US">Total deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_1" xml:lang="en-US">Net deferred tax assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0" xml:lang="en-US">Carry forward tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_0" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_1" xml:lang="en-US">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2" xml:lang="en-US">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2" xml:lang="en-US">Credit tax carry forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_0" xml:lang="en-US">Accrual and reserves</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0" xml:lang="en-US">Valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US">Balance at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2" xml:lang="en-US">Balance at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_3" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract_0" xml:lang="en-US">Deferred tax liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Depreciation_1" xml:lang="en-US">Depreciation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Depreciation_2" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Net loss per ordinary share, basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">Net loss per ordinary share, basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">Net loss per ordinary share, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_0" xml:lang="en-US">Basic and Diluted Net Loss Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_1" xml:lang="en-US">BASIC AND DILUTED NET LOSS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0" xml:lang="en-US">Unrecognized cost of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeStockOptionMember_0" xml:lang="en-US">Employee Stock Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_0" xml:lang="en-US">Revenue, Major Customer [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityAbstract_0" xml:lang="en-US">Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_0" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_1" xml:lang="en-US">Schedule of assets and liabilities measured at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" xml:lang="en-US">Asset Class [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByAssetClassAxis_0" xml:lang="en-US">Asset Class [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis_0" xml:lang="en-US">Liability Class [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_0" xml:lang="en-US">Measurement Frequency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_0" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" xml:lang="en-US">Fair Value by Liability Class [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_0" xml:lang="en-US">Measurement Frequency [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0" xml:lang="en-US">Fair Value Measurements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_0" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_1" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_0" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" xml:lang="en-US">Domestic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_0" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_1" xml:lang="en-US">Estimated Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_2" xml:lang="en-US">Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_1" xml:lang="en-US">Fiscal 2028</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1" xml:lang="en-US">Fiscal 2023 (period remaining)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1" xml:lang="en-US">Fiscal 2027</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1" xml:lang="en-US">Fiscal 2026</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1" xml:lang="en-US">Fiscal 2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1" xml:lang="en-US">Fiscal 2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0" xml:lang="en-US">Estimated Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2" xml:lang="en-US">Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_3" xml:lang="en-US">Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4" xml:lang="en-US">Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1" xml:lang="en-US">Estimated Useful Life (Years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCountryMember_0" xml:lang="en-US">Foreign Tax Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ForeignCountryMember_1" xml:lang="en-US">Federal [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0" xml:lang="en-US">Foreign Currency Transaction Loss, before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1" xml:lang="en-US">Exchange rate fluctuations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0" xml:lang="en-US">Financial Statements in U.S. Dollars</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_0" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" xml:lang="en-US">Foreign</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FurnitureAndFixturesMember_0" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0" xml:lang="en-US">General and administrative [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Goodwill_0" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Goodwill_1" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Goodwill_2" xml:lang="en-US">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_0" xml:lang="en-US">Goodwill, Acquired During Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod_1" xml:lang="en-US">Purchase of goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_0" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1" xml:lang="en-US">Goodwill and Other Intangibles</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillLineItems_0" xml:lang="en-US">Goodwill [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrossProfit_0" xml:lang="en-US">Gross Profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GrossProfit_1" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0" xml:lang="en-US">Impairment losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0" xml:lang="en-US">Impairment of Long-Lived Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0" xml:lang="en-US">Domestic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xml:lang="en-US">Loss before taxes, as reported in the consolidated statements of operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US">Loss before income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0" xml:lang="en-US">Foreign</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_0" xml:lang="en-US">Income Statement Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis_0" xml:lang="en-US">Income Tax Authority, Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_0" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_0" xml:lang="en-US">INCOME TAXES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesPaid_0" xml:lang="en-US">Cash paid for income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1" xml:lang="en-US">Taxes on income (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_0" xml:lang="en-US">Income Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0" xml:lang="en-US">Operating losses and other temporary differences for which valuation allowance was provided</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_0" xml:lang="en-US">Permanent differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0" xml:lang="en-US">Income tax at rate other than the Israeli statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_0" xml:lang="en-US">Non-deductible expenses including equity-based compensation expenses and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_0" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_1" xml:lang="en-US">Adjustment in respect of prior years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_1" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1" xml:lang="en-US">Trade receivables, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredLiabilities_0" xml:lang="en-US">Increase (Decrease) in Deferred Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredLiabilities_1" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1" xml:lang="en-US">Employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xml:lang="en-US">Changes in assets and liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1" xml:lang="en-US">Operating lease liabilities and other liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US">Prepaid expenses, operating lease right-of-use assets and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestExpenseDebt_0" xml:lang="en-US">Interest expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InterestExpenseDebt_1" xml:lang="en-US">Financial expenses related to loan agreement with Kreos</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_0" xml:lang="en-US">Interest Income (Expense), Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestIncomeExpenseNet_1" xml:lang="en-US">Interest income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestIncomeOther_0" xml:lang="en-US">Interest Income, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestIncomeOther_1" xml:lang="en-US">Interest Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestIncomeOther_2" xml:lang="en-US">Interest Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_0" xml:lang="en-US">Inventory Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_0" xml:lang="en-US">INVENTORIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryFinishedGoods_0" xml:lang="en-US">Finished products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryNet_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_InventoryNet_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryRawMaterials_0" xml:lang="en-US">Raw materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryWriteDown_0" xml:lang="en-US">Inventory Write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryWriteDown_1" xml:lang="en-US">Inventory write-down</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IPOMember_0" xml:lang="en-US">IPO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember_0" xml:lang="en-US">Israel Tax Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsMember_0" xml:lang="en-US">Leasehold improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_0" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseDescription_0" xml:lang="en-US">Lease expiration, term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xml:lang="en-US">Total lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0" xml:lang="en-US">2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1" xml:lang="en-US">2025</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0" xml:lang="en-US">Present value of future lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1" xml:lang="en-US">Present value of future lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">CURRENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_1" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_0" xml:lang="en-US">Liabilities, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_1" xml:lang="en-US">Financial Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">Total long-term liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">LONG-TERM LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_0" xml:lang="en-US">Schedule of long-lived assets by geographic region</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_0" xml:lang="en-US">Long-term Debt, Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense_0" xml:lang="en-US">Marketing and Advertising Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense_1" xml:lang="en-US">Sales and marketing, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MoneyMarketFundsMember_0" xml:lang="en-US">Money Market Funds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MoneyMarketFundsMember_1" xml:lang="en-US">Money market funds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0" xml:lang="en-US">Warranty provision:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash (used in) provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from financing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows used in investing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Negative cash flow from operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows used in operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLoss_2" xml:lang="en-US">Net loss attributable to ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLoss_3" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0" xml:lang="en-US">Net loss attributable to ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0" xml:lang="en-US">New Accounting Pronouncements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0" xml:lang="en-US">Supplemental disclosures of non-cash flow information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncurrentAssets_0" xml:lang="en-US">Long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NumberOfReportableSegments_0" xml:lang="en-US">Number of reportable segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses_0" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract_0" xml:lang="en-US">Operating expenses:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss_0" xml:lang="en-US">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_1" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_0" xml:lang="en-US">Rent expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Less: current maturities of operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_1" xml:lang="en-US">Current maturities of operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_2" xml:lang="en-US">Current maturities of operating leases liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Non-current operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1" xml:lang="en-US">Non-current operating leases liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2" xml:lang="en-US">Non-current operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0" xml:lang="en-US">Weighted-average discount rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0" xml:lang="en-US">Weighted-average remaining lease term (in years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwards_0" xml:lang="en-US">Carry-forward losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwardsExpirationDate_0" xml:lang="en-US">Operating Loss Carryforwards, Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember_0" xml:lang="en-US">Order or Production Backlog [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember_1" xml:lang="en-US">Backlog [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0" xml:lang="en-US">GENERAL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsCurrent_0" xml:lang="en-US">Other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_0" xml:lang="en-US">Other Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_1" xml:lang="en-US">Restricted cash and other long-term assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsLineItems_0" xml:lang="en-US">Other Commitments [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsTable_0" xml:lang="en-US">Other Commitments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0" xml:lang="en-US">Foreign currency transactions and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2" xml:lang="en-US">Foreign currency transactions and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract_0" xml:lang="en-US">Other Income and Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_0" xml:lang="en-US">FINANCIAL EXPENSES (INCOME), NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_0" xml:lang="en-US">Other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_0" xml:lang="en-US">Other long-term liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLongTermDebt_0" xml:lang="en-US">Other Long-Term Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLongTermDebt_1" xml:lang="en-US">Restricted cash and other long-term assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherLongTermDebt_2" xml:lang="en-US">Other Long-Term Debt, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit_0" xml:lang="en-US">Other Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit_1" xml:lang="en-US">Actual tax expense (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0" xml:lang="en-US">Payments for Repurchase of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1" xml:lang="en-US">Aggregate consideration paid for repurchasing common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForRoyalties_0" xml:lang="en-US">Royalties paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_0" xml:lang="en-US">Issuance expenses paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_1" xml:lang="en-US">Issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_0" xml:lang="en-US">Payments to Acquire Businesses, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_1" xml:lang="en-US">Cash and cash equivalent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_2" xml:lang="en-US">Aggregate purchase price in cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1" xml:lang="en-US">Acquisition of a business, net of cash acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis_0" xml:lang="en-US">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain_0" xml:lang="en-US">Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy_0" xml:lang="en-US">Accrued Severance Pay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PostemploymentBenefitsPeriodExpense_0" xml:lang="en-US">Severance pay expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xml:lang="en-US">PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_0" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrivatePlacementMember_0" xml:lang="en-US">Private Placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0" xml:lang="en-US">Proceeds from PPP loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1" xml:lang="en-US">Proceeds from long term loan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0" xml:lang="en-US">Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $959</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1" xml:lang="en-US">Total gross proceeds received from the follow-on public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived_0" xml:lang="en-US">Total fund received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockPlans_0" xml:lang="en-US">Gross proceeds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_0" xml:lang="en-US">Proceeds From Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProductMember_0" xml:lang="en-US">Product [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_0" xml:lang="en-US">Property, plant and equipment, gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0" xml:lang="en-US">Property and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0" xml:lang="en-US">Schedule of components of Property and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xml:lang="en-US">Schedule of components of property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0" xml:lang="en-US">Property and equipment estimated useful lives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PurchaseObligation_0" xml:lang="en-US">Non-cancelable outstanding obligations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0" xml:lang="en-US">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RepaymentsOfDebt_0" xml:lang="en-US">Repayments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract_0" xml:lang="en-US">Research and Development [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0" xml:lang="en-US">Research and development, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0" xml:lang="en-US">Research and Development Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_0" xml:lang="en-US">RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1" xml:lang="en-US">Restricted cash included in other long-term assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0" xml:lang="en-US">Restructuring and Related Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_2" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Retained Earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember_1" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0" xml:lang="en-US">Deferred revenue recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0" xml:lang="en-US">Revenue Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_0" xml:lang="en-US">Schedule of revenues within geographic areas</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_0" xml:lang="en-US">Schedule of disaggregation of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_Revenues_0" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues_1" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Revenues_2" xml:lang="en-US">Total revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_Revenues_3" xml:lang="en-US">Total Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1" xml:lang="en-US">ROU assets obtained from new lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RoyaltyExpense_0" xml:lang="en-US">Royalty expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RoyaltyExpense_1" xml:lang="en-US">Royalties expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueNetMember_0" xml:lang="en-US">Sales Revenue, Net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0" xml:lang="en-US">Schedule of taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0" xml:lang="en-US">Schedule of deferred income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0" xml:lang="en-US">Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0" xml:lang="en-US">Schedule of non-cash share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1" xml:lang="en-US">Schedule of intangible assets acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1" xml:lang="en-US">Schedule of future amortization expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1" xml:lang="en-US">Schedule of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_0" xml:lang="en-US">Schedule of Goodwill [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0" xml:lang="en-US">Schedule of loss before taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0" xml:lang="en-US">Schedule of inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0" xml:lang="en-US">Schedule of financial expenses, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_0" xml:lang="en-US">Public Utility Property, Plant, and Equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1" xml:lang="en-US">Public Utility Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1" xml:lang="en-US">Schedule of preliminary fair value of assets acquired and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_0" xml:lang="en-US">Schedule of major customer data as a percentage of total revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_0" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0" xml:lang="en-US">Schedule of employee and non-employee RSUs activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0" xml:lang="en-US">Schedule of options and RSUs outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_0" xml:lang="en-US">Schedule of employee and non-employee shares options activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_0" xml:lang="en-US">Schedule of Share-based Goods and Nonemployee Services Transaction [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_0" xml:lang="en-US">Schedule of warrants outstanding and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_0" xml:lang="en-US">Schedule of concentration of credit risk</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecuredDebtMember_0" xml:lang="en-US">Secured Debt [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SecuredDebtMember_1" xml:lang="en-US">Loan Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_0" xml:lang="en-US">Description of tranche consisting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingAbstract_0" xml:lang="en-US">Segment Reporting [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_0" xml:lang="en-US">GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpense_0" xml:lang="en-US">Selling and Marketing Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpense_1" xml:lang="en-US">Sales and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember_0" xml:lang="en-US">Sales and marketing, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Weighted average grant date fair value, restricted stock units (in USD per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" xml:lang="en-US">RSUs outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0" xml:lang="en-US">Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0" xml:lang="en-US">Expected term (in years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xml:lang="en-US">Expected term of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0" xml:lang="en-US">Risk-free rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_0" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0" xml:lang="en-US">Aggregate intrinsic value (in thousands), Options exercisable at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0" xml:lang="en-US">Number, Options exercisable at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0" xml:lang="en-US">Average exercise price, Options exercisable at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0" xml:lang="en-US">Average remaining contractual life (in years), Options exercisable at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0" xml:lang="en-US">Number, Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xml:lang="en-US">Number, Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xml:lang="en-US">Options granted (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Weighted average grant date fair value, options (in USD per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0" xml:lang="en-US">Aggregate intrinsic value (in thousands), Options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xml:lang="en-US">Number, Options outstanding at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US">Number, Options outstanding at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xml:lang="en-US">Average exercise price, Options outstanding at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US">Average exercise price, Options outstanding at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0" xml:lang="en-US">Average remaining contractual life (in years), Options outstanding at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0" xml:lang="en-US">Total fair value of shares vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Average exercise price, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Average exercise price, Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Average exercise price, Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0" xml:lang="en-US">Accounting for Share-Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0" xml:lang="en-US">Exercise Price Range [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_0" xml:lang="en-US">Options exercisable weighted average remaining contractual life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_0" xml:lang="en-US">Range of exercise price, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0" xml:lang="en-US">Options outstanding and exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0" xml:lang="en-US">Options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0" xml:lang="en-US">Options outstanding weighted average remaining contractual life (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_0" xml:lang="en-US">Range of exercise price, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_0" xml:lang="en-US">Share-based Goods and Nonemployee Services Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice_0" xml:lang="en-US">Share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis_0" xml:lang="en-US">Share Repurchase Program [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain_0" xml:lang="en-US">Share Repurchase Program [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare_0" xml:lang="en-US">Shares issued price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding_0" xml:lang="en-US">Balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding_1" xml:lang="en-US">Balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding_2" xml:lang="en-US">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_0" xml:lang="en-US">Balance at December 31, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_1" xml:lang="en-US">Balance at December 31, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual_2" xml:lang="en-US">Standard Product Warranty Accrual</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments_0" xml:lang="en-US">Usage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPayments_1" xml:lang="en-US">Standard Product Warranty Accrual, Decrease for Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_0" xml:lang="en-US">Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_0" xml:lang="en-US">Warranty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_1" xml:lang="en-US">Warranty Provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_0" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_1" xml:lang="en-US">State [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis_0" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract_0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract_1" xml:lang="en-US">Shareholders&#8217; equity:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract_2" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityReverseStockSplit_0" xml:lang="en-US">Reverse share split, description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Issuance of ordinary shares (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther_0" xml:lang="en-US">Units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0" xml:lang="en-US">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0" xml:lang="en-US">Number, Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Issuance of ordinary shares in an ATM offering of ordinary shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0" xml:lang="en-US">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_0" xml:lang="en-US">Stock Repurchased During Period, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_1" xml:lang="en-US">Number of ordinary shares repurchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1" xml:lang="en-US">Number of ordinary shares repurchased, amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2" xml:lang="en-US">Authorized value of stock repurchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_0" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1" xml:lang="en-US">Outstanding ordinary shares repurchased, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_2" xml:lang="en-US">Authorized number of stock repurchased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems_0" xml:lang="en-US">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SubsequentEventMember_1" xml:lang="en-US">Subsequent Event</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract_0" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_1" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable_0" xml:lang="en-US">Subsequent Event [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_0" xml:lang="en-US">Schedule of net changes in total valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_0" xml:lang="en-US">Supplemental disclosures of cash flow information:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_1" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Supplies_0" xml:lang="en-US">Advances to vendors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_0" xml:lang="en-US">Tax Credit Carryforward, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount_1" xml:lang="en-US">Credit tax carry forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_0" xml:lang="en-US">Technology-Based Intangible Assets [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_1" xml:lang="en-US">Technology [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TrademarksMember_0" xml:lang="en-US">Trademark</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TrademarksMember_1" xml:lang="en-US">Trademarks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockCommonShares_0" xml:lang="en-US">Treasury Stock, Common, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockCommonShares_1" xml:lang="en-US">Treasury stock common shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_TreasuryStockCommonValue_0" xml:lang="en-US">Treasury Shares at cost, 4,022,607 and 2,933,208 ordinary shares at December 31, 2023 and December 31, 2022 respectively</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockCommonValue_1" xml:lang="en-US">Treasury Stock, Common, Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockCommonValue_2" xml:lang="en-US">Treasury Shares at cost, 184,629 ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockPreferredMember_0" xml:lang="en-US">Treasury Stock, Preferred [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TreasuryStockPreferredMember_1" xml:lang="en-US">Treasury Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_0" xml:lang="en-US">Treasury Stock, Shares, Acquired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_1" xml:lang="en-US">Treasury shares at cost (shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnsecuredDebt_0" xml:lang="en-US">Unsecured promissory note</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of Estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember_0" xml:lang="en-US">US Treasury and Government [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember_1" xml:lang="en-US">Treasury bills [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0" xml:lang="en-US">Additions during the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding_0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding_1" xml:lang="en-US">Warrants and rights outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm_0" xml:lang="en-US">Service policy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">Weighted average number of shares used in computing net loss per ordinary share, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2" xml:lang="en-US">Shares used in computing net loss per ordinary shares, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">Weighted average number of shares used in computing net loss per ordinary share, basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">Weighted average number of shares used in computing net loss per ordinary share, basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2" xml:lang="en-US">Shares used in computing net loss per ordinary shares, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_DE_1" xlink:to="lab_country_DE_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_2" xlink:to="lab_country_IL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_3" xlink:to="lab_country_US_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentDescription_4" xlink:to="lab_dei_AmendmentDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_5" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_6" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_7" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_8" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_9" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_10" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_11" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_12" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag_13" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_14" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_15" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_16" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_17" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_18" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_19" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_20" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_21" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_22" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_23" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_24" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_25" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_26" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_27" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_28" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_29" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_30" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_31" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_32" xlink:to="lab_dei_EntityPublicFloat_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_33" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_34" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_35" xlink:to="lab_dei_EntitySmallBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_36" xlink:to="lab_dei_EntityTaxIdentificationNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_37" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_38" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_39" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_40" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_41" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_42" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_43" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_44" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_45" xlink:to="lab_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_46" xlink:to="lab_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_47" xlink:to="lab_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AdditionallyWarrantsIssuedMember_48" xlink:to="lab_lfwd_AdditionallyWarrantsIssuedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AdditionallyWarrantsIssuedMember_49" xlink:to="lab_lfwd_AdditionallyWarrantsIssuedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AggregateNumberOfOrdinaryShares_50" xlink:to="lab_lfwd_AggregateNumberOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AggregateNumberOfOrdinaryShares_51" xlink:to="lab_lfwd_AggregateNumberOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AgreementAxis_52" xlink:to="lab_lfwd_AgreementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AgreementAxis_53" xlink:to="lab_lfwd_AgreementAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AllowanceForSalesReturns_54" xlink:to="lab_lfwd_AllowanceForSalesReturns_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AllowanceForSalesReturns_55" xlink:to="lab_lfwd_AllowanceForSalesReturns_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AllowanceForSalesReturns_56" xlink:to="lab_lfwd_AllowanceForSalesReturns_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AltergIncMember_57" xlink:to="lab_lfwd_AltergIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AltergIncMember_58" xlink:to="lab_lfwd_AltergIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfAdditionalCashEarnouts_59" xlink:to="lab_lfwd_AmountOfAdditionalCashEarnouts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfAdditionalCashEarnouts_60" xlink:to="lab_lfwd_AmountOfAdditionalCashEarnouts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfAdditionalCashEarnouts_61" xlink:to="lab_lfwd_AmountOfAdditionalCashEarnouts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_62" xlink:to="lab_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_63" xlink:to="lab_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_64" xlink:to="lab_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfWarrantProvision_65" xlink:to="lab_lfwd_AmountOfWarrantProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfWarrantProvision_66" xlink:to="lab_lfwd_AmountOfWarrantProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfWarrantProvision_67" xlink:to="lab_lfwd_AmountOfWarrantProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfWarrantProvisionUsage_68" xlink:to="lab_lfwd_AmountOfWarrantProvisionUsage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfWarrantProvisionUsage_69" xlink:to="lab_lfwd_AmountOfWarrantProvisionUsage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_AmountOfWarrantProvisionUsage_70" xlink:to="lab_lfwd_AmountOfWarrantProvisionUsage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BacklogMember_71" xlink:to="lab_lfwd_BacklogMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BacklogMember_72" xlink:to="lab_lfwd_BacklogMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BacklogMember_73" xlink:to="lab_lfwd_BacklogMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BankCommissions_74" xlink:to="lab_lfwd_BankCommissions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BankCommissions_75" xlink:to="lab_lfwd_BankCommissions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BankCommissions_76" xlink:to="lab_lfwd_BankCommissions_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_77" xlink:to="lab_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_78" xlink:to="lab_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_79" xlink:to="lab_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_80" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_81" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_82" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_83" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_84" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_85" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_86" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_87" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_88" xlink:to="lab_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BestOfferingMember_89" xlink:to="lab_lfwd_BestOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BestOfferingMember_90" xlink:to="lab_lfwd_BestOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_91" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_92" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_93" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_94" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_95" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_96" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_97" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_98" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_99" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_100" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_101" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_102" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_103" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_104" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_105" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_106" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_107" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_108" xlink:to="lab_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_109" xlink:to="lab_lfwd_BusinessCombinationRecognizedWarrantProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_110" xlink:to="lab_lfwd_BusinessCombinationRecognizedWarrantProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_111" xlink:to="lab_lfwd_BusinessCombinationRecognizedWarrantProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_112" xlink:to="lab_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_113" xlink:to="lab_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_114" xlink:to="lab_lfwd_CashAndCashEquivalentsRestrictedCashAndRestrictedCashEquivalent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CashlessExerciseOfPreFundedWarrants_115" xlink:to="lab_lfwd_CashlessExerciseOfPreFundedWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CashlessExerciseOfPreFundedWarrants_116" xlink:to="lab_lfwd_CashlessExerciseOfPreFundedWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CertainInstitutionalPurchasersMember_117" xlink:to="lab_lfwd_CertainInstitutionalPurchasersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CertainInstitutionalPurchasersMember_118" xlink:to="lab_lfwd_CertainInstitutionalPurchasersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_119" xlink:to="lab_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_120" xlink:to="lab_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_121" xlink:to="lab_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToOtherCurrentAssets_122" xlink:to="lab_lfwd_ClassificationOfInventoryToOtherCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToOtherCurrentAssets_123" xlink:to="lab_lfwd_ClassificationOfInventoryToOtherCurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_124" xlink:to="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_125" xlink:to="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_126" xlink:to="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_127" xlink:to="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_128" xlink:to="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_129" xlink:to="lab_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNetOne_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_130" xlink:to="lab_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_131" xlink:to="lab_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassOfWarrantOrRightExercisable_132" xlink:to="lab_lfwd_ClassOfWarrantOrRightExercisable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassOfWarrantOrRightExercisable_133" xlink:to="lab_lfwd_ClassOfWarrantOrRightExercisable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassOfWarrantOrRightExercisable_134" xlink:to="lab_lfwd_ClassOfWarrantOrRightExercisable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_135" xlink:to="lab_lfwd_ClassOfWarrantOrRightPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_136" xlink:to="lab_lfwd_ClassOfWarrantOrRightPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_137" xlink:to="lab_lfwd_ClassOfWarrantOrRightPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_138" xlink:to="lab_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_139" xlink:to="lab_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_140" xlink:to="lab_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_141" xlink:to="lab_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_142" xlink:to="lab_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_143" xlink:to="lab_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_144" xlink:to="lab_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_145" xlink:to="lab_lfwd_CommonUnitsAndPreFundedUnits1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_146" xlink:to="lab_lfwd_CommonUnitsAndPreFundedUnits1Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_147" xlink:to="lab_lfwd_CommonUnitsAndPreFundedUnits1Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_148" xlink:to="lab_lfwd_CommonUnitsAndPreFundedUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_149" xlink:to="lab_lfwd_CommonUnitsAndPreFundedUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsMember_150" xlink:to="lab_lfwd_CommonUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CommonUnitsMember_151" xlink:to="lab_lfwd_CommonUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_152" xlink:to="lab_lfwd_ContingentLiabilityRelatedToGrantsReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_153" xlink:to="lab_lfwd_ContingentLiabilityRelatedToGrantsReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_154" xlink:to="lab_lfwd_ContingentLiabilityRelatedToGrantsReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_155" xlink:to="lab_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerAMember_156" xlink:to="lab_lfwd_CustomerAMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerAMember_157" xlink:to="lab_lfwd_CustomerAMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerAMember_158" xlink:to="lab_lfwd_CustomerAMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerAMember_159" xlink:to="lab_lfwd_CustomerAMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerBMember_160" xlink:to="lab_lfwd_CustomerBMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerBMember_161" xlink:to="lab_lfwd_CustomerBMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerCMember_162" xlink:to="lab_lfwd_CustomerCMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerCMember_163" xlink:to="lab_lfwd_CustomerCMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerDMember_164" xlink:to="lab_lfwd_CustomerDMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerDMember_165" xlink:to="lab_lfwd_CustomerDMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerEMember_166" xlink:to="lab_lfwd_CustomerEMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerEMember_167" xlink:to="lab_lfwd_CustomerEMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerFMember_168" xlink:to="lab_lfwd_CustomerFMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerFMember_169" xlink:to="lab_lfwd_CustomerFMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerGMember_170" xlink:to="lab_lfwd_CustomerGMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerGMember_171" xlink:to="lab_lfwd_CustomerGMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerHMember_172" xlink:to="lab_lfwd_CustomerHMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerHMember_173" xlink:to="lab_lfwd_CustomerHMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerIMember_174" xlink:to="lab_lfwd_CustomerIMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerIMember_175" xlink:to="lab_lfwd_CustomerIMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerJMember_176" xlink:to="lab_lfwd_CustomerJMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerJMember_177" xlink:to="lab_lfwd_CustomerJMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipDistributionMember_178" xlink:to="lab_lfwd_CustomerRelationshipDistributionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipDistributionMember_179" xlink:to="lab_lfwd_CustomerRelationshipDistributionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipRentalMember_180" xlink:to="lab_lfwd_CustomerRelationshipRentalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipRentalMember_181" xlink:to="lab_lfwd_CustomerRelationshipRentalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipRentalMember_182" xlink:to="lab_lfwd_CustomerRelationshipRentalMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipWarrantyMember_183" xlink:to="lab_lfwd_CustomerRelationshipWarrantyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipWarrantyMember_184" xlink:to="lab_lfwd_CustomerRelationshipWarrantyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_CustomerRelationshipWarrantyMember_185" xlink:to="lab_lfwd_CustomerRelationshipWarrantyMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_186" xlink:to="lab_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_187" xlink:to="lab_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_188" xlink:to="lab_lfwd_DebtInstrumentProceedsFromIssuanceOfCommonStockRequiredForRepaymentPeriodToBeExtended_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_December2020PrivatePlacementMember_189" xlink:to="lab_lfwd_December2020PrivatePlacementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_December2020PrivatePlacementMember_190" xlink:to="lab_lfwd_December2020PrivatePlacementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredIncomeTax_191" xlink:to="lab_lfwd_DeferredIncomeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredIncomeTax_192" xlink:to="lab_lfwd_DeferredIncomeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredIncomeTax_193" xlink:to="lab_lfwd_DeferredIncomeTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_194" xlink:to="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_195" xlink:to="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_196" xlink:to="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_197" xlink:to="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_198" xlink:to="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_199" xlink:to="lab_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_200" xlink:to="lab_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_201" xlink:to="lab_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_202" xlink:to="lab_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_203" xlink:to="lab_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_204" xlink:to="lab_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_205" xlink:to="lab_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_206" xlink:to="lab_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DescriptionOfUnderwritingAgreement_207" xlink:to="lab_lfwd_DescriptionOfUnderwritingAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DescriptionOfUnderwritingAgreement_208" xlink:to="lab_lfwd_DescriptionOfUnderwritingAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_209" xlink:to="lab_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_210" xlink:to="lab_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_211" xlink:to="lab_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_212" xlink:to="lab_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_213" xlink:to="lab_lfwd_DisclosureOfTermLoansAndWarrantsToPurchaseOrdinarySharesTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnoutLiabilityCurrent_214" xlink:to="lab_lfwd_EarnoutLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnoutLiabilityCurrent_215" xlink:to="lab_lfwd_EarnoutLiabilityCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnoutLiabilityCurrent_216" xlink:to="lab_lfwd_EarnoutLiabilityCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnoutMember_217" xlink:to="lab_lfwd_EarnoutMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnoutMember_218" xlink:to="lab_lfwd_EarnoutMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnoutMember_219" xlink:to="lab_lfwd_EarnoutMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnOutPaymentOfBusinessCombination_220" xlink:to="lab_lfwd_EarnOutPaymentOfBusinessCombination_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnOutPaymentOfBusinessCombination_221" xlink:to="lab_lfwd_EarnOutPaymentOfBusinessCombination_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnOutPaymentOfBusinessCombination_222" xlink:to="lab_lfwd_EarnOutPaymentOfBusinessCombination_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnOutRemeasured_223" xlink:to="lab_lfwd_EarnOutRemeasured_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnOutRemeasured_224" xlink:to="lab_lfwd_EarnOutRemeasured_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EarnOutRemeasured_225" xlink:to="lab_lfwd_EarnOutRemeasured_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EmployeesAndNonEmployeesMember_226" xlink:to="lab_lfwd_EmployeesAndNonEmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EmployeesAndNonEmployeesMember_227" xlink:to="lab_lfwd_EmployeesAndNonEmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_228" xlink:to="lab_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_229" xlink:to="lab_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EquityExchangeProgramMember_230" xlink:to="lab_lfwd_EquityExchangeProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_EquityExchangeProgramMember_231" xlink:to="lab_lfwd_EquityExchangeProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrants_232" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrants_233" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrants_234" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrants_235" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_236" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_237" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_238" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_239" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_240" xlink:to="lab_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceOrdinaryShares_241" xlink:to="lab_lfwd_ExercisePriceOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceOrdinaryShares_242" xlink:to="lab_lfwd_ExercisePriceOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeFiveMember_243" xlink:to="lab_lfwd_ExercisePriceRangeFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeFiveMember_244" xlink:to="lab_lfwd_ExercisePriceRangeFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeFiveMember_245" xlink:to="lab_lfwd_ExercisePriceRangeFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeFourMember_246" xlink:to="lab_lfwd_ExercisePriceRangeFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeFourMember_247" xlink:to="lab_lfwd_ExercisePriceRangeFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeFourMember_248" xlink:to="lab_lfwd_ExercisePriceRangeFourMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeMember_249" xlink:to="lab_lfwd_ExercisePriceRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeMember_250" xlink:to="lab_lfwd_ExercisePriceRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeMember_251" xlink:to="lab_lfwd_ExercisePriceRangeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeOneMember_252" xlink:to="lab_lfwd_ExercisePriceRangeOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeOneMember_253" xlink:to="lab_lfwd_ExercisePriceRangeOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeOneMember_254" xlink:to="lab_lfwd_ExercisePriceRangeOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeThreeMember_255" xlink:to="lab_lfwd_ExercisePriceRangeThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeThreeMember_256" xlink:to="lab_lfwd_ExercisePriceRangeThreeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeThreeMember_257" xlink:to="lab_lfwd_ExercisePriceRangeThreeMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeTwoMember_258" xlink:to="lab_lfwd_ExercisePriceRangeTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeTwoMember_259" xlink:to="lab_lfwd_ExercisePriceRangeTwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ExercisePriceRangeTwoMember_260" xlink:to="lab_lfwd_ExercisePriceRangeTwoMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_261" xlink:to="lab_lfwd_FairValueWarrantsLiabilityActivityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_262" xlink:to="lab_lfwd_FairValueWarrantsLiabilityActivityLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityTable_263" xlink:to="lab_lfwd_FairValueWarrantsLiabilityActivityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityTable_264" xlink:to="lab_lfwd_FairValueWarrantsLiabilityActivityTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FeesAndOtherRelatedExpenses_265" xlink:to="lab_lfwd_FeesAndOtherRelatedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FeesAndOtherRelatedExpenses_266" xlink:to="lab_lfwd_FeesAndOtherRelatedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FieldServiceUnitsMember_267" xlink:to="lab_lfwd_FieldServiceUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FieldServiceUnitsMember_268" xlink:to="lab_lfwd_FieldServiceUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_269" xlink:to="lab_lfwd_FinancialExpensesAndIncomeNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_270" xlink:to="lab_lfwd_FinancialExpensesAndIncomeNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_271" xlink:to="lab_lfwd_FinancialExpensesAndIncomeNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_272" xlink:to="lab_lfwd_FinancialExpensesAndIncomeNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_273" xlink:to="lab_lfwd_FinancialExpensesAndIncomeNet_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesAndIncomeNet_274" xlink:to="lab_lfwd_FinancialExpensesAndIncomeNet_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesIncomeNet_275" xlink:to="lab_lfwd_FinancialExpensesIncomeNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesIncomeNet_276" xlink:to="lab_lfwd_FinancialExpensesIncomeNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesIncomeNet_277" xlink:to="lab_lfwd_FinancialExpensesIncomeNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesIncomeNet_278" xlink:to="lab_lfwd_FinancialExpensesIncomeNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesIncomeNet_279" xlink:to="lab_lfwd_FinancialExpensesIncomeNet_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FinancialExpensesIncomeNet_280" xlink:to="lab_lfwd_FinancialExpensesIncomeNet_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FirstAmendmentMember_281" xlink:to="lab_lfwd_FirstAmendmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FirstAmendmentMember_282" xlink:to="lab_lfwd_FirstAmendmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FixedCommissionAmount_283" xlink:to="lab_lfwd_FixedCommissionAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FixedCommissionAmount_284" xlink:to="lab_lfwd_FixedCommissionAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FixedCommissionRate_285" xlink:to="lab_lfwd_FixedCommissionRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_FixedCommissionRate_286" xlink:to="lab_lfwd_FixedCommissionRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GeneralAbstract_287" xlink:to="lab_lfwd_GeneralAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_288" xlink:to="lab_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GovernmentGrantsPolicyTextBlock_289" xlink:to="lab_lfwd_GovernmentGrantsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GovernmentGrantsPolicyTextBlock_290" xlink:to="lab_lfwd_GovernmentGrantsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GovernmentGrantsPolicyTextBlock_291" xlink:to="lab_lfwd_GovernmentGrantsPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GuarantorObligationsCollateralPledged_292" xlink:to="lab_lfwd_GuarantorObligationsCollateralPledged_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GuarantorObligationsCollateralPledged_293" xlink:to="lab_lfwd_GuarantorObligationsCollateralPledged_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_GuarantorObligationsCollateralPledged_294" xlink:to="lab_lfwd_GuarantorObligationsCollateralPledged_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ImputedInterest_295" xlink:to="lab_lfwd_ImputedInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ImputedInterest_296" xlink:to="lab_lfwd_ImputedInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ImputedInterest_297" xlink:to="lab_lfwd_ImputedInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ImputedInterest_298" xlink:to="lab_lfwd_ImputedInterest_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IncomeTaxesAbstract_299" xlink:to="lab_lfwd_IncomeTaxesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_300" xlink:to="lab_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_301" xlink:to="lab_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_302" xlink:to="lab_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_303" xlink:to="lab_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_304" xlink:to="lab_lfwd_InitialRecognitionOfOperatingLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_305" xlink:to="lab_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_306" xlink:to="lab_lfwd_InitialRecognitionOfOperatingLeaseRightOfUseAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IntangibleAssetsNonCurrent_307" xlink:to="lab_lfwd_IntangibleAssetsNonCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IntangibleAssetsNonCurrent_308" xlink:to="lab_lfwd_IntangibleAssetsNonCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IntangibleAssetsNonCurrent_309" xlink:to="lab_lfwd_IntangibleAssetsNonCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InterestReceived_310" xlink:to="lab_lfwd_InterestReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InterestReceived_311" xlink:to="lab_lfwd_InterestReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InterestReceived_312" xlink:to="lab_lfwd_InterestReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InvestmentOptionsExercisePrices_313" xlink:to="lab_lfwd_InvestmentOptionsExercisePrices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InvestmentOptionsExercisePrices_314" xlink:to="lab_lfwd_InvestmentOptionsExercisePrices_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_InvestmentOptionsExercisePrices_315" xlink:to="lab_lfwd_InvestmentOptionsExercisePrices_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IsraeliMember_316" xlink:to="lab_lfwd_IsraeliMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IsraeliMember_317" xlink:to="lab_lfwd_IsraeliMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IsraelInnovationAuthorityMember_318" xlink:to="lab_lfwd_IsraelInnovationAuthorityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IsraelInnovationAuthorityMember_319" xlink:to="lab_lfwd_IsraelInnovationAuthorityMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IsraelInnovationAuthorityMember_320" xlink:to="lab_lfwd_IsraelInnovationAuthorityMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_321" xlink:to="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_322" xlink:to="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_323" xlink:to="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_324" xlink:to="lab_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_325" xlink:to="lab_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_326" xlink:to="lab_lfwd_IssuanceOfOrdinarySharesInWarrantExerciseAgreementNetOfIssuanceExpensesInAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_KreosCapitalMember_327" xlink:to="lab_lfwd_KreosCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_KreosCapitalMember_328" xlink:to="lab_lfwd_KreosCapitalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_KreosCapitalVMember_329" xlink:to="lab_lfwd_KreosCapitalVMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_KreosCapitalVMember_330" xlink:to="lab_lfwd_KreosCapitalVMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LeaseAgreementsTerm_331" xlink:to="lab_lfwd_LeaseAgreementsTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LeaseAgreementsTerm_332" xlink:to="lab_lfwd_LeaseAgreementsTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LeaseAgreementsTerm_333" xlink:to="lab_lfwd_LeaseAgreementsTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_334" xlink:to="lab_lfwd_LicenseAgreementAndCollaborationAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_335" xlink:to="lab_lfwd_LicenseAgreementAndCollaborationAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_336" xlink:to="lab_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_337" xlink:to="lab_lfwd_LoanAgreementWithKreosAndRelatedWarrantToPurchaseOrdinarySharesTextual_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_338" xlink:to="lab_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_339" xlink:to="lab_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_340" xlink:to="lab_lfwd_LongTermDebtMaturitiesPortionOfPrincipalSubjectToRepaymentExtension_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LongTermEarnoutLiability_341" xlink:to="lab_lfwd_LongTermEarnoutLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LongTermEarnoutLiability_342" xlink:to="lab_lfwd_LongTermEarnoutLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_LongTermEarnoutLiability_343" xlink:to="lab_lfwd_LongTermEarnoutLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_MachineryAndLaboratoryEquipmentMember_344" xlink:to="lab_lfwd_MachineryAndLaboratoryEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_MachineryAndLaboratoryEquipmentMember_345" xlink:to="lab_lfwd_MachineryAndLaboratoryEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_346" xlink:to="lab_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_347" xlink:to="lab_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_348" xlink:to="lab_lfwd_NetOperatingCarryForwardLossesExpirationTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_349" xlink:to="lab_lfwd_NetOperatingCarryForwardLossesExpirationTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_350" xlink:to="lab_lfwd_NetOperatingCarryForwardLossesExpirationTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetOperatingCarryForwardLossesTerms_351" xlink:to="lab_lfwd_NetOperatingCarryForwardLossesTerms_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NetOperatingCarryForwardLossesTerms_352" xlink:to="lab_lfwd_NetOperatingCarryForwardLossesTerms_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_353" xlink:to="lab_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_354" xlink:to="lab_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_355" xlink:to="lab_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_356" xlink:to="lab_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_357" xlink:to="lab_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_358" xlink:to="lab_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NumberOfWarrantsOutstandingTotal_359" xlink:to="lab_lfwd_NumberOfWarrantsOutstandingTotal_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NumberOfWarrantsOutstandingTotal_360" xlink:to="lab_lfwd_NumberOfWarrantsOutstandingTotal_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_NumberOfWarrantsOutstandingTotal_361" xlink:to="lab_lfwd_NumberOfWarrantsOutstandingTotal_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_362" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInDecember2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_363" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInDecember2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_364" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_365" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_366" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_367" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_368" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInJuly2020Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_369" xlink:to="lab_lfwd_OfferingOfOrdinarySharesInJuly2020Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_370" xlink:to="lab_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_371" xlink:to="lab_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_372" xlink:to="lab_lfwd_OperatingLossCarryforwardsPriorPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_373" xlink:to="lab_lfwd_OperatingLossCarryforwardsPriorPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_374" xlink:to="lab_lfwd_OperatingLossCarryforwardsPriorPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaycheckProtectionProgramLoanMember_375" xlink:to="lab_lfwd_PaycheckProtectionProgramLoanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaycheckProtectionProgramLoanMember_376" xlink:to="lab_lfwd_PaycheckProtectionProgramLoanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_377" xlink:to="lab_lfwd_PaymentsForPurchaseOfTreasuryStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_378" xlink:to="lab_lfwd_PaymentsForPurchaseOfTreasuryStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_379" xlink:to="lab_lfwd_PaymentsForPurchaseOfTreasuryStock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaymentToRepurchaseOfShares_380" xlink:to="lab_lfwd_PaymentToRepurchaseOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaymentToRepurchaseOfShares_381" xlink:to="lab_lfwd_PaymentToRepurchaseOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PaymentToRepurchaseOfShares_382" xlink:to="lab_lfwd_PaymentToRepurchaseOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_383" xlink:to="lab_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_384" xlink:to="lab_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PreFundedMember_385" xlink:to="lab_lfwd_PreFundedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PreFundedMember_386" xlink:to="lab_lfwd_PreFundedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PreFundedUnitsMember_387" xlink:to="lab_lfwd_PreFundedUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PreFundedUnitsMember_388" xlink:to="lab_lfwd_PreFundedUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_389" xlink:to="lab_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_390" xlink:to="lab_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_391" xlink:to="lab_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_392" xlink:to="lab_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_393" xlink:to="lab_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromIssuanceOfRegistrationCost_394" xlink:to="lab_lfwd_ProceedsFromIssuanceOfRegistrationCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromIssuanceOfRegistrationCost_395" xlink:to="lab_lfwd_ProceedsFromIssuanceOfRegistrationCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_396" xlink:to="lab_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_397" xlink:to="lab_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_398" xlink:to="lab_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromOfferingCost_399" xlink:to="lab_lfwd_ProceedsFromOfferingCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromOfferingCost_400" xlink:to="lab_lfwd_ProceedsFromOfferingCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromStockOne_401" xlink:to="lab_lfwd_ProceedsFromStockOne_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromStockOne_402" xlink:to="lab_lfwd_ProceedsFromStockOne_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromStockOne_403" xlink:to="lab_lfwd_ProceedsFromStockOne_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromStockTwo_404" xlink:to="lab_lfwd_ProceedsFromStockTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ProceedsFromStockTwo_405" xlink:to="lab_lfwd_ProceedsFromStockTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PropertyAndEquipmentNetTextualAbstract_406" xlink:to="lab_lfwd_PropertyAndEquipmentNetTextualAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_407" xlink:to="lab_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_408" xlink:to="lab_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_409" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_410" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_411" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_412" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_413" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_414" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_415" xlink:to="lab_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectMember_416" xlink:to="lab_lfwd_RegisteredDirectMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectMember_417" xlink:to="lab_lfwd_RegisteredDirectMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectOfferingMember_418" xlink:to="lab_lfwd_RegisteredDirectOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectOfferingMember_419" xlink:to="lab_lfwd_RegisteredDirectOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectOfferingMember_420" xlink:to="lab_lfwd_RegisteredDirectOfferingMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_421" xlink:to="lab_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_422" xlink:to="lab_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_423" xlink:to="lab_lfwd_RegisteredDirectOfferingsIssuanceCostIncurredNotYetPaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_424" xlink:to="lab_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_425" xlink:to="lab_lfwd_RelatedPartiesTransactionsAndBalancesPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_426" xlink:to="lab_lfwd_RelatedPartyTransactionOwnershipPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_427" xlink:to="lab_lfwd_RelatedPartyTransactionOwnershipPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RentalMember_428" xlink:to="lab_lfwd_RentalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RentalMember_429" xlink:to="lab_lfwd_RentalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RentalRevenueForAntiGravityProducts_430" xlink:to="lab_lfwd_RentalRevenueForAntiGravityProducts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RentalRevenueForAntiGravityProducts_431" xlink:to="lab_lfwd_RentalRevenueForAntiGravityProducts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RentalRevenueForAntiGravityProducts_432" xlink:to="lab_lfwd_RentalRevenueForAntiGravityProducts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ReorganizationExpenses_433" xlink:to="lab_lfwd_ReorganizationExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ReorganizationExpenses_434" xlink:to="lab_lfwd_ReorganizationExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_435" xlink:to="lab_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_436" xlink:to="lab_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_437" xlink:to="lab_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_438" xlink:to="lab_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_439" xlink:to="lab_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestOfWorldMember_440" xlink:to="lab_lfwd_RestOfWorldMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestOfWorldMember_441" xlink:to="lab_lfwd_RestOfWorldMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ReStoreProductMember_442" xlink:to="lab_lfwd_ReStoreProductMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ReStoreProductMember_443" xlink:to="lab_lfwd_ReStoreProductMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestrictedCashAndOtherLongTermAssets_444" xlink:to="lab_lfwd_RestrictedCashAndOtherLongTermAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestrictedCashAndOtherLongTermAssets_445" xlink:to="lab_lfwd_RestrictedCashAndOtherLongTermAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestrictedCashAndOtherLongTermAssets_446" xlink:to="lab_lfwd_RestrictedCashAndOtherLongTermAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_447" xlink:to="lab_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_448" xlink:to="lab_lfwd_RestrictedCashIncludedInOtherNonCurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructringActivitiesAxis_449" xlink:to="lab_lfwd_RestructringActivitiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructringActivitiesAxis_450" xlink:to="lab_lfwd_RestructringActivitiesAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructringActivitiesLineItems_451" xlink:to="lab_lfwd_RestructringActivitiesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructringActivitiesLineItems_452" xlink:to="lab_lfwd_RestructringActivitiesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructuringActivitiesDomain_453" xlink:to="lab_lfwd_RestructuringActivitiesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructuringActivitiesDomain_454" xlink:to="lab_lfwd_RestructuringActivitiesDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructuringAndRelatedActivitiesTable_455" xlink:to="lab_lfwd_RestructuringAndRelatedActivitiesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RestructuringAndRelatedActivitiesTable_456" xlink:to="lab_lfwd_RestructuringAndRelatedActivitiesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RevenueObligationAxis_457" xlink:to="lab_lfwd_RevenueObligationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RevenueObligationAxis_458" xlink:to="lab_lfwd_RevenueObligationAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RevenueObligationDomain_459" xlink:to="lab_lfwd_RevenueObligationDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RevenueRecognitionRecognized_460" xlink:to="lab_lfwd_RevenueRecognitionRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RevenueRecognitionRecognized_461" xlink:to="lab_lfwd_RevenueRecognitionRecognized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RewalkRoboticsGmbhMember_462" xlink:to="lab_lfwd_RewalkRoboticsGmbhMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RewalkRoboticsGmbhMember_463" xlink:to="lab_lfwd_RewalkRoboticsGmbhMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ReWalkRoboticsIncMember_464" xlink:to="lab_lfwd_ReWalkRoboticsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ReWalkRoboticsIncMember_465" xlink:to="lab_lfwd_ReWalkRoboticsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RoyaltyBearingGrantsExpenses_466" xlink:to="lab_lfwd_RoyaltyBearingGrantsExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RoyaltyBearingGrantsExpenses_467" xlink:to="lab_lfwd_RoyaltyBearingGrantsExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RoyaltyFeesPercentage_468" xlink:to="lab_lfwd_RoyaltyFeesPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RoyaltyFeesPercentage_469" xlink:to="lab_lfwd_RoyaltyFeesPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RrlAndRrgMember_470" xlink:to="lab_lfwd_RrlAndRrgMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_RrlAndRrgMember_471" xlink:to="lab_lfwd_RrlAndRrgMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_472" xlink:to="lab_lfwd_ScheduleOfContractBalancesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_473" xlink:to="lab_lfwd_ScheduleOfContractBalancesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_474" xlink:to="lab_lfwd_ScheduleOfContractBalancesTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfIncomeTaxLineItems_475" xlink:to="lab_lfwd_ScheduleOfIncomeTaxLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfIncomeTaxLineItems_476" xlink:to="lab_lfwd_ScheduleOfIncomeTaxLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_477" xlink:to="lab_lfwd_ScheduleOfIncomeTaxTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_478" xlink:to="lab_lfwd_ScheduleOfIncomeTaxTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_479" xlink:to="lab_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_480" xlink:to="lab_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_481" xlink:to="lab_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_482" xlink:to="lab_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_483" xlink:to="lab_lfwd_ScheduleOfTradeReceivablesAndDeferredRevenuesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_484" xlink:to="lab_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_485" xlink:to="lab_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_486" xlink:to="lab_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_487" xlink:to="lab_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_488" xlink:to="lab_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_489" xlink:to="lab_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SCIProductsMember_490" xlink:to="lab_lfwd_SCIProductsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SCIProductsMember_491" xlink:to="lab_lfwd_SCIProductsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SecondAmendmentMember_492" xlink:to="lab_lfwd_SecondAmendmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SecondAmendmentMember_493" xlink:to="lab_lfwd_SecondAmendmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SecuritiesPurchaseAgreementsMember_494" xlink:to="lab_lfwd_SecuritiesPurchaseAgreementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SecuritiesPurchaseAgreementsMember_495" xlink:to="lab_lfwd_SecuritiesPurchaseAgreementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SellingAndMarketingExpenseNet_496" xlink:to="lab_lfwd_SellingAndMarketingExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SellingAndMarketingExpenseNet_497" xlink:to="lab_lfwd_SellingAndMarketingExpenseNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ServiceAndWarrantyMember_498" xlink:to="lab_lfwd_ServiceAndWarrantyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ServiceAndWarrantyMember_499" xlink:to="lab_lfwd_ServiceAndWarrantyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_500" xlink:to="lab_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_501" xlink:to="lab_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_502" xlink:to="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_503" xlink:to="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_504" xlink:to="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_505" xlink:to="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_506" xlink:to="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_507" xlink:to="lab_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_508" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_509" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_510" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_511" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_512" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_513" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_514" xlink:to="lab_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_515" xlink:to="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_516" xlink:to="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_517" xlink:to="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_518" xlink:to="lab_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_519" xlink:to="lab_lfwd_ShareholdersEquityTextualAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareRepurchaseProgramMember_520" xlink:to="lab_lfwd_ShareRepurchaseProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ShareRepurchaseProgramMember_521" xlink:to="lab_lfwd_ShareRepurchaseProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_522" xlink:to="lab_lfwd_Sharesissuedduringperiodvaluetreasurystock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_523" xlink:to="lab_lfwd_Sharesissuedduringperiodvaluetreasurystock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_524" xlink:to="lab_lfwd_Sharesissuedduringperiodvaluetreasurystock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_525" xlink:to="lab_lfwd_SignificantAccountingPoliciesTextualAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SiliconValleyBankMember_526" xlink:to="lab_lfwd_SiliconValleyBankMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SiliconValleyBankMember_527" xlink:to="lab_lfwd_SiliconValleyBankMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SparePartsAndWarrantiesMember_528" xlink:to="lab_lfwd_SparePartsAndWarrantiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SparePartsAndWarrantiesMember_529" xlink:to="lab_lfwd_SparePartsAndWarrantiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StateNetOperatingLossCarryForwards_530" xlink:to="lab_lfwd_StateNetOperatingLossCarryForwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StateNetOperatingLossCarryForwards_531" xlink:to="lab_lfwd_StateNetOperatingLossCarryForwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StateNetOperatingLossCarryForwards_532" xlink:to="lab_lfwd_StateNetOperatingLossCarryForwards_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_533" xlink:to="lab_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_534" xlink:to="lab_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_535" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_536" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_537" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_538" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_539" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_540" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_541" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_542" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_543" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_544" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_545" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_546" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_547" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_548" xlink:to="lab_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_549" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_550" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_551" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_552" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_553" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_554" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_555" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_556" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_557" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_558" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_559" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_560" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_561" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_562" xlink:to="lab_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_563" xlink:to="lab_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_564" xlink:to="lab_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SupplementalCashFlowCashAndCashEquivalents_565" xlink:to="lab_lfwd_SupplementalCashFlowCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SupplementalCashFlowCashAndCashEquivalents_566" xlink:to="lab_lfwd_SupplementalCashFlowCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SupplementalCashFlowCashAndCashEquivalents_567" xlink:to="lab_lfwd_SupplementalCashFlowCashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_568" xlink:to="lab_lfwd_SupplementalDisclosuresOfCashFlowInformation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_569" xlink:to="lab_lfwd_SupplementalDisclosuresOfCashFlowInformation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TaxesIncome_570" xlink:to="lab_lfwd_TaxesIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TaxesIncome_571" xlink:to="lab_lfwd_TaxesIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TaxesIncome_572" xlink:to="lab_lfwd_TaxesIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TaxesOnIncome_573" xlink:to="lab_lfwd_TaxesOnIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TaxesOnIncome_574" xlink:to="lab_lfwd_TaxesOnIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TaxesOnIncome_575" xlink:to="lab_lfwd_TaxesOnIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TreasurySharesPolicyTextBlock_576" xlink:to="lab_lfwd_TreasurySharesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TreasurySharesPolicyTextBlock_577" xlink:to="lab_lfwd_TreasurySharesPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TreasurySharesPolicyTextBlock_578" xlink:to="lab_lfwd_TreasurySharesPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_579" xlink:to="lab_lfwd_TwoZeroTwoThreeReorganizationPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_580" xlink:to="lab_lfwd_TwoZeroTwoThreeReorganizationPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_581" xlink:to="lab_lfwd_TwoZeroTwoThreeReorganizationPlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TypeOfCurrencyAxis_582" xlink:to="lab_lfwd_TypeOfCurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_TypeOfCurrencyAxis_583" xlink:to="lab_lfwd_TypeOfCurrencyAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_UnitsPlacedMember_584" xlink:to="lab_lfwd_UnitsPlacedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_UnitsPlacedMember_585" xlink:to="lab_lfwd_UnitsPlacedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_586" xlink:to="lab_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_587" xlink:to="lab_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_588" xlink:to="lab_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_589" xlink:to="lab_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_590" xlink:to="lab_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantExerciseAgreementMember_591" xlink:to="lab_lfwd_WarrantExerciseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantExerciseAgreementMember_592" xlink:to="lab_lfwd_WarrantExerciseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantExerciseMember_593" xlink:to="lab_lfwd_WarrantExerciseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantExerciseMember_594" xlink:to="lab_lfwd_WarrantExerciseMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsExercisableDescrition_595" xlink:to="lab_lfwd_WarrantsExercisableDescrition_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsExercisableDescrition_596" xlink:to="lab_lfwd_WarrantsExercisableDescrition_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsExpitationDate_597" xlink:to="lab_lfwd_WarrantsExpitationDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsExpitationDate_598" xlink:to="lab_lfwd_WarrantsExpitationDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsLiabilityActivity_599" xlink:to="lab_lfwd_WarrantsLiabilityActivity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsLiabilityActivity_600" xlink:to="lab_lfwd_WarrantsLiabilityActivity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsLiabilityActivity_601" xlink:to="lab_lfwd_WarrantsLiabilityActivity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsLiabilityActivity_602" xlink:to="lab_lfwd_WarrantsLiabilityActivity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsLiabilityActivity_603" xlink:to="lab_lfwd_WarrantsLiabilityActivity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinaryShares_604" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinaryShares_605" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_606" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_607" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_608" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_609" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_610" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_611" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_612" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_613" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_614" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_615" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_616" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_617" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_618" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_619" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_620" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_621" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_622" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_623" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_624" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_625" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_626" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_627" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_628" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_629" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_630" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_631" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_632" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_633" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_634" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_635" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_636" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_637" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_638" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_639" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_640" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_641" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_642" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_643" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_644" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_645" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_646" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_647" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_648" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_649" xlink:to="lab_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantyProvisionBalance_650" xlink:to="lab_lfwd_WarrantyProvisionBalance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantyProvisionBalance_651" xlink:to="lab_lfwd_WarrantyProvisionBalance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantyProvisionBalance_652" xlink:to="lab_lfwd_WarrantyProvisionBalance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WarrantyProvisionBalance_653" xlink:to="lab_lfwd_WarrantyProvisionBalance_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WorkforcePercentage_654" xlink:to="lab_lfwd_WorkforcePercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WorkforcePercentage_655" xlink:to="lab_lfwd_WorkforcePercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_WorkforcePercentage_656" xlink:to="lab_lfwd_WorkforcePercentage_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_YaskawaElectricCorporationMember_657" xlink:to="lab_lfwd_YaskawaElectricCorporationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfwd_YaskawaElectricCorporationMember_658" xlink:to="lab_lfwd_YaskawaElectricCorporationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AfricaMember_659" xlink:to="lab_srt_AfricaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember_660" xlink:to="lab_srt_AsiaPacificMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember_661" xlink:to="lab_srt_EuropeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LatinAmericaMember_662" xlink:to="lab_srt_LatinAmericaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_663" xlink:to="lab_srt_MajorCustomersAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_664" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_665" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_666" xlink:to="lab_srt_ProductOrServiceAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_667" xlink:to="lab_srt_ProductsAndServicesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_668" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_669" xlink:to="lab_srt_RangeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_670" xlink:to="lab_srt_RangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_671" xlink:to="lab_srt_StatementGeographicalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis_672" xlink:to="lab_srt_StatementScenarioAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_673" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_674" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_675" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_676" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_677" xlink:to="lab_us-gaap_AccountsPayableCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember_678" xlink:to="lab_us-gaap_AccountsReceivableMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_679" xlink:to="lab_us-gaap_AccountsReceivableNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_680" xlink:to="lab_us-gaap_AccountsReceivableNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet_681" xlink:to="lab_us-gaap_AccountsReceivableNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_682" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_683" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_684" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_685" xlink:to="lab_us-gaap_AdditionalPaidInCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_686" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_687" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_688" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_689" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_690" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_691" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_692" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_693" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_694" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_695" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_696" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_697" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_698" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_699" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_700" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_701" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_702" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_703" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_704" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_705" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_706" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_707" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_708" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_709" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_710" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_711" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_712" xlink:to="lab_us-gaap_AwardTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_714" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_715" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_716" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_717" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_718" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_719" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_720" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_721" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_722" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_723" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_724" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_725" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_726" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_727" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_728" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_729" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_730" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_731" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_732" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_733" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_734" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_735" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_736" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_737" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_738" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_739" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_740" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_741" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_742" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_743" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_744" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_745" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_746" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_747" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_748" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_749" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_750" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_751" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_752" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_753" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_754" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_755" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_756" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_757" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_758" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy_759" xlink:to="lab_us-gaap_BusinessCombinationsPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy_760" xlink:to="lab_us-gaap_BusinessCombinationsPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_761" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_762" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_763" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_764" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_765" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_766" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_767" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_768" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_769" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_770" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_771" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_772" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_773" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_774" xlink:to="lab_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_775" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_776" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_777" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_778" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_779" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_780" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_781" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_782" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_783" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_784" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding_785" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_786" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_787" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_788" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_789" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_790" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_791" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_792" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_793" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_794" xlink:to="lab_us-gaap_CommonStockMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_795" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_796" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_797" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_798" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_799" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_800" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_801" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_802" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_803" xlink:to="lab_us-gaap_CommonStockValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_804" xlink:to="lab_us-gaap_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_805" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_806" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_807" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_808" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_809" xlink:to="lab_us-gaap_ConcentrationRiskLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_810" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1_811" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable_812" xlink:to="lab_us-gaap_ConcentrationRiskTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_813" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockDescription_814" xlink:to="lab_us-gaap_ConversionOfStockDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember_815" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_816" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue_817" xlink:to="lab_us-gaap_CostOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue_818" xlink:to="lab_us-gaap_CostOfRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_819" xlink:to="lab_us-gaap_CostOfSalesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember_820" xlink:to="lab_us-gaap_CreditConcentrationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_821" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember_822" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_823" xlink:to="lab_us-gaap_CustomerRelationshipsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_824" xlink:to="lab_us-gaap_CustomerRelationshipsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_825" xlink:to="lab_us-gaap_DebtDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_826" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_827" xlink:to="lab_us-gaap_DebtInstrumentAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCollateralAmount_828" xlink:to="lab_us-gaap_DebtInstrumentCollateralAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_829" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_830" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_831" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_832" xlink:to="lab_us-gaap_DebtInstrumentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_833" xlink:to="lab_us-gaap_DebtInstrumentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm_834" xlink:to="lab_us-gaap_DebtInstrumentTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm_835" xlink:to="lab_us-gaap_DebtInstrumentTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_836" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_837" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue_838" xlink:to="lab_us-gaap_DeferredRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue_839" xlink:to="lab_us-gaap_DeferredRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue_840" xlink:to="lab_us-gaap_DeferredRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent_841" xlink:to="lab_us-gaap_DeferredRevenueCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent_842" xlink:to="lab_us-gaap_DeferredRevenueCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent_843" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent_844" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_845" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_846" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_847" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_848" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_849" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_850" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_851" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_852" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_853" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_854" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_855" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_856" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_857" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_858" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_859" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_860" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_861" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_862" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_863" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_864" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_865" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_866" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_867" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_868" xlink:to="lab_us-gaap_Depreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_869" xlink:to="lab_us-gaap_Depreciation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_870" xlink:to="lab_us-gaap_Depreciation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_871" xlink:to="lab_us-gaap_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_872" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_873" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_874" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_875" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_876" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_877" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_878" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_879" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_880" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_881" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_882" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_883" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_884" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_885" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_886" xlink:to="lab_us-gaap_EmployeeStockOptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_887" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_888" xlink:to="lab_us-gaap_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_889" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_890" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_891" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_892" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_893" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_894" xlink:to="lab_us-gaap_FairValueByAssetClassAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_895" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_896" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_897" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_898" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_899" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_900" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_901" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_902" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_903" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_904" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_905" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_906" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_907" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_908" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_909" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_910" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_911" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_912" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_913" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_914" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_915" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_916" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_917" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_918" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_919" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_920" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_921" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_922" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_923" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_924" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_925" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_926" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_927" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_928" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_929" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_930" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_931" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_932" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_933" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_934" xlink:to="lab_us-gaap_ForeignCountryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_935" xlink:to="lab_us-gaap_ForeignCountryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_936" xlink:to="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_937" xlink:to="lab_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_938" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_939" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_940" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember_941" xlink:to="lab_us-gaap_FurnitureAndFixturesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_942" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_943" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_944" xlink:to="lab_us-gaap_Goodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_945" xlink:to="lab_us-gaap_Goodwill_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_946" xlink:to="lab_us-gaap_Goodwill_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_947" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod_948" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_949" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_950" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_951" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_952" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_953" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_954" xlink:to="lab_us-gaap_GoodwillLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_955" xlink:to="lab_us-gaap_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_956" xlink:to="lab_us-gaap_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_957" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_958" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_959" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_960" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_961" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_962" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_963" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_964" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_965" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_966" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_967" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid_968" xlink:to="lab_us-gaap_IncomeTaxesPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_969" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_970" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_971" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_972" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_973" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_974" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_975" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_976" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_977" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_978" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_979" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_980" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_981" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_982" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_983" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_984" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_985" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_986" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_987" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_988" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_989" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_990" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_991" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_992" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_993" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_994" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_995" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt_996" xlink:to="lab_us-gaap_InterestExpenseDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt_997" xlink:to="lab_us-gaap_InterestExpenseDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_998" xlink:to="lab_us-gaap_InterestIncomeExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_999" xlink:to="lab_us-gaap_InterestIncomeExpenseNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther_1000" xlink:to="lab_us-gaap_InterestIncomeOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther_1001" xlink:to="lab_us-gaap_InterestIncomeOther_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther_1002" xlink:to="lab_us-gaap_InterestIncomeOther_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1003" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock_1004" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods_1005" xlink:to="lab_us-gaap_InventoryFinishedGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_1006" xlink:to="lab_us-gaap_InventoryNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_1007" xlink:to="lab_us-gaap_InventoryNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_1008" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_1009" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials_1010" xlink:to="lab_us-gaap_InventoryRawMaterials_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown_1011" xlink:to="lab_us-gaap_InventoryWriteDown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown_1012" xlink:to="lab_us-gaap_InventoryWriteDown_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember_1013" xlink:to="lab_us-gaap_IPOMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IsraelTaxAuthorityMember_1014" xlink:to="lab_us-gaap_IsraelTaxAuthorityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember_1015" xlink:to="lab_us-gaap_LeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_1016" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDescription_1017" xlink:to="lab_us-gaap_LesseeOperatingLeaseDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1018" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1019" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1020" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1021" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1022" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1023" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1024" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1025" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1026" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1027" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_1028" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_1029" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1030" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1031" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1032" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_1033" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_1034" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1035" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1036" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_1037" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_1038" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_1039" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_1040" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_1041" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_1042" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1043" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense_1044" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense_1045" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember_1046" xlink:to="lab_us-gaap_MoneyMarketFundsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember_1047" xlink:to="lab_us-gaap_MoneyMarketFundsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_1048" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1049" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1050" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1051" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1052" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1053" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1054" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1055" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1056" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1057" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_1058" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_1059" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_1060" xlink:to="lab_us-gaap_NetIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_1061" xlink:to="lab_us-gaap_NetIncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1062" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1063" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1064" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets_1065" xlink:to="lab_us-gaap_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_1066" xlink:to="lab_us-gaap_NumberOfReportableSegments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_1067" xlink:to="lab_us-gaap_OperatingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_1068" xlink:to="lab_us-gaap_OperatingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1069" xlink:to="lab_us-gaap_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_1070" xlink:to="lab_us-gaap_OperatingIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_1071" xlink:to="lab_us-gaap_OperatingIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_1072" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_1073" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_1074" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_1075" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1076" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1077" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1078" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_1079" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1080" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1081" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_1082" xlink:to="lab_us-gaap_OperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_1083" xlink:to="lab_us-gaap_OperatingLossCarryforwardsExpirationDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember_1084" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember_1085" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1086" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1087" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_1088" xlink:to="lab_us-gaap_OtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_1089" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_1090" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_1091" xlink:to="lab_us-gaap_OtherCommitmentsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable_1092" xlink:to="lab_us-gaap_OtherCommitmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1093" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1094" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1095" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1096" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_1097" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1098" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_1099" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt_1100" xlink:to="lab_us-gaap_OtherLongTermDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt_1101" xlink:to="lab_us-gaap_OtherLongTermDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt_1102" xlink:to="lab_us-gaap_OtherLongTermDebt_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_1103" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit_1104" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1105" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1106" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRoyalties_1107" xlink:to="lab_us-gaap_PaymentsForRoyalties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_1108" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_1109" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_1110" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_1111" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_1112" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1113" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1114" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1115" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1116" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_1117" xlink:to="lab_us-gaap_PlanNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_1118" xlink:to="lab_us-gaap_PlanNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy_1119" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsPeriodExpense_1120" xlink:to="lab_us-gaap_PostemploymentBenefitsPeriodExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1121" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1122" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1123" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1124" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_1125" xlink:to="lab_us-gaap_PrepaidExpenseCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember_1126" xlink:to="lab_us-gaap_PrivatePlacementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1127" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1128" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1129" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1130" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived_1131" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans_1132" xlink:to="lab_us-gaap_ProceedsFromStockPlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_1133" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember_1134" xlink:to="lab_us-gaap_ProductMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_1135" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_1136" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1137" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1138" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1139" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1140" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_1141" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1142" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1143" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1144" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1145" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1146" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1147" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1148" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation_1149" xlink:to="lab_us-gaap_PurchaseObligation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1150" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt_1151" xlink:to="lab_us-gaap_RepaymentsOfDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_1152" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1153" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_1154" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_1155" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1156" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1157" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1158" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1159" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1160" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1161" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1162" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1163" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_1164" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1165" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1166" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1167" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1168" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1169" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_1170" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_1171" xlink:to="lab_us-gaap_RetainedEarningsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1172" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1173" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1174" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_1175" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_1176" xlink:to="lab_us-gaap_Revenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_1177" xlink:to="lab_us-gaap_Revenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_1178" xlink:to="lab_us-gaap_Revenues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_1179" xlink:to="lab_us-gaap_Revenues_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_1180" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1181" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1182" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense_1183" xlink:to="lab_us-gaap_RoyaltyExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense_1184" xlink:to="lab_us-gaap_RoyaltyExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember_1185" xlink:to="lab_us-gaap_SalesRevenueNetMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1186" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1187" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1188" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1189" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1190" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1191" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1192" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1193" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1194" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1195" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1196" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1197" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1198" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1199" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1200" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1201" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1202" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1203" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1204" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1205" xlink:to="lab_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1206" xlink:to="lab_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1207" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1208" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1209" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_1210" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1211" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1212" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_1213" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1214" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1215" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_1216" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1217" xlink:to="lab_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1218" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_1219" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember_1220" xlink:to="lab_us-gaap_SecuredDebtMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember_1221" xlink:to="lab_us-gaap_SecuredDebtMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_1222" xlink:to="lab_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_1223" xlink:to="lab_us-gaap_SegmentReportingAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_1224" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_1225" xlink:to="lab_us-gaap_SellingAndMarketingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_1226" xlink:to="lab_us-gaap_SellingAndMarketingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember_1227" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1228" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1229" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1230" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1231" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1232" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1233" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1234" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1235" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1236" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1237" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1238" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1239" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_1240" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_1241" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1242" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1243" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1244" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1245" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1246" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1247" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1248" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1249" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1250" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1251" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1252" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1253" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1254" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1255" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1256" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1257" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1258" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1259" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1260" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1261" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1262" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1263" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1264" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_1265" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1266" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_1267" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1268" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1269" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1270" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1271" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1272" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_1273" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice_1274" xlink:to="lab_us-gaap_SharePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_1275" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1276" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare_1277" xlink:to="lab_us-gaap_SharesIssuedPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1278" xlink:to="lab_us-gaap_SharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1279" xlink:to="lab_us-gaap_SharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1280" xlink:to="lab_us-gaap_SharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1281" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_1282" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_1283" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual_1284" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments_1285" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPayments_1286" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_1287" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualWarrantiesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy_1288" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy_1289" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_1290" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_1291" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1292" xlink:to="lab_us-gaap_StatementClassOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1293" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_1294" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1295" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1296" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_1297" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1298" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1299" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1300" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1301" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1302" xlink:to="lab_us-gaap_StockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1303" xlink:to="lab_us-gaap_StockholdersEquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1304" xlink:to="lab_us-gaap_StockholdersEquityAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1305" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1306" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityReverseStockSplit_1307" xlink:to="lab_us-gaap_StockholdersEquityReverseStockSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1308" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther_1309" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1310" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1311" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1312" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_1313" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_1314" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_1315" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1316" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1317" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1318" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1319" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1320" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_1321" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_1322" xlink:to="lab_us-gaap_SubsequentEventLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_1323" xlink:to="lab_us-gaap_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_1324" xlink:to="lab_us-gaap_SubsequentEventMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1325" xlink:to="lab_us-gaap_SubsequentEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_1326" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_1327" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_1328" xlink:to="lab_us-gaap_SubsequentEventTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1329" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1330" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1331" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_1332" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1333" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1334" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Supplies_1335" xlink:to="lab_us-gaap_Supplies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount_1336" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount_1337" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1338" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_1339" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember_1340" xlink:to="lab_us-gaap_TrademarksMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember_1341" xlink:to="lab_us-gaap_TrademarksMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares_1342" xlink:to="lab_us-gaap_TreasuryStockCommonShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares_1343" xlink:to="lab_us-gaap_TreasuryStockCommonShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue_1344" xlink:to="lab_us-gaap_TreasuryStockCommonValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue_1345" xlink:to="lab_us-gaap_TreasuryStockCommonValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue_1346" xlink:to="lab_us-gaap_TreasuryStockCommonValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockPreferredMember_1347" xlink:to="lab_us-gaap_TreasuryStockPreferredMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockPreferredMember_1348" xlink:to="lab_us-gaap_TreasuryStockPreferredMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_1349" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_1350" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt_1351" xlink:to="lab_us-gaap_UnsecuredDebt_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_1352" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember_1353" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember_1354" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1355" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1356" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding_1357" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding_1358" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1359" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1360" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1361" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1362" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1363" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1364" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1365" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>lfwd-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#DocumentAndEntityInformation" roleURI="http://www.rewalk.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedBalanceSheets" roleURI="http://www.rewalk.com/role/ConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedStatementsOfOperations" roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#StatementsOfChangesInShareholdersEquity" roleURI="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#StatementsOfChangesInShareholdersEquityParenthetical" roleURI="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" roleURI="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#General" roleURI="http://www.rewalk.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPolicies" roleURI="http://www.rewalk.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PrepaidExpensesAndOtherCurrentAssets" roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#Inventories" roleURI="http://www.rewalk.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PropertyAndEquipmentNet" roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNet"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#CommitmentsAndContingentLiabilities" roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquity" roleURI="http://www.rewalk.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ResearchCollaborationAgreementAndLicenseAgreement" roleURI="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxes" roleURI="http://www.rewalk.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#FinancialExpensesIncomeNet" roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNet"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductData" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesTables" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#InventoriesTables" roleURI="http://www.rewalk.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PropertyAndEquipmentNetTables" roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#CommitmentsAndContingentLiabilitiesTables" roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityTables" roleURI="http://www.rewalk.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesTables" roleURI="http://www.rewalk.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#FinancialExpensesIncomeNetTables" roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNetTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataTables" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeneralDetails" roleURI="http://www.rewalk.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesDetailsTextual" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#InventoriesDetails" roleURI="http://www.rewalk.com/role/InventoriesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#PropertyAndEquipmentNetDetailsTextual" roleURI="http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#CommitmentsAndContingentLiabilitiesDetails" roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#CommitmentsAndContingentLiabilitiesDetailsTextual" roleURI="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails1" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails2" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails3" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails3"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetails4" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetails4"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ShareholdersEquityDetailsTextual" roleURI="http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ResearchCollaborationAgreementAndLicenseAgreementDetails" roleURI="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails1" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails2" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails3" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails3"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetails4" roleURI="http://www.rewalk.com/role/IncomeTaxesDetails4"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#IncomeTaxesDetailsTextual" roleURI="http://www.rewalk.com/role/IncomeTaxesDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#FinancialExpensesIncomeNetDetails" roleURI="http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails1" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetails2" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GeographicInformationAndMajorCustomerAndProductDataDetailsTextual" roleURI="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#INVENTORIESNarrativeDetails" roleURI="http://www.rewalk.com/role/INVENTORIESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#RESTRUCTRINGACTIVITIES" roleURI="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#RESTRUCTRINGACTIVITIESNarrativeDetails" roleURI="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETDetails" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNETTables" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNET" roleURI="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesDetails2" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails4" roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails5" roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SIGNIFICANTACCOUNTINGPOLICIESDetails6" roleURI="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERG" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERG"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGTables" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGTables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails1" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails2" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGDetails3" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#ACQUISITIONOFALTERGNarrativeDetails" roleURI="http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#BASICANDDILUTEDNETLOSSPERSHAREDetails" roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#BASICANDDILUTEDNETLOSSPERSHARETables" roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails" roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#BASICANDDILUTEDNETLOSSPERSHARE" roleURI="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#SignificantAccountingPoliciesDetails" roleURI="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#TestrereDetails1" roleURI="http://www.rewalk.com/role/TestrereDetails1"/>
  <roleRef xlink:type="simple" xlink:href="lfwd-20231231.xsd#TestrereDetails" roleURI="http://www.rewalk.com/role/TestrereDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_39"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AmendmentFlag_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentType_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AmendmentDescription_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentAnnualReport_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentTransitionReport_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityFileNumber_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityRegistrantName_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityTaxIdentificationNumber_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressAddressLine1_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressAddressLine2_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressCityOrTown_17" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressCountry_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressPostalZipCode_19" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_CityAreaCode_20" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_LocalPhoneNumber_21" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_Security12bTitle_22" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_TradingSymbol_23" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_SecurityExchangeName_24" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_25" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityVoluntaryFilers_26" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCurrentReportingStatus_27" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_28" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityFilerCategory_29" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntitySmallBusiness_30" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_31" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityShellCompany_32" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_33" order="320" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityPublicFloat_34" order="330" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_35" order="340" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AuditorName_36" order="350" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AuditorLocation_37" order="360" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AuditorFirmId_38" order="370" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_39" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IntangibleAssetsNonCurrent" xlink:label="loc_lfwd_IntangibleAssetsNonCurrent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutLiabilityCurrent" xlink:label="loc_lfwd_EarnoutLiabilityCurrent_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LongTermEarnoutLiability" xlink:label="loc_lfwd_LongTermEarnoutLiability_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaap_TreasuryStockCommonValue_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_38"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_InventoryNet_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_lfwd_IntangibleAssetsNonCurrent_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_Goodwill_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_AssetsNoncurrent_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_14" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_us-gaap_AccountsPayableCurrent_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_us-gaap_DeferredRevenueCurrent_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_lfwd_EarnoutLiabilityCurrent_20" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_21" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_16" xlink:to="loc_us-gaap_LiabilitiesCurrent_22" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_24" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_24" xlink:to="loc_lfwd_LongTermEarnoutLiability_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_24" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_24" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_24" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_27" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_24" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" xlink:to="loc_us-gaap_Liabilities_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" xlink:to="loc_us-gaap_CommitmentsAndContingencies_31" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" xlink:to="loc_us-gaap_StockholdersEquityAbstract_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_CommonStockValue_32" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_AdditionalPaidInCapital_33" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_TreasuryStockCommonValue_34" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_35" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_32" xlink:to="loc_us-gaap_StockholdersEquity_36" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_38" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesIncomeNet" xlink:label="loc_lfwd_FinancialExpensesIncomeNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_Revenues_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_CostOfRevenue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_GrossProfit_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4" xlink:to="loc_us-gaap_OperatingExpenses_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_lfwd_FinancialExpensesIncomeNet_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_15" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_17" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockPreferredMember" xlink:label="loc_us-gaap_TreasuryStockPreferredMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards" xlink:label="loc_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_14"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_23"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodSharesPrivatePlacement" xlink:label="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_Sharesissuedduringperiodvaluetreasurystock" xlink:label="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_TreasuryStockPreferredMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_11" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_12" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueOrdinaryShares_15" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares_16" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue_17" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares_18" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_19" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses_20" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_21" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1_22" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_23" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses_24" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodValuePrivatePlacement_25" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_StockIssuedDuringPeriodSharesPrivatePlacement_26" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_lfwd_Sharesissuedduringperiodvaluetreasurystock_27" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_28" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_NetIncomeLoss_29" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_30" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_31" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BestOfferingMember" xlink:label="loc_lfwd_BestOfferingMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectOfferingMember" xlink:label="loc_lfwd_RegisteredDirectOfferingMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseMember" xlink:label="loc_lfwd_WarrantExerciseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_lfwd_BestOfferingMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_lfwd_RegisteredDirectOfferingMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_us-gaap_PrivatePlacementMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_lfwd_WarrantExerciseMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_7" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutRemeasured" xlink:label="loc_lfwd_EarnOutRemeasured_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582" xlink:label="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ProceedsFromIssuanceOfRegistrationCostTwo" xlink:label="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExerciseOfPreFundedWarrants" xlink:label="loc_lfwd_ExerciseOfPreFundedWarrants_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentsForPurchaseOfTreasuryStock" xlink:label="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_34"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_34"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet" xlink:label="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_35"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PaymentToRepurchaseOfShares" xlink:label="loc_lfwd_PaymentToRepurchaseOfShares_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_37"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SupplementalDisclosuresOfCashFlowInformation" xlink:label="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_39"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InterestReceived" xlink:label="loc_lfwd_InterestReceived_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_lfwd_EarnOutRemeasured_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_15" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_18" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_21" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_lfwd_ExerciseOfPreFundedWarrants_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_lfwd_PaymentsForPurchaseOfTreasuryStock_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_29" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_30" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_31" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_34" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_34" xlink:to="loc_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet_34" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_34" xlink:to="loc_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet_35" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_34" xlink:to="loc_lfwd_PaymentToRepurchaseOfShares_36" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_34" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_37" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_39" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_39" xlink:to="loc_us-gaap_IncomeTaxesPaid_39" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SupplementalDisclosuresOfCashFlowInformation_39" xlink:to="loc_lfwd_InterestReceived_40" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_42" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_42" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_43" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RegisteredDirectMember" xlink:label="loc_lfwd_RegisteredDirectMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BestOfferingMember" xlink:label="loc_lfwd_BestOfferingMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantExerciseMember" xlink:label="loc_lfwd_WarrantExerciseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_us-gaap_PrivatePlacementMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_lfwd_RegisteredDirectMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_lfwd_BestOfferingMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1" xlink:to="loc_lfwd_WarrantExerciseMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/General">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock" xlink:label="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/Inventories">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PropertyAndEquipmentNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/CommitmentsAndContingentLiabilities">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/FinancialExpensesIncomeNet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestrictedCashAndOtherLongTermAssets" xlink:label="loc_lfwd_RestrictedCashAndOtherLongTermAssets_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TreasurySharesPolicyTextBlock" xlink:label="loc_lfwd_TreasurySharesPolicyTextBlock_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightPolicyTextBlock" xlink:label="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitPlansPolicy" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GovernmentGrantsPolicyTextBlock" xlink:label="loc_lfwd_GovernmentGrantsPolicyTextBlock_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_RestrictedCashAndOtherLongTermAssets_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_TreasurySharesPolicyTextBlock_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_ClassOfWarrantOrRightPolicyTextBlock_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_19" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_20" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_21" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_22" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_GovernmentGrantsPolicyTextBlock_23" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_24" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_25" order="240" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfContractBalancesTableTextBlock" xlink:label="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantyProvisionTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock" xlink:label="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_ScheduleOfContractBalancesTableTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_ScheduleOfWarrantyProvisionTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/InventoriesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PropertyAndEquipmentNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock" xlink:label="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_5" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/FinancialExpensesIncomeNetTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_3" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeneralDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GeneralAbstract" xlink:label="loc_lfwd_GeneralAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_lfwd_GeneralAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_GeneralAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_GeneralAbstract_1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_GeneralAbstract_1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_GeneralAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeesAndNonEmployeesMember" xlink:label="loc_lfwd_EmployeesAndNonEmployeesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_YaskawaElectricCorporationMember" xlink:label="loc_lfwd_YaskawaElectricCorporationMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReStoreProductMember" xlink:label="loc_lfwd_ReStoreProductMember_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SCIProductsMember" xlink:label="loc_lfwd_SCIProductsMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_23"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SignificantAccountingPoliciesTextualAbstract" xlink:label="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RelatedPartyTransactionOwnershipPercentage" xlink:label="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AllowanceForSalesReturns" xlink:label="loc_lfwd_AllowanceForSalesReturns_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueRecognitionRecognized" xlink:label="loc_lfwd_RevenueRecognitionRecognized_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_29"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1" xlink:label="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_30"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SeverancePayMonthlyDepositByEmployeesPercentage" xlink:label="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:label="loc_us-gaap_PostemploymentBenefitsPeriodExpense_32"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyBearingGrantsExpenses" xlink:label="loc_lfwd_RoyaltyBearingGrantsExpenses_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_34"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification" xlink:label="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_35"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalRevenueForAntiGravityProducts" xlink:label="loc_lfwd_RentalRevenueForAntiGravityProducts_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_37"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LeaseAgreementsTerm" xlink:label="loc_lfwd_LeaseAgreementsTerm_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_39"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1" xlink:to="loc_lfwd_EmployeesAndNonEmployeesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_MajorCustomersAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_4" xlink:to="loc_srt_NameOfMajorCustomerDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4" xlink:to="loc_lfwd_YaskawaElectricCorporationMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7" xlink:to="loc_us-gaap_AccountsReceivableMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_10" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_10" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_13" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_13" xlink:to="loc_us-gaap_TypeOfAdoptionMember_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_ProductOrServiceAxis_15" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_15" xlink:to="loc_srt_ProductsAndServicesDomain_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15" xlink:to="loc_lfwd_ReStoreProductMember_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_15" xlink:to="loc_lfwd_SCIProductsMember_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_RangeAxis_19" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_19" xlink:to="loc_srt_RangeMember_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19" xlink:to="loc_srt_MinimumMember_19" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_19" xlink:to="loc_srt_MaximumMember_20" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_23" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_23" xlink:to="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_InventoryWriteDown_23" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_24" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_RelatedPartyTransactionOwnershipPercentage_25" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_AllowanceForSalesReturns_26" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_27" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_RevenueRecognitionRecognized_28" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_29" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1_30" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage_31" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_PostemploymentBenefitsPeriodExpense_32" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_RoyaltyBearingGrantsExpenses_33" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_RoyaltyExpense_34" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification_35" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_RentalRevenueForAntiGravityProducts_36" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_37" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_lfwd_LeaseAgreementsTerm_38" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_SignificantAccountingPoliciesTextualAbstract_23" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_39" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent" xlink:label="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Supplies" xlink:label="loc_us-gaap_Supplies_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_Supplies_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_OtherAssetsCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/InventoriesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryFinishedGoods_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryRawMaterials_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryNet_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PropertyAndEquipmentNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_lfwd_MachineryAndLaboratoryEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FieldServiceUnitsMember" xlink:label="loc_lfwd_FieldServiceUnitsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_lfwd_MachineryAndLaboratoryEquipmentMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_lfwd_FieldServiceUnitsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PropertyAndEquipmentNetTextualAbstract" xlink:label="loc_lfwd_PropertyAndEquipmentNetTextualAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_lfwd_PropertyAndEquipmentNetTextualAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_Depreciation_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ImputedInterest" xlink:label="loc_lfwd_ImputedInterest_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_lfwd_ImputedInterest_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_10" order="90" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraelInnovationAuthorityMember" xlink:label="loc_lfwd_IsraelInnovationAuthorityMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RrlAndRrgMember" xlink:label="loc_lfwd_RrlAndRrgMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommitmentsAndContingenciesLiabilitiesAbstract" xlink:label="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement" xlink:label="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRoyaltiesReceived" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentRoyaltyBearingGrants" xlink:label="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRoyalties" xlink:label="loc_us-gaap_PaymentsForRoyalties_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares" xlink:label="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RoyaltyFeesPercentage" xlink:label="loc_lfwd_RoyaltyFeesPercentage_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaap_ConversionOfStockDescription_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ContingentLiabilityRelatedToGrantsReceived" xlink:label="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees" xlink:label="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaap_RoyaltyExpense_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GuarantorObligationsCollateralPledged" xlink:label="loc_lfwd_GuarantorObligationsCollateralPledged_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaap_LesseeOperatingLeaseDescription_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaap_OtherLongTermDebt_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncomeLeasePayments" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OtherCommitmentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_IsraelInnovationAuthorityMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_RrlAndRrgMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_srt_RangeAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5" xlink:to="loc_srt_RangeMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7" xlink:to="loc_us-gaap_ClassOfStockDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_10" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_10" xlink:to="loc_us-gaap_IPOMember_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_13" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_13" xlink:to="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_PurchaseObligation_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement_14" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_15" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants_16" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_PaymentsForRoyalties_17" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares_18" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_19" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_RoyaltyFeesPercentage_20" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_ConversionOfStockDescription_21" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_ContingentLiabilityRelatedToGrantsReceived_22" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees_23" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_RoyaltyExpense_24" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_lfwd_GuarantorObligationsCollateralPledged_25" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_LesseeOperatingLeaseDescription_26" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_OtherLongTermDebt_27" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract_13" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeLeasePayments_28" order="150" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_16" order="150" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember" xlink:label="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract" xlink:label="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract_4" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4" xlink:to="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10" xlink:to="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10" xlink:to="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10" xlink:to="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10" xlink:to="loc_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice_13" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract_10" xlink:to="loc_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeMember" xlink:label="loc_lfwd_ExercisePriceRangeMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeOneMember" xlink:label="loc_lfwd_ExercisePriceRangeOneMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeTwoMember" xlink:label="loc_lfwd_ExercisePriceRangeTwoMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeThreeMember" xlink:label="loc_lfwd_ExercisePriceRangeThreeMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFourMember" xlink:label="loc_lfwd_ExercisePriceRangeFourMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceRangeFiveMember" xlink:label="loc_lfwd_ExercisePriceRangeFiveMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_InvestmentOptionsExercisePrices" xlink:label="loc_lfwd_InvestmentOptionsExercisePrices_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_19"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_4" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" xlink:to="loc_lfwd_ExercisePriceRangeMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" xlink:to="loc_lfwd_ExercisePriceRangeOneMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" xlink:to="loc_lfwd_ExercisePriceRangeTwoMember_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" xlink:to="loc_lfwd_ExercisePriceRangeThreeMember_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" xlink:to="loc_lfwd_ExercisePriceRangeFourMember_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_4" xlink:to="loc_lfwd_ExercisePriceRangeFiveMember_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_lfwd_InvestmentOptionsExercisePrices_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_17" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_18" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_12" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_19" order="70" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails3">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_CostOfSalesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_7" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_10"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_14"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_19"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ClassOfWarrantOrRightExercisable" xlink:label="loc_lfwd_ClassOfWarrantOrRightExercisable_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExpitationDate" xlink:label="loc_lfwd_WarrantsExpitationDate_27"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember_17" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember_19" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember_20" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember_21" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_24" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_24" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_24" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_24" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_24" xlink:to="loc_lfwd_ClassOfWarrantOrRightExercisable_26" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_24" xlink:to="loc_lfwd_WarrantsExpitationDate_27" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ShareholdersEquityDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareRepurchaseProgramMember" xlink:label="loc_lfwd_ShareRepurchaseProgramMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalMember" xlink:label="loc_lfwd_KreosCapitalMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementAxis" xlink:label="loc_lfwd_AgreementAxis_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementDomain" xlink:label="loc_lfwd_AgreementDomain_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_SecuritiesPurchaseAgreementsMember" xlink:label="loc_lfwd_SecuritiesPurchaseAgreementsMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EquityExchangeProgramMember" xlink:label="loc_lfwd_EquityExchangeProgramMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CertainInstitutionalPurchasersMember" xlink:label="loc_lfwd_CertainInstitutionalPurchasersMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_13"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_14"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInJuly2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OfferingOfOrdinarySharesInDecember2020Member" xlink:label="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_December2020PrivatePlacementMember" xlink:label="loc_lfwd_December2020PrivatePlacementMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnitsMember" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsMember" xlink:label="loc_lfwd_CommonUnitsMember_22"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PreFundedUnitsMember" xlink:label="loc_lfwd_PreFundedUnitsMember_23"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_25"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonUnitsAndPreFundedUnits1Member" xlink:label="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_26"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember" xlink:label="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_34"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_KreosCapitalVMember" xlink:label="loc_lfwd_KreosCapitalVMember_34"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeOfCurrencyAxis" xlink:label="loc_lfwd_TypeOfCurrencyAxis_37"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TypeofCurrencyDomain" xlink:label="loc_lfwd_TypeofCurrencyDomain_37"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IsraeliMember" xlink:label="loc_lfwd_IsraeliMember_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_40"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AdditionallyWarrantsIssuedMember" xlink:label="loc_lfwd_AdditionallyWarrantsIssuedMember_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_47"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ShareholdersEquityTextualAbstract" xlink:label="loc_lfwd_ShareholdersEquityTextualAbstract_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_47"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement" xlink:label="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_48"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds" xlink:label="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_53"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodValueNewIssuesGross" xlink:label="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_55"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionRate" xlink:label="loc_lfwd_FixedCommissionRate_56"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FixedCommissionAmount" xlink:label="loc_lfwd_FixedCommissionAmount_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_64"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AggregateNumberOfOrdinaryShares" xlink:label="loc_lfwd_AggregateNumberOfOrdinaryShares_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_70"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsExercisableDescrition" xlink:label="loc_lfwd_WarrantsExercisableDescrition_71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaap_DebtInstrumentCollateralAmount_72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="loc_us-gaap_ProceedsFromStockPlans_73"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_74"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_FeesAndOtherRelatedExpenses_75"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses" xlink:label="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuritiesLoanedMeasurementDifferenceDescription" xlink:label="loc_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_77"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfUnderwritingAgreement" xlink:label="loc_lfwd_DescriptionOfUnderwritingAgreement_78"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_79"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase" xlink:label="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_80"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_StockIssuedDuringPeriodShareOrdinaryShares" xlink:label="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_81"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ExercisePriceOrdinaryShares" xlink:label="loc_lfwd_ExercisePriceOrdinaryShares_82"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_83"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsToPurchaseOrdinaryShares" xlink:label="loc_lfwd_WarrantsToPurchaseOrdinaryShares_84"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_85"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfWarrantsOutstandingTotal" xlink:label="loc_lfwd_NumberOfWarrantsOutstandingTotal_86"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_87"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_1" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_1" xlink:to="loc_lfwd_ShareRepurchaseProgramMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4" xlink:to="loc_us-gaap_RelatedPartyDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4" xlink:to="loc_lfwd_KreosCapitalMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_lfwd_AgreementAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_AgreementAxis_7" xlink:to="loc_lfwd_AgreementDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_AgreementDomain_7" xlink:to="loc_lfwd_SecuritiesPurchaseAgreementsMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_AgreementDomain_7" xlink:to="loc_lfwd_EquityExchangeProgramMember_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_AgreementDomain_7" xlink:to="loc_lfwd_CertainInstitutionalPurchasersMember_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_12" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_12" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_12" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020Member_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_12" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_12" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInJuly2020Member_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_12" xlink:to="loc_lfwd_OfferingOfOrdinarySharesInDecember2020Member_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_12" xlink:to="loc_lfwd_December2020PrivatePlacementMember_17" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_20" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_20" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_us-gaap_PrivatePlacementMember_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_CommonUnitsAndPreFundedUnitsMember_21" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_CommonUnitsMember_22" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_PreFundedUnitsMember_23" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember_24" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember_25" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_CommonUnitsAndPreFundedUnits1Member_26" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember_27" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_30" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_30" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_30" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_30" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_30" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_30" xlink:to="loc_us-gaap_EmployeeStockOptionMember_31" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_dei_LegalEntityAxis_34" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_34" xlink:to="loc_dei_EntityDomain_34" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_34" xlink:to="loc_lfwd_KreosCapitalVMember_34" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_lfwd_TypeOfCurrencyAxis_37" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_TypeOfCurrencyAxis_37" xlink:to="loc_lfwd_TypeofCurrencyDomain_37" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_TypeofCurrencyDomain_37" xlink:to="loc_lfwd_IsraeliMember_37" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_40" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_40" xlink:to="loc_us-gaap_ClassOfStockDomain_40" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_40" xlink:to="loc_lfwd_AdditionallyWarrantsIssuedMember_40" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_srt_RangeAxis_43" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_43" xlink:to="loc_srt_RangeMember_43" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_43" xlink:to="loc_srt_MinimumMember_43" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_43" xlink:to="loc_srt_MaximumMember_44" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_1" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_47" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_47" xlink:to="loc_lfwd_ShareholdersEquityTextualAbstract_47" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_47" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement_48" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds_49" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_51" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_52" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_53" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_StockIssuedDuringPeriodValueNewIssuesGross_54" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_55" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_FixedCommissionRate_56" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_FixedCommissionAmount_57" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_58" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_59" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_61" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_62" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_63" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_64" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_AggregateNumberOfOrdinaryShares_65" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_66" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_67" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_69" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_70" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_WarrantsExercisableDescrition_71" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_DebtInstrumentCollateralAmount_72" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ProceedsFromStockPlans_73" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_74" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_FeesAndOtherRelatedExpenses_75" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses_76" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_SecuritiesLoanedMeasurementDifferenceDescription_77" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_DescriptionOfUnderwritingAgreement_78" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_79" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase_80" order="330" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_StockIssuedDuringPeriodShareOrdinaryShares_81" order="340" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_ExercisePriceOrdinaryShares_82" order="350" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_83" order="360" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_WarrantsToPurchaseOrdinaryShares_84" order="370" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_85" order="380" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_lfwd_NumberOfWarrantsOutstandingTotal_86" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ShareholdersEquityTextualAbstract_47" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_87" order="400" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementAxis" xlink:label="loc_lfwd_AgreementAxis_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AgreementDomain" xlink:label="loc_lfwd_AgreementDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_LicenseAgreementAndCollaborationAgreementMember" xlink:label="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract" xlink:label="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1" xlink:to="loc_lfwd_AgreementAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_AgreementAxis_1" xlink:to="loc_lfwd_AgreementDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_AgreementDomain_1" xlink:to="loc_lfwd_LicenseAgreementAndCollaborationAgreementMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4" xlink:to="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredIncomeTax" xlink:label="loc_lfwd_DeferredIncomeTax_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesOnIncome" xlink:label="loc_lfwd_TaxesOnIncome_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TaxesIncome" xlink:label="loc_lfwd_TaxesIncome_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_DeferredIncomeTax_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_TaxesOnIncome_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_TaxesIncome_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities" xlink:label="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxLiabilitiesRightOfUseAsset" xlink:label="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_1" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" xlink:to="loc_lfwd_DeferredTaxLiabilitiesRightOfUseAsset_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_9" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_14" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails3">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount" xlink:label="loc_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount" xlink:label="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/IncomeTaxesDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxTable" xlink:label="loc_lfwd_ScheduleOfIncomeTaxTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ReWalkRoboticsIncMember" xlink:label="loc_lfwd_ReWalkRoboticsIncMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RewalkRoboticsGmbhMember" xlink:label="loc_lfwd_RewalkRoboticsGmbhMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ScheduleOfIncomeTaxLineItems" xlink:label="loc_lfwd_ScheduleOfIncomeTaxLineItems_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_IncomeTaxesAbstract" xlink:label="loc_lfwd_IncomeTaxesAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_15"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate" xlink:label="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_16"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_17"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_18"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome" xlink:label="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_20"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments" xlink:label="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_21"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesTerms" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesTerms_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_23"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_OperatingLossCarryforwardsPriorPeriod" xlink:label="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_24"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NetOperatingCarryForwardLossesExpirationTerm" xlink:label="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_25"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_lfwd_ScheduleOfIncomeTaxTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_ReWalkRoboticsIncMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_RewalkRoboticsGmbhMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_lfwd_AltergIncMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_6" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" xlink:to="loc_us-gaap_ForeignCountryMember_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_6" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_srt_RangeAxis_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_11" xlink:to="loc_srt_RangeMember_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11" xlink:to="loc_srt_MinimumMember_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11" xlink:to="loc_srt_MaximumMember_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ScheduleOfIncomeTaxTable_1" xlink:to="loc_lfwd_ScheduleOfIncomeTaxLineItems_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_ScheduleOfIncomeTaxLineItems_15" xlink:to="loc_lfwd_IncomeTaxesAbstract_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption_18" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_us-gaap_OperatingLossCarryforwards_20" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments_21" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_NetOperatingCarryForwardLossesTerms_22" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_us-gaap_OperatingLossCarryforwardsExpirationDate_23" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_OperatingLossCarryforwardsPriorPeriod_24" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_IncomeTaxesAbstract_15" xlink:to="loc_lfwd_NetOperatingCarryForwardLossesExpirationTerm_25" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaap_InterestIncomeOther_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BankCommissions" xlink:label="loc_lfwd_BankCommissions_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FinancialExpensesAndIncomeNet" xlink:label="loc_lfwd_FinancialExpensesAndIncomeNet_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_InterestExpenseDebt_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_InterestIncomeOther_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_lfwd_BankCommissions_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_lfwd_FinancialExpensesAndIncomeNet_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember" xlink:label="loc_srt_AsiaPacificMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LatinAmericaMember" xlink:label="loc_srt_LatinAmericaMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AfricaMember" xlink:label="loc_srt_AfricaMember_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestOfWorldMember" xlink:label="loc_lfwd_RestOfWorldMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_EuropeMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_AsiaPacificMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_LatinAmericaMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_srt_AfricaMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_lfwd_RestOfWorldMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_10" xlink:to="loc_us-gaap_Revenues_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US" xlink:label="loc_country_US_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_country_DE_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaap_NoncurrentAssets_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_US_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_DE_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_6" xlink:to="loc_us-gaap_NoncurrentAssets_6" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerBMember" xlink:label="loc_lfwd_CustomerBMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerCMember" xlink:label="loc_lfwd_CustomerCMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" xlink:to="loc_us-gaap_SalesRevenueNetMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_srt_MajorCustomersAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_4" xlink:to="loc_srt_NameOfMajorCustomerDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4" xlink:to="loc_lfwd_CustomerAMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4" xlink:to="loc_lfwd_CustomerBMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4" xlink:to="loc_lfwd_CustomerCMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_1" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_12" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract" xlink:label="loc_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0" xlink:to="loc_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract_1" xlink:to="loc_us-gaap_NumberOfReportableSegments_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/INVENTORIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0" xlink:to="loc_us-gaap_InventoryWriteDown_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructuringAndRelatedActivitiesTable" xlink:label="loc_lfwd_RestructuringAndRelatedActivitiesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_TwoZeroTwoThreeReorganizationPlanMember" xlink:label="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RestructringActivitiesLineItems" xlink:label="loc_lfwd_RestructringActivitiesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WorkforcePercentage" xlink:label="loc_lfwd_WorkforcePercentage_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses" xlink:label="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0" xlink:to="loc_lfwd_RestructuringAndRelatedActivitiesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructuringAndRelatedActivitiesTable_1" xlink:to="loc_us-gaap_PlanNameAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1" xlink:to="loc_us-gaap_PlanNameDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1" xlink:to="loc_lfwd_TwoZeroTwoThreeReorganizationPlanMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructuringAndRelatedActivitiesTable_1" xlink:to="loc_lfwd_RestructringActivitiesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructringActivitiesLineItems_4" xlink:to="loc_lfwd_WorkforcePercentage_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructringActivitiesLineItems_4" xlink:to="loc_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructringActivitiesLineItems_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructringActivitiesLineItems_4" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RestructringActivitiesLineItems_4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BacklogMember" xlink:label="loc_lfwd_BacklogMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TrademarksMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipWarrantyMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipRentalMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_BacklogMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_lfwd_AltergIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_1" xlink:to="loc_us-gaap_GoodwillLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerAMember" xlink:label="loc_lfwd_CustomerAMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerBMember" xlink:label="loc_lfwd_CustomerBMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerCMember" xlink:label="loc_lfwd_CustomerCMember_9"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerDMember" xlink:label="loc_lfwd_CustomerDMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1" xlink:to="loc_us-gaap_AccountsReceivableMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_srt_MajorCustomersAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_7" xlink:to="loc_srt_NameOfMajorCustomerDomain_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7" xlink:to="loc_lfwd_CustomerAMember_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7" xlink:to="loc_lfwd_CustomerBMember_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7" xlink:to="loc_lfwd_CustomerCMember_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7" xlink:to="loc_lfwd_CustomerDMember_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_13" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_13" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_13" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_12" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_12" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_12" xlink:to="loc_lfwd_EarnoutMember_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_15" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_15" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityTable" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnoutMember" xlink:label="loc_lfwd_EarnoutMember_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FairValueWarrantsLiabilityActivityLineItems" xlink:label="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ChangeInFairValueOfWarrantsLiabilityActivity" xlink:label="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantsLiabilityActivity" xlink:label="loc_lfwd_WarrantsLiabilityActivity_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_1" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1" xlink:to="loc_lfwd_EarnoutMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityTable_1" xlink:to="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_4" xlink:to="loc_lfwd_WarrantsLiabilityActivity_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_4" xlink:to="loc_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_FairValueWarrantsLiabilityActivityLineItems_4" xlink:to="loc_lfwd_WarrantsLiabilityActivity_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantyProvisionBalance" xlink:label="loc_lfwd_WarrantyProvisionBalance_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedWarrantProvision" xlink:label="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvision" xlink:label="loc_lfwd_AmountOfWarrantProvision_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfWarrantProvisionUsage" xlink:label="loc_lfwd_AmountOfWarrantProvisionUsage_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_WarrantyProvisionBalance" xlink:label="loc_lfwd_WarrantyProvisionBalance_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_WarrantyProvisionBalance_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedWarrantProvision_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_AmountOfWarrantProvision_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_AmountOfWarrantProvisionUsage_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_lfwd_WarrantyProvisionBalance_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERG">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_lfwd_AltergIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_11"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_14"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations" xlink:label="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_17"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_Goodwill_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipWarrantyMember" xlink:label="loc_lfwd_CustomerRelationshipWarrantyMember_3"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipRentalMember" xlink:label="loc_lfwd_CustomerRelationshipRentalMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_CustomerRelationshipDistributionMember" xlink:label="loc_lfwd_CustomerRelationshipDistributionMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TrademarksMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipWarrantyMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipRentalMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_lfwd_CustomerRelationshipDistributionMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AltergIncMember" xlink:label="loc_lfwd_AltergIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_AmountOfAdditionalCashEarnouts" xlink:label="loc_lfwd_AmountOfAdditionalCashEarnouts_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_6"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_EarnOutPaymentOfBusinessCombination" xlink:label="loc_lfwd_EarnOutPaymentOfBusinessCombination_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_lfwd_AltergIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_lfwd_AmountOfAdditionalCashEarnouts_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_lfwd_EarnOutPaymentOfBusinessCombination_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_4" xlink:to="loc_us-gaap_Revenues_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock" xlink:label="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive" xlink:label="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_7"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_MachineryAndLaboratoryEquipmentMember" xlink:label="loc_lfwd_MachineryAndLaboratoryEquipmentMember_8"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_FieldServiceUnitsMember" xlink:label="loc_lfwd_FieldServiceUnitsMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_12"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_PropertyPlantAndEquipmentUsefulLifeDescription" xlink:label="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" xlink:to="loc_us-gaap_ComputerEquipmentMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" xlink:to="loc_lfwd_MachineryAndLaboratoryEquipmentMember_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" xlink:to="loc_lfwd_FieldServiceUnitsMember_9" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12" xlink:to="loc_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription_13" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/TestrereDetails1">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaap_AccountsReceivableNet_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaap_DeferredRevenue_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AccountsReceivableNet_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_DeferredRevenue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.rewalk.com/role/TestrereDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationAxis" xlink:label="loc_lfwd_RevenueObligationAxis_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RevenueObligationDomain" xlink:label="loc_lfwd_RevenueObligationDomain_1"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_RentalMember" xlink:label="loc_lfwd_RentalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaap_ProductMember_4"/>
    <loc xlink:type="locator" xlink:href="lfwd-20231231.xsd#lfwd_ServiceAndWarrantyMember" xlink:label="loc_lfwd_ServiceAndWarrantyMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_lfwd_RevenueObligationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RevenueObligationAxis_1" xlink:to="loc_lfwd_RevenueObligationDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lfwd_RevenueObligationDomain_1" xlink:to="loc_lfwd_RentalMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_ProductOrServiceAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4" xlink:to="loc_srt_ProductsAndServicesDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4" xlink:to="loc_us-gaap_ProductMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4" xlink:to="loc_lfwd_ServiceAndWarrantyMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_us-gaap_Revenues_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0E!UL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2I>XPHHHI +1115H
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 VBBBL!A1110 4444 %%%% #J***W$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%%%P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****+@%%%%%P"BBBBX!11
M11< HHHHN 4444 %%%% !1110 44447 2BBBH8PHHHHL 4444@"BBBF 4444
M6 ****+ +1115B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI*3 ****FS&%+24M4A!1
M113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBBE= %%%%%T E%%%0,**** "BDS1FES(!:*3-&:.9 +12
M9HS1S(!:6FYI=PJE) +12;A1N%/GCW$+249HJ6TQA1111= +124M6FK""BBB
MBZ 2BBBILQA1110DP%HHHJQ!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 44F:,TKH!:*3-&:+H!:*3-&:+H!:*3-&[VI.:0"T4F[VHW>U+GB%@HI-WM2
M;O:H<XCL.HIN[VHW>U'/$+#J*;O]J-_M4^VAW'8=2'I2;_:DW>U*56%MPL+1
M3=WM1N]JR]K#N%AU%-W>U&_VI.M!;L=F.HIN_P!J-_M2]O3[A9CJ*;O]J-_M
M1[>GW"S'44W?[4;_ &H]O3[A9CJ6HS)CM^M)YW^S^M7&O3MN'*R6BHO._P!G
M]:/._P!G]:?MH=PY6344Q7W#.*7=[5JJD6MQ68ZBF[O:C=[4^>(K#Z*3-&:U
MNA"T4F:6BZ ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.M-/4!U%%%;B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:2E'6JCNA#J***Z1!1110 ZBBBMQ!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%HHHK404444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA[2?<=A=Q]:;N/K2TVLYU)]PL+N/K1N/K245'M)]QV!W8*2#47FO_>_2GO\
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M&3W"BBBM!$E%%%>D0%*.M)0.M-;@.HHHK>X@HHHHN ^BBBNHD**** "BBB@
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M0_:/]G]:/M'^S^M1[:'<NQ.O6G56^TX_@_6C[7_L?K6,ZT+[BY66:*K?:_\
M8_6C[7_L?K4>UAW#E8Z3_6&F4UI=QSMQGWI/,]JR<XW'R2'T4SS/:CS/:ESQ
M#DD/HIGF>U'F>U<]T:68^F2_=_&CS/:FLVX8Z4-H+,CHIVWWHV^]2%F-IPZ4
M;?>E'2D-(****"@J.I*;M]Z338F-HIVWWHV^]'*Q6$7K3J3&*7-'*QIV"BC-
M&:7(QW04448HY6,**,48HY6!)13=WM1N]J7LI]B+CJ:_W#1N]J/O_+TS35*=
M]A7(J*F\C_:_2CR/]K]*OV4^P7(:*F\C_:_2D\G_ &OTH]E/L*Z(J*E\G_:_
M2CR?]K]*?L9]@YD14M2>3_M?I2^3_M?I51HS["YD145+Y/\ M?I1Y/\ M?I5
M>QGV#F1%2U)Y/^U^E+Y/^U^E5&C4ML',B*BI?)_VOTH\G_:_2J]A4[!S(CHJ
MPEMN&=^.?2G?9/\ ;_2K5"I;87,BK15K[)_M_I1]D_V_TI_5ZG8.9$:_='TI
M:F%O@ ;_ -*7[/\ [7Z5K["IV,[H@HJ?[/\ [7Z4+;9.-_Z4U0J7V"Z(**M_
M8O\ II_X[1]B_P"FG_CM:?5JO87.BI3TZ58^Q?\ 33_QVE%I@??_ $IQP]1/
M8?/$@HJQ]E_V_P!*/LO^W^E7["IV#GB5Z8>M6_LO^W^E'V/_ *:?I5+#U'T$
MYQ*E%6_L7_33_P =H^Q?]-/_ !VJ^K5>PN9%:/[XJ>GK:88'?^E/^S_[7Z52
MPU7L+F1#14WV?_:_2C[/_M?I3^K5>P<Z(12U-Y'^U^E'D?[7Z5:PU6VP<Z(:
M*F\C_:_2CR/]K]*?U:KV%SH%^Z/I2TX)@8S1L]ZOV%3L1=#:*=L]Z79[T_85
M.P70RBI/+]_TH\OW_2J^K5>P71'2BG^7[_I0(_>G'#54]@NAM%.V>]&SWK3V
M%3L*Z&TM+L]Z79[U4:%3L%T-HI^SWHV>]5["IV%=#.].I=GO1M]ZN-&:Z!="
M44NWWHV^]5[*?8+B44X+[TNSWJU1G;85QE%/V>]&SWI^QGV"XT=*6EV^]&WW
MK94Y6%<2BEV^]+M]Z?)(+B44[;[T;?>M/93["N-HIVWWHV^]"IR[!<2BEV^]
M&WWJN207$HI=OO2[?>G[.07&T4[;[T;?>CV4^P7&]Z=1M]Z7%7&$D)L2BEQ1
MBKY6 E%+BC%'*P$HI<48HY6 448HQ568!11BC%%F E%+BC%3RL!**7%&*%%@
M%%&*,55F 448HQ19@%%&*,468!2TF*6J2$%%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDHI70"TE%%)L8444
M5(!1129I.20"T4F:,TN= !I*":2LY25QBT4E%3= .HIN31N-/VD16'44W<:-
MQH=2(["T4W<:-QJ/:1"PZBF[C06-)U8I786'44S>?:C>?:H^L0'9CZ;WI-Y]
MJ;O.>U1/$0"S'T4S>?:C>?:L_K$!V8^DIC.0I/' J'[0_HM1/%4T"3+-%5OM
M#^BT?:']%J?K=,?*RP:2JS7+^BTGVE_1:YJF+I\PU%EJBJOVE_1:/M+^BU'U
MNF/E99/6DJA)?2K(0%3CV--_M"7^ZGY'_&LGB:=Q\K-&FR?ZMOH:H?VA+_=3
M\C_C2-?RE2-J<CT-)XFG8?(QU%5OM#^BT?:']%KG^L0-+,LTHJK]H?T6C[0_
MHM3/$0L-+4M455^TOZ+1]I?T6L?K$"BU5>7_ %AIOVE_1:89"QR<<UG4KP:&
MAU%,W&C<:R]M$JP_M3:3<:3<:SG5B%AU%-W&C<:GVD0L*>E)2@YHQ6<I)LI(
M2BEQ1BIYD.S =*6DZ49ICN+129HS0%T+12XHQ2]G(+B44N*"*/9R"XE%%%/V
M4A<R"BBI%C#*"<T>RD',B.BIO*7U-'E+ZFG[&0<R(:*F\I?4U'M%5&A,.9#:
M*=M%&T5?L)ASH8>E)4JQAC@YI_D+ZFCV$R7)%>BK'D+ZFCR%]31["8KH@'2E
MJ;R5'<T>4OJ:?U:H/G2(:*F\I?4T>4OJ:/JU0?M(D%%6_LJ>K?G1]E3U;\ZO
MZO,CF14IT?WQ5G[*GJWYTY;9 P.6IK#SN+F1'14_D+ZFCR%]36WU6H+G1!2'
MK5CR%]33UM489);\Z<<+4N)S5BG15W[''ZM^='V./U;\ZT^JU">=%*EJY]CC
M]6_.C[)'ZM^=-86H+G13HJY]DC]6_.C[)'ZM^=/ZM4#G13I:N"TCSU;\Z7['
M'ZM^=7'#5+"YT4J*N_8X_5OSH^QQ^K?G5?5:@<Z((ON'ZU)4RVZ*, M2^0OJ
M:VCA:EA<Z(**G\A?4T>0OJ:?U6H'.B&BK'D+ZFCR%]36GU6H+G17IR??%3>0
MOJ:40J#G)IK"U+@Y(2BG[![T;![UM]7F1=#**?L'O2[![T_JTPNB.BI-@]Z-
M@]Z?U6H',B.G=J=L'O2[![U4,-4%=#**?L'O1L'O6GU>870REIVP>]+M%-4)
MA<913]HHVBG["87&44_:*-HJE1D*XRBG[11M%'L9!<913]@]Z-@]Z?L)A<91
MWI^P>]&P>]-4)A<2BG;11M%:^SD*XVBG;11M%'LY!<;13]HHVBG[*07&4M.V
MBDQ35.2"XE%+BC%'(Q"44N*7:*?(P&T4[:*-HI^SD%Q!2T8I:N,6D E%+13L
MP$HI<48I\K 2CO2XHQ3Y6(6BBBM "BBB@ HHHH *6DHIH!:*2BJNA"T4E+3N
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E
M%*X"TE%(34RDK#%HIN31DU'.@'44W)HR:3J)!8=13<FC)I>T0[#CTIM&33<F
MHE4386'44W)HR:GG0#C24A)HR:SE45QV%HI,FC)I>T06"BFY-&367MHCL.HI
MN3378A"0:3KQL%A]%5O-?^]^E'FO_>_2L_K$1V+-(:K^:_\ >_2D,K^OZ5,Z
M\7&P6+%%5_-?U_2CS7]?TK#VB'8L4WO4/FOZ_I4#7$H8_-W]!43JH+%VBJ/V
MB7^]^@H^T2_WOT%9^U0[%UON-]*JU&;B4@_-^@J/S7]?TK&K55QI%BBJ_FOZ
M_I1YK^OZ5E[5#L3-257DE<8^;]*9YTG][]*PG-.12B[%NBJGG2?WOTH\Z3^]
M^E3S(.5A-_K6IE/^_P#,W)-&T>E3S(H91VI^T>E(0,&CF07(Z***R*"D-+3T
M4-G(J9; 1T5/Y:^E'EKZ5G89!2U-Y:^E&Q?2DXMC3L0T5-L7THV+Z5/LV/F1
M#258$:E@,=_6I?(B_N_J:3I-AS(I45=\B+^[^IH\B+^[^II>RD',BFO6G59,
M,8'"_K3?+3T_6FJ$F6IJQ!14_EIZ?K1Y:>GZT?5Y#YT5SUI*NK!&1DK^M'V>
M+^[^IK58:=C-S5RE15W[/%_=_4T?9XO[OZFCZM,.=%:BK'E)Z?K1Y2>GZUM]
M7D5SHKTAZ59\I/3]:<L,9/*_K36'G<3FK%.BKWV>+^[^IH^SQ?W?U-5]5GW1
M'.BC4\?W!4_V>+^[^IIZPQ@8"_K51PLV]T'.BO15GRD_N_K1Y2?W?UJ_JD^Z
M#G16J&K_ )2?W?UJ3[)!_<_4U<,)/NB741F45I_9(/[GZFC[)!_<_4U?U6?=
M"]HC/C^]^%2U<%M"#PGZFG?9XO[OZFG]4GW0>T11HJ]]GB_N_J:/L\7]W]33
M^IU.Z#VB*!ZTE:'V>+^Y^IH^S0_W/U-:+"3MNB741GT5H?9H?[GZFC[-#_<_
M4T?5)]T+G17HJUY2?W?UH\I/[OZT?5)]T'.BK2CK5GRD_N_K0(DS]W]:J.$G
M=:H.=$%%6?*3^[^M'E)_=_6NCZK/NA<Z*U21_=_&I?*3^[^M*$4=!51PL[[H
M3FK#**DVCTHVCTJ_JTR;D=%2;1Z4NQ?2FL)-]4',B*BI=B^E&Q?2G]3J=T+F
M1$.M.I^Q?2EVCTJXX6:6Z#F1'14FT>E&T>E5]6F%QE%/VCTI=H]*U6'E85R.
MBI-H]*-H]*?U>0KC>U%/VCTHVCTJ_82"XRBG[1Z4;1Z4U0D%QE%2;1Z4;1Z5
M?L)!<CI:?M'I1M'I35"0KC**?M'I1M'I5>QD%QE+3MH]*7:/2G&C(+C**?M'
MI1M'I5>QD%QE%/VBDP*3I207&T4[ HP*/9L+C:*?@4;1Z4_8R"XRBG[1Z4;1
MZ4>QD%QM%.P*,"GR,0VBG8%&!1R,!M%.P*,"G[-A<;0*=@48%/V;07$HI:*+
M )24ZC HY&P&T4[ HP*7LV%QM+2X%%/D: 2BEHHL E%+BC I\C 2BEP*,"GR
M, HHHH ****8!12T4[ )12T46 2BEHHL E%+118!**6BBP"4M%%-*P@HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 444E)NP"T4E%+F 6BDI*7. ZBFT4<X#J*9DT9-3[5
M#L/HIF302<=:'55@L.HJ/)]:,GUK+VR[#L24AZTS)]:"3ZU,ZRML%AU%,R:,
MFLO;+L.P^DIN329/K4RKI= L/HIF3ZT9/K4?6%V'8?25%(2$.":AWM_>/YUG
M+$I/8+%NBJF]O[Q_.C>W]X_G2^M+L'*6S254+O\ WF_.DWO_ 'F_.L98I7V*
M42Y15/>_]YOSHWO_ 'F_.I^M+L'*6N]%9S2R;C\[=?6D\V3_ )Z-^=8_6%V"
MQI4R3_5FJ'FR?\]&_.D,DA'+M^=)XA6V'8LT54WM_>/YT;V_O'\ZR]NNP6+=
M(:J[V_O'\Z9)(XQAV_.AUEV'8NT5G>9)_?;\Z/,D_OM^=3[5!8T:K-]]OK5?
MS)/[[?G4H)(!)J9U$PL.HIM%9\X[#CTIE+143]X!**6BHY1D<G:HZL@ ]0#2
M[5_NC\J3IMZEIZ%6BK6U?[H_*C:O]T?E1[)A<A7[HI:EVCT'Y48'H*7L7W$1
M4A^Z?I4V!Z"E506' Z^E'L7W IT5I>5'_P \U_*CRH_^>:_E1]7?<KF,VI(N
M]7O*C_YYK^5*(T'1%_*CZLWU#F*E%7-B?W5_*C8G]U?RH^J2[AS%.BKFQ/[J
M_E4BQIM'R+^5'U.7<3E8SZ*T?*C_ +B_E1Y4?]Q?RH^IR[BYS/7[P^M3U9\M
M,?<7\J;M'H/RJE@I/J'.045/M'H/RHVCT'Y4_J,NX^8KMTIE7412>5!X]*D\
MN/\ N+^5:1P,K;A[1(SJ*T?+C_N+^5'EQ_W%_*J^HR[A[5%-?NBEJX$3'W%_
M*C8G]U?RK18*5MR/:(IT5<V)_=7\J-B?W5_*CZE+N'.BA16CY<?]Q?RH\N/^
MXOY5O]1EW'[5&=3D^]^%7_+C_N+^5'EI_<7\J%@9=Q.JBI15O8O]T?E1L7^Z
M/RJ_J<NY/.5*<.E6=B_W1^5+L7^Z/RJH8.5]P<RK15K8O]T?E1L7^Z/RK7ZG
M+N+G15J>G[%_NC\J=@>@JHX.7<3G<BHJ7 ]!1@>@JOJDNXN8BI:EP/048'H*
MM825MQ<Q%14N!Z"C ]!3^J2[AS$=%28'H*,#T%-85]PYB.BI,#T%&!Z"G]5?
M<.8CHJ3 ]!1@>@H^JON',1THZT_ ]!2X'H*:PSON',,HI^!Z48'I6OU=]Q<P
MRBGX'I1@>E-4'W"XRBGX'I1@>E/V+[BN,IU+@>E+51I-!<;13J*KD"XVBG4N
M!Z4U3;"XRBGX'I1@>E'LF%QM%.HJN1@-HIU%'((2BG45IR -HIU%'( E%+15
M<H"44M%'* E%+11R@)2T44TK""BBBF 4E+12:N E%+12Y1B"EHHJD(**** $
MHI:*FP"44M%%@"BBBJ *0TM%# 2BEHJ>48E+1132L(****8!24M%)JX"44M%
M+E&(*6DHHO80M%)11S %%+118!**6BBP!1115 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%)2;L M%)12Y@%I***3=QA1112 2B@]:2LV]0%HI
M**7, 44WO167.,=0>E-ILG^K-)ST =156BL/:%6+5)5:FMUJ93T%L6Z*I45G
MSA<NTWO52J[?>/UJ)RN%S3HK+HJ+CN:,G^K-055I:RF]2EJ6:*K45',,L&DJ
M TE9RW&6**KT4@!OO'ZTE6%^Z/I2U/*!6HJS3D^^*3B!3HK1HJ.4#.J.7M6K
M0*:B!C45M44_9@8M3+]T?2M2HC]X_6DZ?F-%&BKM%3[/S*L4J*O+]X?6IJI4
M;]27H9=%:E%/V'F*YFK2UHBEJE0TW'S&;16E13]AYASF;16F.E+5K"^8<YET
MJ_>'UK3HI_5?,.<J45;HJ_JOF+G*E JW2BJCA+O<.<J45<HK3ZE_>_ /:%.I
M5^Z*GI::P7][\!.9!14]%5]2_O?@3S%<]#3*MTM5'!?WOP'SE.BKE%5]2_O?
M@'.5H_O?A4E2TM7'!Z?$)R(:*FHI_4_[PN8BHJ:BM%@_[PN8AHJ:BCZG_>#F
M(Z*DHK3ZOYAS$=%244?5_,.8CHJ6BJ^J^8<Q%2U)136'MU%<CHJ2BJ]CYA<C
MI:?2U4:/F%R.BI**KV/F*Y'2T^BFJ7F%QE%/HI^R\PN,HI]%'LO,+C**?11[
M+S"XRBGT4>R\PN,HI]%'LO,+C:*=13Y!#:*=11R -HIU%'( VBG44<@#:*=1
M1R -I:6BJ4; )12T4<H"44M%'* E%+11R@%%%%4 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****5D 444460!11119 %%%%%D 444460!11119 %%%%%D F*,4
MM%%D F*,4M%'*@$Q2T4460!11119 )BC%+11RH!,48I:*.5 %%%%%D 4F*6B
MBR 3%&*6BCE0"8HQ2T4<J 3%&*6BCE0"8HQ2T4<J 3%&*6BCE0"8I:**+( H
MHHHL@"BBBBR ****+( HHHHL@"BBBBR ****+( HHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%%*R ****=@"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXT?\)3??\\K?_OEO\: .NHKD?^$IOO\ GE;_ /?+?XT?\)3??\\K?_OEO\:
M.NHKCG\5WZXQ%;?]\M_C3?\ A+K_ /YXVW_?+?XT =G17&?\)=?_ //&V_[Y
M;_&C_A+K_P#YXVW_ 'RW^- '6-]X_6DKEO\ A)KTC)BM^>?NG_&C_A);S_GE
M!_WR?\: .IIR??%<I_PDMY_SR@_[Y/\ C0/$UZ#GRK?_ +Y/^- '8T5R/_"4
MWW_/*W_[Y;_&C_A*;[_GE;_]\M_C0!UU%<C_ ,)3??\ /*W_ .^6_P :/^$I
MOO\ GE;_ /?+?XT ==17(_\ "4WW_/*W_P"^6_QH_P"$IOO^>5O_ -\M_C0!
MUU%<C_PE-]_SRM_^^6_QJ(^+;\$CR;;_ +Y;_&@#LZ*XS_A+K_\ YXVW_?+?
MXT?\)=?_ //&V_[Y;_&@#LF^Z?I4%<I_PEM^3@PVW/'W6_QIW_"2WG_/*#_O
MD_XT =317+?\)+>?\\H/^^3_ (T?\)+>?\\H/^^3_C0!UL7>I*X]?$]ZO2*W
M_P"^6_QIW_"4WW_/*W_[Y;_&@#KJ*Y'_ (2F^_YY6_\ WRW^-'_"4WW_ #RM
M_P#OEO\ &@#KJ*Y'_A*;[_GE;_\ ?+?XT?\ "4WW_/*W_P"^6_QH ZZBN1_X
M2F^_YY6__?+?XT?\)3??\\K?_OEO\: .NHKD?^$IOO\ GE;_ /?+?XT?\)3?
M?\\K?_OEO\: .NHKD?\ A*;[_GE;_P#?+?XU:L_$%W<;]\<(VXQA3_C0!TE%
M8O\ :]Q_<B_(_P"-']KW']R+\C_C0!M45B_VO<?W(OR/^-:EI,T]LDK !FSG
M'UH FHHHH **** "BBB@ HJ&XE:&,,H!)..:K?;9?[J?D: +]%4/MLO]U/R-
M'VV7^ZGY&@"R_P!\TVN>O]?NH+V2)(X2JXQE3GH/>J__  DMY_SR@_[Y/^-
M'4T5RW_"2WG_ #R@_P"^3_C1_P )+>?\\H/^^3_C0!U-%<M_PDMY_P \H/\
MOD_XT?\ "2WG_/*#_OD_XT =33X_O?A7)_\ "2WG_/*#_OD_XTJ^)KU3D16_
M_?)_QH ["BN1_P"$IOO^>5O_ -\M_C1_PE-]_P \K?\ [Y;_ !H ZZBN1_X2
MF^_YY6__ 'RW^-1MXMOPQ'DVW_?+?XT =E17&?\ "77_ /SQMO\ OEO\:/\
MA+K_ /YXVW_?+?XT =G17&?\)=?_ //&V_[Y;_&I?^$IOO\ GE;_ /?+?XT
M==17(_\ "4WW_/*W_P"^6_QH_P"$IOO^>5O_ -\M_C0!UU%<C_PE-]_SRM_^
M^6_QH_X2F^_YY6__ 'RW^- '745R/_"4WW_/*W_[Y;_&C_A*;[_GE;_]\M_C
M0!UU%<C_ ,)3??\ /*W_ .^6_P :/^$IOO\ GE;_ /?+?XT ==17(_\ "4WW
M_/*W_P"^6_QH_P"$IOO^>5O_ -\M_C0!UU%<9_PEU_\ \\;;_OEO\:/^$NO_
M /GC;?\ ?+?XT =G37^X:X[_ (2Z_P#^>-M_WRW^- \5W[G:8K;!_P!EO\:
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MT?\ "2WG_/*#_OD_XT =317+?\)+>?\ /*#_ +Y/^-'_  DMY_SR@_[Y/^-
M'5+]X?6IZXX>);T'/E0?]\G_ !I__"4WW_/*W_[Y;_&@#KJ*Y'_A*;[_ )Y6
M_P#WRW^-'_"4WW_/*W_[Y;_&@#JI>U1UR[>)[UNL5O\ ]\M_C2?\)+>?\\H/
M^^3_ (T =317+?\ "2WG_/*#_OD_XT?\)+>?\\H/^^3_ (T =>GW!3JY >*+
MT#'E6_\ WRW^-+_PE-]_SRM_^^6_QH ZZD;[I^E<E_PE-]_SRM_^^6_QI#XI
MOB,>5;_]\M_C0!T]%<M_PDMY_P \H/\ OD_XT?\ "2WG_/*#_OD_XT =33X_
MO?A7)_\ "2WG_/*#_OD_XTJ^)KU3D16__?)_QH ["BN1_P"$IOO^>5O_ -\M
M_C1_PE-]_P \K?\ [Y;_ !H ZZH7^^:Y?_A*;[_GE;_]\M_C3#XFO2<^5;_]
M\G_&@#J:*Y;_ (26\_YY0?\ ?)_QH_X26\_YY0?]\G_&@#JE^\/K4]<=_P )
M->@9$5OQS]T_XTW_ (2Z_P#^>-M_WRW^- '9T5QG_"77_P#SQMO^^6_QH_X2
MZ_\ ^>-M_P!\M_C0!V=%<E;>*+Z:0JT5N !GA6_QJS_PD%W_ ,\X?^^3_C0!
MTE%<W_PD%W_SSA_[Y/\ C1_PD%W_ ,\X?^^3_C0!TE%4K*[DN;2.5PH9LYP.
M.I%6/,;T% $M%1>8WH*/,;T% $M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %96I?\?*_[@_F:U:Y_7)I([U C8'E@]/<T )16;]JF_O\ Z"C[5-_?_04
M:5<=6_\ :IO[_P"@KSO^U;W_ )[?^.+_ (4 =+17-?VK>_\ /;_QQ?\ "C^U
M;W_GM_XXO^% '3I]\5-7)#5KX'(G_P#'%_PIW]LW_P#SW_\ '%_PH ZNBN4_
MMF__ .>__CB_X4?VS?\ _/?_ ,<7_"@#JZ*YB/5KYER9^_\ <7_"G?VK>_\
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M7_"C^V;_ /Y[_P#CB_X4 =/+VJ.N>35;U\[ILX_V%_PIW]HW?_/7_P ='^%
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M.C_"@#H%^\/K4]<Q_:5V#_K?_'1_A3O[5O?^>W_C@_PH Z6BN:_M6]_Y[?\
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M5O?^>W_C@_PH Z6BN:_M6]_Y[?\ C@_PILFK7RKD3]_[B_X4 =/17*?VS?\
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M?\^7^]^@H NT52\^7^]^@H\^7^]^@H [+2O^0;#^/\S5RJFA#?HUNS<D[O\
MT(UH[%]* (:*FV+Z4;%]* '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MS?B#_C_C_P"N0_F:Z2L#7 #>ID#_ %8_F: ,6BI]H]!^5&T>@_*@""O-*]2V
MCT'Y5Y;0 4444 %%.3EQFIMJ_P!T?E0!7HJQM7^Z/RHVK_='Y4 -B^[^-/H
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MHTB[N5TN%5N)@!NX#G^\: /0**XS[;=_\_4W_?PT?;;O_GZF_P"_AH [6/\
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M_P#/1_\ OHT :M%97FR_\]'_ .^C1YLO_/1_^^C0!JT57LV9HB6))W=S5B@
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MJ]% %BBJ]% #KG_5CZU4JS10!6HJS10!6HJS10!6HJS10 4444 %%%-D^X:
M'456HH LU#+][\*910 4444 %=57*U9H Z&BN>HH [+0_P#D,0?\"_\ 0378
MUY5H_P#R%8?^!?\ H)KJZ .JHKE:* .YLO\ 4M_O?X59K!\/_P#'A)_UU/\
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M7TI-K?W3^56** *^UO[I_*G("'&0:FHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@"%P2YP#3=K?W3^56** *^UO[I_*E (8$@]:GI&^Z?
MI0 ;E]1^=&Y?4?G5>B@"QN7U'YTH^;IS]*K59M?X_P * %VMZ'\J-K>A_*IZ
M* (-K>A_*K,4B+&%9U!'8FFU2G_US4 :7G1?\]$_[Z%'G1?\]$_[Z%9-% &_
MI\\0U*U)E0 3)DEAZBN]^VVG_/U#_P!_!7E%K_Q]P_\ 71?YUTM '9?;;3_G
MZA_[^"C[;:?\_4/_ '\%<;10!Z#I-S!+=,L<T;G83A7![BMC</4?G7"^$?\
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MKT4 :ND2(NJ0EG4 ;N2?]DUU'VFW_P">\7_?8KB+3_CY3\?Y5IT =)]IM_\
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M* ,;[#<_\\__ !X4?8;G_GG_ ./"MFB@#&^PW/\ SS_\>%8/BVPN3I46(O\
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MC^V;#_GO_P".-_A7*44 >C0.LEO&Z'*L@(/J"*DJMIW_ "#+3_KBG_H(JS0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!(JN =W4#^\:O_:4]&K \.?\@"V_X%_Z$:U: +7VE/1J/M*>C55HH T****
M"LO7;.2]L4BB90PD#?,?8_XUJ5#<_P"K'UH Y'_A'[O_ )Z0_P#?1_PH_P"$
M?N_^>D/_ 'T?\*Z2B@#F_P#A'[O_ )Z0_P#?1_PKD-:TV:'5YXV:,D;>A/\
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M/^N*?^@BK- %_P"VQ_W7_(4Z.Z21P@#9/J*SJFM?^/E/Q_E0!I4444 %%%%
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M5_.C[,_JOYU;HH J?9G]5_.M/0["6:]=59 1&3R3ZBJ];/AK_D(R?]<3_,4
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M *].7PSYIV?;,9[^5_\ 7K;J2#_7+0!A?\(;_P!/_P#Y!_\ LJ/^$-_Z?_\
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MJB@#E?\ A#?^G_\ \@__ &5'_"&_]/\ _P"0?_LJZJB@#F5\([5Q]N_\A?\
MV5+_ ,(E_P!/O_D+_P"O72T4 <U_PB7_ $^_^0O_ *]'_"([N/MW7C_5?_95
MTM*OWA]: .8_X0C_ *B/_D'_ .RH_P"$(_ZB/_D'_P"RKKJ* .1_X0C_ *B/
M_D'_ .RIK>"]N/\ B89S_P!,?_LJ["HY>U '(_\ "&_]/_\ Y!_^RH_X0W_I
M_P#_ "#_ /95U5% '*_\(;_T_P#_ )!_^RIK>"<G/]H?^0?_ +*NLHH Y'_A
M"/\ J(_^0?\ [*C_ (0C_J(_^0?_ +*NNHH Y-?!.U@?[0Z'/^I_^RJ?_A$O
M^GW_ ,A?_7KI:* .:_X1+_I]_P#(7_UZ/^$2_P"GW_R%_P#7KI:* .?@\,>2
MY;[9G(Q_JO\ Z]3_ -@_]//_ )#_ /KULT4 8W]@_P#3S_Y#_P#KT?V#_P!/
M/_D/_P"O6S10!I:-!]ETJ&'=NV[N<8_B)J_5>Q_X\X_Q_F:L4 %%%% &A111
M0 4R2/S%QG'.:?10!7^R_P"W^E'V7_;_ $JQ10!7^R_[?Z5Q6O:5YNM7#^=C
M.WC9_LCWKO:Y36/^0K-_P'_T$4 <Y_8W_3Q_XY_]>C^QO^GC_P <_P#KUJT4
M 97]C?\ 3Q_XY_\ 7KDJ]"KSV@ HHHH :R[AC.*;Y7^U^E244 1^5_M?I1Y7
M^U^E244 -5=HQG-.HHH **** "BBB@ HHHH **** "BBB@ HHHH *C\W_9_6
MI*K4 2^;_L_K1YO^S^M144 3QOO<+C&:F\KW_2JT'^N6KM $?E>_Z4>5[_I4
ME% "QS_9UV;=V3G.<4_[=_TS_P#'JK2?>_"F4 7/MW_3/_QZC[=_TS_\>JG1
M0!Z%8ZYLT^V7[/G$2C[_ +#VJQ_;W_3M_P"1/_K5@6G_ !Y0?]<U_E4U &S_
M &]_T[?^1/\ ZU6M.UGSK^*/[/MSGG?['VKG*OZ-_P A6'_@7_H)H [/[5_L
M?K1]J_V/UJO10!8^U?['ZU+')YBYQCG%4JM6W^K/UH FHHHH *J/>[79?+S@
MX^]5NLJ7_72?[QH L_;O^F?_ (]1]N_Z9_\ CU4Z* (/$&H[-#N&\K.-O\7^
MT/:N'_MG_IA_X_\ _6KJO$?_ " +G_@/_H0K@: -3^V?^F'_ (__ /6H_MG_
M *8?^/\ _P!:LNB@ UF_^T^3^ZV[=W\6?2LOS?\ 9_6K%_\ \L_Q_I5*@"7S
M?]G]:/-_V?UJ*B@"R#D ^M%(OW1]*6@ HHHH **** "G*N[/.,4VI(N] !Y7
MO^E'E>_Z5)10!'Y7O^E'F;>,=.*DJ!OO'ZT /\WV_6CS?;]:CHH D,F01C]:
MCHHH **** &N^W'&<TWS?]G]:)>U14 2^;_L_K1YO^S^M144 6%.Y<TM-C^X
M*=0 4Z-=\BIG&X@9IM26_P#Q\Q?[X_G0!<_LO_IM_P"._P#UZ/[+_P"FW_CO
M_P!>M&B@#._LO_IM_P"._P#UZW/"VD>9J<@\_'[DG[G^TOO52M_PC_R%9?\
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MD6_]^7\Q_A1_9%O_ 'Y?S'^%7Z* *']D6_\ ?E_,?X4UM&MVZO+^8_PK1HH
MS?[$MO[\OYC_  H_L2V_OR_F/\*TJ* ,W^Q+;^_+^8_PH_L2V_OR_F/\*TJ*
M ,W^Q+;^_+^8_P */[$MO[\OYC_"M*B@#-_L2V_OR_F/\*/[$MO[\OYC_"M*
MB@#-_L2V_OR_F/\ "C^Q+;^_+^8_PK2HH S?[$MO[\OYC_"C^Q+;^_+^8_PK
M2HH S?[$MO[\OYC_  H_L2V_OR_F/\*TJ* *T5E%#$(U9R!ZD4_[,GJU344
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^%5:* +7]HW?_/7_ ,='^%<+?ZC=_P!HW7[W_EL_\(]3[5V%<+?_ /(1NO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"U;+_GM_XX?\*<NHVCYVRYQ_LG_"@"U15?[=;?\]/_ !TT?;K;_GI_XZ:
M+%%5_MUM_P ]/_'33&U.S4X,V"/]D_X4 6Z*I_VK9?\ /;_QP_X4?VK9?\]O
M_'#_ (4 7**I_P!J61/^N_\ '3_A3O[1M/\ GK_XZ?\ "@"U157^T;3_ )Z_
M^.G_  H_M&T_YZ_^.G_"@"U15=+VWD;"29.,_=-2>?'_ 'OTH DHJ/SX_P"]
M^E'GQ_WOTH DHI%8,,CD&EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"GJ7_'LO\ OC^1K*K8OHGFA58UR0V>OUK/^PW/_//_ ,>% %>BK'V&
MY_YY_P#CPH^PW/\ SS_\>% '$^*?^0G'_P!<1_Z$U8==+XHT^Z.IQXB_Y8C^
M(>K>]8G]G7?_ #R_\>'^- %6BK7]G7?_ #R_\>'^-']G7?\ SR_\>'^- &+1
M3MC>E&QO2@!M%.V-Z4%6 R10 VBBB@ HHHH **** "JU6:@\MO2@!M%.\MO2
MCRV]* "/[XJ>HD1@P)%2T %%%% !12A21P*78WI0 VBG;&]*-C>E #:*.AHH
M *;)]PTZFN"5(% $%%.\MO2CRV]* &U-%]W\:C\MO2IHHVV].] "T4[8WI1L
M;TH ;13MC>E&QO2@!M%.V-Z4;&]* &T4K*57)X IGF+ZT .HIOF+ZT>8OK0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS_?A_,_X4 9E%:?]AW/]^'\S_A1_8=S_ 'X?S/\ A0!YW14WV9_5:/LS^JT
M0TU_N&K'V9_5:CGB:.%G)&!Z4 5:*9YJ^AH\U?0T /HIGFKZ&G*P89% "T44
M4 %%%,\U?0T /HIGFKZ&CS5]#0 ^BFB0,<#-.H **** )8_N_C3Z9']W\:?0
M 4444 0-]X_6DI6^\?K24 %%%(3M&30 M%,\U?0T>:OH: 'U+']W\:K^:OH:
MEBE7;T/6@":BF>8/0T>8/0T /HIGF#T-,-R@.,-0!-14/VE/1ORH^TIZ-^5
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M_L_K1YO^S^M $E%-C?>X7&,U-Y7O^E $=%2>5[_I1Y7O^E $=%.9=N.<YIM
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M_P!I:['S?;]: )**C\WV_6CS?;]: -VQ_P"/./\ '^9JQ5;3SFQC/U_F:LT
M%%%% !1110 4R3[OXT^D9=PQF@""BI/*]_TH\KW_ $H CJ9/N"F^5[_I3U&!
MB@!:*** "BBB@ HHHH **** "BBB@"K<_P"L'TJ&K<D/F-G=CC'2F?9?]O\
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MFR?<-.HV[_ESC- %:BK/V7_;_2C[+_M_I0!6J:+[OXT_[+_M_I1Y?E\9SWH
M**** "J[?>/UJQ49BR2<]?:@"*BI?*_VOTH\K_:_2@!(/]<M7:IJ/*._KCM4
MGVK_ &/UH L457^U?['ZT?:O]C]: ))>U1T>;YO\.,>]% !1110 4444 %%%
M% !1110 4444 %%%% !5=OO'ZU8J]'HOFQK)]HQO ;&SIG\: ,BBMG^P?^GG
M_P A_P#UZ/[!_P"GG_R'_P#7H H:9_R%K/\ Z[I_Z$*])KCM.T+;J=H?M/29
M#]S_ &A[UZ#_ &7_ --O_'?_ *] &?16A_9?_3;_ ,=_^O1_9?\ TV_\=_\
MKT 6-!_Y>/\ @/\ 6MFL_2[7[-YOS[MV.V/6M"@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "L#6_^/U/^N8_F:WZYW7G*WR 8_P!4
M/YF@"A147F-Z"CS&]!0!+7EE>G>8WH*\QH **** '1_?%3U!']\5/0 4444
M%%%% !1110!.OW1]*6HA(0,<4>8WH* )::_W#3/,;T%(7)&.* &T444 %%%1
MNY4X&.E $E%0^:WH*/-;T% $U5V^\?K3O-;T%.\L,,G//- $5%3>4OJ:/*7U
M- #8/]<M7:JH@1@PSD5+YC>@H EHJ+S&]!1YC>@H 67M4=.9BW6FT %%%% !
M141D()&!UI/-;T% $U%0^:WH*<LA9@#B@"2BBB@ J2+O4=(TK1] .?6@"S15
M3[2_HOY4?:7]%_*@"W4#?>/UJ/[2_HOY4\'<,GOS0 4444 %%%% !1110 44
M44 %%%% $R?<%.J$.0,<4OF-Z"@"6D;[I^E1^8WH*#(2,<4 ,HHHH ***8[%
M<8[T /HJ'S6]!1YK>@H FJ"3[YI?-;T%."AQN.<GTH BHJ;RE]31Y2^IH 9#
M_KX_]X?SK6K-2,+(I&>"#5WS&]!0!+147F-Z"CS&]!0!O>&O^0C)_P!<3_,5
MU-<KX5/F:I*#_P \2>/]Y:Z_RQZF@"*BI?+'J:/+'J: -K3O^/"+\?YFK55K
M 8LHQ]?YFK- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ''45M?V1;_WY?S'^%']D6_\ ?E_,?X4 8M9^N?\ ('G_
M . _^A"NJ_LBW_OR_F/\*S/$&E0)H=PP>3(V]Q_>'M0!YM16A]AB_O/^8H^P
MQ?WG_,4 9]12?>_"M7[#%_>?\Q5"]B6&954D@KGG\: *U%%% !5BJ]/\QO04
M 2T5%YC>@H\QO04 +/\ ZEJI5:=BZE3T-1^4OJ: (:*F\I?4T>4OJ: "+[OX
MT^HB?+.!]>:3S6]!0!-14/FMZ"CS6]!0!-12 Y /M2T %.3[XIM*#@YH GHJ
M+S&]!1YC>@H EJ*3[WX4>8WH*:S%CDT )1110 4444 %%%% #9/N&H*L$;A@
MTWRE]30!#14WE+ZFCRE]30 D7>I*:JA>F>:=0 4444 %%%% !112$X!/M0 M
M%0^:WH*/-;T% $U%0^:WH*L6RB;=NXQCI0 VBK7V9/5J/LR>K4 5:Z2V_P"/
M2'_<7^58OV9/5J[*RTJ!K"W8O)DQ*>H]![4 9E%;7]D6_P#?E_,?X4?V1;_W
MY?S'^% &;8?\A&U_Z[)_,5W5<[9Z5 M[ P>3(D4]1Z_2NL^S)ZM0!5HJU]F3
MU:C[,GJU #;7^+\*L4R.,1YP3SZT^@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_0EKL-[>M $U%0[V]:-[>M &_8_\><?X_S-6*JZ<2;&,GW_ )FK5 !1110
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M/^>7_CQ_QH_LZT_YY?\ CQ_QH Q;;_C[A_WU_G72566PMD=66+#*<@[C5F@
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M +[?G4R\J"?2@!:*** %7[P^M3U6;A21Z5#YC_WV_.@"_15#S'_OM^='F/\
MWV_.@"W+VJ.F1LS9R2?J:?0 4444 3)]P4ZJ3NP<@,0/K3?,?^^WYT 7Z1ON
MGZ51\Q_[[?G2J[E@"S=?6@":BBB@ J2+O4= )'0T 6**@W-ZG\Z-S>I_.@">
MH7^^:3<WJ?SJ"1FWGD_G0!-15?<WJ?SHW-ZG\Z +*_>'UJ>J"LVX<GKZU8W-
MZG\Z )Z*@W-ZG\Z-S>I_.@#H_"W_ "$Y/^N)_P#0EKKJX_P=SJ\H//[@]?\
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M:?W%_*NG\(6\+_;-\,;8V8RH/]Z@".BNL^R6W_/O#_WP*/LEM_S[P_\ ? H
MY.O0=._Y!EI_UQ3_ -!%97V2V_Y]X?\ O@5M0 +;QJH  0  =N* )**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *YOQ!_Q_P ?_7(?S-=)6!K?_'ZG_7,?S- &+15BB@"O7FE>IUY90 44
M44 %%.C^^*GH K459HH 9%]W\:?110 4444 %%%% !1110 4444 %%%2Q_=_
M&@"*BK%% %>BK%0-]X_6@!**** "BBB@ HHHH **** "BBB@"NWWC]:2M!?N
MCZ4M &=3H_OBK]-?[AH AHHHH *CE[5)4D7>@"E16C10!G587[H^E6:@;[Q^
MM "4444 (WW3]*KU:7[P^M3T 9U%:-% %.+O4E6** *]%6** *$GWS3:T:*
M,ZE7[P^M:%(WW3]* (**** "BBI(N] $=%6** *]02??-7ZA?[YH J459HH
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MZ/I2U.OW1]*6@"O3H_\ 6+]14U3V7_'_ &__ %U7^8H 6BNRHH XVNJ\&_\
M+[_VS_\ 9JL5N>'?^7G_ (#_ %H EHK8HH QZU8O]3'_ +HI]% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !6!KA O4R1_JQ_,UOUS?B#_C_ (_^N0_F: *.X>H_.C</4?G4%% $^X>H
M_.O+MK?W3^5>E5Y[0!7VM_=/Y4;6_NG\JL44 0H"'&0:FHHH **** "BBB@
MHHHH 3</4?G1N7U'YU WWC]:2@"QN7U'YT;@>A%5Z=']\4 3T444 %21D!>2
M.M1T4 3[AZC\Z-P]1^=044 3[AZC\ZA;[Q^M)10 4444 %%%% !1110 Y49O
MNJ3CT%+Y4O\ SS?_ +Y-6;'_ ):?A_6KE &5Y4O_ #S?_ODT>5+_ ,\W_P"^
M36K10!46UN2BD6\I!']PTOV2Y_Y]Y?\ O@UT]O\ \>T7^X/Y5)0!RGV2Y_Y]
MY?\ O@TC65TRX%M,3Z",UUE20?ZY: .+_LZ^_P"?.X_[]-_A1_9U]_SYW'_?
MIO\ "O0:* //O[.OO^?.X_[]-_A4D>GWHSFSN/\ OTW^%=[10!POV"\_Y])_
M^_9H^P7G_/I/_P!^S7=44 <+]@O/^?2?_OV:B.FWY8D65SU_YY-_A7?U.OW1
M]* /./[,O_\ GQN?^_3?X4?V9?\ _/C<_P#?IO\ "O2** /.!IM^"";*Y '_
M $R;_"I/L5W_ ,^LW_?LUZ#)_JV^AJC0!QGV*[_Y]9O^_9H^Q7?_ #ZS?]^S
M79T4 <:+&\/2UG_[]FC[!>?\^D__ '[-=M%WJ2@#A?L%Y_SZ3_\ ?LT?8+S_
M )])_P#OV:[JB@#A?L%Y_P ^D_\ W[-'V"\_Y])_^_9KNJ* .%^P7G_/I/\
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MVB@#"^SS?\\9/^^36WX?C=/M&]&7.W&1CUIU7+'_ ):?A_6@"Y1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %<[KZDWR8'_+(?S-=%6!K?\ Q^I_US'\S0!C[&]*-C>E344
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M444 ;MO_ ,>T7^X/Y5)4=O\ \>T7^X/Y5)0 5;TPXU:S)[3H?_'A52K.G?\
M(3M/^NR?^A"@#TO[2GHU'VE/1JJT4 6OM*>C4^.029P#QZU2JQ:_Q?A0!8HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *XKRO?]*[6N.H C\KW_ $H\KW_2I** ,G7H\:+<'/\ =_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<_
MKB@WJ9'_ "S'\S705@:W_P ?J?\ 7,?S- &7L7THV+Z4ZB@!NQ?2O+J]3KRR
M@ HHHH <@!8 U+Y:^E11_?%3T -\M?2CRU]*=10 *=@PO IV]O6FT4 .WMZT
M;V]:;10 THI))')H\M?2G44 -\M?2@(H.0*=10 4444 %.6-'&6&3]:;4L?W
M?QH 3R(O[OZFCR(O[OZFI** (_(B_N_J:C( .!T%6*@;[Q^M "4444 %%%%
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M]_F_QH_M74?^?^Z_[_-_C52B@"W_ &KJ/_/_ '7_ '^;_&C^U=1_Y_[K_O\
M-_C52B@"_%JFH'.;^Z/_ &V;_&I/[3O_ /G^N?\ OZW^-48N]24 6O[3O_\
MG^N?^_K?XT?VG?\ _/\ 7/\ W];_ !JK10!(^J:B'.+^Z_[_ #?XTW^U=1_Y
M_P"Z_P"_S?XU6D^^:;0!;_M74?\ G_NO^_S?XTJZKJ.X?Z?==?\ GLW^-4Z5
M?O#ZT :7]IW_ /S_ %S_ -_6_P :/[3O_P#G^N?^_K?XU5HH M?VG?\ _/\
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M '7_ '^;_&JTGWS3: +?]JZC_P _]U_W^;_&C^U=1_Y_[K_O\W^-5** -/\
MM.__ .?ZY_[^M_C1_:=__P _US_W];_&JM% %K^T[_\ Y_KG_OZW^-']IW__
M #_7/_?UO\:JT4 6O[3O_P#G^N?^_K?XT?VG?_\ /]<_]_6_QJK10!:_M.__
M .?ZY_[^M_C6YI][=M8QLUU,2<\F0^IKF:W]._X\(OQ_F: -#[7<_P#/Q+_W
MV:/M=S_S\2_]]FH:* )OM=S_ ,_$O_?9KT7<WJ?SKS2O2J %W-ZG\Z-S>I_.
MDHH DC)+<D]*DJ*/[WX5+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HI-P]1^=&Y?4?G0 M%)N7U'YT;@>A% "T444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KF_$'_'_ !_]<A_,UTE<[KR%KY",?ZH?S- &113_
M "V]11Y;>HH 97FE>G>6WJ*\QH **** '1_?%3U#$,R 59\MO44 ,HI_EMZB
MCRV]10 RBE92IP:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@"NWWC]:2I#&22<CK2>4WJ* &4Z/[XI?*;U%.6,J
MP)Q0!)1110 4444 %%%% !4Z_='TJ"E^T(O!#<<4 3T5#]I3T;\J/M*>C?E0
M!*WW3]*@I?M"-P W/%)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%,\U?0T>:OH:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[7Z4 14^+[WX4[RO]K]*,>7\W7M0!)14?F_[/ZT>;_L_K0!)6_IW_'A%^/\
M,USGF_[/ZUT6F'=IT1^O\S0!;HHHH *]2KRVO3O-]OUH DHJ/S?;]:/-]OUH
M DHIBON.,4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.KL
M:XKS?;]: )**C\WV_6CS?;]: */B#_D"7'_ ?_0A7#UVFO29T6X&/[O_ *$*
MXN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** -6+_4Q_P"Z*?2P19@C.>JCM[4_RO\ :_2@".K>E?\
M(8LO^OB/_P!"%0>5_M?I5O2XL:O9'/2=.W^T* /3**** "I(N]1U)%WH DHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "N;\0?\ '_'_ -<A_,UTE<]KJ!KY"<_ZL?S- &/1
M4OECU-'ECU- $5>:5ZAY8]37E] !1110 Z/[XJ>H(_OBIZ "BBB@ HJ-W*G
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M%2^6/4T>6/4T 145+Y8]33'4*<"@!M%%% !1110 4444 %%(QVJ2*B\UO04
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MBBB@ HHHH **** "BBB@ HHHH *P-;_X_4_ZYC^9K?K$UA0;M,C_ )9C^9H
MR:*FV+Z4;%]* (:\LKUG8OI7"_V;:?\ /+_QX_XT 8%%;_\ 9MI_SR_\>/\
MC1_9MI_SR_\ 'C_C0!A1_?%3UJMI]JJ[EBP1_M'_ !IGV6'^Y^IH S:*TOLL
M/]S]31]EA_N?J: ,>7[WX4RMY;"V<9:+)_WC2_V;:?\ /+_QX_XT 8%%;_\
M9MI_SR_\>/\ C1_9MI_SR_\ 'C_C0!D+]T?2EK8^P6P&/+_\>-+]AMO^>?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY\;;_OTO^% 'FU%>D_V98?\ /C;?]^E_PH_LRP_Y\;;_ +]+_A0!YM17I/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image00001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0P!WD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBH)[E(,;F')Q1:XFTM
MR>BD4AE!'>EH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %)2TC,%7)Z4 ,FE$,98GI7(
M:CJ!FEP#PIS5O6M4\R0V\3?*>N*PB@[FMZ<=+GF8K$6ERH[/1KW[9: _W>*T
MJY?P_<B+]R#UYKIQTK*2LSMH5%.%Q:***DV"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P=;U,
MP?NX^<CFM>ZN%MH&D8\"N(N[D7%RS$\9XJX1NSDQ5;DC9$##]X7)R2<TO6E(
M!H. ,#K74EH>._>U9-ILH@U!7)^3'-=Q!,DT0=#D5Y^1M((KLM$;-@H]ZPJK
MJ>E@9JW*:=%%%8GHA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4A( R:6L[5;P6]NRYPS#BFE<F4E%79
MC:_>.9!"K#8>M8F% '%.>1YI2SG-!P.U=4(V/#Q%1U)7$)[#K3L#&3UI,C<*
M6J,!A.]N.@K=\/7,AN3$3\@%88("Y JSIUU]ENU<]&.*B:T-\-/DJ)G=T4R)
MM\2MZC-/KE/>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!",T=J6B@#A/'FH(+%K3<
M-S9XKR]1M&*ZWX@?\AN(^QKEL \BNVDK1N?&9G.3KM,3:,^U)@-P:=D=.U&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^]!(SB@G Q0@0@SD_K0>1QTI<YZ=NM)NY]J!BC@<_A28.[WI<X&?RH!SQWH
M.O3\:1>!STH)Q2YSSVHZ (V?PI?8]:0-SS2DX% " '=2GD<4 Y^M(6YHZ@*.
M!STI"#FESW[4@;M0 OMWI #D_K2DX^M&<].W6CH AY''2E' Y_"DW<^U+G S
M^5 "8.ZE^E .>.](3B@ 7@<]*0Y/TIQY&129Q0-(7O[TG.?>CFC/&.]%]1>@
M%<\B@?=YZ4AR6P.E.(.[8.2>!BFQJ-]!8H'NITA3[S' ->L^$_#,>F6BRRC,
MYQDXKG/!?AV1I_/GC/ R,UZ<JA5 %<E6?1'T^5X+D7/)"@8I:**P/="BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M94Z:A'E0T+BG444C0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFX;@I]:3)W9I3[]*.O H(2Z@3W[T=*0 [J<<GZ46$(?TI"2<4[V[4<]_PI@
MR.E(I.3BER1]:,%1D=^M(JZ#/&.U(<YHYQ[4A8[?I306NPRSN% Y->F>"=#\
MF'SI4^\<\BN9\(:%)J%\L\B9A7KD5Z]!"L$*QH %7I7-6GK9'TF58*R]I,D4
M!0 .U+117,?0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BC..M-WI_>7\Z '44W>G]Y?SHWI_>7\Z '44W>
MG]Y?SHWI_>7\Z '44W>G]Y?SI0P/0@_2@!:*** "BBB@ HHHH **** "BBB@
M HHHH **0L!U('XTF]/[R_G0 ZBF[T_O+^=&]/[R_G0 ZBF[T_O+^=&]/[R_
MG0 ZBF[T_O#\Z=0 4444 %%%% !12%@.I ^II-Z?WE_.@!U%-WI_>7\Z-Z?W
ME_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.
M@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.@!U
M%-WI_>7\Z-Z?WE_.@!U%%% !110: "BF[U_O#\Z-Z?WE_.@!U%-WI_>7\Z-Z
M?WE_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE
M_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.@!U%-WI_>7\Z-Z?WE_.@
M!U%-WI_>7\Z-Z?WE_.@!U%&<T4 %%%% !112%E'5@/QH 6BF[T_O+^=&]/[R
M_G0 ZBF[T_O+^=*&!Z$'Z4 +1110 4444 %%%% !1110 4444 %%%)O4=6'Y
MT +13=Z?WE_.C>G]Y?SH =13=Z?WE_.E#*>C _0T +1110 4444 %%%% !11
M10 4444 %%%)N'<@4 +13=Z?WE_.C>G]Y?SH =13=Z?WE_.E#*>A!^AH 6BB
MB@ HHHH **** "BBB@ HHHH ***0LHZL!^- "T4W>G]Y?SHWI_>7\Z '44W>
MG]Y?SIP.: "BBB@ HHHH *0@$8(I:* (&M82?]6OY4^.-4&%4#Z5)13N2HI.
MX4444B@HHHH **0LHZL!]32;T_O+^= #J*;O3^\OYT;T_O+^= #J*;O3^\OY
MT;T_O+^= #J*;O3^\OYT;T_O+^= #J*;O3^\OYT;T_O+^= #J*3<IZ,/SI:
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MFM7>?'G[UK_N?U->*#A0.^*]+#T8RC=F\()H[ _%'Q"#CS6H'Q0\0D9\UJY
M<TF>>*Z/J\.Q?LT=?_PM'Q#_ ,]6I3\4/$(_Y:M7(< 9H!]:/J\.P>S1UX^*
M'B$G'FM0?BCX@_YZMQ7('C@=:."*7U> <B.P_P"%H>(,9\UL4@^*/B#_ )ZM
MS7(9[]J#@?C1]7@')$[ _%#Q"./-:@?%#Q">DK5QXYX/6CV%'U> <D;'7_\
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M2T445(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>^6\R7$*S1G*L,BO'J0<'9G*U9DM%%%9B"BBB@ HHHH **** "BBB@ HHHH
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MG/>EP!]:.O/>CJ'4O:"!_P )'9<_Q_TKZ^T3_D&1_0?RKY!T #_A([+G^/\
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M;G\*\EEQD8]:^EOAAH*6EC#=CJR^GM7/B9)0L953TNBBBO*.<**** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<UX[_P"17NO]P_RKY$CXS]:^NO'?_(KW7^X?Y5\BIP"?<UZ."V9M2'GB@>A_
M.CI^-&<<5W(WZA].U'OC\* <_A29YS2!C6]:^B_@9_R*TW^]_4U\ZN<U]%?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.6YSG'-)SVKJO^%;>)\Y^SI^9_PH'PV\3@_\>Z?F?\*/;0[BYD<J/0]*7)'
M%=3_ ,*V\3XQ]G3\S_A2_P#"M_$P'-NGYG_"CVT.X^9=#DWY7FO9O@C_ ,A%
M_I_0UP;?#;Q.W_+NGYG_  KU'X3>&=3T346:]C"C'8^QK&O4C*#2,:C/9***
M*\LR"BBB@ HHHH X_P"(EBESX9NI&4$HG'YU\I,N+B7V:OKSQN,^$-0/_3/^
MM?(DF?M4_KO->A@Y=#:D(>.E-Y IPSVH;I@=*[V;=#U?X(2.VOX).W#?RKZ&
MKYV^!TA/B';CLW\J^B:\;$?&<LGJ%(2<TM8_B74VTK1IKI,%D4D#-9+5DGAG
MQD\57%YJLFB-CRHCD<>__P!:O*P,CFM+7=6E\0:Q+J$XVNQ/&?>L\'/'?M7K
MTH\L$CJIJR%Y"]*U/#6GMJ/B"TAV;HV?#<5E[CC!^\:]>^#/ADW5Q->70 V$
ME./I16ER0N*H]#VW1M+ATFPCMX5"J% P*T:!P,45Y#=SF"BBBD 5Y)\>?^16
M@X_C_J*];KR?X\#/A:'_ '_ZBM*/QH<=SYY3[@)ZT[MGO3$)V\]:=D_C7M=#
ML1I^% %\7:>WI)_2OL6!P\2D=,"OC31I?LVNVLQZ*^37USX:O%OM&BG4Y! _
ME7G8N/VC"JM37HHHKB,3FO'&IQZ?X:N\R;)"GR\X-?)]_=RZA>R232,^&."Q
MS7L/QN\0#-O:V[$] _/UKQ9!D'WKTL)3LN8VIH.&X/;I29*J:&4@T8>0JBC+
M$]*[)::FTMCM_AAX;B\0Z]&+D?*C;ASZ<U]16T0@MHX5Z1J%'X5Y]\-?"-OI
M5A#J"-^]9>1CU%>B@8KR*]3GE<Y9.XM%%%8$A1110 4444 %5[JY2TMI)Y3M
M1!DDU.:\P^+OBB31M,6SB_Y>%P2#TZ_X54(N4K(:5SS;XJ^(SJFJK#;3EH.0
MP!XKSG)&!T%/,KO*[R,6W'.328SU_"O8I0Y8V.F"LA"-IR*=$IFN8HO^>CA?
MSII)SS7>?#/PFFOZY']J)5$.X'&>G-%::C&XI.Q[-\-/"UOH>@J?)4R2 -N(
MR>>:[L# J*UA2VMHX4^ZBA1^%35X\G=W.=A1114B"BBB@ I'^XWTI:0]* /D
M;QW8M:^*+R1EP'?-<X#OX[5ZU\;-*2RNHIDZR+D\5Y*AP 1T[U[&'=X'5!Z!
MCL:Z/P'=BR\7PS,=JA<?J*YPY8^U20W#VMPDB??!Q6E17@QM75C[-TN\6^L4
MF0Y!&*N5QWPSN'N?"$,DGWMW]!78UXDE9G*]PHHHI""BBB@ KG?'#A?"&H G
MDQ_UKHJ\V^+>NC3-(-L>LZX%735Y)#6Y\UN/]*G;OO-&2:3)\USW8YI<8''X
MU[<-CJCL(>!Q5RSTK4-2;9:PES["J))"^V:^@OA7X>$*QW4L:LK+W'M6->HZ
M>J%*5D>-_P#"(:_C_CT?_OFD_P"$/U_/_'H__?-?7?V&U_YX)^5'V&U_YX)^
M5<7UN1C[1GR+_P (=KV,?9'_ .^35.^T+4M+B#WL+1IV)&*^QOL-M_SP3\J\
MZ^+OAN75?#:BQA0/&2S?3BM(8R3:3&JC;/F\-QT^E(N<YI[QF*5HG^^G6F@G
M/3FN^-F[G0F(WR@X[UZ;X*\ :-XCL(GGD_?N!D;\<UYH!P<UV?PVU_\ LSQ#
M;B=R( X[UCB$^7W3.;LCV#0_A%I.CW0F"!\'.&.:[R+2-/A5=EE "!U$8J6T
MNDNX%FCY1QD&K%>3*4GNSG;8BJJC"@ >@I:**D04444 %%%% !1110!R_CK4
MGTOP_-/&<$(:^3[V=KS4YKACDN<DU],?%N0IX/N2/^>9KYA4_*&'?K7HX-:&
MU)BYP<4UV(Z"E;GD=*0GY.:[&;/8]:^#&AB[ODU0KS&<9_'_ .M7T+7D?P(4
M-X8G;'(?^IKUL&O(KRO,YI[BT445B0%%%% !1110 4444 %%%% !1110 4U_
M]6WT-.K$\5:N-$T22[/0'%-*[ ^;?B=(S^-9D).T(./Q-<=R3]*U_%.K?VSK
M\EZO0C%90SCFO9I*T$=,;V&Y.:54,CB,=6H'7/>M#P_ +OQ+90'H[X-:2=HW
M+D[(^D_A9;-:^$[>-A@A!7=5GZ/IZ:;8QPIT"CM6A7AS=Y-G(PHHHJ1!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!S/CO_D5[K_</\J^18_XL=<U]=^._P#D5[K_ '#_ "KY$CYR.^37
MH8+9FU(?UZ?C1SCVHHZ\CI7>C?J&#W_"C_T*CIU[TF#G'>D CC'UKZ*^!G_(
MK3?[W]37SHYSQ7T7\"_^16F_WOZFN7&? <]0]5HHHKRS(**** "BBB@ HHHH
M **** "BBB@#PCXW9^UCTV_T%>+ID+S7M'QN!^UC_=_H*\74':*]?#?PT;TA
MW.:.>@ZTO;'>DQ^==#W-A "/I0>>G2E//(H'3/:CJ'4O:#G_ (2*RS_?_I7U
M]H>?[,CSZ#^5?(.@ _\ "267^_\ TKZ^T7_D&1_0?RKSL9N8U=C1HHHKA, H
MHHH \,^//WK7_<_J:\4'*C'3%>U?'K[UK_N?U->*+PH/;%>KA?@.F&P[IUZ4
MF#F@^O:E[8-=1H@YQCO2 '/\Z,&EZ]* )H+>2ZE$4(RWM746_P ,/$=Y D\=
MM*489!"UB>'6QJR_45]9^&3GP[9_[E<F)JRA:QSRFTSYL_X5/XFSG[++_P!\
MTG_"I_$W/^BR\_[-?5=%<GUJ9/M&?*G_  J?Q-C'V67_ +YH_P"%3^)O^?67
M_OFOJNBCZU,/:,^5?^%4>)LY^RR_]\TG_"I_$P.?LLO_ 'S7U711]:F'M&?*
MO_"J/$V,?99?^^:/^%4>)L8^RR_]\U]544?6IA[21\J-\)_$Y_Y=9?\ OBO?
M_AUI-UHOA*WL[Q"LR]01["NLHK*=64]R7)O<****S$%-?_5M]#3J:_\ JV^A
MH ^.O%XSXOU';_STY_*L@<?2M;Q8#_PF&HG_ *:?TK*/S?2O;I? CKAL'7K^
M%'_H7:C[O6DP<UHB@ .:;(,X(]:?G/ ICC@?6DP;/H7X/QJVFJ2H//I[5ZJ;
M>,G)1?RKRWX._P#(,7Z_TKUBO'K.TV<TY.Y#]GC_ +B_E1]GC_N+^5345E=D
M<S(?L\>?N+^5'V>/^XOY5-11=AS,B%O'_<7\J0V\?]Q?RJ:BB["[(OL\?]Q?
MRI/L\9_@7\JFHHNPYF0_9X\?<7\J5($C;<J@'V%2T478784444A!1110 444
M4 <_XV_Y%#4/^N?]:^1),B\F_P!\U]?^+T,GA:^0=T_K7R/J4!@OY5/=C7?@
MEN:TRJ,Y.*.>E"@YI6Y7(KT6="['J'P-/_%2D>S?RKZ-KYN^"#B/Q)ECU!_E
M7T@#D9KQL1\9RS5F+7B7QA\47%A=O81O^[91D9]17L.ISBVTZYE+!=L;$9^E
M?(_BO5Y-8UNX>5BVV0@9]C58:'-,(*[,51A,CO1R#2[<\CI2.=HYKU;<IU7L
MBS86,VHWT<<2EF##.!7U;X%TA-,\.6N%VR,GS<5XO\']"-QJTEU,F8R!C-?1
ML<:Q1JB#"CI7FXJJY.QRU'=CZ***XR HHHH *\T^,]J;KPP@ SM)/ZBO2ZY3
MQ[9_;/#\JXSM1C5T_B0X[GR5R'93U!Q3L-GWI\R;;VX7TD8?K3>0:]I;'7#4
M17*RJXZJ:^J_A?,9_!5J[')./Y"OE.48&17U-\)6W>!+4_YZ"N3&_"C&JSN:
MJWMTEI \DA 4 ]:M5YM\5=;%MX?N(8I LH0CK7GPCS2L9(\(\9:G+JGB6[WM
MNC1_EK"3@\=*3>TS&1CECU-+]WGM7M4XJ,;'3%60O4G-=+X TM-7\76]O*N8
MCUX]Q7+.2/?/2O?/@AHT1T=[V:+$P;Y21[FLL1/EB3-V1ZW8V<=C:K!&,*HP
M*LTT9S3J\AG.%%%% !1110 444A.!DT 5+^^CL+=YI6"J 3DU\I^.O$=UX@U
M^9'<M#$_R5ZE\5/'$4=M<:3"V)L%<BO!]S2$N3\QZFN_"TG?F9M3B'< ]*53
MGBDQW-(0>HKT=#:S6A<T_3KC5+]+.!296/ %?3_@CPO!HEA%(RA9]OS9KY>T
M^[EL+U;B-B'7H170CQWJV<"Y?C_:KCKTY3V,YQ;/K(,H_B'YTN]?[P_.ODO_
M (3O5R<_:7X_VJ7_ (3S5O\ GY?_ +ZKD^K2,>5GUGO7^\/SI-Z_WA^=?)H\
M=ZN!_P ?+_\ ?5(?'>K[0/M+_P#?5/ZK(.21]:;U_O#\Z3>O]X?G7R9_PGFK
M\?Z2_P#WU2_\)YJ^[/VE_P#OJCZK,.1GUEO7^\/SHWK_ 'A^=?)O_">:OS_I
M+_\ ?5 \>:N1C[2__?5'U60<C/1?CN-_V;:0?W?;ZFO#P,+[5LZMK]YK 47,
MI?:,<FL?/S>U=]"#A&S-Z::'+G'M44F0RD]<BI,&D89X/6M9*Z+:T/I[X3W:
M2>$H80PWACQ^ KT"O!?@GJK2:J]D2<*,X_ U[U7CUXJ,[(Y9Z,****Q)"BBB
M@ KPKX_N5?3P#UQ_6O=>U?/OQTNUN+JSC!R5(_K6^'C>9<%=GD7)(QUI^?3\
M::HP/>E(]*]A:(Z41RG@8Z9YKZX\!1*OAFV8#G:/Y5\G6L)N+I(@,Y-?77@V
M(P^';=",845P8U[&%1LZ"BBBO/,@JGJD/VC2[J(#+-$P'Y5<H/(Q0@/C[Q7H
M5WHNK2O<HRB1\+D5A<_C7M_QLT9[B.&>)>$?)KP\'<,#K7KX>?-$Z(/0?DMQ
M^="2R6\BR1G&#28P/K01@<]*Z+71I:Z/K/P)J<6H>&[14<,Z)\W-=57@GP0U
MHQS7,$\G#$A 3]*]Z4[E!'>O%K1Y9-'+)68M%%%9$A1110 4444 %%%% 'EO
MQ=U*(^'+FVW#?L(QFOG).8P!^->@_%N^G;Q/<V^\[-Y&,UP"KA>*];"QM"YT
M4P' YZ4U@6(7UZ4H^]STJ6RC,FJP1GH6K>6S+F['T/\ !&V>V\+2A@1N;//U
M->H@5S_@[35T[0;=5&-\:M^E=#7BU'>3.5O4****@04444 %%%% !1110 44
M44 %%%% !7FGQ<UJVA\/2:>S@3,V0,\]*]&EF$43R'HBDFOF/XM:ZNJ^)@86
M^1,J?TK:A#FF5%79P*+M!W=S2G=FA?4TN#GK7L16ECJ2$^;/O74_#_1;O5/$
MUM/;HS)"^7('3BN5<$<9YKVSX"VQ!O7D0C.<$CZ5AB)\L&14>A[D@PBCVI:*
M*\@Y@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** .9\=_\BO=?[A_E7R+&/O?6OKOQW_R*]U_N'^5
M?(D?.1[FO0P6S-J0_KT[4#CGM1[^E&,\UWHWZAC]>E'MWHZ<>M)CG%(0CC%?
M17P,_P"16F_WOZFOG1^3]*^B_@9_R*TO^]_4US8Q+V9A4/5:***\HR"BBB@
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M;#9^S/\ ]\U];'1;0X_=)Q_LT?V+9YSY2?\ ?-'UE![1'R3_ ,(GK?)^S/\
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MC<BY)W.Q9CW)I?<T'%!P1FO42Y4=,8V#.!D5-96_VZ_AM>ID.*@7#NJ+R['
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MS6KD?;O1GM1[" N5'7?\+.\0'GS6H/Q.\0#GS6KD??M1GOVH6'@'*CT7PO\
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M\J^18N,GW->C@=F;4AX(SS0QYXH/'XT@Y&#7=U-V*.GTZTF>?:E/\J,]\46
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M>PI]!2^] ]#1WS76BV'?/:D! [4K>M(#BDT-;&KX<(_M5?J*^L_#/_(O6?\
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M &=\@7\S7U9X$\/C0M$@4?QH&_/FN3%U+1Y3"H[:'6 84#T%+117EF(4444
M%%%% !1110 4444 ?.OQQ7/B+\%_E7E@P%KVCXS:8T^I-< < #^5>*H>]>MA
M/A.BGL.&*#UQWI.GXTHZ8KJ>IK<, _A32P4[CTI3_*KFD:>VL:A';(.68"HD
M[(F3/:_@MX=>TBFO+B,[9<E"1]*]F P,"L;PMIZZ?X?M8-N&5,&MJO&JRYI-
MG*W=A11168@HHHH ***QO$.M1Z-ITEPS#<@SBFE<#S/XQ>+C:V7]G6<VV;)#
M 'MFO!]V7+R<LW>M?Q3KK^(M;FU YVN>GXUC*>U>OAZ?+ WA'0>_ R*;G(]/
M6ESMXZTA5I6"(,L>@K6YJ]$;7A;0+G7]9BMHXF*LP&['%?6>B:>=-TBWM&'S
M1+@UY_\ "OP\+;1K>ZEAVS!0>17J(Z5Y6(J<\CED]0HHHKG)"BBB@ HHHH *
M*** "BBB@ HHHH *X?XKQ-+X%ND4$DYZ?0UW%9'B73AJFC2VQ_B!_E51W0T?
M&H!4[#P14O&,U=UVT^R:W- /X2:H[J]JG\)U1V$QU..*ZOP!JTMKKUO;HY"E
MQQ^-<KN]JU_"+>5XIMC_ +0J:\;P%-:'V*G*+]*6HK>020*P]!4@.:\:QS6%
MHHJ"[G%M;O*W 4<TDKB/F#XL2Y\8W*?]-#7$$!0*ZKXC7:WWBN>5#D%SS7*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <SX[_P"18NO]P_RKY%C/7ZFOKKQW_P BO=?[A_E7R'$V
M"WRG.3VKOP;2N;4B;D4A.3[4TR9XVG\J-_;!Q]*[E)&P[)HR?2F>8?[IX]J7
MS.,[3GZ4^=#''VH'IVIN_'\)Y]J3?V ./I2YD(?UX[4=LXYIF_L0?RHWGK@_
ME1= /YZ]Z/84S?WVG/THWXXP?RHN@'^W:C)]*;O[8.![4"3(Y4\>U%TP'>_>
M@?SIGF'KM/Y4ID_V3SUXI\R'8<?3M7L_[/\ ]_4?Q_I7BI?C&#CZ5[3^S\27
MU#@]_P"E<N+:Y#.H]#W84M%%>6<QX1\;R?M8&.-O]!7BR_=%>T?&]B+L#!QM
M_H*\64_(,@_E7J89KD1M DR?2D&<TWS#UVG\J7S.,[3GZ5U<R-QQXX%(.F#2
M;\'&T_E1OYQ@X^E)R0(T-!)_X2*S_P!^OKW0R3I<>?0?RKY!T!B?$=E\I^_Z
M>U?7^B?\@R/Z#^5>?BY)F%1FC1117$8A1110!X9\>OO6O^Y_4UXHO"@=L5[5
M\>B=UKP?N?U->)!_E P<?2O4PK2B=,-AY].U+UY/6F!^VTX^E'F9/*G\JZN9
M%WT'<YSWI3[4W?\ -D*?RH+D=%/Y4G) MC4\.<:LOU%?6GAG_D7K/_<KY)\.
ML/[54D'&X=J^MO#'_(NV>/[E<&,:=CFGN:]%%%<) 4444 %%%% !1110 444
M4 %%%% !37_U;?0TZFO_ *MOH: /COQ9C_A+]1_ZZ?TK(/3CI6MXN('B_4>#
M_K/3VK'$G;!Q]*]FC*/*=4-AW7K2<YSBF[\G[IX]J7?QG:<_2M;IE#L^G6CV
M[4S?CG!_*C?V /Y4KH8_V[4?7K3-_8@_E1OSS@_E1="'\]>]'TIGF=]IS]*-
M^.QY]J+H!X].U'].E,W]L''THW^H/'3BBZ ?VSCFBF;SUVG\J-^.BGGVHN@'
MGT[4#WIF_M@X^E&_/&#^5%T'F/YZ]Z,\9[TS?WVG/TH#\YVG/THYD@O8Z#P6
M3_PE%MQ_&*^OD_U:_05\?>"I#_PE-L-I^^.WO7V"G^K7Z"O,Q3O(YI[CJ***
MY2 HHHH *X7XM_\ (AW6/\\&NZKD/B5:F[\'7,2C)/\ @:N'Q(:W/D^+[E.#
M<^U$X,%P\14_*<=*;N'3!Y]J]I25CJCL.QEN>E-8[6XI ^>,'\J3!=@H4[B?
M2DYI%-Z'=_"W0(=>\2[9URL>&'ZFOJ*WB$%O'$O1%"C\*\P^$/A:"RTI=5W'
MSG.",>W_ ->O4Z\JO/FD<DG=A1116!(4444 %%%% !1110 4444 <-\1--CG
MT6XN&4%@IY_"OEE&RI(ZYKZY\=C_ (I>ZX_@/\J^0XCC=PV<GM7H82>EF;TV
M2#^=!XX[4F_!X!_*C>.F#CZ5V\R1L@9B$)]*]9^$WA;SKZVU1X\KD-STKRVP
M@;4-1ALT4YD.!Q7U;X$T,Z'H,-M(HWJ@'2N7$U;*R,:C.J4!1A0 !V%+28I:
M\PP"BBB@ HHHH 8\@C5G;A5&2:^??BSXO,VIO:64Q:+[K &O6?'GB&/0-!EE
M?/[Q"HQ_GWKY0O+M[J^GF;<V^0L,_6NG#TTW=FD(W&*-BX%'(./6DW_Q8.?I
M07W=%/Y5ZG.K6.A)(=CMV%=C\.=!_MS78I3'O2!N1CC_ #S7'1;IKB.)5.&.
M#Q7TY\,/"5KHNBQWJ'=)<KE@1T_SBN;$U>6-C.I)6.[@MXH(E2*-44#HHQ4U
M%%>6<X4444 %%%% !1110 4444 %%%% !1110 4V09C;Z&G4C<J1[4 ?'WC1
M63Q3<G&!O/\ .L-B0PXKT#XF:,]E?S7;+\I;L/>O/O,S@E3^5>Q2DN5'3!CL
M]^]365T]C?)<IU4YJN7[A3^5,EE.PX4_E6K::'*[1]=^ =5DUGPM;W<IRS8_
MD*Z>N ^$$RMX%M4YW#'7Z"N_KQ:GQ,YGN%8GBYS'X7OG!P0G4?6MNN=\<2!?
M".H#N8_ZU,=P1\CW<\ES=.S,6RQY--X ^E11N?FRIZ^E.#]>#^5>S3DK'3!6
M0[&1DUZ;\'-&@U2[F>50Q23C/T%>8"3(^Z<_2O9/@+_K;O@_ZS^@K+$R]S0F
M;T/>(D$4*1CHH %/HHKRCG"BBB@ HHHH **** "J6I6,6H6KPS(&4J>"*NTA
M&01ZT)V!'QQXHM39>);V(+M0/A1BL@%MW(KU7XU>'XM*O[>[@RS3$%N/K7E1
MDSSM.1[5Z]&HI11TP>@<YIR2/ 0\3LK9Z@\TW>/[I_*D8C&,-CZ5M)IEN-SZ
M=^%.MPWGAN.V,_F7 ;)!;)Z5Z'7S%\']>ATGQ*PNW<1. JC'?FOIJ*198ED7
M[K#(KQZT>6>ARR5F/HHHK(DK7[!;&;/]TU\@>*\'Q?J)'_/3^E?2_P 0]=;0
M]%$J@G?D5\LZE>&^U6XNBIS(V>E=V#23NS6DM;D6[CWI%ZFF;^^#GZ4;_13S
MUXKO4D= _HWM0.I)IH?L0?RHWYZ@\>U.Z$+DYSCFEZ<CK3-_?:<CVI=X'.#^
M5*Z <M!].U-WCI@_E1O'3!_*A22&QQSUHR>O>F^9GG!_*DW]PIS]*;FA#]S'
MC%.XQ47G$<!&Y]JD2*6<A8T.?I4^TB3<3KR>U(9,#(KH['P%XAU&$200*4(X
MR3_A71Z!\)]6GO$6_14C)Y(R:AUH6W#G1YY;PR74@C@7<[=JZ;0_ FJ:EJ$<
M5S;NL+=3@BO;=&^$>E:9<1W E+.IS@I7>V^GV]LJJD2<#&<5R3Q72)G*=SAO
M"OPPTS1(A(85D9CD[^:[VUM8;6+9!"D:CLJXJ?H**XY3<MS)NX4445(@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$*7_ (558X_U0KUG ]*,#TH]O(/:,\NL/AA96UR)!$!@UZ386RV=E% HPJ#
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MKT];M6DB&!7JF!Z4F!Z4G6DP=1M%/2]-ATJR6V@&$'-7:**R,PHHHH ****
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MQV_ZH9H_X538\?NA7K6!Z4N!Z57MY%^U9Y(?A38[O]4*4?"FQYS$*]:P/2C
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '  ?0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<%<?%_PQ!J?]GJM_/<&3RT6&WW>8V<?+SDT =[17G+?&?PZ 2EEJK <$FW
M_-JJS_'+08(RYT[4=HZY5/\ XJ@#U"BO-]*^,FCZI=VD L+R+[4ZHC':<9..
M>:](H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF]4CR9TZ!9#^HW?^S5TE8N
MJK\TV!Z-^8Q_2LJZO!FE)VFCP3Q6\@N60 JH/.:YI*[KQC:AO-9!]QNM<(N0
M<5U4Y<T4Q35G8M1ACP.<C&#5..7$2#/ 90?SJY S!@=I/TK'+G"]MLO/YU;9
M)T<,K2#[Q4=O6B2(QS+<(26'RMD\E?\ &J4,I!ZUH12!UP?QIC+<*B4;&8.C
MC!R*]:^$]W)-X?O+:8YD@NF!]L@?X9_&O&89V@D*9^Z<CZ5ZG\+;P?VE?1AA
MMN8UD(_VUX_4'/YUG/8'L>HT445D2%%%% !7B/QIS_PD^G=?^//T_P!IJ]NK
MPWXW''B73N!_QZ>G^VU" \]&<]#V['TJ0,1Z]!W-2:+96^IZC':W-XMDL@PD
MK1%AO[ @>OK6KJO@_5M)CGG98;FVA.V2:WEW!,'^(9ROXBF(P[HGR^O\0[^]
M7/#.M3Z%XC%Y!(8V^="V < _6L^X)*XY^\/7UJBTWEW+D]-Q_G3Z ?06F>,K
MN:1OM=WL3:"C"%6!^H&#6ROBR(]-0LC[/"Z?U-?/NG>)[JQ<[AY\,:86(KG/
MH<CG]:T?^$_MG4B72S&V/O1RD8_!@:FS*NCWG_A*$\EG7['+M7)"77)^@*_I
M5O2/$-IJ[F.,-'*!G:W?Z5X5I?B*UOU1&81SD A3P&^GO[5IC6Y;&XCG@?;)
M&<J:6H:'O-?*6F?\E7T<_P#40_\ 9J^E?#7B"W\1:2EW$0)1\LT8_@;_  /:
MOFG3#_Q=?2/^PC_[-3!;FQK6E3VNG75^;UY(IE $!'"G>.>N.,<8 ZFN&OV_
MT*7GL/YUZ-XDDSX;D0JX("D$C@C?VKSRXMI[FUDC@B>61A\J(,D\]AWIK83W
M-?PO_P AG0?^N\?_ *&*^M:^4O#=A>PZQH1EM+A%6>/<6B8 ?..O%?5M# **
M**0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5FWT69V]'CSU]#@_P#H0_*M*HI[=)]N
MXD8ZX_B'<'V.!2:NK#3L[GE7C?3$@-M*!A;F,K[=>#_(_C7DMW$89V!P #CF
MO?\ XEV+7&@)<)@- Q_7_P#57A.LJ)9X[G[PE4;0#P&[_KFM::M&R*;OJRO"
M[;L@#\36+<'R[N1#Q^\)_K_6M:)MIP>M9&I'_B:N,'E V?PQ5RV)-"*3WJ[#
M-@@YK$CGX%64N0.III@:DTH$JGUXKJ_A]K*Z=XDMVD?;$7"L2>!N^7/ZUP)N
ME>10#TY-2IJ'V8(4.'>0$$'LO/\ /%)V: ^O:*RO#6J#6?#=A?@Y:6$;SG^(
M<']0:U:P$%%%% !7A7QTX\0::>YM<?\ C[5[K7A/QR;_ (J/3U/068/_ (^U
M" X+P_?PZ?J:74VG+?\ EKF.%B0 _&&..3CTK;UCQ3K^KPS1SH;:SD.Z2&"
MQHW/\1ZGGU-9/A;6QH&I7%YND24VDL4+HH)61A\IY[9J[/XL\4:SI]U;SW\]
MQ:"/-PHC7 3(Y; X&<4 8DQX'^\/YU4V1RWBQR,55Y-NX=JFD.=O3[P_G520
MXO(O^NX_G5(1JZ;=:997(:5[\D<@(J?XUULVO^"]5LVM[JRU/YA\PVI^8.>#
M7 JYC,FW'SJ4.1VR#_2GV8S.HQ19#N.U,:9;W2QV%W+);M_JO.38X]CCC-6K
M76V^6.[+,O3S!RP^H[UD:Y$J7U@0,;G.?TI_E;O,<N%"@ #'4G.: /4?">M#
M0-0BOK35+*:UEXEB:;82O?ANAKC[&WG@^)VFW3(IMDU#>9ED5DVEN#N!QTKG
M@LT*"3!",<9[&D?$D3,BX<#.WL?I18+GH?B!U?PLZJX9MP^4')^]7")<"/:Q
M.TKT.:+?=$98R?F5L'!XK+LY&!DY/^M?^E&P;G5Z9J:R:Q9AM3N+4/*BR.K?
M)]X9)YXXKZM1TDC62-E=& *LIR"#W%?&<=K++/'%;AII9" J*O)8] !7>^!/
MB5J'A.Y73]2$L^F [6A;[\)]5S_*AH#Z1HJ"SO+?4+*&\M)5EMYD#QNO0@U/
M4@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!S_C2$R^&+D@@;""01G/;^M?/E_.
MAAD4_)Y+AE^7!.>P'U%?0OC&Z-KX<FP2/,(3<.W4_P!*^;]:FB%Q(Q<MZ@*!
MG\16D"EL9J3-)(6/3/7UJKJ$#B[2X^9E8!<KZCL:TYH/*B5^#N 9=HPH4],5
M'&RNI1QE#UJ[7$9D=MYB]2#G'+$?TJ==/.W/F*3CWJ0(\#F)CGN#Z@U,&.,$
MYH20%5;$1QLQ)X7<>.O%9]N);B3=AB44L0>, 5TFF6SZI<VUDNSS)I1$K/Q@
ML<?UK!>VN]%U2XM;E2D\;-&^\?@14OH![I\%O$R264N@W#A9$/F6^3][/WA_
M7\Z]=KX_TC49],NH;FWD:.:)@RL#@@BOISP5XIA\4Z''<[E%U&-LZ#L?7Z&I
MDNH'24445 @KPCXZ?\C)I_\ UYC_ -#:O=Z\'^.G_(R:?_UYC_T-J /.M'U"
M'3+[[3/IUM?IL*^3< [,GOQW%=0OB[3KG1=8L_[%T_3);BU"1/:QMF1MZG:3
MV& 3^%8_A :?_:EU+J5O;W$,-E-*D,[85W4 J/K717VH>%[_ $2]2UTG3;6X
M&G).LD;-O6<N T8SUP.: .$W99?]X5!+_P ?<7_7<?SJ4??7_>%0R_\ 'U%_
MUW'\ZL3)&^\?K4]C_P ?2#W/\JK.?F/UIUD3]MC&>] A/$0Q=:?_ -=#_2F#
MYL =^*=XCR+C3S_TT/\ 2H8&82(Y!VA@3^=(9H:@I>Y%LB[E@0+CWQR:AA'W
M1SN[4CSF0W)*@^>V23U SG'\ORJ,MM0DY]\'%,#8M= U5-^_3YLYXP ?Y5C1
M:-JD32[]-O%_?.1F!N1^530,DF?WLR$?[0/]*(-11BX6[O$V.5X /3\12&:O
MA>UN8O%6DF6WF0"\B)+1D ?,/:O3OC5X=TZ);/68H%CNII#'-LX\SC()'KUY
M]Z\H6^88*:M=@_[41_HU)/?7$QC@6^DNG=L)'Y39)/ISUI >^?!VZ>?P1Y+;
MMMO<O&F3VP&P/Q)KT&N9\!:%+X?\)6MK<KMNI,S3K_==L<?@ !734@"BBB@
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M*R;U ^:&W1.8WSD''-=3X)\77'AC6XKE#F%ODFCSPZD\UVWQ5^'!3S?$.C1
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MZCM4$'@/64E:1[FP!490"Z'7\J+A8]_F^(WA&!L/KEOG_95F_D*8GQ+\'2'
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MOKJOD+P>2WBG2&/>]AQ_WV*^O:EC"BBBD 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5C:WKR:9M@A"R73]%/11ZG_/\ ]=VOZNVEV9\D
M W#J2F>B^_YD?Y%<8T<TLUM+/(7D<%W8^N/\3^E)L:1$MQ/J=W)>W,C.HX3<
M..IY_G6+=,T5S=78/[UE\N(_W!W/UKH)]D-JL,9P%4#BN>OP64BD,XS5),#9
MSL!R?<UR]]=.[DEB375:K"<-7&WORL13 ILY+4Q9720$$J>@(I5Y:F7;+$BL
M3QF@1,;N;G,S_P#?1K<E\,>(4D1%@>4F%)F,<@P@;. <X^8;6R.V#7+)>1*Z
MLK9(((RN:W)/&VN7 _>WTLI#,P9X@S#<&!YQTP[8'09XJ[DEMO#FKIJ7V"5@
MDBH\DCEB4C56*DE@#GE>-N<Y ZTUO#>O"1ECLYY0!N!7C<N=NX*<-C/J!55O
M%^K?:_M+SD?*RM$81Y3!B204QM.2Q[5*?'VL^;-+]L7S)BI=O)7/RG([>M+4
M>A,WAO7%L!>"VD,>T,RYPZ@[B.#R>$)XS1#X;U:YL9;B'9))%*T,EJK$S*R_
M>R,8XR.]2:7XTUB345N0%O)(W,BKL52'_>$'ITS*^1W!QQ63:>)+^P@>"&X*
MAI#(Q,>6WDJ2<GOE%HNP+A\/:[O*?V==;E8(5QR"1N'?TYSTJU/X/U^WNVA:
MRF:-9/+,ZJ2F<XSTSC/'3L:C;XA:RZ2(\D#)(271K<$.",%3GJ"">/>D/Q U
MIKDW!GA\PG/^H&/RHNP(M9T*ZT,QK=7$#/(H94C8EMIR,\CU%9.XX[U/JOB"
MXUB>.>^D4O&GEJ53:,9)_F36?]L@_OBF(LY/K1GWJN+N$_QBC[5%_>% $]=A
MX-O7MM%UU0<A(EE"^A ;G'X"N(^TQ?WQ6SX=URSTZZNDNW(MKFV>)RHR0V#M
M/Y\?C6=5<T&D;4)*-1-GI;:F\GB&WA (CN;(LFX<$J1_0URVN,9O ]OO3_47
MCP;_ %*EAC\L4L.IP/#X6U&:YC6(EK21MW*': <^W2N2U#5VFENK9;@FT-T\
MRQC[N_IN_*N>G2?,F=E;$1Y6EK<B"KZ"FGEL+T!Q4'VJ/^]3?/4=)5 )SR*[
M#S2XH IV:HBXB'+R FG?:8>T@!^M %RGK]T_45GB['>:/\JMV[H\1*-N&1DY
MH G%.!S31UIP%(8]?]8G^]3)UW!AG'-/7_6)_O4DG4_6FMA,J_9T[DFE%O%W
M!/XU)13 ;Y$7]P4OE1#_ )9K3L4N/>@"+RH_[B_E2&./^X/RJ2D- $7E1_W!
M1Y,?]VI*3% &QX0&WQ3I '07T7_H:U]>U\A^$O\ D:M(_P"OZ/\ ]#%?7E2Q
MA1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDLB0Q-)(P5
M%&233ZY'QQJRVEK%:H^)'RY ]@<9_'G\!0!BZOJZ:E+JMTI/E6RJB ^P/]34
M$M\I2'8>0N*X^/4?)2]MR>)UYS]:DAU D+EN@QUJ2CI'GW#&X'ZU3F7?GZ51
M2[W$$FK"SAAUI#,35;7=$QQ7G>IQ%9BN.<UZS<QB6,@=ZXCQ)8)8:>]V0-[M
MY:9]::$<7D)QU-=3I?A(26PNM2&"?NQ'^'Z^_M5+1+1;>&/4YUWR2R>591D?
M>;.#)^!X'OGTKT&[A UBWTQ3F.UA$DY]6Z\TP.7F\.01C,8VCZ5E:Q;QZ59J
M['YY!\@]O6NQU-S_ *%;I_K;V8*/9:Y'QELOO%EQ;*Q6TLE".P_A50,_B2<#
MWQ0!S26%U?Q>>Y,<+$A1W:F'1MO1V%=!+(R:/;7)41_:7988QT2->!5:28*,
M#H* ,4Z65_C;\0*9]AD0_+(1[$5L&0;N>@J,N#^- C+^SSCI(O\ WS08;C'+
MH!ZXK3"FXN%@C(4G[S?W12N\/FED7]S'\L:G^(^IHN!CO92=7?)/0&F_9B/X
M@/\ @-:3<Y9CECR:CVB@"C]G8]9&I/LF3]XU=VCK2[10!1^R'L[?G3UL\]9'
M_.K?'I2%@* (Q9Q;-K22'OC=Q1]GA4="?JU6!;7+G"PG)&<,0I_(\U#(LD;E
M)%9''56&"*5F.Z(S&@/"BC ]*6E IB&[1Z4A0>@IY%,+8H C,2?W1^57K%0L
M# ?WNU46>KM@<P-_O_TIH1<'6I!40J1:8#Q]]/\ >%,D/)^M.'WT_P!X56 \
M\LS/@9( Q[TT(D*LJ*[*P1ONL1P?H:![ G\*0_:6A6$7!:)"2D9D(52>I /3
M-1[+I?X&(_V6!I@6[6!KFZB@#)&9&"AY&PJY[D]A39$*2.F5;:2-RG@^XJOY
MK+_K Z>Y4U(H,@RCAA['- !@^WYTFTGN*O:?I-SJ4PAMRK.>V>:['2?AE>W;
M#[0YC'?%)M(+'#+% ;1RS2?:=X"* -A7!R2>N>E36ND7UZX6VMI96/94)KW3
M1?AEI5GM:5/.;_:KMK+2+*P0"&"-<=P*GF'8\2\%?#37?[:LKZ\A^SV\$RS\
ML,G# XQ^%?0'VIP<?9I#[AD_^*J,,B\>GM1YBCW_  I7&3?:E ^:.5?HA;_T
M'-*MU"2 7V,3@!P5)^@/6JQG4=:/M"8()X/4=C1<"_16<LD:_<8Q^R'C\NGZ
M5(M]M_UFUA_>3K_WS_@2?:BXB[138Y$E3=&X9?4&G4P"BBB@ HHHH **** "
MBBB@ HHHH **** "O(?&UX)]4N9%((60 $=P!C/Z5Z%XBUJ*PM9+9'S<R)T'
M\*GC/^%>5>*B(PCJ?ED@1A^6#28T<7>7>+G@TZ*_QSFL.ZGS.3FF+.1WH&=;
M#?Y[U?@OQQS7%I=L.]3QZ@5__72 [N*[5QC//>N>\:A-0O=+T]7\NWAADN;B
M0?P*#@GZX''N16<FL%3U-9&IZC-?79B\PB*4JLGNH.<?3/- &WIX6_\ &6CQ
M&,16]O")Q%VC0#*K^6/Q-;,-_P";)J=\3EIYMBGVS7-Z=?K'JVK:CTVPB*/\
M<#^E-M;_ &6L,>?^6F]J8'033B;QK9KG]W:6Y?Z'%<+J]^]QJ%^L> EQ<M*Q
M[MSP/H,UL?VF$U"^N]W+0;%_.N760?:8W;D!LG\Z -S7I%6YL[&/[EG;I'C_
M &L9/ZFLQFR0/0Y/UJ.6Y:>[EG<_,[$TS?0(D))/XYI,\Y--WBF[J )%D9%D
M /S/P3[5'GC%-S29H ?G-%-S2;L<F@!V::2!3F 10TS")3R 1EF^@_J>*K27
MQ7BW7R_]O.7/X]OPIV L.%B&;A_+_P!@#+G\.WXU6:_<<6Z"$?WLY<_\"[?A
MBJN"<GKGK255A%VQ?;,SD9R.>:T]17_1['<<R& L<]E+':/R!_.LFT_C(':N
MLO\ 1)8[[RIE*E$1,'L HI,#G(;:6=PD:$DUHC2A"OSNCRG^$GY1_C6TL<%I
M'M48..W4U$2[_P"KA 'J12&8LVGZAL)B%N%_V0M8\T5RCD2,,_2NO:%V'S/^
M"BL+4(@C]_QH QF63NU:6F BV?/]_P#I51Q5W3O^/=O]_P#I0A%T4]:8.M/'
M6F O\:?[PJM#_JS_ +S?S-6?XE_WA5:#_5G_ 'F_G30B2@444P)!-(O1L^S<
MT\/;2-F> !O[\9P?\:AH[T 7UM'V^=:3B<+SM+;9%^C#^H%=IX7^)&IZ.XAO
MU;4+5/OK(-L\0]?<?7(]Z\^C=XW#QL58="#BM&*[ANBJW/[F9?N3IQ@_T_E2
M8'T7IOC'2M6M!<6=RKJ>JD893Z$=JLMKD0'#C\Q7SS:FXLKT%'\B<G 91A9/
M;'8^W0]O2MU=?ND^28%7'4>OO4-%)H]@EU^(?QC\ZIR^)8UZN*\GDUN5OXS5
M9]6E/\1HL.Z/59?%2+QO_6J4GBY%Z/7F#ZC(?XC4#WTA_BHL*YZ<_C(#^*J[
M^.&!X8_G7FC7;GN:C-PQ/)HL%SU"V^(D]G<"5&#9^\#T8>]>G>'?$MAXELO/
MM' D7_6PD_,A_J/>OETSMZUI:'XBOO#^IQWUE*5=#\RGHX[@^U.PKGU316/X
M:\1V?B?1X[^T;!/RRQD\QOW!K8H **** "BBB@ HHHH **** "H[B406TLQ&
M1&A<CUP,U)5>^_Y!]SQG]TW'X&@#S.]N)+O5KEK@@&XC(!'0'M^6!7$^([]F
MTN.-^)(LH?SKN_$EN+.5F' !W*:\@\47^^1P#U.34E'.23YD;G-():HF3GK1
MO]Z8C0\_WH\_T-9WF4&3WH O-<'UJN9COW9JL9*:7H OI=LL;)GACD^]'VH@
M=:S]_O07..M %F2=FSSUJ#/-,+>])D>M $H:G;JBS1F@"7?1NJ/-*#0 _=1F
MGPV\DY.Q<@?>). OU-61'##TQ,_J1\H^@[_C^5,"".%Y%W\)'_?;I^'K1,X@
M3, ._P#YZ..?P';^=3.S2-N=B3[U%(N4(IV%<RW8NQ))8GJ2>33:<W#&E&<@
M]:H!,$8(Z&F\YIY W<?@*4K\V*0&CH\!GO+> #_6S(F/7+ ?UKTWQ4Z-KDS+
MCYF8_KC^E<#X8C(U_3<CE;A7Q]#G^E=1?W!GNF<G)(Y-)@5SY:G.T$U&TV3P
ME*>:3-(8TEV7IBL+4X_FS6\2:QM27(H P7JYI_\ J&_W_P"E59!5JP_U+?[_
M /2A"+HZT\=:C'6I!3 4_>7ZU5M_]7_P(_SJT>J_6JMO_JS_ +S?SIH1+2T4
MM,!*=CBD[T9H *7M29%.&,4 7[&_0*+6\RUN>%;J8_\ ZWM726R"[*Z=>2 2
MD9MKG/WO0$]\]C7%G%;&DW@G0:?,V,G_ $=R?NMZ9]#^AI6 GN8I;6=X9D*R
M(<$&JY<YKHK[_B=:2;AUQJ-GA)^,%U[-_3ZBN9-(8I8TW-&*,4 )FDSQ2T4"
M&TE/I,4 =5X!\62>%M?21V8V,Y$=PGM_>'N/\:^DXY$EB62-@R. RL#P0>AK
MY"Q7NWPB\3_VEH[Z-<R9N;(9BSU:+_ZQ_F*0STFBBB@ HHHH **** "BBB@
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M7Y7>D\?LPX/Z51%"$^:Y'3;@T"@!><XKI=-O$,%M/+RL7^BW/O&PX/X#_P!
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M& WX\2;?!UBG/SWR_HC5XN/N@>U>N_'V7&B:-#G[]TS8^BX_K7D(-(8M%%%
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MF<?D.V>M 'SXMMY7S7*G=VBZ'_@7H/;K]*=N=VW,>%& !P /0#M7HGQGT?\
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MS_*KI_&B*GPLZ9.G?K4FT$#_  J%3[=_>IP1CIVKTD>5(I:DN( ?]H5S]O\
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MS0/!VA>&D']FV")*!@SO\TA_X$>GX8% &[1112 **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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G **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image00002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "N *4# 2(  A$! Q$!_\0
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MHH **** "BBB@ HHHH **** "BBB@ HJ*:YA@_UL@4^G?\JSY=9&,0Q'ZO\
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MGKV_7?\ D7M3_P"O27_T UXA0 4444 >T^'-&&A:/':%E>4DO*ZYPS'TSZ
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>A7O]% '@%%>_T4 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0S!W,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M $5%*0*;0 ZDHXHJO4 HS2BG8%%^PKC* <4X@4W%(8X2 4N=U(%6EP!TIH@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7<* %HHHH **2B@5Q:*2EH&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF!;>[-5GF+=Z@9\U&6-*P[BR#=WJ!H<GK4F^FF2G81%]F'K2;=E/+&H7)IV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 444A.* %HIF\4H;- #J8[86E9@*IW5
MP%C- %"^U 0@_-7':SX@"JP#TOB&]<!MI->9:M>3L[#<: 'ZWX@8LV&KEI=2
M>8G.:BNW=V.<U!$O/- #V)?FFY(JV%&VH9"HJ6F! 6--)IS.*A9Z5@N.+XIA
MD-,:04WS :8#B<T8-"]:F3'>D,B"D]J>(C5D%,=*=E: *V"M.$Q%/9E%0/,@
MJDA$XFJ&6>J<ER!T-0-<;N]+4":2X.:B\\FHR=U*$)J@'>::7S#0L9J0*/2G
M8!@RU*8ZEP*0\"GJ! 01439JR66HV*FE=@5B#28/I5C S3AM]*8$**2>E6%C
MXIP*]A3UI,!!'3U&*D4"G[,]*S:+2&@X%'G$4&%C3?(:D%APN33Q,348@-2B
MW;%-:$L:9B*C:X-.>,BJ[=:M,0XR$FIX6-50.:O6R<BJ5B78NP.WI6A$QQ4,
M"+MZ5:5/2G<D'Y%4Y$/I5TD+UJ)YXQUIJXMS/933,X-6)9D/2JK2#-4,E#FI
M%DJIYRBE$PI 7-_%-:4BJ_FTTS+2L%V2-,:@>0TC2@U"SU-A[@\["J[S,:D,
MBCK4+RI2L58A9SG-,^V-'2R.M4Y3DT[!9&G!J3,<&M6&<..:YB '=6S;!MM-
M,+&A(XQ59Y *9(Q%4Y931<+%OSE]15F&9<]17/O(V>#4L,K@]:";'5)*N*?Y
MBUAQSMCK4PF8]Z Y32:<+4+7A%4S(?6F[P:+BM8M&[)J-I2U1A=W2I53'6BZ
M"Q 49CTIZ0^M6@R*.14,DZ#I2N*S)5A45)L4"LYKO!ZTW[</6@9>E1:IR1"H
MS>;N]()LU2%H-:,]JC,3>E74D3O4FZ,]J+E:&4T)QTJO(I':ME]F.E4I@OI1
M>X6,W)S4T)^84.H)XI(XF+C%"11T.G2[<5T]K,64"N6TZW<D5U^FVC'&156)
M:+:6YD7I5.[M&4'"FNLLK'*C(J>?358'Y: /,Y1+&V=II4U.2'U%=C>:.I!P
MM<Y?:))SM%.R'H0+XC=.]2#Q0W3=6)<Z/<)GK6;)8W"MWHT"R.N_M_S.K4?V
MKGHU<DEM<#N:M10SCJ33L@.A.J-V-0OJDO;-48D;O5I(-W:BPKD;ZI-[U6?5
M)CV-:/V,$=*C:R7TH2!)F2\TD_7-,6Q+G)S6O]G1>U/38#TH'9E&'3O:K\4
MBJW&4QTJ.?IQ0!(+@*N,U!(6D/%50DC25MV%IOQD4VA6*,"2*<X-:T$[@8P:
MUH=+5@,+5D:.0,[:$AZ&/\TG:M+3;<AP:)(UM_O"I[&]B\P"AH6IVND$H%KJ
M[63(%<CI<RN%Q74V?05G*XTS9C.14E1Q?=J2LB@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVD'DD4[,9TEC '09%:R:7"ZY*UB65V5P*Z*SG,@ Q1J%F<_JVFQ1JVU:X74
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^S1CM4,T2 =*T5C#=:AN80%S18I'/7,:C/%4'*K5^].TFLF1LFILQEVTF7S
M*[/2-K;:X6R0&4<UW6B1\+1H-,[W2((SMXKM+&TB*#Y:Y+2%QMKM+$?(*391
M8^R1?W:#:1'^$5/14C*_V*'^Z*>L"+T%2T4 (!BEHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'I2TAZ4 4
M;@@"N>U1EV&NBN ,5SFJJOEF@#SW6B"6KD+@C<:ZO7&PS8KCKAR6- %>1AFH
M#STI7ZU'DT#N(RFF8YJ5<GK4JQJ>M 7$B3-7%3BHE 7I4H>@0_@4QC3MR]S4
M3E?6F/0KS'BLN=QFM*5@:SY44FEJQW1' X)K3BZ5GQ(H-748 <4;$MHM;U J
ME=W"@'%/;>W05$UG)+U4TK7%S(Q+B[^:FQ3;C6RVA%^2IJ-M':+HM-*Q-R*
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MM2 U_/6E$P-8_GGUH^TD=Z=@-L,#3JQ!?,.]68KPGJ:0&E14"3J1UJ4.#WH
M=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4C=*6D;I0!0N0<&N;U53L/-=%=L0#7,:M(
MVPTFA:GGVN#YFKCI_O&NJUR0[FKCYV);BE9C(6ZTS<*1MY/2@(32&/4@U*JD
MTU(CZ5852*I"&@$4[!-2!?6G +3 @\ICWJ-XF'>KN0*8Y6@#,D1L53D0YK6E
MV8ZUGS%<T 5D5O6K40(-1(5S5E2N*>HG8N0LHZUHP2Q=P*P&9_X:033KZT$G
M7+/!MZ"JES+">PKG6O)U'>J%SJ-P/6FA'02219Z"H6EC]JY4ZC<%N<T];Z8]
M<U28'0NZGI4>!GK6$;V;WIGV^<>M581TJ#WI_EYZ&N;74Y1U-/\ [7D'>G8#
MH/(;UH\A_P"]6"NL29ZU:CU5CU-# T6@?^]4+P/_ 'JB_M GH:8;J1NE2,20
M.O>JK2.#U-6?G?J*:UNQ[5+8%3SV'>I4N<=:5K-_2F?9'':@@M)>)BIUO$K.
M%NP[4\0/Z4[E(T?[25:/[: JFMHS=14RZ<#U%6@=R?\ MOWIPUD=ZB&FKZ4[
M^ST'6J%<F_M9#33J ;I4?V2(4TVP_AH$3+=9/6ITGS55+<YZ5:CAH'?L3++4
MGFD#K35C%/\ +XH$1FZ([U&URQ[FIC"IIOD+3$5_,<GJ:>N3UJ<0J*D6-!2L
M5=%<+FG>75C"=J:2*8B':!VJ-P#4S8J%V I#U(&A8FI(T*]:A:?!J:)]_6@5
MBW&PJTE01H#5@(<4#T0,X457EG&,4EP645ES3-F@6Y+,X:JW0U$TCFG1J[=J
M N3K*!4RW6.AIB6S$=*=]D?TH'J))=,PZFJI$CMU-7XK-B>16A!8)QD4 4+2
MV=L=:U$M&"U>@MD7I4T@"K4NPS(E0H#7/:FQP>:Z"\E !YKEM2ESG!J-1HQB
M[";K6[IMP1MYKG"Q\VM>P?D9HN6>A:1<$[>:[G3G8J.:\YT:097FN^TQR5%2
MV!T43GUJSN)'6JD R!5O&!2%H( V>M6(R1UJMN(-6(CGK1=E%H/D4A#'O2@#
M%(21TI 'S+WH\PT=>M+A: $^8]Z/F'>C)'2C)/6@ \PT?,W>EP*3ITH 3##O
M1NQ2Y)ZTN!0%AN2:/F]:4\=*3)JD2+NHY-'%'3I0P#::-V*3+4N!WJ2@SFC8
M:, =*0EJ %SBEW9J/D]:*=@'E"::5(HRU!)[T -S1S2T8-/U 4-BG[P:BP:*
M0$F"::4Q0"U!)HNP&T4&F$FG>X$H.*<'%5P34@HL!)UII0T GM2Y:D SD4]2
M?6FT<]J>H%E)&7O5F.[V]:SP6IX!I7 UX[L-5A9 16$'*5*EVP/6D!MYI:SX
MKH'J:M+.I[T 344T,#3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5$LRGO4@(- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7 BI0<4IQVIM #_,I"V:;Q118 Q1^%**>-M%P(Z*D..U1FC4 HHHI@%%%%)
M%%%%# ****8!1112 **.**& X'%.\RHZ*0#BV:;12C% "45+E<4A&>E # <4
M[?2;:=\O>@!I;--!Q3VQVIG>@"59BM2BZ-0#;2_+0!<CNB35Z&3=63%UK3M^
MU %T4M(.E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG..M(L%ZU:CJFKC-6HSF@39/24 $T[8:!H;2AL4OEFDV$4 /$E'WJCI1GM0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD"M4E(5@!4+4]N*A=ZEE$;*#3-@I':HBY'>F(L!!4BHM4Q+SUJ9&)[TM1EL
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MQ!'6DH0"4=*=L)H*8HN @IP4&F=*,FC4"0J*8:.:*+ )1BG;<T>6:- &YIP
M-(1BDS1<"38,4TBDYHHL E%%% !3@*;12 DV#%(5 IF31DT %%*!FE\LT -H
MIQ7%-H >%%+M%-"FEVF@"6/K6G;]JS(NM:=OVH NCI2T@Z4M !1110 4444
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M#T%ABF[<TA0^M#+0C5&5!IQ&* ,UF4-"#-3)Q2!*>%Q1<1,AS4ZJM5EJ12:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.5<=:YZ&XS6E"^<<U:5R#3)!Z5$RFFHV.]2F08JTK 5F&*B+$5/(<U6?BF@
MRM3?,)J,MSTI <TW8-BS&YS5R-SBL]&Q5F.6H*3+P8FGBJ\;YJRE PP<5$Z^
MM6AC%,D7-2V!GNHJNZFKLD>*JR'%)#(,>M.&*3=F@"FR62@GM4@)J)3BIE.:
MI7)8N:C8'M4VS(IK?+5$WN5]K4H4U+OYZ4HYIW"S$4D5*'--Q12;&B7Y3UI"
M!VJ.E!I# U&<U(33&I%(B)-1EFI['%1-)2;!L"?6F&@MFFDXI7%<3YJ<N:9Y
MF.U/5\T)E)CZ3<:7M43-S3:$R56-3(:K*U6(^M*]B=2U&S=JL*7-0Q&KD>#3
MNBKHA=3MK*NRPS70.@V5AW^!FBZ(9CNS%N:85SUISM\U)UH!$+ CI49+58-1
MM1<T1 <T#/:E:@'%0,4%J<&]:-_M3<$T6 G4@U,JDU!$AJ]&.* !(_6K42@=
M*C J13BI: U+1R'%=GHSYVYK@[:?#CBNST67.VBS&CN("/+%*Q;/%0VS#RQS
M4V^AC8]-U6HZKHV:LH*D5B=":E!J%34@YH'H/XI.>U(%-.SBE<8WYJ2GEQ32
M<U2& )I=QIN:7-.X!FDYHI0V*& 8:DI^\8II.:E )SVIV6I <4[?[4,!ASWH
MI2<T@XI@+EJ#GO3@XQ32V:2 2ERU)3@^.U# 0D]Z2G%LTVF@#![4;33@^*"^
M:6H#.E+N(H-)THL [<324E%&@"X/:C::4-BG%QBBX$>,4N[%!YI.E%@';S29
MI**-$ N/2C::4'%.W^U $>*49I2<T@.*0#LM2'-.WBFELT -HHHH *** : '
M M3LGO2!_:ESNH <K"K$<I'2J@0]:D5MM &G%(QJXAR*S(9,XK1B.10!+111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ,:,$5S^MVRM$>.U='69J4/F1D4 >(^)K!2S\5YY?V81CQ7N&N:/YF
MXXKS37-+,6[B@#SV= K&JP";JN7Z%)"*S]IS5),1TNC3+&RX->E:%J>-HW5X
M[:S^21S75:-K.R51FADZGT!HUSYJKDUT,L0:/\*\\\+:HLBIEA7H<<RO",$=
M*-2D85W;8).*HF9H3P:WKI<@XKGKX;2: U+EKJ<A8#=71V=P9%&37"VC?O?Q
MKL=,.5%(=B[<,,5S&L,/+:NGGCW+7-:O;_NS2 \NU\Y9JX^0?-79:^FUFKCI
M1\U(JPSY::3Z4NRFE<4R0W&EIM H0[C^>U+\U-#8IV_-.XA#439[5(>:0BG=
MC(?FS4R8[TF*<%HO<1,NVIA5=>*E5Z$B7J28%02H"*LJ :=Y(-6D2S%EAYZ5
M 8P.M;KVF1526Q)JF+4S5VBK"3$=#37LRIJ/:4-)"=B^D['O4ZR,:H1-ZU<1
MACK57!(G!S00O>F"0"F,VZE=C'-Y=,.WM490D]:4#%#8#J4'FE5<U*L(/>D@
MT'Q,:MQN:K*@%3*<55T!=1QBAF%5PU!>D%QSXJK(JFI2V::8MU-"*Q5>U)BI
MS!BF&.F+0:,=Z=D#I1Y=-*8IB#S#0&SUIF*<%S0 \;:7Z4W;BC=BFA,E%+Q4
M8:G?C0-"T9%%)MS2!"DC%1,:>4]Z:5Q2+L1'WII"T\C--*>]2PL1D#M32!3R
M,4PBDK!8;A::2!TIQ3-)Y=4!&7-)FI/+H\H5-[ "5:C%0HN*G4T7$[%F,@59
M63'2J2_6IT%"%8G>4[>M95VP.<UHM]VLJ['6F(S9-N341:EDX/6H"^*-44D2
M%J8S"F_>H,=2RAIH&.](12A<T 2+MJ10*B">]/4XH$RR@ J96 JLAS4ZI5(2
M'[_2I8SD\U!MQ4L9YIM!<U+94W"NFTU]F-M<K;'YA71Z>V,5!1U]I.Y4<UKP
MG<.:P+)\@5O6RY I.PUJ6A@#BI%8TS9@4Y1S4,M(LHP[U80BJJ)FK"+BDP)N
MU,:GCI2%<U&P:$-**<4IN,528#UQWIWRU&!2[:8K@?:FT$XH S5!<,BBG;/>
MDQBC<$Q12\4VBBP6%.*2DI1S1< XI*?MI-N*-PN(/>GC;3*2AH8\X[4PT=*4
M4@$XHXIX3-!3%%P&4X8III<4KC0O%-I<4E ,6CBC%&*+ )2TE%%P'<4VEQ24
M7!CABG_+3 ,T[9[T"&G%-IQ&*;0 4444 %%%% !0*** )!MIXQ4%*&Q0!.:8
M6&:;OS28W&@"U PS6E">*RX$Z5J0C H L@TZF"GT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M $>&HX[U,1494&@"> KD5IP]*S($&:TX>E %@4^F"GT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ J*2,-4M% &/?:>)(V^6O-_$GA
MYI0VU:]=D7<N*Q;[3Q,#\M%P/FK5O#4D4C-M-<M=P?9B01TKZ)UW0 RL=GZ5
MY7K_ (>(9L)^E.X'G9;?TI1"W7-:-QIKP,?EJD[,AQ2 %^7K4HDJOOS2YIZ
M6T<YZU;BDK+5FJS&Y[TK#N:JOFI I-48Y:LI,:=B;E@)3\"HA)FGALT6"X_M
M2%@*3)IC52%<4N#3=N:C-*"U!1((JD$.:(LGK5M%XH(94^R;NU1O8GTK3 Q2
MXS5IDF(UBU,^R2#O6X8\TQH?:JLB;&0L4B=S5F.8IUJRT!]*C-O[4K(>P];H
M5)]H!JKY..E*(V!Z4M!W+!*MVIIB!Z"FJ"*D!-%QD?V<TOE$5+N:D))I 5I
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MQ3=X]*<<4W"U(#@<T$XH&*7&: &>92ALT;!2[0* %HXHSBDW"@!>**3(IPH
M2BI %H(6@".E#"D:F=Z +T#C-:</2LBWZBM>#I0!8%/IHIU !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %T*12]*7.1Q2$&D4A-]/5P:CP*![5-@L65-3*^*J)NS5J,>M-@R7=FC!IX
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M/>G'.*;\U(!P&*=31FE.: %HJ([J<,T .(S3"AJ2B@!@7%/HHH **7::-IH
M3K0$S0>*;N.: +D"8-:D/2LJW8YK5AZ4 6!3Z:*=0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*-PJKA8,4TMBGTTX[TAV&[Z7-+\M+Q0)H;N(H\RG'%-.WM3N.P9S1G%-P>U
M]Z5Q6%W^U+G-'RT<5+!B9Q1OI>*/EIH$'6EQBDR.U&: T#?[4F[-+E:..U#!
MB9HWTO%'RT($ ;-.S3>.U%)CN(6Q0'S2_+WI?EHL,4444FX4@%HZ4FX4M #2
MV*0.:4XH^6@!0<TM)Q1G% "_A12;A2YS1J TG%-W^U/.*;\M(!0V:=2#%+F@
M HI-XHR#0 $XIA>I.*;\M "!LT\&FC;3J 'A\4%\TRB@ -,[T^E&V@">WZBM
M:#I6;!MS6E#TH LBG4P4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9K6@Z4 6%7%/IHIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#2F\07<AP7-57NY)OO&J:Y9JN0V^ZGS#5B%@3TI@#YK56R%2&R7%-30,S8V
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M4U;C>,]:HF&F$,E2ZC"QKXA([54GA5ONU1^T,I[U8BN">M+F8)(C$!#=*L(
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MNVVY%;,'W:Q+=<$5KP28% %T4ZHU?-24 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT+4=A_7I2%6I Q%+O-(8VEP:3-*":KH NUJ;]:=O--)-3< ^E.VM30<4OF4
M!!IM*6S24@"BBBF AIA4U)1FA,!@!IXHI#0P%HIA8T!C19@/HH%% !110:&
M44TDBF[C18"2BD!I"2* '45'N-/!HL M%-).*;N-(!Q8"C>#3=N:-N* )**C
MW$4Y230 ZBDS3"QH >6 I-XIO7K1M% #P<TM19(Z4X,: 'FFY.:6DP<T 7+9
MN1FMBW9<5BVX.16K!TH T%(J2H$J84 +1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4AZ4M% &5J&-IKC-6"X;BN^N(!(#FL+4-)1
MT8D4 >.ZRHR<"LK3HM]ST[UVVO:9&A:N>L88H[GDCK0!VVBZ<CPKE>U5-=TL
M!&VK6YHMQ"D2C<.E3:D(IT."#0!X?K-BZ.W%<?? QL<U['KFEJRL0*\PUVRV
M.W% '.))S5R-CBJ2QD-5N/@4 3[AWI<BHJ4'%*P$M'2H]]!;-*P6!V%5G-2M
M4+4]$ S(I-RTAJ)J8$VY:7<M5=QI0QJDD!9W+3@15<4X$TV[")B<4WS #498
MTWO238RVCYJ8&J2'%6$.:+,6I*2,5!(U6@BD5%+&.U,6I5$@!JS%=HO6JK1'
M/2F^2:0:&W#J""K!U!2O6N?5&6GC?TI!H7+F[5B:H&4$\5)Y)?K2K:^U*PB+
MK1D#K5GR,"HWC%!21"6%-)IQ44S%4AC@V*>)!48%/"BAL!X:GAO6HP*<!2N
M_>N*8W/2EP*:1Z4KBNAAXIC,*D()IAC!JDB2 @$UI::Q1Q@U4\L"I(Y/+--)
MA<]#T74'0K\]>EZ%J6=NYLUX+8ZJZ2*,]Z])\,Z@\I7FKL(]==X[F#&,\5RV
MK>'EN@Q"#GVK<TUBT2DUI^6I3FDD!X;K?A5X]Q5,?A7!WVB3I(<9KZ'UNT#J
MV!7G^H:8/-)*T^4+GE)TR=?6HWMYHNI->COI]N/O8%9=Y86I!VD4K!<Y*SN)
M(YER37HWAS4 -NXUQW]FH)<K72:3;F/&!4.+8]#U;3KQ)$4"MV%2ZY%<)IDK
MH%KK+.^P@R:GE:'<N3)MZU6R,TLUXK#EJJ^<A;K5)A<O)S4ZG%4HY1V-3K)F
MD.Q:#BG!LU7##UIPD JD,L@T_<,5760'O4@VD=:!7%8BDSBE.*8: ) ZT9ST
MJ+ IZBE86HO-.R*7%&T4#3&Y!Z4F#2G I-U :BY ZT%A1@&@J*0QN:<&%-H
M%-B'%A3>]+@4E""X TN12 "EVBAB$I00*0TE,8_<M-)!Z4W%%3888HHI:8"4
M444@"BC(HR*+@(3BDWTXBF[1ZT &[-.ZTT 4Z@ XHXHR*,BB[ .E-W8IW6FD
M"@ WYIV::%%.Q0 TD4;AZ4I IN *- 'BD)%,R>U'7K18!=PIP(IH44\"D A(
MINX4X@4TJ* ' @TI-19(Z49)ZT .W+3@13 H/6G@"@!::6%.(II44 -//2DV
MFC@=*-] "Y ZT[<*: #3@HH =2AA3:;WH O0,,UIP]*R+?J*UX.E %Q*F%0I
M4PZ4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 9%7!&!3@ * $" #I3L444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ5ZGI.GJD2_+0!?L]V!FM->E0QPA>U3"@!:*,TPR 4 /HJ,2@T\-F@!:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]JC\KFKA*FD &:M(1 L1]*?Y?M5M"GI3B@;I3L1<I>6*7RQ5K[(QI1:,*I)
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M*+@7[P Q'-<-K<$;;LXJ74O&T$:D;A7":QXWB<G!% &9K=G&=V!7GVIV1WG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)D4
M+13#(H[BHGN57O0!.3BFEP*HR7H'>JLE^/6@#7\U?6D,Z#O6"^HX[U VHDT
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M^2,&NLTQW.VN/TF Y%=QID84+2 ZBP5BHK0,9Q56Q=54<BKQF7%4!"$.:L(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6R\=/'-AI3U]:[O1?'\!"AW!_&OGR^1X)VVYIEOK%Q PP3Q28(^NK'Q5;W0
M5AS[UNPW*3+D$5\OZ!XJG1ERQ_.O4-$\6NZJ"_ZU#*/5LBEK!TW5#<@<UN(<
MC-(!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSIV'8[($4\*#VKGX=?M2.91^=6UUVSQ_K1^=&@C39!BN;\01EH&^E69_$%J
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX:G=PN<UZ-9C,2\=JX#PU&H"\5Z):@>4OTHN43J!Z4_%%%2 8HQ110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )1114#%HHHJT(*9(
M!MHHI,#F=6Z-7&W1/FFBBH9:&QD^M7H"?6BBDAFE;DYZULVO:BBM -).E/[4
M44T2QIIM%%4"'K4R445)+)<<5$PHHIH!E%%%6(2G+112 G7I2T44BB-ZJS=*
M**8C(O#P:P[DG)YHHK1"9ESDX/-8]XQP>:**EF;.9U%FP>37&ZF[9;YC110!
MSLKMN/)J/)]:**!BBIX^M%%,$7HJN1T45#+)3TJ!^M%%2020U>3I112+0ZFF
MBBDQL;WIRT45)!:BJXH&*** *5T*RW^]110 +4@HHH6Y?0ECZU?A[445H9EM
M>E7K'_6K112+1Z5X;_AKT2U_U:_2BBF,LT444@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
&HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image00003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0U!W0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYQW?_OJIE\6R]]W_ 'U7,Y'I1N]!0!UB^+G'7/\ WU3QXQ/H?SKD-Y],44[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?VE=YYG/YU0:0=R:89/2BS U1?W1_P"7AOSJ07-PW_+=ZQ?-8=ZD6Z8#J:+
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M28P>F:$*XN[TI"<]J#],4F?:J'<<,?\ ZZ3C- (],TN#Z8H"XY6Q_#0",]J
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M.*+ =6#D4M9$.L1L.2!5R._A?_EHM%F!;HJ,3QMT84\,#T-(!:*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ****  ]*KS#<.M6*BD7CJ:: YG54P&YKSS6\#=Q7I>J)\K8
MR:\[UR-AN.#3 \\U Y8UD2=>OZUMZDOS'K6'-D=#^M- 1%B.A_6F_,>]0N_/
M)I!+Z?SIW G"D_Q?K1M8\;JC$[#MFI%DSUS5: 'E'LQ_.G+$0<EJ>#Z9HSCM
M3L!,GUS^-2Y&.GZU4\XBE^T'W_.D(LD^@_6H'9Q_^ND$_OCZ5(KJW4YH%8JN
M7/K^=18?^\?SK4V9' _6HWB7OF@=C/(- JRP Z<U"[8["@+"AL=>?QIWF+Z?
MK58R>F/SI!*.] %G=GI4B,1559%]35A&STYHT"Q;C?/_ .NIP[CID?C4$18]
MJL!1BD(7S2.I/YU&\N?_ -=*V1TJI-(118 EG8#@C\ZI27; \G]:BFE//)JA
M*[YX_G1J.YH?;,TAF+5G"0XYIRR+ZFC4"\) >O\ .FNP[ 5 LGH?UIQD]?T-
M B*15/4"H2B$]JE>0=JKM(2>A_.@"PD:CG(_.K*2*GI^=9WF-C_Z],\QNV?S
MH#4WH[U5Z8JW'J?^U^N:YCS']Z3?(.YI CLDU)3_ !#\ZL)J"CN/SKB4N)1Z
MU*+R0=J0SO8K]3W'YU:%]'CAOUS7!17<I[$5:6:=AU:D(ZZ6]7'WOUK.FNE/
M5OUK#8SD?=<U4D^U=D:F%C<:=/[]0M*O]\?G6 YNAU5JA,]PO4&DA(Z195_O
M"ITG [_K7,1WLB\$5:BOR.PIV&=#]HR.*@DNF_R:H)?YZXJ=;A'ZG]::%8=]
MI;T/YT\7+>GZTPM%_>_6@>7V;]:H+$PG8]J"Y;@X_.HC(!T(IGVA<_\ UZ8$
MQ0>GZTFS'.:C\\]J/M'K1<9,&Q_G-+YI_P FJQG4]S1Y]("T'![XIPP:JB4?
M_J-*)1Z4#T+1QV_G43MVX_.FB0]N?K022.:8$+9]:;L)[U+@]JE3=GD"@166
M-\]35B-#W'ZU:4#TJ3*J.?YT )&JCL*EWHHY454EN%7H15">[8=&H'8U'NX%
M_@'YU1GO5.0J@?C6-/=R=@34:222'D&@"S-*S'C(J-(I)#]XU;M[)Y3]TULV
MNFE,$J:0:&?:Z7-*1\QK>M-#< %F-6H'6W R/SJPVLI&,<"@3'0V?D=34YO(
MX1S@UC7>N;@=I%8LVHO(W_UZ8'3SZXB#Y3C\:HMXB<' .?QK#022GG^=6HM/
M9S]TT!8T5UV9CZ?C5F+5IF(Y/YU7@TK&"<BKT=E&G?\ 6D)%^WU23 R?UK3M
M]1XY _.L4;$')'YTX7L<?1A^=(+'2+?)Z#\ZD^V(WI^=<N-34G@U(M^#W'YT
M":.H2Y0^E3>='WQ7++>G^]4RW[#OFGH!T+;&'!%1>1N_CK&&HM4JZB?4T :?
MV8CWIRKM[8JBFHY."Q_.K*7B'J?UHL*Q/NX^\:;EC[T+<QGI4GG+W(% $>2/
M:E4_YZ5+OB(Y/ZU&7C'0T +N3N*:0#T'ZTF\$] :<>G_ ->D,;M/K^M+@^E*
M,X[_ )TGS=JI!J' [T_/XTT;NX%*3_G- Q<CO_A3N!TQ466_R:3FBX$^<]Q1
ME>_-0#/N:D#-Z4!H.R.W'XXINYA2[CW&/I297MUHN,4.IZYI=_'&/SI 6]!^
M-+]?YT (')Z_SHI?E[4F5I@!)[#/XYHW>O\ .@%.Y_6E)P./YT &Y3TXJ3MU
MJ(.>X%/$BT  ('0DTF>?_KU)O!I-P_N_K1H%Q#]32@X]:-V*,D^E(!?-'IG]
M:!,O^32?A3@!Z4 )YX[)^M'G$CH*7&>HH('K2 039/3]:?YG^<U$",]C3MU+
M4&29SVI0.*17':GYR* (7;'_ .NH&?ZU:(W=_P!:88\>E RMD4]6)[&G%0.@
MI5SWS3T"PX,,<C]:D!3TI "1_P#7IR@#K4BL1R 8R *J.&/:M(D8X%1%,_PU
M(K%!2X/!_6K,4K@\D_G3F0CIBF*74]*8&Q973 CYC72V5YTRP_.N)CN&7TJY
M%J++W_6D,]!BN$9?O#\ZE\U/[P_.N#76F0<?SI6\0R#O^5%AG>;UQG<*8;B(
M?Q UP#^(Y/?\ZJR^(9VZ#]:.49Z&]_$O\2_G5636H8^I'YUYU)K-PW4$?C59
M[^=_XC1R@>BOXF@7T_.J[>*X^P'YUYTT\I/)-*&;^^?SIJ(COV\6I[?G4+^+
MU]OSKB1N/?\ 6AHSZT- =<_BQFZ?^A56?Q0>Y/\ WU7,!<<%J88L_P 7ZT6
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M?E5?S!Z4&0^U("QYA]136D/<#\J@\P^E+YG^31<"7<#_  B@GV J+S*7>?\
M]5%P)00!SBF;\'C^5-W'/^-+UHY@ SN/2D$S9I<#THV#L*?,!(M\4J4:DWI5
M;RSWQ2>6/2E<#0356'3BK*:L?4?E6,(2>U.\EQW'YTP-Y-8/?%7(=8 [BN4V
MN.].$CI0([9-:7H<5.-53&=PKA/MK+ZTUM1D]?UHN!WAU56_B6D_M",]9!7
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M]J+@4I(CVIHM\]14[KCT_*F!\'[OZ4V@&_9<]%IPM& ^[3C,>PIRSMTP:5M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&*+B(]N>M!CXXI2V/04PR#NU(9&ZD=ZA+'WJ<SQ#J0?QIGVJ/T'YT"N0-O\
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M&0:Z_34;C@U-BD=/;ME1S5FJUL"$&:LU!04449H **3(]:7- !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ,?\ SQ6?=#Y3Q^E:#8]*IW1;9PIIW Y#5TR&^6O.];B;YNWX5Z5J
MF[#=:\_UJ/.[*FF@//+Y&W'(!K(=06QBNCOX@">#^58,P(8\9_"F(@V8[XIZ
MJ/0?E499P>%-6HBQ'*_I3"XJC_.*?@>YJ9$+=OTJ;R1CM^5,"D3CHN*4.?\
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MJ\#D4ABT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*F67VJH,CL*E0COBF!>27CI4RN3T JM&1CK5E&Q2$2#=WIV3Z4@<8YI0Z^M
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M>H'Y4 8P,@ZL:E1WSPQK1-NA[4"W4=,4P(8S)W/Z59#''.:!&1_^JG&//?\
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ML8&VG%0>HJ;C/*-0\*EMQ6 ?]\URM_X2N"3B$_@M>_&&,]5%1M96[?>C!I7
M^;7\*W@;B%ORJS:^&;U2,VY_[YQ7T+_9EKG(B6G"PMQ_RR7\J /'-/\ #]Z"
MO[D@?[M=AIFBRKC?$#^%=PMM"O2,5(% Z 47"QEVE@J(,Q*/PK06WC7^!?RJ
M6BD T1H/X1^5.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M GF4>8*B;V'ZTBY_R: )3STQ3,'TIP([\_C3MP[8HN P ^E!)[4_>*,@]10
MW)H#MZ4I8]L4TLW<4@)-W%-\RDRWI2'K_P#7H >)#3O-/H*B[=?UI!]?UH E
M\[M2>9ZU'WI2?H: ';AUHW9[?G29/;^=&3W_ )T &6].*:3GM3\_6DY[#- $
M?S4W+?\ ZZF^O\Z,8H BR?2E^;O4V/I0 #[_ (T ,XQ2#KUJ0X'_ .NF$K0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTD%*PRS14(NH3_&*>)$/1A0 ^BD!![TM !1110 4444 %%%% !1110 4444
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MSY9'X4%+0Y>WC'<5IP!![U8?1Y(_^6;?D:C-C.G2-ORH&7(UC/5:L+;Q-_\
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M-8D=/Y47 Y*+P%81GH#_ ,!J_%X4LHNB(?\ @-;NYCVIPW=\47 S8]#LX_\
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MHY(Z@U'*0?X:BC<CI_.GEB>] %26-FZ9%(B%>IS4[-CUJ/.3WHW D15]*<5
M[TU2?7]:&;W_ %IB&LW85$<=Z<6QWQ3"V?>BPF.#>AIZR'TJOO.>,_G4B,W?
M-.P%E3GM4JBHT/%2J1GK^M $BQYJ=%([TQ6&./YU*K'_ ":H">,N/XJMQR$=
MZHJPS_\ 7JRGU_6@+FA%.1W%:,%U[UA(X!X/ZU:CF:C4-3HX;L@CFM&&]]<&
MN7CE?T_6KD4C>_YTP.H2]CQ]T5,MZGH*YV.5NG]:L([=P:87-WSU/.T4><C?
MPBLI)#_M5.'QW/YU.HKFFGEMUQ4ZPP'KBL)[DJ/O'\Z@_M-T/&?SI".NCL[<
M]Q4ZZ? WW64UQ\>MR#J3^=7H-? /+?\ CU CIO[,CQU'YU&VFKV&:S(O$*_W
MA^=6X]?C/4@?C3*$ETS/6.J,NC*_5*UEUN)O0U)_:,3^GYT]AW.9D\.HQ^X*
MKOX71O\ EG79)=0'JP_.K$=S;9X-)@<(OA%&_P"6?\ZG3P8C?\LQ^9KO%N(/
M45/'=VH/)'YU '!CP2@_Y9C\S3CX,51Q'7H8OK3'!'YTGVZUSU'YT6 \Y;PH
MZ?P ?B:KR>'BO\'ZFO36N+)^I7\ZB<V+#[R_G340/)[G0G'1*Q+S1Y #\E>R
MW$5BP/SK^=8=Y:61S@K3L,\4O-(ER>!6)<Z9(N<#]37LE_8VQSC'Y5S=]IL3
M9PHI#N>52VLB'YLU <K7=7>DCG _3%8ESI3 D@5(7,%9Y%/!JS%=_P!XTLUC
M(O135;[/,#]TT"N:T<R-WJ7*$=:QU61>N1^.*E61QZTQF@P!J!X@3UJ,3S?Y
M.:0W#XY% ("BK3=R@TPS.>V*8?,/.*0%E9<=Q4@G'J*S_GI07]_SIA<TA,M!
ME'I5-%?T-2@&BPKBO(3]VFA7/6G%G ^[^M()&^GXT:C%&5ZM2@Y[YJ,NW<4G
MF-V%*PRP&(Z"C<>XJOYTAXV_K3A+*.B$T6 GW+CI2<U!OD/531ND]#^-.PB<
MXQS_ #H&/6H=\GH:83)Z&D.Q.3BC=GH34 \S_:IV91VI@3\^M*&)ZU5W3'LU
M&9AT#?G2 MY'I3A@U2S<_P!VE!F[@FF(MD+32J]CBJ^9CV/YU(J2'[PH "&'
M1J87;UJPL+>]2B%SU7/XT 9YG<<"F^9*W:M86@/;FGK9-Z"JN!BY;^Z:>(Y3
M_#6ZMDPZ@5,EJIX(Q^-.X&"ELS=5_6K45BY/W*VUM8P>]6DA511<#'BTX]U%
M78K-5_AK255[ U(%],F@"I'$%_A J<87^$5-L_"E$0/K3&5VD/\ =_2H7F?'
M%7S ._ZU&8XP>6'YTKB,F22;T)JJ\TWN*WF$('# 51G6+'WQ0!CO/,.K&H&N
MY/4_G5^78#ZU6,(?IBD!6-Y(.K&C[;_M&I6LB>_Y&H&M=M,"5;YNQ-*;V0U4
M='3I_.H"SYP?YT 7C=8H^T$CC-5%CD;[O%3+#,.II,"3SCWS1N+'K^M-PZ^]
M,>=T]/SI:@6E4G_]=.VD=ZS3?E?_ -=-%XSGJ:0&F7*_Q?K432MZU'$LTW"K
MFM"#1KF<C]V?RH0&:9FSR* =U=5;>%+A\'RR?PJTW@R<J3Y9'X4P.-RB]2!5
M^RGAW#D&K=]X6D@!)W&L5K.>WDPN0* /1M$G@++7HND2P;5Y%>':9<R0L"Q(
M_&NXTC6BNT;F_P"^J3&CVFP>$@8%;43+CBO.=(U??M^<_G7<:=/YB#)_6D!J
M44@Z4M2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #68 =:R[V;
M"GYJMW-PL:G)'YURNL:KY:MAP/QQ5) 4]3N>&PQ_.N URZX;YJM:MKY#,-^?
MQKD;Z_-QD<G\:8&/?3!Y*2SMFD<845.MF9I <5T^C:*2ZDK2$+I6B><!NCKJ
M[+PJKX^2MS1-'557(_2NSL[!$04[@<*/!Z[/N"L;5/"Z1(WR?E7L1B 6L/5+
M0.C84FA,6I\^ZMI B)VJ:Y.XADC<CI7MFMZ.TFX[!^5>?ZIHS*S?)57 XO./
MO-33(GK5J_M&A)PM8KEP] R]N!Z$&E !Z_SJK'*>_/XU960_3\:86)5C'K3O
MNTB2#N?Z4.P[?SH D$@'8T&;TJFTCC[H-1^=(3@YIB+QDSUXIA(S44;/WYJ<
M#/:D( WH<4;S]:4J!_\ KJ-FQT_G0%B8,#US4BXJGO(]JD63WHV'L6MB]:;A
M?0TU9C]?QJ43>HI7 C*^@IC*V>E6=X(XI, ]_P!:+C(HV*U>AG '?\ZJ''^3
M0'*^OYTTP:-J&ZYZ&M."Z&.OZURJSL/7\ZL1W9'<_G5<Q)T[7"$56>16[5F1
MWN>/ZU968'J?UIW$$F?3BJLF1T6KOF#'%0NQ[XI@427![5(DK#K3Y'&.GZU5
M+G/!(_&@31HQW.*N)>>XK"$@[D_G4BS8Z$G\:!,Z..Y!/6K:3+7.13-C_P"O
M5I)W7O\ K2&= LJ^M*9T[']:Q!>'N/UI3=D]/YT@NS:\_P#VOUIRW)_O&L'[
M41U_G3EO3Z?K0%SHTNCZFK"W8(KF1?&G?V@??\Z6@TSIC<1]ZADN$QP:PAJ#
M'H?UI&NW_P FD.YK?:&W<$UK:=*Q<<_K7'K=OO'6MW3;EMPY/YU+929Z;I$N
M%&6%=1 ZE1S7G^EW1P,L1^-=997/ YJ0-VBHHGWC_P"O4M2,**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,XHI&SB@"K<RA5/-<=K
M%\%W5TNH[]AQ7G>OW$B[Q5) <YK.I<M\U<7?7N]CS5O6;IPQR*Y:>X<L>:8A
M;E]QX%5-IZXI2[$T!R.HH"PH#>E!S[TX,3[4[MR,_A2 K,I/0FFX([59.WTJ
M-]N*8BN7(I ['_\ 70^/[M,!%4A.X_+=P*4,/2F97WIRD>M,0\=?NYJ09],4
MP9]:<"?K0 \.?2GAO514>YB.E)EJ!E@2>WZU*DK53#8[4X.?>G<9H+*U3I,>
M]9H<CO4BR4707-1)23_]>KD4F/\ ]=8R/[U:BF8>IHN@-J*09ZUH12 =ZY^.
MX;-6EG]Z=T*QT"2K_>_6IED'8FN?2XQT-6$NV_O4Q69T"3C'WJD\Y1U)K#2?
MONJRMR*3L!H/*&' )_&JS@GHN/I3//&/_K4QKHCH:6@A'#>AJ$[O0T/>-Z?I
M49N<^WX4K";%\QQTS3EEG[ U'YQSTS^%2I='MC\J N6(Y[D>HJTEY.O5C5-;
MIO\ (J=)<]5_2@$6/[3E4?\ UZ8=>FBZ5$VQNQ'X57D@5O?\*D9++XLN%%9D
M_C>ZCSR*2XLU;/%8]SI:MGG]*$!:D^(-TIZD?2H3\1[H?Q5AW.D@9P?TK+ET
MX*>M,+G6_P#"R;L=ZD7XBW3=6KA_LJKU-*L0![G\*8SOT\>7#_Q?K4J^,IG/
M)KS[;M^[FIDDD'3F@#T%?$AEZD4[^U?,ZL#^-<&MS,O1:LQW<HYP?RI6 [$S
MI)U(%5)8XVZ8K$34''6GG47J1ZEN6V5NPJK)8H141OI#TJ)KR4]0:-1ZB/9*
M.E0FU%/,['L:<LH[T 1"S!IPT\GM5I+A%Z_RJ8747^10!1_LP=Q2?V<!6E]I
MB/>HWGB]J0[&<;/;3/LX'45:DF7MG\JK/(Y^Z*!6 *H["@J#VJ!GD/48^E1E
MW'<T@+/EKZTHC6J9DD'130)I>X--,"Z8(L4@MXO6JOFR'UHWS>E RV(D'3FE
MVK]*I[Y1V-&^8]B?I18"[Y<9ZL*7RX1_%6?F7-!\WW_&G9@7BL([_K3<1GIB
MJ6)!V)II,G]W%.PR_P#N\4@\ON:H9E]Z-LC=3BE9A<T?W./O?K0'A'4BLWRF
M]333$_K3L!JF6+VI/.B]0/QK,\IL<L?SI/))/4_C181J>;%_>6I$8'I5"&)0
M1D5H1JJ_PT 3*,\5:AB3O4"2 ?PBI?M..@% %](%/3%/-N.U9WVYAV(IPU)Q
MVS18#0%O@4QX<]ZI-JLG3;^E1-J3=Z=@+IB(Z']:0OL[UG-J!]_RJ)KUFZF@
M#4^VJO4TX:FG8U@O/D]:9YGX4[@=#_:H]:1M6VC(Q7/9ST:@^9CCF@#:?6,]
M:JRZI(>E9V'[BD.X_P#ZJ$!.VHR9^]3/M);OS3!">X!_"G !>WZ4 2*\A[?G
M4R,>]0><%J"2]<# 'Z4@-/>OK3&V$5BM>N3WJ2.Z<GN:8%YHM_O31:G/3]:6
M.9V_A-/:1P._Y4K@.6+9]['YTC[1_P#KJM)</VR?PJNTT[' 2E<">5B>]4I(
MY&;@'\ZG6VNICPAK=TW0[B7;NCS^%*X'-II\TQX4UJV6AS,PRA->BZ1X1:0K
MNBS^%=OIO@B/"DP\T7 \UT;PW*6&8S^5=]I7A=B%S&:[>P\,QV^,QC\JWX+*
M.)<!0/PI7 Y>R\-*@&8\5:GT2)8CE1^5=,$ [4R6+>I&!1<9Y1K>FH V(Z\T
MUJT\MSA,?2OH+4="^TJ<9YKB=7\&;@Q*9HN!X5-/+$QP#4]EJLBN >*ZK6O#
M"P;OE(KD9;06\W!/7THN!Z'X=U,LZYS^=>MZ#=[HUYKP/1+WR77D5ZCH&O(B
MJ"U)L#U>(Y0&GUS]CKL4J@;JV8KE9!P30!/10#FBD 4444 %%%&: "BC-% !
M1110 4444 %%(S!1DD50N=4AMQR_Y4 7G8*N363>ZM%"#EJQ=2\66\2,/-KS
MS7?&*-N"24 =AJWB:-0P5A^=>?ZUXADE# ,/SKE+[Q#)/)PY.:B@\V[;IG-,
M"&[O+B:7CFK-A97-PXW D'VK<T[PY-.5;R<UW.C>&'0J6BQ^%.X&)HOAIY%!
M*'\J[?3/#YB*_(:Z'3-*6%!\GZ5N1Q(J_= I7 H65@L:C*XK250HP*6BD 5!
M-#YBXJ>B@#G;[2?,!^7-<;K&@MM8^77J3*".:Q=3@5XV&W]*KF ^?]<T9@6^
M4BN'O=/9'.%->Z:]IX.[Y<_A7G6K:?AFPE%Q6//S"Z'D4>9MXS6C?0;"<C%9
M#L V/Z55P+D,A/858ZCI5&#<QX(K0C0@<FBXK$9#&D"M_=JQ]WMG\*:7&.A_
M*G<+#4S4GY57>7T!J(R>Y%%Q-%QF]A4+'FH1*WK^E29SU'Z4[BL(<]L4F]AU
MI3@^M-QS2;"S'*_/4U()6'3-(H'^14R@8Z?I4L=AHD8]12[O>E/L!33GN*0[
M#BY I-YI.*-Q'1<T:A8>';TJ196[U&K9[8I_RCKBJU"Q(LP!ZU.MT1TJGD#G
M'Z4TO]?RIZB:9I"[;TIKW6:SO,;&,T*[=\4]0+C3$C_Z],WEJC7:>IJ5=GN:
M=Q &P?NDU.DV.HQ3 5]#3AM/4_I5"996?CK3A*>QJF2!TS^5(K$=2:06-'SC
MCM2>83U-41/SCK4@<GM0#N6/,.>/YTX2$U6W\\YJ0..W-)DLL!V]ZD5R>HJL
M&8]L4_Y\=ZAW&BVK+CK2EO2J@W^_Y4;F]Z6HRXC_ ##BMFQE (Y_6N>1G!K3
MLW(89S^5&HSN-.O,8']:Z_3[C<%YKSRPE7(Y(_"NOTN<97!J2CNK-MR]:O#I
M61I\A*BM=>5I#%HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_2K1+8Y%5)6-,9EW."#@?I6'==36[==ZP[D<GBE89E2?>I5'^<42CFF L.]
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M[_K3N!=4KZU81O[IK.1R._ZU;CF [TKB+.'8=:@DC;'K4HN5]12-*''!'YT
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M>BFFF.[[IFOIO_A5FF8[?]\TY?A?IJ]A^5%P/F#R;PGB(TOD7G>,GZ5]0?\
M"L=.SV_[YH/PPTP]A^5%P/EPV]WVC-)]GO\ ^XWY5]2CX9:8/X1^5+_PK/3/
M[H_*G<#Y:^SWW>,G\*/L]Z.D9KZF_P"%9Z8!T'_?-'_"M=-/51^5%P/EQ+:_
M)^X?RJ4V>HD?ZHG\*^H%^&^F+_"/RJPOP^TU?X1_WS0V!\KBTU(?\L3^5/\
MLVIGI"17U1_P@6F_W%_[YH_X0+3?[H_*E<#Y5^R:EWA:GK9:G_SQ;\J^I_\
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M::$([&J0$^[/?-)BFK_GFI-X QG]:: C;([TSS2*=(=WK4/ED]*-1W'&X?\
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M%% !1110 4444 %%%% !1110!'* 5.17*ZO9K)N.#^5=:1D5FWENK@\#]::
M\EUG2MV[@G\*X/5-.*;L)^E>VZIIZN#\M<#K>G;0V$S0,\CO(G4G&1^&*I*[
MJV"#^5=-JEL59ODQ7/2H5;I5"+=O(,CM6_8.O&2*Y:.90>:TK:\5<8-(#N[-
MX^.*UH[=)A]W-<597[Y&TBNKTV]<@9 IW NMHT<@^[^F:R[WP\"IVI^E=C8N
M) ,J*O/:)(O047$>*ZCX=D7)V'\JYRZTN6,G"$_A7NU[HRR*<(:Y;4O#_7"&
MG<#R&2WE3JN*C!8=:[/4=&9"WR&N>N+#8?NTK@4%=O2ITD/?BHG5D[8I@8GK
MS3N%B^KY[TO^>E5HR3TJP$<T"L+R!_\ 6H#-Z_I32'':F98=L4Q.Y:5V]*4D
M_2JZENYJ9: %Y[*3^%-^?^[C\*F7'J*>=M(+%?+=Q3@Q'8C\*F^6F%<]*+@"
MN?7]*F61O6J^UO2G#<.M,33+(8GM3_\ @6/PJL&;\*<)!Z4$ED?7/X5(/J:J
M!AFI0WX_C3 MJ3CK^M2 ^WZ5460>E/$P]<47 G8GM_*HB2:89?\ :%,:4=J!
MDPSGO5F+=W_E5!9B#5J*<=Z LR^!Q_\ 6J%USW-()U[-36E],4#(GC_SBHC"
MI[?I4I9ST H!/>D(6&$(>,ULV5WY1'-92U.BGKB@#K;;7S#CYL5LVOC408RZ
M_G7G3YQP<5E7<DBYPQI6*N>YVWQ%MQ@.Z_G6S:^/;.8@>9'S[U\LSWUQ&W^L
M(JW9ZW<1L,RFCE&?6EOXELI@/WJ_G5^+5+:7[KBOF73?$L^0!(:[W1-?ED*Y
M>IL.Y[0LB/\ =8&G5S6D7YE RV:Z*-MRYI,8^CK112 ;L'UI< =J6B@!.*,T
MFP4;13T 4Y[4FUL_>I<@4;@>](!:*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BF-*B]6%5WU*UC^_*!18"W168VO:>O6=141\3:8O6Y2G8#8
MHKG9O%^FIPLZFLVX\;VZ9V2+^-%@.TI"RCJ0*\WG\?-R%=<?2L^;QU-VQ^M%
MF!ZL94'\0J-KN!>LB_G7D$GC:[;H16?<>+[YN]%@/:FU.V7K(OYU&=9M!_&*
M\*?Q7J!. #35\0WC?>8T68'M\OB&T0??'YUF7/B^WB!VR*:\BDUN9A\S&LRZ
MU&1@<.U%F!ZM<_$-(6X(_.J;?%%!P2@_&O&KJXF8G+,?QK*EE?/)(_&BS ]W
M/Q2C'\:_G2I\4H\\LF/K7S_N8_\ +1OSIA=A_P M&_.BP'T.?B? P^^@_&H)
M?B1 1_K%_.OG[SY!T8_G4;SW!'#'\Z:3 ]RN?B%$^<2+^=8=YXNCN 1O4Y]Z
M\D,L_<L:<LL_H:+ =O>WZ7!.,5F-#;N<MP?I6"LTW^34JW,@/(I@;(L+=_>I
MDTBW;M6.E\Z]@*L1ZFP_B%(#7718/;\JD_L.#'\/Y5G)JS#N*L+JJGJW\Z8K
MCWT>%>X_*F'3X%'44K:@C]\_@:A>8,.,T6 BDMK=:K/##GM^5+-O;H":JO#.
M>B']:+ 2^5;]\&EV6X'0?E5/['>N?EC:I$T?47_Y9/2U GVP]L?E2Y0?PC\J
MD@\/:DY_U+&M&+POJ!',#4 9!D']W]*3S1CH*Z:'PC<,?GC-78_!P_B&*=@.
M*\['1?TIRS.?X#^5=XOA"V Y('XU*OA>P3[S#]:8S@=KR#[OZ4]-/:3^ C\*
M[W^Q-.CZ.*0VMI']TB@#CH_#_F<D?I5E/"2OV/Y5TI:-/NXI/M;K]W%- 8T7
M@Z,GD'\JNIX0A0=!^56O[4N%Z**BDUBZQ]RF!6E\-VZ#I^E95SHT*YP/TJ_-
MJMV<_(*S;B^NFZJ*!6,JYT]5SC^59<ULRGA3^5:TUQ*QY%56D;N :8C-6*7=
MT(_"KL,<@Z@G\*D5QGE15J)U]!0E<3'1*^/NU<CC]>/PIJ2)CH*=O7L!^M58
M+V+2118Z<_2I B>U4U;WQ4JL?6EHA7+.$ II([#]*%90.:0L#T.*3U 8P]OT
MJ"0X[?I4S8^M02 GH*$P*[R=MM,W'TQ2NIS495NPIW'85GXY'Z56D8GM4A#^
MHJ)@>YI,"+G/2M*Q!+CC]*SP?FK6T]27&!2&=3I<60N:[C1X5W+7(Z5"YV\5
MW6DVK_*:EL9V6EJ%08%;B?=K'TZ)E4<5LK]VH8Q:***0!1110 4444 %%%%
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M1 8DS_P*K\?Q$*CEQ_WU1RL#U C--V>]>;K\1=W4J/\ @53I\08SU8?]]4K
M>AA<=S2UPT7CB.3HZ_\ ?578_%\)')7\Z+ =917-+XJ@/5E_.ID\36Q_C7\Z
M+,#?HK(C\06C_P#+1?\ OJIQK%J>CC\Z5@-"BJ0U.V/\8J1;Z!ND@_.G8"S2
M'/85&+B(]''YTX2(?XA2 ?12;AZBC(]: %HI,CUI: "BBB@ HHHH **** "B
MBC(H *3GN!1D4F\4 .HIGF>E 8]S^E #Z*3/IS1D^E "T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$GL*:TJ+U857EU"&
M,'YA^)H M ^QI:P;GQ###G+K_P!]5DW'C6*+(# _C3 [2BO.9/'I!^5A_P!]
M55E^(,V.,?\ ?5%@/36D1!EF JM+J5O&.7%>377CVY<'G'XUAW7C&Z?.&S^-
M%@/8KCQ';Q$X<?G63=>,TC^ZP_.O&;CQ'=R$_,WYU1?5+F3JS?G56$>P3?$
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MS78Z' Q=>E2QG;:':[@I&*[[3+8 +D5SWA^S)5?\*[VQM]J+Q^E2P+%O&%'
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MJS'&!U:@"3?Z$T@D/<T,P4>OX55D<MT%- 6_-SW%&-W<50^?V_*I$D(ZC]*
M+@C'<T[ 'W:K!B?7\JD =ONC]*>P$GG;?6FM=2=A^M*L$C'E?TJW#ILK_P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]TL/I55[6]3[I:ERB/H6'QCIDHYF4?C5R/Q%ITGW9U_.OFGS]2@[M4T.O:G
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M7WGK567CM189G7#E>F*S)IG/49^@K5F"GM5"5%SP#0!FNY)Z$?6HFW^HJXZ
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MHI(45IQZJI'%)-?!U(XIB.1O898,]*RS?R1OC(KIKV,S9P,US]SITVXG;Q3
MFM]4D[L*U(-4/&2#7,F"2,]"*>DTB?Q4[ =O!J ;& *OI<[EYQ7#0W[I]XUH
MPZH,?>H Z&:0?W?TJA([=0*JC4 W\5!NP>V: '&5JC9SGK3#.#_"*C>0D\4
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M%SCO6C#/D=3^=8$4Y!YQ5Z.8'FF!NI*V.OZU9C<]_P"=8L<[_P .:O0S/WH
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MLL!<+766\!5!E1^=4M,C"H,C-;2_=J92*$1<#I3Z**@ HHHH **** "BBB@
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M7'M2'I0  FD_"@9'\- SG_ZU A=N:<HQTI1GTS^%'?\ ^M0@';F':G L?6D
M/^>*D 8#I1<8H4D=*AD4CM4OS'UIK#B@12<XZ_RJL[$],5>D0]JIR)@]_P J
M!E<J:C.ZI6SVYJ(Y]*+@"NX]?RJ0,YJ,9_R*D7Z?I3 F3.>:MQ2!>QJHOT_2
MIT_SQ3 T(YCV-6H[AP<5F)QTX_"IT+>_Y4T(V8I?4XJU'*OKFL:/=W_E5J,D
M'C/Y4 ;23L.E3K.QZ_I68A;'4_E5B,MG_P"M30T::/N]:D*U6A..O\JL;_2@
M!" /6HWSVIS2?[/Z57D<GM^E,0CL!WJ%I .]-?)]:K.K^XH3&6//]LT>?[8J
MEM;WI")#Z_E1<1H"8'I2^9CK6>/,'8T[S''7-%QFAO![XI,@=6S5#S7ST-!F
M8T7$:/FFD\\#J:S#,^>OZT>;ZYI7 U/M QT-,:7=T%41)Z&GB<BBX$S*Q]JC
M,+-U-)]IQ_#^M--T/6BX"_9\4]4V]C59KG'>HWO6]:+H#2$C+WQ4B7.WJ:PF
MO&]3^=,-U*>E,9T#7N.F#4;:BWJ*QD\Q^35B.W:3C^E)H1:;4GI!J,F?_K4+
M8D#[OZ4\6>.O\J+##[<YZFD;42HY8TU[;C@9_"J4\#XX7]*8B275?1JSKG5#
M@Y?]*BFM93T4_E6?/93X^X?RI!8;/?/(WRL:;%%).?O'FHET^X+?=/Y5K6-G
M,K#(/Y46&.MM#DEP236[9>&VXRIK1TN,J!E/TKIK5P .,?A4 9-KX<('>K3:
M,T0]:Z*%U(YYHE9,=*6H')26SI_!4&9$/3%=!<E3[5D3D9/%(1"MU(H_^M4$
MVH. >>:9-+MK,N9^#3&)=:E-_?-9CZA<$\,34<TC,3Q4*D[N?Y46 M)=7!/7
M\JLQRS'O4,!SV!J_%[IB@0*9_>I \P')J9"OKC\*5^G'\J-0*K2/ZFHC,P/-
M+-D]ZI29!ZT#L7TGR:G$IQP*QUFV=OTI_P!K]_TH"Q?EEXY%4)GR>"://W\$
MTTX-&H%=F;TJO(Y':KS1<9S^E5Y(,^_X4",Z63WJJSGVK0E@X^[5%XMO>F U
M9>:T+:0=P*S2,?\ ZJ<DCCH?TH ZNTF'' %;EK,H'8UPUO=,".?TK:M=0*XR
M:=QG6>;QD*/RII?=VK'BOMP^\:M)<$].:0%AW.<8-0,2?X<5*K,_\-#1-Z?I
M2 K[L4])F7IS2_9W/;]*/(D7M^F:!$J7+GC J8!V'6JB@AN<5=AD"]0*8">4
MV.A-,8.G8C\*NBXCQR1^512RHPX/Z4P*+7;(<8_2E&HN.WZ4R;9_=S5-GP>A
MH TUU-^[8_"IUN4F&#S6 9/F^[4Z72+W(I@;)MXY!]T51N=(20<+BFIJL:#!
M8?G3FUA .&I7 Q+O0@">*QKG2F7/%=-<:K&_5N:S;B\,@XY%.X',26S1GI1$
M6C;)%:LAW=OTJNT)ZA3^5%P)8;C.."/PK0AO=O<UD"*7L#_.@^<.BFD!T2ZD
M.]3"^C/\5<J#.?6I4CN#_>_*FTAG3?;D'\0---\G45AI;7#?WC^&:MQ:?.W\
M+4A%YM2([G\J:+XL?XOTI8M*D_B!_$5:31G/1/\ QVJ K@K+]XTTV<3<@UIQ
MZ%.>D?Z5;BT"<GD'\J0'/G3E;IBE&E9Z*?PKKX?#\B]5_2M"+0SC[GZ4F!P\
M6BYZJ:L+H49_AKN1H)_NBI%T5%^]C\J5P.&&AH.B4'1'_AAS7?\ ]GP1#H/R
MI-MJO7 _"A-@>?\ ]AROQY6*5?#TG_/.NXENK*,<NM57U>Q3^):JX',+H4R=
M(S4Z:7.H_P!6:U9O$5G&.'%9\OBR$?=8&G<!!82@\J:D%CZK5"7Q?&>,?K5*
M7Q6G\+ ?C2N!T:6<8ZG%6%B@3JRUPTWBQL<&J,GB>=ONYHN!Z4)+5.I6G&^L
M5_B45Y3)XANWXW-^=0-JUT_\3?G1J*YZRVMV48X9?RJM)XFMT^ZR_E7E;7EP
MW5S^=,\Z=NY-,+GI<WBJ+'$@_*LZ7Q:!_$*X;$K=2:46['O0%SJ)O%#.>&-0
M?V](_1C6 +3N?Y4X1!:87-A]4E?UJ W<S=VJAOV^M+]I([8H"Y<,LIY)-,,C
M'M5<73'C^E/$A/;^M #][4Z.7!Y J(MQTJ%GQT.*07-$R CTJ/.[H:I+(Q[$
MU;@5G/ _2I8$D<+,XXKH-,LBS#Y34%A9.S#C]*[/2--?*_(/RI 6M)TT_+Q7
M=Z58E=O JOI.E':I(_2NMM+'RP.!^5(:)[.$(O-7QTIL:[1T'Y4^DQA1112
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "D.<<4A8^E** (B9>Q'Y4JY_B_E4M%, %%%%( JA=QE@>!^
M57Z8Z;AT%- <9J-B'!^4?E7&:KIN-V$_2O5;JSW*< 5RFK6+[6X%- >-ZM92
M+NX'Y5R\\#J3D?I7HVMVD@+?**XR[@D5CE?UI@810DXQC\*3;C_]57)%<>E0
M-N]!2 KLI]JB*@]:G9,^M0,C9Z?K3 6@$T!2>M+MQ[T .%*1^-(#CM^M&2>N
M*0@YI#GMBG=NM-)% !R>U+BDSQP:-Q[T /&:44T.*<#GN*!CL#UIK4[%-)/I
M0 @)]*49[XI,T94=,T"),^PIISVI,D].*.1WI@.&>]*?]W%,#'TI<L>IH -Q
M!I23CC^5-X'4T;_2@8N2>U'S=\4FX]Z3<!0!(,_W<TA)IOF'M06H :2W8TH)
M[_RH!]LTA]J )-X%'F>]1<]Z0*<]* +"RCTIX8G_ /54 !':I%/L:0B7Y?XJ
M0XQQ1D=^*.#0!!+N[?RJG)GN/TK2*9J!X<^E S+?)]J9@_Y%:1M?85$T04]:
M0%$!O3]*D4'T_2K VCN!2@C/4&F Q?<?I4Z4!0>U2K%Z9II@*O\ GBIDX[?I
M404CM3O,"]J=Q%Z-P>,5=B< =,UC"Z5?O58AO(<@EF%.X&RLG^S^E6$:0_=7
M]*J6M];' +@UKP7=D1]ZBX$*M,>J_I4JM(/X?TJTMQ:GHPJ99K<C[XIH"D&D
M[#]*=\Y^\H_*KV;<]&IK;,?+B@92*Y__ %4WR1ZC\*ED!]*JL3VS0!)Y$9[4
MHLT-0;I!_P#KIPFD'I0 Y[-0.IJNT&WIS^%2F9S499SWIB*LHP.N*I22,#ZU
MH2(S53EMY/X<T@(/-/I2>>W9L4&VN/[N14;6TW_/,T,!6NF Z$_A4)NI">GY
MBI/L\W3:13EM)3U6@"(7$IX[4\,Q]ZLK9OCE:D2V/<"DP*)R>V*0J>[5H-;K
M_='YU!)%M'"TP*FW![_E3E<+W _"FR/(..*I2F3U/X4 :JW:KW!JQ'JB+W%<
MI+)(#_%5<SS+_$U '=C6!V84O]L+Z@_A7!"[ES]X_G4R7TO]\?G2 [C^U(VZ
MFC[6DG\0KC!J#@_,<U,FI?6@#L$\INN*MQP6S]2*XI=7=>C&GC795[DTQG=+
M8V8')6HY4M(A\I6N*/B"8_\ US4;ZN[=2?SHN(Z\ZO';'@K3D\3H#@L/PKAV
MN_,ZY_.H6F'8G\Z0'I47BB,=''XU8'B:)QCS%KRQ9\?Q'\ZD%ZR],_G4V&>G
M-K,4G\8J"2[C<<2"O/DU)QW/YU:CU(GOS2M8#J9&C/4@U5>-'Z$?E60MVS=7
MJQ'<C^^:8%@V8/0_I0+$=QG\*='.#W_6K22 CK2 @CM .V*L*BIW_2G;T%1M
M*M,0]F4#M^50M,!4<LJJ.H_.J4DZD]?UH LO.G>JDLRGH*874]Z;M4GK0-.Q
M$SLW3^51%9<U?2)#W%3"WXXQ0(S4WYY%6%D*CI4TD<<?+&JSW,"]Z0Q6N2/X
M1^51-<D_PBJLUW'_  L/SJD]U_M#\S3 T7DR.OX54DPW8U5^U<U(LX/5A0/0
M:4;L*81)Z?I5D31XYS1YT9[@4"*ZF135J*X8=2/RJ)I$/>D!4]*+!H:<5WSU
MK2@N?>N>4[>0PJ9;AQTQ^= 6.N@OPHQD5=34(N^*XG[;(HZ5$VHS=LC\:0'H
M/]H0X[5$^H1^U<#_ &I,.I;\Z:VJS=B:=Q'<27Z8ZK5&74]O0BN4_M28]>:4
M7;R]1^1I=0-]]:8=Q5=]=D_O5E>67_\ UT[[$Q]Z8%_^W)#_ !&D.K2,.WY&
MJ8T]^P-2+9/1J YKUFZ_R-1-<2'IS5@6;=ZE2U4'YB* ,I[BYS\I(_"E$UR>
MO\C6ZMK >M2+96W;^=# PE,S=5_0U9C5CU'Z5L"QB[8_.IH[%1T&:!V,R.V=
MN@_2IX[$D\K^E:T=LPZ)5V&U/=<?C0(QX]+#=OTJRFC!C@K^E;:)'']XU,+F
MVBYR/QH QU\/KV3]*L)H.!]W]*T#K=M&.77\*K2>*+53C>*-0%CTE%ZJ/RJ]
M#I\0Z@#\*R'\36Y^[(*JR>*47HX_.IU&=:EC!ZU82W@3M7 2^+]O0D_C5.3Q
MK..%/'UIZ@>IB6VB^]M'UIQU6T0?>6O'9_%US)_&:I/XDN&_C-%PL>S2Z_;+
M]UUJE+XG1.C+7D#:]=G^.F?VQ._4_K38CU2;QH(_XE-9MQX]P#C%>=-=O+]Y
MB*B*[N=Q_.A =I<>.IWSM('TK,G\6W<G1JYK9Z<_C3<.#TH"QL2^(KQ^]5'U
M:YDZL:J<@<BC<:+@3&\G;J:89)'ZFF[VI/-QUQ0(4J_<FF$-ZU()">U!W'H*
M (L-1\W^14P3U'ZTHC]/YT("$<]JD&[L!^52B/'4"G<"F T%_0?E3@TGI^E/
M5O<5('44P(UDFS]W]*DW2GJ,?04X.>U.W,>F*8K#<MBDY/6G?-Z4T[^PH"P8
M6@[!WIA24^F*3RB>M,=AX\O/3]*D!7M42PL.X_.G%2.WZTAI#MWN/RIK8/3^
M5 !]*D7WQ^=%@L,BBW..OY5O:=9ER.,U2M8PSCBNMTJSSMVK4L-#4TK3<A?E
M_2NWTK3L%?\ "LW2K*7"_**[+3;1AC*T@-;3K4*@X'Y5M(H"U4MHMJ^E7!TJ
M6"%HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 3%+110 4444 %%%% !1110 C#(K#U.#<K
M<?I6[56XB+J: /+M9LV;=@5PVI:>V3E#7LVI6 8'@UQ>J:?@-\E4@/)KNW:,
MGY367(P4\BNQU:T"EN"*Y&\0*QZ_C0!5:4>A_.F%L]#^M1REP.G'UJ%6)]OQ
MIV M;3W-. 4]\U''DU96,X[4@9"P]*9NQV-3/'Q4)5EZ4"$W>U!.:0AO>F@<
M\DTP'_A^M*%;TIRYI<GUH&,VGO3ACT/YTG.>]+DT 'TS^=+DGUI,T]0>U*X#
M?P-*!_G-.P:6@",CGC^=*-PZ&I.2* OK1H!&2YZT ^_ZT\BC:: $R?2FG./_
M *]28X[TF!F@", GO1M/^34N/04$<?\ UZ8$6T_Y-&TU*,]J,<]*0$.6':@'
M/7^=38'K2;13 8%!Z9%+M<<@T\<>M''K0!'F7-2JKL.:-Y%(9?0D4A$HB(ZG
M'Z4Q@J]_UJ/S'^M02&0TQHE>Y"?_ *ZJR7^._P"M-,32'FG+I^[KG\Z5@(/[
M1D)PH_6K4$<]T1QUJW::7$6&<UV>B:3:[ER.:+ <W9>&);DCY&YKJ--^';SE
M=RM^5>DZ'I-J ORK7<V-A;*@^4?G0!Y;I_PKMV WK^E;L/PETTKD@?E7I4<,
M:#Y0*D[<4KV \U;X3::1]T?E5>3X0Z<1G97J'S=A1\_I0,\BF^$%E_"F/PJA
M+\((<Y4?I7MO/?%&%/84[B/##\* GW4_2F'X9S1_=0U[M\GM1A/047 \$;X>
M7PZ(?RIH\":@G2,G\*]\V)_=%+Y:?W1^5',*QX WA#5UX2$U$?"VN+_RQ/\
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MDX8_G60]PY;DG\ZV]3MG1CDU@OP^#1< \QC_ !'\ZD#-C@_K48"]C4H QUH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !2$9&*6B@"A<VV\'Y:YC5-.+*WR_
MI7:D9%9=_;[U/'Z52U \9UO2FRV!7#:AIK*QR#^5>TZQ8%@V$_2N$U/3W!/R
M?I3 \QN;4J3UJB4=3]VNMU"TV$DQ_I7/W "GIB@"NA(Z\5,LN/XJK&1<X/\
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M"!W3/X4ZBD SRT/5!^5'DQ?\\U_*GT4 1F"$]8D_*HVLK=NL2?\ ?-2EB/\
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M&OY5L1:?!&,"-/RHNP/GV#X5RO\ ?@/Y5JVOPE 8$Q'\J]T$,0_@7\J7"+V
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M.E8#T6XNA&IKF-4UQH@W/'TKDKGXB6\@.)Q^=<MJGBX7 ;:X.:8&OK?BUD+
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MCZT[YNPQ48S_ 'J3)]S^-.P$N&]:3FF@MV%/^;O@4K )S_\ KI#FG[?4DT'
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M+6"7>, _E74Z;:RL1E,_A4.G6,SLORUW&D:;)\N4%(=B32M.<A3MQ79:=8,
M.!3M.TU]@^0?E716MF4QN447 ?:0!5&5%7P,"FH@ ]*?4M@%%%%( HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **3\*6@ HI/PHSQTH 6BFAJ=0 4444 ("?2EHI,@=Z %HIN\=J4'-
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M8CW&:8T8]Q3_ #6[Y%&]CVI 0%/<_P J9DJ> :M8!ZDT8]*+7 B1G/6E)/\
MDT\^8.U1G=WI@-*$]>*3&WIS3AN[4O/<4 ,W2G[HI4EF4]_SI^XCH*!O)Z4@
M+"7MPH^4D?C4XU.[ _UGZU3VN>WY4&.;' /Y4 6FU2Y/\9/XU&=2N2<%V'XU
M3,=X#PF:0K=]T_2F!<-S,>=Y_.D^U3+U9JI,]R.JT@>4]1^M %W^T9,\R?F:
M#J,@Z/\ K5+R9GZ+3UTZY<\*: +(U.3/4_G3QJ$A_B/XTD6CW)_A)J[%H-RW
M5#2&5OMTF/O$_C0+^4=/YUJ1^&[@_P #587PS-W1A2 P_M\O=L4O]H2>I-=
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M7H$=C8IZU;B6T3[N*!'G*>';UO\ EFWY5/'X6OF/^K;\J]*2>%>@%2B^A7H
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#110 @SW-+110
M4444 )@#M2T44 %%%% !4;?3]*=N/84?-3 AP3TI0".IJ; /44  =!1<!%QZ
M4ZBC-( I#N["FF1!U8?G4$NH6T/WY%'XT 2,T@[4P23$]/TK.G\4:9 #NG7C
MWK$O?B#ID (2=<_6F!V:EL?-BD8KCD_K7D.I?%)$SY4@-<W<?%6]=L1_UH2
M]SNWAVGH*Y75?**MR*\K;Q]K%Q]U7Y]C4$FOZS<_>5C]0:=K :FOP1MNQM->
M?W]N%8\ 5T,DU]/_ *Q#^54)[)W!W@T[@<L[*IY/Z5&;H(> 3^M:USIP&>/T
MK*FL@#P<?A2N(<+G?4BQ[^WZ51\ET/&34JRSIT0_E3 M_9W[#]*4VSCM4"W-
MQW7'X5)]ID/4D_A2&.V[>HI=ZK2;BPY)I/)1N^*3 =YJ>M+N)Z#--%L@.>M2
M ;>@IB'#=CD"C;[T@#$YS4BY],U28#?+..*3#"GG?_='Y4PEO2F GS4Y2WO0
M,D4<^M,!^,]<TH7%-P?0TN\KZT@%*D]OTI",#N*<)<]J#CT_2BP"#)'.3^%'
M&?NT#!Z#]*3!STS18!2/?%&1]?PI#GTHYQ]W]*8!GT%-)/J:>H_SB@X]* (O
MFI"Q'7^524P[>X_2@!N]CT%&\]Q2, >@_*DY%" ?O/K1UZ_RI!N[#%."G/.*
M &X7M_*EXQUYIYC)'8U$Z,.U(!=Q7L*<LP[BJCLXZ5 SR>GZ4 :ZW"CTJREZ
M@&.*YW,G;/XBI$::G8#HA=Q^@%#7"GH ?PK%4R_W35E$E8=#^5 %B5T<8(%0
MJB9Z_I3UM9'[$U.MFZ<^6?RHL!+;@*1\OZ5L6K1G&Y1^58I,D8]/PH6[9>N3
M189V=M]GXR!^5:L+VH'0#\*\^&J,!UQ4B:O(/XZ5@/1EEMQTQ^5.:XB [5Y\
MFJS'H?TJPNI3G_\ 50(Z^6_C7N*I2:G@\']*PEGEDZBIDC=OX3^5&P&D=2;T
M_'%1MJ+U7$+$<C]*>MMQTHL K7A;J*A>X&.:62#VJI)$P]?P% $4TX.>/TK-
MGN2G\/Z5:DB;/3]*K26[-_G-%@*$EX_453EOY!W(_"M,V&[J#4;:4&]?RHU
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M110 4444 %%%% !1110 ASVI/FI03Z&EH 09[TM%% !28/K2TA)]* %HHHH
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MCN0,TGJ:0(Q.<5?7RP.A-1N?[JXI7 A$3&G>3QR?UIKO+V-0F28=Z!%C85Z
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M2 @E!1=#/(;/P++,03$P_"NJTSP(\15MA_*O5K;2880/E'Y5>6&-1@*/RI7
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M&/+9J[%=0MW_ %H87.I7Q'<KSO-6H?%DR_>8FN2$B'HU2AD/4TK!<[J'QB^
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M49,HZG]*G\QSU(_ 4[J.GZ4 5MS'MG\*3>P__54K*?0_E4+#UI"'>8U/#O\
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MA3H@J>D QW-  % & !2XI"ON: ".](!:**0#'<T &X4M%% !1110 4W;3J*
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 )D^E+2 GT-+0 44F:,T
M+2<^E&?:C!]: %HHHH *::.<TOX4Q@*6BBD(3)STHY]*,GTI#NI@.HI!FEI
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MM#Q&:$T*\0_ZLT6'<R1;R'M3#;RCM71QZ5<_Q1FGG2;EN/+XH: Y9D=>HQ2
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MASVH 6BD&>]+0 4ASV-+10 @SW-+110 444<T )SZ4M)SWI: "BBB@ HHHH
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M&'-4Y[!) >E7J* ..U;1596PH/X5YQK>@R!F(05[A/;^:#S7/ZAH7G _*#3
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M,/\ ]=%A7,DZ3 PZ9IO]B18X45LA[<=#^M+YT '6CE P3H<9Z**C.ACH%%=
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M0 4444 %%%% "<TM,&[W_&G<TP%HS24?A2 6D_"EHH 3\*/PI:* $Q[TM%%
M"&@?7-+1B@!._2CGTI:0G'8T +1110 4ASV%+10 @^E+110 444A..U "TW:
M*4'VI: &[!ZT;13J0Y]:=P #BD &>M+SCKFF\YZ?I0 _-%-P3WI<''6D M)@
M'M0,^M+0!6GM$F!!%<_J'AB.X!.T<UU-(1D4[@>1ZSX&0[B(LUY_J_A)[<L4
MCQCWKZ6DM4D!# ?E6+?>&;>Z!RBG/M3T%8^6Y+>ZLWX!&#6MIOB1[)EWL>*]
M@U7P%;$$B,#\*\_UKP8L.[8OY"@=C9T;XC1QX5I/SKNM,\:17>W$@.?>OG:Z
MT>>TDSA^#6KI6MR:>R[MW'K2%8^G[/4([@ @K6@"".*\.TCXA0QA0S@8KM=-
M\=6EQM'F#GWI#.]HK-M-7@N0-K]:T%=6&0: '4444 1M$#2K'M[TN3V'YT8;
MN:=P'4444@"LG4C\C<_J*T9)-HKG]5NL*W&?PIV X7Q #\V#7G.JNRLU=WK=
MR6W#!%>?ZJX);)JDA'-W5Q)N/-9DL\N[BKEUNW' %4QG?R/TI=0'Q/<-VJTL
M%S)TS5NPB1R,\_A76:=I\#XROZ4P.,&DW\GW :0^'=4;^ _A7L-AI%K@9 _*
MM^WTBSQQ&#_P$52 ^?O^$;U,<[#2'0M0'5#7T++I-F%^XGY5C7FF6@!^4?E1
M8#PYM+ODZ@C\:88+A.H->EZE;0(&P!^5<E?!03M'Z4 8.UP,M_.D\Q>YIMSY
MFXX:J#F3- &EO4C@_K2;2W0XK.3S2>M7HE?UIH5QQ1AW- 4CUJ4;L=J.E #,
M-ZT#.:?U_P#U4F#Z?I0,,M3AGOFC\2/PI1GW_*BP6';B*!GM3AT_^M0!SQS2
M 3![FG#/I2[32@4Q"8]C2A:>%/84H!SR* LP"&CGN:>%I?+H#4CY['-. ]<4
MNW'2DVGUH 7:*8R#TIV&H^N:0$!A)Z#]:58V%3;@/>ER2.!3 10>YI^%[FHL
M,>AQ3?)F)XI"NA[!>P_6H)%XX%2^1,.M(5*]:0S/D20GC-+&C_Q"K;S*G;%5
MY+M<47#0L1QP?QC%#P6I''6LMYV8_*33X1*[#DTM0L326_\ <&:?!;.6&016
MC9V9?&X&NGT[15DV_(3^%+4+&/86C$CBNUT:Q&5RHK5TOPRK[?W?Z5V&G^%P
MF#M_2BXQ^BVH4+78VJ;4X!JG9:7Y 'RC\JU$3:,4K@/HHHI#"D)/I2TA!]:
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M*J_)^M=;IT!0#*T^RL%5!Q^E:D<00=!28Q44 =*?114@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -&>Y_2G444 %
M%%% !1110 444F: %HI,BEH ***3&* #=[&D^8^U+\V>U+3 .:***0!1110
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MK$O9& .Y:U+R8A3VKF[^X//S47 P]28G=_A7*7TB@G)_2MZ_DW9XKF[Q2Q/
MHN!FRM&3G^E0EX.^/RQ4[P'OBHO)B_B_E3N P-%GY0*F4Y[#\J8(H\\5*J*/
M>F [M_\ 6H Y_P#K4H%. /8BF!&1S_\ 6I<8[FGE32;30 E+TZ&@(?6E"4 .
M&2/_ *U )]:<J'TIQC..U%@&'?3AGN/TIZHV.E.P>W\J8QF&/3^5.&[O3AGN
M*=VZ4"&X;M2C/?\ E2BC//\ ]:@!WX9_"F,Q';%2 #N<4QE]S2L P..]'!__
M %4FP]A2B-N_%*P6%V ]3^F:<%]_TI0A[9-/$+GL10*Q&1CU_*GI.J]<_E0T
M#5&5"]12"Q.;E2.!^E5I7#?PU&\R+UJ$W,9/!I#LB&>W:3[I/Y53:SF7M^E:
MB.S'Y1FM.TTZ2Y(RO6D%CED@DW<UOZ78R2,HP?RKKM.\(+.1NBS7;:1X*BCV
MGRC3&<UHWAEYMOR'_OFN]TKP>P524_2NCTO08[<+A<5T<,(C7%)@8]AH?V;&
M5'XUM1Q!!C J2C(]:D HI,CU%&Y?44 &3Z4M)N7U'YT;E]1^= "T4FY?4?G1
MN7U'YT +13=Z?WA^='F)_>'YT .HI-R^H_.C<OJ* %HI-R^HHW+ZB@!:*3<O
M]X?G1O4_Q#\Z  ]*;EJ=N'J*,CU%,!NXYY_E3MPI,+00#TQ1H N:-PINWU:E
M 44 +QZ4M-PM&Y1W%(!U%0O<Q(.6'YU4EUJSB^]*!3L!HTF >M<_-XOTZ$X,
MJFJ4WC[3$'$@HL!UN!Z4A13VKA)?B-8CI(*IR?$FV_A?'X4[,#T?8M&P5Y>W
MQ%#?=?/X4S_A/G;I(?RHLPN>IC [BG9'K7E!\<7)^Z_Z4P^-+W_GI^E'*!ZU
MFDR/6O*$\<7*_?D)_"K</CKGYY>/I1R@>F9'K2YK@X?'%MQF85JVWBVQEQ^\
M7-%@.GHK,AUNTE'#BKB7<,GW7%*S GHIH=3T-.I %%-89H"GUI@.HHHI %%%
M% !5.[DVH>OY5:;.*Q=29@K<TT@.<UF[P&P17G^K:@PW"NCURZ9 W(KS[5;[
M+-D"JL!B:I=$[N#7,7#AGR3^E:M[,9"0*Q)X96;(%# GMY@&Z?I6Q;7. .WZ
M5SJQS+UXJS$SK_%2 ZF.[!XR*G$BL.E<W'.PJY%=^M,#0FR1TK/E0GM^E6EN
M 1STH,D)]: 9D20-UQ^E59$=?7\JW6",.!FH'M\_PT6$<^QDSR?TI 7'0ULF
MP+G[M+_93]ABBPS(5WSU'Y581W/7!J^-%G8\+FI1H-V1\J46 H;N.PI/-"]2
M*OMX>OL=*JRZ'>)U!_*BPA@E4CH*4,&J$Z==(>GZ4AAG7[PIB+--*>V*B42B
MI564]0#3N*Y&4Y_^M04 ]?RJP+=SV-#6TF.E,1"N1VJ56]<"F_99^PI5L[D]
M%_2BP$P<>F?PI"5/2D&EWK]%J9-%O6ZJ: L5FR!UJK(K'HOZ5M+H%WZ&IET*
M<=10,Y=H9#SM_2F[)1_"?RKK?[(=!\PJ"33U'>G<#F@90?NFK"3NG7^5:4MH
M%]*IR6V3]VD%AR:AC_\ 54HU'=P2*H-:-V!J(VLB\\TPL:WVA6_C HWMU# U
MD9=>U/69A2L*S-,.Y[BI!N_O5FK<$=1FI!> =0118=F://;_  H*G'45174$
M]:47JDT!9EOYO8TOF8[5$DI?I4HC9A0%A-Y/>F%F]1^5*T$@Z4@MY>XH"P;_
M 'S3A+2&!Z40N.M <I()#Z@?A4JM[_I4/EL.E*$;/6@+%E2/8U(.1UQ^-0 L
MM+Y@[T"Y1[X4=34)E H:0>E1-@]#04D/$U+YT?>JC9]33".:0RZ95/1:50[=
M!C\*J*VWGBI!<D"F!<$#D<BG+;@'GBLU]0<< FH?MTQ/&: .KLK5'<#=^E=7
MIVDJ^.]>=Z?J;)(-P-=QI&O(F,L/QI =UIFC8*_*:[+3M.\L#_"N+TWQ/;A5
M!D%=19>);1@/WE2QHZF) JXJ2LR'6;60#$@JT+ZW/_+05(%FBF+-&_W6!IV1
MZT@%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!@5NYIU+10 4449H **** "BBDYH 6BF]^OZTO/I0 M%%)0 M%%%
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M\Z\W$3?2E"NIZT: >T6?C.$X^?\ 6MZT\312XY!KP&*Y:+N3^-;%CKQB89?
M_P!ZD![]#J,4HX(%6U8,,@UY%IWBV%,;I!_WU74V7C"V8 %U_P"^J3B,[:BL
M2#Q%:2#_ %B_]]5=35;5^DJ_G4V O45 +R ])%_.GB:(C_6+^=*P Y('3\JP
M=5D&QNM;NZ,_\M ?QJE>6J3(0#U]ZH#R;7SG=Q7G.JN0S8->U:SX=:8-MS7
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MO.%O)?4?G3OMD_9OR-(#U6#QM=J1F4_G6I!XYG.-TOZUXRMW<=JL1W=V3_\
M7I@>Z6OC/>0#)S]:W[/7Q/C)S7@^G7-T77C]:[W19;CY><4 >J070D&15D=*
MP-,\XH">:W$!QS2: ?1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB<1#\JR;KX83/G;&/RH"QXF9B#S_ "J1)T/6O3;KX87"9_=C\JQ[GP#<0_\
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M!0_LM@>HIPTYAUQ5IKL#J*@;447C-,!OV94Z@T!8QVJ)]0C/?]*K/=AC\O\
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M1110 4444 %%%% !1110 4444 %%%% #0#W_ )TZD&?2EIL!"0.M (/2EHI
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M/EIL-HB*.M6 H'2H;&+1114@%(<]L4M% !1110 4444 %%%% !1110 4444
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M$_>R*>L9'4@T[R_4#\J0"#V.:7)]*-GL/RIQZ=!^5 QOS4OS4G([4HS_ )%
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M/NH3^%*X&E%J.G5JVNL:6N :YR/P+JCG[C?K5V'X>ZNQ&$;]: .RM-?TI,8
MK4C\5Z=&O!_E7&6_PWU<XR&_6M2'X::H1\R-^M '0-X]LXA\DA_*JDWQ*C4'
M:[?E4,/PNNS]\9_"K0^%3D\H/RI7 Q;KXFS-D*[?E6+=>/;N?(5FY]J[R+X3
MQ?Q0K_WS5V+X46@^]&@_X#3 \=N-:O+O.XGGVJD8+B<]"<^U>_0?"_3T/S1H
M?^ UJ0?#O2XQ_J5_[YH ^=(="N)3]S.:U;7PA/*0?*_2OH:+P5ID?_+)/P6K
MT/AVPA^[$OXBBX'A]CX'E;'[JNFL/ TH(_="O5DT^WC^[&OY586-4Z*!]!1<
M#C+'PEY(!9,5OVND1P@?+6O12N!&D2(N-HIXQVQ2%E^M)N7TQ2 =D>M+3 O.
M<C\J<0>QH 6BF_-[4H![F@!:3(I:3 /44 +12;12T %%%% !1110 C$ =:S;
MV8*O6KDQPIZ5S>K7#HIYIH#,U6\4*PKS?7[I2&SD5O:O>R?-R:X/5YI)-W]1
M5".9U.13(2#609,G S5Z\!W'/\JSFB<GBG8"9"?4U,KE>Y_2JR03>M2"!QU'
MZ4 6!,QI'=B.#FF")O0_@*F2VS3 IMYN?NTY?,'7/Z5H"VQZ4-;D#./TI@4Q
M(X[']*D23)[TXQ>O\J9M"GIF@";:6[TOE-BF"0CH,?A2B9O:@8\(1WI3TH$I
M/;-,,F3C;3 B<OZ4B=>34I0MT_E3H[?+9Q2$6(,]LUIQ9V]*K6T!&, ?E6G%
M&V.E,!@!]Z<!+VS^E6%B;T_2IE3'I^5 $$:.Q^;(JVB*!]XT# Z_RI3,JC'%
M)JX$@'OFFL3[U 9O3 I-S'O4V 609ZBH1;[FX6K$:LYZ"KUO;$N*6H"6=H21
MD&NHTZR? VTFGV&[;E!^5=9IVGJ%' _*E=C%TZSE!&17564>Q>E5[2W9<?*/
MRK5C4J.?Y4FP'#I2T44@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH C'Y?A2_+[
MFC::-AJ@%)P.*3<WI001U- /M0 ;R.O\J3>32CDTI6C0!"01UI <=A2E<"D
MSWH 4,<__6H;_/%)QVS1SWH >,XXI,$]3^5'&.:!CM2 ;CG_ .M4E)\WH*:6
M/IBC<!2/<TB_YXHP3WI0"* %YSU%+3.]#46 <>E,XSUQ3ATI!C-,!._'-/!/
MI3>,T[( I, --R?3/X4N[T%)DGOBA &TGL!05QWI#UZT984P%&<=*0#)_P#K
M4;CZT[+>E !M_&EQQQ3=Q^E+S_>I *,]Z*3)'44;@>^* $;KT_2G#I3#]<TH
M)["F ZCGUIA+T#KS2L K"EZ"D-+C(H  2?\ ]5+FD (I?F]J %HIIQWI1TXI
M &::5/;%.Y[TA!IH!F&[TX?[V*#]:3!IA8>,^HI::#3JD HHHH 9( 16!JJ?
M(V,5T#=*PM5W%6IH#S375.6S7!Z@@+'K7HFMQD[N*X348?G-6!S$T/)(-0>7
MSS_*M.>-?0U0D !X_6D JD#TJ3S5 [56PU&TGWH DD<,.GZ5 5W?_JI2KXZ@
M4S++U(H$2*A]JE"X[?I4(DQUIRS"D \COQ33^=*7W=,5&T3GH<4#'9-(<^GZ
M4*C+UJ0#WQ3L P9[+3L-WIV<<9%*<&FA#,TX#_.*,"EY[55Q7'*G/7]*L+FH
M$QWSFK"[NW\J+DMDB_YXIVTTT!Z<-U KCL<=ORIN#VI^2!29]C2&( >]+M_S
MBE##TI<BF,!_GBCF@$4[/M0,3!]#0./_ -5+ANQ%)]10 [@]>:D&/2HP!2YQ
M0!)@]J.>ZTT/Z4_/M30(:,?_ *ZD55/8?E3<@]14B\\"D[#)!"6^ZH_E4,NF
MR2_PU:B5QT.:M(6'7-2P.:G\./)_ 35-O"LN<[37=1N>XQ5E K#DC\J5Q' 0
M^&Y%/W#74:/HSHRYC/Y5OQ6\9/05M6-M&".*0[&EH>GQ@+N0_E7:VMC;&/&T
M5AZ>$CQWKI+61=O2D,8^BV<@YC%8M_X0MIP=L8%=4K BG4@/)-6^'@E#;(R:
MX;5/AM<H6*P-BOI(HIZJ*K3:?!.#N4<T ?)%_P"$+RV)Q&PQ[5B3:9>0\%#^
M5?7=WX3LK@']TO-85W\/+.7.(5J@/E-XKA3AE/Y5"1(#S7TG>?"V-LE85K"N
MOA/*V?+A2G<1X:N0.AI_7L?Q%>I7/PJU!"=L0K*N/AMJJ?\ +.@#A1".N:GB
MMHV/.:Z*3P-JL)YBJ ^&=0B/*?E3N,K6UH,C ./I6K%;(!R*@33[J'KQ4P,Z
M=1FD(E*(HX6H) O?%/,C=Q4;-G^'- %9P@Z?RJ+(/;\ZM%-W\(%-,&>N*6XR
MKE<]J"5]JG:W([5&81_$:&!#GGC^5*&/I3O+4'K3@%]/SH$(&)J1?\\4FY1Q
MBC<!3 DPN.0,U&3GM2$[NE 1O2D A8CH:<)&%+Y1)JQ% ,\XI@-2X?L:N0W$
MOIFD$<8[ U.AC7HM.X$PN)<=*C>1CZ#\*?O6DW*>U*X%&8;N2,UGS#'K6TT.
M\_*#36TJ:8?*GZ4 <XPYZD?2D4NI[_E72Q^%[R7HM68_!&H.?N$T <TEQ(!P
MWZ4C7=SV)/X5V</@"_8\Q_K6M:?#BZ8C=#^M,#S5;Z]!PJ&M&UFO92,J?RKU
MNQ^&@X\R(5T-I\/K6,#= M(#R"ST^YGQE3^5=-IWAR:0C=&:]5M/!]E!C]RM
M:L.C6L/1!2N,X/3O"@.,QXKI+7PQ$BC*"ND2WBC^Z@%2TK@9<.C6Z=8ZM)80
M)T45:HI ,$2#HHIV!Z4M% !@>E%%% !2'=VQ2TGS9[4 -/F=L4@\SOBI**=P
M 4444@$8D#BH6:0_PFIZ* *X#YJ0(W?%244 (!BEI#GM0,]\4 &T9SBEHHH
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MDYQUI#]<T +GG_Z]*6QZ4T ]J4Y[FF [.1S3<@="32<>AS2@-_\ KH ,'/\
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MX5NW\Z>%]10!&H;N:E5%/_ZZ48';]*?D=J:$Q5C'9L?C4@##N?SI%Z<_SIX
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MX'CMO\.I2/G3_P =K3@^'*?QQ+^5>H8'I2TK@<';_#ZS0?-"OY5HP^";"/\
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MSIBQ,.]/&5ZYJD!,.G_UZA9FSS3]XQUIIP>F:!D3'/\ ^NH#N!Z_K5O83_\
M7IODY]:I"*P8]R?SIP.>A-3_ &<CI_.D\HKUIC& 'UI"A/?]:?2[CZT]!$#0
MGU-,,9 ^[5O=_D4P@DU(%4*W;-68-P8<4]86/>K$<+9ZFD!HV;$8Z5M0D%>E
M9%I$1CFM>-2%[4@)MI[<TQE^HH&??\Z4N<8_K2L! X ZDU&&3/K4C.1T IH
M8Y(H8$J8[8_.KULFYAQ^M4XXR3P#6K912[ACI2 V+&W#8QBNFL-/R <50TF
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MY?3%  V[M3=Q[T[/H32]O_K4 1FCFGC/I1WY_E0%A@I^WCO0<'_]5.[47 :
M:=B@9]:*0AK#TI-IIYS3<>YH0##GWH^:G#C_ /52]3_]:F,;S3@N1WI<#T)I
M>W Q2N#$ /K3J09]:6D 44A.* <T !&16=>1L5-:55;E<H>OY4TP.*U2WX:N
M+U*$@GK7?:DN=V:Y#4D49X/Y4P.&OX^O%8%PI4UU.HCD\8_"N:NHRQ.,'\*
M,YBV>HIF#GD4]H7W=*<(']30 P9Q1AZD\MEZ_P J7..P_*F(AYI<&G[AGM2[
MU[C%(!F"*7<:"2>A/Y4"-C[T[##+>M. ;OFG!".M*1CH<?A0A"8^M'S4X _6
M@@_YYJR11N[XIX"_2FKGTIV#Z4$L>N:=G':HPO&>?RI5R3W/X4(5B4%NU.W'
MN*:,CM^E*.?_ -5!20_(QQQ2#.>#2=.Q_*CGM0.P[YN]&*09[FC!':F,>,T
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MBBB@ HHHH 3 ]*6BB@ HHHH **** "DP<]:6B@ HHHH **** "BBB@ HHHH
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ML7CQDUHHNT8X_*IN,=1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR:0QE.'^>:< #UHSCH!1< R!T%&210U)DT"&G_/- .*#2]J8!N)IO>EQ28H
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M]30.P\?7]:48]:9O';-.% A^3ZTH;_.:9CW-+]: 'Y^GYTN3BF<=LTF.>IH
MD!S4J_YYJ)<U*H]?YTQDJ@>@JP@ J.*//3BI,$<9I6 F4^_ZT[(]:@_$TX%@
M* )UQ_DT\+GN*@5\]14RLN>!^M+4"Q"I!X8_A71Z7OW+SGZFL" /D8Q71:8)
M-RT =QI60!G^==)#]W_Z]<WI60!G-=)#]VH8R6BC(HJ0"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHI,CUH 6BHVG1>K#\ZKR:E;Q_><4
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M, MFNMTW422O)KEK'0;AR,&NJT_0;F/!.*&!UEC=[@.:UXWRO6L2QTZ10-Q
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M3G'6@&F;N>E(318+C\^_ZTX%NV:B!:G GTQ18+DN6QS0&YZG\Z:,XZTFUO\
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MU\/)#CBE<#,TRS? R*Z:W@VJ,BI(+1(AP*L 8%)L8!0*6BBI **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 8%H*<]Z<,]S2T[@,*\=Z N?6G\TG/>BX";<=Z#]*=2'/8T7
M :1]: /K3B">]-VD4 @QS05^M&T^M.P?6BXQFTBC!["G\T<T7 ;L]31MIV.:
M"#VHN(,<4@%!'%(..WZ4"%SST-!!-'/K2X/8T )C I!G_(IW--^:@: CFE(^
MM)CGI3N<<4#&Y;TH HVL?XJ-IIB$(Q24[::4CC_ZU%P&?C2\>E&#Z4 ?A^%
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MER,C%8=L[!A716$C''2D!U.GVT:J/E!_"MJ-(PO"C\JP[%FP.?R%;41.T5+
ML<44BD]Z6H&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @W=\4M%% !1110
M 444ASV H 6BBB@ HHHH **** $YS2T4G- "T444 -P,TO/:EHH 09[TM%%
M!112<T +11S10 F!1SVHYI: $YQS31C-/HIW 3GMBD(/K3J*0#11@Y[4O-+3
M C/UI<$BGXHHN P*?6C S3L4M%P&-BE_AI<4M%P& 4;3GM3Z3%%P&L/>FX-/
M()Z?SHP<=:=P(]K48/>I #_DTA!S_P#7H ;C':G8&.M!!]:4#BBX#**=M-&T
MT7 ;SW-&#VIVTTH!QUHN!'DBDR3VJ3 />C:: &;3W%+L!%29P.:,@CBD!#M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'!L':I@,4M%3< I#12'/:@3$P?6EYQUHPW<TA0]F- "9P:7>:;L;UI"I'?\
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MO]FG'! _"@"XEV&[U*)AZUGK8R+T8U*L$HXW?K3L!>$BFG @]ZJB-UZ_SJ0
MTK 3T4Q?\\T[;[FD M%(<]A1U'- "T4@&.YI: "BD(SZT 8H 6BBB@ HHHH
M**** "BBB@ HHII!SQ_.@!U%(.E+0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMB@!:*09[TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYS1NY_\ KT6 ?1124@%HI.?2FD-_DTP'$@4N<U'S3ATHL ZDR*!CUII!S_\
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MY<?E3T HP^(+)OOI5Z+5-/E/"XJI+X&N4^Z/R%1#PE>Q'(!'X4: ;T9MI/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0Y[&EHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI/FSQB@!:*** "BBD.[MB@
M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** $S2T44"04444#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939801328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 27, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001607962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ReWalk Robotics Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3 Hatnufa Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Floor 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Yokneam Illit<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2069203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">4.959.0123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, par value NIS 0.25 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFWD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-Known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,050,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,480,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KOST FORER GABBAY &<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel-Aviv, Israel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm Id</a></td>
<td class="text">1281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111940926816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 28,083<span></span>
</td>
<td class="nump">$ 67,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivable, net of credit losses of $328 and $26, respectively</a></td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">5,653<span></span>
</td>
<td class="nump">2,929<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">39,222<span></span>
</td>
<td class="nump">72,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>LONG-TERM ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Restricted cash and other long-term assets</a></td>
<td class="nump">784<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,861<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IntangibleAssetsNonCurrent', window );">Intangible assets</a></td>
<td class="nump">12,525<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,538<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
<td class="nump">23,970<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">63,192<span></span>
</td>
<td class="nump">74,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Trade payables</a></td>
<td class="nump">5,069<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and payroll accruals</a></td>
<td class="nump">2,034<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,504<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases liability</a></td>
<td class="nump">1,296<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_EarnoutLiabilityCurrent', window );">Earnout liability</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">685<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,795<span></span>
</td>
<td class="nump">4,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_LongTermEarnoutLiability', window );">Earnout liability</a></td>
<td class="nump">2,716<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenues</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating leases liability</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">4,887<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">16,682<span></span>
</td>
<td class="nump">6,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary share of NIS 0.25 par value-Authorized: 120,000,000 shares at December 31, 2023 and December 31, 2022; Issued: 64,132,706 and 63,023,506 shares at December 31, 2023 and December 31, 2022, respectively; Outstanding: 60,110,099 and 60,090,298 shares as of December 31, 2023 and December 31, 2022 respectively</a></td>
<td class="nump">4,487<span></span>
</td>
<td class="nump">4,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">281,109<span></span>
</td>
<td class="nump">279,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury Shares at cost, 4,022,607 and 2,933,208 ordinary shares at December 31, 2023 and December 31, 2022 respectively</a></td>
<td class="num">(3,203)<span></span>
</td>
<td class="num">(2,431)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(235,883)<span></span>
</td>
<td class="num">(213,750)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">46,510<span></span>
</td>
<td class="nump">68,165<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 63,192<span></span>
</td>
<td class="nump">$ 74,236<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_EarnoutLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Earnout liability current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_EarnoutLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_IntangibleAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Intangible assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_IntangibleAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_LongTermEarnoutLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Earnout Liability non current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_LongTermEarnoutLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939900432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses | $</a></td>
<td class="nump">$ 328<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">64,132,706<span></span>
</td>
<td class="nump">63,023,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">60,110,099<span></span>
</td>
<td class="nump">60,090,298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock common shares</a></td>
<td class="nump">4,022,607<span></span>
</td>
<td class="nump">2,933,208<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934430880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 13,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5,511<span></span>
</td>
<td class="nump">$ 5,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">9,401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,606<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">4,453<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,905<span></span>
</td>
<td class="nump">2,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="nump">4,148<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,031<span></span>
</td>
<td class="nump">2,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">13,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,842<span></span>
</td>
<td class="nump">6,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">9,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,134<span></span>
</td>
<td class="nump">5,626<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">28,065<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,007<span></span>
</td>
<td class="nump">15,558<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(23,612)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,102)<span></span>
</td>
<td class="num">(12,655)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_FinancialExpensesIncomeNet', window );">Financial income, net</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(22,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,102)<span></span>
</td>
<td class="num">(12,642)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Taxes on income (benefit)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">467<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (22,133)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (19,569)<span></span>
</td>
<td class="num">$ (12,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per ordinary share, basic | (per share)</a></td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per ordinary share, diluted | (per share)</a></td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares used in computing net loss per ordinary share, basic | shares</a></td>
<td class="nump">59,719,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,378,797<span></span>
</td>
<td class="nump">47,935,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares used in computing net loss per ordinary share, diluted | shares</a></td>
<td class="nump">59,719,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,378,797<span></span>
</td>
<td class="nump">47,935,652<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents an amount lower than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_FinancialExpensesIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate amount of financial expense or income from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_FinancialExpensesIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111932772992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary Share [Member]</div></th>
<th class="th"><div>Additional paid-in capital [Member]</div></th>
<th class="th"><div>Treasury Shares [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="nump">$ 201,392<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (181,445)<span></span>
</td>
<td class="nump">$ 21,774<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">25,332,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation to employees and non-employees</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares</a></td>
<td class="nump">398,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1', window );">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses</a></td>
<td class="nump">$ 832<span></span>
</td>
<td class="nump">35,489<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1', window );">Issuance of ordinary shares in a "Best Efforts" offering, net of issuance expenses, shares</a></td>
<td class="nump">10,921,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue', window );">Exercise of pre-funded warrants and warrants</a></td>
<td class="nump">$ 772<span></span>
</td>
<td class="nump">14,288<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares', window );">Exercise of pre-funded warrants and warrants, shares</a></td>
<td class="nump">10,425,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1', window );">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses</a></td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">26,932<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1', window );">Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses, shares</a></td>
<td class="nump">15,403,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,736)<span></span>
</td>
<td class="num">(12,736)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">62,480,163<span></span>
</td>
<td class="nump">4,661<span></span>
</td>
<td class="nump">278,903<span></span>
</td>
<td class="num">(194,181)<span></span>
</td>
<td class="nump">89,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation to employees and non-employees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares</a></td>
<td class="nump">543,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_Sharesissuedduringperiodvaluetreasurystock', window );">Treasury shares at cost</a></td>
<td class="num">$ (211)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,642)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares at cost (shares)</a></td>
<td class="num">(2,933,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,569)<span></span>
</td>
<td class="num">(19,569)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 4,489<span></span>
</td>
<td class="nump">279,857<span></span>
</td>
<td class="nump">2,431<span></span>
</td>
<td class="num">(213,750)<span></span>
</td>
<td class="nump">68,165<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">60,090,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation to employees and non-employees</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares</a></td>
<td class="nump">1,109,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_Sharesissuedduringperiodvaluetreasurystock', window );">Treasury shares at cost</a></td>
<td class="num">$ (78)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(772)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares at cost (shares)</a></td>
<td class="num">(1,089,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="num">(22,133)<span></span>
</td>
<td class="num">(22,133)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 4,487<span></span>
</td>
<td class="nump">$ 281,109<span></span>
</td>
<td class="num">$ (3,203)<span></span>
</td>
<td class="num">$ (235,883)<span></span>
</td>
<td class="nump">$ 46,510<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">60,110,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_Sharesissuedduringperiodvaluetreasurystock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represent shares issued during period value treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_Sharesissuedduringperiodvaluetreasurystock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of further shares issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of further shares issuance of ordinary shares in a "best efforts" offering, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of further issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_StockIssuedDuringPeriodValueOrdinaryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of further issuance of ordinary shares in a "best efforts" offering, net of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_StockIssuedDuringPeriodValueOrdinaryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937685520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_BestOfferingMember', window );">Best Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="nump">$ 3,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_RegisteredDirectOfferingMember', window );">Registered Direct [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses, amount</a></td>
<td class="nump">$ 3,215<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_BestOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lfwd_BestOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lfwd_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934291088">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (22,133)<span></span>
</td>
<td class="num">$ (19,569)<span></span>
</td>
<td class="num">$ (12,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">239<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,328<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_EarnOutRemeasured', window );">Remeasurement of earnout liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(315)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax', window );">Exchange rate fluctuations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(311)<span></span>
</td>
<td class="num">(408)<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses, operating lease right-of-use assets and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(531)<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="num">(884)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employees and payroll accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredLiabilities', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(269)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Operating lease liabilities and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(973)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
<td class="num">(391)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(20,667)<span></span>
</td>
<td class="num">(17,891)<span></span>
</td>
<td class="num">(11,469)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of a business, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(18,068)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(18,149)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582', window );">Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount of $3,679</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo', window );">Issuance of ordinary shares in a &#8220;registered direct&#8221; offering, net of issuance expenses in the amount of $3,215</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ExerciseOfPreFundedWarrants', window );">Exercise of pre-funded warrants and warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PaymentsForPurchaseOfTreasuryStock', window );">Purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(992)<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
<td class="nump">79,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(39,763)<span></span>
</td>
<td class="num">(20,495)<span></span>
</td>
<td class="nump">67,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,555<span></span>
</td>
<td class="nump">89,050<span></span>
</td>
<td class="nump">21,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,792<span></span>
</td>
<td class="nump">68,555<span></span>
</td>
<td class="nump">89,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of non-cash flow information</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet', window );">Classification of other current assets to property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet', window );">Classification of inventory to property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">481<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PaymentToRepurchaseOfShares', window );">Amounts related to shares re-purchase not yet paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets obtained from new lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">513<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SupplementalDisclosuresOfCashFlowInformation', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">126<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_InterestReceived', window );">Cash received from interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,341<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flows</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,083<span></span>
</td>
<td class="nump">67,896<span></span>
</td>
<td class="nump">88,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash included in other long-term assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">709<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total Cash, cash equivalents, and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28,792<span></span>
</td>
<td class="nump">$ 68,555<span></span>
</td>
<td class="nump">$ 89,050<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 9a.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">See Note 9f.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Classification of Inventory to Property and Equipment, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Classification of other net current assets to property and equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_EarnOutRemeasured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information about earnout remeasured.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_EarnOutRemeasured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ExerciseOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of pre-funded warrants and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ExerciseOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_InterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount Cash received from interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_InterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PaymentToRepurchaseOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent amount of cash out flow of shares repurchased not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PaymentToRepurchaseOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PaymentsForPurchaseOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount represents for Payments For Purchase Of Treasury Stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PaymentsForPurchaseOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ProceedsFromIssuanceOfRegistrationCostTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in a "registered direct" offering, net of issuance expenses in the amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ProceedsFromIssuanceOfRegistrationCostTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_SupplementalDisclosuresOfCashFlowInformation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Disclosures of Cash Flow Information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_SupplementalDisclosuresOfCashFlowInformation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111938358416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="nump">$ 3,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_RegisteredDirectMember', window );">Registered Direct [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses paid</a></td>
<td class="nump">$ 3,215<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_RegisteredDirectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lfwd_RegisteredDirectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936747744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:72pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>NOTE 1:-</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>GENERAL</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>a.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>ReWalk Robotics Ltd. (&#8220;RRL&#8221;, and together with its subsidiaries, the &#8220;Company&#8221;) was incorporated under the laws of the State of Israel on June 20, 2001 and commenced operations on the same date.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>b.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>RRL has three wholly-owned (directly and indirectly) subsidiaries: (i) ReWalk Robotics, Inc. (&#8220;RRI&#8221;) incorporated under the laws of Delaware on February 15, 2012, (ii) ReWalk Robotics GMBH (&#8220;RRG&#8221;) incorporated under the laws of Germany on January 14, 2013, and (iii) AlterG, Inc. (&#8220;AlterG&#8221;) incorporated in Delaware on October 21, 2004 under the name of Gravus, Inc. On June 30, 2005, the Company re-incorporated in Delaware and changed its name to AlterG, Inc. in September 2005.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>c.</span></span></span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company is a medical device company that is designing, developing, and commercializing innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions. The Company&#8217;s initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury (collectively, the &#8220;SCI Products&#8221;). These devices are robotic exoskeletons that are designed for individuals with paraplegia that use the Company&#8217;s patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. These SCI Products allow individuals with spinal cord injury the ability to stand and walk again during everyday activities at home or in the community.</span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has sought to expand the product offerings beyond the SCI Products through internal development and distribution agreements. The Company has developed its ReStore Exo-Suit device, which it began commercializing in June 2019. The ReStore is a powered, lightweight soft exo-suit intended for use during the rehabilitation of individuals with lower limb disability due to stroke. During the second quarter of 2020, the Company signed two separate agreements to distribute additional product lines in the United States. The Company is the exclusive distributor of the MYOLYN MyoCycle FES Pro cycles to United States (&#8220;U.S.&#8221;) rehabilitation clinics and for the MyoCycle Home cycles available to US veterans through VA hospitals. In the second quarter of 2020, the Company also became the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States; however, due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023. We refer to the MediTouch and MyoCycle devices as the Company&#8217;s &#8220;Distributed Products.&#8221;</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>On August 11, 2023, pursuant to an Agreement and Plan of Merger among RRI, AlterG, Atlas Merger Sub, Inc., a wholly owned subsidiary of RRI (&#8220;Merger Sub&#8221;), and Shareholder Representative Services LLC, dated August 11, 2023, RRI acquired AlterG and AlterG became a wholly owned subsidiary of the Company.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>For accounting purposes, RRI was considered the acquirer and AlterG was considered the acquiree. The acquisition was accounted for using the acquisition method of accounting. See Note 5 for additional information.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company made its first acquisition to supplement its internal growth when it acquired AlterG, a leading provider of AlterG Anti-Gravity systems for use in physical and neurological rehabilitation. &#160;The Company paid a cash purchase price of $19.0 million at closing and additional cash earnouts may be paid based upon a percentage of AlterG&#8217;s year-over-year revenue growth over the two years following the closing. The AlterG Anti-Gravity systems use patented, NASA-derived Differential Air Pressure (&#8220;DAP&#8221;) technology to reduce the effects of gravity and allow people to rehabilitate with finely calibrated support and reduced pain. &#160;The Company will continue to evaluate other products for distribution or acquisition that can broaden its product offerings further to help individuals with physical and neurological injury and disability.</span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company markets and sells its products directly to institutions and individuals and through third-party distributors. The Company sells its products directly primarily in the United States, through a combination of direct sales and distributors (depending on the product line) in Germany, Canada, and Australia, and primarily through distributors in other markets. In its direct markets, the Company has established relationships with clinics and rehabilitation centers, professional and college sports teams, and individuals and organizations in the spinal cord injury community, and in its indirect markets, the Company&#8217;s distributors maintain these relationships. RRI and AlterG market and sell products mainly in the United States. RRG markets and sells the Company&#8217;s products mainly in Germany and Europe.</span></span></span></span></div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25">
              <div></div>
            </div>
            <div style="text-align:justify;line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>d.</span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company depends on one contract manufacturer to manufacture the ReWalk and the ReStore products in its portfolio, Sanmina. Reliance on this vendor makes the Company vulnerable to possible capacity constraints and reduces control over component availability, delivery schedules, manufacturing yields and costs.</span></span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">
              <div style="text-align:justify;line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>e.</span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>For the full year ended December 31, 2023 the Company incurred a consolidated net loss of $22.1 million and has an accumulated deficit in the total amount of $235.9 million. The Company&#8217;s negative operating cash flow for the full year ended December 31, 2023 was $20.7 million. Our cash and cash equivalent on December 31, 2023 totalled $28.1 million. The Company has sufficient funds to support its operation for more than 12 months following the approval of its consolidated financial statements for the fiscal year ended December 31, 2023.</span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company expects to incur future net losses and the transition to profitability is dependent upon, among other things, the successful development and commercialization of the Company&#8217;s products and product candidates, the establishment of contracts for the distribution of new product lines, or the acquisition of additional product lines, any of which, or in combination, would contribute to the achievement of a level of revenue adequate to support the cost structure. Until the Company achieves profitability or generates positive cash flows, it will continue to need to raise additional cash. The Company intends to fund future operations through existing cash on hand, additional private and/or public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, the Company may seek additional capital through arrangements with strategic partners or from other sources and will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.</span></span></span></span></span></span></div>
            </div>
          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936747744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:72pt;vertical-align:top;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2:-</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SIGNIFICANT ACCOUNTING POLICIES</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;), applied on a consistent basis, as follows:</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt;vertical-align:top">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of Estimates</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions. The Company&#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company&#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards, contingent liabilities, provision for warranty, allowance for credit losses and sales return reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial Statements in U.S. Dollars:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The functional currency is the currency that best reflects the economic environment in which the Company and its subsidiaries operate and conduct their transactions. Most of the Company&#8217;s revenues and costs are incurred in U.S. dollar. In addition, the Company&#8217;s financing activities are incurred in U.S. dollars. The Company&#8217;s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#8217;s and its subsidiary's functional and reporting currency.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with ASC 830 &#8220;Foreign Currency Matters.&#8221; All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the consolidated statements of operations as financing income or expenses as appropriate.</span></span></div>
          </div>

        <p style="margin:0pt">&#160;</p>
        <div></div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of Consolidation:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances have been eliminated upon consolidation.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash Equivalents:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories are stated at the lower of cost or net realizable value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company periodically evaluates the quantities on hand relative to historical, current, and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its net realized value.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost is determined as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products - based on raw materials and manufacturing costs on an average basis.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials - The weighted average cost method.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value. If actual demand for the Company&#8217;s products deteriorates, or market conditions are less favourable than those projected, additional inventory reserves may be required.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and Equipment:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20-33 (mainly 33)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6 - 10 (mainly 10)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20-50</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over the shorter of the lease term </span></span></div>
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>or estimated useful life</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Business Combinations</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for business combinations in accordance with ASC 805, &#8220;Business Combinations&#8221; (&#8220;ASC 805&#8221;). For business combinations accounted for under the acquisition method, ASC 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. The Company determines the recognition of intangible assets based on the following criteria: (i) the intangible asset arises from contractual or other rights; or (ii) the intangible asset is separable or divisible from the acquired entity and capable of being sold, transferred, licensed, returned or exchanged.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The excess of the fair value of the purchase price over the fair values of the identifiable assets and liabilities is recorded as goodwill. Determining the fair value of the identifiable assets and liabilities requires management to use significant judgment and estimates including the forecasted revenue and revenues growth rates, discount rates, customer contract renewal rates and customer attrition rates. The process of estimating the fair values requires significant estimates, especially with respect to intangible assets. Management&#8217;s determination of fair value of assets acquired and liabilities assumed at the acquisition date is based on the best information available in the circumstances and incorporates management&#8217;s own assumptions and involves a significant degree of judgment.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition related costs include legal fees, consulting and success fees, and other non-recurring integration related costs. Acquisition-related costs are expensed as incurred.</span></span></div>
          </div>

        <p style="margin:0pt">&#160;</p>
        <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">
          <div></div>
        </div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill and Other Intangibles</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has no indefinite-lived intangible assets other than goodwill. Acquired identifiable finite-lived intangible assets include identifiable acquired technology, customer relationships, trademarks and backlog and are amortized on a straight-line basis over the estimated useful lives of the assets. The Company routinely reviews the remaining estimated useful lives of finite-lived intangible assets.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill is not amortized and is tested for impairment at least annually.</span></span></div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates as one reporting unit and the fair value of the reporting unit is estimated using quoted market prices of the Company&#8217;s stock in active markets. The Company tests goodwill for impairment annually in the fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When testing goodwill for impairment, the Company may first perform a qualitative assessment. If the Company determines it is not more likely than not the reporting unit&#8217;s fair value is less than its carrying value, then no further analysis is necessary. If the Company determines that it is more likely than not that the fair value of its reporting unit is less than its carrying amount, then the quantitative impairment test will be performed. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Under the quantitative impairment test, if the carrying amount of the Company&#8217;s reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, no impairments of goodwill have been recognized.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of Long-Lived Assets</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s long-lived assets, including right-of-use (&#8220;ROU&#8221;) assets and identifiable intangible assets that are subject to amortization, are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2023, 2022 and 2021, no impairment losses have been recorded.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash and Other long-term assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company repurchased its ordinary shares and holds them as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction of shareholders' equity.</span></span></div>
          </div>

        <p style="margin:0pt">&#160;</p>
        <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif">
          <div></div>
        </div>
        <div>

            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue Recognition:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to clinics and rehabilitation centres, professional and college sports teams, private individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), and distributors.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in accordance with ASC 606, &#8220;Revenue Recognition&#8221; when, or as, control of the promised good or service is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company applies the following five steps:</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the contract with a customer</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generally considers a purchase order or a signed quote to be a contract with a customer. In evaluating the contract with a customer, the Company analyzes the customer&#8217;s intent and ability to pay the amount of promised consideration (credit risk) and considers the probability of collecting substantially all of the consideration.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the performance obligations in the contract</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At a contract&#8217;s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determine the transaction price</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not offer extended payment terms beyond one year to customers.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocate the transaction price to performance obligations in the contract</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognize revenue when or as the Company satisfies a performance obligation</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control either transfers over time or at a point in time, which affects when revenue is recorded.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has elected to apply the practical expedient for financing component for transactions in which the difference between the payment date and the revenue recognition timing is up to 12 months.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disaggregation of Revenue (in thousands):</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:36pt">

                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,681</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,175</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,916</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,033</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">859</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">533</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranty</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,140</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">477</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">517</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,854</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,511</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,966</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>

              </div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product revenue</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from Products is comprised of sale of Anti-Gravity products, sale of systems products to rehabilitation facilities and sale of ReWalk Personal Exoskeleton systems to end users. Revenues generated from the sale of Products are recognized at a point in time, once the customer has obtained the legal title to the items purchased.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For systems sold to rehabilitation facilities, the Company includes insignificant training and considers the elements in the arrangement to be a single performance obligation. Therefore, the Company recognizes revenue for the system only when control is transferred after delivery and when the training has been completed, in accordance with the agreements terms with the customer.</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                  <div></div>
                </div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For sales of ReWalk Personal Exoskeleton systems to end users, and for sales of ReWalk Personal or ReWalk Rehabilitation Exoskeleton systems to third party distributors, the Company does not provide training to the end user as this training is completed by the rehabilitation center or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generally does not grant a right of return for its products. In rare circumstances when the Company provides a right of return for its products. the Company records reductions to revenue for expected future product returns based on the Company&#8217;s historical experience and estimates.</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023, the Company offered six products: (1) ReWalk Personal Exoskeletons, (2) ReWalk Rehabilitation Exoskeleton, (3) ReStore, (4) AlterG Anti-Gravity systems, (5) MyoCycle and (6) MediTouch. Due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental revenue</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental revenue for the AlterG Anti-Gravity systems is accounted for under ASC Topic 842, Leases. The Company rents its products to customers for a fixed monthly fee over the rental term, which typically ranges from 2 to 3 years. Rental revenues are recorded as earned on a monthly basis. See Note 2x for additional information.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the SCI Products, the Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee for a limited period prior to selling its products.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranties</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company services its products after expiration of the initial warranty. Service revenue, consisting of time and materials to perform the repairs, is recorded as services are rendered.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determining the transaction price requires of level judgment, which is discussed by revenue category in further detail below.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranties are classified as either an assurance type or a service type warranty. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended for a limited period of time. An assurance type warranty is not accounted for as a separate performance obligation under the revenue model.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SCI Products include a <span style="-sec-ix-hidden:Fxbrl_20230214112251731"> five -year warranty</span>. The first  two years are considered as an assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. A service type warranty is either sold with a unit or separately for a unit for which the warranty has expired. A service type warranty is accounted as a separate performance obligation and revenue is recognized ratably over the life of the warranty.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The ReStore device is sold with a two-year warranty which is considered as assurance type warranty.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Distributed Products are sold with assurance type warranty ranging between three years to ten years, depending on the specific product and part.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">or AlterG Anti-Gravity Products, the Company offers customers extended warranty contracts that extend or enhance the technical support, parts, and labor coverage offered as part of the base warranty included with the Anti-Gravity system products. Extended warranty revenue is recognized ratably over the extended warranty coverage period. The Company offers a one-year assurance type warranty to customers in the U.S. and two years assurance type warranty for spare parts only to its international distributors. For these products, the Company determines standalone selling price based on the price at which the performance obligation is sold separately.</span>
                <p style="margin:0pt">&#160;</p>
              </div>
              <div style="line-height:1.25">
                <div></div>
              </div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract balances (in thousands):</span></span></div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>

                <div>
                  <div style="margin-left:36pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivable, net of credit losses (1)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,120</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,036</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues (1) (2)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,010</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance presented net of unrecognized revenue that was not yet collected.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$435 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>

              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenue which represent a contract liability, include unearned amounts related to service type warranty obligations as well as other advances and payments which the Company received from customers prior to satisfying the performance obligation, for which revenue has not yet been recognized. The Company's unearned performance obligations as of December 31, 2023 and the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.</span></span></div>
            </div>

        </div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounting for Share-Based Compensation:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for share-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#8220;OPM&#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s consolidated statements of operations.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company account for forfeitures as they occur.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility is calculated based on actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options, or based on certain peer companies that the Company considered to be comparable, in case there is no sufficient trading volume to rely on market volatility. The expected option term is determined based on the simplified method, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of Restricted Stock Units (&#8220;RSUs&#8221;) granted is determined based on the price of the Company&#8217;s ordinary shares on the date of grant.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for options granted to consultants and other service providers under ASC 718. The fair value of these options was estimated using a Black-Scholes-Merton option-pricing model.</span></span></div>
          </div>

        <div style="line-height:1.25;margin-left:18pt">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants to Acquire Ordinary Shares:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the twelve -month ended December 31, 2021, the Company issued warrants to acquire up to 15,083,611 ordinary shares. There were no issued warrants during the twelve months ended December 31, 2023 and 2022. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815 "Derivatives and Hedging" and determined that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 9f for additional information.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and Development Costs:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the Company received for research and development in the period in which the grant was received.</span></span></div>
          </div>

        <p style="margin:0pt">&#160;</p>
        <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif">
          <div></div>
        </div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">p.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income Taxes</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its taxes on income. As of December 31, 2023, and 2022, the Company did not identify any significant uncertain tax positions.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty provision:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For assurance-type warranty, the Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US Dollars</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">92</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG acquisition &#8211; see note 5</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">535</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">200</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Usage</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(479</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">348</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">r.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of Credit Risks:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution. The bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration exists with respect to these deposits.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The below table reflects the concentration of credit risk for the Company&#8217;s current customers as of December 31, 2023, to which substantial sales were made.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:36pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000446">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000448">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer C</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer D</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></div>
                      </td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>

            <div style="line-height:1.25">
              <div></div>
            </div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance for credit losses is based on the Company's assessments of factors that may affect a customer's ability to pay. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current customer's aging balance, the nature and size of the customer, the financial condition of the customer, and the amount of any receivables in dispute. The Company does not have any off-balance sheet credit exposure related to its customers. As of December 31, 2023, and 2022 trade receivables are presented net of $328 thousand and $26 thousand allowance for credit losses, respectively.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">s.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued Severance Pay:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. All of the employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#8220;section 14&#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Company&#8217;s expenses related to severance pay amounted to $114 thousand , $113 thousand and $104 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Measurements:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company uses a three -tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The three -tiers are defined as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 1. </span>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 2. </span>Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 3. </span>Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such instruments.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables present information about the Company&#8217;s financial assets and liabilities that are measured in fair value on a recurring basis as of December 31, 2023 and December 31, 2022 (in thousands):</span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements as of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Hierarchy</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial assets:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,550</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury bills included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,525</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Assets Measured at Fair Value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,075</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial Liabilities:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities measured at fair value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>

            <div style="line-height:1.25">
              <div></div>
            </div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies cash equivalents within Level 1, because the Company uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair values.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The earnout was valued using a Monte Carlo simulation analysis, which is considered to be a Level 3 fair value measurement.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the earnout liability activity as of December 31, 2023 (in thousands):</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:85.4%;vertical-align:top">&#160;</td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial Measurement (August 11, 2023)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,607</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in fair value</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December 31, 2023</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>

        <div>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="text-align:justify;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">u.<span style="padding-left:7pt">&#160;</span>Basic and Diluted Net Loss Per Share:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted loss per share is computed based on the weighted average number of ordinary shares outstanding during the period, plus dilutive potential shares considered outstanding during the period.</span></span></div>
            </div>

        </div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.<span style="padding-left:8pt">&#160;</span>Contingent liabilities</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for its contingent liabilities in accordance with ASC 450, &#8220;Contingencies.&#8221; A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.<span style="padding-left:8pt">&#160;</span>Government grants</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalty and non-royalty-bearing grants from the Israeli Innovation Authority (the &#8220;IIA&#8221;) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a reduction from research and development expenses (see Note 8c).</span></span></div>
          </div>

        <p style="margin:0pt">&#160;</p>
        <div style="line-height:1.25">
          <div></div>
        </div>

          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x.<span style="padding-left:8pt">&#160;</span>Leases</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating lease liabilities and their corresponding right-of-use assets are recorded at commencement date based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items, such as initial direct costs paid or incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </span></span></div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lessor accounting - Operating leases</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A portion of the AlterG rental revenues for the AlterG Anti-Gravity systems are made through lease arrangements.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG products are available for lease agreements ranging from 12 to 42 months. If the customer terminates the contract during the lease period, they are required to pay a cancellation fee. The lease period may be extended by an additional period as specified in the contract.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In determining the leases classification as a sales type or operating lease, the Company assesses, among other criteria: (i) the lease term to determine if it is for the major part of the economic life of the underlying equipment; and (ii) the present value of the lease payments to determine if they are equal to or greater than substantially all of the fair market value of the equipment at the inception of the lease AlterG Anti-Gravity systems. When these criteria are not met, the lease accounted for as operating leases and revenues are recognized over the term of the lease.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under these arrangements, when the Company acts as the lessor for its product line, the Company accounted for the lease arrangements as operating leases in accordance with ASC 842, &#8220;Lease&#8221; (&#8220;ASC 842&#8221;).</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total rental revenue for the AlterG Anti-Gravity Products has amounted to $249 thousand from the time of acquisition through December 31, 2023.</span></span></div>
          </div>

        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">y. <span style="padding-left:20pt">&#160;</span>New Accounting Pronouncements</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recently Implemented Accounting Pronouncements</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td rowspan="1" style="width:13.57%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                      <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.&#160; &#160; &#160; &#160; &#160; &#160;Financial Instruments</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The Company adopted ASU 2016-13 as of January 1, 2023. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recent Accounting Pronouncements Not Yet Adopted</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:10%;vertical-align:top">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:6%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></div>
                  </td>
                  <td style="width:84%;vertical-align:top">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, &#8220;Income Taxes - Improvements to Income Tax Disclosures&#8221; requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impact of the adoption of this standard.</span></span></div>
                    <div style="text-align:justify;line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:10%;vertical-align:top">&#160;</td>
                  <td style="width:6%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii.</span></span></div>
                  </td>
                  <td style="width:84%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In&#160;November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, &#8220;Segment Reporting&#8221; on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>

      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936681776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock', window );">PREPAID EXPENSES AND OTHER CURRENT ASSETS</a></td>
<td class="text">
          <div>
            <div>
              <div>
                <div style="line-height:1.25">
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 3:-</span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of prepaid expenses and other current assets are as follows (in thousands):</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:36pt">

                    <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">253</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,227</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">242</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to vendors</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">139</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">174</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">747</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">152</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,366</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">649</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>

                </div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936525936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 4:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">INVENTORIES</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of inventories are as follows (in thousands):</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,157</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,421</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,496</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">508</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,653</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,929</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the twelve months ended December 31, 2023, 2022, and 2021, the Company recognized, at cost of revenues, reserves for excess and obsolete in the amount of $398 thousand, $502 thousand, and $252 thousand, respectively.</span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936532096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text">
    <div>
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>NOTE 5:-</span></span><span style="padding-left:20pt">&#160;</span><span><span>BUSINESS COMBINATION</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>On August 11, 2023, pursuant to an Agreement and Plan of Merger among RRI, AlterG, Merger Sub, and Shareholder Representative Services LLC, RRI, August 8, 2023, the Company acquired AlterG and AlterG became a wholly owned subsidiary of the Company. AlterG develops, manufactures, and markets Anti-Gravity systems for use in physical and neurological rehabilitation and athletic training, both in the United States and internationally. The aggregate purchase price was a total of $19.0 million in cash, subject to working capital and other customary purchase price adjustments. Additional cash earnouts may be paid based upon a percentage of AlterG&#8217;s year-over-year future revenue growth over the next two years subject to working capital and other customary purchase price adjustments.</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:36pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The total consideration transferred is as follows (in thousands):</span></span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>18,493</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Earnout payments</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,607</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Total consideration</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>22,100</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:-42.55pt;margin-left:81.8pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Earnout payments</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company will pay an amount of cash equal to 65% of the amount, if any, by which <span>AlterG revenue attributable to the first 12 months period exceeds revenue target ("first earnout payment"), and an amount in cash equal to 65% of the amount, if any, by which AlterG revenue attributable to the following 12 months period exceeds the revenue from the first 12 month period ("second earnout payment").</span> At the date of acquisition, management estimated fair value of the earnout payment based on the actual up to date performance of the acquired entity and the probability of the earn out payment occurrence to be at approximately $3.6 million. The Earn-out was accounted for as a liability and will be remeasured at each reporting period through the consolidated statement of operations.</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:0.05pt;margin-right:9.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company has accounted for the AlterG acquisition as a business combination. The Company has preliminarily allocated the purchase price of approximately $22.1 million fair values, and the excess of the purchase price over the aggregate fair values is recorded as goodwill.</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The following table summarizes the preliminary fair value of assets acquired and liabilities assumed as of the acquisition date (in thousands):</span></span></span></span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash and cash equivalent</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>478</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Restricted cash</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>51</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accounts receivable</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,773</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Inventory</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,330</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Prepaid expenses and other current assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>470</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Right of use asset</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,151</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Property and equipment, net</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>827</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other non-current assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>30</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Goodwill</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>7,538</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Intangible assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>14,133</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accounts payable</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2,082</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accrued compensation</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(766</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other accrued liabilities</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,059</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred revenue</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2,088</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Warranty Obligations</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(535</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Leases Liability</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,151</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Total purchase consideration</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>22,100</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>

          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
      <div></div>
      <div>
        <div style="margin-left:36.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The following table presents the details of the intangible assets acquired at the date of AlterG acquisition (in thousands):</span></span></span></span></span></span></div>
      </div>

        <div>
          <div>&#160;</div>
          <div style="margin-left:36pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Estimated</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Estimated Useful Life</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair Value</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(Years)</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trademark</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>795</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Technology</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>6,161</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Warranty</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>201</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Rental</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2,102</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Distribution</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4,578</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>5</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Backlog</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>296</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>

      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.25pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Under the preliminary purchase price allocation, the Company allocates the purchase price to tangible and identified intangible assets acquired and liabilities assumed based on the preliminary estimates of their fair values. The fair values for the intangible assets acquired were primarily based on significant inputs that are not observable in the market and thus represent a Level 3 measurement in the fair value hierarchy. Customer relationships, distributor relationships, backlog, trademark and developed technology were valued using the income approach, based on estimated projections of expected cash flows to be generated by the assets, discounted to the present value at discount rates commensurate with perceived risk. The discounted cash flow analyses factor in assumptions on revenue and expense growth rates including estimates of customer growth and attrition rates, distributor growth and attrition rates, technology obsolescence, and relief from royalty projections. Additionally, these discounted cash flow analyses factor in expected amounts of working capital, fixed assets, assembled workforce and cost of capital for each intangible asset. Such estimates are subject to change during the measurement period which is not expected to exceed one year. Any adjustments to the preliminary purchase price allocation identified during the measurement period will be recognized in the period in which the adjustments are determined.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:38pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The Company incurred acquisition-related costs of $2.5 million included in General and administrative costs.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The table below presents the pro forma revenue and earnings of the combined business as if the acquisition had occurred as of January 1, 2022 (in thousands):</span></span></span></span></span></span></div>
      <div style="text-align:justify;margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
      <div style="margin-left:36pt">

          <div>
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Twelve Months Ended</span></span></span></span></span></span></div>
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>December 31,</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:middle;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Revenues</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>24,923</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>25,307</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net loss</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(21,761</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(28,369</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>

      </div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.4pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The total revenues and net loss of AlterG, included in the consolidated income statement, since the acquisition date through December 31, 2023, amounted to 7,658 thousand and 249 thousand, respectively.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The pro forma financial information for all periods presented above has been calculated after adjusting the results of AlterG to reflect the business combinations accounting effects resulting from these acquisitions.</span></span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>These proforma results reflect additional depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant, and equipment and intangible asset occurred at the beginning of the period, along with consequential tax effects. The unaudited pro forma results have been prepared for comparative purposes only and are not necessarily indicative of what would have occurred had the business combinations been completed on January 1, 2022, nor it is necessarily indicative of future results of operations of the combined company. Furthermore, the unaudited pro forma financial information does not reflect the impact of any synergies resulting from the acquisition.</span></span></span></span></span></span></div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937602224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</a></td>
<td class="text">
    <div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">NOTE 6:-</span></span></span><span style="padding-left:20pt">&#160;</span><span><span><span style="font-weight:bold">GOODWILL AND OTHER INTANGIBLE ASSETS, NET</span></span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:0.05pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has $7.5 million of goodwill related to its purchase of AlterG in the third quarter of fiscal year 2023, which has an indefinite life, and is not deductible for tax purposes.</span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="margin-left:38pt;line-height:1.25;font-family:Times New Roman, Times, serif;margin-bottom:0pt;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">As of December 31, 2023, the components of, and changes in, the carrying amount of intangible assets, net, were as follows (in thousands):</span></span></span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="margin-left:36pt">

          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:14pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost</span></span></span></span></div>
                </td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2023 Accumulated</span></span></span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortization</span></span></span></span></div>
                </td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:6pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible Assets, Net</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trademark</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>795</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(104</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>691</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Technology</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,161</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(604</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,557</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Warranty</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>201</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(40</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>161</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Rental</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,102</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(206</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,896</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Distribution</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,578</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(358</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,220</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Backlog</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>296</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(296</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Amortized Intangible Assets</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,133</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,608</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,525</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>

          </table>

        <p style="margin:0pt;font-size:10pt">&#160;</p>
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The estimated amortization expense is shown below (in thousands):</span></span></span></p>
        <p style="margin:0pt">&#160;</p>

          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2024</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,347</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2025</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,307</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2026</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,143</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2027</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,172</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2028</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>556</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,525</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>

          </table>

      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936458896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 7:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">PROPERTY AND EQUIPMENT, NET</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of property and equipment, net are as follows (in thousands):</span></span></div>
        <div style="line-height:1.25">&#160;</div>

          <div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,690</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">743</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">468</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">308</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">621</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">621</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,166</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,816</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">658</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,603</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,821</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,341</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,625</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,262</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">196</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses amounted to $239 thousand, $202 thousand, and $266 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936532096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 8:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">COMMITMENTS AND CONTINGENT LIABILITIES</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase commitment:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has contractual obligations to purchase goods from its contract manufacturer as well as raw materials from different vendors. Purchase obligations do not include contracts that may be cancelled without penalty. As of December 31, 2023, non-cancellable outstanding obligations amounted to approximately $8.6 million.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease commitment:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(i)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates from leased facilities in Israel, the United States and Germany. These leases expire between 2024 and 2025. A portion of the Company&#8217;s facilities leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(ii)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2024 and 2026 A subset of the Company&#8217;s cars leases is considered variable. The variable lease payments for such cars leases are based on actual mileage incurred at the stated contractual rate. RRL and RRG have an option to be released from these agreements, which may result in penalties in a maximum amount of approximately $30 thousand as of December 31, 2023.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the Company&#8217;s consolidated balance sheets as of December 31, 2023 are as follows (in thousands): </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,363</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">674</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease payments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,050</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: imputed interest</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(147</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Present value of future lease payments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,903</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: current maturities of operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,296</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">607</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-average remaining lease term (in years) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.92</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-average discount rate</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.21</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease expenses for the years ended December 31, 2023, 2022 and 2021 were $976 thousand, $739 thousand, and $730 thousand, respectively.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s research and development efforts are financed, in part, through funding from the Israel Innovation Authority (&#8220;IIA&#8221;). Since the Company&#8217;s inception through December 31, 2023, the Company received funding from the IIA in the total amount of $2.6 million. Out of the $2.6 million in funding from the IIA, a total amount of $1.6 million were royalty-bearing grants, $400 thousand was received in consideration of 209 convertible preferred A shares, which converted after the Company&#8217;s initial public offering in September 2014 into ordinary shares in a conversion ratio of 1 to 1, while $<span id="xbrl_20240224212733893">570</span> thousand was received without future obligation. The Company is obligated to pay royalties to the IIA, amounting to 3% of the sales of the products and other related revenues generated from such projects, up to 100% of the grants received. The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company paid royalties to the IIA in the total amount of $110 thousand.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties expenses in cost of revenue were $17 thousand, $7 thousand and $14 thousand, for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the contingent liability to the IIA amounted to $1.6 million. The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the IIA. Such approval is not required for the sale or export of any products resulting from such research or development. The IIA, under special circumstances, may approve the transfer of IIA-funded know-how outside Israel.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">dditionally, the License Agreement requires the Company to pay College (&#8220;Harvard&#8221;) royalties on net sales, see Note 10 below for more information about the Collaboration Agreement (as defined below) and the License Agreement (as defined below).</span>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div></div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liens</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As part of the Company&#8217;s restricted cash and other long-term assets, as of December 31, 2023, an amount of $709 thousand has been pledged as security in respect of a guarantee granted to a third party. Such deposit cannot be pledged to others or withdrawn without the consent of such third party.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal Claims:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Occasionally, the Company is involved in various claims such as product liability claims, lawsuits, regulatory examinations, investigations, and other legal matters arising, for the most part, in the ordinary course of business. While the outcome of any pending or threatened litigation and other legal matters is inherently uncertain, the Company does not believe the outcome of any of the matters will have a material adverse effect on the Company&#8217;s consolidated results of operation, liquidity or financial condition.</span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936431712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:67pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">NOTE 9:-</span></td>
          <td style="vertical-align:top;text-align:justify;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">SHAREHOLDERS&#8217; EQUITY</span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Equity raise:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Follow-on offerings</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 19, 2021, the Company entered into a purchase agreement with certain institutional and other accredited investors for the issuance and sale of 10,921,502 ordinary shares, par value NIS 0.25 per share at $3.6625 per ordinary share and warrants to purchase up to an aggregate of 5,460,751 ordinary shares with an exercise price of $3.6 per share, exercisable from February 19, 2021, until August 26, 2026. Additionally, the Company issued warrants to purchase up to 655,290 ordinary shares, with an exercise price of $4.578125 per share, exercisable from February 19, 2021, until August 26, 2026, to the Company February 2021 private placement offering.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 27, 2021, the Company signed a purchase agreement with certain institutional investors for the issuance and sale of 15,403,014 ordinary shares, par value NIS 0.25 per share, pre-funded warrants to purchase up to an aggregate of 610,504 ordinary shares and ordinary warrants to purchase up to an aggregate of 8,006,759 ordinary shares at an exercise price of $2.00 per share. The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant). The ordinary warrants are exercisable at any time and from time to time, in whole or in part, following the date of issuance and ending five and one-half years from the date of issuance. All of the pre-funded warrants were exercised in full on September 27, 2021, and the offering closed on September 29, 2021. Additionally, the Company issued warrants to purchase up to 960,811 ordinary shares, with an exercise price of $2.5438 per share, exercisable from September 27, 2021, until September 27, 2026, to the Company September 2021 registered direct offering.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, a total of 9,814,754 outstanding warrants with exercise prices ranging from $1.25 to $1.79 were exercised, for total gross proceeds of approximately $13.8 million. During the twelve months that ended December 31, 2023 no warrants were exercised.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:18pt">&#160;</td>
              <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
              <td style="width:auto;vertical-align:top">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share option plans:</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 30, 2012, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2012 Equity Incentive Plan.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 19, 2014, the Company&#8217;s board of directors adopted the ReWalk Robotics Ltd. 2014 Incentive Compensation Plan or the &#8220;Plan&#8221;. The Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, RSUs, cash-based awards, other stock-based awards and dividend equivalents to the Company&#8217;s and its affiliates&#8217; respective employees, non-employee directors and consultants.</span></span></div>
        <div style="text-align:justify;line-height:1.25">
          <p style="margin:0pt">&#160;</p>
          <div></div>
        </div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Starting in 2014, the Company grants to directors and employees also RSU under this Plan. An RSU award is an agreement to issue shares of the company&#8217;s ordinary shares at the time the award is vested.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023 and 2022, the Company had reserved 1,018,945 and 2,934,679 shares of ordinary shares, respectively, available for issuance to employees, directors, officers, and non-employees of the Company.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options generally vest over four years, with certain options granted to non-employee directors vesting over one year.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Any option or RSUs that are forfeited or cancelled before expiration becomes available for future grants under the Plan.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A summary of employee and non-employee shares options activity during the fiscal year ended 2023 is as follows: </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">exercise</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life (years)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Aggregate</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">intrinsic</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">value (in</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43,994</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41.27</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:52%;padding-bottom:4px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,823</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52.78</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,171</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.51</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,171</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.51</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">There were no options granted during the fiscal year ended December 31, 2023, 2022 and 2021. The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders, which hold options with positive intrinsic value, exercised their options on the last date of the exercise period. During the years ended December 31, 2023, 2022 and 2021, no options were exercised.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A summary of employee and non-employee RSUs activity during the fiscal year ended 2023 is as follows: </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">shares</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">underlying</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">grant date</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">fair value</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unvested RSUs at the beginning of the year </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,755,057</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.16</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,258,370</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.66</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,109,200</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.14</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:76%;padding-bottom:4px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited </span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(131,813</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.13</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unvested RSUs at the end of the year </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772,414</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.87</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The weighted average grant date fair values of RSUs granted during the fiscal year ended December 31, 2023, 2022 and 2021, were $0.66, $1.00 and $1.69, respectively.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total fair value of shares vested during the year ended December 31, 2023, 2022 and 2021 were $1,268 thousand, $860 thousand, and $802 thousand, respectively. As of December 31, 2023, there were $2.7 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2014 Plan. This cost is expected to be recognized over a period of approximately 2.9 years.</span></span></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The number of options and RSUs outstanding as of December 31, 2023 is set forth below, with options separated by range of exercise price:</span></span></div>
        <div style="text-align:justify;line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="width:42%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise price</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options and</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">as of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(years) (1)</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">as of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(years) (1)</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs only </span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772,414</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$5.37&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,425</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.24</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,425</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.24</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$20.42- $33.75&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,943</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.35</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,943</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.35</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$50-$52.5&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,230</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.46</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,230</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.46</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$182.5-$524.25&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,573</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.65</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,573</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.65</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,805,585</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,171</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="vertical-align:top;width:34pt">&#160;</td>
              <td style="vertical-align:top;width:20pt">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) </span></span></div>
              </td>
              <td style="vertical-align:top;width:auto">
                <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term. </span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">c.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Equity compensation issued to consultants:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company granted 32,895 RSUs during the fiscal year ended December 31, 2023, to non-employee consultants. As of December 31, 2023, there are 21,929 outstanding RSUs held by non-employee consultants.</span></span></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">d.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Share-based compensation expense for employees and non-employees:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-indent:18pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognized share-based compensation expense in the consolidated statements of operations as follows (in thousands): </span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development, net </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">157</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales and marketing </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">381</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">250</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">781</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">633</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">597</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,328</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">993</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">833</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">
          <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">e.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Treasury shares:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On June 2, 2022, the Company&#8217;s Board of Directors approved a share repurchase program to repurchase up to $8.0 million of its Ordinary Shares, par value NIS 0.25 per share. On July 21, 2022, the Company received approval from an Israeli court for the share repurchase program. The program was scheduled to expire on the earlier of January 20, 2023, or reaching $8.0 million of repurchases. On December 22, 2022, the Company&#8217;s Board of Directors approved an extension of the repurchase program, with such extension to be in the aggregate amount of up to $5.8 million. The extension was approved by an Israeli court on February 9, 2023, and it expired on August 9, 2023.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, pursuant to the Company&#8217;s share repurchase program, the Company had repurchased a total of 4,022,607 of its outstanding ordinary shares at a total cost of $3.5 million.</span></span>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div style="text-align:justify;line-height:1.25">
          <div></div>
          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

              <tr>
                <td style="width:18pt">&#160;</td>
                <td style="width:18pt;vertical-align:top"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">f.</span></td>
                <td style="width:auto;vertical-align:top">
                  <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Warrants to purchase ordinary shares:</span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes information about warrants outstanding and exercisable as of December 31, 2023:</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;width:42%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance date</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">per warrant</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">exercisable</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">term</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(number)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(number)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;padding-bottom:2px;width:10%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2015 (1) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,771</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,771</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See footnote (1)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 28, 2016 (2) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,908</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,908</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See footnote (1)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 25, 2019 (5) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45,600</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.187</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45,600</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 21, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 5, 2019 (6) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">408,457</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.140</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">408,457</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">October 7, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 5, 2019 (7) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,015</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.503</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,015</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 3, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2019, and June 6, 2019 (8) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,464,665</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,464,665</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2019 (9) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87,880</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.375</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87,880</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 12, 2019 (10) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">416,667</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">416,667</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 12, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 10, 2019 (11) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 10, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2020 (12) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,400</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.250</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,400</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2025</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2020 (13) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105,840</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.563</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105,840</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2025</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 6, 2020 (14) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">448,698</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.760</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">448,698</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 2, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 6, 2020 (15) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">296,297</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.278</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">296,297</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 2, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 8, 2020 (16) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">586,760</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.340</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">586,760</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 8, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 8, 2020 (17) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">108,806</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.792</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">108,806</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 8, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 26, 2021 (18) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,460,751</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.600</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,460,751</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 26, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 26, 2021 (19) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">655,290</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.578</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">655,290</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 26, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 29, 2021 (20) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,006,759</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,006,759</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 29, 2027</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 29, 2021 (21) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">960,811</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.544</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">960,811</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 27, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,187,375</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,187,375</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>

            </table>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants for ordinary shares issuable upon an exercise price of $7.500 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited (&#8220;Kreos&#8221;) in connection with a loan made by Kreos to the Company and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents common warrants that were issued as part of the Company&#8217;s follow-on public offering in November 2018.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on public offering in November 2018.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on public offering in February 2019.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div></div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019, and June 6, 2019, respectively.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(9)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(11)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020. As of December 31, 2023, 3,740,100 warrants were exercised for total consideration of $4,675,125. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering. As of December 31, 2023, 230,160 warrants were exercised for total consideration of $359,625. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in July 2020. As of December 31, 2023, 2,020,441 warrants were exercised for total consideration of $3,555,976. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(15)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(16)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s private placement offering of ordinary shares in December 2020. As of December 31, 2023, 3,598,072 warrants were exercised for total consideration of $4,821,416. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(17)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement. As of December 31, 2023, 225,981 warrants were exercised for total consideration of $405,003. During the twelve months that ended December 31, 2023, no warrants were exercised.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(18)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s private placement offering of ordinary shares in February 2021.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2021 private placement.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in September 2021.</span></span></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:36pt">&#160;</td>
              <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(21)</span></span></td>
              <td style="width:auto;vertical-align:top;text-align:justify">
                <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s September 2021 registered direct offering.</span></span></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936752592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</a></td>
<td class="text">
    <div>
      <div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>NOTE 10:-</strong></span></span></td>
              <td style="vertical-align:top;width:auto">
                <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</strong></span></span></div>
              </td>
            </tr>

        </table>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 16, 2016, the Company entered into a Collaboration Agreement (as amended, the &#8220;Collaboration Agreement&#8221;) and an Exclusive License Agreement (as amended, the &#8220;License Agreement&#8221;) with Harvard. The Collaboration Agreement concluded on March 31, 2022.</span></span></div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the License Agreement, Harvard has granted the Company an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#8220;soft suit&#8221; exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the joint research collaboration.</span></span>
          <p style="margin:0pt">&#160;</p>
        </div>
        <div style="text-align:justify;line-height:1.25">
          <div></div>
        </div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The License Agreement required the Company to pay Harvard an upfront fee, reimbursements for expenses that Harvard incurred in connection with the licensed patents, royalties on net sales and several milestone payments contingent upon the achievement of certain product development and commercialization milestones. The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid claim of the licensed patents.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, the Company achieved three of the milestones which represent all development milestones under the License Agreement. The Company continues to evaluate the likelihood that the other milestones will be achieved on a quarterly basis.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has recorded expenses in the amount of $29 thousand, $74 thousand, and $293 thousand as research and development expenses related to the License Agreement and to the Collaboration Agreement for the years ended December 31, 2023, 2022 and 2021, respectively. No withholding tax was deducted from the Company&#8217;s payments to Harvard in respect of the Collaboration Agreement and the License Agreement since this is not taxable income in Israel in accordance with Section 170 of the Israel Income Tax Ordinance 1961-5721.</span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483041/730-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 985<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//985-730/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939900288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 11:-</span></span></td>
                <td style="vertical-align:top;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCOME TAXES</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate tax rates in Israel:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Presented hereunder are the tax rates relevant to the Company in the years 2021-2023:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli statutory corporate tax rate and real capital gains were 23% in the years 2021-2023.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.<span style="padding-left:8.5pt">&#160;</span>Income (loss) before taxes on income is comprised as follows (in thousands):</span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Domestic</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,638</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,110</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,780</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,507</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,145</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,102</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,642</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income (benefit) are comprised as follows (in thousands):</span></span></div>
          <div style="text-indent:18pt;line-height:1.25">&#160;</div>

            <div>
              <div style="margin-left:36pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">316</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(29</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:36pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Domestic</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:4px;vertical-align:baseline">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <p style="margin:0pt">&#160;</p>
          <div></div>
          <div style="text-indent:18pt;line-height:1.25;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income taxes (in thousands):</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company&#8217;s deferred tax assets as of December 31, 2023 and 2022 are derived from temporary differences.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. Based on the Company&#8217;s history of losses, the Company established a full valuation allowance for RRL.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Undistributed earnings of certain subsidiaries as of December 31, 2023 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a result, the Company has not provided for any deferred income taxes.</span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carry forward tax losses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">64,090</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,833</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development carry forward expenses-temporary differences</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">844</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrual and reserves</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">849</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">392</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">394</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">456</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit tax carry forwards</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,714</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">480</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">214</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">68,838</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,739</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use asset</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(470</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(214</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible Assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,015</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(144</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65,209</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,525</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:76%;padding-bottom:2px;vertical-align:baseline">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(65,209</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,525</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>

          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The net changes in the total valuation allowance for each of the years ended December 31, 2023, 2022 and 2021, are comprised as follows (in thousands):</span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,525</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(48,098</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(42,941</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes due to exchange rate differences</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,488</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment previous year loss</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">)</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,269</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,410</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,831</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,669</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(65,209</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,525</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(48,098</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>

        </div>
      </div>
      <p style="margin:0pt">&#160;</p>
      <div></div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of the theoretical tax expenses:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit) as reported in the consolidated statements of operations is as follows (in thousands):</span></span></div>
      <div style="line-height:1.25">&#160;</div>

        <div style="margin-left:36pt">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before taxes, as reported in the consolidated statements of operations</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,145</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,102</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,642</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.0</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.0</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,093</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,393</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,908</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax at rate other than the Israeli statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses including equity-based compensation expenses and other&#8201;</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">262</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">102</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating losses and other temporary differences for which valuation allowance was provided</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,410</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,375</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,669</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Permanent differences</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(342</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(775</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(784</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment in respect of prior years</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Actual tax expense (benefit)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">&#160;</td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        </div>

      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span><span style="padding-left:9.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign tax rates:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxable income of RRI and AlterG was subject to tax at the rate of 21% in 2023, 2022 and 2021.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxable income of RRG was subject to tax at the rate of 30% in 2023, 2022, and 2021.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the &#8220;Investment Law&#8221;):</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Conditions for entitlement to the benefits:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the Investment Law, in 2012 the Company elected &#8220;Beneficiary Enterprise&#8221; status which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular rate.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income derived from Beneficiary Enterprise from productive activity will be exempt from tax for ten years from the year in which the Company first has taxable income, providing that 12 years have not passed from the beginning of the year of election. In the event of a dividend distribution from income that is exempt from company tax, as aforementioned, the Company will be required to pay tax of 10%-25% on that income.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Beneficiary Enterprise&#8217;s income. Tax-exempt income generated under the Company&#8217;s &#8220;Beneficiary Enterprise&#8221; program will be subject to taxes upon dividend distribution or complete liquidation.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The entitlement to the above benefits is conditional upon the Company&#8217;s fulfilling the conditions stipulated by the Law and regulations published thereunder.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span><span style="padding-left:8.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Tax assessments:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RRL, RRI and RRG has had final tax assessments up to and including the 2017 tax year.</span></span></div>
      <p style="margin:0pt">&#160;</p>
      <div></div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG files income tax returns in the United States and in various U.S. states. &#160;AlterG returns for the years ended December 31, 2020 and later are generally subject to federal tax examination, while the AlterG returns for the years ended December 31, 2019 and later are generally subject to state tax examination. &#160;However, the AlterG net operating losses and tax credits generally remain subject to tax examination and adjustment until they are utilized on a future tax return and the statute of limitations closes for that year. &#160;Thus, the AlterG tax attributes generally remain open to federal and state tax examination and adjustment.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span><span style="padding-left:9.5pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net operating carry-forward losses for tax purposes:</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, RRL has carry-forward losses amounting to approximately $242.6 million, which can be carried forward for an indefinite period.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, AlterG had approximately $31.4 million of federal net operating loss (&#8220;NOL&#8221;) carry forwards, and $47.2 million of state NOL carry forwards, which will begin to expire in 2025 and 2028, respectively. &#160;The federal net operating losses from years beginning after January 1, 2018, of approximately $14.7 million may be carried forward indefinitely and losses prior to January 1, 2018 of approximately $16.7 million expire beginning in 2028 under prior law.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Internal Revenue Code Section 382 places a limitation ("Section 382 Limitation") on the amount of taxable income which can be offset by NOL carry forwards after a change in control (generally greater than 50% change in the value of the stock owned by 5% shareholders during the testing period) of a loss corporation. California has similar rules. On August 11, 2023, AlterG was involved in an equity transaction that constitutes a Section 382 change in ownership. The change in ownership limits the ability to utilize net operating loss carry forwards in future years. The 382-limitation impact on NOLs has been included in the current period provision. The Company may have had earlier Section 382 changes in ownership. This will be assessed upon realization of tax attributes.</span></span></div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937735328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES (INCOME), NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">FINANCIAL EXPENSES (INCOME), NET</a></td>
<td class="text">
    <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

        <tr>
          <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span>NOTE 12:-</span></span></td>
          <td style="vertical-align:top;width:auto">
            <div style="font-weight:bold"><span style="font-size:10pt"><span>FINANCIAL (EXPENSES) INCOME, NET</span></span></div>
          </td>
        </tr>

    </table>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The components of financial (expenses) income, net were as follows (in thousands):</span></span></div>

          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transactions and other</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest Income</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,354</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank commissions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(25</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,467</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213140028626">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">*) </span>Represent an amount lower than $1.</span></span></div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 610<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//610/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 720<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//720/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111938339776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</a></td>
<td class="text">
    <div>
      <table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)">

          <tr>
            <td style="vertical-align:top;font-weight:bold;width:72pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13:-</span></span></td>
            <td style="vertical-align:top;width:auto">
              <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</span></span></div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company manages its business on a basis of one reportable segment.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues from external customers on the basis of the Company's geographical areas are as follows (in thousands):</span></span></div>

          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue based on customer&#8217;s location:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,636</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,303</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,519</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,044</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,057</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,381</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia-Pacific</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">387</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest of the world</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">787</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,854</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,511</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,966</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>


          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets by geographic region:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">529</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">757</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,404</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">231</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">190</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,123</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,032</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*)</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets are comprised of property and equipment, net, and operating lease right-of-use assets.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>

        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Major customers data as a percentage of total revenue:</span></span></div>
      </div>
    </div>

      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.2</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.2</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000001035">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213145458513">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213145510899">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border:0px;width:100%">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                  <td style="width:auto">
                    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></p>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>

  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936443808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">BASIC AND DILUTED NET LOSS PER SHARE</a></td>
<td class="text">
      <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 14:-</span><span style="padding-left:20pt">&#160;</span><span style="font-weight:bold">BASIC AND DILUTED NET LOSS PER SHARE</span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt">

            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,133</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,569</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,736</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to ordinary shares</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,133</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,569</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,736</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares used in computing net loss per ordinary shares, basic and diluted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,719,064</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,378,797</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47,935,652</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per ordinary share, basic and diluted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.37</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.31</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.27</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>

        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and warrants outstanding would have been anti-dilutive.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the twelve months ended December 31, 2023, the total number of ordinary shares related to the outstanding warrants and share option plans aggregated to 19,220,546, was excluded from the calculations of diluted loss per ordinary share since it would have an anti-dilutive effect.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the twelve months ended December 31, 2022, the total number of ordinary shares related to the outstanding warrants and share option plans aggregated to 19,464,888, was excluded from the calculations of diluted loss per ordinary share since it would have an anti-dilutive effect.</span></span></div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939670096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text">
      <div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 15:-</span></span></span><span style="padding-left:20pt">&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">RESTRUCTURING ACTIVITIES</span></span></span>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 12, 2023, the Board of Directors of the Company approved a re-organization plan (the &#8220;2023 Reorganization Plan&#8221;) that included, among other things, downsizing approximately 15% of the Company&#8217;s workforce and adapting the Company's organizational structure, roles, and responsibilities accordingly.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;margin-left:36pt;line-height:1.25">
          <div style="line-height:1.25;font-family:'Times New Roman',serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0)">During the year ended December 31, 2023, in connection with the 2023 Reorganization Plan, the Company recorded expenses of $670 thousand, for one time employee termination benefits and legal expenses. $175 thousand attributable to research and development, net, $70 thousand to sales and marketing and $425 thousand to General and administrative expenses.</span>&#160;<span style="color:rgb(0, 0, 0)">However, none of these amounts were paid in 2023. The Company does not expect to incur additional costs related to the 2023 Reorganization Plan.</span></span></span></div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//420/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933045696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt;vertical-align:top">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of Estimates</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions. The Company&#8217;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company&#8217;s management evaluates estimates, including those related to inventories, fair values of share-based awards, contingent liabilities, provision for warranty, allowance for credit losses and sales return reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Financial Statements in U.S. Dollars</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial Statements in U.S. Dollars:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The functional currency is the currency that best reflects the economic environment in which the Company and its subsidiaries operate and conduct their transactions. Most of the Company&#8217;s revenues and costs are incurred in U.S. dollar. In addition, the Company&#8217;s financing activities are incurred in U.S. dollars. The Company&#8217;s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#8217;s and its subsidiary's functional and reporting currency.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with ASC 830 &#8220;Foreign Currency Matters.&#8221; All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the consolidated statements of operations as financing income or expenses as appropriate.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of Consolidation:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances have been eliminated upon consolidation.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">d.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash Equivalents:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">e.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories are stated at the lower of cost or net realizable value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company periodically evaluates the quantities on hand relative to historical, current, and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its net realized value.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost is determined as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products - based on raw materials and manufacturing costs on an average basis.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials - The weighted average cost method.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value. If actual demand for the Company&#8217;s products deteriorates, or market conditions are less favourable than those projected, additional inventory reserves may be required.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">f.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and Equipment:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20-33 (mainly 33)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6 - 10 (mainly 10)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20-50</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over the shorter of the lease term </span></span></div>
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>or estimated useful life</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">g.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Business Combinations</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for business combinations in accordance with ASC 805, &#8220;Business Combinations&#8221; (&#8220;ASC 805&#8221;). For business combinations accounted for under the acquisition method, ASC 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. The Company determines the recognition of intangible assets based on the following criteria: (i) the intangible asset arises from contractual or other rights; or (ii) the intangible asset is separable or divisible from the acquired entity and capable of being sold, transferred, licensed, returned or exchanged.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The excess of the fair value of the purchase price over the fair values of the identifiable assets and liabilities is recorded as goodwill. Determining the fair value of the identifiable assets and liabilities requires management to use significant judgment and estimates including the forecasted revenue and revenues growth rates, discount rates, customer contract renewal rates and customer attrition rates. The process of estimating the fair values requires significant estimates, especially with respect to intangible assets. Management&#8217;s determination of fair value of assets acquired and liabilities assumed at the acquisition date is based on the best information available in the circumstances and incorporates management&#8217;s own assumptions and involves a significant degree of judgment.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition related costs include legal fees, consulting and success fees, and other non-recurring integration related costs. Acquisition-related costs are expensed as incurred.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangibles</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">h.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill and Other Intangibles</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has no indefinite-lived intangible assets other than goodwill. Acquired identifiable finite-lived intangible assets include identifiable acquired technology, customer relationships, trademarks and backlog and are amortized on a straight-line basis over the estimated useful lives of the assets. The Company routinely reviews the remaining estimated useful lives of finite-lived intangible assets.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Goodwill is not amortized and is tested for impairment at least annually.</span></span></div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company operates as one reporting unit and the fair value of the reporting unit is estimated using quoted market prices of the Company&#8217;s stock in active markets. The Company tests goodwill for impairment annually in the fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">When testing goodwill for impairment, the Company may first perform a qualitative assessment. If the Company determines it is not more likely than not the reporting unit&#8217;s fair value is less than its carrying value, then no further analysis is necessary. If the Company determines that it is more likely than not that the fair value of its reporting unit is less than its carrying amount, then the quantitative impairment test will be performed. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Under the quantitative impairment test, if the carrying amount of the Company&#8217;s reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2023, no impairments of goodwill have been recognized.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of Long-Lived Assets</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s long-lived assets, including right-of-use (&#8220;ROU&#8221;) assets and identifiable intangible assets that are subject to amortization, are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2023, 2022 and 2021, no impairment losses have been recorded.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RestrictedCashAndOtherLongTermAssets', window );">Restricted Cash and Other Long-Term Assets</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">j.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash and Other long-term assets:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_TreasurySharesPolicyTextBlock', window );">Treasury shares</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">k.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury shares</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company repurchased its ordinary shares and holds them as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction of shareholders' equity.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">l.</span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue Recognition:</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to clinics and rehabilitation centres, professional and college sports teams, private individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), and distributors.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes revenue in accordance with ASC 606, &#8220;Revenue Recognition&#8221; when, or as, control of the promised good or service is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company applies the following five steps:</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the contract with a customer</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generally considers a purchase order or a signed quote to be a contract with a customer. In evaluating the contract with a customer, the Company analyzes the customer&#8217;s intent and ability to pay the amount of promised consideration (credit risk) and considers the probability of collecting substantially all of the consideration.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Identify the performance obligations in the contract</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At a contract&#8217;s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determine the transaction price</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company does not offer extended payment terms beyond one year to customers.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Allocate the transaction price to performance obligations in the contract</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:18pt">&#160;</td>
                    <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recognize revenue when or as the Company satisfies a performance obligation</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control either transfers over time or at a point in time, which affects when revenue is recorded.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has elected to apply the practical expedient for financing component for transactions in which the difference between the payment date and the revenue recognition timing is up to 12 months.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Disaggregation of Revenue (in thousands):</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:36pt">

                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,681</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,175</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,916</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,033</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">859</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">533</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranty</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,140</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">477</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">517</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,854</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,511</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,966</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>

              </div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product revenue</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue from Products is comprised of sale of Anti-Gravity products, sale of systems products to rehabilitation facilities and sale of ReWalk Personal Exoskeleton systems to end users. Revenues generated from the sale of Products are recognized at a point in time, once the customer has obtained the legal title to the items purchased.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For systems sold to rehabilitation facilities, the Company includes insignificant training and considers the elements in the arrangement to be a single performance obligation. Therefore, the Company recognizes revenue for the system only when control is transferred after delivery and when the training has been completed, in accordance with the agreements terms with the customer.</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                  <div></div>
                </div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For sales of ReWalk Personal Exoskeleton systems to end users, and for sales of ReWalk Personal or ReWalk Rehabilitation Exoskeleton systems to third party distributors, the Company does not provide training to the end user as this training is completed by the rehabilitation center or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.</span></span></div>
              </div>
              <div style="line-height:1.25">
                <div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              </div>
              <div style="line-height:1.25">
                <div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company generally does not grant a right of return for its products. In rare circumstances when the Company provides a right of return for its products. the Company records reductions to revenue for expected future product returns based on the Company&#8217;s historical experience and estimates.</span></span></div>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During 2023, the Company offered six products: (1) ReWalk Personal Exoskeletons, (2) ReWalk Rehabilitation Exoskeleton, (3) ReStore, (4) AlterG Anti-Gravity systems, (5) MyoCycle and (6) MediTouch. Due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental revenue</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental revenue for the AlterG Anti-Gravity systems is accounted for under ASC Topic 842, Leases. The Company rents its products to customers for a fixed monthly fee over the rental term, which typically ranges from 2 to 3 years. Rental revenues are recorded as earned on a monthly basis. See Note 2x for additional information.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the SCI Products, the Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee for a limited period prior to selling its products.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranties</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company services its products after expiration of the initial warranty. Service revenue, consisting of time and materials to perform the repairs, is recorded as services are rendered.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Determining the transaction price requires of level judgment, which is discussed by revenue category in further detail below.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranties are classified as either an assurance type or a service type warranty. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended for a limited period of time. An assurance type warranty is not accounted for as a separate performance obligation under the revenue model.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SCI Products include a <span style="-sec-ix-hidden:Fxbrl_20230214112251731"> five -year warranty</span>. The first  two years are considered as an assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. A service type warranty is either sold with a unit or separately for a unit for which the warranty has expired. A service type warranty is accounted as a separate performance obligation and revenue is recognized ratably over the life of the warranty.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The ReStore device is sold with a two-year warranty which is considered as assurance type warranty.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Distributed Products are sold with assurance type warranty ranging between three years to ten years, depending on the specific product and part.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F</span></span><span style="font-family:Times New Roman, Times, serif;font-size:10pt">or AlterG Anti-Gravity Products, the Company offers customers extended warranty contracts that extend or enhance the technical support, parts, and labor coverage offered as part of the base warranty included with the Anti-Gravity system products. Extended warranty revenue is recognized ratably over the extended warranty coverage period. The Company offers a one-year assurance type warranty to customers in the U.S. and two years assurance type warranty for spare parts only to its international distributors. For these products, the Company determines standalone selling price based on the price at which the performance obligation is sold separately.</span>
                <p style="margin:0pt">&#160;</p>
              </div>
              <div style="line-height:1.25">
                <div></div>
              </div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contract balances (in thousands):</span></span></div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>

                <div>
                  <div style="margin-left:36pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivable, net of credit losses (1)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,120</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,036</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues (1) (2)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,010</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance presented net of unrecognized revenue that was not yet collected.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$435 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>

              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenue which represent a contract liability, include unearned amounts related to service type warranty obligations as well as other advances and payments which the Company received from customers prior to satisfying the performance obligation, for which revenue has not yet been recognized. The Company's unearned performance obligations as of December 31, 2023 and the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.</span></span></div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Share-Based Compensation</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">m.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounting for Share-Based Compensation:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for share-based compensation in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#8220;OPM&#8221;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s consolidated statements of operations.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company account for forfeitures as they occur.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility is calculated based on actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options, or based on certain peer companies that the Company considered to be comparable, in case there is no sufficient trading volume to rely on market volatility. The expected option term is determined based on the simplified method, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of Restricted Stock Units (&#8220;RSUs&#8221;) granted is determined based on the price of the Company&#8217;s ordinary shares on the date of grant.</span></span></div>
            <div style="line-height:1.25;margin-left:18pt">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for options granted to consultants and other service providers under ASC 718. The fair value of these options was estimated using a Black-Scholes-Merton option-pricing model.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightPolicyTextBlock', window );">Class Of Warrant Or Right [Policy Text Block]</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">n.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants to Acquire Ordinary Shares:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the twelve -month ended December 31, 2021, the Company issued warrants to acquire up to 15,083,611 ordinary shares. There were no issued warrants during the twelve months ended December 31, 2023 and 2022. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815 "Derivatives and Hedging" and determined that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 9f for additional information.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">o.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and Development Costs:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the Company received for research and development in the period in which the grant was received.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">p.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income Taxes</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its taxes on income. As of December 31, 2023, and 2022, the Company did not identify any significant uncertain tax positions.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Provision</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warranty provision:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For assurance-type warranty, the Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#8217;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US Dollars</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">92</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG acquisition &#8211; see note 5</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">535</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">200</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Usage</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(479</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">348</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risks</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">r.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of Credit Risks:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution. The bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration exists with respect to these deposits.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The below table reflects the concentration of credit risk for the Company&#8217;s current customers as of December 31, 2023, to which substantial sales were made.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.</span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <div style="margin-left:36pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000446">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000448">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer C</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer D</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></div>
                      </td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>

            <div style="line-height:1.25">
              <div></div>
            </div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance for credit losses is based on the Company's assessments of factors that may affect a customer's ability to pay. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current customer's aging balance, the nature and size of the customer, the financial condition of the customer, and the amount of any receivables in dispute. The Company does not have any off-balance sheet credit exposure related to its customers. As of December 31, 2023, and 2022 trade receivables are presented net of $328 thousand and $26 thousand allowance for credit losses, respectively.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Accrued Severance Pay</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">s.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrued Severance Pay:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. All of the employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#8220;section 14&#8221;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Company&#8217;s expenses related to severance pay amounted to $114 thousand , $113 thousand and $104 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Measurements:</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company uses a three -tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The three -tiers are defined as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 1. </span>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 2. </span>Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9642;</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 3. </span>Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such instruments.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables present information about the Company&#8217;s financial assets and liabilities that are measured in fair value on a recurring basis as of December 31, 2023 and December 31, 2022 (in thousands):</span></span></div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements as of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Hierarchy</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial assets:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,550</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury bills included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,525</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Assets Measured at Fair Value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,075</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial Liabilities:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities measured at fair value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>

            <div style="line-height:1.25">
              <div></div>
            </div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies cash equivalents within Level 1, because the Company uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair values.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The earnout was valued using a Monte Carlo simulation analysis, which is considered to be a Level 3 fair value measurement.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table summarizes the earnout liability activity as of December 31, 2023 (in thousands):</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">

                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:85.4%;vertical-align:top">&#160;</td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial Measurement (August 11, 2023)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,607</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in fair value</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December 31, 2023</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>

            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
<td class="text">
            <div>
              <div style="text-align:justify;margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">u.<span style="padding-left:7pt">&#160;</span>Basic and Diluted Net Loss Per Share:</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Diluted loss per share is computed based on the weighted average number of ordinary shares outstanding during the period, plus dilutive potential shares considered outstanding during the period.</span></span></div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingent liabilities</a></td>
<td class="text">
          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">v.<span style="padding-left:8pt">&#160;</span>Contingent liabilities</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for its contingent liabilities in accordance with ASC 450, &#8220;Contingencies.&#8221; A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_GovernmentGrantsPolicyTextBlock', window );">Government grants</a></td>
<td class="text">
          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">w.<span style="padding-left:8pt">&#160;</span>Government grants</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalty and non-royalty-bearing grants from the Israeli Innovation Authority (the &#8220;IIA&#8221;) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a reduction from research and development expenses (see Note 8c).</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
          <div>
            <div style="margin-left:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">x.<span style="padding-left:8pt">&#160;</span>Leases</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating lease liabilities and their corresponding right-of-use assets are recorded at commencement date based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items, such as initial direct costs paid or incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </span></span></div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases with an initial term of 12 months or less are not recorded on the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lessor accounting - Operating leases</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A portion of the AlterG rental revenues for the AlterG Anti-Gravity systems are made through lease arrangements.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG products are available for lease agreements ranging from 12 to 42 months. If the customer terminates the contract during the lease period, they are required to pay a cancellation fee. The lease period may be extended by an additional period as specified in the contract.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In determining the leases classification as a sales type or operating lease, the Company assesses, among other criteria: (i) the lease term to determine if it is for the major part of the economic life of the underlying equipment; and (ii) the present value of the lease payments to determine if they are equal to or greater than substantially all of the fair market value of the equipment at the inception of the lease AlterG Anti-Gravity systems. When these criteria are not met, the lease accounted for as operating leases and revenues are recognized over the term of the lease.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under these arrangements, when the Company acts as the lessor for its product line, the Company accounted for the lease arrangements as operating leases in accordance with ASC 842, &#8220;Lease&#8221; (&#8220;ASC 842&#8221;).</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The total rental revenue for the AlterG Anti-Gravity Products has amounted to $249 thousand from the time of acquisition through December 31, 2023.</span></span></div>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">
          <div>
            <div style="margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">y. <span style="padding-left:20pt">&#160;</span>New Accounting Pronouncements</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recently Implemented Accounting Pronouncements</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td rowspan="1" style="width:13.57%;vertical-align:top;font-family:'Times New Roman',Times,serif">
                      <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.&#160; &#160; &#160; &#160; &#160; &#160;Financial Instruments</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The Company adopted ASU 2016-13 as of January 1, 2023. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recent Accounting Pronouncements Not Yet Adopted</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:10%;vertical-align:top">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:6%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></div>
                  </td>
                  <td style="width:84%;vertical-align:top">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09, &#8220;Income Taxes - Improvements to Income Tax Disclosures&#8221; requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impact of the adoption of this standard.</span></span></div>
                    <div style="text-align:justify;line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:10%;vertical-align:top">&#160;</td>
                  <td style="width:6%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii.</span></span></div>
                  </td>
                  <td style="width:84%;vertical-align:top">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In&#160;November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments&#8217; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, &#8220;Segment Reporting&#8221; on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ClassOfWarrantOrRightPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ClassOfWarrantOrRightPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_GovernmentGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for government grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_GovernmentGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_RestrictedCashAndOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for other long term assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_RestrictedCashAndOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_TreasurySharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the accounting policy for treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_TreasurySharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//712/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933437936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock', window );">Public Utility Property, Plant, and Equipment</a></td>
<td class="text">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20-33 (mainly 33)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6 - 10 (mainly 10)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20-50</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements</span></span></div>
                        </td>
                        <td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Over the shorter of the lease term </span></span></div>
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>or estimated useful life</span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of disaggregation of revenues</a></td>
<td class="text">
                  <div>
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Product</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,681</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,175</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,916</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,033</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">859</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">533</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Service and warranty</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,140</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">477</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">517</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Revenues</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,854</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,511</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,966</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ScheduleOfContractBalancesTableTextBlock', window );">Schedule of contract balances</a></td>
<td class="text">
                <div>
                  <div style="margin-left:36pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivable, net of credit losses (1)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,120</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,036</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues (1) (2)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,010</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance presented net of unrecognized revenue that was not yet collected.</span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:36pt">&#160;</td>
                        <td style="width:36pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                        <td style="width:auto;vertical-align:top;text-align:justify">
                          <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$435 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ScheduleOfWarrantyProvisionTableTextBlock', window );">Schedule of warranty provision</a></td>
<td class="text">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">US Dollars</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in</span></span></div>
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">92</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AlterG acquisition &#8211; see note 5</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">535</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Provision</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">200</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Usage</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                        <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(479</span></span></div>
                        </td>
                        <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at December 31, 2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">348</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of concentration of credit risk</a></td>
<td class="text">
              <div>
                <div style="margin-left:36pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000446">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">27</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000000448">*</span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)%</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer C</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer D</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:18pt">&#160;</td>
                      <td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                      <td style="width:auto;vertical-align:top">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></div>
                      </td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of assets and liabilities measured at fair value</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements as of</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Description</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair Value Hierarchy</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial assets:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:middle;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,550</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Treasury bills included in cash and cash equivalent</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,525</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">$</span></p>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total Assets Measured at Fair Value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,075</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Financial Liabilities:</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 3</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities measured at fair value</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
                <p style="margin:0pt">&#160;</p>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock', window );">Schedule of warrants liability activity</a></td>
<td class="text">
                <div>
                  <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="width:85.4%;vertical-align:top">&#160;</td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid">
                          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Earnout</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Initial Measurement (August 11, 2023)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,607</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Change in fair value</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(315)</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      </tr>
                      <tr>
                        <td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance December 31, 2023</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)">&#160;</td>
                        <td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                        </td>
                        <td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,292</span></span></div>
                        </td>
                        <td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                        <td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap">&#160;</td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ScheduleOfContractBalancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of of Contract balances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ScheduleOfContractBalancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of schedule of warrants liability activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ScheduleOfWarrantyProvisionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warranty provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ScheduleOfWarrantyProvisionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481834/980-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936393632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of prepaid expenses and other current assets</a></td>
<td class="text">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">253</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">81</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,227</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">242</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Advances to vendors</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">139</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">174</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">747</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">152</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,366</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">649</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                        </tr>

                    </table>
                  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936503792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finished products</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,157</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,421</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Raw materials</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,496</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">508</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,653</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,929</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939854880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock', window );">Schedule of total consideration</a></td>
<td class="text">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>18,493</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Earnout payments</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,607</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Total consideration</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>22,100</span></span></span></span></span></span></div>
                    </td>
                    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of preliminary fair value of assets acquired and liabilities</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Cash and cash equivalent</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>478</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Restricted cash</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>51</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accounts receivable</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,773</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Inventory</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3,330</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Prepaid expenses and other current assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>470</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Right of use asset</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1,151</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Property and equipment, net</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>827</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other non-current assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>30</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Goodwill</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>7,538</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Intangible assets</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>14,133</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accounts payable</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2,082</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Accrued compensation</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(766</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Other accrued liabilities</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,059</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Deferred revenue</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(2,088</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Warranty Obligations</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(535</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:2px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Leases Liability</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(1,151</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Total purchase consideration</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>22,100</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of intangible assets acquired</a></td>
<td class="text">
        <div>
          <div>&#160;</div>
          <div style="margin-left:36pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Estimated</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Estimated Useful Life</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Fair Value</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(Years)</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Trademark</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>$</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>795</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>3</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Technology</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>6,161</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Warranty</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>201</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Rental</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2,102</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Customer relationship - Distribution</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>4,578</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>5</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Backlog</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>296</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock', window );">Schedule of pro forma revenue and earnings</a></td>
<td class="text">
          <div>
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Twelve Months Ended</span></span></span></span></span></span></div>
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>December 31,</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2023</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2022</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:middle;background-color:#CCEEFF;width:76%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Revenues</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>24,923</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>25,307</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:middle;width:76%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>Net loss</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(21,761</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>(28,369</span></span></span></span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>)</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(4)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939186656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:14pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Cost</span></span></span></span></div>
                </td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>December 31, 2023 Accumulated</span></span></span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Amortization</span></span></span></span></div>
                </td>
                <td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:6pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Intangible Assets, Net</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Trademark</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>795</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(104</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>691</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Technology</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>6,161</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(604</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>5,557</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Warranty</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>201</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(40</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>161</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Rental</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,102</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(206</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>1,896</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Customer relationship - Distribution</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,578</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(358</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>4,220</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Backlog</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>296</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(296</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total Amortized Intangible Assets</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>14,133</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(1,608</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,525</span></span></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of future amortization expense</a></td>
<td class="text">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2024</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,347</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2025</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,307</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2026</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>3,143</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2027</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>2,172</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Fiscal 2028</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>556</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:top;width:64%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Total</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>12,525</span></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936431712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of components of property and equipment, net</a></td>
<td class="text">
          <div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computer equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,690</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">743</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">468</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">308</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Machinery and laboratory equipment </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">621</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">621</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Field service units </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,166</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,816</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leasehold improvements </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">658</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">333</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,603</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,821</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,341</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,625</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net </span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,262</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">196</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936537952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock', window );">Schedule of minimum royalty payments</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,363</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">674</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2026</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease payments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,050</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: imputed interest</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(147</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Present value of future lease payments</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,903</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less: current maturities of operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,296</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">607</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-average remaining lease term (in years) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.92</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:88%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-average discount rate</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.21</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the Minimum Royalty Payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934431344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of employee and non-employee shares options activity</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">exercise</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">price</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life (years)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Aggregate</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">intrinsic</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">value (in</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the beginning of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">43,994</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">41.27</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercised</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:52%;padding-bottom:4px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10,823</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52.78</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options outstanding at the end of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,171</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.51</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercisable at the end of the year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,171</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37.51</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of employee and non-employee RSUs activity</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">shares</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">underlying</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted-</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">grant date</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">fair value</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unvested RSUs at the beginning of the year </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,755,057</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.16</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Granted </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,258,370</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.66</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vested </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,109,200</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.14</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="width:76%;padding-bottom:4px;vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Forfeited </span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(131,813</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                  <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.13</span></span></div>
                  </td>
                  <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unvested RSUs at the end of the year </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772,414</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0.87</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of options and RSUs outstanding</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="width:42%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Range of exercise price</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options and</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">as of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(years) (1)</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercisable</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">as of</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">average</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">remaining</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">life</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(years) (1)</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSUs only </span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,772,414</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$5.37&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,425</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.24</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,425</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.24</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$20.42- $33.75&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,943</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.35</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,943</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.35</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$50-$52.5&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,230</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.46</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,230</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.46</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$182.5-$524.25&#160;</span></span></div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,573</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.65</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,573</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.65</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="width:42%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1.8%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,805,585</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33,171</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)">
                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.39</span></span></div>
                  </td>
                  <td style="width:0.68%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of non-cash share-based compensation expense</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenue </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development, net </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">157</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">55</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sales and marketing </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">381</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">250</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">171</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">781</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">633</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">597</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,328</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">993</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">833</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrants outstanding and exercisable</a></td>
<td class="text">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:bottom;width:42%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance date</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">per warrant</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">exercisable</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contractual</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">term</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(number)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(number)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;padding-bottom:2px;width:10%;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2015 (1) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,771</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,771</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See footnote (1)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 28, 2016 (2) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,908</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,908</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">See footnote (1)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 25, 2019 (5) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45,600</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.187</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45,600</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 21, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 5, 2019 (6) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">408,457</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.140</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">408,457</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">October 7, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 5, 2019 (7) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,015</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.503</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">49,015</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">April 3, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2019, and June 6, 2019 (8) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,464,665</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,464,665</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2019 (9) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87,880</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.375</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">87,880</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 5, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 12, 2019 (10) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">416,667</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">416,667</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 12, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 10, 2019 (11) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.500</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 10, 2024</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2020 (12) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,400</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.250</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28,400</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2025</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2020 (13) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105,840</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.563</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">105,840</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 10, 2025</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 6, 2020 (14) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">448,698</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.760</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">448,698</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 2, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">July 6, 2020 (15) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">296,297</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.278</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">296,297</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 2, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 8, 2020 (16) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">586,760</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.340</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">586,760</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 8, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 8, 2020 (17) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">108,806</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.792</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">108,806</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 8, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 26, 2021 (18) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,460,751</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.600</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,460,751</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 26, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">February 26, 2021 (19) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">655,290</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.578</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">655,290</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 26, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 29, 2021 (20) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,006,759</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.000</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,006,759</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 29, 2027</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 29, 2021 (21) </span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">960,811</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.544</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">960,811</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 27, 2026</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:42%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,187,375</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,187,375</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  <td style="vertical-align:bottom;width:10%;padding-bottom:4px;vertical-align:bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                </tr>

            </table>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939806832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of loss before taxes on income</a></td>
<td class="text">
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Domestic</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,638</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,110</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,780</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,507</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">138</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,145</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,102</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,642</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of taxes on income</a></td>
<td class="text">
            <div>
              <div style="margin-left:36pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">151</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">316</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(29</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:36pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Domestic</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:2px;vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:64%;padding-bottom:4px;vertical-align:baseline">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline">&#160;</td>
                      <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred income taxes</a></td>
<td class="text">
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax assets:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carry forward tax losses</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">64,090</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">50,833</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development carry forward expenses-temporary differences</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,311</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">844</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accrual and reserves</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">849</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">392</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">394</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">456</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Credit tax carry forwards</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,714</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">480</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">214</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">68,838</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,739</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred tax liabilities:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right-of-use asset</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(470</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(214</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible Assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,015</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(144</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65,209</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52,525</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:76%;padding-bottom:2px;vertical-align:baseline">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Valuation allowance</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(65,209</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,525</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net deferred tax assets</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Schedule of net changes in total valuation allowance</a></td>
<td class="text">
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of year</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,525</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(48,098</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(42,941</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes due to exchange rate differences</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,418</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,488</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment previous year loss</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">)</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(14</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Acquisition</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7,269</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions during the year</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,410</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,831</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3,669</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of year</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(65,209</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(52,525</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(48,098</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)</a></td>
<td class="text">
        <div style="margin-left:36pt">
          <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss before taxes, as reported in the consolidated statements of operations</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,145</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,102</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,642</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.0</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.0</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5,093</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4,393</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2,908</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income tax at rate other than the Israeli statutory tax rate</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">56</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-deductible expenses including equity-based compensation expenses and other&#8201;</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">262</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">102</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating losses and other temporary differences for which valuation allowance was provided</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,410</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,375</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,669</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Permanent differences</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(342</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(775</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(784</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustment in respect of prior years</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
              </tr>
              <tr>
                <td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Actual tax expense (benefit)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">467</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">&#160;</td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                <td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                </td>
                <td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">&#160;</td>
              </tr>

          </table>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936525936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES (INCOME), NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of financial expenses, net</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency transactions and other</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest Income</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,354</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank commissions</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(20</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(25</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,467</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213140028626">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936522832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of revenues within geographic areas</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenue based on customer&#8217;s location:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,636</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,303</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,519</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Europe</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,044</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,057</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,381</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Asia-Pacific</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">387</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">115</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">60</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rest of the world</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">787</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13,854</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,511</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,966</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of long-lived assets by geographic region</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets by geographic region:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Israel</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">529</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">757</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">United States</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,404</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">231</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Germany</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">190</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">44</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,123</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,032</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;vertical-align:top;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*)</span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-lived assets are comprised of property and equipment, net, and operating lease right-of-use assets.</span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of major customer data as a percentage of total revenues</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin-left:36pt">
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year Ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer A</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.2</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14.2</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:FFact_0000000001035">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Customer B</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213145458513">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20230213145510899">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.0</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
            <table cellpadding="0" cellspacing="0" style="border:0px;width:100%">

                <tr>
                  <td style="width:18pt">&#160;</td>
                  <td style="width:36pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*)</span></span></td>
                  <td style="width:auto">
                    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less than 10%</span></span></p>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936752592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock', window );">Schedule of basic and diluted net loss per ordinary share</a></td>
<td class="text">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,133</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,569</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline">&#160;</td>
                    <td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,736</span></span></div>
                    </td>
                    <td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss attributable to ordinary shares</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(22,133</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(19,569</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12,736</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shares used in computing net loss per ordinary shares, basic and diluted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59,719,064</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62,378,797</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">47,935,652</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25">&#160;</div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:64%;vertical-align:bottom">
                      <div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per ordinary share, basic and diluted</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.37</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.31</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(0.27</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of basic and diluted net loss per ordinary share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933145872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_GeneralAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (22,133)<span></span>
</td>
<td class="num">$ (19,569)<span></span>
</td>
<td class="num">$ (12,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">235,883<span></span>
</td>
<td class="nump">213,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Negative cash flow from operations</a></td>
<td class="num">(20,667)<span></span>
</td>
<td class="num">(17,891)<span></span>
</td>
<td class="num">$ (11,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 28,083<span></span>
</td>
<td class="nump">$ 67,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_GeneralAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_GeneralAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111935069488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription', window );">Property Plant And Equipment Useful Life Description</a></td>
<td class="text">Over the shorter of the lease term <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_MachineryAndLaboratoryEquipmentMember', window );">Machinery and laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Field service units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">33 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Field service units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">50 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PropertyPlantAndEquipmentUsefulLifeDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment useful life description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PropertyPlantAndEquipmentUsefulLifeDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_MachineryAndLaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_MachineryAndLaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_FieldServiceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_FieldServiceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939561632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 13,854<span></span>
</td>
<td class="nump">$ 5,511<span></span>
</td>
<td class="nump">$ 5,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">10,681<span></span>
</td>
<td class="nump">4,175<span></span>
</td>
<td class="nump">4,916<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfwd_ServiceAndWarrantyMember', window );">Service And Warranty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RevenueObligationAxis=lfwd_RentalMember', window );">Rental [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="nump">$ 859<span></span>
</td>
<td class="nump">$ 533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfwd_ServiceAndWarrantyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfwd_ServiceAndWarrantyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_RevenueObligationAxis=lfwd_RentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_RevenueObligationAxis=lfwd_RentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934908080">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Trade receivable, net&#160;of credit losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 3,120<span></span>
</td>
<td class="nump">$ 1,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 3,010<span></span>
</td>
<td class="nump">$ 1,191<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Balance presented net of unrecognized revenue that was not yet collected.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">$401 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939556272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantyProvisionBalance', window );">Balance at December 31, 2022</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BusinessCombinationRecognizedWarrantProvision', window );">AlterG acquisition</a></td>
<td class="nump">$ 535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AmountOfWarrantProvision', window );">Provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AmountOfWarrantProvisionUsage', window );">Usage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(479)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantyProvisionBalance', window );">Balance at September 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 348<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_AmountOfWarrantProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents amount of warrant provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_AmountOfWarrantProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_AmountOfWarrantProvisionUsage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents amount of warrant provision usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_AmountOfWarrantProvisionUsage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BusinessCombinationRecognizedWarrantProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents business combination recognized warrant provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BusinessCombinationRecognizedWarrantProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_WarrantyProvisionBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of Warranty provision balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_WarrantyProvisionBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939546880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 4) - Trade Receivables [Member] - Credit Concentration Risk [Member]<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">27.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">13.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Customer D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of credit risk</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Less than 10%</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lfwd_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lfwd_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lfwd_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lfwd_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lfwd_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lfwd_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lfwd_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lfwd_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939754432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 5) - Fair Value, Measurements, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">$ 5,075<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial Liabilities</a></td>
<td class="nump">3,292<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Financial Liabilities</a></td>
<td class="nump">3,292<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember', window );">Treasury bills [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Financial Assets</a></td>
<td class="nump">$ 2,525<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lfwd_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lfwd_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934014448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details 6) - Earnout [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_FairValueWarrantsLiabilityActivityLineItems', window );"><strong>Fair Value Warrants Liability Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsLiabilityActivity', window );">Initial Measurement (August 11, 2023)</a></td>
<td class="nump">$ 3,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity', window );">Change in fair value</a></td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsLiabilityActivity', window );">Balance September 30, 2023</a></td>
<td class="nump">$ 3,292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ChangeInFairValueOfWarrantsLiabilityActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents change in fair value of warrants liability activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ChangeInFairValueOfWarrantsLiabilityActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_FairValueWarrantsLiabilityActivityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_FairValueWarrantsLiabilityActivityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_WarrantsLiabilityActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents warrants liability activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_WarrantsLiabilityActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lfwd_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lfwd_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111940946688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory Write-down</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Deferred revenue recognized</a></td>
<td class="nump">$ 435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RevenueRecognitionRecognized', window );">Revenue Recognition Recognized</a></td>
<td class="text">the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage', window );">Severance Pay Monthly Deposit By Employees Percentage</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsPeriodExpense', window );">Severance pay expense</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expenses</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RentalRevenueForAntiGravityProducts', window );">Rental Revenue For Anti Gravity Products</a></td>
<td class="nump">$ 249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,083,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_LeaseAgreementsTerm', window );">Leases agreement term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_LeaseAgreementsTerm', window );">Leases agreement term</a></td>
<td class="text">42 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfwd_ReStoreProductMember', window );">Re Store Product [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Service policy</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lfwd_SCIProductsMember', window );">SCI Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SignificantAccountingPoliciesTextualAbstract', window );"><strong>Significant Accounting Policies Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Service policy</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_LeaseAgreementsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of lease agreements term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_LeaseAgreementsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_RentalRevenueForAntiGravityProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of rental revenue for anti-gravity products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_RentalRevenueForAntiGravityProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_RevenueRecognitionRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_RevenueRecognitionRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_SeverancePayMonthlyDepositByEmployeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of monthly deposit required by employees as per the severance pay law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_SeverancePayMonthlyDepositByEmployeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_SignificantAccountingPoliciesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_SignificantAccountingPoliciesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period expense related to postemployment benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfwd_ReStoreProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfwd_ReStoreProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lfwd_SCIProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lfwd_SCIProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111938335632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent', window );">Prepaid Expenses To Government Institutions Current</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">1,227<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Supplies', window );">Advances to vendors</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other assets</a></td>
<td class="nump">747<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance to government institutions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937549504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td>
<td class="nump">$ 3,157<span></span>
</td>
<td class="nump">$ 2,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">2,496<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 5,653<span></span>
</td>
<td class="nump">$ 2,929<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939671408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939690496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Aug. 08, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember', window );">Alterg Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 18,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Earnout payments</a></td>
<td class="nump">3,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934787312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalent</a></td>
<td class="nump">$ 478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">1,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">3,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset', window );">Right of use asset</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,538<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">14,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(2,082)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation', window );">Accrued compensation</a></td>
<td class="num">(766)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="num">(1,059)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(2,088)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations', window );">Warranty Obligations</a></td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Leases Liability</a></td>
<td class="num">(1,151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued compensation recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other accrued liabilities recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of restricted cash recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Right of use asset recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warranty obligations recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937604448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Details 2)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 14,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 6,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipWarrantyMember', window );">Customer Relationship Warranty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipRentalMember', window );">Customer Relationship Rental [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 2,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipDistributionMember', window );">Customer Relationship - Distribution [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 4,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Backlog [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Estimated Fair Value</a></td>
<td class="nump">$ 296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipWarrantyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipWarrantyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipRentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipRentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipDistributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipDistributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939772144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues</a></td>
<td class="nump">$ 24,923<span></span>
</td>
<td class="nump">$ 25,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (21,761)<span></span>
</td>
<td class="num">$ (28,369)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111932868560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION  (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 08, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_EarnOutPaymentOfBusinessCombination', window );">Earnout payments</a></td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,854<span></span>
</td>
<td class="nump">$ 5,511<span></span>
</td>
<td class="nump">$ 5,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember', window );">Alterg Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Aggregate purchase price in cash</a></td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription', window );">Description of Earnout payments</a></td>
<td class="text">The Company will pay an amount of cash equal to 65% of the amount, if any, by which <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 7,658<span></span>
</td>
<td class="nump">$ 249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_EarnOutPaymentOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of earn out payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_EarnOutPaymentOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents a narrative description of the history, developments, or effect of the acquisition relative to the percentage of equity in the acquiree held by the acquirer immediately before the acquisition date. Such description may describe any gain recognized as a result of the acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934355392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">$ 14,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(1,608)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">12,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">6,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(604)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">5,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipWarrantyMember', window );">Customer relationship - Warranty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipRentalMember', window );">Customer relationship - Rental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">2,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">1,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationship - Distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">4,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">4,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_BacklogMember', window );">Backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Cost</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Accumulated Amortization</a></td>
<td class="num">(296)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, Net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipWarrantyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipWarrantyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipRentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_CustomerRelationshipRentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_BacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lfwd_BacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933044096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2024</a></td>
<td class="nump">$ 3,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2025</a></td>
<td class="nump">3,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2026</a></td>
<td class="nump">3,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Fiscal 2027</a></td>
<td class="nump">2,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Fiscal 2028</a></td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 12,525<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937586272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS, NET  (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember', window );">Alterg Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Purchase of goodwill</a></td>
<td class="nump">$ 7,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lfwd_AltergIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933408288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 7,603<span></span>
</td>
<td class="nump">$ 3,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">6,341<span></span>
</td>
<td class="nump">3,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,262<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,690<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_MachineryAndLaboratoryEquipmentMember', window );">Machinery and laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_FieldServiceUnitsMember', window );">Field service units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">4,166<span></span>
</td>
<td class="nump">1,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 658<span></span>
</td>
<td class="nump">$ 333<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_MachineryAndLaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_MachineryAndLaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_FieldServiceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfwd_FieldServiceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936515920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PropertyAndEquipmentNetTextualAbstract', window );"><strong>Property And Equipment Net Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenses</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PropertyAndEquipmentNetTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PropertyAndEquipmentNetTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939756384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ImputedInterest', window );">Less: imputed interest</a></td>
<td class="num">(147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Present value of future lease payments</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current maturities of operating leases</a></td>
<td class="num">(1,296)<span></span>
</td>
<td class="num">$ (564)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating leases</a></td>
<td class="nump">$ 607<span></span>
</td>
<td class="nump">$ 333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">1 year 11 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">9.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Less: imputed interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111940304880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract', window );"><strong>Commitments And Contingencies Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Non-cancelable outstanding obligations</a></td>
<td class="nump">$ 8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalties expenses</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Lease expiration, term</a></td>
<td class="text">These leases expire between 2024 and 2025.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Restricted cash and other long-term assets</a></td>
<td class="nump">$ 709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments', window );">Rent expenses</a></td>
<td class="nump">$ 976<span></span>
</td>
<td class="nump">$ 739<span></span>
</td>
<td class="nump">$ 730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract', window );"><strong>Commitments And Contingencies Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Description of conversion ratio</a></td>
<td class="text">ordinary shares in a conversion ratio of 1 to 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_IsraelInnovationAuthorityMember', window );">IIA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract', window );"><strong>Commitments And Contingencies Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Total fund received</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants', window );">Research And Development Royalty Bearing Grants</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RoyaltyFeesPercentage', window );">Royalty Fees Percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ContingentLiabilityRelatedToGrantsReceived', window );">Contingent liability</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees', window );">Percentage Of Grant Received Considered To Determine Royalty Fees</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalties expenses</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_IsraelInnovationAuthorityMember', window );">IIA [Member] | Convertible preferred A shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract', window );"><strong>Commitments And Contingencies Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares', window );">Research And Development Amount Received In Consideration Of Convertible Preferred Shares</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred shares</a></td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_CommitmentsAndContingenciesLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_CommitmentsAndContingenciesLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ContingentLiabilityRelatedToGrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the contingent liability related to grant received as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ContingentLiabilityRelatedToGrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of grant received considered to determine royalty fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of aggregate amount received in consideration of convertible preferred shares by the entity to fund research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ResearchAndDevelopmentRoyaltyBearingGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of aggregate amount received as royalty bearing grants by the entity to fund research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ResearchAndDevelopmentRoyaltyBearingGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_RoyaltyFeesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of royalty fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_RoyaltyFeesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lfwd_IsraelInnovationAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lfwd_IsraelInnovationAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933407120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number, Options outstanding at the beginning of the period</a></td>
<td class="nump">43,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number, Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number, Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number, Forfeited</a></td>
<td class="num">(10,823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number, Options outstanding at the end of the period</a></td>
<td class="nump">33,171<span></span>
</td>
<td class="nump">43,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number, Options exercisable at the end of the period</a></td>
<td class="nump">33,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average exercise price, Options outstanding at the beginning of the period</a></td>
<td class="nump">$ 41.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Average exercise price, Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Average exercise price, Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Average exercise price, Forfeited</a></td>
<td class="nump">52.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average exercise price, Options outstanding at the end of the period</a></td>
<td class="nump">37.51<span></span>
</td>
<td class="nump">$ 41.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Average exercise price, Options exercisable at the end of the period</a></td>
<td class="nump">$ 37.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual life (in years), Options outstanding at the beginning of the period</a></td>
<td class="text">4 years 4 months 20 days<span></span>
</td>
<td class="text">4 years 4 months 20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual life (in years), Options exercisable at the end of the period</a></td>
<td class="text">4 years 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933501632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 1) - Employee Stock Option And Restricted Stock Units Rsu [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Outstanding Roll Forward Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber', window );">Unvested RSUs at the Beginning of the period | shares</a></td>
<td class="nump">2,755,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted | shares</a></td>
<td class="nump">2,258,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested | shares</a></td>
<td class="num">(1,109,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited | shares</a></td>
<td class="num">(131,813)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber', window );">Unvested RSUs at the end of the period | shares</a></td>
<td class="nump">3,772,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Exercise Price Roll Forward Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice', window );">Unvested RSUs at the Beginning of the period | $ / shares</a></td>
<td class="nump">$ 1.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice', window );">Granted | $ / shares</a></td>
<td class="nump">0.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice', window );">Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Vested In Period Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">1.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice', window );">Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Forfeited In Period Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">1.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice', window );">Unvested RSUs at the end of the period | $ / shares</a></td>
<td class="nump">$ 0.87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options and Equity Instruments Other than Options, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Options Plans, Exercise Price Range, Outstanding Options and Equity Instruments Other than Options, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111932882416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 2) - Employee Stock Option [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">3,805,585<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 4 months 20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">33,171<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 4 months 20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">RSUs only [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">3,772,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_InvestmentOptionsExercisePrices', window );">Investment Options Exercise Prices | $ / shares</a></td>
<td class="nump">$ 5.37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">12,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">5 years 2 months 26 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">12,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">5 years 2 months 26 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">$ 20.42<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">$ 33.75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">12,943<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 4 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">12,943<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">4 years 4 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">52.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$50-$52.5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Range of exercise price, minimum | $ / shares</a></td>
<td class="nump">182.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Range of exercise price, maximum | $ / shares</a></td>
<td class="nump">$ 524.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">6,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">3 years 5 months 15 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">6,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">3 years 5 months 15 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">$182.5-$524.25 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options outstanding</a></td>
<td class="nump">1,573<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options outstanding weighted average remaining contractual life (years)</a></td>
<td class="text">1 year 7 months 24 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options outstanding and exercisable</a></td>
<td class="nump">1,573<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Options exercisable weighted average remaining contractual life (years)</a></td>
<td class="text">1 year 7 months 24 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.&#160;</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_InvestmentOptionsExercisePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_InvestmentOptionsExercisePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=lfwd_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934787568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">$ 1,328<span></span>
</td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">$ 833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Non-cash share-based compensation expense</a></td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 633<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934539328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details 4)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">19,187,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">19,187,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember', window );">Warrants To Purchase Ordinary Shares Issued On December Two Thousand Fifteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">4,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">4,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember', window );">Warrants To Purchase Ordinary Shares Issued On December Two Thousand Sixteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">1,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">1,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember', window );">Warrants To Purchase Ordinary Shares Issued On November Twenty Two Thousand Eighteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">45,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">45,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Feb. 21,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember', window );">Warrants To Purchase Ordinary Shares Issued On November Twenty Two Thousand Eighteen One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">408,457<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 5.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">408,457<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Oct.  07,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember', window );">Warrants To Purchase Ordinary Shares Issued On February Twenty Five Two Thousand Nineteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">49,015<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 6.503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">49,015<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Apr.  03,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember', window );">Warrants To Purchase Ordinary Shares Issued On April Five Two Thousand Nineteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">1,464,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">1,464,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jun.  05,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember', window );">Warrants To Purchase Ordinary Shares Issued On April Five Two Thousand Nineteen One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">87,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 9.375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">87,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jun.  05,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember', window );">Warrants To Purchase Ordinary Shares Issued On June Five And Six Two Thousand Nineteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">416,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">416,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Dec. 12,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember', window );">Warrants To Purchase Ordinary Shares Issued On June Five Two Thousand Nineteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jun. 10,  2024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember', window );">Warrants To Purchase Ordinary Shares Issued On June Tweleve Two Thousand Nineteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">28,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">28,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Feb. 10,  2025<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember', window );">Warrants To Purchase Ordinary Shares Issued On June Ten Two Thousand Nineteen Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">105,840<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">105,840<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Feb. 10,  2025<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember', window );">Warrants To Purchase Ordinary Shares Issued On February Ten Two Thousand Twenty Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">448,698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">448,698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jan.  02,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember', window );">Warrants To Purchase Ordinary Shares Issued On February Ten Two Thousand Twenty One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">296,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 2.278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">296,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jan.  02,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember', window );">Warrants To Purchase Ordinary Shares Issued On July Six Two Thousand Twenty Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">586,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">586,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jun.  08,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember', window );">Warrants To Purchase Ordinary Shares Issued On July Six Two Thousand Twenty One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">108,806<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 1.792<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">108,806<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Jun.  08,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember', window );">Warrants To Purchase Ordinary Shares Issued On December Eight Two Thousand Twenty Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">5,460,751<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">5,460,751<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Aug. 26,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember', window );">Warrants To Purchase Ordinary Shares Issued On December Eight Two Thousand Twenty One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">655,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 4.578<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">655,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Aug. 26,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[17]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember', window );">Warrants To Purchase Ordinary Shares Issued On February Twenty Six Two Thousand Twenty One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">8,006,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">8,006,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Mar. 29,  2027<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember', window );">Warrants To Purchase Ordinary Shares Issued On February Twenty Six Two Thousand Twenty One One Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">960,811<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per warrant | $ / shares</a></td>
<td class="nump">$ 2.544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ClassOfWarrantOrRightExercisable', window );">Class Of Warrant Or Right Exercisable</a></td>
<td class="nump">960,811<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExpitationDate', window );">Warrants Expitation Date</a></td>
<td class="text">Sep. 27,  2026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents warrants for ordinary shares issuable upon an exercise price of $7.500 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited (&#8220;Kreos&#8221;) in connection with a loan made by Kreos to the Company and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents common warrants that were issued as part of the Company&#8217;s follow-on public offering in November 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#8217;s follow-on public offering in November 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#8217;s follow-on public offering in February 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s registered direct offering of ordinary shares in April 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s April 2019 registered direct offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019, and June 6, 2019, respectively.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 warrant exercise agreement and concurrent private placement of warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s June 2019 registered direct offering and concurrent private placement of warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#8217;s best efforts offering of ordinary shares in February 2020. As of December 31, 2022, 3,740,100 warrants were exercised for total consideration of $4,675,125. During the twelve months that ended December 31, 2022, no warrants were exercised.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s February 2020 best efforts offering. As of December 31, 2022, 230,160 warrants were exercised for total consideration of $359,625. During the twelve months that ended December 31, 2022, no warrants were exercised.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020. As of December 31, 2022, 2,020,441 warrants were exercised for total consideration of $3,555,976. During the twelve months that ended December 31, 2022, no warrants were exercised.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s July 2020 registered direct offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020. As of December 31, 2022, 3,598,072 warrants were exercised for total consideration of $4,821,416. During the twelve months that ended December 31, 2022, no warrants were exercised.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s December 2020 private placement. As of December 31, 2022, 225,981 warrants were exercised for total consideration of $405,003. During the twelve months that ended December 31, 2022, no warrants were exercised.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in September 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[19]</td>
<td style="vertical-align: top;" valign="top">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#8217;s September 2021 registered direct offering.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ClassOfWarrantOrRightExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Exercisable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ClassOfWarrantOrRightExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_WarrantsExpitationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Expitation Date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_WarrantsExpitationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111925284080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details Textual)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 27, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 22, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 21, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 02, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Jun. 02, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 27, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 19, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 28, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Per share value of stock repurchase authorized | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsToPurchaseOrdinaryShares', window );">Warrants to purchase ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,187,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_NumberOfWarrantsOutstandingTotal', window );">Total number of warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,814,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_KreosCapitalVMember', window );">Kreos Capital V [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Warrants grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExercisableDescrition', window );">Warrants Exercisable Descrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#8217;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, restricted stock units (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,018,945<span></span>
</td>
<td class="nump">2,934,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized cost of shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,268<span></span>
</td>
<td class="nump">$ 860<span></span>
</td>
<td class="nump">$ 802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember', window );">Purchase agreement with certain institutional investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares)</a></td>
<td class="nump">15,403,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Per share value of stock repurchase authorized | &#8362; / shares</a></td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="nump">8,006,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,006,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_DescriptionOfUnderwritingAgreement', window );">Description of underwriting agreement</a></td>
<td class="text">The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember', window );">Purchase agreement with certain institutional investors [Member] | Additionally Warrants Issued [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares)</a></td>
<td class="nump">610,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="nump">960,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember', window );">Purchase Agreement With Certain Institutional Accerdited Investors Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,921,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.6625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Per share value of stock repurchase authorized | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,460,751<span></span>
</td>
<td class="nump">5,460,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,460,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExercisableDescrition', window );">Warrants Exercisable Descrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">exercisable from February 19, 2021, until August 26, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember', window );">Purchase Agreement With Certain Institutional Accerdited Investors Member | Additionally Warrants Issued [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.578125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">655,290<span></span>
</td>
<td class="nump">655,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">655,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WarrantsExercisableDescrition', window );">Warrants Exercisable Descrition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">exercisable from February 19, 2021, until August 26, 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember', window );">Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,740,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,675,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember', window );">Certain institutional purchasers [Member] | Offering of ordinary shares in February 2020 Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember', window );">Certain institutional purchasers [Member] | Offering of ordinary shares in July 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,020,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,555,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember', window );">Certain institutional purchasers [Member] | Offering of ordinary shares in December 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,598,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,821,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember', window );">Certain institutional purchasers [Member] | December 2020 private placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds From Warrant Exercises | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 405,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lfwd_KreosCapitalMember', window );">Kreos Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateralAmount', window );">Drawdown amount under loan agreement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=lfwd_ShareRepurchaseProgramMember', window );">Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ShareholdersEquityTextualAbstract', window );"><strong>Shareholders Equity Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Number of ordinary shares repurchased, amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Outstanding ordinary shares repurchased, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,022,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_DescriptionOfUnderwritingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of underwriting agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_DescriptionOfUnderwritingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_NumberOfWarrantsOutstandingTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_NumberOfWarrantsOutstandingTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ShareholdersEquityTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ShareholdersEquityTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_WarrantsExercisableDescrition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants exercisable, description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_WarrantsExercisableDescrition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_WarrantsToPurchaseOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_WarrantsToPurchaseOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets pledged to secure a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lfwd_KreosCapitalVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lfwd_KreosCapitalVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lfwd_AdditionallyWarrantsIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lfwd_AdditionallyWarrantsIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_AgreementAxis=lfwd_CertainInstitutionalPurchasersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInFebruary2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInFebruary2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInJuly2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInJuly2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInDecember2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_OfferingOfOrdinarySharesInDecember2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=lfwd_December2020PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=lfwd_December2020PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lfwd_KreosCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=lfwd_KreosCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=lfwd_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=lfwd_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111937527136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract', window );"><strong>Research Collaboration Agreement And License Agreement Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="nump">$ 4,148<span></span>
</td>
<td class="nump">$ 4,031<span></span>
</td>
<td class="nump">$ 2,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AgreementAxis=lfwd_LicenseAgreementAndCollaborationAgreementMember', window );">License Agreement and Collaboration Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract', window );"><strong>Research Collaboration Agreement And License Agreement Textual Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_AgreementAxis=lfwd_LicenseAgreementAndCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_AgreementAxis=lfwd_LicenseAgreementAndCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933908512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (19,638)<span></span>
</td>
<td class="num">$ (19,110)<span></span>
</td>
<td class="num">$ (12,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(2,507)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (22,145)<span></span>
</td>
<td class="num">$ (19,102)<span></span>
</td>
<td class="num">$ (12,642)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933952736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_DeferredIncomeTax', window );">Deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_TaxesOnIncome', window );">Taxes on income</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Domestic</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Foreign</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_TaxesIncome', window );">Taxes on income</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_DeferredIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_DeferredIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_TaxesIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_TaxesIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_TaxesOnIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_TaxesOnIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934892128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Carry forward tax losses</a></td>
<td class="nump">$ 64,090<span></span>
</td>
<td class="nump">$ 50,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development carry forward expenses-temporary differences</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrual and reserves</a></td>
<td class="nump">849<span></span>
</td>
<td class="nump">392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation', window );">Share based compensation</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Credit tax carry forwards</a></td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total deferred tax assets</a></td>
<td class="nump">68,838<span></span>
</td>
<td class="nump">52,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="num">(470)<span></span>
</td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible Assets</a></td>
<td class="num">(3,015)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(144)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax assets</a></td>
<td class="nump">65,209<span></span>
</td>
<td class="nump">52,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(65,209)<span></span>
</td>
<td class="num">(52,525)<span></span>
</td>
<td class="num">$ (48,098)<span></span>
</td>
<td class="num">$ (42,941)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of deferred tax assets tax deferred expense share based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111938203136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="num">$ (52,525)<span></span>
</td>
<td class="num">$ (48,098)<span></span>
</td>
<td class="num">$ (42,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount', window );">Valuationallowancedeferred Tax Asset Changes Due To Exchange Rate Differences Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="num">(1,488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount', window );">Adjustment previous year loss</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount', window );">Acquisition</a></td>
<td class="num">(7,269)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Additions during the year</a></td>
<td class="num">(5,410)<span></span>
</td>
<td class="num">(5,831)<span></span>
</td>
<td class="num">(3,669)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at end of year</a></td>
<td class="num">$ (65,209)<span></span>
</td>
<td class="num">$ (52,525)<span></span>
</td>
<td class="num">$ (48,098)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the acquisition, deferred tax asset, adjustments, amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Adjustments, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Changes Due Exchange Rate Differences, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939756192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details 4) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before taxes, as reported in the consolidated statements of operations</a></td>
<td class="num">$ (22,145)<span></span>
</td>
<td class="num">$ (19,102)<span></span>
</td>
<td class="num">$ (12,642)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Theoretical tax benefits on the above amount at the Israeli statutory tax rate</a></td>
<td class="num">$ (5,093)<span></span>
</td>
<td class="num">$ (4,393)<span></span>
</td>
<td class="num">$ (2,908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Income tax at rate other than the Israeli statutory tax rate</a></td>
<td class="nump">56<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses including equity-based compensation expenses and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Operating losses and other temporary differences for which valuation allowance was provided</a></td>
<td class="nump">5,410<span></span>
</td>
<td class="nump">5,375<span></span>
</td>
<td class="nump">3,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Permanent differences</a></td>
<td class="num">(342)<span></span>
</td>
<td class="num">(775)<span></span>
</td>
<td class="num">(784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Adjustment in respect of prior years</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Actual tax expense (benefit)</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934813264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod', window );">Beneficiary enterprise from productive activity, tax exemption period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption', window );">Beneficiary Enterprise From Productive Activity Maximum Time From Period Of Election For Tax Exemption</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome', window );">Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome', window );">Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_ReWalkRoboticsIncMember', window );">Re Walk Robotics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry-forward losses</a></td>
<td class="nump">$ 242.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_RewalkRoboticsGmbhMember', window );">Rewalk Robotics Gmbh [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_AltergIncMember', window );">Alterg Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry-forward losses</a></td>
<td class="nump">$ 31.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_OperatingLossCarryforwardsPriorPeriod', window );">Operating loss carry forwards prior period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_NetOperatingCarryForwardLossesExpirationTerm', window );">Net operating carry forward losses expiration term</a></td>
<td class="text">2025 and 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_AltergIncMember', window );">Alterg Inc [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry-forward losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=lfwd_AltergIncMember', window );">Alterg Inc [Member] | State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_IncomeTaxesAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Carry-forward losses</a></td>
<td class="nump">$ 47.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficiary Enterprise from Productive Activity, Maximum Time from Period of Election for Tax Exemption</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficiary Enterprise from Productive Activity, Tax Exemption Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficiary Enterprise from Productive Activity, Tax Rate on Dividend Distributions from Tax Exempt Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_IncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_IncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_NetOperatingCarryForwardLossesExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating carry forward losses expiration term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_NetOperatingCarryForwardLossesExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_OperatingLossCarryforwardsPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of operating loss carryforwards prior period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_OperatingLossCarryforwardsPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lfwd_ReWalkRoboticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lfwd_ReWalkRoboticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lfwd_RewalkRoboticsGmbhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lfwd_RewalkRoboticsGmbhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=lfwd_AltergIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=lfwd_AltergIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934294016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL EXPENSES (INCOME), NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency transactions and other</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="num">$ (22)<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest Income</a></td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_BankCommissions', window );">Bank commissions</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_FinancialExpensesAndIncomeNet', window );">Financial (expenses) income, net</a></td>
<td class="nump">$ 1,467<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_BankCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of bank commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_BankCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_FinancialExpensesAndIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the Financial Expenses And Income Net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_FinancialExpensesAndIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934788272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 13,854<span></span>
</td>
<td class="nump">$ 5,511<span></span>
</td>
<td class="nump">$ 5,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">7,636<span></span>
</td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">2,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">5,044<span></span>
</td>
<td class="nump">3,057<span></span>
</td>
<td class="nump">3,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfwd_RestOfWorldMember', window );">Rest Of World [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 787<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfwd_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfwd_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111932956960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 3,123<span></span>
</td>
<td class="nump">$ 1,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">2,404<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111933454064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2) - Sales Revenue, Net [Member] - Customer Concentration Risk [Member]<br></strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">12.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">11.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Less than 10%</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lfwd_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lfwd_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=lfwd_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=lfwd_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111936705024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract', window );"><strong>Geographic Information And Major Customer And Product Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111932960768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to ordinary shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (22,133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,736)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares used in computing net loss per ordinary share, basic | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,719,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,378,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,935,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares used in computing net loss per ordinary share, diluted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,719,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,378,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,935,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per ordinary share, basic | (per share)</a></td>
<td class="num">&#8362; (0.37)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">&#8362; (0.31)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">&#8362; (0.27)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per ordinary share, diluted | (per share)</a></td>
<td class="num">&#8362; (0.37)<span></span>
</td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">&#8362; (0.31)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">&#8362; (0.27)<span></span>
</td>
<td class="num">$ (0.27)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111939685952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE  (Details Textual) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive', window );">Shares Excluded from Diluted Loss per Share - Anti-Dilutive</a></td>
<td class="nump">19,220,546<span></span>
</td>
<td class="nump">19,464,888<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the shares excluded from diluted loss per share anti dilutive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140111934873584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES  (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 12, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RestructringActivitiesLineItems', window );"><strong>Restructring Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,148<span></span>
</td>
<td class="nump">$ 4,031<span></span>
</td>
<td class="nump">$ 2,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,922<span></span>
</td>
<td class="nump">$ 9,842<span></span>
</td>
<td class="nump">$ 6,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfwd_TwoZeroTwoThreeReorganizationPlanMember', window );">2023 Reorganization Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_RestructringActivitiesLineItems', window );"><strong>Restructring Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_WorkforcePercentage', window );">Workforce Percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses', window );">Amount of employee termination benefits and legal expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Sales and marketing, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of employee termination benefits and legal expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_RestructringActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_RestructringActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfwd_WorkforcePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of workforce.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfwd_WorkforcePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfwd_TwoZeroTwoThreeReorganizationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfwd_TwoZeroTwoThreeReorganizationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>101
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MIK/HE9R=)&]8)V_XBUDG&"T6:P3K#*SW.Q R&]7"WJ.<&6MAJ-<"=H>M6C"
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MDG(& M.!-72N1I[QKQP^4]S)HS.82E:</QACF@RLCA&$!<;*$(C^;/$:B\*
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M]H^+ *4%D+Y:L7J9?P&L@[U_Z!HX24)3.3E1<E!M+P$F%:,2SX78#JROK/&
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M9@W1,7@^Y,8&KD@0\4-@8'-'9T"=N5^+D#W&Q6,N.TNJ62(N'3H%*6-)WRL
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MPBGQC;@EG\U.3OXNZ\.@A]S-()L0QQ4E 'ZMLHTX(P8*.&>X*9>CWO=>!,
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M:&5E=',O<VAE970Q,BYX;6R%54UOVS ,O?M7$%XQ;$ 6.W+2-ED2H)]8#_U
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M$BL-D&1+CEUPG,/I,/G5X.2@#\XH"CH?9Z3<YC'A\@V42 XFPH06>%%*5]L
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MBNQ%%SU# Z&QT.J)JJ+V2^-_^*-#7C5)==BLH>L7=%@*XXU8!#)NC[9RKF!
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M1AIJE6Y9TK\)E56@\T)*<Q"L@^%O-_\74$L#!!0    ( /-)6U@W.YN370D
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M\4JWY2PY&9M6QHBLAZP@+8^/MU[\X^/7.G'<V+A92,-$4>9Z)6!W!8=,A%M
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M)JZ:)7R!<$-^'5KB*@'/F)?9_5@NQ#-YE)0P"$QW:N]R[PCFOA5,(F?(SJ]
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M(6PX9C#QX(?"T:-G1G9@!E&@0K4.W_Q,)#R/LWF3*>4%;W8<T7Y.H.I?BZ2
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M+R[*O;3(8\528BS/IJX855,*N:GJ*O@0?\:*J1S2LB4^'.RN?'&FL+_3+8F
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MR*JKWRK-=@2BCL?\_#W@[Z!TDS 9GI-TDV02_/(\^H.^7P(Y_*J3H]0\OG-
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M:9"QFV[P;P H>P'/,RG-?F$5'/Y8C'X"4$L#!!0    ( /-)6UA0!GZR[ ,
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M /XVK7"^"> 2$0\S1^@("WY\B '9#<P>T%0&1$;G@0#Q":'5+WUZ'\O&\?[
M^A^W*4P#"9]^H0V@9<!Y161:DH[B)8AV9A"P\@/^Z-#838?3 =9W85G?Q2#C
M^MF2[7W @(CAO"JR+"X[V>$PU.5T]"V KXD5K9N<% FX-6G*$O;B$*45HT*_
M$^J7L)VHL*#BP;\;H*5BER:1R1_2LLB)?F$01KM'YX2Z%)ZJFF65KM(8J34"
M%0QX,^\\0%HUS#Z @D%.Y56<",-\6\# <L[;!T=.<25 JIII#<X+SGUEE[RB
M)4^C.SB1*Z!@@-Q]$H61P/Z38B4<IQ_D7V'H_*1B>5^FJ#@Z;,M2_QQV30P7
MX<D^+.,T&^$^X?CMJ1_MU>$?E4\E^+MCCCIK9(])42*/RH!K[(K<U+BJF%41
MQ$B:U_"/,2B/T03II -R<IJ.AUL19SLXX UC'DZ\CWN$%-.PQ*!(5M_<WT97
M9[,(U[.8_0 Z+FBP>72KV'T;U[6!;:/?YS]$-UGFTUNT@3G*66<F)]OAS<,N
M;AEG-# ;&BF<LTKF3*>$EWJD=7BZ!L#F_2$.%_OD!_16@%0&9F6E$_P>[X%/
M \7@C@[PGTO+?RX'.<5[$'=)NL]XF;=VEC"=+K8S#"R9C@;@,;?Y%O4+11VI
M(XYXPM-O2?1Q"W0 !^81J<JG>CSHL,N)W"_[5$7;^ 'EA\DC.)1@=M T2#]*
M_+D.H?:91>VS06S<QM4V>@W:(L@17%@7/H<AK*:C-I#KB*X8=X7HK=K":9S
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M#M;^OBEA)XE,9>=$'48#+P.<Y$Q*/!92.PBCK, -1D[!TJVB,P#L%644&L-
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MK&IX.@']T_K1F!]:KY_OM32^?N+[7JT'9P-<",ZMR%UT"N/YTN\<,P)D*6G
M@[EY5!;.FZCW@(E?,HV6[(CE8$"A6R-3/,:-MV)_?9XGUE1[E%>HB1.;*>E"
MS9[8UF&81F\MVJR>H0?*T_+\G6FQ@F/G-W.#OK..!!$<0?+:=3O_U3>1EB"=
M43E,!(_H>BCWK %Y.V^7@!J][YGE9\"$("4NP-S*;-!HA(4IC:"CR,U9'=FL
MGZOMGYD-;.S:&/97HS^7939:^0GM(O](3F-B#L@4@;[ QE&6N)' 3S!$,/HD
M'%W46SKC>)C4XS>DELV]@.1\4-3](D>3YOR.YGQG":9;=@X#W$Y'PS#[A=>X
M@Q7Q^M';GVAH@4)#+?[.>WUT]6ODZM-DZFLF =_+.VD:IDM'3;QP,3.U)G=S
M;:^DFR7Z8@WN!I*!E:S,&N"!G8I:8]?2//>D W6CZPV8Z%<@*76'C%<A66?
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M?.'I^6G,-I>(TR-QAO>W=U8 MTS/K"J88-E'F->3NIA8?\&N .;07=76P5M
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M5TXTX5.EN54PW6JQD%Q*D<04.4/X', -6@\]<BV@Z!8*_I7I4JL7@2J&W+V
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M5SGZF<GT<7YU<SF?T]GM]?3JYOSAZO:&]A[80H ^&?4-;F$-^_D.;MK"16_
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M@VEVB\ [@&H)RMZ#8^_!?B+G7&ISBM^J;@QN]JF=CT[HI2<!CL=)[-P6!<N
M%(T2S#0*WO-TDG3HQ,'0N:99B614IX/3I5342#1?7=,H;'^7#'A.+#D+W""L
M=A(O3%/,.PQ3YSM@N982?5B%I_,$-EH[Z0 SQ;&EY:6!'6-OB'![Y$VSK*D:
M3@WD6.YX&AFCMJ$XJ1<G(<:FT<"9[S_\]ABB-++C24IVO0'_3?U6H%9ME])X
MOXTP72GWJWTCG';U_^K>==%KJE9,:,*AP-#@Z'C@$M5UILXPLFZ[P5(:["WM
MM,1F#LHZX'XAI=D:-D'_]S#Y#U!+ P04    " #S25M8D<*07.X"   -!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q]55EO&C$0?M]?86T/)1)E
M+R!-"DA TA8IT*C0]J'J@]D=P*J/K>T-X=]W[(5MVB:\L#[F.\;V#/V=TC_-
M%L"2!\&E&81;:\NK*#+Y%@0U;56"Q)VUTH):G.I-9$H-M/ @P:,TCGN1H$R&
MP[Y?N]/#OJHL9Q+N-#&5$%3OQ\#5;A FX7'A,]MLK5N(AOV2;F !]DMYIW$6
M-2P%$R -4Y)H6 _"47(U[KAX'_"5P<X\&A.7R4JIGVXR+09A[ P!A]PZ!HJ?
M>Y@ YXX(;?PZ<(:-I ,^'A_9W_O<,9<5-3!1_!LK['80O@U) 6M:<?M9[3["
M(9^NX\L5-_Z7[.K8;AJ2O#)6B0,8'0@FZR]].)S#(\#;^!E >@"DWG<MY%U>
M4TN'?:UV1+MH9',#GZI'HSDFW:4LK,9=AC@[G'R:S:;+V<U\N2"C^369?)HO
MI_,/.">WT]%X>CM=3F\6Y&Q)5QS,>3^R*.J@47X0&-<"Z3,"24IF2MJM(3>R
M@.)O@@C=-I;3H^5Q>I+Q&O(VR9(62>,T.\&7-4>0>;[LN2-00C"+#\T:0F5!
M)FB7R0W(G($AU\SD7)E* _D^6AFK\1W]>.H8:I'.TR*NMJY,27,8A%@\!O0]
MA,/7+Y)>_.Y$"ITFA<XI]N$":[6H.!"U=H^$B4H0K?:4VSTIZ=[G]I3GTZQX
MOIW@99"TLEX6X*0;]"XZ;M +DBQ8*DLYX8 ET6@$:2ONQL$M&'-%F"@K"P5A
MT@*F;(.SI',1G =W+G]IR3WEE7>\KJP[WG^HDM9EG!VH\DIK!\$JK#2S[EX0
MAYU)4W=5-=2@0"N][*'$7,DW1\Q_42^#7GP1?//U"L4;>H_[&\ .XWI8$T?0
MM"!G3)(]4&W.@Z1]F?Z/*O!YJ IE4 ."RW::!*^>NM#H48D*T!O?B SQV+I:
MF]6FUXWJ$O\37C?*&=4;)@W:7",T;E]T0Z+KYE-/K"I]P:^4Q?;AAUOLUZ!=
M .ZOE;+'B1-H_@&&OP%02P,$%     @ \TE;6/-;\3.B!@  QQ$  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&ULK5AA;]LX$OVN7T%XC;L$4&2)%"6J
MEP1(V^RVQ7;3B]LM%H?[P-BT+5267(E*FG^_CY1,.XXK] Y% (=#S1O.<-X,
M*9T_5/679J64)M_61=E<C%9:;UY,)LULI=:R":J-*O%D4=5KJ2'6RTFSJ96<
M6]"ZF- P3"9KF9>CRW,[]Z&^/*]:7>2E^E"3IEVO9?WX4A75P\4H&FTG;O/E
M2IN)R>7Y1B[55.E/FP\UI(FS,L_7JFSRJB2U6ER,KJ(7+X71MPI_YNJAV1L3
M$\E=57TQPMOYQ2@T#JE"S;2Q(/'O7KU216$,P8VOO<V16]( ]\=;Z[_:V!'+
MG6S4JZKXG,_UZF(D1F2N%K(M]&WU\$;U\7!C;U85C?TE#YUN0D=DUC:Z6O=@
M>+#.R^Z__-;OPQY A-\!T!Y K=_=0M;+UU++R_.Z>B"UT88U,["A6C2<RTN3
ME*FN\30'3E].WUS=7K^Y^?WU]>WTG^3ZWY_>?OR+G'R4=X5J3L\G&DL8Q<FL
M-_>R,T>_8RZBY'U5ZE5#KLNYFC\U,(%OSD&Z=? E';3X6LT"PB*?T)"R 7O,
M!<RL/?8=>]=?VUP_DO]<W36Z!B?^>RS(SD1\W(2IDQ?-1L[4Q0B%T*CZ7HTN
M__%+E(3_&G P=@[&0]8OIZB[>5LH4BV(6F^*ZE$I(LLY*:ORS$TT*XFE2;4Q
MW&XZ<B.N8\$,+G<\F#_:]9VJO<^6TVI.Y+VJ4:)$?5/U+&\4V=3Y3#U_7BO3
M!_)R269@@=G>5A:DR!>*G#PJ63>GWM5R6:NEU(KDT,A1W3-R+XL6&GE)]*IJ
M&P0+Q9L^-'221F/*6)4:&HK<J65>VF6P1V;"V/9BYF=9[(V]. IHZL4!RR"<
M>;_5LH23&'5_UWT0NQG4]T+E1N<D"GU!F7?J<1JDPCX=<$0A+?LN,.9':815
M61KP:.?"UD2_?Z:Z_D<39(!9W#&+_P1FW4X_#?-I<)$A/IEU>]ZVZ YU\6A3
MN+>M9FW'JC-'JZ7)()D;TBQD7G=\\3Z5]ZHQ[.L\'J(&]5/._9"G7A1$B6,$
M]2D7/DM#+PR2Q/O3F@,'_"C,?!QKH 'TXR?\0"L2$>N>L.,^/$NIGZ;4CV$H
M#$0ZE,G$93+YX4RZ%E#V7NQMZ+'T#5N^E>6R(\C34K\Y7.5FOQH:@T"G5C;-
MVV[]__0'<A+M2O]ZOUQ^\AK=5I7%XUYZNFXPY@$#43!%N<<#&C\9CVD8Q/2,
MC!D+4FX>93$S9?IT/.;AV1@]A'N)3UGHL2!.]H?C2."A48D#F(Y\GC)0*GDR
M9+X(N<\%[]I WQK,>(!#J>-0^L,<,@U@)IM55YYGYIHSQ_:M<?5KI+T]J6]F
MK(X1:G"9X_W@+^2ANR$\R:AG,XH?:GXB[U75:.->K>Y5B8H?>Z87HH#Q$WJW
ML";KV<IR<@Z5HMK@NJA]4BKM12AVG :<>U.)NXQ5PK7SB]*@AL=$Y%$>>F8_
M?U,EF%-8#3G''2LW-P-S6?12J"6,>3Q+O8^5EH59V6=4&%<RAE_!V%!!"Y<,
M\</)>)"UZ4\'!PZ<VSL]CN5A>(6W3=/*<J9L&_4^'UG#'8Q=R9,-DM+[<E3_
MT">D:U=O6M5K[Z2T??]T-SBHWXC;6HQ1@>;(PXF'IMM)4QQ%BZK2986N;Y0<
ME H+3<@)11?VLU X:"<]@_ZJ[NH6KQR$<@O-R G'JMQ/@#'82*1;<:?;=9C8
MN\)V%,0A$R!#X<?@UQ@M(8I#)]_,=&4\3(\C4R S'T$#F,!?MA4[/=:CWK6E
MVH)\N\EV)MF:$2;J.(G]).%[D6]G=O #6^0D._5$Z@MA@L[0Y/A6?(Y!+^M!
M40BWHP2V4^MW:%+4RRXGG;H#APZ,W>>A'_;[;#SMQ3U%P-RN]S,AH,@N4AU;
M*&YTJ-9>/%3F1^$,VX3N*>(.SQ/FY.<&WK7%8[?#%ALCY%CX228L-DU")[^3
M94</JYP<(L$KFJ'/9V:S*.ZAPLF'2+=YPJ'!+2X2WZQGUF7P=2O;_1+?AZ8F
M7($#(^E<SJB3GT!W_.Z<CH %HSCX$^*69&^>@2F$W<Q5N\2+Z!9PW 2HE>"*
M13/C>1QPQ+V5#^%3M=%])6=;/ 7)!'B!6'EF=\YP9#?SWC;Z7C\];@)4R^"Q
MB")K@,>QD_?TT]X+U!:JWC=%L!L>Z^23O9?KM:J7]A-"@].Q+77WGNUFW5>*
MJ^[E?*?>?>) %+B=-J10"T!#W!]&I.X^&W2"KC;V5?VNTGCQM\.5DK@J&P4\
M-UUM*Y@%W+>;R[\!4$L#!!0    ( /-)6U@&?J% W04  $H/   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;*57VV[C-A!]UU<0WK9P #G6U9:SB8%<
MMFB O02;=-NBZ ,MT3&[LN@EJ3CY^YZA9"79.*Z+/EBB1?+,S)D;>;Q6^JM9
M"&'9_;*LS$EO8>WJ:#@T^4(LN3E4*U%A9J[TDEO\U;=#L]*"%V[3LAQ&03 :
M+KFL>M-C]^U*3X]5;4M9B2O-3+U<<OUP)DJU/NF%O<V'S_)V8>G#<'J\XK?B
M6MA?5U<:_X8=2B&7HC)254R+^4GO-#PZRVB]6_!%BK5Y,F9DR4RIK_3GLCCI
M!:20*$5N"8'C=2?.15D2$-3XUF+V.I&T\>EX@_ZSLQVVS+@1YZK\319V<=++
M>JP0<UZ7]K-:_R):>U+"RU5IW).MV[5!C^6UL6K9;H8&2UDU;W[?\K#/AJC=
M$#F]&T%.RPMN^?18JS73M!IH-'"FNMU03E;DE&NK,2NQSTXO/YY_^O".W9S^
M_NZ:]6_XK!3FX'AH 4T+AGD+<]; 1*_ A!'[H"J[,.Q=58CB.< 0.G6*11O%
MSJ*=B!<B/V1QZ+,HB.(=>'%G:.SPXM<,K7*U%.R&W[,+:?)2F5H+]N?IS%B-
MT/AKF\T-8K(=D=+ER*QX+DYZR <C])WH37]Z$XZ"MSOT33I]DUWHTVND7U&7
M@JDY@[*&S0124##+[X5AB&?I#-JF]F[@/P37C9<8.!;+F=#$LT<\TR.B1^A=
M -Q8F7L_>/UPXH_BS#MHQV$8M./('V<T1H(@_"NO'_EI,,:'S NQ 4NBR ^3
M]'%K$'5;1PG&.YA*.Z;2O9G:@YV=8-N=NB=EY[76HK*-><[,, WIB5478BXP
M6W@#+PY'X&6RX<&]D]$8STGB_7?O#+I?YP4'2I  ?"F#[>!\U'$^VIOSHC6M
MY;SQP3;F=T)N9_X5#C9LDBS&C1'6''GG7.L'AB19<]W,4-X( Z-'B1], @S2
MP,_BV/L,?*[S!>-5 ?WOT)M6Z#26Y<\PQ#UZ'Q &5BQ72J-IL4+.(5I4.7!#
M/PY#+TL2[S3/=<U+!]?J;C Q\>))Y%TO./*66D?!0!!!<NI(F$R\)!UYY[!$
M6J?Q,_DD81PF\.Q[@=VLE'PF2VDEP!/D782Y&V4AMWC)AS?*8&KFI<C1>/*<
ML2= 1Y[KPP,U']00X?9Z_61,6=TG 0?>965Y=2O1&=AI ]V/_2"DI!YX5QKG
M VT?G.GB6RT=CXBY)''S'W&NV*I=ZD?!A+1+H]3[PLN:-UVZQ#&!@UZOWRZ!
M'NVJ@U?1V@S8%=GC+K+'>T=V!7'Y L:CILB*6<?UW4M=MP7[;BE[IOD9+PF?
M<8OR?RNK2E:WI-@#ME-F=\1@G&2(\;9()Y$_24*,SUOMBQIYJ1#0C3E,<RN>
MQ?( L9:$&1SG)QFAG!9_X_3AD@+I>"=5;9Q8EU20S [(R<['ISG\;J2+Z?[8
MCT83]QD31>&^DGQ-JMN%:'3OIY#F8BQ%E)*FB*F1V_C$9H&8>F)M%Q"O6+[#
M^UGG_6QO[VN1JRI'GC3>G@F[%J)R-N"'6HOZBWB@,&P+A4L"FL>!HOYNJC\3
ME9A+N_5PM5.I_]63WG]_=/"1,S -Y<RZDNWTA:%&E;+@],U8O,CQAEB@]'8$
MF'W:N7>-S;55*&)D/(69!WU^Q.,P>'S=?,=?RXWKW(Z_F;K#<ZEJA!\"@;Y=
M&LU%*9UZWTF@>$ (Q&TX^/%FB#0(,E?"-IV)T%SP*V!J //JW]!3:M< &7L?
M534 X35N$E0--^V!&E]9%Q3@5 'MP^!EL7]<3#'BA/_T)HN"\"WR)!I%'E'Y
MJ>$:.$WG>ES+MG8@:A1LO9!H9%NJ$EO#TRNM[B1T]IJ$2_UXG'I-JET)W&HJ
M2O"GA: ?.S_VQ^/4O;+D>3&0=!<S*URJ*#I66D(%2E#L3.(V[S^1RFZ4H3B\
MG@K['DZ&3^XW2Z%OW2W.@%^$1W/5Z;YV%\73YG[TN+RY97[@&G74L%+,L34X
M'.,XJ)N;6_/'JI6[+<V4Q=W+#1>X[ I-"S _5\IN_I" [OH\_0=02P,$%
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MFJJF"S8+(ZNZ\ZRD0<;U=(-_'$#9"WB^EM(\+:R"]J_(^']02P,$%     @
M\TE;6*#06"72 @  (P8  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL
M?95M;]HP$,??\RE.V32U4M0\\5 Z0(+"U$IMAZ#=-$U[89(#K"9V9CNE^_8[
M)^%A*^5-.#MW/__OG#MZ&ZF>]1K1P&N6"MUWUL;D5YZGXS5F3%_(' 6]64J5
M,4-+M?)TKI E95"6>J'OM[V,<>$,>N7>5 UZLC I%SA5H(LL8^K/"%.YZ3N!
ML]V8\=7:V UOT,O9"N=HGO*IHI6WHR0\0Z&Y%*!PV7>&P=6H:?U+AV\<-_K
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M7$ LL[PP=(>G"J#=MP5KM+INA_A^N]EHAV[4N70[W4ZCV7&[4<MMM\*]X+?
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MIJ;Z0VDGF.^)$/JI8QTT]>3X?U!+ P04    " #S25M8]!LXQA0#   ^"P
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M<UZT0]5L=9L>JSODJ_F)O&7KYKU^J(N?>OV9;G[LM@516[O2.5SD[6.JQ<\
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M[&:6.5%P+MAOFNMBY)UX*(<%J9F>BN8G=/,,+5\FF'*_J&ESAT,/9;72HNS
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MPZKZ774$+70)7%(A"ZIN)O+( TPMD/,K2L5S1U75YA 5_@-02P,$%     @
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MLZKFEPF8/;>T'<SSJ1#ZO6$3E$=ZX7]02P,$%     @ \TE;6%(+@6&  @
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M+ I0+1\#PL.FM/2/1JK=MXZ^@*UQS_5;)\S7!*OY;5OO2WFKU?$I\H!%63$
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M.D ]7S$F'P?ZJ"@_&AS_ 5!+ P04    " #S25M8A_O3\8L"  "A!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6RM5=%NFS 4_16+55,G=85 FFX=
M04I*IO6A69:FF_;HP$VP"C:U39+^_:X-86E%JC[T!7SM>\[UN<:'<"OD@\H
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M2+H0P[94;FGP=EBX<)6[X+_B O;1#4ME)-"G= &+.D!;S:><E/\RJ2O?BAA
M>(HZ^"/R/;]C<&CR=G/?8!Z\W1Q;9M,I7U$GP^N\]HI8DE"IUIH4:)PNT$21
M1=,5I"$%@:XIF=.82MW^-IX+R=52^L?T%O)1NN91='ZY$&L2PF5+)1 !? NM
MT>^_X9[WAXE!EV"!([ :N]V2W:X-?73+TI.0I"'$9!X#4JE12!7'BF#$YC%=
M$9V>C%&=XYYEN#J];D>#GN<-V]M]GJR#'\N3([ :3V<E3V=6GA[8,XFS*(,G
MM>D(,')RUN $]P\8:78YZ!$80+IEEYKSO=+YGM7Y:U!;@W:<\NQ]?D02>&*:
M@!UG%BE>4:S11 X': YR!Y#JU=Y%*G)TX^S4M&:LV,?&@B.P&IW]DLZ^/19
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M+]#_R(-7P3Q2P499_'<4R/"\<](! 1O362SOL_D-*P/*'?2S6.1_P;Q\UNT
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MQO4#ZOXXR^3B1!NHMND,_P=02P,$%     @ \TE;6+&IJ$@'!   5!4  !D
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MYR13S1AP!%0:B.]+0OA31TY0%5(G_P%02P,$%     @ \TE;6,RCJ;$J#P
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MR I:AQI<BVT_1__XPF5\"H,W.\NO 0;R'0#6&VHG ("B&\EZ);98SP@_',,
M(D\"R[-M.9KE11.R622S!=GP@I,;(1H0-&_,@+<;=U./5#GY9\'SDES$PN<I
M^8T\!??SHGI&WJT!4S\DRT1<_?3''T+&[!?R;/F9OGA&DHS,\BRKMW_?)-6"
MQ"3-0<EE/.?DZJZ6#LU4"TXN\N4JSNZ( &M0D\S610$.2.]V-DD[GX+4S2*'
M3^ -^+R*A3;KK$I2*87'19J $6#XT^19PRA;[D;NB<N>)O!+LESR>0(C"!H
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M6C99@K7"ZGD1;^;@>!BK\UK9#R(6SF\*SI<@O_9K/I,#_S D62A#TK?()><
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MZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%I(:>TZW&0MI5.6%VQ&+.R=\'Z)\ZI
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M-^BQ_^MFA$X34(06\@R=HZ=1@DY/SM )H@P]YGPN"<MDUU4ZJ*&Z:1U@4 7
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M, #]?L*Y6F],@&;JQ_\!4$L#!!0    ( /-)6U@Z66>E^@(   @*   9
M>&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;*U6W6[:,!A]%2NKIE9:FU\"=! )
M2*?UHEM5VFW2M N3?(#5Q&:V ]W;STY"!B2D2.L-V,XYYSL^3FP/-HP_BR6
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MQ0)R6#*]0]4&T@7?XF_&BUP1JLJQ.RDHI*S<S[?YAUWM!\ZX+8 !%?AM5&1
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M/2P46EDHU&VA7,9:J(?_?!-P4UJ/'ZAQ J4Q*(VC:+:ZE7%"8<8)A1HG4%H
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M@XD@<I5E5+SW(.6;CN58VX.G9!$K?6 '[25=P!34RW(B<&>7*%&2 9,)9T3
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MWWR0J0!Y?TZI>%JHV3IYE_+^ U!+ P04    " #S25M8:]_)X6$#  #I#0
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M.5Z'W"/;&T@3JDD^GX1,_:)MZFMHR%\S3J(4+"*(@CCYXI=4B#V 63\!L%*
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M94.<PS1Y5R0=3E;J6OM$N*AWU5R*MQA0Z2#&YX3P74=.D+WN.K\ 4$L#!!0
M   ( /-)6U@8PK\-:P(  /4$   9    >&PO=V]R:W-H965T<R]S:&5E=#<X
M+GAM;'U4VV[;, S]%4(#A@T8ZL1)VZ%S##A)+QF0"]QT>QCVH-B,K566/$E.
MNK^?)"=>!K1YL26*/#R'(A7MI7K6):*!EXH+/2*E,?5-$.BLQ(KJ"UFCL"=;
MJ2IJ[%85@:X5TMP'53P(>[VKH*),D#CRMI6*(]D8S@2N%.BFJJCZ,T8N]R/2
M)T=#RHK2.$,01S4M\!'-4[U2=A=T*#FK4&@F!2C<CDC2OQD/G;]W^,9PKT_6
MX)1LI'QVFUD^(CU'"#EFQB%0^]OA!#EW0);&[P,FZ5*ZP-/U$?W.:[=:-E3C
M1/+O+#?EB'PFD..6-MRD<O^ !SV7#B^37/LO[%O?ZVL"6:.-K [!ED'%1/NG
M+X<ZG 2$X1L!X2$@]+S;1)[EE!H:1TKN03EOB^867JJ/MN28<)?R:)0]93;.
MQ/>WR_LT63W,)C!;W"W3>;*>+1>0+*8P3[XN4Y@\/:Z7\]O4FU;I<OHT6<,T
M62?P88J&,JYAC2^FH?QC%!C+R.$&V2'[N,T>OI&]'\)<"E-JN!4YYO\#!%9*
MIR<\ZAF'9Q&GF%W H/\)PEXX (V%;2!S!G?0U6G@<0=OU0EEH6A=L@QFHIT%
MUU2)R&%.?TD%$W]7J+QII63>9 ;<E<"/9*.-LNWW\[4"M6F'KZ=U(WFC:YKA
MB-B9TZAV2.+W[_I7O2]G1 T[4<-SZ/&BJ3:6L=S:\:JE,G3#\5@S_1K9%N[*
MP[EQW\7]*-B=,@A.6M%6H_ #IR&3C3!M5W;6;J:3MI7_N;</PIRJ@@D-'+<V
MM'=Q?4E M4/6;HRL?6-OI+&E]\O2ODNHG(,]WTIICAN7H'OIXK]02P,$%
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M$,>_BI6KJE;J;9YXRA:06)*[(G5/"-CV174O3!A(M(G-V0:V_?2UDVR60(A
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M#9#WUY2*UQ/EH-P6&_X&4$L#!!0    ( /-)6UA'=:WW=P,  -L7   -
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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MU/Y]6NRWM>@^^I6%FF%VJPOOGXK"5?O"TJ_2P_._BY[_&?7N;U!+ P04
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M-U!+ 0(4 Q0    ( /-)6U@'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ \TE;6$*8_&GO    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ \TE;6)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #S25M8(3<ZX-<'  !2,P  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ \TE;6%2A_'(F!P  /1\  !@              ("!&Q   'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( /-)6U@6]9 RZP(  /,'   8
M              " @7<7  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " #S25M8ZK@!9'8%   B%@  &               @(&8&@  >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ \TE;6#\&)4=+!P
M:BX  !@              ("!1"   'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( /-)6UB)NFLW?0(  / %   8              " @<4G
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #S25M8O<P)
M1P,*   Z,0  &               @(%X*@  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ \TE;6-J;S3%T @  Y@4  !@
M ("!L30  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( /-)
M6UAN9CHQJ@P   \@   8              " @5LW  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " #S25M8!YAD;V\K  "-A@  &0
M        @($[1   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( /-)6UA7, .BN (   P&   9              " @>%O  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ \TE;6&")Y[3G @  %@8
M !D              ("!T'(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " #S25M80 @<;[,*  !"&@  &0              @('N=0
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( /-)6UBKXSH
M^0,  &\(   9              " @=B   !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ \TE;6$(F<Q]! P  ^08  !D
M ("!"(4  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #S
M25M8-SN;DUT)  # %@  &0              @(& B   >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( /-)6U@-BDMO=1$  "(]   9
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M970R,2YX;6Q02P$"% ,4    " #S25M84 9^LNP#  #/"0  &0
M    @('#O0  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M /-)6UBI:'0=S0,  #$(   9              " @>;!  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ \TE;6+"-*SHF+0  59,  !D
M             ("!ZL4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " #S25M8]DA/3,@%  #S#@  &0              @(%'\P  >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( /-)6UBV[H#:F0(
M ),%   9              " @4;Y  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ \TE;6,"Y<'=: @  #P4  !D              ("!
M%OP  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #S25M8
MY1R _%L$   W"@  &0              @(&G_@  >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( /-)6UB&2C/D30,  &('   9
M      " @3D# 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ \TE;6):OHU/G @  *@8  !D              ("!O08! 'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #S25M8D<*07.X"   -!@
M&0              @(';"0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( /-)6UCS6_$SH@8  ,<1   9              " @0 - 0!X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ \TE;6 9^H4#=
M!0  2@\  !D              ("!V1,! 'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    " #S25M8>""LR:$"  "#!0  &0
M@('M&0$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( /-)
M6U@]F@POR0,  )8(   9              " @<4< 0!X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ \TE;6*#06"72 @  (P8  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( /-)6UC IRX>Z (  .P(   9
M  " @28Q 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
M\TE;6/R<T1Z, P  ZQ   !D              ("!130! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    " #S25M8B?YTVI4#   =$0  &0
M            @($(. $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( /-)6U@!-WJ+IP(  .L%   9              " @=0[ 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ \TE;6,GB9Q]K!0
MZ!T  !D              ("!LCX! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    " #S25M8FD$6(LD"  #-!P  &0              @(%4
M1 $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( /-)6UAP
MY"\%9 (  "8&   9              " @51' 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ \TE;6$V>S3!V @  A 8  !D
M     ("![TD! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
M" #S25M8[\)\A;0"  !0"0  &0              @(&<3 $ >&PO=V]R:W-H
M965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( /-)6U@S01-L,P0  +P1   9
M              " @8=/ 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L!
M A0#%     @ \TE;6,V%O?[P P  WA,  !D              ("!\5,! 'AL
M+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " #S25M84@N!88 "
M   X!@  &0              @($86 $ >&PO=V]R:W-H965T<R]S:&5E=#4R
M+GAM;%!+ 0(4 Q0    ( /-)6UC/"Z#C" 0  &X3   9              "
M@<]: 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ \TE;
M6%,%]R!Z!0  %BP  !D              ("!#E\! 'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    " #S25M8[DZ2:8D"  !Y!@  &0
M        @(&_9 $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( /-)6UA[E_.V60(  %$%   9              " @7]G 0!X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ \TE;6*$$=ICQ P  )A0
M !D              ("!#VH! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q0
M2P$"% ,4    " #S25M8A_O3\8L"  "A!@  &0              @($W;@$
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( /-)6UC-UY#B
MD0,  &@,   9              " @?EP 0!X;"]W;W)K<VAE971S+W-H965T
M-3DN>&UL4$L! A0#%     @ \TE;6$9L1W9]!0  U1T  !D
M ("!P70! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " #S
M25M8,08]=-4#  "L$0  &0              @(%U>@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( /-)6UCH^;L&P ,  *L,   9
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M970V-BYX;6Q02P$"% ,4    " #S25M800#85P #  !V"@  &0
M    @(%6N $ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (
M /-)6UC3"5_<QP(   $(   9              " @8V[ 0!X;"]W;W)K<VAE
M971S+W-H965T-C@N>&UL4$L! A0#%     @ \TE;6#I99Z7Z @  " H  !D
M             ("!B[X! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"
M% ,4    " #S25M81*$O]'P$  !N%P  &0              @(&\P0$ >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( /-)6U@[(?=S=@,
M +(*   9              " @6_& 0!X;"]W;W)K<VAE971S+W-H965T-S$N
M>&UL4$L! A0#%     @ \TE;6'"N6EIK!   F0X  !D              ("!
M',H! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " #S25M8
MJ($A#+\&  "I/0  &0              @(&^S@$ >&PO=V]R:W-H965T<R]S
M:&5E=#<S+GAM;%!+ 0(4 Q0    ( /-)6U@-T=,1$ ,  !4)   9
M      " @;35 0!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%
M  @ \TE;6,]4?S?C P  ^!,  !D              ("!^]@! 'AL+W=O<FMS
M:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    " #S25M89G=N1S #  !7#0
M&0              @($5W0$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+
M 0(4 Q0    ( /-)6UAKW\GA80,  .D-   9              " @7S@ 0!X
M;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ \TE;6!C"OPUK
M @  ]00  !D              ("!%.0! 'AL+W=O<FMS:&5E=',O<VAE970W
M."YX;6Q02P$"% ,4    " #S25M8;_:2<PP$  #)$@  &0
M@(&VY@$ >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( /-)
M6UC(A/#*A0(  -P%   9              " @?GJ 0!X;"]W;W)K<VAE971S
M+W-H965T.# N>&UL4$L! A0#%     @ \TE;6. SH<KS P  (A,  !D
M         ("!M>T! 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
M    " #S25M81W6M]W<#  #;%P  #0              @ '?\0$ >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( /-)6UB7BKL<P    !,"   +
M  "  8'U 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /-)6UBY[^PXO04  )TU
M   /              "  6KV 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" #S25M8JYPQ2VX"  #:+P  &@              @ %4_ $ >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #S25M81.3?6!X"  "7+@
M$P              @ 'Z_@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
..60!9 &88  !) 0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>260</ContextCount>
  <ElementCount>395</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>104</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical</Role>
      <ShortName>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/General</Role>
      <ShortName>GENERAL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERG</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/CommitmentsAndContingentLiabilities</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquity</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement</Role>
      <ShortName>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - FINANCIAL EXPENSES (INCOME), NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/FinancialExpensesIncomeNet</Role>
      <ShortName>FINANCIAL EXPENSES (INCOME), NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - RESTRUCTURING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES</Role>
      <ShortName>RESTRUCTURING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/Inventories</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - BUSINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERGTables</Role>
      <ShortName>BUSINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ACQUISITIONOFALTERG</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/CommitmentsAndContingentLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityTables</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/FinancialExpensesIncomeNetTables</Role>
      <ShortName>FINANCIAL EXPENSES (INCOME), NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/FinancialExpensesIncomeNet</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeneralDetails</Role>
      <ShortName>GENERAL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/General</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/TestrereDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/TestrereDetails1</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0046 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0047 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/InventoriesDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/InventoriesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0048 - Disclosure - INVENTORIES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/INVENTORIESNarrativeDetails</Role>
      <ShortName>INVENTORIES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/InventoriesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0049 - Disclosure - BUSINESS COMBINATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails</Role>
      <ShortName>BUSINESS COMBINATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ACQUISITIONOFALTERGTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0050 - Disclosure - BUSINESS COMBINATION (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1</Role>
      <ShortName>BUSINESS COMBINATION (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ACQUISITIONOFALTERGTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0051 - Disclosure - BUSINESS COMBINATION (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2</Role>
      <ShortName>BUSINESS COMBINATION (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ACQUISITIONOFALTERGTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0052 - Disclosure - BUSINESS COMBINATION (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3</Role>
      <ShortName>BUSINESS COMBINATION (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ACQUISITIONOFALTERGTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0053 - Disclosure - BUSINESS COMBINATION  (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails</Role>
      <ShortName>BUSINESS COMBINATION  (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ACQUISITIONOFALTERGTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0054 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0055 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0056 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET  (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS, NET  (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0059 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0060 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0061 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0062 - Disclosure - SHAREHOLDERS' EQUITY (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityDetails1</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0063 - Disclosure - SHAREHOLDERS' EQUITY (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityDetails2</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0064 - Disclosure - SHAREHOLDERS' EQUITY (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityDetails3</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0065 - Disclosure - SHAREHOLDERS' EQUITY (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityDetails4</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0066 - Disclosure - SHAREHOLDERS' EQUITY (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ShareholdersEquityDetailsTextual</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ShareholdersEquityTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0067 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails</Role>
      <ShortName>RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0068 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0069 - Disclosure - INCOME TAXES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesDetails1</Role>
      <ShortName>INCOME TAXES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0070 - Disclosure - INCOME TAXES (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesDetails2</Role>
      <ShortName>INCOME TAXES (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0071 - Disclosure - INCOME TAXES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesDetails3</Role>
      <ShortName>INCOME TAXES (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0072 - Disclosure - INCOME TAXES (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesDetails4</Role>
      <ShortName>INCOME TAXES (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0073 - Disclosure - INCOME TAXES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/IncomeTaxesDetailsTextual</Role>
      <ShortName>INCOME TAXES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/IncomeTaxesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0074 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails</Role>
      <ShortName>FINANCIAL EXPENSES (INCOME), NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/FinancialExpensesIncomeNetTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0075 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0076 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0077 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0078 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual</Role>
      <ShortName>GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0079 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0080 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE  (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE  (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="zk2431037.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0081 - Disclosure - RESTRUCTURING ACTIVITIES  (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES  (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES</ParentRole>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lfwd-20231231.xsd</File>
    <File>lfwd-20231231_cal.xml</File>
    <File>lfwd-20231231_def.xml</File>
    <File>lfwd-20231231_lab.xml</File>
    <File>lfwd-20231231_pre.xml</File>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="zk2431037.htm">zk2431037.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
    <File>image00001.jpg</File>
    <File>image00003.jpg</File>
    <File>image1.jpg</File>
    <File>image2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="811">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>108
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2431037.htm": {
   "nsprefix": "lfwd",
   "nsuri": "http://www.rewalk.com/20231231",
   "dts": {
    "schema": {
     "local": [
      "lfwd-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "lfwd-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lfwd-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lfwd-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfwd-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2431037.htm"
     ]
    }
   },
   "keyStandard": 310,
   "keyCustom": 85,
   "axisStandard": 25,
   "axisCustom": 2,
   "memberStandard": 40,
   "memberCustom": 63,
   "hidden": {
    "total": 12,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://www.rewalk.com/20231231": 2,
    "http://fasb.org/us-gaap/2023": 6
   },
   "contextCount": 260,
   "entityCount": 1,
   "segmentCount": 104,
   "elementCount": 711,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 811,
    "http://xbrl.sec.gov/dei/2023": 38
   },
   "report": {
    "R1": {
     "role": "http://www.rewalk.com/role/DocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
     "longName": "0002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations",
     "longName": "0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity",
     "longName": "0005 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "shortName": "STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
     "longName": "0006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)",
     "shortName": "STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdBestOfferingMember",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdBestOfferingMember",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
     "longName": "0008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectMember",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.rewalk.com/role/General",
     "longName": "0009 - Disclosure - GENERAL",
     "shortName": "GENERAL",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.rewalk.com/role/SignificantAccountingPolicies",
     "longName": "0010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets",
     "longName": "0011 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.rewalk.com/role/Inventories",
     "longName": "0012 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERG",
     "longName": "0013 - Disclosure - BUSINESS COMBINATION",
     "shortName": "BUSINESS COMBINATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET",
     "longName": "0014 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.rewalk.com/role/PropertyAndEquipmentNet",
     "longName": "0015 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.rewalk.com/role/CommitmentsAndContingentLiabilities",
     "longName": "0016 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.rewalk.com/role/ShareholdersEquity",
     "longName": "0017 - Disclosure - SHAREHOLDERS' EQUITY",
     "shortName": "SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement",
     "longName": "0018 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT",
     "shortName": "RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.rewalk.com/role/IncomeTaxes",
     "longName": "0019 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.rewalk.com/role/FinancialExpensesIncomeNet",
     "longName": "0020 - Disclosure - FINANCIAL EXPENSES (INCOME), NET",
     "shortName": "FINANCIAL EXPENSES (INCOME), NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData",
     "longName": "0021 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA",
     "shortName": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE",
     "longName": "0022 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES",
     "longName": "0023 - Disclosure - RESTRUCTURING ACTIVITIES",
     "shortName": "RESTRUCTURING ACTIVITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "0024 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.rewalk.com/role/SignificantAccountingPoliciesTables",
     "longName": "0025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables",
     "longName": "0026 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.rewalk.com/role/InventoriesTables",
     "longName": "0027 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERGTables",
     "longName": "0028 - Disclosure - BUSINESS COMBINATION (Tables)",
     "shortName": "BUSINESS COMBINATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables",
     "longName": "0029 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.rewalk.com/role/PropertyAndEquipmentNetTables",
     "longName": "0030 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables",
     "longName": "0031 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityTables",
     "longName": "0032 - Disclosure - SHAREHOLDERS' EQUITY (Tables)",
     "shortName": "SHAREHOLDERS' EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.rewalk.com/role/IncomeTaxesTables",
     "longName": "0033 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.rewalk.com/role/FinancialExpensesIncomeNetTables",
     "longName": "0034 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Tables)",
     "shortName": "FINANCIAL EXPENSES (INCOME), NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables",
     "longName": "0035 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)",
     "shortName": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables",
     "longName": "0036 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Tables)",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.rewalk.com/role/GeneralDetails",
     "longName": "0037 - Disclosure - GENERAL (Details)",
     "shortName": "GENERAL (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
     "longName": "0038 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:PropertyPlantAndEquipmentUsefulLifeDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:PropertyPlantAndEquipmentUsefulLifeDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.rewalk.com/role/TestrereDetails",
     "longName": "0039 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 1)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_srtProductOrServiceAxis_usgaapProductMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "div",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.rewalk.com/role/TestrereDetails1",
     "longName": "0040 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 2)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "lfwd:ScheduleOfContractBalancesTableTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "lfwd:ScheduleOfContractBalancesTableTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6",
     "longName": "0041 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 3)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "lfwd:WarrantyProvisionBalance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "lfwd:ScheduleOfWarrantyProvisionTableTextBlock",
       "div",
       "div",
       "us-gaap:StandardProductWarrantyPolicy",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230930",
      "name": "lfwd:BusinessCombinationRecognizedWarrantProvision",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "lfwd:ScheduleOfWarrantyProvisionTableTextBlock",
       "div",
       "div",
       "us-gaap:StandardProductWarrantyPolicy",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
     "longName": "0042 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 4)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4",
     "longName": "0043 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 5)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_20230930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5",
     "longName": "0044 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details 6)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details 6)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_20230811_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember",
      "name": "lfwd:WarrantsLiabilityActivity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "lfwd:ScheduleOfWarrantsLiabilityActivityTableTextBlock",
       "div",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230811_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember",
      "name": "lfwd:WarrantsLiabilityActivity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "lfwd:ScheduleOfWarrantsLiabilityActivityTableTextBlock",
       "div",
       "div",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual",
     "longName": "0045 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Textual)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InventoryWriteDown",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "lfwd:ScheduleOfContractBalancesTableTextBlock",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails",
     "longName": "0046 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.rewalk.com/role/InventoriesDetails",
     "longName": "0047 - Disclosure - INVENTORIES (Details)",
     "shortName": "INVENTORIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:InventoryFinishedGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.rewalk.com/role/INVENTORIESNarrativeDetails",
     "longName": "0048 - Disclosure - INVENTORIES (Details Textual)",
     "shortName": "INVENTORIES (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:InventoryWriteDown",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:InventoryDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R49": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
     "longName": "0049 - Disclosure - BUSINESS COMBINATION (Details)",
     "shortName": "BUSINESS COMBINATION (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1",
     "longName": "0050 - Disclosure - BUSINESS COMBINATION (Details 1)",
     "shortName": "BUSINESS COMBINATION (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
     "longName": "0051 - Disclosure - BUSINESS COMBINATION (Details 2)",
     "shortName": "BUSINESS COMBINATION (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3",
     "longName": "0052 - Disclosure - BUSINESS COMBINATION (Details 3)",
     "shortName": "BUSINESS COMBINATION (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails",
     "longName": "0053 - Disclosure - BUSINESS COMBINATION  (Details Textual)",
     "shortName": "BUSINESS COMBINATION  (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_20230801to20230808",
      "name": "lfwd:EarnOutPaymentOfBusinessCombination",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230801to20230808",
      "name": "lfwd:EarnOutPaymentOfBusinessCombination",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails",
     "longName": "0054 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1",
     "longName": "0055 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details 1)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails",
     "longName": "0056 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET  (Details Textual)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET  (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_20230101to20230930_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-2",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230930_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-2",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
     "longName": "0057 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual",
     "longName": "0058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Textual)",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R59": {
     "role": "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails",
     "longName": "0059 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
     "longName": "0060 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:PurchaseObligation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:PurchaseObligation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityDetails",
     "longName": "0061 - Disclosure - SHAREHOLDERS' EQUITY (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityDetails1",
     "longName": "0062 - Disclosure - SHAREHOLDERS' EQUITY (Details 1)",
     "shortName": "SHAREHOLDERS' EQUITY (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember",
      "name": "lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember",
      "name": "lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityDetails2",
     "longName": "0063 - Disclosure - SHAREHOLDERS' EQUITY (Details 2)",
     "shortName": "SHAREHOLDERS' EQUITY (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityDetails3",
     "longName": "0064 - Disclosure - SHAREHOLDERS' EQUITY (Details 3)",
     "shortName": "SHAREHOLDERS' EQUITY (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityDetails4",
     "longName": "0065 - Disclosure - SHAREHOLDERS' EQUITY (Details 4)",
     "shortName": "SHAREHOLDERS' EQUITY (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "lfwd:ClassOfWarrantOrRightExercisable",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
     "longName": "0066 - Disclosure - SHAREHOLDERS' EQUITY (Details Textual)",
     "shortName": "SHAREHOLDERS' EQUITY (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "NIS_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "NIS_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails",
     "longName": "0067 - Disclosure - RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)",
     "shortName": "RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.rewalk.com/role/IncomeTaxesDetails",
     "longName": "0068 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.rewalk.com/role/IncomeTaxesDetails1",
     "longName": "0069 - Disclosure - INCOME TAXES (Details 1)",
     "shortName": "INCOME TAXES (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.rewalk.com/role/IncomeTaxesDetails2",
     "longName": "0070 - Disclosure - INCOME TAXES (Details 2)",
     "shortName": "INCOME TAXES (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.rewalk.com/role/IncomeTaxesDetails3",
     "longName": "0071 - Disclosure - INCOME TAXES (Details 3)",
     "shortName": "INCOME TAXES (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_20221231",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.rewalk.com/role/IncomeTaxesDetails4",
     "longName": "0072 - Disclosure - INCOME TAXES (Details 4)",
     "shortName": "INCOME TAXES (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
     "longName": "0073 - Disclosure - INCOME TAXES (Details Textual)",
     "shortName": "INCOME TAXES (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails",
     "longName": "0074 - Disclosure - FINANCIAL EXPENSES (INCOME), NET (Details)",
     "shortName": "FINANCIAL EXPENSES (INCOME), NET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
     "longName": "0075 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)",
     "shortName": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_srtStatementGeographicalAxis_countryUS",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1",
     "longName": "0076 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)",
     "shortName": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231231",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
     "longName": "0077 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)",
     "shortName": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual",
     "longName": "0078 - Disclosure - GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)",
     "shortName": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
     "longName": "0079 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE (Details)",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "NIS_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "us-gaap:EarningsPerShareDiluted",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails",
     "longName": "0080 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE  (Details Textual)",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE  (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails",
     "longName": "0081 - Disclosure - RESTRUCTURING ACTIVITIES  (Details Textual)",
     "shortName": "RESTRUCTURING ACTIVITIES  (Details Textual)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "C_20230101to20231231",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20231201to20231212_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember",
      "name": "lfwd:WorkforcePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431037.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock price per share",
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r743"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivables [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Trade receivable, net\u00a0of credit losses",
        "verboseLabel": "Trade receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r698",
      "r749",
      "r851"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivable, net",
        "verboseLabel": "Trade receivable, net of credit losses of $328 and $26, respectively",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r195",
      "r575"
     ]
    },
    "lfwd_AcquisitionDeferredTaxAssetAdjustmentsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AcquisitionDeferredTaxAssetAdjustmentsAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition, Deferred Tax Asset, Adjustments, Amount",
        "documentation": "Represents the acquisition, deferred tax asset, adjustments, amount.",
        "verboseLabel": "Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r743",
      "r856"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r611",
      "r781",
      "r782",
      "r783",
      "r834",
      "r857"
     ]
    },
    "lfwd_AdditionallyWarrantsIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AdditionallyWarrantsIssuedMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additionally Warrants Issued [Member]",
        "label": "Additionally Warrants Issued [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r227",
      "r228",
      "r229",
      "r230",
      "r239",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r323",
      "r420",
      "r421",
      "r422",
      "r447",
      "r448",
      "r449",
      "r450",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r548",
      "r549",
      "r550",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation to employees and non-employees",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r387"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance expenses, amount",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r143"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AfricaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AfricaMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Africa [Member]"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "lfwd_AggregateNumberOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AggregateNumberOfOrdinaryShares",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of ordinary shares.",
        "label": "Aggregate number of ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_AgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AgreementAxis",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement Axis",
        "label": "Agreement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_AgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AgreementDomain",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "verboseLabel": "Non-cash share-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r427"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Allowance for credit losses",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r284",
      "r298"
     ]
    },
    "lfwd_AllowanceForSalesReturns": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AllowanceForSalesReturns",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Sales Returns",
        "label": "Allowance For Sales Returns",
        "verboseLabel": "Net of sales return reserve"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_AltergIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AltergIncMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails",
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about AlterG Inc.",
        "label": "Alterg Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedNetLabel": "Accumulated Amortization",
        "verboseLabel": "Accumulated Amortization",
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r57",
      "r60"
     ]
    },
    "lfwd_AmountOfAdditionalCashEarnouts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AmountOfAdditionalCashEarnouts",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount Of Additional Cash Earnouts",
        "documentation": "Information about amount of additional cash earnouts.",
        "terseLabel": "Amount of additional cash earnouts"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_AmountOfEmployeeTerminationBenefitsAndLegalExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AmountOfEmployeeTerminationBenefitsAndLegalExpenses",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount Of Employee Termination Benefits And Legal Expenses",
        "documentation": "Represents the amount of employee termination benefits and legal expenses.",
        "verboseLabel": "Amount of employee termination benefits and legal expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_AmountOfWarrantProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AmountOfWarrantProvision",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount Of Warrant Provision",
        "documentation": "It represents amount of warrant provision.",
        "verboseLabel": "Provision"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_AmountOfWarrantProvisionUsage": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "AmountOfWarrantProvisionUsage",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount Of Warrant Provision Usage",
        "documentation": "It represents amount of warrant provision usage.",
        "verboseLabel": "Usage"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AsiaPacificMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AsiaPacificMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of total consideration",
        "documentation": "Tabular disclosure of contingent consideration in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r198",
      "r220",
      "r261",
      "r268",
      "r273",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r468",
      "r470",
      "r505",
      "r569",
      "r649",
      "r743",
      "r756",
      "r796",
      "r797",
      "r841"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r207",
      "r220",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r468",
      "r470",
      "r505",
      "r743",
      "r796",
      "r797",
      "r841"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Financial Assets",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent",
        "totalLabel": "Total long-term assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r468",
      "r470",
      "r505",
      "r796",
      "r797",
      "r841"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm Id",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1",
      "http://www.rewalk.com/role/ShareholdersEquityDetails2",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "lfwd_BacklogMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BacklogMember",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Backlog [Member]",
        "terseLabel": "Backlog",
        "documentation": "Information about Backlog."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BankCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BankCommissions",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails": {
       "parentTag": "lfwd_FinancialExpensesAndIncomeNet",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of bank commissions.",
        "label": "Bank commissions",
        "negatedLabel": "Bank commissions"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic And Diluted Net Loss Per Ordinary Share [Table Text Block]",
        "documentation": "Tabular disclosure of basic and diluted net loss per ordinary share.",
        "verboseLabel": "Schedule of basic and diluted net loss per ordinary share"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beneficiary Enterprise from Productive Activity, Maximum Time from Period of Election for Tax Exemption",
        "label": "Beneficiary Enterprise From Productive Activity Maximum Time From Period Of Election For Tax Exemption",
        "verboseLabel": "Beneficiary enterprise from productive activity, maximum time from period of election for tax exemption"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beneficiary Enterprise from Productive Activity, Tax Exemption Period",
        "label": "Beneficiary Enterprise From Productive Activity Tax Exemption Period",
        "verboseLabel": "Beneficiary enterprise from productive activity, tax exemption period"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beneficiary Enterprise from Productive Activity, Tax Rate on Dividend Distributions from Tax Exempt Income",
        "label": "Beneficiary Enterprise From Productive Activity Tax Rate On Dividend Distributions From Tax Exempt Income",
        "verboseLabel": "Beneficiary enterprise from productive activity, tax rate on dividend distributions from tax exempt income"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BestOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BestOfferingMember",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Best Offering [Member]",
        "label": "Best Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r739",
      "r740"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85",
      "r462",
      "r739",
      "r740"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Amount of additional cash earnouts",
        "verboseLabel": "Earnout payments",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Information, Nonrecurring Adjustments [Table Text Block]",
        "terseLabel": "Schedule of pro forma revenue and earnings",
        "documentation": "Tabular disclosure of the nature and amount of any material, nonrecurring adjustments directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information)."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net loss",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenues",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs",
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration",
        "verboseLabel": "Purchase price",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r12"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERG"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATION",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r463"
     ]
    },
    "lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accrued compensation recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Compensation",
        "negatedLabel": "Accrued compensation",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Leases Liability",
        "terseLabel": "Leases Liability",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "documentation": "Amount of lease obligation assumed in business combination."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash",
        "verboseLabel": "Cash and cash equivalent",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 100.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 150.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "negatedLabel": "Deferred revenue",
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 120.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87"
     ]
    },
    "lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of other accrued liabilities recognized as of the acquisition date.",
        "negatedLabel": "Other accrued liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 130.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 110.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, net",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87"
     ]
    },
    "lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of restricted cash recognized as of the acquisition date.",
        "terseLabel": "Restricted cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Restricted Cash"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Asset",
        "documentation": "The amount of Right of use asset recognized as of the acquisition date.",
        "terseLabel": "Right of use asset"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed Warranty Obligations",
        "negatedLabel": "Warranty Obligations",
        "documentation": "The amount of warranty obligations recognized as of the acquisition date.",
        "terseLabel": "Warranty Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase consideration",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "lfwd_BusinessCombinationRecognizedWarrantProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "BusinessCombinationRecognizedWarrantProvision",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Recognized Warrant Provision",
        "documentation": "It represents business combination recognized warrant provision.",
        "verboseLabel": "AlterG acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Description",
        "terseLabel": "Description of Earnout payments",
        "documentation": "In a business combination achieved in stages, this element represents a narrative description of the history, developments, or effect of the acquisition relative to the percentage of equity in the acquiree held by the acquirer immediately before the acquisition date. Such description may describe any gain recognized as a result of the acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations Policy [Policy Text Block]",
        "verboseLabel": "Business Combinations",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
      "http://www.rewalk.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r193",
      "r716"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Total Cash, cash equivalents, and restricted cash",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r127",
      "r217"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash, cash equivalents, and restricted cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r127"
     ]
    },
    "lfwd_CertainInstitutionalPurchasersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CertainInstitutionalPurchasersMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain institutional purchasers [Member]",
        "label": "Certain institutional purchasers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ChangeInFairValueOfWarrantsLiabilityActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ChangeInFairValueOfWarrantsLiabilityActivity",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Warrants Liability Activity",
        "documentation": "It represents change in fair value of warrants liability activity.",
        "verboseLabel": "Change in fair value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r199",
      "r200",
      "r201",
      "r220",
      "r243",
      "r244",
      "r246",
      "r248",
      "r255",
      "r256",
      "r287",
      "r336",
      "r338",
      "r339",
      "r340",
      "r343",
      "r344",
      "r349",
      "r350",
      "r352",
      "r355",
      "r362",
      "r505",
      "r605",
      "r606",
      "r607",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r636",
      "r658",
      "r676",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r767",
      "r778",
      "r784"
     ]
    },
    "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants grant date",
        "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ClassOfWarrantOrRightExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ClassOfWarrantOrRightExercisable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of Warrant or Right, Exercisable",
        "label": "Class Of Warrant Or Right Exercisable",
        "verboseLabel": "Warrants outstanding and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercise price",
        "terseLabel": "Exercise price per share",
        "verboseLabel": "Exercise price per warrant",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant to purchase one ordinary share",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveTerseLabel": "Warrants to acquire common stock",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of warrants issued",
        "verboseLabel": "Warrants to purchase common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ClassOfWarrantOrRightPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ClassOfWarrantOrRightPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for warrants or rights.",
        "label": "Class Of Warrant Or Right [Policy Text Block]",
        "verboseLabel": "Warrants to Acquire Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "lfwd_ClassificationOfInventoryToPropertyAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ClassificationOfInventoryToPropertyAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of Inventory to Property and Equipment, Net",
        "label": "Classification Of Inventory To Property And Equipment Net",
        "verboseLabel": "Classification of inventory to property and equipment"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of other net current assets to property and equipment",
        "label": "Classification of other current assets to property and equipment, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r96",
      "r570",
      "r635"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r330",
      "r331",
      "r700",
      "r792"
     ]
    },
    "lfwd_CommitmentsAndContingenciesLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CommitmentsAndContingenciesLiabilitiesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liabilities",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r701"
     ]
    },
    "lfwd_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Aggregate Offering Price Authorized Under Equity Distribution Agreement",
        "label": "Common Stock Aggregate Offering Price Authorized Under Equity Distribution Agreement",
        "verboseLabel": "Aggregate offering price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares reserved for future issuance (in shares)",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "lfwd_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issuance costs under equity distribution agreement as a percent of gross proceeds.",
        "label": "Common Stock Issuance Costs Under Equity Distribution Agreement As Percent Of Gross Proceeds",
        "verboseLabel": "Stock issuance costs under equity distribution agreement as a percent of gross proceeds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Share [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r746",
      "r747",
      "r748",
      "r750",
      "r751",
      "r752",
      "r753",
      "r781",
      "r782",
      "r834",
      "r855",
      "r857"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value per share",
        "verboseLabel": "Per share value of stock repurchase authorized",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r636"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r107",
      "r636",
      "r655",
      "r857",
      "r858"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Value",
        "terseLabel": "Ordinary share of NIS 0.25 par value-Authorized: 120,000,000 shares at September 30, 2022 and December 31, 2021; Issued: 62,901,945 and 62,480,163 shares as of September 30, 2022 and December 31, 2021 respectively; Outstanding: 62,717,316 and 62,480,163 shares as of September 30, 2022 and December 31, 2021 respectively",
        "verboseLabel": "Ordinary share of NIS 0.25 par value-Authorized: 120,000,000 shares at December 31, 2023 and December 31, 2022; Issued: 64,132,706 and 63,023,506 shares at December 31, 2023 and December 31, 2022, respectively; Outstanding: 60,110,099 and 60,090,298 shares as of December 31, 2023 and December 31, 2022 respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r571",
      "r743"
     ]
    },
    "lfwd_CommonUnitsAndPreFundedUnits1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CommonUnitsAndPreFundedUnits1Member",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common units and pre-funded units one [Member]",
        "label": "Common Units And Pre Funded Units 1 [Member]",
        "verboseLabel": "Common units and pre-funded units one [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CommonUnitsAndPreFundedUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CommonUnitsAndPreFundedUnitsMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common units and pre-funded units [Member]",
        "label": "Common units and pre-funded units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CommonUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CommonUnitsMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common units [Member]",
        "label": "Common units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r94",
      "r95",
      "r281",
      "r699"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r94",
      "r95",
      "r281",
      "r600",
      "r699"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r94",
      "r95",
      "r281",
      "r699",
      "r770"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations of Credit Risks",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r174"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of credit risk",
        "verboseLabel": "Concentration risk",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r94",
      "r95",
      "r281"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r50",
      "r51",
      "r94",
      "r159",
      "r699"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r94",
      "r95",
      "r281",
      "r699"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r720"
     ]
    },
    "lfwd_ContingentLiabilityRelatedToGrantsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ContingentLiabilityRelatedToGrantsReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the contingent liability related to grant received as of the balance sheet date.",
        "label": "Contingent Liability Related To Grants Received",
        "verboseLabel": "Contingent liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockDescription",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of conversion ratio",
        "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r44"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible preferred A shares [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r352",
      "r750",
      "r751",
      "r752",
      "r753"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible preferred shares",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r65",
      "r106",
      "r142",
      "r358"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenues",
        "verboseLabel": "Cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r220",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r505",
      "r796"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditConcentrationRiskMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "lfwd_CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CumulativeEffectToAccruedDeficitFromAdoptionOfNewStandards",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect To Accrued Deficit From Adoption Of New Standards"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails1": {
       "parentTag": "lfwd_TaxesOnIncome",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r446",
      "r454",
      "r780"
     ]
    },
    "lfwd_CustomerAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerAMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A [Member]",
        "label": "Customer A [Member]",
        "verboseLabel": "Customer A [Member]",
        "terseLabel": "Customer A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CustomerBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerBMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer B [Member]",
        "label": "Customer B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CustomerCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerCMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer C [Member]",
        "label": "Customer C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r281"
     ]
    },
    "lfwd_CustomerDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerDMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer D [Member]",
        "label": "Customer D [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CustomerRelationshipDistributionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerRelationshipDistributionMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for Customer relationship - Distribution.",
        "label": "Customer Relationship - Distribution [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CustomerRelationshipRentalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerRelationshipRentalMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationship - Rental",
        "label": "Customer Relationship Rental [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_CustomerRelationshipWarrantyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "CustomerRelationshipWarrantyMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "terseLabel": "Customer relationship - Warranty",
        "label": "Customer Relationship Warranty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationship - Distribution",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DE",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Germany [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCollateralAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCollateralAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Drawdown amount under loan agreement",
        "documentation": "Amount of assets pledged to secure a debt instrument."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "lfwd_December2020PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "December2020PrivatePlacementMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2020 private placement [Member]",
        "label": "December 2020 private placement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of prepaid expenses and other current assets",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_DeferredIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DeferredIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails1": {
       "parentTag": "lfwd_TaxesOnIncome",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax.",
        "negatedLabel": "Deferred",
        "label": "Deferred Income Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred taxes",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r153",
      "r180",
      "r453",
      "r454",
      "r780"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenues and advance payments",
        "verboseLabel": "Deferred revenue",
        "terseLabel": "Deferred revenues",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenues",
        "verboseLabel": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Deferred revenues",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development carry forward expenses-temporary differences",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r831"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry forward tax losses",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r831"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Property and equipment",
        "negatedLabel": "Property and equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total",
        "terseLabel": "Credit tax carry forwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r831"
     ]
    },
    "lfwd_DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.",
        "label": "Deferred Tax Assets Tax Deferred Expense Lease Liabilities",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrual and reserves",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r831"
     ]
    },
    "lfwd_DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of deferred tax assets tax deferred expense share based compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Share Based Compensation",
        "verboseLabel": "Share based compensation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2",
      "http://www.rewalk.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "negatedPeriodEndLabel": "Balance at end of year",
        "negatedPeriodStartLabel": "Balance at beginning of year",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "lfwd_DeferredTaxExpenseEffectOfChangeInTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DeferredTaxExpenseEffectOfChangeInTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of deferred tax expense effect of change in tax rate.",
        "label": "Deferred Tax Expense Effect Of Change In Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_DeferredTaxLiabilitiesRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from right-of-use asset.",
        "negatedLabel": "Right-of-use asset",
        "label": "Deferred Tax Liabilities Right Of Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "verboseLabel": "Depreciation expenses",
        "terseLabel": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r62"
     ]
    },
    "lfwd_DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DescriptionOfIncomeTaxLawForEncouragementOfCapitalInvestments",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of income tax law for encouragement of capital investments.",
        "label": "Description of income tax law for encouragement of capital investments"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_DescriptionOfUnderwritingAgreement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DescriptionOfUnderwritingAgreement",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of underwriting agreement.",
        "label": "Description of underwriting agreement"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of wainwright or its designees warrants to purchase.",
        "label": "Description of wainwright or its designees warrants to purchase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762",
      "r764"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_EarnOutPaymentOfBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EarnOutPaymentOfBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of earn out payment.",
        "label": "Earn Out Payment Of Business Combination",
        "terseLabel": "Earnout payments"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_EarnOutRemeasured": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EarnOutRemeasured",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earn Out Remeasured",
        "documentation": "Information about earnout remeasured.",
        "terseLabel": "Remeasurement of earnout liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per ordinary share, basic and diluted",
        "terseLabel": "Net loss per ordinary share, basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r241",
      "r243",
      "r246",
      "r247",
      "r248",
      "r252",
      "r493",
      "r494",
      "r565",
      "r579",
      "r722"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per ordinary share, diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r243",
      "r246",
      "r247",
      "r248",
      "r252",
      "r493",
      "r494",
      "r565",
      "r579",
      "r722"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Net Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "BASIC AND DILUTED NET LOSS PER SHARE",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r249",
      "r250",
      "r251"
     ]
    },
    "lfwd_EarnoutLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EarnoutLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Liability Current",
        "documentation": "Represent the amount of Earnout liability current",
        "verboseLabel": "Earnout liability"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_EarnoutMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EarnoutMember",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4",
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout [Member]",
        "documentation": "This member stands for Earnout.",
        "verboseLabel": "Earnout [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r511"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4",
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statutory tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r436",
      "r456"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees and payroll accruals",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized cost of shares",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "lfwd_EmployeeStockOptionAndRestrictedStockUnitsRsuMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EmployeeStockOptionAndRestrictedStockUnitsRsuMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents details pertaining to employee share option and RSU.",
        "label": "Employee Stock Option And Restricted Stock Units Rsu [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_EmployeesAndNonEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EmployeesAndNonEmployeesMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees and non- employees [Member]",
        "label": "Employees and non- employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-Known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Major Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r186",
      "r211",
      "r212",
      "r213",
      "r224",
      "r225",
      "r226",
      "r228",
      "r236",
      "r238",
      "r254",
      "r291",
      "r297",
      "r364",
      "r420",
      "r421",
      "r422",
      "r449",
      "r450",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r492",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r537",
      "r590",
      "r591",
      "r592",
      "r611",
      "r676"
     ]
    },
    "lfwd_EquityExchangeProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "EquityExchangeProgramMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Exchange Program [Member]",
        "label": "Equity Exchange Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "lfwd_ExerciseOfPreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExerciseOfPreFundedWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of pre-funded warrants and warrants.",
        "label": "Exercise Of Pre Funded Warrants",
        "verboseLabel": "Exercise of pre-funded warrants and warrants",
        "terseLabel": "Exercise of pre-funded warrants and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExerciseOfPreFundedWarrantsAndWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExerciseOfPreFundedWarrantsAndWarrantsShares",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares exercise of pre-funded warrants and warrants.",
        "label": "Exercise of pre-funded warrants and warrants, shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExerciseOfPreFundedWarrantsAndWarrantsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExerciseOfPreFundedWarrantsAndWarrantsValue",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of exercise of pre-funded warrants and warrants.",
        "label": "Exercise Of Pre Funded Warrants And Warrants Value",
        "verboseLabel": "Exercise of pre-funded warrants and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceOrdinaryShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceOrdinaryShares",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price ordinary shares.",
        "label": "Exercise Price Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceRangeFiveMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information by five range of option prices pertaining to options granted.",
        "label": "Exercise Price Range Five [Member]",
        "verboseLabel": "$182.5-$524.25 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceRangeFourMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information by four range of option prices pertaining to options granted.",
        "label": "Exercise Price Range Four [Member]",
        "verboseLabel": "$50-$52.5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceRangeMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range [Member]",
        "label": "Exercise Price Range [Member]",
        "verboseLabel": "RSUs only [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information by one range of option prices pertaining to options granted.",
        "label": "Exercise Price Range One [Member]",
        "verboseLabel": "5.37 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceRangeThreeMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information by three range of option prices pertaining to options granted.",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "$37.14-$38.75 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information by two range of option prices pertaining to options granted.",
        "label": "Exercise Price Range Two [Member]",
        "verboseLabel": "$20.42- $33.75 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r501"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r501"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of assets and liabilities measured at fair value",
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r92",
      "r93",
      "r158"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r498",
      "r540",
      "r541",
      "r542",
      "r728",
      "r729",
      "r736",
      "r737",
      "r738"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4",
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r157"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r500",
      "r502"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r377",
      "r382",
      "r498",
      "r540",
      "r736",
      "r737",
      "r738"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r498",
      "r542",
      "r728",
      "r729",
      "r736",
      "r737",
      "r738"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4",
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r540",
      "r541",
      "r542",
      "r728",
      "r729",
      "r736",
      "r737",
      "r738"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Fair Value, Measurements, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r502"
     ]
    },
    "lfwd_FairValueWarrantsLiabilityActivityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FairValueWarrantsLiabilityActivityLineItems",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Warrants Liability Activity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_FairValueWarrantsLiabilityActivityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FairValueWarrantsLiabilityActivityTable",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Warrants Liability Activity [Table]",
        "documentation": "Disclosure of information about fair value warrants liability activity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails1": {
       "parentTag": "lfwd_TaxesIncome",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "verboseLabel": "Domestic",
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r435"
     ]
    },
    "lfwd_FeesAndOtherRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FeesAndOtherRelatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fees and other related expenses.",
        "label": "Fees and other related expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_FieldServiceUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FieldServiceUnitsMember",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Field service units [Member]",
        "label": "Field service units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_FinancialExpensesAndIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FinancialExpensesAndIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Expenses And Income Net",
        "documentation": "Represents the Financial Expenses And Income Net.",
        "totalLabel": "Financial (expenses) income, net",
        "verboseLabel": "Financial expenses (income), net",
        "negatedLabel": "Financial income, net",
        "negatedTotalLabel": "Financial (expenses) income, net"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_FinancialExpensesIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FinancialExpensesIncomeNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate amount of financial expense or income from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Financial expenses (income), net",
        "totalLabel": "Financial (expenses) income, net",
        "verboseLabel": "Financial expenses (income), net",
        "negatedLabel": "Financial income, net",
        "negatedTotalLabel": "Financial (expenses) income, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated Useful Life (Years)",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Fiscal 2028",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2023 (period remaining)",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Fiscal 2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2024",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r319",
      "r320",
      "r321",
      "r547",
      "r551"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveTerseLabel": "Estimated Fair Value",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible Assets, Net",
        "totalLabel": "Total",
        "verboseLabel": "Cost",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r547"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Estimated Fair Value",
        "verboseLabel": "Cost",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "lfwd_FixedCommissionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FixedCommissionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed commission amount.",
        "label": "Fixed commission amount"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_FixedCommissionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "FixedCommissionRate",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed commission rate.",
        "label": "Fixed commission rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Authority [Member]",
        "verboseLabel": "Federal [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Transaction Loss, before Tax",
        "terseLabel": "Exchange rate fluctuations",
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r837",
      "r838"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Statements in U.S. Dollars",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r510"
     ]
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails1": {
       "parentTag": "lfwd_TaxesIncome",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations",
        "verboseLabel": "Foreign",
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office furniture and equipment [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_GeneralAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "GeneralAbstract",
     "presentation": [
      "http://www.rewalk.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r660"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "lfwd_GeographicInformationAndMajorCustomerAndProductDataAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "GeographicInformationAndMajorCustomerAndProductDataAbstract",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographic Information And Major Customer And Product Data [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 40.0
      },
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 140.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails1",
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "verboseLabel": "Goodwill",
        "terseLabel": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r305",
      "r564",
      "r727",
      "r743",
      "r789",
      "r790"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Purchase of goodwill",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r727"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "verboseLabel": "Goodwill and Other Intangibles",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r56"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r727"
     ]
    },
    "lfwd_GovernmentGrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "GovernmentGrantsPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for government grants.",
        "label": "Government Grants [Policy Text Block]",
        "verboseLabel": "Government grants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit",
        "totalLabel": "Gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r220",
      "r261",
      "r267",
      "r272",
      "r275",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r505",
      "r724",
      "r796"
     ]
    },
    "lfwd_GuarantorObligationsCollateralPledged": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "GuarantorObligationsCollateralPledged",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor obligations as collateral pledged.",
        "label": "Guarantor Obligations Collateral Pledged",
        "verboseLabel": "Amount pledged as security"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IL",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761",
      "r762"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment losses",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r61",
      "r138"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r139"
     ]
    },
    "lfwd_ImputedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ImputedInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Less: imputed interest.",
        "negatedLabel": "Less: imputed interest",
        "label": "Imputed Interest",
        "verboseLabel": "Less: imputed interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r455"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.rewalk.com/role/IncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rewalk.com/role/IncomeTaxesDetails",
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss before taxes, as reported in the consolidated statements of operations",
        "totalLabel": "Loss before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r118",
      "r163",
      "r261",
      "r267",
      "r272",
      "r275",
      "r566",
      "r577",
      "r724"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r455"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r327",
      "r661"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r661"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r431",
      "r437",
      "r438",
      "r444",
      "r451",
      "r457",
      "r458",
      "r459",
      "r610"
     ]
    },
    "lfwd_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement1",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.",
        "label": "Income Tax Examination Likelihood Of Unfavorable Settlement 1",
        "verboseLabel": "Maximum percentage of likely to be realized upon ultimate settlement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on income",
        "verboseLabel": "Taxes on income (benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r181",
      "r237",
      "r238",
      "r264",
      "r435",
      "r452",
      "r580"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r433",
      "r434",
      "r438",
      "r439",
      "r443",
      "r445",
      "r604"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating losses and other temporary differences for which valuation allowance was provided",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent differences",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r436"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax at rate other than the Israeli statutory tax rate",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Theoretical tax benefits on the above amount at the Israeli statutory tax rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-deductible expenses including equity-based compensation expenses and other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": "us-gaap_OtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Adjustment in respect of prior years",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "lfwd_IncomeTaxesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "IncomeTaxesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for income taxes",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r41"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 120.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Trade payables",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 100.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Trade receivables, net",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 110.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Deferred Liabilities",
        "terseLabel": "Deferred revenues",
        "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 140.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Employees and payroll accruals",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 130.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Operating lease liabilities and other liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses, operating lease right-of-use assets and other assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "lfwd_IntangibleAssetsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "IntangibleAssetsNonCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Non Current",
        "documentation": "Represent the amount of Intangible assets",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails": {
       "parentTag": "lfwd_FinancialExpensesAndIncomeNet",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "verboseLabel": "Financial expenses related to loan agreement with Kreos",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r346",
      "r347",
      "r730",
      "r731"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest income",
        "documentation": "The net amount of operating interest income (expense)."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails": {
       "parentTag": "lfwd_FinancialExpensesAndIncomeNet",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income, Other",
        "terseLabel": "Interest Income",
        "negatedLabel": "Interest Income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_InterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "InterestReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Received",
        "documentation": "Represent the amount Cash received from interest",
        "terseLabel": "Cash received from interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished products",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 30.0
      },
      "http://www.rewalk.com/role/InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
      "http://www.rewalk.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "totalLabel": "Inventories",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r717",
      "r743"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventories",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r192",
      "r203",
      "r299",
      "r300",
      "r302",
      "r545",
      "r721"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/INVENTORIESNarrativeDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Write-down",
        "verboseLabel": "Inventory write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "lfwd_InvestmentOptionsExercisePrices": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "InvestmentOptionsExercisePrices",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price.",
        "label": "Investment Options Exercise Prices",
        "verboseLabel": "Exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_IsraelInnovationAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "IsraelInnovationAuthorityMember",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israeli Innovation Authority [Member]",
        "label": "Israel Innovation Authority [Member]",
        "terseLabel": "IIA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IsraelTaxAuthorityMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel Tax Authority [Member]",
        "documentation": "Designated tax department of the government of Israel."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_IsraeliMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "IsraeliMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israeli Member",
        "label": "Israeli [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount.",
        "label": "Issuance Of Ordinary Shares In Private Placement Net Of Issuance Expenses Paid In Amount Of 3582",
        "verboseLabel": "Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount of $3,679",
        "terseLabel": "Issuance of ordinary shares in a private placement, net of issuance expenses paid in the amount of $3,679"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_KreosCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "KreosCapitalMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kreos Capital [Member]",
        "label": "Kreos Capital [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_KreosCapitalVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "KreosCapitalVMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kreos Capital V [Member]",
        "label": "Kreos Capital V [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LatinAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "LatinAmericaMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latin America [Member]"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "lfwd_LeaseAgreementsTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "LeaseAgreementsTerm",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements Term",
        "documentation": "Represents the amount of lease agreements term.",
        "verboseLabel": "Leases agreement term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseDescription",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease expiration, term",
        "documentation": "Description of lessee's operating lease."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022",
        "terseLabel": "2023",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023",
        "terseLabel": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of future lease payments",
        "totalLabel": "Present value of future lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r220",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r469",
      "r470",
      "r471",
      "r505",
      "r634",
      "r723",
      "r756",
      "r796",
      "r841",
      "r842"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r162",
      "r573",
      "r743",
      "r779",
      "r787",
      "r836"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r191",
      "r220",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r469",
      "r470",
      "r471",
      "r505",
      "r743",
      "r796",
      "r841",
      "r842"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "verboseLabel": "Financial Liabilities",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total long-term liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r102",
      "r103",
      "r104",
      "r105",
      "r220",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r469",
      "r470",
      "r471",
      "r505",
      "r796",
      "r841",
      "r842"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_LicenseAgreementAndCollaborationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "LicenseAgreementAndCollaborationAgreementMember",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Agreement and to the Collaboration Agreement member.",
        "label": "License Agreement and Collaboration Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of long-lived assets by geographic region",
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "lfwd_LongTermEarnoutLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "LongTermEarnoutLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Earnout Liability",
        "documentation": "Represent the amount of Earnout Liability non current",
        "verboseLabel": "Earnout liability"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_MachineryAndLaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "MachineryAndLaboratoryEquipmentMember",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery and laboratory equipment [Member]",
        "label": "Machinery and laboratory equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r281",
      "r735",
      "r799",
      "r852",
      "r853"
     ]
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketing and Advertising Expense",
        "verboseLabel": "Sales and marketing, net",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r384",
      "r544",
      "r587",
      "r626",
      "r627",
      "r682",
      "r684",
      "r686",
      "r687",
      "r689",
      "r711",
      "r712",
      "r725",
      "r732",
      "r741",
      "r745",
      "r798",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r384",
      "r544",
      "r587",
      "r626",
      "r627",
      "r682",
      "r684",
      "r686",
      "r687",
      "r689",
      "r711",
      "r712",
      "r725",
      "r732",
      "r741",
      "r745",
      "r798",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "verboseLabel": "Money market funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails2",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "auth_ref": [
      "r281",
      "r735",
      "r799",
      "r852",
      "r853"
     ]
    },
    "lfwd_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net aggregate proceeds of the first tranche closing after deducting fees and other related expenses in the amount of approximately.",
        "label": "Net aggregate proceeds of after deducting fees and other related expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows used in investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rewalk.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Negative cash flow from operations",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128",
      "r129"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 30.0
      },
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rewalk.com/role/GeneralDetails",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss attributable to ordinary shares",
        "terseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r129",
      "r164",
      "r189",
      "r208",
      "r209",
      "r213",
      "r220",
      "r227",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r245",
      "r261",
      "r267",
      "r272",
      "r275",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r494",
      "r505",
      "r578",
      "r657",
      "r674",
      "r675",
      "r724",
      "r754",
      "r796"
     ]
    },
    "lfwd_NetOperatingCarryForwardLossesExpirationTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "NetOperatingCarryForwardLossesExpirationTerm",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Operating Carry Forward Losses Expiration Term",
        "documentation": "Net operating carry forward losses expiration term",
        "verboseLabel": "Net operating carry forward losses expiration term"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_NetOperatingCarryForwardLossesTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "NetOperatingCarryForwardLossesTerms",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating carry-forward losses, terms.",
        "label": "Net operating carry-forward losses, terms"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionsQuantification",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition of lease assets and liabilities related to operating leases.",
        "label": "New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoptions Quantification",
        "verboseLabel": "Addition of lease assets and liabilities related to operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of non-cash flow information"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-lived assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r785"
     ]
    },
    "lfwd_NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHARENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Excluded From Diluted Loss Per Share Anti Dilutive",
        "documentation": "Represents the shares excluded from diluted loss per share anti dilutive.",
        "verboseLabel": "Shares Excluded from Diluted Loss per Share - Anti-Dilutive"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_NumberOfWarrantsOutstandingTotal": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "NumberOfWarrantsOutstandingTotal",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of warrants outstanding.",
        "label": "Number Of Warrants Outstanding Total",
        "terseLabel": "Total number of warrants outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_OfferingOfOrdinarySharesInDecember2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "OfferingOfOrdinarySharesInDecember2020Member",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering of ordinary shares in December 2020 [Member]",
        "label": "Offering of ordinary shares in December 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_OfferingOfOrdinarySharesInFebruary2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "OfferingOfOrdinarySharesInFebruary2020Member",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering of ordinary shares in February 2020 [Member]",
        "label": "Offering of ordinary shares in February 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_OfferingOfOrdinarySharesInFebruary2020TwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "OfferingOfOrdinarySharesInFebruary2020TwoMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering of ordinary shares in February 2020 Two [Member]",
        "label": "Offering of ordinary shares in February 2020 Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_OfferingOfOrdinarySharesInJuly2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "OfferingOfOrdinarySharesInJuly2020Member",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering of ordinary shares in July 2020 [Member]",
        "label": "Offering of ordinary shares in July 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r267",
      "r272",
      "r275",
      "r724"
     ]
    },
    "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLeaseIncomeLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent expenses",
        "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r532"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: current maturities of operating leases",
        "label": "Current maturities of operating leases",
        "terseLabel": "Current maturities of operating leases liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails",
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current operating leases",
        "terseLabel": "Non-current operating leases liability",
        "totalLabel": "Non-current operating leases",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r742"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r529",
      "r742"
     ]
    },
    "lfwd_OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "OperatingLeasesMaximumPenaltiesPayableOnEarlyReleaseOfAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum amount of penalties payable on early release of lease agreement.",
        "label": "Operating Leases Maximum Penalties Payable On Early Release Of Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry-forward losses",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsExpirationDate",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards, Expiration Date",
        "documentation": "Expiration date of each operating loss carryforward included in operating loss carryforward, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "lfwd_OperatingLossCarryforwardsPriorPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "OperatingLossCarryforwardsPriorPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards Prior Period",
        "documentation": "Represents the amount of operating loss carryforwards prior period.",
        "verboseLabel": "Operating loss carry forwards prior period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrderOrProductionBacklogMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Order or Production Backlog [Member]",
        "terseLabel": "Backlog [Member]",
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r156",
      "r601",
      "r602"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r743"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Restricted cash and other long-term assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails": {
       "parentTag": "lfwd_FinancialExpensesAndIncomeNet",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency transactions and other",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency transactions and other",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL EXPENSES (INCOME), NET",
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r149"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r743"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_OtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Long-Term Debt",
        "terseLabel": "Restricted cash and other long-term assets",
        "totalLabel": "Other Long-Term Debt, Total",
        "documentation": "Amount of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r161",
      "r850"
     ]
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails4": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Tax Expense (Benefit)",
        "totalLabel": "Actual tax expense (benefit)",
        "documentation": "Amount of other income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r828",
      "r832"
     ]
    },
    "lfwd_PaymentToRepurchaseOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PaymentToRepurchaseOfShares",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment To Repurchase Of Shares",
        "documentation": "Represent amount of cash out flow of shares repurchased not yet paid.",
        "terseLabel": "Amounts related to shares re-purchase not yet paid"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PaymentsForPurchaseOfTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PaymentsForPurchaseOfTreasuryStock",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represents for Payments For Purchase Of Treasury Stock.",
        "negatedLabel": "Purchase of treasury shares",
        "label": "Payments For Purchase Of Treasury Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalties paid",
        "documentation": "The amount of cash paid for royalties during the current period."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance expenses paid",
        "verboseLabel": "Issuance expenses",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Businesses, Gross",
        "verboseLabel": "Cash and cash equivalent",
        "terseLabel": "Aggregate purchase price in cash",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r467"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of a business, net of cash acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "lfwd_PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of grant received considered to determine royalty fees.",
        "label": "Percentage Of Grant Received Considered To Determine Royalty Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826"
     ]
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PostemploymentBenefitPlansPolicy",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Severance Pay",
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_PostemploymentBenefitsPeriodExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PostemploymentBenefitsPeriodExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance pay expense",
        "documentation": "Period expense related to postemployment benefits."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PreFundedUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PreFundedUnitsMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded units [Member]",
        "label": "Pre-funded units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 20.0
      },
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "PREPAID EXPENSES AND OTHER CURRENT ASSETS [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PrepaidExpenseAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PrepaidExpenseAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for prepaid expenses and other current assets.",
        "label": "Prepaid Expense And Other Assets Disclosure Text Block",
        "terseLabel": "PREPAID EXPENSES AND OTHER CURRENT ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r303",
      "r304",
      "r718"
     ]
    },
    "lfwd_PrepaidExpensesToGovernmentInstitutionsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PrepaidExpensesToGovernmentInstitutionsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance to government institutions.",
        "label": "Prepaid Expenses To Government Institutions Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares in a private placement, net of issuance expenses in the amount of $959",
        "verboseLabel": "Total gross proceeds received from the follow-on public offering",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "lfwd_ProceedsFromIssuanceOfRegistrationCostTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ProceedsFromIssuanceOfRegistrationCostTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares in a \"registered direct\" offering, net of issuance expenses in the amount.",
        "label": "Proceeds From Issuance Of Registration Cost Two",
        "terseLabel": "Issuance of ordinary shares in a \u201cregistered direct\u201d offering, net of issuance expenses in the amount of $3,215"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRoyaltiesReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total fund received",
        "documentation": "Cash received for royalties during the current period."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_ProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductMember",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual",
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r546",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r714",
      "r733",
      "r744",
      "r771",
      "r793",
      "r794",
      "r799",
      "r852"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual",
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r546",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r714",
      "r733",
      "r744",
      "r771",
      "r793",
      "r794",
      "r799",
      "r852"
     ]
    },
    "lfwd_PropertyAndEquipmentNetTextualAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PropertyAndEquipmentNetTextualAbstract",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property And Equipment Net Textual Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Type [Axis]",
        "verboseLabel": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT, NET",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r175",
      "r178",
      "r179"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r194",
      "r576"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r568",
      "r576",
      "r743"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r175",
      "r178",
      "r574"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of Property and Equipment, Net",
        "terseLabel": "Schedule of components of property and equipment, net",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment estimated useful lives",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PropertyPlantAndEquipmentUsefulLifeDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescription",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment Useful Life Description",
        "documentation": "Property plant and equipment useful life description."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase agreement with certain institutional and accredited investors [Member]",
        "label": "Purchase Agreement With Certain Institutional Accerdited Investors Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PurchaseAgreementWithCertainInstitutionalInvestorsMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase agreement with certain institutional investors [Member]",
        "label": "Purchase agreement with certain institutional investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_PurchaseAgreementWithCertainInstitutionalInvestorsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "PurchaseAgreementWithCertainInstitutionalInvestorsOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase agreement with certain institutional investors [Member]",
        "label": "Purchase Agreement With Certain Institutional Investors One Member",
        "verboseLabel": "Purchase agreement with certain institutional investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cancelable outstanding obligations",
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "verboseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r376",
      "r384",
      "r414",
      "r415",
      "r416",
      "r543",
      "r544",
      "r587",
      "r626",
      "r627",
      "r682",
      "r684",
      "r686",
      "r687",
      "r689",
      "r711",
      "r712",
      "r725",
      "r732",
      "r741",
      "r745",
      "r748",
      "r791",
      "r798",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335",
      "r376",
      "r384",
      "r414",
      "r415",
      "r416",
      "r543",
      "r544",
      "r587",
      "r626",
      "r627",
      "r682",
      "r684",
      "r686",
      "r687",
      "r689",
      "r711",
      "r712",
      "r725",
      "r732",
      "r741",
      "r745",
      "r748",
      "r791",
      "r798",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848"
     ]
    },
    "lfwd_ReStoreProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ReStoreProductMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ReStore product [Member]",
        "label": "Re Store Product [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ReWalkRoboticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ReWalkRoboticsIncMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the ReWalk Robotics Inc., a wholly-owned subsidiary of the entity.",
        "label": "Re Walk Robotics Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RegisteredDirectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RegisteredDirectMember",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered Direct.",
        "label": "Registered Direct [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RegisteredDirectOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RegisteredDirectOfferingMember",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered Direct [Member]",
        "label": "Registered Direct Offering Member",
        "verboseLabel": "Registered Direct [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r538",
      "r539",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r654",
      "r656",
      "r681"
     ]
    },
    "lfwd_RelatedPartyTransactionOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RelatedPartyTransactionOwnershipPercentage",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related party transaction, ownership percentage.",
        "label": "Related Party Transaction Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r538",
      "r539",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r654",
      "r656",
      "r681",
      "r840"
     ]
    },
    "lfwd_RentalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RentalMember",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rental [Member]",
        "documentation": "The member stands for rental."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RentalRevenueForAntiGravityProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RentalRevenueForAntiGravityProducts",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rental Revenue For Anti Gravity Products",
        "documentation": "Represents the amount of rental revenue for anti-gravity products.",
        "verboseLabel": "Rental revenue for anti-gravity products"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of aggregate amount received in consideration of convertible preferred shares by the entity to fund research and development activity.",
        "label": "Research And Development Amount Received In Consideration Of Convertible Preferred Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r827"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails",
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development, net",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r429",
      "r849"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development, net [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "lfwd_ResearchAndDevelopmentRoyaltyBearingGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ResearchAndDevelopmentRoyaltyBearingGrants",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of aggregate amount received as royalty bearing grants by the entity to fund research and development activity.",
        "label": "Research And Development Royalty Bearing Grants"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ResearchCollaborationAgreementAndLicenseAgreementTextualAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Collaboration Agreement And License Agreement Textual Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r430"
     ]
    },
    "lfwd_RestOfWorldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RestOfWorldMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest Of World [Member]",
        "documentation": "Rest of the world member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash and Cash Equivalents, Current",
        "totalLabel": "Restricted Cash and Cash Equivalents, Current, Total",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r193",
      "r217"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash included in other long-term assets",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r170",
      "r217"
     ]
    },
    "lfwd_RestrictedCashAndOtherLongTermAssets": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RestrictedCashAndOtherLongTermAssets",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for other long term assets.",
        "label": "Restricted Cash And Other Long Term Assets",
        "verboseLabel": "Restricted Cash and Other Long-Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RestructringActivitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RestructringActivitiesLineItems",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructring Activities [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r328",
      "r329"
     ]
    },
    "lfwd_RestructuringAndRelatedActivitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RestructuringAndRelatedActivitiesTable",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring And Related Activities [Table]",
        "documentation": "Disclosure of information about Restructuring activity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
      "http://www.rewalk.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r143",
      "r572",
      "r594",
      "r599",
      "r609",
      "r637",
      "r743"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r224",
      "r225",
      "r226",
      "r228",
      "r236",
      "r238",
      "r291",
      "r297",
      "r420",
      "r421",
      "r422",
      "r449",
      "r450",
      "r475",
      "r478",
      "r479",
      "r482",
      "r492",
      "r590",
      "r592",
      "r611",
      "r857"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue recognized",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r266",
      "r270",
      "r271",
      "r277",
      "r279",
      "r281",
      "r373",
      "r374",
      "r546"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r713"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenues within geographic areas",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "lfwd_RevenueObligationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RevenueObligationAxis",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Obligation [Axis]",
        "label": "Revenue Obligation [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RevenueObligationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RevenueObligationDomain",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Obligation [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RevenueRecognitionRecognized": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RevenueRecognitionRecognized",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Recognition Recognized",
        "label": "Revenue Recognition Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of disaggregation of revenues",
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveLabel": "Revenue",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "verboseLabel": "Total Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r220",
      "r262",
      "r263",
      "r266",
      "r270",
      "r271",
      "r277",
      "r279",
      "r281",
      "r287",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r505",
      "r566",
      "r796"
     ]
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RewalkRoboticsGmbhMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RewalkRoboticsGmbhMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ReWalk Robotics GMBH",
        "label": "Rewalk Robotics Gmbh [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets obtained from new lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r742"
     ]
    },
    "lfwd_RoyaltyBearingGrantsExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RoyaltyBearingGrantsExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the expenses related to royalty bearing grants.",
        "label": "Royalty-bearing grants expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty expenses",
        "verboseLabel": "Royalties expenses",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "lfwd_RoyaltyFeesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RoyaltyFeesPercentage",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of royalty fees.",
        "label": "Royalty Fees Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_RrlAndRrgMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "RrlAndRrgMember",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RRL and RRG [Member]",
        "label": "RRL and RRG [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_SCIProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "SCIProductsMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SCI Products [Member]",
        "label": "SCI Products [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Revenue, Net [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r769"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails",
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85",
      "r462"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of taxes on income",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "lfwd_ScheduleOfContractBalancesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ScheduleOfContractBalancesTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of of Contract balances.",
        "label": "Schedule Of Contract Balances [Table Text Block]",
        "verboseLabel": "Schedule of contract balances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of deferred income taxes",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of non-cash share-based compensation expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of intangible assets acquired",
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r547"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Table]",
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r727"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of loss before taxes on income",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "lfwd_ScheduleOfIncomeTaxLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ScheduleOfIncomeTaxLineItems",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Income Tax Line Items",
        "label": "Schedule Of Income Tax Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ScheduleOfIncomeTaxTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ScheduleOfIncomeTaxTable",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about income tax.",
        "label": "Schedule of Income Tax [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r113",
      "r114",
      "r115"
     ]
    },
    "lfwd_ScheduleOfMinimumRoyaltyPaymentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ScheduleOfMinimumRoyaltyPaymentsTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the Minimum Royalty Payments.",
        "label": "Schedule Of Minimum Royalty Payments Table Text Block",
        "terseLabel": "Schedule of minimum royalty payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/FinancialExpensesIncomeNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial expenses, net",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.rewalk.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Utility Property, Plant, and Equipment [Table Text Block]",
        "terseLabel": "Public Utility Property, Plant, and Equipment",
        "documentation": "Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of preliminary fair value of assets acquired and liabilities",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "presentation": [
      "http://www.rewalk.com/role/ResearchCollaborationAgreementAndLicenseAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r827"
     ]
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of major customer data as a percentage of total revenues",
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r117"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of options and RSUs outstanding",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of employee and non-employee shares options activity",
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-based Goods and Nonemployee Services Transaction [Table]",
        "documentation": "Details pertaining to each transaction in which an entity acquires goods or services other than employee services in exchange for equity securities of the company, including the purpose of the transaction, identification and quantity of the securities issued, the accounting made, disclosure of amounts by which report lines were affected, and noncash effects on the statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of employee and non-employee RSUs activity",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of warrants outstanding and exercisable",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "lfwd_ScheduleOfWarrantsLiabilityActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ScheduleOfWarrantsLiabilityActivityTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Warrants Liability Activity [Table Text Block]",
        "documentation": "Tabular disclosure of schedule of warrants liability activity.",
        "verboseLabel": "Schedule of warrants liability activity"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ScheduleOfWarrantyProvisionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ScheduleOfWarrantyProvisionTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Warranty Provision [Table Text Block]",
        "verboseLabel": "Schedule of warranty provision",
        "documentation": "Tabular disclosure of warranty provision."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of future amortization expense",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of concentration of credit risk",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r50",
      "r51",
      "r94",
      "r159"
     ]
    },
    "us-gaap_SecuritiesLoanedMeasurementDifferenceDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuritiesLoanedMeasurementDifferenceDescription",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of tranche consisting",
        "documentation": "Description of measurement difference between recognized amounts and resulting measurement differences for securities loaned."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "lfwd_SecuritiesPurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "SecuritiesPurchaseAgreementsMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities Purchase Agreements [Member]",
        "label": "Securities Purchase Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Exchange on which Security is Registered",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "auth_ref": [
      "r279",
      "r280",
      "r623",
      "r624",
      "r625",
      "r683",
      "r685",
      "r688",
      "r690",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r715",
      "r734",
      "r748",
      "r799",
      "r852"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductData"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r265",
      "r269",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations",
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing, net [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "lfwd_ServiceAndWarrantyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ServiceAndWarrantyMember",
     "presentation": [
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service And Warranty [Member]",
        "documentation": "The member stands for Service and warranty."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_SeverancePayMonthlyDepositByEmployeesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "SeverancePayMonthlyDepositByEmployeesPercentage",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of monthly deposit required by employees as per the severance pay law.",
        "label": "Severance Pay Monthly Deposit By Employees Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average grant date fair value, restricted stock units (in USD per share)",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSUs outstanding",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r388",
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingRollForwardAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Outstanding Roll Forward Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageExercisePriceRollForwardAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Exercise Price Roll Forward Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options and Equity Instruments Other than Options, Outstanding, Number",
        "periodEndLabel": "Unvested RSUs at the end of the period",
        "periodStartLabel": "Unvested RSUs at the Beginning of the period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Outstanding Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number, Options exercisable at the end of the period",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average exercise price, Options exercisable at the end of the period",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number, Forfeited",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number, Granted",
        "verboseLabel": "Options granted (in shares)",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average grant date fair value, options (in USD per share)",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value (in thousands), Options outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number, Options outstanding at the end of the period",
        "periodStartLabel": "Number, Options outstanding at the beginning of the period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Average exercise price, Options outstanding at the end of the period",
        "periodStartLabel": "Average exercise price, Options outstanding at the beginning of the period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1",
      "http://www.rewalk.com/role/ShareholdersEquityDetails2",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average exercise price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average exercise price, Forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r399"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average exercise price, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options forfeited.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Forfeited In Period Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options granted.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Granted In Period Weighted Average Exercise Price",
        "verboseLabel": "Granted"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options vested.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Restricted Stock Options Vested In Period Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting for Share-Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r392",
      "r411",
      "r412",
      "r413",
      "r414",
      "r417",
      "r423",
      "r424",
      "r425",
      "r426"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range of exercise price, minimum",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding and exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range of exercise price, maximum",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Goods and Nonemployee Services Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareRepurchaseProgramMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share repurchase program [Member]",
        "label": "Share Repurchase Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term (in years)",
        "verboseLabel": "Expected term of shares",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value (in thousands), Options exercisable at the end of the period",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average remaining contractual life (in years), Options exercisable at the end of the period",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average remaining contractual life (in years), Options outstanding at the beginning of the period",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total fair value of shares vested",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options exercisable weighted average remaining contractual life (years)",
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding weighted average remaining contractual life (years)",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "lfwd_SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Options Plans, Exercise Price Range, Outstanding Options and Equity Instruments Other than Options, Weighted Average Exercise Price",
        "periodEndLabel": "Unvested RSUs at the end of the period",
        "periodStartLabel": "Unvested RSUs at the Beginning of the period",
        "label": "Sharebased Compensation Shares Authorized Under Stock Options Plans Exercise Price Range Outstanding Options And Equity Instruments Other Than Options Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_ShareholdersEquityTextualAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ShareholdersEquityTextualAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders Equity Textual Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_Sharesissuedduringperiodvaluetreasurystock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "Sharesissuedduringperiodvaluetreasurystock",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount represent shares issued during period value treasury stock.",
        "label": "Sharesissuedduringperiodvaluetreasurystock",
        "terseLabel": "Treasury shares at cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r218"
     ]
    },
    "lfwd_SignificantAccountingPoliciesTextualAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "SignificantAccountingPoliciesTextualAbstract",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies Textual Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandardProductWarrantyPolicy",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warranty",
        "verboseLabel": "Warranty Provision",
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "verboseLabel": "State [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r199",
      "r200",
      "r201",
      "r220",
      "r243",
      "r244",
      "r246",
      "r248",
      "r255",
      "r256",
      "r287",
      "r336",
      "r338",
      "r339",
      "r340",
      "r343",
      "r344",
      "r349",
      "r350",
      "r352",
      "r355",
      "r362",
      "r505",
      "r605",
      "r606",
      "r607",
      "r608",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r636",
      "r658",
      "r676",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r767",
      "r778",
      "r784"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r33",
      "r186",
      "r211",
      "r212",
      "r213",
      "r224",
      "r225",
      "r226",
      "r228",
      "r236",
      "r238",
      "r254",
      "r291",
      "r297",
      "r364",
      "r420",
      "r421",
      "r422",
      "r449",
      "r450",
      "r475",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r492",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r537",
      "r590",
      "r591",
      "r592",
      "r611",
      "r676"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r623",
      "r624",
      "r625",
      "r683",
      "r685",
      "r688",
      "r690",
      "r697",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r715",
      "r734",
      "r748",
      "r799",
      "r852"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r254",
      "r546",
      "r603",
      "r622",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r645",
      "r646",
      "r647",
      "r648",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r676",
      "r749"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetails",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical",
      "http://www.rewalk.com/role/TestrereDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r254",
      "r546",
      "r603",
      "r622",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r636",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r645",
      "r646",
      "r647",
      "r648",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r676",
      "r749"
     ]
    },
    "lfwd_StockIssuedDuringPeriodShareOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodShareOrdinaryShares",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares, shares.",
        "label": "Stock Issued During Period Share Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuance of ordinary shares in a \"Warrant exercise\" agreement, net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Shares Issuance Of Ordinary Shares In Net Of Warrant Exercise Issuance Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuance of ordinary shares in a \"Registered Direct\" offerings , net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Shares Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of further shares issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Shares Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses1",
        "terseLabel": "Issuance of ordinary shares in a \"registered direct\" offering, net of issuance expenses, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares (in shares)",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r106",
      "r107",
      "r143",
      "r605",
      "r676",
      "r692"
     ]
    },
    "lfwd_StockIssuedDuringPeriodSharesOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesOrdinaryShares",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuance of ordinary shares in a \"best efforts\" offering, net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Shares Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodSharesOrdinaryShares1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesOrdinaryShares1",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of further shares issuance of ordinary shares in a \"best efforts\" offering, net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Shares Ordinary Shares1",
        "terseLabel": "Issuance of ordinary shares in a \"Best Efforts\" offering, net of issuance expenses, shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodSharesPrivatePlacement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesPrivatePlacement",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period under private placement.",
        "label": "Stock Issued During Period Shares Private Placement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares upon vesting of RSUs by employees and non-employees, shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r106",
      "r107",
      "r143"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r106",
      "r107",
      "r143",
      "r398"
     ]
    },
    "lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInNetOfWarrantExerciseIssuanceExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of issuance of ordinary shares in a \"Warrant exercise\" agreement, net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Value Issuance Of Ordinary Shares In Net Of Warrant Exercise Issuance Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of issuance of ordinary shares in a \"Registered Direct\" offerings , net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Value Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of further issuance of ordinary shares in a registered direct offerings, net of issuance expenses in the amount.",
        "label": "Stock Issued During Period Value Issuance Of Ordinary Shares In Registered Direct Net Of Issuance Expenses1",
        "terseLabel": "Issuance of ordinary shares in a \"registered direct\" offering, net of issuance expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares in an ATM offering of ordinary shares, net of issuance expenses",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r106",
      "r107",
      "r143",
      "r611",
      "r676",
      "r692",
      "r755"
     ]
    },
    "lfwd_StockIssuedDuringPeriodValueNewIssuesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValueNewIssuesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues, Gross",
        "label": "Stock Issued During Period Value New Issues Gross"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodValueOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValueOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of issuance of ordinary shares in a \"best efforts\" offering, net of issuance expenses.",
        "label": "Stock Issued During Period Value Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodValueOrdinaryShares1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValueOrdinaryShares1",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of further issuance of ordinary shares in a \"best efforts\" offering, net of issuance expenses.",
        "label": "Stock Issued During Period Value Ordinary Shares1",
        "terseLabel": "Issuance of ordinary shares in a \"Best Efforts\" offering, net of issuance expenses"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_StockIssuedDuringPeriodValuePrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "StockIssuedDuringPeriodValuePrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period under private placement.",
        "label": "Stock Issued During Period Value Private Placement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of ordinary shares upon vesting of RSUs by employees and non-employees",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r106",
      "r107",
      "r143"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Number of ordinary shares repurchased, amount",
        "verboseLabel": "Authorized value of stock repurchased",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Outstanding ordinary shares repurchased, shares",
        "verboseLabel": "Authorized number of stock repurchased",
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total shareholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r110",
      "r111",
      "r132",
      "r638",
      "r655",
      "r677",
      "r678",
      "r743",
      "r756",
      "r779",
      "r787",
      "r836",
      "r857"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:",
        "verboseLabel": "SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "SHAREHOLDERS' EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r219",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r359",
      "r360",
      "r361",
      "r364",
      "r483",
      "r679",
      "r680",
      "r696"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse share split, description",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.rewalk.com/role/CommitmentsAndContingentLiabilitiesDetailsTextual",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net changes in total valuation allowance",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information:",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flows"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_SupplementalDisclosuresOfCashFlowInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "SupplementalDisclosuresOfCashFlowInformation",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Disclosures of Cash Flow Information.",
        "verboseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Supplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Supplies",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances to vendors",
        "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r719",
      "r726",
      "r788"
     ]
    },
    "lfwd_TaxesIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "TaxesIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxes on income.",
        "label": "Taxes Income",
        "totalLabel": "Taxes on income"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_TaxesOnIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "TaxesOnIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/IncomeTaxesDetails1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxes on income.",
        "label": "Taxes On Income",
        "totalLabel": "Taxes on income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r786",
      "r839"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.rewalk.com/role/ACQUISITIONOFALTERGDetails2",
      "http://www.rewalk.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNETDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademark",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.rewalk.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_TreasurySharesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "TreasurySharesPolicyTextBlock",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the accounting policy for treasury shares.",
        "label": "Treasury Shares [Policy Text Block]",
        "terseLabel": "Treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock common shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury Shares at cost, 4,022,607 and 2,933,208 ordinary shares at December 31, 2023 and December 31, 2022 respectively",
        "label": "Treasury Stock, Common, Value",
        "terseLabel": "Treasury Shares at cost, 184,629 ordinary shares",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r66",
      "r67"
     ]
    },
    "us-gaap_TreasuryStockPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockPreferredMember",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Preferred [Member]",
        "verboseLabel": "Treasury Shares [Member]",
        "documentation": "Previously issued preferred shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Treasury shares at cost (shares)",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r107",
      "r143"
     ]
    },
    "lfwd_TwoZeroTwoThreeReorganizationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "TwoZeroTwoThreeReorganizationPlanMember",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Zero Two Three Reorganization Plan [Member]",
        "documentation": "2023 Reorganization Plan",
        "verboseLabel": "2023 Reorganization Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r227",
      "r228",
      "r229",
      "r230",
      "r239",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r323",
      "r420",
      "r421",
      "r422",
      "r447",
      "r448",
      "r449",
      "r450",
      "r464",
      "r465",
      "r466",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r503",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r548",
      "r549",
      "r550",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "lfwd_TypeOfCurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "TypeOfCurrencyAxis",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of Currency [Axis]",
        "label": "Type Of Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_TypeofCurrencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "TypeofCurrencyDomain",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails",
      "http://www.rewalk.com/role/GeographicInformationAndMajorCustomerAndProductDataDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasuryAndGovernmentMember",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury and Government [Member]",
        "verboseLabel": "Treasury bills [Member]",
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r736",
      "r854"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r172",
      "r173",
      "r176",
      "r177"
     ]
    },
    "lfwd_ValuationAllowanceDeferredTaxAssetAdjustmentsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ValuationAllowanceDeferredTaxAssetAdjustmentsAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Adjustments, Amount",
        "negatedLabel": "Adjustment previous year loss",
        "label": "Valuation Allowance, Deferred Tax Asset, Adjustments, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additions during the year",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "lfwd_ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.rewalk.com/role/IncomeTaxesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Changes Due Exchange Rate Differences, Amount",
        "label": "Valuationallowancedeferred Tax Asset Changes Due To Exchange Rate Differences Amount"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantExerciseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantExerciseMember",
     "presentation": [
      "http://www.rewalk.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.rewalk.com/role/StatementsOfChangesInShareholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Exercise.",
        "label": "Warrant Exercise [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding",
        "verboseLabel": "Warrants and rights outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service policy",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "lfwd_WarrantsExercisableDescrition": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsExercisableDescrition",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercisable, description.",
        "label": "Warrants Exercisable Descrition"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsExpitationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsExpitationDate",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Expitation Date.",
        "label": "Warrants Expitation Date"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsLiabilityActivity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsLiabilityActivity",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents warrants liability activity.",
        "verboseLabel": "Warrants liability activity",
        "label": "Warrants Liability Activity",
        "periodStartLabel": "Initial Measurement (August 11, 2023)",
        "periodEndLabel": "Balance September 30, 2023"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinaryShares",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants to purchase ordinary shares.",
        "label": "Warrants to purchase ordinary shares"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants To Purchase Ordinary Shares[Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 5, 2019 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On April Five Two Thousand Nineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 5, 2019 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On April Five Two Thousand Nineteen One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 8, 2020 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On December Eight Two Thousand Twenty Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 8, 2020 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On December Eight Two Thousand Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants to Purchase Ordinary Shares Issued on December Two Thousand Fifteen [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On December Two Thousand Fifteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants to Purchase Ordinary Shares Issued on December Two Thousand Sixteen [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On December Two Thousand Sixteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 10, 2020 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On February Ten Two Thousand Twenty Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 10, 2020 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On February Ten Two Thousand Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 25, 2019 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On February Twenty Five Two Thousand Nineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 26, 2021 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On February Twenty Six Two Thousand Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 26, 2021 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On February Twenty Six Two Thousand Twenty One One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 6, 2020 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On July Six Two Thousand Twenty Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 6, 2020 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On July Six Two Thousand Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 5, 2019 and June 6, 2019 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On June Five And Six Two Thousand Nineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 5, 2019 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On June Five Two Thousand Nineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 10, 2019 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On June Ten Two Thousand Nineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 12, 2019 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On June Tweleve Two Thousand Nineteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 20, 2018 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On November Twenty Two Thousand Eighteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 20, 2018 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On November Twenty Two Thousand Eighteen One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 29, 2021 [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On September Twenty Nine Two Thousand Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesIssuedOnSeptemberTwentyNineTwoThousandTwentyOneOneMember",
     "presentation": [
      "http://www.rewalk.com/role/ShareholdersEquityDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 29, 2021 One [Member]",
        "label": "Warrants To Purchase Ordinary Shares Issued On September Twenty Nine Two Thousand Twenty One One Member"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_WarrantyProvisionBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WarrantyProvisionBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.rewalk.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warranty Provision Balance",
        "documentation": "Represents the amount of Warranty provision balance.",
        "periodStartLabel": "Balance at December 31, 2022",
        "periodEndLabel": "Balance at September 30, 2023"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of shares used in computing net loss per ordinary share, diluted",
        "verboseLabel": "Shares used in computing net loss per ordinary shares, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r248"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.rewalk.com/role/BASICANDDILUTEDNETLOSSPERSHAREDetails",
      "http://www.rewalk.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares used in computing net loss per ordinary share, basic and diluted",
        "terseLabel": "Weighted average number of shares used in computing net loss per ordinary share, basic",
        "verboseLabel": "Shares used in computing net loss per ordinary shares, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r248"
     ]
    },
    "lfwd_WorkforcePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "WorkforcePercentage",
     "presentation": [
      "http://www.rewalk.com/role/RESTRUCTRINGACTIVITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workforce Percentage",
        "documentation": "Represents the percentage of workforce.",
        "verboseLabel": "Workforce Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "lfwd_YaskawaElectricCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.rewalk.com/20231231",
     "localname": "YaskawaElectricCorporationMember",
     "presentation": [
      "http://www.rewalk.com/role/SignificantAccountingPoliciesDetailsTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "YEC [Member]",
        "label": "Yaskawa Electric Corporation Member"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(3)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2C",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "b",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "25",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "980",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481834/980-20-45-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-6"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "610",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//610/tableOfContent"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "720",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//720/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "985",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//985-730/tableOfContent"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-4"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//420/tableOfContent"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//712/tableOfContent"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>109
<FILENAME>0001178913-24-000730-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-24-000730-xbrl.zip
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M6*>3R0T4/&&U";-+QJ1[S59G)6?]HHB;_J0"Z V4%.,"J:"S31*9L [Q;[5
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M>LY7#:/_9-KP>+%I%973095<4J46Y&\4O*[O>!6+5E:>F DU[>_/XL:>=^&
M3.B,$<5FG,UM!IMP36B29%2@,97*$)F0"ZFF>?#5D=YD3(;LGU3<(5V 6GFH
MR:6)]LB.F3#RT[NC9K/>46S,M5$T,:ZAT=GM?'\H-',4SJC-WECH=$'N$CD7
M#"FUZL'(48@D,F0BD<$1LI0G &E!LL2HC&%:Y'27WH$,!:\CW#D C&F()D7D
ME!O4!EYN7:"@XH2%3&N*((+DE-XQ8M%<JM9HBV 39A:N#L!45B#D"J4%Q!(,
MAT%(9V0^X>&$Z,S^68V?,\5R)78=4ZX%\J\M0^;<3+!.G;+0V6GUIK!01ECM
M#,.0$A=E-+Y#5QY\RY6,Q#P!2A;W%2I5^!'BZ%:E?I[$B'AJ./3P)!19!)U
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M1!I/R(1VB(E:4& !17"Y8BY;.4QN@LPL:K2H%H%$69AKJ*$[R6;,C257'$&
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M4+?J%,/#P(C3]"/+1QECMM#M^A<.>&"WW&>98XZ\?E&PLG$T8\V:$2N0>"4
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MTR4+&9U8HOW98IU6<3*8/+9$8,&'C((EPCDX?!/H6^R'_T!ULC^+9-"M',&
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M+ZH%Z(-H^@[ ?:8:KPZW0^);[^R;=]Y+CXW6XA%CN>N!)!R2Y5TSY.0V)UO
M@X4='4T_K.Q08FY:YH.O+UB,DMIM;AH@NUX))'*>JL.9OK%+(9/Z+#+4R O&
M%3%P0H'(WD.G"+U@>KRD(_,M3<%.O=6\N%6]:*Q+/#1RE8U[]K[(T,6ZX3%K
MA* NLU;03,;P&?%9SR!!S+_\O;XE,-"ZV!4WTY.QI:Z,A(V24')U9MQ/VI0/
MUWW3"2'8QFB;%=+" Q1D;O]%4*)C  [CAM$PC02><ST8H '/C[E08:3&JY?.
MU7_ 5JE6_<X#LJUQ<,+&>[32&<31;-M96*;'1%EJ]N:W4L'"(9ZUM!?)*%D
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M, 6P$ 21AA\]\3*=&>JP2J^4; O)-1*K>Y":@M8.O(+1E&*M,HSS.P3MW.4
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M8#$6?-]B-W@1$[[LJ J2"1=?&,\ 6@;]![N7FB60V7;2)G.A?7Y8>;CS7 D
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M8LSQ_D8#0;&/H+1$%]Z].9#XE=9M)P!.:_71Y0?<9=K#J:AVYUF8QV@V$7W
MR7MM+N)X?\K 3"PU1E!6E]+0ZR?I;%SF0T6Y.GF<73@+JTOHGX4-!,7=!A#Q
MNOL\/47X&JMQSU)W)K9!/ '@,#*;=F@6EI[RRX#BMV_*F&MI\&MZ[&B/M6'%
M+,S"Z&LSCG)N8A:&]7S*LW(:>7:>7C#N, [>#5_.M/?8]*/])$_']83D'N!O
MX--8BH<A,BS\4QYU0==R%L*CWV&T?A8FS_SVG355>+#\"\9EYA=V3Q_EDABM
MQXIO!)J.?TH"'-H-,)8&6FU8"YAFU=L0**:O!"_4C0)O)M##.K_!+=^;\8W_
M$= CI2%K7%I?E,_L,;=<="Z4>[?M=A.Q'_.F&=5BT.,76#^.V";ZIAIMM:%]
ME/ER0H!^E&N3;[^LCDY+&)K:MVXB8_5F(D X +J!("L'I!;O=M/0K VPOSF&
MNT6 T#/E;EO8S;&#Y0".%P]9LMX- =PHXB9U2X-)&Q*PL8/5U/.?<)820^9W
MVW)Q-^XA*G%60HL$( CG.X"F:O]HU&TB-T[/U@9HCH]&2Z@]P]"R:4 8;!#+
M%^]PF1-F\>LEHL\8"1!$]18K2W]/S=<3K>1:MD %@]2BE1,9N/MM"0C/BY')
M0K1]] /:0O)\%LAV!2E1%'XH%'=4&$4 @(OR-$;B'.$X +_0I@ 3 EF0;B58
MO2>RLDQW?M,8_W4NFFZS0T,%CC_AA($3 <"K4O24YW3.&S!9[**TG$X5SZL8
M%83N#GVZNX5<F!%EF>W<!:X0 * < G0V'T$1WAX,$PU3LT;9!X?@]K91,]NH
M688%(N\BTB?2VJCLDM>!1*MEL+N*F$W^XTS_\9P9*"XM?5-DVM?'F4%O9J[B
MMI-T%FG7( X,2'5SJ+<$*S/Z?*JJ7RZ,SM[\<DI#K=F!>SPI73-E(V^_*P#<
MA%&R81W(-/;@<.>1F,;H3#,J^OD.8D=3/8VC,M,;9#)]7.U*AN?P7>-DM:E[
M4[*W!+<V3!"&C3I,WP['K7/U,E@"HIV&M7@D#XX1@SL>,DKNFGJV9/U+'4:6
M !0> 4)YM<LDEFB8$TD.G#*0!!19U;<464CJG(794LHH-$RZC,3JZ][[>;<7
M7@)M;G5I/;[!;7F.4>&6&,^TUN-Z#9=M?[OJANHQPTJZ5!Q#J5:;0KV.]H_L
M?^S#2NLQIH1_@OB]PUX"HXFLV'!L31&8?L\CQ[W <AY.&,=+:XLCV2LW5B^J
M4:C>^>IR-_LA:TS'W[R7PI<1TU9BI \G\'B!&*++7KU(,+XP<AB'_$3O6R$L
M%6S!I:UZ&9,2O2[C*U1>(+JS%79-)6T/'M,)7$3O/NO#8C^,DZ]1P$\ET:PS
M#7TNNWPG[#)5N)-O&HFSGJF^F3O)'2>.>;R^W3NR[AH"Q15\M0Z"0NOCW\V?
M'Y^>/U)4'"6/,(I\E!ZA1+5P&R.?[]H##\FU'9;FU3<VK'*.G^ZIDL!_\K9&
M<6V"JA2S@WRHX4;6TWU663RU&W"V:U=3!Z ><<>DM_W&YN!,31\"(X\:#5)T
M\Y6#0#%3A3NZ,/KD(HUUM=;3/4(*OIY/B?G%7"R]9'RKX, (L]]SZGX7:8Q\
M[O7EM?R0/CSQI3M]HP0>M/NXRT=76SL(9)\[$$Q '5,:7 %X,7+\ 4] #1M3
M2*!$FPRU=H0NB(W=E=JEFE3.*])30F;T0[838_<;OF# $I8O5JKY9,BJMUZ"
MH8^VN- 6=J$-(J6]+L,OXX3":(E8*7%C@ZB/-CWHR9#QDR$R]:"3CW;\C?S
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MJ1N6W08,I (G[A:H2?%4DF&-U(01@;Q>>>"!"L^8BK@U[D+[-=BD0>V]Q V
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M6+,+1((4N(K>L24%NR6)"E6X S*OP%F]2RUJE=U(X>'ZW]CM!1Z7C.<759>
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M]U$E7IXK!IU98B7%-M2I@Q((!CM7D*049M)';;;83U0ZC'FXR"6+U"BEU-M
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MW/8XEXGCKRZJGW1CZA.N%.,Z:_3L(<",>X?)5Z^[GVY<9VIHD&4$]!$1L:R
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MPP_#2X06?TV;D=QA<'^MVP:;^;->5->K0^(4AC?AJY)NLHM3^9PJJ%JO;B[
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M;"%M4J5[:I-^:#.O>+_),&0;;_^3?;"],_&5;)3K]AOM6+D0#HN$@XZ06<I
MIS#(U*S>+CQC'G,>Y>4A7AU[>??:;&-O74X79NN/=BQ,AF6X\ZGQZB_N)S%*
MKP_(F3_N>+/G3%'C)-_N*MIH5+;3D INR$REV,9;3?S,B !SB2;(:(F 3D5G
M=#UK!#(^9_1=)R:+P(1W&>7AGR@=:!\U9BYV^DL<F63<>]_W?]Q%$ZE+AZD9
MPSG--F]9U2^[>% XK)HB E&)@E,B4!9_VKVGXY0P$[><"W["GBP3 6,'+F2*
MB>L=1G&C=E3,OX9;0S7K;N-::AGQAA)\ ZT8B<#M<'P,AX=!!DH5!GI8F,A
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M9,7040DGD(%$B$FEIW*4NG=,21+OPA.A1OMLM.ASLKLQ19^59+;FNY8FX]^
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M=Q\'-< U5-X'ZN7$-7Q=:GL6E5]CK?U!R4E.X'62VKFZ1R:&-7J"7\.*W/X
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M<1_)49I\LQ.J;D;+_TX!>2#7M<K_6VK[GQ^WZZ&QKF/__-AM2.#-!M^,"0Q
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M%8ELLQL7"K)XP+"-R1@9MSM9[R:UWS\;SQZ,X?&TTZE5EUKAY11,U?%?=\\
MEK(A*9EG3SU?S^!.-*BNU$/#&]X";3C5C*G)>&X_VWJ]J!_(\X7!,M8EG%VV
ML^S](1$_,D7/5E)_*M>5%,,E4W;OO_7%&2Q#5@7>K3P+N9CF^ZGM70ALRABE
M2%5/U1) ;A'7:0H;AJK%W2VHSFAG( =H^XOUS%J[_^5%LV/\GX-3%Q:HH02X
MCF0_?23HVWY+WFM@EB7EF1B-3+L+MR:'D<QD=4/JY]+0)7J&/&8=^UXQ%IE]
M94OUTFJ=Y*VI\0B^\4>[F/P%_U-!,]^1Q59WAHQ3Y@DLGWL_=E$6OAC0W/FI
M?5N?=L&:\V4KFRW$0!G_A0]J:EDEDC @TA5KYG[7[[-!1:LH28LMQ\R[$V +
M6+<:#PB/^%;-!J>*,I%LD;YU"-#-;;&TI*>+/GQ)AVZ^5=0WV[\T>")P"BNV
M* ?MP?866"OI<G/-R)4DJ:WF<PT3,\""BNR//+VBY>Y?]"#J% J==OKZ&"Z;
M@19^_C;>?SSV=(S_?\+H\X?2*J9DCD/ ]),2J9TL<[M#,E5Q;1FE8[*&31Z&
M/L_KFM\5MK#E0(M6/8W'##_\%'<'HW)Z&N\((0SNV/L2NLUXA)5O^>'>!RPG
M;/K9-&SNQM7&LQ38#%:<K'VVJD@=S=WQ%0P8X?.29Y^_Z+#/M6"%2+"MZ02=
MJZPPL4;S,#/>,Z<S-%X-R1]_4MA8/W;VK<:L659#58!]IOZU*XW3:W$W,R)>
M-;)#GC6,2;*)\ )+8@-]>J0YP%V#_&C]2KG2<-[>2/ZC"G3_OYJ:_3\!0F)!
M:RQES+(K@$U)' ;WADN)9V_%KZ6"]7Z['(X[F-Z?(^DW>')T.9.:[CI=;\#9
M?WHH\WJ=!X>_Z/N^O2\[W:"<K&6=9:%9Y77"*L$=F.>K/+K<4RU?59L$2(4Z
MK1-6]G']?WLC2M6$-H,N-^,_/AK$KQ: !\/HK\O_UQU_T0$6@#=KV7*9[C_Y
M6?^KCGJ)/;_;B_Y9O8& ?5L2VS^39.\S<!H8IW#RSVG-^WX/JYUNTIX_7\9L
M!&A=%"C^T]U?M?(G'+K_M&,:>(XXGC]5I]<?(PK 6.* _FQRB;2V?TVA,SA.
M!_'9IIY@&3P#'T!-ZT2(*8;HRL5=8%A2#]6>4&+0Y_WUA1F7$/DD&_]A;2)>
M?GS40H$V_?VORZR_=\SXGHV@ZWKS3PI8Q*?D@O"IY/_0Z?_B:;5CT*3+_]+M
M>RNOTEUS><7D2?KGM[B-.Q&3\2^\Y1P\4.F^3PZ!\]68O><[QFU%A\!IN:Q*
MY]C893=U%QVW3U &7\7(#:3:(7!2I8E-9K#PIC5%3'"SYV<&S VX#3WJ$ A!
M3$)WYOOA#3UX\/Z&_93T 9_7@LZ006G#U,M!^6:A4Y$[]@.+*91B"S].>?EK
MO!^\J##$O)NP$Q.QL6Y9A]YAG#D$?'83IIIZPZS=K<4>PC(9]"R\W_[)RY$D
M4W!&7^.<.7'.2]\#(WZHKS9O(R;I#X'+II4IX4U^!;1[\%3469W*9I@7[&HL
M_<,/H3;6O\8-71O(A4_8;@<38"4NHVLC\1$E94790YAH'JN_W,^!,LA<5]D=
M+)0X'6JVF?V3<\B_B\<[?5\3X^11:<L=5RI]%].;8-8I&ZHZJHJ*+(; &Y0>
M$ Z!=13*76>'0F4=VE'N8H@%IX6KKB:(ZBFYO#NR5G8-_)-FT^?/PZ#6]RIC
M>*"FJYE'0VY-&!CS]=X;K%V"&UCP2NA*3U9?DF7J$'^X$F3[DZX9>BHX4NS7
M@)1]!PL5W-22O0HC\QN+_#O9X/N7H:<. ;11ICSQMOQTOC%G'7,JU%0.15O_
MLP<3&<K.R</NH.O/>S37,L8V=@DVV_%02^, 5ZX/Q*5*FZ2VZ734IPN5(\;:
M9&2G*_/R2'#@=L^&%YA;NVY?%W\"VVD/;J8[E1Q=XH)-IC.5#8$2^RJW6OZ2
M$S,Q0/?7KA3+7*<@#DP^[&&,7#7O;I7T46=?/3P)L;,!_C<UD<\>C*@U57\J
M33?<]%-^PM;K:=A+T\RB[114>\Y(RVHI)LZ0X-%LTY>I=5=ELR2J=;_4<H;/
M$$'..O12T62/2[7<(5R0TFS_:X68_R=1NAW2;_#/ MI5\15=#)B],+_<?LPA
M8/3CABK=NWT5/-3\$_["8H&P>#SKN)'5=MKD::* PR>[55YM0'=Q!P(<,/:2
M^5X$F-$M_8J1--VVJ1SGT>R/=%KCUYP&6J.E8/KXL,GB38:]<^WTOXGJ-#JA
M/W@R\@7,&VGFK^(?FQTAW6OB15G/YDU<0_9D!_U#H*$;3\F\9EJ.1P^&[;IG
M;WAYTJH.+1P"1[HFOV :>R31!0%C:-U,X++*P,20Y'D/+/$;Z=@='@;C?^E=
M>:$"OA4F(4^4<Q8DJF+HR(PH1&9*^>1_UU=79F@(A$H.!4R]'((2EQ?BC50@
M/A]TI/;$YS+X_+H7'E%+.!OY0H10DN<@_W)D/R$D3Q19,GU+/LG%S"/746=?
MJR#RL20\Z>:<XDW]IXY^\9GJ?;@W'VO'O.(BIXWMG[TZ!#CNR.].UG:@,+%;
MDF-'#O>4<>"^$KZT!+']S.N1^5/U*:JMCA74JP1GJ%W%-S2/6 T[O_XG?OZ?
M$RI$C4W9L?^E&3?"=I!F[O<9*)*BMHTS<FX4]?Q22SE.($; N,27&[,LHYBJ
MX09K3KQ&X9]5\R#F*2I-#D0TXA/%A\#R(6!@-I2@]U0PS(:5O42)P3CYX3^Z
M,;%O]E=YF!C7GK_RYY[?-.T?W%Q-RFNB-D;YJ@_<T5P);^IN+]5+O+O6C>E8
MT\88O)N6?#CO@*)14QM-N"XNA=XVM?BU^!J_%%J6J*E*'\#JC^V7B"O/ZB-F
M_5>'-C!G25EED[>PN__:0O)J2!NZ&_-\15D)9E-7RM.\1OM-/JW H3<HV(ZY
MZYI*+]'@O9]Q_C'8JB7;V38#C%/R]/N/W"8.%+Y]TRCY<(5D$V70SW-VUZ\I
M ^OHJ#)MR;W=9^+W^$YYU-O2=JK(AL]7UG>F<_6,1=%$&PQ,^>4$;AP"LJ85
M9(> <2>'1">,]JDT:YY]J]D/AJKK$FMWQ.9K3\AHY7D%C+*N-EUT26FH@9>%
M% I.&NK_N-(EL$ 'X*YMLC,71_,VJ.+6\,MFY6];*$TZU+CRP*+$;/_B/]:F
M &VPV 3\M P<GK$@,G+[2T<1 +)XB0<U":3/N?$^^MA6RX>*6T+9] NR.#R_
MS"G97E@@*VCSI,@EO"O'5Q=/M[_AQ$?TM%[/)=?N,+8> C&JK1$"M?,K/YUR
M$>4?MM,*:Q!4:@*.ESO]>%+G^7+MC-8$*"Z*78XT,VX)V-&$>$ PO?+DCY.W
M&L^(%$G? :V)M8<BF 3O/]#GLX<]8B .6/%_?C.,\6L0ZQ.W(5UPJ*\IOC W
MU2M"X X/)[.KRSICW2^'^-(T>QN9*XB8?#WO]DE@/__E0F^UNNCY\??B8><,
M?K-UVAH'?7A#+YX"/ECBRA&F[TSA8GI@P18ZK7*7Z$L#/.*.5D+!BVCJTY(+
M&C](B>[XP\YIHA/Z/>H9X&\T<=ATVF.W97J#F/;T?O)MTJHF/?Z+MY[)('97
MC'A@CWW/QB<E*-V=8^!'_K-G?@3:[! 2)3<L 7BT%^ZB)Y<"K$DU<K;@U98B
M/[_3D(I1:4L6S#Y[-:3];M/I7>'P?-&E-ZMIU,)7'#1/J8#%\,CLEQX:-$',
MPX;L 1CD-NMDHLNW5QJ#E_F6'"*RV/6&VAM:RV833-&]&ZIBTE:BVMFR@?GC
M,Q4C1>=[E!B>_L6B."7(,"'[RMLA/MGV%"<IO;5/4%1W'@(#9=V85H+PNTS\
MH]V8NIA=8VT6*M=/@OPSJ43W SD*([_\'W#D_PC#B\H38]5T^76CBK_%J%EV
M![U?)L9!# I3).RQSK:;#,L?7)4WCQPP.P>7W)' ?Z<,PKSC;D?NT3=*ZA @
MNF<.Z.I SB]#I",:8ELN\VPUE[4$:<J'["'91.WB?7T\+7&=U&L92O#M<45F
MSB,JVK%=(LG]/E1^+S=MUP]8)Y%SL:P5*]6K#MVBRZ]&.)X?G)^7'5NTE#Q5
MWB+5__ "F](#&=$'17)?=[%*^+&8PC.7;<(_N#0:JW_,'\\GI:OV-7?(-3>!
MMV:$R#H[Y*ZT1I9<%C<.]?GVS.M<7LRR65]#<?&%AM8![TR49+<_'VZWLZ/N
M2D;RQMP5,Q67,U5.3*>3:5P[!*7?%6LH,1B^^*].X&9^,;KFWQA=F_(@M@)5
M^$>2%X4OWYC"((*&W^NSTX"2I?37<9V@WDJ+; 6XNN:>"TZQRS^V8CG"CR^-
MQGY78-QF/[0/7GV@Y3OO-3M8$[I-C)CGBW\LPPW,O&HG$C?H;J6'"GP5_C,B
M+<.#=8$Z@*"-!^1>>>Q7+?KPE01Y\%YMM_$K'@&<10WKMNW86\)PZX2*4^S]
M7?V80V"^\%GQ-?K %CZPC/XZ0U+1=5/R+[N4AT!HQ)=(+"%N8_,E,5"U$8*)
MLY "[X=YFL&A1 96_#L#J]JW'V"Z=?22YOC57\\7PF+&2@X!M]T$_,V]5*AV
MR2*<O68#M9?2CPFE/46R@\E_NDV;0%0;<MYZYF90=R]DYG,X2&86 M-/YD4S
MM\K%!I\/8'"KWY\CQ+)[09- V5R9 -NG7;V-9;4NM\B&V'5L->D'=^P& E7*
M:WECIQ<2HV B\H/8?9T9(6,##>'H@NF>!?QLT25"CK2VD!5;'QI@ZF%6'YH8
MD,L/@3=?]IL58Y+C[M4= DUC7R)W'&N[TK/K-$OE&KOEITX^(LPAI;X2?Z-\
M1!A'2N'99SD,+ _N^-%()1!%]6W.C@0_^ZIVRJD?OI"]7N"(W7>P;/[N5:O7
M*AFS:Z2Z+I_D8^A/YG'C;IVHS4A$<<WVOH"AR7-0"?L/)$>7F[)7,R!4MJ!B
M8<O^[/6L7"Q5??+V/A_,7]2S2YY*,4K!1 ^WVW/ Z_3VP!8<X:-[EG;X@$^N
M^/ZL1"9/!.])<-F"PNS(:QBT*[B3Y"X:WIO]\1!XG1EU"&01YW0C6?: WT%H
MA^HV=->Q]JN1A_]9.NN?X><("J66&\WP.,N" Z)?;'J#)I2C5I%4>(M9KJ/#
M>]>I5I=?#1+YTXG%K^^]A[Q1>BCI[1H$X=0>434T.QV4C:*</6V^NJP&CR2E
MV#MJ[14UR[BA<19-GE(&I[?5=T'C-^N\7&WWX@E9520$W+)%YXKRMLKITJ7.
M X>4LRA2?D>?:F)RH??U[T@%QB/\9$5#1%:2&29LP]9]F79T.98[1$YQ04N@
MDH:K1>[*=I"=A\G/M/++3G5+>KU5E0%2MY#ZN^;7"6H/[C5=;;'/DL9\4DX(
MTQHOX,-&%-/&"F6;TO& 2AR*D$UH,9P\&3<EEO(E5N" QKO6 F9LLU*Z]K.&
M[[O7:.#^ LMNWWT=0S]]6F4[>U;C'X[A\_SV^(A_>*W+,>+,M7O.0"J=_';1
M)+A'1OKSQ9V,CI16TAIK&R&9Z*BDGR8$,1S\[+ZV!\VM8B2R]&JE[.=#8"._
M4V31HI E_I*3NX$IU?=5*9BN<WI,TJA4WYMS;Y2><=:HC).8WW&R'2V6/3=Q
M,2#AV2?N,B/"?0ER-9REZC=%MF(!:G5&AKLD(^6HD,]7^ZHN/-Y\(5,9(9)<
M3?[D%M8X172XD\?S,H.>R>L_RI.19J##M*Y7$@22Z1^826&0L7R4:3<YQOS)
MI>T^FY(AU]>?HI%"V[G8VV*+QC^O J^<AB[X' *)F&2_,7G3-_-38^;MSHTS
MKZ=F$'-7=S%%ZE17BP;([[.I9)Z,R- _XS49GS@+#7%<9VNIZ$@6F!,*6,W;
MMK=MWWFUOJ_E2W")1,)LZD<]D"5MQ1]HAVGAEH1JMWL(V/U; U#5'B7&*4C]
M/Q*(VR-8QIZE$Q*<6K:#.B\R5=?OO.X,2\LJ TUI/32N&'3Z&E[^\BUH>^ 2
M-H#_SJ1VO@]N5ES^94ZKK,-(5G631^--B+7H?9)$??8*G/%/=Y]1K5)3A=ZR
MU+Q''*Y%-[QD<V]0S44&EGR'MSY-R10GG'KTA.#+?<!OKKIUH5]%MEROG%;)
MW7(EV*%V;8('I[+/,;*\OZVVJ[?(Y=<XPI4$3C'KC59AVG=PTB'?#N**RE:'
M\X=M6S9Q.KM7^%?I+7)^]YUK9Q-1J_T6>KM7PYO:+2T<DR/:/=]XOEA+N+^0
M#Y3+G!&></$'\\A!.*]ULA(XF??CAW??O,Y-,AX"SS=L!V>L1<]<,4=VVX3N
MVFCVI_87I)>'-#[6;67+G]PTHPX.DJ2HUIF 1U[H2Y"]-EZYY C:QJ2\3$.)
M:O*PZ:0'MF5FM2R<IS!XK2153AWT>\7O1':4=<B[+@HZ,?QRZ%OQ5QX4%HI$
M^M!'D.NG?3?A\.JU*I>LW+,:K<IR<>,U,W%\(L:3QGX8*2RSUA>J7VQ3(YDQ
MV@GC_SE77D'EHJJM S%*3IDXT##4$>X8F%$<>%,(;SB'FB4H]OK'T;KHN$+"
M:.E$$3$IO64J01NK;@=)/#CM0^"ID$47_%/& 9_/D9PE";%Y*C?NU*Z$+(P?
M FU2.KT)!!H\Z7K? _DX]E[9EJQ['C*>B#"BOW: -_!,<L"GS@GAM.08\2<D
MI>ZG^C/XF&RQ) C792PO:"==*'G=*L7@TL_>WQREXCNP)AAB3DLMR\?T>&I]
M/4.RRT6['9P]H64O?5%N;,;GW!G3-FNXGD74.#HT_O,E^0?5CXO/RHALHD1Q
M:%,Z+BX4\H&47G1_9\LL9HP%?[GVQ26C^QYGV/,$O""8]F0P/@D=LN$1?7WU
M^I0@V'[7H+&&MPCS:"#M[;D6590P\MRYM*<(ZU1B^"6]_E_XBCVM32M\56 4
M7@Z/\PU-HI6:PF#\I0^!*(N%@\;]_"G5M3>M9IBT(W8![0WR\43@MKNE?(QA
MXO/ +H$A<5861S1W?OEU?H46]=8PXQXXZ2$P911_L#SO,&O$-/-W!&,(_1>"
MT?'G!(,+ZR+O %TZ!!0M+E7P"XSXB]LL6A_\F!-H[MZOPJ">$5C$,^1+?7KI
M+-;=$D1P@Y_99^IT,D%])1SH"45<8&]$6G]M*C&X4+*E[!T"O34UW<3!,+/[
M@5=1K]TA1(*K]* 5?PBH[^[=1&_>]S[B&#\?SHA=.^(8$U=^#4'D[SB&9[./
M96M*M0-A=D-L,GB)VAUUAW*%[<J0OI^47N+&@@)N4=4MV2&U=Q?LNX7@8:@Y
MP/D]Q^JD<C*\ELVEE,R4%V++K=R98I=R4=^$A>Y&H)F752G1:UG+A$N0 ]XQ
M:1#:@G?F1OFJGY0NK8IHYS86#%47GRW"CD3</\<6DV"VZY'EG;3BMIXY&N$,
MYY=\33O')^RB:OF!V RTR4$P7"H 5;H-9O>U$S#$>%WX97^^E+ M'Z=EQ2E5
M_89AMLMR]O: P^MWLG1%Z[^*+N4"ZK_*+W>(OVE7&5>T,?Q6>-'.JMTMW651
M\'6;_ B?N/(; 4'T@3(=O"H)R@<JC_?79U<+HNIF,WW<B12D<8*D+T$S<29X
M>=N@HK7:-I1>QD5QP@O!-.61(2N!4ZJ[Q=V[^CVJ]UVE[3C].@/E"TB^_RW(
MG#&$LLM.))FOYK$?,B63%=]S9S4;S4J+/:C4PZS@M-8D6P9;>R-%#MYL3D;8
M;IWZN;6L<OY=U<;(\*[>#$S W[#B-=U"J[ULN(@_[;52N=C'[=-W5A$)7%"T
MQ8;8NT/@95(\*K'VZZW'HMBE4O\XL6"G <<:(W1B=?6"U$>S=,^B3:,75].'
M#P$,(^%6VNT1H?W @D-@(92HOCTHSB57#>?T4+X3 FB"8-BVU!2\3\0BT$R^
MF=6S?"6S04C_61[T#,OW'7-PAVSN#G8L*(N/Y=H\G^1HPN9$T0!;, \C#@[.
MYD,IG<LEE,RD)KN88QKL;OO:/8):$\Y_:H93AU9"]8@1"PN9^&.TLCB'KS4S
M'QS<7+V_P@3:(&;B8B?<]VP2W)X20VB[_Y6!%",\8]_]MP,$S01<XXT$8\&3
M!B?N[\\B@2)9/A)'+,/!$&ZPVC BBNY+;X".J=?+#B?0U)*]'(PVSEC5P852
M.M^M09SB6],I>:U>W@.'<YR?-_)A!F\WWHM\_UK;]3%W1=BF:%,P^MOZT)T!
M^T4;6Q4IL8I#X+Y1N!?*[361PBG\E09\V=XRCE%>Z2_3\QMW(6:/#@TU8EYY
MDR,;[D]UK5S*$_?H\$B[&PE&_/P_5R\;Z,>8#G!7Q2^S\Z,,T*;VT\H^]!K/
M>,1^*MTVF==0O)V?NF(4[Y;CE="EBA5BD;L3,8!^)'2^I=:OJUM@K(9FVWZR
M_D+"ZH5&G@X'R,T=*VM):?;:1V>:2=,!@(U<0Y6"@L^AS4;Z'XK\W/S1,"H@
M.\_B<LBKKE8298>I0P RGVV"E]FBY+3M<A9I-;#(Q%NVBMS6NOC>43CLBK9?
M?D.?I["V2;*;Q;.S,=OOD!*5H11CLK9.<J8N.R\V%Q2,$G2CPHHD"G'27 ]_
MBD(V%GO#.W'F*6%5ERF>I]L]T2L2UJZPBDB"-Y1WNPI+]5]/?QNC>45%;,CW
MDE^-?#%:6_YMH<S9BZ55%W)H!)I6S)-?1<[P(EE;ZB^X^P5EB\ZC>U#DFTD0
M[/8SA^M51@4_W:X<:> ?<S^!SAI^A_#,X0)[EVJ!7CIU/#3R#,/9V@WT;L+(
M\Y;0B-F7E8_+X]#X"M&^3C'7+ZWJGI3CF ^E4I]I7#TCD3ZU]9VG?5&E[4QW
MO[O*YC= N7/DTFL0VP94J. T9PH-Z)1 )*.  +.AS:--#?C.9$H<S_#E0V V
MU/^6+./,][K@GV\.@;5F>7ZY]L>'@(S!:NY<^KCBIK3U(7#)8#5GK&&XWI)3
M<C/?W:#<;'7YE._%#[71#FF-91Q4>-19+^$UQ?>=)N]_8B4=C0?OV^041)[R
M\L18]DY]2KIU@ZZ*PL=8Z=)-1(5O)Y3MV7<)1%2+0!8>'KR\?_4)=T3PS_H/
M617(9LPTX_QU>[W/XD\+>2SHU*-[-[6D-IP,EOG:<KI<.KD*IV>19XR5Q-P6
M=)Y_KOJ,";F\?&&O,W)*(!]U:IMGTGL)NL<82_;B/F0/OI'_;:$E_QQSL:O:
M[1 &O=N_TOAQ@F"B%]7/R+5ZU)M)UM?TEFJ^EOV3.E3HASI?APG*-4YF/TW7
M/[S,^90>S;8\%M7"$*41Y)W!472+K4N@Y.SP.EU=SOGXAC5F+B/IO4@W"^2F
M].,C*7JCZQVN%:\T/F/ZKGB@!7OD59)2TW7;2?'WVU#KTD,@F6_'<-W(^#1X
M:+&6*'!#OXAO!"^>:8,>):+8C6K7ZN7Y([2D!OHC?Q-P):A33.=I@F>F]X5Z
M"4&W0(M'6.BS<RP.UCHO$]VZC7OOWD.\.9$)E;'_H6?:4)7>H6_37.89+^4]
M[,&LS)Z>2E?^>!V5[:NW\D5G<&!F]*.F,RDF>#N^WC0Y\!**V_KG?"L9S-@/
M<O-!1<%#M[M;#.X2BUH&.&TG&@]S$9-Y&G/C(-_;<H'YUT/0L;/4:CBS0N4K
M=A&T$A*RX3<G/*RTS/945/OO#8AN+UG=;6O,R=]!I=30;Z\ZW!/-1V_PA2,K
MD3[35>TN5)W,'1_:4.P9$+9W'0/O+O]E&?[KJBB_ETQR?["Y.BR@V(CL$>5!
MF"#<6KUDO>SGT%/OV)E+M^LO2HSNF&Q[L.9FX=3C?LGE;7VW%)B9?S7OYK(J
M,^1I3+,?\XH00<D./D;(JO%P"?U#5<7-6OZ96[^L42@OBK?MS\:Q$AD^O&>R
M_NV W.MS</'#:@36^2^41S!12&QAHO99.(YN<5D-C56F8?-:-J=SNRNSCE,8
M]_', $&ZE;T7571+,P_ \BM1P_#: X&%17KYX:C9;CC_#E@!3#@C(+1U"&3Z
M^:53V_VZNE;T_NW 4 ^1<SVM^_7\VDA+&.8 />_03!_"'K>8PN[_EPJ*(?O0
M[_2&UL<]<W<#D2V;*Y"=^Z3;PFU9W562(:EH+$H1+7I%:528Q-N3BTM2; 'V
MN&&CJL\JI8W'"ZV^6DN'S^=C$Z?:13="5P6)D;;"S"LA@M*DQ< %QG[K$*!*
M=#P$=-W6$01&">P6^$?H9H= Y +]N1*;ERE/L4]V@R,S01,2LUM$NN:8'EF@
M*9LOHT%L.@)W)E(@><H6^7YH1_7'4+FB*YL%>)UMP]^Z\.SSNU0>*+;V_O66
MY;;A M%?T4UKEVT;GJ]Z9LFQ'\&:7>VCQ)#D76(E%1Y7P+$G%NN,957F[V0P
MNFBE!=]XM"XZ[W (Y#].2Z6+\#5.V=84$](1V372FW+I+:DR1[_:@,#1.KC;
M7(') XMZVZ<Q=$_EQ_;YY!ZW!"]H=%T=*^$#]Z%@K!\LWLT$T-I]].0:C!FZ
M)@N?P 0Y>E0J7NB_>PCLYE?+4XGJP_M#OVQ+J?6=6S@0&%CH0.KESKEU.,TF
MPQNR>ZX2,OP-H2$L/+8JTQ;/E:P7N76D959\>7ND&_C@$X:V*6M-_K?F# TV
MHVD]O9?W^</IH?-*/$<_"5Z1'=6TH;(%P4G)1$).A;B)WHW:T95CL"4R(WV!
M[AS$B*KD\&S*2IZH)CP7&B<E'P*[I-_*WR3.1<$X)ZKOP;U%ZZGXZ$19D$3\
M4GH(HRR#H?"=<CTEAA,"K$VEU_?4WYP7B1/[I&N6M6WFPY*S)+'D:X>\,>50
MIF?->H?1@"<;UH_7_3;9J0#O(TK)1+(5MCFQ@D!E!85A'JQD1N[S# :70;\:
MLVA[,0[Y"AP"T<$VV_"KM^]9+K7EYLDAB>K9*OF7C)/,<1-1)LKR;-[ED6/?
MU1W#^]TB737\"RLC<^>NX=O(ZE5;O%'O ^THHVK6/ IK)Y4+=Y^_M.'=>5J!
M%6M=='1V&&@TF [OS"U,Z_*;X[\]<&[Y*J ?X+)\A_U<SX/!C7RO20(SB7P@
M<E;09.WLV/-;YYYF?EJA+BO3.\UYUS#J6\):L747[&'-V^U@V\MRD P%:_L<
M^3C?CH#H(5R,B5[>_-7KQMSC'@L&)DY$UBV_/@Q_FU/>0F<:_44@]_:>9O8&
M<N:@Q:Q4KGGE$-@/O%S[G3';Q.)L.3WN% #C0([@[Q=T*1<TA/+FGOK+/KB!
M7DI;G],#,@K5=\^G+<]OYQN78SR^O5RZ\R2>BW>?J#@#2RE,'KGNHY0U:$'F
M#]G@P1JW[[='E E<,>;;$GX(>UMI^*>1UY] H72:FQE.YRY6@].OB55)(KXO
M2$U7&;7=CE9Z6+>8L(N^^?&:J>/IQ4;R^LDJZ_&4Y]/F2B62%-8>V%5YK,4V
M!87 EZ;^J@*WSGFB9S9[]G>;229R_!CD.MMYNR6(X!2GJ\\@]G-+R-L ,-*+
MKD6>L1D>?O'B%\YV+J+9#2+Y;B0?T< U69];*2;]L\D/VP0]#Z2-G*>]%C3K
MF<CZ-J.Z,9\8.PK<FV^?:+V+GK4(7,'6/Y$JS7_L+7KIT4E0HDOH1/&>I)BL
M.JM$_=?GC!M/ JOD1BA": I2O'6IIIL&IHV4;W&[I)Q=!W9%2;D[ZJKNNB]8
MRMTM"*NN/RJ-D[9/2,]RQ6G+2^V<5]":&OMJ[QPQYUXW"_'(V?HH7/[3#LO=
M=P%"*@4R1QG:72Z6JUH1B5]I+I+UC)PVO^R]U6BNY22:PT$3?2Y[PB+8XH*2
M'01%3 WXR?Y8%F/+KZN1'&MUDSF-(+UUQ=EOX0=T2;RW1@V_E+KESU,5_O9U
M9* YD^W8@WKSQ(;I4[![B93S=E51/_GJ7#IA"];YJ46-%YH66$A-$C$#4.K4
MZ!_U*ZT<G&5/=JEV,'6;*8YXQROBDF:$])K"GI_-$<FO \/<+/S%%JR3$4+$
M+*+N_M_])8?(%K:+YBH*CR_*Q-5+L,>M>1F%#\M_=G;XF00C2U&NHA5Y84*(
MPT_/<1E4M2J*T/5C$$_?)&:MOZCC7NN-00T&J#*+!B.?<#O"+.NJB$FRE=Q2
MI7P:*F-A!A7DS2[T'IQ4VXWI?;6EY"V1N=?XQD&/F"W/</"F1[VWC_;1!7?5
MLGA0*I<Q%OHKTT19F/CKDL.@+7:@[;SO$0'BZRC95B1LV\/>=BX[G8&^C WW
MR'4WO!@^%J>RH!8Q.G^'['+^, FF2V?VCJ%OD:"I0(KIMK@VBW^(4ZJUKSU<
M?2[O3<15Q&VZW7NU'868ESQ/W.(J/Q 7X^;?U2C#"[=A?7>*O9Q.G5+)=.QE
MC^USL$),_6#>OK;6&.^JW?WYF]..MD2A+F3586&9T?:#_8AL@WK@B["H*,N+
M\X-"V?/QIR4X*%F!W8?5E\2,+]-,G$^F<!N)7]C69W^7R299^,VDS]6'M<(1
M=4:U'?Q$;(.G$7W&=,&4X4HSAUV:F00XTS>GPZ5^IOK&>&DU>UR.SJ.K.]G<
M=+WE>,,=Q-<P>Y7<]4<, 5.@!0V+VR_^B_[T.$FGUS)!R0>U1;>*BN*:Y?J.
MP5@<E77N_5;6,83Z+%A$G'SX2-6/S?N =V%;5V*F,JI6%]>*O"C9NJ 1.1BY
M:0?BBN'>P%DJ^U(3.YI:;M7FHI+,[OWOEG2<#P$-R"% M\XX.5_+.RNV"&5]
MOFLB__,7Y4GA#_YMX^CU(>#82TPL,,HC4OLEW9W!*%%08(I%OS6D)VQ-J>2D
MO46WRKZAI]DA\,<MHAK%[G,$?FE!>.2N,6:$H^4=T^;O-1W//]1T_K!OI,2D
M"U??1$?*_\Z!SL6!1ZH=A>K<&ZU<DN'J4BXJVK;?S"\&1KBDM$04OYUESFR^
MQD8C1 ?=3D#U&P\F,Q$EX8D^Z-@1;WQU"- _D)NL^;2"WG\U"%\R3@H;AL1\
M'R3*(N#UG[U6]EN1Q4/LUV9L-[A5[A*80$^C>@@<A4Q+GY0CHK'F5:NW&;-K
MI#/*C+*/K(LH]^7<@JTITR$Y-S8R%\,&,\$6?!$2D*WLR7<\$G+KGRGG_.A7
MW.%-2&UBU%??@*U&!B,(%^S]B!P05NTU4'/-%4WT70+G_VE%\1W'#NN<W?IO
M=2 %*)M7L4T+2^2!.R$N)M+?P:89]ZGY<^ &<42\X$P?]Q_E$>7S(7P1;N:6
MC7Q/+61*W.J@DP*Q,GB<*8&Q?(_G1>I;B#7TJ]XMMYO0=YL,.C,<5F,9!:.T
MCXOMHM224XWBO#Y^G_8AYE^JOW;^S>!-E^W<T;3?5:HN11.3?>3KQ>MC036^
MVP.%K%^^^-C>)XY*X2[=8"F"UCO#\!::SVXZ:43M;25]?T_;OMW5L@0%N.GF
M&3437.C'T]\H6V%;T*<6I_?8.NS/O+E;E^P?A]T]&^N!O"= +E-!*-E(>>9>
MTB?ZXF[KUSQRE\F\VZ[O#/VHH:&-!-Z7 = F^2C4FU-'RFJ+&?A!;_!UQ?<+
MH9N8 QHFR/-//*_6IKN;1>8VF$3/^/GI;)RSVW:?:O,5Y_%=EJ58=W$?J+;O
ME?Z1W;8TR9&XN3AL+5F6<*L$^B8AO3JTRKZCSX9[BZB('[F/"#@_W[2JE8WG
M"+"@CV'%\]QBL7FZQ*W2%"RQ'VYH+/*!J]Z?PRL">VL@J]A;XR:R;I<%"]N[
ME^)RM;)"I&@ZG(MVLCK4>3H\(D> X^2R_NWADH-=TWSH6VSHTQ7*SB=PFJHK
M(UEI-%NWC C*H3'3+\2MQV1(T@2?3^1<;KNH0*&VT&ULK/F2D>N67@"Y7)6=
M=&5BY^A?E^.W Q@T_35:Q=$IX_K])*V^JIB6F(D=,@.RQ&2P?]SJP>+4Y[BU
M4>WI1'R,^?.F97H-I%= @2M44-@P1UY]$A@16;#(.MJBZIPX_4T61^M2S&Z7
MU\J4G_ @['/(NLO-S!=6KP6RM'LJ$)ZRYR;.A=!FYXA-X1E7M0UWUU$(A3I0
M;T4M&4X/-P8I.<FD1N7[W5C#0NQVA?JL:-)P,)9;V$O[ &P W4!%/>:T%7JH
MW'8AW"\^]]M)I)2MC@H3Z@V!RRY8"]-[@6DTQMSK6MR7+->;FPS1@N=D_7(]
M";&U/C$CU13N(H.$$S_0U\JFJIZF@B,;:H)0"7(G1Y%E+_VMPZ;\X]8_EDY1
M2X=AHEZ^,I#D*2_64W*+_F.P$=8GT]1)0T7XWEG;KM7C. 2^Z. L;V]';-OM
MRGR*"0,1G:NYO95;X9A62LU.X7=NCPJDJ.YBBKH9Q$8TP$,TO\4_#G?G!B(-
MLW]5?TPBL/K4(7#5TBA[MX08^BLG:",P+!]J0"%8^7 _[BI>]H&IR:095[3+
M[R'W;WDDHN"N+:9VH[DVSO>13U3>6,JNTW?_BS6%^)KB!.WGSB98WP=PJ9UK
MDSK"A$G+9=76C<)]EL&9_G@]L PA]FW]@L:RJG%$R9RXM3M,IVX#'?:0F0"=
M<\!=K4.]KR$//@0H?5M+T<0+_*M7!3=H;U<3'4BA*VF.@[&E=:^3H'QY1?Y&
M(-9(8()-(2)=?D%;.G!-/,+#<M'/6:-^2+70QI-&;E)_*T8$,M%Y!44TTMQ]
MWH5G#5B09.&KNEW+S<)*TE7/<ODXM_>N0VA&G"7YH\''9\;7P@X!_EO3MO3B
M:>L/POQOA53!1\/H>@OT>4=2852F>.V[?^)620H#N_.I@ZXH>5DV'P+D-Z/A
M#M^"683(5:Z[6"R:I31=%IWW/_>&W*S(D?"L)%.<^:+HAISFJYEV63 #%I=0
ME&-2^MY_L_"*BIBQ%1CI<W+,6"J]]9'\&/(QE9E86>C/$XZ"!#A_NPQ>)]3:
MP06"S8.$ZAN'!_E [4:ZXD]QI9&=XH=AY5CMA7*][HW9<$<'54KA[R,%?J.,
M-__QN-M_!MPL_KA=L],F*V)I_H?8;Y"&UOQ]_T;%0L=4:F.?%XLO7'_<+^6^
M/!@#V8/UAEE'ML1$).52AMOO"OWM?,@")XAQW?CH2&_FKR.],RUPZH:T>:)!
M>"O_S^>V&'3!3WV=6D=:?YT'267U0MENCT:61)H?_3>7Q ME2;,O^EC5I55=
MHID)&L+FM7A4V=C[8:J=N)59!S656AN+2.NO3@T\VKV)EV_]5=D@*$8=_-J[
M >0GN#[.;O]6V;#>$Y:!T4U;>(JXL52RB.HI.;_]=3J7&;^P;'H(5!QH>:6'
M\<KB+3#XA>#?MFY>M3$OA&XXUY+TZ=Q=0,/,L*%T;%(]@>:VW5?(^6:1XAR)
MGIGULG:4U30Z="YYA?)5 @M"U/"V2AO"M._[B1\[5$?!WX)(>Z)@Q."_AG_/
ME>!@8$$T"=(_#:J_G^?H_TM4A6Q_L&YAB9)?Z]LU,AZ;*:FZL^;5^'N<W\64
MJ(RKF%VC39)$V&Y,!L[+LTC@1DIXI59@!MPMX,$,+&0]IZU+UDU%460N)3@5
M_@ E^UMT7VYXI#S2IW4K;F68$(?[\6V32$YN6\C:UK@EV'WO3_]X")3]O)HB
M'(P:HMNQ&_PX'7_/L5-=0&C/OU5BC9?PX\/L5A*?ZX=/8KP%M=NJE_[6,D7@
MI(A^Z!>I@P#Y!3[Y"8X/AT!R[%%#VP+4MJJC_&SVZO_@[;W#FMK6;^$@"HH"
M%D!Z5%":-.DU-D! NA!J4%&I(KU#! 24%JD* E%Z#TCO2$>DA1(ITD+O@00"
MA/ EN/<^^YRS[^_YON^Y]_Z1YTE6UII)8,UWCG>\8[PSSZWZS67+78U$ RNE
M7-[4]\=>!J[#MGU=)&?P:T55O+_-RUHM)_STY#Y8;!"<Y6,YH!29=J[R"&!\
MA^@Z3Z.LD/<S?8/!!:DAJ,+.&H^\Q[%JET5][4OCQ@.VK@23RFMEMG?3:X#F
M>(4PO-=X2HW2*Y3,5+#@=-Y3:#4HSL5U1MW-280TP6Z30V$S1KF8"98I'BUM
MUNB?N =JN5P G3G;%7C5Q?+[['R=.UKJ7<%\A$OE[!/Y9^LG:N_X+=[TL\$6
MQ2(CNG.^^![LZSU[F>VHR9ZTF\?Z$K$3G'?JXQ$@OB!TU;[SD]0S+_=ODV=5
M7+,+\QMC6#BT&DB_H#X80/%:U!3:/$D'HU^<%^OTX8S[B0HSMM>MZN)Q<R:*
MEAS8^W-+]VA"U?:T6B0GGPZG!S(W=OM&N)Y/_!55_;1>&P\['=)6DHH=!244
M)K'7K3!J.<>Q\(R&M(G^U/M*S1!.U;P4BHT,*5X'4L =JH'8WOW0G>7-R==O
M*%V/ "0(G(UP0K V8%@Z!9M">?./HPS7^5S518&%W@C%*^^7N[):KXH4S5K^
M!%>N5.0]SWPX.QTP"^Y4O#Z4/EQ6\RYK*CT\+6FWL)9;6"!1#_Q"+;O=V"E2
M;.*]L#PVHX,RLFS9B$/@B866Y QOKQ&[D&(9=K=9ZUQKJI6C3U+U>N?N?"UU
M8_4E?&"+8TO:H9X ?($T6=5/GRI[<Q[-QG5VCV:[V%GKOO.@U\^D<S3&O(67
MKOP]7(M!G#%2;; O5EL9>0'KDIR''H63AD,O76S/" O]S+>1:?5!H(&7RFMR
MOH>JOJ[X[FS2E]5[;:JPQQYL&_9.B..=)W.%(O;-E.7P!X!(^LO,.F_N4EG=
MKZPMU^;K2J9V@ZYXM!5PWR$T*FYV(/@WUR-')PH83OHMO3TY4U^X.1%('U*:
MO?I8+NKVMS8Y,!-_1MW@$QD727U&!GY>?0X 0ZD.Q/']FV=/ZU_@^[[(Z[V"
M*1/CL$,^NY@LY<J7:G*;:=]O.]GZR.UV!0YNW9:+T6QT[&4X(4EY^]O2<-T;
M5P%Q.P]=HH:82;G5QP@D 'K)'&+=\VS@91+.*I:4@,>]28$4O% A[)@277<D
MW]WJ3C.*DVD1(.3UM!7H=.L8)9+^CPX)07^STK&KM%HGTE.:R4:?[B5ACKBX
M\' SV(WZ9'R#Z_E-_1_<A'82:O1IY?P5.%S'SMHW$=WG[;6;*;U')SN YYG/
M+)<5YL:8%2S:^5)L<IY\1:MQ5=L09.J=B-O?:O O^N@CR,N59XF36(Z;&7+_
M)'.]4D>),>$OV?,#+U8IBD%_T\LM0. HWEG3X_-+5#C=4"\'?]IEGF?BCB#F
MVCNT<V%&S5(;C,&W%7$S:0#+.N-!B3,XN?;JY,@%F3:;PAZ%E9\96M$\2N)"
MMV[)#IBN/0S5/IW'ZOIET/7TFAYW5:OIK[0<73>56@+SYE MZR.O[[")[R*:
MO@W[N)6R;@\VY9?TS2)&H EMT/O"^%KCZ-I"IPHWTE_I=D"5\%NI,.H@!!?/
MJ8%]E E$'9.E)VF@W02:RZ;<&X[5GX_2+L,I^EQARWFW/FA)S9#$]&)=@YJJ
M[J, 5\$5'SJ*%0AB\^[0#(K01'?:'DJS9>08!3/>-YD.#HB/%_D5F5^?,M3[
M+EJ[.$X/N9@:NA7I\(\)W<,P[H>%7X+I3^HML<5QC;Y6U,9_(LWL& ;M-*LI
M>F?3!'E'2 X&=E]=';%VWL\2G44*'Y#:'!&PQ&J?]3<.G;+7_J6/G,+;>VUB
M*@[$1QPLN+8*HONR<A63\ \<I\;LH+VBD#<RC',-IQ$?B!?&;/T.  @]Q,7<
MTI&NZR0L)'#K_X90A,[V7P*1=T ?;+>O*[IACTFH81STO5Y)<V'\-[K@).6<
M-(#>85@!2SO'2AT;CCX+K4P-&:2$-Q?<\-Q)OR':IJ4@!^Z'4X+^U(> $:GU
M5-". JF#R4&4I!C^!>/_S"2X*0XKN!W3!J\99^K2R*]!OX@!M49:WT7_8!&V
M5*95F'<RT"SI&RE#?;N2EQ"04I?]W0QI!CJ_4E>ZC#5JX&:4T>_""3UP),KB
M=^&$BWA13@AT3"+< )5PM7\FZB]82(GF%:<I,8#/O";S*=-PSBI;\UU0#H*!
MG1='UH5\^0-<6._>5G"$%%Z:DK5>E7;&I7=01\8"[PQ_"! S4PX0X5!1TWZP
MHCQ]>VK[=J+PTF51X\F\*LJ3+^IV[^-S/AM9[>QLC;=Q7#[)A$@6D4IRS630
M56U]8AR=72;F4(7=( @> >B@O8/FNT/ S8I:F2, 2 <ZJ;]-'_^QAW=K8*#
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M5R-@/W0QOK4.AI _[3SM;;ZKLE487P6C*/<1M0&- +]7>V&N8\2BUDEA]$%
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MIE: M".\D5=W(K?<)0:1=*<$'<K':L1H_B"'::&5DVI[9]M06J#0C:C(NPW
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MZP&\,&8@6.G&ZIK7<^+VPG:A>?@:PO[3KF:E'?=GQD:$ UXFY^G8ZAS^-IU
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M,MP'N"8-Z]35_X'KER]9%8IZ7MW4H'TR=*VRKC1I:W<$97PQW*%S\4=2$77
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M$$   0000  !!!!   $$$$   0000  !!!!   $$$.!_!\*KW?\'4$L#!!0
M   ( /-)6UB%]C?-8LD! &#Q 0 .    :6UA9V4P,# P,RYJ<&?LNV=44]'[
M+I@0FB"@TA&(@DI50() *$&1*AU"%T24JA3I00B(@M(1$$0ZA(0."E*4(BV
MT@,H54 ( >F$FG+C?]U[Y\/,AYE9:WXS:V9VUOZ0LW=VSEOV^SQ/S@[U)_4W
MX)R^MIXV  @$ A[07@#J-$ 3P,S(R,3(P,S$Q'3F##/+62ZVLZRL9_DO<')P
M"0F A84$! 4O7;DA=DE$6E104%Q10EI6#@*!@,64U91NJMZ0A]S\MPCPS)DS
M9UG/\K&Q\=V\+'CYYO_A1FT'G&>F5V#R!P%% '3G@:#S0&H7  P  !F _]4
M_[T!Z4#T#(Q,S&=86&D3ZL\!Z( @$!T]B(&!GIXV&D8;!]"?9[AP6>XV(Z>I
M$Y.(+]?-R)0"9M$[M=^XS4:VK\@_?/;B# L/+Q^_P-5K8N(2DA"%6XI*RE#-
MNUK:.KIZ^N86<$LK:QM;YT>/75S=W#W\_ ,"@X)#$%$O7T7'O'X3^S8U+?U=
M1N;[K,*B8E0)&E-:]O%37?WGAL:FYH[.KNX>;&]?_^@8;GQB\N>OJ87%I3_+
M*_A5PMK.[MX^\>#PZ/CDGUU   CX/]K_IEWG:7;1T=.#Z)G^V06D"_HWX3P]
MPV4YQ@NW39F<?#E%;D8R<]U)*:C]=D94WFR;^^&S$1:>*Y"%JSO_3/LOR_[W
M&?;B_Y1E_].P_\6N*<!9$) 6/-!Y  QP>")>&,'R_[1^Q_>>%N"2,BH_VT+&
M3Q 9/$R/LWPTU2475/'K*US0YK?I ZBM5")2(/\O#&B:)""A*D,P:@^LLQ)4
M?<!A>F).!2Q<5UJ Z4LSW==Z)MI=.<NT?(\*.!/C+;-?V!Y09W65]B8:BCTQ
M0W8\\*-4_[N(^Z^+KV&[0[M<13T@2@@ES9K]8^RR3MPP%<"@&OQ1G@1#\8#0
MA4T%BVEJKXQRKT8017<+?["M20FIWGY"!70Q&"B4FY,>QLE",&4@RWK8[K!Y
M-/H)<CF_\ =K'=P48P<^=I/H.)C93S9U88B5O-KTJED)'3)"!02; ??-5;M@
M71)!U9A\)E.])F.$+4"\,/;_[_^W]N1D:!; 5O)6%H1?FFD)_FC\:>&Z",4?
MB(CMSN@*3*$"!)#S<'UC/EL9'<?!""A"*D4=TB D!(-6*B8Z@:+ 9*)6Q$:<
M^)J'6.[5TU'@T63F&OC<"SJNZM^>;W'A(@.#8R<C#]3&ZR]:8V]6+WJ4'[WH
M5_^()A,=%1R##S8-%C+#%09GCS[3LC14C$S4 %NUQ>X3E?92*2>8I+C]'2K@
MNCGEI#JY>(>Q$/NFF+0&VZC4:QZD G( 89&T7,[-@O:V'8[+'DT;40&Y<51
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M5**)++ZF<#LB^A%C=W>';C#H&"[/HN+J1BI3 AZ6QP($5UXFL]T+V.=V<M*
MG1#/I,E4+QF>6A-2-7C..A\A.XK<DNS'[IY^P>7_"<IG9A8]>D-R;_\=0'9W
M5& W0K8/TW]Y4VX215XKYU>++$^.$2L1!QF-A/"O-#R- #QOJWQHV_KCD>M.
MI74UG,GI:*S&?NKU*U"*>=Q+(=TJA*$Y*![.'W#+N=/\(YO1]XV1_-_5>-V
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MD=F9Q'#B[;Z-O(Y7@B?F-14V-Q6/N6U=E-8\G-K7X2NB0A+6TJY&LR$*Z<]
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MFV:#IZMU &B#R;O,(%+*+?,NH!Q<U?)<:Q 7.'?, K#%G>DA+GP\KC7_0/6
MA8%"/S;<'D/77,D=>1<+!3V"3,R%($UNI,>YTP]*G#J]<%D<:6++?Z6@K/LY
MJ,%["[I>R?0IP$0>$M.39074#=;%T>SCI"W#._3PH65.WX)K)/\ZH72D[CMQ
M13P&=0D@K+'FW;B[:<*/'<1A>(\<5(H*J6XI\(8R!8+FL*!A<!7IGLYQB9)\
M@71'(]>&6297EZ&<%'<L1-$Q&ZKK1V&Q15Y@-<9]%%\C-UIHE0D6I##5R87+
MF8%<P&0LBC<8GKF%2:H4# :NW4#S?D2:/2@7%;OH<W"9;VLV,/74'=J_L5&;
MQXF@XQ$$()H-[K8(+SX.QK#>R5O@F\RIO7.ZD/SM*D;T*-7=2VQ*G/DB&KSA
MK:R.IMXK"L9 U,X&11(>7@)T8TLYZE<?P1.$Y#J"5O?R584#GQ^C^6+1Z^8R
M;)6;N@^=4\*72S6%-=T+A[>EHE=Y1+JOE[N;_^#$/5/*5EQ-66GZ[X8_V> 8
M96&"[L'3BLQ0ZM_&?5J/<OVRC7Z^B8C^A$+]?R[G($,._\N-^'^@R=TKUU3V
M*3O'=F0)%E$SE0O,G+GW^Q8"Y8#E<.>JK@CG[SO6=C;1*/F;^+-X>:*[? EU
MEGD7(0Y;YZ2KK>RM_6@>^@4]/(A0++B?]-44+>+/SU%+N=QS7-@S (ODNOBM
M30\OE^3L5UUD>;K"M6>RQ=U0,C'K_Q)'WI96<,Q\-(&(SCY6/R08+7T]S)N3
M%PZ&F9EAU<[P/-J0J (3'A*'OX,V'W?$;B%C.4BW<R(UJ/[EX+4T;*$@!? "
M'GM;<25>9Q$$V%781'8G5_]+_5V3KH?9UUP9NT!6*3[I%#]D2S',MU?",0'=
M7LGFD,ZQ .JJNOW\QS#QQ9"E$==XP"K+<^W@.(-VJ?2]6#.E\-GITA6-;9C
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MJ_P&5G4B+#2R%C$9]M6Z01R/!)?*!?U*-3M,B%1)YRJ>VQD.CXO_)1?K 9<
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M4Q*#VT$_7XO-_R%0>O;E*U+VD*B(I4,JL]0G6LO:GN67@*:VE'O</C[NA9>
MSZ\N 6]Q".=IAK/GEX"3WW"Y23'D;N6RML<KZ&XA&\4 9=P@<,,N]>^)R-5<
MV^]7JC-9Y?SW9,7J$N"+$'92WKT_> E(]2>B_S1O>5P"4OR7)H#SUH]&U4\U
MR-#M*YO?&<Z,HQIW;C)T- ]^1O[14/K[T'/:E<Z VF?VX!?)-'.)RW0,[I/Y
M<$U#D\"%YLP S+?B_R,^0&Y)Y_YXZI-!V>:\N&F6V?D-V[:IRCEV_ >X/P#*
MMW<<A8S6VW>^]I-]^ET*6+FISIAZ";C!#5G.W=1^J[&66^Z:>[,;:C^:1&*T
M/+^"6769NS_C+GZ<X5WLG4G T3ILI.,)<7UV-[IK#:$(Z";]\9X\NJ*BL&_P
MD+HF98E;_^)&S/R'8(BU@_=OC%SQIK:LP "4"&^2F?\0='6_Q+<R;&>\H0J?
M\?PJLW&/QYC:]$=&+P$=LG>4:4?2?*Z;'JARLMO4*U,3,=IEE9P'K2T<8 X\
M/$36"W3^F(LU5/[F*^'EZH1+P(?R4GUZD_"?)+.1LH>;P^2%%G$,?6HHVM)@
M"OE>V4*V]WCZ$9>M9KA@_KE>V.!@N^G@@ET!3563J<B4F?V6 H.:OMQ^#CZT
MZ16?P1P)-%U=LF5*-_4>#8J:1SJIQL0.(9LH-:V"*4T.+(\+I-O*092?:8),
M]6^!,1 P%J:"PQ^2<?1 U*,_K"NU?<!'K6-UH5LWJ&%4JA/<B.A\Q>O;1Y[G
M&A?KFR'_LH&/9.(CXV/=J&*U]LPG;&6N?,V )>UU[?5V#DLNZ]2_8?+41UTO
MGS"GG=?IC(2MP52C[R(R*R <H[5A:NS>9Z-PT7=[%BB=K_)Y8Q3%PREF[P<(
M8_;%58"WL^5>UCYO/-BIFBYD[\;3Z4=K03W^&/VVPHRVOV,OE:6D9#;*  @6
M]!P5_O[_EN:0NG)CEEP?%1/LNC4=4K?8Q\:%QFV*7MU"+^J*.!TU9*YLG5H4
MPC*KIMT'CDH.FH7=4,K[9W>]>JB^<JF]?-:D=!HJ$'%F3ML>I>RR6\1+E[83
M#2\Y!*9H6OV8U[?^4,U9N:XG+HP\B ZA;D0GWO2[$/;D=ZI?UJ-YO)BWD*QP
M"> M_\!\Y "AL:_10'Z7.2QV$(XZ7-TMIDT:/D03DX%=&7XL6C/,5!&L$-L0
M,Y[(H,7]DE^3< 9<GGL$20-@)=F->!=BQJ3%<4*.J?LO*.-#W^^)A)@7(\$,
M\UH33L .B'#^04XHR12E,Q62;.L<_M2[2^>XS1-7$YYS1L2H-FR[DL].A+2E
M"$Q0>Q',WEZXQ6N=,4N*790@$O7ERA2=:SALN84?-/"-HL3C-)N]9TKUE<MG
M,#<'A68]N-/SVLVS"U\>E9WH?-P6L9VYMT$ILR5U;L@F_;81,4'$:$2'3)8:
M>0Q#?$SSCJ7P-$'T*UJI7CMGN#(3_VGKH@V9=9WC!$4QLC?A/X3^NET)Q+1#
M%E0]Y"^RK^ ?O/H@%,E7C.J2&F1O6BMLG8T.-=MO1\=5Y!^C-.6__IL>-NB5
M8]'!;J8US9F&'RDYG>$HI'S.P)3:HA\V*&V##BGJ3).,2!L9(, Y&V)=^Q6"
M(^;<0.]BPGY+#O@CPT'HZT#ELM&W+$0/>MA4 &/V#D_]FI*-0G*]/*>M4&+<
M*LBYCH[H4B5[=SKB1(.-O,"<$BEB/3KQ^E_AWOUA/WM<>:?O@Y"==56.1*ON
M_)2!>:CK+?I;9E*!/$#_PY("_'V*E(6$V]!WQV69C=K4%(?%4S!:1'B-0(-+
MOQJQI.&OFFB9_N.;3)O:(4Z#&37D2V%(7!JMVCT21]6W_L4O+/F>MQ;Y#LLS
M+>^]]*#8+WRM4#N<WNQ<5O2)P4ZD.JIO*AY Q*B[<!R*'!91\V<8<N?&&32]
M0<X!4SR?,-I%"[^;3 9^#A4N?!>,-XL<_G*,N3W HRP$B9057Z'>Y@",/95F
MT"!BU I5M=3.S*Y7%H"UUBV<OB.V0Y+)>'".?YE)S._U/G"'%^O\N01$Y7Y?
M3$'11'6(SX68BKT+3@9V%/GS72$%J]Z_53A5.HZWKXB\64T^3_ T5652>.-Z
MONAKDC:3E;L2R_HO(A%A".&XH68@#OWKTVHH=%[OIK.E!8KEKJW66EW.T'\7
MPT8@Z"S?+H81Y6&"IX';"HSMEN6*O7<Z,TF&G#&3#6I(Y^H.1N9CU6Q_&4MG
MM' -"\X9O6X<C+C!64)$EU7E=.Z7&?E<'!@<I#=Y:W2L1'22D5B(F++/5=SM
M(2Q4*R>%U/C!COGC.T@U@O%%J!^ Q )Z[I)$,/LIK.A]:DAEXG9&8C3,!N7.
M5WR07JQ"O5)))E>H*3CA3;_XS&!$L(#6PAGZ4F'<&#K &ZRNO6[LNM/P8<67
M1)D35:)0?$ST'4[LL<. ;J+/+B04V%&O6P$WP=-W'J)HI1R*25;(OAQ0 ER+
M8$YP\"OUJB*MKNO1VYPSIGD!UXT>AF-)5J24*?XP1%3A093*&BCT(%U9&7L*
MT:T@<2:=1^Q7/@F\!*RG$3'-_Y':B244OR\!\YPA<S2?)1B:<KJ;/[X 3@%3
M+-RJB:#05=ZA-,8$$8-9?;-N PA-[1CU5V1?^G'Q !07$_VKD3(Y!+M;.C3^
M:+I-M\\F%4+"U+'\S(G*[OC5ZM/P;[W4;8BQ+1(AS)NC;KZ8WM:3-^^D0%0N
M+A(NR^$ZK$CA/_J!_AFM!5-S]KH=X(6%84C<7EMV[Q.":"IY@-/ %*D<N \[
MM69)?/Q&X(/FQM2+7%Q-D;TG+@'V)O=/;.Y/-Y4?&_J>NFEK4J=F"LPN&=><
M+P$N##N&H*%_=;/?G>QM!_DH1M/Z2@O1)!ZA2\ ?(>11>-G+@4L )J[A*DJ;
ML-N<"_J]O1 D]0)GNZPHL7#I/YNJMA'G((F]D!3A/Z&*+KMH"NZ55,0W!,TU
MK6/?_+^;QIZKA?>2)N( :@"N-EU[/K!0CAMUO.#!9 /U;C'J]LVW>XE/CDT.
MB<(2M7#CF/='5TQ+;CQ>IOFP@/7QR6])V_KZ90,V 6)T O,?.;W%W:*[Y) 8
M@DDK'A\UC[:D^*L%##".N8V(Q07.ZJH,7D1*304,3YX?"8P'6Z/.G_@O)$SE
M[M XOO&LGCN"I$@D=&[7F/(NMR#G#=C$M,5U60U#]HJ3$^)MHV.V-%.W[&)4
M*W26%4B\,(U00FY_Z44![NXWKAJ-CN59?J<D_7WAXDG.*[ 3F "VD#=Z]G#C
M<[2/,%<*)ZD*98"G_(_;D@N NHHR$;\]K>7^]<,J8KO_@X#SGDG_%!2MCMQQ
M#KT_\*6X(ABB6]KF>>4&V]Y7OT&]Z&?8<]HMR?WS$5.,*')3;RM>UYV3_QZQ
MO;I?Q"YP]:]U^1TGLAY08$C)E#UFA> W,#-_YB*'(./7^E*VZ<_!O_7X;7U^
MF[4S-\C/ ?L2,L4^6ES15=(SLWLY<QD!6%QHX_.J8R):;4 OQ,Q>?LUM PN\
M@)F3V_?%MT1*)ZR$3?G-%B\_J;FRE2]3_TT>%@=67H4TY>(J(CI']SS$M#N9
MX+);,)V#IWJ7Q\*=PHN)[]R_&K-D,7H YC38QL0#%EZ8RHO/+7Q>*<M#,<;\
MT_;SEM3P(4;ZJ1#$!]B1B&<T3 L69'062;!!$4OM^BU[V?GV6/K?.<!-?G[E
M64,()W*_=_+V2.L%IOB89Z1\#3NH7+83)114!T^M8'06GC1<0'%)UX)I9)M-
MH:W"922A;\A\BX%7"Y/]N0]5:H<6=)8@,HRZ7;8G5F]=[D!$.# STDXG.K*+
MHQ.Y:9VB[G"<1@)MVZJ6X,!C9%?\[U[9+]0?9?"YW0UW1L%M 8;[=TCKL@]O
MYN2R?H\;DWT#MJ;>L8-<% IS4LDJ6__L_.9F*3Y@9W-JDT^3[6RQ;F?O5J:G
M?:;OX\>1'!>?%T._ZI0U9"KF45\RL%_:OF1\I_;_D@"Q=VD.\_J"*K._F[^8
MT%;KU@<#:L2+/6_U)IB;#427?UG;/./HQ&]M?WC5W*:XX/M$7SW[RR5 1C/4
M[\3^5OG<P*^L((X^1/2WM1 B(K%2&/_WB/.A_YA X*NW98%P$,5:@(K0A':G
M:&YB>:8G</P7U7.U4XXS_1>M'RY6B1M3\!8B9'\(.Q('"'9GB &=(9:_AM3Y
MB;WI-DBJ7+:_K['0/(Y8+GM/HK3^W INO4:'0\R:AA+*)5XMG7^E,([26O.V
M5W9#W!)O-?QU"<CV([C$\R?0_20]" 5K X3<DVOW='NHH)O6U>[?MA4@Y0!W
M(S.GMBB[6 B3.06:O>=?0^H$MS?_NJ$48J>/T/>;XL4+S/57ZFD=]JD75=DS
MBOX^O&5!4<[?]I"O(M]D#R1\=Y6JX95%5^)R56/I(+TS@3T]WJG,K;Q'X,U"
MK031D#-+X+#,K2Y?XG%>1U6S&506Y*P\ZO04E+7%F^C!R5W;/G.;ATOC\;X0
M2;C';?SH9;"0>C4G>?"!GKF$#'UW>L-JN2F5W1S)E[?F!,/^(G##S8]AQ_29
MVF8T+49I)?$A/R#^Z&YN(6BJ\@S4*:^2F\UV)SXD>7#)GSDR^:2@YZ^P!VWV
M"[ZJ0AF7.G-JXDIV&S.9B,Z6WH$E?7*."Q<EJ&%'CZIE6$*CY/<D=ZDQ:TPC
M<X?35C3 X^("'<>M902="#(.? F%WV&>>3# 0H$57*-[6> R&.(K^1$20X[2
M4OIFKTNNC7@WILU7?\B\R,F-IUTU%SAA$?@<-%I3$/Q!UER[]SS_**_=R#/9
M5'.M4C?#,K?%0G+(F?RB[N#),1;F&LI]Q&M3[$T8QE^[7>,+"WAT06<9/2$-
M'^G92O#IHJ-C=Q:BUAN^GNQ7/G3[L$M>_?IY1TKH*B+P8EAKX&)BS?K.]84\
M29L3'B/4+W!LH B4XB)K]$<\_4^3M\E7X\"^O 2\QNO]4F*T\:0Y-U- ":"H
M8LC47L!JF&X'@F9KOL&?E6O .I,T0G,$*.I<?_ <LFCP\.7 .G:EQO:*'=FL
M-; \9C<_-L@S'SO5HX%QSE/ZL43L05Z[!J@83&DNS31NK%R0TU9.<PG0I1(<
M<(S^+/WGBR73P+H%+\57'+GV33^JBBZ1+_W:)?FSXQQISPG#-U.=OK]],YO]
MY/B8:Q.T;1?^Y9,F>:CL75/',18[?7WM-1E+W!6%6L)33IU<N-[,J"Q!;D>'
MU?%"WID'#GCKC\-7CU W%TU7B]?-Y_$?L;)Q$:3 4LFPJ0S F@,>#)MKN1_
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M+P$Y;J@J4 %].*97Z+#T1>A6;C<J$8LBKMUDSNX]9#'6\G2RR$XX 6:;)[G
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MN'PD:7GUOCR4/?I+9%Y.5PI/4"ED0MVF!DRG;/1+. "<K%FN19H=K':LYJ\
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M+0+V%FOXOLQFX*.]W'3][VYX+\: AA?>+4Y [MQ< !J9X ,AP+LP?X"74ZL
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MK9"5R0^ ,AD"'Y(* YPY<&%@I:I/'S;, G6#I-C2_!@(@Y0S&B@9^Q&1J7-
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MMA0>2C9SE5:D%G2Z.+3J[+4)#^U_@M^%)8-!TVC.KX*VYERBLU/@9/5GB>!
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M$%AZH+/GWT1S3+57ZK(Q/]GQ$3$;X:(U[W[F=%8WM1"J&#OV+< X]UL^V'H
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MU2^7GLXZ_C\-_-F[$ZP"1R>'YURJ<:R4LLP4*PTI23V-2Z4@B\& ;1FIK<"
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M#!.6?*)!K[3DF9/&<@VIVJ"QS/E&+SSG4$HKE1;MFB^Y+Q2$^36Z:/PQP24
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MO+AUMZJLV[#8#N)D/\G376/_3!.L24$LB(J\&V.[JF3HP;LM^G)M.%]&]\3
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M >@P8RA]<PYNL9'F\=@O!A9/*,NX$<$5J<*5NA'S$?)&^[$O"V#@1OJT:VL
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MJMZ8PPS#@?ZZ0P<)J$$F0%K]?M9_E:$?DU1O<[%)LOTIN;%-GDG4S"B0;_:
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M"B7K>4^ZXPP=S?!^@C0JCOBH _($KNLSHYN(@,1]>)9,GX9C/SP'PZ3)GTG
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M9L$83RX 1L)+YJ@4EB7['3Z_LUF2) _Q3@B#RKFM$8-19D,\B?7IS QU(EH
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M9N]F':13[YROF4I92=B'N[[UM9G..LZ_^JC_=UI?/!M7F(YO.K:^5[@NOA(
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M/W-#.8D"G#>3S&:&-[@0%.(8OV?9+8>]S*P?;)?.VB#0#)<,J";56J=T//K
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M*,45R(]!W.=;,1]AL;_M:1_>"O?[NC]$O#;,QDB]J704-SM38)(PK%<!+@9
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M9^P$ZMJVAG)C^FCB+R&3!L5?.[HE4G HQ?%**'F187(-!UI]LI[BS8)X@#*
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M=>/X]V]OIU43\:U)GRE"?/.&J-./0TB0 />LZE\M]O)7<IVQ.,, 58O2_9Q
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M7M536GBG#CX,.2B2];V&S;][!-ZA$%/*;VSD'([$5T)2J1<H94.$Z-ONC5X
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MN1YWJ?0_,:!33 E.Z\0?F0,2,TSSD)(V6>0B!)A!WQ4ZG2A(H3!)3U6)!X2
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ML/ Q$(=F#R X^8?D+BT)-3B#EPJ4S)9@[2>MO' [P?/C7C_R9E/8AT8$\^'
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MEAEKMNXRI^/B-RQ[2:I<<?EHK_=-_8F13?*9AVLMLG#O^1VK']MO'N=TTK[
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M\%>BG^B3F%C+?2LF?94YS !:BLM85NKDF2W32>/5FH5[QI?\]F:\.C\T24J
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MEI.?',ZFAQ;/WGR>WVBR(/64ZKS=8BM8W[ZBI\":W(9H+IF*">8TBP/\]]!
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MTNRZ%UDBCQ#YLNI=#PJU:M_G"]@5WA&1Q$JN5T(CP_'RYVYP9M?-VM8,,E'
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MCG>I:PM>G3"@'01)/SSK].",G&%<8 >)TZ-Z+\ XG>, 0%G/ZB<)D4,SL@^
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M=R#58KNELD-U92M]RC 7YH7Z,>@FBY.*5++ (X<:N%;ESN-D*6B5RVKOZ3[
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M-BWC69&2$L89N0/'HQE#2;US#J'SF\YQOQP.G'O-AI3 *N!0[QP&D(I7>;.
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MR,=S63[5BSWT-Y,["IS7$]Q @VK5_!')$]>A[)\G2RI]EDA>1L\.WU50CUF
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MS,GTASM@X#\^J&9N^35]>MV_UY!RV4;_[M90C6FZ:;+)FIE#08>ZDK(7IWS
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M<W7;+$1=?&'X7U0M_3_[GVM '1X$%M[VTJ_^ 2(!_QTF\?O3_P)02P,$%
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M@+M$@*,&X''@$'#@GGL $ # (<']JP#_I<#!(R B(:.@HJ&_>GFA]C4 #X>
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M:#3<2J?X1@Y_T0EH>=;HSOY1[5^:_<\IYO?_2;/_JMA_TVL>P$" >YD\!!P
M#-S<,V;YH/__1DJ>C+4KQKZ27'Q.$7]S2:X9F4$^#->8*>Z:5GH6I-:0VE[-
M9E13BQG@1NA1/R/D#5]%V$_!-;GHE:CX4^,4/@N ;&D^:"0_$,_>8X6>/H!
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MU2=MZ0BW.</&NN]',59N+HB=,*J4\G6FX.XFAJ&#1['V5IW3D5J1@'5.-\3
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M!4A1_^-MW^[\K</7-T)=N'9'D\^ S%V[5C*5/0TAVSZ\;WJ/6A335].<8=J
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M\>2(\]G";VQ*Y^;6.Q?9$1\#QG;LR:N?S$47XJC?2:^B#]3T!E_0L&U'<"Z
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MUS<1TU\KX^E5<E<M>]U[0<^LVQ(_.N@@Z#X^Z8[+%WC56T'H-R]&,?:GL;M
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MD+"]U+ 'ZI!^''H#"J]V@V)?[SQ]691]'+TLQQ![R'T&OJF$)8I<CELT9O,
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M&+SK$VIY8K=ZHR?J)-_>?5G:\*!4+//3!Y0[=.#J_C\F_8UO\Z;W;[I)OA-
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MF81:HNXTDA+*<I;J3J"Z8R>2MW1 +Z'U095HO2XW5P4'/:0!2 7JQK+;CC2
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MLW&;A0G?K1%"1F&$^0U 72B-]*CO;=91CM\P4H0:K0/ZR8ZZXO"LZ7L%5AX
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MS[!V>MQXW9)]]U JSWJK;MYB@[6+5> <[DLR@9<-:#@!I\Y$$OI7;D^]2Q<
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MU>S%+2?=_-\=,!5I^JQ'%R.;<(_!,"TXE7/&XP8[V8K:.6QGMP+GWB!"+]U
M 3*;%OF2LJ$L&!?V3."9T_&62K4L[+E<D: LE%NQ&ZIOX)'Q9917VME)M,_W
MX:>KW.;1U3UJF2+&OJ/N:Z9GU,3"MIMPR1>J\9_2TK&<OXXU4-FK?2^029[3
MD6\E&A:RK0\EV!>Y*8;<%ST(^M,UWCS0B!<C&X/%"JB;]FMM1SS=W<M (A.A
M#Y18S]L/X 5\BV3H(P?KQS?>[5X+FU4)052;,0RD25ANGBFWK-JLOA,OYR0\
M9']7-6_QWE_!)ECHM6_HBZE92^7<J3LEKEO":_E&)1T#PJ!8D]BNJ#-F#0.%
M(J]8VPGJ'G_5+NH-HK 9(?>*-U";[N]VY"SZ*-O:#='5JG5WG'""KZ@'# H=
MY,\1:$[.MI=1\2<H)KF1[(F_0O)C6'_ZS-=%UTXX[RE_M(I=]KQE8M9WKC%X
M)#"R<26;9WC[4?N/B4:;_282(MHN/-*4P@89Y-3,M/)6FE3'(T2W\O?'T1GR
MW7C;$_%5?9WR6P479\_-:IAEA_S,DN14AQ[9K52V*ST&+]@;UPMS*"^?>_1T
M^J+;C)^9IF*IM:+IXMT! +EQT$T19OPM"BDEFL3,XDK)Y'[$6MIR<,NIM3^"
MW$)PFCWYT GQ4 O3Y"S(7+H#CE<49YV#G%B44DH[-7Z4R)D)'XX,R4>T_PEQ
M6[HSG_"DI=(7-_FH^*V=H&'P\&:,5NI G.%E_G-:V0;!!GD8]ZC+B_FMFO_Z
MD>Q_'5"A<1T08+RP,LJY*@DR0F&:4>,0T63 2[89_SE!\LNX8X)IZM=_:BV(
M$9=1%CJ%SL86R,-FS_^VFS?*^H5--4\YJ;ZF]M6#8_!F:N0W0'O@[-(%7SF#
M[Y5?704GHKU\*GNSN-;3CS)L[UYX\ '381IPN"CFU@KP=L9"QP\H<'TR!-;V
MS*/&:56>?33E*U;NP:'HE*)313J6K^^P.^J? #P"HUZ$7I\<O0JKNF1J?F7S
M1WVSPL:2&_?;//*DL=XOZ:_HWP AVMBNX"<&+]_]Y+G*B[FF<V]_2759E","
ME][<DCRG/,5_HG.2U/3Y7+>Y@YS[)W$/PW=UN2' +#O:Z9$Z?N5/,,\>..#O
MEV#_ -"-(N6UI /:&!!>E$PPW^4 E-W$^5O0K&O92$S2C(C$K+R=W>ODN=1(
M]<489R'8,?8Q&GR)EU,6)CS,2U..%K=XC=[@)E=+T[>(P[%[X(SN+DADHIF3
M THMS+:"]>'-1?* Q"_6#D=IHRBY.C3V2E4*+&<O"V*Q-/-@0]$)FW?DZ5G!
M;O=@#&DV(:^LV_I$Q+:CZ-@(<[\_SRM/(8[YT5F&$L0*>XS$)]XY3QH_Y"="
M=KA?Y<!9OC@+/2?8C<E?K=A#KP>09B >QT[^2JOZG,&X$F$R<WVMQ.L6;W"Y
M!*RDN,9+$UP:FEC=:+419>N;S)1:=7.R/#N@UX32\HE7CP/CD/Q:SN+(]Y2@
M/-/R*697H\82I4U,G=LZ<U@,"9G.Z",WY1Z$#L&@GH&U!0B[88T[6A"&W;BR
M^J(P\^#C3L8FKEJ@@HKWY$JPYOVZH5W>BL0'#2A3Z0 WQ-';[]TI]A$O*UB>
MVH3&$47H\S B-7L;<PC48!>T+.WZX#&7;Z;X=I*^)Y<I%,&"I;@UG)Z./.UK
M"ZK4<TL,PB0[OYPB-AJMQ]8Q@F^_FC(%ESX#>STS(WZO'\"4FFF*'HRB5/!T
M#2&<^GD=O43:\34&G9Q+U>WJ'H%!4ZHW2SP*GS[7#Q3W/KXMP3"/<2PF-9SX
M:&WDC[E'E]Q:>\ *?7+JYE[MO?NOJRG^,3-*WP1^Z6%KB@5_J?C&_&R!GKK$
M'6FP^_D9V1 ?W7O^* :610EG'G[ GLQ&/Z^&%.F>C?F2S6O+#===BE6M-HFU
MJH4J2QGJ#]X]PNS81OI4[FOVTC&S-O939W2M)HC8F663*8&HE!Q^CPO>G';4
M/1.R&[%CTU'B+-5L /F1?^.^:*:+A5>TEZD2-/5)74GEVAW0H-7X&1.K[J/[
M;D/CO$=9[=D+4J@X2%R-IP+YE8I-1CJB\^S%5R\U2DKG;7BJLC##GKJ AF>7
MO8[K$S]M1;;NUZC!]GDUHF%9AM>,#;P/'=)[Y(A5N;;D:O"72U>(??*9M-)+
MG$!$WS.5):VF:>XUMA1?_+WQ3B 3C)OYZ<G$9FK_J2F0__)AMG\C5%PONH?S
MM/MCII&@E;X36_S8@M-ISE0<&P2<&'OA33"I_\'H_'"F\E3L%>PL&JE0_^$L
M]9?D5W?F"WGLGZV' PH0/?.W_=-Y>9M7GAX/>=D%IY1_,*>C*)9D$AGPL>QY
M>N[G>Z<XG5V_ <"O?D69NW<K*4(WL>!;]<^>-025#+U"'M;;4@(72T7)_6 *
MA.N''%A"O/OVMGBZ^.?4#^8DPN&&[#VUPT6 Q,^E@2\%*@DUNXU=S3D_=+#?
MCT=PWPK842P62R+.?FD\U_J2YG'1A0B8."&EQ*H(99\Q#-JO#!NM*$QB5#YC
M.]YK^(DZDZ/<S;3D<UNLH ;5EGNSO9S4[[QHNB;KP;D[ #GPHNYB\EBV[)T7
M=;\! 7?>S?MF'/Z"LGME<_,^U%-"<U/]JOC1?<+A_C/5R/2_49;[8YNV$@[?
M3RG2:Y_DS,YTU^\R[@KY<B5>F\R]-777.< ^;Y^YZ5Z3<I3&H__@#C'R^C=<
M4HH@S59EGXK3;, JY]P5O;1?ERA;1QTU%8</;7N, DS<)8KL;M1.D3,JS8LN
M'#FIN5NK)1>\] US^<XB6X1WL?35=U>9LT#@+ATGO>G!<],^$GG1[2BFKFA
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M*L[XSG[3;.@:6Y!S!KF*>_;D?_/LPIZ;58]@_;6LX<Q_-K%L$N0C?N">#"+
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MV8/WNZ.:Q\DOFQ2*X4!?:[GZ V;0OQIM"I#OU*"U@92B:!*7":E@\3_.,/
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MO9$>HL@X >".DU,71*RXR94!1-NIN_C4NEYZU>6?(>#,J&:FG:MUTFQ2.NC
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MX_U?= '"3:%490SYWUYF^J^(&B9+D)-->/Q]V$95[,HHVP#+/=&Z\:X+!Y6
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M5[2<6Q^AREPI'<:NN2I?1-8&C\":'=K;4PB':_,O82=H+JWY[&OGN*1M'K1
M&AAAOICQ9B_3_R1>$?Y^KF1HYR)74 :2I 1E ]CA0Y7L,&FW$G57'<L)$FE(
MPYSYS*3N$B*WN0F?T)!T_Q?+GL <MS>\;?!,9J0M.;-F]>4\2/*$R\"$=6UU
MWN,:V.<1D(ZA)TBI' TS62+\Y7?.'2I-W@7_P3+31W(1L'Q7@L=Y,6RU:4[L
MP"G!!L.ZE]YY^ \B9;8_*T3Y,+R"6Y>OHWX)LW[U7XLA=>=8<:PJB3P3Z6J#
M3O%_#N5U(#7_<]L".<IRLO<UJQF_A2DW&2;-L+M'BB2-"FXT5&(G4 #*H\V9
M,$>S_>8ZHW>!@#;_[DGK_X(T*/W@1^]2[X^;N09[A[)9>V)C Y5SO[/[??>"
M7Y=]C3+\'#';2OD3-\]<P:;XVB?-,79_/:HVU 2H;%SX&U3(?#2=$E2L*WDC
MW9[0C5@B&PCRZX\=7V[^XV/RF%@?[[H5QS9RN8*D/-Y#:\4>=;AKO'?@ULK
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MT)V%Z83N\I>:NPGRBU78C;EI\*"#(QQ[^/L-6W@ *6JW$Y3Q4G.O,S];[-K
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M4=W\33VFIH55ACK*T:H* IP2KR\-%+F.<CSI3 S^"?<_"$!1'MZK:>[,6X$
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MO:EK,8!+/67;]Q7MX/DN,*".!:PD^):^^,A4OCZ[S(@[!<VWM+LE&Z$CR<F
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MG@68K9;;=XLWNBT-3U>L!&9HF>#7^"G^/'H8-CN_6Y""TLR>IWO=I_-//6M
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MUD"O72-4,"VHN+3OR+U9E>"V)M79X\%M+?,W\\5>]8M^0V8;<W[6L8XG;?K
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MHKW*!L@ZQ U]GV&DD <*! EJM7-3E04A/90Y$YR&R8:ICR607$G1:J_@ LT
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M$0%SM+S(0_,/$%4VKQ%FW3P:,I.M;L)?%%$N-Y:Z7\[>(B=(825DVKZ(K$C
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MO/ ,^E8MSU<?_,8U]1D#$,;P1Y:_;6VNEXYYZW[J([0G+QK$/*!%4'GLX;I
M<W!T5E+R UQ#[FRH2INH5&ZE.P+W.S_6\:O/FL6T^)+P#!&B6Q68QR1Y.XZB
MVD NQUR$M>SE^! ]R&OP^0GV;&26)!4Z]*R%U^.*2ZCJ,7G=X+<E"^4!MW%1
M#:(-"!7Q"JA]":=<VD\"[W@P=-U_B#+]FY[@5_C(9H4O5?%;!0<4*@@\0RN!
M_+D86?X\:"'CFE5W&K7J2F*)A7NZ\)I%W[(\^PW6P 67_'LA-LM4-:&5X"12
MU)NT2S,)17JHAI?;323[IFST[4Z*O)&#Q<OWC:1SKP+,V5+5>?QOOV&<?H/
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MBL"U9C?@05TF7#KE7-^H115+5<TR6?:M($)<.)5I62(M;$L&*P\A9Z?4!_W
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M!CGIM1@IJ<NP:V0H!P>$3EGDFND?NQCY1VI8 I3S!O=,*%=;WUG7\.W(<9.
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MXS3DUR/5Q^JI1C&V5O'HH=.A2_NE;6-(]>A/X!#*C>0#1(:U^)W!G3Y(;W4
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M6I1$QJ*ODD&-XR%Q$LWZ2Q4HD0%,\EV-BSI4HI&\*/F=?(:(L-,6#]E5L(I
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M>HHJ?M=PAKWCZ2^=0E^?N [179KEUEQHG)UCFV252G\- @2]\SQ]3Z?T5RS
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M$+UXG-8%QI)8%D3AX/\-_A>8+[H5JB#_5G?='59!_]:M '&P%YH/3E7?,)P
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M/ K">.]4MX0"!+ZE#[X*H8,]=_H&]A>QI19XIHVP?/8PVI';'?^%9CJ7 =,
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MY)JZ)81V>GQ*B=?7\B.S^<P$!H/I*B@321*/-JA1#@:C!;J?RA_5(FE&)*N
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M; 5L0WF7 <<V\R: #H"_OT4UXA A215-V'TTM<[]9>4%Z!K]^]L()E)_]L?
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ME,-]R4BN(/N2D<+2 RF;S4EB84O2\=+XY7+XV-)X::3ED:+9#:8K3S66J\M
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MTS]B/_$R'2?[;F<#+MB-HI YLJ@Z)YM.L)I@/#)XT'[C@8YIYO4A'>Q'!=W
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MFNJG4Y2V9#OLS?JD71AH2D0JZF##'8S3*1 ] +A\L'TB>3] $L',&2.AU]Z
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M^(@.F<37^Q8&B7_@$QCC?['5%6,"J2M\ZA5!HZ)5H]:9FDN#!(AL\UBZV[1
M@F.^GGH@.6V1%%&&J8!JN0ZM,S7W%KEAP;-L[E^BKP[PG7(8F,2:7@!,%Y*:
MJ2#7IW6FY/21V,CFC]AWVO4WUT$83FP(=^L )B]L&/L3O1)."J!FVRDY^.UU
M./8SFDA3]#7&+VBW2;B>[%5IFE@A><I,WXI:-(HS]*B@[ 9$!?L2UEVEK,.L
M!"%^AT/%+U 59]@Q90*A[=Y-E;"7[.-.M F<54?%$-#[NT6[%F2?!$*5<<J;
M[B?+GCMX[)O-FFH;.">-1KN9B*Z6I =GZ%*IVOUC,VMQ":WRA:S%-<Y$18%9
MI^5  6R6?8H$D#!-Z2KD(R6'JH,V+(2@($%U=;:!*=";K1BC0R)+;FU"2O,>
MH]5R@I6S8<N06FC7S=H^1$%32*4KXH=$)D5O;]C&V8Y&OG+?P/VULV4ZI"VX
M9DSH<2"%8LV/:@XT!/.#6?L+"6"=A)JQXBB).#1M&!]KGC^?#(TUW_2*3;&R
MF$@=#2IYSU9D6S%KV4GP0=XH<[QCKL9T8V+X]V[HES?BF!@@OK.Y(6_+,3&D
MO-QVR3;UF!@[7FH;;&D0,C%,O 3]@@8E$R/"JYK%=0N3B6'@)<94V#YE8BAX
M97.W;M;BQ83O_)'$5X#CWCX^N*N9C]\<I9*F[WRS_QW 21Q&B'*(\S.G1P^:
MCG8O+^-3/?(/=,;A1$I^#"H KP4>OPNV(/L00^'3Z1K"BUT%8WBQ6X#' .+)
M=9?: B7>3#=N7<UC<HZ37Y%T<3\A;8_A1$HMKP=MRI]RWU3O7&9Y)6]:5JGZ
M-@6<?=GCS?Y@S:X)X/8_:D3R_8Z!Y/N=[.N11B,XC6'PR/8J+1=I]:A$%-,X
M=.U;>^4BV9\)K%;.TN&&>XT/M3':*-#L9<*K%[0DG92:<6_-158N8DFZ)-'C
MF" Y_$< /8?W5NJ@H)HW'=HVJG[>,65'%3NH35K$&IUU)",R7]>+BQ4T^Y22
M$WHP'D:*V5)7C[,D!^,\D[B "?0Q9 VS],-<M%7B*K+*("A)9!W#%-F2I! $
M)<,TTPT((@E8ANF4&U!%E,L,TP4W&:RJ4&>8\E>2(*JHJ%VG*V:+5G8V&6JH
M5B;EE:74O@.C--?YC72'PTR9ANU84T0E1#PJI+[$I<O?7+M/P!F'(8@$0V V
M:U*[6O F\%<QA#CT3H*$0=-AT5ZC/TJQ5R;BHWS#6A1)ZA276M JTP>T0:M6
M<:D/"4]QJ2+RC!B2RRD#R>54BT*P.]U23]$U&Y\,E#.?L"^;%1=2-<&MM^MA
MQW]LQA(9#=;9L6FPR/0Q#IUCTOO4B*L<6H.@)#GT#+NS-20E.34-? JB= &9
M$INS^17T[.1W<O([Z88C$R2O 1R#&4_&A1O^O-A= '_UL+7A3T[H1%Y5 VC)
MX7##R/&JZE<OV!X(L\ES ^AI!9CE!S4"^H+Y59<J0Z]1+ZC%ZP,_;9RO*YTS
M+Z'4\K)H*?X@Q=G%]@8Y**:X\PNQSB^4>L+DK4[$.I]H]()1-TGZ\8(AG"Y+
MU)W\F937LD:][X88BOQ&N*_5 PGYS#T$Q3V0.#6',!J&+(Q; /$?[ T8R1!2
MJF:-/O:AC#NYD1V1&YF$U&^</DX&NRC5M?N!6;HM&>"4Q46Y49B7M47#\!H=
M0J1S]U'B/<>\.$]TJ'626'<BLU8R%VV5.,I5:S@T7=3<W@S2P3<E:E)S>C-,
M&]]^7;W>+53P<FI>)"=1X(+D5B^R9NU(HJ II/(ONT<E-K4<W:$[MO+NTGU;
M&A?3N^7B^V2YF-U\'4^6LS]FR]GT[@;GJ,>!5)H\9F<\!83Q*H)H%\SBL[B
MZ90J4DU=OO6DESCIQG<6P+,CX.P[9*8)%*NMW<1RZ]F^0%ZS<K'>,'*U:]6"
MBC+Z+9^#_P=@@/ZW1.70&D?H;=_],UFMN$>VLEZP^M$P565RH!\!_+D.T%ZW
MW_!H;"04561T&6^Q]PJ2T+:/7K # ,<5<?UD>-(H4E'B6I9$:DY#JM'SU,LW
MI3TM'3/M-F,:L--UZTY4]\V&/T&4[J1CYPD@N3E$W_ADL"MJ3U-W!SPO!5,
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M,ER %7"?\-3@>B/0J@QJ' R)--4Z!)N2Z(BM]J>V,;^T4X#.43=J$'Z-56\
MXW <T4"5O$[3%NA1$JW::*!J.Y>,!CI2\^"\83A06;\G3N^78KU?YKWKR,$S
MN&BD*H(N?NI#%<6\/=#LOC2I?7 J*3JE@IPY14,T6475/!HBXYIAKK;JM0=$
M5+":2U<7\P(>"N(6W=3+MYPC6;]5S!1".5>AHUJ_[<9U4*N6>N<R+Y >'6J=
M)-;]S*Q5R45+,/;4KWW#H:ETFS3,F-.&JM(MU3!'KS94E6Z_VKUV&T=<E=PO
M#+<L*KF)'ERH>[<QSK[>S*YFD_'-<CR9S+_?+&<W7V_GU[/);'J7V1@_: X4
M8+OP#]N+<X=5W[EV[7O72\(S? -V&"/Y:.ZCBTT,LR!'-X$/\Z\7=NB*1110
MV8]V2Z8*]#SCI[(^]#_KSY%?[!+L0F$*:'7Z0Y\_V*EQ.F'M=S^X#P%,+O<S
M_S&.T,]HNT'CDT;:*9'!?]3;49?:>?<M\,$NC<MR%?L._W4XN8)VW-_OEC!A
M^@ZMHJ_!$X ^UC%RX3/KJ4E7_TIG;D_OUO>[4/'Q[RZ 2%9YV%WC2%+BVQBC
M ?WQ!W(LV0 E\>?K ,6'6Z2=_JA,IEB8L'O$7<.,6D90<-Z(@G.5R0.-GVF]
M[Q8EE%<0_"<&_FHGOE70:NN/<4%B>P&IT: =U#:#I+ XGL07%Z.Z&42I':?>
MEU1^V]E)7A_J]:R1;@^F @[[RB8F&U4)$A_<KOJ69B?% V5J0S^(Z4)VO=!I
M(-4.9#]K/+TJ%-1=NB'V^T!4L?QV:76L,]VZG])HR-' KFB=C3I2L+*C)RG6
MPU$TL2J568-S(U+*' [_">HU8UV.F*"%YIE*39I9ED<=!)-93%79G1@DIA3L
MT3.(&PS&H!5W%-XG>K=NMDK17(\S<1(X+!!4.QJ^$XE2P6$&45_YZDC?*SJ/
M8U_5L !..Z>4AM4\!T!9 L0G#4$;>SP[!@F\Q'HA*&W-=>;M?NA/NX2@ZKA'
MCS_Q_8$"G4-RERIBP_>53DFOLIVLR#Z*O<>P:66XCZHF92I3&?ZZ6</7L7.D
M/2-\?G]3D6R]H#\+O!T6*RK+M[:[9OCIRC:A* D[OT=F%G;!ZGUZQ*HT:Y^,
MH2K/[=Z,VJ=A[-NF34M@3]M%: -+K: HF?WDP?8WB!D%&^=K:8PR;5A:@TXT
M.'-(DK;X(3 82[(LW8UNPD=A*"8#[^T:_'IOP2*7X..] Y^NP-WLW:P#=)@4
M2Q['?5]?QY-_?I_=S9:S^<W\:GR]G"Z^]I(M@A IF76=%:G68PX) JSP8E?Z
M)IY<0JPI(Q(.G+).G+).''W6B1S7)-C>NWX::0"=XQO?_1,X,P==#-RU:]<R
M0%45H.BW> N<B1T^H!^FJ,B3[6&;I0!#NNE8^],WPOA.@C":KW/@4T00NL*@
MDS&T5_G/DAN(2(O:G\P1!G*"-FT7G?/)EP3@&D!.TF299JS/??B:<PY?BDC=
MX&@;S+V^#0_(W#PE13'Y7GY*BM)H. V]$[?;]SH_WP?)+?G#WK P9<HG#4L(
MZ#LI)5V;H#FUCDCV3Y992RQYJ&8['QU4L5F$MS:,]E)%:=IPPU.U;UV_Y5,\
MUW$SR@D9DXVAD)2(N1F5E$38>BE%.YD#<(AI?I"IPZ+ZL8+5@Q]XP69W88<$
M?G()$*DO&VZ*DQ>BG+4]4TCOQ%)%T&M:YYU!7."PCIX\P'(]ZT-G\"[=,(+N
M?8R_RX.LU]:>DV>.!84YO(6!$R?B4R7%/6/NLBOJC[#4VP;94T 5@63T7"+Y
MN>Q-&<3O(5C'WK6[;B:Z[*N7$]WH#,?0519Z"9EL<-HS16R1YCE!&C16R29)
MAC0O*#*CF6JX!G20&4*0/(=.L:"H:JCRJ34?Q"5A0_5.W7'@0-36_JRN;_J)
M4GS.A0\#XX*P^)\SX#?S+!6]G(F&VS)4"*C\Z\2 B>=?.PQT\;O!AU>$D)]\
M_4Z^?B=?OY.O7]^L[$>9=FOODD@BRR"#DP,%X5<8A*P9SJNJZ('8>(OSCL[7
M8\=QTT,#F_ZS9Q?4=[[L6B8XQ-U%X+$T&[ C0[1#IRB ((QF^]D!PA5TD^-2
MSE-.OOV2"UV; <-,GL=1-CV("BC:J E459-2WG!?1MET[%T069H[R94/.*+>
MJ?Q&].O7%^ )^#%@P<^+]*0G/[F2GEQ)3ZZD)U?2DRNIR+XG('P.@EXQ8=90
MQ;LRA\]&LJRAVO@&XR\F%ANJ=]?@]5O*-ZU-YZZ9>(8@G9/^<0BDEX7PG+!/
M?<4U<S>^NW97MA^-5RN\!;O^YC;PW)4+PE[4QG<1&GF\!X@HB^N%]:N(<PA<
M!7"EH!K-7@BC$D;T;8\/IPU?X" %%"5NY7=]:*CJSX,26A!]0^MH&V^9F"IE
M]*"R7_BHRF74I*Q5.GH]:7IA@.[4T>[6P_M9^G+J$2^YB]T2=<LQ9PC4UN[X
M2L6$$7$U\@*UM5-T#>P0/ 2>,]L^PN I#?+-]4=FU-). 1)9'F,DEQ?<Y**G
MU-"?YC6&2'"((4!SX<I]P9_XK*=74J1,_V:O'M#QG23>N;;O XAK[OC<%:\L
MJU"GA3EU@>?< ?CDKL!WQ!,Z[UC%]6N^N]]$#-ONA?S)!6JKRIDIT!7;!M:@
M%6OTL0\5/U$BIRGV#R7BX:GM:Q16.7$HA!NG@J\!I. WU%&:@*].P*&$?XPD
M'%P'#$RJ)#F3CB+/"6]YR]TLS,T$)XA?DOC*)<2L12>)G4PX^\XR0(+IUQQ#
M[52MJ&7>BPRU5C4B6.J>9:A%JCGAC%N<=FN4N(V]\QW;<(N[S#5$\")XQ)0V
MO#[V_:1A"<(( MC/\X63'4I&PY'9-.?WGKNQ&4\'Z(6[ D+5;[&**P/##V]2
M>5]I% \4*O4XMJ7LG>$<9N<LPV1)*JHFK(H81IP#+>N:GC>'65Y[$)@,"5?1
M7RDGBY(R%?-1\AVQ:$2T\FJ,/-J&N!]]N)0#^.BD'39=?<0\+(U3%;/1BE!F
MJ&\V#RR1M,JA;IXOMK+!&H2>EB%8F*>498&EDD440\Q:9ERTU-M[16HY:J)X
M,I"A=AT5TW% "J6RD,4A1ZD.I28S)@0"X&S?3W&]$(>NF/KQ-G,POW;Q8T>M
M(BI1US1?+P'<<AU1N'6UZUSVB#"(^3JQ^'#O68Q:)0IZF>4B+*9,>C95Q3(0
M7 5_?8\[N4=-_.W_ U!+ P04    " #S25M80G@CZR8) 0 XYPT %0   &QF
M=V0M,C R,S$R,S%?;&%B+GAM;.R];7/C.)(N^OW\"M[>C1N[$5W=[:I^W;.[
M)^2W&LVX+!];U;VS$S<4, G)F*9(+4C:UOSZFPGP31()@A((T#7S8:;+-I!X
MGB2 3+QE_OO_>5V'WC/E"8NC__CJ[)OOOO)HY,<!BU;_\566+M_]_-7_^<__
M]>\ABWY_) GUH'B4_,=73VFZ^;=OOWUY>?GF]9&'W\1\]>W[[[[[\&U1\"M9
M\M]>$[93^N5#4?;LV__Z=//@/]$U><>B)"617]5",4WUSG[YY9=OQ5^A:,+^
M+1'U;V*?I() )RZOM03^]*XH]@Y_]>[L_;L/9]^\)L%7__F_/._?_Y]W[[SI
M[?SJX_2_O,>M=_6W=_]U?G_CO7LG_LKCD-[3I2?0_5NZW=#_^"IAZTV(K,3O
MGCA=-D,,.?\6ZW\;T15):8#-_X+-G_V(S?]3_NL;\DC#KSPL^?E^VLKVEQU9
MLM*WMC#>4<[BX"HZ#NQ>;<NH'U+"TQ-PU^I;0SZ/4Q(>A;E6TQK:6WJ<?LMZ
M]O0*<R(]3J]53:-HTT.DO96YH\40_WT#[>\@HZ\IC0(:%-BPIF)B%8+%A(PR
M46KL[\@+<7*.^2'5!.0)60GUOUG%S]_Z<1:E? MRWW\H?GB'/PBV^2\6EU>%
M*(%?-+"H_K@XD^PL()G>*)!,;Q;OK2'Y_*! \OEA\<$ DH RB0+^42& 'Q:3
M-708^%]Z21.?LPV:X@8\;447W]M!=QV251<L++/X85@\6<! QC7CZVG0AJ=>
M9O&C#3R%#Z5&5)1:_&0#TRU94S4>++'X>5 L%RS=3C@E%W'0!J9>9/'+L&AB
M<-8GCTG*B9^VP:F769Q]-RR@C',<."SQ2?AG2C@X;Y=@!MNPM11?G)F8M]MA
M7L9^A@-\$D49">_I)N9MZFLJNC@S,9EWP[MFT4.Z3J\XC_E%#*KR<;0I9J[N
MBHNS86?_"@%^4ND(7\/ODD[$>^479\,:@MV&L>_IPRQ++\Z&M0Y%L^5"2#&6
M&LLNSH8U%T6C<TZBA&$GTQI,^\479\-:D+)=D-@%#8HLSH8U(E=1BC8B"#A-
MDOP_X'G3LQ9LK>479\/:E[:&W_<$^G[Q?EB[L],P&N 9G\<O;>Y+2^G%^V&M
MSFZSTA_70IB[[N^'M3H[;=[%24K"_V8;A:/37F'Q?E@K(UN^@.'*23B%]>GK
MGZA:E7ME%^^'M2YYH_%Z'8,ECOW?'YX(:&F6I;BUB?NI:K2*BHOWP]J<'('T
MS.3T#*T^I"1MM8ZJ*HOWPUH@V?;5FO(5M/F1QR_I$ZAO0R)UAVBLL7@_K!V2
M35^SD-YFZT?*E0BK8HOW-NP1ML<OP&E8Q1WSTD[)Q7L;-F@:^3&'CB76F]BS
M:#XK=LY/RIJ+#S;LTC1**:Z^V#,%IXSD Z4#=5.5Q0<;%NHN>PR9?QW&1(VQ
M5F[QP89MNJ<KANO8*%7L!30577RP88\>GF@8ZLP]]8*+#S8LT<.:A.%YEH O
MEJAG\9V2BP\V;,V<O$X#Z-ULR>1^DL;DV%)G\<&&M?DU#F$&(5Q.A&I][I5=
M?+!A87Z#_O6G"%S:!TJ2.*+!-$FR#HVVU%E\&-;V3/TES[?O)FE*P<OIV.-H
MK[#X,*PENJ$K$N9.[RMK^^Q[I1;?#VMA< \VO'N"#Z8<-?O%%M\/:TD>J)]Q
M4,'9^\<Y2\.VR7J_V.+[8>U(T=[5J_]$HA55V)&FHHOOA[4C<T[0Q7_8KA_C
ML 773IG%]SVM1[A\"42;9^_E989_PM\L)O[_9$SNR%S2)05G(X 9=I(D-)T$
M?\V2%+=&DLD:/:<&7+UE++[O:5A&@[NG?1D-[IYFIPUW$(@&P4?8_D8X^E>)
ML!/!)]HR^VC56WS?T\I8Q]?3M+3A6ZVXN!<@9^'9<L9A,(-W()?YK?#4U18_
M]+0QEM'U-#6MZ#BEXBBFV?@>%EK\T-.:&&RYIZ%H:SD,XQ>\"W<=\P<2TN2>
MIAF/VD&TE%_\8,A.&,-C:/XWAL?0O!["LGTUC?R.Z6:WV.('0[/SD:T;FGN%
MI9DMJ[GT@B1/5X1'<9:V?Q%EK<4/AN;=(;#]:&C6'02;H3DW;^5JO0GC+:5S
MRM<PM6.#YS2B2P8.1A3()<_KAD:)PDKT%[7XT=#\[9B%(5O@F(4A"Y(WG7M9
M=SQ^9DGS32-E^<6/ABR(,3R&+(@Q/(9L2HO\SPE9-2V=NRLM?C1K;TPB,VMM
M#"+[R8RM.2?^[V&\4OL'.X46/YFQ),>T;&;V/Z9E,S/V.8E^QZ-<EN"';)V-
M]XHM?C(STQ[;NIEY]=C6S<RBYR1A/IBP2Q9F^8.!.$GN8'%:7YK.R6,(MN\U
M/0?9O[=#["]K\9.9V=<]#S-SM7L>9F9VZ1WY#%JYPA/:#6<)O>;Q&J;K(!/'
MM1/\?Y9N/Y%7ML[6<[:6!<2U/'"YPOPR9LSGY/7JE:[;;L@/V^#B9T,6Y0O2
MB"%+]P5IQ) %U@=8;UZB,\#Z4.CB9T,6?H3,#'D/(V1FR#/I!>*>I'067<*/
M 46;DZ2</6:(*L$Z)4R\9M1XECAXFXN?#?E,7YQ>#/E@7YQ>#/ET-('EZA+&
M9M2UN#HHN?C9E#]V H9?#'E ^64I6,8\YIMH]]2/5Q'[&PV*2TKHC8JCV40<
MVW(:X 8;_)J%+&4T@;]E:_BE[_.,!G@WC$9)VQ,\&\TN?C'D#7VAVC'D&7VA
MVC'D77VAVC'DH1F$.4N?*,^QUOYJ0T,M32]^,>3M?>%:,N3[?>%:,N0)?N%:
M,N07&H1Z3]&7]5.804GR9$,YNRTN?C'DIWY).CG[;GR.\PB4,CY_^9ZMGF#1
M\SF1A:UH9;=)4,OX'.51J&5\'O(HU#(^US@_C]_.'D.V$J*L&.F&9D$]X_.)
M1Z6>\3G#HU+/^+S@4:G'@ONK>ZNKEQ" ;L%+'0AZWX!48X)NQN-#]Q%ZJ;B^
M"WWVF83X;F?7O82_[_ZB*ME&YD2Q0,^,YS9:>F8\L-'2,^-)H=@0AL35*^4^
M2^AL><?I=88A08MW4BH*'54!IAF/9G"89CR+"\I3PJ)IE*0LS>2U_;N,^T\D
MH3Q1'V#IU 6@9FR\!:!FK.V%>)L[C:X)X[^2,*/E!=JD,/O;XJ2T%7 /&0#<
MC*VU#[QO"*[Q #=D9T.2)&6\B-ER&CW#3!GS[3P6.Z)YC!7I/K8B[R,$H!NR
MH2Z@&[*/[:V"*[6!N6(+=@PMUP8?3]ZV;SSTEP0D#%E!MR0,V4BW) Q9T-Y-
MSZ+66S9'"0,JAFSL&*@8LL)CH&+(+N^U?C@UGCQ<>HA<G/4-4/96:!FTZ:7S
M,.-B0SGWY'$O2(E=40\ &K3<PP T:)^' 6C0]NXW=!>'S-]V/A71J0M #=K7
M88$:M*'# C5D(?%A6![&)@HNX@C#BM+(9S2I[^FVQ[\_0@J -V03JQBN98"4
MX@+J'6<^G63I4\QQ:_%S%%".\V.ZK5_>+2.*J)@9:@)H&[*?;XQVW_!L7PIM
M0_:WPH3ADC"RRD6<I$D7@ F^U_,IOG?^R/'U'H]]2H/VM:OA=D !ANS[VU6
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M14)'-8!G9OX>"IZAU_6#P3,SOW_,",J/>2T'\$4<XIH8ALA=2(-5^Y5'K<H
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MMZR803VNMZR803TZ ?*6OHB_)!]YG!PU8>Q* -"#>G-#@1[4CQ--GK3&:I
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MH;/M/?1#9]O^EW&#\Z/QRPPO(,E'A1J(FZH!"]N6?A@6MNVU(H9SKY11O>0
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M!UX._!PKO!SX)7NXVJ-I]Z+7+@98.O!,'+!TX*/LP9M&S^ OQ;POK5H]X.'
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MNS)2<F"UFU&I,\NIJB$-!U:[&8]^  ==$4C/@:UOQG82L1U*#GR#H2F-QI=
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MW?U4C30:.-$O+O3[A=/Q$<)@OWJEW&>8PNR.T^LL"LJAWNP9%O7PX%%4Q.$
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ME^6(/^E>&-*3ONMAP-A1?M\#RJJ/7).#<U<I*0_T?AB(U7Z<%_ R #D&XY<
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M&Q(^9(]_I3ZH"Z9KF8KAZC6%4=*650/EOL.IST/)7WN5[*^]7#K.\:5\+V\
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MM$BV#0Y94>9QKIYX5 'KATO#KK>&T:#6O(C9I49VJ+T;F-H1?7,:R6!\TTC
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MVX R ?-V9W&<A$ ]T;9-Y"N)5GF;LFZZ"S/(G/HA$;?) %/&+QJ)&V,RLG&
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M<DV$N*J>)LXKNV#1K.YI@J_Q@DVG=2[?X<CC,7BULK6G:]^],UZ^>5ES:N%
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MT ./]OG!\'CV-4'V@SS=;1U*6ON#G]5A;[4'=R8Y T+KYJ8+0O87X,>=,68
MJDT")_# =%CSA=R8%MD/ZG<R#B<?^,'SQ5$0T(T?&^N7P1]5"B%.X]*T47@#
MA3.@A5$Z#?X@3D,=Q5W7#)5=X&C3^?HQCS:6.2:WS"\?'%&G1)-=,&D+SY:8
M:JDBCXYLWT&DP:%+VJ"=\E[):>V!J9J9O//^M?):&6D3NZ8DB,R%JZL-4".
M%3[UZV+9H-@N(RY\%7;U$?AAQ=JF=\A4S::#3#U)M5JL:EP^&D:^8;/+_86?
M18&6==@FPFZ*/PVN9W(Z\QZ!3$1>HGB3#_.^LY.]Z &9]KUV0"XHY$K(LZ,U
MG7E7CLE?\=]; P,:4E\=='DS<%&, (F8QX0@;#%L@H"^6.PH=//3P#E;]K(J
M>W*6B]']Y)*G9;F:W#S,QU?>[7CNW4SO[[V[\<R[_VTT&Z/H@F=-C9Y)<?,
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M0K=NEQ-4,>6NF4,"574Y,,=LC&_L0/+R+_JG0FWV)G>\7(.J(\1H2B^\>A^
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M=C/6EUJR<>7\&?=9UB[SW>NU3K_.1G>_32Z]R>WU=/9-/E"^O?*^C?XZA3S
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MB&4"%;_4'7._R ZOLK#"603[=11'>40R]K?-BOTR".AFIVKGKP:/=^#/HMG
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M8_2-9S7'D(O>]SE&WR=M+X;\F,?H&VV-E;SOUL]A8 T.F8D V^(U" RNF8D
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MH^ESE$5I<N''\%+_^Q=#'1 C ;(-Z!!8_>\F@8,ZL#K%30+D%XLZ!%8WM4F
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M(+U5?ZEFP[/YSEHG%D>U,&</#C,."W-NX'9[& '$7,3.!;L6[ &)-5=M7?
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MM:>XP^"?1.1E(GCT5/TV#F&G5YOF7TK>A;561[AQ"G95'Y(IE\BPDFJGL-/
M4Z%,%JKSWXBUB)+=V0S61ATPY0>*UA3>],+5=1+K(%^21R'GB5S>)E(O^3<O
M-4VP4NI!'L"N@K:[E5@NU6S)&1*D)P.63"'5ZU%8^-3&GFN+U8<"L,2IC3T#
M>,T/1!S0I:4\$_(YF6?OGNR_"#/!^J?[>W5;%9D,?358Z]-<L?X?<:VU%^F;
MY9G63@CC-YU:ARH DIRQODX*-E9D'>WKI& ;J-(X7P[/(@R%VKQ"-<&2KR/<
M,.[:;; F'F7MA@-8O<7V&H=9^O3\6H_ 6-75;.FZ_7(_RV6A-5O.I?I$QB=8
MXM7>"V>H_4,P5H7=RZ'3"L@\->D(OGJ2M*32J>_GRUS'?"/FH:\OA6$!60MS
M]N ,=&K8G#LX U4:-'<Z7K:CJS^G6(@6F##J?EL0!DK3;^(2Q%K$N:"#%]6Z
MQ?<P6USG:98LZ:*]'^4!?>OH4D8J JW.,,'RM/OX<]J&QG"[FSE8NW:D*QZ@
MO_Y4,\?8BZHHAY,]3K#0[4?\NJ^.6G"Q7+73Q][JU71:6B N]Q(N59'9_%G]
M-IT7Z]'=*C*PIL,^RWVUT6(IEM.M"S$)U,!TJD(\ C6PEK*0T^%[&ZB!@92%
M'.9CJ6+H_20I^KZ3GK:Y 8#U:O=VZO(=:&L'SWX4/.1.?6O\!6U<T!Y%OX@R
MU04F-!_P>[K5@=G/1_PZK Y]$GJSW3#!JK<[15VV82=H3$QVBKH+^MF+Z+RY
M_H \B.W!8BQ9VV_AL-Z?_84(\DC,YM5M;7W!-PW+K?G&3Z6TX@2+THYVQ@(X
M;;DD<;&)7PB3=81S.IP02\U^Q"^+ZK@1<R&EGLL50QX-@ELAL&Y50'*SKT\6
MU?!U/A>T#BCJIB/1^B=!CE387N]4 <O8?L@QCPK1-YN%>!9R'?KB>>%)<:7&
M/+UEJ?IT(<48*>-22ID@O<7A7R(HKD!KE9GJ(X+5<H_SQ,]4A8T.A]5ZC_=4
M'E499XIF?0\#48ZF5YMOWK\3V5BB*'*]*6I6I7JK^QYD?(?PSZ)Z;L,XS(2>
MM]S%F>*JH0JM_/26$BS3E,[;;8=JU1M^A''Q^6GV,$@>#_^TSU9UD,(>X6GN
MJRXQ@;G-LUR*Z9+>F+_J=3'%A#IC*-8*/NB#&/2U0U78(!\_S(/<5YCQ=:F_
M[A;4?- -@]XQ'&6K$UBP<'M_IP??@GB/\,<!_F])$KR'453VZS.L<XQL6+1B
M,<NY$O-$;F<\-^I_:1;ZE!NY$'G?;8$SK(W\4=],JD6QRBR158[%+GX+DCK@
MA 50?5;^(8F3=NY6,,:<85WF/5VRJ 1\^:IZN2VHXH 3'D#S'U'HOV9Z$=SF
M0MT9EGS>W^NI5H7%PNIHKQRJ8KN@<!>HZ,)Y6&VGU7.<UGJ@^EN^I-7"W8^#
M!;4[S+-8]*"#59L%-SS0LWA4V]Y7NNK/L06=_/!CF/2Q4:M;S6Z%%;D/X)Y3
MY=B>#:AZ#U;T_J!K%I4"UH^W_5ZU[K9,*1P\I52J=?U84-N//H5/5?W8!;%S
ME4"?.^]>+B@/H6^ZKYT%0S["@_E4:*=7Z-^FTSQ;)))&L-<X$%(#FJWH[UI)
M[6I3:9 ]*L3BB?I1W2$MV/=1'OTI*[795RW(_=$>S[ERMT#H8U^\CJN5%'ZQ
M_ZM/'J7Z<X:_ Q:SA6,]G5G5TK(7(7E(8M'>[$P;0A/UVVXQB]C/-X]JH>9<
M))%Z7U*:$&:;AR03I0YC.I-%Z[9ZDL7\8*Q7!E61TA$<94$LO-S8#M,_%/54
M_[U5S9;(5B4,4OXQ_ES"%WXNZ5[0C_I VAG6K.^6YA8Z)M/=THY#US/C^\2+
M1?!->'1ML)#;F\\%93 5-R+U9;@JY'_.L!3]:&=.VTS/W^KYW/:ZZ1D6HX=&
MC(#T7B8]P\KS-O9.X451<<OUFR?_$!1A?8+V#,O.&\S8@L'$R&#&$<SV(X@I
MRY"QRU;J99\$!Q..?A.6(#!A ";<0#164]!B2D'U[F*Z)U_HG.G$H@LO+N</
MOVG^=Q<7)P6_"Z*!(IBNA?3>A/[CC9>)6R^4I43(&9:JYQ,EN_YVB$I0,YBU
M2!7NA[S\K&!E_5\7Q:>LZG]JA%5_HYK&7.]7!?$?4M&8<_ZR($ZPHNM/G][7
M*V!5%Y=OPG48B#B@:PI4PY@!'_WIKOMP9TF]"^['&'"42&="=8KY]_$>^VDK
M$_/_(S[VD[WT_TPBKSAD4KWV> KR"Y[ONJ\>"IY>*Y1"W,69D&K8J"IWY(3H
MD$\_Q:J]WU[M/\.)/@[@_A0K1S'L@IATB,MM(N<BI./^5'$X<\B1'_VI*_7P
M4RK+1W^J2M5S<LK^=H9SI!SQL:Y[Z#X<958-H'I'G/8CU6=>AG$:^GH<(&J$
M,[,<\;&N*W.?+M)%52^:X 0PAW_:YZBZG?6VUID-JE#SY.<7Q."ZF@_SWNU
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M%-@MSB'XV?S:2Q>W4?*>-O0>#9G[3(8\ -V&L1?[H2(#29&AN@G,Q"N&'7
M6(D?&[+CM8LZ#7I7:Y@"-U"!3G%VP1L&_6YQ7L&?&Q+/=8L[G0OU!6\8PCO%
MSSD%O_W^G!MRP6$S5N] $XQAT,9F7,$81FYHQNH=(1GW7JGC<T-F-FLOK#JA
M :IA@+?VP@DJI1>2J=!_>%Y%H>ZKAJ%_V-YU2Q:+%3=JJA6_%4<QB\7N!_&N
M_Y020C-'&';!%:16G"2 9AYA-N<*KG]'7:$U)!C;PQ];^(UL+-4)@8#0FYG+
M.'?\P.O[&,V7UY 5S,H#4XBX=YMYT#AWKL%OM]Y[NB2!-?,DLSE[<&:B-&#.
M!EQU!J0^Q#1=TH[KA!":^9&%#SYM:()I9D@V/DX"IIDF6?AP/8/IA%B=)=T]
MA_>27#6.!>EAU4RA]O;,KH/;5XDA.]3'/)]PE9C)U]Z>7;XX^8]4_)G3GLBZ
MO?]P;LA$A8Q<=O=V3-6.V[DAW52O!4<(F";U6["!T-@'.C=DDT)&?-JB>3+M
MW)!*"EIQA8*Y#;9B Z7<OCHW9([J,^#3%B_J@<6N];DA<12PX06C.HY];LCD
M!*T<0PF#T).;9Z].:5JVB2$3$K1R"F6Y5!'-YK0F4%QHCZ+DW5/&S7?>D'7(
MQH%3@*M5I'>CO:@Z,7 7SQ.Y]-I[\^>&A#^6/DX#IH$96/IP##/4:R6&3#=5
M(8?M\>+]O)8B"+-K3\J-JD.= UM/>BEVR 9,=GSA0$9@M',(1_B+.(F2MXU>
M +U3/3Y^"]4X/TU3D:4UB\;95.P\N&PQ6XB00UAZ< A1>H%0@\\?6S0X$TFG
ML,NVZ0D<TH9N89>!Z_S1&TU=KI/ELKJO2@@@1<!63MO   4R 8,5*RBEC.\Y
M3C$!C7BU20T$CO;8B"<0//0C(X=+?:V8'J68"RDIBWSUU<(#O\F02Q?K 80'
M?*,A$T#EHK'_9QY*O?J,%?Q-=ES:IP,'*^H;[=S!>8U3X><JB!OQ@Y@RUJUO
MEW38 J^IF,V_IEFH9GUZ-,12\#M%70;]7'6 :1S\EJR%C)?-Y7"LQ6ZVY P)
M#NT#ENX@=9>(;LKOJ)HGZEG%]8(D3.[B>FJ)Y<Q'.W/8EOL ASQAO#-WP,NK
MAR37\D120&W]@7,L^FTT=-B20X @?S ;\@1$VDP$"I*(06.7+=76GJKVU6_"
M*%>_[5'#.,<BTF-]G19LR$E&^SHIV)#6C/7E<'X&0NW$>.6EH4^@(0\:YXE?
M!\>0(4\:Z>F$($/2-,Y3V;'_][]U?/?*X=__2_V@_D^2@7__?U!+ P04
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M_NC3EZ0$WL3/7FXD1AUL,_AMSPPTK,JO#5:UKM1T:7C:;;=>K '8WJT;+KP
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M/J*B?GKMM"B4:TU8KR5A&PT;S]T%[_O173#S=::W4K1[(&N:4=T!952-<U-
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M4#TG&D2LABP_4]9SK:^*DS1#5=8*MZ\4:\:=Z8$D/21!*_Q86:/3OAZPVH)
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M9&NT :>*<VF<>2&;5*H>X/8=W.(95Q/@EWIN83M%!?C'FZT7[ $HF"EQE1^
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M!@&("Z,55>F\MOV?Z/MOW#!TR8W:2<-DRY=0-J^\(G&)]?0AH8'"G&1U'D3
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M(FTTPSS(DP>P.$]-*FJ-#+<B0/S3P)BE*$GSVE[\1*>-3<W2(.U&4L;SQ'(
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M;Z@AW*<XZ*'0I.XFB-]K]*W0OT(7G9$80.&&1[76ZZS[TW1YD.TF#@+27;K
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M%:0QO6DI?_V X7FQ0_#O_Q]02P,$%     @ \TE;6"_@[0NBHP, >2TD  T
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MI5M9!#A6_J-P(_M@- F6/ EWYI&Z#!SQK<P+ *0;QB:YT,,;F8?=X9V=P6_
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MU=IJ5-^Q .<2:F!P:GY@ Q$'H/2"%@VK<,)PRL#$TJ83@ -,D'\'$>2$7)N
M?L 1,G]O5NJZKDV 2N@EM:3T,C5X^9A;Q.%:U2AK:!=KD:_]&G _U+ILXD2P
MS-^T=\@Z0?2C=C+U;.W,&3OX]KM__*T%#/.!GJ:_C0\_ JP01AX7?'CG1".-
M ;G"),>@\FJ#F1P=/H,(Z/KC"?-FL A (DQ-V'.1.U-KHG6^@U'O1C[\!="
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MFT<A58Z0:%(L%J^P]']-84^IDRAMEVF3HBL-=07F,4&-YQ;TBH>BS@3VU/<
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M=H8&='+73--L5<WFDTRLYY;0?3Z)8GP]($8 BP72J]7-/(FWOEC8%-5EE_%
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MOL7<?TT#)[0="]LROW),W_N)A_AJ[@'B2R6W]73T0C:\6(W<:"&*-RQ13OR
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M:Z5?T2X#YQ;E1_+1TAG\SXWH<GC%4<(E7V_7RZ)W(NX/HJ$7=N0$$9?3_G;
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MB$+>+Z<9Z78MBK6..[\B>8+I 0B(,ON<$,DHF^00ZJ3#-/:!<11B+Q/<*YB
M1H&"0\6S+'FHJNA(JKIYI9/'03.Y<40J* YNQ_D2R9FZZ&9,G-TH&)2[M:3
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MJ$&Y($Z!2OO6XSS7D-)20^%C"YU(M,L1B;GD -P9T;1XM=;B-=XP+5:KU?C
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M%V_Q6"JHH4R[1QW('=$;P]EY _]5H]_V2P9SE;@(:?AZ2L9OIM?2@>H@\ZJ
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ME\&$?4&7548F(1SB&!;Q"%E:C_\9:()RYK,3(3<EZL[2O/@G,T,BA@F#\DV
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M(QA"*>)%=4I\=; ;&L*G?=+DRTDF^,0ZG5<DW/ZM.FP^.>R4;-[+Q2T8=>L
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M_?#6C#JIJ-HRUPZZ<E90K3<T..T[16H89X<WP T7WFF[JW<A87 5+358"K'
MF,/NZ0*M%BM:NPP"?0B*9@Y8KPW["U)Y0B0<OQ%NB9->'*%DCTYR.:71L*^;
M!5LJ.BSXI, B$'%BDI%ULFI$Q>08W7?U)^#I7"+EDX'DXJ9&MD0N$;C9J3Y"
M3E-HGN1T="0=A(.*I].)JN -&W0:F*DA&JZ^&=V>G9Z&0#6]YU4G)D7R;1]Q
M,A'-C'LF;M/ U,S_5[]?@'\#IV+;Y.5L.QW(0"#6-@AF(Y_7LF8?3:E&Z\O2
MGB3 R#($U1Q>0R*L6U*VP>JPT^=A&QG.+_'$]@U^_X19IS0A<7\@V!5-=::9
MTA"D0HA;&*483C:_"##2RGF:7JY7=S6V8/5!77Y!/]KH&Z[NJG*:WI!CC0VS
MXJ7)-5^3E]]07^5+F,=ZOGF>/,,/B(MT?7VIZ3=PJ"BCS1#4DK/.H1&X#^]+
M6],ZA_7!P %FPO]_&QZ>HI;A+.H;AEN2[Y9L48B&[-ZCZXSGEI+C#;4-2E%Y
MR_.[/F37[^PP?9TOI"ABA\R+JH6]W6K>]%+TF7&J7O$=P$1=:<E*:J9&L_6+
MY4O$(?Q;]:]U56C?RE5.U0O\!CNT,LOT1QFD?/$'%"YB>!Z78%_Q/'Y;!^V3
M63?[\P8=&M8_3HOL)^[F100=9\X$95O.=R^]26UY,L>Q[.61DH!&Q"^;/(33
M$MKEF1DY]=MKD_D,WEKF>E5I$]E"?GWYP\\OW]&F79 ]57>.&6&V?A_ 4;>\
M](@ZZ__D\^5W+[J\RJX+C1(/XCD2*4Q%JA!8K*JP^<PB-GETK7(H5B"1;".#
M[+#291UF\,3^ZM+B)].A21KS?F.O%PX4)&MR+8+D';?*FT/;V'<?9XFGH*3<
MT00,"1:R5M3 5*/WDT-0F,;'E#L.Y>JAUXS[T. %%Q7KKMHZ0026ASS)JPUB
M4FPO[>7<":.3ZAG_?'V3GIRI&3662Q4VM-.D?L1BRGO6!C2JX<5 Y"0P;O/[
M<6$"$2 <$^^XC9)'06.%PYUSKCC2P>'9Z,1L/A%ZD]W$V.S U*/@*O\DGEO#
M2TVK!@ZOP3D+NR4L3:?+P\*3G4U!=!)*:S;<A7JM<5+Q[K;OP(59+VQ.!X<G
M9P,;:=_SP)0FVV,3V3P*_I3[(AR&:D," *+[Q<Y#Z=AMMOOF]/CX-/G\.>V_
M/\UB#E&>JB?I!O2FYL$3>9>Q@8M,6DAA?&Q_<C2K0< =VL #'_FZW15(.'R6
M+K),"9?,X;8^?ZFM[U6)63E,1@EV*3->4<R,$M>K6"D>B%(/1RXOQ4,* Z!8
M:,6DP9U:?)M L%J5S/X5@42Y!#"O:0H1%^ZK^7@Q%_L]TM3^5,3\K"+F\*F(
M^;6#'U86&)QF)":!]J%'H(*S<+);(_\PN31?29V<Z.^I_=T<'X4RO)365>38
M8*V*[6N)P,#V)^QJ7H?@,/F[DG>D.T;!*8>%J7&PK\<T8<XLU@Y?%",3_.%+
M3!V.+1VAQ0@K3KSU4\&O3Y3/R")MO<":Q*P/*B[9EWRSMJ! !V)\"R'59@V,
MF@STJ9;#]-,F<)E780;_M08_DBXNK:5*0LKI37%-DJDRQ^O$'J8WZ_$_'1 -
MLZSF.'[J^R.V4&.2(_I5*Q:Z/FB]::+)>RHZ5.1A,; ,M2YY9FJJ3U*2F!I'
MJU8=I]XA"?4J>LP/"SBKD,M:'L*MH7!7K)8L^.T$)@7,)3BAZ.[WMS51Q-,O
M4A%TE].'V+!N:^J(B/8&K;G<R\),RH:ZXA?E0Q+&A+?6KU!ZAA( _<.+1O7X
M'.&ET*VE2LEK>B;K:]ZG_0OK?:>I"81!E/\ACYNX?ZWYOLR2T$7=U)M\ACG&
MDDF\=<:95T@GG365HMG>)<@CIM"LB^8;MHU,\NE&)K=Q8DO,CD$JQ1HFJ [N
MZ@<SW6&Q<54E6EB)?MTMJK"2^ ZX.U7.LF^)'[I9P6OQ&F^X:P!=+W3D)NRV
MZ53Z."D+N%@$@2)V8W)7SZCHN5PWR[I50&C'>JRY22F0XV)[9LU]0IH+=)ZQ
MU>C6'U]'F*+-20_5X).XB/@ .E@O84(CAC:L$PBRP=4*K([/P$&'10^#CK!^
MU#"_2-?+*02JJW1:,IJ 7S]SWF.?.?>B6T:^AC#Z5LNF8,N#39"7"T%+V:Z0
M;=8L/3T"A6-,8*IGI*UYJP &F$>W],EVPR[.+XDV'Y5EPFEM_?>1@6-X/R5D
M"'- EDNT5RHMPG$@,:,R/;;-EI,ULY7RY)I8N9HY6=J%KK2]RP'O7&(=7"_2
MIJUGU)<H2X=3'A#HK:H9^P4HJ>Y;_E/PIE<0$QRPV#I#+=#'KN:[YH,:0BJB
M4U1Z0)[X[FJGWB(\Y(5899/8Y^G"V\]#A]9"=R&OL-.CM  //G004AM)@T"C
M!;985H@287X'G2@L7W[D5DDUY79=ZM(TRABR#213#$9(%.EK9&"<8'\QUC9G
M:.3X\-O]7JSU8ESZ.1J'?45->FFQ+A/QAH3'&%E@+!^H/6!@;F!YXP4:]%L.
M/TNC<@_+$E<D6G&"Q8C#B1I 4H++FPWX9<PUOW)JTP]4!3!1.?MP6BYH2?/I
MC&.;+ZRI4GA/[6V1H]2R=_N*>GR$R]**!+TNIPMLO+O9XQU@<>)G3 0,CA3S
M11E/AB@56M1@X-9*BO[JET\KU%!FBG'V];=R8$FEKE,Y:TN1,T1#B]D[9A%E
MGW>O,,1K+S+X1D0&]ZJGT\ [F?C*8[\.8D48")B^G'D<\9.:[SY,_E%:GFC)
M%WSD4EI2(W+>L=*DLM@W&TJ4<"GQ_$:P1+V8(ADV%LP)BT= D!8!(KSL=(DQ
MA1_=ES%WI6X(.5BM$W6!(NH$@>)S-;J!NR";X^VO8Y"2<\6-RXZ8?LP+V#^U
M0&#9*MUSBX3>1>_:Z3&@"B*1E/-S8]H2W+D6CIB'[H3B'#9526A,]'2)#\+#
MB">(,\ -U?Y%?1YTJ+SVP1^D7U074<P!*ATFXJL*I$LTD%;D";DXG.9./>HX
M9!#5$?M!K]+M&LJ91HP/$.H"%A+. GE[[TOGL7:$&Y-.05#CC99WTQ^8.PR>
M:C#H3G74LY(XT8K!1?>CM=#@R7D0-?%$+36#X\[;VP:L1,C43>\H,BSQ+P1B
MS_!W(W&6*]AZZ2A;(1PF;$=!"X7;A?D8GGSR? P'X3/\E=K3 NZ>C*./3D:$
MEW+/X@A<^A0Z]KVCMP84-2KH%,/3YN SK%M]?'*6491"%.9RRD(%5#<9<A>\
MTXM<=V8I0G\J%:PVFR-!/6.;-%UHM&5B5!5JX6VEY==4UI%9BH3AJ%VI?DY@
M)7"XK==U4]:1B 4]_+Q<W=5%_.2I/;D%B_0IO'?BJNQZ>-0S/8*ZL]([(UFL
M>.QEW);AS-_>@Q1TL'^?!-Y^M;(896R5;M1QY7#&(=EGFRAJ+;5HQP20O!W#
M>%6&.%]$#;CDZ7?832+!)^Z3\PH]")XV0"8\2U X8,#R?A4,-1%#&N72P/#H
M)DJ?!3N2*.73&L4=R_9YE^HRIP7,\E6LLVS(HZHA0#M\:^6J^ASC2P,HMO0H
M.>T&O0D,Q5K*L^$J()QO8#=-*-)$W@KTSI&AM2TJ6E@6BS5K998'=T9B"Q0&
M7.);H@!N5I0,S22/,;;"/MFWF_$F04Y^GDZ3@#X:[)Y5EH=8;98BM2DQO'UW
M.#@,8C0K$14BBTV>K'V#;L<P&IIN"$(*[A.6S].;R M<(%RO>?/N\CE^]O3\
M@J)SVG\%/.2&3AQ63.1]+SI>\>C?R#C@(=ZICRQXN*?NSR\OG!X_%4Z_ 6S7
MSH([U "DFE'5"DK$%G'?9LT2=2(8S9E99CUNK<XL3T"7,D<=CQJ%&Z6?,Y+>
M4>RX^8Y[4V.VW-O!VK_]9/2.A\[:](<8>Q7GC!'%2@-KT?ZOW&AXB);^3.2:
M*OF@$]P[:',#<; "N-[G>N2+XHO MGI2#&NQ@\EX(/I3%I0P%D\J6:N*IB?!
M"JI:*;DMHAG8&L,BT6;/B!M1#K<QS"N%P7R:9,P$Q)TD=$,FPINBCU@JD;@?
M7V+CHY)/X+[L23'T/2\Z<SH8I1;6NAU5JQBLCIAVI"7!"&5%G<P=?I1$O,(0
MBEFH$Y?-7U%QE1!"L:K>=I:QP:8TKUZT\^5LX9Z371UO@C>F?K>TT^_6FYC;
M#P(YSAC^$!1+WW)'UC=CX.FY I^O_B#MX*-)$,</C Y0OO'^\^WX9A7!$86*
M<9N&Z_WG2B<]#L3]XH0I82#[WM.R( H\"CE7U$8*/OB$^FI_<<%D?"TBP(RX
MQ78HA8:,TRN^4?*JKHLL?=&L;]F.7M7MG"AL+R<KL1KPX5<OKBXIXU!IS[8D
MP:0,8-*P\#1<B,''TO&U7=A.1@V]5/V+NY\3[3R$C0>[*D?V7H&T6 <J<@EP
M?R\*U*ZJ5JN(RLKFFJR]?D(F2>8,;2+]-ZKD-O<EF"DI.E)7<V=&]WBV]+</
MO&E*&?W;T$[YEBOIE&/>+ZICQAV^,-OEG,$*9+#QX":D3X<,+RKYVWN#?=*[
MD 4PT*9EQ6T=L-Q")RDAZD\&1\_>/T?]9)DE+$RZ$I5TFO*'PZ?L]^YX@>#J
M]>7S#!5K,(@,]RA*N.I]S7Z\73PEE]PCN60#=?<H-;/*5Q7H9^JQ" JA/Y9Z
MN%SA3^EUEL@_KG%_ZK^OY4-;\B#,O4J 73RONGG,OG>AWA_R'0B 0+)$V!TN
MB 3Q6!PZ RZ]MA?0YM-2^G4BI=A#'K&;+)Y(IC7UE:!Q.<F5]I0F@GIB&9KG
MOL#U&E@H*HU'R5'NJ).L#R+,."/ A #:2*0LFVRL[BOJ7Q0D"A>U5W4P)VK%
MB'%-ICUZE<0927@_'N7G3HWF1.C#PG9>8+$1O[<RX1%]&4+TIS*RQ*=16:F?
MT/6AT$NU$$67B:6V1,I_,A=%>L- R7#DT@GPGS=O,^MRC#UV7QZ:56+2N11*
M*W":B(IX(,R]YS*<-7O#/%-V:-6L5W?3M4C3U8N#>=5JETLX%2*;+W=GNT\M
MK\+/&EZ/*)!R/T>B+RN\HA77<ENJ5BN'1M0W1U C65@\X5NO =^]^W;8'+TK
MP%@"=ZT"^7L@"44W'LY $CQ/)0!PBR#<3HC,Y$:<J61O'''S]8I4[0Z$S 5S
M;(A/XU^UVIJ/]7ERI4E4D_MA.&6]'F.'.+-8R":=B( 8O54BEIDO\ZI1V!'A
M_X7,1V-*&(T@/ 1MD.9)Z%I>+]R4D;W"REW0V6)JN[V&>69\M[:^6U?;:V2&
MAAWY>Z.5]I&U\JBU$"O-ZW?WZ@U+1V&,O((2'9NE,=X10?C6 D.KI$;&0U!Q
M-100I,-N7J(@>(\KI32)S-@HIH-Y$@D=-(?O\6G&KRJ>5/8<0G/KHR>Z6F[V
M+_'"J;]PN+)JNVY["$ET/:9DY+\$%0>*2:C)AP'%WH,5MJ]P[^XJ\3!'V$[S
MRH#7> +UCT.=]IM2DM_X.#)R->7H75!YI"E*=V:I?E*/6R4+5EW;])WA2.72
MYDQE2?R <^2,*I"EK%71FZ"?CJC.PIW-NN*"Z< $-TP".%BNKHWX2'Q\)A@S
M+V2&7,T;\6,2T3)++[<_R3+(Y2U=WMZ8_%&+.FARV@!WW_;XZ+ #1P_]M)PI
MA)Y5SX.O022\6 [8NI/Y"J_S#;^@X7F6#B[.3M-G<)^#'!9EP; /OA:W8 1S
MD>-]=9"Z2O#VW?L'#M&F=)XC;1'S!'$DWD6\IB>#BVU=C8H;F.!-=[VBU"L*
MVH:IF4_K>II8",L$_[88PIO9?>7>MQZRF.*_\BQG"&^D1!)ED;:6:4+M(VZM
MR\OU/MOUM#,TG.W/7*+WV,$Z$]H:6V29NW""JW&-,+F5U(!R]VJ"IK@-I%U2
M<R#OK!4R7X$;-,5'I6Q64]TB66#;%Z,XFT<E:335^#NP^4E.YZ<2;<0^=ZPB
MK5G=H"W0A8TZC(J$/#HOG0O+TK!.VA:'49/!,:N$M^M&0N:E($$*?K0N6 *(
M? #T8]2%^;SE]%2Y^O+*U>BI<O655]&+[JKW;6;CDGSR-/;)Y5?JN6?)UL[!
MU!Q6"0BC$/W5'.WT(X[V78[5?>;J_T2//^EX_,[7WQKAYV]?^IJH4:+$IYE1
MIEU3<(*8P23.Z=!1ON8\5&SWZ4;A5-:_X/@V9>0E:!>:\S )9;5EBMFBXRDN
M)A"/@3D3*,^-H"E??((C&X[7A3X%GX/!#7O$"W,'+P0.,1E0J.OA0.D:8UM5
MG'"@E _73?)5[BDN\6<51"N-.K%=P5\5#*N_7$D4_L[=*3&E1^Y6HK8(1D1&
M7=LN!55Q4PT<CY(SV/DE03=E7G71@9M$B TY!SILFY)"8+]5TPQ83%+..B+@
M6:[<BE*/)Z2;X+ 3LLR0<J'117$9 Y:6J$V!SLH2O[PB'0[9$=0CB4DH\U3(
ML2*Z]W;KVMQKA1\GUPC]PL'Y$9LK@G^LX^PC]]?R_6EF^<M)>###Y] &Y_8N
M>]P NN$\63W%7H]5_AX>WZDE&)!'*!5S_@QE-0EACQ =Y+CG3^TYD(^6JS#/
M4?3&QU4G7F,*7)@JYA.BK$^-Q9)YV?]1V>84Z;72_W")W4%Z8R'DO0VT=F8S
M?=9I9P: ]M78V,OZ6WZZ+S"Z:<CY6IJ>@H7K%R\S9_K$B'.;[8XKN-H-[*B[
M:ERM0G9.-VK_5T4OD-@V-B3ZUQ3ORW+922<R!<2"%)29^Q$]YTI;*AE7N2XV
MB7C4@MS$7[D;,TH^,C9R0.+!H.& %P"!TS$SBBD,X::$1PPE+Y$BPTJ='49M
MLMIV\4/<#QL#YCC:T2$5H.ZS6&AJ= J@.HLV*=YALB[.M/49X 1OP^R#45"R
M==EC;NI*R6,SN^<?TIVE;  75;EMF% TEXXS8T<DZIC$3JAH#1",DM$#X/E%
MEL\96/UNPQX!O@'B&1&-(\4MPIIOE#Y()EC(&CGE U&%';.6AL7E$:PZT6RJ
M:8[G4Y)UD])Z:/.@NL,%(W$%MG0>> WJ@<L?I!642?NE[M]@M&OB@4&T3#W-
MZ&F" !1QGY$9_K[.FX)W[-OO&:M$!9UP/E>KK<C7+7=,M+NUGI G* O15$_R
M$*+F&X66W)7=Z>&%$TA>S1O3^)(_AJHF"\IKDWL$X^8WA@Q1;4E ;N?)6?*/
M5B &@C2+,!4S%HJ;B:1./A[CT42%+7SQ/C0.LE[.?&PM162X;M>-":>M2-G;
MF0U-D7&"M:3WUO(,+8+W(,3/:,,.Q(A%@]DWI/X_UC#[PZ/!*"QZ!>8P8P.E
M#^BE]8;\21SRRT$?<E$*PVY=WL,D\CR\7&UC\+:[J6?V(.6"5*2Q,"D1Y4CD
MC[BOBC4>X,RDU!7"40$DSERG^7RLM?*@A\#;CA31N%.1_;T MB)Q@K)0F3;7
MX\@UT(CTU$NU\2-LY=0M*1\RRX_5DKDD@SBQG?/8:I,B8]'5@?VKVZ5"_D^^
M18@<T+OHD+%Q"SX]FVT5XR#WLV3\ZA98(%6^HV3[CBQ,L$;!D_&5!$.#N&AC
MW1@3<O^XNQ&/7)"XFG6A)&*GC96]\#II\# PW.\0C*;:$T(<]EV\HQU43&ZV
M;GG.2%%4O[WC7=>8):U:>\'\1KF9?KF<;=0SYR)SWQLVU \V0N*'(KC#'\6@
M7 2#8CI#W30MTR$R@E6\G 2S[=N98ZF%]]9?5)LH-@GX<8KS,&XG/NO^S4X]
MY3LW;!*.X"U[H%9@Q9J*8B6798T\0*RL5LZ1%.BVRO& HY_ 84'F4T'O,WU0
M> 2NVI=FO.*U0V""GA71]K03DML1K(6R3 M B.^6&[<= 3?I*/6'*'6,K'K+
M@(GK-^M6-_W&M67O-HUI7?2B"&+$0*J( 48*1!L1 O.\FJT;S?;;N/%MZ: L
ME(AJF-26@7@"9JZ8:YI(9Z8VE67S.+3P(,3V= 5I@U&D@<$;V':J!H$U+_\Q
M=J90L'+DL?+[<D<&"A,ECU'^JQDB-4 ZAMG)16GCN'=-J/7)4+9!_UC(!)IQ
MJ\YF(,0WM62EB QE"3( -[30F< H$%0ZJ^,R;'\,&_EE6AH'6QH:O;#= Z'2
M<>Y4R.7=VC>H:!3">M\$%2<9Z3R.?%H#0B6*QXXT>W+8W;0YT\[F)-_;WS3>
MC/B9HLD?2)8/'6?T<SIWZ&[*_>MK]$,R7WY8E@7A%%]TN-LE7GO#_L5>H9D^
M&41UF\!#SLDG&21GRN_KV=HDFO#7B8HBT_'2P3Z$=M,.TM'J 0<S=J.-G,'>
M,7D %'\+(F:J^R9XIB:2B]"EHLIO%[70BA.."5&3V"0@19.JP3I%@U)(J$>E
M)SZZERR"P453\P@#>W*'2):(=9RP&4?&G ?DDD<:BY7QRJ?!2Z-#SAJ@>AI.
M-S0,F1[6<<"E(^YVU<1X:8*!MK::-/'+'#L4SS=(_YJ('09?!GT>0^CP5!J0
M,6<*?*9Z>BJ1?GF)].2I1/H-V(S<Y@LJ5FAU^L #I'2FY@<.K5O."V\2\)')
M68M4X+NQHY*V[S(WZ=<Q-TED;APDTHT%'Z0-,' 7RZ?Z*'\E8)+[CE$W$;VY
MM^F>D8+@1(O:\H\T&L&QY#.2ML.G1HGV"G7M&3'DL:AH^:-Z3VA-$VYL^FK(
M_I5$J]5W$\$DW3]GH#*_7PX.ZBY.1UR_<4D:'-C1R%W=:H</^\XQ47JR0X9?
ML*X0D]RVF#X1@TNR;F&IB.,FS-7W HYGFRX*RPK4(YN/CJC( PJ;-8(C-1"C
M(BKR+#*:#RUXN7!4/YAL2F)<=*U1$VGMF(,A&1O!?':E8JQ*YV829CQ2!:=D
ML5V! &DS>'VXR4R\FQ/7J@#(U=(*U5.(<2'<)002OMKU1W//WB!,]?4?MF?F
MDA+HOK=!-TYT?&?I8CTO"1+F=-1\BIF8C#:' NB5O.!??]NC$: D1?UI..&P
MUO3O?SKZ$_V\Q!J'_%P5__ZG7XM!/CP97TP')^5X='HV'9].CP>C85D4%Y/B
M^.CL3WHDOKAY\^IO8"?>X;6CXY;/]O0=U511,.UM/4>U=?H%=7]5T\XIYR=\
M5DY7W:,.'(4T_;^K!O^#_RCT?G(5?!W@#XC3LBH>^]QW*;4?P,[0.X*3@E-V
M<7IV\=UCW\;B6^^WXP>0%?,GO@Q="M^#I8M5J#MNP9 %(QT8WQG;/0P'_Y<>
M'?Z+L_TMW__963F9G S/3DXFX]%P,CD_.CTYN3C/IZ/IZ=')T>G3^_^M[[]#
M>9YK1LUU"C ;4:1)JXM& WAKWI1,]Z0LUHV"#4@5,6Y?-7RXK@8;T^^]L@;'
MQ?1\?#X:3X\O1B>CP?GT> I+[.+L;#B9GIQ>/*VLW[JR7(VC _8P$(?$P0'(
M$;(RF*E;>$]/$EK@*![0E14VL5;A(L01MDJMBGY<PZ0^K0T+[J&#VILE*\?G
M@SP_.C\['XQ'YV=#^/=D,KZ8C,[/1V=G%\73>ONMZ\TGG_Z^J/ZU+M5=OR[4
M!^ZV\\B"I,2@]*;Q-]51DF_"BGKV]Q?7S]-07*:5)&2/$/!BG&+CR;GM0;Q5
M0E^A=QY@.#;0'V;U&.+-1\?[ KZ+6/OTV0\PAA?/][9V1Q>#R03^;PR#'^6#
M$UBQIZ?C4W#.C@>GT\G1T]K]K6NWTR4=JE9;MM, 1U%^-$ACN*ZORK4_8_*3
M*DS4^%Q(<E([X1'U8&L7OI(CD6%#;P-C 6Z-)%Q-/M,BC+*M/.3";L=EK%GU
MGN)7ZJ^.[L*@YUT7A\%B&T[)2?ZFG*R;[Z+]-*F;IIP$_FBMM'WV7&U/% E/
M;=U NX^Y;H#Y7!N/W+O%45-1%Y&H"QZXJ/XJW$ERN P#%LA;U'^+AJC 3I[[
MJIY%9.T"K@VY:\7:R[5M.'P/0A;LRS2<3\;@AI_G1X.CXQ'8@O.+X724%Q>G
MHQ/PV\O)DVGXK:9A5P/LX5=]U5^1N";BJ)&.@YXNU6Z1/1 *)+^)4,!DI?[S
MYJT)2/'I3H!'C^8W3-$N4'\H$'-ZRED0QS C%H*R;?:@F<,N;,52F2,<8*^A
MCTS&T]*POHE2T^",3%$<^*X,73 &5$$/AN&Z8'RIEOVJ'#=KK+"AO'AO.5OG
M,RCM/C:UK\/<)J\(#?=VS9ES:GGA*R*I \2*=;,DNGT8]1B32%.EFQ ^L&:A
M4&TM)O7T[]D4SL/XA!T79@5!Q/2>KJ/K_=+<Y@N5&\%KWL@-]'?/KF]^>9ZE
M\+_IX'AT?O)7E$?C$ATR?RJM6 ?&7/OY)&[J4V1B$;6-1;>=^6,+'N:)56KH
MZM17*KH4';Z-[3V ,VQ*:T15EQ/]7V P37:^US:-\:LP"6P+W$SLGP*+Q2[=
M?)IXC6^T)F7,:H+Z/W#NSMBO62_L1V1$6.J9[GFD'!9<1-01@I2*($F'<C_=
M?J_,<=?[HG3!BC1<--F)(<J]58_?AW3<^$J(4\30 NMJ<YC>B(8H9O8S=$5V
MP=L?2@)0^&7(J@..Q&5'OI?&8[TV.0GMEEQ(<0^/Z7X_QHD2W7.O0;X12@/R
M& ,7LY6?DC87"-VW3R6?E>.3_'1\GI\/\Q'\O_,S^+_3T=GY<#(=#H=/"9_?
M[*F@\- *5]FL7*VHUO60-U3!M%],F4,)??Z%+A*!NL.JG30F?E'=@U5=E@N6
ML=I?MF9R/AKD%X.C27$VFN9Y?I$?CXO)R?GQ\*P8YD]UA]^\6%COIVS2F)&$
M<%K8]DO036S/990*_9YDH?>V%L[/CL?G93X8'D^FH[.B  LR&)^,QM-A,9I.
M3Y]"G-^\%B3"SAQ@CXOX>3%'9Y<*4M@W7%*/.7>"M67UZ[HINWB^_96HBN-\
M.CXJ(1(^'YT-L#AU,2JFPVD)ORZ'3XG=W[P\A.>4^S(MJX]K /5O2'MKC>KQ
MK:P,UI!O[]:KHG[P907X^]Z6Q\G1<%Q<C ?'X\G1Z.*HO,C+HZ/QQ<E@-#J%
M7SRY'5]@/:8(BB><%(D2:%L<+!91J''D#4C/\ @?9XQ;7L D6TF*(*,%=Z)U
MK,W^RI=E,2A.IM.SO!@=C4Z+\J(<'IU,+N!8NAC"9\NG9?5;EY6>1;@4D&DB
M+"*"DG,KW4:E>.)R]A[*V.-\."F.A^='X]%H,CX;#\].!T5Q5$POAA='P_.G
M=?!%YH5;M)D?C#F>;3T$13 S"K!$]K4.3@>GQ6!Z7HS@O!F='^7CT<5)7IZ/
MCH:G9R<7)T_'S&_/PZ^;=BU0V7DE@E0J+_Q'3,9?+C;2G#[QTCR8(.KM.$OC
MCK.DVW&VQ3W01EFCD/5V[7R8[)G<Y8M;IHTG+LIZAKA0#/Q1 YN[VZB'']:7
M9.&QO]+(I!-+K45]"RJ;[3K%11JYV,+\^G,<"4*QRKBL6X13L]9;:..5!YN*
MU*8H@\F7$X^6LHS_4YO#E[<YG#ZU.7RQ D<'DNSJ-[]TM"\/;_;=/^KU5&E(
M'0Y^J^3WY/V3* T-IV^) $-?_>>F1#+672:F2)(^A8-=6\A<":Z;4R#31[66
MP[\?&M>^\>3%@AEB9N.R3/I:JEK:".>+:R___AR;W,_^<C8Z0>_R]8NWFCI'
MHOIY1+8.7QB>FN(;M8E)HDS*07_?NM>+JI$*UL7Q7T;#O[Q\>97Q?5YPS0MN
M:*QHCL3_=ETQV5-13]9S:YE&*K]Z02A]Q]/,4YXE??3XA>^:4%AQL.2>]"TB
M>Z,.^!XNA] 2@"K(-5+J;%P?6Q;!F*F :@SR.[I0G2@(RUQF.Y9&9NZ?( [E
MG[MIJN^KVXK_F>Q0!=GK7OR^G%+[?H<<05941)2KS3*\"T+Y)QS0N) B=)WR
M$CEVC2*BDX;SO_I W[UZB9W7@2*(]QXO4!$B17PRO65A ]!73]8 .?@[^A0L
M[1#Z+?&"S/3#Y\Z,R+OJ&5;_MF2]VW(V/7#-D;*O(ZY$;DXF+>8#U6+6+Z *
MCY%^_<RT547Z?5UL'"LZ-G_V?IN*9D24POU(Z"JMP60:+:$;AM6%.Z5'3))*
MB3!1II/'OAY->31B!@P0[<[+] H=Z"ES:<+EKL)[H.KB8EHU<W0\T3E"U06A
M!A1BK+Q_SP;0>$PYQ]F8<$[TR(F@U=IZ*]SHZFYE:Q1=-B()3:*5*FU<Q@8"
M2]ED5B#L:YT*+?-V]'YE6XA%J+4+6*2SJNC,'S&XN D47$;@"0$3'5& @^W/
MS/ KR&W.U"%\@V<L<K&R7/J"0*M*:J"2VKC-U5]F@I,DWO(O7U[JME\KQ"%%
MB(>7Z(9KG>$R@_^>I\]V[S^A)L_"E,&?A5"2_F1KT+_()&(P$?4_[;+K%*FW
M^B^%SVU11Y5T%XL$>(_P+0F(!N(\QI%/N[ D)=CF9BJ:#Y3 V_#^W/A3.EXR
M!%. (W=!S9O1NK@OB7,=UP7-MLW_.)=V4+6K3) FACGI-\PO+PE1TD6:H,&.
M[3*?XT0+.BDK1-BO\LZ6W[W-;7DFN#R5/TI\)B'W4(R.?S&E4:+([A6&^J;T
MJDS^E&$+F2-*H!7:&;]HA>,(!B+3IXI[D6@:S1A^:MXYSJ2ILUZOP@V+M=%2
MA7<H;Y#!);@75!U<64\+LL^AMS+YF(WS._SMGAE$M 68(X.?#FTOEA\J)Y%!
MT_/L_0)+*KGI+T!,!I]23%B6Z&HMZI))\/D=Q4I;JOGYK/R #+2TA'X&3^H.
M*4"OT>0O"O6 PTQU/X%D$JL:0B]L9QR3U  <N6(?$AHNBC<_5QW3=]O'!](I
MM3,N+DX;\+0?ZBT=4QULQ8 S7"UJ[W?Z]"U*.0\Q$Y(0+JXLW"!"VL2D^YA)
M7U:G2@%T!UNH&V]F@9X1W9E@1^1VJ!VNEC 05(GRY@QI,1]V/",83-'+1I?$
MW\E-X\>>G >D&1H<#G:OLR(]VM\DF(5G[(ZA@-"\8BCZ<RG]ZZ+4S2WRI7__
MZ8J/)OJZ40O39,A'@S HLB7><K!B#.7P_.LE[^1$>(R.CYYGCH2[0S[2B9[C
M.6,[5%>$S)9=\?>?8$J$0A9. V8Z,L79*;\5MDM*L2<O_P=L^T^_;RKF.I%"
M%;'3-@@R*\H#,$NW@>$C;MG\P[!!WE#TA)X^18)>9+WMPO@8"L91?* 32OPF
M47G5<E8B*4!T/>5+9'6<24X87*4@$UY-*]Z(%^]LM<]A*K@.?8XQ!48)B] J
M(6Z7F92K@H']!/<G?YUL1$ULAZ)YSWZUC432AQ*\L)WESXHC3?\TG&="Z5%Q
M F2'HH-_A_SJI,"[B)H>6'U6GGX704N_E*=PJNJVB\_C,G:;0Z:%'#YVW0D=
M&,^3@:5AL4RP5,]Q/(.:N9VCFH_73<L(PGO$V-[B7H#-NF-J]KJ^B41$,MD.
MIJ[B.SXCU5U8\ X3MH.9<IBIIQA6?W1$R%LO%SF%10)JQQ2^J"58Z3NZIZMZ
M;SE%]/5$->Q0L$'4$&N.-Z/$O@;Z[%RR)#/K*;#G1#T_U1WIO4( O195Z*#Q
MJ)6%'61A3. \)TIBV V8?L=7/EU3I[ _I+<Q0;G8 %'KW+6@\W%3Y\4W6C*?
MF)!E@2\X=@Y^JB;O,7V<I:_@%91(9EO-^<7\0H_Q(W7T$/'3JP8"?\KS78ZQ
MI^IOX-/L.7F[-<.9B[AZ=(;QD=_+(R?HD_6U ><;9<-QP@CZ+;C#& DI'2<W
M6*#U0@20(Z[.:D$M6'31-42].3>BH2> -KPPCNZ[,,G1WN!N"S38_Z4M6;K'
MVY)\2CH2E&6.L:JTJ:PRJ,#5J&G^ _R+,$HL=8'8):HYX7!@W>K$Q<,B3C?E
MVZ![&[/K%D5:8,U34NJU@.J<[#G9@BD,<T$9<$VPM'?5DA-Y<&HM<<FBS;[;
MM##&7#KB%+JN2B\ZO0UOL0F="SR4.'W^3NE5G8%#D/MRK4S%SMRQ-9#.VXW1
MYB.7\%W>C$41'3TILC&B+<!E>,T.J,B$G*L]X'076(05Z]<I<YV)C59M>Z2G
M[.OE\*-#XAU77R0%/"%FDQYC]VGA]V>_07C<I[ E6O@&O!K&Z8M1<U\#.]*@
M'^B;F$7[DMBJHGM8QX)R*E<8D<U(:R[PGN,! Z?%FE*TR/Y!KM3!>'. _TTH
M'T$2>>3,,N1_Q9TY=#JQV!O,#?<Q\@:,IE3HXYA_%2QR*Z\#M>LQKIR5Q:UX
MV1ALR8==%I.W^2IQ-ZE6/9SX;I7AX# ";U2NE//[J=>W!6>-<A7<E*I2CMBO
M@-N6%E!/=Z:LFJ3_$3%U2\2_E#6=DI5'_5,TYFM2)>)Q$ LO9YS:SI7CL^$2
M-J^V8;VZNM2(^ZGV_.6UY[.GVO,W\([Y6(2E:N?\#O%L3)UVC4I"NPZ- GQF
M9KW/%#60&"$C/IF96_Z(LI8?W6KB9:QJQI>'L#"+MEZP(%D21C'/W],(UFW_
M0.9Y0;>F#GL="NLUD'%!;TBLDD!NJ"5^]Y U.!93XT9%H[^OJX+[1TMRX6U4
M*%>2"[LN!($S543!GCDPB/ 2RDWGXNZ1T<KS_<U BN'!5Z4BD!1RH/Z8GL;,
MJ8I7KNGLAW>ZVH278Y7^V ]@YR L%E4A]7SK:+TA E$\CTN0)]Y'=#Y*-><!
M<-MI0\Z,_4[(\SB)Y:A5Z1VM,8F/;2ED35IFT2M*\"IX/MVGIW9<9(E=/**S
M,;(:9JG!,YB:D46!/>T4/P*7O5N;$B32<2WI$^9?KUKC9G0L@8GS]((_:*V,
M<=G$>[OP)_2(RJ)SH$*0?H\G+2P<=&Y"JG'*,\)-? ?$K?/0K@E#@(/%MCZW
MH+>&ZU3!(CJI\**I]I[/\U"PP70*<>N: EZ%+(/864@)$"=,=H5=GN8N%%SF
MZ.K@II&(=;ASN(XMS,/TRM:HNI#B^8RIC& 58N=]F*Z-?@:+PCJA7E\$X7GE
M73Z;J@_@MSHVQ\!890_"R--5/C?5J(GP"U]WOX@/3<24%!.!P4%I+^K 3.0:
MB@QDMHL207-6&I.7R68Q#%7<X#N6EM3".@H7B:N-)H*Z_-B=6JV8%RREWJV>
M428%@3\ZP]RZ+1%@( )3TA08U)'P>==^&!TG20,U)>9?=1%QN=[W%FY,URAA
M*TQV+\1/I$\.9I:WY!*A+_EDXPZ4*&VE-0L"-M[>-KAC*0V.NW4VTSBR@!V3
MHU38*\ZTM:K0#G8$'R'LH]L<N0#2<57+K<OURF R"MA@W9BRU:0[9W.*CG8>
MO"SDVQ:()?HN!:II8A K!YCFZ)V.9M(3VX9WRE#/N4S5OQT?BD;@F)^58#C8
M=(]@#8G+&%03HC/A64&+2>"$:1K,I=MQ2=B:N!"F:ZH$X;YBTB]F#N#:E)EU
M1#C1OZN""&3E[.^HAG)7(5Q! JU3+W2(+ZMJR60K!;:[4L:!C#1>NS^0^#49
M>R;;(5O?=\KGDV[X H;ZGM/:=)#3!/QS7=SR'H)?21PBHWEU==EIK^YD&>*D
M0AIE%<3^A]XI7E7CG#57Z?O.G.@9(M\37#PQ]C=$3,Y6TVAZ^[ZZ]YQM)S34
ME:10[I#"M@".3WUZ>PGO>W<ZZ*:@ ^)=YS?!\96J\WOI4@K>+%,N1LZ>&Z%X
MGFR-[$/CDFT5=E/#2EEAK3#K+BPLH*X7F)B-CS&M<M$NK,E%D:C:*PBFSACN
M_97QV-&S9*T S:U9K(T0@07[??HK?D4J A2548.]I#/%%07'L<1%R!F!0]P3
MMZP^.C8U3RV?B(G:<Q?Q/-S5RGWM5 "BW";ZP(N-/PR9@WS&,@9&-\W/W&O^
MC B<!18:BFE:J1]A'0%_QGD4]BXZBJ>SM>-KL9NO5&9*,[7WI>9(.*6YAL.M
MWZ<6G$REX#3V/!,]0PDYHYL+2V>6_MSW$E0KRFEYU$L4:M0WJ%SMW-7+"16G
M]%>7V$8Q30<7%Z>6O/GQ^LVEI6]8JVM"7.^%W2:<M;R<._GR.(PVLHT0IU+&
M$@YAU#1&^0=J4D%E;PPK5BO*F(K&#OVM)"'&R1TL=F9L)4LB_&1<0\SP$&,Y
M+<1<]YQE8-10$P9SWMVXA.-!B !*#O=5(',[6H0#G,4K&6MC=A;) HJ-\<G5
M,Y:N]+ERV0>Z:-3[(%U1N)\74J90!I9[0OGG"8^ G/*,65T6"R:-25WKR0P6
M.I/@Z2E/=$ON7-6=^,BK@)CRUU]G<@RT*P[2$]D^/=<*3Q,N4H-[UF#?"QU,
MME9B[5,Z5_P%<><O1%INQ_#H6.&>QLSE$"2EP#X0(B?0G5F@<"$$WEQY9"QF
M2&M@58*#G_><A-C8W[">2ZO'LB%M/.=)SYQ/L\Z\9SUOGKAJRCF?A2ZJ#>V\
M[COSG!A)P+);]74F.: W3/V?(+RH# '2Y72*XL=HHZ[P"I<3$D\QQ(U$?V(B
MZ"/XM9?@3? KT0NP:7A;X@S#O^6/DY7,,Q/X$R$4EOW%:EQ:RC>S.[)A7G&U
MV,)ZKY5C1:MMB\*;BXR1@87R[>2^P8&2!<5X.(LYEUU[TO:J$,/U7_HY3MVG
M4>H^L\MA:4X%Q"S3OG>S_T;+7[ F)':X66.E;%%&^7C_2Z-',S\K7RS6GJ>2
M3*G#BCHH<]&L.^"CC)F6.&<4\CD:RV0NYT5XQ:G4W["2@\8\T:70JR4D7P>C
MVV#]3X T:$=H):D@!H262)")N8NX(+@BE'4U1Q<+7^DTGV-M:4[HX*>^N*]0
MFSA_JDU\;< KAWP,$<N[7C_Q-),S,-E(>G2R;D174N$JL!%4SK(G?6[,?"VC
M3ZJ%ZCPZ@%346$M6^)'#Y#J(^Z7O3'6'%#Q?PA7!LYK03:\4<R7?\S;JQ^MW
M+Z]^#'ZG-$Y(MIARHY[#W\./-(CI@]ZG,!UJGNC(J,IMZ3^9S\PF4U!M:+ <
M1[9>/P0;F+<2+FPRE6+$(K%#120CN!7/:QC(]L?Z(SB>DTR!X#0ANV8!6\?>
MP[.9^TX9>UL=U@G'JNL&0^"%%-32&,0[BYL%:EL+H?V.VN:FU-A!>M?A9*X=
MNV5F3Y03S(_;,NIIDJ?16]G8B!'A3(%M)C@RBCW(::=8CAZ4>2C9DY*WQ"TR
M.R<XSF#;W1-Q(QCWH#AD1HL(Y"'JG*39/907P\$1.+OEXA:>4N1Q'\7;I,:6
M['*#$G9OK=.L?]KY$+3<//_B%KT4@3/!4=% X!+$:K&]W'@9258)M?-DG).
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M5S=S7+T;\[.I\YDUA<C;5D*=%7>5'W1=)*$U=SLAP<A*@ 8(O* K2IKG#GZ
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M>$D/?.0(W8B-_V.L1F/8<:@03;$&:GQ&(BOI\R^+Q$C_!R,4$1B<H]/VKOP
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M,?OGMFHKDHN"]4,*8J!.41K<LFR3)G*D0Y-+L#%(X9PTI%IN-Z5>P+@A26<
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M:$*0R_F.*X^O0-DTRB8V]%=()TAD:ZS!F]DWSTT14#D+F:$1A$F)&$ST$8V
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M.&MA5<+MC15> #K?@MMQ7,F1.%3D6#%_/NWJH8))(V\=E-1@96*:7!=B PY
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MU]=^M;IV+: ]!#Y$P!"@@D%@2"XN!A[^IOX =2C=E@-/WS F#))H8=V 6(D
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M-T-&A6Z3,GAB:_+]89S&]9>;.M[NYNT(I4D/EWSW4! 3L6& B'1#\_3-Y:#
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M0X&_OT@Z<@35XY-N!KV]7>PX9#<4;EUP*,1@X.$!.P7G8KO">((1G>%(A0L
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MUQR(B*0*UCO;-K:TMG0O)+/-?*'7@ED76+WT*SCI5\#3 DTK")CG8P/@$VP
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M69'[V@B1;B[\C;?\^XM*PW-T\3KMN\A75<_=3%K^ ?G7,M.U]K]%6N0X7])
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M>R:S";3$'4TW4!PWKK/LYY^O7<G#/%'XKND_]E$J+/-'[NV;&(F@%D9Z]BT
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M;(J#4@A5G=S7IJ33(ZVO;BVS$<.F3[4A85/YR)]PKA7)Q4KI"3/U&7]DQ2:
M%\\=,/"8W 'U0B25=DVBZ^&3L^C/X-[D6X%5H(>Z_A3U4N%A%!([#>>3LM;*
M\#;#KB8WQ#0\N(\ G] 7M10+6NIPQ)D1SS'F$1X!PWC+Z%A4'#=M>@7!T:.3
M\2!-OA<R[<]H?'?J1E9G)'+$+LWCV5K-I,!<5]P02=?(+KK]Y:Y^08 V<2 %
M&O>IX;D9>B5#9-.UQ,;2)S^HBSGY@;+$=>*&]3=4]F9WU_8Z41E*4IN'\[F;
M:D"/(7= T@$NE=V L].P(I[=T3^ZO+*= ]<-Y"%'*9XN[=J$D*-Y),'_UFV&
M]1#P5SM6S1[6EER 53U1A['- $.#.V[?Y2MC4QSZ*V,ABW? !?SRXJJ]V8X4
MMCMA&\9M\#) )*+'@ 0>ZR>VA'FH\86Q3-B.933&^+5#F6#YX8$'B#?GUR:9
M27Y>>J@<BN8+X8HI<R\@IX'+)ZSDTS!KG5^K8YVSCGLW]3:W4B3638\9"S&J
MRHK=/M#*PB1Y#.VF*OO4) TP*\F)ZDNKH;B:+E2L-8KPT\9[9@;3\]ATZI;N
M>*)H<\R;*?EDBML7?'6U 9,9N37L?XN5)-R/&HA,]"$OY![K8V4&+%=)8^.V
MD<_<K*-^K /=915WAL@=83LF[ZF?9 M@WF82B7L1PD6%UOGEG D#BBSJFEI&
MAF[$>8WOL,9F(&O*@I0*F$2_1(3/6I00LYY0A)3@9@ C[:>VRO)M"LEK.*]!
MZ!R7HIF'^=5MA";S\,L5OH)VNA\%H(@<)\TAH.09\50*NP69Z:@T67B%DJ=V
ME:^PE?6YJY+E"DJ\,\MX32"6G)?APQ.[T=WG$B(AN*1%759YKKF3\B,# <F;
M)^GK)E(J8UE>9.ZR.+X6 ??F\7K<KJ,%G6*\*-C*H[=H&>U^@^C)!2^#R#D[
M^@KU@?>1BL;1&-^RF9:<^"KZ=;6#;@ZX/C5<-B2*\B/X!;2!O3L6E4^@Z=@I
M88QJP8,"^'++=#B<BY2PB!--B831+98C@]_". L9B5*&=JG=8B-);O^0>8B>
MR<' I^?;&WDF!VEA (G>FQ@__#!P2>79L52F3>=P51=>&/QB*Z05G4H7I&5<
MU-7EX^;*WHQ 2"5!@Q<9(I+R!'(8714=#8T$2/I\T[.3R9;'2#^K(CM/6J4:
M;+Y7WTKUQ%X5X\ =< EY(8-=/56,?XF*\>%3Q?A7*GIE,?2XQB,/,V4EA[[F
MIC<:>'<8HE<2?:KRD;7-NS;N8C.C-%O*O2O'D\N^*XFX/_70LP%=:F)C )PK
MKYM*<W4)*(:*%(P(0T?GQF$UQ**Y:\EZ81Q'J@P('$A898PNB2=&:!2P;!W7
MWDUMH!SR/^@&VHTF.6OSD*\)+Q3_YMLD);MEX#;7]:T%ZN^:CS699.I\&W_-
M]((<]UF36+[.Y %19_,RA@<OIH#<11^'/:3RVOEL/[=D]"J]_*!CTU!6VE$%
M==\LXH&I"< X ,8QF6+)#Q/MQ\9&Y*B;M:RCD:TH0LX*/-3DYEW%R0RM6G0M
M<=RBK>D<< H=L3?1O'%G;+F64COB@,H_EF^=>%>_7Z,Y'F+#H4_SCXT5Z?CY
MY8X*2K^YJE>22A)6$_:&# =8(E%="UJ,R1KLA3P,6-Z^9W)N:?IT1RW8.5"$
M!@D.9U#O<MT*Y_"ESV7NS;#7G].,=)UO7KX=V\5P([ZI[CR1;PWWD7DS9?XV
MJTOPY>E,=I;O>%"(4TV'Z\YF]?6:F9X8>6O$_<G12 <_>C&K]I/P)2R$02C^
MVYV$)E&OB>-(H-J6O9GA*GB>=%^T:;OUO%TT[1VZ/<B?[M7M/C]LNGU"")?M
MG1,,]RX7B^&*@JPE:4]+D.;R62&)_,"%H )LJP9X /-S)=OBQC*(>1M$0 RF
M->AT2NQ?TMJV(1[*QI6$N)-MW+Z-K@&?9"Y^K5IT'M>=7P-,SAA^"2ET&4^D
M?,9.C'4PAU##<.9%L@7\P%5ZW<$TP.1LN_YOD4C4'C++AR0<.^4L9$%%*GG7
MG/MB?.DNTS\9\_:3CS_^K9$64U%;(6=:%;'R#3E;4+-']3ZX-D/_Z]?,=L1E
M/2E@953BFB<<R&T14.JWGD,._E"19WY7T:F6%;^ATJ[7/C3- V-C,.55K$D:
M&*,E:/@&=(G<TJAI""ET]N=H\'#P3E@>L^*;J_+E5;S4")+PTF,H_=;S\(0A
ML$6Z@?4QBK'EX'43[TFK3CEY^CAFP:X%K=OZ&[DI;T9N1RY1NW0?TKJM)JQV
MP)\XX2,II+Y<TI'FZD:?77R+[*=PO.*+6RT$S9MZ4?D!=<ZT9TWXGJ1O^PVS
M%!D5%SF;2MQ.;FL3TE_L82I2)87^@&3E5P<*%)\>I!6BO7:AS<)P*TG!H>]5
MA>4Q-='K9J&#J12V4'B0@LPK0P(RE9I!WD#%CS!(\FV]G$+L%-YRTW9QLV_4
M=]'!.LQ$8?E/3=QO^CLR7K*<PJX5QLFNF+T+FR5G?*"HMLZGUD:=UG!(C"Q(
MLP]H'\ZKJV95%N'G'^SQB9NCG%Z*_6G6_DQ:1R2EE?5,TQ(++NG.9Z*FV%Q5
M"1Z(':R1Y]U)-J9!KBG&5TJHLEXDEKSD VC5;-!M2OY/*@\1$&>E+8"YO'&S
M!GW<.$>0<!>:&DM&8^#GKBO2JV0SP.B7QK<ANPN[\4S8*-(+C"SV\\F6D\3-
M6IJ,IGT;2R_2;?/G,/2/<=I8#6W4$3-N%M&_6:4RYVM!X3!00CVW" EG/[9+
M;!0&GFI:;^5V-N?;*0J2),?@G;W:MEM)C3D9$6IF@7J-NW;(HHR[2+?G;@!.
MR%N!.R.(:&D8N =OK77LW\YSXYXHV5%$)\J$D"]>O<PPA)Q$YB7+MGTO?!^5
M4ON)J=J!YFIFQDY=;$7'AH/B<.!*ZNRRW\(44Y((2+]$(HLP)VR7V@VJ=CO!
MQ(EWNKEN5_<JZYS5D@D=EG7I)XQ/'9N?7RW@2$@6[IT1]:N-OV875[-;TD$/
M381H+$,M=FT\.DL&R:>Y-+EMO4\GJV7*98-@SX;3&46>NDML*^FV"Z/7W4+W
M;!,I,YT+ &"HGA.?NW*[Y^@OR1/EA<$T1(.Q9-=2CK)#M[8)<)^'JW-OGH&^
MW 7IE!+<V3P<?EO*;K0?ZY!;'XJ-&6AH#G^";B3$FM(BV5Q;B[79&0 &#P9K
M=9M&H6M55 O;";,@D+A4JAQ"X@HI;15>\22E3H#>>+;B@\XWB^@ES&;HZKI4
MDE3=KX',W"6%8:>=+SN.5\W%LY*L+Z!K(\@ 5)@RPI8[,1Z><26DJZ:)BM;2
MH?I-7]7E"M18J8F\^3&G/ZF,[6+39ZF9_^GEN*/_S>6XL?KKORS>W$:=CFDC
M:7W,&O3NT^%I>(#TAL/@;E*#@WF)ZBYK>A0T/\@#?AUM:91^&% I6O&JZ<G/
MH>Q0S9"*1'LWL+TI8H=FRV<:\4"P:$(\)=VG>F!K>7ZL=XSCZH,7>H?ZG'9M
M64G:3 LB04 [=O>HT4'.G+4?&+H'(8U_5NY78,ABLW(OFT,8T@13- !56>&7
M"#6J,&9-A[TA##S,7.A4/E#8O.O%D2S?6A_/%RX^("CO+FLW(LGRGN#+H&+K
MA#QA6'.#R.,5A#Y5[:@T/W%/JB3*7")36J=VS)Z5RZ;-?E3Y_D:(V, >*01V
MI37<J2+H?6I2^L)D$0([_$S/Q3:5N[Z&2,G1=Z<SU$:=O4K=9])G,"!;%?JZ
MVE'P4L-3)EY%6,&OVG3, LY=%Y?2Q%.FVHM0TB'EPBX6ZAU#/M%B ,72\J.$
MZZA"%BENAL"S= /L"3(O=J'P6\:DT@,/$D8Z-WOL3-!+$&Q1AB=3]IXN@<6U
M[X%+4*B)"#X,#D6",(WV4GVBLEQ45=XY']02L\_3V"N]D%564YJ%Z:28 %&[
MXI-]X!?.>[:\OJ?<2J[N3>@T#>7&BCMP/EZ:6O=W+IOT#4[K]0WMC%NEX)HX
M4*LHW.6RZS#V'8[T(O5%Q8\0!2-WU4@@!EY'Q*_8'T8F\-.R[.EDG854US@=
M,")JA9.UKR8T?>-= AT8<U\20]Y_BK!\'5(<4YBNX4Q)9U75Z!@T:PX_1HAZ
M1YT-";1X6&,6!S YMI:YC' E,=P7GI,U19A4R[#^HV(7ZP"",1GS/4T<.AI(
MH"";V&R1Z?7=9@'36_(9W-[QVAM2-62ENW*5BEJWUB)E[6V>@2&;;%E:8Q0_
M/N)DK=R*HQ8_FN<[&?<\3+@1GG2!GBO6M1:*9:CU>F@=76D92>[4I!OH*O%/
M7+//TF=].]%Q978*G9ZP6ZK^TOJ14$^F^-6!O,GP<6\P=0%Q/II;86[J+!5H
MO.%C3T:A_*>VJ09[9]4ZVN5E6V6C  ?\J.Q1\W I%G>Q=F$6UQ^N)UC-M$#]
MJ9',+C>)]HG6\/4W+]VA=*,HIJVO05JQ)&]NR!L34[DSS)INMEE*8=F0"H/E
M ;XBSWDF-#DPJQVP9M9?6UAJY8$<ST$ S5_GL*<?$[N?43P,<^<\OV83#4W(
M5LIR$XG*7)N8S-]_;#[/SWBYR=;+A?M>;J*,H=25W'.Z$XK#[B98/"8R4YQ=
MU#=O^JZ400<[\_3I,L$N RB;7:?W-QX,(MX.KMQO_QS?N6J7@]OHT[XDO-'D
MCZ.W&4U]%79G?J]BU_W2L$*F%B(5SBC1!;%G;$!K8(_#=TV4I_)XWS7SFC)_
M\GSW/!&HA_%41B9T?S7)+:OU8>&1.,>G);-FK>0GU(^_;-;4E#R]]8,?%BUI
MPD5Y8Z0BJMUY_MVH9&(,<Y>WGJ#+M1X^CG/[BJRJE9BO\16'8O%4+AJ/CN'[
M[6.[RF\P:UK^]ROF'^-:I[UC+'IYPZTE^?5S!GUR-?79*VU<F&2=<]HC1\V5
M^!=)C\RAH"^@WY(MD-XD-'Z^_.!]IC3IJ^:B9NZ&(!]<L2&==I95-V=B/+^D
MW;_\#9H>?[GBL"GXAF%O/&7&FYO;G5(;AAM1,@5<UW7IC+?G^(W.>W#"3K6G
MZ6JT9E%JW;_@W=B4Y#T8_0;'M3$,;#<*UG1]6M'5#-XE2K6S[,F[W#EEQ9%Z
M-]TB^?1]NL37")K93F)JXW]JI($%\L'85FNF:JP;*OGRR0'PF6J$,EZ@8F>=
M1#CK)65=T& P"G'?R74?V6!_[XA5TIO>U!U[^<0+0G "_DN5B&PEUQDDUVG%
M2%]G'6))"<1L<V.WT+GB+5[1 4U/DJ7G$@(W&C%])G()@O+!^0\/2.7<MC(X
MS['$8F<+)=[%H5NSA<Q@"]M;G6UQJI?MZB7<+0,2Q,VE4)=*LQH,,YV1T@N"
M'5&1V"A8B%*+@5OPX:\*N21% 7FR!#NK] SW07F6FCH*:H=W=F&E4: )I1%-
MF_ZD@:#9NL]=D?'U*#TGQ/U/R=B/<K4>ADZ4N&TT/!@6&31X9?!#ED36J4<9
M(^-DFY$QU\F._22WLF%T7]?9V!CLLDM[?E8I_([DQ+^F$/DS],Z7/(\5O1Y6
M]_N?5.P\_M]<[/SEIZ80!+N_:J[ID%"Y[ <EG7U_%<]L_[6Y+^\Q91# ;Z\
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M];G>1_BYW@?35M5B3 #B[GA\^,CN(\N?55JWA>X.3TE-G9AE*Z0BA$G: XI
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M(+W2+_3ZCM)HKC>*GO%MH*>>E5U'!X)<P=*/X(-D4)-0/,\?V5?*7MT61M>
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MWR2\\ Y>XI-5:=:R8UZZ%Z;PN).([VI0'><LM^8W<R/"<%DTD"9-8^/W&OT
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M1I7"NO>,$_08:XH9;C-0IT@BF1$2(7_U@(URKS%P _P+TCFP.\8M::-?\D^
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M89.D=!12Z\=+301J;0:1B;!3O715+LWVR_"NWT^>39\SJHZOR+(ELY(F4Z8
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MSM^(J^J1*WC.&^U@<Q3&)Z7#'^G<F)]F&[TKJV[X)<*/;0RGMQ_F%'P2'L8
M4Y06_42MZ:I\[.2>YDK=[01[S8VY4U<DC1);_8T<XNM+.-/H815QE3!2_RXT
MB+ I$!P*UH0$0CRLX7Z"M+D'I&2W:OZGXP_=3QA./#P^/CHY_;#6>.+98!#F
MDL^HBYM=-/6;,(O3(N?NX*"N(\(S[*;%Z<;B%JR<$:BP?*YC@9O7R1V%=>X
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MQ(6#5YRXL%8?/#&#N1A<^H?_,6]&KFRH('N/F()9+G"3,*V@ K5)4$USN"+
M^D$M G.1PR1P8_NN0 T<>%4UII"3$>I6QY&+ABN</#9LXYR% LB=(F.05:GM
MRL6GDFA7*CDA)=[*I6[:0>_H(3J'' ?5(5=T<CGI:%'I'O;D M8W%^[E@AY
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M8W; @+,\G URLT%,F!A915-G"6A+J-"S"JPS2VH@);B\PNI ;R)/D),Q%V'
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MU%Z3#XZ:LC&^] >L\YD]?/?RP2MR\*VPUN?T[[6#=F?=,O^Y:7;+9ELV>^Z
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MZ*%&>:<5EKPD"O#*D(9=*<:J2(O1EA%<M<8T0;L'J<Q>D211\7'1YQ@MUCC
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M\(L4_L D6%S7ND/L?RC) \#9(/-K>G;N-YTR2=/',BZ@H\!9EZ>O*?C]WS"
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MV9D.W)E.S$PMAT<*DZU!$( H46.^+/%OE=*6*Q1D>&9LU$Y,4DIW,!4FS5$
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M(@YI&U%Y4$2EN8VHW$=%#RNIMTQ\WKVX/#DYJ>9B_*,/?UU[>D^C7O./3BZ
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M_LS_D*3](O<_JPBID<N5W3UJ8#0#]ZIB@SP<;.5M.<3D_Z]F5TS\37INT5;
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M;8<A48^X(RP<8QNZ%\1#A:5C'1QR36I[II;CG7&L\O<15HZDV*,1YFC7Y#A
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M7Q82O3Z;H<$3YPGM-8B_6&HVF+JY8'A+,JGR8*S6'/8G.6E'<P.3T8)P-Y$
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MAOUW7=/[[FUDM:BKZQI&W<&&0APD5H> L80>W"-Z8F&")4,Y!T-,++&+H^G
M5[14-KJ5@$E8!^B<]/%1;:*AP&?<-L,@?3MU0H44EZ;XO V[PGJ&Y7C!/3=.
MBTH5P5+JEN?$!O"L6W/=CVZ^3D8'<RPZ$-T2$9HY1@<H6D8T4G-*NH1.]1%I
MV;H08TAWWQ>(VQA[JX_ W(8UH4!!TN/*SOK!HU/@$5HF? X0.P9 :$WQ*J&5
MB\'S8R3^QO0VKFCDP*%76$8R<),/<JQ\U7W$<&D-1K7&+GQ>&^'JT$-W2E<'
M=\N>SFTSWK$9'Z+AUSK"#"* NPX51) DZF+<"E3QZ 3?*&T$8HT+EQ^UTM/[
M<>7K0,JFM\??F&@\,!!S=?\"O)<^!,86@K<4*4A#Z3@,D8<'\Z'@&]QXO6"$
M[OY>_H#PZ-FQG@,ACXC])C$>&+A+-!)E"$)Z\\?_T..==)0F7<?A*_C/?/04
M( 59]6A2,6#9L!4C!U)92K?0>R)6(OGJ17^+(T<H7.RT^0C U[]#FW0V1P>)
M8T%Z8 12$GJ. $AG^6B  21N&!VA#2' .'RM!Y$,AM<_&)D7#6W]#3 "VG%<
M3^Z6$W2,1Q>]!;N;%BFSX=_<@Q#WBGF(_S 6_;9\#P0;LZ-CZY+>G.61*<OX
M14L2WF A5I0^G05_Y<\?9\$&[1<L&=;LVQ8L&1;H2\1)AE\D*@?2PH$K$R$C
M_QA;LET;\FG;FL;*(BYH9[9OK.8^I,1#+1>_70DU4I1S+:\P\1*J"34:YRHO
M-[&_JQ8)YO8<JRF&@]0#?[N]>?..Y)RVPHF5F>F4LM-Y1(#'2O":/GJ,45TN
MOH8>DB)G<:&9JG-9Q:7F2;"U5B4[2$\AF_.(] ZDHN"4,""':E4:K21F.Z9^
M66RU<2EL>U31]'1LZ GLPE,X(MK$"#Z;!D1Z50CQIA>B_-_8)31!RH[SB)8]
M<)X0BR_U)$-W2FZG4RNK;O@+,WTPEI^1*HPVRYE2K1>B,?BF-S;A:.F!4ZAC
M7644.O"I_0O?&T_=' 4.[B55)IHN?"5.]D#?1<MA^A9=11BZ=(B-V=5M#X<*
M!$8]['$@NE)<]W*#Q>@A#0\)@GX4#! ^+#!&8>TON!KX;S.(]$D7W1^[Q\GX
MT)P"=0SO&'J(3G\1Z':!>9&X%Q:+NVD/T$^0?/I&;=AX,)8YAB$#AP\^Q]F#
M9!,"_1SO";;23^>6CTU\&QZZ\)3H)'K!65:JR:JAF^*/9BZ9KD/C"=;?;N&#
MU*FJB33YP"MC.39ZB63JP/)H!%:\9<='I*[C*ZG'9^TZ!V0\O.K%-A,_-?8P
M>OL3SD-8NO$1)_[R AX0#%Y#Q,96F-"XL^I^"LWA"SY*R5GXBY&)ULHV_(T,
M^X+ )&8T"_T8@7,,%V4DWG?/FT]G2RQ.#(#!V&#,F[J&,T,?>9R]UC(BY=[X
MPX@G 0'/".(3@G@^4CUK/9]'7@S#\8AG(UQ'')<TIBY]0$\[/&MZ&*#+Z9:E
MXOX:"Z_,ZR@EE>_CZL,!D/>[\X+]=)W1"#O(:3QK1EF0]5@@JDQA[,.^6')"
M<,VJ;">=0QWN^(19.*^CDSH\I**C>=,IY:4_$H6%]WI=0(" U1L<+8.#$$@,
MP)+O? K]B3-R+.?IC8:R!7YY/(O(F:1;1A3.%G/#4V41N\Q\&AY#! '#F".]
M((I,)!J<1>+/D4:I!^.*;GW0,4L/_<>WU2 ^+*)'000T%A&')H0RR&BM]+0<
M\1 <_^AF=E@G)95.S.5^EN7^^IC&+^>>27@-D?%C "0>24&0I$_@7Z$BP,HJ
M<B-NQ84,UHVX7*)G3\LJ0/SCN,)I@7'D[%#1<NYY"R>+!V0BT&H'^EI":7M$
MS.?&?^?F(K6O@P/.?@,]VS@'2 7 $C;)Z!N3P+:X7P-=_),LGTL S=,BGH"X
M27S9D^!/B'-A\23B6G@,I1!C(84$IKG8I31SD,Z>IBY%[OP@>%^WG\P@_0$G
MH5)'#-$-'/"3I"Z&* 2>#C(1C\0>HL,(&A.;J"Y"Y/<)W #HLHDY$[#9<P31
MYGR/'F&/2'M0]"NR#HWX,]"[=NR=>-X*WY'?H0^4Z(,@E8ADA7+AGV7AO[)+
MN]WH3_7<>*B[;KH J[J1C9LPHTL8<)75B%4_"'>-6_07=\44/[<-A/NZ24WC
MZ]7G59-&<BB+8>!,/'-LDOBWQ)@H@,1&$']ZF+>S8THS%_W818L?GU3,!!'W
M'-!,*S+<N8_4_V4/R,H*AH@7 A$)AI[[ID5\IFO\#_OL!IUY/!4BX>%82H98
MV"GP"4.<UPMC2;!F2[<@+MHH#XUF,X1;Y2!8U@FD!IG>0LQ&$[CTP9/KO.#\
M26I8H6FJF\9+E@;=]D5W1V>6XWRGF578IS*W<'PZT$E2%9U5L/;H:+"=*4X8
MM8F9YSLD/F7J%#]UOPJ7^[@.4$/; O?P< ]/Y?8D[N$)?0VCO4[[/1TV- UU
MC5@1=]VL<XBLNG$VG==AV8%53\T6)PN21*PW+^YC"60G7-<'VEC_>Z8U>NAU
MBV"RK4+.:KQ($$\7YJ$NIDXEE2BGS5@TC?&7PT/.,;H0&0(G?Y&,:[PD@2MH
M;^=5&&R"OXN";L@B+*6;+>)Q@KPST_/#E&+T$MT&WX0DIB5"=U;EZ\4%4V<$
M+2&J3K2ZA4B8G<VC-+Z5GV4C0#%02;(^0+*ND^;KHVOAGIBJ*,L-J:DHFJ@H
MC37=-._0!VEZ:?[1'SZ F_Z@.P"_=2XO._^F9:57VVN"/SK#7A==E5]*,Z.[
MT %?:0$JQ#?=?X/?+.=1WU8XF5/W?L7H<,C"(M)Z%=QT2LWH5, ZMRQ**D-)
M]95=^U0]>M4UJ'(;1&&D09:PZ/BBV/@RI)P<DMS 1W>NNV] ;I)2=MMZDQZY
M HMS>"4%=IG0XTFLU<I"5G@6\M(&QH@G>AF\"%8IMK_OOF!![?/B%_LDC6YE
MKSVX9VD^ZTKO@L[=-1A^NQSVKGN=0:\[W,@NY8__JG\W[-_VKCL/W6L0])8&
MM+GTHMCWMI[3"31D;XZDV!W2)JVH5*<S]Y!>L;GVRK8QKSEM#T][_WEEX#^G
M1J!8MGO(W MDB' TEIF_I.[$C";K[23!/$(>QQ"3IJW-G@NW7CO#@T,SPYOR
MZSOI758#71]/L_2PQHZ'!3 =/"M8=T#<W."0)3J@2GDN'!*O5;M#G2YDLSZ]
M3$P?GF'F@4CR>G'UV?K]6U;C.9&G(7+Y1(D<"_B5(FY.)*40B5PI(CD. =>V
M=91%%:EY2@O]1],^Y+"5N>Q<9SC$0FN.>W?$8F7!<;D^/;>YYX5V?#/RW(SC
M4.5X(2H/3??;8(!;25&<N,@3*/*CN_QHJE#F/;T%.HZAJ&;?;/PCEP.[&/;#
MG52BQC:XC,*S;NWHF'0T(P86D:.6+0/2R6(8Y>[>3WGN4J+7)5VO=H77*_!3
MW;A!79+UCBHM=%3-O;,G79]=8";IV"/\I[O@D(Y_I;LN#M7 29!KG>/$<07F
MMDD__#:\1FN.%@7=6WD'1M PI[KE_?KN#+TC@<"XR_:K?V'/IV<CQS\+KD#Z
M3TL06TKH\0K'ORMZO63NR.N8XO#!X8-A^&AD!1]R9O#1: JM=J.N\)&5$,<D
MS3W@?#*<R 81X3SB<NPVI)4#78CC.2W'\VCQCI_6DF<\P$N1)$E!_VG)JR3:
ML2SG!:>AW#CNM3-_],=S*^B*Y0VB9U_1*OZYGG2*W$K0*<V%2S<]31%;4M;3
MRXX3Y207"DN9?87P9 &'8GZ/V'RP,,G Z0Z-9H)D$^1Y!_U"&%"09+&<HZ(<
M*9(S VO,T#J2&;*#:TE \EP5F>'D#5OW+ISI)JWD97M!IBK)<(F:$='D&+:%
M8&8TU5RQJK)4E@[/VJMX%A!GE](FT@W[F# [A!Z+..-E06G45AVL)G,P,HQ3
MY5%5S(9',[39J.VZ<FA6PDDN@8(Y4&#/?D;4XK@F+$;:R#3D+#W=+,6>H8<&
M<6=+7;]*0:XC!E8%Z$J8NT)Z>T-:4JYRA"8TM)*\4F6'=7)F.TUF2YC.=S!;
MAJ9CH2V7)!(P%AZ[50*HK)SZX/BZ589Q(MM%+!SEF%68<AY\%=!225AR"[-Q
M*&U!QDD#C. ENW8/SOZ<_7-B?W5?]L].6FK*@B:5Y,<LA?W9B8+)(]7R1+VU
MN4^+>]=KNE\G[P"^[=_]=O;0'7P%^:<@,N*\8608N?B0F%@>[H/D]%,I#QD7
MYKAP4(G%Y/O%A;EM]=R@Y[LFZ>!@A!FK-)C/<I"BC1MA\'"^.AS35;!J)?)#
M8Y%!=XYM%&#<;K;4N@8'59,9&!G&R?)D(NDR+4]F&+#7KBU/LJ..Y$!@_1EI
M4V@_ 0OJ'@2$<<Z<\=G<@T4*%:<E7%<!5!))>1&IW&)*&> Q]L??/$AP)M<#
M7Q):#:F*B4CLD2KGAL.X(9&5MR\W9'?4MGA27B5EN7O7033CTTY1N-C4##>7
M)"4-V):4N([ -%VE [ U:7B4'.\MW?8[]J@;4F3><?.2(#=*"DWC"CS3PSA5
MYM36Y-_MQ9P9YOSS2DF5U.-[JVTON=9^"GK*:@4H55'E14J<-7X972PH(S((
M%A&!+LF")FM55%38HU3.#(<Q@RHU&_+AS'#PJ3HV7^'H[&_H.N^^G%61!7B&
M6I+D?G.<T8MI;>M6FMWV\;04GI:2$RAJJBHF](V0N//UVPN:DJQO63E^XCEI
MG/DKROR:I#2T1+3 %N:OL@A4Z42TJE3WH7G[I<0A\MHCIU1[1$O6M2XRYE!6
MA':3G8Q:9@03SG'UY;ADH?PB(PHEH;FF7GPU&:Y:L0^Y9CVQHLFPJJ14?'FX
MHYS33Z6\N2M8K[*M:)6G7FU9F/R$/?10,'+FV*O-OE!55D.QZJY8.C%T0QFU
M7-6]AB)(;3;JIVUDO*+5/8X ' '*08 -E=3R+:&F"G)9@?:9(T!<6/HA^  W
M$J*?[:D-;KO\TU1WGTS[S'=F%X@LPK?!1#802D1%!_UZ YD!2F> $%J*&S],
M(- -PYFB^^.^E,!V?-PXQT4?([I$=/;D(@%LIKND :$_@1[$]$=,/CK.S1^;
MMFX;)KK(\]$'.%K3.]](+T>NXM9=,2RHNYA&)BGN]$.2]5/_:/EG ?V*XC]6
M'HNV;;;_GJW01@S_#+2TT%T9E[),/Q25;O[Y8TL6I4]GP5_U\\=9L N?)VXX
MI@! Z?A%Q&V)!22HBK^)S3'8,&P=HCK.CQ2NDLI/^,5,?X)GCR[4OY_I8S2#
M"]UZT=^\E8F0D7^,+=FN[?B4&FY#JIE%NQXCH)2T21[V0C]X=*Q1=5E^T/VS
M<_L'&/0O^P^]JR&X?;@^!YV[:S#\=CGL7?<Z@UYW<^6TO18IG_;U_;MA_[9W
MW7GH7H/+SFWG[JH+AK]WM]5[*W_4W\Z'YTA L2S=]1"N(B1UYIYNCSSP'KX:
M<.8#;T)1=P1FT W>(8C5/QPTJW5820X_8$#+"H[:7]^)[\A[?):&[]?,[.>5
MJ?V<&K,L./97<&*!)>^6#F<ZQ/T,&KGXB_,P!&?J0VKL>-BR9!RL>^"E.62)
MDF=0.3QT#0TX?43,H4A"GA(I8XZ0TR1R^42)'!MT*D7<G$A*(1*Y4D1R' +F
MX0#>O97YE"CN=2Y[M[T')&-3H?OWSJ#[>__VNCL88FU-:GX"W?_[UGOX=Y[[
MFZ^_;"=7ENJM8\[)RS>#78\ID^;CJV^#0??N <2PY")/M,B/^/(CK$(Y^/06
MJ%JA77D$)KCZ"(*9_H9M*KP";16VK"P_9577*YV7,E$PKV,8:+*^=T]YHXBL
M>TT0&[7MG,WA@L-%%=8K'5PD*@JFAHLL8^S;6DE)+:SK.XS7^^E.9Y;S!G&$
M O:3Z6^N8UDX@,&=HZWGQ7].H=Y) E(2-?Y"*AE "X>HW)KZHVF9O@D+:4(K
M"Z)24E7P<@0-SA&,<40C4>CB$([(\KR56R5%%;-QEE96IKN&8XCH8P1<^ SM
M.61;1F)&<6$UUZD*V)5(> ]I<$!)L) J?H(FUK:Q1S7Y@9%AG"Q;)K+B4[-E
M=G*$(I;4#H-K[<?Y*REM +2S<Y=(G3B7P%GNP>,!*Y!*W[@>?XI:BY;LL;?4
M;"146MZ*D0#DLDJ"<R6>LP-FAV1[NWW9(;N35VM4TJ)U\OI[5W=M9^X7?+1R
M3>&$-(5$L4U%TJ3E6OP!%19Z@&O-VG;TJ"8_,#*,DV5+351$]4"VK'(]W.KH
M[E4I?DO:+(.@&&(D6I@%14'R:IRG5(VSD2B#1*BO8)>^)"@2&T51>!5<SG>%
M\%VB^%!ZOLO.[-!HE=1*B['\QWJV%J*U'1F2(UA1D'B[$59)-AUV)AP918LK
MDM!LLX.<[%I$. 9P#,@) Q+>FX)%)U5HEA5S6>D.1,>37*Y]!$[+39O[M+A;
MO:;[=?*>W]O^W6]G#]W!UWB5"+8-[MS-5(7EX6Y*3C^5<JMQB8Y+")583+Y?
M7*+CL7PL#N-4@X8:HJ0NTNM)T-"M8S\]0'>Z&CR4<TI]LRS_.Y>3F1[&R7*F
MU)*EQJ&<R>/YJJ%X%)#1SXOFG&1V42-1MF\EG[>@!O,XTY[GV57E$;7DA$1%
MNGTX(3N';:M=4DDZ-@[+RHIKB#S.PABVDE/:N49P0AI! L<29? VY L7=+(W
MQ&9=%81J,@8CPSA5_FPFBO(=PI\9%M-1E+KRYVDFY%D.&JH/W2D+H?2LA,@R
M&_[*)"&E [)$A;[5U*"") RMQ4Q\*S/AZYSOZLMWB1)\>_%=AEEY=4F%Y4EY
MFY+RF)(E6%&;>$H.JT2;#C\3I02*%UE4H=4JR2S"$_,X"G 4$)N)P@;%"U"X
M'T))[<IX;AZ/Y*Y;9#![B\GWBZM=!ZE=7-GB8A;KI)I.S-I6 R7?B+*&T#BI
MR@<L#)8S/V?^&/-O*WZ2KVE:$)LE]8CAFA77K.HFJ;.WF'R_>##NMDY3_:]?
M>P]?NW</0]"YNP97_;N'WMUOZ#TO@\*8F'3XN%(DR(E:2U8U.2&'7#G3J>E/
MH>U['7MTA<@*'=G0-O902EX]\\(VK5_?^>X<HL$DA8UJ!,E5DZ 8&4:)=(V(
M4DPHU_O1]5IYNRYT799(/-7=)],^L^#8OVB=-[29_ZF0(V\XT5TX<2RD='K_
M_+$E2\U/ /YW;OIO%SRUL\:R'GN+R?>KJK)Y*NS*5</G4@4O^E;=C6-D&)Q^
M3E/Z X8^,WW=XO)>C>4']A:3[U=5Y3VRK*8]@K9_<1; 51S!I.:Y4A2"]=V1
M:>ON&_ (E#EC<-<;@JVV$$64)45JRHK4;K02:;78%N+80]\QOM_K;M\=^KH/
M1__2K3F\ARX!S!0V$32(OV;0_2NX?N&#[-W=['!"IO.1)LJ.'#;N51OE$>,6
MT1:O,?NL? !FN@N>\:C..G-_XKB( $87NS=,%36EH6JRO&WB9-3>XKXI-HJ0
MC9?'#B4**NPWT-6=.62@DBP*:"CX7[![:^@3@.Z#:VC Z2-T@2(AB$!C ;H]
M2GPJ?P(]SYNGVCY%DN2VVI;51!9:8E7H/7-:D88J2(HL--=4C2)S3#<1K8&P
MX_")9$&##45  UI;_@KLO9$"0-?/(/KY,[3>/H'^W/=\=*5I/Z5C30U[2[1$
MADQB26(WSFN#14&2$,6WDQ'RJ3<8_6DVE42D_YZSR627\4Q$06XG<Y6C7?;P
MH9=RHY?VF?LQ*ZU95R"2J[76TQ3P$!%-<DZ74\M*E^.F+J:'<;(,N3:D80=#
M9ME53BTK<ZV^ML-"J*LS&IEXLW0+*7#F"&G_W&IXRF5/6XD"P L*N4<$TK.O
M*'GD6]B_)0F26!*B<'LLYP3,"0F#5'I.R.YDE9MMH:65).RR<6Y65G)[<*'N
MS=TW,(SL-H;C^4(*RXLD:FU16E/;*;PG$>P"&2^P/^1B=E$%;$9:5[1UM]4E
MC$UL2FHS:5;;9R99F%QDH:TH@BRNL;@X2[Z&PPUL; N\7,]C&BW>I[%@2DU-
M%5N)2HMK>"E_*PQFIEK4BBUWWS^PO6(<-6J &BU1:B8K'.V!&AD*M(*JE)2*
M>[JH<6J5KSN&,9_.+1PH@6AS;!JFSU0I4EYYE_'*N^MA-6$B2"@U ^CK:'PC
MW&P/$8(7(\1K2H=YBF3 0RN(+D,HJVA"JU62='940=XJP2J'"0X3*6"BG8A%
M/ @F,I/!8C A*4)3*ZG!V,G 1+4,H3R?JY)J*!/+PX-<./U4*B:C*@HMK0/J
M;<SI9^K YF(KXV)K.JDUX64@=L* _+J$[/*-\FP(FE1%V93W<N(\=R#/)?S]
MJ7@NPT*9+4%JK,OVJB+/<;V+$8&5D6%PN;FB&\?(,#C]Y*5WJ6SK7;'^"R0,
MC"T];,OBY2<3HH>"D3-_M& %9*^?\MR6M,)JI58LG;2ZK7->QQX5K"\V%$%J
ML]'A82-+%JTO<FS@V% .-FSKIY<6&[+3:YNJ("ML]"<^'AOB0M@/P0<ZHAWZ
MV9Y:9O$BU00"W3"<*?KQ&UH78#L^EJM<]#$B)D0"3R[)1G1]7 #!GT /8M(@
MAAX2T34V;=TV3&P0Q[5P2'GC\XU;N7V"P3)^GH67T'I'%V2"X6+-HLMB]PKV
M5Q3_$=9(\IT9_=WB;MM6!=!E 61=/BTO;APY##0_Z(8/":A(691FPH^E&W*#
MA5%1^G06_-7PT.E2?)ZXX9@"Z*'C%Q$U&A;474R$D^"6!(_P-[$Y!JN&K3)4
MM_B1,GI2Z0B_F.E/\.S1A?KW,WV,9G"A6R_ZF[<R$3+RCU]6-R!<S)6K\2>I
M*6UE^R*:"%X$"Q/;TG=?,#]]3D4Z=!@O](-'!&2Y,,N@^V?G]@\PZ%_V'WI7
M0W#[<'U..A@,OUT.>]>]SF!;WX+RQW_5OQOV;WO7G8<N&O,#^D.;,/1O0/^^
M.^@\]- %]-;X&%E<T;]9?/\7 07SM6,;$\=]ET!M]J;][7QXC@YTR])=#T$:
M C%G[B'-T0/OX:L!9WY0U0PKDS/H!N\0NNF;(TOVQ75R)  #6E9P /WZ3GQ'
MWN,3)GR_9F8_KTSMY]1(A8O$K:## D'>+1U9=(C[F0]R<=;F87;-UFDC[GC:
MLB@9+'S@%SEDC9)'3SE,]&]T*@%HC^!RWEV>,AMC+HC3)'CY1.D=&T,J1=R<
M2$HA$ID3"2>2740B58I(LG K-=1RBB(76=9] )^A/8=L9TLRXM,LVTQ:EF&Y
MJNN5SJR<*#P9L,3:^B>B)$J^DVT;<45H:6H=\I<985)&AL&QHDKKE0XK$C4Q
MMV"%'&%%=DXG3="D6I0Z8(1'&1D&AXHJK5<ZJ$A4O=P"%5($%5*&4-%NE.2>
MKD;0(-;N,C"'LJ3,73D>\7"[!2IU/)WDI-))UO34\?S^. "W@E2FMJ"*)8E!
M95LS.=^=)M^MZ2&TG>_R4#\4H;&FB1#G.\YW->4[25S3]&\[W^4ARRN"V*AB
MY:V3<<SP3$N>*<?M8RP/@]-/13>.D6%P^N%&M_5RY&^NXWE@YCIC7A*8:R#9
M:R")HDF$X.X)O15D;U,%5:N+_L&YCG-="JY+E$W:SG5Y6-LDH2W6I7 2YSK.
M=2FX+E'^83O7Y6%KDQ'7U>6LX[:V:BF9C R#Z[H5W3A&AL'IIZ(;Q\@P./UD
M=G)7V;#6GT%7]W$]%_@Z@[8'O0O>0?YPWBEK6KS/.=\OOE\,[%<MM<%<4F(]
MJ+O&A-32&<%G:#DS7!%, #8LQL-3=3&'72FP"D:P1)W#D" []NAZ08Y=*A05
MY@*2U&2?>[:Y@6MKG$]SY-,UB>/[\6D>3B-5$.O1#+L^#,+(,$Z63]<D;>_'
MISFYF91V7?F46Z_>?1DBHJ"]'= (OD-LQ^+6J\RUZRK@3R(3? @M-+PG!#]?
M0](H5IB7%*$ME]37@-N<.%=@KD@D$N_%%7F(SFVAI7*FJ,HC:LD4B2S?O9@B
M#SFU(;3;)85#L2&#K@G*JKL!_#=H0]PP PNO^FAJVJ;G8T_L<VD515A1X-.$
M7S*KY><\^ K@JY3(Y@Y('>%K9XG0BY7'VPADV8GT9M>.QY&!(T-.R)#,LMH;
M&?+029J"I)14&Y8C T<&C@Q(DSH>&?*I[]B0V:G%Q'T*Q>:IG);IAIT8.O86
MD^\7WZ_Z[!>/44W9\M;Q=0LXB0P)M@,(>#A-#>3A1(YVE*<3",!%-4Z16X+8
M*,ELQJXFS)GSE)DS$3N>ACGS,%S)DB"*3<Z<+'$%(\,X6>9,!(RG8<X\;$>2
M)FA:;;,YN*6(:[+E:[+L+2;?+[Y?]=DO'M^506$-R_&*,1EQ_RSWS^Y-I^_3
MB=6)_*Z(OGNVX4SA+2+R8DQ2P$.+ARY#ZJ\B-*22@LES=\^62Q4?*K>('+ X
M8,4!*Y$0E@ZP<C#3+0!+:@N2R &+ Q8'+ Y8JX"5R-5+!U@YF"YC@"4+#:VN
M0?-5 BQN;N7FH/+-0>PM)M\OOE_UV2]N;CWX.+TQ;=TV3-T")I&6BJLCR74"
MKA-D$\OP^NA:U&@J2XHD:6U):36C> 9K_#*ZB,@\#&:@NL$=+*A+64PU$-1&
M2:%'/&F.PT/-X2'^JS,/&F?FZ]G$'*&C]B(!$YJHB)KZ[LLOJ\Q7:1ZLDG;.
MPB)R;#@5;$AC392EP\6&?"V*[+1]XT&2W&IW"E8%]A:3[Q??K_KL%T^G32>X
M8 <F>(1(3H"!D0[X^BM/IV5"9*ZJ-+S>N1ZJR*HH(PD6:<>BJK03#O:%7_W&
M=:97Z)&F/4="8N!X=VSODE KO>X!TVKWU7=UI%X@>=I]Z_EPZMTY-I:@78?4
M$.TA6=J%7N'6.%D6)+46:;JGH/=S,#HE,$KHYHGD_F*!J+8ACAR(JH4 C SC
M=($H4<B@6"#*/72QK$X#IPM$.4:P5%GU)9P",!]2O??]([3AV/1+<S.QXD)B
MUCU495A/E,"(X#IP_UQ2ZBL\9(2=U)=ZHB\'B!,'B'3XD,CE38\/N71392B.
MC)D8,<Y_]>6_1&IJ>O[+HU!5FYW>!]P15VQ(!K?_Y&7_86)Y>*E%3C^<?E@?
M!J>?O,R&:L7-AG?0+ZUZV):URT\)00\%(V?^:,$*"/L_Y;DM:;6C2JU82OME
M(E '\4&)5<9D05+8B%K?R)/<<LE!BX-6J:"5Z"J^"[3R#L/1&FT.6ART.&AQ
MT-H$6DJB5?<NT,H[9*>IL-%NL[Z@Q8WDU;(.,3(,;J2JZ,8Q,@Q./Q7=.$:&
MP>F'&\FW&\G!#+H@#$0'WD1WH0 >=<\T@&Z/P,BTYCX<,25,<@6/*WBYY;UJ
MHJBVD9;72(0#=W771N3IW4-WB-GDFK+&7H;UN][P+\1P?Y$;1(J?&%?\Y+1Z
M7ZJIM"2UV4Q$+JY.Y1+S>VD3$<^5=:&,7)_E1CB.T1RC-V"TW%Y3_#\]1F_V
M(Q2/T8K8D*1#,;J8B2",ECA&<XSF&,TQ.CU&*ZU6\PB,WNPV*1ZC51%)TH=B
M=#$3$<]E+D=SOQ#W"[$_#&Z7K>C&,3(,3C\5W3A&AL'IA_N%UHL_?Y+[PQ'0
MT2ST)PB0O/F(741CZASRP-Q#WYHVVM3I;$Y:M=O<EY2!#EQ@<GBE=,U4^ED3
M_9NLX!(2<X?2\ATAY?XXT#B)SN7UY[[G(_)$U+*7!X1R0UQ1Z]W=[,@93S65
MAJA*<B+$<,-4$G/8WY5SR$2TMM"4VH+86)<$7SF%,\>B%!QXZ@X\B*V2QOOC
M@6>S63\_X%$T54I463T6>+*=2$,6E&9+:+9K8>GBP,.!YV#@D66YE;!('P\\
MFVW5^0&/*BK)\L[' D^V$U&;0EO1A(:VKAI?+8 GKA#_$'R@(X:AGVUG@H3%
MN'">>9A H!M8)]7M-Z*4.CZZ&FTTTCV1NNK#)U>WP$QW?:S+^A/H04PSI$:6
MCA7><=0+%U&6#Z=(&_?.-VXEZ^OQRP<Z!K#MSP#.$"/@B>)%TJ?.W,::_ M2
MX_T)^N0GZ= %".CH\RR\A-HS+LB,PM6919?%[A40N"C^([2!^,Z,_FYQMVW+
M .@Z +(0GY97,WY>&!#76 X?$K"1LC"]X,?2';CYYX\M),9\.@O^-O#0Z5)\
MGKCAF((#AXY?1.QH6%!W,1=.@EN24PA_$YMCL&JXC!<U=/U(L\R2%K#PBQD"
MP[-'%^K?S_0QFL&%;KWH;][*1,C(/WY9W8!P,5>NQI^D)JV5[8MH(G@1+$QL
M2]]]P8#R.17IT&&\T \>'6N4"W<,NG]V;O\ @_YE_Z%W-02W#]?GH'-W#8;?
M+H>]ZUYGT.L.#R+]8L8_?.@\=+]V[QZ&H'\#KG[OW/W6'8+>'1C^WAET?^_?
M7G<'0TRM4O,3Z/[?M][#O^F#\/E+W_]%,-%\[=C&Q''?)0XM]B;][7QXCH0X
MR])=#QL@_8DS]Y ,X('W\-6 ,Y^:' &"<WVS%W=?X"9G(#"@904G+G'/X_?X
M2 W?KYG+SRN3^3DU,F&C[PH:+!#CW=(938>XG^TZ@RKAQ?B,,RWPV=CQL&5]
M(5CWH(3FP874ETZ:<KBF']KCB>"<IVA:=F'83,E%WO&PJI)#!ZT15E)T:P<I
ML#G\F6Z.SDR;D_&)D_$#DG^]N?O&">'$":%C&//IW-)S=BQS6J@ +3PX?D6/
M-:*X3-#=H>L%:ENEJ/FX8)K35$AV<6%=%1)JR*\4>7,R*>%@)]9H3B:<3+:2
MB:'/S-VG/J>34Z<3ZC;F9,+)9"N9C.#8-$Q^[' ZV4XG\+]STZ^6]2F+A >Y
MQ5BJ8@Y;>ZE;NFU H'LX4.0:&I D0"@2FILHBVRW0F8D"X?=)"4&(_M6ZPLW
MY=50N#1Q>R(.<OMK[N$?#,, IBZ!J2MG.G-L'.;3>36]X!KTX=2QA[YC?/]*
M*/S( #E9$Q1%%F19JT/W\/IP$2/#.%EF3L2U$I8+;+V4/W/FYL-[7$I":VU)
M"<[.G)U/E)W50MAY$:5QKYNCGGU%K5P9LC8:DJ"T2VHMSYF;Z6&<"G.'>2B*
M*$NJJ&JRTFXT$TG$N3!X&+]";G[OPC%T73@ZG+_'YBL<G?T-7>?=ES/.U"QQ
M$R/#J"%3IVO74Q!'#Z"OHTF/PIIPV9W5L58_+4E0U5HHV.523C&%.#GNU!-W
MTL%.HNIZ>MC)1L*7A&9S77T.EBF_<&]&E3T5Q"Q\]JCC@DPX\Q7:GDX(TG<
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M#*.&J'6,!"-J4EL160"M6CF?N.C"]#!J" )'B"Z:V!2U5C,_>TO6,D=#E>O
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MB5K#"[G0&K^,+G#M\?[<CXA@5'36NR)I3.'(RJ;DF*[+J3T5M1]%[,K>Q%Z
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M2UV D##),U/2Y\,$ MTPG"D:+O8>XNYTZ!FZBSZV26[WDXL4MIGN^CB"UY]
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M*> &)TM)#*]6&7ZPA6#6A"\2&5<\]AWX"QY&SG1F&QQ.5["?EAMQE"#Q8_U
M.>%?_GW]^=]?C2\+_W)A@;KY]/$6J<&P\!.-)?6"V!K&('ML"V?6T8(!HI6.
M](*K3N]1+_@7B@CY=/,!%!9I.7S/K?' 8,U,+R'#_[T D0*2*H3]. 5CMO(2
MP_4^D)1%YO#*-0"%?N='0(=W]+42I\:]XX\9L_'TR> +#A9T\;*_@U$^HDAL
M*<J(/ YKP<<@'GV0K-S$Z<Y90-D%GL7RKTYM;GHR6-8&PIKTR13I7M$*(A+!
M@Y0KTR-WH]L[-7Y'VAZCR^%G7H-[$N]%K!9YH1:36_TA)D8[%A1J[]>4Z\<J
MA<&!NX@F,!RC(_>@9<RC@$>F1[(8'G^1;!ILP3?7)'GSA0435/LS'^0'.,VM
MV'.["%W8%OG[;70O?#FP(Z7+;@B7/7;,%_@X>$+,H<FMBD^%$7H[!3L''H$>
MZ0V;QX=+P!NW+! $\?GS9<L0!W.Y>>$[3.NOR GP5QHM/5?^*9ENZ3 U8EO7
M,CA6"OH$<@>S$R(/.QXC\<Q]CH( EQL#JIB)X-BH[82=)G8@T)>^_#(F% -]
MXJ1.Z&+YPE@Y*B6F7S=CX=2W<=>2X9T:<2+(@&[5E)36FK'9V[R--C-M1A;1
MV F K?251H,B[GY)U\16V"3P'\$8>9PR#VVE#/NA4'"9:1/A!/X#[C]NF"2+
M"]BS$XPWH>6BU)BRAD"=E7N%:;U^*I. ].E0VR]3U#< S5I@^:&YZ0@-]W<P
MVMH&+)9+UF)HX#$UCI(<BX1F1'F$&7A^!+.>@5MQS\2C[^%YMA'-\7;4GYBG
M8DY8,KM862W@_A-0W,$)_@5#?V >Z&*Y<O@#D38:77@!K@ Z1HKDY<@$GRQ;
M.%PTY=ZUC*\7MQ<GL-S4).*#@_8U_(*>\H43&'ARC\?RL4S^</$M-IHT=Q!V
M'G8SLJ2M D^Q!(S@1+Z<UHO\N#GSY\)>TC:'"5MU#(0-$A=VSKD7H4*D)S\(
M9;4)OL'&=2W<RD?8)LH:<#QAP[ 'TXWHB(;.@>;*1T#22;D!)+HT.D;'U *>
MN0]\H':/2#GO@HRC@)X+;YHR=[Y.M$+ZJ](?D49Y(VV*I$WP@TDT2XY!4GTO
MP$=3X7[8 \>#"821.&!3X7^U'\*1%#8YF*"!?8)I<@O=F,[X'LO>!O(!!H:A
MJB)CNA6_R41W\!XM7^F=B2=(:SKEC6*@Y+7-YN#J(4?+ T+=IL:(O8K_MXQ+
MTS-M4QA$%[!U >RB_)B,3HTC]988<4*N+;DE3CP]]77:@D>'F'$,2SA\RI 7
M77&4.77FDMIUIRGK3U%R'CP2YC,&B>+$\34*AH$XY,CE8,0S<R9KR[*[YVL)
M1K$34Q #BD,VZC%2$2V972R"4^LT S$3FN)%G*5G?"J,R,1R$8^-R32A&7Q*
M"9W@0WXKH/#">%S^>>HH"&_\"+)EOO8I\O,EP5.%3$EZ:?I^RL GO]=F!5&T
MP\HR[;2;-%,M1UC;QW]HNUQ$25L@KB<?PJU%-RN/X-*UXD0)2 ,%1T6%9U&%
MQW)//)BKQ=&<72; *H_YV>=QVSZ1TRT,H>TI&<CW*%,_Q'H<$/%>A'&W*!#&
MI?99/Z=2L7$53XY5A%1YJ%'!17#\EG%K>AA_ X7#P$J@Z)TG(G'@8]@8,#1_
ML)3B,1XBUV.!"FV"*\\=XAD3&21<D)L.PW42J'$TSKF8A>\*?P5/A6!J&#(2
M@5*R<_%8T77P_,7@%A@3D8LLE,P2[9^%PUR;2Q.!4Y7".@<O94<OQ8<O.?XJ
M/H!9UP(O4&EK2:U2Y7H(:00O16:)?U>97L<CP/+_?I(').,([%X*78CCJ@_,
M$@D[*JJ?DB^.@!:AV(M>1N&!%>V"M*'H2X42S$Y[,.@.V\-L/<)7%HINJ)_A
M84_N(3A,%5<.EA=7TK$87/;JUV[W--]+, DC@5!#?PKVP+2L:!:Y-'.;C1V+
MSOM$G(?0-\P91BRK+P:L1+]? ->&C@RS/YH!YG7PB^2U'\1;UX12>.JZ] :G
M>3@GM3#%B1L>FXC8ODR?!>40]Z:(#^=6TQY&BRLN8:=]GL?* 7K".MUO(CII
MOU]\Y\R^\J[5H"[B-(*=$UO[- _PF:SI=13(YA]Y4'$T PK8%"G/A56LNE[]
M02_'?]L M%YK@7[MCI8P8?ZXGT=CY 1<E7&$9IF,9F/T$<VI.'N;B&[FDS$&
M+-SIP@<OG&;CL>8<(]G PG@H'_+5A9@),3LXWZ7DO$+=[,U&>G)0\@#"DF4A
M2O9S3M%N"D&"4@/R(5-=:3+&8U,]Q-R ^*P$@V%.J#(R*/$.'0*D0#PO:,E#
M51&L VL=!+<(6_'( E.;@]#+9;?HZ2=QU'%I0$E$#$68T8(/1*'R17'$CYZ/
M78&DCY(0:SJ./H99/V8S >25>H0=#^-*TD(P;$=GK)18TY+)6%H<M64\^I%K
MB[&(%!.9)&!:4X?)S =\@^'BZN"?ZC#%M$'XF>(.Q=PBSXN'F P3D9=U:GSW
M0L=-YV.(9_/,KL'H)@P=)4PM 2_)(565-$]JX6E7[F#"8WBZZ1O@/W&6/4?*
MI,!0]@]1%XHE15Q:+8D*\K*?L!6Q>H1%!NEDM]+K#'(XI)SK?\# YQ'LK:4=
M:&" FMV'."G4$7AFQ("@2:LI"+"?2%U(TW Q'G9ABAV^]!'DNDF]HX)\V)ND
M&DC,B4\G5%=>/*ITE!D/SCAC/])+0MDS24P=WS.1(E,D H:X_!.8"L;T83-H
M$-3P7/ .]Z/ DFR8VPMX54 )J22CTV3PU0_Q#6J2--B B:,A8' ?H9JC@!QJ
M.C/2YT(ONL=\1'G:E=UKH67HZ(E("__D(.TPY)PCL@+2DC.,">%Y.B'W50X2
M1*^L33XDZ '_2-4-9P$%-A!?+JU*3P934+JLS)5^N]OM=\XZO?9PU.EDS95;
MS'@&_0\D?!%G"7P#?0T6 7]N47*N%+G6WGNF7B%G"=2KN)@*BKOY@N*\9;-9
M7WOGI<.W5[]]O?IT=7GQ]<ZXN+R\_O[U[NKK;\:WZ\]7EP+B8)71EU^4K*&G
M<7O&N'N"65=+@^XNV_6PT!(W*9R*F:VB6@D3AP*;Y#QI'#W/"52GY<SQ/%<8
M I@R!K]CN9)=>.R7RD U?KM(,BI:Z#2X#I:*>C(N BJ=\CA-^*N%:8["R>!O
ME^[W4W:K"NI#+K  3O#U^"-LZ QG]F3QJ,;\HFJE"N.4-2Z?RA>:'WJ1%% O
M6J<Q_395'<^6K4)JI@S_U>*6_#O*ND1KER1L+!O!=:-40<Q\\$QA]XM#L1_D
MGXJ=:QE_1O9DEB 3HV$^FR^I!].>=L]<X=K%-GREYV(BG2T*LIB)%6,HK+1T
M/RV/5*L3D&^ Y]-AWH(>@#F5JO2IVKO1!3$IS4[6@: KB\.A>#%Y9Z*-#-WI
M.L*5<)*L(XFWHYQZ$*8B';_X'O$6B@S$_ES!3K;B2$?1@&(G'*[!H(F';F2J
MF 7O(:4*!.7;I\8%^&&4Q<DCE]PS]/MM2E(4WD\X]?4EHT)D*DLC3U.IS:+X
MA[;_*DV0ZVLO&O2(H?DJ_4=X[8X'\\!*-KQN;#J!@0\0*\,Q-_U$4 $6.-OH
M."?KJRUJ2V2Z<A51E XTIBVAAB=C [^WP 9Q4I$DD3T6,/!1L8@2N.\!J.<6
MBR/B"1!9B6%@) #,"!@O1A5QX6'D^'3*JO)@\+#8$9>^LDYD<4VAY!":_;U.
M[RVY<6)_5-"&XK+T"VV ")B:/W Q8Y(&O]B/9/!%AH2U92RFPYP"6N6RYCS2
M)PO=2N91#MWZDQ_ D[U+ M&W%G<8_A.!:'[AV?11)I61J[EXOJ,9J\N79$G5
MVFS*(W,<NME4A'2'.IQT]@<!6[?</]'&V-A2I;;4./(L%025$D151,:?243?
M@]C'<CE7G$.@ 0/BPY]AC;CWX 2^)PHR/"F>4W%MS\YA(\F@H@3G\#T*SL--
MH.E"382=&E\P7EIRP""UO9;#0ZHD/O=7!"-P#LN#PO$#I<&!Q1=:R7;Y(Y]B
M^(D[U2J+1.I%LMIRJNNM+C/A2WD(6+3*.,Q(6BGI]V>'GMNKQ7]SG4I$'I8R
MHM2H5VG-XV*<"PK5P/P17&'F>RS$'90!FR2I6U"+7"+:#'G*9LJ(34)'TL2?
M@=$3"2K#6M\,1&<V0G1Q>VF,>FU5@2H- 4-9 L87,\2,>%6%:ERXKLY;!D(5
M2/M'&'Z2]+1QQ).[-UUZ,9\RAF?56.0CQDP2(0E#I3PQS?_"HYSD/,G46<VA
M'!HZ$5(6.V:NX-DV<$<1<ME3;;(JR,*)5BO.##^TG/!.DQ.>W=TEV>!5;/!1
M.Y>(HH/1-F9VYG]'8V;G 9T.W<S^EIPL@(!.D7%C7>_B%$CV:):I)58<QRHR
MGXNQ C!F 88MR%:%L25U-3>FY@/&59AG@!&JP#$H;FCI.UWSD,<H=Y!>G/?7
MR-TL#QZ+W,W7[!RZW$72-33:;83M!M93:QU)O@F?@I<JVMU/X?4$^@>7V!1<
MYZ'$D5+QYP"Q(5PJ.B**D2E5E M%[I8?.!.J!)Z9H4Q8$Y(:$6)E>B[X,*!+
M\8PB.<V(@2CJ+F<'63E[)0\A%HUHS7+<L8C6O&]]Z*+U*CDY:Z3JQI92"-20
M+$@IVP3H'YWM<LKGQ61TD**8%8[\3"=M:)I*(:*.$57JDRAR(1E+A9R!PW_@
M;PZ!W]#1*X=WG,S@0HP24<Q)1PBELT;_'@Q9$#9XVOBRHI IA"$ZS,8% 0V6
MG#7C-OV%\&I26XE\;0DS\4#Z+3FV;<E09:@0/OP_161/G 4_^"YHCU/CO3KP
MI=I>^2X*J&.+(QB.$U"LVIK"JA "9< P;@DW$3*3S+6@C7\,L"V?#1Y-?. M
M8%80I#NF)KA6T-*>ME=O;DVR6=]O^F(W-@ZR&55P"*A#Y,2*N7I'OS:?'$]@
MQL0E)R=)9D)@/J+-!E<JG)=T';@X.**B20,\Y@"ALRBIX(43W$UJW4[HI$MD
M("/IR84BX2_@[UZN^ W8)'+-("=[-9QH*<KH:Y)F DA7";V86'-U+0(=-94M
MI*7:1!PW090&2219!BY+(K9-=5:%@]"+:3!D#TJ4GQK?!"0=?BF%L\R>(3PU
M M<C;2'>A<J;_9R#N8P2W<&:,8E>!+R')6,"$'<&*F>"WD\R1[B+\L%.C=^%
M(A!J(<[O28R#&(XXC?F63N))+V!.:Z1L$,1EI#0OF\UTP-W2BC42L@[UDA#5
M91)\*8& IX&BLP<[].!'$L9"G.WY8C6$_FRE@1]SUI!$\E-ZL69>8KH2M]OO
M#;K]82X)Z1M"0P7A A%;PPO/QM &%0PVGF/F?T?C.>9[VQZZYZB(6*"=*0I^
M04[DN^4<DJ]:WN+Z,[7^&<\3[8T6B7D!MJM!6\Q!HS@2A/6#]@F-9B U2UZ8
M(/@2N!!,_@07(L;P52"H*L\5[V!8!XUX0O'AC,H>#67AJ2K+-SV/THE1<>S$
M*,_N:AX3:(54[W=ZW3,0Z[U<O]5;B9QT/?Y&9;S?0S)G2H7]9L2\QN2%XD3D
MP%/^0BSM*TA_(7S.![]D4A>>H14RJJ!$7!5^6:H(U(\9H3D<G+;[OQ1WMR]%
MZ<F2RG,1H;2GEJ(-%8Z^US\]'Y:,7H+2J>0.N2U&=_[3H"/*I\Q.ILL4R[=M
M%U'^4AD;8]5*%F-DJ#7>%/GDDW<0,[#;QI9OO1'\,QB\V2R);24X(GL#Q7IC
M8[NP-CUO9SE+:'H[D"05CHO.<UE0I7KA.^G/S\ZX%(SG#QZ$-PBY</'3X?CA
MB^,YLVCVA2!I_H@XOJ#T^>\7=XNYN%5<J:@AOD(\)P7F<\*9]=:. H3 08"C
MK"-U4FD1<KD)&UT$\^=.%Z'7RRZ"\5IB ?=Z;PY,K-5>9%TC%A1FX >>0W@K
M*;-W7^+K$$53;,UVNIUA!P1LN]<;Y=#5ZB.>/JDMAZL^ 1?"7WPE<PYSO'E2
MZ5C_O%=?$?6DA>CD1'4LI3KM0Y-21V%\?4%T(8_)9A.N>8]Q4XKX[EN:O1AC
MK+]))J_.QN[XT8YW'Z[Y'.]]=:NC,\CR\X'Q<.WY\Q,"76,(@UKQ(NQE51B*
MU4O\@LP+0O?J]@8#M#-R,#5U,"^0'6FS98\ZQ 1:K5"?ZOOD\@7K8%@\;0D&
MN24X&!F$1R?'8$1\9B:GCHN81!3(YJ)[DU/':CCHLFS0[@S.^Z-^-S[.1>:I
MPL4?&+<"AQ \*H3Z?[U61RJ4D<WBEK(N;CDU;LT=8Z^U[_58;1HI%K'FSXW&
M;%W8Y%7D7"Y5BH\FBV"4<[D$ZLN2C(+"._:4CJ"0-L][9]UA#AC\/9[Q,<XO
MDU0:61[4)" <30+"Y.@2$!39&CK='DWZ@9[5V,XD->XG;2\NN,1TL'NU^%K^
M73GL0GO04K@+A;NF,!<4#J>\2:%PGAJ?2E^9Z3?LV2R/;2YR%5IJ+ F '2;5
M3;P$ %UF*<@*I%8:<0UAN"@_#1/]8#U V)[(WDJN &8 [8FX+S++01\!5C:U
MC!@HPE3@+3I6F2FS)>!'6X*0Z)VI9!HSE_E_J8$C@H8WH2(L.8?[).]<S[>P
M,(4\<,RWQFOG#?V6O95*"IB$LE;@\IBC@;WM"9$C0)+C[_"+UT[94QP.DAEQ
M!_$K:NZ*P&KX0:+$)85>!G:WE7DLV,R*[A@;]PP'S,'$;0D<CC$+Y*98"'L!
M?PG -9PG@F%84_2(]I976Q^&A:5@/$$%C$E,?9-MJJSLS0QP'NTK3L<9.Z9&
M6EDH0KUF 6AXXOLV(JUC5I&@695 E!])E<>7H$UBSV2>0(3',';B7"@&W=-!
M YF>[ZM#'\; 2+*SL\QC14Q&ZO4C/UNPT_Z,FJC)OG !\]BCRE\2!*RN,<,P
M$/P9"!Q$@<7IJZV10\ROC39C?7X:$"+C<TS6PN(5$K$!?1$*(,2,(#@UOL3+
MEC15E1NC94WK.Y,1@WGL22$)R^0<$D1*_! 85C'VIH+!<0(KFF&RM6H*@"@W
MP5QD%&L['T\!BV!T8$1QSX/O4E)T:N5L-L&:4YB8HI&7+2(NM/U2&)JBJ$/!
M*[AL@MT0&!-0F0@EJ3JLRT8G\D?"JR2E@,HPP-84@5*%$XDYFWH% HC&;S])
MOUVFRI-L1T&B0,3V@F=4MOGO5F'MY%V@TIZYAX:-U&VPD7+]<I>B(ZWMH'=A
MHN=GN52AWZ1*O?#LJUC 7Y"4;BH&,O\[&H=]>G0.NR)C4AO7I#82<FX\]PV?
M8I9YS*T"'T H7T2YMA2D-D&B9YQ*863EOEUE)^K&H*-'?%,.AU=H3,)PR<:5
M2(NF\"8B+QEK=B:%OLB+-OBR?14]]!.PMRGV0#G!.HVB;=7@-Q.7[D+M=<IS
M6_$D95:FO3WUI!B@8*%Y6*+F'JAUZLPY^?]8BAC\$#0HBS%%) 8)=X8 J_]1
M):'I0A4!>+Y6G4HZ] +&")B_S,4BQ >'/?(,,98_<?FZO&RBC)6!@P09:GM(
M4@86F7$5U=-P$L#GQ'.P4%8.N6MBZ=9V.72"DRC$(B+HZ5T8,!DE;NB0#Z=D
M+G1XBC;Q^[\B'S_(\EPI,4O@HH$5K1\BI$L%S>*F#'/@+B5R-K=;<I.4GS_V
MHP"$^5^120>;U/UORCR&S(DQ&-&L4 3R1!.25&  =LFQJ%>D7MZ<-&2.AX%%
MPDA4]R)2BL7WP'<OF^&HBARW"]>L9,/RO1_'3@#,!@1)#21,W#K0[J+"'<48
MYQ10P9IQ_58M7"T($7>#.O2ZS@\4I:17\,L\W2;PX@F!PQ.H>)QNH[Z0J>)V
M&C<^#_/#1=,,L! 6*/CQW0Q#%F:P6#9,BKN+L9:,4Q4OIM@.QY)GNY*Q"DJ5
M@]709L1R:GR#VQ2WJY2+S^PTY^'N,%?&_>X7<Y/'"#8%.Z1 :BSL<VJ#XK5"
MEV  Y--I>.GQJ"7$WJOJ5&79@%N&,R[CS&(X^M2R8=2:V:+K9[+&:8J4QQ[_
MH2"A_GZ=^15:@?YV%(44%7_9,N""A'VN=W6+3,)X-7EJ.1-8U'CUZX:ZD,FU
MZ[=SU0Q7\>2N@P\.G_O<=*_'GWUO\AF-LR:6@O\[WEB*<W2QE*N4[$-"/B%*
M-@0I'TTPI>XH#$7]3%S<#>'T"4]/1R.BT_,3?WR"!Y@JW^'F^KO*=4C%6G2'
M.>]7QV"L/+K_4QH"THU2&'.$U(I.:]Z3*LG5Z W;<:Z&RFUL&93=F$;Z4#D;
M3S3@S;#,5C ]F4/PV@_D7W@@,']39M8;-^J#;,X='V'FGB"ZI4TQP1\G0_T"
MT>)3B1GW"P$I-<<L"*UAXI)1REB9[ (?>>K4&,^UDL[@>+!EA7&_-M6AGMZH
M!Q[ 0.78-DY102!@T8$2@OAFL8D*"DJWPGRU-$)-9Z>F647P*>F-4V*PR3$H
MPZS8YU0#_Y!T#<0D<;B-(*D*; WXMTNK#W]T,J:'ZJV2-CHPG%=WDZ.7R@J^
M 7L8KH4-ENCK%.Y&,7T'#H>0T8U]<33VQ9]'9U\D!"RD6')D0]J-LM %ZS>(
M3[NR-8K7/\G:B'^@EK^.UM)5)#FE=]0&]YL[,IW3I^IZF<*$TAN#K+)?J^J"
M02="^/BD\96,@*M'4PNZ>LGI-"!?IS_H#$?#04I6WP6D(A>WV"BV<0)S''HL
M0OK'T0EI1;FBQW'C].W!Z<,HICR %FV'"#[6C/>$)"K6Z9']C#+;"-.[EH[J
MSA'HU),]0PDMF$!=XT/NS,W4^D^ OJI<3OH!W\@"_M^$*1"N/"3;:@I=A1+)
MI4E8*3EWQ.EUO2:][EGI=5F:7I%N-^R,NN>#LVX_A_AR(]+!/P7^[%)F>O_N
MA--+F9RP20NAR$8H_NX0; ?\7[$"7%;4_00[HO3&7=D2^8RB-0;Z;'N"GKHU
MQT_41=PD%495/3P:5NE"E-7@%EDB)?6W3S,VLK<>N,&A0H=:/V_1_<64?2D5
M*GO:L. H)LA"25#;M6-@IM6N<)EB FIB,L4J&'#N[B.$U5_Y2&Q/ VOG6,KG
MG(J@K"@%0.48H-B!Z\>,\Z1'-L@5ETV8P?%(&'-_S!E=YCP(4'PL'[,C;*SP
M^G'JR^:0+)7)R&6$<P;#>F"4YB@F, 9E%YBB3XZ/J67.[#X*N*@D$H'CB2Q+
M<SRPK>C)HCNDP_@;4>606H5*_-!0:^;$7E5<E1P\#-O#^."A0 CIQPW48L 4
MQ2E8?AD7ML$>.FB(X^$U7J- ?#"=+"DA5"%[1>\M&I*GHM]T-B$[=2L[7$3@
M!17K"0DBK,]EY)T*&5WQ GBD*DF4&0G8Y@ 'QK6193C*G,]=1Y9X)D6;8TRV
MX"&;5XJU%7_Y5&(\!*.CT(<O,3B>:&[LU=CH5#8VMF%J;.T$6QQN+A2'B8I*
M$@=FS)J5+8_28$ZAU9%CF4*+X^E,<SSR6U@;KNCT24(0 PYQ.(*<4Y+&5'()
MHH\R3*4\-$OW%1O=Q=W0Y+%AV;7I%##*2ON/E)'JDOCHG5KAB(-JK9O0W$R=
M?0H;26B*M&A_;8%Z<$)JKO=&&B9JUE+!W&NGS&2U6#0!;# =8FX<K17\$Q\=
MZR^H8CDTHCK^X?!$=??X1;5,&"7CS;]WL6V5PO[0N?AE2N[M9&V&FB351)W%
MYB+-)R4?*>57RL><N9D(/L=;(IY3V4?R627[WHBT M(])I'6.TJ1IK!)1 R!
MG$-3'*%044PCO39J3>;6-].9-047DO&V?2U130DY51H1.]PY;UMY^VB;Q=$I
M71!F8@#;%6-UW9>X#L9GHD3''X\QD_.G;"@)AK,L[PAF'!9\X2/@AR=2_"C8
MIT*&C1HHD ''I ;Z1ZD&+F09>;$6T.JC&G-W9X+I:IP.!^ ?IN,)6"=OXI:9
MHL(.1I40E&B<',#!TN>=&NKT5Z;:RX$8,\1#FI?>%P-X44Q9O-))<LD+J8R9
MH.&*'Z<W.XY;T5-?8M-%48RG,$++X;,J=N)NA+'VP^$)X\%1"N,;=584'Q7A
M88\XZTF9?QR8@)-C:I8P32..-YX0X'"]LD3;F3(I2)5)<J=$^8ENE&M'=V;Y
MP1U6-&E!XTMY$W,$.(E\H(+W@&'3F#!>,O<=4>2$W[:D#V&">8OB_%%T5$]-
MK$J1R?'M;A8;ABK*A8+$PT@9\D,EB/*"SCMM!UT"]++$,;S8S=D<E)'\7E-Q
M9"@E#ISMH(/!D%3N6?C(9!V\\C,(/E+A6ZC]T;%N83,)7Y ;T1S'V.D:,YCJ
M=,LJKXX[]\'AYF02L$EL72A.?4VVJ1]Q6$G^IM*9\2969F5KY=49^MA<>=1N
M#WJY1I%R;C>JYN!;(G2N8YGS41;9W1&57(]O2?H(0KQ#2;W)ELME:7KTR\&U
M72YMO+PT>4_\'%L8Q;U!Y+154BCFI*[?[&CME.**K9F79:PE\X/-0.;Y?Z\Z
MKS8UU]4)COF7MU>\O;@W-/6%-C:\['OM&?UOC#Y]S-67KML%91\;_PYT8<A.
MD/49B,+'P)Q7HX5EC9$:'JT-CW8;%A4'X:!&CYH?&Z*K)=%U&Z)KB&[71-<Y
M:J+;KN4AFS7V?ZG20W W1LD6B.2;.(+>)YW(*/6SUGD+,FH3PZJ\_3O9Z[_O
M<Y<U B>D*;F^YT>TOC*(]"F0AVA%C10&_?[9H-?_(PO3T\GU5I"!I0IH/-AG
M5_+Q=2#[Y5(3W;C=+OZDFN<BIB4]ZOOM!]@S6%1X:>^583/+F9DN_W^O3GJI
M%KMOO6AV8OOAB;SBU:^==FLXZJAB;#7?M9M]UHM;=V7[-.*N$7='L;[/$G=E
M<?0B<=>-Q5UW+^*NWX*)--)N3R.M[;#JQ8V-M*NQM,O!/B^1=IU8VG7V).W.
M.\-&VL7SV$F(X5##!S?,"TVW%L2Q!^6QNU>6"]AC$I[GO<%HLYXQXBC*RY-L
M#!*?XA>DWDTZQJUVKU=/V5D/*[!ATB-ETN?X<SMFTM'@O&'1.O!+PZ([9='G
M."$[9M'!R]"BN_(N"DYBC_E,4WK)HHN?&02F%RYJ03V;W8>MAL52.1(P4)D?
M@:-KMPS\?V]J-O8E,:@M3^80=<2@WSO?L*]5%JA"#:$^>_;ODB$WJ"VZK4Z_
M74]]L4F.W[DEV(BK1ES56UQMXQ1QZ^*J?W;6"*M:#[X15HVPVKRPVL8AX-:%
MU:#3"*O:.?#]755!;:.NVP]-5U4$5^T,I*WW]DEIR>KN3BU@ZQ3;C[!8-R5*
M#T),UC47Y7A6N% 1;=*;W\QQ:*\U&O0/0G^4,OV^#=E&&C72J.XK7$T:/<-9
MWXPIVQIT:EJTT BC1ACM@-X:8;0)9WQ#PNA\6-,LVZT+HV5><^'7I8W7C.*F
M0D9YH] E=VVF.0H]X*T#3JYC[: 72_IUVRL05J!GN\+LRM^8W^,U%K!W.AC4
MKY^-PD6C%F_?%!BXPPFU+B#<0>R;"^(%_WOAA<[);X'Y@$U>%'1X*_Z9+WC(
M9NF6=YDV=V/3P@^.[/ZK[KQAOYON#^,;"SCUO?OXT^<_F,M"N$4]57;BBSA"
M:L?AF[CGGRWF0-"U\JGQ?!!N40-H+ )!]%7/O+C/ T+^^?>(:LL$Z)[+)C T
M0E57(+F.F*_J<EP):6_#=+=I(EO&'0W+P",_(0:GI$GNN_92*D\W('$\ZM:+
MP(_8$LH9@T9#"/E  /<5=%4"'IA1SVN)J4WA]8GHSZ@:2:U :KZ;LH#!+RP]
MEH+N@Z(7'Y.S Y9P%P(.5 &29GH%4C-D,#E<![3S0B0[325L93PG9*-[1@^9
MS8&CF=TJ:G-(DYL$3$Y7H.K'OY2T(BC2QE7;<"\EZK4#U=6[=+];U1:Z'$^Q
MM)UWT: /H:UWOVGK74*5QM+VWDMIMY'2L916;7_7-2]$7]OQLD? ;_*KF[3L
M+WEV.'4";!H2@.6D-\Q-"^6XV0B84 ^@!1(Q*@T.-40!^RWDL;A VFPD866[
MWZ(>PZ(EH?Q=&XB \9^:#PAIS!X</^+4V% ]$2^7$[Y3KX1!3@)SMHZ* <G/
M(VLJUS6:PZB4_FB,IQ? EL7],V.RGV#R #9SP/$BVP4LC */6%%OIDT],@,T
MZRTGL*(9]GS SD6Q^:'>(?F(5WIFEG8#&PD7?R2T;K+S$DN)241E8QS!\YAZ
MCGP\3S=NDH^-.]0!ZP+384"#GA,XA/N-4H?!7LZPA_F6^.'@L+PCPL3'4\&T
M=*%^3+#"W/D9[^%;XW7GS3)Q#_+V=??-:M$-E_7PLMN0I-KK_AOCP@7A^5O:
M!Y8"'BX8O#&^+/S+!=@JM(VOA_ %LYT['\3=J?$A(I\Q\KC"W?:#A92"*<-=
M-$*)[XRI"M<ZHRQ$BS#1LP5506P^HW* !_V/Z44FO*77:='RU1H'?D>Q)%$G
MM.M04FV8*3W]V.%;0MK4&PA\M<@C40<W@"$-1@2VI;_SYXYEC/K=EO&9@;3+
M=&P/A.,:I@-"<5LT>IAIC)V?\&#J5 ":8,R8;%A!Y@N-%NE<=:D(%W,4FG E
M^<%<!'VZ^. >=5ZCT) ^R23Z@UTLD#7@*D]U#5+O%;V!C%MX_5=LTMS]*89G
MV]1< 1[G>"*:OO56Q76DFT^24&XOK^*H6J:WJLM](9))U\(6@(=T$C?#GOE@
MYJ7[72RQ$@,3H^T+&230S%\2<;8B#)UH!#&YSLQ!.D6-ZMO8]\FG7GRJ$51*
MW]=Y%W<D#@OJU)Q**7''1=ZZU(J[8*8$EPAU@:GF!*F.90XV7P%25$5^*$+$
MDDI:;HF 'J=.Z'@3-N+!Y48;+X!;N=9)3TJ]N>F@8Z@UWT&Q%0],R#.4PB^Q
M*X_J3DM2H;!GG&PQ1S:0"[O@&G]&]@0-(Z5%L,.JPT$3<>$K*[F##? F:)B!
MH!I' 352LEEH.MA1U?4?7]YJ_QX+!2([RS4Y=ZAI%2I2T6H*6_EQ'@5DP(*"
M%HVFDCY5^$W"'Q?QWR)D(:+=^,#<8Y(+Q\"-B2^7.J81[;F3&S&,(1HS"<.9
M^N&.(T]0B(F1=-G!M5!E2!:%<2X9CG!6TV:124T8@7?Q,*JL7Z&PG?0.3J08
M7QY=Z8:$.A:!]4L][(0SZ\3Y>3)U;)MY;S/=D#K=[J!SUNN\^A5,R =FG%#?
MW4RQM3!(QR!.PY4-EGJ=3F\(_]<[RR9F2";@%YY]@\O"KZ.0NDR"#+H#8524
MR[JR9D+ZEAGT-"UC Z?_UHZ"1XQ#, _F&3[ZPL;-YA8(WM18B2_C)M5$3#-N
M)?'G&#+N=JR863M_TH3I$F8O_ 'OD<*#3M $#U-2B^AP)[@(33OB4?H!_TRL
MQ_A1U)D-]3(HPV7O2[BU$J?B(F6ZX,G38V6<QFZ*ZXQCQSV>^HOCZ#L*$!--
M@\Y\D&UE]>T%\DTS:4) &=HM)MR7N:8?5(P>UB:5T* M;0FC(ZNBF92T$P3O
M24@0<JC@*_K0@@V;,Q)G*E[)Y\S"X^E8C2(_X.G%R]N$3YD95WW(LO/35[^"
M,"N*NA0[U]*O3D(GL5R.]UJUA);]F,4%*$R9-S55;DO(K*E'06<>S>=^ #(<
M]U2>=[GF/5QOH5PS)RR.KV(;4[A(23@,:VN"5:AN.SFJ+P@B:2'VC[F!5Q2R
M13.6 Q7**QU[BB,1/E ("9TR)DF%I&26Q??3VU.A)I7&+;V=#@GGR(^TDB)I
M I[IA,+2##Q3ZEC]U._4D!$5SK0\JM1)H'1S@*26-;1.3AC$5[#UB8XL46U*
M+"=J]K0LGV+-;(I-G7&MRG0XM#R'09/G4)I]LRK+X7 4Q:44P<"7KCB.?%ZW
MV:=-;)EZK=)BM@]4%E?MH:/R]M::,CMRV?58S?"]G.#&&\>6M8U=LY<NW=+T
MF4WRY'=2JKV/AI6[Z]EV+#W9ZM(5=J_590W9-&0CA]9T#EXVOZ:?9IV8L.D<
MW!!=TSGX$)NXG@T+JUJ/&0/Y+C!M2KQBS@.Z8BW#8Q1%M )F.Z'A^IRCC]QY
M4]>:XWHAX*V)17 TB'<'C5=P-+M0#=-@F#TZOQ"GKOPF%@-?65AV7KX16(->
MJ],]#"CF9XF8.N"P-/*Q#IS9R,<Z[$(U^9A++:HJ'S>'084-P@X']N4X 55+
MO(%#M?0_, D($)=<8!76ZVYM#?O:*J6#$'4'K7 .8H6K*9-15IDH/I38.%LV
ML]N=PS&S:VM"-Y*HD41U7N%JDNA\?4FT28.V<_Y2055W@&/XC'1>L7"4AE,Q
M]^89.39:BEPFW2:=QU/"826+N-3>UZQ]\7:1CE1IXXINS1)'Z,^WPM0%(?>U
MQFI&H5\PUG=Y_V.I.!.9GIN?GLQ.0QP;SJCB0QX\1)Z>82SSCBE=^M$4)5T+
MN!"HQ25@CRJI[MILEJQA.9L6\F$YBS:<6/;C@7)BWD<^)D[\^])N1:KH[JS=
MZ9SG3@ZDZ? I\&<J[?1W)YQ>RES]CY0S#$1[@:>(G-EWYL\=]93H]P8Y<R-)
M\U5U$GK"%,*O=.$5Z3")RA,FZ:/#DR9 "+8 O\'G41&#*('(/KH2LHNVVUN7
M5"6)W,L!D8^J:"@;$I-5&0&32LDPXXH=PW4$"-&B%5?"1IX$*3%G%!Z&&UT!
M]..75#@F]1U8JV(\@E0G&"!1H6T_B(1T4<6U$!B;A5 <S'E04+I)64R"HT'H
M10M%D\4%)BVM5%--?ZHI6$(#3>@]5;CSWSR9>_'3N40WRC$!36Y9BCMV1QNT
MV]U!]WPT[*=2W*6PN1&#PM?<Q..K(%5^I0HE"=R5['F,$":06C46EW5&$CE,
MVURJO2O<8$4)<-'?>Z<= VC0I<46"TUE[O?X2'<,?V)=$)9.8=$0W$$5T@(>
M)\N&*T5'[JM21LY<^02.7EVA,.@/NX/>* >>?SLU _8>"Z*0DACA;/G>]9RZ
MQ'OVE8<Y5+ *WT#D\F^^ZUB+9]4KY"L5ZF]?Y>5TL;#/F1F=T6IKJO"F7=E1
MLYP&K#C(9QM0VS*=Y,$@2EJ4ID3>)T3?AD[@56J*:)B%"U*D[3.\7Z#AE_%U
M2MVFR2;/,!O!2*H%E*4$%Q"89ISV2A1G6MI>%<%>(XS:66?4,K!4L-M^I^_M
MR6WH6S]2VTU7==X9K^7E\G;Y]9M3];P$ \>B$2)^"P+<2A4EE(_I!,:#Z48$
M7H#7APLY:FDB&"9H'[1HA;:R\4ZX5(!T1EP@EAM"QIY\ X&-WWPAI"\UP.MO
M7Y+!X8K%+R3[P0]T,"5ZG7#('; #7#%8=Y%2I \PB4RQL("[P(L\GH*/@SEQ
M)TPTJJ@4CLM\LZ"<B$* Z;NDC'D(_Q&&$@S/GS,!_%0!-JSACQQ_:!AO*8Z0
M>\9C),*8/+!^6I(?T1L"->GESAR!CV&F)SAK8\; _[)7;SU1N@GFDDYQ&=A"
MR<LT)/C_8^:@D<8%XC(#2]NRHBP0?4,%U:#57,G&\.5[U[1^G-Q:4]]E_.0+
MJ& 4!/,8QPMEB4 -% L/'X#QS?D\\.%G%$6: )/[KR!]A026#]/W6'QUDGY^
M+"M- WQ]="F .K#>?T97@QD&GQ-GB<:AMV_ XO]8H,)^_  ?)R7F"/7)):^)
MX P1E)6&V$HD&WV61?P//O@#Y!'&6#WQ=7)2" Z : KR6^T.1%,Q72L2+D7,
M,^!H1J:KXPYSTB[BC3/@'"GK% O1--$AA!DJN9G&"!%Z *5E"]4'(G7ZZ<'B
M*-4B^/%B!LFH+-AV$Z3QG+% 5U4*Q$M1CH8/(WPINC80:>5POX6@%.CJ,@'.
M9?!H#+OC,-%=@T8-:P1NA4!Q1F0)+]ZK>/$$D12M-4'&*4B&K"AR9G-7@*()
M.FR11K)Q38!,BZ&>%8;8@^FXY#<@"J $?4?\3!.AB_%[I;/%V'+O$HX?.C*.
M)S"&@45@>F@[P@L]/YI,RX=0_?5J&U-[*\84./S'R1BA90CP O4S(2LY&0SL
MA<-<&5H@@(T07Q,!+]S[&#<34#8>62+ /K1U\3L4(6 <(9D-S)/ \DW'-D!,
MPN#Q0<@S(MZ  H%QQF@F<_3\:)[F(KFZ$>1K"/*TR7C#$-"$B$%8JM\]%+[*
M]+NY_<Z5[1?K\"5L)"21)+.L:9:6F\4F:;.5S_5<I(R.=PNQ<> S6.((?T>,
M)0**L54E1$; -51H<#\D[%Z*6@38C7H#AKR3@)GT)9;9!&F=O6JKLV&ETHC5
M!@BB*&:5S9#H#5/AQDN$T;P>2US!ZX!0!450:C-H&DUTJLI-NXI.Y0'##STZ
MI1 Q44)<6&0^&]=*1%.LBM<M,G6\XOQ#<D@8/C(7L5 )&;WDM+"3Z4D'CDX"
MJT8[:LH=C>;X:>D9KCQ3Z73;O7X"&U0%.+6HR^WF<L(&K?:HUQH6=-O.FA*R
M>Y'QB/^ R9A=#SNWNK2XO.PLEK0DGO=FH@KRF%I'":7.D3PR12\_U)W]4=MX
M]4&@A4<.G^*;/\OC04=U._A(H;I7]"*\:=09P$U "P\FGG (/?TO9D]HE?&#
M9G+%KE4\!C[U([#+L95@%M!8! 7I$>2LH(MLQR]*#BZQY\*8T0DA=4\X'S^C
M>\(F=/=S5'6N1@?L7&8&UA2H^ /"B?MS=)4_BM!5<Y2DAGPDRMH_.F6MZ)?X
M6*-@D$T\;/3T#GLM:_M@:_M@X3X(#&]029,D$Z#X0")]'B$@[:U(=&2%)XLX
M8B;UD8+=E$% P4WLOB;5?6'Z!PCOH&RT\O!$08;K+5U$1%"F,]&C-B;LJP*1
M;JUO:UYDEX*4'AH\Z;"!)\W!DRX#)GV*59$KD;CR+'_&[LR?C=^?^=_1F!+S
MHS,E!-$:0+65ND314!J[85OA6D?L1HB[49I<TF_'R27Z[A5FDO3;*F#?DC%9
MT=]"NGGQD1,ZS/>+)*$91D .KHP1)S>HL_08$=FD[A#%!P"V0XCS=)UJ63 &
M5]VS'&KG1]DBE',BO&A\*_7MD^YJ[OV.](7QI3,Z:XICS:*7LBE.LN Y>& E
M;S8?Y0&D2JF$E64P,NPEI-K+ZD/%I^L)*IC]&7"6=O^U/K08$9<]1ES7?\1U
M:6&'(P],)L[-8-$23[$CBQ4NL>J%IQ)"<:PT16R]X3H_F+LX@2^]$_395>HI
MD/Q_JI2TO$P6D]1/JM=TT*BF;B4\9'.1<H Y([0K(H]%D:&@*G%XD5"]Z)*I
MSK9QY^8^=T3VD-:0B)[NB,0L010LIFMU WSX 32GMQL6.RJ^1Z87]"MZ&M\G
MC0.HW:%L2L-4Z^/DO)?1^2>> GNV8Q'UB\0K2J[22 F_]BC\@[^W*)? 4P/6
MDK>2WA)H!JEV!JFY*(;B0!6FHWIP1K83JLQW'#0X'KX;J4<+OT0D,\!.,&R8
M!ZN!W"W;&<#N(..H[J,<MLBS]<65K)_(#.:QL1.JO!(772Y,+1'ND4H_HR6@
MN0_:O\1KD>(FT;]<Y:G!F\/0)0\MEU 41(PGI^.4A0_2QR4)I65_IPK4M*&2
M=,?_"%%/J80HRD^-B^)<^%8<A<QTE7!$) _W'AF3EE?/92DCVWK'[/J#7#HX
M]<P(;-E/10:B%TVT3@WY2$SLOX[.Q%:D*DP&7L,<[^,U S[Y6I^@DU3]32L;
M*<.N?*!\XUV*4UB3M :,ZPFK 3NZ&A14F[NFE?3\D6D329&/.)N!!U#.!/:'
M/S4^4;=X9>@)2[0H1T9KJ83Y&2RN)L.+D\S&B+)TL -02T\,(T,9E(+ES$41
M$]D$F/F8/)8:T\;V-TUOS@+YPTYLRY7-/ZKT.#GOG'?:W9(>)[&J4!N[NR8G
MS^Q8TMYYQY)GEFIO$35_.YCYJZNS]P1=OF?@\CK"EG^_-3[XKDO=4M>#@JGA
M9!SO""81E\AOK%I]2SSW1#B>96 \SQ.)0L"/1K]L"2^U#B"2"K4%;)P<=,*^
M"";!3-LNTO'.!U61%FH(XK;!A5P"X'8<*UL)O*V?;O:7,W\E7VX5PNV\^SS\
MMEIQ5XVUQV%J!MDGF;)29229?-[.._!=,&<S9,9@[_2R<_&_JQ>6B\E#%8%Z
M\G*_,^IT!O"_]A]QF*#3Z?3;@VZO-VR?=U+2\3V>'C+.+_W9O2,Z.R= ,5)T
MQI)S>:B@?=YK;T1X#@K@J.K)#366C,=K5\?DN'>:.#8C>H>2]D49I&F1>T''
MLG%<MJ)TW9AIVFT_$^6\5D2[1PF<R-H*81B3,R3(V@O7[]R<L.V30QF@]-*E
M>X9X*L&*A]?),/%2(/--C* JN/JZ0ZJ3-'Q=31QV*XE#HL3=R$1*&('+7OW:
M/SO?@W!\ C<4RKTZT<)ZK7+V;2WOK)-I'63\DL#T>LV8MV$)[+XKW^'UY&LB
MVB]L_:OIU=Y3X]X;;*+4']7/N:A!%[Y]H9#7+:_UK)/-:[WT"<A8U'[>./S'
M)373QK^:K-:CR6K-Y](=>E9KBFXIK5 0KH&4V]2@[R[#-:ZG<CP.4D" /E)F
MZ=P/L2B 4/5X=/]G)LU4@H%E=M$2NX@0@ *D$5-" \?#+%)\$%YB\FF+_M6@
M_606:6#:3-:*XPX]$XWO>+?MKB#=EU845S&_M%1D1\4;HM? S/R34#>]'U1)
M<L4#D[DBHQDQ^PC +RZ ^XUASX7%J7$;65/UG!@S.7W]S%RH"KF?6(1#R+V>
M*+1SG9D3)@5X5'8B?X+K!8[<GQ%0CNU86FV4(K>9Z<A:K/*)4I4C["S6VVFE
M@DC:3AA)> 0LT_)AU"*%6H=!D,3+?L(4J4#(%^# A4\2H\,U3-8$YS5%4$O'
M*WN] $> !34G KSAGKD.>Y!U@^E+<393(#DU, 65)*IY1'4G?'07+0,+O,"$
M3/$?@0--F#\!*PO>BOGF\N<4W\)\':X6+V!\3HSN2X ^-;>&$\LY$;;0?S2$
M?12P,8(:<X77H:US1CRJ^H <'R-T!Z* Q.U62AJ<4%VHH">0ST@<**VI2( +
M^*H9B--FXRI8(-F]R?%"1C%A02"H-9@CO$=(-E&Q9\;;EFQ.F))B/V!(N>W:
MWB95*7_HGX%CD*N8DQ40_'J<6JKK,9IH[Q?XKZA$V5PM1'$EQ%KU'G1#4SC1
M%$YL()HY; HGJ'59HG>:3/W\)!H>;(J7MLV#^SQ;VC+O-:16.U+;6WW-P8IY
M83B>#8\Y<51UVC4N]GXD5<\C[1H-ZO@S1_6[3CBS3IR?)U/'MIGW-G^T.WSU
MZ__-$NW!T6[]<Y9^.=S%;03#L0B&U1WFL<BGVQOF<-US9^G?6(!?F!/6*2IW
MC$-;5/CX!P_"+WBNHO0DO_CI\#\PF41]<_&%'.D_(H[OR[WN_>(]\ZPI=B&C
M6\5ELO$KOXF#CZN><K>8,^T!XF U=YUXBI:V,H\"%N>MG'3UQ)7NJJ3XL_JE
MK1ROG-V<F-V%07S@QN[[O1-R4TA:2SVSE@$ZJI$!>IA"KP;&9<.(M63$2@9?
MK],YV[W!]_Y8#;Y.KWX&WV'*M<,RYEY =/-R[X1<IWA!+0?U,H,86:-RD&NO
MN*8^R^3F5-!GET>BS\;.3V:?_(<%_JM?3^JGR79=7G,,,J&6@WJ9@BIG?/<'
M_5X.D7_KQO>Q"*N#,+Z;:.OJM6VBK2N-[P][)^0FR',P>B9G$'=W;A!_.!(=
M4W.#N [&;B,8#D8PY S0P=EY>[1S _18A$/> .T<LHBH$_GNPK@LKIM? R+C
MR<5G=&OM82-*UFBI3?XD"(G"&P?]0AB)ZL61^9[?6Z'4_YM#)%MCDB4P%$MX
M<5NX$Y^Q*)VZ.';:ZS!?^73+&*^ M\J8KFHO>_6<?)7G4A";I<Q;5(%9VL@^
M^[A#:&9_UC2S+R&C\H;V961VV!7?6*H?MUBF\GM9\NWZV"X6:[I3_:=ES?9_
M<VJTS+G 1O''QEAOP(>0%[()7U+\C??(YK^A;\S-11K+(F"3R#4#%_]Z<-BC
M!**PV5^1:2U4!]UE8XT'"N],L.>UP>D==&&MDAFHIV=A!G#($[Q:]N86<"#P
M7$3"0+P)7/_D9G&3N"B!NL!6NX[>!3BY4'4)3. V9.-$A?6"H!FVP^=1F.F5
M;?OP(\*%3,T'1G?YX_&)'*;!IXR%.>@.K8DN G/$6 H5.N3F46@(FF..710]
M?*;':/A_K^)[]+"A0+^?]3TNU-9^\H,/?G0?CB,W;_E?BBW:+N1<-P\Y9ZC.
M7+0F5><Y:I_E?*SGSG-S+66ZPV73+.>TEH*!<!Z8NZAYW^.S878#OOD\9+.Y
MZR^0]]^+]M'?@'-XT_I8#?E(0.+R("*'#A)W08W2;>.6P>B(/;^9BP8;;E?V
MTK<HX!$V@0<E*B#"8HRBU(X8G\W'EKS",82T85)K(H)<Z I%S..;P"!"W"XP
M&.!KWV,(R!5.XZ=S4.W!@F0QX6\MP#1'C9L(LA:"69G&W ]((R%V&//'H-Q=
M5UD>R3CD%S<WGPV&V$QB-/=Q/V1;=EWF3.BW3E_=4C#-SOFP9[S&H7;;[Y([
MZ(O.NS<P! 7+)3"TP*B45[4DHE;) OF>2\8B+07\J8"W6@@T;5+[91Q6I9.0
MLTPS8S4-F,47\?@/XNGO%Q_5:)+HYUJH\4O"B/T5*GETVLN?9/\BU]X)XI40
MY- B-"L).P>_XOP$3A.AR-$N660Q.@S,/)BJL-?A!H&41E?0#=I&@YW(P)1.
M8301;AK]$9'QFZ);\=#7@F+(GKWWP2I5U)^CF#<X (4D15/S=1IX)V@7UHFU
M8J,5C76)E.<ZPH]P)+F@&9Q8HA*#+V4*-WA?)=Z?'X*\R8*M@</ /'2H-(<A
M+:>$OR)^J68*]_J]L_-JEAARG>/;'\4H=M3"IM/I+[&%6U5G.>AV-C7+S-G*
MAF:9%RY/<6QZ@[/^\'PS\^S$\^QL;I[M9;NI0 91A0*U>ZCM"GQ?\GNE ]PY
M+)<G5]7QR72"_S7=B'T!R0[R&S=(.#OBW\W U36^3Y6;=N7[Y+7>H?L^2,4&
MD;&AT7&#C+T[9&S<@ ?: +#A;9#O'IEFPKGX:4U-;X)10<=B(A#\Z$>NC6Z%
MB!PR(7QE[#5$AV5N.K9$$_7XF*$'H^R[A?':)"3>4#SRC;+M8O!L?, ,M(YA
MV@\FV>D@X@W,'H"'*S$?ORIY+MJ_GD'''>A@X*NENKMGX2-CGGK&W$0N@%=1
ME%N\?9:0GF&;V<!LA(:3"1<&C!DG8*,&QCA9M2E\-@-K*I#"71@:;#LI&=OA
MEHMFL GN6HFQ*]]LH_>C/90BWK# 41"(6#5WT$-"O%MZUE,>!RKF)/=(6+8Y
M:7.!U@K>*O,4+#+<[H#BQH"WMD!B;9)9!XA,#9HT"YH.JV;X\,1 (LEZ\PC1
MEZ>P$^:#Z;CXK0R7^P+7&0/O^!"Z<PQ&0\GM-@M9@'? -)))GAI78YCEN #I
M7>R@? 01\1BWA +Q8R!0O,0%:]B-G>AX>B+RKSWJT8$[@?HM().)'V #7'E*
M$<TE-;G^(^/RB0(9'%XLWHMN,D@'9PQR.%YG?:= /%N1:R;(VQK5*83SF$7'
M/@9T*PC+IXJV1M6G;B+Y?0!)#/_UM_-AO_ONV&R%_%TID,#/Q&^=4T-.^#HG
M/>+3Q,@S;9P#?/HK\O$_I(UD% 4= JDM.*D<Q\;P%:R&$KN:Y@&IFUOH&ALK
M#4<W''U@'-V-.?J*V+@EFVA0>M,*]FT)M8MZ4S,FF$,/L,%LL4+LUH*&COKT
M#FV2AJ,;CFXX>EL<W8LY^GN!C8\:-^XH$9!;"GHVA O@!\]7?ASX::9T/N@4
M*NU]V/@B?TY9,?XC.:?1;"[Z[1P0<Q]V; ']%\L,@@5E9]$! U>ML0H[&X'H
MF?H!^$7@WVDG@P692G$7K;FYD%_-YX'_TYGA :)P7C6WRHZ8<K;H#2?TAAEF
M?6'P ,;$L>N3UARL.5\JWU/A=Q+7B;671W6P?B*&CV$7\]Z/4IW4XL.HQ$4O
MB6+$.CL.9V"CJ>71D;+N0?3P[+==XS7%G<3I 7^S/0]Z65^:3J?3;_?;H_;9
M\"Q7TQ>']R]HC2X\^W.R0C)4:E][-VH5X(*OOA<ORGM<DSO<G:VWK=F5 ;+4
MZM#,DTU7/E3&<!=#Z Z>4=/V7!AY.81GCN!@)_Z<<L)J+7%FCFV[+-,C 08@
M^R.DVDJO6U=8QS8)VO& %@.6TG8CA27;WOLGU<^6EYD]1V8D?/)BZ.<#:)3
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M)CY(6O0LX%GQ"AN<A:$KLFM;\HU!Y*+!UX*G/CA .G"W^ 'ICC.7W@@$  K
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M*X^#N*I&JO$JE&0Y%V<XYW*5"S*;C]P, 3?L?R+P-+KMSK!E?+JX?0^N#T>
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M) DU>0@31\JH9T"OH#["3+;QF%E4?D!Y<PXZ[P;&VS%G&00TA6<IURC9A<Z
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M#>;9S#;T7$[9^1T)5O1_A[_@VU#KS8ZM["<>]A"%*T*@&D[-V ,&]!]AOG+
MX+T/C%/O>/;38EPV8KWGOLM"9E"^.3/,&9CP=._?"WE.;VW=Z0SAO^?ML_(3
MMM\#H+$/_J-7)<M[$\?ZYR,CQX8JC[Y5=4Y ;6?EI3?+YM2-Y[3)8%P>M,9(
MYH2[6'5>Y_WS_I/FU8GGU=E@,YRE\P**G3/X]H&YB],EDK2X/"LG=K;?2UZ3
M1UJQ4_IMK[2>]D\NI<IG.Z;GT$MFA:\54NK3?_UM!-3Y[D3^%X^CYW(E_SD-
MU*"DK2 FT ;=8;G,#%!E3.4SR8# 7[1)2K&*X=ET,44N*J!^F)L3=G(?,//'
MB3F&*;PUW4=SP3,SH:'_X]<M[]TZ)7IZ[4N_,^H..NUA'M_W?<1!VW .XOG>
M\4PD[0T6[#VI@&HW";#_%/R9^Y=*Y 9:B5SRFWJ'LEM(8W=3992YQ[W_?GOU
M]>/MK7%Y_>7]U=>+NZOKKUD1L>P_+ZGLK&Q+KCWC(IJ M61T8A-C'@4\,D'_
MAS[H%>-B$C!&C0Q1R7QSX2LP#+ZP8((PHF"O3(R;FZN6<>$"!__64K_<1O="
M+=U.S8!-@=;@RQLV1QO$"TT4Z<8M6",. KM__GS9DD\1HQFIP>CVC6G]%3D!
MV$7B5?1T^><]LX#W#--XA#>Y"P,4&%S'HWONV(X9+'#(VJ-.U7TVV$:N/P<A
M"TL6C4$! 6]R,7#8TQ_8D?[""YV3WP+SP0D7!E_PD,V$!15QLICFTP5'PYIN
M\E@4@(R;T!<P;_/><9V0F)]^-\,I6%H@2,+ =#P@]9:!8E597M]!H\+ ;^$.
M)FPS!V6[D!XFS.S4P I"<P*;,H%K<+.LJ0D#F8-T8L:C"7?!QH7P]I7F&XJO
M8:??'U"3^ES=O+G 7>=W_H58=R7/&/\M\'EAAD![I 07_#7Z(^+X)'4?/88[
M.(Z+GP[_ [M:T39,KCSK"QFZ)2;%,&52#%;A^YV?MO,V!?"(2RO@&9;)IRTD
MCC_!M$ J?_2#'VB'@Y1U0KF1/L'D6D",P$U 0)F%-FWT,6B!@)A :(D-HF<;
MH"P]/P+2F9D+($V#NB+=P\VV$<V1$(PY"U!K@_[#;1+$B#JY<_:.&PNX_P2;
M>YW@7\8X0J)49KP!FO01" 9_)Y+Q8 O >_#I-K[!:>U+EN9OT7W)E=JMBHS-
M.88[%;K(P8)%@8- 0+% R <0"1X?LP!%G,/7* 2NOC/UJ1E&NVG8[IR=Y^(U
M!,VA"8M+6&\@8Z#)2WVY-EM 7 0>\<RBXO8.BXH+ 35*T=J6@Q'DS?7+RX\?
M/WV2MOYHM&[?H]T'"DL8[Q*$\Y-Y)S6C4MR3FATSEPZH=)-7C/1 =SX7A-_-
MMJ^YRIMJ-%:;95]I?J(6..^-SL][%;SGFSB^>66#-G#&#@IH@>0D;53[PK,_
M.\+H=AB'WT#_V,CW\,-'N.0!#$HP;DJ,U\V9K&M"4H]:_?/5)Y"U)-J-=TDK
M@XUZHCI+M-:S.W;4AJ\^"@<#' OAH]52J6VN#<#N<YGK3@![TF=[S]:NT194
MTVW]\_-\:*5 O5SZ/+P>*RWV$;1;N+A#?U \'7^NF]+JM8;MU=6S!R6*]J^M
MCM?YNLM'/&I)*XTO=IRZJ_'%JNBK0?^LFP/X+O#%TJ&X)'#9V>&QP)J9!MU6
MIYT_&#@(8MR1CY4-@!;!\1; ?NXNN\OQT/%_>]+OG@X&R=$_1:!'G=/1LPY>
M9<P57_<6STL<ZS!]NLVGT>EKWSYM:RM/HO'M\+27V8S>Z+0_.)QC\ J'%?WS
M]O#L+(=:4R :;T,VUX0:1IW"Q14>XS(>7GG2QF<?&+<"9XZ7;$5FTC&3.CI_
M=%P7*0L/])/L/G%8^5<$=EGH&\/!+^J87%S2,IPQW+!H&??PA*EC37/,+I9/
M'J:K$THS# /G/A+')_!@?.+8"3#)H*L2'.=PNV]3$B*S>7QK"#3$0N/U*W$]
M2_/$JS?B9#Z9A#S-76\2589+!V]X>%HZ9+Q,/6(<^+."::I;7K_B#';8SL]'
M';(:%R'=;^.9/HS?3#:84A/,B4C!  IR$$7"-L:F$Q@/IALQ-=_,P^6!LR]3
M.JT05RB:XPSI+3 VTI>>%3\A3K!@Y'_26N/W\\"_%S'5A?XR0W^;;UD$[&O1
M&M[CLAKF'.[\20-V%Q62$9#-SKK#83\^$T3"?HN2\3H*94+"];B YU9ST$92
M"WJG>=@"E5D@,C-PK">X+I2)85E(@KA;/K;<-4S#==1"XN(26]XC'<V8B6EA
MF" ":PM$&K"Y'^"YIR*B< KVPF1*JX]>% 92B!(X)HN(/1@;_ES:9/L[OU^E
M+<Z+M,7P@+2%+EBGN6W&_5$)2@D7B]V_EY2+$."*= 7=Z,^;!\QU9O!S $,T
M3)!$%FTTL6(Z7P-%Q5.8K'\^Z.42MFMJYJ_'HMWN:1YC*<[^2:2F3/(B628R
MX:5DRZZPRK-)<JZTAV">!J;=!YBN#ULW\7T;F7IOS)=AJ[/#XJI$[0IMS*,9
M3 C>R*4>4HRQR.@_T<X\46"XM6YR#HB_XT$@;I&NZR1ODC[<6([-OI-JNJ-!
MWDY-@/CSIZC,KG"&6BN\_EVFUCR_R'P+<=W:1)7P:)VX39GA\H1] V&5-2OB
M<@&[FD$[["+*6QNRV$2,=[OKNYGX;FT6O(K9U^NW.X->+M]R]YDV&ZL>ZY^M
MAJBJ'>5M.)B[(224=*K,0?+ #>,AF$7H*EF;R?3<L@K:(9#"/D&*#I*8*@G4
M0;?=Z_13P:I-2M.$H%&N;A<"934P\?;YY]#DY;$:]1<BH$6A#0:*'*BU_L+T
MP.WY78SA18KH_GFWO5V;5S0T%%?>Q!RS7<NWTSH[VTK">&/['B0OQ  >]1?4
MC=5;7S*J)E('O='95D5J3,U;;O_3ZVTE(:PQ>P^2^+\%C"KUV<\Y\[C$7U %
M\Z3CY3E3_65L8PPWQG"AY!Z-1E7._3=C#$N&^BCX":Z_1F82OVTY+EP'N=[8
MQO5@C1M\+9[[(V /2?#Z"_#&2*XO/542M<-VOSTZVUYH&*=^/?[.Q<5;CC5T
MFO!P8R=K=C)FF<H45DSYF&/V:<OP#D&P-I9Q8QD7B>M.I[W=U C%-8B@&,H<
M"6*<K<KN47<K)=J-)7R0K$#^EP&T<')H 8W&'JXO5544L(-A'G=\DP*6B/NK
M[UEZ"&*[ >0Z1!D.380>JU7\FRS]J+\L;4S@Q@0NDM#PUR GH159;U60GK4&
MO2:3M[%3DVR&T/0F#M8(-09J8Z#N1OSUNN?Y'H2;S6I05"TN)H/U;FIZ.Y&Q
MG7ZKTZM#RMBAR=)C-5CC+-^YN6A2?!O#M8XT^KJBZ![!OSM(:]!_D-SS33#/
M5D5WM]4>Y=ND':-Y7&]J?+.U)6],?TTK!1%6\/DSS!K:%$YH8_V_6.N_H@[I
M=P?#T=;R-2197VI4O=V(RC"/5'7 IGZ]*>P@],*QNC'B3-.4:D,#_:F_UFC\
MF<:?*=9%9YU^;VNZ2&1A"X;1?MUR#F%[<%X#C=2X, >@J@Y<(WU@LHFCA(>M
MOR)JW)?Z4E-%E3'HG UV4>:N_:#H_$:0^=9#8'4X(6[41'W4Q+%Z-+^;06!Z
MX<*XOH=1"S3G^NN0QIEIG)EBS33L=@9;<V84LVB\LEV@K-Z@!FJH<6/JII_6
M:C-J<H;+5_=5_LQ,A$%03%<';)EU6OK%J_PDV?Z\/J+/>_>&.VH>"+E5TR=G
M[<YY]VR[(+9S[/]$U)^HE1=18OL$]FJT1_K;'7HWSVQH79O]$*U!X\8;F^X1
MNF7'IV 7#L472FL3V4Q!:I2#I:9#QIX_R@VIJ-;/._WNAM2Z2J@N5.]?MPR7
ML;U&HSN2"EOKEEVD'?]/YH)LQ]'2]J+PTUS-5#3->4NTJP8P3RY-+6CZ _Z-
M],E^6FYD:V_6N4>N3+O]BVI;!@I:O"T9PS(VJ=J QF+8)E*]1*Z_UBT-7RLX
M]--__6W4;7?>G<C_=KLX8S&W?TZ#F 2$/!$3:,-&6BXS ]R_J7SFVS[X$/B+
M-DDI*'#CTVUV\A0E?YB;$W9R'S#SQXDYABF\-=U'<\$S,Z&A_^/7[+ZIU<Q<
MC=]4ECVY72>Z4;N:W_/"?4[W7A*MZPZX>]8\8!Q;<(C.DBPT'3=N?^5D*ZRT
MWEGI5I0%O>PVTRHK_:%"9ZNS/@CI''I=TMGJDP/"FWUV'O*E-K&_Q[^907$+
MR4WTMOIG1G#3Y\*67\L(+]/TRWB![;*V?TK\_#=TR]ZP9 )/,-1*R*?X]KPN
M>6X_[$=QZ[WOVCL5:!]5I]NZG/%NQ@0Z#BH]0C(SOG,VCESCLS/>0\+.-DEN
M@S&IZ@&G#?+ 5EZZE"V>%&1_>;SS"5NP_B^V8*T+PVS-<VU(]CA(]O6_P?WE
MVXO_UX5>=W<.<38\T.R5N\"T&3A>/^I_PG HQPD'20>'?%QPD M>Z3C@?- 9
M=G,E_2+"XRZ+\'16AV_^B#@^;4FXZ/WBB_FG'URZ)N<7/QTN[XA%!O_"9O<L
MV$REYOG+2"C;3"+,<4O*)@GUJ=)D6>"XWP&N/\N=+9;SOP@%8"2@[*!P@R)$
M$PXGG%EO[2A8@)'ZZM=>]NCKI4F%C5>4':ZMRJRI!QLPJ4,*YMX+O)I:LFV:
M7OUNIS,<G/]Q&!99S!CO39Z_:X-FVK#5&=8A0_.P[+%&&-1>&"RUG(IE0:T,
MJFH2H-3*ZN_?RCHT8^I8(X*7$8=1LL (F"LJR:;.W#@Q5(E9_6VOQOU]H>[O
M*HNN/SSKU]VBP])0Q8(W&@<J]MN@,==MU\&4:V)NC= Y9*&SPG(LDCGUL!RK
M2II2H[&[?Z.Q"<W5@Q?*C,8;!E1X ,V &@^]OK15T;@;G@^[AVK<"3;9I&G7
MZK3K@)5^6#9<(P5J+P566%M%0J#>UE::]9L 71.@>ZJM]<'A8>#<1X>!%]#X
MRR_47UYEQXU&HX.UXW06W* UUV\-SNH ^]F$ZAK1<\BB9X7Q6"1YZFT\%LF;
M4A-RL'\3L@G7U8,?WL,^N/ZD_E9BXY'7EXBJV7/=]EG_K.[VG+CC&HL'KX-O
M@6]'-"7))IN,RYT?54.J)BK7R(#5AE6A"*B'856-\4M-JL[^3:J]64[_)W-!
M'K(LC3"5!CTJA#-;&P*FI#S[3S"5G?%",)OC(4#>V[8 LI(80\1[;X?PW.0[
M@3LT.AT>$.#5=YA<0$!5\P 4Y\SQS&"18(C.87&98;JN;Y'/T*)+L?VBZ2W4
M]TQ 8V5N"GTCP<;R;&!M 3/([*6H65ZJ^1S^CF"#!L+DVH;OY8;*)/*(@N1R
M F.,@ H/"*C 3PU"]$J^0%9<A=SUR *:!&PKK&OR:@ZD 1.P3"^$V^<108*9
MH6'"Y9X?&OX]+/8#84PY8J!8H<1"FE0XC;@1, DF9IC&9_; 7*-GS)C)HX#-
M&#V5;DO&:TP=%IBPKHM3HS!LRUN&K7PX/_?3O1!#L&NJ7HK&8N.K_3G,*HS3
M?L6LZ:6V@;!>$[E,%KS3,.?SP#>M:2M9#19#OL!/?S(2>[0)[.<</F'O69-/
MC;'K/W(DAGMF3)B'<+2XG0MZNEAYF@*U@<81^6J+:9W$*L BJTN,@#8;1@4K
M!@N'\&J/3C@UYBRP&,IL(W#X#['QVG/CP< *F.X" =G'8#_!FL&B$Y7-Y0P\
MU7"*U@IGXP%1@]?Y"&\1;X=5<2.$'$B3GZ5V2%Z,]YLA; Z9MW1K>KN67:=M
M#1"6[S)N,<]B+;H:&8"-C7'@SXS 7YANN-"WX=2XL&UZ&K#H@IB65U^-> /-
MF>AL#U-[](,?.%]+@'JWC+'S$Z^0&XC_G0'AVW0A\)@E5L_R>4@K(VXC[F-
M1SGV.S5N(_@Z64YD*A[=XXR0)D"R>!.80A0HRM3Y!O;>\>'=4P<?S8D;XUG
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MNHZRH7-Q[6.P3OM85U#QG#);C^)SVB.!-377Y-><6],LN3WM-!XS>Q[_)_V
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MCEN2S&$+[+2-SL#L%D:LDE+',WO5IB7/Z!O-R3Q?@KST!'(L9GYA'<J(W;9
M\<#U.MJ>;+3T]5Q](AYZ89VB^#0V*;F9UW:WO':YIJ=8?5'7\S!2IMA@"&)"
M_34X513K]X6C3W3(ZF,24V\54A"/L*@[FV?Y;B<^/B5(50B2<?:"A+O8"0F0
M8BMIV,HX(;8J'Y?+/1-;98-:/%,?O2#<K,M7L,@5G71FQK%5A&L:1V7TJ!Y<
MU5(=;ZG*!RQN4_:ZNSC+V8/KAZ7I+(*=;^&3('6#U"$G&J6_3)9U^6O=JU#&
M<<]1*)5[S+/J?L^6V%GKS/K%]X+<*LJI+A5KO_QA?C^?T71+02%?R1TE=LW1
M6]W!]G:"QQ7?ZC=.!1\*/BJ'C_;!\&%(!Q^] AF4C0./*E6Y$[!";\=C>TC)
M./*!?R(\=TH?1QU/]9/%ZI!N0'7%"1^%&XMA;^=(JMOG6$C@KL^ H/!;J<V@
MN]O[9\@O?S7J=[*(I'0#4AAA%(]5*%<_JQ@CS (]=DX2(\[8(_>K-9S >WP>
M*N18#YYOA1[\*8&:)H.)71-T2LXEQ6 QTSNL<M4)>[(F' SW?$GXMPH3MFOH
M\N#CL?4C)9S-$LY^[3J+$DZI%9,3T-8_V]0984SL$[J9D(D"Y522;D#*8#0&
M1]&,F'A\Y]+Q&PI'F?ZDEM[=GH$NO_ IC]+Q!Z0 PM2.HIU5"1!ZJZ^?*4!4
MJ;55G#-0@0!\H59 )QXH:O9TYGM/=,JRU([&"17%E1?GQ*4 <WB]""Y?2EL]
M,NP>,$19V*X8[NI'.NU+A.(F)1-E6L,=B5SY\N24*!!0() % >-(QWE5@X!I
M2A1RU:@,H.-YR>I*VI3.")1N0+77XCP"R93WX_@#4GQV;".ZW=#$^W5[ZX;Y
MU*'-PNO)R(NP/$J3=$6)DAA.@I[%=.^2,J7*25%H=35Y->:U4GT\LUD!C0*:
MX].S&-"4E%-54C^YODS1*A4"3;X6]T/FIN6:F_S#C07:=M"Z5%TW<4&5HSI@
MCU)UW51=M\7 E2#M+4BJ )>JZZ;82M5UD\@!B,,^@5"SJ^$PFD:.%=(16",S
M'\P-UIQ(JE@;^9S:1<ZY91GU@<?U)\#DQ:S]3!9_2C8^I40#?G<H_G+ECM+]
MO-8Z!RIU0'9;9EM>O\!!TGO<V!Y9Q%>!SBF#3J8L0(6@4Z8SLEN@S\^Y@$Y3
M2@'4?L:L\GUKG*K*XU;K&K^]WCB8$]BLOVUH?B3+MG8@J8]YNGX"'-*X$_@3
MH'DQ%;IX"9G*^U^VC*XAK5I\$'X<-V!(P=ZQ1%#!GJRP5[PX3S[LE><-T <2
M)6T?&?1*#%Y:[8J9WU1X+Z-_S5%DW -6]N:E:<<8H2\SZ@9PLS6%)<9SK- C
M?RTD0^U,"87TDXNT"BU!>@QSD)&>I+MJJ^A,,DG)6V9B)#,I#P?@89MF@J95
MP=EDLBNWS$9/9J.7-YN<6C7);/"K\ <E<VKY :'N"/@N'>Q$D$?83X--'(?6
M(CX-9A0>]42=^>4&B"S:*7RV$J.XMD_XQA[,2[(5X\6,O6 QC!1BI+II#QV8
M/Z+E)-D^U]RY/$*0_%D1L2\:ZRB"*);G;2XH@:_EB//Y;W_I _._NQ#_&FV<
MJVB</O'C00EE@T] @TUD,5/Q3*:!X)74) 5$H@-Z.:(SLP7%%V;6([UX\*GU
MYX4UABF\M9QG:QZLS(0-_:?WE:_W$KL=W%%^D!'CC]YT:H<L9QD4E(\P1MBJ
MJ3NT::!ZRJ?UGGQ=I]:>\OV3[2G_\?;77V_NL8_\=]96_N/MU_N;K[_ W^3+
MS=6'FR\W]S?7W^5K+[\W7^\80[Z5LP5X+2WF\KIFE> 4TXCG]Y%CUVO3N5]8
MU=.!X2K1,*W,[EQ@@,C@N0/,V .,%ZIP8T?^<&(%P"0)T!;IZ)F=W:H9D^;W
M9=/E"-9')2M^#\H<]C*RW#D!$K*M!]6^R'*(]P #9+IG@,;%+*;RH^>- C+V
MO2G!,J+Q5P@\/!KC=WU0!N%9SR"B^*]O/<,UV.5M4$'Y]T;V>$Q]+)G^!$JD
MYP>7)%G$]&M''G&]D-CNT(E&-'D5C&=BX0OGY $^M5Q$ U!%GVW45$,"II'E
MA/-+<A40;YRGH<(F?B&^Q^ %OA6$H+$"G"P-(&U=6;.9[[W8.!5GOD:G?WGP
M';YC&SKLU9V^WF\/LIF;8JZWR9MV=-!VEW3ZSA:=OG^9H],#;SCPRR9]7.&U
MY'C]T$R\OIU1WT(=F#A4?M@^+7[FJ7R2\O-K^TUY#)VCDM?(X^F-U6/\3L7>
MQWA^1&"GM!T[!!L0MC=R$_@6=5K,N8+U1>&&[R'[#KI1?J& [B[L9T7LSVYF
MN_E"@X#21.I8,:U/8$+Z]JR@QP^G X+*AAZ@[]'V*6R]X3.E+NZH[=C;T[E<
M==B0*S+#P#W8(6$K#A=D04^$WGL7I"DA7F '!.QC&*X#&VT0/?Q!0;W '=AU
M43&!O1/L9T8W_CPWP)>1;SX6-[]Q1_2%O/[X[>;-)<%EB&^'![#;O]T0"X8?
M^I3%_X.&\F2!;H)2SO%H9LUYY4V<E$^'WJ,+[#"*WP=TM#WVU_/$'D[89PN=
M0?C(O/1SGBT<[##R?3K:O.$JB#MYB#L=C+N[^\)$Y.[NEW@G1[>P<!+;/J'3
MF>/-*3PA J'TA:;.%>X5'<!Z]*FH=\O@!:^ BH^2Z45@"# L!)'+ YTN8 R@
M1$##=1##QK4 %\"[P(8!@4S'HL^A8AT0X)2""&0]_2 $D0>&Y2#UPF8"HE'K
MD2;2CG/  04APYJT>85;PB5)TW!B/6'C3Z - Q+ *[!N?!IO&+AYA R'%\1J
M"0Q"4\BG0>2@L23L'[&U6' 1K)9H*HP9I-&**6-J"Q>_E6\RR0A;DAO4BPTN
M8BU=<W@*[>?4]H?T1PZ+5Q4Y; ;+2EVQ43&F<M'RA2?R[\!BK<@2?PZS<,7M
MF1L<X/+XI9Z;+S(@(YBAP/CVP7)0=$DPH13WQ7P>8>.U<&:.XST'Y#7;,#E?
M!6_>;@XI/) !-I:KR%.;8DN]K1FHY&A=LZOWDY-1K/G^]OMP0D>10V_'O]HN
M2M"=-T>_PC>QA/?(PH?Z[1>0WYQR&MD=9EWD;:$ VWZ__.JAM8>O("L5#/]8
M&T4A5W7&VH<CQT(6C?TJA6SU-?20,YZKF\D$RS-6OXCM*D'>3Q']"I2[?Z;.
M$_T51C2IMMZ=WC*[>]>[DT2^=@[KR@_J.ASJI>9:]&$<95UKA.CJ7U5.ATA)
M(2L3>5\4LOY#+?_^V:LV,;[7E@.GY,:@&LJ:' .ZND=9ZCK+"#2QB$"32PC(
M@<&98_5VSS0*G7.LQ>&)3VFU.J,D"N-1RP34B-]2<_6]%UK.B@=0%FZ0#8>E
MQUBI.:V8#IM)HRJ*G95"IM'2.IJTJ'E<1"Q==X4%1H:4A6^1 =]BX\LH9$?M
M(?5I$%:S]F7OC0DI]\*HZK74P\9W!(U4,MY\70Q4!TNG1S><E6\$)U<)G"0
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M_/&K[=K3:%JF1.JY]GG![&&DPD K:*651P7KI7PJ]'+,JV4U0P01,S%Y]+V
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M]V.)M27&C<M,A7%>8;6X-K*?:K%68V'^&?HR=*+1LH6\^979-RR;W*EO"P^
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M#;4M!.E2PK6T4%Q,8 M6$U".E&T2OU<U:J/5-CK'=*3(JG8J_#D5_%G*8LK
M3WZSI)VK2A4N*K52/.,N/D']N#B$Q*13X_14D[7IKIU+H[V:[ZH02"'0R2#0
M%@THO^A)V1I0*NQ/:4!* Y)\7 I_:M. "E:TV1-^LK"C-*#SU8!4!%1!/Z:A
M5:H4?/&>J<]_LZ=V>"*B=O_LE>D'-;3+=K;0U<6::E69%2Q8GW'/%?QM-E,K
MN#54R+SL976[NEW9<AT3J1-,R4\PBZ%+P0+(RFV^#5[V-!H'[4JZH37SZ/G$
MQJ[P,'_@\AJQ1<M!*C?^P<"YUHAM7YJ=(QJQT@MGD\>N$#%_X#)KB/FUO]6Q
M@M(0Y1#-)H]=X6'^P"76$#OJF$-IB!()IPK71JFL-OKS1(\Y)CXM-^ [VR#E
MHN#ZY8?/J4..>M?/N#S^*8>4^IB4NI;L>M1FD3?KL2M/[.3ALQ?YI1B6W19@
MG@I7DVQ<"G_JLN/,:NVXL_?TIX%JK2%G7K:[9Q&OUJ!Q*0BJ3P6J)V?QQ%SK
M2@52^%/WH)J*/YM5H&IS%L_>E:U4H)5/5<A^(:V@VI#,T_1EYRH%![A"]7Z>
M+[2@-]NLMJCG:7JSRU[!CM&^S$G(5$'[A4,0"A3[EWYVZ^,4ZIN=Q!9HN]KT
ML%-UPMM/)26-MSH]%=QUJF-7R'K2R+K1MF[G9VVJXX4*('BM;:U?=E6<V(F.
M78'K28/K%K6UGJS54SLX46JK0M;M8U?(>M+(NEEMK3;_51T)*;55CF.CXR)L
MLX*?5Z"Q#= X\B*0X5W[OAX=U?<?NLS*\"D$4A_<RZVO=5J=OBK *=NX%*BL
M'[K$>N!Y14=OSC4=G$5\3H/&I3!E_=!E5E1.(=SY4$7%;.D]76DIDHU+(<KZ
MH4NLI9Q7 +/24O+=03^LW( +EKYGE3 _+"XLO7N/X?[,7D:&U'%FU@CUV7^\
MTEZQOX'JP_CO'.;_^PKW_[U%./\3)@#OEJ7HG8 I3?OQ74H>'3H.WW$?W5^X
M3"RMQ#)ALH1++?'*LH;>3+S2;*,,QY//+DF19Q@,![)K67?\]6O]#2D@%?M.
MTXI";\=IIA?SCR@([?&\DIE_M)QAY# P)-Z8/ L<(Q8',N+'2,: 2T 9"0'+
M8-. Q[I>2&QWZ$0C2L())7???PO@%RN$1_F4//H6P-VH19XG]G!")O!8 J.T
M 6?'\-B09AY[N=]"K(I_2I17Q'XS<Z7181;?-K7\1]N]@ 5]BR(G_A3[IY86
M@]G2 _;&@-4E.PP!E@^JV.8/HWY9X<@,7^=ZUU?5H_YF$%CSE=7- BB[D;O?
M%2;.J_?#RX1S"HT'A3-W/'E;#_)B2>.\_F]DAW/@_X4Z0NP@B$#X0@_%(HB<
M$*0G>+MYH\X%I<QFN+3KK4K$X;M=OE8H@"L6&&3)MV9W5I.B> ]PA,J>Y<YC
M'"*YYNC+@^]P3<S03;UOMLU!6UMN\_MOR\<G!/?>M\@?3D"/O/5!H"U__EW8
M>MOTND/-0Z/5'V2=V!QO0=M#A$;\'=L!L#%!Y8]00-D1^42'3$DDIMXB.)H6
M\A<\Y((*?3+-;)?D*L"-(.];$T1T&#HQ]-; &!!OX:SCXYA09T0>YNL?OA':
M#V>BK;RY&>\57!\!KD<5P_5ZCBIM"@P"+IAQN0SG] 5_IRC9)):' /2?T9*$
M'!7@&5E0'7-#OM2G@O@^'7J/+AKU)-BV/K;+L!.1"B-[+-PI -E"BGW=&1QZ
M,U"'F:5/K #6TW&\YX"\9E_TH@"6-'CS=K/F>N"VNDK19>C*\8G$NUI;,V#[
M,=MMS33ZV59LPPD=10Z]'2?>!>H_V4.:[X&]@HD/V6^WX[N$PM_@K1[<%\ &
M";SP >[YL\B.2&&OFB$#^1%=$6 !QAS^$APN@,O"]P7HNF3^OCO Q%Z!Z0S4
M[!&$DN^8$]-+A9H=VZO"!PV41([^QRO]55D3V+0'K;Y4V_+697^F6' 1I'<(
M#5/K/@0@H'X&Q3BG<*,9GNN,*H&U_Z R=YU1YDIPXY6^L._ S@_I!<HE!41Z
M]JW9%GUCSR@N)4#%!<@X<_G!#><DA$4QDQ3,9"AF4LQ4%C/I)\%,Y6[C7(?O
MMG\L$G$N=Y5Z-(K0@/3I$W4C6N1PH[353B(8#J!BB0A2QG#D6-2_UKF*F2B+
M)+JC\70L%!S6R50B$4X(.LKW45QSKT[A4(L;=^A-Z??8W_-%.#A2@1<HQ+?C
M[Y9#@[Q"1+" 0&$8H)GVZ5^86USZ@RJ"O6J4QJHU#@5?"KZDIF,Q^,K4^]@;
MOHP$O@P)X$OO*OQ2^'4,N5/X52=^92IJ[(U?>H)?N@SX54F%;YGQJRHC76HF
MOZ,!M?SAA!V[C\ *=[P9\EF+N#0\CCE>(]97_ZKU^"@U6Q3#ODS1B]I-SYA]
MK]S1IP7SBO>4B8:=GAQP>%Q538EF4T0S4]N@=K.J+M$<M)5D*LELCF1F*@34
M;C#4)9F=2JJ*'$LRU1G>&K9GEB>S'Z:6_R<-,=Z]6::B=(ZD6K"T\8Q7#&\S
MQ1-J-U*^4P?H\0AP^VLL(.6#K=FOI#J"S Z;9@NF9,,Y>YS(U$2HW6*J!2>,
MSMDY=ILMF)(-Y^QQHG]T^ZT6G*BHVI+,.%&5A;<25MHN->VB CGXA;K4MQQF
MTEFCJ>W:08CI?4]'BL\L3K]*8+=(.:CC N\A(Y2#Y8I!;R8]LW933H@&0._5
MDF"4C[\]6>RYHM)7FUJFX$#! <)!M[S(YWTMMOK@H&M6TCA&P8&"@U.!@_(B
MB?<US.J#@\Y DGB4RN#@-([;ZDB*E\Q!)-EP*O%7244NY0]5_*7XZU2'H_A+
M^6G7U7/S0LM1+ME&FC2R)&DUGY+%C,/RTK36%ZX]X+"M91K]$S?H%-0<24 4
MU-0+->5E1:VXI<M)EQ@H1[("&@4T4E.R&-"4E^.UXO N!6CZ)W]B=;R>2ND'
MJC8L>6PBABMM77_:_+K^]SZU@LB?\P+RJ@_+GEA_ZY+_BUQ*#-9(Q&"-1.(R
M_7_[2]_0>^\"\L&S_!%K/&+[=!AZ?D"LV<SWGK 7%5\ XM.9:+Y"X,JC;TVQ
MDTGJTVB&'_QU>Y,7PS &>M_,UC9AK?7NDB=^XZ]9- B\FGJ1&^JYJFQ7,^+X
M51QN]BEXCHK=9/(O;SP\[2[M3)UM.]-E-@2>P$(YHLN7'08D[E]#> .;%IE9
M/GFRG(B2KS??"S3*01J:>CL;+LP?>,-:&;&>B=^HSSZKA6HP^-]GU/]=O'&7
M'CL:2$"6;O PSG^7A'&R,\?^-UE6QHX3U&;\RAC7<LC8]Z;8[NPF\"WJV##]
MR ]9-Q#\WCJFOB38QR+F\&<K ";@31I89RCZ,@,1(1[O64$MW[%AA+"J_V>Y
M$2ZHH<4=>^!% &'#"28L;I4*6(M.IZ^9'3W;//, J>@9>D.D8K$2 5OJI-:^
ML3]R88^1$'12\0K\?G;!6^39#B<DB(:3U.VPU ]):Q+K\=&GCZ#Y$HO1&A]6
M$.W8N@[:[:Z1B1\Y8%UU>*XDZ]JYS'H6XW7ELK0@*DI3LCH/\ZQPPCV?Z8//
M!&D0RQ'&B=NAD+P1WG,5/<*>&M]1O*]5D_?QM8W!8&F#R *F!';,DY!U0+<,
MGQ-KE+H'=_V0'?_ .XML1H!;?6V0B9C,9_&X(_AJ_]][[T.*54=;VH.7P_C[
M=(-KMQ".NEHV1BK>WM.]V;QXJ^>O(E:8$'<HRE,7TIE 7^IJ_0R*?+/FK$\2
MD!.)C1N_Y0XI:P=4.#+]V"!B7N9L_3&(+(OW!MMTK16ZFWQOMH=9#TH8*GUA
M;5>7[8OTDU,6Z;+I# @P.]C>S=;07S;(S86)CJ_ER/,904'3WUV(?_%0:"8
M\^>)'P]*>+A$>^G9R[NA XH.NC$FXIG,[8574I,4%,.J]LN]GS(G]_&%F?5(
M+QY 1_KSPAK#%-Y:SK,U#U9FPH;^T_OBCHB-1N82IN8[+'Y*K6[&VE3NC'5?
MJ=*=,6Y(5]FX42GNQ<E^N[(!-,R1<;Q>@KS/'VNMRF0NB*8P&'AR 'HYWTYP
MK[0>8+<%U5)0/KWUHN9(7Z@_M /V!"M?AWI;I0)Y>.= <Z#WLD9ATCF0;?L3
MSP$$"'A7XZ]>2&-.O/7O<+2J,R ?_"$Q7&UC]? ']CK1#J>2LY]ZNN#$&B/!
MSIM';H=38A&XW9H;E;R2LG0XBE&@X++*.8D4HDO-GD?H :;DI5Q6N^;* OI(
M[&%1,)1S*N@X%TJ1DAHE-6J7*7V7D7,>,(5&CS]EKYTB;A6)*=(JMC-D6>J/
M<"-Z>R/+:33+PING!_%JY6VX%P9LLW*/U>9=.?.^=MEIW)M3!-N&\%GU8>"*
MX$JP3TFP]QR$=O3]KXK<8N:7;GIQU)5#&;U#7NMO5)U_:89S[G5YNYDZ_Q\=
M*PANQ\+Y(<[9;A=>A"WA2[E?3R)N8I?*O?=-'"/'$</I^-Y;-Q:;^V?O?N)%
M ;SZLST.*75+BG3JG5^=WF8+JFHTNQ?9SA[?,A$&N0 5'Y"PS(+D8A)ED!>L
M?%30^^W[IWWS$7J7'4WU,C@[[%,Z4WF8DB0GH71O!!1T]\N&'4IAJN1DHT+6
MW^YZJ:9#'<5@12]TO9"BV2K164 5CO\JK7^CSZS_+GEM',GZKW&7.N8.)#4[
M%-M=,NT:9+7(O\-64=8&H[<&FB2EO(ZK<1Y?3N60%4FL9*EI5 A/>IGLQ499
MP.M YC0LX'/'&J43%)-AO1$6IU((RK(FE:68)=[9GR4G)22,#K,F!^1U1YTE
MRS.<<_>+]C*%KZ2P7+]Z3V*C D2<I[:K:WQ<:1[23JLKBU:ISE74F;(Z4ZX.
MYS*EJN6UJ'<'OX,,:[TO28,U!8&-',[90TM;/D-?Z4_JB+EBH5@J%).1B<Z2
M3,1L>_TRLT-6*N>3%19O5EZS3*1Y'@N17$QAF!.<SL7(FE_,J>5?4#=MV_/B
M/>W5BN=2NE2D!MRKF6\[)'&5=-7!NW*R;]Q[Y0R%WPHUMVZV1?)>.[#6;[4[
MDNCOYWXP)H?<2.)6D)I&Q;"E06'H>P'. 5Z#SJ7>ED3Q/W?449I",6F6, !<
MJ0GJ:'YO"WO00 L[Q<]%C>S;8>AA-':O029VX_V>*V9X3T4LR#.<<W>W]XO%
MQM9M\L?.0(Y]G^TGFL*_KT"]\KSN@Y:F9WM4-$M"U9%=0V54$O="X^E8#.LR
M+7;D=4'L!X '^""ZEQU-DKZ["@8;.9RSAQ=#/I^(TJ-4],*Q?2M]4S[?RDYR
M4=2YPNU\LT&N%:E!ES6W%EX3WBN4?=*-_2A]%<Z@#BDV;LAM*7T;#":JW(KU
M5KO;;G6[DNS&YWZD*(?$2.)ID)I&Q5"ETQPOPDY0H^H)5 8!S7S524MQ5SYC
M72D&*G1A#_.Z)Y]Y7823BUK5"S.P(49UX[V=:<.;O!ZH< 5YAG/V/O9^XTSZ
MLJ(.^[U6OR^)DJU.Z%2@@@I4J [EBA5 E=[%4'*:Q.#2[$EBNB@ ;.1PSAU8
M!EJSO!Y*=U+!"=5Z3P9ZL[PG>^1\-,Z!(C7.,FKJ1NP=T345A:!.&C;NN7+6
MA$0^1HRY8D6+*XL*U+NM;O<$4R5EE"(5B'!>P-*@(HR[H\U!J0R:BD:0 W*4
MCE!,E"4L>J@4!!60L)])+6&UPL+,7-2H3OK:<5.P(99UX[V<W/K6$NM;5\$)
M\@SG[+WK<I9/C+&OJBV\H[6DT;?5N9P*3%"!"=4A7(.*..X">Z>1^J# KY'#
M.7M0D;"6I-*95$#"D;PG$E:B+" -.P4C< .^(3X3J0$V:9HA2*J1U[JA(A+4
M:<.&#;>OR5GS$:'A_IDZM+IMU^BWVK)LN^=^-"B'P$CB/I":1L5 I4'%%7=$
MF@.\ [@F"F^DP!NE'!238PFK&"K-0(4A[&I(]S4)RPX68^2=.R8*XZ_3"'NZ
M\4[-/)O;5'$(\@SGS!WJ?4W.NH<,_*A;67$CK=/JR])&31W%J3@$%8=0'<(U
MJ ;C#K!WD*.ATU7M&\X.^Y365!ZF2%@14JE,*@SA2-X3":M*;I>&T_:<2(VQ
M_Q<Y<]Z;@3E$VBH(09TS;-QNY:SDF#2&6<(9WB:FG(3'=K_5'?3EV'//_4Q0
M#GF1Q'4@-8V*84J#ZB;N!#0'.09Z74DT_'-'&Z49%))B7<(BA4HM4 $(NYK0
MNH2E!8OP<>%0?LME-C0O@-!MA G=>%?FBIG=47$'\@SGW#WHNIR5#C=A7ED%
MAHU!MV4,)"ECI [@5/"!"CZH#N8:5'=Q5^P[P-%@7!H]2>P7!8"-',[9 XN$
M52"5\J3"$([I0Y&PEF1!D3AE-XK46)N4YNPG;I*NBD909PX;MUY92S<Z\^5Z
MM24>.73ZW98Z&Y1$3N60%4G\"%+3J!B>-*I08D&0.2@*P90ESOC<D49I!,4D
M6,JJA$H=4!$(.UC/4M82W,S#.Q42[#?(9FZ\#S/'KNZI\ -YAG/N[G-#UK*&
M^8!7EO=<U_JMOM:58]]6)V\J]$"%'E0'<8TJLE@<]P[+;Q@8"OS.#?R4WE0>
MJ$A9\5$I32KDX"A.$T/*NI%;Q>%D_292 VQ22,+@.1DZ>:WW5;"!.EK8N.'*
M69\Q]N]=X[<K.F-HM;M:J]?1Y=AXS_TH4 Z9D<2#(#6-BN%*@ZHB[@@V!S@(
MS,ON*19V;R+>*/V@F!Q+6(E0*0<J!&$O:UK".H+%>+FH07T5/49!&!N S;"I
M&^_8S+.[!RH809[AG+U37<[RAINAKRSO>K?3:1D#291N=2JG0A)42$)U0->@
MFHN[H]\!?H?V94?50S@_"%0Z5&G08DI8"%(I4"H\X:@.%5/"JI*%A>*4?2I2
MX^UW.@MY\H8QB!TFAJ8"%=1!Q,8-6/*"C@Q>J@P3[+<TK=OJ=09R[,3G?GXH
MA^A(XEZ0FD;%X*6)A11WPIR#RBEJ*FQ!#MA1VD(Q<9:Y?*%2%53TPA[&MLSE
M!XNP=%&#^U<+7AG;AKU&V-LS:X06QP6_\+8]>VF^6S373->/9*:72^!*W/2>
M/Z)^:H!DY$6PM1 <EM8B^-\;20:]P9E?]2SDX.UB.H2<=1@+86Y9FL2@J[7Z
MNB11D&6"0&TF@_S(=8J;ER1^D5,D;3'L;%#-R;T!]2"/2J?=5J@JQ:"5/JCT
MP4*8)F$53J4,'A&V"OJB:E8"9'9A25@#=%<)*NK%2KE/>@V*',EAUO*0.Q:I
M8P&$=-N__%M[\[?M=FG9+X?6>1JT]'ZO9?8ZTNZ@TBGUQW6#'%,\FT&,,^$-
MA>;2H/F@%"-,07D]ALZ1=<<\+?F'E1N03=+WK*KI/RPN++U[C^'^S%Y&AM1Q
M!*W^\4I[Q?[&)8G_SA&<OZ](SM];A,L.8<+S;ED"DS6!14E!AD/'X3MN;_Z%
MB]/22BP3)DNX%"?PYYM=%/;U[)/[A566"+U9)6CR6G^S*HH%1FA%H9<SPC05
M_XB"T![/<Y@8.:**J=S1&2 4F*(!>196+<(3\81!2SB$$1M,6L9@T0S@$UY$
MA7N=S-"_3KPQ^6LNR+X\^ ZWLPW=- R]UVYW]:IR*?5.RH:_HP[8T*-OEA_.
M[^&; 1]6\&&>OI(8]?^/3[W@HX7N J=,=WSOLI,3X$C@:9RV+0+ .9R09^I3
M\H@SI","U"OB].@4:@40A.C[^.Q[TW_CFU;IN'%+TSNQ?T30=D3M+_31<J[=
MT%Y#O7_MZL](.FZ8.KHS],XJ3I+0(^P-1+R"_(N\OGX!&H9OR.?('9$O]M1&
MPKW^VU_ZAJ&]8W>SW_5W;XCMXL1<ROGRV0XGQ"*.!VP\M4:4/,S%T^$UX822
MC]X49&D.;#XBL$*Y2Y'FZ[;>,?M&S]#6%8%)"/R)!D/?QE&42^KWP\CW08J=
M>2R83%A?P\2?)Q[\!B(-O\\L)%@$SW/81&$!'!OH#M+[VGY#%NN@,;=2![_V
MVH8K]G1*1S8L(;P !!X^%J2"2031=,H\;/@8BP"-'JG?8E<\QQZQ2RU\$HS;
M?[1<^W_)W6EBLU5APPP]=CM>#"P^=@<0P T8S%B.@Y\$T0/:U*$-?\_9AW@_
M,#\%!//\&+=67H*/QG\]^- GE!$6[P9."M@HV>?A!#C#8I2#9WO/+C 6OL\&
M$@ D+C^S!10?.A'NN.S1X0)J"",_"G?J?F1*O?<NX".$5X!N'2P3-?V(9QNF
MAG>1J0>LR(;6T7Z,!_'DA?S%(T*!XMX4^).I[\G4@\A_LI_P)C%=:QQ2?_4]
ME^2KYU+Q'2!TLAE,K!%YH'0!^" 2[-DK0FN8EWLX(;,;YZI:E5*15M0II23)
MK209IZ@D#;WI%*4R%@^0QY!OW39S^J-P(,K&TI>O%&7V\4REW$_T(;QQ@] '
M67+#CP!$ +Z^Y5Q-/8#OG,VCJQM&OQK-!P0"%@,&UTUK/A>=;9'BESEJ#Q#;
M03*,?.MY!,@*+QH)-/J"^_'5HT\I3ED IS=D.QO3B!+$,5A=;[U[2;Y3"H/P
M0M<+*=&9YIKL?[:#: =4FP:7"HK.&HI,!459_6,,H.(]7\ C9M$#*%APWQA>
M HH"J"U?O2<A:YK>5^)SWN+3/DOQ$<HXVZ">P6A#-=UBWYN!+<)MF#&W4VPP
M;M#* L%1DJ8D;7])ZYRBI&T5,69 !_83)3/'&G+USWID/W/DS88G[2UMBX*J
MFCY0TG;>TM8].VD;PK@M&QU3,,(P0IFR') 3'L4&&YR-CJ^9;S^!F9B2QC6B
MYM-'.X"-$1X^LGTZ#!>R!DIGY@P!S#MXM*-D3\G>Z][9R1X*4!G[VT*&-LC?
MBGCEG6K/XIE.+?_1=M]J:7:9Y1UXURJBZ6-SMG+VRUON::<K+TP])B59?%87
MP!Y\9HOY;EK9C7*;#7\6+Q%1"2;<DWHM9ZK/N'":_NY"_&L,D+J<F#]/_'A0
M(LB&3T";O;P;.M3R,:IA(I[)(F_P2FJ2@F(&WI]&CFP4>'QA!HQW\>!3Z\\+
M=A#PUG*>K7FP,A,V])_>K_)(3,V5N_&3PN*2RV',41BO[BHL*Y0^&DKWSPZE
M\S4DVWVB0>C%"I)XPB((PDK<U@#BK/5DA[FH!RUV-,<^Z<:?P#AF>!3]1)VY
M4H/.6\ &9R=@9:E!3*:8%K1!&E'XAIXKHB-R#!LP4^+1*E$\;U'4M;.3Q4,W
M.]M=B*$2GS,7G],.BJUG*]O@4%-;F9+%PK)XDK%7=7JV'V ')'0,TLLB*3<Z
MM5-G2H9V2:[RPR-;9%M\O*%K[4[7,-M:L8+!7R-\P>WX.P50L$.;!A\MQZ&C
M#_/5$.^<5"6#A1AC^%<2<I4$A'WDM+Q)D_);0DD>(E8H4?Y6$.YVO)(@GZ3&
M(\E**2!AMGIMK:7GA=HG?,-89A''R@[O/8PFQUAE>T3])#!Y:RX#7RM8*2V3
MR_#-]X:4C@(6<,]?'6<RY"Y$4H! YB5)AP&:2V& YK;^4*UNK]/2C6PZVR7Y
M%#&Q8K'(S]1YHH1E" @)I^X(5BE'D%QOW9JJC>_,-[Z3C/2K10E=VL7R][^#
M]S:M!W^<U=YV_^R5LKT!#5L@<G5N;GJ[V\_$I9_"YI:W)OOO;V9GT.JJW4WM
M;C7L;B<9B"MUP-+_14XY=EVGW3,+E@MJ\MZ']"K-IC-:\*16NYTM"UC=M@<+
MI9^.3;=V.0[8[UI H]:@UU4[GMKQ*M_QSC,@OIQ#!;%S%8\25.)U;N*E(N /
M5"CSCN$V*I2+).8RE$JC:W8S-OK)*94Q>4H\+.@,^BVM9]2I6)IFKY^IU]-4
MQ7+CDAQR6 !RU6KK2KE4NU_UNY_*0=E7N5S:Q;*;X*'[6D_3ND:Q(G'R[VMI
MJ/S&*?4M)E0Y;A(#[/%^G4Z2GC;0>YD69G+O93LMPP$[F-9I:9JI]B^U?U6^
M?ZGLG+JMM_0AN:[D[\SE3R7OE!%LHN?HCTJRSEJR#)6*4_=!=ZJGE-K:E "J
M9)Y]M[9E03K:X5OJ<<FO.>TG*J[P(,I<I*3]U7L<<I'B]KV,L_P.UM$"0/Q$
MGZCCS9B?P!WA D1 X>_>.(05II_L8.AX0>33>^"[#XXW_'-[W[]7A(*Y/X.7
MA7Y$!7O^G%J1GT\3C'*DE8W@F>/Q@^>,Q!AZ1KX,'MZ;)PA]SWU\__7V_IKH
MVML+$ C^R4X0E#.3!2JMP9NEL::F7.D\[ZZ_7U_=??PG^7C[Y<O5A]N[J_N;
MVZ_DZI>[Z^M?K[_>DZNOG\B7FX_77[]?+SY=2Y0*=^8L;L>P@ S(=Z2BN_?!
MCZU@16Y=\JLU)SJOS $_TZT"6($?0&WL1P":%RO!_> )3^FB3/5KV", I-![
MQ[\O&E"LN3]I2<%Z2[CD.BE]^$6T.-C^Z,R=R4-9#X5_6OZ3Y8\NR3V;3?ZP
M,9,4B^VPPMJ_(JC&+D=C\[YT3OSQVZ(V^2K)6S&9":CG2=N6Y>8AB[J6+?+L
M^<X(\(B"[C"WG'!^\0!;&:KC<6L+7@@]-@-FH.6[O(E#_"(?:[<S#[('7X*)
M<\"*N2* [8\$D1US [S="_ZD#@UAA8,YZ"!3$M+AQ(5MX]&FO,V/XX$6!$^;
M/H!V(FJFV[@96<DXQS#C-8/T>35Y\J?K/5],O&?&U$@#;\;8#0;J/; [K35/
MP%(#+JM-SSB2 JU&J9+P?W@@?5@OAVW[V+QLP<SK*YP5KFRV&P^>3XDR4U,E
MR@XJ428CF-WGP1C(UG\CVU^!+I#;&>R+,?# RZ+9&)2/D(PIQ?I5@!>1'[ G
M!*+I AI)5%A6\1=M5S1OR.F_A.\3F#"*T:XE0 ?1">YS:<@:  4,5P)0^GW+
MP0X26)W$I3C&J2CE[2(PXGQ8>S+6"6@XL>$;<66$!%=];Q2!$39:F!"BLL)T
MBL=JL%*B/5'RGH#OI/&DLC1D+7KX&")F%HXC^ #(,J2\,0\8?/#*5-NEEYF]
M.')EE+""$#CW@EVAY F& 6-R+'N:W+%"J^*[=)-WX+5A!$L[+5]JY&'<JP3!
M%NLG6HGXL2. =8M*,T#JUFC]EA\K5/RE\7JSIF$4%BQ"OQQ?*=AU[8GGC;@T
ML V1]95*#PEYYH$NQHY=]<A_(\L'P'/FY,$*[#-9XS1549GRZ1 WFM$"5(2G
MQ6*];PJV&M1-P^QH>B\311([$:[<4<J/<,W?M=U1L"9,07#+X@+Z)5+:2G*A
MQ% #K"2Z&O(13KPH -!I%:919V"N=;04I5&Q4(YCT*C7WD0C1.=B=&IK9J>G
M'THG/:&3+AF=C$$V9"4A%&%2*91P_#L-GHF4QM: \*5F]TEF'<0=%O/-4M%/
M@V!KR&!]3 PR&GL<4G*EH";YZC$- WOF,6O)>B'/, %X%&S\&/WD>]/\:(!8
MGX!!+E28^.F+-CKY0X]MG^R\ ]"#<&NPL8TJ<;T0Q\3\AW#!FS*5X2;P+>JP
M0YXAPI^%7V&*TG>A->D]+1Z"N/F&?_L>)LC#<_$[^J"K7W1ZFX]P]G0.9PRI
M7=R[L42U8>W:>M_LM_N]=@9Y^)Q@2K5X<5=\9W)[=5?\NKF>7=E\N]RGJS.?
M[A97[D'.W".X<V^^?KS]]9K<7_U_U]\+-6;/]5]GFH@O69S9!N*[ZWS+7SJZ
MBK=H?QHW5$5K#[OL!G1F^;S%+.#CDA]H!)@ *NJ0@;EC/2?-3?^(?#L8V</8
MED) ]6?>PKBBH&"+QJ?;SML.IBT391L&[<*7^G71UEJ=5_HI L;X>O<O.VG\
MSMY=SH ^BA6@;+7PEV"QP[VM>A&.P^#?N&4)3 MV'N6,:_G<'EQ0 30DL!1!
M(UCI,RWL&Z[TH$IS@1O:B9+J/E%@;/BN%0*@^VA.KS(-4ZA\BD'JHN?WHV6[
M(@:Z@,[>[L#_C&RK^6OFC0%=,5$U[N!M=]@]>6@[-M>PP\\4H^*=[_$ EVXN
M8 'QB/3D6U<1Z-(^@-!7& M3],4-C!#I&S(Z_2S"CO-"J;\PTEJ]L46I+T*E
M=D_7S6P?^6JHM&K_-(A*,/)LQD,U5-(2*FGR4,G(VH?;/_AQ#;2=Z%;\<+G;
MYBL,N-=@YP1OR ,=LP[OH/LP]W=L'/(8)#]NO<[;VP7D-2,M-]"#-]5L%EO,
M.!0,K=WNMXU5P?@^G("Y[=#;,9_C!S:WA7$G]+DK=_09/@<5_QXUW4,MO2*;
M7,9X$$8?/]Q*[+T"]A\W2 9@PRT?7QU@%ZX8@SF&3I[EDV<&\@OK["E^*/8N
M9E!Q1H9'=+DWYAI<>W-5ZNNY9F \=* J\O(_7NFORIK&^G#+O-=J6]XKSD/%
M:\7RD\##LYO#:)D]Q5VE;L:2KP30_@.P3:XS7KA"YNX1%OC=\\0.Z07**@7@
M>O:MV;8USQK@\?B44%4A5,;9RQ3N8"<D0(JMI&$K0[&58JORV4H_(;8J?[OG
M5D"W_6,VGLU_?'AM:.T6,<P^_.ATWI2J"52PVK%=5O>*B_.P@VA8*IZ4,2!9
M%O6O=:]F"KM\G)J@YN DJ/DZUUV8R5W*5/KEOH\O7L#*HWSDT6-86FLFJJ\$
M*SX2&L326,0;<G@(" F W'#;J_?ZH-4U^SG>O::!0NX&(0LC91(LY:>G ED%
MLC*!;.9LKUR073G3*QUD=3W;SZ-YH*! 5H&L MD&4K,8R&9+UI8+LBLA 26#
MK-'J]17(2@^RA[AE%@Z8 GXC*Z!($GEH)XZ_J^/(A/=VH<Z>.]""SY?\HO J
MX1-%=M=:!/_+,OJA;]\ U@<-1Q96*8C7F225/?!:<&7=C@>CU=%Z-:+U'K)Q
MXD"L8.3D8:08BF0BNDI%D0HLZ_=U.BS+ HY#!40)XUD(8Z9E;JG"6($%]EZO
M]?R@'G&LQ$AIPQ#WL0H/X^3R@\C6+<'!\RL7MK ^S<B+,.!W"2CJ7X)FN<>*
MXO!)T[>@ 9;IQ[4'6E^_A+X55^F]">DT^.JYB-R^Y\!<'V]8<;H@K-U",UIZ
M.]OKNGYH/Q!7E!FG8/I8RZM@6@J8[AP7IBL_7-:RS0T;ARL*IA5,'VMY%4Q+
M =.9G.MZ8;KJX^EN6\&T[#"=[_A932/.%NLAJW5A25Z1K6*$D3;G?2A;^9G[
ME?SYUP_4I6,[?,,*LI2<2E^ Y@?DUL/_M';&^;O(K<?Z,9Z+)>OB/'N8O*@^
M^('/NO2\^E5!V"G7GC0LVSXWWWZ#Q[>.]."#?;N;]HVCI=VMOKC>W'LY<^\.
MS;X_PD+O=\JYYF!%"5KU@E9OAJN<<K931GY3A$HQF%0,5CPW7S&88K ]&*QX
MEGY3&*P:M:#*?/TC>#<^8H,5-SS&XM>1ZB1/LI/4'N@25[7.E"=YO<Z9]'TA
M9VN\++5GZ!_@-)8* 7;Q'$OM.Y:*J@I7%:Y*&<B<2=C?&5:KR!S0._HIPZF$
M6"#AD.01)05/1X*G02;5?6=XJB27(K?T^MG 4]5N@,K/":JHTT?'%!NK'I4-
MJCO\*\R(^^2 53.FDA/5I..X8@":Y)YC&\.W,9<F\%F-F3RV7^CHXG_4]UZ]
MOY +*65RP"NY57*[3FZ-G>6VTO!U4^\J.59RK.1X5[_UP-Q9D*NP6'(:4S=7
M?.7A@7*\T:=WK%IG(-:)>K_J0V-IQJB\K:<S),5O\HSR'(:D^*TR]6)CI9R]
M\UKWRHBK\&W%\CQWS>$\O<.J0S-E&T#!@I9=>\FR8TENMRXW[$X^^F@/(3T+
M4TZAFD(U22E8#-0Z.X%:%;$_[>X!!8>/"F9*Y3D2:RMPJ <<NCN!0Q5^[$'[
M1+%AG9&6^2BWJ@7)UK78SD8;G+2JA,#*)979K$H(J!("QP\25()6Y,4J 5>5
M$% ,IDH(* 9K.(.I$@+)\*6-=:DBF4 T9VQF3HF$YZ8R+:Y*)JO)?177;C0!
M1TV]TVX;6J_;_7W%JS70,CEFGRGL+9:S)L<LK[[MV:51J(@9!6$*PJ2!L$R'
MT5(@K(33/05AQQJEE$.21]P4A$D&89GVIJ5 6 EGD K"%N.O)HYTG[;P1V#O
M71O#EWK>?% CV5U#0<IN)7MP9$5)S61EC27-LT$YLQW=!FU S&E)O>'/)^94
M84DSL:08E&1MP3*@Y+0C/<ON$J]$4HGD1MNF#)$\Z?C*LB7R],X=58Z];$-2
M.:CRC/(<AJ3X39Y1GL.0%+])EF,OE>:@DMBD/I$Z@R2V@KY6,YO%IK+VE0=5
M89K"-/DH6 S2<DJ1J)Q]E;,O,V,K:*@'&G(*>JB,_2H]RIF/BF?L9SZ*2?<U
MFL*:#Y<NS>()\P3]MXR3XD'/EF[%IR*WT)>A$XU61I+F6T$[3?OQG4C[#[T9
M?_+B?9L8M&AJODBL$B\1*V3"/:G7<MGX_+>_]&'+>G<A_C5UG!VGU,\3/QZ4
MD&H^ 0V6>NA0RT>3?B*>R40=KZ0F*404#QN6"Q!DO ?QA9GU2"\>?&K]>6&-
M80IO+>?9F@<K,V%#_^G]ZAK%U%RY&S\I+/7Y*_Q3:G6S7+2:W&:[(Z#_6[T/
M+\[DMF46OGSD&EVN0$#Z*;'8LH(3_<M.FJVS=Y?;O878#!I)B#!)7MLN"2=>
M%%CN*'CS=@ML[>5S69-W^$<4A/9X_FZU]D9FM2KM9;-,#9^.'3H,@2*4N#3$
M3PD=C^&C@'AC$M+IS/,M?TY&-GSJ4W<(7WJ@X3.E+OO2T/+].:PLL:8@6/Q;
M5A!0^ T(3!S;>K =.[3A:["CD+'M6N[0MAQX,SPYQ&_.(G_F!91_ 9\9/RH*
M8+CXK<60DYLOR3W<^=&; BWFB")Z[UT 6YB8)-X:#X.-*5V6@:#ES]Z&^C*Q
M? I?].TG?)OO3?-GO<K=I\LI-RXC71#@XN!Z # Z]O_8D362,H?(+7:?6 U4
M00(;*!J0YPF%"[" (;$#,O6 TH[])W7F<#^,S/60\ZR06(Y#8)T#7&7&%OQ-
M^-"\)7VVX7[\\D,\.#JZ)!\LY!?/38\EX8R)'80>K"@\U?%P=LM#I@%NYW8P
M@2=89!S!\Y\L)^)SAM%YS\"VE#'CW=V7\^&%W]P1$,ZW'Z(0* .;KPM,P01J
M"%J7!5@:1 ^PV+;EHXBOD[5G$")B3T&AA,=:SI+P@G2'%+"8A!XLINT^P5K@
MV@1T\3[<VP Z0)]S\'ZV=&,>;K$T@$MR!8. QP21$RZO\ 3&ABPS\[TG>R2
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M"F\MY]F:!RLS84/_Z?WJVL347+D;/RG,7]F5_2FUJO+COSBM!-2F06(;H(N
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MGX>)0QB2\6.>>-<52-.I6HN1XE8O<>.:.^5H510C;HI29A%3*6Y2W'(4-ZU
M1;X8<6N7V6SA!,Y$2N]R4Y5V?TO:2;(,SV?7LZ>BU,:0G6^.'74%5=WK@.;)
MW&)-UWO=0Q2H@^P54@:'R-CHX4\B73E">D<D@R5/X:VNW*'$'(DYI6!.1P/8
M.22BYB"CK3C,$2E,5$*.A!P).=DAQVBUE4-"90\R7(N#'(DXD>D(>"PE0,U^
MZ3X3NT>%R*26ZRK75:YKXNVGW5.F\+)ZHB@HLD9YE3PA:Y0+8@DEC^_40^+P
M"FE5HS6ZAD Q];)7C40[B7;UHWDVM#LD%*^(5NI&PU $"B268"?!3H)=_6B>
M#>P..<<OHMF,T>BUQ?58OX9^,UFJR2L]O<=QRHWK/-Y8/_"T[_LXD 7D90'Y
MX]=G?;O0U6/;K[YZK"P:OQFX%*07"Y(LPRR+QDNVDD7C977O%ZPQT;^;-E'
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M7>DI+5W3^/:T ]-S #5]4%WN9J972&Q^2BS2/T'-L!Z6Y612\'?%HIV&H_$
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M7!A833I6ZP<^*[.K03D+\@G(2Z@8/&,;YOP$]\W\E/+IB&P"C?!2-P#:.O3
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M_[]WITOX:Q8\V>?_!E!+ 0(4 Q0    ( /-)6UBLFCI9!0,  +@.   0
M          "  0    !E>&AI8FET7S(Q+3$N:'1M4$L! A0#%     @ \TE;
M6%GYSLK[!0  '!P  !               ( !,P,  &5X:&EB:71?,C,M,2YH
M=&U02P$"% ,4    " #S25M87>P*$U@(  !/(@  $               @ %<
M"0  97AH:6)I=%\S,2TQ+FAT;5!+ 0(4 Q0    ( /-)6UB0_E-B0@@  ,4A
M   0              "  >(1  !E>&AI8FET7S,Q+3(N:'1M4$L! A0#%
M  @ \TE;6#NSYTC=!0  P!<  !               ( !4AH  &5X:&EB:71?
M,S(M,2YH=&U02P$"% ,4    " #S25M8 2IA4<X%  !M&   $
M    @ %=(   97AH:6)I=%\S,BTR+FAT;5!+ 0(4 Q0    ( /-)6UCD-T!Y
M')D  (X1 0 *              "  5DF  !I;6%G93 N:G!G4$L! A0#%
M  @ \TE;6%2U,\^NE   %P$!  X              ( !G;\  &EM86=E,# P
M,#$N:G!G4$L! A0#%     @ \TE;6(7V-\UBR0$ 8/$!  X
M ( !=U0! &EM86=E,# P,#,N:G!G4$L! A0#%     @ \TE;6%IQ2/1<20
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M,#(S,3(S,5]D968N>&UL4$L! A0#%     @ \TE;6$)X(^LF"0$ ..<- !4
M             ( !V+<$ &QF=V0M,C R,S$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( /-)6UC!Q%#1)F4  %GO!@ 5              "  3'!!0!L9G=D+3(P
M,C,Q,C,Q7W!R92YX;6Q02P$"% ,4    " #S25M8+^#M"Z*C P!Y+20 #0
M            @ &*)@8 >FLR-#,Q,#,W+FAT;5!+!08     $0 1 !H$  !7
%R@D    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>zk2431037_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lfwd="http://www.rewalk.com/20231231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lfwd-20231231.xsd" xlink:type="simple"/>
    <context id="C_20230101to20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-08</instant>
        </period>
    </context>
    <context id="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-08</endDate>
        </period>
    </context>
    <context id="C_20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipWarrantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipWarrantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipRentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipRentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipDistributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:CustomerRelationshipDistributionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230801to20230808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-08</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:IsraelInnovationAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_srtAsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_srtAsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_srtAsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_countryIL">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_countryUS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtStatementGeographicalAxis_countryDE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtStatementGeographicalAxis_countryDE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtStatementGeographicalAxis_lfwdRestOfWorldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfwd:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_lfwdRestOfWorldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfwd:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtStatementGeographicalAxis_lfwdRestOfWorldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfwd:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:BacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lfwd:BacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230930_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:RegisteredDirectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:LicenseAgreementAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20240227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <instant>2024-02-27</instant>
        </period>
    </context>
    <context id="C_20210202to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-02</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="C_20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="C_20210901to20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="C_20210901to20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="C_20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfwd:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfwd:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lfwd:EmployeeStockOptionAndRestrictedStockUnitsRsuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">lfwd:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:WarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20150101to20151231_deiLegalEntityAxis_lfwdKreosCapitalVMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:KreosCapitalVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="C_20161228_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lfwd:KreosCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-28</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20151231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">lfwd:KreosCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="C_20220602_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210201to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="C_20210201to20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lfwd:AdditionallyWarrantsIssuedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:PurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInDecember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInDecember2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInJuly2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInJuly2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020TwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020TwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:OfferingOfOrdinarySharesInFebruary2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:December2020PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">lfwd:December2020PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lfwd:AgreementAxis">lfwd:CertainInstitutionalPurchasersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220721_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-21</instant>
        </period>
    </context>
    <context id="C_20221222_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lfwd:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-22</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdBestOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:BestOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lfwd:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231201to20231212_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfwd:TwoZeroTwoThreeReorganizationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfwd:TwoZeroTwoThreeReorganizationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtProductOrServiceAxis_lfwdReStoreProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ReStoreProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">lfwd:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_srtProductOrServiceAxis_lfwdSCIProductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:SCIProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_srtProductOrServiceAxis_usgaapProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtProductOrServiceAxis_usgaapProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtProductOrServiceAxis_usgaapProductMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_lfwdRevenueObligationAxis_lfwdRentalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lfwd:RevenueObligationAxis">lfwd:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_lfwdRevenueObligationAxis_lfwdRentalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lfwd:RevenueObligationAxis">lfwd:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_lfwdRevenueObligationAxis_lfwdRentalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lfwd:RevenueObligationAxis">lfwd:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ServiceAndWarrantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ServiceAndWarrantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lfwd:ServiceAndWarrantyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20230930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230930_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230930_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_20230811_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-11</instant>
        </period>
    </context>
    <context id="C_20230812to20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-12</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lfwd:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:MachineryAndLaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfwd:FieldServiceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230101to20231231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:RewalkRoboticsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:RewalkRoboticsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:RewalkRoboticsGmbhMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:ReWalkRoboticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapStateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_20230101to20231231_deiLegalEntityAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001607962</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">lfwd:AltergIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <unit id="NIS_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>lfwd:segment</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="C_20230101to20231231" id="FFact_0000000001043">0001607962</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20230101to20231231" id="FFact_0000000001044">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="C_20230101to20231231" id="FFact_0000000001045">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_20230101to20231231"
      id="Fdei_EntityTaxIdentificationNumber20230221042354850">00-0000000</dei:EntityTaxIdentificationNumber>
    <lfwd:FinancialExpensesAndIncomeNet
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213140028626"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"
      id="FFact_0000000001035"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"
      id="Fxbrl_20230213145458513"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"
      id="Fxbrl_20230213145510899"
      unitRef="pure"
      xsi:nil="true"/>
    <lfwd:FinancialExpensesIncomeNet
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230213115503054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      id="FFact_0000000000446"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      id="FFact_0000000000448"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_20231231_srtProductOrServiceAxis_lfwdSCIProductsMember"
      id="Fxbrl_20230214112251731">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <dei:DocumentType
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112549533">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112555996">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20230101to20231231"
      id="Fxbrl_20231216103530967">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20230101to20231231"
      id="Fxbrl_20231216111836216">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20230101to20231231"
      id="Fxbrl_20231216111856641">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112602301">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112759821">001-36612</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112814956">ReWalk Robotics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112819931">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112826511">3 Hatnufa Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112834811">Floor 6</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112839187">Yokneam Illit</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112850769">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112859220">2069203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112906186">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112915301">4.959.0123</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240226144236291">Ordinary Shares, par value NIS 0.25 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112929217">LFWD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501112936746">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113149840">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113158305">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113204770">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113210527">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113218185">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113230475">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113248536">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113300995">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_20230101to20231231"
      id="Fxbrl_20231216101033126">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230501113316846">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_20230630"
      decimals="0"
      id="Fxbrl_20230501113328597"
      unitRef="USD">35050478</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20240227"
      decimals="INF"
      id="Fxbrl_20230501113339229"
      unitRef="shares">59480132</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId contextRef="C_20230101to20231231" id="FFact_0000000000032">1281</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240226173350336">KOST FORER GABBAY &amp;</dei:AuditorName>
    <dei:AuditorLocation contextRef="C_20230101to20231231" id="FFact_0000000000034">Tel-Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000035"
      unitRef="USD">28083000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000036"
      unitRef="USD">67896000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223111331182"
      unitRef="USD">328000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223111353081"
      unitRef="USD">26000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000037"
      unitRef="USD">3120000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000038"
      unitRef="USD">1036000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000039"
      unitRef="USD">2366000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000040"
      unitRef="USD">649000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000041"
      unitRef="USD">5653000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000042"
      unitRef="USD">2929000</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000043"
      unitRef="USD">39222000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000044"
      unitRef="USD">72510000</us-gaap:AssetsCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000045"
      unitRef="USD">784000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000046"
      unitRef="USD">694000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000047"
      unitRef="USD">1861000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000048"
      unitRef="USD">836000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000049"
      unitRef="USD">1262000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000050"
      unitRef="USD">196000</us-gaap:PropertyPlantAndEquipmentNet>
    <lfwd:IntangibleAssetsNonCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223111434241"
      unitRef="USD">12525000</lfwd:IntangibleAssetsNonCurrent>
    <lfwd:IntangibleAssetsNonCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223111441762"
      unitRef="USD">0</lfwd:IntangibleAssetsNonCurrent>
    <us-gaap:Goodwill
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223111454400"
      unitRef="USD">7538000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223111513656"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000051"
      unitRef="USD">23970000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000052"
      unitRef="USD">1726000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000053"
      unitRef="USD">63192000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000054"
      unitRef="USD">74236000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000057"
      unitRef="USD">5069000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000058"
      unitRef="USD">1950000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000059"
      unitRef="USD">2034000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000060"
      unitRef="USD">1282000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000061"
      unitRef="USD">1504000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000062"
      unitRef="USD">301000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000055"
      unitRef="USD">1296000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000056"
      unitRef="USD">564000</us-gaap:OperatingLeaseLiabilityCurrent>
    <lfwd:EarnoutLiabilityCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223111531511"
      unitRef="USD">576000</lfwd:EarnoutLiabilityCurrent>
    <lfwd:EarnoutLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223111550304"
      unitRef="USD">0</lfwd:EarnoutLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000063"
      unitRef="USD">1316000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000064"
      unitRef="USD">685000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000065"
      unitRef="USD">11795000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000066"
      unitRef="USD">4782000</us-gaap:LiabilitiesCurrent>
    <lfwd:LongTermEarnoutLiability
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223111601459"
      unitRef="USD">2716000</lfwd:LongTermEarnoutLiability>
    <lfwd:LongTermEarnoutLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223111618216"
      unitRef="USD">0</lfwd:LongTermEarnoutLiability>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000067"
      unitRef="USD">1506000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000068"
      unitRef="USD">890000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000069"
      unitRef="USD">607000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000070"
      unitRef="USD">333000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000071"
      unitRef="USD">58000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000072"
      unitRef="USD">66000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000073"
      unitRef="USD">4887000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000074"
      unitRef="USD">1289000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000075"
      unitRef="USD">16682000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000076"
      unitRef="USD">6071000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20231231"
      id="Fxbrl_20240223105824526"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20221231"
      id="Fxbrl_20240223105831205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230213172319680"
      unitRef="NIS_per_Share">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000078"
      unitRef="NIS_per_Share">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230214053645228"
      unitRef="shares">120000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000079"
      unitRef="shares">120000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20230213112949242"
      unitRef="shares">64132706</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230213112956319"
      unitRef="shares">63023506</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20230214055452653"
      unitRef="shares">60110099</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230213113027734"
      unitRef="shares">60090298</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000085"
      unitRef="USD">4487000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000086"
      unitRef="USD">4489000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000087"
      unitRef="USD">281109000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000088"
      unitRef="USD">279857000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20230214105901072"
      unitRef="shares">4022607</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20240223105714719"
      unitRef="shares">2933208</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213111754081"
      unitRef="USD">3203000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213111801774"
      unitRef="USD">2431000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000089"
      unitRef="USD">-235883000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000090"
      unitRef="USD">-213750000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000091"
      unitRef="USD">46510000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000092"
      unitRef="USD">68165000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000093"
      unitRef="USD">63192000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000094"
      unitRef="USD">74236000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000095"
      unitRef="USD">13854000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000096"
      unitRef="USD">5511000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000097"
      unitRef="USD">5966000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000098"
      unitRef="USD">9401000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000099"
      unitRef="USD">3606000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000100"
      unitRef="USD">3063000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000101"
      unitRef="USD">4453000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000102"
      unitRef="USD">1905000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000103"
      unitRef="USD">2903000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000104"
      unitRef="USD">4148000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000105"
      unitRef="USD">4031000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000106"
      unitRef="USD">2939000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000107"
      unitRef="USD">13922000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000108"
      unitRef="USD">9842000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000109"
      unitRef="USD">6993000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000110"
      unitRef="USD">9995000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000111"
      unitRef="USD">7134000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000112"
      unitRef="USD">5626000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000113"
      unitRef="USD">28065000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000114"
      unitRef="USD">21007000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000115"
      unitRef="USD">15558000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000116"
      unitRef="USD">-23612000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000117"
      unitRef="USD">-19102000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000118"
      unitRef="USD">-12655000</us-gaap:OperatingIncomeLoss>
    <lfwd:FinancialExpensesIncomeNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213115913875"
      unitRef="USD">-1467000</lfwd:FinancialExpensesIncomeNet>
    <lfwd:FinancialExpensesIncomeNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000121"
      unitRef="USD">-13000</lfwd:FinancialExpensesIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223105404398"
      unitRef="USD">-22145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000123"
      unitRef="USD">-19102000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000124"
      unitRef="USD">-12642000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000125"
      unitRef="USD">-12000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000126"
      unitRef="USD">467000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000127"
      unitRef="USD">94000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000128"
      unitRef="USD">-22133000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000129"
      unitRef="USD">-19569000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000130"
      unitRef="USD">-12736000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20240225004900065"
      unitRef="NIS_per_Share">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20230101to20231231"
      decimals="2"
      id="Fxbrl_20240225004814776"
      unitRef="NIS_per_Share">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20240225004929118"
      unitRef="NIS_per_Share">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20240225004830611"
      unitRef="NIS_per_Share">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20240225004938878"
      unitRef="NIS_per_Share">-0.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20240225004840147"
      unitRef="NIS_per_Share">-0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240225004700425"
      unitRef="shares">59719064</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240225004604120"
      unitRef="shares">59719064</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20240225004710111"
      unitRef="shares">62378797</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20240225004635413"
      unitRef="shares">62378797</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20240225004722287"
      unitRef="shares">47935652</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20240225004640323"
      unitRef="shares">47935652</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_0000000000172"
      unitRef="shares">25332225</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000173"
      unitRef="USD">1827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000174"
      unitRef="USD">201392000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045239675"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_0000000000175"
      unitRef="USD">-181445000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_0000000000176"
      unitRef="USD">21774000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230214050536515"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000177"
      unitRef="USD">833000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045253195"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045737411"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000178"
      unitRef="USD">833000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_0000000000179"
      unitRef="shares">398164</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000180"
      unitRef="USD">31000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000181"
      unitRef="USD">-31000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045308210"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045808051"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230214050245787"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdBestOfferingMember"
      decimals="-3"
      id="FFact_0000000000183"
      unitRef="USD">3679000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <lfwd:StockIssuedDuringPeriodSharesOrdinaryShares1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_0000000000184"
      unitRef="shares">10921502</lfwd:StockIssuedDuringPeriodSharesOrdinaryShares1>
    <lfwd:StockIssuedDuringPeriodValueOrdinaryShares1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000185"
      unitRef="USD">832000</lfwd:StockIssuedDuringPeriodValueOrdinaryShares1>
    <lfwd:StockIssuedDuringPeriodValueOrdinaryShares1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000186"
      unitRef="USD">35489000</lfwd:StockIssuedDuringPeriodValueOrdinaryShares1>
    <lfwd:StockIssuedDuringPeriodValueOrdinaryShares1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045317130"
      unitRef="USD">0</lfwd:StockIssuedDuringPeriodValueOrdinaryShares1>
    <lfwd:StockIssuedDuringPeriodValueOrdinaryShares1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045815626"
      unitRef="USD">0</lfwd:StockIssuedDuringPeriodValueOrdinaryShares1>
    <lfwd:StockIssuedDuringPeriodValueOrdinaryShares1
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000188"
      unitRef="USD">36321000</lfwd:StockIssuedDuringPeriodValueOrdinaryShares1>
    <lfwd:ExerciseOfPreFundedWarrantsAndWarrantsShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_0000000000189"
      unitRef="shares">10425258</lfwd:ExerciseOfPreFundedWarrantsAndWarrantsShares>
    <lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000190"
      unitRef="USD">772000</lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue>
    <lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000191"
      unitRef="USD">14288000</lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue>
    <lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045324826"
      unitRef="USD">0</lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue>
    <lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045824098"
      unitRef="USD">0</lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue>
    <lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000193"
      unitRef="USD">15060000</lfwd:ExerciseOfPreFundedWarrantsAndWarrantsValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_20210101to20211231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectOfferingMember"
      decimals="-3"
      id="FFact_0000000000194"
      unitRef="USD">3215000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <lfwd:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_0000000000195"
      unitRef="shares">15403014</lfwd:StockIssuedDuringPeriodSharesIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000196"
      unitRef="USD">1199000</lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000197"
      unitRef="USD">26932000</lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045336466"
      unitRef="USD">0</lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045840938"
      unitRef="USD">0</lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000199"
      unitRef="USD">28131000</lfwd:StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesInRegisteredDirectNetOfIssuanceExpenses1>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230214050511427"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230214050505475"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045359925"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_0000000000206"
      unitRef="USD">-12736000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000207"
      unitRef="USD">-12736000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000209"
      unitRef="USD">62480163000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000210"
      unitRef="USD">4661000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045413642"
      unitRef="USD">278903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_0000000000211"
      unitRef="USD">-194181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000212"
      unitRef="USD">89383000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230214050446027"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000213"
      unitRef="USD">993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045421561"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045934986"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000214"
      unitRef="USD">993000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="FFact_0000000000215"
      unitRef="shares">543343</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000216"
      unitRef="USD">39000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000217"
      unitRef="USD">-39000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045431322"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214045952457"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230214050231003"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20240223111257860_xbrl_20230213144339403"
      unitRef="shares">-2933208</us-gaap:TreasuryStockSharesAcquired>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20240223111257860_xbrl_20230213144442451"
      unitRef="USD">-211000</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20240223111257860_xbrl_20230214050313843"
      unitRef="USD">0</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20240223111257860_xbrl_20230213144626406"
      unitRef="USD">-2431000</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20240223111257860_xbrl_20230214050051930"
      unitRef="USD">0</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223111257860_xbrl_20230213150705871"
      unitRef="USD">-2642000</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230214050406195"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230214050421835"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045511674"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_0000000000236"
      unitRef="USD">-19569000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000237"
      unitRef="USD">-19569000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20240223110903813"
      unitRef="shares">60090298</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="FFact_0000000000239"
      unitRef="USD">4489000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="FFact_0000000000240"
      unitRef="USD">279857000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045521729"
      unitRef="USD">2431000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="FFact_0000000000241"
      unitRef="USD">-213750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000242"
      unitRef="USD">68165000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230214050343571"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230213143856752"
      unitRef="USD">1328000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045531002"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214050031882"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213143813750_Fact_0000000000178"
      unitRef="USD">1328000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230213144043463_Fact_0000000000179"
      unitRef="shares">1109200</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230213144043463_Fact_0000000000180"
      unitRef="USD">76000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230213144043463_Fact_0000000000181"
      unitRef="USD">-76000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230214045547258"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214050042386"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230214050217259"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230213144339403"
      unitRef="shares">-1089399</us-gaap:TreasuryStockSharesAcquired>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230213144442451"
      unitRef="USD">-78000</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230214050313843"
      unitRef="USD">0</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230213144626406"
      unitRef="USD">-772000</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230214050051930"
      unitRef="USD">0</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <lfwd:Sharesissuedduringperiodvaluetreasurystock
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213150705871"
      unitRef="USD">-850000</lfwd:Sharesissuedduringperiodvaluetreasurystock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230221161452108"
      unitRef="USD">-0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230221161500959"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230221161507919"
      unitRef="USD">-0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230213144102938_Fact_0000000000236"
      unitRef="USD">-22133000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213144102938_Fact_0000000000237"
      unitRef="USD">-22133000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230213144150665_Fact_0000000000238"
      unitRef="shares">60110099</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230213144150665_Fact_0000000000239"
      unitRef="USD">4487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230213144150665_Fact_0000000000240"
      unitRef="USD">281109000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapTreasuryStockPreferredMember"
      decimals="-3"
      id="Fxbrl_20230213150722524"
      unitRef="USD">-3203000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230213144150665_Fact_0000000000241"
      unitRef="USD">-235883000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213144150665_Fact_0000000000242"
      unitRef="USD">46510000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000243"
      unitRef="USD">-22133000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000244"
      unitRef="USD">-19569000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000245"
      unitRef="USD">-12736000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000246"
      unitRef="USD">239000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000247"
      unitRef="USD">202000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000248"
      unitRef="USD">266000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240227143628290"
      unitRef="USD">1608000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240227143636963"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240227143654356"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000249"
      unitRef="USD">1328000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000250"
      unitRef="USD">993000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000251"
      unitRef="USD">833000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000252"
      unitRef="USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000253"
      unitRef="USD">316000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000254"
      unitRef="USD">-29000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <lfwd:EarnOutRemeasured
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123422747_Fact_0000000000252"
      unitRef="USD">-315000</lfwd:EarnOutRemeasured>
    <lfwd:EarnOutRemeasured
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123422747_Fact_0000000000253"
      unitRef="USD">0</lfwd:EarnOutRemeasured>
    <lfwd:EarnOutRemeasured
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123422747_Fact_0000000000254"
      unitRef="USD">0</lfwd:EarnOutRemeasured>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123424851_Fact_0000000000252"
      unitRef="USD">11000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123424851_Fact_0000000000253"
      unitRef="USD">0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123424851_Fact_0000000000254"
      unitRef="USD">0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123426651_Fact_0000000000252"
      unitRef="USD">-45000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123426651_Fact_0000000000253"
      unitRef="USD">79000</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionLossBeforeTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123426651_Fact_0000000000254"
      unitRef="USD">0</us-gaap:ForeignCurrencyTransactionLossBeforeTax>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213132603222"
      unitRef="USD">311000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000259"
      unitRef="USD">408000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000260"
      unitRef="USD">-99000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000261"
      unitRef="USD">531000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000262"
      unitRef="USD">-94000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000263"
      unitRef="USD">-592000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213132623934"
      unitRef="USD">277000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000265"
      unitRef="USD">117000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000266"
      unitRef="USD">-432000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000267"
      unitRef="USD">1037000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000268"
      unitRef="USD">566000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213151537465"
      unitRef="USD">-884000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000270"
      unitRef="USD">-14000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000271"
      unitRef="USD">140000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000272"
      unitRef="USD">275000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213132658787"
      unitRef="USD">-269000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000274"
      unitRef="USD">-34000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000275"
      unitRef="USD">74000</us-gaap:IncreaseDecreaseInDeferredLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000276"
      unitRef="USD">-973000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213151613737"
      unitRef="USD">-153000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000278"
      unitRef="USD">-391000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000279"
      unitRef="USD">-20667000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000280"
      unitRef="USD">-17891000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000281"
      unitRef="USD">-11469000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123430355_Fact_0000000000252"
      unitRef="USD">18068000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123430355_Fact_0000000000253"
      unitRef="USD">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123430355_Fact_0000000000254"
      unitRef="USD">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000282"
      unitRef="USD">81000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000283"
      unitRef="USD">25000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000284"
      unitRef="USD">47000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000285"
      unitRef="USD">-18149000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000286"
      unitRef="USD">-25000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000287"
      unitRef="USD">-47000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="FFact_0000000000318"
      unitRef="USD">3679000</us-gaap:PaymentsOfStockIssuanceCosts>
    <lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213231158622"
      unitRef="USD">0</lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582>
    <lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213124756646"
      unitRef="USD">0</lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582>
    <lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213231152958"
      unitRef="USD">36321000</lfwd:IssuanceOfOrdinarySharesInPrivatePlacementNetOfIssuanceExpensesPaidInAmountOf3582>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_lfwdRegisteredDirectMember"
      decimals="-3"
      id="FFact_0000000000322"
      unitRef="USD">3215000</us-gaap:PaymentsOfStockIssuanceCosts>
    <lfwd:ProceedsFromIssuanceOfRegistrationCostTwo
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213231215958"
      unitRef="USD">0</lfwd:ProceedsFromIssuanceOfRegistrationCostTwo>
    <lfwd:ProceedsFromIssuanceOfRegistrationCostTwo
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213124808685"
      unitRef="USD">0</lfwd:ProceedsFromIssuanceOfRegistrationCostTwo>
    <lfwd:ProceedsFromIssuanceOfRegistrationCostTwo
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213231209903"
      unitRef="USD">28131000</lfwd:ProceedsFromIssuanceOfRegistrationCostTwo>
    <lfwd:ExerciseOfPreFundedWarrants
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213133255195"
      unitRef="USD">0</lfwd:ExerciseOfPreFundedWarrants>
    <lfwd:ExerciseOfPreFundedWarrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000327"
      unitRef="USD">0</lfwd:ExerciseOfPreFundedWarrants>
    <lfwd:ExerciseOfPreFundedWarrants
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000328"
      unitRef="USD">15060000</lfwd:ExerciseOfPreFundedWarrants>
    <lfwd:PaymentsForPurchaseOfTreasuryStock
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213132126265"
      unitRef="USD">992000</lfwd:PaymentsForPurchaseOfTreasuryStock>
    <lfwd:PaymentsForPurchaseOfTreasuryStock
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213153846345"
      unitRef="USD">2500000</lfwd:PaymentsForPurchaseOfTreasuryStock>
    <lfwd:PaymentsForPurchaseOfTreasuryStock
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213153904715"
      unitRef="USD">0</lfwd:PaymentsForPurchaseOfTreasuryStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213152442041"
      unitRef="USD">-992000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000330"
      unitRef="USD">-2500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000331"
      unitRef="USD">79512000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213133113041"
      unitRef="USD">45000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213154813996"
      unitRef="USD">-79000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213154824814"
      unitRef="USD">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213152756011"
      unitRef="USD">-39763000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000333"
      unitRef="USD">-20495000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000334"
      unitRef="USD">67996000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000335"
      unitRef="USD">68555000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000336"
      unitRef="USD">89050000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20230221200509741"
      unitRef="USD">21054000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223123504369"
      unitRef="USD">28792000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000339"
      unitRef="USD">68555000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000340"
      unitRef="USD">89050000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000344"
      unitRef="USD">0</lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet>
    <lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000345"
      unitRef="USD">22000</lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet>
    <lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213231847568"
      unitRef="USD">34000</lfwd:ClassificationOfOtherCurrentAssetsToPropertyAndEquipmentNet>
    <lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000350"
      unitRef="USD">481000</lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet>
    <lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000351"
      unitRef="USD">67000</lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet>
    <lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000352"
      unitRef="USD">32000</lfwd:ClassificationOfInventoryToPropertyAndEquipmentNet>
    <lfwd:PaymentToRepurchaseOfShares
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123437986_Fact_0000000000252"
      unitRef="USD">0</lfwd:PaymentToRepurchaseOfShares>
    <lfwd:PaymentToRepurchaseOfShares
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123437986_Fact_0000000000253"
      unitRef="USD">142000</lfwd:PaymentToRepurchaseOfShares>
    <lfwd:PaymentToRepurchaseOfShares
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123437986_Fact_0000000000254"
      unitRef="USD">0</lfwd:PaymentToRepurchaseOfShares>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123440530_Fact_0000000000252"
      unitRef="USD">513000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123440530_Fact_0000000000253"
      unitRef="USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123440530_Fact_0000000000254"
      unitRef="USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000371"
      unitRef="USD">126000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000372"
      unitRef="USD">113000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000373"
      unitRef="USD">40000</us-gaap:IncomeTaxesPaid>
    <lfwd:InterestReceived
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213160047968"
      unitRef="USD">1341000</lfwd:InterestReceived>
    <lfwd:InterestReceived
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000375"
      unitRef="USD">0</lfwd:InterestReceived>
    <lfwd:InterestReceived
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000376"
      unitRef="USD">0</lfwd:InterestReceived>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213133556489"
      unitRef="USD">28083000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213133605897"
      unitRef="USD">67896000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230213134422132"
      unitRef="USD">88337000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213134447328"
      unitRef="USD">709000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213134505203"
      unitRef="USD">659000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230213134516052"
      unitRef="USD">713000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213134525739"
      unitRef="USD">28792000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213134555684"
      unitRef="USD">68555000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230213134626502"
      unitRef="USD">89050000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000377">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:72pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;NOTE 1:-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;GENERAL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;ReWalk Robotics Ltd. (&#x201c;RRL&#x201d;, and together with its subsidiaries, the &#x201c;Company&#x201d;) was incorporated under the laws of the State of Israel on June 20, 2001 and commenced operations on the same date.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;RRL has three wholly-owned (directly and indirectly) subsidiaries: (i) ReWalk Robotics, Inc. (&#x201c;RRI&#x201d;) incorporated under the laws of Delaware on February 15, 2012, (ii) ReWalk Robotics GMBH (&#x201c;RRG&#x201d;) incorporated under the laws of Germany on January 14, 2013, and (iii) AlterG, Inc. (&#x201c;AlterG&#x201d;) incorporated in Delaware on October 21, 2004 under the name of Gravus, Inc. On June 30, 2005, the Company re-incorporated in Delaware and changed its name to AlterG, Inc. in September 2005.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company is a medical device company that is designing, developing, and commercializing innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions. The Company&#x2019;s initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury (collectively, the &#x201c;SCI Products&#x201d;). These devices are robotic exoskeletons that are designed for individuals with paraplegia that use the Company&#x2019;s patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. These SCI Products allow individuals with spinal cord injury the ability to stand and walk again during everyday activities at home or in the community.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company has sought to expand the product offerings beyond the SCI Products through internal development and distribution agreements. The Company has developed its ReStore Exo-Suit device, which it began commercializing in June 2019. The ReStore is a powered, lightweight soft exo-suit intended for use during the rehabilitation of individuals with lower limb disability due to stroke. During the second quarter of 2020, the Company signed two separate agreements to distribute additional product lines in the United States. The Company is the exclusive distributor of the MYOLYN MyoCycle FES Pro cycles to United States (&#x201c;U.S.&#x201d;) rehabilitation clinics and for the MyoCycle Home cycles available to US veterans through VA hospitals. In the second quarter of 2020, the Company also became the exclusive distributor of the MediTouch Tutor movement biofeedback systems in the United States; however, due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023. We refer to the MediTouch and MyoCycle devices as the Company&#x2019;s &#x201c;Distributed Products.&#x201d;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;On August 11, 2023, pursuant to an Agreement and Plan of Merger among RRI, AlterG, Atlas Merger Sub, Inc., a wholly owned subsidiary of RRI (&#x201c;Merger Sub&#x201d;), and Shareholder Representative Services LLC, dated August 11, 2023, RRI acquired AlterG and AlterG became a wholly owned subsidiary of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;For accounting purposes, RRI was considered the acquirer and AlterG was considered the acquiree. The acquisition was accounted for using the acquisition method of accounting. See Note 5 for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company made its first acquisition to supplement its internal growth when it acquired AlterG, a leading provider of AlterG Anti-Gravity systems for use in physical and neurological rehabilitation. &#160;The Company paid a cash purchase price of $19.0 million at closing and additional cash earnouts may be paid based upon a percentage of AlterG&#x2019;s year-over-year revenue growth over the two years following the closing. The AlterG Anti-Gravity systems use patented, NASA-derived Differential Air Pressure (&#x201c;DAP&#x201d;) technology to reduce the effects of gravity and allow people to rehabilitate with finely calibrated support and reduced pain. &#160;The Company will continue to evaluate other products for distribution or acquisition that can broaden its product offerings further to help individuals with physical and neurological injury and disability.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company markets and sells its products directly to institutions and individuals and through third-party distributors. The Company sells its products directly primarily in the United States, through a combination of direct sales and distributors (depending on the product line) in Germany, Canada, and Australia, and primarily through distributors in other markets. In its direct markets, the Company has established relationships with clinics and rehabilitation centers, professional and college sports teams, and individuals and organizations in the spinal cord injury community, and in its indirect markets, the Company&#x2019;s distributors maintain these relationships. RRI and AlterG market and sell products mainly in the United States. RRG markets and sells the Company&#x2019;s products mainly in Germany and Europe.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The Company depends on one contract manufacturer to manufacture the ReWalk and the ReStore products in its portfolio, Sanmina. Reliance on this vendor makes the Company vulnerable to possible capacity constraints and reduces control over component availability, delivery schedules, manufacturing yields and costs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For the full year ended December 31, 2023 the Company incurred a consolidated net loss of $22.1 million and has an accumulated deficit in the total amount of $235.9 million. The Company&#x2019;s negative operating cash flow for the full year ended December 31, 2023 was $20.7 million. Our cash and cash equivalent on December 31, 2023 totalled $28.1 million. The Company has sufficient funds to support its operation for more than 12 months following the approval of its consolidated financial statements for the fiscal year ended December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company expects to incur future net losses and the transition to profitability is dependent upon, among other things, the successful development and commercialization of the Company&#x2019;s products and product candidates, the establishment of contracts for the distribution of new product lines, or the acquisition of additional product lines, any of which, or in combination, would contribute to the achievement of a level of revenue adequate to support the cost structure. Until the Company achieves profitability or generates positive cash flows, it will continue to need to raise additional cash. The Company intends to fund future operations through existing cash on hand, additional private and/or public offerings of debt or equity securities, cash exercises of outstanding warrants or a combination of the foregoing. In addition, the Company may seek additional capital through arrangements with strategic partners or from other sources and will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20230213110552606"
      unitRef="USD">-22100000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20231231"
      decimals="-5"
      id="Fxbrl_20230213110606448"
      unitRef="USD">-235900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20230213110610952"
      unitRef="USD">-20700000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20231231"
      decimals="-5"
      id="Fxbrl_20230213110614536"
      unitRef="USD">28100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224171306811">
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:72pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 2:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;), applied on a consistent basis, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions. The Company&#x2019;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company&#x2019;s management evaluates estimates, including those related to inventories, fair values of share-based awards, contingent liabilities, provision for warranty, allowance for credit losses and sales return reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial Statements in U.S. Dollars:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The functional currency is the currency that best reflects the economic environment in which the Company and its subsidiaries operate and conduct their transactions. Most of the Company&#x2019;s revenues and costs are incurred in U.S. dollar. In addition, the Company&#x2019;s financing activities are incurred in U.S. dollars. The Company&#x2019;s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#x2019;s and its subsidiary's functional and reporting currency.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with ASC 830 &#x201c;Foreign Currency Matters.&#x201d; All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the consolidated statements of operations as financing income or expenses as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principles of Consolidation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances have been eliminated upon consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash Equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories are stated at the lower of cost or net realizable value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company periodically evaluates the quantities on hand relative to historical, current, and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its net realized value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost is determined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished products - based on raw materials and manufacturing costs on an average basis.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials - The weighted average cost method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value. If actual demand for the Company&#x2019;s products deteriorates, or market conditions are less favourable than those projected, additional inventory reserves may be required.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and Equipment:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20-33 (mainly 33)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6 - 10 (mainly 10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Machinery and laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Field service units&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20-50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over the shorter of the lease term &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;or estimated useful life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Business Combinations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for business combinations in accordance with ASC 805, &#x201c;Business Combinations&#x201d; (&#x201c;ASC 805&#x201d;). For business combinations accounted for under the acquisition method, ASC 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. The Company determines the recognition of intangible assets based on the following criteria: (i) the intangible asset arises from contractual or other rights; or (ii) the intangible asset is separable or divisible from the acquired entity and capable of being sold, transferred, licensed, returned or exchanged.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The excess of the fair value of the purchase price over the fair values of the identifiable assets and liabilities is recorded as goodwill. Determining the fair value of the identifiable assets and liabilities requires management to use significant judgment and estimates including the forecasted revenue and revenues growth rates, discount rates, customer contract renewal rates and customer attrition rates. The process of estimating the fair values requires significant estimates, especially with respect to intangible assets. Management&#x2019;s determination of fair value of assets acquired and liabilities assumed at the acquisition date is based on the best information available in the circumstances and incorporates management&#x2019;s own assumptions and involves a significant degree of judgment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition related costs include legal fees, consulting and success fees, and other non-recurring integration related costs. Acquisition-related costs are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has no indefinite-lived intangible assets other than goodwill. Acquired identifiable finite-lived intangible assets include identifiable acquired technology, customer relationships, trademarks and backlog and are amortized on a straight-line basis over the estimated useful lives of the assets. The Company routinely reviews the remaining estimated useful lives of finite-lived intangible assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill is not amortized and is tested for impairment at least annually.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates as one reporting unit and the fair value of the reporting unit is estimated using quoted market prices of the Company&#x2019;s stock in active markets. The Company tests goodwill for impairment annually in the fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When testing goodwill for impairment, the Company may first perform a qualitative assessment. If the Company determines it is not more likely than not the reporting unit&#x2019;s fair value is less than its carrying value, then no further analysis is necessary. If the Company determines that it is more likely than not that the fair value of its reporting unit is less than its carrying amount, then the quantitative impairment test will be performed. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Under the quantitative impairment test, if the carrying amount of the Company&#x2019;s reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, no impairments of goodwill have been recognized.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s long-lived assets, including right-of-use (&#x201c;ROU&#x201d;) assets and identifiable intangible assets that are subject to amortization, are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d; whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2023, 2022 and 2021, no impairment losses have been recorded.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restricted cash and Other long-term assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company repurchased its ordinary shares and holds them as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction of shareholders' equity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;

            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue Recognition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to clinics and rehabilitation centres, professional and college sports teams, private individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), and distributors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue in accordance with ASC 606, &#x201c;Revenue Recognition&#x201d; when, or as, control of the promised good or service is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company applies the following five steps:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the contract with a customer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generally considers a purchase order or a signed quote to be a contract with a customer. In evaluating the contract with a customer, the Company analyzes the customer&#x2019;s intent and ability to pay the amount of promised consideration (credit risk) and considers the probability of collecting substantially all of the consideration.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At a contract&#x2019;s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determine the transaction price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not offer extended payment terms beyond one year to customers.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allocate the transaction price to performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognize revenue when or as the Company satisfies a performance obligation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control either transfers over time or at a point in time, which affects when revenue is recorded.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has elected to apply the practical expedient for financing component for transactions in which the difference between the payment date and the revenue recognition timing is up to 12 months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disaggregation of Revenue (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:36pt"&gt;

                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,175&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service and warranty&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from Products is comprised of sale of Anti-Gravity products, sale of systems products to rehabilitation facilities and sale of ReWalk Personal Exoskeleton systems to end users. Revenues generated from the sale of Products are recognized at a point in time, once the customer has obtained the legal title to the items purchased.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For systems sold to rehabilitation facilities, the Company includes insignificant training and considers the elements in the arrangement to be a single performance obligation. Therefore, the Company recognizes revenue for the system only when control is transferred after delivery and when the training has been completed, in accordance with the agreements terms with the customer.&lt;/span&gt;&lt;/span&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;
                  &lt;div&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For sales of ReWalk Personal Exoskeleton systems to end users, and for sales of ReWalk Personal or ReWalk Rehabilitation Exoskeleton systems to third party distributors, the Company does not provide training to the end user as this training is completed by the rehabilitation center or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generally does not grant a right of return for its products. In rare circumstances when the Company provides a right of return for its products. the Company records reductions to revenue for expected future product returns based on the Company&#x2019;s historical experience and estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2023, the Company offered six products: (1) ReWalk Personal Exoskeletons, (2) ReWalk Rehabilitation Exoskeleton, (3) ReStore, (4) AlterG Anti-Gravity systems, (5) MyoCycle and (6) MediTouch. Due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental revenue for the AlterG Anti-Gravity systems is accounted for under ASC Topic 842, Leases. The Company rents its products to customers for a fixed monthly fee over the rental term, which typically ranges from 2 to 3 years. Rental revenues are recorded as earned on a monthly basis. See Note 2x for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the SCI Products, the Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee for a limited period prior to selling its products.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service and warranties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company services its products after expiration of the initial warranty. Service revenue, consisting of time and materials to perform the repairs, is recorded as services are rendered.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determining the transaction price requires of level judgment, which is discussed by revenue category in further detail below.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranties are classified as either an assurance type or a service type warranty. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended for a limited period of time. An assurance type warranty is not accounted for as a separate performance obligation under the revenue model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SCI Products include a &lt;span style="-sec-ix-hidden:Fxbrl_20230214112251731"&gt; five -year warranty&lt;/span&gt;. The first  two years are considered as an assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. A service type warranty is either sold with a unit or separately for a unit for which the warranty has expired. A service type warranty is accounted as a separate performance obligation and revenue is recognized ratably over the life of the warranty.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The ReStore device is sold with a two-year warranty which is considered as assurance type warranty.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Distributed Products are sold with assurance type warranty ranging between three years to ten years, depending on the specific product and part.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;F&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;or AlterG Anti-Gravity Products, the Company offers customers extended warranty contracts that extend or enhance the technical support, parts, and labor coverage offered as part of the base warranty included with the Anti-Gravity system products. Extended warranty revenue is recognized ratably over the extended warranty coverage period. The Company offers a one-year assurance type warranty to customers in the U.S. and two years assurance type warranty for spare parts only to its international distributors. For these products, the Company determines standalone selling price based on the price at which the performance obligation is sold separately.&lt;/span&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract balances (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:36pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade receivable, net of credit losses (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenues (1) (2)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,010&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance presented net of unrecognized revenue that was not yet collected.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$435 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenue which represent a contract liability, include unearned amounts related to service type warranty obligations as well as other advances and payments which the Company received from customers prior to satisfying the performance obligation, for which revenue has not yet been recognized. The Company's unearned performance obligations as of December 31, 2023 and the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounting for Share-Based Compensation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for share-based compensation in accordance with ASC 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#x201c;OPM&#x201d;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company account for forfeitures as they occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility is calculated based on actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options, or based on certain peer companies that the Company considered to be comparable, in case there is no sufficient trading volume to rely on market volatility. The expected option term is determined based on the simplified method, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of Restricted Stock Units (&#x201c;RSUs&#x201d;) granted is determined based on the price of the Company&#x2019;s ordinary shares on the date of grant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for options granted to consultants and other service providers under ASC 718. The fair value of these options was estimated using a Black-Scholes-Merton option-pricing model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants to Acquire Ordinary Shares:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the twelve -month ended December 31, 2021, the Company issued warrants to acquire up to 15,083,611 ordinary shares. There were no issued warrants during the twelve months ended December 31, 2023 and 2022. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815 "Derivatives and Hedging" and determined that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 9f for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and Development Costs:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the Company received for research and development in the period in which the grant was received.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;p.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its taxes on income. As of December 31, 2023, and 2022, the Company did not identify any significant uncertain tax positions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;q.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranty provision:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For assurance-type warranty, the Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#x2019;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US Dollars&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AlterG acquisition &#x2013; see note 5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:88%;padding-bottom:2px;vertical-align:baseline"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Usage&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;r.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concentrations of Credit Risks:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution. The bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration exists with respect to these deposits.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The below table reflects the concentration of credit risk for the Company&#x2019;s current customers as of December 31, 2023, to which substantial sales were made.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:36pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000000446"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000000448"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer C&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer D&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 10%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The allowance for credit losses is based on the Company's assessments of factors that may affect a customer's ability to pay. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current customer's aging balance, the nature and size of the customer, the financial condition of the customer, and the amount of any receivables in dispute. The Company does not have any off-balance sheet credit exposure related to its customers. As of December 31, 2023, and 2022 trade receivables are presented net of $328 thousand and $26 thousand allowance for credit losses, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;s.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued Severance Pay:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to Israel&#x2019;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#x2019;s salary for each year of employment, or a portion thereof. All of the employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#x201c;section 14&#x201d;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Company&#x2019;s expenses related to severance pay amounted to $114 thousand , $113 thousand and $104 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;t.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company uses a three -tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The three -tiers are defined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x25aa;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 1. &lt;/span&gt;Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x25aa;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 2. &lt;/span&gt;Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x25aa;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 3. &lt;/span&gt;Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such instruments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities that are measured in fair value on a recurring basis as of December 31, 2023 and December 31, 2022 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Description&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value Hierarchy&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds included in cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury bills included in cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Assets Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Financial Liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Earnout&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies cash equivalents within Level 1, because the Company uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair values.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The earnout was valued using a Monte Carlo simulation analysis, which is considered to be a Level 3 fair value measurement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes the earnout liability activity as of December 31, 2023 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Earnout&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial Measurement (August 11, 2023)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="text-align:justify;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;u.&lt;span style="padding-left:7pt"&gt;&#160;&lt;/span&gt;Basic and Diluted Net Loss Per Share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per share is computed based on the weighted average number of ordinary shares outstanding during the period, plus dilutive potential shares considered outstanding during the period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;v.&lt;span style="padding-left:8pt"&gt;&#160;&lt;/span&gt;Contingent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for its contingent liabilities in accordance with ASC 450, &#x201c;Contingencies.&#x201d; A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;w.&lt;span style="padding-left:8pt"&gt;&#160;&lt;/span&gt;Government grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalty and non-royalty-bearing grants from the Israeli Innovation Authority (the &#x201c;IIA&#x201d;) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a reduction from research and development expenses (see Note 8c).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;x.&lt;span style="padding-left:8pt"&gt;&#160;&lt;/span&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating lease liabilities and their corresponding right-of-use assets are recorded at commencement date based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items, such as initial direct costs paid or incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases with an initial term of 12 months or less are not recorded on the balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lessor accounting - Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A portion of the AlterG rental revenues for the AlterG Anti-Gravity systems are made through lease arrangements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AlterG products are available for lease agreements ranging from 12 to 42 months. If the customer terminates the contract during the lease period, they are required to pay a cancellation fee. The lease period may be extended by an additional period as specified in the contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In determining the leases classification as a sales type or operating lease, the Company assesses, among other criteria: (i) the lease term to determine if it is for the major part of the economic life of the underlying equipment; and (ii) the present value of the lease payments to determine if they are equal to or greater than substantially all of the fair market value of the equipment at the inception of the lease AlterG Anti-Gravity systems. When these criteria are not met, the lease accounted for as operating leases and revenues are recognized over the term of the lease.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under these arrangements, when the Company acts as the lessor for its product line, the Company accounted for the lease arrangements as operating leases in accordance with ASC 842, &#x201c;Lease&#x201d; (&#x201c;ASC 842&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The total rental revenue for the AlterG Anti-Gravity Products has amounted to $249 thousand from the time of acquisition through December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;y. &lt;span style="padding-left:20pt"&gt;&#160;&lt;/span&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recently Implemented Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="width:13.57%;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&#160; &#160; &#160; &#160; &#160; &#160;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The Company adopted ASU 2016-13 as of January 1, 2023. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:10%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:6%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:84%;vertical-align:top"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09, &#x201c;Income Taxes - Improvements to Income Tax Disclosures&#x201d; requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impact of the adoption of this standard.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:10%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:6%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:84%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In&#160;November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, &#x201c;Segment Reporting&#x201d; on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

      &lt;/div&gt;
    </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="C_20230101to20231231" id="FFact_0000000000378">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of Estimates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions. The Company&#x2019;s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company&#x2019;s management evaluates estimates, including those related to inventories, fair values of share-based awards, contingent liabilities, provision for warranty, allowance for credit losses and sales return reserve. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000379">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial Statements in U.S. Dollars:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The functional currency is the currency that best reflects the economic environment in which the Company and its subsidiaries operate and conduct their transactions. Most of the Company&#x2019;s revenues and costs are incurred in U.S. dollar. In addition, the Company&#x2019;s financing activities are incurred in U.S. dollars. The Company&#x2019;s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company&#x2019;s and its subsidiary's functional and reporting currency.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with ASC 830 &#x201c;Foreign Currency Matters.&#x201d; All transaction gains and losses of the remeasured monetary balance sheet items are reflected in the consolidated statements of operations as financing income or expenses as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000380">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principles of Consolidation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances have been eliminated upon consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000381">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash Equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000385">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Inventories are stated at the lower of cost or net realizable value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company periodically evaluates the quantities on hand relative to historical, current, and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its net realized value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost is determined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished products - based on raw materials and manufacturing costs on an average basis.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:18pt;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials - The weighted average cost method.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value. If actual demand for the Company&#x2019;s products deteriorates, or market conditions are less favourable than those projected, additional inventory reserves may be required.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230213124352469">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and Equipment:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20-33 (mainly 33)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6 - 10 (mainly 10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Machinery and laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Field service units&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20-50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over the shorter of the lease term &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;or estimated useful life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214132735237">
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;border-bottom:#000000 2px solid"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20-33 (mainly 33)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6 - 10 (mainly 10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Machinery and laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Field service units&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20-50&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:65.04%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:34.96%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Over the shorter of the lease term &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;or estimated useful life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      id="FFact_0000000000390">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      id="FFact_0000000000391">P33Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      id="Fxbrl_20231216125503382">P6Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      id="FFact_0000000000393">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember"
      id="FFact_0000000000394">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"
      id="Fxbrl_20240224235531218">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"
      id="FFact_0000000000395">P50Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <lfwd:PropertyPlantAndEquipmentUsefulLifeDescription
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240225015948429">Over the shorter of the lease term </lfwd:PropertyPlantAndEquipmentUsefulLifeDescription>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224171937266">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Business Combinations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for business combinations in accordance with ASC 805, &#x201c;Business Combinations&#x201d; (&#x201c;ASC 805&#x201d;). For business combinations accounted for under the acquisition method, ASC 805 requires recognition of assets acquired, liabilities assumed, and any non-controlling interest at the acquisition date, measured at their fair values as of that date. The Company determines the recognition of intangible assets based on the following criteria: (i) the intangible asset arises from contractual or other rights; or (ii) the intangible asset is separable or divisible from the acquired entity and capable of being sold, transferred, licensed, returned or exchanged.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The excess of the fair value of the purchase price over the fair values of the identifiable assets and liabilities is recorded as goodwill. Determining the fair value of the identifiable assets and liabilities requires management to use significant judgment and estimates including the forecasted revenue and revenues growth rates, discount rates, customer contract renewal rates and customer attrition rates. The process of estimating the fair values requires significant estimates, especially with respect to intangible assets. Management&#x2019;s determination of fair value of assets acquired and liabilities assumed at the acquisition date is based on the best information available in the circumstances and incorporates management&#x2019;s own assumptions and involves a significant degree of judgment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition related costs include legal fees, consulting and success fees, and other non-recurring integration related costs. Acquisition-related costs are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224172000970">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill and Other Intangibles&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For business combinations, the purchase prices are allocated to the tangible assets and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has no indefinite-lived intangible assets other than goodwill. Acquired identifiable finite-lived intangible assets include identifiable acquired technology, customer relationships, trademarks and backlog and are amortized on a straight-line basis over the estimated useful lives of the assets. The Company routinely reviews the remaining estimated useful lives of finite-lived intangible assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Goodwill is not amortized and is tested for impairment at least annually.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates as one reporting unit and the fair value of the reporting unit is estimated using quoted market prices of the Company&#x2019;s stock in active markets. The Company tests goodwill for impairment annually in the fourth quarter and whenever events or changes in circumstances indicate the carrying amount of goodwill may not be recoverable.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;When testing goodwill for impairment, the Company may first perform a qualitative assessment. If the Company determines it is not more likely than not the reporting unit&#x2019;s fair value is less than its carrying value, then no further analysis is necessary. If the Company determines that it is more likely than not that the fair value of its reporting unit is less than its carrying amount, then the quantitative impairment test will be performed. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Under the quantitative impairment test, if the carrying amount of the Company&#x2019;s reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;text-indent:0pt;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, no impairments of goodwill have been recognized.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000402">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s long-lived assets, including right-of-use (&#x201c;ROU&#x201d;) assets and identifiable intangible assets that are subject to amortization, are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d; whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2023, 2022 and 2021, no impairment losses have been recorded.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <lfwd:RestrictedCashAndOtherLongTermAssets contextRef="C_20230101to20231231" id="FFact_0000000000403">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;j.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restricted cash and Other long-term assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other long-term assets include long-term prepaid expenses and restricted cash deposits for offices and cars leasing based upon the term of the remaining restrictions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </lfwd:RestrictedCashAndOtherLongTermAssets>
    <lfwd:TreasurySharesPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230213114516865">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;k.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company repurchased its ordinary shares and holds them as treasury shares. The Company presents the cost to repurchase treasury shares as a reduction of shareholders' equity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </lfwd:TreasurySharesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240226182957243">
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;l.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue Recognition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generates revenues from sales of products. The Company sells its products directly to end customers and through distributors. The Company sells its products to clinics and rehabilitation centres, professional and college sports teams, private individuals (who finance the purchases by themselves, through fundraising or reimbursement coverage from insurance companies), and distributors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes revenue in accordance with ASC 606, &#x201c;Revenue Recognition&#x201d; when, or as, control of the promised good or service is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company applies the following five steps:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the contract with a customer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generally considers a purchase order or a signed quote to be a contract with a customer. In evaluating the contract with a customer, the Company analyzes the customer&#x2019;s intent and ability to pay the amount of promised consideration (credit risk) and considers the probability of collecting substantially all of the consideration.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At a contract&#x2019;s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determine the transaction price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring products or services to the customer.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company does not offer extended payment terms beyond one year to customers.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Allocate the transaction price to performance obligations in the contract&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recognize revenue when or as the Company satisfies a performance obligation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control either transfers over time or at a point in time, which affects when revenue is recorded.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has elected to apply the practical expedient for financing component for transactions in which the difference between the payment date and the revenue recognition timing is up to 12 months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Disaggregation of Revenue (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:36pt"&gt;

                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,175&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service and warranty&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue from Products is comprised of sale of Anti-Gravity products, sale of systems products to rehabilitation facilities and sale of ReWalk Personal Exoskeleton systems to end users. Revenues generated from the sale of Products are recognized at a point in time, once the customer has obtained the legal title to the items purchased.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For systems sold to rehabilitation facilities, the Company includes insignificant training and considers the elements in the arrangement to be a single performance obligation. Therefore, the Company recognizes revenue for the system only when control is transferred after delivery and when the training has been completed, in accordance with the agreements terms with the customer.&lt;/span&gt;&lt;/span&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;
                  &lt;div&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For sales of ReWalk Personal Exoskeleton systems to end users, and for sales of ReWalk Personal or ReWalk Rehabilitation Exoskeleton systems to third party distributors, the Company does not provide training to the end user as this training is completed by the rehabilitation center or by the distributor that have previously completed the ReWalk Training program. Therefore, the Company recognizes revenue in such sales upon delivery.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="text-align:justify;margin-left:33.55pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company generally does not grant a right of return for its products. In rare circumstances when the Company provides a right of return for its products. the Company records reductions to revenue for expected future product returns based on the Company&#x2019;s historical experience and estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During 2023, the Company offered six products: (1) ReWalk Personal Exoskeletons, (2) ReWalk Rehabilitation Exoskeleton, (3) ReStore, (4) AlterG Anti-Gravity systems, (5) MyoCycle and (6) MediTouch. Due to unsatisfactory sales performance of the MediTouch product lines, the Company terminated this agreement as of January 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental revenue&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental revenue for the AlterG Anti-Gravity systems is accounted for under ASC Topic 842, Leases. The Company rents its products to customers for a fixed monthly fee over the rental term, which typically ranges from 2 to 3 years. Rental revenues are recorded as earned on a monthly basis. See Note 2x for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the SCI Products, the Company also offers a rent-to-purchase model in which the Company recognizes revenue ratably according to the agreed rental monthly fee for a limited period prior to selling its products.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service and warranties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company services its products after expiration of the initial warranty. Service revenue, consisting of time and materials to perform the repairs, is recorded as services are rendered.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Determining the transaction price requires of level judgment, which is discussed by revenue category in further detail below.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranties are classified as either an assurance type or a service type warranty. A warranty is considered an assurance type warranty if it provides the customer with assurance that the product will function as intended for a limited period of time. An assurance type warranty is not accounted for as a separate performance obligation under the revenue model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;SCI Products include a &lt;span style="-sec-ix-hidden:Fxbrl_20230214112251731"&gt; five -year warranty&lt;/span&gt;. The first  two years are considered as an assurance type warranty and the additional period is considered an extended service arrangement, which is a service type warranty. A service type warranty is either sold with a unit or separately for a unit for which the warranty has expired. A service type warranty is accounted as a separate performance obligation and revenue is recognized ratably over the life of the warranty.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The ReStore device is sold with a two-year warranty which is considered as assurance type warranty.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Distributed Products are sold with assurance type warranty ranging between three years to ten years, depending on the specific product and part.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;F&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;or AlterG Anti-Gravity Products, the Company offers customers extended warranty contracts that extend or enhance the technical support, parts, and labor coverage offered as part of the base warranty included with the Anti-Gravity system products. Extended warranty revenue is recognized ratably over the extended warranty coverage period. The Company offers a one-year assurance type warranty to customers in the U.S. and two years assurance type warranty for spare parts only to its international distributors. For these products, the Company determines standalone selling price based on the price at which the performance obligation is sold separately.&lt;/span&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div&gt;&lt;/div&gt;
              &lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contract balances (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:36pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade receivable, net of credit losses (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenues (1) (2)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,010&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance presented net of unrecognized revenue that was not yet collected.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$435 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenue which represent a contract liability, include unearned amounts related to service type warranty obligations as well as other advances and payments which the Company received from customers prior to satisfying the performance obligation, for which revenue has not yet been recognized. The Company's unearned performance obligations as of December 31, 2023 and the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214132800531">
                  &lt;div&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Product&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,175&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,916&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,033&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;859&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;533&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Service and warranty&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;477&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                </us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtProductOrServiceAxis_usgaapProductMember"
      decimals="-3"
      id="Fxbrl_20240224175447534_Fact_0000000000410"
      unitRef="USD">10681000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtProductOrServiceAxis_usgaapProductMember"
      decimals="-3"
      id="Fxbrl_20240224175447534_Fact_0000000000411"
      unitRef="USD">4175000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtProductOrServiceAxis_usgaapProductMember"
      decimals="-3"
      id="Fxbrl_20240224175447534_Fact_0000000000412"
      unitRef="USD">4916000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_lfwdRevenueObligationAxis_lfwdRentalMember"
      decimals="-3"
      id="Fxbrl_20240224175449358_Fact_0000000000410"
      unitRef="USD">1033000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_lfwdRevenueObligationAxis_lfwdRentalMember"
      decimals="-3"
      id="Fxbrl_20240224175449358_Fact_0000000000411"
      unitRef="USD">859000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_lfwdRevenueObligationAxis_lfwdRentalMember"
      decimals="-3"
      id="Fxbrl_20240224175449358_Fact_0000000000412"
      unitRef="USD">533000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224175454398_Fact_0000000000410"
      unitRef="USD">2140000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224175454398_Fact_0000000000411"
      unitRef="USD">477000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtProductOrServiceAxis_lfwdServiceAndWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224175454398_Fact_0000000000412"
      unitRef="USD">517000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000410"
      unitRef="USD">13854000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000411"
      unitRef="USD">5511000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000412"
      unitRef="USD">5966000</us-gaap:Revenues>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_20231231_srtProductOrServiceAxis_lfwdReStoreProductMember"
      id="Fxbrl_20230213113636337">P2Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <lfwd:ScheduleOfContractBalancesTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214132841000">
                &lt;div&gt;
                  &lt;div style="margin-left:36pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:95%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Trade receivable, net of credit losses (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,120&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred revenues (1) (2)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,010&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance presented net of unrecognized revenue that was not yet collected.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                          &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$435 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </lfwd:ScheduleOfContractBalancesTableTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000416"
      unitRef="USD">3120000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000417"
      unitRef="USD">1036000</us-gaap:AccountsReceivableNet>
    <us-gaap:DeferredRevenue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000418"
      unitRef="USD">3010000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000419"
      unitRef="USD">1191000</us-gaap:DeferredRevenue>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213113701196"
      unitRef="USD">435000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <lfwd:RevenueRecognitionRecognized
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240225002529864">the estimated revenue expected to be recognized in the future related to the service type warranty amounts to $3.1 million, which will be fulfilled over one to five years.</lfwd:RevenueRecognitionRecognized>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214154625382">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;m.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accounting for Share-Based Compensation:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for share-based compensation in accordance with ASC 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (&#x201c;OPM&#x201d;). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company account for forfeitures as they occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its share-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary share, expected share price volatility and the expected option term. Expected volatility is calculated based on actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options, or based on certain peer companies that the Company considered to be comparable, in case there is no sufficient trading volume to rely on market volatility. The expected option term is determined based on the simplified method, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of Restricted Stock Units (&#x201c;RSUs&#x201d;) granted is determined based on the price of the Company&#x2019;s ordinary shares on the date of grant.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:18pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for options granted to consultants and other service providers under ASC 718. The fair value of these options was estimated using a Black-Scholes-Merton option-pricing model.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lfwd:ClassOfWarrantOrRightPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000436">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;n.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants to Acquire Ordinary Shares:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the twelve -month ended December 31, 2021, the Company issued warrants to acquire up to 15,083,611 ordinary shares. There were no issued warrants during the twelve months ended December 31, 2023 and 2022. The Company assessed the warrants pursuant to ASC 480 "Distinguishing Liabilities from Equity" and ASC 815 "Derivatives and Hedging" and determined that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 9f for additional information.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </lfwd:ClassOfWarrantOrRightPolicyTextBlock>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20240225001203400"
      unitRef="USD">15083611000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="C_20230101to20231231" id="FFact_0000000000437">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;o.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and Development Costs:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs are charged to the consolidated statement of operations as incurred and are presented net of the amount of any grants the Company received for research and development in the period in which the grant was received.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000439">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;p.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for income taxes in accordance with ASC 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;), using the liability method whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and the tax basis for assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amounts that are more likely-than-not to be realized.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ASC 740 contains a two-step approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits in its taxes on income. As of December 31, 2023, and 2022, the Company did not identify any significant uncertain tax positions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy contextRef="C_20230101to20231231" id="FFact_0000000000445">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;q.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warranty provision:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For assurance-type warranty, the Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company&#x2019;s warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US Dollars&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AlterG acquisition &#x2013; see note 5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:88%;padding-bottom:2px;vertical-align:baseline"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Usage&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:StandardProductWarrantyPolicy>
    <lfwd:ScheduleOfWarrantyProvisionTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214132919102">
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;US Dollars&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;in&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AlterG acquisition &#x2013; see note 5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;535&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:88%;padding-bottom:2px;vertical-align:baseline"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Usage&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;348&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </lfwd:ScheduleOfWarrantyProvisionTableTextBlock>
    <lfwd:WarrantyProvisionBalance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000440"
      unitRef="USD">92000</lfwd:WarrantyProvisionBalance>
    <lfwd:BusinessCombinationRecognizedWarrantProvision
      contextRef="C_20230101to20230930"
      decimals="-3"
      id="Fxbrl_20240224181155550_xbrl_20231114052336091"
      unitRef="USD">535000</lfwd:BusinessCombinationRecognizedWarrantProvision>
    <lfwd:AmountOfWarrantProvision
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000441"
      unitRef="USD">200000</lfwd:AmountOfWarrantProvision>
    <lfwd:AmountOfWarrantProvisionUsage
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000442"
      unitRef="USD">-479000</lfwd:AmountOfWarrantProvisionUsage>
    <lfwd:WarrantyProvisionBalance
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000443"
      unitRef="USD">348000</lfwd:WarrantyProvisionBalance>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_20230101to20231231" id="FFact_0000000000471">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;r.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concentrations of Credit Risks:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade receivables.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s cash and cash equivalents are deposited in major banks in Israel, the United States and Germany. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. The Company maintains cash and cash equivalents with diverse financial institutions and monitors the amount of credit exposure to each financial institution. The bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration exists with respect to these deposits.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The below table reflects the concentration of credit risk for the Company&#x2019;s current customers as of December 31, 2023, to which substantial sales were made.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Concentration of credit risk with respect to trade receivable is primarily limited to a customer to which the Company makes substantial sales.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="margin-left:36pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000000446"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000000448"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer C&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer D&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 10%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The allowance for credit losses is based on the Company's assessments of factors that may affect a customer's ability to pay. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current customer's aging balance, the nature and size of the customer, the financial condition of the customer, and the amount of any receivables in dispute. The Company does not have any off-balance sheet credit exposure related to its customers. As of December 31, 2023, and 2022 trade receivables are presented net of $328 thousand and $26 thousand allowance for credit losses, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214132947301">
              &lt;div&gt;
                &lt;div style="margin-left:36pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000000446"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000000448"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer C&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                          &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer D&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:54pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 10%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
            </us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      decimals="2"
      id="Fxbrl_20230213122412367"
      unitRef="pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      decimals="2"
      id="Fxbrl_20230213122431177"
      unitRef="pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      decimals="2"
      id="FFact_0000000000450"
      unitRef="pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerCMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      decimals="2"
      id="Fxbrl_20230213122445435"
      unitRef="pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      decimals="2"
      id="FFact_0000000000452"
      unitRef="pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerDMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapAccountsReceivableMember_usgaapConcentrationRiskByTypeAxis_usgaapCreditConcentrationRiskMember"
      decimals="2"
      id="Fxbrl_20230213122457908"
      unitRef="pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213123241844"
      unitRef="USD">328000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230213123248078"
      unitRef="USD">26000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="C_20230101to20231231" id="FFact_0000000000476">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;s.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrued Severance Pay:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to Israel&#x2019;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#x2019;s salary for each year of employment, or a portion thereof. All of the employees of the RRL elected to be included under section 14 of the Severance Pay Law, 1963 (&#x201c;section 14&#x201d;). According to this section, these employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with section 14 release the Company from any future severance payments (under the above Israeli Severance Pay Law) in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Company&#x2019;s expenses related to severance pay amounted to $114 thousand , $113 thousand and $104 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:PostemploymentBenefitPlansPolicy>
    <lfwd:SeverancePayMonthlyDepositByEmployeesPercentage
      contextRef="C_20230101to20231231"
      decimals="4"
      id="FFact_0000000000472"
      unitRef="pure">0.0833</lfwd:SeverancePayMonthlyDepositByEmployeesPercentage>
    <us-gaap:PostemploymentBenefitsPeriodExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213123343796"
      unitRef="USD">114000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:PostemploymentBenefitsPeriodExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213123352196"
      unitRef="USD">113000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:PostemploymentBenefitsPeriodExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213123357469"
      unitRef="USD">104000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000477">
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;t.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company uses a three -tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The three -tiers are defined as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x25aa;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 1. &lt;/span&gt;Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x25aa;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 2. &lt;/span&gt;Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x25aa;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 3. &lt;/span&gt;Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The carrying amounts of cash and cash equivalents, short term deposits, trade receivables and trade payables approximate their fair value due to the short-term maturity of such instruments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities that are measured in fair value on a recurring basis as of December 31, 2023 and December 31, 2022 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Description&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value Hierarchy&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds included in cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury bills included in cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Assets Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Financial Liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Earnout&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;
              &lt;div&gt;&lt;/div&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company classifies cash equivalents within Level 1, because the Company uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair values.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The earnout was valued using a Monte Carlo simulation analysis, which is considered to be a Level 3 fair value measurement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:38.25pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes the earnout liability activity as of December 31, 2023 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;

                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Earnout&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial Measurement (August 11, 2023)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20231114040807672">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:middle;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Description&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:bottom;width:25%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair Value Hierarchy&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Financial assets:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:middle;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds included in cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;background-color:rgb(204, 238, 255);width:25%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,550&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Treasury bills included in cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;$&lt;/span&gt;&lt;/p&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total Assets Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,075&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="text-decoration:underline"&gt;Financial Liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Earnout&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:middle;width:2%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:middle;width:25%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
            </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20230930_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208242_xbrl_20231114040301156"
      unitRef="USD">2550000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByAssetClassAxis_usgaapMoneyMarketFundsMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208242_xbrl_20231114040321655"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20230930_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208246_xbrl_20231114040337583"
      unitRef="USD">2525000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByAssetClassAxis_usgaapUSTreasuryAndGovernmentMember_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208246_xbrl_20231114040352540"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20230930_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208251_xbrl_20231114163536004"
      unitRef="USD">5075000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208251_xbrl_20231114163644690"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_20230930_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208254_xbrl_20231114040456623_xbrl_20231114040301156"
      unitRef="USD">3292000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel3Member_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208254_xbrl_20231114040456623_xbrl_20231114040321655"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208257_xbrl_20231114040551803_xbrl_20231114040456623_xbrl_20231114040301156"
      unitRef="USD">3292000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20240224181208257_xbrl_20231114040551803_xbrl_20231114040456623_xbrl_20231114040321655"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <lfwd:ScheduleOfWarrantsLiabilityActivityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20231114043103809">
                &lt;div&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="width:11.39%;vertical-align:top;border-bottom:#000000 2px solid"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Earnout&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Initial Measurement (August 11, 2023)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Change in fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(315)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="width:85.4%;vertical-align:top;background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.34%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:10.05%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="width:1.06%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:1.08%;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </lfwd:ScheduleOfWarrantsLiabilityActivityTableTextBlock>
    <lfwd:WarrantsLiabilityActivity
      contextRef="C_20230811_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember"
      decimals="-3"
      id="Fxbrl_20240224181228922_xbrl_20231114042729572"
      unitRef="USD">3607000</lfwd:WarrantsLiabilityActivity>
    <lfwd:ChangeInFairValueOfWarrantsLiabilityActivity
      contextRef="C_20230812to20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember"
      decimals="-3"
      id="Fxbrl_20240224181228923_xbrl_20231114042843938"
      unitRef="USD">315000</lfwd:ChangeInFairValueOfWarrantsLiabilityActivity>
    <lfwd:WarrantsLiabilityActivity
      contextRef="C_20230930_usgaapFairValueByLiabilityClassAxis_lfwdEarnoutMember"
      decimals="-3"
      id="Fxbrl_20240224181234367_xbrl_20231114042759943"
      unitRef="USD">3292000</lfwd:WarrantsLiabilityActivity>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000491">
            &lt;div&gt;
              &lt;div style="text-align:justify;margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;u.&lt;span style="padding-left:7pt"&gt;&#160;&lt;/span&gt;Basic and Diluted Net Loss Per Share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of ordinary shares outstanding during the period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Diluted loss per share is computed based on the weighted average number of ordinary shares outstanding during the period, plus dilutive potential shares considered outstanding during the period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000492">
          &lt;div&gt;
            &lt;div style="margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;v.&lt;span style="padding-left:8pt"&gt;&#160;&lt;/span&gt;Contingent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for its contingent liabilities in accordance with ASC 450, &#x201c;Contingencies.&#x201d; A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <lfwd:GovernmentGrantsPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000499">
          &lt;div&gt;
            &lt;div style="margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;w.&lt;span style="padding-left:8pt"&gt;&#160;&lt;/span&gt;Government grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalty and non-royalty-bearing grants from the Israeli Innovation Authority (the &#x201c;IIA&#x201d;) of the Ministry of Economy and Industry in Israel for funding of approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred, and are presented as a reduction from research and development expenses (see Note 8c).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </lfwd:GovernmentGrantsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000500">
          &lt;div&gt;
            &lt;div style="margin-left:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;x.&lt;span style="padding-left:8pt"&gt;&#160;&lt;/span&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating lease liabilities and their corresponding right-of-use assets are recorded at commencement date based on the present value of lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items, such as initial direct costs paid or incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases with an initial term of 12 months or less are not recorded on the balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lessor accounting - Operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A portion of the AlterG rental revenues for the AlterG Anti-Gravity systems are made through lease arrangements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AlterG products are available for lease agreements ranging from 12 to 42 months. If the customer terminates the contract during the lease period, they are required to pay a cancellation fee. The lease period may be extended by an additional period as specified in the contract.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In determining the leases classification as a sales type or operating lease, the Company assesses, among other criteria: (i) the lease term to determine if it is for the major part of the economic life of the underlying equipment; and (ii) the present value of the lease payments to determine if they are equal to or greater than substantially all of the fair market value of the equipment at the inception of the lease AlterG Anti-Gravity systems. When these criteria are not met, the lease accounted for as operating leases and revenues are recognized over the term of the lease.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under these arrangements, when the Company acts as the lessor for its product line, the Company accounted for the lease arrangements as operating leases in accordance with ASC 842, &#x201c;Lease&#x201d; (&#x201c;ASC 842&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The total rental revenue for the AlterG Anti-Gravity Products has amounted to $249 thousand from the time of acquisition through December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:LesseeLeasesPolicyTextBlock>
    <lfwd:LeaseAgreementsTerm
      contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember"
      id="Fxbrl_20240225003637472">P12Y</lfwd:LeaseAgreementsTerm>
    <lfwd:LeaseAgreementsTerm
      contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember"
      id="Fxbrl_20240225003648971">P42Y</lfwd:LeaseAgreementsTerm>
    <lfwd:RentalRevenueForAntiGravityProducts
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240225000541381"
      unitRef="USD">249000</lfwd:RentalRevenueForAntiGravityProducts>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230214154904726">
          &lt;div&gt;
            &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;y. &lt;span style="padding-left:20pt"&gt;&#160;&lt;/span&gt;New Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recently Implemented Accounting Pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td rowspan="1" style="width:13.57%;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                      &lt;div style="line-height:1.25;font-family:'Times New Roman', Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&#160; &#160; &#160; &#160; &#160; &#160;Financial Instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In June 2016, FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The Company adopted ASU 2016-13 as of January 1, 2023. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:10%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:6%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:84%;vertical-align:top"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In December 2023, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09, &#x201c;Income Taxes - Improvements to Income Tax Disclosures&#x201d; requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impact of the adoption of this standard.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:10%;vertical-align:top"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:6%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:84%;vertical-align:top"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In&#160;November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments&#x2019; significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280, &#x201c;Segment Reporting&#x201d; on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20230220102403022">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:top;font-weight:bold;width:67pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NOTE 3:-&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                          &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;PREPAID EXPENSES AND OTHER CURRENT ASSETS&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The components of prepaid expenses and other current assets are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:36pt"&gt;

                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,227&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advances to vendors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;747&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;649&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;

                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </lfwd:PrepaidExpenseAndOtherAssetsDisclosureTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223112912519">
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,227&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;242&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Advances to vendors&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;747&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;152&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,366&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;649&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  </us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000503"
      unitRef="USD">253000</lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent>
    <lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000504"
      unitRef="USD">81000</lfwd:PrepaidExpensesToGovernmentInstitutionsCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000505"
      unitRef="USD">1227000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000506"
      unitRef="USD">242000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Supplies
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000507"
      unitRef="USD">139000</us-gaap:Supplies>
    <us-gaap:Supplies
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000508"
      unitRef="USD">174000</us-gaap:Supplies>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000509"
      unitRef="USD">747000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000510"
      unitRef="USD">152000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000511"
      unitRef="USD">2366000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000512"
      unitRef="USD">649000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000522">
    &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

        &lt;tr&gt;
          &lt;td style="vertical-align:top;font-weight:bold;width:67pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NOTE 4:-&lt;/span&gt;&lt;/td&gt;
          &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;INVENTORIES&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The components of inventories are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,421&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,496&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,653&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,929&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the twelve months ended December 31, 2023, 2022, and 2021, the Company recognized, at cost of revenues, reserves for excess and obsolete in the amount of $398 thousand, $502 thousand, and $252 thousand, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223113120447">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:93%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Finished products&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,421&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Raw materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,496&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,653&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,929&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000515"
      unitRef="USD">3157000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000516"
      unitRef="USD">2421000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000517"
      unitRef="USD">2496000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000518"
      unitRef="USD">508000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000519"
      unitRef="USD">5653000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000520"
      unitRef="USD">2929000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230221162309076"
      unitRef="USD">398000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230221162316072"
      unitRef="USD">502000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230221162319494"
      unitRef="USD">252000</us-gaap:InventoryWriteDown>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224182510607">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;NOTE 5:-&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:20pt"&gt;&#160;&lt;/span&gt;&lt;span&gt;&lt;span&gt;BUSINESS COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On August 11, 2023, pursuant to an Agreement and Plan of Merger among RRI, AlterG, Merger Sub, and Shareholder Representative Services LLC, RRI, August 8, 2023, the Company acquired AlterG and AlterG became a wholly owned subsidiary of the Company. AlterG develops, manufactures, and markets Anti-Gravity systems for use in physical and neurological rehabilitation and athletic training, both in the United States and internationally. The aggregate purchase price was a total of $19.0 million in cash, subject to working capital and other customary purchase price adjustments. Additional cash earnouts may be paid based upon a percentage of AlterG&#x2019;s year-over-year future revenue growth over the next two years subject to working capital and other customary purchase price adjustments.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:36pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The total consideration transferred is as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;18,493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Earnout payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,607&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total consideration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;22,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-indent:-42.55pt;margin-left:81.8pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Earnout payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company will pay an amount of cash equal to 65% of the amount, if any, by which &lt;span&gt;AlterG revenue attributable to the first 12 months period exceeds revenue target ("first earnout payment"), and an amount in cash equal to 65% of the amount, if any, by which AlterG revenue attributable to the following 12 months period exceeds the revenue from the first 12 month period ("second earnout payment").&lt;/span&gt; At the date of acquisition, management estimated fair value of the earnout payment based on the actual up to date performance of the acquired entity and the probability of the earn out payment occurrence to be at approximately $3.6 million. The Earn-out was accounted for as a liability and will be remeasured at each reporting period through the consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-indent:0.05pt;margin-right:9.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company has accounted for the AlterG acquisition as a business combination. The Company has preliminarily allocated the purchase price of approximately $22.1 million fair values, and the excess of the purchase price over the aggregate fair values is recorded as goodwill.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The following table summarizes the preliminary fair value of assets acquired and liabilities assumed as of the acquisition date (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;478&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Restricted cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,773&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,330&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;470&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Right of use asset&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,151&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;827&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;14,133&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accounts payable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,082&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accrued compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(766&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,059&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,088&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warranty Obligations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(535&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:88%;padding-bottom:2px;vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Leases Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,151&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total purchase consideration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;22,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;div&gt;
        &lt;div style="margin-left:36.05pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The following table presents the details of the intangible assets acquired at the date of AlterG acquisition (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;

        &lt;div&gt;
          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:36pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Estimated&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Estimated Useful Life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(Years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trademark&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;795&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6,161&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Warranty&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Rental&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Distribution&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4,578&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Backlog&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;text-indent:0.05pt;margin-right:6.25pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Under the preliminary purchase price allocation, the Company allocates the purchase price to tangible and identified intangible assets acquired and liabilities assumed based on the preliminary estimates of their fair values. The fair values for the intangible assets acquired were primarily based on significant inputs that are not observable in the market and thus represent a Level 3 measurement in the fair value hierarchy. Customer relationships, distributor relationships, backlog, trademark and developed technology were valued using the income approach, based on estimated projections of expected cash flows to be generated by the assets, discounted to the present value at discount rates commensurate with perceived risk. The discounted cash flow analyses factor in assumptions on revenue and expense growth rates including estimates of customer growth and attrition rates, distributor growth and attrition rates, technology obsolescence, and relief from royalty projections. Additionally, these discounted cash flow analyses factor in expected amounts of working capital, fixed assets, assembled workforce and cost of capital for each intangible asset. Such estimates are subject to change during the measurement period which is not expected to exceed one year. Any adjustments to the preliminary purchase price allocation identified during the measurement period will be recognized in the period in which the adjustments are determined.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:38pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company incurred acquisition-related costs of $2.5 million included in General and administrative costs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The table below presents the pro forma revenue and earnings of the combined business as if the acquisition had occurred as of January 1, 2022 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:38.7pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
      &lt;div style="margin-left:36pt"&gt;

          &lt;div&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Twelve Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;24,923&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;25,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(21,761&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(28,369&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

      &lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;text-indent:0.05pt;margin-right:6.4pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The total revenues and net loss of AlterG, included in the consolidated income statement, since the acquisition date through December 31, 2023, amounted to 7,658 thousand and 249 thousand, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The pro forma financial information for all periods presented above has been calculated after adjusting the results of AlterG to reflect the business combinations accounting effects resulting from these acquisitions.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;text-indent:0.05pt;margin-right:6.3pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;These proforma results reflect additional depreciation and amortization that would have been charged assuming the fair value adjustments to property, plant, and equipment and intangible asset occurred at the beginning of the period, along with consequential tax effects. The unaudited pro forma results have been prepared for comparative purposes only and are not necessarily indicative of what would have occurred had the business combinations been completed on January 1, 2022, nor it is necessarily indicative of future results of operations of the combined company. Furthermore, the unaudited pro forma financial information does not reflect the impact of any synergies resulting from the acquisition.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-5"
      id="Fxbrl_20240226144531129"
      unitRef="USD">19000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224182601790">
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;18,493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Earnout payments&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,607&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total consideration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;22,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-3"
      id="Fxbrl_20240224182938993"
      unitRef="USD">18493000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="C_20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-3"
      id="Fxbrl_20240224182949929"
      unitRef="USD">3607000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-3"
      id="Fxbrl_20240224182954721"
      unitRef="USD">22100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription
      contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      id="Fxbrl_20240224184906775">The Company will pay an amount of cash equal to 65% of the amount, if any, by which </us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDescription>
    <lfwd:EarnOutPaymentOfBusinessCombination
      contextRef="C_20230801to20230808"
      decimals="-5"
      id="Fxbrl_20240224184726640"
      unitRef="USD">3600000</lfwd:EarnOutPaymentOfBusinessCombination>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-5"
      id="Fxbrl_20240224184749536"
      unitRef="USD">22100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224182628575">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Cash and cash equivalent&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;478&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Restricted cash&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;51&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,773&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Inventory&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3,330&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;470&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Right of use asset&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1,151&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;827&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other non-current assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;7,538&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;14,133&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accounts payable&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,082&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Accrued compensation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(766&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Other accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,059&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Deferred revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2,088&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Warranty Obligations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(535&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:88%;padding-bottom:2px;vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Leases Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(1,151&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total purchase consideration&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;22,100&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183401530"
      unitRef="USD">478000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183520314"
      unitRef="USD">51000</lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183549200"
      unitRef="USD">1773000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183553870"
      unitRef="USD">3330000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183558886"
      unitRef="USD">470000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183604087"
      unitRef="USD">1151000</lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183611030"
      unitRef="USD">827000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183615694"
      unitRef="USD">30000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:Goodwill
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183624054"
      unitRef="USD">7538000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183632919"
      unitRef="USD">14133000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183638183"
      unitRef="USD">2082000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183642568"
      unitRef="USD">766000</lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensation>
    <lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183647143"
      unitRef="USD">1059000</lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAccruedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183651750"
      unitRef="USD">2088000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183656215"
      unitRef="USD">535000</lfwd:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantyObligations>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183701927"
      unitRef="USD">1151000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224183709142"
      unitRef="USD">22100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224182743126">
        &lt;div&gt;
          &lt;div&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:36pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Estimated&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Estimated Useful Life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(Years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Trademark&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;795&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;6,161&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Warranty&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Rental&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2,102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Distribution&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;4,578&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Backlog&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"
      decimals="-3"
      id="Fxbrl_20240224183951623"
      unitRef="USD">795000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"
      id="Fxbrl_20240224184112372">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20240224184211659_xbrl_20240224183951623"
      unitRef="USD">6161000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"
      id="Fxbrl_20240224184211659_xbrl_20240224184112372">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224184214674_xbrl_20240224183951623"
      unitRef="USD">201000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"
      id="Fxbrl_20240224184214674_xbrl_20240224184112372">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"
      decimals="-3"
      id="Fxbrl_20240224184216962_xbrl_20240224183951623"
      unitRef="USD">2102000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"
      id="Fxbrl_20240224184216962_xbrl_20240224184112372">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember"
      decimals="-3"
      id="Fxbrl_20240224184218882_xbrl_20240224183951623"
      unitRef="USD">4578000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipDistributionMember"
      id="Fxbrl_20240224184218882_xbrl_20240224184112372">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember"
      decimals="-3"
      id="Fxbrl_20240224184220747_xbrl_20240224183951623"
      unitRef="USD">296000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapOrderOrProductionBacklogMember"
      id="Fxbrl_20240224184220747_xbrl_20240224184112372">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20240224184933783"
      unitRef="USD">2500000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224182826627">
          &lt;div&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td rowspan="1" style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Twelve Months Ended&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;background-color:#CCEEFF;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;24,923&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;25,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:middle;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(21,761&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(28,369&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:BusinessAcquisitionProFormaInformationNonrecurringAdjustmentsTableTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224184418399"
      unitRef="USD">24923000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240224184425935"
      unitRef="USD">25307000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224184435045"
      unitRef="USD">-21761000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240224184446635"
      unitRef="USD">-28369000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:Revenues
      contextRef="C_20230801to20230808_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-3"
      id="Fxbrl_20240224185017577"
      unitRef="USD">7658000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-3"
      id="Fxbrl_20240224185042803"
      unitRef="USD">249000</us-gaap:Revenues>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224175948099">
    &lt;div&gt;
      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;NOTE 6:-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:20pt"&gt;&#160;&lt;/span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:0.05pt;margin-left:38.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company has $7.5 million of goodwill related to its purchase of AlterG in the third quarter of fiscal year 2023, which has an indefinite life, and is not deductible for tax purposes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="margin-left:38pt;line-height:1.25;font-family:Times New Roman, Times, serif;margin-bottom:0pt;margin-top:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;As of December 31, 2023, the components of, and changes in, the carrying amount of intangible assets, net, were as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="margin-left:36pt"&gt;

          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:14pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31, 2023 Accumulated&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:6pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible Assets, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trademark&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;795&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;691&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,161&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(604&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,557&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Warranty&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;161&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Rental&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(206&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,896&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Distribution&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,578&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(358&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,220&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:64%;padding-bottom:2px;vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Backlog&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Amortized Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,133&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,608&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

        &lt;p style="margin:0pt;font-size:10pt"&gt;&#160;&lt;/p&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The estimated amortization expense is shown below (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,347&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,172&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2028&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;556&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;

      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="C_20230101to20230930_usgaapBusinessAcquisitionAxis_lfwdAltergIncMember"
      decimals="-2"
      id="Fxbrl_20240224175327663"
      unitRef="USD">7500</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224180124162">
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:14pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Cost&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;December 31, 2023 Accumulated&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Amortization&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:center;vertical-align:bottom;padding-bottom:2px;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;padding-bottom:2px"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:6pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Intangible Assets, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Trademark&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;795&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(104&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;691&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Technology&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;6,161&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(604&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;5,557&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Warranty&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(40&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;161&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Rental&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,102&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(206&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;1,896&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Customer relationship - Distribution&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,578&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(358&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;4,220&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:64%;padding-bottom:2px;vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Backlog&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(296&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;background-color:#CCEEFF;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total Amortized Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;14,133&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;(1,608&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        </us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"
      decimals="-3"
      id="Fxbrl_20240224175314110_xbrl_20231110042331576_23"
      unitRef="USD">795000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"
      decimals="-3"
      id="Fxbrl_20240224175314110_xbrl_20231110042331576_27"
      unitRef="USD">104000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTrademarksMember"
      decimals="-3"
      id="Fxbrl_20240224175314110_xbrl_20231110101228212"
      unitRef="USD">691000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20240224175314113_xbrl_20231110042331576_33"
      unitRef="USD">6161000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20240224175314113_xbrl_20231110042331576_37"
      unitRef="USD">604000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapTechnologyBasedIntangibleAssetsMember"
      decimals="-3"
      id="Fxbrl_20240224175314113_xbrl_20231110101206388"
      unitRef="USD">5557000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224175314117_xbrl_20231110042331576_43"
      unitRef="USD">201000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224175314117_xbrl_20231110042331576_47"
      unitRef="USD">40000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipWarrantyMember"
      decimals="-3"
      id="Fxbrl_20240224175314117_xbrl_20231110042331576_411"
      unitRef="USD">161000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"
      decimals="-3"
      id="Fxbrl_20240224175314120_xbrl_20231110042331576_53"
      unitRef="USD">2102000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"
      decimals="-3"
      id="Fxbrl_20240224175314120_xbrl_20231110042331576_57"
      unitRef="USD">206000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdCustomerRelationshipRentalMember"
      decimals="-3"
      id="Fxbrl_20240224175314120_xbrl_20231110042331576_511"
      unitRef="USD">1896000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20240224175314124_xbrl_20231110042331576_63"
      unitRef="USD">4578000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20240224175314124_xbrl_20231110042331576_67"
      unitRef="USD">358000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_usgaapCustomerRelationshipsMember"
      decimals="-3"
      id="Fxbrl_20240224175314124_xbrl_20231110042331576_611"
      unitRef="USD">4220000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember"
      decimals="-3"
      id="Fxbrl_20240224175314128_xbrl_20231110042331576_73"
      unitRef="USD">296000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember"
      decimals="-3"
      id="Fxbrl_20240224175314128_xbrl_20231110042331576_77"
      unitRef="USD">296000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231_usgaapFiniteLivedIntangibleAssetsByMajorClassAxis_lfwdBacklogMember"
      decimals="-3"
      id="Fxbrl_20240224175314128_xbrl_20231110042331576_711"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224175314131_xbrl_20231110042331576_83"
      unitRef="USD">14133000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224175314131_xbrl_20231110042331576_87"
      unitRef="USD">1608000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175314131_xbrl_20231110042331576_811"
      unitRef="USD">12525000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224180213353">
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2024&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,347&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,307&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2026&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;3,143&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2027&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;2,172&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Fiscal 2028&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;556&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:top;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;12,525&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        </us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175320961_xbrl_20231110042304382_23"
      unitRef="USD">3347000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175320962_xbrl_20231110042304382_33"
      unitRef="USD">3307000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175320964_xbrl_20231110042304382_43"
      unitRef="USD">3143000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175320965_xbrl_20231110042304382_53"
      unitRef="USD">2172000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175320967_xbrl_20231110042304382_63"
      unitRef="USD">556000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240224175320969_xbrl_20231110042304382_73"
      unitRef="USD">12525000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000543">
    &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

        &lt;tr&gt;
          &lt;td style="vertical-align:top;font-weight:bold;width:67pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NOTE 7:-&lt;/span&gt;&lt;/td&gt;
          &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The components of property and equipment, net are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,690&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;743&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;468&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;308&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Machinery and laboratory equipment &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Field service units &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,816&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,603&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,821&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,625&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment, net &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;196&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation expenses amounted to $239 thousand, $202 thousand, and $266 thousand for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223115425936">
          &lt;div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computer equipment &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,690&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;743&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;468&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;308&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Machinery and laboratory equipment &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;621&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Field service units &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,166&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,816&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leasehold improvements &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;333&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,603&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,821&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,341&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,625&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment, net &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;196&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="FFact_0000000000523"
      unitRef="USD">1690000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="FFact_0000000000524"
      unitRef="USD">743000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      decimals="-3"
      id="FFact_0000000000525"
      unitRef="USD">468000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapFurnitureAndFixturesMember"
      decimals="-3"
      id="FFact_0000000000526"
      unitRef="USD">308000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember"
      decimals="-3"
      id="FFact_0000000000527"
      unitRef="USD">621000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdMachineryAndLaboratoryEquipmentMember"
      decimals="-3"
      id="FFact_0000000000528"
      unitRef="USD">621000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"
      decimals="-3"
      id="FFact_0000000000529"
      unitRef="USD">4166000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_lfwdFieldServiceUnitsMember"
      decimals="-3"
      id="FFact_0000000000530"
      unitRef="USD">1816000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      decimals="-3"
      id="FFact_0000000000531"
      unitRef="USD">658000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdImprovementsMember"
      decimals="-3"
      id="FFact_0000000000532"
      unitRef="USD">333000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000533"
      unitRef="USD">7603000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000534"
      unitRef="USD">3821000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000535"
      unitRef="USD">6341000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000536"
      unitRef="USD">3625000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000537"
      unitRef="USD">1262000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000538"
      unitRef="USD">196000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000540"
      unitRef="USD">239000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000541"
      unitRef="USD">202000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000542"
      unitRef="USD">266000</us-gaap:Depreciation>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000592">
    &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

        &lt;tr&gt;
          &lt;td style="vertical-align:top;font-weight:bold;width:67pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NOTE 8:-&lt;/span&gt;&lt;/td&gt;
          &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;COMMITMENTS AND CONTINGENT LIABILITIES&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Purchase commitment:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has contractual obligations to purchase goods from its contract manufacturer as well as raw materials from different vendors. Purchase obligations do not include contracts that may be cancelled without penalty. As of December 31, 2023, non-cancellable outstanding obligations amounted to approximately $8.6 million.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating lease commitment:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company operates from leased facilities in Israel, the United States and Germany. These leases expire between 2024 and 2025. A portion of the Company&#x2019;s facilities leases is generally subject to annual changes in the Consumer Price Index (CPI). The changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(ii)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RRL and RRG lease cars for their employees under cancelable operating lease agreements expiring at various dates in between 2024 and 2026 A subset of the Company&#x2019;s cars leases is considered variable. The variable lease payments for such cars leases are based on actual mileage incurred at the stated contractual rate. RRL and RRG have an option to be released from these agreements, which may result in penalties in a maximum amount of approximately $30 thousand as of December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s future lease payments for its facilities and cars, which are presented as current maturities of operating leases and non-current operating leases liabilities on the Company&#x2019;s consolidated balance sheets as of December 31, 2023 are as follows (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: imputed interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(147&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Present value of future lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,903&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: current maturities of operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-average remaining lease term (in years) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease expenses for the years ended December 31, 2023, 2022 and 2021 were $976 thousand, $739 thousand, and $730 thousand, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s research and development efforts are financed, in part, through funding from the Israel Innovation Authority (&#x201c;IIA&#x201d;). Since the Company&#x2019;s inception through December 31, 2023, the Company received funding from the IIA in the total amount of $2.6 million. Out of the $2.6 million in funding from the IIA, a total amount of $1.6 million were royalty-bearing grants, $400 thousand was received in consideration of 209 convertible preferred A shares, which converted after the Company&#x2019;s initial public offering in September 2014 into ordinary shares in a conversion ratio of 1 to 1, while $&lt;span id="xbrl_20240224212733893"&gt;570&lt;/span&gt; thousand was received without future obligation. The Company is obligated to pay royalties to the IIA, amounting to 3% of the sales of the products and other related revenues generated from such projects, up to 100% of the grants received. The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the Company paid royalties to the IIA in the total amount of $110 thousand.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties expenses in cost of revenue were $17 thousand, $7 thousand and $14 thousand, for the years ended December 31, 2023, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the contingent liability to the IIA amounted to $1.6 million. The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the IIA. Such approval is not required for the sale or export of any products resulting from such research or development. The IIA, under special circumstances, may approve the transfer of IIA-funded know-how outside Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;dditionally, the License Agreement requires the Company to pay College (&#x201c;Harvard&#x201d;) royalties on net sales, see Note 10 below for more information about the Collaboration Agreement (as defined below) and the License Agreement (as defined below).&lt;/span&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liens&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As part of the Company&#x2019;s restricted cash and other long-term assets, as of December 31, 2023, an amount of $709 thousand has been pledged as security in respect of a guarantee granted to a third party. Such deposit cannot be pledged to others or withdrawn without the consent of such third party.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Legal Claims:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Occasionally, the Company is involved in various claims such as product liability claims, lawsuits, regulatory examinations, investigations, and other legal matters arising, for the most part, in the ordinary course of business. While the outcome of any pending or threatened litigation and other legal matters is inherently uncertain, the Company does not believe the outcome of any of the matters will have a material adverse effect on the Company&#x2019;s consolidated results of operation, liquidity or financial condition.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PurchaseObligation
      contextRef="C_20231231"
      decimals="-5"
      id="Fxbrl_20230213125818493"
      unitRef="USD">8600000</us-gaap:PurchaseObligation>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="C_20230101to20231231" id="FFact_0000000000563">These leases expire between 2024 and 2025.</us-gaap:LesseeOperatingLeaseDescription>
    <lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223120636180">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,363&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,050&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: imputed interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(147&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Present value of future lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,903&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less: current maturities of operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-current operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;607&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-average remaining lease term (in years) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:88%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </lfwd:ScheduleOfMinimumRoyaltyPaymentsTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000566"
      unitRef="USD">1363000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000567"
      unitRef="USD">674000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213125847323"
      unitRef="USD">13000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000568"
      unitRef="USD">2050000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <lfwd:ImputedInterest
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000569"
      unitRef="USD">-147000</lfwd:ImputedInterest>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000570"
      unitRef="USD">1903000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000571"
      unitRef="USD">1296000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000572"
      unitRef="USD">607000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_20231231" id="FFact_0000000000573">P1Y11M1D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_20231231"
      decimals="4"
      id="FFact_0000000000574"
      unitRef="pure">0.0921</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213125937048"
      unitRef="USD">976000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213125942584"
      unitRef="USD">739000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:OperatingLeaseLeaseIncomeLeasePayments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213125949313"
      unitRef="USD">730000</us-gaap:OperatingLeaseLeaseIncomeLeasePayments>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="-5"
      id="Fxbrl_20230214005355014"
      unitRef="USD">2600000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="-5"
      id="Fxbrl_20230213131612634"
      unitRef="USD">2600000</us-gaap:ProceedsFromRoyaltiesReceived>
    <lfwd:ResearchAndDevelopmentRoyaltyBearingGrants
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="-5"
      id="Fxbrl_20230213131623874"
      unitRef="USD">1600000</lfwd:ResearchAndDevelopmentRoyaltyBearingGrants>
    <lfwd:ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember"
      decimals="-3"
      id="Fxbrl_20230213131725050"
      unitRef="USD">400000</lfwd:ResearchAndDevelopmentAmountReceivedInConsiderationOfConvertiblePreferredShares>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember_usgaapStatementClassOfStockAxis_usgaapConvertiblePreferredStockMember"
      decimals="INF"
      id="Fxbrl_20230213131738827"
      unitRef="shares">209</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConversionOfStockDescription
      contextRef="C_20230101to20231231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      id="Fxbrl_20230213131752876">ordinary shares in a conversion ratio of 1 to 1</us-gaap:ConversionOfStockDescription>
    <lfwd:RoyaltyFeesPercentage
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="2"
      id="Fxbrl_20230213131801581"
      unitRef="pure">0.03</lfwd:RoyaltyFeesPercentage>
    <lfwd:PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="2"
      id="Fxbrl_20230213131809862"
      unitRef="pure">1</lfwd:PercentageOfGrantReceivedConsideredToDetermineRoyaltyFees>
    <us-gaap:RoyaltyExpense
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="-3"
      id="Fxbrl_20230213131932927"
      unitRef="USD">110000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213131823871"
      unitRef="USD">17000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213131830824"
      unitRef="USD">7000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213131836112"
      unitRef="USD">14000</us-gaap:RoyaltyExpense>
    <lfwd:ContingentLiabilityRelatedToGrantsReceived
      contextRef="C_20231231_deiLegalEntityAxis_lfwdIsraelInnovationAuthorityMember"
      decimals="-5"
      id="Fxbrl_20230213131846121"
      unitRef="USD">1600000</lfwd:ContingentLiabilityRelatedToGrantsReceived>
    <us-gaap:OtherLongTermDebt
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230213132046214"
      unitRef="USD">709000</us-gaap:OtherLongTermDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000866">
    &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

        &lt;tr&gt;
          &lt;td style="vertical-align:top;font-weight:bold;width:67pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;NOTE 9:-&lt;/span&gt;&lt;/td&gt;
          &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold"&gt;SHAREHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Equity raise:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Follow-on offerings&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 19, 2021, the Company entered into a purchase agreement with certain institutional and other accredited investors for the issuance and sale of 10,921,502 ordinary shares, par value NIS 0.25 per share at $3.6625 per ordinary share and warrants to purchase up to an aggregate of 5,460,751 ordinary shares with an exercise price of $3.6 per share, exercisable from February 19, 2021, until August 26, 2026. Additionally, the Company issued warrants to purchase up to 655,290 ordinary shares, with an exercise price of $4.578125 per share, exercisable from February 19, 2021, until August 26, 2026, to the Company February 2021 private placement offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 27, 2021, the Company signed a purchase agreement with certain institutional investors for the issuance and sale of 15,403,014 ordinary shares, par value NIS 0.25 per share, pre-funded warrants to purchase up to an aggregate of 610,504 ordinary shares and ordinary warrants to purchase up to an aggregate of 8,006,759 ordinary shares at an exercise price of $2.00 per share. The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant). The ordinary warrants are exercisable at any time and from time to time, in whole or in part, following the date of issuance and ending five and one-half years from the date of issuance. All of the pre-funded warrants were exercised in full on September 27, 2021, and the offering closed on September 29, 2021. Additionally, the Company issued warrants to purchase up to 960,811 ordinary shares, with an exercise price of $2.5438 per share, exercisable from September 27, 2021, until September 27, 2026, to the Company September 2021 registered direct offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, a total of 9,814,754 outstanding warrants with exercise prices ranging from $1.25 to $1.79 were exercised, for total gross proceeds of approximately $13.8 million. During the twelve months that ended December 31, 2023 no warrants were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share option plans:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 30, 2012, the Company&#x2019;s board of directors adopted the ReWalk Robotics Ltd. 2012 Equity Incentive Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 19, 2014, the Company&#x2019;s board of directors adopted the ReWalk Robotics Ltd. 2014 Incentive Compensation Plan or the &#x201c;Plan&#x201d;. The Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, RSUs, cash-based awards, other stock-based awards and dividend equivalents to the Company&#x2019;s and its affiliates&#x2019; respective employees, non-employee directors and consultants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Starting in 2014, the Company grants to directors and employees also RSU under this Plan. An RSU award is an agreement to issue shares of the company&#x2019;s ordinary shares at the time the award is vested.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023 and 2022, the Company had reserved 1,018,945 and 2,934,679 shares of ordinary shares, respectively, available for issuance to employees, directors, officers, and non-employees of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options generally vest over four years, with certain options granted to non-employee directors vesting over one year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Any option or RSUs that are forfeited or cancelled before expiration becomes available for future grants under the Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A summary of employee and non-employee shares options activity during the fiscal year ended 2023 is as follows: &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life (years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;value (in&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,994&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:52%;padding-bottom:4px;vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,823&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the end of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercisable at the end of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;There were no options granted during the fiscal year ended December 31, 2023, 2022 and 2021. The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders, which hold options with positive intrinsic value, exercised their options on the last date of the exercise period. During the years ended December 31, 2023, 2022 and 2021, no options were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A summary of employee and non-employee RSUs activity during the fiscal year ended 2023 is as follows: &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;underlying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unvested RSUs at the beginning of the year &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,755,057&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,258,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vested &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,109,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:76%;padding-bottom:4px;vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(131,813&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unvested RSUs at the end of the year &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The weighted average grant date fair values of RSUs granted during the fiscal year ended December 31, 2023, 2022 and 2021, were $0.66, $1.00 and $1.69, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total fair value of shares vested during the year ended December 31, 2023, 2022 and 2021 were $1,268 thousand, $860 thousand, and $802 thousand, respectively. As of December 31, 2023, there were $2.7 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2014 Plan. This cost is expected to be recognized over a period of approximately 2.9 years.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The number of options and RSUs outstanding as of December 31, 2023 is set forth below, with options separated by range of exercise price:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range of exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(years) (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(years) (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs only &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.37&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$20.42- $33.75&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,943&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,943&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$50-$52.5&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$182.5-$524.25&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,805,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:top;width:34pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="vertical-align:top;width:20pt"&gt;
                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
              &lt;td style="vertical-align:top;width:auto"&gt;
                &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term. &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

              &lt;tr&gt;
                &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;c.&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Equity compensation issued to consultants:&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company granted 32,895 RSUs during the fiscal year ended December 31, 2023, to non-employee consultants. As of December 31, 2023, there are 21,929 outstanding RSUs held by non-employee consultants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

              &lt;tr&gt;
                &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;d.&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Share-based compensation expense for employees and non-employees:&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="text-indent:18pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognized share-based compensation expense in the consolidated statements of operations as follows (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenue &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development, net &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales and marketing &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;781&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;597&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,328&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;993&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

              &lt;tr&gt;
                &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;e.&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div style="text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Treasury shares:&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On June 2, 2022, the Company&#x2019;s Board of Directors approved a share repurchase program to repurchase up to $8.0 million of its Ordinary Shares, par value NIS 0.25 per share. On July 21, 2022, the Company received approval from an Israeli court for the share repurchase program. The program was scheduled to expire on the earlier of January 20, 2023, or reaching $8.0 million of repurchases. On December 22, 2022, the Company&#x2019;s Board of Directors approved an extension of the repurchase program, with such extension to be in the aggregate amount of up to $5.8 million. The extension was approved by an Israeli court on February 9, 2023, and it expired on August 9, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, pursuant to the Company&#x2019;s share repurchase program, the Company had repurchased a total of 4,022,607 of its outstanding ordinary shares at a total cost of $3.5 million.&lt;/span&gt;&lt;/span&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

              &lt;tr&gt;
                &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="width:18pt;vertical-align:top"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;f.&lt;/span&gt;&lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Warrants to purchase ordinary shares:&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table summarizes information about warrants outstanding and exercisable as of December 31, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuance date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;per warrant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;term&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(number)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(number)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2015 (1) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See footnote (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 28, 2016 (2) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See footnote (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 25, 2019 (5) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 21, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 5, 2019 (6) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;408,457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;408,457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;October 7, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 5, 2019 (7) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.503&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 3, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2019, and June 6, 2019 (8) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,464,665&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,464,665&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2019 (9) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 12, 2019 (10) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;416,667&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;416,667&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 12, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 10, 2019 (11) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 10, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2020 (12) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2020 (13) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 6, 2020 (14) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;448,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;448,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 2, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 6, 2020 (15) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;296,297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.278&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;296,297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 2, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 8, 2020 (16) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;586,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;586,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 8, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 8, 2020 (17) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 8, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 26, 2021 (18) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,460,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,460,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 26, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 26, 2021 (19) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;655,290&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.578&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;655,290&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 26, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 29, 2021 (20) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,006,759&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,006,759&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 29, 2027&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 29, 2021 (21) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;960,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;960,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 27, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,187,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,187,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants for ordinary shares issuable upon an exercise price of $7.500 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited (&#x201c;Kreos&#x201d;) in connection with a loan made by Kreos to the Company and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#x2019;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents common warrants that were issued as part of the Company&#x2019;s follow-on public offering in November 2018.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#x2019;s follow-on public offering in November 2018.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#x2019;s follow-on public offering in February 2019.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s registered direct offering of ordinary shares in April 2019.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s April 2019 registered direct offering.&lt;/span&gt;&lt;/span&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019, and June 6, 2019, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(9)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s June 2019 warrant exercise agreement and concurrent private placement of warrants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(11)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s June 2019 registered direct offering and concurrent private placement of warrants.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s best efforts offering of ordinary shares in February 2020. As of December 31, 2023, 3,740,100 warrants were exercised for total consideration of $4,675,125. During the twelve months that ended December 31, 2023, no warrants were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s February 2020 best efforts offering. As of December 31, 2023, 230,160 warrants were exercised for total consideration of $359,625. During the twelve months that ended December 31, 2023, no warrants were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s registered direct offering of ordinary shares in July 2020. As of December 31, 2023, 2,020,441 warrants were exercised for total consideration of $3,555,976. During the twelve months that ended December 31, 2023, no warrants were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(15)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s July 2020 registered direct offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(16)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s private placement offering of ordinary shares in December 2020. As of December 31, 2023, 3,598,072 warrants were exercised for total consideration of $4,821,416. During the twelve months that ended December 31, 2023, no warrants were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(17)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s December 2020 private placement. As of December 31, 2023, 225,981 warrants were exercised for total consideration of $405,003. During the twelve months that ended December 31, 2023, no warrants were exercised.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(18)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s private placement offering of ordinary shares in February 2021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s February 2021 private placement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s registered direct offering of ordinary shares in September 2021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="width:36pt"&gt;&#160;&lt;/td&gt;
              &lt;td style="width:36pt;vertical-align:top"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(21)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s September 2021 registered direct offering.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20210202to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000654"
      unitRef="shares">10921502</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000655"
      unitRef="NIS_per_Share">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000656"
      unitRef="USD_per_Share">3.6625</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000657"
      unitRef="shares">5460751</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000658"
      unitRef="USD_per_Share">3.6</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:WarrantsExercisableDescrition
      contextRef="C_20210201to20210219_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      id="Fxbrl_20230213231801285">exercisable from February 19, 2021, until August 26, 2026</lfwd:WarrantsExercisableDescrition>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000659"
      unitRef="shares">655290</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      decimals="INF"
      id="FFact_0000000000660"
      unitRef="USD_per_Share">4.578125</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:WarrantsExercisableDescrition
      contextRef="C_20210201to20210219_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalAccerditedInvestorsMember"
      id="Fxbrl_20230213231849967">exercisable from February 19, 2021, until August 26, 2026</lfwd:WarrantsExercisableDescrition>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20210901to20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000661"
      unitRef="shares">15403014</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000662"
      unitRef="NIS_per_Share">0.25</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20210901to20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000663"
      unitRef="shares">610504</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000664"
      unitRef="shares">8006759</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000665"
      unitRef="USD_per_Share">2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:DescriptionOfUnderwritingAgreement
      contextRef="C_20210901to20210927_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      id="FFact_0000000000666">The Pre-Funded Warrants have an exercise price of $0.001 per Ordinary Share and are immediately exercisable and can be exercised at any time after their original issuance until such pre-funded warrants are exercised in full. Each ordinary shares was sold at an offering price of $2.035 and each pre-funded warrant was sold at an offering price of $2.034 (equal to the purchase price per ordinary share minus the exercise price of the pre-funded warrant).</lfwd:DescriptionOfUnderwritingAgreement>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000667"
      unitRef="shares">960811</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210927_usgaapStatementClassOfStockAxis_lfwdAdditionallyWarrantsIssuedMember_usgaapSubsidiarySaleOfStockAxis_lfwdPurchaseAgreementWithCertainInstitutionalInvestorsMember"
      decimals="INF"
      id="FFact_0000000000668"
      unitRef="USD_per_Share">2.5438</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:NumberOfWarrantsOutstandingTotal
      contextRef="C_20231231"
      decimals="INF"
      id="Fxbrl_20230213230048560"
      unitRef="shares">9814754</lfwd:NumberOfWarrantsOutstandingTotal>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_srtRangeAxis_srtMinimumMember"
      decimals="INF"
      id="Fxbrl_20230213175822808"
      unitRef="USD_per_Share">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_srtRangeAxis_srtMaximumMember"
      decimals="INF"
      id="Fxbrl_20230213175829064"
      unitRef="USD_per_Share">1.79</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20230101to20231231"
      decimals="-5"
      id="Fxbrl_20230213175852234"
      unitRef="USD">13800000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="Fxbrl_20230213180434110"
      unitRef="shares">1018945</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="Fxbrl_20230213180439271"
      unitRef="shares">2934679</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223133930542">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life (years)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;value (in&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the beginning of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;43,994&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;41.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercised&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:52%;padding-bottom:4px;vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10,823&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options outstanding at the end of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:52%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:52%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercisable at the end of the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37.51&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_0000000000674"
      unitRef="shares">43994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20221231"
      decimals="INF"
      id="FFact_0000000000675"
      unitRef="USD_per_Share">41.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_20220101to20221231" id="FFact_0000000000676">P4Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230214162103893"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230214162208421"
      unitRef="USD_per_Share">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230214162141286"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230214162222550"
      unitRef="USD_per_Share">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_0000000000682"
      unitRef="shares">10823</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="FFact_0000000000683"
      unitRef="USD_per_Share">52.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000684"
      unitRef="shares">33171</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000685"
      unitRef="USD_per_Share">37.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_20230101to20231231" id="FFact_0000000000686">P4Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000688"
      unitRef="shares">33171</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000689"
      unitRef="USD_per_Share">37.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="C_20230101to20231231" id="FFact_0000000000690">P4Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223134242480">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Number of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;underlying&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;fair value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unvested RSUs at the beginning of the year &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,755,057&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Granted &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,258,370&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vested &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,109,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:76%;padding-bottom:4px;vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Forfeited &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(131,813&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Unvested RSUs at the end of the year &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0.87&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber
      contextRef="C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000693"
      unitRef="shares">2755057</lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber>
    <lfwd:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice
      contextRef="C_20221231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="Fxbrl_20230214162434759"
      unitRef="USD_per_Share">1.16</lfwd:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000695"
      unitRef="shares">2258370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="Fxbrl_20230214162447647"
      unitRef="USD_per_Share">0.66</lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsGrantedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000697"
      unitRef="shares">1109200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000698"
      unitRef="USD_per_Share">1.14</lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsVestedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000699"
      unitRef="shares">131813</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000700"
      unitRef="USD_per_Share">1.13</lfwd:ShareBasedCompensationArrangementsByShareBasedPaymentRestrictedStockOptionsForfeitedInPeriodWeightedAverageExercisePrice>
    <lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber
      contextRef="C_20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000701"
      unitRef="shares">3772414</lfwd:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsOutstandingNumber>
    <lfwd:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice
      contextRef="C_20231231_usgaapAwardTypeAxis_lfwdEmployeeStockOptionAndRestrictedStockUnitsRsuMember"
      decimals="INF"
      id="FFact_0000000000702"
      unitRef="USD_per_Share">0.87</lfwd:SharebasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeOutstandingOptionsAndEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230213182329782"
      unitRef="USD_per_Share">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20230213182403626"
      unitRef="USD_per_Share">1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fxbrl_20230213182357641"
      unitRef="USD_per_Share">1.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="-3"
      id="Fxbrl_20230213182417788"
      unitRef="USD">1268000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="-3"
      id="Fxbrl_20230213182423124"
      unitRef="USD">860000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="-3"
      id="Fxbrl_20230213182431629"
      unitRef="USD">802000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="-5"
      id="Fxbrl_20230213182444566"
      unitRef="USD">2700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="Fxbrl_20230213182450823">P2Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223134338946">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Range of exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(years) (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;as of&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(years) (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RSUs only &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,772,414&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$5.37&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,425&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$20.42- $33.75&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,943&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,943&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$50-$52.5&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.46&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$182.5-$524.25&#160;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom;background-color:rgb(204, 238, 255)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1.8%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,805,585&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33,171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:1%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:9%;vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0)"&gt;
                    &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.39&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td style="width:0.68%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeMember"
      decimals="INF"
      id="FFact_0000000000713"
      unitRef="shares">3772414</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <lfwd:InvestmentOptionsExercisePrices
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"
      decimals="INF"
      id="FFact_0000000000715"
      unitRef="USD_per_Share">5.37</lfwd:InvestmentOptionsExercisePrices>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"
      decimals="INF"
      id="FFact_0000000000716"
      unitRef="shares">12425</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"
      id="FFact_0000000000717">P5Y2M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"
      decimals="INF"
      id="FFact_0000000000718"
      unitRef="shares">12425</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeOneMember"
      id="FFact_0000000000719">P5Y2M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"
      decimals="INF"
      id="FFact_0000000000720"
      unitRef="USD_per_Share">20.42</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"
      decimals="INF"
      id="FFact_0000000000721"
      unitRef="USD_per_Share">33.75</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"
      decimals="INF"
      id="FFact_0000000000722"
      unitRef="shares">12943</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"
      id="FFact_0000000000723">P4Y4M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"
      decimals="INF"
      id="FFact_0000000000724"
      unitRef="shares">12943</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeTwoMember"
      id="FFact_0000000000725">P4Y4M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeThreeMember"
      decimals="INF"
      id="FFact_0000000000726"
      unitRef="USD_per_Share">50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeThreeMember"
      decimals="INF"
      id="FFact_0000000000727"
      unitRef="USD_per_Share">52.5</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"
      decimals="INF"
      id="FFact_0000000000734"
      unitRef="shares">6230</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"
      id="FFact_0000000000735">P3Y5M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"
      decimals="INF"
      id="FFact_0000000000736"
      unitRef="shares">6230</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"
      id="FFact_0000000000737">P3Y5M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"
      decimals="INF"
      id="FFact_0000000000732"
      unitRef="USD_per_Share">182.5</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFourMember"
      decimals="INF"
      id="FFact_0000000000733"
      unitRef="USD_per_Share">524.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember"
      decimals="INF"
      id="FFact_0000000000740"
      unitRef="shares">1573</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember"
      id="FFact_0000000000741">P1Y7M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember"
      decimals="INF"
      id="FFact_0000000000742"
      unitRef="shares">1573</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember_usgaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lfwdExercisePriceRangeFiveMember"
      id="FFact_0000000000743">P1Y7M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="FFact_0000000000744"
      unitRef="shares">3805585</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="FFact_0000000000745">P4Y4M20D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="FFact_0000000000746"
      unitRef="shares">33171</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_20230101to20231231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="FFact_0000000000747">P4Y4M20D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <lfwd:WarrantsToPurchaseOrdinaryShares
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230213183439405"
      unitRef="shares">32895</lfwd:WarrantsToPurchaseOrdinaryShares>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223134403289">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost of revenue &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development, net &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sales and marketing &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;171&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General and administrative &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;781&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;633&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;597&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,328&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;993&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"
      decimals="-3"
      id="FFact_0000000000750"
      unitRef="USD">9000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"
      decimals="-3"
      id="FFact_0000000000751"
      unitRef="USD">16000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapCostOfSalesMember"
      decimals="-3"
      id="FFact_0000000000752"
      unitRef="USD">10000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_0000000000753"
      unitRef="USD">157000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_0000000000754"
      unitRef="USD">94000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="FFact_0000000000755"
      unitRef="USD">55000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"
      decimals="-3"
      id="FFact_0000000000756"
      unitRef="USD">381000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"
      decimals="-3"
      id="FFact_0000000000757"
      unitRef="USD">250000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapSellingAndMarketingExpenseMember"
      decimals="-3"
      id="FFact_0000000000758"
      unitRef="USD">171000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_0000000000759"
      unitRef="USD">781000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_0000000000760"
      unitRef="USD">633000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="FFact_0000000000761"
      unitRef="USD">597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000762"
      unitRef="USD">1328000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000763"
      unitRef="USD">993000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000764"
      unitRef="USD">833000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="C_20220602_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"
      decimals="-5"
      id="Fxbrl_20230213222918352"
      unitRef="USD">8000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20220602_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"
      decimals="INF"
      id="Fxbrl_20230213222931458"
      unitRef="NIS_per_Share">0.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="C_20220721_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"
      decimals="-5"
      id="Fxbrl_20230222055803517"
      unitRef="USD">8000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="C_20221222_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"
      decimals="-5"
      id="Fxbrl_20230222055944621"
      unitRef="USD">5800000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="C_20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"
      decimals="INF"
      id="Fxbrl_20230213223518090"
      unitRef="shares">4022607</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20230101to20231231_usgaapShareRepurchaseProgramAxis_lfwdShareRepurchaseProgramMember"
      decimals="-5"
      id="Fxbrl_20230213223526081"
      unitRef="USD">3500000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223134439177">
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Issuance date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;per warrant&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Warrants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;outstanding&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;exercisable&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contractual&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;term&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(number)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(number)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2015 (1) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,771&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See footnote (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 28, 2016 (2) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;See footnote (1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 25, 2019 (5) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.187&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45,600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 21, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 5, 2019 (6) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;408,457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;408,457&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;October 7, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 5, 2019 (7) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.503&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;49,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;April 3, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2019, and June 6, 2019 (8) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,464,665&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,464,665&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2019 (9) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;87,880&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 5, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 12, 2019 (10) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;416,667&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;416,667&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 12, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 10, 2019 (11) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.500&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 10, 2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2020 (12) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28,400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2020 (13) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.563&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;105,840&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 10, 2025&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 6, 2020 (14) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;448,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;448,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 2, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;July 6, 2020 (15) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;296,297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.278&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;296,297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 2, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 8, 2020 (16) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;586,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;586,760&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 8, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 8, 2020 (17) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;108,806&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 8, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 26, 2021 (18) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,460,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.600&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,460,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 26, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;February 26, 2021 (19) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;655,290&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.578&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;655,290&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 26, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 29, 2021 (20) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,006,759&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,006,759&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 29, 2027&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 29, 2021 (21) &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;960,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;960,811&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 27, 2026&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;width:42%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,187,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,187,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:bottom;width:10%;padding-bottom:4px;vertical-align:bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          </us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember"
      decimals="INF"
      id="FFact_0000000000766"
      unitRef="shares">4771</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember"
      decimals="INF"
      id="FFact_0000000000767"
      unitRef="USD_per_Share">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandFifteenMember"
      decimals="INF"
      id="FFact_0000000000768"
      unitRef="shares">4771</lfwd:ClassOfWarrantOrRightExercisable>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember"
      decimals="INF"
      id="FFact_0000000000769"
      unitRef="shares">1908</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember"
      decimals="INF"
      id="FFact_0000000000770"
      unitRef="USD_per_Share">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberTwoThousandSixteenMember"
      decimals="INF"
      id="FFact_0000000000771"
      unitRef="shares">1908</lfwd:ClassOfWarrantOrRightExercisable>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember"
      decimals="INF"
      id="FFact_0000000000772"
      unitRef="shares">45600</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember"
      decimals="INF"
      id="FFact_0000000000773"
      unitRef="USD_per_Share">7.187</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember"
      decimals="INF"
      id="FFact_0000000000774"
      unitRef="shares">45600</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenMember"
      id="FFact_0000000000775">2024-02-21</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember"
      decimals="INF"
      id="FFact_0000000000776"
      unitRef="shares">408457</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember"
      decimals="INF"
      id="FFact_0000000000777"
      unitRef="USD_per_Share">5.14</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember"
      decimals="INF"
      id="FFact_0000000000778"
      unitRef="shares">408457</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnNovemberTwentyTwoThousandEighteenOneMember"
      id="FFact_0000000000779">2024-10-07</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000780"
      unitRef="shares">49015</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000781"
      unitRef="USD_per_Share">6.503</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000782"
      unitRef="shares">49015</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentyFiveTwoThousandNineteenMember"
      id="FFact_0000000000783">2024-04-03</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000784"
      unitRef="shares">1464665</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000785"
      unitRef="USD_per_Share">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000786"
      unitRef="shares">1464665</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenMember"
      id="FFact_0000000000787">2024-06-05</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember"
      decimals="INF"
      id="FFact_0000000000788"
      unitRef="shares">87880</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember"
      decimals="INF"
      id="FFact_0000000000789"
      unitRef="USD_per_Share">9.375</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember"
      decimals="INF"
      id="FFact_0000000000790"
      unitRef="shares">87880</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnAprilFiveTwoThousandNineteenOneMember"
      id="FFact_0000000000791">2024-06-05</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000792"
      unitRef="shares">416667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000793"
      unitRef="USD_per_Share">6</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000794"
      unitRef="shares">416667</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveAndSixTwoThousandNineteenMember"
      id="FFact_0000000000795">2024-12-12</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000796"
      unitRef="shares">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000797"
      unitRef="USD_per_Share">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000798"
      unitRef="shares">50000</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneFiveTwoThousandNineteenMember"
      id="FFact_0000000000799">2024-06-10</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000800"
      unitRef="shares">28400</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000801"
      unitRef="USD_per_Share">1.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000802"
      unitRef="shares">28400</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTweleveTwoThousandNineteenMember"
      id="FFact_0000000000803">2025-02-10</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000804"
      unitRef="shares">105840</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000805"
      unitRef="USD_per_Share">1.563</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember"
      decimals="INF"
      id="FFact_0000000000806"
      unitRef="shares">105840</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJuneTenTwoThousandNineteenMember"
      id="FFact_0000000000807">2025-02-10</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000808"
      unitRef="shares">448698</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000809"
      unitRef="USD_per_Share">1.76</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000810"
      unitRef="shares">448698</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyMember"
      id="FFact_0000000000811">2026-01-02</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000812"
      unitRef="shares">296297</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000813"
      unitRef="USD_per_Share">2.278</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000814"
      unitRef="shares">296297</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTenTwoThousandTwentyOneMember"
      id="FFact_0000000000815">2026-01-02</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000816"
      unitRef="shares">586760</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000817"
      unitRef="USD_per_Share">1.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000818"
      unitRef="shares">586760</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyMember"
      id="FFact_0000000000819">2026-06-08</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000820"
      unitRef="shares">108806</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000821"
      unitRef="USD_per_Share">1.792</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000822"
      unitRef="shares">108806</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnJulySixTwoThousandTwentyOneMember"
      id="FFact_0000000000823">2026-06-08</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000824"
      unitRef="shares">5460751</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000825"
      unitRef="USD_per_Share">3.6</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember"
      decimals="INF"
      id="FFact_0000000000826"
      unitRef="shares">5460751</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyMember"
      id="FFact_0000000000827">2026-08-26</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000828"
      unitRef="shares">655290</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000829"
      unitRef="USD_per_Share">4.578</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000830"
      unitRef="shares">655290</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnDecemberEightTwoThousandTwentyOneMember"
      id="FFact_0000000000831">2026-08-26</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000832"
      unitRef="shares">8006759</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000833"
      unitRef="USD_per_Share">2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember"
      decimals="INF"
      id="FFact_0000000000834"
      unitRef="shares">8006759</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneMember"
      id="FFact_0000000000835">2027-03-29</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember"
      decimals="INF"
      id="FFact_0000000000836"
      unitRef="shares">960811</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember"
      decimals="INF"
      id="FFact_0000000000837"
      unitRef="USD_per_Share">2.544</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember"
      decimals="INF"
      id="FFact_0000000000838"
      unitRef="shares">960811</lfwd:ClassOfWarrantOrRightExercisable>
    <lfwd:WarrantsExpitationDate
      contextRef="C_20230101to20231231_usgaapClassOfWarrantOrRightAxis_lfwdWarrantsToPurchaseOrdinarySharesIssuedOnFebruaryTwentySixTwoThousandTwentyOneOneMember"
      id="FFact_0000000000839">2026-09-27</lfwd:WarrantsExpitationDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000848"
      unitRef="shares">19187375</us-gaap:ClassOfWarrantOrRightOutstanding>
    <lfwd:ClassOfWarrantOrRightExercisable
      contextRef="C_20231231"
      decimals="INF"
      id="FFact_0000000000849"
      unitRef="shares">19187375</lfwd:ClassOfWarrantOrRightExercisable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20151231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember"
      decimals="INF"
      id="Fxbrl_20230213221744619"
      unitRef="USD_per_Share">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
      contextRef="C_20150101to20151231_deiLegalEntityAxis_lfwdKreosCapitalVMember"
      id="FFact_0000000000850">2015-12-31</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <lfwd:WarrantsExercisableDescrition
      contextRef="C_20150101to20151231_deiLegalEntityAxis_lfwdKreosCapitalVMember"
      id="Fxbrl_20230214153827207">currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#x2019;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2023.</lfwd:WarrantsExercisableDescrition>
    <us-gaap:DebtInstrumentCollateralAmount
      contextRef="C_20161228_usgaapRelatedPartyTransactionsByRelatedPartyAxis_lfwdKreosCapitalMember"
      decimals="-5"
      id="FFact_0000000000854"
      unitRef="USD">8000000</us-gaap:DebtInstrumentCollateralAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member"
      decimals="INF"
      id="Fxbrl_20230221045623403"
      unitRef="shares">3740100</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020Member"
      decimals="-3"
      id="Fxbrl_20230221045640309"
      unitRef="USD">4675125000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember"
      decimals="INF"
      id="Fxbrl_20230221045607023"
      unitRef="shares">230160</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInFebruary2020TwoMember"
      decimals="-3"
      id="Fxbrl_20230221045614684"
      unitRef="USD">359625000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member"
      decimals="INF"
      id="Fxbrl_20230221045547348"
      unitRef="shares">2020441</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInJuly2020Member"
      decimals="-3"
      id="Fxbrl_20230221045554109"
      unitRef="USD">3555976000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member"
      decimals="INF"
      id="Fxbrl_20230221045526364"
      unitRef="shares">3598072</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdOfferingOfOrdinarySharesInDecember2020Member"
      decimals="-3"
      id="Fxbrl_20230221045533780"
      unitRef="USD">4821416000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20230221045700629"
      unitRef="shares">225981</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdCertainInstitutionalPurchasersMember_usgaapClassOfWarrantOrRightAxis_lfwdDecember2020PrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20230221045709176"
      unitRef="USD">405003000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000000870">
    &lt;div&gt;
      &lt;div&gt;
        &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

            &lt;tr&gt;
              &lt;td style="vertical-align:top;font-weight:bold;width:72pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;NOTE 10:-&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="vertical-align:top;width:auto"&gt;
                &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;RESEARCH COLLABORATION AGREEMENT AND LICENSE AGREEMENT&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/td&gt;
            &lt;/tr&gt;

        &lt;/table&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 16, 2016, the Company entered into a Collaboration Agreement (as amended, the &#x201c;Collaboration Agreement&#x201d;) and an Exclusive License Agreement (as amended, the &#x201c;License Agreement&#x201d;) with Harvard. The Collaboration Agreement concluded on March 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the License Agreement, Harvard has granted the Company an exclusive, worldwide royalty-bearing license under certain patents of Harvard relating to lightweight &#x201c;soft suit&#x201d; exoskeleton system technologies for lower limb disabilities, a royalty-free license under certain related know-how and the option to obtain a license under certain inventions conceived under the joint research collaboration.&lt;/span&gt;&lt;/span&gt;
          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;
          &lt;div&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The License Agreement required the Company to pay Harvard an upfront fee, reimbursements for expenses that Harvard incurred in connection with the licensed patents, royalties on net sales and several milestone payments contingent upon the achievement of certain product development and commercialization milestones. The Harvard License Agreement will continue in full force and effect until the expiration of the last-to-expire valid claim of the licensed patents.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, the Company achieved three of the milestones which represent all development milestones under the License Agreement. The Company continues to evaluate the likelihood that the other milestones will be achieved on a quarterly basis.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has recorded expenses in the amount of $29 thousand, $74 thousand, and $293 thousand as research and development expenses related to the License Agreement and to the Collaboration Agreement for the years ended December 31, 2023, 2022 and 2021, respectively. No withholding tax was deducted from the Company&#x2019;s payments to Harvard in respect of the Collaboration Agreement and the License Agreement since this is not taxable income in Israel in accordance with Section 170 of the Israel Income Tax Ordinance 1961-5721.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember"
      decimals="-3"
      id="Fxbrl_20230213132350179"
      unitRef="USD">29000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember"
      decimals="-3"
      id="Fxbrl_20230213132355930"
      unitRef="USD">74000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231_lfwdAgreementAxis_lfwdLicenseAgreementAndCollaborationAgreementMember"
      decimals="-3"
      id="Fxbrl_20230213132403571"
      unitRef="USD">293000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224183848740">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:72pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 11:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate tax rates in Israel:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Presented hereunder are the tax rates relevant to the Company in the years 2021-2023:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Israeli statutory corporate tax rate and real capital gains were 23% in the years 2021-2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;Income (loss) before taxes on income is comprised as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Domestic&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,638&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,110&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:2px;vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,507&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,642&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Taxes on income (benefit) are comprised as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="text-indent:18pt;line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:36pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;151&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:64%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:36pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Domestic&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:64%;padding-bottom:2px;vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:64%;padding-bottom:4px;vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
          &lt;div&gt;&lt;/div&gt;
          &lt;div style="text-indent:18pt;line-height:1.25;margin-top:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred income taxes (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company&#x2019;s deferred tax assets as of December 31, 2023 and 2022 are derived from temporary differences.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. Based on the Company&#x2019;s history of losses, the Company established a full valuation allowance for RRL.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Undistributed earnings of certain subsidiaries as of December 31, 2023 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a result, the Company has not provided for any deferred income taxes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carry forward tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;64,090&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development carry forward expenses-temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;844&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrual and reserves&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;849&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;392&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Credit tax carry forwards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;480&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;68,838&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:76%;padding-bottom:2px;vertical-align:baseline"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(65,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The net changes in the total valuation allowance for each of the years ended December 31, 2023, 2022 and 2021, are comprised as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(48,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(42,941&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes due to exchange rate differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustment previous year loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;)&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,269&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(65,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(48,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation of the theoretical tax expenses:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit) as reported in the consolidated statements of operations is as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

        &lt;div style="margin-left:36pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before taxes, as reported in the consolidated statements of operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,642&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Theoretical tax benefits on the above amount at the Israeli statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,093&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,393&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax at rate other than the Israeli statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses including equity-based compensation expenses and other&#x2009;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating losses and other temporary differences for which valuation allowance was provided&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Permanent differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustment in respect of prior years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Actual tax expense (benefit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;

      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:9.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign tax rates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Taxable income of RRI and AlterG was subject to tax at the rate of 21% in 2023, 2022 and 2021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Taxable income of RRG was subject to tax at the rate of 30% in 2023, 2022, and 2021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;g.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (the &#x201c;Investment Law&#x201d;):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Conditions for entitlement to the benefits:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the Investment Law, in 2012 the Company elected &#x201c;Beneficiary Enterprise&#x201d; status which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular rate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income derived from Beneficiary Enterprise from productive activity will be exempt from tax for ten years from the year in which the Company first has taxable income, providing that 12 years have not passed from the beginning of the year of election. In the event of a dividend distribution from income that is exempt from company tax, as aforementioned, the Company will be required to pay tax of 10%-25% on that income.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Beneficiary Enterprise&#x2019;s income. Tax-exempt income generated under the Company&#x2019;s &#x201c;Beneficiary Enterprise&#x201d; program will be subject to taxes upon dividend distribution or complete liquidation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The entitlement to the above benefits is conditional upon the Company&#x2019;s fulfilling the conditions stipulated by the Law and regulations published thereunder.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;h.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:8.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Tax assessments:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;RRL, RRI and RRG has had final tax assessments up to and including the 2017 tax year.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;AlterG files income tax returns in the United States and in various U.S. states. &#160;AlterG returns for the years ended December 31, 2020 and later are generally subject to federal tax examination, while the AlterG returns for the years ended December 31, 2019 and later are generally subject to state tax examination. &#160;However, the AlterG net operating losses and tax credits generally remain subject to tax examination and adjustment until they are utilized on a future tax return and the statute of limitations closes for that year. &#160;Thus, the AlterG tax attributes generally remain open to federal and state tax examination and adjustment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-indent:18pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:9.5pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net operating carry-forward losses for tax purposes:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, RRL has carry-forward losses amounting to approximately $242.6 million, which can be carried forward for an indefinite period.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2023, AlterG had approximately $31.4 million of federal net operating loss (&#x201c;NOL&#x201d;) carry forwards, and $47.2 million of state NOL carry forwards, which will begin to expire in 2025 and 2028, respectively. &#160;The federal net operating losses from years beginning after January 1, 2018, of approximately $14.7 million may be carried forward indefinitely and losses prior to January 1, 2018 of approximately $16.7 million expire beginning in 2028 under prior law.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
      &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Internal Revenue Code Section 382 places a limitation ("Section 382 Limitation") on the amount of taxable income which can be offset by NOL carry forwards after a change in control (generally greater than 50% change in the value of the stock owned by 5% shareholders during the testing period) of a loss corporation. California has similar rules. On August 11, 2023, AlterG was involved in an equity transaction that constitutes a Section 382 change in ownership. The change in ownership limits the ability to utilize net operating loss carry forwards in future years. The 382-limitation impact on NOLs has been included in the current period provision. The Company may have had earlier Section 382 changes in ownership. This will be assessed upon realization of tax attributes.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember"
      decimals="2"
      id="Fxbrl_20230213145314219"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember"
      decimals="2"
      id="Fxbrl_20230213144711350"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20200101to20201231_usgaapIncomeTaxAuthorityNameAxis_usgaapIsraelTaxAuthorityMember"
      decimals="2"
      id="Fxbrl_20230213144701076"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223144044842">
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Domestic&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,638&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,110&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:2px;vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,507&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;138&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,642&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000878"
      unitRef="USD">-19638000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000879"
      unitRef="USD">-19110000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000880"
      unitRef="USD">-12780000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000881"
      unitRef="USD">-2507000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000882"
      unitRef="USD">8000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000883"
      unitRef="USD">138000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000884"
      unitRef="USD">-22145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000885"
      unitRef="USD">-19102000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000886"
      unitRef="USD">-12642000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223144314043">
            &lt;div&gt;
              &lt;div style="margin-left:36pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Current&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;151&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;316&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:64%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:36pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Domestic&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:64%;padding-bottom:2px;vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="width:64%;padding-bottom:4px;vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:baseline"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="width:1%;padding-bottom:4px;vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000888"
      unitRef="USD">-12000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000889"
      unitRef="USD">151000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000890"
      unitRef="USD">123000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <lfwd:DeferredIncomeTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000891"
      unitRef="USD">0</lfwd:DeferredIncomeTax>
    <lfwd:DeferredIncomeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000892"
      unitRef="USD">-316000</lfwd:DeferredIncomeTax>
    <lfwd:DeferredIncomeTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000893"
      unitRef="USD">29000</lfwd:DeferredIncomeTax>
    <lfwd:TaxesOnIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000894"
      unitRef="USD">-12000</lfwd:TaxesOnIncome>
    <lfwd:TaxesOnIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000895"
      unitRef="USD">467000</lfwd:TaxesOnIncome>
    <lfwd:TaxesOnIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000896"
      unitRef="USD">94000</lfwd:TaxesOnIncome>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213154420766_Fact_0000000000900"
      unitRef="USD">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213154420766_Fact_0000000000901"
      unitRef="USD">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213154420766_Fact_0000000000902"
      unitRef="USD">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000900"
      unitRef="USD">-12000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000901"
      unitRef="USD">467000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000902"
      unitRef="USD">94000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <lfwd:TaxesIncome
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000903"
      unitRef="USD">-12000</lfwd:TaxesIncome>
    <lfwd:TaxesIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000904"
      unitRef="USD">467000</lfwd:TaxesIncome>
    <lfwd:TaxesIncome
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000905"
      unitRef="USD">94000</lfwd:TaxesIncome>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223144332603">
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carry forward tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;64,090&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;50,833&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development carry forward expenses-temporary differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,311&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;844&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accrual and reserves&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;849&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;392&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;456&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Credit tax carry forwards&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,714&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;480&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;68,838&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,739&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Right-of-use asset&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(214&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,015&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(144&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:76%;padding-bottom:2px;vertical-align:baseline"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(65,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net deferred tax assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000907"
      unitRef="USD">64090000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000908"
      unitRef="USD">50833000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000909"
      unitRef="USD">1311000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000910"
      unitRef="USD">844000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000911"
      unitRef="USD">849000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000912"
      unitRef="USD">392000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <lfwd:DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20230221105010103_Fact_0000000000911"
      unitRef="USD">394000</lfwd:DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation>
    <lfwd:DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230221105010103_Fact_0000000000912"
      unitRef="USD">456000</lfwd:DeferredTaxAssetsTaxDeferredExpenseShareBasedCompensation>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223155141498_Fact_0000000000907"
      unitRef="USD">1714000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223155141498_Fact_0000000000908"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <lfwd:DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000913"
      unitRef="USD">480000</lfwd:DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities>
    <lfwd:DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000914"
      unitRef="USD">214000</lfwd:DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000915"
      unitRef="USD">68838000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000916"
      unitRef="USD">52739000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <lfwd:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000917"
      unitRef="USD">470000</lfwd:DeferredTaxLiabilitiesRightOfUseAsset>
    <lfwd:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000918"
      unitRef="USD">214000</lfwd:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223155146219_Fact_0000000000907"
      unitRef="USD">-3015000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223155146219_Fact_0000000000908"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="C_20231231"
      decimals="-3"
      id="Fxbrl_20240223155148314_Fact_0000000000907"
      unitRef="USD">-144000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20240223155148314_Fact_0000000000908"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000919"
      unitRef="USD">65209000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000920"
      unitRef="USD">52525000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000921"
      unitRef="USD">65209000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000922"
      unitRef="USD">52525000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000923"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000924"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223144348387">
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(48,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(42,941&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes due to exchange rate differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,418&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustment previous year loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;)&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Acquisition&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7,269&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions during the year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,831&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(65,209&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(52,525&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(48,098&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000926"
      unitRef="USD">52525000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000927"
      unitRef="USD">48098000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_0000000000928"
      unitRef="USD">42941000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000929"
      unitRef="USD">0</lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount>
    <lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000930"
      unitRef="USD">1418000</lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount>
    <lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000931"
      unitRef="USD">-1488000</lfwd:ValuationallowancedeferredTaxAssetChangesDueToExchangeRateDifferencesAmount>
    <lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240226140612653"
      unitRef="USD">5000</lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount>
    <lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213155451007"
      unitRef="USD">14000</lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount>
    <lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000934"
      unitRef="USD">0</lfwd:ValuationAllowanceDeferredTaxAssetAdjustmentsAmount>
    <lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224230420217_xbrl_20230213155446375"
      unitRef="USD">-7269000</lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount>
    <lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240224230420217_xbrl_20230213155451007"
      unitRef="USD">0</lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount>
    <lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240224230420217_Fact_0000000000934"
      unitRef="USD">0</lfwd:AcquisitionDeferredTaxAssetAdjustmentsAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000935"
      unitRef="USD">5410000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000936"
      unitRef="USD">5831000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000937"
      unitRef="USD">3669000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000000938"
      unitRef="USD">65209000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000000939"
      unitRef="USD">52525000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_0000000000940"
      unitRef="USD">48098000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223144408211">
        &lt;div style="margin-left:36pt"&gt;
          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Loss before taxes, as reported in the consolidated statements of operations&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,145&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,642&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Theoretical tax benefits on the above amount at the Israeli statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5,093&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4,393&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2,908&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income tax at rate other than the Israeli statutory tax rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Non-deductible expenses including equity-based compensation expenses and other&#x2009;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;102&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating losses and other temporary differences for which valuation allowance was provided&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,669&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Permanent differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(775&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adjustment in respect of prior years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;
              &lt;tr&gt;
                &lt;td style="width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Actual tax expense (benefit)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                &lt;td colspan="1" style="width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td colspan="1" style="width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;&#160;&lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      </us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000942"
      unitRef="USD">-22145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000943"
      unitRef="USD">-19102000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000944"
      unitRef="USD">-12642000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20230101to20231231"
      decimals="2"
      id="FFact_0000000000945"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231"
      decimals="3"
      id="FFact_0000000000946"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231"
      decimals="3"
      id="FFact_0000000000947"
      unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000948"
      unitRef="USD">-5093000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000949"
      unitRef="USD">-4393000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000950"
      unitRef="USD">-2908000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213160009177_Fact_0000000000951"
      unitRef="USD">56000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213160009177_Fact_0000000000952"
      unitRef="USD">-2000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213160009177_Fact_0000000000953"
      unitRef="USD">7000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000954"
      unitRef="USD">0</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000955"
      unitRef="USD">262000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000956"
      unitRef="USD">102000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000957"
      unitRef="USD">5410000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000958"
      unitRef="USD">5375000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000959"
      unitRef="USD">3669000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000960"
      unitRef="USD">-342000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000961"
      unitRef="USD">-775000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000962"
      unitRef="USD">-784000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223155439943_Fact_0000000000960"
      unitRef="USD">-43000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223155439943_Fact_0000000000961"
      unitRef="USD">0</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223155439943_Fact_0000000000962"
      unitRef="USD">0</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20230213160019546_Fact_0000000000963"
      unitRef="USD">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230213160019546_Fact_0000000000964"
      unitRef="USD">0</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230213160019546_Fact_0000000000965"
      unitRef="USD">8000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000966"
      unitRef="USD">-12000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000967"
      unitRef="USD">467000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000968"
      unitRef="USD">94000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"
      decimals="2"
      id="Fxbrl_20231216140603322"
      unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"
      decimals="2"
      id="Fxbrl_20231216140556608"
      unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"
      decimals="2"
      id="Fxbrl_20230213144755943"
      unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember"
      decimals="2"
      id="Fxbrl_20231216140621676"
      unitRef="pure">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember"
      decimals="2"
      id="Fxbrl_20231216140615011"
      unitRef="pure">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdRewalkRoboticsGmbhMember"
      decimals="2"
      id="Fxbrl_20230213144800051"
      unitRef="pure">0.30</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod contextRef="C_20230101to20231231" id="FFact_0000000000977">P10Y</lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxExemptionPeriod>
    <lfwd:BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption contextRef="C_20230101to20231231" id="FFact_0000000000978">P12Y</lfwd:BeneficiaryEnterpriseFromProductiveActivityMaximumTimeFromPeriodOfElectionForTaxExemption>
    <lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome
      contextRef="C_20230101to20231231_srtRangeAxis_srtMinimumMember"
      decimals="2"
      id="FFact_0000000000979"
      unitRef="pure">0.10</lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome>
    <lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome
      contextRef="C_20230101to20231231_srtRangeAxis_srtMaximumMember"
      decimals="2"
      id="FFact_0000000000980"
      unitRef="pure">0.25</lfwd:BeneficiaryEnterpriseFromProductiveActivityTaxRateOnDividendDistributionsFromTaxExemptIncome>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20231231_deiLegalEntityAxis_lfwdReWalkRoboticsIncMember"
      decimals="-5"
      id="Fxbrl_20230213160514050"
      unitRef="USD">242600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember"
      decimals="-5"
      id="Fxbrl_20240226141105239"
      unitRef="USD">31400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20231231_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapStateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fxbrl_20240226141123559"
      unitRef="USD">47200000</us-gaap:OperatingLossCarryforwards>
    <lfwd:NetOperatingCarryForwardLossesExpirationTerm
      contextRef="C_20230101to20231231_deiLegalEntityAxis_lfwdAltergIncMember"
      id="Fxbrl_20240226141138302">2025 and 2028</lfwd:NetOperatingCarryForwardLossesExpirationTerm>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember_usgaapIncomeTaxAuthorityNameAxis_usgaapForeignCountryMember"
      decimals="-5"
      id="Fxbrl_20240226141153085"
      unitRef="USD">14700000</us-gaap:OperatingLossCarryforwards>
    <lfwd:OperatingLossCarryforwardsPriorPeriod
      contextRef="C_20180101_deiLegalEntityAxis_lfwdAltergIncMember"
      decimals="-5"
      id="Fxbrl_20240226141205791"
      unitRef="USD">16700000</lfwd:OperatingLossCarryforwardsPriorPeriod>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000001000">
    &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

        &lt;tr&gt;
          &lt;td style="vertical-align:top;font-weight:bold;width:72pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;NOTE 12:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
          &lt;td style="vertical-align:top;width:auto"&gt;
            &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;FINANCIAL (EXPENSES) INCOME, NET&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;

    &lt;/table&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The components of financial (expenses) income, net were as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions and other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest Income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank commissions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20230213140028626"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;*) &lt;/span&gt;Represent an amount lower than $1.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223122326676">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency transactions and other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest Income&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,354&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank commissions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,467&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20230213140028626"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000987"
      unitRef="USD">133000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000988"
      unitRef="USD">-22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000989"
      unitRef="USD">38000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:InterestIncomeOther
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240223123158362"
      unitRef="USD">1354000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240223123212166"
      unitRef="USD">0</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240223123222290"
      unitRef="USD">0</us-gaap:InterestIncomeOther>
    <lfwd:BankCommissions
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000993"
      unitRef="USD">20000</lfwd:BankCommissions>
    <lfwd:BankCommissions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000000994"
      unitRef="USD">22000</lfwd:BankCommissions>
    <lfwd:BankCommissions
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000995"
      unitRef="USD">25000</lfwd:BankCommissions>
    <lfwd:FinancialExpensesAndIncomeNet
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000000996"
      unitRef="USD">1467000</lfwd:FinancialExpensesAndIncomeNet>
    <lfwd:FinancialExpensesAndIncomeNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000000998"
      unitRef="USD">13000</lfwd:FinancialExpensesAndIncomeNet>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="C_20230101to20231231" id="FFact_0000000001040">
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" style="font-size:10pt;font-family:Times New Roman, Times, serif;width:100%;color:rgb(0, 0, 0)"&gt;

          &lt;tr&gt;
            &lt;td style="vertical-align:top;font-weight:bold;width:72pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 13:-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
            &lt;td style="vertical-align:top;width:auto"&gt;
              &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/td&gt;
          &lt;/tr&gt;

      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company manages its business on a basis of one reportable segment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total revenues from external customers on the basis of the Company's geographical areas are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue based on customer&#x2019;s location:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,519&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,044&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,057&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia-Pacific&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;387&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest of the world&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;787&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;


          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets by geographic region:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Germany&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets are comprised of property and equipment, net, and operating lease right-of-use assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;

        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Major customers data as a percentage of total revenue:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;

      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000001035"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20230213145458513"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20230213145510899"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 10%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

  </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240223125143289"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223125203861">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Revenue based on customer&#x2019;s location:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,636&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,303&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,519&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Europe&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,044&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,057&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Asia-Pacific&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;387&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rest of the world&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;787&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total revenues&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13,854&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,511&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,966&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_0000000001005"
      unitRef="USD">7636000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_0000000001006"
      unitRef="USD">2303000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_0000000001007"
      unitRef="USD">2519000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_srtEuropeMember"
      decimals="-3"
      id="FFact_0000000001008"
      unitRef="USD">5044000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_srtEuropeMember"
      decimals="-3"
      id="FFact_0000000001009"
      unitRef="USD">3057000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_srtEuropeMember"
      decimals="-3"
      id="FFact_0000000001010"
      unitRef="USD">3381000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_srtAsiaPacificMember"
      decimals="-3"
      id="FFact_0000000001011"
      unitRef="USD">387000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_srtAsiaPacificMember"
      decimals="-3"
      id="FFact_0000000001012"
      unitRef="USD">115000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_srtAsiaPacificMember"
      decimals="-3"
      id="FFact_0000000001013"
      unitRef="USD">60000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231_srtStatementGeographicalAxis_lfwdRestOfWorldMember"
      decimals="-3"
      id="Fxbrl_20240223125344982"
      unitRef="USD">787000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_lfwdRestOfWorldMember"
      decimals="-3"
      id="Fxbrl_20240223125735347"
      unitRef="USD">36000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231_srtStatementGeographicalAxis_lfwdRestOfWorldMember"
      decimals="-3"
      id="Fxbrl_20240223125750616"
      unitRef="USD">6000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="FFact_0000000001020"
      unitRef="USD">13854000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="FFact_0000000001021"
      unitRef="USD">5511000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_0000000001022"
      unitRef="USD">5966000</us-gaap:Revenues>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223125219492">
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets by geographic region:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;757&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;United States&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,404&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;231&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:10pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Germany&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;vertical-align:top;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Long-lived assets are comprised of property and equipment, net, and operating lease right-of-use assets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        </us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="C_20231231_srtStatementGeographicalAxis_countryIL"
      decimals="-3"
      id="FFact_0000000001024"
      unitRef="USD">529000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20221231_srtStatementGeographicalAxis_countryIL"
      decimals="-3"
      id="FFact_0000000001025"
      unitRef="USD">757000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20231231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_0000000001026"
      unitRef="USD">2404000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20221231_srtStatementGeographicalAxis_countryUS"
      decimals="-3"
      id="FFact_0000000001027"
      unitRef="USD">231000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20231231_srtStatementGeographicalAxis_countryDE"
      decimals="-3"
      id="FFact_0000000001028"
      unitRef="USD">190000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20221231_srtStatementGeographicalAxis_countryDE"
      decimals="-3"
      id="FFact_0000000001029"
      unitRef="USD">44000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20231231"
      decimals="-3"
      id="FFact_0000000001030"
      unitRef="USD">3123000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="FFact_0000000001031"
      unitRef="USD">1032000</us-gaap:NoncurrentAssets>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240223125235177">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin-left:36pt"&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year Ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer A&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:FFact_0000000001035"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Customer B&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20230213145458513"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="-sec-ix-hidden:Fxbrl_20230213145510899"&gt;*&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" cellspacing="0" style="border:0px;width:100%"&gt;

                &lt;tr&gt;
                  &lt;td style="width:18pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:36pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;*)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto"&gt;
                    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less than 10%&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20230101to20231231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"
      decimals="3"
      id="FFact_0000000001033"
      unitRef="pure">0.122</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20220101to20221231_srtMajorCustomersAxis_lfwdCustomerAMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"
      decimals="3"
      id="FFact_0000000001034"
      unitRef="pure">0.142</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_20210101to20211231_srtMajorCustomersAxis_lfwdCustomerBMember_usgaapConcentrationRiskByBenchmarkAxis_usgaapSalesRevenueNetMember_usgaapConcentrationRiskByTypeAxis_usgaapCustomerConcentrationRiskMember"
      decimals="3"
      id="Fxbrl_20230213145523610"
      unitRef="pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224191043321">
      &lt;div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE 14:-&lt;/span&gt;&lt;span style="padding-left:20pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-weight:bold"&gt;BASIC AND DILUTED NET LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per ordinary share (in thousands, except share and per share data):&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt"&gt;

            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,736&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss attributable to ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,736&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Shares used in computing net loss per ordinary shares, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,719,064&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,378,797&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,935,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per ordinary share, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;

        &lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of ordinary shares and warrants outstanding would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the twelve months ended December 31, 2023, the total number of ordinary shares related to the outstanding warrants and share option plans aggregated to 19,220,546, was excluded from the calculations of diluted loss per ordinary share since it would have an anti-dilutive effect.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the twelve months ended December 31, 2022, the total number of ordinary shares related to the outstanding warrants and share option plans aggregated to 19,464,888, was excluded from the calculations of diluted loss per ordinary share since it would have an anti-dilutive effect.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:EarningsPerShareTextBlock>
    <lfwd:BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240224191102857">
            &lt;div&gt;
              &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px;vertical-align:bottom"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);vertical-align:baseline"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,736&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);vertical-align:baseline;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss attributable to ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(22,133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(19,569&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12,736&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Shares used in computing net loss per ordinary shares, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59,719,064&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62,378,797&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;47,935,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="vertical-align:bottom;width:64%;vertical-align:bottom"&gt;
                      &lt;div style="text-indent:-8.65pt;margin-left:8.65pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Net loss per ordinary share, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;vertical-align:bottom"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(0.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                    &lt;td colspan="1" style="vertical-align:bottom;width:1%;vertical-align:bottom;white-space:nowrap"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          </lfwd:BasicAndDilutedNetLossPerOrdinaryShareTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224192413364_Fact_0000000000128"
      unitRef="USD">-22133000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240224192413364_Fact_0000000000129"
      unitRef="USD">-19569000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240224192413364_Fact_0000000000130"
      unitRef="USD">-12736000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20230101to20231231"
      decimals="-3"
      id="Fxbrl_20240224192423512_Fact_0000000000128"
      unitRef="USD">-22133000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20240224192423512_Fact_0000000000129"
      unitRef="USD">-19569000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20240224192423512_Fact_0000000000130"
      unitRef="USD">-12736000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230213105231681"
      unitRef="shares">59719064</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240224192433025_Fact_0000000000134"
      unitRef="shares">59719064</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230213105240146"
      unitRef="shares">62378797</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20240224192433025_Fact_0000000000135"
      unitRef="shares">62378797</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230213105249498"
      unitRef="shares">47935652</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20240224192433025_Fact_0000000000136"
      unitRef="shares">47935652</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20230213105205583"
      unitRef="USD_per_Share">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240224192413366_Fact_0000000000131"
      unitRef="USD_per_Share">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230213105214455"
      unitRef="USD_per_Share">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20240224192413366_Fact_0000000000132"
      unitRef="USD_per_Share">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230213105224480"
      unitRef="USD_per_Share">-0.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20240224192413366_Fact_0000000000133"
      unitRef="USD_per_Share">-0.27</us-gaap:EarningsPerShareBasic>
    <lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive
      contextRef="C_20230101to20231231"
      decimals="INF"
      id="Fxbrl_20240224193823449"
      unitRef="shares">19220546</lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive>
    <lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20240224193844593"
      unitRef="shares">19464888</lfwd:NumberOfSharesExcludedFromDilutedLossPerShareAntiDilutive>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="C_20230101to20231231"
      id="Fxbrl_20240226134602269">
      &lt;div&gt;
        &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE 15:-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="padding-left:20pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;RESTRUCTURING ACTIVITIES&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 12, 2023, the Board of Directors of the Company approved a re-organization plan (the &#x201c;2023 Reorganization Plan&#x201d;) that included, among other things, downsizing approximately 15% of the Company&#x2019;s workforce and adapting the Company's organizational structure, roles, and responsibilities accordingly.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25"&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:rgb(0, 0, 0)"&gt;During the year ended December 31, 2023, in connection with the 2023 Reorganization Plan, the Company recorded expenses of $670 thousand, for one time employee termination benefits and legal expenses. $175 thousand attributable to research and development, net, $70 thousand to sales and marketing and $425 thousand to General and administrative expenses.&lt;/span&gt;&#160;&lt;span style="color:rgb(0, 0, 0)"&gt;However, none of these amounts were paid in 2023. The Company does not expect to incur additional costs related to the 2023 Reorganization Plan.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <lfwd:WorkforcePercentage
      contextRef="C_20231201to20231212_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"
      decimals="2"
      id="Fxbrl_20240224171054032"
      unitRef="pure">0.15</lfwd:WorkforcePercentage>
    <lfwd:AmountOfEmployeeTerminationBenefitsAndLegalExpenses
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"
      decimals="-3"
      id="Fxbrl_20240224171136760"
      unitRef="USD">670000</lfwd:AmountOfEmployeeTerminationBenefitsAndLegalExpenses>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"
      decimals="-3"
      id="Fxbrl_20240224171156688"
      unitRef="USD">175000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"
      decimals="-3"
      id="Fxbrl_20240224171235576"
      unitRef="USD">70000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_20230101to20231231_usgaapPlanNameAxis_lfwdTwoZeroTwoThreeReorganizationPlanMember"
      decimals="-3"
      id="Fxbrl_20240224171248551"
      unitRef="USD">425000</us-gaap:SellingAndMarketingExpense>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#FFact_0000000001035"
          xlink:label="FFact_0000000001035"
          xlink:type="locator"/>
        <link:footnote id="FN20230213122658952" xlink:label="FN20230213122658952" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Less than 10%</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000001035"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213145458513"
          xlink:label="Fxbrl_20230213145458513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213145458513"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213145510899"
          xlink:label="Fxbrl_20230213145510899"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213145510899"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213115913875"
          xlink:label="Fxbrl_20230213115913875"
          xlink:type="locator"/>
        <link:footnote id="FN20230214190043507" xlink:label="FN20230214190043507" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount lower than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213115913875"
          xlink:to="FN20230214190043507"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000327"
          xlink:label="FFact_0000000000327"
          xlink:type="locator"/>
        <link:footnote id="FN20240226172242835" xlink:label="FN20240226172242835" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 9a.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000327"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:footnote id="FN20240226172623659" xlink:label="FN20240226172623659" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 9f.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000327"
          xlink:to="FN20240226172623659"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000328"
          xlink:label="FFact_0000000000328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000328"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000328"
          xlink:to="FN20240226172623659"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213124756646"
          xlink:label="Fxbrl_20230213124756646"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213124756646"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213124808685"
          xlink:label="Fxbrl_20230213124808685"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213124808685"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213133255195"
          xlink:label="Fxbrl_20230213133255195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213133255195"
          xlink:to="FN20240226172623659"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213133255195"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213231152958"
          xlink:label="Fxbrl_20230213231152958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213231152958"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213231158622"
          xlink:label="Fxbrl_20230213231158622"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213231158622"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213231209903"
          xlink:label="Fxbrl_20230213231209903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213231209903"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213231215958"
          xlink:label="Fxbrl_20230213231215958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213231215958"
          xlink:to="FN20240226172242835"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000717"
          xlink:label="FFact_0000000000717"
          xlink:type="locator"/>
        <link:footnote id="FN20230213183214461" xlink:label="FN20230213183214461" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.&#160;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000717"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000719"
          xlink:label="FFact_0000000000719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000719"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000723"
          xlink:label="FFact_0000000000723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000723"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000725"
          xlink:label="FFact_0000000000725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000725"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000735"
          xlink:label="FFact_0000000000735"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000735"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000737"
          xlink:label="FFact_0000000000737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000737"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000741"
          xlink:label="FFact_0000000000741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000741"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000743"
          xlink:label="FFact_0000000000743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000743"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000745"
          xlink:label="FFact_0000000000745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000745"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000747"
          xlink:label="FFact_0000000000747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000747"
          xlink:to="FN20230213183214461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000766"
          xlink:label="FFact_0000000000766"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191805234" xlink:label="FN20230214191805234" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants for ordinary shares issuable upon an exercise price of $7.500 per share, which were granted on December 31, 2015 to Kreos Capital V (Expert) Fund Limited (&#x201c;Kreos&#x201d;) in connection with a loan made by Kreos to the Company and are currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of the Company with or into, or the sale or license of all or substantially all the assets or shares of the Company to, any other entity or person, other than a wholly owned subsidiary of the Company, excluding any transaction in which the Company&#x2019;s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. None of these warrants had been exercised as of December 31, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000766"
          xlink:to="FN20230214191805234"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000767"
          xlink:label="FFact_0000000000767"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000767"
          xlink:to="FN20230214191805234"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000768"
          xlink:label="FFact_0000000000768"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000768"
          xlink:to="FN20230214191805234"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000769"
          xlink:label="FFact_0000000000769"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191754407" xlink:label="FN20230214191754407" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents common warrants that were issued as part of the $8.0 million drawdown under the Loan Agreement which occurred on December 28, 2016. See footnote 1 for exercisability terms.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000769"
          xlink:to="FN20230214191754407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000770"
          xlink:label="FFact_0000000000770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000770"
          xlink:to="FN20230214191754407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000771"
          xlink:label="FFact_0000000000771"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000771"
          xlink:to="FN20230214191754407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000772"
          xlink:label="FFact_0000000000772"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191736834" xlink:label="FN20230214191736834" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents common warrants that were issued as part of the Company&#x2019;s follow-on public offering in November 2018.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000772"
          xlink:to="FN20230214191736834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000773"
          xlink:label="FFact_0000000000773"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000773"
          xlink:to="FN20230214191736834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000774"
          xlink:label="FFact_0000000000774"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000774"
          xlink:to="FN20230214191736834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000775"
          xlink:label="FFact_0000000000775"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000775"
          xlink:to="FN20230214191736834"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000776"
          xlink:label="FFact_0000000000776"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191719804" xlink:label="FN20230214191719804" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents common warrants that were issued to the underwriters as compensation for their role in the Company&#x2019;s follow-on public offering in November 2018.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000776"
          xlink:to="FN20230214191719804"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000777"
          xlink:label="FFact_0000000000777"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000777"
          xlink:to="FN20230214191719804"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000778"
          xlink:label="FFact_0000000000778"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000778"
          xlink:to="FN20230214191719804"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000779"
          xlink:label="FFact_0000000000779"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000779"
          xlink:to="FN20230214191719804"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000780"
          xlink:label="FFact_0000000000780"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191708673" xlink:label="FN20230214191708673" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the exclusive placement agent as compensation for its role in the Company&#x2019;s follow-on public offering in February 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000780"
          xlink:to="FN20230214191708673"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000781"
          xlink:label="FFact_0000000000781"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000781"
          xlink:to="FN20230214191708673"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000782"
          xlink:label="FFact_0000000000782"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000782"
          xlink:to="FN20230214191708673"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000783"
          xlink:label="FFact_0000000000783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000783"
          xlink:to="FN20230214191708673"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000784"
          xlink:label="FFact_0000000000784"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191658539" xlink:label="FN20230214191658539" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s registered direct offering of ordinary shares in April 2019. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000784"
          xlink:to="FN20230214191658539"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000785"
          xlink:label="FFact_0000000000785"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000785"
          xlink:to="FN20230214191658539"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000786"
          xlink:label="FFact_0000000000786"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000786"
          xlink:to="FN20230214191658539"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000787"
          xlink:label="FFact_0000000000787"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000787"
          xlink:to="FN20230214191658539"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000788"
          xlink:label="FFact_0000000000788"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191649202" xlink:label="FN20230214191649202" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s April 2019 registered direct offering.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000788"
          xlink:to="FN20230214191649202"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000789"
          xlink:label="FFact_0000000000789"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000789"
          xlink:to="FN20230214191649202"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000790"
          xlink:label="FFact_0000000000790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000790"
          xlink:to="FN20230214191649202"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000791"
          xlink:label="FFact_0000000000791"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000791"
          xlink:to="FN20230214191649202"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000792"
          xlink:label="FFact_0000000000792"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191637851" xlink:label="FN20230214191637851" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement on June 5, 2019, and June 6, 2019, respectively. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000792"
          xlink:to="FN20230214191637851"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000793"
          xlink:label="FFact_0000000000793"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000793"
          xlink:to="FN20230214191637851"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000794"
          xlink:label="FFact_0000000000794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000794"
          xlink:to="FN20230214191637851"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000795"
          xlink:label="FFact_0000000000795"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000795"
          xlink:to="FN20230214191637851"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000796"
          xlink:label="FFact_0000000000796"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191626730" xlink:label="FN20230214191626730" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s June 2019 warrant exercise agreement and concurrent private placement of warrants. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000796"
          xlink:to="FN20230214191626730"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000797"
          xlink:label="FFact_0000000000797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000797"
          xlink:to="FN20230214191626730"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000798"
          xlink:label="FFact_0000000000798"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000798"
          xlink:to="FN20230214191626730"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000799"
          xlink:label="FFact_0000000000799"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000799"
          xlink:to="FN20230214191626730"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000800"
          xlink:label="FFact_0000000000800"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191613929" xlink:label="FN20230214191613929" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to certain institutional investors in a warrant exercise agreement in June 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000800"
          xlink:to="FN20230214191613929"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000801"
          xlink:label="FFact_0000000000801"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000801"
          xlink:to="FN20230214191613929"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000802"
          xlink:label="FFact_0000000000802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000802"
          xlink:to="FN20230214191613929"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000803"
          xlink:label="FFact_0000000000803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000803"
          xlink:to="FN20230214191613929"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000804"
          xlink:label="FFact_0000000000804"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191559676" xlink:label="FN20230214191559676" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s June 2019 registered direct offering and concurrent private placement of warrants. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000804"
          xlink:to="FN20230214191559676"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000805"
          xlink:label="FFact_0000000000805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000805"
          xlink:to="FN20230214191559676"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000806"
          xlink:label="FFact_0000000000806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000806"
          xlink:to="FN20230214191559676"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000807"
          xlink:label="FFact_0000000000807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000807"
          xlink:to="FN20230214191559676"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000808"
          xlink:label="FFact_0000000000808"
          xlink:type="locator"/>
        <link:footnote id="FN20230221050033557" xlink:label="FN20230221050033557" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">	 Represents warrants that were issued to certain institutional purchasers in a private placement in the Company&#x2019;s best efforts offering of ordinary shares in February 2020. As of December 31, 2022, 3,740,100 warrants were exercised for total consideration of $4,675,125. During the twelve months that ended December 31, 2022, no warrants were exercised.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000808"
          xlink:to="FN20230221050033557"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000809"
          xlink:label="FFact_0000000000809"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000809"
          xlink:to="FN20230221050033557"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000810"
          xlink:label="FFact_0000000000810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000810"
          xlink:to="FN20230221050033557"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000811"
          xlink:label="FFact_0000000000811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000811"
          xlink:to="FN20230221050033557"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000812"
          xlink:label="FFact_0000000000812"
          xlink:type="locator"/>
        <link:footnote id="FN20230221050050277" xlink:label="FN20230221050050277" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s February 2020 best efforts offering. As of December 31, 2022, 230,160 warrants were exercised for total consideration of $359,625. During the twelve months that ended December 31, 2022, no warrants were exercised.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000812"
          xlink:to="FN20230221050050277"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000813"
          xlink:label="FFact_0000000000813"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000813"
          xlink:to="FN20230221050050277"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000814"
          xlink:label="FFact_0000000000814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000814"
          xlink:to="FN20230221050050277"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000815"
          xlink:label="FFact_0000000000815"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000815"
          xlink:to="FN20230221050050277"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000816"
          xlink:label="FFact_0000000000816"
          xlink:type="locator"/>
        <link:footnote id="FN20230221050124457" xlink:label="FN20230221050124457" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in July 2020. As of December 31, 2022, 2,020,441 warrants were exercised for total consideration of $3,555,976. During the twelve months that ended December 31, 2022, no warrants were exercised.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000816"
          xlink:to="FN20230221050124457"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000817"
          xlink:label="FFact_0000000000817"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000817"
          xlink:to="FN20230221050124457"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000818"
          xlink:label="FFact_0000000000818"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000818"
          xlink:to="FN20230221050124457"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000819"
          xlink:label="FFact_0000000000819"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000819"
          xlink:to="FN20230221050124457"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000820"
          xlink:label="FFact_0000000000820"
          xlink:type="locator"/>
        <link:footnote id="FN20230214191510956" xlink:label="FN20230214191510956" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s July 2020 registered direct offering.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000820"
          xlink:to="FN20230214191510956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000821"
          xlink:label="FFact_0000000000821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000821"
          xlink:to="FN20230214191510956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000822"
          xlink:label="FFact_0000000000822"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000822"
          xlink:to="FN20230214191510956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000823"
          xlink:label="FFact_0000000000823"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000823"
          xlink:to="FN20230214191510956"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000824"
          xlink:label="FFact_0000000000824"
          xlink:type="locator"/>
        <link:footnote id="FN20230221050209309" xlink:label="FN20230221050209309" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">	 Represents warrants that were issued to certain institutional purchasers in a private placement in our private placement offering of ordinary shares in December 2020. As of December 31, 2022, 3,598,072 warrants were exercised for total consideration of $4,821,416. During the twelve months that ended December 31, 2022, no warrants were exercised.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000824"
          xlink:to="FN20230221050209309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000825"
          xlink:label="FFact_0000000000825"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000825"
          xlink:to="FN20230221050209309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000826"
          xlink:label="FFact_0000000000826"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000826"
          xlink:to="FN20230221050209309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000827"
          xlink:label="FFact_0000000000827"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000827"
          xlink:to="FN20230221050209309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000828"
          xlink:label="FFact_0000000000828"
          xlink:type="locator"/>
        <link:footnote id="FN20230221050221334" xlink:label="FN20230221050221334" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s December 2020 private placement. As of December 31, 2022, 225,981 warrants were exercised for total consideration of $405,003. During the twelve months that ended December 31, 2022, no warrants were exercised.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000828"
          xlink:to="FN20230221050221334"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000829"
          xlink:label="FFact_0000000000829"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000829"
          xlink:to="FN20230221050221334"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000830"
          xlink:label="FFact_0000000000830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000830"
          xlink:to="FN20230221050221334"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000831"
          xlink:label="FFact_0000000000831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000831"
          xlink:to="FN20230221050221334"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000832"
          xlink:label="FFact_0000000000832"
          xlink:type="locator"/>
        <link:footnote id="FN20240224222832702" xlink:label="FN20240224222832702" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents warrants that were issued to certain institutional purchasers in a private placement in our registered direct offering of ordinary shares in September 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000832"
          xlink:to="FN20240224222832702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000833"
          xlink:label="FFact_0000000000833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000833"
          xlink:to="FN20240224222832702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000834"
          xlink:label="FFact_0000000000834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000834"
          xlink:to="FN20240224222832702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000835"
          xlink:label="FFact_0000000000835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000835"
          xlink:to="FN20240224222832702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000836"
          xlink:label="FFact_0000000000836"
          xlink:type="locator"/>
        <link:footnote id="FN20240224223024526" xlink:label="FN20240224223024526" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">	 Represents warrants that were issued to the placement agent as compensation for its role in the Company&#x2019;s September 2021 registered direct offering.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000836"
          xlink:to="FN20240224223024526"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000837"
          xlink:label="FFact_0000000000837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000837"
          xlink:to="FN20240224223024526"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000838"
          xlink:label="FFact_0000000000838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000838"
          xlink:to="FN20240224223024526"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000839"
          xlink:label="FFact_0000000000839"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000839"
          xlink:to="FN20240224223024526"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000416"
          xlink:label="FFact_0000000000416"
          xlink:type="locator"/>
        <link:footnote id="FN20240224211802328" xlink:label="FN20240224211802328" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Balance presented net of unrecognized revenue that was not yet collected.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000416"
          xlink:to="FN20240224211802328"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000417"
          xlink:label="FFact_0000000000417"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000417"
          xlink:to="FN20240224211802328"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000418"
          xlink:label="FFact_0000000000418"
          xlink:type="locator"/>
        <link:footnote id="FN20240224211739424" xlink:label="FN20240224211739424" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">$401 thousands of the December 31, 2022 deferred revenue balance was recognized as revenue during the year ended December 31, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000418"
          xlink:to="FN20240224211739424"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000418"
          xlink:to="FN20240224211802328"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000419"
          xlink:label="FFact_0000000000419"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000419"
          xlink:to="FN20240224211739424"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000419"
          xlink:to="FN20240224211802328"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000446"
          xlink:label="FFact_0000000000446"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000446"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_0000000000448"
          xlink:label="FFact_0000000000448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_0000000000448"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213122445435"
          xlink:label="Fxbrl_20230213122445435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213122445435"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230213122457908"
          xlink:label="Fxbrl_20230213122457908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230213122457908"
          xlink:to="FN20230213122658952"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
